{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "8c4294ba-55d4-441a-a141-dd8fa03a1cc1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Generated query: (((Dohna-Schwake Christian[Author]) AND (\"2019\"[Date - Publication] : \"3000\"[Date - Publication])) OR ((Dohna Schwake Christian[Author]) AND (\"2019\"[Date - Publication] : \"3000\"[Date - Publication])) OR ((dohna-schwake c) AND (\"2019\"[Date - Publication] : \"3000\"[Date - Publication])) OR (Bruns Nora[Author]) OR (bruns n essen) OR (Schwarz Simone[Author]) OR (Goretzki Sarah[Author]) OR (Goretzki Sarah Charlotte[Author]) OR (Goretzki S) OR (Goretzki) OR (Greve Sandra[Author]) OR (Brensing Pia[Author]) OR (Paul Luisa[Author]) OR (Hojeij Rayan[Author]) OR (\"German Neonatal Network\"[Corporate Author]) OR (\"GNN\"[Corporate Author]))\n",
      "First retrieving 2 specific PMIDs...\n",
      "Retrieved 2 specific publications\n",
      "Searching PubMed for: (((Dohna-Schwake Christian[Author]) AND (\"2019\"[Date - Publication] : \"3000\"[Date - Publication])) OR ((Dohna Schwake Christian[Author]) AND (\"2019\"[Date - Publication] : \"3000\"[Date - Publication])) OR ((dohna-schwake c) AND (\"2019\"[Date - Publication] : \"3000\"[Date - Publication])) OR (Bruns Nora[Author]) OR (bruns n essen) OR (Schwarz Simone[Author]) OR (Goretzki Sarah[Author]) OR (Goretzki Sarah Charlotte[Author]) OR (Goretzki S) OR (Goretzki) OR (Greve Sandra[Author]) OR (Brensing Pia[Author]) OR (Paul Luisa[Author]) OR (Hojeij Rayan[Author]) OR (\"German Neonatal Network\"[Corporate Author]) OR (\"GNN\"[Corporate Author]))\n",
      "Found 453 articles via query\n",
      "Retrieving details for 451 additional articles...\n",
      "  Fetching batch 1 of 1 (451 articles)...\n",
      "Total publications found: 453\n",
      "Results saved to index.md\n"
     ]
    },
    {
     "data": {
      "text/markdown": [
       "---\n",
       "type: page\n",
       "title: Publications by our lab members\n",
       "---\n",
       "\n",
       "## 2025\n",
       "\n",
       "* **The Phoenix Sepsis Score in Pediatric Oncology Patients With Sepsis at PICU Admission: Test of Performance in a European Multicenter Cohort, 2018-2020.**  \n",
       "  Wosten-van Asperen RM, la Roi-Teeuw HM, Tissing WJE, Jordan I, **Dohna-Schwake C**, Bottari G, Pappachan J, Crazzolara R, Amigoni A, Mizia-Malarz A, Moscatelli A, Sanchez-Martin M, Willems J, Schlapbach LJ. *Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 26(2):e177-e185*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39982155/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Structure and Dynamics of Macrophage Infectivity Potentiator Proteins from Pathogenic Bacteria and Protozoans Bound to Fluorinated Pipecolic Acid Inhibitors.**  \n",
       "  Perez Carrillo VH, Whittaker JJ, Wiedemann C, Harder JM, Lohr T, Jamithireddy AK, Dajka M, **Goretzki B**, Joseph B, Guskov A, Harmer NJ, Holzgrabe U, Hellmich UA. *Journal of medicinal chemistry, 68(5):5926-5941*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39976355/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Ultrasound Super-Resolution Imaging of Neonatal Cerebral Vascular Reorganization.**  \n",
       "  **Schwarz S**, Denis L, Nedoschill E, Buehler A, Danko V, Hilger AC, Brevis Nunez F, Durr NR, Schlunz-Hendann M, Brassel F, Felderhoff-Muser U, Reutter H, Woelfle J, Jungert J, **Dohna-Schwake C**, **Bruns N**, Regensburger AP, Couture O, Mandelbaum H, Knieling F. *Advanced science (Weinheim, Baden-Wurttemberg, Germany):e2415235*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39899647/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Performance of ICD-10-based injury severity scores in pediatric trauma patients using the ICD-AIS map and survival rate ratios.**  \n",
       "  **Hojeij R**, **Brensing P**, Nonnemacher M, Kowall B, Felderhoff-Muser U, Dudda M, **Dohna-Schwake C**, Stang A, **Bruns N**. *Journal of clinical epidemiology, 178:111634*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39647538/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Severity of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 Diminished During Successive Waves of the COVID-19 Pandemic: Data from a Nationwide German Survey.**  \n",
       "  Lohrmann F, Doenhardt M, Diffloth N, Jakob A, Hospach A, Schneider DT, Trotter A, Brunner J, **Goretzki S**, Arens S, Rank M, Mauer R, Armann J, Berner R, Hufnagel M. *The Journal of pediatrics, 278:114419*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39603520/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Management and outcome of cutaneous diphtheria in adolescent refugees in Germany, June 2022 - October 2023.**  \n",
       "  Zink A, Hofer J, Schneider C, Kessler F, Klenze H, Klauwer D, Maleki K, Muller A, **Goretzki S**, Wang S, Kobbe R, Ramirez AV, Bode S, Janda A, Fressle R, Remppis J, Henneke P, Rieg S, Berger A, Sing A, Hufnagel M, Spielberger BD. *Infection, 53(1):329-337*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39190269/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **An [illustrative] update on pediatric emergency medicine ultrasound: part 2 - abdominal and urogenital applications.**  \n",
       "  Dong Y, Hoffmann B, **Schwarz S**, Nourkami-Tutdibi N, Huang YL, Chen S, Cekuolis A, Augustiniene R, Snelling PJ, Schreiber-Dietrich D, Grevelding L, Dietrich CF. *Medical ultrasonography, 27(1):63-72*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39078993/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2024\n",
       "\n",
       "* **Dual BACH1 regulation by complementary SCF-type E3 ligases.**  \n",
       "  **Goretzki B**, Khoshouei M, Schroder M, Penner P, Egger L, Stephan C, Argoti D, Dierlamm N, Rada JM, Kapps S, Muller CS, Thiel Z, Mutlu M, Tschopp C, Furkert D, Freuler F, Haenni S, Tenaillon L, Knapp B, Hinniger A, Hoppe P, Schmidt E, Gutmann S, Iurlaro M, Ryzhakov G, Fernandez C. *Cell, 187(26):7585-7602.e25*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39657677/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Case report: Acute liver failure during deferasirox therapy and the potential role of pharmacogenetics.**  \n",
       "  Garcia-Farina B, Rink L, Santarini V, Westkemper M, **Dohna-Schwake C**, Mohlendick B. *Frontiers in pharmacology, 15:1477755*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39508042/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Ultrasound Localization Microscopy for the Assessment of Microvascular Circulation in Ischemic Perinatal Stroke.**  \n",
       "  Regensburger AP, Wachter F, Denis L, Mandelbaum H, Schey F, Buehler A, Siebenlist G, **Schwarz S**, Schulz-Heise S, Rompel O, Trollmann R, Woelfle J, Jungert J, Couture O, Reutter H, Hanslik G, Knieling F. *Stroke, 55(12):e323-e325*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39474686/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **The effect of live-performed music therapy with physical contact in preterm infants on parental perceived stress and salivary cortisol levels.**  \n",
       "  Dewan MV, Ader M, Kleinbeck T, Dathe AK, Schedlowski M, Engler H, Felderhoff-Mueser U, **Bruns N**, Kobus S. *Frontiers in psychology, 15:1441824*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39434912/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **How to perform Point of Care Ultrasound at resuscitation and when it is useful.**  \n",
       "  Wastl D, Blaivas M, Horn R, Michels G, Seibel A, **Schwarz S**, Hoffmann BH, Hoffmann O, Von Ow D, Dietrich CF. *Medical ultrasonography*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39420822/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **An [illustrative] update on pediatric emergency ultrasound: part 3 - cerebral, musculoskeletal and other applications.**  \n",
       "  **Schwarz S**, Dong Y, Snelling PJ, Hoffmann B, Nourkami-Tutdibi N, Huang YL, Chen S, Cekuolis A, Augustiniene R, Schreiber-Dietrich D, Grevelding L, Dietrich CF. *Medical ultrasonography*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39420818/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Telemedicine-based antibiotic stewardship program in pediatrics: study protocol of a stepped wedge cluster randomized trial-the TeleKasper study.**  \n",
       "  Diexer S, Ihling A, Gomes D, Moritz S, Simon A, **Dohna-Schwake C**, Mikolajczyk R, Huebner J, von Both U. *Trials, 25(1):678*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39402608/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Characterization of the Immune-Modulating Properties of Different beta-Glucans on Myeloid Dendritic Cells.**  \n",
       "  Rainer H, **Goretzki A**, Lin YJ, Schiller HR, Krause M, Doring S, Strecker D, Junker AC, Wolfheimer S, Toda M, Scheurer S, Schulke S. *International journal of molecular sciences, 25(18)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39337403/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Oxadiazolines as Photoreleasable Labels for Drug Target Identification.**  \n",
       "  Bon C, **Goretzki B**, Flamme M, Shelton C, Davis H, Lima F, Garcia F, Brittain S, Brocklehurst CE. *Journal of the American Chemical Society, 146(39):26759-26765*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39288302/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Emergency surgery influences oncological outcome in small intestinal neuroendocrine tumors.**  \n",
       "  Butz F, Supper L, Reinhard L, Dukaczewska A, Jann H, Fehrenbach U, Muller-Debus CF, Skachko T, Pratschke J, **Goretzki PE**, Mogl MT, Dobrindt EM. *Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society, 113(4):303-313*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39230104/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Feasibility, efficacy, and safety of animal-assisted activities with visiting dogs in inpatient pediatric oncology.**  \n",
       "  Steff K, Grasemann M, Ostermann K, **Goretzki SC**, Rath PM, Reinhardt D, Schundeln MM. *World journal of pediatrics : WJP, 20(9):915-924*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39112809/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Neonatal Sepsis Episodes and Retinopathy of Prematurity in Very Preterm Infants.**  \n",
       "  Glaser K, Hartel C, Klingenberg C, Herting E, Fortmann MI, Speer CP, Stensvold HJ, Huncikova Z, Ronnestad AE, Nentwich MM, Stahl A, Dammann O, Gopel W. *JAMA network open, 7(7):e2423933*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39052290/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Surgical Site Infections After Pediatric Liver Transplantation-Impact of a Change in Perioperative Prophylactic Antibiotic Protocol.**  \n",
       "  **Bruns N**, Hauschild J, Lainka E, **Dohna-Schwake C**. *Pediatric transplantation, 28(5):e14830*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39030994/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Short-term outcomes of asphyxiated neonates depending on requirement for transfer in the first 24 h of life.**  \n",
       "  **Bruns N**, Feddahi N, **Hojeij R**, Rossi R, **Dohna-Schwake C**, Stein A, Kobus S, Stang A, Kowall B, Felderhoff-Muser U. *Resuscitation, 202:110309*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/39002696/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **The effect of live music therapy on white matter microstructure in very preterm infants - A randomized controlled trial.**  \n",
       "  Dewan MV, Jungilligens J, Kobus S, Diezel M, Dathe AK, Schweiger B, Huning B, Felderhoff-Muser U, **Bruns N**. *European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 51:132-139*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38941879/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Cerebral Doppler imaging in neonates: A guide for clinical application and diagnosis.**  \n",
       "  Horsch S, **Schwarz S**, Arnaez J, Steggerda S, Arena R, Govaert P. *Developmental medicine and child neurology, 66(12):1570-1589*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38940604/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Association of bilaterally suppressed EEG amplitudes and outcomes in critically ill children.**  \n",
       "  **Paul L**, **Greve S**, Hegemann J, Gienger S, Loffelhardt VT, Della Marina A, Felderhoff-Muser U, **Dohna-Schwake C**, **Bruns N**. *Frontiers in neuroscience, 18:1411151*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38903601/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Position statement on genuine physiotherapy research at German university hospitals.**  \n",
       "  Klotz SGR, Bokel A, Friderichs-Nedohibchenko M, Stickdorn I, Vogel B, Doods B, Feldmann F, Ghiazza M, Giehl M, Hoberg A, Jansen L, Kohlhofer D, Leonhardt R, Meier SF, Muller C, Pannzek M, **Schwarz S**, Traut M, Urdahl M. *German medical science : GMS e-journal, 22:Doc06*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38883338/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Small molecule induced STING degradation facilitated by the HECT ligase HERC4.**  \n",
       "  Mutlu M, Schmidt I, Morrison AI, **Goretzki B**, Freuler F, Begue D, Simic O, Pythoud N, Ahrne E, Kapps S, Roest S, Bonenfant D, Jeanpierre D, Tran TT, Maher R, An S, Rietsch A, Nigsch F, Hofmann A, Reece-Hoyes J, Parker CN, Guerini D. *Nature communications, 15(1):4584*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38811577/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **An [illustrative] update on pediatric emergency medicine ultrasound: part 1 - trauma and thoracic applications.**  \n",
       "  Dong Y, **Schwarz S**, Hoffmann B, Nourkami-Tutdibi N, Huang YL, Chen S, Cekuolis A, Augustiniene R, Snelling PJ, Schreiber-Dietrich D, Grevelding L, Dietrich CF. *Medical ultrasonography, 26(4):393-404*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38805622/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Effects of an early transfer from incubator to a warming crib in very low birthweight preterm infants.**  \n",
       "  **Greve S**, **Bruns N**, Dathe AK, Schuendeln MM, Felderhoff-Mueser U, Stein A. *BMC pediatrics, 24(1):319*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38724933/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **COMFORTneo scale in preterm infants during live performed music therapy-Difference between close physical contact and hand touch contact.**  \n",
       "  Kobus S, Kleinbeck T, Ader M, Dewan MV, Dathe AK, Feddahi N, Felderhoff-Mueser U, **Bruns N**. *Frontiers in neuroscience, 18:1359769*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38606306/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Correlation of Comfort Score and Narcotrend Index during Procedural Sedation with Midazolam and Propofol in Children.**  \n",
       "  **Bruns N**, Joist CA, Joist CM, Daniels A, Felderhoff-Muser U, **Dohna-Schwake C**, Tschiedel E. *Journal of clinical medicine, 13(5)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38592307/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Adaption of Follow-Up Visits for Preterm and High-Risk Children for Video Consultations.**  \n",
       "  Dathe AK, **Greve S**, Teschler U, Heuser-Spura KM, Cordier L, Albayrak B, Felderhoff-Mueser U, Huening BM. *Telemedicine journal and e-health : the official journal of the American Telemedicine Association, 30(7):e2004-e2012*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38466975/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Pediatric Community-Acquired Brain Abscesses: A Single-center Retrospective Study.**  \n",
       "  Lu KH, **Bruns N**, Pentek C, Della Marina A, Gangfuss A, Kolbel H, Dogan B, Dziobaka J, Ahmadipour Y, Damman P, Felderhoff-Muser U, **Dohna-Schwake C**, **Goretzki SC**. *The Pediatric infectious disease journal, 43(6):e214-e217*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38451881/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Current practice of intracranial pressure monitoring in children with severe traumatic brain injury-a nationwide prospective surveillance study in Germany.**  \n",
       "  **Brensing P**, **Greve S**, **Hojeij R**, Dammann P, Felderhoff-Muser U, **Dohna-Schwake C**, **Bruns N**. *Frontiers in pediatrics, 12:1355771*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38405592/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Outbreak of severe community-acquired bacterial infections among children in North Rhine-Westphalia (Germany), October to December 2022.**  \n",
       "  **Goretzki SC**, van der Linden M, Itzek A, Huhne T, Adelmann RO, Ala Eldin F, Albarouni M, Becker JC, Berghauser MA, Boesing T, Boeswald M, Brasche M, Brevis Nunez F, Camara R, Deibert C, Dohle F, Dolgner J, Dziobaka J, Eifinger F, Elting N, Endmann M, Engelmann G, Frenzke H, Gappa M, Gharavi B, Goletz C, Hahn E, Heidenreich Y, Heimann K, Hensel KO, Hoffmann HG, Hoppenz M, Horneff G, Klassen H, Koerner-Rettberg C, Langler A, Lenz P, Lohmeier K, Muller A, Niemann F, Paulussen M, Pentek F, Perez R, Pingel M, Repges P, Rothoeft T, Rubo J, Schade H, Schmitz R, Schonhoff P, Schwade JN, Schwarz T, Seiffert P, Selzer G, Spille U, Thiel C, Thimm A, Urgatz B, van den Heuvel A, van Hop T, Giesen V, Wirth S, Wollbrink T, Wuller D, Felderhoff-Muser U, **Dohna-Schwake C**, Lam TT, Claus H, **Bruns N**. *Infection, 52(3):1099-1111*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38366304/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Morphological chest CT changes in cystic fibrosis and massive hemoptysis.**  \n",
       "  Dohna M, Kuhl H, Sutharsan S, **Bruns N**, Vo Chieu VD, Hellms S, Kornemann N, Montag MJ. *Radiologie (Heidelberg, Germany), 64(Suppl 1):76-85*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38326635/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Influence of Lymphatic, Microvascular and Perineural Invasion on Oncological Outcome in Patients with Neuroendocrine Tumors of the Small Intestine.**  \n",
       "  Butz F, Dukaczewska A, Kunze CA, Kromer JM, Reinhard L, Jann H, Fehrenbach U, Muller-Debus CF, Skachko T, Pratschke J, **Goretzki PE**, Mogl MT, Dobrindt EM. *Cancers, 16(2)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38254794/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Clinical recommendations for the inpatient management of lower respiratory tract infections in children and adolescents with severe neurological impairment in Germany.**  \n",
       "  Mauritz MD, von Both U, **Dohna-Schwake C**, Gille C, Hasan C, Huebner J, Hufnagel M, Knuf M, Liese JG, Renk H, Rudolph H, Schulze-Sturm U, Simon A, Stehling F, Tenenbaum T, Zernikow B. *European journal of pediatrics, 183(3):987-999*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38172444/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Increased rate of complications of pediatric acute otitis media and sinusitis in 2022/2023].**  \n",
       "  Voss N, Sadok N, **Goretzki S**, **Dohna-Schwake C**, Meyer MF, Mattheis S, Lang S, Stahr K. *HNO, 72(2):83-89*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38108853/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Targeted PCR of Mucorales in pediatric bronchoalveolar lavage samples indicates low prevalence of airway colonization and sample contamination.**  \n",
       "  Kavvalou A, Stehling F, **Goretzki SC**, **Dohna-Schwake C**, Rath PM, Steindor M. *Infectious diseases (London, England), 56(3):255-258*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38015560/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Endoscopic ultrasound-guided ethanol ablation versus surgical resection of insulinomas.**  \n",
       "  Jurgensen C, Eckart M, Haberbosch L, Tacke F, Sandforth A, Birkenfeld AL, Overkamp D, Daniels M, Mogl M, **Goretzki P**, Strasburger C, Mai K, Spranger J, Jumpertz von Schwartzenberg R. *Ultraschall in der Medizin (Stuttgart, Germany : 1980), 45(5):519-527*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37931914/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Aortic Steal Correlates with Acute Organ Dysfunction and Short-Term Outcomes in Neonates with Vein of Galen Malformation.**  \n",
       "  **Schwarz S**, Brevis Nunez F, Durr NR, Schlunz-Hendann M, Brassel F, Felderhoff-Muser U, **Dohna-Schwake C**, **Bruns N**. *Neonatology, 121(1):106-115*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37906988/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2023\n",
       "\n",
       "* **A comparison of pediatric inflammatory multisystem syndrome temporarily-associated with SARS-CoV-2 and Kawasaki disease.**  \n",
       "  Hufnagel M, Armann J, Jakob A, Doenhardt M, Diffloth N, Hospach A, Schneider DT, Trotter A, Roessler M, Schmitt J, Berner R. *Scientific reports, 13(1):1173*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36670127/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Pediatric intensive care unit admissions network-rationale, framework and method of operation of a nationwide collaborative pediatric intensive care research network in Germany.**  \n",
       "  **Bruns N**, **Dohna-Schwake C**, Olivieri M, Urschitz MS, Blomenkamp S, Frosch C, Lieftuchter V, Tomidis Chatzimanouil MK, Hoffmann F, Brenner S. *Frontiers in pediatrics, 11:1254935*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38269291/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Increased SARS-CoV-2 reactive low avidity T cells producing inflammatory cytokines in pediatric post-acute COVID-19 sequelae (PASC).**  \n",
       "  Paniskaki K, **Goretzki S**, Anft M, Konik MJ, Meister TL, Pfaender S, Lechtenberg K, Vogl M, Dogan B, Dolff S, Westhoff TH, Rohn H, Felderhoff-Mueser U, Stervbo U, Witzke O, **Dohna-Schwake C**, Babel N. *Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 34(12):e14060*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38146118/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Review on Pediatric Malignant Focal Liver Lesions with Imaging Evaluation: Part II.**  \n",
       "  Dong Y, Cekuolis A, Schreiber-Dietrich D, Augustiniene R, **Schwarz S**, Moller K, Nourkami-Tutdibi N, Chen S, Cao JY, Huang YL, Wang Y, Taut H, Grevelding L, Dietrich CF. *Diagnostics (Basel, Switzerland), 13(24)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38132242/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Determinants of human papillomavirus vaccine hesitancy among Lebanese parents.**  \n",
       "  Zakhour R, Tamim H, Faytrouni F, Makki M, **Hojeij R**, Charafeddine L. *PloS one, 18(12):e0295644*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38091310/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Review on Pediatric Malignant Focal Liver Lesions with Imaging Evaluation: Part I.**  \n",
       "  Dong Y, Cekuolis A, Schreiber-Dietrich D, Augustiniene R, **Schwarz S**, Moller K, Nourkami-Tutdibi N, Chen S, Cao JY, Huang YL, Wang Y, Taut H, Grevelding L, Dietrich CF. *Diagnostics (Basel, Switzerland), 13(23)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/38066809/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents.**  \n",
       "  Paniskaki K, **Goretzki S**, Anft M, Konik MJ, Lechtenberg K, Vogl M, Meister TL, Pfaender S, Zettler M, Jager J, Dolff S, Westhoff TH, Rohn H, Felderhoff-Mueser U, Stervbo U, Witzke O, **Dohna-Schwake C**, Babel N. *BMC infectious diseases, 23(1):818*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37993788/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Music therapy modulates mothers' perception of their preterm infants.**  \n",
       "  Kobus S, Diezel M, Dewan MV, Huening B, Dathe AK, Marschik PB, Felderhoff-Mueser U, **Bruns N**. *Frontiers in psychology, 14:1231741*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37928582/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Distinct clinical phenotypes in paediatric cancer patients with sepsis are associated with different outcomes-an international multicentre retrospective study.**  \n",
       "  Wosten-van Asperen RM, la Roi-Teeuw HM, van Amstel RB, Bos LD, Tissing WJ, Jordan I, **Dohna-Schwake C**, Bottari G, Pappachan J, Crazzolara R, Comoretto RI, Mizia-Malarz A, Moscatelli A, Sanchez-Martin M, Willems J, Rogerson CM, Bennett TD, Luo Y, Atreya MR, Faustino EVS, Geva A, Weiss SL, Schlapbach LJ, Sanchez-Pinto LN. *EClinicalMedicine, 65:102252*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37842550/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Time to Antibiotics (TTA) - Reassessment from the German Working Group for Fever and Neutropenia in Children and Adolescents (DGPI/GPOH)].**  \n",
       "  Simon A, Lehrnbecher T, Baltaci Y, **Dohna-Schwake C**, Groll A, Laws HJ, Potratz J, Hufnagel M, Bochennek K. *Klinische Padiatrie, 235(6):331-341*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37751768/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Erythrocyte transfusions are associated with retinopathy of prematurity in extremely low gestational age newborns.**  \n",
       "  Glaser K, Hartel C, Dammann O, Herting E, Andres O, Speer CP, Gopel W, Stahl A. *Acta paediatrica (Oslo, Norway : 1992), 112(12):2507-2515*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37667535/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Legionella pneumophila macrophage infectivity potentiator protein appendage domains modulate protein dynamics and inhibitor binding.**  \n",
       "  Wiedemann C, Whittaker JJ, Perez Carrillo VH, **Goretzki B**, Dajka M, Tebbe F, Harder JM, Krajczy PR, Joseph B, Hausch F, Guskov A, Hellmich UA. *International journal of biological macromolecules, 252:126366*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37633566/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Outcome after conservative or surgical treatment for new-onset epilepsy in children with cerebral cavernous malformation.**  \n",
       "  Santos AN, Rauschenbach L, Riess C, Georgiades I, Ficilar B, Gallardo EG, Quesada CM, Li Y, Tippelt S, **Dohna-Schwake C**, Schmidt B, Jabbarli R, Siegel AM, Benet A, Wrede KH, Sure U, Dammann P. *Seizure, 111:23-29*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37494759/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Early Prediction of Mortality after Birth Asphyxia with the nSOFA.**  \n",
       "  Dathe AK, Stein A, **Bruns N**, Craciun ED, Tuda L, Bialas J, Brasseler M, Felderhoff-Mueser U, Huening BM. *Journal of clinical medicine, 12(13)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37445355/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Crosstalk between regulatory elements in disordered TRPV4 N-terminus modulates lipid-dependent channel activity.**  \n",
       "  **Goretzki B**, Wiedemann C, McCray BA, Schafer SL, Jansen J, Tebbe F, Mitrovic SA, Noth J, Cabezudo AC, Donohue JK, Jeffries CM, Steinchen W, Stengel F, Sumner CJ, Hummer G, Hellmich UA. *Nature communications, 14(1):4165*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37443299/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Prognostic differences in grading and metastatic lymph node pattern in patients with small bowel neuroendocrine tumors.**  \n",
       "  Reinhard L, Mogl MT, Benz F, Dukaczewska A, Butz F, Dobrindt EM, Tacke F, Pratschke J, **Goretzki PE**, Jann H. *Langenbeck's archives of surgery, 408(1):237*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37332044/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Development of an Ultrasound Scoring System to Describe Brain Maturation in Preterm Infants.**  \n",
       "  Stein A, Sody E, **Bruns N**, Felderhoff-Muser U. *AJNR. American journal of neuroradiology, 44(7):846-852*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37321856/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Special features of the diagnostics and treatment of hereditary primary hyperparathyroidism].**  \n",
       "  Mogl MT, **Goretzki PE**. *Chirurgie (Heidelberg, Germany), 94(7):586-594*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37291366/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Doppler Ultrasound Flow Reversal in the Superior Sagittal Sinus to Detect Cerebral Venous Congestion in Vein of Galen Malformation.**  \n",
       "  **Schwarz S**, Brevis Nunez F, Durr NR, Brassel F, Schlunz-Hendann M, Feldkamp A, Rosenbaum T, Felderhoff-Muser U, Schulz K, **Dohna-Schwake C**, **Bruns N**. *AJNR. American journal of neuroradiology, 44(6):707-715*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37230540/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Surgical Approach to Liver Metastases in GEP-NET in a Tertiary Reference Center.**  \n",
       "  Butz F, Dukaczewska A, Jann H, Dobrindt EM, Reinhard L, Lurje G, Pratschke J, **Goretzki PE**, Schoning W, Mogl MT. *Cancers, 15(7)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37046708/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **A flagellin-conjugate protein induces dual NLRC4- and NLRP3-inflammasome activation which modulates inflammatory cytokine secretion from macrophages.**  \n",
       "  Lin YJ, Jamin A, Wolfheimer S, Fiedler A, Junker AC, **Goretzki A**, Scheurer S, Schulke S. *Frontiers in immunology, 14:1136669*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/37026001/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Giant Cavernous Malformation Mimicking an Infiltrative Intracranial Neoplasm in Children-Case Report and Systematic Review of the Literature.**  \n",
       "  Gonzalez-Gallardo E, Rauschenbach L, Santos AN, Riess C, Li Y, Tippelt S, Della Marina A, **Dohna-Schwake C**, Sure U, Dammann P. *World neurosurgery, 174:30-41*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36889633/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **High Prevalence of Alternative Diagnoses in Children and Adolescents with Suspected Long COVID-A Single Center Cohort Study.**  \n",
       "  **Goretzki SC**, Brasseler M, Dogan B, Huhne T, Bernard D, Schonecker A, Steindor M, Gangfuss A, Della Marina A, Felderhoff-Muser U, **Dohna-Schwake C**, **Bruns N**. *Viruses, 15(2)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36851793/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **A European International Multicentre Survey on the Current Practice of Perioperative Antibiotic Prophylaxis for Paediatric Liver Transplantations.**  \n",
       "  Hauschild J, **Bruns N**, Lainka E, **Dohna-Schwake C**. *Antibiotics (Basel, Switzerland), 12(2)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36830202/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Functional outcome after initial and multiple intracerebral hemorrhages in children with cerebral cavernous malformations.**  \n",
       "  Santos AN, Rauschenbach L, Gull HH, Dinger TF, Chihi M, Li Y, Tippelt S, **Dohna-Schwake C**, Schmidt B, Jabbarli R, Wrede KH, Sure U, Dammann P. *European journal of neurology, 30(5):1364-1370*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36789485/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **IgD shapes the pre-immune naive B cell compartment in humans.**  \n",
       "  Dirks J, Andres O, **Paul L**, Manukjan G, Schulze H, Morbach H. *Frontiers in immunology, 14:1096019*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36776874/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Functional outcome after pediatric cerebral cavernous malformation surgery.**  \n",
       "  Rauschenbach L, Santos AN, Dinger TF, Darkwah Oppong M, Li Y, Tippelt S, **Dohna-Schwake C**, Schmidt B, Jabbarli R, Wrede KH, Sure U, Dammann P. *Scientific reports, 13(1):2286*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36759693/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Pulmonary Sonography - Neonatal Diagnosis Part 2.**  \n",
       "  **Schwarz S**. *Ultraschall in der Medizin (Stuttgart, Germany : 1980), 44(3):240-268*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36669528/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Pediatric neurocritical care].**  \n",
       "  **Bruns N**, Schara-Schmidt U, **Dohna-Schwake C**. *Der Nervenarzt, 94(2):75-83*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36645451/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Re: \"Watch Out for Drug-Induced Coma and Burst Suppression Pattern in Infants and Children Mimicking Severe Neurological Disease\" by Falsaperla et al.**  \n",
       "  **Bruns N**. *Therapeutic hypothermia and temperature management, 13(1):42-43*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36576494/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment - Cell Type-Specific Findings (Part 2).**  \n",
       "  Lin YJ, **Goretzki A**, Rainer H, Zimmermann J, Schulke S. *Current allergy and asthma reports, 23(1):41-52*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36520269/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment - Disease-Specific Findings (Part 1).**  \n",
       "  **Goretzki A**, Zimmermann J, Rainer H, Lin YJ, Schulke S. *Current allergy and asthma reports, 23(1):29-40*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36441389/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Feasibility of Video Consultation for Preterm Neurodevelopmental Follow-up Care During the COVID-19 Pandemic: Cohort Study.**  \n",
       "  Albayrak B, Cordier LJ, **Greve S**, Teschler U, Dathe AK, Felderhoff-Muser U, Huning BM. *JMIR pediatrics and parenting, 6:e40940*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36409307/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Stimulation of naive B cells with a fusion protein consisting of FlaA and Bet v 1 induces regulatory B cells ex vivo.**  \n",
       "  **Goretzki A**, Lin YJ, Meier C, Dorn B, Wolfheimer S, Jamin A, Schott M, Wangorsch A, Vieths S, Jakob T, Scheurer S, Schulke S. *Allergy, 78(3):663-681*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36196479/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Pulmonary Sonography - Neonatal Diagnosis Part 1.**  \n",
       "  **Schwarz S**. *Ultraschall in der Medizin (Stuttgart, Germany : 1980), 44(1):14-35*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36075237/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Surgery of hyperparathyroidism].**  \n",
       "  Mogl MT, **Goretzki PE**. *Chirurgie (Heidelberg, Germany), 94(2):177-188*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35925141/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Dissection of the Brachiocephalic Trunk with Subsequent Occlusion of Both Common Carotid Arteries in a Newborn with an Aortic Arch Variant - From Cerebral Doppler Ultrasound to Diagnosis.**  \n",
       "  **Schwarz S**, Tarusinov G, Brevis F. *Ultraschall in der Medizin (Stuttgart, Germany : 1980), 44(3):e164-e167*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35211943/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2022\n",
       "\n",
       "* **Music Therapy in Preterm Infants Reduces Maternal Distress.**  \n",
       "  Kobus S, Diezel M, Dewan MV, Huening B, Dathe AK, Marschik PB, Felderhoff-Mueser U, **Bruns N**. *International journal of environmental research and public health, 20(1)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36613052/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Organizational characteristics of European pediatric onco-critical care: An international cross-sectional survey.**  \n",
       "  Nielsen JSA, Agbeko R, Bate J, Jordan I, **Dohna-Schwake C**, Potratz J, Moscatelli A, Bottari G, Pappachan J, Witt V, Crazzolara R, Amigoni A, Mizia-Malarz A, Sanchez Martin M, Willems J, van den Heuvel-Eibrink MM, Schlapbach LJ, Wosten-van Asperen RM. *Frontiers in pediatrics, 10:1024273*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36533247/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Development of restrictive eating disorders in children and adolescents with long-COVID-associated smell and taste dysfunction.**  \n",
       "  Brasseler M, Schonecker A, Steindor M, Della Marina A, **Bruns N**, Dogan B, Felderhoff-Muser U, Hebebrand J, **Dohna-Schwake C**, **Goretzki SC**. *Frontiers in pediatrics, 10:1022669*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36518782/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Next Generation Sequencing of Free Microbial DNA for Rapid Identification of Pathogens in Critically Ill Children with Systemic Inflammatory Response Syndrome (SIRS).**  \n",
       "  **Goretzki SC**, Schafer M, Dogan B, **Bruns N**, Tschiedel E, Rath PM, Voigt S, Grumaz S, Horvatek P, Schonberger S, Stehling F, Brenner T, **Dohna-Schwake C**. *Frontiers in bioscience (Landmark edition), 27(11):302*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36472101/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Bronchial artery diameter in massive hemoptysis in cystic fibrosis.**  \n",
       "  Dohna M, Kuhl H, Sutharsan S, **Dohna-Schwake C**, Vo Chieu VD, Hellms S, Kornemann N, Renz DM, Montag MJ. *BMC pulmonary medicine, 22(1):424*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36397043/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Recurrent Late-Onset Sepsis in Extremely Low Birth Weight Infants Is Associated with Motor Deficits in Early School Age.**  \n",
       "  Humberg A, Fortmann MI, Spiegler J, Rausch TK, Siller B, Silwedel C, Marissen J, Herting E, Gopel W, Hartel C. *Neonatology, 119(6):695-702*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36327925/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Role of Glycolysis and Fatty Acid Synthesis in the Activation and T Cell-Modulating Potential of Dendritic Cells Stimulated with a TLR5-Ligand Allergen Fusion Protein.**  \n",
       "  **Goretzki A**, Lin YJ, Zimmermann J, Rainer H, Junker AC, Wolfheimer S, Vieths S, Scheurer S, Schulke S. *International journal of molecular sciences, 23(20)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36293550/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Administrative data in pediatric critical care research-Potential, challenges, and future directions.**  \n",
       "  **Bruns N**, Sorg AL, Felderhoff-Muser U, **Dohna-Schwake C**, Stang A. *Frontiers in pediatrics, 10:1014094*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36245724/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **The Disordered MAX N-terminus Modulates DNA Binding of the Transcription Factor MYC:MAX.**  \n",
       "  Schutz S, Bergsdorf C, **Goretzki B**, Lingel A, Renatus M, Gossert AD, Jahnke W. *Journal of molecular biology, 434(22):167833*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36174765/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **The impact of age and electrode position on amplitude-integrated EEGs in children from 1 month to 17 years of age.**  \n",
       "  **Greve S**, Loffelhardt VT, Della Marina A, Felderhoff-Muser U, **Dohna-Schwake C**, **Bruns N**. *Frontiers in neurology, 13:952193*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36090865/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy.**  \n",
       "  Zimmermann J, **Goretzki A**, Meier C, Wolfheimer S, Lin YJ, Rainer H, Krause M, Wedel S, Spies G, Fuhrer F, Vieths S, Scheurer S, Schulke S. *Frontiers in immunology, 13:916491*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/36059475/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Sleep problems in infancy and early school age in very preterm infants.**  \n",
       "  Neitmann J, Hanke K, Humberg A, Siller B, Spiegler J, Juhnke K, Gilmore J, Odendahl R, Herting E, Gopel W, Hartel C, Fortmann I. *Early human development, 173:105656*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35987047/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Impact of Physical Contact on Preterm Infants' Vital Sign Response to Live Music Therapy.**  \n",
       "  Kobus S, Diezel M, Dewan MV, Huening B, Dathe AK, Felderhoff-Mueser U, **Bruns N**. *International journal of environmental research and public health, 19(15)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35954880/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation.**  \n",
       "  Hartel C, Herting E, Humberg A, Hanke K, Mehler K, Keller T, Mauer I, Frieauff E, Meyer S, Thome UH, Wieg C, Schmidtke S, Kribs A, Gopel W. *JAMA network open, 5(8):e2225810*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35943742/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Prevalence of osteopathologies in a single center cohort of survivors of childhood primary brain tumor.**  \n",
       "  Schundeln MM, Fritzemeier S, **Goretzki SC**, Hauffa PK, Munteanu M, Kiewert C, Hauffa BP, Fleischhack G, Tippelt S, Grasemann C. *Frontiers in pediatrics, 10:913343*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35923779/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Differentiated Strategies for the Therapy of Liver Metastases in Gastro-entero-pancreatic Neuroendocrine Neoplasia].**  \n",
       "  Mogl MT, Ollinger R, Jann H, Gebauer B, Fehrenbach U, Amthauer H, Wetz C, Schmelzle M, Raschzok N, Krenzien F, **Goretzki PE**, Pratschke J, Schoening W. *Zentralblatt fur Chirurgie, 147(3):270-280*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35705089/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Extent of intrinsic disorder and NMR chemical shift assignments of the distal N-termini from human TRPV1, TRPV2 and TRPV3 ion channels.**  \n",
       "  Wiedemann C, **Goretzki B**, Merz ZN, Tebbe F, Schmitt P, Hellmich UA. *Biomolecular NMR assignments, 16(2):289-296*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35666427/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Pediatric ICU Admissions After Adolescent Suicide Attempts During the Pandemic.**  \n",
       "  **Bruns N**, Willemsen L, Stang A, Kowall B, Holtkamp K, Kamp O, Dudda M, Hey F, Hoffmann F, Blankenburg J, Eifinger F, Fuchs H, Haase R, Baier J, Andree C, Heldmann M, Maldera V, Potratz J, Kurz D, Mand N, Doerfel C, Rothoeft T, Schultz M, Ohlert M, Silkenbaumer K, Boesing T, Indraswari F, Niemann F, Jahn P, Merker M, Braun N, Nunez FB, Engler M, Heimann K, Brasche M, Wolf G, Freymann H, Dercks M, Hoppenz M, Felderhoff-Muser U, **Dohna-Schwake C**. *Pediatrics, 150(2)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35534988/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Backbone NMR assignments of the extensive human and chicken TRPV4 N-terminal intrinsically disordered regions as important players in ion channel regulation.**  \n",
       "  **Goretzki B**, Tebbe F, Mitrovic SA, Hellmich UA. *Biomolecular NMR assignments, 16(2):205-212*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35451798/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Immune Metabolism-An Opportunity to Better Understand Allergic Pathology and Improve Treatment of Allergic Diseases?**  \n",
       "  **Goretzki A**, Zimmermann J, Lin YJ, Schulke S. *Frontiers in allergy, 3:825931*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35386646/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Impact of the First COVID Lockdown on Accident- and Injury-Related Pediatric Intensive Care Admissions in Germany-A Multicenter Study.**  \n",
       "  **Bruns N**, Willemsen LY, Holtkamp K, Kamp O, Dudda M, Kowall B, Stang A, Hey F, Blankenburg J, Sabir H, Eifinger F, Fuchs H, Haase R, Andree C, Heldmann M, Potratz J, Kurz D, Schumann A, Muller-Knapp M, Mand N, Doerfel C, Dahlem P, Rothoeft T, Ohlert M, Silkenbaumer K, Dohle F, Indraswari F, Niemann F, Jahn P, Merker M, Braun N, Brevis Nunez F, Engler M, Heimann K, Wolf GK, Wulf D, Hankel S, Freymann H, Allgaier N, Knirsch F, Dercks M, Reinhard J, Hoppenz M, Felderhoff-Muser U, **Dohna-Schwake C**. *Children (Basel, Switzerland), 9(3)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35327736/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Multiubiquitination of TRPV4 reduces channel activity independent of surface localization.**  \n",
       "  Aisenberg WH, McCray BA, Sullivan JM, Diehl E, DeVine LR, Alevy J, Bagnell AM, Carr P, Donohue JK, **Goretzki B**, Cole RN, Hellmich UA, Sumner CJ. *The Journal of biological chemistry, 298(4):101826*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35300980/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **TRPV4 mutations causing mixed neuropathy and skeletal phenotypes result in severe gain of function.**  \n",
       "  Taga A, Peyton MA, **Goretzki B**, Gallagher TQ, Ritter A, Harper A, Crawford TO, Hellmich UA, Sumner CJ, McCray BA. *Annals of clinical and translational neurology, 9(3):375-391*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35170874/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Role of extracorporeal membrane oxygenation in pediatric cancer patients: a systematic review and meta-analysis of observational studies.**  \n",
       "  Slooff V, Hoogendoorn R, Nielsen JSA, Pappachan J, Amigoni A, Caramelli F, Aziz O, Wildschut E, Verbruggen S, Crazzolara R, **Dohna-Schwake C**, Potratz J, Willems J, Llevadias J, Moscatelli A, Montaguti A, Bottari G, Di Nardo M, Schlapbach L, Wosten-van Asperen R. *Annals of intensive care, 12(1):8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35092500/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Hyperkalemia Following Parathyroidectomy in Patients with Renal Hyperparathyroidism-New Thresholds for Urgent Perioperative Dialysis.**  \n",
       "  Bures C, Uluk Y, Besmens M, Akca A, Dobrindt EM, Pratschke J, **Goretzki P**, Mogl M, Uluk D. *Journal of clinical medicine, 11(2)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35054103/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Breastfeeding and Readmission for Hyperbilirubinemia in Late Preterm and Term Infants in Beirut, Lebanon.**  \n",
       "  Hanin EA, Rayan H, Hani T, Taleb J, Dany AH, Lama C. *Indian pediatrics, 59(3):218-221*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/34969942/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Functional Short-Term Outcomes and Mortality in Children with Severe Traumatic Brain Injury: Comparing Decompressive Craniectomy and Medical Management.**  \n",
       "  **Bruns N**, Kamp O, Lange K, Lefering R, Felderhoff-Muser U, Dudda M, **Dohna-Schwake C**. *Journal of neurotrauma, 39(13-14):944-953*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/34877889/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Antibiotics in critically ill children-a narrative review on different aspects of a rational approach.**  \n",
       "  **Bruns N**, **Dohna-Schwake C**. *Pediatric research, 91(2):440-446*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/34873285/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Natural Course of Cerebral Cavernous Malformations in Children: A Five-Year Follow-Up Study.**  \n",
       "  Santos AN, Rauschenbach L, Saban D, Chen B, Herten A, Dinger TF, Li Y, Tippelt S, Della Marina A, **Dohna-Schwake C**, Schmidt B, Jabbarli R, Wrede KH, Sure U, Dammann P. *Stroke, 53(3):817-824*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/34706565/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Association of ApoE Genotypes and Recovery From Intracerebral Hemorrhage in Very Low Birth Weight Infants.**  \n",
       "  Humberg A, Dzietko M, Schulz S, Felderhoff-Muser U, Huning B, Stein A, Fortmann MI, Marissen J, Rausch TK, Herting E, Hartel C, Gopel W. *Stroke, 53(2):514-522*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/34619984/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Latency duration of preterm premature rupture of membranes and neonatal outcome: a retrospective single-center experience.**  \n",
       "  Muller H, Stahling AC, **Bruns N**, Weiss C, Ai M, Koninger A, Felderhoff-Muser U. *European journal of pediatrics, 181(2):801-811*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/34605998/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2021\n",
       "\n",
       "* **What if... I Asked Cancer Patients About Psychological Distress? Barriers in Psycho-Oncological Screening From the Perspective of Nurses-A Qualitative Analysis.**  \n",
       "  Dreismann L, **Goretzki A**, Ginger V, Zimmermann T. *Frontiers in psychiatry, 12:786691*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35153856/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Characterization of aEEG During Sleep and Wakefulness in Healthy Children.**  \n",
       "  Loffelhardt VT, Della Marina A, **Greve S**, Muller H, Felderhoff-Muser U, **Dohna-Schwake C**, **Bruns N**. *Frontiers in pediatrics, 9:773188*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/35127587/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **The Fusion Protein rFlaA:Betv1 Modulates DC Responses by a p38-MAPK and COX2-Dependent Secretion of PGE(2) from Epithelial Cells.**  \n",
       "  Lin YJ, Flaczyk A, Wolfheimer S, **Goretzki A**, Jamin A, Wangorsch A, Vieths S, Scheurer S, Schulke S. *Cells, 10(12)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/34943923/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Immune Metabolism of IL-4-Activated B Cells and Th2 Cells in the Context of Allergic Diseases.**  \n",
       "  Lin YJ, **Goretzki A**, Schulke S. *Frontiers in immunology, 12:790658*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/34925372/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Parents' Perception of Family-Centered Music Therapy with Stable Preterm Infants.**  \n",
       "  Kobus S, Diezel M, Huening B, Dewan MV, Felderhoff-Mueser U, **Bruns N**. *International journal of environmental research and public health, 18(23)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/34886539/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **The Flagellin:Allergen Fusion Protein rFlaA:Betv1 Induces a MyD88- and MAPK-Dependent Activation of Glucose Metabolism in Macrophages.**  \n",
       "  Lin YJ, Papp G, Miskey C, Fiedler A, **Goretzki A**, Wolfheimer S, Zimmermann J, Crauwels P, Ivics Z, van Zandbergen G, Vieths S, Scheurer S, Schulke S. *Cells, 10(10)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/34685593/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Hospitalization and Morbidity Rates After Pediatric Traumatic Brain Injury: A Nation-Wide Population-Based Analysis.**  \n",
       "  **Bruns N**, Trocchi P, Felderhoff-Muser U, **Dohna-Schwake C**, Stang A. *Frontiers in pediatrics, 9:747743*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/34660495/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Music Therapy Is Effective during Sleep in Preterm Infants.**  \n",
       "  Kobus S, Diezel M, Dewan MV, Huening B, Dathe AK, Felderhoff-Mueser U, **Bruns N**. *International journal of environmental research and public health, 18(16)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/34443994/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Coil embolisation for massive haemoptysis in cystic fibrosis.**  \n",
       "  Dohna M, Renz DM, Stehling F, **Dohna-Schwake C**, Sutharsan S, Neurohr C, Wirtz H, Eickmeier O, Grosse-Onnebrink J, Sauerbrey A, Soditt V, Poplawska K, Wacker F, Montag MJ. *BMJ open respiratory research, 8(1)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/34385150/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Next-generation sequencing diagnostics of bacteremia in pediatric sepsis.**  \n",
       "  Schmoch T, Westhoff JH, Decker SO, Skarabis A, Hoffmann GF, **Dohna-Schwake C**, Felderhoff-Muser U, Skolik C, Feisst M, Klose C, Bruckner T, Luntz S, Weigand MA, Sohn K, Brenner T. *Medicine, 100(25):e26403*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/34160425/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Epidemiology, Diagnostics, and Management of Vein of Galen Malformation.**  \n",
       "  Brevis Nunez F, **Dohna-Schwake C**. *Pediatric neurology, 119:50-55*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/33895584/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Immune metabolism in allergies, does it matter?-A review of immune metabolic basics and adaptations associated with the activation of innate immune cells in allergy.**  \n",
       "  **Goretzki A**, Lin YJ, Schulke S. *Allergy, 76(11):3314-3331*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/33811351/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Unstructural Biology of TRP Ion Channels: The Role of Intrinsically Disordered Regions in Channel Function and Regulation.**  \n",
       "  **Goretzki B**, Guhl C, Tebbe F, Harder JM, Hellmich UA. *Journal of molecular biology, 433(17):166931*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/33741410/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **NAT2 polymorphisms as a cause of metamizole-induced agranulocytosis.**  \n",
       "  Radulovic I, Dogan B, **Dohna-Schwake C**, Schundeln MM, Siffert W, Mohlendick B. *Pharmacogenetics and genomics, 31(6):140-143*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/33675325/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Neuropathy-causing TRPV4 mutations disrupt TRPV4-RhoA interactions and impair neurite extension.**  \n",
       "  McCray BA, Diehl E, Sullivan JM, Aisenberg WH, Zaccor NW, Lau AR, Rich DJ, **Goretzki B**, Hellmich UA, Lloyd TE, Sumner CJ. *Nature communications, 12(1):1444*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/33664271/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Insulinoma in pregnancy (a case presentation and systematic review of the literature).**  \n",
       "  Dobrindt EM, Mogl M, **Goretzki PE**, Pratschke J, Dukaczewska AK. *Rare tumors, 13:2036361320986647*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/33613925/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **EVALI (E-cigarette or vaping product use associated lung injury): First case report of an adolescent in Europe.**  \n",
       "  Schafer M, Steindor M, Stehling F, **Dohna-Schwake C**. *Pediatric pulmonology, 56(5):1274-1275*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/33497507/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.**  \n",
       "  Ozdirik B, Amthauer H, Schatka I, **Goretzki PE**, Mogl MT, Fehrenbach U, Tacke F, Jann H, Roderburg C. *Molecular and clinical oncology, 14(1):20*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/33363730/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Sedation for bronchoscopy in children: A prospective randomized double-blinded trial.**  \n",
       "  Tschiedel E, Eckerland M, Felderhoff-Mueser U, **Dohna-Schwake C**, Stehling F. *Pediatric pulmonology, 56(5):1221-1229*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/33336889/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **aEEG as a useful tool for neuromonitoring in critically ill children - Current evidence and knowledge gaps.**  \n",
       "  **Bruns N**, Felderhoff-Muser U, **Dohna-Schwake C**. *Acta paediatrica (Oslo, Norway : 1992), 110(4):1132-1140*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/33210762/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Aminoglycosides were associated with higher rates of surgical patent ductus arteriosus closure in preterm infants.**  \n",
       "  Marissen J, Erdmann H, Bockenholt K, Hoppenz M, Rausch TK, Hartel C, Herting E, Gopel W. *Acta paediatrica (Oslo, Norway : 1992), 110(3):826-832*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/32810301/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2020\n",
       "\n",
       "* **Iatrogenic severe hyperglycemia due to parenteral administration of glucose in children - a case series.**  \n",
       "  **Bruns N**, Grosse Lordemann A, Rasche T, Meyburg J, Kruger M, Wieg C, Gratopp A, Hoppenz M, Heitmann F, Hoppen T, Loffler G, Felderhoff-Muser U, **Dohna-Schwake C**. *Italian journal of pediatrics, 46(1):179*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/33261643/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Unusual Presentation of Polyautoimmunity and Renal Tubular Acidosis in an Adolescent With Hashimoto's Thyroiditis and Central Pontine Myelinolysis.**  \n",
       "  **Bruns N**, Finkelberg I, Al-Attrach I, Hoyer PF, Buscher R. *Frontiers in endocrinology, 11:548877*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/33162932/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **More Than 500 Kids Could Be Saved Each Year! Ten Consensus Actions to Improve Quality of Pediatric Resuscitation in DACH-Countries (Austria, Germany, and Switzerland).**  \n",
       "  Jung P, Brenner S, Bachmann I, Both C, Cardona F, **Dohna-Schwake C**, Eich C, Eifinger F, Huth R, Heimberg E, Landsleitner B, Olivieri M, Sasse M, Weisner T, Wagner M, Warnke G, Ziegler B, Boettiger BW, Nadkarni V, Hoffmann F. *Frontiers in pediatrics, 8:549710*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/33117762/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Further evidence for POMK as candidate gene for WWS with meningoencephalocele.**  \n",
       "  **Paul L**, Rupprich K, Della Marina A, Stein A, Elgizouli M, Kaiser FJ, Schweiger B, Koninger A, Iannaccone A, Hehr U, Kolbel H, Roos A, Schara-Schmidt U, Kuechler A. *Orphanet journal of rare diseases, 15(1):242*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/32907597/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children.**  \n",
       "  **Bruns N**, Moosmann J, Munch F, **Dohna-Schwake C**, Woelfle J, Cesnjevar R, Dittrich S, Felderhoff-Muser U, Muller H. *Journal of visualized experiments : JoVE(162)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/32894267/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Preterm birth and sustained inflammation: consequences for the neonate.**  \n",
       "  Humberg A, Fortmann I, Siller B, Kopp MV, Herting E, Gopel W, Hartel C. *Seminars in immunopathology, 42(4):451-468*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/32661735/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Thyroid nodules: The Guidelines of the American Thyroid Association from a European Perspective].**  \n",
       "  Derwahl KM, **Goretzki P**. *Deutsche medizinische Wochenschrift (1946), 145(17):1227-1235*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/32634841/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Influence of Parathyroidectomy on Kidney Graft Function in Secondary and Tertiary Hyperparathyroidism.**  \n",
       "  Bures C, Seika P, Skachko T, Dobrindt EM, Rayes N, Pratschke J, **Goretzki PE**, Mogl MT. *Transplantation proceedings, 52(10):3134-3143*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/32402458/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Long-term outcome of surgical resection in patients with gastroenteropancreatic neuroendocrine neoplasia: results from a German nation-wide multi-centric registry.**  \n",
       "  Begum N, Maasberg S, Pascher A, Plockinger U, Gress TM, Wurst C, Weber F, Raffel A, Krausch M, Holzer K, Bartsch DK, Musholt TJ, Keck T, Anlauf M, Rinke A, Pape UF, **Goretzki PE**. *Langenbeck's archives of surgery, 405(2):145-154*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/32372309/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Postnatal serum creatinine is elevated in preterm infants with PPROM-induced anhydramnios.**  \n",
       "  **Bruns N**, Stahling AC, **Greve S**, Weiss C, Koninger A, Felderhoff-Muser U, Muller H. *Pediatrics and neonatology, 61(4):414-419*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/32278744/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **The Impact of Gender on Diagnosis and Treatment in Endocrine Surgery.**  \n",
       "  **Goretzki PE**. *Visceral medicine, 36(1):2*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/32110649/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Two-year outcome data suggest that less invasive surfactant administration (LISA) is safe. Results from the follow-up of the randomized controlled AMV (avoid mechanical ventilation) study.**  \n",
       "  Herting E, Kribs A, Hartel C, von der Wense A, Weller U, Hoehn T, Vochem M, Moller J, Wieg C, Roth B, Gopel W. *European journal of pediatrics, 179(8):1309-1313*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/32067100/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Surgical necrotizing enterocolitis but not spontaneous intestinal perforation is associated with adverse neurological outcome at school age.**  \n",
       "  Humberg A, Spiegler J, Fortmann MI, Zemlin M, Marissen J, Swoboda I, Rausch TK, Herting E, Gopel W, Hartel C. *Scientific reports, 10(1):2373*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/32047169/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **aEEG Use in Pediatric Critical Care-An Online Survey.**  \n",
       "  **Bruns N**, Felderhoff-Muser U, **Dohna-Schwake C**, Woelfle J, Muller H. *Frontiers in pediatrics, 8:3*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/32039124/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **NMR assignments of a dynamically perturbed and dimerization inhibited N-terminal domain variant of a spider silk protein from E. australis.**  \n",
       "  **Goretzki B**, Heiby JC, Hacker C, Neuweiler H, Hellmich UA. *Biomolecular NMR assignments, 14(1):67-71*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/31786743/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Correlation of lateral ventricular size and deep gray matter volume in MRI at term equivalent age with neurodevelopmental outcome at a corrected age of 24 months and with handedness in preterm infants.**  \n",
       "  Storbeck T, **Bruns N**, Weiss C, Felderhoff-Muser U, Muller H. *European journal of pediatrics, 179(2):271-278*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/31724086/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Bacterial infections in children after liver transplantation: A single-center surveillance study of 345 consecutive transplantations.**  \n",
       "  **Dohna Schwake C**, Guiddir T, Cuzon G, Benissa MR, Dubois C, Miatello J, Merchaoui Z, Durand P, Tissieres P. *Transplant infectious disease : an official journal of the Transplantation Society, 22(1):e13208*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/31693773/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Early Postoperative Fasting Serum Glucose Levels are Useful in Depicting Future Diabetes Mellitus in Patients with Curative Insulinoma Surgery.**  \n",
       "  Akca A, Starke AAR, Dobek A, Ulrich A, **Goretzki PE**. *Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 128(3):158-163*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/31039599/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Neurological outcome at 24 months corrected age of prematurely born infants after preterm premature rupture of membranes (PPROM) of at least 7 days: a two-center experience in Germany.**  \n",
       "  Muller H, Storbeck T, Katzer D, **Bruns N**, Wossner-Stegmann G, Ai M, Koninger A, Muller A, Felderhoff-Muser U, Bagci S. *The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 33(8):1315-1320*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/30153748/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2019\n",
       "\n",
       "* **Research priorities in pediatric onco-critical care: an international Delphi consensus study.**  \n",
       "  Soeteman M, Potratz J, Nielsen JSA, Willems J, Valla FV, Brierley J, Wosten-van Asperen RM. *Intensive care medicine, 45(11):1681-1683*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/31444505/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Total Versus Near-total Thyroidectomy in Graves Disease: Results of the Randomized Controlled Multicenter TONIG-trial.**  \n",
       "  Maurer E, Maschuw K, Reuss A, Zieren HU, Zielke A, **Goretzki P**, Simon D, Dotzenrath C, Steinmuller T, Jahne J, Kemen M, Coerper S, Leister I, Nies C, Hartel M, Turler A, Holzer K, Agha A, Knoop M, Musholt T, Aminossadati B, Bartsch DK. *Annals of surgery, 270(5):755-761*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/31634179/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Methionine in a protein hydrophobic core drives tight interactions required for assembly of spider silk.**  \n",
       "  Heiby JC, **Goretzki B**, Johnson CM, Hellmich UA, Neuweiler H. *Nature communications, 10(1):4378*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/31558722/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Amplitude-Integrated EEG for Neurological Assessment and Seizure Detection in a German Pediatric Intensive Care Unit.**  \n",
       "  **Bruns N**, Sanchez-Albisua I, Weiss C, Tschiedel E, **Dohna-Schwake C**, Felderhoff-Muser U, Muller H. *Frontiers in pediatrics, 7:358*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/31555625/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **PICU mortality of children with cancer admitted to pediatric intensive care unit a systematic review and meta-analysis.**  \n",
       "  Wosten-van Asperen RM, van Gestel JPJ, van Grotel M, Tschiedel E, **Dohna-Schwake C**, Valla FV, Willems J, Angaard Nielsen JS, Krause MF, Potratz J, van den Heuvel-Eibrink MM, Brierley J. *Critical reviews in oncology/hematology, 142:153-163*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/31404827/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Adjuvant Allergen Fusion Proteins as Novel Tools for the Treatment of Type I Allergies.**  \n",
       "  Blanco-Perez F, Papp G, **Goretzki A**, Moller T, Anzaghe M, Schulke S. *Archivum immunologiae et therapiae experimentalis, 67(5):273-293*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/31222414/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease.**  \n",
       "  Marten O, Koerber F, Bloom D, Bullinger M, Buysse C, Christensen H, De Wals P, **Dohna-Schwake C**, Henneke P, Kirchner M, Knuf M, Lawrenz B, Monteiro AL, Sevilla JP, Van de Velde N, Welte R, Wright C, Greiner W. *Health and quality of life outcomes, 17(1):87*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/31118091/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **19F NMR as a versatile tool to study membrane protein structure and dynamics.**  \n",
       "  Rose-Sperling D, Tran MA, Lauth LM, **Goretzki B**, Hellmich UA. *Biological chemistry, 400(10):1277-1288*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/31004560/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **NFkappaB- and MAP-Kinase Signaling Contribute to the Activation of Murine Myeloid Dendritic Cells by a Flagellin A:Allergen Fusion Protein.**  \n",
       "  Moeller T, Wolfheimer S, **Goretzki A**, Scheurer S, Schulke S. *Cells, 8(4)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/30991709/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Surgical therapy of adrenal tumors: guidelines from the German Association of Endocrine Surgeons (CAEK).**  \n",
       "  Lorenz K, Langer P, Niederle B, Alesina P, Holzer K, Nies C, Musholt T, **Goretzki PE**, Rayes N, Quinkler M, Waldmann J, Simon D, Trupka A, Ladurner R, Hallfeldt K, Zielke A, Saeger D, Poppel T, Kukuk G, Hotker A, Schabram P, Schopf S, Dotzenrath C, Riss P, Steinmuller T, Kopp I, Vorlander C, Walz MK, Bartsch DK. *Langenbeck's archives of surgery, 404(4):385-401*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/30937523/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **The vaccine adjuvant MPLA activates glycolytic metabolism in mouse mDC by a JNK-dependent activation of mTOR-signaling.**  \n",
       "  Blanco-Perez F, **Goretzki A**, Wolfheimer S, Schulke S. *Molecular immunology, 106:159-169*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/30623816/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Visual Distraction During Sleep Induction with Propofol in Pediatric Patients - Can Cartoon Watching Influence the Sedative Dose?**  \n",
       "  Tschiedel E, Beckers K, Grosse-Lordemann A, Basu O, Felderhoff-Muser U, **Dohna-Schwake C**. *Klinische Padiatrie, 231(1):35-40*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/30231262/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2018\n",
       "\n",
       "* **[Not Available].**  \n",
       "  Mogl MT, **Goretzki PE**. *Zentralblatt fur Chirurgie, 143(5):451-454*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/30357782/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Neuroendocrine Neoplasia within the German NET Registry].**  \n",
       "  No authors listed. *Zeitschrift fur Gastroenterologie, 56(10):1237-1246*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/30304748/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic data.**  \n",
       "  Wu CW, Dionigi G, Barczynski M, Chiang FY, Dralle H, Schneider R, Al-Quaryshi Z, Angelos P, Brauckhoff K, Brooks JA, Cernea CR, Chaplin J, Chen AY, Davies L, Diercks GR, Duh QY, Fundakowski C, **Goretzki PE**, Hales NW, Hartl D, Kamani D, Kandil E, Kyriazidis N, Liddy W, Miyauchi A, Orloff L, Rastatter JC, Scharpf J, Serpell J, Shin JJ, Sinclair CF, Stack BC Jr, Tolley NS, Slycke SV, Snyder SK, Urken ML, Volpi E, Witterick I, Wong RJ, Woodson G, Zafereo M, Randolph GW. *The Laryngoscope, 128 Suppl 3:S18-S27*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/30291765/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **International neural monitoring study group guideline 2018 part I: Staging bilateral thyroid surgery with monitoring loss of signal.**  \n",
       "  Schneider R, Randolph GW, Dionigi G, Wu CW, Barczynski M, Chiang FY, Al-Quaryshi Z, Angelos P, Brauckhoff K, Cernea CR, Chaplin J, Cheetham J, Davies L, **Goretzki PE**, Hartl D, Kamani D, Kandil E, Kyriazidis N, Liddy W, Orloff L, Scharpf J, Serpell J, Shin JJ, Sinclair CF, Singer MC, Snyder SK, Tolley NS, Van Slycke S, Volpi E, Witterick I, Wong RJ, Woodson G, Zafereo M, Dralle H. *The Laryngoscope, 128 Suppl 3:S1-S17*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/30289983/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract.**  \n",
       "  **Goretzki PE**, Mogl MT, Akca A, Pratschke J. *Reviews in endocrine & metabolic disorders, 19(2):169-178*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/30280290/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Structural Basis of TRPV4 N Terminus Interaction with Syndapin/PACSIN1-3 and PIP(2).**  \n",
       "  **Goretzki B**, Glogowski NA, Diehl E, Duchardt-Ferner E, Hacker C, Gaudet R, Hellmich UA. *Structure (London, England : 1993), 26(12):1583-1593.e5*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/30244966/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Practice guideline neuroendocrine tumors - AWMF-Reg. 021-27].**  \n",
       "  No authors listed. *Zeitschrift fur Gastroenterologie, 56(6):583-681*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/29890561/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Update of the S2k guidelines : Surgical treatment of benign thyroid diseases].**  \n",
       "  Musholt TJ, Bockisch A, Clerici T, Dotzenrath C, Dralle H, **Goretzki PE**, Hermann M, Holzer K, Karges W, Krude H, Kussmann J, Lorenz K, Luster M, Niederle B, Nies C, Riss P, Schabram J, Schabram P, Schmid KW, Simon D, Spitzweg C, Steinmuller T, Trupka A, Vorlander C, Weber T, Bartsch DK. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 89(9):699-709*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/29876616/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Relationship between brain function (aEEG) and brain structure (MRI) and their predictive value for neurodevelopmental outcome of preterm infants.**  \n",
       "  Huning B, Storbeck T, **Bruns N**, Dransfeld F, Hobrecht J, Karpienski J, Sirin S, Schweiger B, Weiss C, Felderhoff-Muser U, Muller H. *European journal of pediatrics, 177(8):1181-1189*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/29789947/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **In Reply.**  \n",
       "  Bartsch DK, Luster M, **Goretzki PE**. *Deutsches Arzteblatt international, 115(13):221*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/29669680/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Antifungal Treatment and Outcome in Very Low Birth Weight Infants: A Population-based Observational Study of the German Neonatal Network.**  \n",
       "  Fortmann I, Hartz A, Paul P, Pulzer F, Muller A, Bottger R, Proquitte H, Dawczynski K, Simon A, Rupp J, Herting E, Gopel W, Hartel C. *The Pediatric infectious disease journal, 37(11):1165-1171*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/29601449/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Indications for the Surgical Management of Benign Goiter in Adults.**  \n",
       "  Bartsch DK, Luster M, Buhr HJ, Lorenz D, Germer CT, **Goretzki PE**. *Deutsches Arzteblatt international, 115(1-02):1-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/29345225/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Rare renal tumors].**  \n",
       "  Akca A, Otto T, Hinsch N, Lammers BJ, Starke AAR, **Goretzki PE**. *Der Urologe. Ausg. A, 57(2):193-197*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/29242949/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Measurement of Basal Serum Calcitonin for the Diagnosis of Medullary Thyroid Cancer.**  \n",
       "  Allelein S, Ehlers M, Morneau C, Schwartz K, **Goretzki PE**, Seppel T, Feldkamp J, Krieg A, Knoefel WT, Kuebart A, Haase M, Dringenberg T, Schmid C, Schott M. *Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 50(1):23-28*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/29169190/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2017\n",
       "\n",
       "* **Health of VLBW infants in Germany at five years of age: What do parents describe?**  \n",
       "  Spiegler J, Stichtenoth G, Konig IR, Herting E, Gopel W. *Early human development, 115:88-92*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/29024833/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates.**  \n",
       "  **Bruns N**, Blumenthal S, Meyer I, Klose-Verschuur S, Felderhoff-Muser U, Muller H. *Journal of visualized experiments : JoVE(127)*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/28930990/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **The association of mannose-binding lectin 2 polymorphisms with outcome in very low birth weight infants.**  \n",
       "  Hartz A, Pagel J, Humberg A, Preuss M, Schreiter L, Rupp J, Figge J, Karsten CM, Nurnberg P, Herting E, Gopel W, Hartel C. *PloS one, 12(5):e0178032*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/28558032/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Delivery mode and intraventricular hemorrhage risk in very-low-birth-weight infants: Observational data of the German Neonatal Network.**  \n",
       "  Humberg A, Hartel C, Paul P, Hanke K, Bossung V, Hartz A, Fasel L, Rausch TK, Rody A, Herting E, Gopel W. *European journal of obstetrics, gynecology, and reproductive biology, 212:144-149*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/28363188/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Comparison of two common aEEG classifications for the prediction of neurodevelopmental outcome in preterm infants.**  \n",
       "  **Bruns N**, Dransfeld F, Huning B, Hobrecht J, Storbeck T, Weiss C, Felderhoff-Muser U, Muller H. *European journal of pediatrics, 176(2):163-171*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/27924356/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Glucocorticoid Receptor Gene Variants and Neonatal Outcome in Very-Low-Birth-Weight Preterm Infants.**  \n",
       "  Schreiner C, Schreiner F, Hartel C, Heckmann M, Heep A, Bartmann P, Woelfle J, Muller A, Herting E, Gopel W. *Neonatology, 111(1):22-29*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/27509264/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2016\n",
       "\n",
       "* **Clinical Evaluation of the First Automated Assay for the Detection of Stimulating TSH Receptor Autoantibodies.**  \n",
       "  Allelein S, Ehlers M, **Goretzki S**, Hermsen D, Feldkamp J, Haase M, Dringenberg T, Schmid C, Hautzel H, Schott M. *Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 48(12):795-801*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/27923250/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism.**  \n",
       "  Ozolins A, Narbuts Z, Vanags A, Simtniece Z, Visnevska Z, Akca A, Wirowski D, Gardovskis J, Strumfa I, **Goretzki PE**. *Langenbeck's archives of surgery, 401(7):943-951*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/26658808/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Total Parathyroidectomy With Routine Thymectomy and Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism: Results of a Nonconfirmatory Multicenter Prospective Randomized Controlled Pilot Trial.**  \n",
       "  Schlosser K, Bartsch DK, Diener MK, Seiler CM, Bruckner T, Nies C, Meyer M, Neudecker J, **Goretzki PE**, Glockzin G, Konopke R, Rothmund M. *Annals of surgery, 264(5):745-753*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/27741007/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Media Stories on NICU Outbreaks Lead to an Increased Prescription Rate of Third-Line Antibiotics in the Community of Neonatal Care.**  \n",
       "  Hartel C, Hartz A, Bahr L, Gille C, Gortner L, Simon A, Orlikowsky T, Muller A, Korner T, Henneke P, Haase R, Zemlin M, Viemann D, Gebauer C, Thome U, Ziegler A, Rupp J, Herting E, Gopel W. *Infection control and hospital epidemiology, 37(8):924-930*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/27143176/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **NOD2 Loss-of-Function Mutations and Risks of Necrotizing Enterocolitis or Focal Intestinal Perforation in Very Low-birth-weight Infants.**  \n",
       "  Hartel C, Hartz A, Pagel J, Rupp J, Stein A, Kribs A, Muller A, Haase R, Gille C, Bottger R, Kittel J, Jensen R, Wieg C, Herting E, Gopel W. *Inflammatory bowel diseases, 22(2):249-56*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/26752461/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Does Breastmilk Influence the Development of Bronchopulmonary Dysplasia?**  \n",
       "  Spiegler J, Preuss M, Gebauer C, Bendiks M, Herting E, Gopel W. *The Journal of pediatrics, 169:76-80.e4*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/26621048/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2015\n",
       "\n",
       "* **Short-term outcome of very-low-birthweight infants with arterial hypotension in the first 24 h of life.**  \n",
       "  Faust K, Hartel C, Preuss M, Rabe H, Roll C, Emeis M, Wieg C, Szabo M, Herting E, Gopel W. *Archives of disease in childhood. Fetal and neonatal edition, 100(5):F388-92*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/26199082/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Resection of Ileoinguinal and Ileohypogastric Nerves Combined with Gluing in Modified Lichtenstein Repair.**  \n",
       "  Baer A, Bohnert N, **Goretzki PE**, Lammers BJ. *Surgical technology international, 26:143-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/26055002/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Electrocortical Activity at 7 Days of Life is Affected in Extremely Premature Infants with Patent Ductus Arteriosus.**  \n",
       "  **Bruns N**, Metze B, Buhrer C, Felderhoff-Muser U, Huseman D. *Klinische Padiatrie, 227(5):264-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/25875399/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Length and weight of very low birth weight infants in Germany at 2 years of age: does it matter at what age they start complementary food?**  \n",
       "  Spiegler J, Eisemann N, Ehlers S, Orlikowsky T, Kannt O, Herting E, Gopel W. *European journal of clinical nutrition, 69(6):662-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/25872910/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Preterm prelabor rupture of membranes and outcome of very-low-birth-weight infants in the German Neonatal Network.**  \n",
       "  Hanke K, Hartz A, Manz M, Bendiks M, Heitmann F, Orlikowsky T, Muller A, Olbertz D, Kuhn T, Siegel J, von der Wense A, Wieg C, Kribs A, Stein A, Pagel J, Herting E, Gopel W, Hartel C. *PloS one, 10(4):e0122564*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/25856083/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Less invasive surfactant administration is associated with improved pulmonary outcomes in spontaneously breathing preterm infants.**  \n",
       "  Gopel W, Kribs A, Hartel C, Avenarius S, Teig N, Groneck P, Olbertz D, Roll C, Vochem M, Weller U, von der Wense A, Wieg C, Wintgens J, Preuss M, Ziegler A, Roth B, Herting E. *Acta paediatrica (Oslo, Norway : 1992), 104(3):241-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/25474712/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Local recurrence in the neck and survival after thyroidectomy for metastatic renal cell carcinoma.**  \n",
       "  Iesalnieks I, Machens A, Bures C, Krenz D, Winter H, Vorlander C, Bareck E, Alesina PF, Musholt T, Steinmuller T, Anthuber M, **Goretzki P**, Trupka A, Mayr M, Weber T, Schlitt HJ, Dralle H, Hermann M, Agha A. *Annals of surgical oncology, 22(6):1798-805*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/25472649/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2014\n",
       "\n",
       "* **Impairment of bone health in pediatric patients with hemolytic anemia.**  \n",
       "  Schundeln MM, **Goretzki SC**, Hauffa PK, Wieland R, Bauer J, Baeder L, Eggert A, Hauffa BP, Grasemann C. *PloS one, 9(10):e108400*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/25299063/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Mitochondrial mutation m.1555A>G as a risk factor for failed newborn hearing screening in a large cohort of preterm infants.**  \n",
       "  Gopel W, Berkowski S, Preuss M, Ziegler A, Kuster H, Felderhoff-Muser U, Gortner L, Mogel M, Hartel C, Herting E. *BMC pediatrics, 14:210*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/25155176/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Encapsulated cells expressing a chemotherapeutic activating enzyme allow the targeting of subtoxic chemotherapy and are safe and efficacious: data from two clinical trials in pancreatic cancer.**  \n",
       "  Lohr JM, Haas SL, Kroger JC, Friess HM, Hoft R, **Goretzki PE**, Peschel C, Schweigert M, Salmons B, Gunzburg WH. *Pharmaceutics, 6(3):447-66*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/25116885/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very low birth weight infants.**  \n",
       "  Hartel C, Pagel J, Rupp J, Bendiks M, Guthmann F, Rieger-Fackeldey E, Heckmann M, Franz A, Schiffmann JH, Zimmermann B, Hepping N, von der Wense A, Wieg C, Herting E, Gopel W. *The Journal of pediatrics, 165(2):285-289.e1*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/24880888/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Postoperative vocal cord dysfunction despite normal intraoperative neuromonitoring: an unexpected complication with the risk of bilateral palsy.**  \n",
       "  Melin M, Schwarz K, Pearson MD, Lammers BJ, **Goretzki PE**. *World journal of surgery, 38(10):2597-602*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/24867468/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Neuroendocrine neoplasms of the distal jejunum and ileum].**  \n",
       "  Anlauf M, Sipos B, Boeck I, Baldus SE, Heikaus S, Krausch M, Knoefel WT, Begum N, **Goretzki P**, Schott M, Auernhammer CJ, Cremer B, Rinke A, Ezziddin S, Fottner C, Popperl G, Lahner H, Horsch D, Gabbert HE, Komminoth P, Perren A, Kloppel G, Wiedenmann B, Pavel M, Pape U. *Der Pathologe, 35(3):283-93; quiz 294*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/24671468/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Prevalence of xerostomia and hyposalivation and their association with quality of life in elderly patients in dependence on dental status and prosthetic rehabilitation: a pilot study.**  \n",
       "  Hahnel S, **Schwarz S**, Zeman F, Schafer L, Behr M. *Journal of dentistry, 42(6):664-70*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/24632475/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Functional long-term results after rectal cancer surgery--technique of the athermal mesorectal excision.**  \n",
       "  Touloumtzidis A, Sostmann B, Hilgers N, Renter MA, Kuhn P, **Goretzki PE**, Lammers BJ. *International journal of colorectal disease, 29(3):285-92*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/24306821/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Multifocal papillary thyroid carcinoma--a consensus report of the European Society of Endocrine Surgeons (ESES).**  \n",
       "  Iacobone M, Jansson S, Barczynski M, **Goretzki P**. *Langenbeck's archives of surgery, 399(2):141-54*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/24263684/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Photophysics and electrochemistry of a platinum-acetylide disubstituted perylenediimide.**  \n",
       "  Llewellyn BA, Slater AG, **Goretzki G**, Easun TL, Sun XZ, Davies ES, Argent SP, Lewis W, Beeby A, George MW, Champness NR. *Dalton transactions (Cambridge, England : 2003), 43(1):85-94*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/24077462/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Hedgehog-signaling is upregulated in non-producing human adrenal adenomas and antagonism of hedgehog-signaling inhibits proliferation of NCI-H295R cells and an immortalized primary human adrenal cell line.**  \n",
       "  Werminghaus P, Haase M, Hornsby PJ, Schinner S, Schott M, Malendowicz LK, Lammers BJ, **Goretzki PE**, Muller-Mattheis V, Markus Giessing, Willenberg HS. *The Journal of steroid biochemistry and molecular biology, 139:7-15*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/24063979/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Risk for late-onset blood-culture proven sepsis in very-low-birth weight infants born small for gestational age: a large multicenter study from the German Neonatal Network.**  \n",
       "  Troger B, Gopel W, Faust K, Muller T, Jorch G, Felderhoff-Muser U, Gortner L, Heitmann F, Hoehn T, Kribs A, Laux R, Roll C, Emeis M, Mogel M, Siegel J, Vochem M, von der Wense A, Wieg C, Herting E, Hartel C. *The Pediatric infectious disease journal, 33(3):238-43*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/24030351/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Neuroendocrine tumours of the GI tract--data from the German NET Registry].**  \n",
       "  Begum N, Maasberg S, Plockinger U, Anlauf M, Rinke A, Popperl G, Lehnert H, Izbicki JR, Krausch M, Vashist YK, Raffel A, Burk CG, Hoffmann J, **Goretzki P**, Pape UF. *Zentralblatt fur Chirurgie, 139(3):276-83*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/23042103/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2013\n",
       "\n",
       "* **[Intraoperative neuromonitoring in thyroid surgery. Recommendations of the Surgical Working Group for Endocrinology].**  \n",
       "  Dralle H, Lorenz K, Schabram P, Musholt TJ, Dotzenrath C, **Goretzki PE**, Kussmann J, Niederle B, Nies C, Schabram J, Scheuba C, Simon D, Steinmuller T, Trupka A. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 84(12):1049-56*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/24337220/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Is the covering of the resection margin after distal pancreatectomy advantageous?**  \n",
       "  Akca A, **Goretzki PE**, Wirowski D, Renter MA, Bolke E, Matuschek C, Gerber PA, Lammers BJ. *European journal of medical research, 18(1):33*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/24073931/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Use of analgesic and sedative drugs in VLBW infants in German NICUs from 2003-2010.**  \n",
       "  Mehler K, Oberthuer A, Haertel C, Herting E, Roth B, Goepel W. *European journal of pediatrics, 172(12):1633-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/23877637/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Polymorphisms in FTO and MAF Genes and Birth Weight, BMI, Ponderal Index, Weight Gain in a Large Cohort of Infants with a Birth Weight below 1500 Grams.**  \n",
       "  Haller S, Spiegler J, Hemmelmann C, Kuster H, Vochem M, Moller J, Muller D, Kribs A, Hoehn T, Hartel C, Herting E, Gopel W. *PloS one, 8(6):e66331*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/23840443/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Failed surgery in primary hyperparathyroidism - what has changed with time.**  \n",
       "  Wirowski D, **Goretzki PE**, Schwarz K, Lammers BJ, Dotzenrath C, Roher HD. *Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 121(6):323-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/23512418/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.**  \n",
       "  Dralle H, Musholt TJ, Schabram J, Steinmuller T, Frilling A, Simon D, **Goretzki PE**, Niederle B, Scheuba C, Clerici T, Hermann M, Kussmann J, Lorenz K, Nies C, Schabram P, Trupka A, Zielke A, Karges W, Luster M, Schmid KW, Vordermark D, Schmoll HJ, Muhlenberg R, Schober O, Rimmele H, Machens A. *Langenbeck's archives of surgery, 398(3):347-75*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/23456424/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Pregnancy risk factors for very premature delivery: what role do hypertension, obesity and diabetes play?**  \n",
       "  Spiegler J, Stichtenoth G, Weichert J, Konig IR, Schlaud M, V D Wense A, Olbertz D, Gurth H, Schiffmann JH, Bohnhorst B, Gortner L, Herting E, Gopel W. *Archives of gynecology and obstetrics, 288(1):57-64*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/23400353/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Surgical therapy for thyroid gland malignancies].**  \n",
       "  **Goretzki PE**, Schwarz K, Lammers B. *HNO, 61(1):71-81; quiz 82*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/23325061/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Very low birth weight infants after discharge: What do parents describe?**  \n",
       "  Spiegler J, Schlaud M, Konig IR, Teig N, Hubert M, Herting E, Gopel W. *Early human development, 89(5):343-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/23266151/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **IONM-guided goiter surgery leading to two-stage thyroidectomy--indication and results.**  \n",
       "  Melin M, Schwarz K, Lammers BJ, **Goretzki PE**. *Langenbeck's archives of surgery, 398(3):411-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/23179319/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Cinacalcet effects on the perioperative course of patients with secondary hyperparathyroidism.**  \n",
       "  Wirowski D, **Goretzki PE**, Schwarz K, Lammers BJ. *Langenbeck's archives of surgery, 398(1):131-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/23007384/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1.**  \n",
       "  Lopez CL, Falconi M, Waldmann J, Boninsegna L, Fendrich V, **Goretzki PK**, Langer P, Kann PH, Partelli S, Bartsch DK. *Annals of surgery, 257(2):308-14*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/22580937/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2012\n",
       "\n",
       "* **Causes of delivery and outcomes of very preterm twins stratified to zygosity.**  \n",
       "  Spiegler J, Hartel C, Schulz L, von Wurmb-Schwark N, Hoehn T, Kribs A, Kuster H, Siegel J, Wieg C, Weichert J, Herting E, Gopel W. *Twin research and human genetics : the official journal of the International Society for Twin Studies, 15(4):532-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/22853920/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Epidemic microclusters of blood-culture proven sepsis in very-low-birth weight infants: experience of the German Neonatal Network.**  \n",
       "  Hartel C, Faust K, Avenarius S, Bohnhorst B, Emeis M, Gebauer C, Groneck P, Heitmann F, Hoehn T, Hubert M, Kribs A, Kuster H, Laux R, Mogel M, Muller D, Olbertz D, Roll C, Siegel J, Stein A, Vochem M, Weller U, von der Wense A, Wieg C, Wintgens J, Hemmelmann C, Simon A, Herting E, Gopel W. *PloS one, 7(6):e38304*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/22768043/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Conservation and divergence between cytoplasmic and muscle-specific actin capping proteins: insights from the crystal structure of cytoplasmic Cap32/34 from Dictyostelium discoideum.**  \n",
       "  Eckert C, **Goretzki A**, Faberova M, Kollmar M. *BMC structural biology, 12:12*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/22657106/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Correspondence (letter to the editor): Incomplete picture.**  \n",
       "  Starke AA, **Goretzki PE**, Saddig C. *Deutsches Arzteblatt international, 109(4):66; author reply 66-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/22334829/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Surgery for neuroendocrine tumors of the gastroenteropancreatic system (GEP-NET)].**  \n",
       "  **Goretzki PE**, Starke A, Akca A, Lammers BJ. *Der Internist, 53(2):152-60*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/22290318/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **ATP-binding cassette member A3 (E292V) gene mutation and pulmonary morbidity in very-low-birth-weight infants.**  \n",
       "  Hartel C, Felderhoff-Muser U, Gebauer C, Hoehn T, Kribs A, Laux R, Moller J, Segerer H, Teig N, von der Wense A, Wieg C, Stichtenoth G, Herting E, Gopel W. *Acta paediatrica (Oslo, Norway : 1992), 101(4):380-3*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/22145626/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Continuous intraoperative neuromonitoring of the recurrent laryngeal nerve in thyroid surgery (CIONM) - Where are we now? An update to the European Symposium of Continuous Neuromonitoring in Thyroid Surgery].**  \n",
       "  Schneider R, Lamade W, Hermann M, **Goretzki P**, Timmermann W, Hauss J, Leinung S. *Zentralblatt fur Chirurgie, 137(1):88-90*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/21365536/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2011\n",
       "\n",
       "* **Evaluation of Biocompatibility of Alloplastic Materials: Development of a Tissue Culture In Vitro Test System.**  \n",
       "  Gerullis H, Georgas E, Eimer C, **Goretzki PE**, Lammers BJ, Klosterhalfen B, Boros M, Wishahi M, Heusch G, Otto T. *Surgical technology international, 21:21-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/22504966/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells.**  \n",
       "  Saiko P, Graser G, Madlener S, **Schwarz S**, Krupitza G, Jaeger W, Somepalli V, Golakoti T, Fritzer-Szekeres M, Szekeres T. *Nucleosides, nucleotides & nucleic acids, 30(12):1190-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/22132974/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.**  \n",
       "  Gopel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, Siegel J, Avenarius S, von der Wense A, Vochem M, Groneck P, Weller U, Moller J, Hartel C, Haller S, Roth B, Herting E. *Lancet (London, England), 378(9803):1627-34*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/21963186/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Diagnostics and treatment in functional pancreatic neuroendocrine tumours].**  \n",
       "  Mussig K, Dudziak K, Horger M, Anlauf M, **Goretzki PE**. *Deutsche medizinische Wochenschrift (1946), 136(24):1319-30*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/21656454/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease.**  \n",
       "  Musholt TJ, Clerici T, Dralle H, Frilling A, **Goretzki PE**, Hermann MM, Kussmann J, Lorenz K, Nies C, Schabram J, Schabram P, Scheuba C, Simon D, Steinmuller T, Trupka AW, Wahl RA, Zielke A, Bockisch A, Karges W, Luster M, Schmid KW. *Langenbeck's archives of surgery, 396(5):639-49*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/21424798/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Hormone replacement after thyroid and parathyroid surgery: Importance of postoperative hypocalcemia.**  \n",
       "  Wirowski D, Schwarz K, Lammers BJ, **Goretzki PE**. *Deutsches Arzteblatt international, 108(8):133; author reply 134*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/21403810/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Extra-adrenal pheochromocytoma in the organ of Zuckerkandl: diagnosis and treatment strategies.**  \n",
       "  Kahraman D, **Goretzki PE**, Szangolies M, Schade H, Schmidt M, Kobe C. *Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 119(7):436-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/21374546/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Tumor necrosis factor-alpha promoter -308 G/A polymorphism and susceptibility to sepsis in very-low-birth-weight infants.**  \n",
       "  Hartel C, Hemmelmann C, Faust K, Gebauer C, Hoehn T, Kribs A, Laux R, Nikischin W, Segerer H, Teig N, von der Wense A, Wieg C, Herting E, Gopel W. *Critical care medicine, 39(5):1190-5*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/21317641/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2010\n",
       "\n",
       "* **Water-jet dissection in rectal cancer surgery: surgical and oncological outcomes.**  \n",
       "  Touloumtzidis A, Kuhn P, **Goretzki PE**, Lammers BJ. *Surgical technology international, 20:115-23*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/21082555/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Substantial deficiencies.**  \n",
       "  **Goretzki P**, Lammers B, Touloumtzidis A, Otto T. *Deutsches Arzteblatt international, 107(33):573; author reply 574*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/20830282/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Insulinoma associated with pregnancy].**  \n",
       "  Akca A, Mann K, Starke A, Lammers BJ, **Goretzki PE**. *Deutsche medizinische Wochenschrift (1946), 135(30):1484-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/20648406/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Pancreatic hyperinsulinism--changes of the clinical picture and importance of differences in sporadic disease course (experience with 144 patients operated in the period 1986-2009)].**  \n",
       "  **Goretzki P**, Starke A, Lammers B, Schwarz K, Roher HD. *Zentralblatt fur Chirurgie, 135(3):218-25*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/20560122/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Diagnosis and treatment of small follicular thyroid carcinomas.**  \n",
       "  Clerici T, Kolb W, Beutner U, Bareck E, Dotzenrath C, Kull C, Niederle B. *The British journal of surgery, 97(6):839-44*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/20473996/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **The impact of intraoperative neuromonitoring (IONM) on surgical strategy in bilateral thyroid diseases: is it worth the effort?**  \n",
       "  **Goretzki PE**, Schwarz K, Brinkmann J, Wirowski D, Lammers BJ. *World journal of surgery, 34(6):1274-84*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/20143072/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Supramolecular assemblies formed on an epitaxial graphene superstructure.**  \n",
       "  Pollard AJ, Perkins EW, Smith NA, Saywell A, **Goretzki G**, Phillips AG, Argent SP, Sachdev H, Muller F, Hufner S, Gsell S, Fischer M, Schreck M, Osterwalder J, Greber T, Berner S, Champness NR, Beton PH. *Angewandte Chemie (International ed. in English), 49(10):1794-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/20135656/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Solubilized derivatives of perylenetetracarboxylic dianhydride (PTCDA) adsorbed on highly oriented pyrolytic graphite.**  \n",
       "  Russell JC, Blunt MO, **Goretzki G**, Phillips AG, Champness NR, Beton PH. *Langmuir : the ACS journal of surfaces and colloids, 26(6):3972-4*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/20017490/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2009\n",
       "\n",
       "* **Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients.**  \n",
       "  Erlic Z, Rybicki L, Peczkowska M, Golcher H, Kann PH, Brauckhoff M, Mussig K, Muresan M, Schaffler A, Reisch N, Schott M, Fassnacht M, Opocher G, Klose S, Fottner C, Forrer F, Plockinger U, Petersenn S, Zabolotny D, Kollukch O, Yaremchuk S, Januszewicz A, Walz MK, Eng C, Neumann HP. *Clinical cancer research : an official journal of the American Association for Cancer Research, 15(20):6378-85*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/19825962/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Building multistate redox-active architectures using metal-complex functionalized perylene bis-imides.**  \n",
       "  **Goretzki G**, Davies ES, Argent SP, Warren JE, Blake AJ, Champness NR. *Inorganic chemistry, 48(21):10264-74*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/19799381/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Less pain intensity after lichtenstein-repair by using BioGlue for mesh fixation.**  \n",
       "  Bar A, Sauer T, Bohnert N, **Goretzki PE**, Lammers BJ. *Surgical technology international, 18:125-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/19579199/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Implementing the general use of dissection devices in thyroid surgery from prospective randomized trial to daily use.**  \n",
       "  **Goretzki PE**, Schwarz K, Lammers BJ. *Surgical technology international, 18:86-92*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/19579193/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Does multiple gland disease in primary hyperparathyroidism correlate with age or sex?**  \n",
       "  Wirowski D, Lammers BJ, Pohl P, Schwarz K, **Goretzki PE**. *Langenbeck's archives of surgery, 394(5):885-90*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/19533167/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Nestin as a marker in the classification of adrenocortical tumors.**  \n",
       "  Lachenmayer A, Lichtenauer UD, Cox T, Schott M, Malendowicz LK, **Goretzki PE**, Cupisti K, Scherbaum WA, Bornstein SR, Willenberg HS. *Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 41(5):397-401*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/19294612/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Self-assembly of a pyridine-terminated thiol monolayer on Au(111).**  \n",
       "  Silien C, Buck M, **Goretzki G**, Lahaye D, Champness NR, Weidner T, Zharnikov M. *Langmuir : the ACS journal of surfaces and colloids, 25(2):959-67*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/19138159/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Indication and performance of endocrine surgery. The significance of molecular genetic examination].**  \n",
       "  **Goretzki PE**, Wirowski D, Schwarz K, Pohl P, Bohner H, Starke A, Lammers BJ. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 80(2):122-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/19096808/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2008\n",
       "\n",
       "* **Bis-morpholine-substituted perylene bisimides: impact of isomeric arrangement on electrochemical and spectroelectrochemical properties.**  \n",
       "  **Goretzki G**, Davies ES, Argent SP, Alsindi WZ, Blake AJ, Warren JE, McMaster J, Champness NR. *The Journal of organic chemistry, 73(22):8808-14*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/18855454/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Functionalized supramolecular nanoporous arrays for surface templating.**  \n",
       "  Perdigao LM, Saywell A, Fontes GN, Staniec PA, **Goretzki G**, Phillips AG, Champness NR, Beton PH. *Chemistry (Weinheim an der Bergstrasse, Germany), 14(25):7600-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/18666294/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **A left nonrecurrent inferior laryngeal nerve in a patient with right-sided aorta, truncus arteriosus communis, and an aberrant left innominate artery.**  \n",
       "  Fellmer PT, Bohner H, Wolf A, Roher HD, **Goretzki PE**. *Thyroid : official journal of the American Thyroid Association, 18(6):647-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/18578615/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Thyroid metastases of renal cell carcinoma: clinical course in 45 patients undergoing surgery. Assessment of factors affecting patients' survival.**  \n",
       "  Iesalnieks I, Winter H, Bareck E, Sotiropoulos GC, **Goretzki PE**, Klinkhammer-Schalke M, Brockner S, Trupka A, Anthuber M, Rupprecht H, Raab M, Meyer W, Reichmann F, Kastel M, Mayr M, Braun W, Schlitt HJ, Agha A. *Thyroid : official journal of the American Thyroid Association, 18(6):615-24*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/18578610/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Presentation of 6 cases with parathyroid cysts and discussion of the literature.**  \n",
       "  Wirowski D, Wicke C, Bohner H, Lammers BJ, Pohl P, Schwarz K, **Goretzki PE**. *Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 116(8):501-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/18523916/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Routine measurement of serum calcitonin in patients with nodular thyroid disorders?].**  \n",
       "  Dietlein M, Wieler H, Schmidt M, Schwab R, **Goretzki PE**, Schicha H. *Nuklearmedizin. Nuclear medicine, 47(2):65-72*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/18392315/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Is it meaningful to preserve a palsied recurrent laryngeal nerve?**  \n",
       "  Chi SY, Lammers B, Boehner H, Pohl P, **Goretzki PE**. *Thyroid : official journal of the American Thyroid Association, 18(3):363-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/18303959/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Differentiation of insulin secretion patterns in insulinoma.**  \n",
       "  Saddig C, **Goretzki PE**, Starke AA. *World journal of surgery, 32(5):918-29*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/18259806/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma.**  \n",
       "  Ramage JK, **Goretzki PE**, Manfredi R, Komminoth P, Ferone D, Hyrdel R, Kaltsas G, Kelestimur F, Kvols L, Scoazec JY, Garcia MI, Caplin ME. *Neuroendocrinology, 87(1):31-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/18097130/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Abdominal preoperation. No contraindication for laparoscopic transabdominal adrenalectomy].**  \n",
       "  Pohl PP, Meyer A, Lammers BJ, **Goretzki PE**. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 79(6):571-5*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/17879074/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2007\n",
       "\n",
       "* **Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1.**  \n",
       "  Schaaf L, Pickel J, Zinner K, Hering U, Hofler M, **Goretzki PE**, Spelsberg F, Raue F, von zur Muhlen A, Gerl H, Hensen J, Bartsch DK, Rothmund M, Schneyer U, Dralle H, Engelbach M, Karges W, Stalla GK, Hoppner W. *Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 115(8):509-17*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/17853334/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.**  \n",
       "  Machens A, Schaaf L, Karges W, Frank-Raue K, Bartsch DK, Rothmund M, Schneyer U, **Goretzki P**, Raue F, Dralle H. *Clinical endocrinology, 67(4):613-22*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/17590169/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2006\n",
       "\n",
       "* **Well-differentiated pancreatic nonfunctioning tumors/carcinoma.**  \n",
       "  Falconi M, Plockinger U, Kwekkeboom DJ, Manfredi R, Korner M, Kvols L, Pape UF, Ricke J, **Goretzki PE**, Wildi S, Steinmuller T, Oberg K, Scoazec JY. *Neuroendocrinology, 84(3):196-211*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/17312380/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **A case of catecholamine and glucocorticoid excess syndrome due to a corticotropin-secreting paraganglioma.**  \n",
       "  Willenberg HS, Feldkamp J, Lehmann R, Schott M, **Goretzki PE**, Scherbaum WA. *Annals of the New York Academy of Sciences, 1073:52-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/17102072/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Coincidence of insulinoma with nesidioblastosis or false diagnosis in 2 of 15 patients?**  \n",
       "  **Goretzki PE**, Starkel A. *The American journal of surgical pathology, 30(7):919-20; author reply 920-1*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/16819338/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Dianhydride-amine hydrogen bonded perylene tetracarboxylic dianhydride and tetraaminobenzene rows.**  \n",
       "  Ma J, Rogers BL, Humphry MJ, Ring DJ, **Goretzki G**, Champness NR, Beton PH. *The journal of physical chemistry. B, 110(25):12207-10*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/16800538/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Islet hyperplasia in adults: challenge to preoperatively diagnose non-insulinoma pancreatogenic hypoglycemia syndrome.**  \n",
       "  Starke A, Saddig C, Kirch B, Tschahargane C, **Goretzki P**. *World journal of surgery, 30(5):670-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/16555022/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2005\n",
       "\n",
       "* **Letter Re: Id1 gene expression in hyperplastic and neoplastic thyroid tissues.**  \n",
       "  Rao AS, **Goretzki PE**, Kohrle J, Brabant G. *The Journal of clinical endocrinology and metabolism, 90(10):5906*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/16207897/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Do Germans keep patients too long in hospital? A prospective randomized trial.**  \n",
       "  Dotzenrath CM, Cupisti K, Raffel A, Aust B, Yang Q, Kruger B, Ohmann C, Roher HD, **Goretzki PE**. *World journal of surgery, 29(9):1189-93*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/16088423/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Radiosynoviorthesis in osteoarthritis and other disorders with concomitant synovitis in comparison to rheumatoid arthritis.**  \n",
       "  Rau H, Franke C, **Goretzki G**, Spitz J. *Cancer biotherapy & radiopharmaceuticals, 20(3):349-55*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/15989483/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[New aspects in hernia surgery].**  \n",
       "  Lammers BJ, **Goretzki PE**, Otto T. *Der Urologe. Ausg. A, 44(7):774-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/15937683/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Malignant metastatic insulinoma-postoperative treatment and follow-up.**  \n",
       "  Starke A, Saddig C, Mansfeld L, Koester R, Tschahargane C, Czygan P, **Goretzki P**. *World journal of surgery, 29(6):789-93*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/15880279/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Monitoring of the hypoglossal nerve during general anesthesia.**  \n",
       "  Bohner H, Terorde N, **Goretzki PE**. *Journal of vascular surgery, 41(4):734*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/15874945/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.**  \n",
       "  Frank-Raue K, Rondot S, Hoeppner W, **Goretzki P**, Raue F, Meng W. *The Journal of clinical endocrinology and metabolism, 90(7):4063-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/15870131/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Photochemical hydrosilylation of 11-undecenyltriethylammonium bromide with hydrogen-terminated Si surfaces for the development of robust microcantilever sensors for Cr(VI).**  \n",
       "  Boiadjiev VI, Brown GM, Pinnaduwage LA, **Goretzki G**, Bonnesen PV, Thundat T. *Langmuir : the ACS journal of surfaces and colloids, 21(4):1139-42*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/15697249/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2004\n",
       "\n",
       "* **Convenient and versatile subcellular extraction procedure, that facilitates classical protein expression profiling and functional protein analysis.**  \n",
       "  Abdolzade-Bavil A, Hayes S, **Goretzki L**, Kroger M, Anders J, Hendriks R. *Proteomics, 4(5):1397-405*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/15188407/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery].**  \n",
       "  Bosing NM, Heise JW, **Goretzki PE**, Sarbia M, Roher HD. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 75(11):1088-97*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/15168031/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Therapeutic strategy of papillary cystic and solid neoplasm (PCSN): a rare non-endocrine tumor of the pancreas in children.**  \n",
       "  Raffel A, Cupisti K, Krausch M, Braunstein S, Trobs B, **Goretzki PE**, Willnow U. *Surgical oncology, 13(1):1-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/15145028/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Economic restraints shorten the length of hospital stay: thyroid operation as a model case].**  \n",
       "  Raffel A, Cupisti K, Dotzenrath B, Kruger B, Ohmann C, Schulte KM, **Goretzki PE**, Roher HD. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 75(7):702-5*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/15138657/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Pheochromocytoma during pregnancy: laparoscopic and conventional surgical treatment of two cases.**  \n",
       "  Wolf A, **Goretzki PE**, Rohrborn A, Feldkamp J, Simon D, Scherbaum WA, Roher HD. *Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 112(2):98-101*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/15031775/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Multicenter study of radiosynoviorthesis. Clinical outcome in osteoarthritis and other disorders with concomitant synovitis in comparison with rheumatoid arthritis].**  \n",
       "  Rau H, Lohmann K, Franke C, **Goretzki G**, Lemb MA, Muller J, Panholzer PJ, Stelling E, Spitz J. *Nuklearmedizin. Nuclear medicine, 43(2):57-62*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/15029266/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2003\n",
       "\n",
       "* **Spindle epithelial tumour with thymus-like differentiation (SETTLE) of the thyroid gland with widespread metastases in a 13-year-old girl.**  \n",
       "  Raffel A, Cupisti K, Rees M, Janig U, Bernbeck B, Jazbec J, **Goretzki PE**, Gobel U. *Clinical oncology (Royal College of Radiologists (Great Britain)), 15(8):490-5*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/14690006/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Angiographic ablation of an ectopic mediastinal hyperplastic parathyroid gland using a left internal mammary artery coronary bypass.**  \n",
       "  Ernst S, Cupisti K, Kemper J, Dotzenrath C, **Goretzki PE**, Furst G. *AJR. American journal of roentgenology, 181(1):95-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/12818837/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **3D QSAR analyses-guided rational design of novel ligands for the (alpha4)2(beta2)3 nicotinic acetylcholine receptor.**  \n",
       "  Gohlke H, **Schwarz S**, Gundisch D, Tilotta MC, Weber A, Wegge T, Seitz G. *Journal of medicinal chemistry, 46(11):2031-48*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/12747776/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients.**  \n",
       "  Dotzenrath C, Cupisti K, **Goretzki E**, Mondry A, Vossough A, Grabensee B, Roher HD. *Langenbeck's archives of surgery, 387(9-10):348-54*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/12536330/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2002\n",
       "\n",
       "* **Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and the Baltic States.**  \n",
       "  Kurzawski G, Suchy J, Kladny J, Safranow K, Jakubowska A, Elsakov P, Kucinskas V, Gardovski J, Irmejs A, Sibul H, Huzarski T, Byrski T, Debniak T, Cybulski C, Gronwald J, Oszurek O, Clark J, Gozdz S, Niepsuj S, Slomski R, Plawski A, Lacka-Wojciechowska A, Rozmiarek A, Fiszer-Maliszewska L, Bebenek M, Sorokin D, Stawicka M, Godlewski D, Richter P, Brozek I, Wysocka B, Jawien A, Banaszkiewicz Z, Kowalczyk J, Czudowska D, **Goretzki PE**, Moeslein G, Lubinski J. *Journal of medical genetics, 39(10):E65*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/12362047/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Kasabach-Merritt syndrome in giant hemangioma of the liver. A case report].**  \n",
       "  Vogel T, Lammers B, von Herbay A, Kunz BM, Donner AJ, Furst G, **Goretzki PE**. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 73(7):729-32*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/12242984/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Effects of the putatively oncogenic protein kinase Calpha D294G mutation on enzymatic activity and cell growth and its occurrence in human thyroid neoplasias.**  \n",
       "  Assert R, Kotter R, Schiemann U, **Goretzki P**, Pfeiffer AF. *Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 34(6):311-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/12173071/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Importance of lymph node metastases in follicular thyroid cancer.**  \n",
       "  Witte J, **Goretzki PE**, Dieken J, Simon D, Roher HD. *World journal of surgery, 26(8):1017-22*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/12045860/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Adrenal involvement in multiple endocrine neoplasia type 1.**  \n",
       "  Langer P, Cupisti K, Bartsch DK, Nies C, **Goretzki PE**, Rothmund M, Roher HD. *World journal of surgery, 26(8):891-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/12016472/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165.**  \n",
       "  Gohlke H, Gundisch D, **Schwarz S**, Seitz G, Tilotta MC, Wegge T. *Journal of medicinal chemistry, 45(5):1064-72*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11855986/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Therapy of suspected intrathoracic parathyroid adenomas. Experiences using open transthoracic approach and video-assisted thoracoscopic surgery.**  \n",
       "  Cupisti K, Dotzenrath C, Simon D, Roher HD, **Goretzki PE**. *Langenbeck's archives of surgery, 386(7):488-93*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11819104/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Syntheses and evaluation of pyridazine and pyrimidine containing bioisosteres of (+/-)-pyrido[3.4-b]homotropane and pyrido-[3.4-b]tropane as novel nAChR ligands.**  \n",
       "  Gundisch D, Kampchen T, **Schwarz S**, Seitz G, Siegl J, Wegge T. *Bioorganic & medicinal chemistry, 10(1):1-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11738601/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2001\n",
       "\n",
       "* **[Congenital diaphragmatic hernia in a polytrauma patient].**  \n",
       "  Harms JM, Bohner H, Wenserski F, Rohrborn A, Muller E, **Goretzki PE**. *Der Unfallchirurg, 104(11):1107-10*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11760344/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **The microbiology of postoperative peritonitis.**  \n",
       "  Roehrborn A, Thomas L, Potreck O, Ebener C, Ohmann C, **Goretzki PE**, Roher HD. *Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 33(9):1513-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11568851/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Soluble Fas is increased in hyperthyroidism independent of the underlying thyroid disease.**  \n",
       "  Feldkamp J, Pascher E, Schott M, **Goretzki P**, Seissler J, Scherbaum WA. *The Journal of clinical endocrinology and metabolism, 86(9):4250-3*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11549657/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Parathyroid carcinoma: problems in diagnosis and the need for radical surgery even in recurrent disease.**  \n",
       "  Dotzenrath C, **Goretzki PE**, Sarbia M, Cupisti K, Feldkamp J, Roher HD. *European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 27(4):383-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11417985/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Is there any consensus in diagnostic and operative strategy with respect to medullary thyroid cancer? A questionnaire answered by 73 endocrine surgical units.**  \n",
       "  Dotzenrath C, **Goretzki PE**, Cupisti K, Simon D, Witte J, Yang Q, Ohmann C, Roher HD. *Langenbeck's archives of surgery, 386(1):47-52*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11405089/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential?**  \n",
       "  Dotzenrath C, Cupisti K, **Goretzki PE**, Yang Q, Simon D, Ohmann C, Roher HD. *The European journal of surgery = Acta chirurgica, 167(3):173-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11316400/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Clinical management of malignant adrenal tumors.**  \n",
       "  Kopf D, **Goretzki PE**, Lehnert H. *Journal of cancer research and clinical oncology, 127(3):143-55*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11260859/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[When is total thyroidectomy indicated? What applies in thyroid carcinoma: radical surgery according to findings].**  \n",
       "  **Goretzki PE**, Witte J. *MMW Fortschritte der Medizin, 143(1-2):32-4*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11216010/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Malignant endocrine tumors in patients with MEN 1 disease.**  \n",
       "  Dotzenrath C, **Goretzki PE**, Cupisti K, Yang Q, Simon D, Roher HD. *Surgery, 129(1):91-5*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11150038/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Follicular thyroid cancer cells: a model of metastatic tumor in vitro (review).**  \n",
       "  Hoelting T, **Goretzki PE**, Duh QY. *Oncology reports, 8(1):3-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11115561/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 2000\n",
       "\n",
       "* **Surgical treatment of postoperative, incidentally diagnosed small sporadic C-cell carcinomas of the thyroid.**  \n",
       "  Cupisti K, Simon D, Wolf A, Gerharz CD, **Goretzki PE**, Dotzenrath C, Witte J, Roher HD. *Langenbeck's archives of surgery, 385(8):526-30*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11201009/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Stomach saving duodenopancreatectomy. Indications and contraindications. The most important surgical steps].**  \n",
       "  Roher HD, Heise JW, **Goretzki PE**. *Zentralblatt fur Chirurgie, 125(12):961-5*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11190613/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[\"Field cancerization\"--an additional phenomenon in development of colon tumors? K-ras codon 12 mutations in normal colonic mucosa of patients with colorectal neoplasms].**  \n",
       "  Aivado M, Gynes M, Gorelov V, Schmidt WU, Roher HD, **Goretzki PE**. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 71(10):1230-4; discussion 1234-5*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11077584/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Surgery for Graves' disease: total versus subtotal thyroidectomy-results of a prospective randomized trial.**  \n",
       "  Witte J, **Goretzki PE**, Dotzenrath C, Simon D, Felis P, Neubauer M, Roher HD. *World journal of surgery, 24(11):1303-11*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11038198/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Therapeutic experience of 65 cases with organic hyperinsulinism.**  \n",
       "  Hellman P, **Goretzki P**, Simon D, Dotzenrath C, Roher HD. *Langenbeck's archives of surgery, 385(5):329-36*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11026704/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Gastric cancer: which patients benefit from systematic lymphadenectomy?**  \n",
       "  Bosing NM, **Goretzki PE**, Roher HD. *European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 26(5):498-505*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/11016473/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Binding of the NG2 proteoglycan to kringle domains modulates the functional properties of angiostatin and plasmin(ogen).**  \n",
       "  **Goretzki L**, Lombardo CR, Stallcup WB. *The Journal of biological chemistry, 275(37):28625-33*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/10889192/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Growth regulation of thyroid and thyroid tumors in humans.**  \n",
       "  **Goretzki PE**, Simon D, Dotzenrath C, Schulte KM, Roher HD. *World journal of surgery, 24(8):913-22*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/10865035/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function.**  \n",
       "  Willenberg HS, Bornstein SR, Hiroi N, Path G, **Goretzki PE**, Scherbaum WA, Chrousos GP. *Molecular psychiatry, 5(2):137-41*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/10822340/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Lack of MEN1 gene mutations in 27 sporadic insulinomas.**  \n",
       "  Cupisti K, Hoppner W, Dotzenrath C, Simon D, Berndt I, Roher HD, **Goretzki PE**. *European journal of clinical investigation, 30(4):325-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/10759881/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1999\n",
       "\n",
       "* **cAMP-synthesis in a medullary thyroid carcinoma cell line: response to adrenergic agents and prostaglandines.**  \n",
       "  Mertens PR, **Goretzki PE**, Keck E. *Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 107(8):488-95*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/10612479/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Complications in thyroid surgery. Incidence and therapy].**  \n",
       "  Roher HD, **Goretzki PE**, Hellmann P, Witte J. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 70(9):999-1010*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/10501664/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.**  \n",
       "  Yebra M, **Goretzki L**, Pfeifer M, Mueller BM. *Experimental cell research, 250(1):231-40*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/10388537/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Expression of wild-type ret, ret/PTC and ret/PTC variants in papillary thyroid carcinoma in Germany.**  \n",
       "  Mayr B, Potter E, **Goretzki P**, Ruschoff J, Dietmaier W, Hoang-Vu C, Dralle H, Brabant G. *Langenbeck's archives of surgery, 384(1):54-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/10367631/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Studies of oncogenes and tumor-suppressor genes in human thyroid carcinomas, and their clinical implications.**  \n",
       "  **Goretzki PE**, Dotzenrath C, Simon D, Roher HD. *Langenbeck's archives of surgery, 384(1):1-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/10367623/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan.**  \n",
       "  **Goretzki L**, Burg MA, Grako KA, Stallcup WB. *The Journal of biological chemistry, 274(24):16831-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/10358027/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **An in vitro model for peroxisome proliferation utilizing primary hepatocytes in sandwich culture.**  \n",
       "  Hildebrand H, Schmidt U, Kempka G, Jacob R, Ahr HJ, Ebener C, **Goretzki PE**, Bader A. *Toxicology in vitro : an international journal published in association with BIBRA, 13(2):265-73*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/20654484/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1998\n",
       "\n",
       "* **[Tumor necrosis factor-alpha (TNF-alpha) gene polymorphism in surgical intensive care patients with SIRS].**  \n",
       "  Dumon K, Rossbach C, Harms B, Gorelov V, Gross-Weege W, Schneider EM, **Goretzki PE**, Roher HD. *Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress, 115(Suppl I):387-90*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/14518281/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Protein expression of hMSH2 and hMLH1 in HNPCC: evaluation of a prescreening method].**  \n",
       "  Vossen S, Moslein G, Katzer M, Gabbert HE, Muller W, Wirtz C, **Goretzki PE**, Roher HD. *Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress, 115:1461-3*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9931912/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Surgical procedure for hyperthyroidism in children and adolescents].**  \n",
       "  Witte J, **Goretzki PE**, Roher HD. *Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress, 115:1048-50*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9931786/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Pelvic exenteration from the surgical viewpoint].**  \n",
       "  **Goretzki PE**, Goebell PJ, Vogel T, Schnurch HG, Roher HD. *Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress, 115:246-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9931619/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Geographical differences of thyroid carcinoma and basic molecular principles].**  \n",
       "  **Goretzki PE**, Witte J, Dotzenrath C, Schulte KM, Simon D, Roher HD. *Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress, 115:200-2*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9931611/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Genetic and biochemical screening for endocrine disease.**  \n",
       "  **Goretzki PE**, Hoppner W, Dotzenrath C, Clark OH, Simon D, Cupisti K, Schulte H, Roher HD. *World journal of surgery, 22(12):1202-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9841744/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Low-density-lipoprotein-receptor-related protein (LRP) interacts with a GTP-binding protein.**  \n",
       "  **Goretzki L**, Mueller BM. *The Biochemical journal, 336 ( Pt 2)(Pt 2):381-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9820815/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Rare loss of heterozygosity of the MTS1 and MTS2 tumor suppressor genes in differentiated human thyroid cancer.**  \n",
       "  Schulte KM, Staudt S, Niederacher D, Finken-Eigen M, Kohrer K, **Goretzki PE**, Roher HD. *Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 30(9):549-54*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9808321/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Regulation of the HGF-receptor c-met in the thyroid gland.**  \n",
       "  Schulte KM, Antoch G, Ellrichmann M, Finken-Eigen M, Kohrer K, Simon D, **Goretzki PE**, Roher HD. *Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 106(4):310-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9792464/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Significance of oncogenes in development and prognosis of differentiated thyroid gland carcinomas].**  \n",
       "  **Goretzki PE**, Schulte KM. *Der Internist, 39(6):584-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9677513/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Therapeutic management of rare malignant pancreatic tumors in children.**  \n",
       "  Vossen S, **Goretzki PE**, Goebel U, Willnow U. *World journal of surgery, 22(8):879-82*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9673563/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Chance and risk of controlling rabies in large-scale and long-term immunized fox populations.**  \n",
       "  Tischendorf L, Thulke HH, Staubach C, Muller MS, Jeltsch F, **Goretzki J**, Selhorst T, Muller T, Schluter H, Wissel C. *Proceedings. Biological sciences, 265(1399):839-46*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9633109/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Reoperative surgery for organic hyperinsulinism: indications and operative strategy.**  \n",
       "  Simon D, Starke A, **Goretzki PE**, Roeher HD. *World journal of surgery, 22(7):666-71; discussion 671-2*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9606279/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Redifferentiation therapy with retinoids: therapeutic option for advanced follicular and papillary thyroid carcinoma.**  \n",
       "  Simon D, Koehrle J, Reiners C, Boerner AR, Schmutzler C, Mainz K, **Goretzki PE**, Roeher HD. *World journal of surgery, 22(6):569-74*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9597930/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Functional retinoid and thyroid hormone receptors in human thyroid-carcinoma cell lines and tissues.**  \n",
       "  schmutzler C, Brtko J, Winzer R, Jakobs TC, Meissner-Weigl J, Simon D, **Goretzki PE**, Kohrle J. *International journal of cancer, 76(3):368-76*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9579574/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[From limited to extensive radical operation in thyroid carcinoma].**  \n",
       "  Simon D, **Goretzki PE**, Roher HD. *Praxis, 87(11):383-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9562814/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma.**  \n",
       "  Mayr B, Potter E, **Goretzki P**, Ruschoff J, Dietmaier W, Hoang-Vu C, Dralle H, Brabant G. *British journal of cancer, 77(6):903-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9528832/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1997\n",
       "\n",
       "* **Receptor-mediated endocytosis of urokinase-type plasminogen activator is regulated by cAMP-dependent protein kinase.**  \n",
       "  **Goretzki L**, Mueller BM. *Journal of cell science, 110 ( Pt 12):1395-402*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9217325/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?**  \n",
       "  Mayr B, Brabant G, **Goretzki P**, Ruschoff J, Dietmaier W, Dralle H. *The Journal of clinical endocrinology and metabolism, 82(4):1306-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9100614/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Inhibition of the interaction of urokinase-type plasminogen activator (uPA) with its receptor (uPAR) by synthetic peptides.**  \n",
       "  Burgle M, Koppitz M, Riemer C, Kessler H, Konig B, Weidle UH, Kellermann J, Lottspeich F, Graeff H, Schmitt M, **Goretzki L**, Reuning U, Wilhelm O, Magdolen V. *Biological chemistry, 378(3-4):231-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9165076/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.**  \n",
       "  Farnebo F, Teh BT, Dotzenrath C, Wassif WS, Svensson A, White I, Betz R, **Goretzki P**, Sandelin K, Farnebo LO, Larsson C. *Human genetics, 99(3):342-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9050920/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Surgical therapy of neuroendocrine tumors of the thymus].**  \n",
       "  Cupisti K, Dotzenrath C, Simon D, **Goretzki PE**, Roher HD. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 68(2):136-40*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9156979/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Special diagnostic and therapeutic aspects of insulinoma].**  \n",
       "  Roher HD, Simon D, Starke A, **Goretzki PE**. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 68(2):116-21*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9156976/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Does rationing of intensive care beds lead to premature ward return with preventable complications?].**  \n",
       "  Ebener C, **Goretzki PE**, Grabitz K, Elbertzhagen D, Roher HD. *Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress, 114:1396-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9574440/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Does decreased preoperative diagnosis in goiter surgery present special challenges for the surgeon? What stays indispensible? What is superfluous?].**  \n",
       "  Witte J, **Goretzki PE**, Roher HD. *Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress, 114:1145-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9574360/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Instrumental diagnosis for therapeutic decisions--what is possible and desirable, what is essential and what is superfluous--in goiter surgery].**  \n",
       "  Roher HD, Simon D, **Goretzki PE**. *Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress, 114:387-90*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9574162/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Guidelines in oncologic surgery--malignant thyroid tumors].**  \n",
       "  Roher HD, Simon D, **Goretzki PE**. *Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress, 114:142-5*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9574114/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Results of selective venous site-specific catheterization in occult C-cell carcinoma of the thyroid gland].**  \n",
       "  Cupisti K, Simon D, Dotzenrath C, **Goretzki PE**, Roher HD. *Langenbecks Archiv fur Chirurgie, 382(6):295-301*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9498199/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Surgery for Graves disease in childhood and adolescence.**  \n",
       "  Witte J, **Goretzki PE**, Roher HD. *Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 105 Suppl 4:58-60*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9439918/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Conventional operation for therapy of incidentaloma].**  \n",
       "  Simon D, **Goretzki PE**, Roher HD. *Zentralblatt fur Chirurgie, 122(6):473-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9334115/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Surgical concept in sporadic and familial pheochromocytoma].**  \n",
       "  **Goretzki PE**, Simon D, Roher HD. *Zentralblatt fur Chirurgie, 122(6):467-72*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9334114/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].**  \n",
       "  Witte J, Schlotmann U, Simon D, Dotzenrath C, Ohmann C, **Goretzki PE**. *Zentralblatt fur Chirurgie, 122(4):259-65*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9221636/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Iodide or L-thyroxine to prevent recurrent goiter in an iodine-deficient area: prospective sonographic study.**  \n",
       "  Feldkamp J, Seppel T, Becker A, Klisch A, Schlaghecke R, **Goretzki PE**, Roher HD. *World journal of surgery, 21(1):10-4*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8943171/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1996\n",
       "\n",
       "* **A frequent mutation/polymorphism in tumor suppressor gene INK4B (MTS-2) in papillary and medullary thyroid cancer.**  \n",
       "  **Goretzki PE**, Gorelov V, Dotzenrath C, Witte J, Roeher HD. *Surgery, 120(6):1081-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8957499/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer.**  \n",
       "  Moslein G, Tester DJ, Lindor NM, Honchel R, Cunningham JM, French AJ, Halling KC, Schwab M, **Goretzki P**, Thibodeau SN. *Human molecular genetics, 5(9):1245-52*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8872463/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors?**  \n",
       "  Dotzenrath C, Teh BT, Farnebo F, Cupisti K, Svensson A, Toell A, **Goretzki P**, Larsson C. *The Journal of clinical endocrinology and metabolism, 81(9):3194-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8784068/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma.**  \n",
       "  Simon D, **Goretzki PE**, Witte J, Roher HD. *World journal of surgery, 20(7):860-6; discussion 866*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8678963/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Endocrine pancreatic tumors].**  \n",
       "  **Goretzki PE**, Simon D, Starke A, Roher HD. *Therapeutische Umschau. Revue therapeutique, 53(5):408-12*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8685860/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator.**  \n",
       "  Magdolen V, Rettenberger P, Koppitz M, **Goretzki L**, Kessler H, Weidle UH, Konig B, Graeff H, Schmitt M, Wilhelm O. *European journal of biochemistry, 237(3):743-51*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8647121/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Is total thyroidectomy and lymph node excision as therapy of differentiated thyroid gland carcinomas in childhood justified?].**  \n",
       "  Witte J, **Goretzki PE**, Simon D, Roher HD. *Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress, 113:196-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9101829/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Molecular genetics of primary and secondary hyperparathyroidism.**  \n",
       "  Dotzenrath C, **Goretzki PE**, Farnebo F, Teh BT, Weber G, Roher HD, Larsson C. *Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 104 Suppl 4:105-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8981014/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **INT-2 gene amplification in differentiated human thyroid cancer.**  \n",
       "  Schulte KM, Niederacher D, An HX, Staudt S, Simon D, Beckmann MW, **Goretzki PE**. *Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 104 Suppl 4:101-4*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8981013/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **A modified PCR-based method for rapid non-radioactive detection of clinically important pathogens.**  \n",
       "  Gorelov VN, Dumon K, Barteneva NS, Roher HD, **Goretzki PE**. *Microbiology and immunology, 40(9):611-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8908604/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Ulcer surgery '96--choice of methods in an emergency].**  \n",
       "  Roher HD, Imhof M, **Goretzki PE**, Ohmann C. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 67(1):20-5*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8851671/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Results of surgical therapy in renal hyperparathyroidism. Follow-up of 143 patients].**  \n",
       "  Dotzenrath C, **Goretzki PE**, Roher HD. *Langenbecks Archiv fur Chirurgie, 381(1):46-50*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8717175/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Distribution of Gs-alpha activating mutations in human thyroid tumors measured by subcloning.**  \n",
       "  Gorelov VN, Gyenes M, Neser F, Roher HD, **Goretzki PE**. *Journal of cancer research and clinical oncology, 122(8):453-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8698744/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1995\n",
       "\n",
       "* **[Preventive radical surgery of C-cell carcinoma in MEN-II syndrome based on genetic screening].**  \n",
       "  Roher HD, Simon D, **Goretzki PE**, Hoppner W, Lederbogen S, Seppel T. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 66(12):1196-202*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8582162/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **A competitive chromogenic assay to study the functional interaction of urokinase-type plasminogen activator with its receptor.**  \n",
       "  Rettenberger P, Wilhelm O, Oi H, Weidle UH, **Goretzki L**, Koppitz M, Lottspeich F, Konig B, Pessara U, Kramer MD, et al.. *Biological chemistry Hoppe-Seyler, 376(10):587-94*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8590627/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Differentiated thyroid gland carcinomas in \"autonomous adenomas\" in childhood].**  \n",
       "  Muller A, **Goretzki P**, Witte J, Gerharz P, Roher HD. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 66(10):1018-20*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8529444/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **N-3 but not N-6 fatty acids reduce the expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells.**  \n",
       "  Pietsch A, Weber C, **Goretzki M**, Weber PC, Lorenz RL. *Cell biochemistry and function, 13(3):211-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/7554100/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer.**  \n",
       "  Thomssen C, Schmitt M, **Goretzki L**, Oppelt P, Pache L, Dettmar P, Janicke F, Graeff H. *Clinical cancer research : an official journal of the American Association for Cancer Research, 1(7):741-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9816040/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Current aspects of surgery of the parathyroid glands].**  \n",
       "  Dotzenrath C, **Goretzki PE**, Simon D, Witte J, Roher HD. *Journal de chirurgie, 132(5):270-4*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/7642736/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Expression of the human urokinase-type plasminogen activator receptor in E. coli and Chinese hamster ovary cells: purification of the recombinant proteins and generation of polyclonal antibodies in chicken.**  \n",
       "  Magdolen V, Rettenberger P, Lopens A, Oi H, Lottspeich F, Kellermann J, Creutzburg S, **Goretzki L**, Weidle UH, Wilhelm O, et al.. *Electrophoresis, 16(5):813-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/7588568/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Retinoic acid inhibits basal and interferon-gamma-induced expression of intercellular adhesion molecule 1 in monocytic cells.**  \n",
       "  Weber C, Calzada-Wack JC, **Goretzki M**, Pietsch A, Johnson JP, Ziegler-Heitbrock HW. *Journal of leukocyte biology, 57(3):401-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/7533818/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Molecular analysis of mutations in thyroid tumors with TGGE.**  \n",
       "  Simon D, **Goretzki PE**, Schafer C, Gorelov V, Ebeling B, Roher HD. *Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 103(5):275-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8536054/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Overexpression of Gs alpha subunit in thyroid tumors bearing a mutated Gs alpha gene.**  \n",
       "  Gorelov VN, Dumon K, Barteneva NS, Palm D, Roher HD, **Goretzki PE**. *Journal of cancer research and clinical oncology, 121(4):219-24*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/7751320/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1994\n",
       "\n",
       "* **[Surgical treatment of esophageal perforations].**  \n",
       "  **Goretzki PE**, Horstmann O, Verreet PR, Rohr HD. *Journal de chirurgie, 131(10):440-4*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/7860679/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Diminished expression of the alpha 5 beta 1 integrin (fibronectin receptor) by invasive clones of a human follicular thyroid cancer cell line.**  \n",
       "  Demeure MJ, Doffek KM, Rezaee M, **Goretzki PE**, Wilson SD. *World journal of surgery, 18(4):569-75; discussion 575-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/7725746/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Significance of P53 in human thyroid tumors.**  \n",
       "  Simon D, **Goretzki PE**, Gorelev V, Ebling B, Reishaus E, Lyons J, Haubruck H, Roher HD. *World journal of surgery, 18(4):535-40; discussion 540-1*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/7725741/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **A method to increase the sensitivity of mutation specific oligonucleotide hybridization using asymmetric polymerase-chain reaction (PCR).**  \n",
       "  Gorelov VN, Roher HD, **Goretzki PE**. *Biochemical and biophysical research communications, 200(1):365-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8166707/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Surgical strategy in persistence and recurrence in surgery of primary hyperparathyroidism].**  \n",
       "  Dotzenrath C, **Goretzki PE**, Roher HD. *Langenbecks Archiv fur Chirurgie, 379(4):218-23*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/7934579/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1993\n",
       "\n",
       "* **Persistent hypertension after successful adrenal operation.**  \n",
       "  Simon D, **Goretzki PE**, Lollert A, Roher HD. *Surgery, 114(6):1189-95*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8256225/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Principals of limited or radical surgery for differentiated thyroid cancer.**  \n",
       "  Roeher HD, Simon D, Witte J, **Goretzki PE**. *Thyroidology, 5(3):93-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/7524636/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Surgical reintervention for differentiated thyroid cancer.**  \n",
       "  **Goretzki PE**, Simon D, Frilling A, Witte J, Reiners C, Grussendorf M, Horster FA, Roher HD. *The British journal of surgery, 80(8):1009-12*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8402050/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Renal hyperparathyroidism following kidney transplantation.**  \n",
       "  Dotzenrath C, **Goretzki PE**, Roher HD. *Annali italiani di chirurgia, 64(4):381-4*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8154661/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: growth inhibition by cAMP.**  \n",
       "  Derwahl M, Kuemmel M, **Goretzki P**, Schatz H, Broecker M. *Biochemical and biophysical research communications, 191(3):1131-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8385451/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion.**  \n",
       "  Kobayashi H, Ohi H, Shinohara H, Sugimura M, Fujii T, Terao T, Schmitt M, **Goretzki L**, Chucholowski N, Janicke F, et al.. *British journal of cancer, 67(3):537-44*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8382511/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Surgical therapy of secondary hyperparathyroidism after kidney transplantation].**  \n",
       "  Dotzenrath C, **Goretzki PE**, Roher HD. *Langenbecks Archiv fur Chirurgie, 378(2):121-4*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8474295/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Experience with presymptomatic screening of patients with C cell carcinoma of the thyroid gland].**  \n",
       "  Frilling A, Roher HD, Ponder BA, **Goretzki PE**, Schlaghecke R, Reiners C. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 64(1):28-35*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/8094664/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1992\n",
       "\n",
       "* **[Surgical treatment of carcinoid tumors of the intestine].**  \n",
       "  Simon D, **Goretzki PE**, Branscheid D, Roher JD. *Journal de chirurgie, 129(10):449-55*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/1294589/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications.**  \n",
       "  **Goretzki PE**, Lyons J, Stacy-Phipps S, Rosenau W, Demeure M, Clark OH, McCormick F, Roher HD, Bourne HR. *World journal of surgery, 16(4):576-81; discussion 581-2*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/1413827/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Invasion by cultured human follicular thyroid cancer correlates with increased beta 1 integrins and production of proteases.**  \n",
       "  Demeure MJ, Damsky CH, Elfman F, **Goretzki PE**, Wong MG, Clark OH. *World journal of surgery, 16(4):770-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/1384245/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L.**  \n",
       "  **Goretzki L**, Schmitt M, Mann K, Calvete J, Chucholowski N, Kramer M, Gunzler WA, Janicke F, Graeff H. *FEBS letters, 297(1-2):112-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/1551416/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Flow cytofluorometry in tumour cell receptor analysis. Survey of the literature and recent developments concerning the urokinase-type plasminogen activator (uPA).**  \n",
       "  Chucholowski N, Schmitt M, **Goretzki L**, Schuren E, Moniwa N, Weidle U, Kramer M, Wagner B, Janicke F, Graeff H. *Biochemical Society transactions, 20(1):208-16*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/1321752/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **G-protein mutations in thyroid tumors.**  \n",
       "  **Goretzki PE**, Simon D, Roher HD. *Experimental and clinical endocrinology, 100(1-2):14-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/1468509/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1991\n",
       "\n",
       "* **Management of primary hyperparathyroidism caused by multiple gland disease.**  \n",
       "  **Goretzki PE**, Dotzenrath C, Roeher HD. *World journal of surgery, 15(6):693-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/1685044/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours.**  \n",
       "  Wright PA, Lemoine NR, **Goretzki PE**, Wyllie FS, Bond J, Hughes C, Roher HD, Williams ED, Wynford-Thomas D. *Oncogene, 6(9):1693-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/1923534/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cells.**  \n",
       "  Schmitt M, Chucholowski N, Busch E, Hellmann D, Wagner B, **Goretzki L**, Janicke F, Gunzler WA, Graeff H. *Seminars in thrombosis and hemostasis, 17(3):291-302*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/1724574/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Surgery for immunogenic hyperthyroidism.**  \n",
       "  Roher HD, Horster FA, Frilling A, **Goretzki PE**, Witte J. *Experimental and clinical endocrinology, 97(2-3):292-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/1915647/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Correlated abnormalities of transforming growth factor-beta 1 response and p53 expression in thyroid epithelial cell transformation.**  \n",
       "  Wyllie FS, Dawson T, Bond JA, **Goretzki P**, Game S, Prime S, Wynford-Thomas D. *Molecular and cellular endocrinology, 76(1-3):13-21*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/1820969/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).**  \n",
       "  Kobayashi H, Schmitt M, **Goretzki L**, Chucholowski N, Calvete J, Kramer M, Gunzler WA, Janicke F, Graeff H. *The Journal of biological chemistry, 266(8):5147-52*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/1900515/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Morphology and function-based surgery in different forms of hyperthyroidism].**  \n",
       "  Roher HD, Horster FA, Frilling A, **Goretzki PE**. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 62(3):176-81*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/1709844/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Biological and clinical relevance of the urokinase-type plasminogen activator (uPA) in breast cancer.**  \n",
       "  Schmitt M, **Goretzki L**, Janicke F, Calvete J, Eulitz M, Kobayashi H, Chucholowski N, Graeff H. *Biomedica biochimica acta, 50(4-6):731-41*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/1801751/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1990\n",
       "\n",
       "* **Actin architecture of cultured human thyroid cancer cells: predictor of differentiation?**  \n",
       "  Demeure MJ, Hughes-Fulford M, **Goretzki PE**, Duh QY, Clark OH. *Surgery, 108(6):986-92; discussion 992-3*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2247845/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **West Germany: still an underdeveloped country in the diagnosis and early treatment of primary hyperparathyroidism?**  \n",
       "  Dotzenrath C, **Goretzki PE**, Roher HD. *World journal of surgery, 14(5):660-1; discussion 662*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2238668/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Subtotal thyroid gland resection as therapy for thyrotoxic crises].**  \n",
       "  Frilling A, **Goretzki PE**, Horster FA, Grussendorf M, Roher HD. *Deutsche medizinische Wochenschrift (1946), 115(19):735-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2338059/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **The influence of surgery on endocrine ophthalmopathy.**  \n",
       "  Frilling A, **Goretzki PE**, Grussendorf M, Erbsloh M, Roher HD. *World journal of surgery, 14(3):442-5; discussion 445-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2368450/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Acute pancreatitis as the initial manifestation of primary hyperparathyroidism in children].**  \n",
       "  Dotzenrath C, Raunest J, **Goretzki PE**, Schmitt-Graff A, Roher HD. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 61(4):329-30*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2347271/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Iodine-induced crisis in thyroid autonomy: a surgical emergency].**  \n",
       "  Frilling A, **Goretzki PE**, Roher HD. *Acta medica Austriaca, 17 Suppl 1:86-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2389645/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Progress in the diagnosis and therapy of C cell carcinoma of the thyroid gland].**  \n",
       "  Frilling A, **Goretzki PE**, Roher HD. *Langenbecks Archiv fur Chirurgie, 375(6):333-9*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2280648/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Therapeutic strategy and prognosis of malignant struma].**  \n",
       "  Roher HD, **Goretzki PE**, Frilling A. *Zentralblatt fur Chirurgie, 115(7):389-97*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2195806/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Growth regulation of normal thyroids and thyroid tumors in man.**  \n",
       "  **Goretzki PE**, Frilling A, Simon D, Roeher HD. *Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 118:48-63*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2173080/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1989\n",
       "\n",
       "* **[Various strategies in the diagnosis and therapy of thyroid gland cancer. Results of a survey].**  \n",
       "  **Goretzki PE**, Frilling A, Ohmann C, Wins L, Grussendorf M, Roher HD. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 60(6):398-402*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2758893/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Intrathoracic struma].**  \n",
       "  Roher HD, **Goretzki PE**, Wahl RA, Frilling A. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 60(6):384-90*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2667906/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Indications for and basic principles of the surgical treatment of thyroid diseases].**  \n",
       "  Roher HD, **Goretzki PE**, Frilling A. *Der Radiologe, 29(3):119-24*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2652183/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Effect of near total thyroidectomy on ophthalmopathy in patients with Graves' disease.**  \n",
       "  Grussendorf M, Inanc Y, **Goretzki PE**, Roher HD, Horster FA, Kruskemper HL. *Developments in ophthalmology, 20:86-90*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2591630/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **The importance of screening for medullary thyroid carcinoma in families of patients with MEN 2.**  \n",
       "  Frilling A, **Goretzki PE**, Bastian L, Roeher HD. *Henry Ford Hospital medical journal, 37(3-4):122-3*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2576942/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1988\n",
       "\n",
       "* **Thyroid-stimulating antibodies of Graves' disease in thyroid cancer.**  \n",
       "  Roher HD, **Goretzki PE**, Frilling A. *The New England journal of medicine, 319(25):1669-70*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3200284/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **A new siliconized-glass fiber as support for protein-chemical analysis of electroblotted proteins.**  \n",
       "  Eckerskorn C, Mewes W, **Goretzki H**, Lottspeich F. *European journal of biochemistry, 176(3):509-19*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2458922/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Persistent postoperative hyperthyroidism--a surgical problem].**  \n",
       "  Frilling A, **Goretzki PE**, Roher HD. *Wiener medizinische Wochenschrift (1946), 138(18):450-1*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3188552/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Classical versus lower segment caesarean section for very-low-birthweight infants.**  \n",
       "  Dietl JA, **Goretzki K**, Hirsch HA. *Lancet (London, England), 1(8596):1227*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2897041/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Acute abdomen in unrecognized hyperparathyroidism].**  \n",
       "  **Goretzki PE**, Becker H, Dotzenrath C, Grussendorf M, Roher HD. *Wiener klinische Wochenschrift, 100(11):373-5*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3407198/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Subtotal thyroidectomy as a superior therapeutic principle in the treatment of endocrine ophthalmopathy: a comparison with retrobulbar irradiation and thyrostatic therapy alone].**  \n",
       "  Grussendorf M, Horster FA, Inanc Y, **Goretzki PE**, Roher HD, Kruskemper HL. *Wiener klinische Wochenschrift, 100(11):355-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3407195/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Reinterventions for hyperparathyroidism in multiple endocrine adenopathy].**  \n",
       "  Roher HD, **Goretzki PE**, Dotzenrath C. *Wiener klinische Wochenschrift, 100(11):364-6*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2900582/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Reintervention in C-cell carcinoma].**  \n",
       "  Wahl RA, **Goretzki PE**, Branscheid D, Vietmeier P, Roher HD. *Wiener klinische Wochenschrift, 100(11):348-51*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2900580/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Echinococcus cyst of the thyroid gland. A case report].**  \n",
       "  Dotzenrath C, Burring KF, **Goretzki PE**. *Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 59(2):106-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3359872/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Fetal outcome following cesarean section in premature labor. Isthmocorpus longitudinal section or isthmian transverse section?].**  \n",
       "  Dietl J, Dannecker G, **Goretzki K**, Hirsch HA. *Geburtshilfe und Frauenheilkunde, 48(1):13-5*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3350321/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Autotransplantation of parathyroid gland tissue--on the indications for total parathyroidectomy with autotransplantation].**  \n",
       "  **Goretzki PE**. *Langenbecks Archiv fur Chirurgie, 373(6):323-4*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3210848/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1987\n",
       "\n",
       "* **Nerve growth factor (NGF) sensitizes human medullary thyroid carcinoma (hMTC) cells for cytostatic therapy in vitro.**  \n",
       "  **Goretzki PE**, Wahl RA, Becker R, Koller C, Branscheid D, Grussendorf M, Roeher HD. *Surgery, 102(6):1035-42*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3686343/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Observation of carboxylic groups in the lattice of sintered Ba2YCu3O7-y high-Tc superconductors.**  \n",
       "  Parmigiani F, Chiarello G, Ripamonti N, **Goretzki H**, Roll U. *Physical review. B, Condensed matter, 36(13):7148-7150*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/9942447/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Management of goiter and thyroid nodules in an area of endemic goiter.**  \n",
       "  Roher HD, **Goretzki PE**. *The Surgical clinics of North America, 67(2):233-49*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3551146/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Surgery of metastases of differentiated thyroid cancers].**  \n",
       "  Roher HD, **Goretzki PE**, Wahl RA. *Langenbecks Archiv fur Chirurgie, 371(2):103-13*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3669824/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Pathophysiological and clinical implications of thyroid growth-stimulating immunoglobulins: evidence for their intrathyroidal production.**  \n",
       "  Schatz H, Ludwig I, Wiss F, **Goretzki PE**. *Acta endocrinologica. Supplementum, 281:334-41*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3475914/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Adenylate cyclase stimulation and [3H]thymidine incorporation in human thyroid tissues and thyrocyte cultures: the effect of IgG preparation from patients with different thyroid disorders.**  \n",
       "  **Goretzki PE**, West M, Koob R, Koller C, Joseph K, Roher HD. *Acta endocrinologica. Supplementum, 281:281-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3475910/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Thyrotropin (TSH) stimulates cell growth and DNA synthesis in monolayer cultures of human thyrocytes independent of the adenylate-cyclase system.**  \n",
       "  **Goretzki PE**, Koob R, Koller C, Roher HD. *Acta endocrinologica. Supplementum, 281:273-80*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3475909/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1986\n",
       "\n",
       "* **The effect of thyrotropin and cAMP on DNA synthesis and cell growth of human thyrocytes in monolayer culture.**  \n",
       "  **Goretzki PE**, Koob R, Koller T, Simon R, Branscheid D, Clark OH, Roher HD. *Surgery, 100(6):1053-61*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3024342/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins.**  \n",
       "  Eisel U, Jarausch W, **Goretzki K**, Henschen A, Engels J, Weller U, Hudel M, Habermann E, Niemann H. *The EMBO journal, 5(10):2495-502*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3536478/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Screening for bacterial Fc-receptor activity on nitrocellulose membranes.**  \n",
       "  Lammler C, Schaufuss P, **Goretzki K**, Blobel H. *Journal of immunological methods, 90(1):47-50*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3519777/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[The cold thyroid nodule].**  \n",
       "  Roher HD, **Goretzki P**. *Langenbecks Archiv fur Chirurgie, 369:191-4*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3807517/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1985\n",
       "\n",
       "* **Thyroid function after surgery for autonomous and non-autonomous nodular endemic goitre--effect of iodide-substitution.**  \n",
       "  Wahl RA, Joseph K, Bogner E, Ohmann C, **Goretzki P**, Roher HD. *Klinische Wochenschrift, 63(17):812-20*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3903336/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Low T3 syndrome in patients following major surgery.**  \n",
       "  Tsuchiya A, **Goretzki PE**, Gramse M, Joseph K, Wahl RA. *The Japanese journal of surgery, 15(4):285-90*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/4057698/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Indication for operation of patients with autonomously functioning thyroid tissue in endemic goiter areas.**  \n",
       "  **Goretzki PE**, Wahl RA, Branscheid D, Joseph K, Tsuchiya A, Roher HD. *World journal of surgery, 9(1):149-55*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3838608/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Estrogen and thyroid-stimulating hormone (TSH) receptors in neoplastic and nonneoplastic human thyroid tissue.**  \n",
       "  Clark OH, Gerend PL, Davis M, **Goretzki PE**, Hoffman PG Jr. *The Journal of surgical research, 38(2):89-96*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/2982058/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **[Radicality principles in operations on malignant thyroid tumors].**  \n",
       "  Wahl RA, **Goretzki PE**, Joseph K, Roher HD. *Langenbecks Archiv fur Chirurgie, 366:61-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/4058200/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Enzymatic hydrolysis of tetanus toxin by intrinsic and extrinsic proteases. Characterization of the fragments by monoclonal antibodies.**  \n",
       "  **Goretzki K**, Habermann E. *Medical microbiology and immunology, 174(3):139-50*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/3897815/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1984\n",
       "\n",
       "* **Absence of high-affinity binding sites for beta-adrenergic blockers and lack of adenyl cyclase stimulation to beta-adrenergic stimulators in most normal and adenomatous human thyroid tissues.**  \n",
       "  **Goretzki PE**, Wahl RA, Branscheid D, Roeher HD. *Surgery, 96(6):1001-8*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/6150553/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1983\n",
       "\n",
       "* **Serum and tissue T3 levels in endotoxin shock in the rat.**  \n",
       "  **Goretzki PE**, Cavalieri RR, Wahl RA, Ellis RJ, McMahon FA, Goldfien S, Gerend P, Clark OH. *The Journal of surgical research, 35(3):211-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/6887841/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue.**  \n",
       "  Clark OH, Gerend PL, **Goretzki P**, Nissenson RA. *The Journal of clinical endocrinology and metabolism, 57(1):140-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/6304132/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Surgery for hyperthyroidism: indications, pretreatment, operative strategy and results.**  \n",
       "  Roeher HD, Wahl R, **Goretzki P**, Branscheid D. *Annales chirurgiae et gynaecologiae, 72(3):101-4*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/6194731/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "* **Monoclonal antibodies against tetanus toxin and toxoid.**  \n",
       "  Ahnert-Hilger G, Bizzini B, **Goretzki K**, Muller H, Volckers C, Habermann E. *Medical microbiology and immunology, 172(2):123-35*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/6193402/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1982\n",
       "\n",
       "* **Coexistence of hyperthyroidism and thyroid cancer.**  \n",
       "  Wahl RA, **Goretzki P**, Meybier H, Nitschke J, Linder M, Roher HD. *World journal of surgery, 6(4):385-90*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/7123975/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1981\n",
       "\n",
       "* **Prophylaxis of recurrent goiter by high-dose L-thyroxine.**  \n",
       "  **Goretzki P**, Roeher HD, Horeyseck G. *World journal of surgery, 5(6):855-7*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/7342482/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n",
       "## 1979\n",
       "\n",
       "* **[Mode of action and tolerance of a single weekly dose of 1 mg of L-thyroxine for the prevention of recurrence of goiter].**  \n",
       "  Roher HD, **Goretzki P**, Horeyseck G. *Chirurgisches Forum fur experimentelle und klinische Forschung:251-4*. <a href=\"https://pubmed.ncbi.nlm.nih.gov/456135/\" style=\"text-decoration: none;\">PubMed</a>\n",
       "\n",
       "\n"
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "defaultdict(list,\n",
       "            {'2023': [{'PMID': '36670127',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230124',\n",
       "               'LR': '20230316',\n",
       "               'IS': '2045-2322 (Electronic) 2045-2322 (Linking)',\n",
       "               'VI': '13',\n",
       "               'IP': '1',\n",
       "               'DP': '2023 Jan 20',\n",
       "               'TI': 'A comparison of pediatric inflammatory multisystem syndrome temporarily-associated with SARS-CoV-2 and Kawasaki disease.',\n",
       "               'PG': '1173',\n",
       "               'LID': '10.1038/s41598-022-26832-5 [doi] 1173',\n",
       "               'AB': 'The connection between Pediatric Inflammatory Multisystem Syndrome (PIMS) and Kawasaki Disease (KD) is not yet fully understood. Using the same national registry, clinical features and outcome of children hospitalized in Germany, and Innsbruck (Austria) were compared. Reported to the registry were 395 PIMS and 69 KD hospitalized patients. Patient age in PIMS cases was higher than in KD cases (median 7 [IQR 4-11] vs. 3 [IQR 1-4] years). A majority of both PIMS and KD patients were male and without comorbidities. PIMS patients more frequently presented with organ dysfunction, with the gastrointestinal (80%), cardiovascular (74%), and respiratory (52%) systems being most commonly affected. By contrast, KD patients more often displayed dermatological (99% vs. 68%) and mucosal changes (94% vs. 64%), plus cervical lymph node swelling (51% vs. 34%). Intensive care admission (48% vs. 19%), pulmonary support (32% vs. 10%), and use of inotropes/vasodilators (28% vs. 3%) were higher among PIMS cases. No patients died. Upon patient discharge, potentially irreversible sequelae-mainly cardiovascular-were reported (7% PIMS vs. 12% KD). Despite differences in age distribution and disease severity, PIMS and KD cases shared many common clinical and prognostic characteristics. This supports the hypothesis that the two entities represent a syndrome continuum.',\n",
       "               'CI': ['(c) 2023. The Author(s).'],\n",
       "               'FAU': ['Hufnagel, Markus',\n",
       "                'Armann, Jakob',\n",
       "                'Jakob, Andre',\n",
       "                'Doenhardt, Maren',\n",
       "                'Diffloth, Natalie',\n",
       "                'Hospach, Anton',\n",
       "                'Schneider, Dominik T',\n",
       "                'Trotter, Andreas',\n",
       "                'Roessler, Martin',\n",
       "                'Schmitt, Jochen',\n",
       "                'Berner, Reinhard'],\n",
       "               'AU': ['Hufnagel M',\n",
       "                'Armann J',\n",
       "                'Jakob A',\n",
       "                'Doenhardt M',\n",
       "                'Diffloth N',\n",
       "                'Hospach A',\n",
       "                'Schneider DT',\n",
       "                'Trotter A',\n",
       "                'Roessler M',\n",
       "                'Schmitt J',\n",
       "                'Berner R'],\n",
       "               'AD': ['Division of Pediatric Infectious Diseases and Rheumatology, Department of Pediatrics and Adolescent Medicine, University Medical Center, Medical Faculty, University of Freiburg, Mathildenstr. 1, 79106, Freiburg, Germany. markus.hufnagel@uniklinik-freiburg.de.',\n",
       "                'Department of Pediatrics, University Hospital, Medical Faculty Carl Gustav Carus, Technische Universitat Dresden, Dresden, Germany.',\n",
       "                'Department of Pediatric Cardiology and Pediatric Intensive Care, Ludwig Maximilians University of Munich, Munich, Germany.',\n",
       "                'Department of Pediatrics, University Hospital, Medical Faculty Carl Gustav Carus, Technische Universitat Dresden, Dresden, Germany.',\n",
       "                'Department of Pediatrics, University Hospital, Medical Faculty Carl Gustav Carus, Technische Universitat Dresden, Dresden, Germany.',\n",
       "                'Olga-Hospital, Stuttgart, Germany.',\n",
       "                'Clinic of Pediatrics, Municipal Hospital Dortmund, Dortmund, Germany.',\n",
       "                \"Children's Hospital and Center for Perinatal Medicine, Singen, Germany.\",\n",
       "                'Center for Evidence-Based Healthcare, Medical Faculty Carl Gustav Carus, Technische Universitat Dresden, Dresden, Germany.',\n",
       "                'Center for Evidence-Based Healthcare, Medical Faculty Carl Gustav Carus, Technische Universitat Dresden, Dresden, Germany.',\n",
       "                'Department of Pediatrics, University Hospital, Medical Faculty Carl Gustav Carus, Technische Universitat Dresden, Dresden, Germany.'],\n",
       "               'CN': ['PIMS-DGPI Working Group'],\n",
       "               'LA': ['eng'],\n",
       "               'SI': ['DRKS/DRKS00021506'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20230120',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Sci Rep',\n",
       "               'JT': 'Scientific reports',\n",
       "               'JID': '101563288',\n",
       "               'RN': ['pediatric multisystem inflammatory disease, COVID-19 related'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Child',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Female',\n",
       "                '*COVID-19/complications',\n",
       "                'SARS-CoV-2',\n",
       "                '*Mucocutaneous Lymph Node Syndrome/complications',\n",
       "                'Systemic Inflammatory Response Syndrome/complications'],\n",
       "               'PMC': 'PMC9857913',\n",
       "               'COIS': ['Reinhard Berner received grants from the Federal State of Saxony, Germany. The',\n",
       "                'study was partially supported by funding from the Federal State of Saxony,',\n",
       "                'Germany. The Federal State of Saxony had no role in the design and conduct of the',\n",
       "                'study. Jakob Armann received grants from the Federal State of Saxony, Germany.',\n",
       "                'The study was partially supported by funding from the Federal State of Saxony,',\n",
       "                'Germany. The Federal State of Saxony had no role in the design and conduct of the',\n",
       "                'study. Jochen Schmitt received institutional funding for investigator-initiated',\n",
       "                'research from Novartis, Sanofi, Pfizer, ALK, and acted as a consultant for',\n",
       "                'Novartis, Sanofi, and Lilly in a function unrelated to this study. The other',\n",
       "                'authors have no competing interests to disclose.'],\n",
       "               'FIR': ['Adamiak-Brych, Grazyna',\n",
       "                'Aderhold, Martina',\n",
       "                'Aggar, Sara',\n",
       "                'Ahmed, Mohammed-Ahmed',\n",
       "                'Akanbi, Sandra',\n",
       "                'Anders, Kristin',\n",
       "                'Arens, Stefan',\n",
       "                'Armann, Jakob',\n",
       "                'Bassmann, Christoph',\n",
       "                'Baumbach, Lisa',\n",
       "                'Bayrhof, Otto-Jonas',\n",
       "                'Beier, Gerald',\n",
       "                'Berger, Ardua',\n",
       "                'Bernard, Daniel',\n",
       "                'Berner, Reinhard',\n",
       "                'Berwald, Mario',\n",
       "                'Biering, Adina',\n",
       "                'Blumlein, Ulrike',\n",
       "                'Blume, Stefanie',\n",
       "                'Bockenholt, Kai',\n",
       "                'Bolke, Carsten',\n",
       "                'Boesing, Thomas',\n",
       "                'Bonacker, Robert',\n",
       "                'Borchers, Monika-Maria',\n",
       "                'Brenner, Britta',\n",
       "                'Brinkmann, Folke',\n",
       "                'Bruhler, Jasmin',\n",
       "                'Brunner, Jurgen',\n",
       "                'Buchtala, Laura',\n",
       "                'Budde, Jorg',\n",
       "                'Bullmann, Reinhard',\n",
       "                'Schoppe, Marc Carre',\n",
       "                'Cvetanovic, Gordana',\n",
       "                'Czwienzek, Alina',\n",
       "                'Degirmenci, Metin',\n",
       "                'Dejas, Fenja',\n",
       "                'Demirdelen, Berguzar',\n",
       "                'Diederichs, Anke',\n",
       "                'Dittrich, Maren',\n",
       "                'Dohring, Katharina',\n",
       "                'Donath, Helena',\n",
       "                'Ebert, Franziska',\n",
       "                'Eff, Annemarie',\n",
       "                'Ehrentraut, Kerstin',\n",
       "                'Eissler, Fiene',\n",
       "                'Eissner, Anne',\n",
       "                'Endres, Elisa',\n",
       "                'Engler, Matthias',\n",
       "                'Fiedler, Andreas',\n",
       "                'Fingerhut, Karin',\n",
       "                'Finster, Agnes',\n",
       "                'Fischer, Doris',\n",
       "                'Flumann, Simon',\n",
       "                'Foth, Svenja',\n",
       "                'Fremery, Christian',\n",
       "                'Frenzke, Holger',\n",
       "                'Galow, Lukas',\n",
       "                'Gappa, Monika',\n",
       "                'Gerling, Stephan',\n",
       "                'Gitzinger, Stina',\n",
       "                'Glaser, Nicola',\n",
       "                'Goj, Karoline',\n",
       "                'Goretzki, Sarah Christina',\n",
       "                'Groger, Katrin',\n",
       "                'Groteclaes, Tim',\n",
       "                'Gruner, Judith',\n",
       "                'Grunwedel, Mike',\n",
       "                'Haag, Stephan',\n",
       "                'Hacker, Lisa',\n",
       "                'Halwas, Nikolaus',\n",
       "                'Hanke, Christof',\n",
       "                'Haupt, Anne',\n",
       "                'Heinrich, Christina',\n",
       "                'Heinrich, Julia',\n",
       "                'Hempel, Lutz',\n",
       "                'Hermann, Matthias',\n",
       "                'Herzog, Matthias',\n",
       "                'Heubner, Georg',\n",
       "                'Hillebrand, Georg',\n",
       "                'Himpel, Matthias',\n",
       "                'Hilker, Kai-Alexandra',\n",
       "                'Hittmeyer, Cara',\n",
       "                'Hoche, Alexander',\n",
       "                'Hofgen, Mirjam',\n",
       "                'Hopner, Uwe',\n",
       "                'Holtkamp, Katharina',\n",
       "                'Hoppen, Thomas',\n",
       "                'Horstkemper, Marita',\n",
       "                'Horstmann, Judith',\n",
       "                'Hospach, Anton',\n",
       "                'Hufnagel, Markus',\n",
       "                'Ido, Nora',\n",
       "                'Iliaev, Vladimir',\n",
       "                'Ioannou, Phryne',\n",
       "                'Jakob, Andre',\n",
       "                'Jantzen, Dirk',\n",
       "                'Jenssen, Sohnke',\n",
       "                'Jung, Claudia',\n",
       "                'Kaiser-Labusch, Petra',\n",
       "                'Kalhoff, Herrmann',\n",
       "                'Keck, Johanna',\n",
       "                'Kelch, Felicitas',\n",
       "                'Keller, Thomas',\n",
       "                'Kelzon, Svetlana',\n",
       "                'Kern, Jan',\n",
       "                'Kessner, Marie-Sophie',\n",
       "                'Kever, Daniel',\n",
       "                'Kirchner, Arni',\n",
       "                'Kirschstein, Martin',\n",
       "                'Kitz, Richard',\n",
       "                'Klauwer, Dietrich',\n",
       "                'Kleff, Christine',\n",
       "                'Kluthe, Christof',\n",
       "                'Knechtel, Jan',\n",
       "                'Knop, Lisanne',\n",
       "                'Koster, Holger',\n",
       "                'Vasconcelos, Malte Kohns',\n",
       "                'Konrad, Florian',\n",
       "                'Kosteczka, Robert',\n",
       "                'Koukli, Georgia',\n",
       "                'Kowski, Sascha',\n",
       "                'Kuhnigk, Mirco',\n",
       "                'Kuska, Marion',\n",
       "                'Kwaschnowitz, Sachicko',\n",
       "                'Lange, Veit',\n",
       "                'Lautner, Gerrit',\n",
       "                'Libuschewski, Hanna',\n",
       "                'Liese, Johannes',\n",
       "                'Lindemann, Linus',\n",
       "                'Lorenz, Norbert',\n",
       "                'Lorenzen, Niko',\n",
       "                'Lubitz, Daniela',\n",
       "                'Machata, Heike',\n",
       "                'Mader, Franziska',\n",
       "                'Malath, Ingrid',\n",
       "                'Mampe, Cornelie',\n",
       "                'Markowsky, Andrea',\n",
       "                'Mauritz, Maximilian',\n",
       "                'Meister, Jochen',\n",
       "                'Menden, Melanie',\n",
       "                'Menzel, Felix',\n",
       "                'Merker, Michael',\n",
       "                'Meyer, Jens',\n",
       "                'Meyer-Dobkowitz, Lars',\n",
       "                'Mohorovicic, Marko',\n",
       "                'Moise, Laura Gabriela',\n",
       "                'Morawski, Yvonne',\n",
       "                'Motzkus, Laura',\n",
       "                'Muller, Bianca',\n",
       "                'Muller, Guido',\n",
       "                'Muller, Mirja',\n",
       "                'Muller, Meike',\n",
       "                'Niehaus, Thomas',\n",
       "                'Oberthur, Andre',\n",
       "                'Ohlendorf, Johanna',\n",
       "                'Olar, Florina',\n",
       "                'Opgen-Rhein, Bernd',\n",
       "                'Ostreicher, Iris',\n",
       "                'Parthey, Kathlee',\n",
       "                'Pentek, Falk',\n",
       "                'Potzsch, Simone',\n",
       "                'Ponsa, Corinna',\n",
       "                'Rambow, Jenny',\n",
       "                'Reck, Heike',\n",
       "                'Reichert, Friedrich',\n",
       "                'Reil, Annika',\n",
       "                'Reinhardt, Thomas',\n",
       "                'Richter, Carolin',\n",
       "                'Richter, Jost Wigand',\n",
       "                'Rieber, Nikolaus',\n",
       "                'Ringe, Hannelore',\n",
       "                'Ruhlmann, Alexander',\n",
       "                'Samol, Anja',\n",
       "                'Sauerbrey, Kristin',\n",
       "                'Schafer, Miriam',\n",
       "                'Schaeffer, Nico',\n",
       "                'Scheffler, Miriam',\n",
       "                'Schlick, Christian',\n",
       "                'Schmitt, Caroline',\n",
       "                'Schneider, Dominik',\n",
       "                'Schneider, Hans-Christoph',\n",
       "                'Schnelke, Alexander',\n",
       "                'Schrewe, Roland',\n",
       "                'Schrod, Lothar',\n",
       "                'Schroers, Oliver',\n",
       "                'Schutz, Katharina',\n",
       "                'Schultess, Leonie',\n",
       "                'Schumacher, Isabel',\n",
       "                'Seidel, Sabrina',\n",
       "                'Simon, Arne',\n",
       "                'Soditt, Volker',\n",
       "                'Sonmez, Ezgi',\n",
       "                'Spancken, Elena',\n",
       "                'Spath, Lisa',\n",
       "                'Spinner, Sebastian',\n",
       "                'Stastny, Barbara',\n",
       "                'Steidl, Michael',\n",
       "                'Steif, Benedikt',\n",
       "                'Steimer, Ann-Kathrin',\n",
       "                'Stemberg, Frank',\n",
       "                'Stockmann, Antje',\n",
       "                'Stohring, Thomas',\n",
       "                'Sumbadze, Daria',\n",
       "                'Teichmann, Axel',\n",
       "                'Thiel, Lion',\n",
       "                'Trankner, Jan',\n",
       "                'Trau, Stefanie',\n",
       "                'Treichel, Tina',\n",
       "                'Trotter, Andreas',\n",
       "                'van den Heuvel, Alijda',\n",
       "                'Vehse, Kai',\n",
       "                'Vischer, Lena',\n",
       "                'Wahjudi, Tatjana',\n",
       "                'Waldecker, Karin',\n",
       "                'Walden, Ulrike',\n",
       "                'Warneke, Laura',\n",
       "                'Weber, Sarah',\n",
       "                'Wehl, Gotz',\n",
       "                'Wehrhoff, Falk',\n",
       "                'Weigert, Alexander',\n",
       "                'Wenzel, Sandra',\n",
       "                'Werner, Annika',\n",
       "                'Weste, Clarissa',\n",
       "                'Wichmann, Barbara',\n",
       "                'Wild, Florian',\n",
       "                'Willmer, Denise',\n",
       "                'Wolf, Felicitas',\n",
       "                'Wrenger, Nina',\n",
       "                'Wurm, Donald',\n",
       "                'Yussif, Anne-Sophie',\n",
       "                'Zeissig, Yvonne',\n",
       "                'Zugge, Ulrich'],\n",
       "               'IR': ['Adamiak-Brych G',\n",
       "                'Aderhold M',\n",
       "                'Aggar S',\n",
       "                'Ahmed MA',\n",
       "                'Akanbi S',\n",
       "                'Anders K',\n",
       "                'Arens S',\n",
       "                'Armann J',\n",
       "                'Bassmann C',\n",
       "                'Baumbach L',\n",
       "                'Bayrhof OJ',\n",
       "                'Beier G',\n",
       "                'Berger A',\n",
       "                'Bernard D',\n",
       "                'Berner R',\n",
       "                'Berwald M',\n",
       "                'Biering A',\n",
       "                'Blumlein U',\n",
       "                'Blume S',\n",
       "                'Bockenholt K',\n",
       "                'Bolke C',\n",
       "                'Boesing T',\n",
       "                'Bonacker R',\n",
       "                'Borchers MM',\n",
       "                'Brenner B',\n",
       "                'Brinkmann F',\n",
       "                'Bruhler J',\n",
       "                'Brunner J',\n",
       "                'Buchtala L',\n",
       "                'Budde J',\n",
       "                'Bullmann R',\n",
       "                'Schoppe MC',\n",
       "                'Cvetanovic G',\n",
       "                'Czwienzek A',\n",
       "                'Degirmenci M',\n",
       "                'Dejas F',\n",
       "                'Demirdelen B',\n",
       "                'Diederichs A',\n",
       "                'Dittrich M',\n",
       "                'Dohring K',\n",
       "                'Donath H',\n",
       "                'Ebert F',\n",
       "                'Eff A',\n",
       "                'Ehrentraut K',\n",
       "                'Eissler F',\n",
       "                'Eissner A',\n",
       "                'Endres E',\n",
       "                'Engler M',\n",
       "                'Fiedler A',\n",
       "                'Fingerhut K',\n",
       "                'Finster A',\n",
       "                'Fischer D',\n",
       "                'Flumann S',\n",
       "                'Foth S',\n",
       "                'Fremery C',\n",
       "                'Frenzke H',\n",
       "                'Galow L',\n",
       "                'Gappa M',\n",
       "                'Gerling S',\n",
       "                'Gitzinger S',\n",
       "                'Glaser N',\n",
       "                'Goj K',\n",
       "                'Goretzki SC',\n",
       "                'Groger K',\n",
       "                'Groteclaes T',\n",
       "                'Gruner J',\n",
       "                'Grunwedel M',\n",
       "                'Haag S',\n",
       "                'Hacker L',\n",
       "                'Halwas N',\n",
       "                'Hanke C',\n",
       "                'Haupt A',\n",
       "                'Heinrich C',\n",
       "                'Heinrich J',\n",
       "                'Hempel L',\n",
       "                'Hermann M',\n",
       "                'Herzog M',\n",
       "                'Heubner G',\n",
       "                'Hillebrand G',\n",
       "                'Himpel M',\n",
       "                'Hilker KA',\n",
       "                'Hittmeyer C',\n",
       "                'Hoche A',\n",
       "                'Hofgen M',\n",
       "                'Hopner U',\n",
       "                'Holtkamp K',\n",
       "                'Hoppen T',\n",
       "                'Horstkemper M',\n",
       "                'Horstmann J',\n",
       "                'Hospach A',\n",
       "                'Hufnagel M',\n",
       "                'Ido N',\n",
       "                'Iliaev V',\n",
       "                'Ioannou P',\n",
       "                'Jakob A',\n",
       "                'Jantzen D',\n",
       "                'Jenssen S',\n",
       "                'Jung C',\n",
       "                'Kaiser-Labusch P',\n",
       "                'Kalhoff H',\n",
       "                'Keck J',\n",
       "                'Kelch F',\n",
       "                'Keller T',\n",
       "                'Kelzon S',\n",
       "                'Kern J',\n",
       "                'Kessner MS',\n",
       "                'Kever D',\n",
       "                'Kirchner A',\n",
       "                'Kirschstein M',\n",
       "                'Kitz R',\n",
       "                'Klauwer D',\n",
       "                'Kleff C',\n",
       "                'Kluthe C',\n",
       "                'Knechtel J',\n",
       "                'Knop L',\n",
       "                'Koster H',\n",
       "                'Vasconcelos MK',\n",
       "                'Konrad F',\n",
       "                'Kosteczka R',\n",
       "                'Koukli G',\n",
       "                'Kowski S',\n",
       "                'Kuhnigk M',\n",
       "                'Kuska M',\n",
       "                'Kwaschnowitz S',\n",
       "                'Lange V',\n",
       "                'Lautner G',\n",
       "                'Libuschewski H',\n",
       "                'Liese J',\n",
       "                'Lindemann L',\n",
       "                'Lorenz N',\n",
       "                'Lorenzen N',\n",
       "                'Lubitz D',\n",
       "                'Machata H',\n",
       "                'Mader F',\n",
       "                'Malath I',\n",
       "                'Mampe C',\n",
       "                'Markowsky A',\n",
       "                'Mauritz M',\n",
       "                'Meister J',\n",
       "                'Menden M',\n",
       "                'Menzel F',\n",
       "                'Merker M',\n",
       "                'Meyer J',\n",
       "                'Meyer-Dobkowitz L',\n",
       "                'Mohorovicic M',\n",
       "                'Moise LG',\n",
       "                'Morawski Y',\n",
       "                'Motzkus L',\n",
       "                'Muller B',\n",
       "                'Muller G',\n",
       "                'Muller M',\n",
       "                'Muller M',\n",
       "                'Niehaus T',\n",
       "                'Oberthur A',\n",
       "                'Ohlendorf J',\n",
       "                'Olar F',\n",
       "                'Opgen-Rhein B',\n",
       "                'Ostreicher I',\n",
       "                'Parthey K',\n",
       "                'Pentek F',\n",
       "                'Potzsch S',\n",
       "                'Ponsa C',\n",
       "                'Rambow J',\n",
       "                'Reck H',\n",
       "                'Reichert F',\n",
       "                'Reil A',\n",
       "                'Reinhardt T',\n",
       "                'Richter C',\n",
       "                'Richter JW',\n",
       "                'Rieber N',\n",
       "                'Ringe H',\n",
       "                'Ruhlmann A',\n",
       "                'Samol A',\n",
       "                'Sauerbrey K',\n",
       "                'Schafer M',\n",
       "                'Schaeffer N',\n",
       "                'Scheffler M',\n",
       "                'Schlick C',\n",
       "                'Schmitt C',\n",
       "                'Schneider D',\n",
       "                'Schneider HC',\n",
       "                'Schnelke A',\n",
       "                'Schrewe R',\n",
       "                'Schrod L',\n",
       "                'Schroers O',\n",
       "                'Schutz K',\n",
       "                'Schultess L',\n",
       "                'Schumacher I',\n",
       "                'Seidel S',\n",
       "                'Simon A',\n",
       "                'Soditt V',\n",
       "                'Sonmez E',\n",
       "                'Spancken E',\n",
       "                'Spath L',\n",
       "                'Spinner S',\n",
       "                'Stastny B',\n",
       "                'Steidl M',\n",
       "                'Steif B',\n",
       "                'Steimer AK',\n",
       "                'Stemberg F',\n",
       "                'Stockmann A',\n",
       "                'Stohring T',\n",
       "                'Sumbadze D',\n",
       "                'Teichmann A',\n",
       "                'Thiel L',\n",
       "                'Trankner J',\n",
       "                'Trau S',\n",
       "                'Treichel T',\n",
       "                'Trotter A',\n",
       "                'van den Heuvel A',\n",
       "                'Vehse K',\n",
       "                'Vischer L',\n",
       "                'Wahjudi T',\n",
       "                'Waldecker K',\n",
       "                'Walden U',\n",
       "                'Warneke L',\n",
       "                'Weber S',\n",
       "                'Wehl G',\n",
       "                'Wehrhoff F',\n",
       "                'Weigert A',\n",
       "                'Wenzel S',\n",
       "                'Werner A',\n",
       "                'Weste C',\n",
       "                'Wichmann B',\n",
       "                'Wild F',\n",
       "                'Willmer D',\n",
       "                'Wolf F',\n",
       "                'Wrenger N',\n",
       "                'Wurm D',\n",
       "                'Yussif AS',\n",
       "                'Zeissig Y',\n",
       "                'Zugge U'],\n",
       "               'EDAT': '2023/01/21 06:00',\n",
       "               'MHDA': '2023/01/25 06:00',\n",
       "               'PMCR': ['2023/01/20'],\n",
       "               'CRDT': ['2023/01/20 23:16'],\n",
       "               'PHST': ['2022/07/10 00:00 [received]',\n",
       "                '2022/12/20 00:00 [accepted]',\n",
       "                '2023/01/20 23:16 [entrez]',\n",
       "                '2023/01/21 06:00 [pubmed]',\n",
       "                '2023/01/25 06:00 [medline]',\n",
       "                '2023/01/20 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1038/s41598-022-26832-5 [pii]',\n",
       "                '26832 [pii]',\n",
       "                '10.1038/s41598-022-26832-5 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Sci Rep. 2023 Jan 20;13(1):1173. doi: 10.1038/s41598-022-26832-5.'},\n",
       "              {'PMID': '38269291',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20241023',\n",
       "               'IS': '2296-2360 (Print) 2296-2360 (Electronic) 2296-2360 (Linking)',\n",
       "               'VI': '11',\n",
       "               'DP': '2023',\n",
       "               'TI': 'Pediatric intensive care unit admissions network-rationale, framework and method of operation of a nationwide collaborative pediatric intensive care research network in Germany.',\n",
       "               'PG': '1254935',\n",
       "               'LID': '10.3389/fped.2023.1254935 [doi] 1254935',\n",
       "               'AB': 'The Pediatric Intensive Care Unit Admissions (PIA) network aims to establish a nationwide database in Germany to gather epidemiological, clinical, and outcome data on pediatric critical illness. The heterogeneity of pediatric patients in intensive care units (PICU) poses challenges in obtaining sufficient case numbers for reliable research. Multicentered approaches, such as patient registries, have proven effective in collecting large-scale data. However, Germany lacks a systematic registration system for pediatric intensive care admissions, hindering epidemiological and outcome assessments. The PIA network intends to address these gaps and provide a framework for clinical and epidemiological research in pediatric intensive care. The network will interconnect PICUs across Germany and collect structured data on diagnoses, treatment, clinical course, and short-term outcomes. It aims to identify areas for improvement in care, enable disease surveillance, and potentially serve as a quality control tool. The PIA network builds upon the existing infrastructure of the German Pediatric Surveillance Unit ESPED and utilizes digitalized data collection techniques. Participating units will complete surveys on their organizational structure and equipment. The study population includes patients aged >/=28 days admitted to participating PICUs, with a more detailed survey for cases meeting specific criteria. Data will be collected by local PIA investigators, anonymized, and entered into a central database. The data protection protocol complies with regulations and ensures patient privacy. Quarterly data checks and customized quality reports will be conducted to monitor data completeness and plausibility. The network will evaluate its performance, data collection feasibility, and data quality. Eligible investigators can submit proposals for data analyses, which will be reviewed and analyzed by trained statisticians or epidemiologists. The PIA network aims to improve pediatric intensive care medicine in Germany by providing a comprehensive understanding of critical illness, benchmarking treatment quality, and enabling disease surveillance.',\n",
       "               'CI': ['(c) 2024 Bruns, Dohna-Schwake, Olivieri, Urschitz, Blomenkamp, Frosch, Lieftuchter,',\n",
       "                'Tomidis Chatzimanouil, Hoffmann and Brenner.'],\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Olivieri, Martin',\n",
       "                'Urschitz, Michael S',\n",
       "                'Blomenkamp, Susanne',\n",
       "                'Frosch, Clara',\n",
       "                'Lieftuchter, Victoria',\n",
       "                'Tomidis Chatzimanouil, Markos K',\n",
       "                'Hoffmann, Florian',\n",
       "                'Brenner, Sebastian'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Dohna-Schwake C',\n",
       "                'Olivieri M',\n",
       "                'Urschitz MS',\n",
       "                'Blomenkamp S',\n",
       "                'Frosch C',\n",
       "                'Lieftuchter V',\n",
       "                'Tomidis Chatzimanouil MK',\n",
       "                'Hoffmann F',\n",
       "                'Brenner S'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Pediatric Intensive Care Unit, Dr. von Hauner Childrens Hospital, LMU Munich, Munich, Germany.',\n",
       "                'Division of Pediatric Epidemiology, Institute of Medical Biostatistics, Epidemiology, and Informatics, University Medical Centre of the Johannes Gutenberg-University, Mainz, Germany.',\n",
       "                'Division of Pediatric Epidemiology, Institute of Medical Biostatistics, Epidemiology, and Informatics, University Medical Centre of the Johannes Gutenberg-University, Mainz, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Pediatric Intensive Care Unit, Dr. von Hauner Childrens Hospital, LMU Munich, Munich, Germany.',\n",
       "                'Pediatric Intensive Care Medicine, Department of Pediatrics, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany.',\n",
       "                'Pediatric Intensive Care Unit, Dr. von Hauner Childrens Hospital, LMU Munich, Munich, Germany.',\n",
       "                'Pediatric Intensive Care Medicine, Department of Pediatrics, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20240110',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Pediatr',\n",
       "               'JT': 'Frontiers in pediatrics',\n",
       "               'JID': '101615492',\n",
       "               'PMC': 'PMC10806156',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['PICU outcome',\n",
       "                'admission',\n",
       "                'epidemiology',\n",
       "                'network',\n",
       "                'pediatric critical illness',\n",
       "                'pediatric intensive care unit',\n",
       "                'quality control',\n",
       "                'surveillance'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest. The authors declared that they were an editorial board',\n",
       "                'member of Frontiers, at the time of submission. This had no impact on the peer',\n",
       "                'review process and the final decision.'],\n",
       "               'EDAT': '2024/01/25 06:43',\n",
       "               'MHDA': '2024/01/25 06:44',\n",
       "               'PMCR': ['2024/01/10'],\n",
       "               'CRDT': ['2024/01/25 04:26'],\n",
       "               'PHST': ['2023/07/10 00:00 [received]',\n",
       "                '2023/12/22 00:00 [accepted]',\n",
       "                '2024/01/25 06:44 [medline]',\n",
       "                '2024/01/25 06:43 [pubmed]',\n",
       "                '2024/01/25 04:26 [entrez]',\n",
       "                '2024/01/10 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fped.2023.1254935 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Pediatr. 2024 Jan 10;11:1254935. doi: 10.3389/fped.2023.1254935. eCollection 2023.'},\n",
       "              {'PMID': '38146118',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20231227',\n",
       "               'LR': '20231227',\n",
       "               'IS': '1399-3038 (Electronic) 0905-6157 (Linking)',\n",
       "               'VI': '34',\n",
       "               'IP': '12',\n",
       "               'DP': '2023 Dec',\n",
       "               'TI': 'Increased SARS-CoV-2 reactive low avidity T cells producing inflammatory cytokines in pediatric post-acute COVID-19 sequelae (PASC).',\n",
       "               'PG': 'e14060',\n",
       "               'LID': '10.1111/pai.14060 [doi]',\n",
       "               'AB': 'BACKGROUND: A proportion of the convalescent SARS-CoV-2 pediatric population presents nonspecific symptoms, mental health problems, and a reduction in quality of life similar to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID-19 symptomatic. However, data regarding its clinical manifestation and immune mechanisms are currently scarce. METHODS: In this study, we perform a comprehensive clinical and immunological profiling of 17 convalescent COVID-19 children with post-acute COVID-19 sequelae (PASC) manifestation and 13 convalescent children without PASC manifestation. A detailed medical history, blood and instrumental tests, and physical examination were obtained from all patients. SARS-CoV-2 reactive T-cell response was analyzed via multiparametric flow cytometry and the humoral immunity was addressed via pseudovirus neutralization and ELISA assay. RESULTS: The most common PASC symptoms were shortness of breath/exercise intolerance, paresthesia, smell/taste disturbance, chest pain, dyspnea, headache, and lack of concentration. Blood count and clinical chemistry showed no statistical differences among the study groups. We detected higher frequencies of spike (S) reactive CD4(+) and CD8(+) T cells among the PASC study group, characterized by TNFalpha and IFNgamma production and low functional avidity. CRP levels are positively correlated with IFNgamma producing reactive CD8(+) T cells. CONCLUSIONS: Our data might indicate a possible involvement of a persistent cellular inflammatory response triggered by SARS-CoV-2 in the development of the observed sequelae in pediatric PASC. These results may have implications on future therapeutic and prevention strategies.',\n",
       "               'CI': ['(c) 2023 The Authors. Pediatric Allergy and Immunology published by European',\n",
       "                'Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.'],\n",
       "               'FAU': ['Paniskaki, Krystallenia',\n",
       "                'Goretzki, Sarah',\n",
       "                'Anft, Moritz',\n",
       "                'Konik, Margarethe J',\n",
       "                'Meister, Toni L',\n",
       "                'Pfaender, Stephanie',\n",
       "                'Lechtenberg, Klara',\n",
       "                'Vogl, Melanie',\n",
       "                'Dogan, Burcin',\n",
       "                'Dolff, Sebastian',\n",
       "                'Westhoff, Timm H',\n",
       "                'Rohn, Hana',\n",
       "                'Felderhoff-Mueser, Ursula',\n",
       "                'Stervbo, Ulrik',\n",
       "                'Witzke, Oliver',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Babel, Nina'],\n",
       "               'AU': ['Paniskaki K',\n",
       "                'Goretzki S',\n",
       "                'Anft M',\n",
       "                'Konik MJ',\n",
       "                'Meister TL',\n",
       "                'Pfaender S',\n",
       "                'Lechtenberg K',\n",
       "                'Vogl M',\n",
       "                'Dogan B',\n",
       "                'Dolff S',\n",
       "                'Westhoff TH',\n",
       "                'Rohn H',\n",
       "                'Felderhoff-Mueser U',\n",
       "                'Stervbo U',\n",
       "                'Witzke O',\n",
       "                'Dohna-Schwake C',\n",
       "                'Babel N'],\n",
       "               'AUID': ['ORCID: 0000-0002-6226-7558'],\n",
       "               'AD': ['Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.',\n",
       "                'Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                \"Department of Pediatrics I, Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany.\",\n",
       "                'Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.',\n",
       "                'Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.',\n",
       "                'Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.',\n",
       "                \"Department of Pediatrics I, Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany.\",\n",
       "                \"Department of Pediatrics III, Pediatric Pulmonology and Sleep Medicine, Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany.\",\n",
       "                \"Department of Pediatrics I, Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany.\",\n",
       "                'Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.',\n",
       "                'Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                \"Department of Pediatrics I, Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany.\",\n",
       "                'Center for Translational Neuro- and Behavioral Sciences C-TNBS, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.',\n",
       "                'Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                \"Department of Pediatrics I, Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany.\",\n",
       "                'Center for Translational Neuro- and Behavioral Sciences C-TNBS, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.',\n",
       "                'Berlin Institute of Health at Charite - University Clinic Berlin, BIH Center for Regenerative Therapies (BCRT) Berlin, Berlin, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Pediatr Allergy Immunol',\n",
       "               'JT': 'Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology',\n",
       "               'JID': '9106718',\n",
       "               'RN': ['0 (Cytokines)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Child',\n",
       "                '*Post-Acute COVID-19 Syndrome',\n",
       "                'SARS-CoV-2',\n",
       "                'Cytokines',\n",
       "                'CD8-Positive T-Lymphocytes',\n",
       "                'Quality of Life',\n",
       "                '*COVID-19',\n",
       "                'Disease Progression',\n",
       "                'Dyspnea'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['T cells',\n",
       "                'long COVID',\n",
       "                'neutralizing antibodies',\n",
       "                'pediatric PASC'],\n",
       "               'EDAT': '2023/12/26 06:41',\n",
       "               'MHDA': '2023/12/27 06:41',\n",
       "               'CRDT': ['2023/12/26 00:53'],\n",
       "               'PHST': ['2023/11/13 00:00 [revised]',\n",
       "                '2023/07/22 00:00 [received]',\n",
       "                '2023/11/29 00:00 [accepted]',\n",
       "                '2023/12/27 06:41 [medline]',\n",
       "                '2023/12/26 06:41 [pubmed]',\n",
       "                '2023/12/26 00:53 [entrez]'],\n",
       "               'AID': ['10.1111/pai.14060 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Pediatr Allergy Immunol. 2023 Dec;34(12):e14060. doi: 10.1111/pai.14060.'},\n",
       "              {'PMID': '38132242',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20231224',\n",
       "               'IS': '2075-4418 (Print) 2075-4418 (Electronic) 2075-4418 (Linking)',\n",
       "               'VI': '13',\n",
       "               'IP': '24',\n",
       "               'DP': '2023 Dec 14',\n",
       "               'TI': 'Review on Pediatric Malignant Focal Liver Lesions with Imaging Evaluation: Part II.',\n",
       "               'LID': '10.3390/diagnostics13243659 [doi] 3659',\n",
       "               'AB': 'Malignant focal liver lesions (FLLs) represent various kinds of epithelial and mesenchymal tumors. In pediatric patients, the understanding of pediatric liver diseases and associated imaging manifestations is essential for making accurate diagnosis and differential diagnosis. This paper will discuss the latest knowledge of the common pediatric malignant FLLs, including undifferentiated embryonal sarcoma, rhabdomyosarcoma, epithelioid hemangioendothelioma, angiosarcoma, and malignant rhabdoid tumor. Medical imaging features are not only helpful for clinical diagnosis, but can also be useful in the evaluation and follow-up of pre- and post-treatment. The future perspectives of contrast-enhanced ultrasound (CEUS) enhancement patterns of FLLs in pediatric patients are also mentioned.',\n",
       "               'FAU': ['Dong, Yi',\n",
       "                'Cekuolis, Andrius',\n",
       "                'Schreiber-Dietrich, Dagmar',\n",
       "                'Augustiniene, Rasa',\n",
       "                'Schwarz, Simone',\n",
       "                'Moller, Kathleen',\n",
       "                'Nourkami-Tutdibi, Nasenien',\n",
       "                'Chen, Sheng',\n",
       "                'Cao, Jia-Ying',\n",
       "                'Huang, Yun-Lin',\n",
       "                'Wang, Ying',\n",
       "                'Taut, Heike',\n",
       "                'Grevelding, Lara',\n",
       "                'Dietrich, Christoph F'],\n",
       "               'AU': ['Dong Y',\n",
       "                'Cekuolis A',\n",
       "                'Schreiber-Dietrich D',\n",
       "                'Augustiniene R',\n",
       "                'Schwarz S',\n",
       "                'Moller K',\n",
       "                'Nourkami-Tutdibi N',\n",
       "                'Chen S',\n",
       "                'Cao JY',\n",
       "                'Huang YL',\n",
       "                'Wang Y',\n",
       "                'Taut H',\n",
       "                'Grevelding L',\n",
       "                'Dietrich CF'],\n",
       "               'AUID': ['ORCID: 0000-0002-0212-1477',\n",
       "                'ORCID: 0009-0001-5893-088X',\n",
       "                'ORCID: 0000-0001-8946-0609',\n",
       "                'ORCID: 0000-0001-6015-6347'],\n",
       "               'AD': ['Department of Ultrasound, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China.',\n",
       "                'Ultrasound Section, Department of Pediatric Radiology, Radiology and Nuclear Medicine Centre, Vilnius University Hospital Santaros Klinikos, 08661 Vilnius, Lithuania.',\n",
       "                'Localinomed and Pediatric Department, Kliniken Salem, 3013 Bern, Switzerland.',\n",
       "                'Ultrasound Section, Department of Pediatric Radiology, Radiology and Nuclear Medicine Centre, Vilnius University Hospital Santaros Klinikos, 08661 Vilnius, Lithuania.',\n",
       "                'Department of Neonatology and Pediatric Intensive Care Medicine, Sana Kliniken Duisburg GmbH, 47055 Duisburg, Germany.',\n",
       "                'Medical Department I/Gastroenterology, SANA Hospital Lichtenberg, 10365 Berlin, Germany.',\n",
       "                'Saarland University Medical Center, Hospital of General Pediatrics and Neonatology, 66421 Homburg, Germany.',\n",
       "                'Department of Ultrasound, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China.',\n",
       "                'Department of Ultrasound, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China.',\n",
       "                'Department of Ultrasound, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China.',\n",
       "                'Department of Ultrasound, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China.',\n",
       "                \"Children's Hospital, Universitatsklinikum Dresden, Technische Universitat Dresden, 01069 Dresden, Germany.\",\n",
       "                'Department of Pediatrics, Division of Pneumology, Allergology, Infectious Diseases and Gastroenterology, University Hospital Frankfurt, Goethe University, 60323 Frankfurt, Germany.',\n",
       "                'Department of Ultrasound, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China.',\n",
       "                'Department Allgemeine Innere Medizin (DAIM), Kliniken Hirslanden Beau Site, Salem und Permanence, 3013 Bern, Switzerland.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'DEP': '20231214',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Diagnostics (Basel)',\n",
       "               'JT': 'Diagnostics (Basel, Switzerland)',\n",
       "               'JID': '101658402',\n",
       "               'PMC': 'PMC10743166',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['contrast-enhanced ultrasound (CEUS)',\n",
       "                'diagnosis',\n",
       "                'focal liver lesions (FLLs)',\n",
       "                'imaging',\n",
       "                'malignant',\n",
       "                'pediatric'],\n",
       "               'COIS': ['There is no conflict of interest relevant to this article. Author Simone Schwarz',\n",
       "                'was employed by the company Sana Kliniken Duisburg GmbH. The remaining authors',\n",
       "                'declare that the research was conducted in the absence of any commercial or',\n",
       "                'financial relationships that could be construed as a potential conflict of',\n",
       "                'interest. The [company Sana Kliniken Duisburg GmbH-companies in affiliation] had',\n",
       "                'no role in the design of the study; in the collection, analyses, or',\n",
       "                'interpretation of data; in the writing of the manuscript, or in the decision to',\n",
       "                'publish the results.'],\n",
       "               'EDAT': '2023/12/22 12:41',\n",
       "               'MHDA': '2023/12/22 12:42',\n",
       "               'PMCR': ['2023/12/14'],\n",
       "               'CRDT': ['2023/12/22 09:03'],\n",
       "               'PHST': ['2023/10/17 00:00 [received]',\n",
       "                '2023/12/04 00:00 [revised]',\n",
       "                '2023/12/06 00:00 [accepted]',\n",
       "                '2023/12/22 12:42 [medline]',\n",
       "                '2023/12/22 12:41 [pubmed]',\n",
       "                '2023/12/22 09:03 [entrez]',\n",
       "                '2023/12/14 00:00 [pmc-release]'],\n",
       "               'AID': ['diagnostics13243659 [pii]',\n",
       "                'diagnostics-13-03659 [pii]',\n",
       "                '10.3390/diagnostics13243659 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Diagnostics (Basel). 2023 Dec 14;13(24):3659. doi: 10.3390/diagnostics13243659.'},\n",
       "              {'PMID': '38091310',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20231216',\n",
       "               'LR': '20231216',\n",
       "               'IS': '1932-6203 (Electronic) 1932-6203 (Linking)',\n",
       "               'VI': '18',\n",
       "               'IP': '12',\n",
       "               'DP': '2023',\n",
       "               'TI': 'Determinants of human papillomavirus vaccine hesitancy among Lebanese parents.',\n",
       "               'PG': 'e0295644',\n",
       "               'LID': '10.1371/journal.pone.0295644 [doi] e0295644',\n",
       "               'AB': \"INTRODUCTION: Human papillomavirus (HPV) is the most common sexually transmitted infection. HPV is responsible for cancer of cervix uteri. Despite its safety and immunogenicity, HPV vaccine hesitancy is one of the most challenging topics that pediatricians face. METHODS: We aimed to describe the impact of knowledge, attitude, and practice towards vaccines in general, on practice related to HPV vaccination in Lebanon. A questionnaire addressed to parents of students (3-18 years of age) was distributed in 2 public and 2 private schools randomly selected from the greater Beirut area during the school year 2017-2018. Questionnaires covered knowledge, attitude, and practices of vaccination in general and HPV vaccine in particular. RESULTS: Out of 400 distributed questionnaires, 306 (76.5%) were returned. Of the 185 parents aware of HPV vaccine, 60% hadn't given or were not planning to give the HPV vaccine to their children. Of parents not in favor of HPV vaccine, 7.5 thought that vaccines aren't necessary versus none among those in favor of HPV vaccine(p = 0.02). Thirteen percent of those not in favor of HPV vaccine thought that vaccines are not safe versus 2.7% in the group in favor (p = 0.02). An effect of gender on vaccine acceptance was noted: mothers vs fathers and daughters vs sons. Lack of recommendation by pediatricians and the thought that too little is known about the vaccine were the most selected reasons for parents not wanting to vaccinate their children against HPV, whereas cost and religious and cultural beliefs seemed to have no impact. CONCLUSION: Most parents in our study did not vaccinate or weren't willing to vaccinate their children against HPV even when they were in favor of vaccines in general. Physician recommendation was shown to be one of the most important predictors of vaccination. Effort should be put into educating parents about the importance of the vaccine and its well-established safety and efficacy regardless of gender. Lebanese physicians should also be educated and empowered to recommend HPV vaccine more strongly and consistently.\",\n",
       "               'CI': ['Copyright: (c) 2023 Zakhour et al. This is an open access article distributed under',\n",
       "                'the terms of the Creative Commons Attribution License, which permits unrestricted',\n",
       "                'use, distribution, and reproduction in any medium, provided the original author',\n",
       "                'and source are credited.'],\n",
       "               'FAU': ['Zakhour, Ramia',\n",
       "                'Tamim, Hani',\n",
       "                'Faytrouni, Farah',\n",
       "                'Makki, Maha',\n",
       "                'Hojeij, Rayan',\n",
       "                'Charafeddine, Lama'],\n",
       "               'AU': ['Zakhour R',\n",
       "                'Tamim H',\n",
       "                'Faytrouni F',\n",
       "                'Makki M',\n",
       "                'Hojeij R',\n",
       "                'Charafeddine L'],\n",
       "               'AD': ['Division of Pediatric Infectious Diseases, McGovern Medical School Houston, University of Texas, Austin, Texas, United States of America.',\n",
       "                'Department of Internal Medicine, Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon.',\n",
       "                'College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.',\n",
       "                'Department of Pediatrics, Medcare Medical Centers, Dr Sulaiman Al Habib Medical Group, United Arab Emirates.',\n",
       "                'Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon.',\n",
       "                'Division of Pediatric Infectious Diseases, McGovern Medical School Houston, University of Texas, Austin, Texas, United States of America.',\n",
       "                'Division of Pediatric Infectious Diseases, McGovern Medical School Houston, University of Texas, Austin, Texas, United States of America.'],\n",
       "               'AUID': ['ORCID: 0000-0002-0584-497X'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20231213',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'PLoS One',\n",
       "               'JT': 'PloS one',\n",
       "               'JID': '101285081',\n",
       "               'RN': ['0 (Papillomavirus Vaccines)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Child',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                '*Papillomavirus Infections/prevention & control',\n",
       "                '*Papillomavirus Vaccines',\n",
       "                'Health Knowledge, Attitudes, Practice',\n",
       "                'Parents',\n",
       "                'Mothers',\n",
       "                'Vaccination',\n",
       "                'Surveys and Questionnaires',\n",
       "                'Patient Acceptance of Health Care'],\n",
       "               'PMC': 'PMC10718448',\n",
       "               'COIS': ['The authors have no conflicts of interest to disclose.'],\n",
       "               'EDAT': '2023/12/13 18:42',\n",
       "               'MHDA': '2023/12/17 09:45',\n",
       "               'PMCR': ['2023/12/13'],\n",
       "               'CRDT': ['2023/12/13 13:39'],\n",
       "               'PHST': ['2023/01/22 00:00 [received]',\n",
       "                '2023/11/27 00:00 [accepted]',\n",
       "                '2023/12/17 09:45 [medline]',\n",
       "                '2023/12/13 18:42 [pubmed]',\n",
       "                '2023/12/13 13:39 [entrez]',\n",
       "                '2023/12/13 00:00 [pmc-release]'],\n",
       "               'AID': ['PONE-D-23-01940 [pii]',\n",
       "                '10.1371/journal.pone.0295644 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'PLoS One. 2023 Dec 13;18(12):e0295644. doi: 10.1371/journal.pone.0295644. eCollection 2023.'},\n",
       "              {'PMID': '38066809',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20231209',\n",
       "               'IS': '2075-4418 (Print) 2075-4418 (Electronic) 2075-4418 (Linking)',\n",
       "               'VI': '13',\n",
       "               'IP': '23',\n",
       "               'DP': '2023 Nov 29',\n",
       "               'TI': 'Review on Pediatric Malignant Focal Liver Lesions with Imaging Evaluation: Part I.',\n",
       "               'LID': '10.3390/diagnostics13233568 [doi] 3568',\n",
       "               'AB': 'Malignant focal liver lesions (FLLs) are commonly reported in adults but rarely seen in the pediatric population. Due to the rarity, the understanding of these diseases is still very limited. In children, most malignant FLLs are congenital. It is very important to choose appropriate imaging examination concerning various factors. This paper will outline common pediatric malignant FLLs, including hepatoblastoma, hepatocellular carcinoma, and cholangiocarcinoma and discuss them against the background of the latest knowledge on comparable/similar tumors in adults. Medical imaging features are of vital importance for the non-invasive diagnosis and follow-up of treatment of FLLs in pediatric patients. The use of CEUS in pediatric patients for characterizing those FLLs that remain indeterminate on conventional B mode ultrasounds may be an effective option in the future and has great potential to be integrated into imaging algorithms without the risk of exposure to ionizing radiation.',\n",
       "               'FAU': ['Dong, Yi',\n",
       "                'Cekuolis, Andrius',\n",
       "                'Schreiber-Dietrich, Dagmar',\n",
       "                'Augustiniene, Rasa',\n",
       "                'Schwarz, Simone',\n",
       "                'Moller, Kathleen',\n",
       "                'Nourkami-Tutdibi, Nasenien',\n",
       "                'Chen, Sheng',\n",
       "                'Cao, Jia-Ying',\n",
       "                'Huang, Yun-Lin',\n",
       "                'Wang, Ying',\n",
       "                'Taut, Heike',\n",
       "                'Grevelding, Lara',\n",
       "                'Dietrich, Christoph F'],\n",
       "               'AU': ['Dong Y',\n",
       "                'Cekuolis A',\n",
       "                'Schreiber-Dietrich D',\n",
       "                'Augustiniene R',\n",
       "                'Schwarz S',\n",
       "                'Moller K',\n",
       "                'Nourkami-Tutdibi N',\n",
       "                'Chen S',\n",
       "                'Cao JY',\n",
       "                'Huang YL',\n",
       "                'Wang Y',\n",
       "                'Taut H',\n",
       "                'Grevelding L',\n",
       "                'Dietrich CF'],\n",
       "               'AUID': ['ORCID: 0000-0002-0212-1477',\n",
       "                'ORCID: 0009-0001-5893-088X',\n",
       "                'ORCID: 0000-0001-8946-0609',\n",
       "                'ORCID: 0000-0001-6015-6347'],\n",
       "               'AD': ['Department of Ultrasound, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.',\n",
       "                'Ultrasound Section, Department of Pediatric Radiology, Radiology and Nuclear Medicine Centre, Vilnius University Hospital Santaros Klinikos, 08661 Vilnius, Lithuania.',\n",
       "                'Localinomed and Pediatric Department, Kliniken Salem, 3013 Bern, Switzerland.',\n",
       "                'Ultrasound Section, Department of Pediatric Radiology, Radiology and Nuclear Medicine Centre, Vilnius University Hospital Santaros Klinikos, 08661 Vilnius, Lithuania.',\n",
       "                'Department of Neonatology and Pediatric Intensive Care Medicine, Sana Kliniken Duisburg GmbH, 47055 Duisburg, Germany.',\n",
       "                'Medical Department I/Gastroenterology, SANA Hospital Lichtenberg, 10365 Berlin, Germany.',\n",
       "                'Saarland University Medical Center, Hospital of General Pediatrics and Neonatology, 66421 Homburg, Germany.',\n",
       "                'Department of Ultrasound, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.',\n",
       "                'Department of Ultrasound, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.',\n",
       "                'Department of Ultrasound, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.',\n",
       "                'Department of Ultrasound, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.',\n",
       "                \"Children's Hospital, Universitatsklinikum Dresden, Technische Universitat Dresden, 01069 Dresden, Germany.\",\n",
       "                'Department of Pediatrics, Division of Pneumology, Allergology, Infectious Diseases and Gastroenterology, University Hospital Frankfurt, Goethe University, 60323 Frankfurt, Germany.',\n",
       "                'Department Allgemeine Innere Medizin (DAIM), Kliniken Hirslanden Beau Site, Salem und Permanence, 3013 Bern, Switzerland.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'DEP': '20231129',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Diagnostics (Basel)',\n",
       "               'JT': 'Diagnostics (Basel, Switzerland)',\n",
       "               'JID': '101658402',\n",
       "               'PMC': 'PMC10706220',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['contrast enhanced ultrasound (CEUS)',\n",
       "                'diagnosis',\n",
       "                'focal liver lesions (FLLs)',\n",
       "                'imaging',\n",
       "                'malignant',\n",
       "                'pediatric'],\n",
       "               'COIS': ['The author Simone Schwarz is an employee for Department of Neonatology and',\n",
       "                'Pediatric Intensive Care Medicine, Sana Kliniken Duisburg GmbH. The other authors',\n",
       "                'declare no conflict of interest.'],\n",
       "               'EDAT': '2023/12/09 10:43',\n",
       "               'MHDA': '2023/12/09 10:44',\n",
       "               'PMCR': ['2023/11/29'],\n",
       "               'CRDT': ['2023/12/09 01:01'],\n",
       "               'PHST': ['2023/10/16 00:00 [received]',\n",
       "                '2023/11/13 00:00 [revised]',\n",
       "                '2023/11/27 00:00 [accepted]',\n",
       "                '2023/12/09 10:44 [medline]',\n",
       "                '2023/12/09 10:43 [pubmed]',\n",
       "                '2023/12/09 01:01 [entrez]',\n",
       "                '2023/11/29 00:00 [pmc-release]'],\n",
       "               'AID': ['diagnostics13233568 [pii]',\n",
       "                'diagnostics-13-03568 [pii]',\n",
       "                '10.3390/diagnostics13233568 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Diagnostics (Basel). 2023 Nov 29;13(23):3568. doi: 10.3390/diagnostics13233568.'},\n",
       "              {'PMID': '37993788',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20231124',\n",
       "               'LR': '20231125',\n",
       "               'IS': '1471-2334 (Electronic) 1471-2334 (Linking)',\n",
       "               'VI': '23',\n",
       "               'IP': '1',\n",
       "               'DP': '2023 Nov 22',\n",
       "               'TI': 'Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents.',\n",
       "               'PG': '818',\n",
       "               'LID': '10.1186/s12879-023-08805-9 [doi] 818',\n",
       "               'AB': 'Cross-reactive cellular and humoral immunity can substantially contribute to antiviral defense against SARS-CoV-2 variants of concern (VOC). While the adult SARS-CoV-2 cellular and humoral immunity and its cross-recognition potential against VOC is broadly analyzed, similar data regarding the pediatric population are missing. In this study, we perform an analysis of the humoral and cellular SARS-CoV-2 response immune of 32 convalescent COVID-19 children (children), 27 convalescent vaccinated adults(C + V+) and 7 unvaccinated convalescent adults (C + V-). Similarly to adults, a significant reduction of cross-reactive neutralizing capacity against delta and omicron VOC was observed 6 months after SARS-CoV-2 infection. While SAR-CoV-2 neutralizing capacity was comparable among children and C + V- against all VOC, children demonstrated as expected an inferior humoral response when compared to C + V+. Nevertheless, children generated SARS-CoV-2 reactive T cells with broad cross-recognition potential. When compared to V + C+, children presented even comparable frequencies of WT-reactive CD4 + and CD8 + T cells with high avidity and functionality. Taking into consideration the limitations of study - unknown disease onset for 53% of the asymptomatic pediatric subjects, serological detection of SARS-CoV-2 infection-, our results suggest that following SARS-CoV-2 infection children generate a humoral SARS-CoV-2 response with neutralizing potential comparable to unvaccinated COVID-19 convalescent adults as well a sustained SARS-CoV-2 cellular response cross-reactive to VOC.',\n",
       "               'CI': ['(c) 2023. The Author(s).'],\n",
       "               'FAU': ['Paniskaki, Krystallenia',\n",
       "                'Goretzki, Sarah',\n",
       "                'Anft, Moritz',\n",
       "                'Konik, Margarethe J',\n",
       "                'Lechtenberg, Klara',\n",
       "                'Vogl, Melanie',\n",
       "                'Meister, Toni L',\n",
       "                'Pfaender, Stephanie',\n",
       "                'Zettler, Markus',\n",
       "                'Jager, Jasmin',\n",
       "                'Dolff, Sebastian',\n",
       "                'Westhoff, Timm H',\n",
       "                'Rohn, Hana',\n",
       "                'Felderhoff-Mueser, Ursula',\n",
       "                'Stervbo, Ulrik',\n",
       "                'Witzke, Oliver',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Babel, Nina'],\n",
       "               'AU': ['Paniskaki K',\n",
       "                'Goretzki S',\n",
       "                'Anft M',\n",
       "                'Konik MJ',\n",
       "                'Lechtenberg K',\n",
       "                'Vogl M',\n",
       "                'Meister TL',\n",
       "                'Pfaender S',\n",
       "                'Zettler M',\n",
       "                'Jager J',\n",
       "                'Dolff S',\n",
       "                'Westhoff TH',\n",
       "                'Rohn H',\n",
       "                'Felderhoff-Mueser U',\n",
       "                'Stervbo U',\n",
       "                'Witzke O',\n",
       "                'Dohna-Schwake C',\n",
       "                'Babel N'],\n",
       "               'AD': ['Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany. krystallenia.paniskaki@umm.de.',\n",
       "                'Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany. krystallenia.paniskaki@umm.de.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.',\n",
       "                'Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics III, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.',\n",
       "                'Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.',\n",
       "                'Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.',\n",
       "                'Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.',\n",
       "                'Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.',\n",
       "                'Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.',\n",
       "                'Berlin Institute of Health at Charite - University Clinic Berlin, BIH Center for Regenerative Therapies (BCRT) Berlin, Berlin, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20231122',\n",
       "               'PL': 'England',\n",
       "               'TA': 'BMC Infect Dis',\n",
       "               'JT': 'BMC infectious diseases',\n",
       "               'JID': '100968551',\n",
       "               'RN': ['0 (Antibodies, Viral)',\n",
       "                '0 (Antibodies, Neutralizing)',\n",
       "                'SARS-CoV-2 variants'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Child',\n",
       "                'Adolescent',\n",
       "                'Humans',\n",
       "                '*SARS-CoV-2',\n",
       "                '*COVID-19',\n",
       "                'Immunity, Cellular',\n",
       "                'CD8-Positive T-Lymphocytes',\n",
       "                'Immunity, Humoral',\n",
       "                'Antibodies, Viral',\n",
       "                'Antibodies, Neutralizing'],\n",
       "               'PMC': 'PMC10664582',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Adaptive immunity',\n",
       "                'Children',\n",
       "                'Neutralizing antibodies',\n",
       "                'SARS-CoV-2',\n",
       "                'T cells'],\n",
       "               'COIS': ['The authors declare no competing interests.'],\n",
       "               'EDAT': '2023/11/23 00:42',\n",
       "               'MHDA': '2023/11/24 06:42',\n",
       "               'PMCR': ['2023/11/22'],\n",
       "               'CRDT': ['2023/11/22 23:57'],\n",
       "               'PHST': ['2023/06/16 00:00 [received]',\n",
       "                '2023/11/08 00:00 [accepted]',\n",
       "                '2023/11/24 06:42 [medline]',\n",
       "                '2023/11/23 00:42 [pubmed]',\n",
       "                '2023/11/22 23:57 [entrez]',\n",
       "                '2023/11/22 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1186/s12879-023-08805-9 [pii]',\n",
       "                '8805 [pii]',\n",
       "                '10.1186/s12879-023-08805-9 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'BMC Infect Dis. 2023 Nov 22;23(1):818. doi: 10.1186/s12879-023-08805-9.'},\n",
       "              {'PMID': '37928582',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20231107',\n",
       "               'IS': '1664-1078 (Print) 1664-1078 (Electronic) 1664-1078 (Linking)',\n",
       "               'VI': '14',\n",
       "               'DP': '2023',\n",
       "               'TI': \"Music therapy modulates mothers' perception of their preterm infants.\",\n",
       "               'PG': '1231741',\n",
       "               'LID': '10.3389/fpsyg.2023.1231741 [doi] 1231741',\n",
       "               'AB': \"Premature birth imposes considerable challenges on the preterm infant, but also challenges the mother, who may not yet be prepared for motherhood and encounter psychological stress during the post-partum period. This secondary analysis of a prospective randomized controlled trial (RCT) aimed to investigate how mothers perceive their preterm infants. We surveyed 33 mothers of preterm infants born before 32  weeks of gestation, who were participating in an RCT on music therapy. We employed the neonatal perception inventory (NPI), an instrument designed to assess the mother's perception and expectations regarding her infant immediately after birth. Infants were randomly assigned to either standard care (control group) or standard care plus music therapy (intervention group). Eighteen mothers from the intervention group participated in the survey (mean age 34.1  +/-  4.6 years) and 15 mothers from the control group (mean age 29.6  +/-  4.2  years). At the time of the infant's hospital discharge, mothers rated their expectations of how they felt a baby should behave (NPI I) and how they perceived their own infant (NPI II). The NPI score difference was calculated by subtracting the NPI II from the NPI I. Mean NPI I scores were comparable between both groups, but NPI II scores in the intervention group were better [18.0, 95% confidence interval (CI) 16.6-19.4] than in the control group (19.1, 95% CI 18.0-20.3). The relative probability of mothers rating their own baby as better than average was 1.94 (95% CI 1.00-3.79) for mothers whose infants received music therapy. These findings suggest that music therapy in the neonatal intensive care unit can positively influence mothers' perception of their hospitalized preterm infant.\",\n",
       "               'CI': ['Copyright (c) 2023 Kobus, Diezel, Dewan, Huening, Dathe, Marschik,',\n",
       "                'Felderhoff-Mueser and Bruns.'],\n",
       "               'FAU': ['Kobus, Susann',\n",
       "                'Diezel, Marlis',\n",
       "                'Dewan, Monia Vanessa',\n",
       "                'Huening, Britta',\n",
       "                'Dathe, Anne-Kathrin',\n",
       "                'Marschik, Peter B',\n",
       "                'Felderhoff-Mueser, Ursula',\n",
       "                'Bruns, Nora'],\n",
       "               'AU': ['Kobus S',\n",
       "                'Diezel M',\n",
       "                'Dewan MV',\n",
       "                'Huening B',\n",
       "                'Dathe AK',\n",
       "                'Marschik PB',\n",
       "                'Felderhoff-Mueser U',\n",
       "                'Bruns N'],\n",
       "               'AD': ['Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Faculty of Medicine, Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), University Duisburg-Essen, Essen, Germany.',\n",
       "                'Center of Artistic Therapy, University Medicine Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Faculty of Medicine, Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Faculty of Medicine, Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Faculty of Medicine, Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Faculty of Medicine, Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Health and Nursing, Occupational Therapy, Ernst-Abbe-University of Applied Sciences, Jena, Germany.',\n",
       "                'Child and Adolescent Psychiatry and Psychotherapy, Systemic Ethology and Developmental Science, University Medical Center Gottingen and Leibniz ScienceCampus Primate Cognition, Gottingen, Germany.',\n",
       "                'iDN - Interdisciplinary Developmental Neuroscience, Division of Phoniatrics, Medical University of Graz, Graz, Austria.',\n",
       "                \"Center of Neurodevelopmental Disorders (KIND), Center for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.\",\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Faculty of Medicine, Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Faculty of Medicine, Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), University Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20231019',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Psychol',\n",
       "               'JT': 'Frontiers in psychology',\n",
       "               'JID': '101550902',\n",
       "               'PMC': 'PMC10620800',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['music',\n",
       "                'music therapy',\n",
       "                'neonatal intensive care unit',\n",
       "                'neonatology',\n",
       "                'neonatology and pediatric intensive care',\n",
       "                'premature infants',\n",
       "                'preterm infants'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2023/11/06 06:42',\n",
       "               'MHDA': '2023/11/06 06:43',\n",
       "               'PMCR': ['2023/10/19'],\n",
       "               'CRDT': ['2023/11/06 04:36'],\n",
       "               'PHST': ['2023/05/30 00:00 [received]',\n",
       "                '2023/10/06 00:00 [accepted]',\n",
       "                '2023/11/06 06:43 [medline]',\n",
       "                '2023/11/06 06:42 [pubmed]',\n",
       "                '2023/11/06 04:36 [entrez]',\n",
       "                '2023/10/19 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fpsyg.2023.1231741 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Psychol. 2023 Oct 19;14:1231741. doi: 10.3389/fpsyg.2023.1231741. eCollection 2023.'},\n",
       "              {'PMID': '37842550',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20240312',\n",
       "               'IS': '2589-5370 (Electronic) 2589-5370 (Linking)',\n",
       "               'VI': '65',\n",
       "               'DP': '2023 Nov',\n",
       "               'TI': 'Distinct clinical phenotypes in paediatric cancer patients with sepsis are associated with different outcomes-an international multicentre retrospective study.',\n",
       "               'PG': '102252',\n",
       "               'LID': '10.1016/j.eclinm.2023.102252 [doi] 102252',\n",
       "               'AB': 'BACKGROUND: Identifying phenotypes in sepsis patients may enable precision medicine approaches. However, the generalisability of these phenotypes to specific patient populations is unclear. Given that paediatric cancer patients with sepsis have different host response and pathogen profiles and higher mortality rates when compared to non-cancer patients, we determined whether unique, reproducible, and clinically-relevant sepsis phenotypes exist in this specific patient population. METHODS: We studied patients with underlying malignancies admitted with sepsis to one of 25 paediatric intensive care units (PICUs) participating in two large, multi-centre, observational cohorts from the European SCOTER study (n = 383 patients; study period between January 1, 2018 and January 1, 2020) and the U.S. Novel Data-Driven Sepsis Phenotypes in Children study (n = 1898 patients; study period between January 1, 2012 and January 1, 2018). We independently used latent class analysis (LCA) in both cohorts to identify phenotypes using demographic, clinical, and laboratory data from the first 24 h of PICU admission. We then tested the association of the phenotypes with clinical outcomes in both cohorts. FINDINGS: LCA identified two distinct phenotypes that were comparable across both cohorts. Phenotype 1 was characterised by lower serum bicarbonate and albumin, markedly increased lactate and hepatic, renal, and coagulation abnormalities when compared to phenotype 2. Patients with phenotype 1 had a higher 90-day mortality (European cohort 29.2% versus 13.4%, U.S. cohort 27.3% versus 11.4%, p < 0.001) and received more vasopressor and renal replacement therapy than patients with phenotype 2. After adjusting for severity of organ dysfunction, haematological cancer, prior stem cell transplantation and age, phenotype 1 was associated with an adjusted OR of death at 90-day of 1.9 (1.04-3.34) in the European cohort and 1.6 (1.2-2.2) in the U.S. cohort. INTERPRETATION: We identified two clinically-relevant sepsis phenotypes in paediatric cancer patients that are reproducible across two international, multicentre cohorts with prognostic implications. These results may guide further research regarding therapeutic approaches for these specific phenotypes. FUNDING: Part of this study is funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.',\n",
       "               'CI': ['(c) 2023 The Authors.'],\n",
       "               'FAU': ['Wosten-van Asperen, Roelie M',\n",
       "                'la Roi-Teeuw, Hannah M',\n",
       "                'van Amstel, Rombout Be',\n",
       "                'Bos, Lieuwe Dj',\n",
       "                'Tissing, Wim Je',\n",
       "                'Jordan, Iolanda',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Bottari, Gabriella',\n",
       "                'Pappachan, John',\n",
       "                'Crazzolara, Roman',\n",
       "                'Comoretto, Rosanna I',\n",
       "                'Mizia-Malarz, Agniezka',\n",
       "                'Moscatelli, Andrea',\n",
       "                'Sanchez-Martin, Maria',\n",
       "                'Willems, Jef',\n",
       "                'Rogerson, Colin M',\n",
       "                'Bennett, Tellen D',\n",
       "                'Luo, Yuan',\n",
       "                'Atreya, Mihir R',\n",
       "                'Faustino, E Vincent S',\n",
       "                'Geva, Alon',\n",
       "                'Weiss, Scott L',\n",
       "                'Schlapbach, Luregn J',\n",
       "                'Sanchez-Pinto, L Nelson'],\n",
       "               'AU': ['Wosten-van Asperen RM',\n",
       "                'la Roi-Teeuw HM',\n",
       "                'van Amstel RB',\n",
       "                'Bos LD',\n",
       "                'Tissing WJ',\n",
       "                'Jordan I',\n",
       "                'Dohna-Schwake C',\n",
       "                'Bottari G',\n",
       "                'Pappachan J',\n",
       "                'Crazzolara R',\n",
       "                'Comoretto RI',\n",
       "                'Mizia-Malarz A',\n",
       "                'Moscatelli A',\n",
       "                'Sanchez-Martin M',\n",
       "                'Willems J',\n",
       "                'Rogerson CM',\n",
       "                'Bennett TD',\n",
       "                'Luo Y',\n",
       "                'Atreya MR',\n",
       "                'Faustino EVS',\n",
       "                'Geva A',\n",
       "                'Weiss SL',\n",
       "                'Schlapbach LJ',\n",
       "                'Sanchez-Pinto LN'],\n",
       "               'AD': [\"Department of Paediatric Intensive Care, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, the Netherlands.\",\n",
       "                \"Department of Paediatric Intensive Care, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, the Netherlands.\",\n",
       "                'Intensive Care, Amsterdam UMC-location AMC, University of Amsterdam, Amsterdam, the Netherlands.',\n",
       "                'Intensive Care, Amsterdam UMC-location AMC, University of Amsterdam, Amsterdam, the Netherlands.',\n",
       "                'Princess Maxima Centre for Pediatric Oncology, Utrecht, the Netherlands.',\n",
       "                'Department of Paediatric Oncology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.',\n",
       "                'Department of Paediatric Intensive Care and Institut de Recerca, Hospital Sant Joan de Deu, University of Barcelona, Barcelona, Spain.',\n",
       "                'Consorcio de Investigacion Biomedica en Red de Epidemiologia y Salud Publica, Madrid, Spain.',\n",
       "                \"Department of Paediatrics I, Paediatric Intensive Care, Children's Hospital Essen, Germany.\",\n",
       "                'West German Centre for Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                \"Paediatric Intensive Care Unit, Children's Hospital Bambino Gesu, IRCSS, Rome, Italy.\",\n",
       "                \"Department of Paediatric Intensive Care, Southampton Children's Hospital, UK.\",\n",
       "                'Department of Paediatrics, Paediatric Intensive Care Unit, Medical University of Innsbruck, Innsbruck, Austria.',\n",
       "                \"Department of Paediatric Intensive Care, Department of Woman's and Child's Health, Padua University Hospital, Padua, Italy.\",\n",
       "                'Department of Paediatric Oncology, Haematology and Chemotherapy Unit, Medical University of Silesia, Katowice, Poland.',\n",
       "                'Neonatal and Paediatric Intensive Care Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy.',\n",
       "                'Department of Paediatric Intensive Care, Hospital Universitario La Paz, Madrid, Spain.',\n",
       "                'Department of Paediatric Intensive Care, Ghent University Hospital, Ghent, Belgium.',\n",
       "                'Department of Paediatrics, Division of Critical Care, Indianapolis University School of Medicine, Indianapolis, IN, USA.',\n",
       "                'Departments of Biomedical Informatics and Paediatrics, University of Colorado School of Medicine, Aurora, CO, USA.',\n",
       "                'Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.',\n",
       "                \"Department of Paediatrics (Critical Care), University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Centre, Cincinnati, OH, USA.\",\n",
       "                'Department of Paediatrics, Yale School of Medicine, New Haven, CT, USA.',\n",
       "                \"Department of Anaesthesiology, Critical Care, and Pain Medicine and Computational Health Informatics Program, Boston Children's Hospital, USA.\",\n",
       "                'Department of Anaesthesia, Harvard Medical School, Boston, MA, USA.',\n",
       "                \"Division of Critical Care, Department of Paediatrics, Nemours Children's Health, Delaware, USA.\",\n",
       "                \"Department of Intensive Care and Neonatology and Children's Research Centre, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.\",\n",
       "                'Child Health Research Centre, The University of Queensland, Brisbane, Queensland, Australia.',\n",
       "                \"Department of Paediatrics (Critical Care) and Preventive Medicine (Health & Biomedical Informatics), Northwestern University Feinberg School of Medicine and Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA.\"],\n",
       "               'CN': ['POKER (PICU Oncology Kids in Europe Research group) research consortium of ESPNIC',\n",
       "                '(European Society of Paediatric & Neonatal Intensive Care), and',\n",
       "                'Novel Data-Driven Sepsis Phenotypes in Children study group'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['R01 LM013337/LM/NLM NIH HHS/United States',\n",
       "                'R21 HD096402/HD/NICHD NIH HHS/United States',\n",
       "                'UL1 TR001863/TR/NCATS NIH HHS/United States'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20231005',\n",
       "               'PL': 'England',\n",
       "               'TA': 'EClinicalMedicine',\n",
       "               'JT': 'EClinicalMedicine',\n",
       "               'JID': '101733727',\n",
       "               'PMC': 'PMC10570699',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Latent class analysis',\n",
       "                'Oncology',\n",
       "                'Paediatric intensive care',\n",
       "                'Phenotype',\n",
       "                'Sepsis'],\n",
       "               'COIS': ['LDJB is supported by the Amsterdam UMC fellowship, Health Holland, ZonMW,',\n",
       "                'Innovative Medicine Initiative, and by the Dutch Lung Foundation (Longfonds)',\n",
       "                'through the Dirkje Postma Award and personal fees from Scailyte, Sobi NL,',\n",
       "                'Impentri, Novartis, AstraZeneca and CLS Behring, outside the submitted work. AM',\n",
       "                'received personal fees from Drager, outside the submitted work. CMR reports a',\n",
       "                'research grant from the Indiana University Pediatric Critical Care, outside the',\n",
       "                'submitted work. TDB reports funding from U.S. AHRQ (R18 HS029298), outside the',\n",
       "                'submitted work. EVSF repots funding from US NIH, outside the submitted work. SLW',\n",
       "                'reports grants from the US NIH/NICHD (R01HD102396 and R01HD105939) and',\n",
       "                'NIH/National Institute of General Medical Sciences (R21GM146159), and royalties',\n",
       "                'from Up To Date, outside the submitted work. LNS reports grants from the US NIH',\n",
       "                '(R01HD105939 and R21GM146159), and personal fees from Celldom, Saccharo, Allyx,',\n",
       "                'outside the submitted work.'],\n",
       "               'FIR': ['Caballero, Marina',\n",
       "                'Margarit, Adriana',\n",
       "                'Campos, Roi',\n",
       "                'Moller, Paula',\n",
       "                'Serpe, Carmela',\n",
       "                'Amigoni, Angela',\n",
       "                'Damps, Maria',\n",
       "                'Montaguti, Alessia',\n",
       "                'Tardini, Giacomo',\n",
       "                'Bubeck-Wardenburg, Juliane',\n",
       "                'Farris, Reid Farris',\n",
       "                'Hall, Mark',\n",
       "                'Chong, Grace',\n",
       "                'Shah, Sareen',\n",
       "                'Khemani, Robinder',\n",
       "                'Stroup, Emily'],\n",
       "               'IR': ['Caballero M',\n",
       "                'Margarit A',\n",
       "                'Campos R',\n",
       "                'Moller P',\n",
       "                'Serpe C',\n",
       "                'Amigoni A',\n",
       "                'Damps M',\n",
       "                'Montaguti A',\n",
       "                'Tardini G',\n",
       "                'Bubeck-Wardenburg J',\n",
       "                'Farris RF',\n",
       "                'Hall M',\n",
       "                'Chong G',\n",
       "                'Shah S',\n",
       "                'Khemani R',\n",
       "                'Stroup E'],\n",
       "               'EDAT': '2023/10/16 06:48',\n",
       "               'MHDA': '2023/10/16 06:49',\n",
       "               'PMCR': ['2023/10/05'],\n",
       "               'CRDT': ['2023/10/16 04:54'],\n",
       "               'PHST': ['2023/07/27 00:00 [received]',\n",
       "                '2023/09/14 00:00 [revised]',\n",
       "                '2023/09/15 00:00 [accepted]',\n",
       "                '2023/10/16 06:49 [medline]',\n",
       "                '2023/10/16 06:48 [pubmed]',\n",
       "                '2023/10/16 04:54 [entrez]',\n",
       "                '2023/10/05 00:00 [pmc-release]'],\n",
       "               'AID': ['S2589-5370(23)00429-7 [pii]',\n",
       "                '102252 [pii]',\n",
       "                '10.1016/j.eclinm.2023.102252 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'EClinicalMedicine. 2023 Oct 5;65:102252. doi: 10.1016/j.eclinm.2023.102252. eCollection 2023 Nov.'},\n",
       "              {'PMID': '37751768',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20231113',\n",
       "               'LR': '20231113',\n",
       "               'IS': '1439-3824 (Electronic) 0300-8630 (Linking)',\n",
       "               'VI': '235',\n",
       "               'IP': '6',\n",
       "               'DP': '2023 Nov',\n",
       "               'TI': '[Time to Antibiotics (TTA) - Reassessment from the German Working Group for Fever and Neutropenia in Children and Adolescents (DGPI/GPOH)].',\n",
       "               'PG': '331-341',\n",
       "               'LID': '10.1055/a-2135-4210 [doi]',\n",
       "               'AB': 'BACKGROUND: The current German guidance from 2016 recommends a Time to Antibiotics (TTA) of<60 min in children and adolescents with febrile neutropenia (FN). METHODS: Critical analysis of available studies and recent meta-analyses, and discussion of the practical consequences in the FN working group of the German Societies for Paediatric Oncology and Haematology and Paediatric Infectious Diseases. RESULTS: The available evidence does not support a clinically significant outcome benefit of a TTA<60 min in all paediatric patients with FN. Studies suggesting such a benefit are biased (mainly triage bias), use different TTA definitions and display further methodical limitations. In any case, a TTA<60 min remains an essential component of the 1st hour-bundle in paediatric cancer patients with septic shock or sepsis with organ dysfunction. CONCLUSION: Provided that all paediatric FN patients receive a structured medical history and physical examination (including vital signs) by experienced and trained medical personnel in a timely fashion, and provided that a sepsis triage and management bundle is established and implemented, a TTA lower than 3 hours is sufficient and reasonable in stable paediatric cancer patients with FN.',\n",
       "               'CI': ['Thieme. All rights reserved.'],\n",
       "               'FAU': ['Simon, Arne',\n",
       "                'Lehrnbecher, Thomas',\n",
       "                'Baltaci, Yeliz',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Groll, Andreas',\n",
       "                'Laws, Hans-Jurgen',\n",
       "                'Potratz, Jenny',\n",
       "                'Hufnagel, Markus',\n",
       "                'Bochennek, Konrad'],\n",
       "               'AU': ['Simon A',\n",
       "                'Lehrnbecher T',\n",
       "                'Baltaci Y',\n",
       "                'Dohna-Schwake C',\n",
       "                'Groll A',\n",
       "                'Laws HJ',\n",
       "                'Potratz J',\n",
       "                'Hufnagel M',\n",
       "                'Bochennek K'],\n",
       "               'AUID': ['ORCID: 0000-0001-9558-3330',\n",
       "                'ORCID: 0000-0001-8973-5406'],\n",
       "               'AD': ['Padiatrische Onkologie und Hamatologie, Universitatskinderklinik Homburg, Homburg, Germany.',\n",
       "                'Klinik fur Kinder- und Jugendheilkunde, Klinikum der Johann-Wolfgang-Goethe-Universitat, Frankfurt, Germany.',\n",
       "                'Padiatrische Onkologie und Hamatologie, TeleKasper Projekt, Universitatskinderklinik Homburg, Homburg, Germany.',\n",
       "                'Kinderklinik 1, Universitatsklinik Essen, Essen, Germany.',\n",
       "                'Pad. Hamatologie und Onkologie, Univ.-Klinikum Munster, Klinik fur Kinder- und Jugendmedizin, Munster, Germany.',\n",
       "                'Klinik fur Kinder-Onkologie, - Hamatologie und - Klinische Immunologie, Universerstitatsklinikum Dusseldorf, Dusseldorf, Germany.',\n",
       "                'Padiatrische Onkologie und Hamatologie, Universitatskinderklinik Munster, Muenster, Germany.',\n",
       "                'Klinik fur Kinderheilkunde und Jugendmedizin, Universitatskinderklinik Freiburg, Freiburg, Germany.',\n",
       "                'Padiatrische Hamatologie und Onkologie, Universitatsklinik Frankfurt, Frankfurt, Germany.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Time to Antibiotics (TTA) - Uberlegungen der Arbeitsgruppe Fieber bei Granulozytopenie im Kindes- und Jugendalter (GPOH/DGPI) zu einer Neubewertung.',\n",
       "               'DEP': '20230926',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Klin Padiatr',\n",
       "               'JT': 'Klinische Padiatrie',\n",
       "               'JID': '0326144',\n",
       "               'RN': ['0 (Anti-Bacterial Agents)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Child',\n",
       "                'Adolescent',\n",
       "                'Anti-Bacterial Agents/adverse effects',\n",
       "                '*Neutropenia/chemically induced/diagnosis/drug therapy',\n",
       "                'Fever/diagnosis/drug therapy/etiology',\n",
       "                '*Neoplasms/complications/drug therapy',\n",
       "                '*Shock, Septic/diagnosis/drug therapy'],\n",
       "               'COIS': ['Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht.'],\n",
       "               'EDAT': '2023/09/27 00:42',\n",
       "               'MHDA': '2023/11/13 06:42',\n",
       "               'CRDT': ['2023/09/26 19:03'],\n",
       "               'PHST': ['2023/11/13 06:42 [medline]',\n",
       "                '2023/09/27 00:42 [pubmed]',\n",
       "                '2023/09/26 19:03 [entrez]'],\n",
       "               'AID': ['10.1055/a-2135-4210 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Klin Padiatr. 2023 Nov;235(6):331-341. doi: 10.1055/a-2135-4210. Epub 2023 Sep 26.'},\n",
       "              {'PMID': '37667535',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20231109',\n",
       "               'LR': '20240815',\n",
       "               'IS': '1651-2227 (Electronic) 0803-5253 (Linking)',\n",
       "               'VI': '112',\n",
       "               'IP': '12',\n",
       "               'DP': '2023 Dec',\n",
       "               'TI': 'Erythrocyte transfusions are associated with retinopathy of prematurity in extremely low gestational age newborns.',\n",
       "               'PG': '2507-2515',\n",
       "               'LID': '10.1111/apa.16965 [doi]',\n",
       "               'AB': 'AIM: Retinopathy of prematurity (ROP) is a major morbidity in preterm infants causing visual impairment including blindness. Prevention and timely treatment are critical. We investigated the potential role of red blood cell (RBC) transfusions as risk factor for ROP development. METHODS: Retrospective cohort study of data from 68 tertiary level neonatal intensive care units in Germany. Preterm infants born at 22 + 0 to 28 + 6 weeks of gestation between January 2009 and December 2021 were enrolled. RESULTS: We included n = 12 565 infants. Prevalence of any ROP was 49.2% with most infants being diagnosed with stage 1 (21.5%) and 2 disease (17.2%). ROP stage 3 was present in 10.2%, stage 4 in 0.3%, and ROP requiring treatment in 6.6%. Infants with ROP had significantly more frequently a history of RBC transfusions. Adjusting for confounders, RBC transfusions were associated with increased odds of ROP (OR 1.4, p < 0.001), ROP progression (OR 2.1, p < 0.01) and ROP requiring treatment (OR 3.6, p < 0.001). Restrictive transfusion approaches correlated with decreased (OR 0.7, p < 0.001), liberal regimes with increased odds (OR 1.2, p = 0.001). CONCLUSION: The present study confirmed an association of RBC transfusions and ROP. Our findings emphasise the need for anaemia prevention and critical re-evaluation of transfusion practices in preterm infants.',\n",
       "               'CI': ['(c) 2023 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf',\n",
       "                'of Foundation Acta Paediatrica.'],\n",
       "               'FAU': ['Glaser, Kirsten',\n",
       "                'Hartel, Christoph',\n",
       "                'Dammann, Olaf',\n",
       "                'Herting, Egbert',\n",
       "                'Andres, Oliver',\n",
       "                'Speer, Christian P',\n",
       "                'Gopel, Wolfgang',\n",
       "                'Stahl, Andreas'],\n",
       "               'AU': ['Glaser K',\n",
       "                'Hartel C',\n",
       "                'Dammann O',\n",
       "                'Herting E',\n",
       "                'Andres O',\n",
       "                'Speer CP',\n",
       "                'Gopel W',\n",
       "                'Stahl A'],\n",
       "               'AUID': ['ORCID: 0000-0002-2158-0222',\n",
       "                'ORCID: 0000-0002-0046-4863',\n",
       "                'ORCID: 0000-0002-6486-4727'],\n",
       "               'AD': [\"Division of Neonatology, Department of Women's and Children's Health, University of Leipzig Medical Center, Leipzig, Germany.\",\n",
       "                'Department of Pediatrics, University Hospital of Wurzburg, Wurzburg, Germany.',\n",
       "                'Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Wurzburg, Wurzburg, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Wurzburg, Wurzburg, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Ophthalmology, University Medicine Greifswald, Greifswald, Germany.'],\n",
       "               'CN': ['German Neonatal Network'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20230904',\n",
       "               'PL': 'Norway',\n",
       "               'TA': 'Acta Paediatr',\n",
       "               'JT': 'Acta paediatrica (Oslo, Norway : 1992)',\n",
       "               'JID': '9205968',\n",
       "               'RN': ['11096-26-7 (Erythropoietin)'],\n",
       "               'SB': 'IM',\n",
       "               'CIN': ['Acta Paediatr. 2024 Mar;113(3):615-616. doi: 10.1111/apa.17079. PMID: 38129765'],\n",
       "               'MH': ['Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Humans',\n",
       "                'Infant, Premature',\n",
       "                'Gestational Age',\n",
       "                'Infant, Low Birth Weight',\n",
       "                '*Retinopathy of Prematurity/epidemiology/etiology',\n",
       "                'Erythrocyte Transfusion/adverse effects',\n",
       "                'Retrospective Studies',\n",
       "                '*Erythropoietin',\n",
       "                '*Anemia, Neonatal/therapy',\n",
       "                'Risk Factors'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['erythrocyte transfusion',\n",
       "                'preterm infant',\n",
       "                'red blood cell transfusion',\n",
       "                'retinopathy of prematurity',\n",
       "                'risk factor'],\n",
       "               'EDAT': '2023/09/05 06:41',\n",
       "               'MHDA': '2023/11/09 06:42',\n",
       "               'CRDT': ['2023/09/05 02:19'],\n",
       "               'PHST': ['2023/08/20 00:00 [revised]',\n",
       "                '2023/06/30 00:00 [received]',\n",
       "                '2023/08/24 00:00 [accepted]',\n",
       "                '2023/11/09 06:42 [medline]',\n",
       "                '2023/09/05 06:41 [pubmed]',\n",
       "                '2023/09/05 02:19 [entrez]'],\n",
       "               'AID': ['10.1111/apa.16965 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Acta Paediatr. 2023 Dec;112(12):2507-2515. doi: 10.1111/apa.16965. Epub 2023 Sep 4.'},\n",
       "              {'PMID': '37633566',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20231115',\n",
       "               'LR': '20231122',\n",
       "               'IS': '1879-0003 (Electronic) 0141-8130 (Linking)',\n",
       "               'VI': '252',\n",
       "               'DP': '2023 Dec 1',\n",
       "               'TI': 'Legionella pneumophila macrophage infectivity potentiator protein appendage domains modulate protein dynamics and inhibitor binding.',\n",
       "               'PG': '126366',\n",
       "               'LID': 'S0141-8130(23)03262-2 [pii] 10.1016/j.ijbiomac.2023.126366 [doi]',\n",
       "               'AB': \"Macrophage infectivity potentiator (MIP) proteins are widespread in human pathogens including Legionella pneumophila, the causative agent of Legionnaires' disease and protozoans such as Trypanosoma cruzi. All MIP proteins contain a FKBP (FK506 binding protein)-like prolyl-cis/trans-isomerase domain that hence presents an attractive drug target. Some MIPs such as the Legionella pneumophila protein (LpMIP) have additional appendage domains of mostly unknown function. In full-length, homodimeric LpMIP, the N-terminal dimerization domain is linked to the FKBP-like domain via a long, free-standing stalk helix. Combining X-ray crystallography, NMR and EPR spectroscopy and SAXS, we elucidated the importance of the stalk helix for protein dynamics and inhibitor binding to the FKBP-like domain and bidirectional crosstalk between the different protein regions. The first comparison of a microbial MIP and a human FKBP in complex with the same synthetic inhibitor was made possible by high-resolution structures of LpMIP with a [4.3.1]-aza-bicyclic sulfonamide and provides a basis for designing pathogen-selective inhibitors. Through stereospecific methylation, the affinity of inhibitors to L. pneumophila and T. cruzi MIP was greatly improved. The resulting X-ray inhibitor-complex structures of LpMIP and TcMIP at 1.49 and 1.34 A, respectively, provide a starting point for developing potent inhibitors against MIPs from multiple pathogenic microorganisms.\",\n",
       "               'CI': ['Copyright (c) 2023 The Author(s). Published by Elsevier B.V. All rights reserved.'],\n",
       "               'FAU': ['Wiedemann, C',\n",
       "                'Whittaker, J J',\n",
       "                'Perez Carrillo, V H',\n",
       "                'Goretzki, B',\n",
       "                'Dajka, M',\n",
       "                'Tebbe, F',\n",
       "                'Harder, J-M',\n",
       "                'Krajczy, P R',\n",
       "                'Joseph, B',\n",
       "                'Hausch, F',\n",
       "                'Guskov, A',\n",
       "                'Hellmich, U A'],\n",
       "               'AU': ['Wiedemann C',\n",
       "                'Whittaker JJ',\n",
       "                'Perez Carrillo VH',\n",
       "                'Goretzki B',\n",
       "                'Dajka M',\n",
       "                'Tebbe F',\n",
       "                'Harder JM',\n",
       "                'Krajczy PR',\n",
       "                'Joseph B',\n",
       "                'Hausch F',\n",
       "                'Guskov A',\n",
       "                'Hellmich UA'],\n",
       "               'AD': ['Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, Jena, Germany.',\n",
       "                'Groningen Institute for Biomolecular Sciences and Biotechnology, University of Groningen, 9747AG Groningen, the Netherlands.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, Jena, Germany.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, Jena, Germany; Center for Biomolecular Magnetic Resonance, Goethe-University, Frankfurt/Main, Germany.',\n",
       "                'Department of Physics, Freie Universitat Berlin, Germany.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, Jena, Germany.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, Jena, Germany.',\n",
       "                'Department of Chemistry and Biochemistry Clemens-Schopf-Institute, Technical University Darmstadt, Darmstadt, Germany.',\n",
       "                'Department of Physics, Freie Universitat Berlin, Germany.',\n",
       "                'Department of Chemistry and Biochemistry Clemens-Schopf-Institute, Technical University Darmstadt, Darmstadt, Germany; Centre for Synthetic Biology, Technical University of Darmstadt, 64283 Darmstadt, Germany.',\n",
       "                'Groningen Institute for Biomolecular Sciences and Biotechnology, University of Groningen, 9747AG Groningen, the Netherlands.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, Jena, Germany; Center for Biomolecular Magnetic Resonance, Goethe-University, Frankfurt/Main, Germany; Cluster of Excellence Balance of the Microverse, Friedrich Schiller University Jena, Jena, Germany. Electronic address: ute.hellmich@uni-jena.de.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20230824',\n",
       "               'PL': 'Netherlands',\n",
       "               'TA': 'Int J Biol Macromol',\n",
       "               'JT': 'International journal of biological macromolecules',\n",
       "               'JID': '7909578',\n",
       "               'RN': ['0 (Bacterial Proteins)',\n",
       "                'EC 5.2.1.- (Tacrolimus Binding Proteins)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*Legionella pneumophila/metabolism',\n",
       "                'Scattering, Small Angle',\n",
       "                'X-Ray Diffraction',\n",
       "                'Bacterial Proteins/chemistry',\n",
       "                'Tacrolimus Binding Proteins/chemistry',\n",
       "                \"*Legionnaires' Disease\",\n",
       "                'Macrophages/metabolism'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Protein dynamics',\n",
       "                'Protein inhibitor complex',\n",
       "                'Virulence factor'],\n",
       "               'COIS': ['Declaration of competing interest The authors declare that they have no known',\n",
       "                'competing financial interests or personal relationships that could have appeared',\n",
       "                'to influence the work reported in this paper.'],\n",
       "               'EDAT': '2023/08/27 05:43',\n",
       "               'MHDA': '2023/11/15 06:42',\n",
       "               'CRDT': ['2023/08/26 19:27'],\n",
       "               'PHST': ['2023/04/24 00:00 [received]',\n",
       "                '2023/08/13 00:00 [revised]',\n",
       "                '2023/08/14 00:00 [accepted]',\n",
       "                '2023/11/15 06:42 [medline]',\n",
       "                '2023/08/27 05:43 [pubmed]',\n",
       "                '2023/08/26 19:27 [entrez]'],\n",
       "               'AID': ['S0141-8130(23)03262-2 [pii]',\n",
       "                '10.1016/j.ijbiomac.2023.126366 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Int J Biol Macromol. 2023 Dec 1;252:126366. doi: 10.1016/j.ijbiomac.2023.126366. Epub 2023 Aug 24.'},\n",
       "              {'PMID': '37494759',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'Publisher',\n",
       "               'LR': '20231012',\n",
       "               'IS': '1532-2688 (Electronic) 1059-1311 (Linking)',\n",
       "               'VI': '111',\n",
       "               'DP': '2023 Oct',\n",
       "               'TI': 'Outcome after conservative or surgical treatment for new-onset epilepsy in children with cerebral cavernous malformation.',\n",
       "               'PG': '23-29',\n",
       "               'LID': 'S1059-1311(23)00195-4 [pii] 10.1016/j.seizure.2023.07.011 [doi]',\n",
       "               'AB': 'OBJECTIVE: This study aimed to investigate and compare the outcome of conservatively or surgically treated children with cerebral cavernous malformation (CCM) and new-onset CCM-related epilepsy (CRE) during a 5-year period. METHODS: In this observational monocentric cohort study, data were collected ambispectivley. Our database was screened for CCM patients treated between 2003 and 2020. Patients </=18 years of age with complete magnetic resonance imaging dataset, clinical baseline characteristics, and diagnosis of new-onset CRE were included. Definite seizure control was classified as International League Against Epilepsy class <2. Functional outcome was assessed using the modified Rankin Scale score. CRE patients were separated into two groups according to their treatment modality. Seizure control, intake of antiseizure medication, and functional outcomes were assessed. Systematic literature research was performed to identify other cases of new-onset CRE in children and to compare the collected data with published data. RESULTS: Thirty-nine pediatric CRE patients were analyzed. A total of 18 (46.1%) patients were conservatively treated, while 21 (53.8%) underwent surgical CCM removal. While the functional outcome was similar in both groups at the last follow-up, definite seizure control was better in the surgical group (77.8%) than in the conservative group (25.0%) both after 5-years of follow-up (p = 0.038), and at last follow-up with 85.7% versus 50% respectively (p = 0.035). We found substantially higher rates of discontinuation of antiseizure medication at the last available follow-up in patients undergoing surgical resection (p = 0.009). The systematic literature review identified 4 studies with a total of 30 additional children with early onset CRE. CONCLUSION: Surgical treatment of pediatric patients with new-onset CRE had higher rates of complete seizure control and early discontinuation of antiseizure medication than conservative treatment. Neurological outcomes of patients managed surgically or conservatively were comparable. These results encourage early surgical management of children with CRE even in the absence of pharmacoresistant epilepsy, but randomized control trials are urgently needed for further decision-making.',\n",
       "               'CI': ['Copyright (c) 2023 British Epilepsy Association. Published by Elsevier Ltd. All',\n",
       "                'rights reserved.'],\n",
       "               'FAU': ['Santos, Alejandro N',\n",
       "                'Rauschenbach, Laurel',\n",
       "                'Riess, Christoph',\n",
       "                'Georgiades, Iason',\n",
       "                'Ficilar, Berrin',\n",
       "                'Gallardo, Enrique G',\n",
       "                'Quesada, Carlos M',\n",
       "                'Li, Yan',\n",
       "                'Tippelt, Stephan',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Schmidt, Borge',\n",
       "                'Jabbarli, Ramazan',\n",
       "                'Siegel, Adrian M',\n",
       "                'Benet, Arnau',\n",
       "                'Wrede, Karsten H',\n",
       "                'Sure, Ulrich',\n",
       "                'Dammann, Philipp'],\n",
       "               'AU': ['Santos AN',\n",
       "                'Rauschenbach L',\n",
       "                'Riess C',\n",
       "                'Georgiades I',\n",
       "                'Ficilar B',\n",
       "                'Gallardo EG',\n",
       "                'Quesada CM',\n",
       "                'Li Y',\n",
       "                'Tippelt S',\n",
       "                'Dohna-Schwake C',\n",
       "                'Schmidt B',\n",
       "                'Jabbarli R',\n",
       "                'Siegel AM',\n",
       "                'Benet A',\n",
       "                'Wrede KH',\n",
       "                'Sure U',\n",
       "                'Dammann P'],\n",
       "               'AD': ['Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany; Center for Translational Neuro- & Behavioral Sciences (C-TNBS), University Duisburg Essen, Essen, Germany. Electronic address: alejandro.santos@uk-essen.de.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany; Center for Translational Neuro- & Behavioral Sciences (C-TNBS), University Duisburg Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany; Center for Translational Neuro- & Behavioral Sciences (C-TNBS), University Duisburg Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany; Center for Translational Neuro- & Behavioral Sciences (C-TNBS), University Duisburg Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany; Center for Translational Neuro- & Behavioral Sciences (C-TNBS), University Duisburg Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany; Center for Translational Neuro- & Behavioral Sciences (C-TNBS), University Duisburg Essen, Essen, Germany.',\n",
       "                'Department for Neurology, University Hospital Essen, Essen, Germany.',\n",
       "                'Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Essen, Essen, Germany.',\n",
       "                'Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany; Center for Translational Neuro- & Behavioral Sciences (C-TNBS), University Duisburg Essen, Essen, Germany.',\n",
       "                'Department of Neurology, University of Zurich, Zurich, Switzerland.',\n",
       "                'Department of Neurosurgery, Barrow Neurological Institute, Phoenix, USA.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany; Center for Translational Neuro- & Behavioral Sciences (C-TNBS), University Duisburg Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany; Center for Translational Neuro- & Behavioral Sciences (C-TNBS), University Duisburg Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany; Center for Translational Neuro- & Behavioral Sciences (C-TNBS), University Duisburg Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20230717',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Seizure',\n",
       "               'JT': 'Seizure',\n",
       "               'JID': '9306979',\n",
       "               'SB': 'IM',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Cavernous-related epilepsy',\n",
       "                'Conservative',\n",
       "                'New-onset epilepsy',\n",
       "                'Pediatric',\n",
       "                'Surgical'],\n",
       "               'COIS': ['Declaration of Competing Interest The authors have declared that no competing',\n",
       "                'interest exists.'],\n",
       "               'EDAT': '2023/07/27 01:09',\n",
       "               'MHDA': '2023/07/27 01:09',\n",
       "               'CRDT': ['2023/07/26 18:00'],\n",
       "               'PHST': ['2023/04/24 00:00 [received]',\n",
       "                '2023/07/09 00:00 [revised]',\n",
       "                '2023/07/16 00:00 [accepted]',\n",
       "                '2023/07/27 01:09 [pubmed]',\n",
       "                '2023/07/27 01:09 [medline]',\n",
       "                '2023/07/26 18:00 [entrez]'],\n",
       "               'AID': ['S1059-1311(23)00195-4 [pii]',\n",
       "                '10.1016/j.seizure.2023.07.011 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Seizure. 2023 Oct;111:23-29. doi: 10.1016/j.seizure.2023.07.011. Epub 2023 Jul 17.'},\n",
       "              {'PMID': '37445355',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20230718',\n",
       "               'IS': '2077-0383 (Print) 2077-0383 (Electronic) 2077-0383 (Linking)',\n",
       "               'VI': '12',\n",
       "               'IP': '13',\n",
       "               'DP': '2023 Jun 27',\n",
       "               'TI': 'Early Prediction of Mortality after Birth Asphyxia with the nSOFA.',\n",
       "               'LID': '10.3390/jcm12134322 [doi] 4322',\n",
       "               'AB': '(1) Birth asphyxia is a major cause of delivery room resuscitation. Subsequent organ failure and hypoxic-ischemic encephalopathy (HIE) account for 25% of all early postnatal deaths. The neonatal sequential organ failure assessment (nSOFA) considers platelet count and respiratory and cardiovascular dysfunction in neonates with sepsis. To evaluate whether nSOFA is also a useful predictor for in-hospital mortality in neonates (>/=36 + 0 weeks of gestation (GA)) following asphyxia with HIE and therapeutic hypothermia (TH), (2) nSOFA was documented at </=6 h of life. (3) A total of 65 infants fulfilled inclusion criteria for TH. All but one infant received cardiopulmonary resuscitation and/or respiratory support at birth. nSOFA was lower in survivors (median 0 [IQR 0-2]; n = 56, median GA 39 + 3, female n = 28 (50%)) than in non-survivors (median 10 [4-12], p < 0.001; n = 9, median GA 38 + 6, n = 4 (44.4%)). This was also observed for the respiratory (p < 0.001), cardiovascular (p < 0.001), and hematologic sub-scores (p = 0.003). The odds ratio for mortality was 1.6 [95% CI = 1.2-2.1] per one-point increase in nSOFA. The optimal cut-off value of nSOFA to predict mortality was 3.5 (sensitivity 100.0%, specificity 83.9%). (4) Since early accurate prognosis following asphyxia with HIE and TH is essential to guide decision making, nSOFA (</=6 h of life) offers the possibility of identifying infants at risk of mortality.',\n",
       "               'FAU': ['Dathe, Anne-Kathrin',\n",
       "                'Stein, Anja',\n",
       "                'Bruns, Nora',\n",
       "                'Craciun, Elena-Diana',\n",
       "                'Tuda, Laura',\n",
       "                'Bialas, Johanna',\n",
       "                'Brasseler, Maire',\n",
       "                'Felderhoff-Mueser, Ursula',\n",
       "                'Huening, Britta M'],\n",
       "               'AU': ['Dathe AK',\n",
       "                'Stein A',\n",
       "                'Bruns N',\n",
       "                'Craciun ED',\n",
       "                'Tuda L',\n",
       "                'Bialas J',\n",
       "                'Brasseler M',\n",
       "                'Felderhoff-Mueser U',\n",
       "                'Huening BM'],\n",
       "               'AUID': ['ORCID: 0000-0001-5351-3975',\n",
       "                'ORCID: 0000-0002-0497-4609',\n",
       "                'ORCID: 0000-0003-3809-1887',\n",
       "                'ORCID: 0000-0002-6815-5573'],\n",
       "               'AD': ['Neonatology, Paediatric Intensive Care and Paediatric Neurology, Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Department of Health and Nursing, Occupational Therapy, Ernst-Abbe-University of Applied Sciences, 07745 Jena, Germany.',\n",
       "                'Neonatology, Paediatric Intensive Care and Paediatric Neurology, Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Neonatology, Paediatric Intensive Care and Paediatric Neurology, Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Neonatology, Paediatric Intensive Care and Paediatric Neurology, Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Neonatology, Paediatric Intensive Care and Paediatric Neurology, Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Neonatology, Paediatric Intensive Care and Paediatric Neurology, Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Neonatology, Paediatric Intensive Care and Paediatric Neurology, Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Neonatology, Paediatric Intensive Care and Paediatric Neurology, Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Neonatology, Paediatric Intensive Care and Paediatric Neurology, Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University of Duisburg-Essen, 45122 Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20230627',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'J Clin Med',\n",
       "               'JT': 'Journal of clinical medicine',\n",
       "               'JID': '101606588',\n",
       "               'PMC': 'PMC10342709',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['birth asphyxia',\n",
       "                'critical illness assessment',\n",
       "                'hypoxic-ischemic encephalopathy (HIE)',\n",
       "                'mortality',\n",
       "                'nSOFA',\n",
       "                'neonate',\n",
       "                'organ dysfunction',\n",
       "                'outcome prediction',\n",
       "                'resuscitation',\n",
       "                'therapeutic hypothermia'],\n",
       "               'COIS': ['The authors declare no conflict of interest.'],\n",
       "               'EDAT': '2023/07/14 13:06',\n",
       "               'MHDA': '2023/07/14 13:07',\n",
       "               'PMCR': ['2023/06/27'],\n",
       "               'CRDT': ['2023/07/14 01:11'],\n",
       "               'PHST': ['2023/04/26 00:00 [received]',\n",
       "                '2023/06/11 00:00 [revised]',\n",
       "                '2023/06/25 00:00 [accepted]',\n",
       "                '2023/07/14 13:07 [medline]',\n",
       "                '2023/07/14 13:06 [pubmed]',\n",
       "                '2023/07/14 01:11 [entrez]',\n",
       "                '2023/06/27 00:00 [pmc-release]'],\n",
       "               'AID': ['jcm12134322 [pii]',\n",
       "                'jcm-12-04322 [pii]',\n",
       "                '10.3390/jcm12134322 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'J Clin Med. 2023 Jun 27;12(13):4322. doi: 10.3390/jcm12134322.'},\n",
       "              {'PMID': '37443299',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230717',\n",
       "               'LR': '20240923',\n",
       "               'IS': '2041-1723 (Electronic) 2041-1723 (Linking)',\n",
       "               'VI': '14',\n",
       "               'IP': '1',\n",
       "               'DP': '2023 Jul 13',\n",
       "               'TI': 'Crosstalk between regulatory elements in disordered TRPV4 N-terminus modulates lipid-dependent channel activity.',\n",
       "               'PG': '4165',\n",
       "               'LID': '10.1038/s41467-023-39808-4 [doi] 4165',\n",
       "               'AB': 'Intrinsically disordered regions (IDRs) are essential for membrane receptor regulation but often remain unresolved in structural studies. TRPV4, a member of the TRP vanilloid channel family involved in thermo- and osmosensation, has a large N-terminal IDR of approximately 150 amino acids. With an integrated structural biology approach, we analyze the structural ensemble of the TRPV4 IDR and the network of antagonistic regulatory elements it encodes. These modulate channel activity in a hierarchical lipid-dependent manner through transient long-range interactions. A highly conserved autoinhibitory patch acts as a master regulator by competing with PIP(2) binding to attenuate channel activity. Molecular dynamics simulations show that loss of the interaction between the PIP(2)-binding site and the membrane reduces the force exerted by the IDR on the structured core of TRPV4. This work demonstrates that IDR structural dynamics are coupled to TRPV4 activity and highlights the importance of IDRs for TRP channel function and regulation.',\n",
       "               'CI': ['(c) 2023. The Author(s).'],\n",
       "               'FAU': ['Goretzki, Benedikt',\n",
       "                'Wiedemann, Christoph',\n",
       "                'McCray, Brett A',\n",
       "                'Schafer, Stefan L',\n",
       "                'Jansen, Jasmin',\n",
       "                'Tebbe, Frederike',\n",
       "                'Mitrovic, Sarah-Ana',\n",
       "                'Noth, Julia',\n",
       "                'Cabezudo, Ainara Claveras',\n",
       "                'Donohue, Jack K',\n",
       "                'Jeffries, Cy M',\n",
       "                'Steinchen, Wieland',\n",
       "                'Stengel, Florian',\n",
       "                'Sumner, Charlotte J',\n",
       "                'Hummer, Gerhard',\n",
       "                'Hellmich, Ute A'],\n",
       "               'AU': ['Goretzki B',\n",
       "                'Wiedemann C',\n",
       "                'McCray BA',\n",
       "                'Schafer SL',\n",
       "                'Jansen J',\n",
       "                'Tebbe F',\n",
       "                'Mitrovic SA',\n",
       "                'Noth J',\n",
       "                'Cabezudo AC',\n",
       "                'Donohue JK',\n",
       "                'Jeffries CM',\n",
       "                'Steinchen W',\n",
       "                'Stengel F',\n",
       "                'Sumner CJ',\n",
       "                'Hummer G',\n",
       "                'Hellmich UA'],\n",
       "               'AD': ['Friedrich Schiller University Jena, Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Jena, Germany.',\n",
       "                'Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe University, Frankfurt am Main, Germany.',\n",
       "                'Friedrich Schiller University Jena, Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Jena, Germany.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.',\n",
       "                'Department of Theoretical Biophysics, Max Planck Institute of Biophysics, Frankfurt am Main, Germany.',\n",
       "                'Department of Biology, University of Konstanz, Konstanz, Germany.',\n",
       "                'Konstanz Research School Chemical Biology, University of Konstanz, Konstanz, Germany.',\n",
       "                'Friedrich Schiller University Jena, Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Jena, Germany.',\n",
       "                'Department of Chemistry, Section Biochemistry, Johannes Gutenberg-University Mainz, Mainz, Germany.',\n",
       "                'Department of Chemistry, Section Biochemistry, Johannes Gutenberg-University Mainz, Mainz, Germany.',\n",
       "                'Department of Theoretical Biophysics, Max Planck Institute of Biophysics, Frankfurt am Main, Germany.',\n",
       "                'IMPRS on Cellular Biophysics, Frankfurt am Main, Germany.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.',\n",
       "                'European Molecular Biology Laboratory, EMBL Hamburg Unit, Deutsches Elektronen-Synchrotron, Hamburg, Germany.',\n",
       "                'Center for Synthetic Microbiology (SYNMIKRO) & Department of Chemistry, Philipps-University Marburg, Marburg, Germany.',\n",
       "                'Department of Biology, University of Konstanz, Konstanz, Germany.',\n",
       "                'Konstanz Research School Chemical Biology, University of Konstanz, Konstanz, Germany.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.',\n",
       "                'Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.',\n",
       "                'Department of Theoretical Biophysics, Max Planck Institute of Biophysics, Frankfurt am Main, Germany.',\n",
       "                'Institute of Biophysics, Goethe University Frankfurt, Frankfurt am Main, Germany.',\n",
       "                'Friedrich Schiller University Jena, Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Jena, Germany. ute.hellmich@uni-jena.de.',\n",
       "                'Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe University, Frankfurt am Main, Germany. ute.hellmich@uni-jena.de.',\n",
       "                'Cluster of Excellence Balance of the Microverse, Friedrich Schiller University Jena, Jena, Germany. ute.hellmich@uni-jena.de.'],\n",
       "               'AUID': ['ORCID: 0000-0003-4351-8857',\n",
       "                'ORCID: 0000-0001-6581-9728',\n",
       "                'ORCID: 0000-0001-7942-8701',\n",
       "                'ORCID: 0000-0003-1400-4929',\n",
       "                'ORCID: 0000-0002-8718-7343',\n",
       "                'ORCID: 0000-0003-1447-4509',\n",
       "                'ORCID: 0000-0001-5088-6012',\n",
       "                'ORCID: 0000-0001-7768-746X',\n",
       "                'ORCID: 0000-0001-7162-285X'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['K08 NS102509/NS/NINDS NIH HHS/United States',\n",
       "                'R35 NS122306/NS/NINDS NIH HHS/United States'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Research Support, N.I.H., Extramural',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20230713',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Nat Commun',\n",
       "               'JT': 'Nature communications',\n",
       "               'JID': '101528555',\n",
       "               'RN': ['0 (TRPV Cation Channels)', '0 (Lipids)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['*TRPV Cation Channels/metabolism',\n",
       "                'Protein Domains',\n",
       "                '*Cell Physiological Phenomena',\n",
       "                'Regulatory Sequences, Nucleic Acid',\n",
       "                'Lipids'],\n",
       "               'PMC': 'PMC10344929',\n",
       "               'COIS': ['The authors declare no competing interests.'],\n",
       "               'EDAT': '2023/07/14 13:06',\n",
       "               'MHDA': '2023/07/17 06:42',\n",
       "               'PMCR': ['2023/07/13'],\n",
       "               'CRDT': ['2023/07/13 23:53'],\n",
       "               'PHST': ['2022/12/21 00:00 [received]',\n",
       "                '2023/06/27 00:00 [accepted]',\n",
       "                '2023/07/17 06:42 [medline]',\n",
       "                '2023/07/14 13:06 [pubmed]',\n",
       "                '2023/07/13 23:53 [entrez]',\n",
       "                '2023/07/13 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1038/s41467-023-39808-4 [pii]',\n",
       "                '39808 [pii]',\n",
       "                '10.1038/s41467-023-39808-4 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Nat Commun. 2023 Jul 13;14(1):4165. doi: 10.1038/s41467-023-39808-4.'},\n",
       "              {'PMID': '37332044',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230620',\n",
       "               'LR': '20240121',\n",
       "               'IS': '1435-2451 (Electronic) 1435-2443 (Print) 1435-2443 (Linking)',\n",
       "               'VI': '408',\n",
       "               'IP': '1',\n",
       "               'DP': '2023 Jun 19',\n",
       "               'TI': 'Prognostic differences in grading and metastatic lymph node pattern in patients with small bowel neuroendocrine tumors.',\n",
       "               'PG': '237',\n",
       "               'LID': '10.1007/s00423-023-02956-8 [doi] 237',\n",
       "               'AB': 'PURPOSE: Neuroendocrine tumors of the small intestine (si-NET) describe a heterogenous group of neoplasms. Based on the Ki67 proliferation index si-NET are divided into G1 (Ki67 < 2%), G2 (Ki67 3-20%) and rarely G3 (Ki67 > 20%) tumors. However, few studies evaluate the impact of tumor grading on prognosis in si-NET. Moreover, si-NET can form distinct lymphatic spread patterns to the mesenteric root, aortocaval lymph nodes, and distant organs. This study aims to identify prognostic factors within the lymphatic spread patterns and grading. METHODS: Demographic, pathological, and surgical data of 208 (90 male, 118 female) individuals with si-NETs treated at Charite University Medicine Berlin between 2010 and 2020 were analyzed retrospectively. RESULTS: A total of 113 (54.5%) specimens were defined as G1 and 93 (44.7%) as G2 tumors. Interestingly, splitting the G2 group in two subgroups: G2 low (Ki67 3-9%) and G2 high (Ki67 10-20%), displayed significant differences in overall survival (OS) (p = 0.008) and progression free survival (PFS) (p = 0.004) between these subgroups. Remission after surgery was less often achieved in patients with higher Ki67 index (> 10%). Lymph node metastases (N +) were present in 174 (83.6%) patients. Patients with isolated locoregional disease showed better PFS and OS in comparison to patients with additional aortocaval and distant lymph node metastases. CONCLUSION: Lymphatic spread pattern influences patient outcome. In G2 tumors, low and high grading shows heterogenous outcome in OS and PFS. Differentiation within this group might impact follow-up, adjuvant treatment, and surgical strategy.',\n",
       "               'CI': ['(c) 2023. The Author(s).'],\n",
       "               'FAU': ['Reinhard, Lisa',\n",
       "                'Mogl, Martina T',\n",
       "                'Benz, Fabian',\n",
       "                'Dukaczewska, Agata',\n",
       "                'Butz, Frederike',\n",
       "                'Dobrindt, Eva Maria',\n",
       "                'Tacke, Frank',\n",
       "                'Pratschke, Johann',\n",
       "                'Goretzki, Peter E',\n",
       "                'Jann, Henning'],\n",
       "               'AU': ['Reinhard L',\n",
       "                'Mogl MT',\n",
       "                'Benz F',\n",
       "                'Dukaczewska A',\n",
       "                'Butz F',\n",
       "                'Dobrindt EM',\n",
       "                'Tacke F',\n",
       "                'Pratschke J',\n",
       "                'Goretzki PE',\n",
       "                'Jann H'],\n",
       "               'AD': ['Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat Zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat Zu Berlin, and Berlin Institute of Health, Berlin, Germany. martina.mogl@charite.de.',\n",
       "                'Department of Hepatology and Gastroenterology, Campus Charite Mitte | Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat Zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat Zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat Zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat Zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Hepatology and Gastroenterology, Campus Charite Mitte | Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat Zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat Zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat Zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Hepatology and Gastroenterology, Campus Charite Mitte | Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat Zu Berlin, and Berlin Institute of Health, Berlin, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20230619',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'RN': ['0 (Ki-67 Antigen)',\n",
       "                'Gastro-enteropancreatic neuroendocrine tumor'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Male',\n",
       "                'Stomach Neoplasms',\n",
       "                'Female',\n",
       "                '*Neuroendocrine Tumors/pathology',\n",
       "                '*Pancreatic Neoplasms/pathology',\n",
       "                'Lymph Nodes/pathology',\n",
       "                'Intestinal Neoplasms',\n",
       "                'Lymphatic Metastasis',\n",
       "                'Neoplasm Grading',\n",
       "                'Prognosis',\n",
       "                'Retrospective Studies',\n",
       "                'Humans',\n",
       "                'Ki-67 Antigen'],\n",
       "               'PMC': 'PMC10277262',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['GEP-NET', 'Grading', 'Lymph node metastases', 'Si-NET'],\n",
       "               'COIS': ['The authors declare no competing interest.'],\n",
       "               'EDAT': '2023/06/19 00:42',\n",
       "               'MHDA': '2023/06/20 06:42',\n",
       "               'PMCR': ['2023/06/19'],\n",
       "               'CRDT': ['2023/06/18 23:37'],\n",
       "               'PHST': ['2023/01/04 00:00 [received]',\n",
       "                '2023/05/23 00:00 [accepted]',\n",
       "                '2023/06/20 06:42 [medline]',\n",
       "                '2023/06/19 00:42 [pubmed]',\n",
       "                '2023/06/18 23:37 [entrez]',\n",
       "                '2023/06/19 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s00423-023-02956-8 [pii]',\n",
       "                '2956 [pii]',\n",
       "                '10.1007/s00423-023-02956-8 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 2023 Jun 19;408(1):237. doi: 10.1007/s00423-023-02956-8.'},\n",
       "              {'PMID': '37321856',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230714',\n",
       "               'LR': '20240702',\n",
       "               'IS': '1936-959X (Electronic) 0195-6108 (Print) 0195-6108 (Linking)',\n",
       "               'VI': '44',\n",
       "               'IP': '7',\n",
       "               'DP': '2023 Jul',\n",
       "               'TI': 'Development of an Ultrasound Scoring System to Describe Brain Maturation in Preterm Infants.',\n",
       "               'PG': '846-852',\n",
       "               'LID': '10.3174/ajnr.A7909 [doi]',\n",
       "               'AB': 'BACKGROUND AND PURPOSE: Cerebral maturation in preterm infants predominantly occurs postnatally, necessitating the development of objective bedside markers to monitor this process. This study aimed to develop a straightforward objective Ultrasound Score of Brain Development to assess cortical development in preterm infants. MATERIALS AND METHODS: A total of 344 serial ultrasound examinations from 94 preterm infants born at </= 32 weeks of gestation were analyzed to identify brain structures suitable for a scoring system. RESULTS: Among 11 candidate structures, 3 cerebral landmarks were selected due to their correlation with gestational age: the interopercular opening (P < .001), the height of the insular cortex (P < .001), and the depth of the cingulate sulcus (P < .001). These structures can be easily visualized in a single midcoronal view in the plane through the third ventricle and the foramina of Monro. A score point from 0 to 2 was assigned to each measurement, culminating in a total score ranging from 0 to 6. The Ultrasound Score of Brain Development correlated significantly with gestational age (P < .001). CONCLUSIONS: The proposed Ultrasound Score of Brain Development has the potential for application as an objective indicator of brain maturation in correlation with gestational age, circumventing the need to rely on individual growth trajectories and percentiles for each specific structure.',\n",
       "               'CI': ['(c) 2023 by American Journal of Neuroradiology.'],\n",
       "               'FAU': ['Stein, A',\n",
       "                'Sody, E',\n",
       "                'Bruns, N',\n",
       "                'Felderhoff-Muser, U'],\n",
       "               'AU': ['Stein A', 'Sody E', 'Bruns N', 'Felderhoff-Muser U'],\n",
       "               'AUID': ['ORCID: 0000-0002-0497-4609',\n",
       "                'ORCID: 0000-0003-3171-2089',\n",
       "                'ORCID: 0000-0003-3809-1887',\n",
       "                'ORCID: 0000-0002-7765-8893'],\n",
       "               'AD': ['From the Department of Pediatrics I, Neonatology, University Duisburg-Essen, University Hospital Essen, Essen, Germany anja.stein@uk-essen.de.',\n",
       "                'From the Department of Pediatrics I, Neonatology, University Duisburg-Essen, University Hospital Essen, Essen, Germany.',\n",
       "                'From the Department of Pediatrics I, Neonatology, University Duisburg-Essen, University Hospital Essen, Essen, Germany.',\n",
       "                'From the Department of Pediatrics I, Neonatology, University Duisburg-Essen, University Hospital Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20230615',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'AJNR Am J Neuroradiol',\n",
       "               'JT': 'AJNR. American journal of neuroradiology',\n",
       "               'JID': '8003708',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Humans',\n",
       "                '*Infant, Premature',\n",
       "                'Ultrasonography',\n",
       "                'Gestational Age',\n",
       "                '*Brain/diagnostic imaging'],\n",
       "               'PMC': 'PMC10337624',\n",
       "               'EDAT': '2023/06/16 01:08',\n",
       "               'MHDA': '2023/07/14 13:08',\n",
       "               'PMCR': ['2024/07/01'],\n",
       "               'CRDT': ['2023/06/15 21:42'],\n",
       "               'PHST': ['2023/01/17 00:00 [received]',\n",
       "                '2023/05/22 00:00 [accepted]',\n",
       "                '2023/07/14 13:08 [medline]',\n",
       "                '2023/06/16 01:08 [pubmed]',\n",
       "                '2023/06/15 21:42 [entrez]',\n",
       "                '2024/07/01 00:00 [pmc-release]'],\n",
       "               'AID': ['ajnr.A7909 [pii]',\n",
       "                '23-00042 [pii]',\n",
       "                '10.3174/ajnr.A7909 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'AJNR Am J Neuroradiol. 2023 Jul;44(7):846-852. doi: 10.3174/ajnr.A7909. Epub 2023 Jun 15.'},\n",
       "              {'PMID': '37291366',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230703',\n",
       "               'LR': '20230703',\n",
       "               'IS': '2731-698X (Electronic) 2731-6971 (Linking)',\n",
       "               'VI': '94',\n",
       "               'IP': '7',\n",
       "               'DP': '2023 Jul',\n",
       "               'TI': '[Special features of the diagnostics and treatment of hereditary primary hyperparathyroidism].',\n",
       "               'PG': '586-594',\n",
       "               'LID': '10.1007/s00104-023-01897-8 [doi]',\n",
       "               'AB': 'Between 2% and 10% of patients with primary hyperparathyroidism (pHPT) are diagnosed with hereditary forms of primary hyperparathyroidism (hpHPT). They are more prevalent in younger patients before the age of 40 years, in patients with persistence or recurrence of pHPT and pHPT patients with multi-glandular disease (MGD). The various forms of hpHPT diseases can be classified into four syndromes, i.e., hpHPT associated with diseases of other organ systems, and four diseases that are confined to the parathyroid glands. Approximately 40% of patients with hpHPT suffer from multiple endocrine neoplasia type 1 (MEN-1) or show germline mutations of the MEN‑1 gene. Currently, germline mutations that lead to a specific diagnosis in patients with hpHPT have currently been described in 13 different genes, which enables a clear diagnosis of the disease; however, a clear genotype-phenotype correlation does not exist, even though the complete loss of a coded protein (e.g. due to frame-shift mutations in the calcium sensing receptor, CASR) often leads to more severe clinical consequences than merely a reduced function of the protein (e.g. due to point mutation). As the various hpHPT diseases require different treatment approaches, which do not correspond to that of sporadic pHPT, a clear definition of the specific form of hpHPT must always be strived for. Therefore, before surgery of a pHPT with clinical, imaging or biochemical suspicion of hpHPT, genetic proof or exclusion of hpHPT is necessary. The differentiated treatment approach for hpHTP can only be defined by taking the clinical and diagnostic results of all the abovenamed findings into account.',\n",
       "               'CI': ['(c) 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH,',\n",
       "                'ein Teil von Springer Nature.'],\n",
       "               'FAU': ['Mogl, Martina T', 'Goretzki, Peter E'],\n",
       "               'AU': ['Mogl MT', 'Goretzki PE'],\n",
       "               'AD': ['Chirurgische Klinik, Charite Campus Mitte/Campus Virchow-Klinikum, Berlin, Charite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin und Humboldt-Universitat zu Berlin, Chariteplatz 1, 10117, Berlin, Deutschland. martina.mogl@charite.de.',\n",
       "                'Chirurgische Klinik, Charite Campus Mitte/Campus Virchow-Klinikum, Berlin, Charite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin und Humboldt-Universitat zu Berlin, Chariteplatz 1, 10117, Berlin, Deutschland.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article', 'Review'],\n",
       "               'TT': 'Besonderheiten in Diagnostik und Therapie des hereditaren primaren Hyperparathyreoidismus.',\n",
       "               'DEP': '20230608',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurgie (Heidelb)',\n",
       "               'JT': 'Chirurgie (Heidelberg, Germany)',\n",
       "               'JID': '9918383081906676',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*Hyperparathyroidism, Primary/diagnosis/genetics/therapy',\n",
       "                '*Multiple Endocrine Neoplasia Type 1/diagnosis/genetics/therapy',\n",
       "                'Parathyroid Glands'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Familial hypocalciuric hypercalcemia',\n",
       "                'Genotype-phenotype correlation',\n",
       "                'Germline mutations',\n",
       "                'Hyperparathyroidism-jaw tumor syndrome',\n",
       "                'Multiple endocrine neoplasia'],\n",
       "               'EDAT': '2023/06/09 01:09',\n",
       "               'MHDA': '2023/07/03 06:41',\n",
       "               'CRDT': ['2023/06/08 23:29'],\n",
       "               'PHST': ['2023/05/08 00:00 [accepted]',\n",
       "                '2023/07/03 06:41 [medline]',\n",
       "                '2023/06/09 01:09 [pubmed]',\n",
       "                '2023/06/08 23:29 [entrez]'],\n",
       "               'AID': ['10.1007/s00104-023-01897-8 [pii]',\n",
       "                '10.1007/s00104-023-01897-8 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurgie (Heidelb). 2023 Jul;94(7):586-594. doi: 10.1007/s00104-023-01897-8. Epub 2023 Jun 8.'},\n",
       "              {'PMID': '37230540',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230612',\n",
       "               'LR': '20240603',\n",
       "               'IS': '1936-959X (Electronic) 0195-6108 (Print) 0195-6108 (Linking)',\n",
       "               'VI': '44',\n",
       "               'IP': '6',\n",
       "               'DP': '2023 Jun',\n",
       "               'TI': 'Doppler Ultrasound Flow Reversal in the Superior Sagittal Sinus to Detect Cerebral Venous Congestion in Vein of Galen Malformation.',\n",
       "               'PG': '707-715',\n",
       "               'LID': '10.3174/ajnr.A7891 [doi]',\n",
       "               'AB': 'BACKGROUND AND PURPOSE: Vein of Galen malformation is a rare congenital cerebrovascular malformation. In affected patients, increased cerebral venous pressure constitutes an important etiologic factor for the development of brain parenchymal damage. The aim of this study was to investigate the potential of serial cerebral venous Doppler measurements to detect and monitor increased cerebral venous pressure. MATERIALS AND METHODS: This was a retrospective monocentric analysis of ultrasound examinations within the first 9 months of life in patients with vein of Galen malformation admitted at <28 days of life. Categorization of perfusion waveforms in the superficial cerebral sinus and veins into 6 patterns was based on antero- and retrograde flow components. We performed an analysis of flow profiles across time and correlation with disease severity, clinical interventions, and congestion damage on cerebral MR imaging. RESULTS: The study included 44 Doppler ultrasound examinations of the superior sagittal sinus and 36 examinations of the cortical veins from 7 patients. Doppler flow profiles before interventional therapy correlated with disease severity determined by the Bicetre Neonatal Evaluation Score (Spearman rho = -0.97, P = < .001). At this time, 4 of 7 patients (57.1%) showed a retrograde flow component in the superior sagittal sinus, whereas after embolization, none of the 6 treated patients presented with a retrograde flow component. Only patients with a high retrograde flow component (equal or more than one-third retrograde flow, n = 2) showed severe venous congestion damage on cerebral MR imaging. CONCLUSIONS: Flow profiles in the superficial cerebral sinus and veins appear to be a useful tool to noninvasively detect and monitor cerebral venous congestion in vein of Galen malformation.',\n",
       "               'CI': ['(c) 2023 by American Journal of Neuroradiology.'],\n",
       "               'FAU': ['Schwarz, S',\n",
       "                'Brevis Nunez, F',\n",
       "                'Durr, N R',\n",
       "                'Brassel, F',\n",
       "                'Schlunz-Hendann, M',\n",
       "                'Feldkamp, A',\n",
       "                'Rosenbaum, T',\n",
       "                'Felderhoff-Muser, U',\n",
       "                'Schulz, K',\n",
       "                'Dohna-Schwake, C',\n",
       "                'Bruns, N'],\n",
       "               'AU': ['Schwarz S',\n",
       "                'Brevis Nunez F',\n",
       "                'Durr NR',\n",
       "                'Brassel F',\n",
       "                'Schlunz-Hendann M',\n",
       "                'Feldkamp A',\n",
       "                'Rosenbaum T',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Schulz K',\n",
       "                'Dohna-Schwake C',\n",
       "                'Bruns N'],\n",
       "               'AUID': ['ORCID: 0000-0001-6930-1061',\n",
       "                'ORCID: 0000-0002-3940-151X',\n",
       "                'ORCID: 0000-0002-3750-0856',\n",
       "                'ORCID: 0000-0001-6592-1351',\n",
       "                'ORCID: 0000-0002-9628-2123',\n",
       "                'ORCID: 0000-0002-0726-3925',\n",
       "                'ORCID: 0000-0002-0436-9169',\n",
       "                'ORCID: 0009-0005-6826-9801',\n",
       "                'ORCID: 0000-0001-8973-5406',\n",
       "                'ORCID: 0000-0003-3809-1887'],\n",
       "               'AD': ['From the Clinic for Pediatrics and Adolescent Medicine (S.S., F.B.N., A.F., T.R.) simone.schwarz@sana.de.',\n",
       "                'From the Clinic for Pediatrics and Adolescent Medicine (S.S., F.B.N., A.F., T.R.).',\n",
       "                'Clinic for Radiology and Neuroradiology (N.R.D., F.B., M.S.-H., K.S.).',\n",
       "                'Clinic for Radiology and Neuroradiology (N.R.D., F.B., M.S.-H., K.S.).',\n",
       "                'Center for Pediatric Interventional Radiology/Neuroradiology and Interventional Treatment of Vascular Malformations (F.B.), Sana Clinics Duisburg, Duisburg, Germany.',\n",
       "                'Clinic for Radiology and Neuroradiology (N.R.D., F.B., M.S.-H., K.S.).',\n",
       "                'From the Clinic for Pediatrics and Adolescent Medicine (S.S., F.B.N., A.F., T.R.).',\n",
       "                'From the Clinic for Pediatrics and Adolescent Medicine (S.S., F.B.N., A.F., T.R.).',\n",
       "                'Clinic for Pediatrics I (U.F.-M., C.D.-S., N.B.).',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (U.F.-M., C.D.-S., N.B.), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Clinic for Radiology and Neuroradiology (N.R.D., F.B., M.S.-H., K.S.).',\n",
       "                'Clinic for Pediatrics I (U.F.-M., C.D.-S., N.B.).',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (U.F.-M., C.D.-S., N.B.), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Clinic for Pediatrics I (U.F.-M., C.D.-S., N.B.).',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (U.F.-M., C.D.-S., N.B.), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20230525',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'AJNR Am J Neuroradiol',\n",
       "               'JT': 'AJNR. American journal of neuroradiology',\n",
       "               'JID': '8003708',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Infant, Newborn',\n",
       "                'Humans',\n",
       "                'Superior Sagittal Sinus/diagnostic imaging',\n",
       "                '*Vein of Galen Malformations/complications/diagnostic imaging',\n",
       "                '*Hyperemia',\n",
       "                'Retrospective Studies',\n",
       "                '*Cerebral Veins/diagnostic imaging/abnormalities',\n",
       "                'Ultrasonography, Doppler'],\n",
       "               'PMC': 'PMC10249685',\n",
       "               'EDAT': '2023/05/26 01:05',\n",
       "               'MHDA': '2023/06/12 06:42',\n",
       "               'PMCR': ['2024/06/01'],\n",
       "               'CRDT': ['2023/05/25 20:53'],\n",
       "               'PHST': ['2023/02/14 00:00 [received]',\n",
       "                '2023/05/03 00:00 [accepted]',\n",
       "                '2023/06/12 06:42 [medline]',\n",
       "                '2023/05/26 01:05 [pubmed]',\n",
       "                '2023/05/25 20:53 [entrez]',\n",
       "                '2024/06/01 00:00 [pmc-release]'],\n",
       "               'AID': ['ajnr.A7891 [pii]',\n",
       "                '23-00131 [pii]',\n",
       "                '10.3174/ajnr.A7891 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'AJNR Am J Neuroradiol. 2023 Jun;44(6):707-715. doi: 10.3174/ajnr.A7891. Epub 2023 May 25.'},\n",
       "              {'PMID': '37046708',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20230415',\n",
       "               'IS': '2072-6694 (Print) 2072-6694 (Electronic) 2072-6694 (Linking)',\n",
       "               'VI': '15',\n",
       "               'IP': '7',\n",
       "               'DP': '2023 Mar 29',\n",
       "               'TI': 'Surgical Approach to Liver Metastases in GEP-NET in a Tertiary Reference Center.',\n",
       "               'LID': '10.3390/cancers15072048 [doi] 2048',\n",
       "               'AB': 'Indications for liver resection in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NET) vary from liver resection with curative intent to tumor debulking or tissue sampling for histopathological characterization. With increasing expertise, the number of minimally invasive liver surgeries (MILS) in GEP-NET patients has increased. However, the influence on the oncological outcome has hardly been described. The clinicopathological data of patients who underwent liver resection for hepatic metastases of GEP-NET at the Department of Surgery, Charite-Universitatsmedizin Berlin, were analyzed. Propensity score matching (PSM) was performed to compare MILS with open liver surgery (OLS). In total, 22 patients underwent liver surgery with curative intent, and 30 debulking surgeries were analyzed. Disease-free survival (DFS) was longer than progression-free survival (PFS) (10 vs. 24 months), whereas overall survival (OS) did not differ significantly (p = 0.588). Thirty-nine (75%) liver resections were performed as OLS, and thirteen (25%) as MILS. After PSM, a shorter length of hospital stay was found for the MILS group (14 vs. 10 d, p = 0.034), while neither DFS/PFS nor OS differed significantly. Both curative intended and cytoreductive resection of hepatic GEP-NET metastases achieved excellent outcomes. MILS led to a reduced length of hospital, while preserving a good oncological outcome.',\n",
       "               'FAU': ['Butz, Frederike',\n",
       "                'Dukaczewska, Agata',\n",
       "                'Jann, Henning',\n",
       "                'Dobrindt, Eva Maria',\n",
       "                'Reinhard, Lisa',\n",
       "                'Lurje, Georg',\n",
       "                'Pratschke, Johann',\n",
       "                'Goretzki, Peter E',\n",
       "                'Schoning, Wenzel',\n",
       "                'Mogl, Martina T'],\n",
       "               'AU': ['Butz F',\n",
       "                'Dukaczewska A',\n",
       "                'Jann H',\n",
       "                'Dobrindt EM',\n",
       "                'Reinhard L',\n",
       "                'Lurje G',\n",
       "                'Pratschke J',\n",
       "                'Goretzki PE',\n",
       "                'Schoning W',\n",
       "                'Mogl MT'],\n",
       "               'AUID': ['ORCID: 0000-0002-5963-1558',\n",
       "                'ORCID: 0000-0002-1616-9826'],\n",
       "               'AD': ['Department of Surgery, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Gastroenterology, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20230329',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Cancers (Basel)',\n",
       "               'JT': 'Cancers',\n",
       "               'JID': '101526829',\n",
       "               'PMC': 'PMC10093386',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['debulking surgery',\n",
       "                'laparoscopic liver surgery',\n",
       "                'minimally invasive liver surgery',\n",
       "                'neuroendocrine liver metastases'],\n",
       "               'COIS': ['The authors declare no conflict of interest.'],\n",
       "               'EDAT': '2023/04/14 06:00',\n",
       "               'MHDA': '2023/04/14 06:01',\n",
       "               'PMCR': ['2023/03/29'],\n",
       "               'CRDT': ['2023/04/13 01:07'],\n",
       "               'PHST': ['2023/01/30 00:00 [received]',\n",
       "                '2023/03/07 00:00 [revised]',\n",
       "                '2023/03/28 00:00 [accepted]',\n",
       "                '2023/04/14 06:01 [medline]',\n",
       "                '2023/04/13 01:07 [entrez]',\n",
       "                '2023/04/14 06:00 [pubmed]',\n",
       "                '2023/03/29 00:00 [pmc-release]'],\n",
       "               'AID': ['cancers15072048 [pii]',\n",
       "                'cancers-15-02048 [pii]',\n",
       "                '10.3390/cancers15072048 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Cancers (Basel). 2023 Mar 29;15(7):2048. doi: 10.3390/cancers15072048.'},\n",
       "              {'PMID': '37026001',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230410',\n",
       "               'LR': '20230417',\n",
       "               'IS': '1664-3224 (Electronic) 1664-3224 (Linking)',\n",
       "               'VI': '14',\n",
       "               'DP': '2023',\n",
       "               'TI': 'A flagellin-conjugate protein induces dual NLRC4- and NLRP3-inflammasome activation which modulates inflammatory cytokine secretion from macrophages.',\n",
       "               'PG': '1136669',\n",
       "               'LID': '10.3389/fimmu.2023.1136669 [doi] 1136669',\n",
       "               'AB': 'BACKGROUND: A recombinant fusion protein combining the adjuvant and TLR5-ligand flagellin with the major birch pollen allergen Bet v 1 (rFlaA:Betv1) has been suggested to prevent the manifestation of birch allergy. Noteworthy, rFlaA:Betv1 induced both pro- and anti-inflammatory responses which were differentially regulated. However, the mechanism by which flagellin fusion proteins modulate allergen-specific immune responses, especially the mechanisms underlying IL-1beta secretion and their contribution to the overall immune responses remains elusive. OBJECTIVE: To investigate the mechanisms underlying the production of IL-1beta from rFlaA:Betv1 stimulated macrophages. METHODS: Macrophages were derived from mouse peritoneal-, human buffy-coat-, and PMA-differentiated THP-1 (wild type or lacking either ASC, NLRP3, or NLRC4) cells. Macrophages were stimulated with non-modified rFlaA:Betv1, mutant variants lacking either the flagellin DC0 domain or a sequence motif formerly described to mediate TLR5-activation, and respective controls in the presence or absence of inhibitors interfering with MAPK- and NFkappaB-signaling. Cytokine secretion was analyzed by ELISA and intracellular signaling by Western Blot. To study the contribution of IL-1beta to the overall immune responses, IL1R-deficient mouse peritoneal macrophages were used. RESULTS: rFlaA:Betv1 consistently activated all types of investigated macrophages, inducing higher IL-1beta secretion compared with the equimolar mixture of both proteins. rFlaA:Betv1-induced activation of THP-1 macrophages was shown to be independent of either the TLR5-activating sequence motif or the flagellin DC0 domain but depended on both NLRP3- and NLRC4-inflammasomes. In addition, NFkappaB and SAP/JNK MAP kinases regulated rFlaA:Betv1-induced inflammasome activation and cytokine secretion by modulating pro-Caspase-1- and pro-IL-1beta-expression in THP-1 macrophages. Finally, lack of IL-1beta positive feedback via the IL1R strongly diminished the rFlaA:Betv1-induced secretion of IL-1beta, IL-6, and TNF-alpha from peritoneal macrophages. CONCLUSION: The mechanisms contributing to rFlaA:Betv1-induced IL-1beta secretion from macrophages were shown to be complex, involving both NLRC4- and NLRP3-inflammsomes, as well as NFkappaB- and SAP/JNK MAP kinase-signaling. Better understanding the mechanisms regulating the activation of immune cells by novel therapeutic candidates like the rFlaA:Betv1 fusion protein will allow us to further improve and develop new treatment strategies when using flagellin as an adjuvant.',\n",
       "               'CI': ['Copyright (c) 2023 Lin, Jamin, Wolfheimer, Fiedler, Junker, Goretzki, Scheurer and',\n",
       "                'Schulke.'],\n",
       "               'FAU': ['Lin, Yen-Ju',\n",
       "                'Jamin, Annette',\n",
       "                'Wolfheimer, Sonja',\n",
       "                'Fiedler, Anna',\n",
       "                'Junker, Ann-Christine',\n",
       "                'Goretzki, Alexandra',\n",
       "                'Scheurer, Stephan',\n",
       "                'Schulke, Stefan'],\n",
       "               'AU': ['Lin YJ',\n",
       "                'Jamin A',\n",
       "                'Wolfheimer S',\n",
       "                'Fiedler A',\n",
       "                'Junker AC',\n",
       "                'Goretzki A',\n",
       "                'Scheurer S',\n",
       "                'Schulke S'],\n",
       "               'AD': ['Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20230321',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Immunol',\n",
       "               'JT': 'Frontiers in immunology',\n",
       "               'JID': '101560960',\n",
       "               'RN': ['0 (Adjuvants, Immunologic)',\n",
       "                '0 (Allergens)',\n",
       "                '0 (Calcium-Binding Proteins)',\n",
       "                '0 (CARD Signaling Adaptor Proteins)',\n",
       "                '12777-81-0 (Flagellin)',\n",
       "                '0 (Inflammasomes)',\n",
       "                '0 (NLR Family, Pyrin Domain-Containing 3 Protein)',\n",
       "                '0 (NLRC4 protein, human)',\n",
       "                '0 (Nlrp3 protein, mouse)',\n",
       "                '0 (Recombinant Proteins)',\n",
       "                '0 (Toll-Like Receptor 5)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Animals',\n",
       "                'Humans',\n",
       "                'Mice',\n",
       "                'Adjuvants, Immunologic/pharmacology',\n",
       "                'Allergens',\n",
       "                'Calcium-Binding Proteins/metabolism',\n",
       "                'CARD Signaling Adaptor Proteins/metabolism',\n",
       "                '*Flagellin',\n",
       "                '*Inflammasomes/metabolism',\n",
       "                'Macrophages',\n",
       "                'NLR Family, Pyrin Domain-Containing 3 Protein/metabolism',\n",
       "                'Recombinant Proteins',\n",
       "                'Toll-Like Receptor 5/metabolism'],\n",
       "               'PMC': 'PMC10070734',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['NLRC4',\n",
       "                'NLRP3',\n",
       "                'flagellin fusion protein',\n",
       "                'inflammasome',\n",
       "                'macrophage'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2023/04/08 06:00',\n",
       "               'MHDA': '2023/04/10 06:42',\n",
       "               'PMCR': ['2023/01/01'],\n",
       "               'CRDT': ['2023/04/07 02:37'],\n",
       "               'PHST': ['2023/01/03 00:00 [received]',\n",
       "                '2023/02/20 00:00 [accepted]',\n",
       "                '2023/04/10 06:42 [medline]',\n",
       "                '2023/04/07 02:37 [entrez]',\n",
       "                '2023/04/08 06:00 [pubmed]',\n",
       "                '2023/01/01 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fimmu.2023.1136669 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Immunol. 2023 Mar 21;14:1136669. doi: 10.3389/fimmu.2023.1136669. eCollection 2023.'},\n",
       "              {'PMID': '36889633',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230605',\n",
       "               'LR': '20240613',\n",
       "               'IS': '1878-8769 (Electronic) 1878-8750 (Linking)',\n",
       "               'VI': '174',\n",
       "               'DP': '2023 Jun',\n",
       "               'TI': 'Giant Cavernous Malformation Mimicking an Infiltrative Intracranial Neoplasm in Children-Case Report and Systematic Review of the Literature.',\n",
       "               'PG': '30-41',\n",
       "               'LID': 'S1878-8750(23)00285-1 [pii] 10.1016/j.wneu.2023.02.135 [doi]',\n",
       "               'AB': 'BACKGROUND: Giant cavernous malformations (GCMs) are rare and poorly characterized neurovascular lesions in adults or children and often misclassified. In this study, we provide a review of pediatric GCM cases to highlight this rare entity as an important differential diagnosis in preoperative assessment. METHODS: We report a pediatric case of GCM that presented as an intracerebral, periventricular, and infiltrative mass lesion. We performed a systematic review of published literature describing cases of GCM in children using the PubMed, Embase, and Cochrane Library databases. Studies describing cerebral or spinal cavernous malformation >4 cm were included. Demographic, clinical, radiographic, and outcome data were extracted. RESULTS: Thirty-eight studies accounting for 61 patients were reviewed. most patients were 1-10 years old and 55.73% were male. Average lesion sizes ranged between 4 and 6 cm (40.98% >6 cm; 8.19% >10 cm). Supratentorial localization was most common (75.40%), with frontal and parieto-occipital regions being frequent localizations. Infratentorial lesions (24.60%) were located within the cerebellum (16.39%) and brainstem (8.19%). One case of spinal cavernoma was found. The main clinical manifestations were seizures (44.26%), focal neurologic deficit (36.06%), and headache (22.95%). Imaging showed contrast enhancement (36.06%), cystic features (27.86%), and infiltrative growth pattern (4.91%). CONCLUSIONS: GCMs show variable clinical and radiologic features, representing a diagnostic challenge for treating surgeons. Imaging may show various tumorlike features such as cystic or infiltrative patterns with contrast enhancement. The existence of GCM should be considered preoperatively. Gross total resection should be attempted whenever possible, because it correlates with a good recovery and long-term outcomes. Also, a clear definition criteria of when a cerebral cavernous malformation is termed giant should be established.',\n",
       "               'CI': ['Copyright (c) 2023 Elsevier Inc. All rights reserved.'],\n",
       "               'FAU': ['Gonzalez-Gallardo, Enrique',\n",
       "                'Rauschenbach, Laurel',\n",
       "                'Santos, Alejandro N',\n",
       "                'Riess, Christoph',\n",
       "                'Li, Yan',\n",
       "                'Tippelt, Stephan',\n",
       "                'Della Marina, Adela',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Sure, Ulrich',\n",
       "                'Dammann, Philipp'],\n",
       "               'AU': ['Gonzalez-Gallardo E',\n",
       "                'Rauschenbach L',\n",
       "                'Santos AN',\n",
       "                'Riess C',\n",
       "                'Li Y',\n",
       "                'Tippelt S',\n",
       "                'Della Marina A',\n",
       "                'Dohna-Schwake C',\n",
       "                'Sure U',\n",
       "                'Dammann P'],\n",
       "               'AD': ['Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany; Center for Translational Neuro- & Behavioral Sciences (C-TNBS), University Duisburg Essen, Essen, Germany. Electronic address: enrique.gonzalezg@outlook.com.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany; Center for Translational Neuro- & Behavioral Sciences (C-TNBS), University Duisburg Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany; Center for Translational Neuro- & Behavioral Sciences (C-TNBS), University Duisburg Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany; Center for Translational Neuro- & Behavioral Sciences (C-TNBS), University Duisburg Essen, Essen, Germany.',\n",
       "                'Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics, University Hospital Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics, University Hospital Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics, University Hospital Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany; Center for Translational Neuro- & Behavioral Sciences (C-TNBS), University Duisburg Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany; Center for Translational Neuro- & Behavioral Sciences (C-TNBS), University Duisburg Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports',\n",
       "                'Journal Article',\n",
       "                'Review',\n",
       "                'Systematic Review'],\n",
       "               'DEP': '20230306',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World Neurosurg',\n",
       "               'JT': 'World neurosurgery',\n",
       "               'JID': '101528275',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Humans',\n",
       "                'Child',\n",
       "                'Male',\n",
       "                'Infant',\n",
       "                'Child, Preschool',\n",
       "                'Female',\n",
       "                '*Brain Neoplasms/diagnostic imaging/surgery',\n",
       "                '*Hemangioma, Cavernous, Central Nervous System/diagnostic imaging/surgery',\n",
       "                '*Hemangioma, Cavernous/diagnostic imaging/surgery',\n",
       "                'Cerebellum/pathology',\n",
       "                'Diagnosis, Differential'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['CCM',\n",
       "                'Cavernous malformation',\n",
       "                'Giant cavernoma',\n",
       "                'Pediatric',\n",
       "                'Previous'],\n",
       "               'EDAT': '2023/03/09 06:00',\n",
       "               'MHDA': '2023/06/05 06:42',\n",
       "               'CRDT': ['2023/03/08 19:34'],\n",
       "               'PHST': ['2022/12/18 00:00 [received]',\n",
       "                '2023/02/26 00:00 [revised]',\n",
       "                '2023/02/27 00:00 [accepted]',\n",
       "                '2023/06/05 06:42 [medline]',\n",
       "                '2023/03/09 06:00 [pubmed]',\n",
       "                '2023/03/08 19:34 [entrez]'],\n",
       "               'AID': ['S1878-8750(23)00285-1 [pii]',\n",
       "                '10.1016/j.wneu.2023.02.135 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World Neurosurg. 2023 Jun;174:30-41. doi: 10.1016/j.wneu.2023.02.135. Epub 2023 Mar 6.'},\n",
       "              {'PMID': '36851793',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230301',\n",
       "               'LR': '20231106',\n",
       "               'IS': '1999-4915 (Electronic) 1999-4915 (Linking)',\n",
       "               'VI': '15',\n",
       "               'IP': '2',\n",
       "               'DP': '2023 Feb 20',\n",
       "               'TI': 'High Prevalence of Alternative Diagnoses in Children and Adolescents with Suspected Long COVID-A Single Center Cohort Study.',\n",
       "               'LID': '10.3390/v15020579 [doi] 579',\n",
       "               'AB': 'BACKGROUND: Long COVID (LC) is a diagnosis that requires exclusion of alternative somatic and mental diseases. The aim of this study was to examine the prevalence of differential diagnoses in suspected pediatric LC patients and assess whether adult LC symptom clusters are applicable to pediatric patients. MATERIALS AND METHODS: Pediatric presentations at the Pediatric Infectious Diseases Department of the University Hospital Essen (Germany) were assessed retrospectively. The correlation of initial symptoms and final diagnoses (LC versus other diseases or unclarified) was assessed. The sensitivity, specificity, negative and positive predictive values of adult LC symptom clusters were calculated. RESULTS: Of 110 patients, 32 (29%) suffered from LC, 52 (47%) were diagnosed with alternative somatic/mental diseases, and 26 (23%) remained unclarified. Combined neurological and respiratory clusters displayed a sensitivity of 0.97 (95% CI 0.91-1.00) and a negative predictive value of 0.97 (0.92-1.00) for LC. DISCUSSION/CONCLUSIONS: The prevalence of alternative somatic and mental diseases in pediatric patients with suspected LC is high. The range of underlying diseases is wide, including chronic and potentially life-threatening conditions. Neurological and respiratory symptom clusters may help to identify patients that are unlikely to be suffering from LC.',\n",
       "               'FAU': ['Goretzki, Sarah C',\n",
       "                'Brasseler, Maire',\n",
       "                'Dogan, Burcin',\n",
       "                'Huhne, Tom',\n",
       "                'Bernard, Daniel',\n",
       "                'Schonecker, Anne',\n",
       "                'Steindor, Mathis',\n",
       "                'Gangfuss, Andrea',\n",
       "                'Della Marina, Adela',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Bruns, Nora'],\n",
       "               'AU': ['Goretzki SC',\n",
       "                'Brasseler M',\n",
       "                'Dogan B',\n",
       "                'Huhne T',\n",
       "                'Bernard D',\n",
       "                'Schonecker A',\n",
       "                'Steindor M',\n",
       "                'Gangfuss A',\n",
       "                'Della Marina A',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dohna-Schwake C',\n",
       "                'Bruns N'],\n",
       "               'AD': [\"Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University Duisburg-Essen, Children's Hospital Essen, 45147 Essen, Germany.\",\n",
       "                'Center for Translational Neuro- and Behavioral Sciences C-TNBS, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'West German Centre for Infectious Diseases (WZI), University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                \"Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University Duisburg-Essen, Children's Hospital Essen, 45147 Essen, Germany.\",\n",
       "                'Center for Translational Neuro- and Behavioral Sciences C-TNBS, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'West German Centre for Infectious Diseases (WZI), University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                \"Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University Duisburg-Essen, Children's Hospital Essen, 45147 Essen, Germany.\",\n",
       "                'West German Centre for Infectious Diseases (WZI), University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                \"Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University Duisburg-Essen, Children's Hospital Essen, 45147 Essen, Germany.\",\n",
       "                \"Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University Duisburg-Essen, Children's Hospital Essen, 45147 Essen, Germany.\",\n",
       "                \"Department of Pediatrics III, Pediatric Pulmonology and Sleep Medicine, University Duisburg-Essen, Children's Hospital Essen, 45147 Essen, Germany.\",\n",
       "                \"Department of Pediatrics III, Pediatric Pulmonology and Sleep Medicine, University Duisburg-Essen, Children's Hospital Essen, 45147 Essen, Germany.\",\n",
       "                \"Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University Duisburg-Essen, Children's Hospital Essen, 45147 Essen, Germany.\",\n",
       "                'Center for Translational Neuro- and Behavioral Sciences C-TNBS, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                \"Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University Duisburg-Essen, Children's Hospital Essen, 45147 Essen, Germany.\",\n",
       "                'Center for Translational Neuro- and Behavioral Sciences C-TNBS, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                \"Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University Duisburg-Essen, Children's Hospital Essen, 45147 Essen, Germany.\",\n",
       "                'Center for Translational Neuro- and Behavioral Sciences C-TNBS, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                \"Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University Duisburg-Essen, Children's Hospital Essen, 45147 Essen, Germany.\",\n",
       "                'Center for Translational Neuro- and Behavioral Sciences C-TNBS, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'West German Centre for Infectious Diseases (WZI), University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                \"Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University Duisburg-Essen, Children's Hospital Essen, 45147 Essen, Germany.\",\n",
       "                'Center for Translational Neuro- and Behavioral Sciences C-TNBS, University Duisburg-Essen, 45147 Essen, Germany.'],\n",
       "               'AUID': ['ORCID: 0000-0003-0182-7379',\n",
       "                'ORCID: 0000-0003-2724-5297',\n",
       "                'ORCID: 0000-0002-9975-0092',\n",
       "                'ORCID: 0000-0003-0737-6142',\n",
       "                'ORCID: 0000-0003-3809-1887'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20230220',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Viruses',\n",
       "               'JT': 'Viruses',\n",
       "               'JID': '101509722',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Humans',\n",
       "                'Adolescent',\n",
       "                'Child',\n",
       "                '*Post-Acute COVID-19 Syndrome',\n",
       "                'Prevalence',\n",
       "                'Cohort Studies',\n",
       "                'Retrospective Studies',\n",
       "                '*COVID-19/diagnosis/epidemiology'],\n",
       "               'PMC': 'PMC9961131',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['differential diagnoses',\n",
       "                'pediatric Long COVID',\n",
       "                'post COVID',\n",
       "                'post-acute sequelae SARS-CoV-2 infection',\n",
       "                'symptom cluster'],\n",
       "               'COIS': ['The authors declare no conflict of interest.'],\n",
       "               'EDAT': '2023/03/01 06:00',\n",
       "               'MHDA': '2023/03/03 06:00',\n",
       "               'PMCR': ['2023/02/20'],\n",
       "               'CRDT': ['2023/02/28 01:42'],\n",
       "               'PHST': ['2022/12/23 00:00 [received]',\n",
       "                '2023/01/31 00:00 [revised]',\n",
       "                '2023/02/18 00:00 [accepted]',\n",
       "                '2023/02/28 01:42 [entrez]',\n",
       "                '2023/03/01 06:00 [pubmed]',\n",
       "                '2023/03/03 06:00 [medline]',\n",
       "                '2023/02/20 00:00 [pmc-release]'],\n",
       "               'AID': ['v15020579 [pii]',\n",
       "                'viruses-15-00579 [pii]',\n",
       "                '10.3390/v15020579 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Viruses. 2023 Feb 20;15(2):579. doi: 10.3390/v15020579.'},\n",
       "              {'PMID': '36830202',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20230228',\n",
       "               'IS': '2079-6382 (Print) 2079-6382 (Electronic) 2079-6382 (Linking)',\n",
       "               'VI': '12',\n",
       "               'IP': '2',\n",
       "               'DP': '2023 Feb 1',\n",
       "               'TI': 'A European International Multicentre Survey on the Current Practice of Perioperative Antibiotic Prophylaxis for Paediatric Liver Transplantations.',\n",
       "               'LID': '10.3390/antibiotics12020292 [doi] 292',\n",
       "               'AB': '(1) Background: Postoperative infections are major contributors of morbidity and mortality after paediatric liver transplantation (pLTX). Evidence and recommendations regarding the most effective antimicrobial strategy are lacking. (2) Results: Of 39 pLTX centres, 20 responded. Aminopenicillins plus ss-lactamase inhibitors were used by six (30%) and third generation cephalosporins by three (15%), with the remaining centres reporting heterogenous regimens. Broad-spectrum regimens were the standard in 10 (50%) of centres and less frequent in the 16 (80%) centres with an infectious disease specialist. The duration ranged mainly between 24-48 h and 3-5 days in the absence and 3-5 days or 6-10 days in the presence of risk factors. Strategies regarding antifungal, antiviral, adjunctive antimicrobial, and surveillance strategies varied widely. (3) Methods: This international multicentre survey endorsed by the European Liver Transplant Registry queried all European pLTX centres from the registry on their current practice of perioperative antibiotic prophylaxis and antimicrobial strategies via an online questionnaire. (4) Conclusions: This survey found great heterogeneity regarding all aspects of postoperative antimicrobial treatment, surveillance, and prevention of infections in European pLTX centres. Evidence-based recommendations are urgently needed to optimise antimicrobial strategies and reduce the spectrum and duration of antimicrobial exposure.',\n",
       "               'FAU': ['Hauschild, Juliane',\n",
       "                'Bruns, Nora',\n",
       "                'Lainka, Elke',\n",
       "                'Dohna-Schwake, Christian'],\n",
       "               'AU': ['Hauschild J', 'Bruns N', 'Lainka E', 'Dohna-Schwake C'],\n",
       "               'AD': ['Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Paediatrics II, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.'],\n",
       "               'AUID': ['ORCID: 0000-0003-3809-1887'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20230201',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Antibiotics (Basel)',\n",
       "               'JT': 'Antibiotics (Basel, Switzerland)',\n",
       "               'JID': '101637404',\n",
       "               'PMC': 'PMC9952614',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['antibiotic exposure',\n",
       "                'antibiotics',\n",
       "                'antimicrobials',\n",
       "                'infection prevention',\n",
       "                'infection surveillance',\n",
       "                'infectious disease specialist',\n",
       "                'paediatric liver transplantation',\n",
       "                'perioperative prophylaxis'],\n",
       "               'COIS': ['The authors declare no conflict of interest.'],\n",
       "               'EDAT': '2023/02/26 06:00',\n",
       "               'MHDA': '2023/02/26 06:01',\n",
       "               'PMCR': ['2023/02/01'],\n",
       "               'CRDT': ['2023/02/25 01:14'],\n",
       "               'PHST': ['2022/12/21 00:00 [received]',\n",
       "                '2023/01/27 00:00 [revised]',\n",
       "                '2023/01/30 00:00 [accepted]',\n",
       "                '2023/02/25 01:14 [entrez]',\n",
       "                '2023/02/26 06:00 [pubmed]',\n",
       "                '2023/02/26 06:01 [medline]',\n",
       "                '2023/02/01 00:00 [pmc-release]'],\n",
       "               'AID': ['antibiotics12020292 [pii]',\n",
       "                'antibiotics-12-00292 [pii]',\n",
       "                '10.3390/antibiotics12020292 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Antibiotics (Basel). 2023 Feb 1;12(2):292. doi: 10.3390/antibiotics12020292.'},\n",
       "              {'PMID': '36789485',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230406',\n",
       "               'LR': '20230406',\n",
       "               'IS': '1468-1331 (Electronic) 1351-5101 (Linking)',\n",
       "               'VI': '30',\n",
       "               'IP': '5',\n",
       "               'DP': '2023 May',\n",
       "               'TI': 'Functional outcome after initial and multiple intracerebral hemorrhages in children with cerebral cavernous malformations.',\n",
       "               'PG': '1364-1370',\n",
       "               'LID': '10.1111/ene.15749 [doi]',\n",
       "               'AB': 'BACKGROUND AND PURPOSE: We aimed to assess the course and predictors of functional outcome after single and multiple intracerebral hemorrhage (ICH) in pediatric patients with cerebral cavernous malformations (CCMs) and to conduct a risk assessment of a third bleed during the first follow-up year after second ICH. METHODS: We included patients aged </=18 years with complete baseline characteristics, a magnetic resonance imaging dataset, >/=1 CCM-related ICH and >/=1 follow-up examination, who were treated between 2003 and 2021. Neurological functional status was obtained using modified Rankin Scale scores at diagnosis, before and after each ICH, and at last follow-up. Kaplan-Meier analysis was performed to determine the cumulative 1-year risk of third ICH. RESULTS: A total of 55 pediatric patients (median [interquartile range] age 12 [11] years) were analyzed. Univariate analysis identified brainstem cavernous malformation (BSCM; p = 0.019) as a statistically significant predictor for unfavorable outcome after second ICH. Outcome after second ICH was significantly worse in 12 patients (42.9%; p = 0.030) than after first ICH and in five patients (55.6%; p = 0.038) after a third ICH compared to a second ICH. Cumulative 12-month risk of rebleeding during the first year after a second ICH was 10.7% (95% confidence interval 2.8%-29.37%). CONCLUSIONS: Pediatric patients with a BSCM have a higher risk of worse outcome after second ICH. Functional outcome improves over time after an ICH but worsens following each ICH compared to baseline or previous ICH. Second bleed was associated with neurological deterioration compared to initial ICH, and this deteriorated further after a third ICH.',\n",
       "               'CI': ['(c) 2023 The Authors. European Journal of Neurology published by John Wiley & Sons',\n",
       "                'Ltd on behalf of European Academy of Neurology.'],\n",
       "               'FAU': ['Santos, Alejandro N',\n",
       "                'Rauschenbach, Laurel',\n",
       "                'Gull, Hannah Hadice',\n",
       "                'Dinger, Thiemo Florin',\n",
       "                'Chihi, Mehdi',\n",
       "                'Li, Yan',\n",
       "                'Tippelt, Stephan',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Schmidt, Borge',\n",
       "                'Jabbarli, Ramazan',\n",
       "                'Wrede, Karsten H',\n",
       "                'Sure, Ulrich',\n",
       "                'Dammann, Philipp'],\n",
       "               'AU': ['Santos AN',\n",
       "                'Rauschenbach L',\n",
       "                'Gull HH',\n",
       "                'Dinger TF',\n",
       "                'Chihi M',\n",
       "                'Li Y',\n",
       "                'Tippelt S',\n",
       "                'Dohna-Schwake C',\n",
       "                'Schmidt B',\n",
       "                'Jabbarli R',\n",
       "                'Wrede KH',\n",
       "                'Sure U',\n",
       "                'Dammann P'],\n",
       "               'AUID': ['ORCID: 0000-0002-6616-5313',\n",
       "                'ORCID: 0000-0001-8348-4298',\n",
       "                'ORCID: 0000-0003-2376-2211',\n",
       "                'ORCID: 0000-0001-7076-3503'],\n",
       "               'AD': ['Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuroscience and Behavioral Science (C-TNBS), University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuroscience and Behavioral Science (C-TNBS), University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuroscience and Behavioral Science (C-TNBS), University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuroscience and Behavioral Science (C-TNBS), University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuroscience and Behavioral Science (C-TNBS), University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Essen, Essen, Germany.',\n",
       "                'Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuroscience and Behavioral Science (C-TNBS), University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuroscience and Behavioral Science (C-TNBS), University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuroscience and Behavioral Science (C-TNBS), University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuroscience and Behavioral Science (C-TNBS), University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20230303',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Eur J Neurol',\n",
       "               'JT': 'European journal of neurology',\n",
       "               'JID': '9506311',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Child',\n",
       "                '*Hemangioma, Cavernous, Central Nervous System/complications/diagnostic imaging',\n",
       "                'Cerebral Hemorrhage/complications/diagnostic imaging',\n",
       "                'Risk Assessment',\n",
       "                'Magnetic Resonance Imaging',\n",
       "                'Kaplan-Meier Estimate'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['CCM',\n",
       "                'brainstem cavernous malformation',\n",
       "                'cavernous angioma',\n",
       "                'functional outcome',\n",
       "                'mRS',\n",
       "                'modified Rankin scale',\n",
       "                'natural evolution',\n",
       "                'pediatric'],\n",
       "               'EDAT': '2023/02/16 06:00',\n",
       "               'MHDA': '2023/04/06 06:41',\n",
       "               'CRDT': ['2023/02/15 02:43'],\n",
       "               'PHST': ['2023/02/10 00:00 [revised]',\n",
       "                '2022/12/07 00:00 [received]',\n",
       "                '2023/02/13 00:00 [accepted]',\n",
       "                '2023/04/06 06:41 [medline]',\n",
       "                '2023/02/16 06:00 [pubmed]',\n",
       "                '2023/02/15 02:43 [entrez]'],\n",
       "               'AID': ['10.1111/ene.15749 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Neurol. 2023 May;30(5):1364-1370. doi: 10.1111/ene.15749. Epub 2023 Mar 3.'},\n",
       "              {'PMID': '36776874',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230214',\n",
       "               'LR': '20230307',\n",
       "               'IS': '1664-3224 (Electronic) 1664-3224 (Linking)',\n",
       "               'VI': '14',\n",
       "               'DP': '2023',\n",
       "               'TI': 'IgD shapes the pre-immune naive B cell compartment in humans.',\n",
       "               'PG': '1096019',\n",
       "               'LID': '10.3389/fimmu.2023.1096019 [doi] 1096019',\n",
       "               'AB': 'B cell maturation and immunoglobulin (Ig) repertoire selection are governed by expression of a functional B cell receptor (BCR). Naive B cells co-express their BCR as IgM and IgD isotype. However, the role of the additionally expressed IgD on naive B cells is not known. Here we assessed the impact of IgD on naive B cell maturation and Ig repertoire selection in 8 individuals from 3 different families with heterozygous loss-of-function or loss-of expression mutations in IGHD. Although naive B cells from these individuals expressed IgM on their surface, the IGHD variant in heterozygous state entailed a chimeric situation by allelic exclusion with almost half of the naive B cell population lacking surface IgD expression. Flow cytometric analyses revealed a distinct phenotype of IgD-negative naive B cells with decreased expression of CD19, CD20 and CD21 as well as lower BAFF-R and integrin-beta7 expression. IgD-negative B cells were less responsive in vitro after engaging the IgM-BCR, TLR7/9 or CD40 pathway. Additionally, a selective disadvantage of IgD-negative B cells within the T2 transitional and mature naive B cell compartment as well as reduced frequencies of IgM(lo/-) B cells within the mature naive B cell compartment lacking IgD were evident. RNA-Ig-seq of bulk sorted B cell populations showed an altered selection of distinct V(H) segments in the IgD-negative mature naive B cell population. We conclude that IgD expression on human naive B cells is redundant for generation of naive B cells in general, but further shapes the naive B cell compartment starting from T2 transitional B cells. Our observations suggest an unexpected role of IgD expression to be critical for selection of distinct Ig V(H) segments into the pre-immune Ig repertoire and for the survival of IgM(lo/-) naive B cells known to be enriched in poly-/autoreactive B cell clones.',\n",
       "               'CI': ['Copyright (c) 2023 Dirks, Andres, Paul, Manukjan, Schulze and Morbach.'],\n",
       "               'FAU': ['Dirks, Johannes',\n",
       "                'Andres, Oliver',\n",
       "                'Paul, Luisa',\n",
       "                'Manukjan, Georgi',\n",
       "                'Schulze, Harald',\n",
       "                'Morbach, Henner'],\n",
       "               'AU': ['Dirks J',\n",
       "                'Andres O',\n",
       "                'Paul L',\n",
       "                'Manukjan G',\n",
       "                'Schulze H',\n",
       "                'Morbach H'],\n",
       "               'AD': ['Pediatric Immunology, Department of Pediatrics, University Hospital Wurzburg, Wurzburg, Germany.',\n",
       "                'Pediatric Immunology, Department of Pediatrics, University Hospital Wurzburg, Wurzburg, Germany.',\n",
       "                'Pediatric Immunology, Department of Pediatrics, University Hospital Wurzburg, Wurzburg, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University of Duisburg Essen, Essen, Germany.',\n",
       "                'Institute of Experimental Biomedicine I, University Hospital Wurzburg, Wurzburg, Germany.',\n",
       "                'Institute of Experimental Biomedicine I, University Hospital Wurzburg, Wurzburg, Germany.',\n",
       "                'Pediatric Immunology, Department of Pediatrics, University Hospital Wurzburg, Wurzburg, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20230126',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Immunol',\n",
       "               'JT': 'Frontiers in immunology',\n",
       "               'JID': '101560960',\n",
       "               'RN': ['0 (Immunoglobulin D)',\n",
       "                '0 (Immunoglobulin M)',\n",
       "                '0 (Receptors, Antigen, B-Cell)',\n",
       "                '0 (Immunoglobulin Isotypes)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*Immunoglobulin D/metabolism',\n",
       "                'Immunoglobulin M',\n",
       "                '*B-Lymphocytes',\n",
       "                'Receptors, Antigen, B-Cell/genetics/metabolism',\n",
       "                'Immunoglobulin Isotypes/metabolism'],\n",
       "               'PMC': 'PMC9908586',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['B cell',\n",
       "                'B cell maturation',\n",
       "                'B cell receptor',\n",
       "                'IgD',\n",
       "                'IgM',\n",
       "                'immunoglobulin repertoire'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2023/02/14 06:00',\n",
       "               'MHDA': '2023/02/15 06:00',\n",
       "               'PMCR': ['2023/01/01'],\n",
       "               'CRDT': ['2023/02/13 03:26'],\n",
       "               'PHST': ['2022/11/11 00:00 [received]',\n",
       "                '2023/01/10 00:00 [accepted]',\n",
       "                '2023/02/13 03:26 [entrez]',\n",
       "                '2023/02/14 06:00 [pubmed]',\n",
       "                '2023/02/15 06:00 [medline]',\n",
       "                '2023/01/01 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fimmu.2023.1096019 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Immunol. 2023 Jan 26;14:1096019. doi: 10.3389/fimmu.2023.1096019. eCollection 2023.'},\n",
       "              {'PMID': '36759693',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230213',\n",
       "               'LR': '20230318',\n",
       "               'IS': '2045-2322 (Electronic) 2045-2322 (Linking)',\n",
       "               'VI': '13',\n",
       "               'IP': '1',\n",
       "               'DP': '2023 Feb 9',\n",
       "               'TI': 'Functional outcome after pediatric cerebral cavernous malformation surgery.',\n",
       "               'PG': '2286',\n",
       "               'LID': '10.1038/s41598-023-29472-5 [doi] 2286',\n",
       "               'AB': 'The purpose of this study was to investigate the functional outcome following surgical resection of cerebral cavernous malformations (CCM) in pediatric patients. We screened our institutional database of CCM patients treated between 2003 and 2021. Inclusion regarded individuals younger or equal than 18 years of age with complete clinical baseline characteristics, magnetic resonance imaging dataset, and postoperative follow-up time of at least three months. Functional outcome was quantified using the modified Rankin Scale (mRS) score and assessed at admission, discharge, and last follow-up examination. The primary endpoint was the postoperative functional outcome. As a secondary endpoint, predictors of postoperative functional deterioration were assessed. A total of 49 pediatric patients with a mean age of 11.3 +/- 5.7 years were included for subsequent analyses. Twenty individuals (40.8%) were female. Complete resection of the lesion was achieved in 44 patients (89.8%), and two patients with incomplete resection were referred for successive remnant removal. The mean follow-up time after surgery was 44 months (IQR: 13 - 131). The mean mRS score was 1.6 on admission, 1.7 at discharge, and 0.9 at the latest follow-up. Logistic regression analysis adjusted to age and sex identified brainstem localization (aOR = 53.45 [95%CI = 2.26 - 1261.81], p = .014) as a predictor of postoperative deterioration. This study indicates that CCM removal in children can be regarded as safe and favorable for the majority of patients, depending on lesion localization. Brainstem localization implies a high risk of postoperative morbidity and indication for surgery should be balanced carefully. Minor evidence indicates that second-look surgery for CCM remnants might be safe and favorable.',\n",
       "               'CI': ['(c) 2023. The Author(s).'],\n",
       "               'FAU': ['Rauschenbach, Laurel',\n",
       "                'Santos, Alejandro N',\n",
       "                'Dinger, Thiemo F',\n",
       "                'Darkwah Oppong, Marvin',\n",
       "                'Li, Yan',\n",
       "                'Tippelt, Stephan',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Schmidt, Borge',\n",
       "                'Jabbarli, Ramazan',\n",
       "                'Wrede, Karsten H',\n",
       "                'Sure, Ulrich',\n",
       "                'Dammann, Philipp'],\n",
       "               'AU': ['Rauschenbach L',\n",
       "                'Santos AN',\n",
       "                'Dinger TF',\n",
       "                'Darkwah Oppong M',\n",
       "                'Li Y',\n",
       "                'Tippelt S',\n",
       "                'Dohna-Schwake C',\n",
       "                'Schmidt B',\n",
       "                'Jabbarli R',\n",
       "                'Wrede KH',\n",
       "                'Sure U',\n",
       "                'Dammann P'],\n",
       "               'AUID': ['ORCID: 0000-0001-8348-4298'],\n",
       "               'AD': ['Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany. laurel.rauschenbach@uk-essen.de.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences, C-TNBS, University Duisburg Essen, Essen, Germany. laurel.rauschenbach@uk-essen.de.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences, C-TNBS, University Duisburg Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences, C-TNBS, University Duisburg Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences, C-TNBS, University Duisburg Essen, Essen, Germany.',\n",
       "                'Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.',\n",
       "                'Department of Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, Essen, Germany.',\n",
       "                'Department of Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, Essen, Germany.',\n",
       "                'Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences, C-TNBS, University Duisburg Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences, C-TNBS, University Duisburg Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences, C-TNBS, University Duisburg Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences, C-TNBS, University Duisburg Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20230209',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Sci Rep',\n",
       "               'JT': 'Scientific reports',\n",
       "               'JID': '101563288',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Child',\n",
       "                'Female',\n",
       "                'Child, Preschool',\n",
       "                'Adolescent',\n",
       "                'Infant',\n",
       "                'Male',\n",
       "                '*Hemangioma, Cavernous, Central Nervous System/diagnostic imaging/surgery/complications',\n",
       "                'Treatment Outcome',\n",
       "                'Retrospective Studies',\n",
       "                'Brain Stem/pathology',\n",
       "                'Magnetic Resonance Imaging'],\n",
       "               'PMC': 'PMC9911771',\n",
       "               'COIS': ['The authors declare no competing interests.'],\n",
       "               'EDAT': '2023/02/10 06:00',\n",
       "               'MHDA': '2023/02/14 06:00',\n",
       "               'PMCR': ['2023/02/09'],\n",
       "               'CRDT': ['2023/02/09 23:51'],\n",
       "               'PHST': ['2022/10/04 00:00 [received]',\n",
       "                '2023/02/06 00:00 [accepted]',\n",
       "                '2023/02/09 23:51 [entrez]',\n",
       "                '2023/02/10 06:00 [pubmed]',\n",
       "                '2023/02/14 06:00 [medline]',\n",
       "                '2023/02/09 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1038/s41598-023-29472-5 [pii]',\n",
       "                '29472 [pii]',\n",
       "                '10.1038/s41598-023-29472-5 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Sci Rep. 2023 Feb 9;13(1):2286. doi: 10.1038/s41598-023-29472-5.'},\n",
       "              {'PMID': '36669528',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230608',\n",
       "               'LR': '20230608',\n",
       "               'IS': '1438-8782 (Electronic) 0172-4614 (Linking)',\n",
       "               'VI': '44',\n",
       "               'IP': '3',\n",
       "               'DP': '2023 Jun',\n",
       "               'TI': 'Pulmonary Sonography - Neonatal Diagnosis Part 2.',\n",
       "               'PG': '240-268',\n",
       "               'LID': '10.1055/a-1996-0767 [doi]',\n",
       "               'AB': 'A healthy, air-filled lung can only be visualized by its artifacts, and pathologies of the lung are revealed by changes in these artifacts. Because ultrasound artifacts are predominantly used in pulmonary sonography to assess pathologic processes, the variability of sonographically imageable phenomena is limited. For this reason, different pulmonary diseases may present very similarly in ultrasound. Therefore, a correct interpretation of the findings is only possible in the clinical context, taking into account the age-dependent differential diagnoses.The particular relevance of lung ultrasound in the treatment of neonatal patients results from a close correlation between the extent of sonographically-depictable pathologies and parameters of respiratory insufficiency. This suggests a direct correlation between ultrasound findings and the severity of lung injury. Lung ultrasound thus represents a unique, ubiquitously available, bedside, serial method for monitoring the pulmonary status.',\n",
       "               'CI': ['Thieme. All rights reserved.'],\n",
       "               'FAU': ['Schwarz, Simone'],\n",
       "               'AU': ['Schwarz S'],\n",
       "               'AUID': ['ORCID: 0000-0001-6930-1061'],\n",
       "               'AD': ['Clinic for Pediatrics and Adolescent Medicine, Sana-Kliniken Duisburg GmbH, Duisburg, Germany.'],\n",
       "               'LA': ['eng', 'ger'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'TT': 'Lungensonografie - Diagnostik in der Neonatologie Teil 2.',\n",
       "               'DEP': '20230120',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Ultraschall Med',\n",
       "               'JT': 'Ultraschall in der Medizin (Stuttgart, Germany : 1980)',\n",
       "               'JID': '8303585',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Infant, Newborn',\n",
       "                'Humans',\n",
       "                '*Lung/diagnostic imaging',\n",
       "                '*Lung Diseases/diagnostic imaging',\n",
       "                'Ultrasonography/methods',\n",
       "                'Diagnosis, Differential',\n",
       "                'Thorax'],\n",
       "               'COIS': ['Declaration of financial interestsReceipt of research funding: no; receipt of',\n",
       "                'payment/financial advantage for providing services as a lecturer: no; paid',\n",
       "                'consultant/internal trainer/salaried employee: no; patent/business',\n",
       "                'interest/shares (author/partner, spouse, children) in company: no;',\n",
       "                'patent/business interest/shares (author/partner, spouse, children) in sponsor of',\n",
       "                'this CME article or in company whose interests are affected by the CME article:',\n",
       "                'no.Declaration of non-financial interestsThe authors declare that there is no',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2023/01/21 06:00',\n",
       "               'MHDA': '2023/06/08 06:42',\n",
       "               'CRDT': ['2023/01/20 19:12'],\n",
       "               'PHST': ['2023/06/08 06:42 [medline]',\n",
       "                '2023/01/21 06:00 [pubmed]',\n",
       "                '2023/01/20 19:12 [entrez]'],\n",
       "               'AID': ['10.1055/a-1996-0767 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Ultraschall Med. 2023 Jun;44(3):240-268. doi: 10.1055/a-1996-0767. Epub 2023 Jan 20.'},\n",
       "              {'PMID': '36645451',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230207',\n",
       "               'LR': '20230207',\n",
       "               'IS': '1433-0407 (Electronic) 0028-2804 (Linking)',\n",
       "               'VI': '94',\n",
       "               'IP': '2',\n",
       "               'DP': '2023 Feb',\n",
       "               'TI': '[Pediatric neurocritical care].',\n",
       "               'PG': '75-83',\n",
       "               'LID': '10.1007/s00115-022-01424-w [doi]',\n",
       "               'AB': 'Pediatric neurocritical care requires multidisciplinary expertise for the care of critically ill children. Approximately 14-16% of critically ill children in pediatric intensive care suffer from a primary neurological disease, whereby cardiac arrest and severe traumatic brain injury play major roles in Europe. The short-term goal of interventions in the pediatric intensive care unit is to stabilize vital functions, whereas the overarching goal is to achieve survival without neurological damage that enables fulfillment of the individual developmental physiological potential. For this reason, evidence-based methods for brain monitoring during the acute phase and recovery are necessary, which can be performed clinically or with technical devices. This applies to critically ill children with primary neurological diseases and for all children at risk for secondary neurological insults. Patients with diseases of the peripheral nervous system are also treated in pediatric intensive care medicine. In these patients, the primary aim frequently consists of bridging the time until recovery after acute deterioration, for example during an infection. In these patients, monitoring the cerebral function can be especially challenging, because due to the underlying disease the results of the examination cannot be interpreted in the same way as for previously neurologically healthy children. This article summarizes the complexity of pediatric neurocritical care by presenting examples of diagnostic and therapeutic approaches in the context of various neurological diseases that can be routinely encountered in the pediatric intensive care unit and can only be successfully treated by multidisciplinary teams.',\n",
       "               'CI': ['(c) 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH,',\n",
       "                'ein Teil von Springer Nature.'],\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Schara-Schmidt, Ulrike',\n",
       "                'Dohna-Schwake, Christian'],\n",
       "               'AU': ['Bruns N', 'Schara-Schmidt U', 'Dohna-Schwake C'],\n",
       "               'AD': ['Zentrum fur Kinder- und Jugendmedizin, Klinik fur Kinderheilkunde I (Neonatologie, Padiatrische Intensivmedizin, Neuropadiatrie), Universitatsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland. nora.bruns@uk-essen.de.',\n",
       "                'Center for Translational and Behavioral Sciences (TNBS), Universitatsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland. nora.bruns@uk-essen.de.',\n",
       "                'Zentrum fur Kinder- und Jugendmedizin, Klinik fur Kinderheilkunde I (Neonatologie, Padiatrische Intensivmedizin, Neuropadiatrie), Universitatsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland.',\n",
       "                'Center for Translational and Behavioral Sciences (TNBS), Universitatsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland.',\n",
       "                'Zentrum fur Kinder- und Jugendmedizin, Klinik fur Kinderheilkunde I (Neonatologie, Padiatrische Intensivmedizin, Neuropadiatrie), Universitatsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland.',\n",
       "                'Center for Translational and Behavioral Sciences (TNBS), Universitatsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article', 'Review'],\n",
       "               'TT': 'Padiatrische Neurointensivmedizin.',\n",
       "               'DEP': '20230116',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Nervenarzt',\n",
       "               'JT': 'Der Nervenarzt',\n",
       "               'JID': '0400773',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Child',\n",
       "                'Humans',\n",
       "                'Critical Care',\n",
       "                'Critical Illness',\n",
       "                '*Nervous System Diseases/diagnosis/therapy',\n",
       "                'Intensive Care Units, Pediatric',\n",
       "                '*Neurology'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Cerebral function',\n",
       "                'Critically ill child',\n",
       "                'Neuromonitoring',\n",
       "                'Pediatric neurology',\n",
       "                'Treatment strategies'],\n",
       "               'EDAT': '2023/01/17 06:00',\n",
       "               'MHDA': '2023/02/08 06:00',\n",
       "               'CRDT': ['2023/01/16 11:13'],\n",
       "               'PHST': ['2022/12/06 00:00 [accepted]',\n",
       "                '2023/01/17 06:00 [pubmed]',\n",
       "                '2023/02/08 06:00 [medline]',\n",
       "                '2023/01/16 11:13 [entrez]'],\n",
       "               'AID': ['10.1007/s00115-022-01424-w [pii]',\n",
       "                '10.1007/s00115-022-01424-w [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Nervenarzt. 2023 Feb;94(2):75-83. doi: 10.1007/s00115-022-01424-w. Epub 2023 Jan 16.'},\n",
       "              {'PMID': '36576494',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230306',\n",
       "               'LR': '20230313',\n",
       "               'IS': '2153-7933 (Electronic) 2153-7658 (Linking)',\n",
       "               'VI': '13',\n",
       "               'IP': '1',\n",
       "               'DP': '2023 Mar',\n",
       "               'TI': 'Re: \"Watch Out for Drug-Induced Coma and Burst Suppression Pattern in Infants and Children Mimicking Severe Neurological Disease\" by Falsaperla et al.',\n",
       "               'PG': '42-43',\n",
       "               'LID': '10.1089/ther.2022.0052 [doi]',\n",
       "               'FAU': ['Bruns, Nora'],\n",
       "               'AU': ['Bruns N'],\n",
       "               'AUID': ['ORCID: 0000-0003-3809-1887'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Letter'],\n",
       "               'DEP': '20221220',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Ther Hypothermia Temp Manag',\n",
       "               'JT': 'Therapeutic hypothermia and temperature management',\n",
       "               'JID': '101543518',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Child',\n",
       "                'Infant',\n",
       "                'Coma/chemically induced/diagnosis',\n",
       "                '*Hypothermia, Induced',\n",
       "                '*Nervous System Diseases',\n",
       "                'Electroencephalography'],\n",
       "               'EDAT': '2022/12/29 06:00',\n",
       "               'MHDA': '2023/03/07 06:00',\n",
       "               'CRDT': ['2022/12/28 11:03'],\n",
       "               'PHST': ['2022/12/29 06:00 [pubmed]',\n",
       "                '2023/03/07 06:00 [medline]',\n",
       "                '2022/12/28 11:03 [entrez]'],\n",
       "               'AID': ['10.1089/ther.2022.0052 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Ther Hypothermia Temp Manag. 2023 Mar;13(1):42-43. doi: 10.1089/ther.2022.0052. Epub 2022 Dec 20.'},\n",
       "              {'PMID': '36520269',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230112',\n",
       "               'LR': '20230226',\n",
       "               'IS': '1534-6315 (Electronic) 1529-7322 (Print) 1529-7322 (Linking)',\n",
       "               'VI': '23',\n",
       "               'IP': '1',\n",
       "               'DP': '2023 Jan',\n",
       "               'TI': 'Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment - Cell Type-Specific Findings (Part 2).',\n",
       "               'PG': '41-52',\n",
       "               'LID': '10.1007/s11882-022-01058-7 [doi]',\n",
       "               'AB': \"PURPOSE OF REVIEW: Over the last years, we have learned that the metabolic phenotype of immune cells is closely connected to the cell's effector function. Understanding these changes will allow us to better understand allergic disease pathology and improve allergy treatment by modulating immune metabolic pathways. As part two of a two-article series, this review reports on the recent studies investigating the metabolism of the cell types involved in allergies and discusses the initial application of these discoveries in allergy treatment. RECENT FINDINGS: The cell types involved in allergic reactions display pronounced and highly specific metabolic changes (here discussed for epithelial cells, APCs, ILC2s, mast cells, eosinophils, and Th2 cells). Currently, the first drugs targeting metabolic pathways are tested for their potential to improve allergy treatment. Immune-metabolic changes observed in allergy so far are complex and depend on the investigated disease and cell type. However, our increased understanding of the underlying principles has pointed to several promising target molecules that are now being investigated to improve allergy treatment.\",\n",
       "               'CI': ['(c) 2022. The Author(s).'],\n",
       "               'FAU': ['Lin, Y-J',\n",
       "                'Goretzki, A',\n",
       "                'Rainer, H',\n",
       "                'Zimmermann, J',\n",
       "                'Schulke, Stefan'],\n",
       "               'AU': ['Lin YJ',\n",
       "                'Goretzki A',\n",
       "                'Rainer H',\n",
       "                'Zimmermann J',\n",
       "                'Schulke S'],\n",
       "               'AD': [\"Vice President's Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Germany.\",\n",
       "                \"Vice President's Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Germany.\",\n",
       "                \"Vice President's Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Germany.\",\n",
       "                \"Vice President's Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Germany.\",\n",
       "                \"Vice President's Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Germany. Stefan.Schuelke@pei.de.\"],\n",
       "               'AUID': ['ORCID: 0000-0002-9674-5116'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                'Review'],\n",
       "               'DEP': '20221215',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Curr Allergy Asthma Rep',\n",
       "               'JT': 'Current allergy and asthma reports',\n",
       "               'JID': '101096440',\n",
       "               'RN': ['0 (Cytokines)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*Immunity, Innate',\n",
       "                'Lymphocytes',\n",
       "                '*Hypersensitivity/therapy',\n",
       "                'Th2 Cells/metabolism',\n",
       "                'Mast Cells',\n",
       "                'Cytokines/metabolism'],\n",
       "               'PMC': 'PMC9832094',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['APC',\n",
       "                'Allergy',\n",
       "                'Fatty acid oxidation',\n",
       "                'ILC2',\n",
       "                'Immune metabolism',\n",
       "                'Immunotherapy',\n",
       "                'Oxidative phosphorylation',\n",
       "                'Th2',\n",
       "                'Warburg'],\n",
       "               'COIS': ['The authors declare no competing interests.'],\n",
       "               'EDAT': '2022/12/16 06:00',\n",
       "               'MHDA': '2023/01/13 06:00',\n",
       "               'PMCR': ['2022/12/15'],\n",
       "               'CRDT': ['2022/12/15 11:17'],\n",
       "               'PHST': ['2022/10/14 00:00 [accepted]',\n",
       "                '2022/12/16 06:00 [pubmed]',\n",
       "                '2023/01/13 06:00 [medline]',\n",
       "                '2022/12/15 11:17 [entrez]',\n",
       "                '2022/12/15 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s11882-022-01058-7 [pii]',\n",
       "                '1058 [pii]',\n",
       "                '10.1007/s11882-022-01058-7 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Curr Allergy Asthma Rep. 2023 Jan;23(1):41-52. doi: 10.1007/s11882-022-01058-7. Epub 2022 Dec 15.'},\n",
       "              {'PMID': '36441389',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230112',\n",
       "               'LR': '20230226',\n",
       "               'IS': '1534-6315 (Electronic) 1529-7322 (Print) 1529-7322 (Linking)',\n",
       "               'VI': '23',\n",
       "               'IP': '1',\n",
       "               'DP': '2023 Jan',\n",
       "               'TI': 'Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment - Disease-Specific Findings (Part 1).',\n",
       "               'PG': '29-40',\n",
       "               'LID': '10.1007/s11882-022-01057-8 [doi]',\n",
       "               'AB': 'PURPOSE OF REVIEW: Recent high-level publications have shown an intricate connection between immune effector function and the metabolic state of the respective cells. In the last years, studies have begun analyzing the metabolic changes associated with allergies. As the first part of a two-article series, this review will briefly summarize the basics of immune metabolism and then focus on the recently published studies on metabolic changes observed in allergic patients. RECENT FINDINGS: In the last 3 years, immune-metabolic research in allergology had a clear focus on asthma with some studies also reporting findings in food allergy and atopic dermatitis. Current results suggest asthma to be associated with a shift in cellular metabolism towards increased aerobic glycolysis (Warburg metabolism), while also displaying substantial changes in fatty acid- and amino acid metabolism (depending on investigated patient collective, asthma phenotype, and disease severity). Understanding immune-metabolic changes in allergies will allow us to (I) better understand allergic disease pathology and (II) modulate immune-metabolic pathways to improve allergy treatment.',\n",
       "               'CI': ['(c) 2022. The Author(s).'],\n",
       "               'FAU': ['Goretzki, A',\n",
       "                'Zimmermann, J',\n",
       "                'Rainer, H',\n",
       "                'Lin, Y-J',\n",
       "                'Schulke, Stefan'],\n",
       "               'AU': ['Goretzki A',\n",
       "                'Zimmermann J',\n",
       "                'Rainer H',\n",
       "                'Lin YJ',\n",
       "                'Schulke S'],\n",
       "               'AD': [\"Vice President's Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Germany.\",\n",
       "                \"Vice President's Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Germany.\",\n",
       "                \"Vice President's Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Germany.\",\n",
       "                \"Vice President's Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Germany.\",\n",
       "                \"Vice President's Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Germany. stefan.schuelke@pei.de.\"],\n",
       "               'AUID': ['ORCID: 0000-0002-9674-5116'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                'Review'],\n",
       "               'DEP': '20221128',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Curr Allergy Asthma Rep',\n",
       "               'JT': 'Current allergy and asthma reports',\n",
       "               'JID': '101096440',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*Asthma',\n",
       "                '*Food Hypersensitivity',\n",
       "                '*Dermatitis, Atopic/therapy'],\n",
       "               'PMC': 'PMC9832111',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Allergic dermatitis',\n",
       "                'Allergy',\n",
       "                'Asthma',\n",
       "                'Food allergy',\n",
       "                'Immune metabolism',\n",
       "                'Immunotherapy'],\n",
       "               'COIS': ['The authors declare no competing interests.'],\n",
       "               'EDAT': '2022/11/29 06:00',\n",
       "               'MHDA': '2023/01/13 06:00',\n",
       "               'PMCR': ['2022/11/28'],\n",
       "               'CRDT': ['2022/11/28 11:21'],\n",
       "               'PHST': ['2022/10/14 00:00 [accepted]',\n",
       "                '2022/11/29 06:00 [pubmed]',\n",
       "                '2023/01/13 06:00 [medline]',\n",
       "                '2022/11/28 11:21 [entrez]',\n",
       "                '2022/11/28 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s11882-022-01057-8 [pii]',\n",
       "                '1057 [pii]',\n",
       "                '10.1007/s11882-022-01057-8 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Curr Allergy Asthma Rep. 2023 Jan;23(1):29-40. doi: 10.1007/s11882-022-01057-8. Epub 2022 Nov 28.'},\n",
       "              {'PMID': '36409307',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20230328',\n",
       "               'IS': '2561-6722 (Electronic) 2561-6722 (Linking)',\n",
       "               'VI': '6',\n",
       "               'DP': '2023 Jan 25',\n",
       "               'TI': 'Feasibility of Video Consultation for Preterm Neurodevelopmental Follow-up Care During the COVID-19 Pandemic: Cohort Study.',\n",
       "               'PG': 'e40940',\n",
       "               'LID': '10.2196/40940 [doi] e40940',\n",
       "               'AB': \"BACKGROUND: During the COVID-19 pandemic, parents of infants born very preterm or at risk were exceptionally worried about being infected. The only means of protection during the onset of the pandemic was social distancing. Video consultations for neurodevelopmental follow-up care were offered as an alternative way to stay in contact with patients and their families, to provide expert support, and to monitor and assess children's development. OBJECTIVE: To assess the feasibility of and family satisfaction with video consultations, interviews were conducted after video and in-person consultations. METHODS: An interview with 28 questions was created to evaluate parental satisfaction with the consultations (eg, their confidentiality and the children's behavior). A total of 93 interviews with parents were conducted between March 2020 and February 2021 and compared (58 after video consultations and 35 after in-person consultations). The interviews were conducted at the end of the consultations by a trained professional. The video consultations were conducted using a certified platform created by Zava Sprechstunde Online, maintaining data protection with end-to-end encryption. Follow-up consultations (video or in-person) were performed at corrected ages of 3, 6, and 12 months as well as 2, 3, 4, and 5 years. The rate of total follow-up appointments attended during the survey period was evaluated and compared with the previous year. RESULTS: There were no significant differences between the video and in-person consultation groups in satisfaction, attitudes on the confidentiality of the consultation, or discussion of private and sensitive information. Following video consultations, parents were significantly more likely to report that they were avoiding contact with medical professionals during the pandemic (P=.045; Shapiro-Wilk W=1094.5, Cohen d=-0.1782146) than the in-person consultation group. Parents in the video-consultation group stated that performing a guided examination on their child was comfortable and helped them understand their child's development. In fact, they agreed to take advantage of future video consultations. The rate of total follow-up appointments increased compared to the previous year. Between March 2019 and February 2020, 782 of 984 (79.5%) children born at Essen University Hospital attended a follow-up appointment. During the survey period, between March 2020 and February 2021, a total of 788 of 1086 children (73%) attended a follow-up appointment, of which 117 (14.9%) were video consultations. CONCLUSIONS: The feasibility of attending video consultations for follow-up care of very preterm or at-risk infants and parental satisfaction with these consultations were as high as for in-person consultations. Parents rated video consultations as being as confidential as in-person appointments. Telemedicine can be offered as an equivalent alternative to in-person consultations and is particularly useful under certain circumstances, such as for very sick children who require assistive devices or respiratory support and oxygen or for those living a long distance away.\",\n",
       "               'CI': ['(c)Bilge Albayrak, Larissa Jane Cordier, Sandra Greve, Uta Teschler, Anne-Kathrin',\n",
       "                'Dathe, Ursula Felderhoff-Muser, Britta Maria Huning. Originally published in JMIR',\n",
       "                'Pediatrics and Parenting (https://pediatrics.jmir.org), 25.01.2023.'],\n",
       "               'FAU': ['Albayrak, Bilge',\n",
       "                'Cordier, Larissa Jane',\n",
       "                'Greve, Sandra',\n",
       "                'Teschler, Uta',\n",
       "                'Dathe, Anne-Kathrin',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Huning, Britta Maria'],\n",
       "               'AU': ['Albayrak B',\n",
       "                'Cordier LJ',\n",
       "                'Greve S',\n",
       "                'Teschler U',\n",
       "                'Dathe AK',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Huning BM'],\n",
       "               'AUID': ['ORCID: 0000-0002-5574-0781',\n",
       "                'ORCID: 0000-0001-6313-1508',\n",
       "                'ORCID: 0000-0001-6957-9100',\n",
       "                'ORCID: 0000-0001-5480-247X',\n",
       "                'ORCID: 0000-0001-5351-3975',\n",
       "                'ORCID: 0000-0002-7765-8893',\n",
       "                'ORCID: 0000-0002-6815-5573'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20230125',\n",
       "               'PL': 'Canada',\n",
       "               'TA': 'JMIR Pediatr Parent',\n",
       "               'JT': 'JMIR pediatrics and parenting',\n",
       "               'JID': '101727244',\n",
       "               'PMC': 'PMC9879316',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['COVID-19',\n",
       "                'COVID-19 pandemic',\n",
       "                'follow-up care',\n",
       "                'neurodevelopmental outcome',\n",
       "                'very preterm infant',\n",
       "                'video consultation'],\n",
       "               'COIS': ['Conflicts of Interest: None declared.'],\n",
       "               'EDAT': '2022/11/22 06:00',\n",
       "               'MHDA': '2022/11/22 06:01',\n",
       "               'PMCR': ['2023/01/25'],\n",
       "               'CRDT': ['2022/11/21 11:02'],\n",
       "               'PHST': ['2022/07/10 00:00 [received]',\n",
       "                '2022/11/17 00:00 [accepted]',\n",
       "                '2022/11/11 00:00 [revised]',\n",
       "                '2022/11/22 06:00 [pubmed]',\n",
       "                '2022/11/22 06:01 [medline]',\n",
       "                '2022/11/21 11:02 [entrez]',\n",
       "                '2023/01/25 00:00 [pmc-release]'],\n",
       "               'AID': ['v6i1e40940 [pii]', '10.2196/40940 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'JMIR Pediatr Parent. 2023 Jan 25;6:e40940. doi: 10.2196/40940.'},\n",
       "              {'PMID': '36196479',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230306',\n",
       "               'LR': '20230309',\n",
       "               'IS': '1398-9995 (Electronic) 0105-4538 (Linking)',\n",
       "               'VI': '78',\n",
       "               'IP': '3',\n",
       "               'DP': '2023 Mar',\n",
       "               'TI': 'Stimulation of naive B cells with a fusion protein consisting of FlaA and Bet v 1 induces regulatory B cells ex vivo.',\n",
       "               'PG': '663-681',\n",
       "               'LID': '10.1111/all.15542 [doi]',\n",
       "               'AB': 'BACKGROUND: The experimental fusion protein rFlaA:Betv1 was shown to efficiently suppress allergen-specific sensitization in mice. However, the detailed mechanism of rFlaA:Betv1-mediated immune modulation is not fully understood. In this study, we investigated the effect of rFlaA:Betv1 on naive murine B cells. METHODS: Immune modulating capacity of rFlaA:Betv1 was screened in IL-10 reporter mice. B cells were isolated from spleens of naive C57Bl/6, TLR5(-/-) , or MyD88(-/-) mice, stimulated with rFlaA:Betv1 and controls, and monitored for the expression of the regulatory B cell markers CD1d, CD24, CD38, and surface IgM by flow cytometry. Secreted cytokines, antibodies, and reactivity of the induced antibodies were investigated by ELISA and intracellular flow cytometry. Suppressive capacity of rFlaA:Betv1-stimulated B cells was tested in mDC:CD4(+) T cell:B cell triple cultures. RESULTS: Upon in vivo application of rFlaA:Betv1 into IL-10-GFP reporter mice, CD19(+) B cells were shown to produce anti-inflammatory IL-10, suggesting B cells to contribute to the immune-modulatory properties of rFlaA:Betv1. rFlaA:Betv1-induced IL-10 secretion was confirmed in human B cells isolated from buffy coats. In vitro stimulation of naive murine B cells with rFlaA:Betv1 resulted in an mTOR- and MyD88-dependent production of IL-10 and rFlaA:Betv1 induced Bet v 1-reactive IgG production, which was not observed for IgA. rFlaA:Betv1-stimulated B cells formed a CD19(+) CD24(+) CD1d(+) IgM(+) CD38(+) Breg subpopulation capable of suppressing Bet v 1-induced TH2 cytokine secretion in vitro. CONCLUSION: rFlaA:Betv1 can act as a thymus-independent B cell antigen, stimulating the mTOR- and MyD88-dependent differentiation of B cells displaying a regulatory phenotype, IL-10 secretion, antigen-binding antibody production, and a suppressive capacity in vitro.',\n",
       "               'CI': ['(c) 2022 The Authors. Allergy published by European Academy of Allergy and Clinical',\n",
       "                'Immunology and John Wiley & Sons Ltd.'],\n",
       "               'FAU': ['Goretzki, Alexandra',\n",
       "                'Lin, Yen-Ju',\n",
       "                'Meier, Clara',\n",
       "                'Dorn, Britta',\n",
       "                'Wolfheimer, Sonja',\n",
       "                'Jamin, Annette',\n",
       "                'Schott, Maike',\n",
       "                'Wangorsch, Andrea',\n",
       "                'Vieths, Stefan',\n",
       "                'Jakob, Thilo',\n",
       "                'Scheurer, Stephan',\n",
       "                'Schulke, Stefan'],\n",
       "               'AU': ['Goretzki A',\n",
       "                'Lin YJ',\n",
       "                'Meier C',\n",
       "                'Dorn B',\n",
       "                'Wolfheimer S',\n",
       "                'Jamin A',\n",
       "                'Schott M',\n",
       "                'Wangorsch A',\n",
       "                'Vieths S',\n",
       "                'Jakob T',\n",
       "                'Scheurer S',\n",
       "                'Schulke S'],\n",
       "               'AD': ['Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Department of Dermatology and Allergology, University Medical Center, Justus Liebig University, Giessen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Department of Dermatology and Allergology, University Medical Center, Justus Liebig University, Giessen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.'],\n",
       "               'AUID': ['ORCID: 0000-0002-5184-5455',\n",
       "                'ORCID: 0000-0002-9674-5116'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20221020',\n",
       "               'PL': 'Denmark',\n",
       "               'TA': 'Allergy',\n",
       "               'JT': 'Allergy',\n",
       "               'JID': '7804028',\n",
       "               'RN': ['130068-27-8 (Interleukin-10)',\n",
       "                '0 (Myeloid Differentiation Factor 88)',\n",
       "                '12777-81-0 (Flagellin)',\n",
       "                'EC 2.7.11.1 (TOR Serine-Threonine Kinases)',\n",
       "                '0 (Immunoglobulin M)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Mice',\n",
       "                'Humans',\n",
       "                'Animals',\n",
       "                '*Interleukin-10',\n",
       "                '*B-Lymphocytes, Regulatory',\n",
       "                'Myeloid Differentiation Factor 88/genetics',\n",
       "                'Flagellin/chemistry/genetics',\n",
       "                'TOR Serine-Threonine Kinases',\n",
       "                'Immunoglobulin M'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['AIT',\n",
       "                'MyD88',\n",
       "                'flagellin',\n",
       "                'regulatory B cell',\n",
       "                'vaccine'],\n",
       "               'EDAT': '2022/10/06 06:00',\n",
       "               'MHDA': '2023/03/07 06:00',\n",
       "               'CRDT': ['2022/10/05 02:12'],\n",
       "               'PHST': ['2022/08/30 00:00 [revised]',\n",
       "                '2022/02/17 00:00 [received]',\n",
       "                '2022/09/18 00:00 [accepted]',\n",
       "                '2022/10/06 06:00 [pubmed]',\n",
       "                '2023/03/07 06:00 [medline]',\n",
       "                '2022/10/05 02:12 [entrez]'],\n",
       "               'AID': ['10.1111/all.15542 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Allergy. 2023 Mar;78(3):663-681. doi: 10.1111/all.15542. Epub 2022 Oct 20.'},\n",
       "              {'PMID': '36075237',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230209',\n",
       "               'LR': '20230209',\n",
       "               'IS': '1438-8782 (Electronic) 0172-4614 (Linking)',\n",
       "               'VI': '44',\n",
       "               'IP': '1',\n",
       "               'DP': '2023 Feb',\n",
       "               'TI': 'Pulmonary Sonography - Neonatal Diagnosis Part 1.',\n",
       "               'PG': '14-35',\n",
       "               'LID': '10.1055/a-1885-5664 [doi]',\n",
       "               'AB': 'Diseases of the respiratory system are among the main problems of premature patients in the neonatal intensive care unit. Radiography of the thorax is the gold standard of imaging. This results in high cumulative radiation exposure with potential negative long-term consequences. Ultrasound examination of thoracic structures represents a promising radiation-free and ubiquitously available alternative.A healthy, ventilated lung can only be imaged via artifacts, since total reflection of the sound waves occurs due to the high impedance difference between tissue and air-filled lung. Pathologies of pleura and subpleural lung tissue lead to changes in the acoustic properties of the tissue and thus to variations in the artifacts that can be imaged. The main sonographic characteristics of pulmonary pathology are: pleural line abnormalities, increased B-lines and comet-tail artifacts, lung consolidations, a visible pulmonary pulse, pleural sliding abnormalities, and visualization of effusions. Deviations from normal sonographic findings can be assigned to specific underlying pathophysiologies, so that conclusions about the disease can be drawn in conjunction with the clinical symptoms.',\n",
       "               'CI': ['Thieme. All rights reserved.'],\n",
       "               'FAU': ['Schwarz, Simone'],\n",
       "               'AU': ['Schwarz S'],\n",
       "               'AD': ['Clinic for Pediatrics and Adolescent Medicine, Sana Kliniken Duisburg GmbH, Duisburg, Germany.'],\n",
       "               'LA': ['eng', 'ger'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'TT': 'Lungensonografie - Diagnostik in der Neonatologie Teil 1.',\n",
       "               'DEP': '20220908',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Ultraschall Med',\n",
       "               'JT': 'Ultraschall in der Medizin (Stuttgart, Germany : 1980)',\n",
       "               'JID': '8303585',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Infant, Newborn',\n",
       "                'Humans',\n",
       "                '*Lung/diagnostic imaging',\n",
       "                '*Lung Diseases',\n",
       "                'Pleura/diagnostic imaging',\n",
       "                'Ultrasonography',\n",
       "                'Diagnosis, Differential'],\n",
       "               'COIS': ['Declaration of financial interestsReceipt of research funding: no; receipt of',\n",
       "                'payment/financial advantage for providing services as a lecturer: no; paid',\n",
       "                'consultant/internal trainer/salaried employee: no; patent/business',\n",
       "                'interest/shares (author/partner, spouse, children) in company: no;',\n",
       "                'patent/business interest/shares (author/partner, spouse, children) in sponsor of',\n",
       "                'this CME article or in company whose interests are affected by the CME article:',\n",
       "                'no.Declaration of non-financial interestsThe authors declare that there is no',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2022/09/09 06:00',\n",
       "               'MHDA': '2023/02/10 06:00',\n",
       "               'CRDT': ['2022/09/08 19:02'],\n",
       "               'PHST': ['2022/09/09 06:00 [pubmed]',\n",
       "                '2023/02/10 06:00 [medline]',\n",
       "                '2022/09/08 19:02 [entrez]'],\n",
       "               'AID': ['10.1055/a-1885-5664 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Ultraschall Med. 2023 Feb;44(1):14-35. doi: 10.1055/a-1885-5664. Epub 2022 Sep 8.'},\n",
       "              {'PMID': '35925141',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230207',\n",
       "               'LR': '20230207',\n",
       "               'IS': '2731-698X (Electronic) 2731-6971 (Linking)',\n",
       "               'VI': '94',\n",
       "               'IP': '2',\n",
       "               'DP': '2023 Feb',\n",
       "               'TI': '[Surgery of hyperparathyroidism].',\n",
       "               'PG': '177-188',\n",
       "               'LID': '10.1007/s00104-022-01652-5 [doi]',\n",
       "               'AB': 'The surgical removal of diseased parathyroid glands is the only curative treatment for primary and secondary hyperparathyroidism. Before an intervention, the confirmed diagnosis and an accurate localization are decisive for selection of the appropriate procedure. After appropriate localization diagnostics, a focussed intervention is possible for primary hyperparathyroidism, whereby every intervention must be controlled by intraoperative monitoring of parathyroid hormone. Reoperations or multiple glandular disease necessitate a differentiated approach with appropriate prior diagnostics.',\n",
       "               'CI': ['(c) 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH,',\n",
       "                'ein Teil von Springer Nature.'],\n",
       "               'FAU': ['Mogl, Martina T', 'Goretzki, Peter E'],\n",
       "               'AU': ['Mogl MT', 'Goretzki PE'],\n",
       "               'AD': ['Endokrine Chirurgie, Chirurgische Klinik, Charite - Universitatsmedizin Berlin, Berlin, Deutschland. martina.mogl@charite.de.',\n",
       "                'Endokrine Chirurgie, Charite - Universitatsmedizin Berlin, Chirurgische Klinik, Campus Charite Mitte | Campus Virchow-Klinikum, Chariteplatz 1, 10117, Berlin, Deutschland. martina.mogl@charite.de.',\n",
       "                'Endokrine Chirurgie, Chirurgische Klinik, Charite - Universitatsmedizin Berlin, Berlin, Deutschland.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Chirurgie des Hyperparathyreoidismus.',\n",
       "               'DEP': '20220601',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurgie (Heidelb)',\n",
       "               'JT': 'Chirurgie (Heidelberg, Germany)',\n",
       "               'JID': '9918383081906676',\n",
       "               'RN': ['0 (Parathyroid Hormone)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*Parathyroidectomy/methods',\n",
       "                'Parathyroid Glands/surgery',\n",
       "                'Parathyroid Hormone',\n",
       "                '*Hyperparathyroidism, Secondary/surgery',\n",
       "                'Monitoring, Intraoperative'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Diagnostics',\n",
       "                'Hyperparathyroidism',\n",
       "                'Multiple glandular disease',\n",
       "                'Recurrence',\n",
       "                'Treatment'],\n",
       "               'EDAT': '2022/08/05 06:00',\n",
       "               'MHDA': '2023/02/08 06:00',\n",
       "               'CRDT': ['2022/08/04 11:14'],\n",
       "               'PHST': ['2022/04/25 00:00 [accepted]',\n",
       "                '2022/08/05 06:00 [pubmed]',\n",
       "                '2023/02/08 06:00 [medline]',\n",
       "                '2022/08/04 11:14 [entrez]'],\n",
       "               'AID': ['10.1007/s00104-022-01652-5 [pii]',\n",
       "                '10.1007/s00104-022-01652-5 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurgie (Heidelb). 2023 Feb;94(2):177-188. doi: 10.1007/s00104-022-01652-5. Epub 2022 Jun 1.'},\n",
       "              {'PMID': '35211943',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230608',\n",
       "               'LR': '20250310',\n",
       "               'IS': '1438-8782 (Electronic) 0172-4614 (Linking)',\n",
       "               'VI': '44',\n",
       "               'IP': '3',\n",
       "               'DP': '2023 Jun',\n",
       "               'TI': 'Dissection of the Brachiocephalic Trunk with Subsequent Occlusion of Both Common Carotid Arteries in a Newborn with an Aortic Arch Variant - From Cerebral Doppler Ultrasound to Diagnosis.',\n",
       "               'PG': 'e164-e167',\n",
       "               'LID': '10.1055/a-1756-4667 [doi]',\n",
       "               'FAU': ['Schwarz, Simone',\n",
       "                'Tarusinov, Gleb',\n",
       "                'Brevis, Francisco'],\n",
       "               'AU': ['Schwarz S', 'Tarusinov G', 'Brevis F'],\n",
       "               'AUID': ['ORCID: 0000-0001-6930-1061'],\n",
       "               'AD': ['Department of Pediatrics, Sana Kliniken Duisburg GmbH, Duisburg, Germany.',\n",
       "                'Department of Pediatric Cardiology, Herzzentrum Duisburg, Duisburg, Germany.',\n",
       "                'Department of Pediatrics, Sana Kliniken Duisburg GmbH, Duisburg, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports'],\n",
       "               'TT': 'Geburtstraumatische Dissektion des Truncus brachiocephalicus mit nachfolgendem Verschluss beider Arteriae Carotides communes bei einem Neugeborenen mit einer Aortenbogenvariante- vom cerebralen Dopplerultraschall zur Diagnose.',\n",
       "               'DEP': '20220224',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Ultraschall Med',\n",
       "               'JT': 'Ultraschall in der Medizin (Stuttgart, Germany : 1980)',\n",
       "               'JID': '8303585',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Infant, Newborn',\n",
       "                'Humans',\n",
       "                '*Aorta, Thoracic/diagnostic imaging',\n",
       "                '*Brachiocephalic Trunk/diagnostic imaging',\n",
       "                'Ultrasonography',\n",
       "                'Ultrasonography, Doppler',\n",
       "                'Carotid Artery, Common/diagnostic imaging'],\n",
       "               'COIS': ['The authors declare that they have no conflict of interest.'],\n",
       "               'EDAT': '2022/02/26 06:00',\n",
       "               'MHDA': '2023/06/08 06:42',\n",
       "               'CRDT': ['2022/02/25 05:41'],\n",
       "               'PHST': ['2023/06/08 06:42 [medline]',\n",
       "                '2022/02/26 06:00 [pubmed]',\n",
       "                '2022/02/25 05:41 [entrez]'],\n",
       "               'AID': ['10.1055/a-1756-4667 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Ultraschall Med. 2023 Jun;44(3):e164-e167. doi: 10.1055/a-1756-4667. Epub 2022 Feb 24.'}],\n",
       "             '2019': [{'PMID': '31444505',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20200616',\n",
       "               'LR': '20210110',\n",
       "               'IS': '1432-1238 (Electronic) 0342-4642 (Linking)',\n",
       "               'VI': '45',\n",
       "               'IP': '11',\n",
       "               'DP': '2019 Nov',\n",
       "               'TI': 'Research priorities in pediatric onco-critical care: an international Delphi consensus study.',\n",
       "               'PG': '1681-1683',\n",
       "               'LID': '10.1007/s00134-019-05706-x [doi]',\n",
       "               'FAU': ['Soeteman, Marijn',\n",
       "                'Potratz, Jenny',\n",
       "                'Nielsen, Jeppe S Angaard',\n",
       "                'Willems, Jef',\n",
       "                'Valla, Frederic V',\n",
       "                'Brierley, Joe',\n",
       "                'Wosten-van Asperen, Roelie M'],\n",
       "               'AU': ['Soeteman M',\n",
       "                'Potratz J',\n",
       "                'Nielsen JSA',\n",
       "                'Willems J',\n",
       "                'Valla FV',\n",
       "                'Brierley J',\n",
       "                'Wosten-van Asperen RM'],\n",
       "               'AD': ['Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.',\n",
       "                \"Department of General Pediatrics-Intensive Care Medicine, University Children's Hospital Munster, Munster, Germany.\",\n",
       "                'Department Intensive Care Medicine, Rigshospitalet, Copenhagen, Denmark.',\n",
       "                'Department of Pediatric Intensive Care, Ghent University Hospital, Ghent, Belgium.',\n",
       "                'Pediatric Intensive Care Unit, Hopital Universitaire Femme Mere Enfant, Hospices Civils de Lyon, Lyon-Bron, France.',\n",
       "                'Department of Critical Care and Bioethics, Great Ormond Street Hospital for Children NHS Trust, Great Ormond Street, London, UK.',\n",
       "                \"Department of Pediatric Intensive Care, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands. r.m.vanasperen@umcutrecht.nl.\"],\n",
       "               'AUID': ['ORCID: 0000-0002-2469-2131'],\n",
       "               'CN': ['POKER (PICU Oncology Kids in Europe Research group) research consortium of ESPNIC',\n",
       "                '(European Society of Paediatric Neonatal Intensive Care)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Letter'],\n",
       "               'DEP': '20190823',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Intensive Care Med',\n",
       "               'JT': 'Intensive care medicine',\n",
       "               'JID': '7704851',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Consensus',\n",
       "                'Critical Care/*methods',\n",
       "                'Delphi Technique',\n",
       "                'Humans',\n",
       "                'Internationality',\n",
       "                'Medical Oncology/*methods',\n",
       "                'Pediatrics/*methods',\n",
       "                'Research/*trends'],\n",
       "               'FIR': ['van Grotel, Martine',\n",
       "                'Tschiedel, Eva',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Krause, Martin F',\n",
       "                'van Gestel, Josephus P J',\n",
       "                'Marquis, Patrick',\n",
       "                'Aziz, Omer',\n",
       "                'van den Heuvel-Eibrink, Marry M'],\n",
       "               'IR': ['van Grotel M',\n",
       "                'Tschiedel E',\n",
       "                'Dohna-Schwake C',\n",
       "                'Krause MF',\n",
       "                'van Gestel JPJ',\n",
       "                'Marquis P',\n",
       "                'Aziz O',\n",
       "                'van den Heuvel-Eibrink MM'],\n",
       "               'EDAT': '2019/08/25 06:00',\n",
       "               'MHDA': '2020/06/17 06:00',\n",
       "               'CRDT': ['2019/08/25 06:00'],\n",
       "               'PHST': ['2019/07/17 00:00 [accepted]',\n",
       "                '2019/08/25 06:00 [pubmed]',\n",
       "                '2020/06/17 06:00 [medline]',\n",
       "                '2019/08/25 06:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00134-019-05706-x [pii]',\n",
       "                '10.1007/s00134-019-05706-x [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Intensive Care Med. 2019 Nov;45(11):1681-1683. doi: 10.1007/s00134-019-05706-x. Epub 2019 Aug 23.'},\n",
       "              {'PMID': '31634179',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20200316',\n",
       "               'LR': '20211213',\n",
       "               'IS': '1528-1140 (Electronic) 0003-4932 (Linking)',\n",
       "               'VI': '270',\n",
       "               'IP': '5',\n",
       "               'DP': '2019 Nov',\n",
       "               'TI': 'Total Versus Near-total Thyroidectomy in Graves Disease: Results of the Randomized Controlled Multicenter TONIG-trial.',\n",
       "               'PG': '755-761',\n",
       "               'LID': '10.1097/SLA.0000000000003528 [doi]',\n",
       "               'AB': 'BACKGROUND: Previous data suggest that the incidence of hypoparathyroidism after surgery for Graves disease (GD) is lower after subtotal thyroidectomy compared to total thyroidectomy (TT). The present study evaluated the incidence of postoperative hypoparathyroidism after near-total (NTT) versus TT in GD. METHODS/DESIGN: In a multicenter prospective randomized controlled clinical trial, patients with GD were randomized intraoperatively to NTT or TT. Primary endpoint was the incidence of transient postoperative hypoparathyroidism. Secondary endpoints were permanent hypoparathyroidism, transient recurrent laryngeal nerve palsy (RLNP), reoperations for bleeding, inadvertently removed parathyroid glands, and recurrent hyperthyroidism after 12 months. RESULTS: Eighteen centers randomized 205 patients to either TT (n = 102) or NTT (n = 103) within 16 months. According to intention-to-treat postoperative transient hypoparathyroidism occurred in 19% (20/103) patients after NTT and in 21% (21 of 102) patients after TT (P = 0.84), which persisted >6 months in 2% and 5% of the NTT and TT groups (P = 0.34). The rates of parathyroid autotransplantation (NTT 24% vs TT 28%, P = 0.50) and transient RLNP (NTT 3% vs TT 4%, P = 0.35) was similar in both groups. The rate of reoperations for bleeding tended to be higher in the NTT group (3% vs 0%, P = 0.07) and the rate of inadvertently removed parathyroid glands was significantly higher after NTT (13% vs 3%, P = 0.01). An existing endocrine orbitopathy improved in 35% and 24% after NTT and TT (P = 0.61). Recurrent disease occurred in only 1 patient after TT (P = 0.34). CONCLUSION: NTT for GD is not superior to TT regarding transient postoperative hypoparathyroidism.',\n",
       "               'FAU': ['Maurer, Elisabeth',\n",
       "                'Maschuw, Katja',\n",
       "                'Reuss, Alexander',\n",
       "                'Zieren, Hans Udo',\n",
       "                'Zielke, Andreas',\n",
       "                'Goretzki, Peter',\n",
       "                'Simon, Dietmar',\n",
       "                'Dotzenrath, Cornelia',\n",
       "                'Steinmuller, Thomas',\n",
       "                'Jahne, Joachim',\n",
       "                'Kemen, Matthias',\n",
       "                'Coerper, Stephan',\n",
       "                'Leister, Ingo',\n",
       "                'Nies, Christoph',\n",
       "                'Hartel, Mark',\n",
       "                'Turler, Andreas',\n",
       "                'Holzer, Katharina',\n",
       "                'Agha, Ayman',\n",
       "                'Knoop, Michael',\n",
       "                'Musholt, Thomas',\n",
       "                'Aminossadati, Benaz',\n",
       "                'Bartsch, Detlef K'],\n",
       "               'AU': ['Maurer E',\n",
       "                'Maschuw K',\n",
       "                'Reuss A',\n",
       "                'Zieren HU',\n",
       "                'Zielke A',\n",
       "                'Goretzki P',\n",
       "                'Simon D',\n",
       "                'Dotzenrath C',\n",
       "                'Steinmuller T',\n",
       "                'Jahne J',\n",
       "                'Kemen M',\n",
       "                'Coerper S',\n",
       "                'Leister I',\n",
       "                'Nies C',\n",
       "                'Hartel M',\n",
       "                'Turler A',\n",
       "                'Holzer K',\n",
       "                'Agha A',\n",
       "                'Knoop M',\n",
       "                'Musholt T',\n",
       "                'Aminossadati B',\n",
       "                'Bartsch DK'],\n",
       "               'AD': ['Department of Visceral, Thoracic, and Vascular Surgery, Philipps University, Marburg, Germany.',\n",
       "                'Department of General, Visceral, and Thoracic Surgery, Hospital Lippe, Lippe, Germany.',\n",
       "                'Coordinating Center for Clinical Trials-KKS, Philipps University Marburg, Germany.',\n",
       "                'Department of General and Visceral Surgery, St. Agatha Hospital Koln, Cologne, Germany.',\n",
       "                'Department of Endocrine Surgery, Katharinen Hospital, Stuttgart, Germany.',\n",
       "                'Department of Endocrine Surgery, Lukas Hospital, Neuss, Germany.',\n",
       "                'Department of general and Visceral Surgery, Bethesda Hospital, Duisburg, Germany.',\n",
       "                'Department of Endocrine Surgery, Helios University, Wuppertal, Germany.',\n",
       "                'Department of General and Visceral Surgery, DRK Hospital Berlin Westend, Berlin, Germany.',\n",
       "                'Department of General and Visceral Surgery, Hospital Diakovere Henriettenstift, Hannover, Germany.',\n",
       "                'Department of Visceral Surgery, Evangelisches Krankenhaus, Herne, Germany.',\n",
       "                'Department of General and Visceral Surgery, Hospital Martha-Maria, Nurnberg, Germany.',\n",
       "                'Department of Minimal-Invasive, Endocrine and Visceral Surgery, Hospital Berlin, Waldfriede, Germany.',\n",
       "                'Department of General and Visceral Surgery, Niels-Stensen-Kliniken Marien Hospital, Osnabruck, Germany.',\n",
       "                'Department of Surgery, Hospital Dortmund GmbH, Dortmund, Germany.',\n",
       "                'Department of General and Visceral Surgery, Johanniter Hospital, Bonn, Germany.',\n",
       "                'Department of General and Visceral Surgery, Johann Wolfgang Goethe-University Hospital, Frankfurt, Germany.',\n",
       "                'Department of General, Visceral and Endocrine Surgery, Hospital Munchen Bogenhausen, Munchen, Germany.',\n",
       "                'Department of General and Visceral Surgery, Hospital Frankfurt Oder, Frankfurt, Germany.',\n",
       "                'Section of Endocrine Surgery, Department of General, Visceral and Transplant Surgery, University Medical Center, Johannes Gutenberg University, Mainz, Germany.',\n",
       "                'Coordinating Center for Clinical Trials-KKS, Philipps University Marburg, Germany.',\n",
       "                'Department of Visceral, Thoracic, and Vascular Surgery, Philipps University, Marburg, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'SI': ['DRKS/DRKS00004161'],\n",
       "               'PT': ['Comparative Study',\n",
       "                'Journal Article',\n",
       "                'Multicenter Study',\n",
       "                'Randomized Controlled Trial'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Ann Surg',\n",
       "               'JT': 'Annals of surgery',\n",
       "               'JID': '0372354',\n",
       "               'SB': 'IM',\n",
       "               'CIN': ['Ann Surg. 2021 Dec 1;274(6):e684-e685. doi: 10.1097/SLA.0000000000003816. PMID:',\n",
       "                '32032085'],\n",
       "               'MH': ['Adult',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Graves Disease/*diagnosis/*surgery',\n",
       "                'Humans',\n",
       "                'Hypoparathyroidism/etiology/*surgery',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Parathyroid Glands/*transplantation',\n",
       "                'Postoperative Complications/diagnosis/surgery',\n",
       "                'Prospective Studies',\n",
       "                'Risk Assessment',\n",
       "                'Severity of Illness Index',\n",
       "                'Thyroidectomy/adverse effects/*methods',\n",
       "                'Time Factors',\n",
       "                'Transplantation, Autologous/methods',\n",
       "                'Treatment Outcome',\n",
       "                'Young Adult'],\n",
       "               'EDAT': '2019/10/22 06:00',\n",
       "               'MHDA': '2020/03/17 06:00',\n",
       "               'CRDT': ['2019/10/22 06:00'],\n",
       "               'PHST': ['2019/10/22 06:00 [entrez]',\n",
       "                '2019/10/22 06:00 [pubmed]',\n",
       "                '2020/03/17 06:00 [medline]'],\n",
       "               'AID': ['00000658-201911000-00006 [pii]',\n",
       "                '10.1097/SLA.0000000000003528 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Ann Surg. 2019 Nov;270(5):755-761. doi: 10.1097/SLA.0000000000003528.'},\n",
       "              {'PMID': '31558722',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20200106',\n",
       "               'LR': '20210110',\n",
       "               'IS': '2041-1723 (Electronic) 2041-1723 (Linking)',\n",
       "               'VI': '10',\n",
       "               'IP': '1',\n",
       "               'DP': '2019 Sep 26',\n",
       "               'TI': 'Methionine in a protein hydrophobic core drives tight interactions required for assembly of spider silk.',\n",
       "               'PG': '4378',\n",
       "               'LID': '10.1038/s41467-019-12365-5 [doi] 4378',\n",
       "               'AB': \"Web spiders connect silk proteins, so-called spidroins, into fibers of extraordinary toughness. The spidroin N-terminal domain (NTD) plays a pivotal role in this process: it polymerizes spidroins through a complex mechanism of dimerization. Here we analyze sequences of spidroin NTDs and find an unusually high content of the amino acid methionine. We simultaneously mutate all methionines present in the hydrophobic core of a spidroin NTD from a nursery web spider's dragline silk to leucine. The mutated NTD is strongly stabilized and folds at the theoretical speed limit. The structure of the mutant is preserved, yet its ability to dimerize is substantially impaired. We find that side chains of core methionines serve to mobilize the fold, which can thereby access various conformations and adapt the association interface for tight binding. Methionine in a hydrophobic core equips a protein with the capacity to dynamically change shape and thus to optimize its function.\",\n",
       "               'FAU': ['Heiby, Julia C',\n",
       "                'Goretzki, Benedikt',\n",
       "                'Johnson, Christopher M',\n",
       "                'Hellmich, Ute A',\n",
       "                'Neuweiler, Hannes'],\n",
       "               'AU': ['Heiby JC',\n",
       "                'Goretzki B',\n",
       "                'Johnson CM',\n",
       "                'Hellmich UA',\n",
       "                'Neuweiler H'],\n",
       "               'AUID': ['ORCID: 0000-0001-8191-8945',\n",
       "                'ORCID: 0000-0002-7721-6657',\n",
       "                'ORCID: 0000-0002-5900-3068',\n",
       "                'ORCID: 0000-0001-7162-285X',\n",
       "                'ORCID: 0000-0002-6657-001X'],\n",
       "               'AD': ['Department of Biotechnology and Biophysics, Julius-Maximilians-University Wurzburg, Am Hubland, 97074, Wurzburg, Germany.',\n",
       "                'Institute for Pharmacy and Biochemistry, Johannes-Gutenberg-University Mainz, Johann-Joachim Becherweg 30, 55128, Mainz, Germany.',\n",
       "                'Center for Biomolecular Magnetic Resonance, Goethe-University, Max-von-Laue-Strasse 9, 60438, Frankfurt, Germany.',\n",
       "                'Medical Research Council Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, CB2 0QH, UK.',\n",
       "                'Institute for Pharmacy and Biochemistry, Johannes-Gutenberg-University Mainz, Johann-Joachim Becherweg 30, 55128, Mainz, Germany. u.hellmich@uni-mainz.de.',\n",
       "                'Center for Biomolecular Magnetic Resonance, Goethe-University, Max-von-Laue-Strasse 9, 60438, Frankfurt, Germany. u.hellmich@uni-mainz.de.',\n",
       "                'Department of Biotechnology and Biophysics, Julius-Maximilians-University Wurzburg, Am Hubland, 97074, Wurzburg, Germany. hannes.neuweiler@uni-wuerzburg.de.'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['MC_U105184326/MRC_/Medical Research Council/United Kingdom'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                \"Research Support, U.S. Gov't, Non-P.H.S.\"],\n",
       "               'DEP': '20190926',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Nat Commun',\n",
       "               'JT': 'Nature communications',\n",
       "               'JID': '101528555',\n",
       "               'RN': ['0 (Silk)',\n",
       "                '9007-76-5 (Fibroins)',\n",
       "                'AE28F7PNPL (Methionine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Algorithms',\n",
       "                'Amino Acid Sequence',\n",
       "                'Animals',\n",
       "                'Fibroins/chemistry/genetics/*metabolism',\n",
       "                'Hydrophobic and Hydrophilic Interactions',\n",
       "                'Methionine/genetics/*metabolism',\n",
       "                'Mutation',\n",
       "                'Protein Conformation',\n",
       "                'Protein Folding',\n",
       "                'Protein Multimerization',\n",
       "                'Sequence Homology, Amino Acid',\n",
       "                'Silk/chemistry/*metabolism',\n",
       "                'Spectrometry, Fluorescence',\n",
       "                'Spiders/genetics/*metabolism',\n",
       "                'Thermodynamics'],\n",
       "               'PMC': 'PMC6763431',\n",
       "               'COIS': ['The authors declare no competing interests.'],\n",
       "               'EDAT': '2019/09/29 06:00',\n",
       "               'MHDA': '2020/01/07 06:00',\n",
       "               'PMCR': ['2019/09/26'],\n",
       "               'CRDT': ['2019/09/28 06:00'],\n",
       "               'PHST': ['2019/05/09 00:00 [received]',\n",
       "                '2019/09/05 00:00 [accepted]',\n",
       "                '2019/09/28 06:00 [entrez]',\n",
       "                '2019/09/29 06:00 [pubmed]',\n",
       "                '2020/01/07 06:00 [medline]',\n",
       "                '2019/09/26 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1038/s41467-019-12365-5 [pii]',\n",
       "                '12365 [pii]',\n",
       "                '10.1038/s41467-019-12365-5 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Nat Commun. 2019 Sep 26;10(1):4378. doi: 10.1038/s41467-019-12365-5.'},\n",
       "              {'PMID': '31555625',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20201001',\n",
       "               'IS': '2296-2360 (Print) 2296-2360 (Electronic) 2296-2360 (Linking)',\n",
       "               'VI': '7',\n",
       "               'DP': '2019',\n",
       "               'TI': 'Amplitude-Integrated EEG for Neurological Assessment and Seizure Detection in a German Pediatric Intensive Care Unit.',\n",
       "               'PG': '358',\n",
       "               'LID': '10.3389/fped.2019.00358 [doi] 358',\n",
       "               'AB': \"Objective: The aim of our study was to assess the use of aEEG in our pediatric intensive care unit (PICU), indications for neuromonitoring and its findings, utility for seizure detection, and associations with outcome. Design: We retrospectively analyzed non-neonates who were treated in our PICU and received amplitude-integrated EEG (aEEG). Patients: 27 patients aged between 29 days and 10 0/12 years (median 7.3 months) were included, who received a total of 35 aEEGS. Measurements: aEEG tracings were assessed for background (BG) pattern and its evolution, seizures, and side differences using a visual classification (Hellstrom-Westas). Clinical data were collected from patients' histories and analyzed for correlation with aEEG findings. Main results: While rare in early years, there was an increase in use over time. Most aEEGs were conducted because of (suspected) seizures or for management of antiepileptic treatment. aEEG had low sensitivity but high specificity for recognition of pathological BG pattern with reference to conventional EEG. Worsening of BG pattern or failure to improve was associated with death. Seizure detection rates by aEEG were higher than by clinical observation, especially for identification of non-convulsive epileptic state (ES). Side differences in aEEG were rare, but if present, they were associated with unilateral brain injury. Conclusions: aEEG is useful for the detection of seizures and ES in pediatric intensive care patients. Abnormal BG pattern and poor evolution of BG are negatively associated with survival. aEEG is a potential supplement to conventional EEG, facilitating long-term surveillance of cerebral function when continuous full-channel EEG is not available. Further investigation is needed.\",\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Sanchez-Albisua, Iciar',\n",
       "                'Weiss, Christel',\n",
       "                'Tschiedel, Eva',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Muller, Hanna'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Sanchez-Albisua I',\n",
       "                'Weiss C',\n",
       "                'Tschiedel E',\n",
       "                'Dohna-Schwake C',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Muller H'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Medical Statistics and Biomathematics, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Division of Neonatology and Pediatric Intensive Care, Department of Pediatrics, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20190828',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Pediatr',\n",
       "               'JT': 'Frontiers in pediatrics',\n",
       "               'JID': '101615492',\n",
       "               'PMC': 'PMC6722192',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['aEEG',\n",
       "                'amplitude-integrated EEG',\n",
       "                'continuous EEG',\n",
       "                'neuromonitoring',\n",
       "                'outcome',\n",
       "                'pediatric critical care',\n",
       "                'seizure'],\n",
       "               'EDAT': '2019/09/27 06:00',\n",
       "               'MHDA': '2019/09/27 06:01',\n",
       "               'PMCR': ['2019/08/28'],\n",
       "               'CRDT': ['2019/09/27 06:00'],\n",
       "               'PHST': ['2019/05/07 00:00 [received]',\n",
       "                '2019/08/15 00:00 [accepted]',\n",
       "                '2019/09/27 06:00 [entrez]',\n",
       "                '2019/09/27 06:00 [pubmed]',\n",
       "                '2019/09/27 06:01 [medline]',\n",
       "                '2019/08/28 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fped.2019.00358 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Pediatr. 2019 Aug 28;7:358. doi: 10.3389/fped.2019.00358. eCollection 2019.'},\n",
       "              {'PMID': '31404827',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20191127',\n",
       "               'LR': '20191127',\n",
       "               'IS': '1879-0461 (Electronic) 1040-8428 (Linking)',\n",
       "               'VI': '142',\n",
       "               'DP': '2019 Oct',\n",
       "               'TI': 'PICU mortality of children with cancer admitted to pediatric intensive care unit a systematic review and meta-analysis.',\n",
       "               'PG': '153-163',\n",
       "               'LID': 'S1040-8428(18)30249-X [pii] 10.1016/j.critrevonc.2019.07.014 [doi]',\n",
       "               'AB': 'BACKGROUND: Outcomes for children diagnosed with cancer have improved dramatically over the past 20 years. However, although 40% of pediatric cancer patients require at least one intensive care admission throughout their disease course, PICU outcomes and resource utilization by this population have not been rigorously studied in this specific group. METHODS: Using a systematic strategy, we searched Medline, Embase, and CINAHL databases for articles describing PICU mortality of pediatric cancer patients admitted to PICU. Two investigators independently applied eligibility criteria, assessed data quality, and extracted data. We pooled PICU mortality estimates using random-effects models and examined mortality trends over time using meta-regression models. RESULTS: Out of 1218 identified manuscripts, 31 studies were included covering 16,853 PICU admissions with the majority being retrospective in nature. Overall pooled weighted mortality was 27.8% (95% confidence interval (CI), 23.7-31.9%). Mortality decreased slightly over time when post-operative patients were excluded. The use of mechanical ventilation (odds ratio (OR): 18.49 [95% CI 13.79-24.78], p\\u202f<\\u202f0.001), inotropic support (OR: 14.05 [95% CI 9.16-21.57], p\\u202f<\\u202f0.001), or continuous renal replacement therapy (OR: 3.24 [95% CI 1.31-8.04], p\\u202f=\\u202f0.01) was significantly associated with PICU mortality. CONCLUSIONS: PICU mortality rates of pediatric cancer patients are far higher when compared to current mortality rates of the general PICU population. PICU mortality has remained relatively unchanged over the past decades, a slight decrease was only seen when post-operative patients were excluded. This compared infavorably with the improved mortality seen in adults with cancer admitted to ICU, where research-led improvements have led to the paradigm of unlimited, aggressive ICU management without any limitations on resuscitations status, for a time-limited trial.',\n",
       "               'CI': ['Copyright (c) 2019 The Authors. Published by Elsevier B.V. All rights reserved.'],\n",
       "               'FAU': ['Wosten-van Asperen, Roelie M',\n",
       "                'van Gestel, Josephus P J',\n",
       "                'van Grotel, Martine',\n",
       "                'Tschiedel, Eva',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Valla, Frederic V',\n",
       "                'Willems, Jef',\n",
       "                'Angaard Nielsen, Jeppe S',\n",
       "                'Krause, Martin F',\n",
       "                'Potratz, Jenny',\n",
       "                'van den Heuvel-Eibrink, Marry M',\n",
       "                'Brierley, Joe'],\n",
       "               'AU': ['Wosten-van Asperen RM',\n",
       "                'van Gestel JPJ',\n",
       "                'van Grotel M',\n",
       "                'Tschiedel E',\n",
       "                'Dohna-Schwake C',\n",
       "                'Valla FV',\n",
       "                'Willems J',\n",
       "                'Angaard Nielsen JS',\n",
       "                'Krause MF',\n",
       "                'Potratz J',\n",
       "                'van den Heuvel-Eibrink MM',\n",
       "                'Brierley J'],\n",
       "               'AD': [\"Department of Pediatric Intensive Care, Wilhelmina Children's Hospital/University Medical Center Utrecht, the Netherlands. Electronic address: r.m.vanasperen@umcutrecht.nl.\",\n",
       "                \"Department of Pediatric Intensive Care, Wilhelmina Children's Hospital/University Medical Center Utrecht, the Netherlands.\",\n",
       "                'Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.',\n",
       "                'Department of Pediatric Intensive Care, Universitatsklinik Essen, Essen, Germany.',\n",
       "                'Department of Pediatric Intensive Care, Universitatsklinik Essen, Essen, Germany.',\n",
       "                'Pediatric Intensive Care Unit, Hopital Universitaire Femme Mere Enfant, Hospices Civils de Lyon, Lyon-Bron, France.',\n",
       "                'Department of Pediatric Intensive Care, Ghent University Hospital, Ghent, Belgium.',\n",
       "                'Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark.',\n",
       "                'Department of Pediatrics, Universitatsklinikum Schleswig-Holstein, Kiel, Germany.',\n",
       "                \"Department of General Pediatrics-Intensive Care Medicine, University Children's Hospital Munster, Munster, Germany.\",\n",
       "                'Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.',\n",
       "                'Department of Critical Care & Bioethics, Great Ormond Street Hospital for Children NHS Trust, Great Ormond Street, London, UK.'],\n",
       "               'CN': ['POKER (PICU Oncology Kids in Europe Research group) research consortium'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Meta-Analysis', 'Systematic Review'],\n",
       "               'DEP': '20190803',\n",
       "               'PL': 'Netherlands',\n",
       "               'TA': 'Crit Rev Oncol Hematol',\n",
       "               'JT': 'Critical reviews in oncology/hematology',\n",
       "               'JID': '8916049',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Child',\n",
       "                'Child, Preschool',\n",
       "                'Female',\n",
       "                '*Hospital Mortality',\n",
       "                '*Hospitalization',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                '*Intensive Care Units, Pediatric',\n",
       "                'Male',\n",
       "                'Neoplasms/*mortality',\n",
       "                'Retrospective Studies'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Cancer', 'Mortality', 'Pediatric intensive care units'],\n",
       "               'EDAT': '2019/08/14 06:00',\n",
       "               'MHDA': '2019/11/28 06:00',\n",
       "               'CRDT': ['2019/08/13 06:00'],\n",
       "               'PHST': ['2018/05/30 00:00 [received]',\n",
       "                '2019/03/27 00:00 [revised]',\n",
       "                '2019/07/17 00:00 [accepted]',\n",
       "                '2019/08/14 06:00 [pubmed]',\n",
       "                '2019/11/28 06:00 [medline]',\n",
       "                '2019/08/13 06:00 [entrez]'],\n",
       "               'AID': ['S1040-8428(18)30249-X [pii]',\n",
       "                '10.1016/j.critrevonc.2019.07.014 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Crit Rev Oncol Hematol. 2019 Oct;142:153-163. doi: 10.1016/j.critrevonc.2019.07.014. Epub 2019 Aug 3.'},\n",
       "              {'PMID': '31222414',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20200122',\n",
       "               'LR': '20200122',\n",
       "               'IS': '1661-4917 (Electronic) 0004-069X (Linking)',\n",
       "               'VI': '67',\n",
       "               'IP': '5',\n",
       "               'DP': '2019 Oct',\n",
       "               'TI': 'Adjuvant Allergen Fusion Proteins as Novel Tools for the Treatment of Type I Allergies.',\n",
       "               'PG': '273-293',\n",
       "               'LID': '10.1007/s00005-019-00551-8 [doi]',\n",
       "               'AB': 'While acute allergic symptoms can be managed by emergency medication, to date, allergen-specific immunotherapy (SIT) with allergen extracts is the only available curative treatment option. However, the risk of anaphylactic reactions, long treatment duration, varying extract quality, and underrepresentation of certain allergens currently prevent many patients from successfully undergoing SIT. Novel strategies are needed to enhance efficacy, safety, and convenience of allergy treatment. Fusion proteins combining allergen and adjuvant into a single molecule can efficiently induce immune responses by targeting the allergen to the relevant immune cells in vivo. Simultaneous co-delivery of both antigen and adjuvant to the same cell in a fixed molecular ratio triggers the uptake and presentation of the conjugated allergen in the context of the adjuvant-induced immune cell activation. This review summarizes the published strategies to improve the treatment of type I allergies using fusion proteins consisting of allergen (peptides) and either (1) immune-activating bacterial (flagellin, MPLA, S-layer, cholera-, and tetanus toxin), (2) viral (PreS, VP-1, TAT), or (3) fungal (FIP-fve) components, (4) immune-activating DNA motifs, (5) forced delivery of allergens to the MHC-II loading pathway, and (6) killing of immune cells expressing allergen-specific IgE by fusion of the allergen to diphtheria toxin.',\n",
       "               'FAU': ['Blanco-Perez, Frank',\n",
       "                'Papp, Garibald',\n",
       "                'Goretzki, Alexandra',\n",
       "                'Moller, Tobias',\n",
       "                'Anzaghe, Martina',\n",
       "                'Schulke, Stefan'],\n",
       "               'AU': ['Blanco-Perez F',\n",
       "                'Papp G',\n",
       "                'Goretzki A',\n",
       "                'Moller T',\n",
       "                'Anzaghe M',\n",
       "                'Schulke S'],\n",
       "               'AD': [\"Vice President's Research Group: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich Str. 51-59, 63225, Langen, Germany.\",\n",
       "                \"Vice President's Research Group: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich Str. 51-59, 63225, Langen, Germany.\",\n",
       "                \"Vice President's Research Group: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich Str. 51-59, 63225, Langen, Germany.\",\n",
       "                \"Vice President's Research Group: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich Str. 51-59, 63225, Langen, Germany.\",\n",
       "                'Product Testing of Immunological Biomedicines, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                \"Vice President's Research Group: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich Str. 51-59, 63225, Langen, Germany. Stefan.Schuelke@pei.de.\"],\n",
       "               'AUID': ['ORCID: 0000-0002-9674-5116'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['SCHU2951/4-1/German Research Foundation (DFG)/'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'DEP': '20190620',\n",
       "               'PL': 'Poland',\n",
       "               'TA': 'Arch Immunol Ther Exp (Warsz)',\n",
       "               'JT': 'Archivum immunologiae et therapiae experimentalis',\n",
       "               'JID': '0114365',\n",
       "               'RN': ['0 (Adjuvants, Immunologic)',\n",
       "                '0 (Allergens)',\n",
       "                '0 (Recombinant Fusion Proteins)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adjuvants, Immunologic/genetics/*therapeutic use',\n",
       "                'Allergens/genetics/immunology/*therapeutic use',\n",
       "                'Animals',\n",
       "                'Antigen Presentation/*immunology',\n",
       "                '*Desensitization, Immunologic',\n",
       "                'Humans',\n",
       "                'Hypersensitivity, Immediate/immunology/prevention & control/*therapy',\n",
       "                'Lymphocyte Activation/immunology',\n",
       "                'Recombinant Fusion Proteins/genetics/immunology/therapeutic use'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Allergen', 'Fusion protein', 'PAMP', 'PRR', 'SIT'],\n",
       "               'EDAT': '2019/06/22 06:00',\n",
       "               'MHDA': '2020/01/23 06:00',\n",
       "               'CRDT': ['2019/06/22 06:00'],\n",
       "               'PHST': ['2019/02/27 00:00 [received]',\n",
       "                '2019/06/13 00:00 [accepted]',\n",
       "                '2019/06/22 06:00 [pubmed]',\n",
       "                '2020/01/23 06:00 [medline]',\n",
       "                '2019/06/22 06:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00005-019-00551-8 [pii]',\n",
       "                '10.1007/s00005-019-00551-8 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Arch Immunol Ther Exp (Warsz). 2019 Oct;67(5):273-293. doi: 10.1007/s00005-019-00551-8. Epub 2019 Jun 20.'},\n",
       "              {'PMID': '31118091',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20190610',\n",
       "               'LR': '20200225',\n",
       "               'IS': '1477-7525 (Electronic) 1477-7525 (Linking)',\n",
       "               'VI': '17',\n",
       "               'IP': '1',\n",
       "               'DP': '2019 May 22',\n",
       "               'TI': 'A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease.',\n",
       "               'PG': '87',\n",
       "               'LID': '10.1186/s12955-019-1159-0 [doi] 87',\n",
       "               'AB': \"BACKGROUND: Value assessment of vaccination programs against serogroup B invasive meningococcal disease (IMD) is on the agenda of public health authorities. Current evidence on the burden due to IMD is unfit for pinning down the nature and magnitude of the full social and economic costs of IMD for two reasons. First, the concepts and components that need to be studied are not agreed, and second, measures of the concepts that have been studied are weak and inconsistent. Thus, the economic evaluation of the available serogroup B meningococcal (MenB) vaccines is difficult. The aims of this DELPHI study are to: (1) agree on the concepts and components determining the burden of MenB diseases that need to be studied; and (2) seek consensus on appropriate methods and study designs to measure quality of life (QoL) associated with MenB induced long-term sequelae in future studies. METHODS: We designed a DELPHI questionnaire based on the findings of a recent systematic review on the QoL associated with IMD-induced long-term sequelae, and iteratively interviewed a panel of international experts, including physicians, health economists, and patient representatives. Experts were provided with a controlled feedback based on the results of the previous round. RESULTS: Experts reached consensus on all questions after two DELPHI rounds. Major gaps in the literature relate (i) to the classification of sequelae, which allows differentiation of severity levels, (ii) to the choice of QoL measures, and (iii) to appropriate data sources to examine long-term changes and deficits in patients' QoL. CONCLUSIONS: Better conceptualisation of the structure of IMD-specific sequelae and of how their diverse forms of severity might impact the QoL of survivors of IMD as well as their family network and care-providers is needed to generate relevant, reliable and generalisable data on QoL in the future. The results of this DELPHI panel provide useful guidance on how to choose the study design, target population and appropriate QoL measures for future research and hence, help promote the appropriateness and consistency in study methodology and sample characteristics.\",\n",
       "               'FAU': ['Marten, Ole',\n",
       "                'Koerber, Florian',\n",
       "                'Bloom, David',\n",
       "                'Bullinger, Monika',\n",
       "                'Buysse, Corinne',\n",
       "                'Christensen, Hannah',\n",
       "                'De Wals, Philippe',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Henneke, Philipp',\n",
       "                'Kirchner, Markus',\n",
       "                'Knuf, Markus',\n",
       "                'Lawrenz, Burkhard',\n",
       "                'Monteiro, Andrea L',\n",
       "                'Sevilla, Joseph Patrick',\n",
       "                'Van de Velde, Nicolas',\n",
       "                'Welte, Robert',\n",
       "                'Wright, Claire',\n",
       "                'Greiner, Wolfgang'],\n",
       "               'AU': ['Marten O',\n",
       "                'Koerber F',\n",
       "                'Bloom D',\n",
       "                'Bullinger M',\n",
       "                'Buysse C',\n",
       "                'Christensen H',\n",
       "                'De Wals P',\n",
       "                'Dohna-Schwake C',\n",
       "                'Henneke P',\n",
       "                'Kirchner M',\n",
       "                'Knuf M',\n",
       "                'Lawrenz B',\n",
       "                'Monteiro AL',\n",
       "                'Sevilla JP',\n",
       "                'Van de Velde N',\n",
       "                'Welte R',\n",
       "                'Wright C',\n",
       "                'Greiner W'],\n",
       "               'AUID': ['ORCID: 0000-0002-2576-9110'],\n",
       "               'AD': ['Department of Health Economics and Health Care Management, School of Public Health, Bielefeld University, Universitatsstr. 25, 33615, Bielefeld, Germany. ole.marten@uni-bielefeld.de.',\n",
       "                'GSK, Prinzregentenplatz 9, 81675, Munich, Germany.',\n",
       "                'Present Address: Institute of Health Economics and Health Care Management, Helmholtz Center Munich, German Research Center for Environmental Health (GmbH), Ingolstadter Landstr. 1, 85764, Neuherberg, Germany.',\n",
       "                'Department of Global Health and Population, Harvard T.H. Chan School of Public Health, 665 Huntington Avenue, Boston, Massachusetts, 02115, USA.',\n",
       "                'Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.',\n",
       "                \"Department of Pediatrics, Intensive Care Unit, Erasmus Medical Center, Sophia Children's Hospital, Wytemaweg 80, 3015, CN, Rotterdam, The Netherlands.\",\n",
       "                'Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.',\n",
       "                'Department of Social and Preventive Medicine, Laval University, Avenue de la Medecine 1050, Quebec City, G1V 0A6, Canada.',\n",
       "                'Pediatrics I, University Hospital of Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Center for Pediatrics and Adolescent Medicine and Center for Chronic Immunodeficiency, Medical Center - University of Freiburg, 79106, Freiburg, Germany.',\n",
       "                'GSK, Prinzregentenplatz 9, 81675, Munich, Germany.',\n",
       "                \"HELIOS Dr. Horst Schmidt Kliniken, Children's Hospital, Ludwig-Erhard-Str. 100, 65199, Wiesbaden, Germany.\",\n",
       "                'Pediatric Infectious Diseases, University Medicine, Mainz, 55131, Germany.',\n",
       "                'Association of Professional Pediatricians and Adolescent Medicine Specialists in Germany (Berufsverband der Kinder- und Jugendarzte e.V., BVKJ), Mielenforster Str. 2, 51069, Koln, Germany.',\n",
       "                'Private Practice for Pediatrics and Adolescent Medicine, Grafenstr. 80, 59821, Arnsberg, Germany.',\n",
       "                'Asas Avaliacoes Economicas Em Saude Ltda ME, Rua Mario Pederneiras, 00055, APT 103 BLC II, Humaita, Rio de Janeiro, 22261-020, Brazil.',\n",
       "                'Present Address: Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA.',\n",
       "                'Life Sciences Group, Data for Decisions, LLC, 681 Main Street, Suite 3-37, Waltham, Massachusetts, 02451, USA.',\n",
       "                'GSK, 20 Avenue Fleming, 1300, Wavre, Belgium.',\n",
       "                'GSK, Prinzregentenplatz 9, 81675, Munich, Germany.',\n",
       "                'Meningitis Research Foundation, Newminster House, Baldwin Street, Bristol, BS1 1LT, UK.',\n",
       "                'Department of Health Economics and Health Care Management, School of Public Health, Bielefeld University, Universitatsstr. 25, 33615, Bielefeld, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20190522',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Health Qual Life Outcomes',\n",
       "               'JT': 'Health and quality of life outcomes',\n",
       "               'JID': '101153626',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Delphi Technique',\n",
       "                'Female',\n",
       "                '*Global Burden of Disease',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Meningococcal Infections/*economics/prevention & control',\n",
       "                'Middle Aged',\n",
       "                '*Quality of Life',\n",
       "                'Research Design',\n",
       "                'Surveys and Questionnaires'],\n",
       "               'PMC': 'PMC6532178',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['DELPHI',\n",
       "                'Meningococcal disease',\n",
       "                'Neisseria meningitidis',\n",
       "                'Quality of life'],\n",
       "               'COIS': ['Monika Bullinger, Corinne Buysse, Wolfgang Greiner, Markus Knuf, Ole Marten, and',\n",
       "                'Andrea Monteiro declare that they have no competing interests. Markus Kirchner,',\n",
       "                'Nicolas Van de Velde, and Robert Welte are employees of the GSK group of',\n",
       "                'companies. Florian Koerber was employed by the GSK group of companies at the time',\n",
       "                'of study conduct. Nicolas Van de Velde and Robert Welte hold shares in the GSK',\n",
       "                'group of companies. To support his research on the value of vaccination, David',\n",
       "                'Bloom received grants from the Bill and Melinda Gates Foundation, the World',\n",
       "                'Health Organization, GSK, Merck, Pfizer, Sanofi Pasteur, and Sanofi Pasteur-MSD.',\n",
       "                'He also reports personal fees from GSK, Merck, Dynavax, and Pfizer, and',\n",
       "                'participation in advisory boards for the same. He received personal fees for',\n",
       "                'conducting research on the value of treatment from Gilead Life Sciences as well.',\n",
       "                'Hannah Christensen is affiliated to the National Institute for Health Research',\n",
       "                'Health Protection Research Unit (NIHR HPRU) in Evaluation of Interventions at',\n",
       "                'University of Bristol in partnership with Public Health England (PHE). She',\n",
       "                'reports monies paid to her employer from AstraZeneca, GSK, IMS Health, and Sanofi',\n",
       "                'Pasteur. The views expressed are those of the author(s) and not necessarily those',\n",
       "                'of the NHS, the NIHR, the Department of Health or Public Health England. Philippe',\n",
       "                'De Wals received research grants, and reimbursements of travel expenses from',\n",
       "                'vaccine manufacturers including GSK, Novartis, Sanofi Pasteur, and Pfizer, as',\n",
       "                'well as from governmental agencies including the Quebec Ministry of Health and',\n",
       "                'Social Services, Health Canada, and the Public Health Agency of Canada. Philippe',\n",
       "                'De Wals has an advisory role as member of the Quebec immunization Committee and',\n",
       "                'the (Canadian) National Advisory Committee on Immunization. Christian',\n",
       "                'Dohna-Schwake reports a personal fee for GSK advisory board attendance. Philipp',\n",
       "                'Henneke received reimbursements of travel expenses and honoraria from GSK, Pfizer',\n",
       "                'and Abbvie, as well as from the Bill & Melinda Gates Foundation and the WHO.',\n",
       "                'Burkhard Lawrenz reports personal fees from GSK, during the conduct of the study,',\n",
       "                'and personal fees from MSD, Sanofi, SPMSD, and Pfizer, outside the submitted',\n",
       "                'work. JP Sevilla reports personal fees from GSK, during the conduct of the study,',\n",
       "                'and outside the submitted work. He is employed by Data for Decisions LLC, an',\n",
       "                'economics consulting firm which contracts to perform vaccine-related economic',\n",
       "                'research for many pharmaceutical companies including but not limited to GSK. He',\n",
       "                'is also a Research Associate at the Harvard Chan School of Public Health (Chan',\n",
       "                'School) where his research activities involve vaccine-related economic research',\n",
       "                'supported by grants from pharmaceutical companies. At the Chan School, he is also',\n",
       "                'a Technical Advisor on the Secretariat of the Value of Vaccines Research Network,',\n",
       "                'which is funded by the Bill and Melinda Gates Foundation. Claire Wright is',\n",
       "                'employed by the Meningitis Research Foundation (MRF), which has received',\n",
       "                'educational grants from GSK and sponsorship for their biannual conference. She',\n",
       "                'was also awarded a fee from GSK for contributing to an advisory board regarding',\n",
       "                'this work. The consultancy fee was paid directly to MRF.'],\n",
       "               'EDAT': '2019/05/24 06:00',\n",
       "               'MHDA': '2019/06/14 06:00',\n",
       "               'PMCR': ['2019/05/22'],\n",
       "               'CRDT': ['2019/05/24 06:00'],\n",
       "               'PHST': ['2018/09/19 00:00 [received]',\n",
       "                '2019/05/13 00:00 [accepted]',\n",
       "                '2019/05/24 06:00 [entrez]',\n",
       "                '2019/05/24 06:00 [pubmed]',\n",
       "                '2019/06/14 06:00 [medline]',\n",
       "                '2019/05/22 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1186/s12955-019-1159-0 [pii]',\n",
       "                '1159 [pii]',\n",
       "                '10.1186/s12955-019-1159-0 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Health Qual Life Outcomes. 2019 May 22;17(1):87. doi: 10.1186/s12955-019-1159-0.'},\n",
       "              {'PMID': '31004560',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20200217',\n",
       "               'LR': '20200217',\n",
       "               'IS': '1437-4315 (Electronic) 1431-6730 (Linking)',\n",
       "               'VI': '400',\n",
       "               'IP': '10',\n",
       "               'DP': '2019 Sep 25',\n",
       "               'TI': '19F NMR as a versatile tool to study membrane protein structure and dynamics.',\n",
       "               'PG': '1277-1288',\n",
       "               'LID': '10.1515/hsz-2018-0473 [doi]',\n",
       "               'AB': 'To elucidate the structures and dynamics of membrane proteins, highly advanced biophysical methods have been developed that often require significant resources, both for sample preparation and experimental analyses. For very complex systems, such as membrane transporters, ion channels or G-protein coupled receptors (GPCRs), the incorporation of a single reporter at a select site can significantly simplify the observables and the measurement/analysis requirements. Here we present examples using 19F nuclear magnetic resonance (NMR) spectroscopy as a powerful, yet relatively straightforward tool to study (membrane) protein structure, dynamics and ligand interactions. We summarize methods to incorporate 19F labels into proteins and discuss the type of information that can be readily obtained for membrane proteins already from relatively simple NMR spectra with a focus on GPCRs as the membrane protein family most extensively studied by this technique. In the future, these approaches may be of particular interest also for many proteins that undergo complex functional dynamics and/or contain unstructured regions and thus are not amenable to X-ray crystallography or cryo electron microscopy (cryoEM) studies.',\n",
       "               'FAU': ['Rose-Sperling, Dania',\n",
       "                'Tran, Mai Anh',\n",
       "                'Lauth, Luca M',\n",
       "                'Goretzki, Benedikt',\n",
       "                'Hellmich, Ute A'],\n",
       "               'AU': ['Rose-Sperling D',\n",
       "                'Tran MA',\n",
       "                'Lauth LM',\n",
       "                'Goretzki B',\n",
       "                'Hellmich UA'],\n",
       "               'AD': ['Institute for Pharmacy and Biochemistry, Johannes Gutenberg University, Johann-Joachim-Becher-Weg 30, D-55128 Mainz, Germany.',\n",
       "                'Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe University Frankfurt, Max-von-Laue Str. 9, D-60438 Frankfurt, Germany.',\n",
       "                'Institute for Pharmacy and Biochemistry, Johannes Gutenberg University, Johann-Joachim-Becher-Weg 30, D-55128 Mainz, Germany.',\n",
       "                'Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe University Frankfurt, Max-von-Laue Str. 9, D-60438 Frankfurt, Germany.',\n",
       "                'Institute for Pharmacy and Biochemistry, Johannes Gutenberg University, Johann-Joachim-Becher-Weg 30, D-55128 Mainz, Germany.',\n",
       "                'Institute for Pharmacy and Biochemistry, Johannes Gutenberg University, Johann-Joachim-Becher-Weg 30, D-55128 Mainz, Germany.',\n",
       "                'Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe University Frankfurt, Max-von-Laue Str. 9, D-60438 Frankfurt, Germany.',\n",
       "                'Institute for Pharmacy and Biochemistry, Johannes Gutenberg University, Johann-Joachim-Becher-Weg 30, D-55128 Mainz, Germany.',\n",
       "                'Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe University Frankfurt, Max-von-Laue Str. 9, D-60438 Frankfurt, Germany.'],\n",
       "               'AUID': ['ORCID: 0000-0001-7162-285X'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                'Review'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Biol Chem',\n",
       "               'JT': 'Biological chemistry',\n",
       "               'JID': '9700112',\n",
       "               'RN': ['0 (Ligands)',\n",
       "                '0 (Membrane Proteins)',\n",
       "                '284SYP0193 (Fluorine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Fluorine',\n",
       "                'Ligands',\n",
       "                'Magnetic Resonance Spectroscopy/*methods',\n",
       "                'Membrane Proteins/*chemistry',\n",
       "                'Protein Binding',\n",
       "                'Protein Conformation'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['19F NMR spectroscopy',\n",
       "                'GPCR',\n",
       "                'labeling schemes',\n",
       "                'membrane protein',\n",
       "                'protein dynamics'],\n",
       "               'EDAT': '2019/04/21 06:00',\n",
       "               'MHDA': '2020/02/18 06:00',\n",
       "               'CRDT': ['2019/04/21 06:00'],\n",
       "               'PHST': ['2018/12/20 00:00 [received]',\n",
       "                '2019/04/17 00:00 [accepted]',\n",
       "                '2019/04/21 06:00 [pubmed]',\n",
       "                '2020/02/18 06:00 [medline]',\n",
       "                '2019/04/21 06:00 [entrez]'],\n",
       "               'AID': ['/j/bchm.just-accepted/hsz-2018-0473/hsz-2018-0473.xml [pii]',\n",
       "                '10.1515/hsz-2018-0473 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Biol Chem. 2019 Sep 25;400(10):1277-1288. doi: 10.1515/hsz-2018-0473.'},\n",
       "              {'PMID': '30991709',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20200130',\n",
       "               'LR': '20211204',\n",
       "               'IS': '2073-4409 (Print) 2073-4409 (Electronic) 2073-4409 (Linking)',\n",
       "               'VI': '8',\n",
       "               'IP': '4',\n",
       "               'DP': '2019 Apr 15',\n",
       "               'TI': 'NFkappaB- and MAP-Kinase Signaling Contribute to the Activation of Murine Myeloid Dendritic Cells by a Flagellin A:Allergen Fusion Protein.',\n",
       "               'LID': '10.3390/cells8040355 [doi] 355',\n",
       "               'AB': 'Fusion proteins incorporating the TLR5-ligand flagellin are currently undergoing clinical trials as vaccine candidates for many diseases. We recently reported a flagellin:allergen fusion protein containing the TLR5-ligand flagellin A (FlaA) from Listeriamonocytogenes and the major birch pollen allergen Bet v 1 (rFlaA:Betv1) to prevent allergic sensitization in an experimental mouse model. This study analyzes the signaling pathways contributing to rFlaA:Betv1-mediated pro- and anti-inflammatory cytokine secretion and cell metabolism in myeloid dendritic cells (mDCs) in vitro. The influence of mammalian target of rapamycin (mTOR)-, NF?B-, and MAP kinase (MAPK)-signaling on cytokine secretion and metabolic activity of bone marrow (BM)-derived mDCs stimulated with rFlaA:Betv1 were investigated by pre-treatment with either mTOR- (rapamycin), NF?B- (dexamethason, BMS-345541, TPCA-1, triptolide, or BAY-11) or MAPK- (SP600125, U0126, or SB202190) inhibitors, respectively. rFlaA:Betv1-mediated IL-10 secretion as well as activation of mDC metabolism, rather than pro-inflammatory cytokine secretion, were inhibited by rapamycin. Inhibition of NFkappaB-signaling suppressed rFlaA:Betv1-induced IL-12, while inhibition of MAPK-signaling dose-dependently suppressed rFlaA:Betv1-induced IL-10 as well as pro-inflammatory IL-6 and TNF-alpha production. Notably, with the exception of a partial JNK-dependency, rFlaA:Betv1-mediated effects on mDC metabolism were mostly NF?B- and MAPK-independent. Therefore, MAPK-mediated activation of both NFkappaB- and mTOR-signaling likely is a key pathway for the production of pro- and anti-inflammatory cytokines by flagellin fusion protein vaccines.',\n",
       "               'FAU': ['Moeller, Tobias',\n",
       "                'Wolfheimer, Sonja',\n",
       "                'Goretzki, Alexandra',\n",
       "                'Scheurer, Stephan',\n",
       "                'Schulke, Stefan'],\n",
       "               'AU': ['Moeller T',\n",
       "                'Wolfheimer S',\n",
       "                'Goretzki A',\n",
       "                'Scheurer S',\n",
       "                'Schulke S'],\n",
       "               'AD': ['Paul-Ehrlich-Institut, Vice President s Research Group 1: Molecular Allergology; 63225 Langen (Hesse), Germany. tobias.moeller1990@gmx.de.',\n",
       "                'Paul-Ehrlich-Institut, Vice President s Research Group 1: Molecular Allergology; 63225 Langen (Hesse), Germany. Sonja.Wolfheimer@pei.de.',\n",
       "                'Paul-Ehrlich-Institut, Vice President s Research Group 1: Molecular Allergology; 63225 Langen (Hesse), Germany. Alexandra.Goretzki@pei.de.',\n",
       "                'Paul-Ehrlich-Institut, Vice President s Research Group 1: Molecular Allergology; 63225 Langen (Hesse), Germany. Stephan.Scheurer@pei.de.',\n",
       "                'Paul-Ehrlich-Institut, Vice President s Research Group 1: Molecular Allergology; 63225 Langen (Hesse), Germany. stefan.schuelke@pei.de.'],\n",
       "               'AUID': ['ORCID: 0000-0002-2859-562X'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20190415',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Cells',\n",
       "               'JT': 'Cells',\n",
       "               'JID': '101600052',\n",
       "               'RN': ['0 (Antigens, Plant)',\n",
       "                '0 (Cytokines)',\n",
       "                '0 (NF-kappa B)',\n",
       "                '0 (Recombinant Fusion Proteins)',\n",
       "                '0 (Vaccines)',\n",
       "                '126161-14-6 (Bet v 1 allergen, Betula)',\n",
       "                '12777-81-0 (Flagellin)',\n",
       "                '130068-27-8 (Interleukin-10)',\n",
       "                'EC 2.7.11.1 (TOR Serine-Threonine Kinases)',\n",
       "                'EC 2.7.11.24 (Mitogen-Activated Protein Kinases)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Animals',\n",
       "                'Antigens, Plant/*adverse effects/genetics/immunology',\n",
       "                'Cytokines/immunology',\n",
       "                'Dendritic Cells/drug effects/*immunology',\n",
       "                'Drug Hypersensitivity/etiology/*immunology',\n",
       "                'Flagellin/*adverse effects/immunology/metabolism',\n",
       "                'Interleukin-10/immunology',\n",
       "                'MAP Kinase Signaling System/*immunology',\n",
       "                'Mice',\n",
       "                'Mice, Inbred BALB C',\n",
       "                'Mitogen-Activated Protein Kinases/metabolism',\n",
       "                'Myeloid Cells/drug effects/immunology',\n",
       "                'NF-kappa B/*immunology',\n",
       "                'Recombinant Fusion Proteins/*adverse effects/genetics/immunology',\n",
       "                'TOR Serine-Threonine Kinases/immunology',\n",
       "                'Vaccines/immunology'],\n",
       "               'PMC': 'PMC6523117',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Bet v 1',\n",
       "                'MAPK',\n",
       "                'NF?B',\n",
       "                'TLR5',\n",
       "                'birch allergy',\n",
       "                'flagellin',\n",
       "                'fusion protein',\n",
       "                'metabolism',\n",
       "                'signalling',\n",
       "                'vaccine'],\n",
       "               'COIS': ['The authors have no conflicts of interest to declare.'],\n",
       "               'EDAT': '2019/04/18 06:00',\n",
       "               'MHDA': '2019/04/18 06:01',\n",
       "               'PMCR': ['2019/04/01'],\n",
       "               'CRDT': ['2019/04/18 06:00'],\n",
       "               'PHST': ['2018/12/12 00:00 [received]',\n",
       "                '2019/03/26 00:00 [revised]',\n",
       "                '2019/04/12 00:00 [accepted]',\n",
       "                '2019/04/18 06:00 [entrez]',\n",
       "                '2019/04/18 06:00 [pubmed]',\n",
       "                '2019/04/18 06:01 [medline]',\n",
       "                '2019/04/01 00:00 [pmc-release]'],\n",
       "               'AID': ['cells8040355 [pii]',\n",
       "                'cells-08-00355 [pii]',\n",
       "                '10.3390/cells8040355 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Cells. 2019 Apr 15;8(4):355. doi: 10.3390/cells8040355.'},\n",
       "              {'PMID': '30937523',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20200110',\n",
       "               'LR': '20200225',\n",
       "               'IS': '1435-2451 (Electronic) 1435-2443 (Linking)',\n",
       "               'VI': '404',\n",
       "               'IP': '4',\n",
       "               'DP': '2019 Jun',\n",
       "               'TI': 'Surgical therapy of adrenal tumors: guidelines from the German Association of Endocrine Surgeons (CAEK).',\n",
       "               'PG': '385-401',\n",
       "               'LID': '10.1007/s00423-019-01768-z [doi]',\n",
       "               'AB': 'BACKGROUND AND AIMS: Previous guidelines addressing surgery of adrenal tumors required actualization in adaption of developments in the area. The present guideline aims to provide practical and qualified recommendations on an evidence-based level reviewing the prevalent literature for the surgical therapy of adrenal tumors referring to patients of all age groups in operative medicine who require adrenal surgery. It primarily addresses general and visceral surgeons but offers information for all medical doctors related to conservative, ambulatory or inpatient care, rehabilitation, and general practice as well as pediatrics. It extends to interested patients to improve the knowledge and participation in the decision-making process regarding indications and methods of management of adrenal tumors. Furthermore, it provides effective medical options for the surgical treatment of adrenal lesions and balances positive and negative effects. Specific clinical questions addressed refer to indication, diagnostic procedures, effective therapeutic alternatives to surgery, type and extent of surgery, and postoperative management and follow-up regime. METHODS: A PubMed research using specific key words identified literature to be considered and was evaluated for evidence previous to a formal Delphi decision process that finalized consented recommendations in a multidisciplinary setting. RESULTS: Overall, 12 general and 52 specific recommendations regarding surgery for adrenal tumors were generated and complementary comments provided. CONCLUSION: Effective and balanced medical options for the surgical treatment of adrenal tumors are provided on evidence-base. Specific clinical questions regarding indication, diagnostic procedures, alternatives to and type as well as extent of surgery for adrenal tumors including postoperative management are addressed.',\n",
       "               'FAU': ['Lorenz, K',\n",
       "                'Langer, P',\n",
       "                'Niederle, B',\n",
       "                'Alesina, P',\n",
       "                'Holzer, K',\n",
       "                'Nies, Ch',\n",
       "                'Musholt, Th',\n",
       "                'Goretzki, P E',\n",
       "                'Rayes, N',\n",
       "                'Quinkler, M',\n",
       "                'Waldmann, J',\n",
       "                'Simon, D',\n",
       "                'Trupka, A',\n",
       "                'Ladurner, R',\n",
       "                'Hallfeldt, K',\n",
       "                'Zielke, A',\n",
       "                'Saeger, D',\n",
       "                'Poppel, Th',\n",
       "                'Kukuk, G',\n",
       "                'Hotker, A',\n",
       "                'Schabram, P',\n",
       "                'Schopf, S',\n",
       "                'Dotzenrath, C',\n",
       "                'Riss, P',\n",
       "                'Steinmuller, Th',\n",
       "                'Kopp, I',\n",
       "                'Vorlander, C',\n",
       "                'Walz, M K',\n",
       "                'Bartsch, D K'],\n",
       "               'AU': ['Lorenz K',\n",
       "                'Langer P',\n",
       "                'Niederle B',\n",
       "                'Alesina P',\n",
       "                'Holzer K',\n",
       "                'Nies C',\n",
       "                'Musholt T',\n",
       "                'Goretzki PE',\n",
       "                'Rayes N',\n",
       "                'Quinkler M',\n",
       "                'Waldmann J',\n",
       "                'Simon D',\n",
       "                'Trupka A',\n",
       "                'Ladurner R',\n",
       "                'Hallfeldt K',\n",
       "                'Zielke A',\n",
       "                'Saeger D',\n",
       "                'Poppel T',\n",
       "                'Kukuk G',\n",
       "                'Hotker A',\n",
       "                'Schabram P',\n",
       "                'Schopf S',\n",
       "                'Dotzenrath C',\n",
       "                'Riss P',\n",
       "                'Steinmuller T',\n",
       "                'Kopp I',\n",
       "                'Vorlander C',\n",
       "                'Walz MK',\n",
       "                'Bartsch DK'],\n",
       "               'AUID': ['ORCID: 0000-0003-0281-1950'],\n",
       "               'AD': ['Universitatsklinikum Halle, Halle/Saale, Germany. kerstin.lorenz@uk-halle.de.',\n",
       "                'Klinikum Hanau, Hanau, Germany.',\n",
       "                'Ordination Siebenbrunnenstrasse, Wien, Austria.',\n",
       "                'Kliniken Essen-Mitte, Essen, Germany.',\n",
       "                'Universitatsklinikum Marburg, Marburg, Germany.',\n",
       "                'Marienhospital Osnabruck, Osnabruck, Germany.',\n",
       "                'Universitatsklinikum Mainz, Mainz, Germany.',\n",
       "                'Charite Universitatsmedizin Berlin, Berlin, Germany.',\n",
       "                'Universitatsklinikum Leipzig, Leipzig, Germany.',\n",
       "                'Endokrinologiepraxis Berlin, Berlin, Germany.',\n",
       "                'MIVENDO Klinik Hamburg, Hamburg, Germany.',\n",
       "                'Evangelisches Krankenhaus BETHESDA Duisburg, Duisburg, Germany.',\n",
       "                'Klinikum Starnberg, Klinikum Starnberg, Germany.',\n",
       "                'Ludwig-Maximilians-Universitat Munchen, Munchen, Germany.',\n",
       "                'Ludwig-Maximilians-Universitat Munchen, Munchen, Germany.',\n",
       "                'Diakonie-Klinikum Stuttgart, Stuttgart, Germany.',\n",
       "                'Universitatsklinikum Hamburg, Hamburg, Germany.',\n",
       "                'Heinrich-Heine-Universitat Dusseldorf, Dusseldorf, Germany.',\n",
       "                'Universitatsklinikum Bonn, Bonn, Germany.',\n",
       "                'Universitatsklinikum Zurich, Zurich, Switzerland.',\n",
       "                'RAE Ratacjzak und Partner, Sindelfingen, Germany.',\n",
       "                'Krankenhaus Agatharied, Hausham, Germany.',\n",
       "                'HELIOS Universitatsklinikum Wuppertal, Wuppertal, Germany.',\n",
       "                'Medizinische Universitat Wien, Wien, Austria.',\n",
       "                'Deutsches Rotes Kreuz Krankenhaus Berlin, Berlin, Germany.',\n",
       "                'AWMF, Frankfurt am Main, Germany.',\n",
       "                'Burgerhospital Frankfurt, Frankfurt am Main, Germany.',\n",
       "                'Kliniken Essen-Mitte, Essen, Germany.',\n",
       "                'Universitatsklinikum Marburg, Marburg, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Practice Guideline',\n",
       "                'Systematic Review'],\n",
       "               'DEP': '20190401',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adrenal Gland Neoplasms/*surgery',\n",
       "                'Delphi Technique',\n",
       "                'Endocrine Surgical Procedures/*methods',\n",
       "                'Evidence-Based Medicine',\n",
       "                'Germany',\n",
       "                'Humans'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Adrenal Cushing disease',\n",
       "                'Adrenal surgery',\n",
       "                'Conn syndrome',\n",
       "                'Guideline',\n",
       "                'Pheochromocytoma'],\n",
       "               'EDAT': '2019/04/03 06:00',\n",
       "               'MHDA': '2020/01/11 06:00',\n",
       "               'CRDT': ['2019/04/03 06:00'],\n",
       "               'PHST': ['2019/02/14 00:00 [received]',\n",
       "                '2019/02/19 00:00 [accepted]',\n",
       "                '2019/04/03 06:00 [pubmed]',\n",
       "                '2020/01/11 06:00 [medline]',\n",
       "                '2019/04/03 06:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00423-019-01768-z [pii]',\n",
       "                '10.1007/s00423-019-01768-z [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 2019 Jun;404(4):385-401. doi: 10.1007/s00423-019-01768-z. Epub 2019 Apr 1.'},\n",
       "              {'PMID': '30623816',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20190430',\n",
       "               'LR': '20211204',\n",
       "               'IS': '1872-9142 (Electronic) 0161-5890 (Linking)',\n",
       "               'VI': '106',\n",
       "               'DP': '2019 Feb',\n",
       "               'TI': 'The vaccine adjuvant MPLA activates glycolytic metabolism in mouse mDC by a JNK-dependent activation of mTOR-signaling.',\n",
       "               'PG': '159-169',\n",
       "               'LID': 'S0161-5890(18)30639-4 [pii] 10.1016/j.molimm.2018.12.029 [doi]',\n",
       "               'AB': 'INTRODUCTION: The detoxified TLR4-ligand MPLA is a successfully used adjuvant in clinically approved vaccines. However, its capacity to activate glycolytic metabolism in mDC and the influence of MPLA-induced metabolic changes on cytokine secretion are unknown. AIM: To analyze the capacity of MPLA to activate mDC metabolism and the mechanisms contributing to MPLA-induced metabolism activation and cytokine secretion. METHODS: C57BL/6 bone-marrow-derived myeloid dendritic cells (mDCs) were stimulated with LPS or MPLA and analyzed for intracellular signaling, cytokine secretion, and metabolic state. mDC were pre-treated with rapamycin (mTOR-inhibitor), U0126, SP600125, SB202190 (MAPK kinase inhibitors), as well as dexamethasone (MAPK- and NFkappaB-inhibitor) and analyzed for MPLA-induced cytokine secretion and cell metabolic state. RESULTS: Stimulation of mDCs with either LPS or MPLA resulted in a pronounced, mTOR-dependent activation of glucose metabolism characterized by induction of the Warburg Effect, increased glucose consumption from the culture medium, as well as release of LDH. Compared to LPS, MPLA induced significantly lower cytokine secretion. The activation of mDC metabolism was comparable between LPS- and MPLA-stimulated mDCs. The MPLA-induced cytokine secretion could be partially inhibited using mTOR-, MAP kinase-, and NFkappaB-inhibitors, whereas the activation of glucose metabolism was shown to depend on both mTOR- and JNK-signaling. SUMMARY: The MPLA-induced activation of glycolytic metabolism in mouse mDC was shown to depend on a JNK-mediated activation of mTOR-signaling, while both MAPK- and NFB-signaling contributed to pro-inflammatory cytokine secretion. Understanding the mechanisms by which MPLA activates dendritic cells will both improve our understanding of its adjuvant properties and contribute to the future development and safe application of this promising adjuvant.',\n",
       "               'CI': ['Copyright (c) 2018 Elsevier Ltd. All rights reserved.'],\n",
       "               'FAU': ['Blanco-Perez, Frank',\n",
       "                'Goretzki, Alexandra',\n",
       "                'Wolfheimer, Sonja',\n",
       "                'Schulke, Stefan'],\n",
       "               'AU': ['Blanco-Perez F',\n",
       "                'Goretzki A',\n",
       "                'Wolfheimer S',\n",
       "                'Schulke S'],\n",
       "               'AD': ['Paul-Ehrlich-Institut, Vice President s Research Group 1: Molecular Allergology, Langen, Germany.',\n",
       "                'Paul-Ehrlich-Institut, Vice President s Research Group 1: Molecular Allergology, Langen, Germany.',\n",
       "                'Paul-Ehrlich-Institut, Vice President s Research Group 1: Molecular Allergology, Langen, Germany.',\n",
       "                'Paul-Ehrlich-Institut, Vice President s Research Group 1: Molecular Allergology, Langen, Germany. Electronic address: stefan.schuelke@pei.de.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20190109',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Mol Immunol',\n",
       "               'JT': 'Molecular immunology',\n",
       "               'JID': '7905289',\n",
       "               'RN': ['0 (Adjuvants, Immunologic)',\n",
       "                '0 (Cytokines)',\n",
       "                '0 (Lipid A)',\n",
       "                'EC 2.7.1.1 (mTOR protein, mouse)',\n",
       "                'EC 2.7.11.1 (TOR Serine-Threonine Kinases)',\n",
       "                'EC 2.7.12.2 (MAP Kinase Kinase 4)',\n",
       "                'MWC0ET1L2P (monophosphoryl lipid A)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adjuvants, Immunologic/*pharmacology',\n",
       "                'Animals',\n",
       "                'Cytokines/immunology',\n",
       "                'Dendritic Cells/cytology/*immunology',\n",
       "                'Glycolysis/*drug effects/immunology',\n",
       "                'Lipid A/*analogs & derivatives/pharmacology',\n",
       "                'MAP Kinase Kinase 4/*immunology',\n",
       "                'MAP Kinase Signaling System/*drug effects/immunology',\n",
       "                'Mice',\n",
       "                'TOR Serine-Threonine Kinases/*immunology'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['MAP kinase',\n",
       "                'MPLA',\n",
       "                'Metabolism',\n",
       "                'Monophosphoryl lipid A',\n",
       "                'NFkappaB',\n",
       "                'mDC',\n",
       "                'mTOR'],\n",
       "               'EDAT': '2019/01/10 06:00',\n",
       "               'MHDA': '2019/05/01 06:00',\n",
       "               'CRDT': ['2019/01/10 06:00'],\n",
       "               'PHST': ['2018/08/07 00:00 [received]',\n",
       "                '2018/11/28 00:00 [revised]',\n",
       "                '2018/12/29 00:00 [accepted]',\n",
       "                '2019/01/10 06:00 [pubmed]',\n",
       "                '2019/05/01 06:00 [medline]',\n",
       "                '2019/01/10 06:00 [entrez]'],\n",
       "               'AID': ['S0161-5890(18)30639-4 [pii]',\n",
       "                '10.1016/j.molimm.2018.12.029 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Mol Immunol. 2019 Feb;106:159-169. doi: 10.1016/j.molimm.2018.12.029. Epub 2019 Jan 9.'},\n",
       "              {'PMID': '30231262',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20190429',\n",
       "               'LR': '20190429',\n",
       "               'IS': '1439-3824 (Electronic) 0300-8630 (Linking)',\n",
       "               'VI': '231',\n",
       "               'IP': '1',\n",
       "               'DP': '2019 Jan',\n",
       "               'TI': 'Visual Distraction During Sleep Induction with Propofol in Pediatric Patients - Can Cartoon Watching Influence the Sedative Dose?',\n",
       "               'PG': '35-40',\n",
       "               'LID': '10.1055/a-0609-6643 [doi]',\n",
       "               'AB': 'BACKGROUND: In general anesthesia, cartoon watching and playing video games reduce anxiety in children. It is unknown whether watching a video in the intervention room has a similar effect, and therefore is able to reduce sedative doses in children undergoing small medical procedures. Aim of this prospective study was to determine the effect of watching a standardized cartoon immediately before and during sleep induction for deep sedation on consumption of propofol in children. PATIENTS AND METHODS: 50 children aged 2-14 years undergoing deep sedation were randomly assigned to 2 groups: (A) watching or (B) not watching a standardized videoclip during sleep induction with propofol. The achievement of predefined sedation depth was objectified by measuring Comfort Score (aim 10-14) and Bispectral Index (aim 50-60). RESULTS: The median sleep induction dose of propofol did not differ in both groups (A: 1.76 (0.62-4.37) mg/kg; B: 1.37 (0.66-5.26) mg/kgKG; p=0.65). Cartoon watching was associated with shorter sleep onset latency (A: 120 (60-480)s; B: 240 (40-600)s; p=0.043). Subgroup analysis reveals this especially for school children and girls. In both groups no complications occurred. CONCLUSION: Children watching a standard cartoon during sleep induction for deep sedation have a shorter sleep onset time but sedative dose is not reduced.',\n",
       "               'CI': ['(c) Georg Thieme Verlag KG Stuttgart . New York.'],\n",
       "               'FAU': ['Tschiedel, Eva',\n",
       "                'Beckers, Kristina',\n",
       "                'Grosse-Lordemann, Anja',\n",
       "                'Basu, Oliver',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian'],\n",
       "               'AU': ['Tschiedel E',\n",
       "                'Beckers K',\n",
       "                'Grosse-Lordemann A',\n",
       "                'Basu O',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dohna-Schwake C'],\n",
       "               'AD': ['Kinderklinik 1, Universitatsklinik Essen, Essen, Germany.',\n",
       "                'Klinik fur Kinderheilkunde 1, Universitatsklinik Essen, Essen, Germany.',\n",
       "                'Pediatrics I, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Klinik fur Kinderheilkunde 3, Universitatsklinik Essen, Essen, Germany.',\n",
       "                'Kinderheilkunde 1, University Hospital Essen, Essen, Germany.',\n",
       "                'Kinderklinik 1, Universitatsklinik Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Randomized Controlled Trial'],\n",
       "               'TT': 'Visuelle Ablenkung wahrend Sedierungseinleitung mit Propofol bei Kindern - Konnen Cartoons die Sedativadosis beeinflussen?',\n",
       "               'DEP': '20180919',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Klin Padiatr',\n",
       "               'JT': 'Klinische Padiatrie',\n",
       "               'JID': '0326144',\n",
       "               'RN': ['0 (Hypnotics and Sedatives)', 'YI7VU623SF (Propofol)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Anesthesia/methods/*psychology',\n",
       "                'Anxiety/*prevention & control',\n",
       "                'Child',\n",
       "                'Child, Preschool',\n",
       "                'Consciousness/drug effects',\n",
       "                'Deep Sedation/*methods/psychology',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hypnotics and Sedatives/*administration & dosage/pharmacology',\n",
       "                'Preoperative Care/methods/*psychology',\n",
       "                'Propofol/*administration & dosage/pharmacology',\n",
       "                'Prospective Studies',\n",
       "                'Video Games/*psychology'],\n",
       "               'COIS': ['The authors declare no conflict of interest.'],\n",
       "               'EDAT': '2018/09/20 06:00',\n",
       "               'MHDA': '2019/04/30 06:00',\n",
       "               'CRDT': ['2018/09/20 06:00'],\n",
       "               'PHST': ['2018/09/20 06:00 [pubmed]',\n",
       "                '2019/04/30 06:00 [medline]',\n",
       "                '2018/09/20 06:00 [entrez]'],\n",
       "               'AID': ['10.1055/a-0609-6643 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Klin Padiatr. 2019 Jan;231(1):35-40. doi: 10.1055/a-0609-6643. Epub 2018 Sep 19.'}],\n",
       "             '2025': [{'PMID': '39982155',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20250221',\n",
       "               'LR': '20250223',\n",
       "               'IS': '1529-7535 (Print) 1947-3893 (Electronic) 1529-7535 (Linking)',\n",
       "               'VI': '26',\n",
       "               'IP': '2',\n",
       "               'DP': '2025 Feb 1',\n",
       "               'TI': 'The Phoenix Sepsis Score in Pediatric Oncology Patients With Sepsis at PICU Admission: Test of Performance in a European Multicenter Cohort, 2018-2020.',\n",
       "               'PG': 'e177-e185',\n",
       "               'LID': '10.1097/PCC.0000000000003683 [doi]',\n",
       "               'AB': 'OBJECTIVES: The Pediatric Sepsis Definition Task Force developed and validated a new organ dysfunction score, the Phoenix Sepsis Score (PSS), as a predictor of mortality in children with suspected or confirmed infection. The PSS showed improved performance compared with prior scores. However, the criteria were derived in a general pediatric population, in which only 10% had cancer. Given that pediatric cancer patients with sepsis have higher mortality compared with noncancer patients with sepsis, we aimed to assess the PSS in PICU patients with cancer and sepsis. DESIGN: Retrospective multicenter cohort study. SETTING: Twelve PICUs across Europe. PATIENTS: Each PICU identified patients 18 years young or younger, with underlying malignancy and suspected or proven sepsis, and admission between January 1, 2018, and January 1, 2020. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The PSS and three other scores, including Phoenix-8, Pediatric Logistic Organ Dysfunction-2 (PELOD-2) score, and pediatric Sequential Organ Failure Assessment (pSOFA) score, were calculated for comparison. The primary outcome was 90-day all-cause mortality. We compared score performance using area under the receiver operating characteristic curve (AUROC) and area under the precision-recall curve (AUPRC) analyses. Among 383 patients with proven or suspected sepsis, 90-day mortality was 19.3% (74/383). We failed to identify an association between a particular score and performance for 90-day mortality. The mean (95% CI) values for the AUROC of each score was: PSS 0.66 (0.59-0.72), Phoenix-8 0.65 (0.58-0.72), PELOD-2 0.64 (0.57-0.71), and pSOFA 0.67 (0.60-0.74) and for the AUPRC of each score: PSS 0.32 (0.23-0.42), Phoenix-8 0.32 (0.23-0.42), PELOD-2 0.32 (0.22-0.43), and pSOFA 0.36 (0.26-0.46). Similar results were obtained for PICU mortality or sepsis-related PICU mortality. CONCLUSIONS: Contrary to the general PICU population, our retrospective test of the PSS in a PICU oncology dataset with suspected or proved sepsis from European PICUs, 2018-2020, failed to identify improved performance in association with mortality. This unique patient population deserves development of organ dysfunction scores that reflect organ dysfunction and mortality data specifically from these patients and will require prospective validation in future studies.',\n",
       "               'CI': ['Copyright (c) 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on',\n",
       "                'behalf of the Society of Critical Care Medicine and the World Federation of',\n",
       "                'Pediatric Intensive and Critical Care Societies.'],\n",
       "               'FAU': ['Wosten-van Asperen, Roelie M',\n",
       "                'la Roi-Teeuw, Hannah M',\n",
       "                'Tissing, Wim J E',\n",
       "                'Jordan, Iolanda',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Bottari, Gabriella',\n",
       "                'Pappachan, John',\n",
       "                'Crazzolara, Roman',\n",
       "                'Amigoni, Angela',\n",
       "                'Mizia-Malarz, Agnieszka',\n",
       "                'Moscatelli, Andrea',\n",
       "                'Sanchez-Martin, Maria',\n",
       "                'Willems, Jef',\n",
       "                'Schlapbach, Luregn J'],\n",
       "               'AU': ['Wosten-van Asperen RM',\n",
       "                'la Roi-Teeuw HM',\n",
       "                'Tissing WJE',\n",
       "                'Jordan I',\n",
       "                'Dohna-Schwake C',\n",
       "                'Bottari G',\n",
       "                'Pappachan J',\n",
       "                'Crazzolara R',\n",
       "                'Amigoni A',\n",
       "                'Mizia-Malarz A',\n",
       "                'Moscatelli A',\n",
       "                'Sanchez-Martin M',\n",
       "                'Willems J',\n",
       "                'Schlapbach LJ'],\n",
       "               'AD': [\"Department of Pediatric Intensive Care, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands.\",\n",
       "                \"Department of Pediatric Intensive Care, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands.\",\n",
       "                'Princess Maxima Centre for Pediatric Oncology, Utrecht, The Netherlands.',\n",
       "                'Department of Pediatric Oncology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.',\n",
       "                'Department of Pediatric Intensive Care and Institut de Recerca, Hospital Sant Joan de Deu, University of Barcelona, Barcelona, Spain.',\n",
       "                'Consorcio de Investigacion Biomedica en Red de Epidemiologia y Salud Publica, Madrid, Spain.',\n",
       "                \"Department of Pediatrics I, Pediatric Intensive Care, Children's Hospital Essen, Germany.\",\n",
       "                'West German Centre for Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                \"Department of Pediatric Intensive Care, Children's Hospital Bambino Gesu, IRCSS, Rome, Italy.\",\n",
       "                \"Department of Pediatric Intensive Care, Southampton Children's Hospital, Southampton, United Kingdom.\",\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Unit, Medical University of Innsbruck, Innsbruck, Austria.',\n",
       "                \"Department of Pediatric Intensive Care, Department of Woman's and Child's Health, Padua University Hospital, Padua, Italy.\",\n",
       "                'Department of Oncology, Hematology and Chemotherapy, Division of Pediatrics, Medical University of Silesia, Upper Silesian Child Health Centre, Katowice, Poland.',\n",
       "                'Department of Neonatal and Pediatric Intensive Care, IRCCS Istituto Giannina Gaslini, Genova, Italy.',\n",
       "                'Department of Pediatric Intensive Care, Hospital Universitario La Paz, Madrid, Spain.',\n",
       "                'Department of Pediatric Intensive Care, Ghent University Hospital, Ghent, Belgium.',\n",
       "                \"Department of Intensive Care and Neonatology, and Children's Research Centre, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.\",\n",
       "                'Child Health Research Centre, The University of Queensland, Brisbane, QLD, Australia.'],\n",
       "               'CN': ['PICU Oncology Kids in Europe Research (POKER) group research consortium of',\n",
       "                'European Society for Paediatric and Neonatal Intensive Care (ESPNIC)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Multicenter Study'],\n",
       "               'DEP': '20250206',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Pediatr Crit Care Med',\n",
       "               'JT': 'Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies',\n",
       "               'JID': '100954653',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*Intensive Care Units, Pediatric/statistics & numerical data',\n",
       "                'Retrospective Studies',\n",
       "                '*Sepsis/mortality/diagnosis/complications',\n",
       "                'Child',\n",
       "                'Male',\n",
       "                'Europe/epidemiology',\n",
       "                'Female',\n",
       "                '*Neoplasms/complications/mortality',\n",
       "                '*Organ Dysfunction Scores',\n",
       "                'Child, Preschool',\n",
       "                'Infant',\n",
       "                'Adolescent',\n",
       "                'ROC Curve',\n",
       "                'Hospital Mortality'],\n",
       "               'PMC': 'PMC11792984',\n",
       "               'COIS': ['Dr. Dohna-Schwake received funding from AstraZeneca, Sana Einkauf, Recordati,',\n",
       "                'Bayer AG, and Fresenius. Dr. Bottari received support for article research from',\n",
       "                'the National Institutes of Health. Dr. Moscatelli received funding from the Air',\n",
       "                'Liquide Advisory Board. Dr. Schlapbach received grants from the NOMIS Foundation,',\n",
       "                'the Sana Foundation, and the Stiftung fur naturwissenschaftliche und technische',\n",
       "                'Forschung (Zurich, Switzerland). The remaining authors have disclosed that they',\n",
       "                'do not have any potential conflicts of interest.'],\n",
       "               'EDAT': '2025/02/21 12:22',\n",
       "               'MHDA': '2025/02/21 12:23',\n",
       "               'PMCR': ['2025/02/04'],\n",
       "               'CRDT': ['2025/02/21 09:43'],\n",
       "               'PHST': ['2025/02/21 12:23 [medline]',\n",
       "                '2025/02/21 12:22 [pubmed]',\n",
       "                '2025/02/21 09:43 [entrez]',\n",
       "                '2025/02/04 00:00 [pmc-release]'],\n",
       "               'AID': ['00130478-202502000-00005 [pii]',\n",
       "                'PCCM-D-24-00470 [pii]',\n",
       "                '10.1097/PCC.0000000000003683 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Pediatr Crit Care Med. 2025 Feb 1;26(2):e177-e185. doi: 10.1097/PCC.0000000000003683. Epub 2025 Feb 6.'},\n",
       "              {'PMID': '39976355',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20250313',\n",
       "               'LR': '20250318',\n",
       "               'IS': '1520-4804 (Electronic) 0022-2623 (Print) 0022-2623 (Linking)',\n",
       "               'VI': '68',\n",
       "               'IP': '5',\n",
       "               'DP': '2025 Mar 13',\n",
       "               'TI': 'Structure and Dynamics of Macrophage Infectivity Potentiator Proteins from Pathogenic Bacteria and Protozoans Bound to Fluorinated Pipecolic Acid Inhibitors.',\n",
       "               'PG': '5926-5941',\n",
       "               'LID': '10.1021/acs.jmedchem.5c00134 [doi]',\n",
       "               'AB': 'Macrophage infectivity potentiator (MIP) proteins, found in pro- and eukaryotic pathogens, influence microbial virulence, host cell infection, pathogen replication, and dissemination. MIPs share an FKBP (FK506 binding protein)-like prolyl-cis/trans-isomerase domain, making them attractive targets for inhibitor development. We determined high-resolution crystal structures of Burkholderia pseudomallei and Trypanosoma cruzi MIPs in complex with fluorinated pipecolic acid inhibitors. The inhibitor binding profiles in solution were compared across B. pseudomallei, T. cruzi, and Legionella pneumophila MIPs using (1)H, (15)N, and (19)F NMR spectroscopy. Demonstrating the versatility of fluorinated ligands for characterizing inhibitor complexes, (19)F NMR spectroscopy identified differences in ligand binding dynamics across MIPs. EPR spectroscopy and SAXS further revealed inhibitor-induced global structural changes in homodimeric L. pneumophila MIP. This study demonstrates the importance of integrating diverse methods to probe protein dynamics and provides a foundation for optimizing MIP-targeted inhibitors in this structurally conserved yet dynamically variable protein family.',\n",
       "               'FAU': ['Perez Carrillo, Victor Hugo',\n",
       "                'Whittaker, Jacob J',\n",
       "                'Wiedemann, Christoph',\n",
       "                'Harder, Jean-Martin',\n",
       "                'Lohr, Theresa',\n",
       "                'Jamithireddy, Anil K',\n",
       "                'Dajka, Marina',\n",
       "                'Goretzki, Benedikt',\n",
       "                'Joseph, Benesh',\n",
       "                'Guskov, Albert',\n",
       "                'Harmer, Nicholas J',\n",
       "                'Holzgrabe, Ulrike',\n",
       "                'Hellmich, Ute A'],\n",
       "               'AU': ['Perez Carrillo VH',\n",
       "                'Whittaker JJ',\n",
       "                'Wiedemann C',\n",
       "                'Harder JM',\n",
       "                'Lohr T',\n",
       "                'Jamithireddy AK',\n",
       "                'Dajka M',\n",
       "                'Goretzki B',\n",
       "                'Joseph B',\n",
       "                'Guskov A',\n",
       "                'Harmer NJ',\n",
       "                'Holzgrabe U',\n",
       "                'Hellmich UA'],\n",
       "               'AD': ['Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, 07743 Jena, Germany.',\n",
       "                'Groningen Institute for Biomolecular Sciences and Biotechnology, University of Groningen, 9747AG Groningen, The Netherlands.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, 07743 Jena, Germany.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, 07743 Jena, Germany.',\n",
       "                'Institute of Pharmacy and Food Chemistry, University of Wurzburg, Am Hubland, 97074 Wurzburg, Germany.',\n",
       "                'Living Systems Institute, University of Exeter, Stocker Road, EX4 4QD Exeter, U.K.',\n",
       "                'Department of Physics, Free University of Berlin, 14195 Berlin, Germany.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, 07743 Jena, Germany.',\n",
       "                'Center for Biomolecular Magnetic Resonance, Goethe-University, 60438 Frankfurt/Main, Germany.',\n",
       "                'Department of Physics, Free University of Berlin, 14195 Berlin, Germany.',\n",
       "                'Groningen Institute for Biomolecular Sciences and Biotechnology, University of Groningen, 9747AG Groningen, The Netherlands.',\n",
       "                'Living Systems Institute, University of Exeter, Stocker Road, EX4 4QD Exeter, U.K.',\n",
       "                'Institute of Pharmacy and Food Chemistry, University of Wurzburg, Am Hubland, 97074 Wurzburg, Germany.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, 07743 Jena, Germany.',\n",
       "                'Center for Biomolecular Magnetic Resonance, Goethe-University, 60438 Frankfurt/Main, Germany.',\n",
       "                'Cluster of Excellence \"Balance of the Microverse\", Friedrich Schiller University Jena, 07743 Jena, Germany.'],\n",
       "               'AUID': ['ORCID: 0000-0001-8966-111X',\n",
       "                'ORCID: 0000-0003-4351-8857',\n",
       "                'ORCID: 0000-0002-2322-5371',\n",
       "                'ORCID: 0009-0009-8725-3927',\n",
       "                'ORCID: 0000-0003-4968-889X',\n",
       "                'ORCID: 0000-0003-2340-2216',\n",
       "                'ORCID: 0000-0002-4073-0505',\n",
       "                'ORCID: 0000-0002-0364-7278',\n",
       "                'ORCID: 0000-0001-7162-285X'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20250220',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Med Chem',\n",
       "               'JT': 'Journal of medicinal chemistry',\n",
       "               'JID': '9716531',\n",
       "               'RN': ['0 (Pipecolic Acids)',\n",
       "                '0 (Bacterial Proteins)',\n",
       "                '0 (Protozoan Proteins)',\n",
       "                'EC 5.2.1.8 (Mip protein, Legionella pneumophila)',\n",
       "                'EC 5.2.1.8 (Peptidylprolyl Isomerase)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['*Pipecolic Acids/chemistry/pharmacology',\n",
       "                '*Trypanosoma cruzi/drug effects/metabolism',\n",
       "                '*Bacterial Proteins/metabolism/antagonists & inhibitors/chemistry',\n",
       "                '*Legionella pneumophila/drug effects',\n",
       "                'Burkholderia pseudomallei/drug effects',\n",
       "                'Halogenation',\n",
       "                'Crystallography, X-Ray',\n",
       "                'Protozoan Proteins/antagonists & inhibitors/metabolism/chemistry',\n",
       "                'Models, Molecular',\n",
       "                'Peptidylprolyl Isomerase/antagonists & inhibitors/metabolism'],\n",
       "               'PMC': 'PMC11912469',\n",
       "               'COIS': ['The authors declare no competing financial interest.'],\n",
       "               'EDAT': '2025/02/20 12:25',\n",
       "               'MHDA': '2025/03/13 06:27',\n",
       "               'PMCR': ['2025/03/17'],\n",
       "               'CRDT': ['2025/02/20 08:13'],\n",
       "               'PHST': ['2025/03/13 06:27 [medline]',\n",
       "                '2025/02/20 12:25 [pubmed]',\n",
       "                '2025/02/20 08:13 [entrez]',\n",
       "                '2025/03/17 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1021/acs.jmedchem.5c00134 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Med Chem. 2025 Mar 13;68(5):5926-5941. doi: 10.1021/acs.jmedchem.5c00134. Epub 2025 Feb 20.'},\n",
       "              {'PMID': '39899647',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'Publisher',\n",
       "               'LR': '20250203',\n",
       "               'IS': '2198-3844 (Electronic) 2198-3844 (Linking)',\n",
       "               'DP': '2025 Feb 3',\n",
       "               'TI': 'Ultrasound Super-Resolution Imaging of Neonatal Cerebral Vascular Reorganization.',\n",
       "               'PG': 'e2415235',\n",
       "               'LID': '10.1002/advs.202415235 [doi]',\n",
       "               'AB': 'During the first days of neonatal growth, the central nervous system (CNS) develops self-regulatory mechanisms to ensure constant cerebral perfusion. However, this vascular neogenesis takes place at a microscopic scale that cannot be observed with current clinical imaging techniques. Ultrasound localization microscopy (ULM) allows us to observe micro-vessels of the order of a few microns at depths of several centimeters. This can be done using conventional clinical ultrasound scanners and contrast sequences (CEUS). In this study, ULM is used to observe the human microvasculature in neonatal patients undergoing treatment for life-threatening malformations forming direct connections between the cerebral arterial and venous systems. It is observed that neuroendovascular treatment of neonatal arteriovenous malformations causes remodeling and reorganization of the cerebral vasculature by also activating corticomedullary vascular connections. ULM enables us to follow microvascular changes in human neonates with high spatio-temporal resolution. ULM may provide a novel clinical translatable tool, particularly including cerebral imaging in very young patients.',\n",
       "               'CI': ['(c) 2025 The Author(s). Advanced Science published by Wiley-VCH GmbH.'],\n",
       "               'FAU': ['Schwarz, Simone',\n",
       "                'Denis, Louise',\n",
       "                'Nedoschill, Emmanuel',\n",
       "                'Buehler, Adrian',\n",
       "                'Danko, Vera',\n",
       "                'Hilger, Alina C',\n",
       "                'Brevis Nunez, Francisco',\n",
       "                'Durr, Nikola R',\n",
       "                'Schlunz-Hendann, Martin',\n",
       "                'Brassel, Friedhelm',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Reutter, Heiko',\n",
       "                'Woelfle, Joachim',\n",
       "                'Jungert, Jorg',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Bruns, Nora',\n",
       "                'Regensburger, Adrian P',\n",
       "                'Couture, Olivier',\n",
       "                'Mandelbaum, Henriette',\n",
       "                'Knieling, Ferdinand'],\n",
       "               'AU': ['Schwarz S',\n",
       "                'Denis L',\n",
       "                'Nedoschill E',\n",
       "                'Buehler A',\n",
       "                'Danko V',\n",
       "                'Hilger AC',\n",
       "                'Brevis Nunez F',\n",
       "                'Durr NR',\n",
       "                'Schlunz-Hendann M',\n",
       "                'Brassel F',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Reutter H',\n",
       "                'Woelfle J',\n",
       "                'Jungert J',\n",
       "                'Dohna-Schwake C',\n",
       "                'Bruns N',\n",
       "                'Regensburger AP',\n",
       "                'Couture O',\n",
       "                'Mandelbaum H',\n",
       "                'Knieling F'],\n",
       "               'AD': ['Department of Neonatology and Pediatric Intensive Care Medicine, Sana Clinics Duisburg, Zu den Rehwiesen 9, 47055, Duisburg, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.',\n",
       "                \"Laboratoire d'Imagerie Biomedicale, Sorbonne Universite, CNRS, INSERM, 15 Rue de l'Ecole de Medecine, 75006, Paris, France.\",\n",
       "                'Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestrasse 15, 91054, Erlangen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestrasse 15, 91054, Erlangen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestrasse 15, 91054, Erlangen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestrasse 15, 91054, Erlangen, Germany.',\n",
       "                'Department of Neonatology and Pediatric Intensive Care Medicine, Sana Clinics Duisburg, Zu den Rehwiesen 9, 47055, Duisburg, Germany.',\n",
       "                'Clinic for Radiology and Neuroradiology, Sana Clinics Duisburg, Zu den Rehwiesen 9, 47055, Duisburg, Germany.',\n",
       "                'Clinic for Radiology and Neuroradiology, Sana Clinics Duisburg, Zu den Rehwiesen 9, 47055, Duisburg, Germany.',\n",
       "                'Clinic for Radiology and Neuroradiology, Sana Clinics Duisburg, Zu den Rehwiesen 9, 47055, Duisburg, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestrasse 15, 91054, Erlangen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestrasse 15, 91054, Erlangen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestrasse 15, 91054, Erlangen, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestrasse 15, 91054, Erlangen, Germany.',\n",
       "                \"Laboratoire d'Imagerie Biomedicale, Sorbonne Universite, CNRS, INSERM, 15 Rue de l'Ecole de Medecine, 75006, Paris, France.\",\n",
       "                'Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestrasse 15, 91054, Erlangen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestrasse 15, 91054, Erlangen, Germany.'],\n",
       "               'AUID': ['ORCID: 0000-0002-3535-2626'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['Deutsche Gesellschaft fur Ultraschall in der Medizin/',\n",
       "                'ERC Starting Grant No 101115742/HORIZON EUROPE European Research Council/',\n",
       "                '772786/HORIZON EUROPE European Research Council/'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20250203',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Adv Sci (Weinh)',\n",
       "               'JT': 'Advanced science (Weinheim, Baden-Wurttemberg, Germany)',\n",
       "               'JID': '101664569',\n",
       "               'SB': 'IM',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['CEUS',\n",
       "                'Vein of Galen malformation',\n",
       "                'microbubbles',\n",
       "                'super-resolution imaging',\n",
       "                'ultrasound',\n",
       "                'ultrasound localization microscopy'],\n",
       "               'EDAT': '2025/02/03 18:20',\n",
       "               'MHDA': '2025/02/03 18:20',\n",
       "               'CRDT': ['2025/02/03 14:03'],\n",
       "               'PHST': ['2024/12/29 00:00 [revised]',\n",
       "                '2024/11/19 00:00 [received]',\n",
       "                '2025/02/03 18:20 [medline]',\n",
       "                '2025/02/03 18:20 [pubmed]',\n",
       "                '2025/02/03 14:03 [entrez]'],\n",
       "               'AID': ['10.1002/advs.202415235 [doi]'],\n",
       "               'PST': 'aheadofprint',\n",
       "               'SO': 'Adv Sci (Weinh). 2025 Feb 3:e2415235. doi: 10.1002/advs.202415235.'},\n",
       "              {'PMID': '39647538',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20250130',\n",
       "               'LR': '20250130',\n",
       "               'IS': '1878-5921 (Electronic) 0895-4356 (Linking)',\n",
       "               'VI': '178',\n",
       "               'DP': '2025 Feb',\n",
       "               'TI': 'Performance of ICD-10-based injury severity scores in pediatric trauma patients using the ICD-AIS map and survival rate ratios.',\n",
       "               'PG': '111634',\n",
       "               'LID': 'S0895-4356(24)00390-1 [pii] 10.1016/j.jclinepi.2024.111634 [doi]',\n",
       "               'AB': 'OBJECTIVES: The performance of injury severity scores (ISSs), used widely to quantify injury severity and predict outcomes, has not been investigated in German pediatric cases. This study aims to identify the most feasible and accurate injury score predictor of mortality in German children with trauma using International Classification of Diseases 10 (ICD-10). STUDY DESIGN AND SETTING: Between 2014 and 2020, a retrospective observational cohort study of hospital admissions cases aged <18 years with injury-related ICD-10 codes, using the German hospital database (GHD), was conducted. The maximum abbreviated injury scale and ISS were calculated using the International Classification of Diseases-Abbreviated Injury Scale (ICD-AIS) map provided by the Association for the Advancement of Automotive Medicine, adjusted to the German modification of the ICD-10 classification. The survival risk ratio was used to calculate the single-worst ICD-derived injury (single International Classification of Disease Injury Severity Score [ICISS]) and a multiplicative ICISS. Logistic regressions were conducted for each of the four above-mentioned scores (predictors) to predict in-hospital mortality (outcome) in the selected trauma population and within four clinically relevant subgroups using discrimination and calibration. RESULTS: 1,720,802 were trauma patients, and ICD-AIS mapping was possible in 1,328,377 cases. Cases with mapping failure (n = 392,425; 22.8%) were younger and had a higher mortality rate were excluded from the performance analysis. ICISS-derived scores had a better discrimination and calibration than ICD-AIS based scores in the overall cohort and all four subgroups (area under the curve [AUC] ranges between 0.985 and 0.998 vs 0.886 and- 0.972, respectively). CONCLUSION: Empirically derived measures of injury severity were superior to ICD-AIS mapped scores in the GHD to predict mortality in pediatric trauma patients. Given the high percentage of mapping failure and high mortality among cases with single-coded injury, the single ICISS may be the most suitable measure of injury severity in this group of patients.',\n",
       "               'CI': ['Copyright (c) 2024 The Authors. Published by Elsevier Inc. All rights reserved.'],\n",
       "               'FAU': ['Hojeij, Rayan',\n",
       "                'Brensing, Pia',\n",
       "                'Nonnemacher, Michael',\n",
       "                'Kowall, Bernd',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dudda, Marcel',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Stang, Andreas',\n",
       "                'Bruns, Nora'],\n",
       "               'AU': ['Hojeij R',\n",
       "                'Brensing P',\n",
       "                'Nonnemacher M',\n",
       "                'Kowall B',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dudda M',\n",
       "                'Dohna-Schwake C',\n",
       "                'Stang A',\n",
       "                'Bruns N'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Electronic address: rayan.hojeij@uk-essen.de.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany.',\n",
       "                'Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Trauma, Hand and Reconstructive Surgery, University Hospital Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Observational Study'],\n",
       "               'DEP': '20241207',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Clin Epidemiol',\n",
       "               'JT': 'Journal of clinical epidemiology',\n",
       "               'JID': '8801383',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*International Classification of Diseases',\n",
       "                'Child',\n",
       "                'Male',\n",
       "                'Female',\n",
       "                'Retrospective Studies',\n",
       "                'Child, Preschool',\n",
       "                '*Injury Severity Score',\n",
       "                '*Wounds and Injuries/classification/mortality',\n",
       "                'Adolescent',\n",
       "                'Germany/epidemiology',\n",
       "                'Infant',\n",
       "                '*Hospital Mortality',\n",
       "                'Abbreviated Injury Scale',\n",
       "                'Survival Rate',\n",
       "                'Infant, Newborn'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Injury severity',\n",
       "                'International classification of diseases',\n",
       "                'Mortality',\n",
       "                'Pediatric trauma',\n",
       "                'Survival probabilities'],\n",
       "               'COIS': ['Declaration of competing interest The authors declare that they have no known',\n",
       "                'competing financial interests or personal relationships that could have appeared',\n",
       "                'to influence the work reported in this paper.'],\n",
       "               'EDAT': '2024/12/09 00:22',\n",
       "               'MHDA': '2025/01/31 00:20',\n",
       "               'CRDT': ['2024/12/08 19:13'],\n",
       "               'PHST': ['2023/12/05 00:00 [received]',\n",
       "                '2024/06/19 00:00 [revised]',\n",
       "                '2024/12/03 00:00 [accepted]',\n",
       "                '2025/01/31 00:20 [medline]',\n",
       "                '2024/12/09 00:22 [pubmed]',\n",
       "                '2024/12/08 19:13 [entrez]'],\n",
       "               'AID': ['S0895-4356(24)00390-1 [pii]',\n",
       "                '10.1016/j.jclinepi.2024.111634 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Clin Epidemiol. 2025 Feb;178:111634. doi: 10.1016/j.jclinepi.2024.111634. Epub 2024 Dec 7.'},\n",
       "              {'PMID': '39603520',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20250226',\n",
       "               'LR': '20250226',\n",
       "               'IS': '1097-6833 (Electronic) 0022-3476 (Linking)',\n",
       "               'VI': '278',\n",
       "               'DP': '2025 Mar',\n",
       "               'TI': 'Severity of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 Diminished During Successive Waves of the COVID-19 Pandemic: Data from a Nationwide German Survey.',\n",
       "               'PG': '114419',\n",
       "               'LID': 'S0022-3476(24)00522-5 [pii] 10.1016/j.jpeds.2024.114419 [doi]',\n",
       "               'AB': 'OBJECTIVE: To elucidate how the clinical presentation of Pediatric Inflammatory Multisystem Syndrome temporally associated with Severe Acute Respiratory Syndrome-related Coronavirus 2 (PIMS-TS) was influenced by the successive variants of concern (VOC) and patient age. STUDY DESIGN: A nationwide PIMS-TS registry was established in Germany in May 2020, shortly after the first cases were described in the US and United Kingdom. The registry captured information on patient characteristics, clinical course, laboratory findings, imaging, and outcome. All pediatric hospitals in Germany, along with one in Austria, were invited to participate. Between March 18, 2020, and April 30, 2023, 920 cases were reported. RESULTS: By examining a combination of data on clinical features, laboratory findings, treatment, imaging results, and outcomes, our analysis demonstrated disease severity to have continuously declined over the course of the Wildtype, Alpha, Delta, and Omicron waves. Based on clinical symptoms, laboratory and diagnostic findings, and intensive care unit admission rates, older children, irrespective of the related VOC, were shown to experience more severe, acute PIMS-TS; however, they had lower rates of coronary aneurysm. CONCLUSIONS: During the course of COVID-19 pandemic, as each new VOC emerged, PIMS-TS lessened in severity. In parallel, older children came to experience more debilitating disease.',\n",
       "               'CI': ['Copyright (c) 2024 The Author(s). Published by Elsevier Inc. All rights reserved.'],\n",
       "               'FAU': ['Lohrmann, Florens',\n",
       "                'Doenhardt, Maren',\n",
       "                'Diffloth, Natalie',\n",
       "                'Jakob, Andre',\n",
       "                'Hospach, Anton',\n",
       "                'Schneider, Dominik T',\n",
       "                'Trotter, Andreas',\n",
       "                'Brunner, Jurgen',\n",
       "                'Goretzki, Sarah',\n",
       "                'Arens, Stefan',\n",
       "                'Rank, Michael',\n",
       "                'Mauer, Rene',\n",
       "                'Armann, Jakob',\n",
       "                'Berner, Reinhard',\n",
       "                'Hufnagel, Markus'],\n",
       "               'AU': ['Lohrmann F',\n",
       "                'Doenhardt M',\n",
       "                'Diffloth N',\n",
       "                'Jakob A',\n",
       "                'Hospach A',\n",
       "                'Schneider DT',\n",
       "                'Trotter A',\n",
       "                'Brunner J',\n",
       "                'Goretzki S',\n",
       "                'Arens S',\n",
       "                'Rank M',\n",
       "                'Mauer R',\n",
       "                'Armann J',\n",
       "                'Berner R',\n",
       "                'Hufnagel M'],\n",
       "               'AD': ['Division of Neonatology and Pediatric Intensive Care, Department for Pediatrics and Adolescent Medicine, University Medical Center, Medical Faculty, University of Freiburg, Freiburg, Germany; Division of Pediatric Infectious Diseases and Rheumatology, Department for Pediatrics and Adolescent Medicine, University Medical Center, Medical Faculty, University of Freiburg, Freiburg, Germany. Electronic address: florens.lohrmann@uniklinik-freiburg.de.',\n",
       "                'Division of Neonatology, Department of Pediatrics and Adolescent Medicine, Paracelsus Medical University, Salzburg, Austria.',\n",
       "                'Department of Pediatrics, University Hospital, Medical Faculty Carl Gustav Carus, Technische Universitat Dresden, Dresden, Germany.',\n",
       "                \"Department of Pediatric Cardiology and Pediatric Intensive Care, Ludwig Maximilian's University of Munich, Munchen, Germany.\",\n",
       "                'Department of Pediatrics, Olga-Hospital, Stuttgart, Germany.',\n",
       "                'Clinic of Pediatrics, Municipal Hospital Dortmund, Dortmund, Germany.',\n",
       "                \"Children's Hospital and Center for Perinatal Medicine, Singen, Germany.\",\n",
       "                'Department of Pediatrics, Innsbruck Medical University, Innsbruck, Austria; Faculty of Medicine and Dentistry, Danube Private University, Innsbruck, Austria.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University of Duisburg-Essen, Essen, Germany.',\n",
       "                \"Children's Hospital Auf der Bult, Hannover, Germany.\",\n",
       "                'Institute for Medical Informatics and Biometry, Medical Faculty Carl Gustav Carus, Technische Universitat Dresden, Dresden, Germany.',\n",
       "                'Institute for Medical Informatics and Biometry, Medical Faculty Carl Gustav Carus, Technische Universitat Dresden, Dresden, Germany.',\n",
       "                'Department of Pediatrics, University Hospital, Medical Faculty Carl Gustav Carus, Technische Universitat Dresden, Dresden, Germany.',\n",
       "                'Department of Pediatrics, University Hospital, Medical Faculty Carl Gustav Carus, Technische Universitat Dresden, Dresden, Germany.',\n",
       "                'Division of Pediatric Infectious Diseases and Rheumatology, Department for Pediatrics and Adolescent Medicine, University Medical Center, Medical Faculty, University of Freiburg, Freiburg, Germany.'],\n",
       "               'CN': ['PIMS-DGPI Working Group'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20241126',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Pediatr',\n",
       "               'JT': 'The Journal of pediatrics',\n",
       "               'JID': '0375410',\n",
       "               'RN': ['pediatric multisystem inflammatory disease, COVID-19 related',\n",
       "                'SARS-CoV-2 variants'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*COVID-19/epidemiology/complications',\n",
       "                'Germany/epidemiology',\n",
       "                '*Systemic Inflammatory Response Syndrome/epidemiology/diagnosis',\n",
       "                'Child',\n",
       "                'Male',\n",
       "                'Child, Preschool',\n",
       "                'Female',\n",
       "                '*Severity of Illness Index',\n",
       "                '*Registries',\n",
       "                'Infant',\n",
       "                'Adolescent',\n",
       "                'SARS-CoV-2'],\n",
       "               'COIS': ['Declaration of Competing Interest Our registry was supported in part by the',\n",
       "                'Federal State of Saxony in Germany and the German Society for Pediatric',\n",
       "                'Infectious Diseases (DGPI). The authors declare no conflict of interest.'],\n",
       "               'FIR': ['Adam-Schnepf, Leonie',\n",
       "                'Adamiak-Brych, Grazyna',\n",
       "                'Aderhold, Martina',\n",
       "                'Aggar, Sarah',\n",
       "                'Ahmed, Mostafa Mohamed',\n",
       "                'Akanbi, Sandra',\n",
       "                'Allo, Regina-Sophie',\n",
       "                'Anders, Kristin',\n",
       "                'Arens, Stefan',\n",
       "                'Armann, Jakob',\n",
       "                'Avenmarg, Kentaro',\n",
       "                'Barikbin, Payman',\n",
       "                'Barquin, Fermin',\n",
       "                'Bassmann, Christoph',\n",
       "                'Baumbach, Lisa',\n",
       "                'Bayrhof, Otto-Jonas',\n",
       "                'Beier, Gerald',\n",
       "                'Belau, Nele',\n",
       "                'Bender, Giulia',\n",
       "                'Berger, Ardua',\n",
       "                'Bergmann, Marie',\n",
       "                'Bernard, Daniel',\n",
       "                'Berner, Reinhard',\n",
       "                'Berwald, Mario',\n",
       "                'Bienenstein, Evelyn',\n",
       "                'Biering, Adina',\n",
       "                'Birkenstock, Sophia',\n",
       "                'Bley, Julia',\n",
       "                'Blume, Stefanie',\n",
       "                'Blumlein, Ulrike',\n",
       "                'Bockenholt, Kai',\n",
       "                'Boesing, Thomas',\n",
       "                'Boever, Julie',\n",
       "                'Bohme, Henning',\n",
       "                'Bolke, Carsten',\n",
       "                'Bonacker, Robert',\n",
       "                'Bonney, Nora',\n",
       "                'Borchers, Monika-Maria',\n",
       "                'Borsch, Ekaterina',\n",
       "                'Bosse, Hans Martin',\n",
       "                'Botschen, Katharina',\n",
       "                'Braun, Sandra',\n",
       "                'Brenner, Britta',\n",
       "                'Brinkmann, Folke',\n",
       "                'Brocke, Amrei',\n",
       "                'Bruckner, Thomas',\n",
       "                'Bruhler, Jasmin',\n",
       "                'Brunner, Jurgen',\n",
       "                'Buchtala, Laura',\n",
       "                'Budde, Jorg',\n",
       "                'Buderus, Stephan',\n",
       "                'Bullmann, Reinhard',\n",
       "                'Busch, Katrin',\n",
       "                'Schoppe, Marc Carre',\n",
       "                'Christians, Claus',\n",
       "                'Cvetanovic, Gordana',\n",
       "                'Czaplinska, Agnieszka',\n",
       "                'Czech, Jonas',\n",
       "                'Czwienzek, Alina',\n",
       "                'Degirmenci, Metin',\n",
       "                'Dejas, Fenja',\n",
       "                'Demirdelen, Berguzar',\n",
       "                'Diederichs, Anke',\n",
       "                'Diffloth, Natalie',\n",
       "                'Dittrich, Maren',\n",
       "                'Doenhardt, Maren',\n",
       "                'Dohring, Katharina',\n",
       "                'Doll, Ulrike',\n",
       "                'Donath, Helena',\n",
       "                'Dorn, Annegret',\n",
       "                'Dressen, Svenja',\n",
       "                'Dubenhorst, Jens',\n",
       "                'Ebert, Franziska',\n",
       "                'Eff, Annemarie',\n",
       "                'Ehrentraut, Kerstin',\n",
       "                'Ehrsam, Christoph',\n",
       "                'Eissler, Fiene',\n",
       "                'Eissner, Anne',\n",
       "                'Elbe, Maria',\n",
       "                'Elsen, Lisa',\n",
       "                'Endmann, Matthias',\n",
       "                'Endres, Stefanie',\n",
       "                'Endres, Elisa',\n",
       "                'Engler, Matthias',\n",
       "                'Erbe, Oxana',\n",
       "                'Erler, Anna-Lisa',\n",
       "                'Ewest, Stephan',\n",
       "                'Fiedler, Andreas',\n",
       "                'Fingerhut, Karin',\n",
       "                'Finster, Agnes',\n",
       "                'Fischer, Doris',\n",
       "                'Fischl, Kristina',\n",
       "                'Flumann, Simon',\n",
       "                'Foth, Svenja',\n",
       "                'Franssen, Meike',\n",
       "                'Fremerey, Christian',\n",
       "                'Frenzke, Holger',\n",
       "                'Frohle, Michael',\n",
       "                'Galow, Lukas',\n",
       "                'Gams, Franziska',\n",
       "                'Gappa, Monika',\n",
       "                'Gartner, Sabine',\n",
       "                'Gatti, Andre',\n",
       "                'Geerdts, Lars',\n",
       "                'Gerling, Stephan',\n",
       "                'Giesen, Verena',\n",
       "                'Gitzinger, Stina',\n",
       "                'Glas, Katharina',\n",
       "                'Glaser, Nicola',\n",
       "                'Glaser, Isabell',\n",
       "                'Glockel, Ulrich',\n",
       "                'Goj, Karoline',\n",
       "                'Goretzki, Sarah Christina',\n",
       "                'Gottschalk, Julia',\n",
       "                'Gotz, Oliver',\n",
       "                'Groger, Katrin',\n",
       "                'Groteclaes, Tim',\n",
       "                'Gruber, Kathrin',\n",
       "                'Gruner, Judith',\n",
       "                'Grunwedel, Mike',\n",
       "                'Gutbier, Christian',\n",
       "                'Haag, Stephan',\n",
       "                'Haddad, Nechama',\n",
       "                'Hagel, Yasmin',\n",
       "                'Hagemann, Swantje',\n",
       "                'Halwas, Nikolaus',\n",
       "                'Handel, Norman',\n",
       "                'Haniel, Franziska',\n",
       "                'Hanke, Christof',\n",
       "                'Harneit, Paul Lennard',\n",
       "                'Hassan, Hanan',\n",
       "                'Haupt, Anne',\n",
       "                'Heffels, Marie-Kristin',\n",
       "                'Heinrich, Christina',\n",
       "                'Heinrich, Julia',\n",
       "                'Hempel, Lutz',\n",
       "                'Henke, Christina',\n",
       "                'Hepp, Christian',\n",
       "                'Hermann, Matthias',\n",
       "                'Hermens, Jan-Simon',\n",
       "                'Hermsen, Manfred',\n",
       "                'Herzog, Matthias',\n",
       "                'Heubner, Georg',\n",
       "                'Hilker, Kai-Alexandra',\n",
       "                'Hillebrand, Georg',\n",
       "                'Himpel, Matthias',\n",
       "                'Hittmeyer, Cara',\n",
       "                'Hoche, Alexander',\n",
       "                'Hoffmeister, Eric',\n",
       "                'Hofgen, Mirjam',\n",
       "                'Holtkamp, Katharina',\n",
       "                'Holzrichter, Irene',\n",
       "                'Hopner, Uwe',\n",
       "                'Hoppen, Thomas',\n",
       "                'Horschitz, Sophie',\n",
       "                'Horstkemper, Marita',\n",
       "                'Horstmann, Judith',\n",
       "                'Horvath, Dora',\n",
       "                'Hospach, Anton',\n",
       "                'Huhne, Tom',\n",
       "                'Hufnagel, Markus',\n",
       "                'Hunfeld, Birte',\n",
       "                'Huseman, Dieter',\n",
       "                'Ido, Nora',\n",
       "                'Iliaev, Vladimir',\n",
       "                'Indraswari, Fithri',\n",
       "                'Ioannou, Phryne',\n",
       "                'Isberner, Riekje',\n",
       "                'Jacker, Michaela',\n",
       "                'Jahn, Friederike',\n",
       "                'Jakob, Andre',\n",
       "                'Janata, Pauline',\n",
       "                'Jantzen, Dirk',\n",
       "                'Jedwilayties, Simone',\n",
       "                'Jenssen, Sonke',\n",
       "                'Jung, Claudia',\n",
       "                'Justus, Georgia',\n",
       "                'Kaiser, Iris',\n",
       "                'Kaiser, Lukas',\n",
       "                'Kaiser-Labusch, Petra',\n",
       "                'Kalhoff, Hermann',\n",
       "                'Kasner, Charlotte',\n",
       "                'Kassberger, Fabian',\n",
       "                'Keck, Johanna',\n",
       "                'Kelch, Felicitas',\n",
       "                'Keller, Thomas',\n",
       "                'Kelzon, Svetlana',\n",
       "                'Kern, Jan',\n",
       "                'Kessner, Marie-Sophie',\n",
       "                'Kever, Daniel',\n",
       "                'Khalidi, Zohal',\n",
       "                'Kirchner, Arni',\n",
       "                'Kirschstein, Martin',\n",
       "                'Kirschstein, David',\n",
       "                'Kissner, Lydia',\n",
       "                'Kitz, Richard',\n",
       "                'Klauwer, Dietrich',\n",
       "                'Kleff, Christine',\n",
       "                'Kleimeyer, Christian',\n",
       "                'Kleinbercher, Priska',\n",
       "                'Klementz, Karsten',\n",
       "                'Kluthe, Christof',\n",
       "                'Knechtel, Jan',\n",
       "                'Knop, Lisanne',\n",
       "                'Knop, Katharina',\n",
       "                'Koch, Hans Georg',\n",
       "                'Kohler, Simone',\n",
       "                'Vasconcelos, Malte Kohns',\n",
       "                'Konrad, Florian',\n",
       "                'Koop, Sabrina',\n",
       "                'Kortes, Marion',\n",
       "                'Kosteczka, Robert',\n",
       "                'Koster, Holger',\n",
       "                'Koukli, Georgia',\n",
       "                'Kowski, Sascha',\n",
       "                'Krauss, Karl',\n",
       "                'Kretzschmar, Benno',\n",
       "                'Kronberger, Aaron',\n",
       "                'Kuhnigk, Mirco',\n",
       "                'Kulzer, Lorenz',\n",
       "                'Kuska, Marion',\n",
       "                'Kwaschnowitz, Sachiko',\n",
       "                'Lamprecht, Pia-Sophie',\n",
       "                'Lange, Martina',\n",
       "                'Lange, Veit',\n",
       "                'Lautner, Gerrit',\n",
       "                'Lee, Sea-Hyun',\n",
       "                'Lerner, Johann Caspar',\n",
       "                'Leuschner, Alexander',\n",
       "                'Libuschewski, Hanna',\n",
       "                'Liese, Johannes',\n",
       "                'Lindemann, Linus',\n",
       "                'Lindl, Ilona',\n",
       "                'Linke, Julia',\n",
       "                'Lipek, Tobias',\n",
       "                'Loffler, Kim',\n",
       "                'Lohrmann, Florens',\n",
       "                'Lohse, Karolin',\n",
       "                'Lorenz, Norbert',\n",
       "                'Lorenzen, Niko',\n",
       "                'Lubitz, Daniela',\n",
       "                'Machata, Heike',\n",
       "                'Machon, Kathrin',\n",
       "                'Mader, Franziska',\n",
       "                'Magin, Katharina',\n",
       "                'Maier, Lisa',\n",
       "                'Malath, Ingrid',\n",
       "                'Mampe, Cornelie',\n",
       "                'Markowsky, Andrea',\n",
       "                'Galvez, Alejandro Martinez',\n",
       "                'Mauer, Rene',\n",
       "                'Mauritz, Maximilian',\n",
       "                'Mehler, Katrin',\n",
       "                'Meister, Jochen',\n",
       "                'Menden, Melanie',\n",
       "                'Menzel, Felix',\n",
       "                'Merker, Michael',\n",
       "                'Meyer, Jens',\n",
       "                'Meyer-Dobkowitz, Lars',\n",
       "                'Mezger, Alexander',\n",
       "                'Mohorovicic, Marko',\n",
       "                'Moise, Laura',\n",
       "                'Morawski, Yvonne',\n",
       "                'Motzkus, Laura',\n",
       "                'Muller, Bianca',\n",
       "                'Muller, Annemarie',\n",
       "                'Muller, Mirja',\n",
       "                'Muller, Guido',\n",
       "                'Muller, Meike',\n",
       "                'Nathan, Suzanne',\n",
       "                'Neuenhofer, Hannah',\n",
       "                'Neumann, Larissa',\n",
       "                'Niehaus, Thomas',\n",
       "                'Obenthur, Andre',\n",
       "                'Oberthur, Andre',\n",
       "                'Ohlendorf, Johanna',\n",
       "                'Olar, Florina',\n",
       "                'Opgen-Rhein, Bernd',\n",
       "                'Ostreicher, Iris',\n",
       "                'Parthey, Kathleen',\n",
       "                'Perazzi, Eugenia',\n",
       "                'Piehler, Lisa',\n",
       "                'Pohlmeier, Constanze',\n",
       "                'Polmann, Jan',\n",
       "                'Ponsa, Corinna',\n",
       "                'Potzsch, Simone',\n",
       "                'Preussner, Anja',\n",
       "                'Rademacher, Luisa',\n",
       "                'Rambow, Jenny',\n",
       "                'Rank, Michael',\n",
       "                'Raum, Jacqueline',\n",
       "                'Reck, Heike',\n",
       "                'Rehmann, Victoria',\n",
       "                'Reichert, Friedrich',\n",
       "                'Reil, Annika',\n",
       "                'Reinhardt, Thomas',\n",
       "                'Richter, Jost Wigand',\n",
       "                'Richter, Carolin',\n",
       "                'Rieber, Nikolaus',\n",
       "                'Ringe, Hannelore',\n",
       "                'Rubo, Jochen',\n",
       "                'Ruhlmann, Alexander',\n",
       "                'Salzbrunn, Margrit',\n",
       "                'Samol, Anja',\n",
       "                'Sauerbrey, Kristin',\n",
       "                'Schaeffer, N',\n",
       "                'Schafer, Miriam',\n",
       "                'Scheffler, Miriam',\n",
       "                'Scheidler, Ira',\n",
       "                'Scherbaum, Vanessa Sarah',\n",
       "                'Schettler, Claudia',\n",
       "                'Schick, Christoph',\n",
       "                'Schiller, Benjamin',\n",
       "                'Schlick, Christian',\n",
       "                'Schlingschroder, Christina',\n",
       "                'Schmitt, Caroline',\n",
       "                'Schmitt-Bohn, Katharina',\n",
       "                'Schnegg, Clivia',\n",
       "                'Schneider, Dominik T',\n",
       "                'Schneider, Hans-Christoph',\n",
       "                'Schnelke, Alexander',\n",
       "                'Schreier, Stefan',\n",
       "                'Schrewe, Roland',\n",
       "                'Schrod, Lothar',\n",
       "                'Schroers, Oliver',\n",
       "                'Schult, Louisa',\n",
       "                'Schultess, Leonie',\n",
       "                'Schulze-Sturm, Ulf',\n",
       "                'Schumacher, Isabel',\n",
       "                'Schutz, Katharina',\n",
       "                'Schwagerl, Valeria',\n",
       "                'Seidel, Sabrina',\n",
       "                'Sieben, Michael',\n",
       "                'Silkenbaumer, Katrin',\n",
       "                'Simon, Annika',\n",
       "                'Simon, Arne',\n",
       "                'Sindel, Isabelle',\n",
       "                'Smith, Bryony',\n",
       "                'Soditt, Volker',\n",
       "                'Solomou, Christina',\n",
       "                'Sonmez, Ezgi',\n",
       "                'Spancken, Elena',\n",
       "                'Spath, Lisa',\n",
       "                'Spehl, Marco',\n",
       "                'Spinner, Sebastian',\n",
       "                'Spittel, Dana',\n",
       "                'Stastny, Barbara',\n",
       "                'Steidl, Michael',\n",
       "                'Steif, Benedikt',\n",
       "                'Steimer, Ann-Kathrin',\n",
       "                'Stein, Detlef',\n",
       "                'Steinbach, Vera',\n",
       "                'Steinhauser, Maximilian',\n",
       "                'Stemberg, Frank',\n",
       "                'Stetefeld, Annika',\n",
       "                'Stockmann, Antje',\n",
       "                'Stohring, Thomas',\n",
       "                'Strothmann, Esther',\n",
       "                'Sumbadze, Daria',\n",
       "                'Tabatabai, Julia',\n",
       "                'Teichmann, Axel',\n",
       "                'Temming, Svenja',\n",
       "                'Terliesner, Nicolas',\n",
       "                'Thiel, Lion',\n",
       "                'Thiele, Antje',\n",
       "                'Thomas, Linda',\n",
       "                'Toni, Irmgard',\n",
       "                'Trankner, Jan',\n",
       "                'Trau, Stefanie',\n",
       "                'Treichel, Tina',\n",
       "                'Trotter, Andreas',\n",
       "                'Urgatz, Bartholomaus',\n",
       "                'van den Bruck, Rhea',\n",
       "                'van den Heuvel, Alijda',\n",
       "                'Vanselow, Doris',\n",
       "                'Vehse, Kai',\n",
       "                'Vischer, Lena',\n",
       "                'von Blomberg, Sophia',\n",
       "                'Voss, Sarah',\n",
       "                'Wagner-Siegel, Anna',\n",
       "                'Wahjudi, Tatjana',\n",
       "                'Walden, Ulrike',\n",
       "                'Walther, Ulrike',\n",
       "                'Warneke, Laura',\n",
       "                'Weber, Sarah',\n",
       "                'Wehl, Gotz',\n",
       "                'Wehrhoff, Falk',\n",
       "                'Weigert, Alexander',\n",
       "                'Weniger, Kristin',\n",
       "                'Wenzel, Sandra',\n",
       "                'Werner, Annika',\n",
       "                'Werner, Sarah',\n",
       "                'Wetzel, Ulrike',\n",
       "                'Wetzel, Dirk',\n",
       "                'Wichmann, Barbara',\n",
       "                'Wiethoff, Christiane Maria',\n",
       "                'Wild, Florian',\n",
       "                'Willmer, Denise',\n",
       "                'Wittschorek, Mark',\n",
       "                'Wolf, Felicitas',\n",
       "                'Wollny, Antje',\n",
       "                'Wrenger, Nina',\n",
       "                'Wroblewski, Andreas',\n",
       "                'Wurm, Donald',\n",
       "                'Yalaz, Nilgun',\n",
       "                'Yussif, Anne-Sophie',\n",
       "                'Zbieranek, Kai',\n",
       "                'Zeissig, Yvonne',\n",
       "                'Zellerhoff, Martin',\n",
       "                'Zimmeck, Valerie',\n",
       "                'Zugge, Ulrich'],\n",
       "               'IR': ['Adam-Schnepf L',\n",
       "                'Adamiak-Brych G',\n",
       "                'Aderhold M',\n",
       "                'Aggar S',\n",
       "                'Ahmed MM',\n",
       "                'Akanbi S',\n",
       "                'Allo RS',\n",
       "                'Anders K',\n",
       "                'Arens S',\n",
       "                'Armann J',\n",
       "                'Avenmarg K',\n",
       "                'Barikbin P',\n",
       "                'Barquin F',\n",
       "                'Bassmann C',\n",
       "                'Baumbach L',\n",
       "                'Bayrhof OJ',\n",
       "                'Beier G',\n",
       "                'Belau N',\n",
       "                'Bender G',\n",
       "                'Berger A',\n",
       "                'Bergmann M',\n",
       "                'Bernard D',\n",
       "                'Berner R',\n",
       "                'Berwald M',\n",
       "                'Bienenstein E',\n",
       "                'Biering A',\n",
       "                'Birkenstock S',\n",
       "                'Bley J',\n",
       "                'Blume S',\n",
       "                'Blumlein U',\n",
       "                'Bockenholt K',\n",
       "                'Boesing T',\n",
       "                'Boever J',\n",
       "                'Bohme H',\n",
       "                'Bolke C',\n",
       "                'Bonacker R',\n",
       "                'Bonney N',\n",
       "                'Borchers MM',\n",
       "                'Borsch E',\n",
       "                'Bosse HM',\n",
       "                'Botschen K',\n",
       "                'Braun S',\n",
       "                'Brenner B',\n",
       "                'Brinkmann F',\n",
       "                'Brocke A',\n",
       "                'Bruckner T',\n",
       "                'Bruhler J',\n",
       "                'Brunner J',\n",
       "                'Buchtala L',\n",
       "                'Budde J',\n",
       "                'Buderus S',\n",
       "                'Bullmann R',\n",
       "                'Busch K',\n",
       "                'Schoppe MC',\n",
       "                'Christians C',\n",
       "                'Cvetanovic G',\n",
       "                'Czaplinska A',\n",
       "                'Czech J',\n",
       "                'Czwienzek A',\n",
       "                'Degirmenci M',\n",
       "                'Dejas F',\n",
       "                'Demirdelen B',\n",
       "                'Diederichs A',\n",
       "                'Diffloth N',\n",
       "                'Dittrich M',\n",
       "                'Doenhardt M',\n",
       "                'Dohring K',\n",
       "                'Doll U',\n",
       "                'Donath H',\n",
       "                'Dorn A',\n",
       "                'Dressen S',\n",
       "                'Dubenhorst J',\n",
       "                'Ebert F',\n",
       "                'Eff A',\n",
       "                'Ehrentraut K',\n",
       "                'Ehrsam C',\n",
       "                'Eissler F',\n",
       "                'Eissner A',\n",
       "                'Elbe M',\n",
       "                'Elsen L',\n",
       "                'Endmann M',\n",
       "                'Endres S',\n",
       "                'Endres E',\n",
       "                'Engler M',\n",
       "                'Erbe O',\n",
       "                'Erler AL',\n",
       "                'Ewest S',\n",
       "                'Fiedler A',\n",
       "                'Fingerhut K',\n",
       "                'Finster A',\n",
       "                'Fischer D',\n",
       "                'Fischl K',\n",
       "                'Flumann S',\n",
       "                'Foth S',\n",
       "                'Franssen M',\n",
       "                'Fremerey C',\n",
       "                'Frenzke H',\n",
       "                'Frohle M',\n",
       "                'Galow L',\n",
       "                'Gams F',\n",
       "                'Gappa M',\n",
       "                'Gartner S',\n",
       "                'Gatti A',\n",
       "                'Geerdts L',\n",
       "                'Gerling S',\n",
       "                'Giesen V',\n",
       "                'Gitzinger S',\n",
       "                'Glas K',\n",
       "                'Glaser N',\n",
       "                'Glaser I',\n",
       "                'Glockel U',\n",
       "                'Goj K',\n",
       "                'Goretzki SC',\n",
       "                'Gottschalk J',\n",
       "                'Gotz O',\n",
       "                'Groger K',\n",
       "                'Groteclaes T',\n",
       "                'Gruber K',\n",
       "                'Gruner J',\n",
       "                'Grunwedel M',\n",
       "                'Gutbier C',\n",
       "                'Haag S',\n",
       "                'Haddad N',\n",
       "                'Hagel Y',\n",
       "                'Hagemann S',\n",
       "                'Halwas N',\n",
       "                'Handel N',\n",
       "                'Haniel F',\n",
       "                'Hanke C',\n",
       "                'Harneit PL',\n",
       "                'Hassan H',\n",
       "                'Haupt A',\n",
       "                'Heffels MK',\n",
       "                'Heinrich C',\n",
       "                'Heinrich J',\n",
       "                'Hempel L',\n",
       "                'Henke C',\n",
       "                'Hepp C',\n",
       "                'Hermann M',\n",
       "                'Hermens JS',\n",
       "                'Hermsen M',\n",
       "                'Herzog M',\n",
       "                'Heubner G',\n",
       "                'Hilker KA',\n",
       "                'Hillebrand G',\n",
       "                'Himpel M',\n",
       "                'Hittmeyer C',\n",
       "                'Hoche A',\n",
       "                'Hoffmeister E',\n",
       "                'Hofgen M',\n",
       "                'Holtkamp K',\n",
       "                'Holzrichter I',\n",
       "                'Hopner U',\n",
       "                'Hoppen T',\n",
       "                'Horschitz S',\n",
       "                'Horstkemper M',\n",
       "                'Horstmann J',\n",
       "                'Horvath D',\n",
       "                'Hospach A',\n",
       "                'Huhne T',\n",
       "                'Hufnagel M',\n",
       "                'Hunfeld B',\n",
       "                'Huseman D',\n",
       "                'Ido N',\n",
       "                'Iliaev V',\n",
       "                'Indraswari F',\n",
       "                'Ioannou P',\n",
       "                'Isberner R',\n",
       "                'Jacker M',\n",
       "                'Jahn F',\n",
       "                'Jakob A',\n",
       "                'Janata P',\n",
       "                'Jantzen D',\n",
       "                'Jedwilayties S',\n",
       "                'Jenssen S',\n",
       "                'Jung C',\n",
       "                'Justus G',\n",
       "                'Kaiser I',\n",
       "                'Kaiser L',\n",
       "                'Kaiser-Labusch P',\n",
       "                'Kalhoff H',\n",
       "                'Kasner C',\n",
       "                'Kassberger F',\n",
       "                'Keck J',\n",
       "                'Kelch F',\n",
       "                'Keller T',\n",
       "                'Kelzon S',\n",
       "                'Kern J',\n",
       "                'Kessner MS',\n",
       "                'Kever D',\n",
       "                'Khalidi Z',\n",
       "                'Kirchner A',\n",
       "                'Kirschstein M',\n",
       "                'Kirschstein D',\n",
       "                'Kissner L',\n",
       "                'Kitz R',\n",
       "                'Klauwer D',\n",
       "                'Kleff C',\n",
       "                'Kleimeyer C',\n",
       "                'Kleinbercher P',\n",
       "                'Klementz K',\n",
       "                'Kluthe C',\n",
       "                'Knechtel J',\n",
       "                'Knop L',\n",
       "                'Knop K',\n",
       "                'Koch HG',\n",
       "                'Kohler S',\n",
       "                'Vasconcelos MK',\n",
       "                'Konrad F',\n",
       "                'Koop S',\n",
       "                'Kortes M',\n",
       "                'Kosteczka R',\n",
       "                'Koster H',\n",
       "                'Koukli G',\n",
       "                'Kowski S',\n",
       "                'Krauss K',\n",
       "                'Kretzschmar B',\n",
       "                'Kronberger A',\n",
       "                'Kuhnigk M',\n",
       "                'Kulzer L',\n",
       "                'Kuska M',\n",
       "                'Kwaschnowitz S',\n",
       "                'Lamprecht PS',\n",
       "                'Lange M',\n",
       "                'Lange V',\n",
       "                'Lautner G',\n",
       "                'Lee SH',\n",
       "                'Lerner JC',\n",
       "                'Leuschner A',\n",
       "                'Libuschewski H',\n",
       "                'Liese J',\n",
       "                'Lindemann L',\n",
       "                'Lindl I',\n",
       "                'Linke J',\n",
       "                'Lipek T',\n",
       "                'Loffler K',\n",
       "                'Lohrmann F',\n",
       "                'Lohse K',\n",
       "                'Lorenz N',\n",
       "                'Lorenzen N',\n",
       "                'Lubitz D',\n",
       "                'Machata H',\n",
       "                'Machon K',\n",
       "                'Mader F',\n",
       "                'Magin K',\n",
       "                'Maier L',\n",
       "                'Malath I',\n",
       "                'Mampe C',\n",
       "                'Markowsky A',\n",
       "                'Galvez AM',\n",
       "                'Mauer R',\n",
       "                'Mauritz M',\n",
       "                'Mehler K',\n",
       "                'Meister J',\n",
       "                'Menden M',\n",
       "                'Menzel F',\n",
       "                'Merker M',\n",
       "                'Meyer J',\n",
       "                'Meyer-Dobkowitz L',\n",
       "                'Mezger A',\n",
       "                'Mohorovicic M',\n",
       "                'Moise L',\n",
       "                'Morawski Y',\n",
       "                'Motzkus L',\n",
       "                'Muller B',\n",
       "                'Muller A',\n",
       "                'Muller M',\n",
       "                'Muller G',\n",
       "                'Muller M',\n",
       "                'Nathan S',\n",
       "                'Neuenhofer H',\n",
       "                'Neumann L',\n",
       "                'Niehaus T',\n",
       "                'Obenthur A',\n",
       "                'Oberthur A',\n",
       "                'Ohlendorf J',\n",
       "                'Olar F',\n",
       "                'Opgen-Rhein B',\n",
       "                'Ostreicher I',\n",
       "                'Parthey K',\n",
       "                'Perazzi E',\n",
       "                'Piehler L',\n",
       "                'Pohlmeier C',\n",
       "                'Polmann J',\n",
       "                'Ponsa C',\n",
       "                'Potzsch S',\n",
       "                'Preussner A',\n",
       "                'Rademacher L',\n",
       "                'Rambow J',\n",
       "                'Rank M',\n",
       "                'Raum J',\n",
       "                'Reck H',\n",
       "                'Rehmann V',\n",
       "                'Reichert F',\n",
       "                'Reil A',\n",
       "                'Reinhardt T',\n",
       "                'Richter JW',\n",
       "                'Richter C',\n",
       "                'Rieber N',\n",
       "                'Ringe H',\n",
       "                'Rubo J',\n",
       "                'Ruhlmann A',\n",
       "                'Salzbrunn M',\n",
       "                'Samol A',\n",
       "                'Sauerbrey K',\n",
       "                'Schaeffer N',\n",
       "                'Schafer M',\n",
       "                'Scheffler M',\n",
       "                'Scheidler I',\n",
       "                'Scherbaum VS',\n",
       "                'Schettler C',\n",
       "                'Schick C',\n",
       "                'Schiller B',\n",
       "                'Schlick C',\n",
       "                'Schlingschroder C',\n",
       "                'Schmitt C',\n",
       "                'Schmitt-Bohn K',\n",
       "                'Schnegg C',\n",
       "                'Schneider DT',\n",
       "                'Schneider HC',\n",
       "                'Schnelke A',\n",
       "                'Schreier S',\n",
       "                'Schrewe R',\n",
       "                'Schrod L',\n",
       "                'Schroers O',\n",
       "                'Schult L',\n",
       "                'Schultess L',\n",
       "                'Schulze-Sturm U',\n",
       "                'Schumacher I',\n",
       "                'Schutz K',\n",
       "                'Schwagerl V',\n",
       "                'Seidel S',\n",
       "                'Sieben M',\n",
       "                'Silkenbaumer K',\n",
       "                'Simon A',\n",
       "                'Simon A',\n",
       "                'Sindel I',\n",
       "                'Smith B',\n",
       "                'Soditt V',\n",
       "                'Solomou C',\n",
       "                'Sonmez E',\n",
       "                'Spancken E',\n",
       "                'Spath L',\n",
       "                'Spehl M',\n",
       "                'Spinner S',\n",
       "                'Spittel D',\n",
       "                'Stastny B',\n",
       "                'Steidl M',\n",
       "                'Steif B',\n",
       "                'Steimer AK',\n",
       "                'Stein D',\n",
       "                'Steinbach V',\n",
       "                'Steinhauser M',\n",
       "                'Stemberg F',\n",
       "                'Stetefeld A',\n",
       "                'Stockmann A',\n",
       "                'Stohring T',\n",
       "                'Strothmann E',\n",
       "                'Sumbadze D',\n",
       "                'Tabatabai J',\n",
       "                'Teichmann A',\n",
       "                'Temming S',\n",
       "                'Terliesner N',\n",
       "                'Thiel L',\n",
       "                'Thiele A',\n",
       "                'Thomas L',\n",
       "                'Toni I',\n",
       "                'Trankner J',\n",
       "                'Trau S',\n",
       "                'Treichel T',\n",
       "                'Trotter A',\n",
       "                'Urgatz B',\n",
       "                'van den Bruck R',\n",
       "                'van den Heuvel A',\n",
       "                'Vanselow D',\n",
       "                'Vehse K',\n",
       "                'Vischer L',\n",
       "                'von Blomberg S',\n",
       "                'Voss S',\n",
       "                'Wagner-Siegel A',\n",
       "                'Wahjudi T',\n",
       "                'Walden U',\n",
       "                'Walther U',\n",
       "                'Warneke L',\n",
       "                'Weber S',\n",
       "                'Wehl G',\n",
       "                'Wehrhoff F',\n",
       "                'Weigert A',\n",
       "                'Weniger K',\n",
       "                'Wenzel S',\n",
       "                'Werner A',\n",
       "                'Werner S',\n",
       "                'Wetzel U',\n",
       "                'Wetzel D',\n",
       "                'Wichmann B',\n",
       "                'Wiethoff CM',\n",
       "                'Wild F',\n",
       "                'Willmer D',\n",
       "                'Wittschorek M',\n",
       "                'Wolf F',\n",
       "                'Wollny A',\n",
       "                'Wrenger N',\n",
       "                'Wroblewski A',\n",
       "                'Wurm D',\n",
       "                'Yalaz N',\n",
       "                'Yussif AS',\n",
       "                'Zbieranek K',\n",
       "                'Zeissig Y',\n",
       "                'Zellerhoff M',\n",
       "                'Zimmeck V',\n",
       "                'Zugge U'],\n",
       "               'EDAT': '2024/11/28 00:24',\n",
       "               'MHDA': '2025/02/27 05:02',\n",
       "               'CRDT': ['2024/11/27 19:29'],\n",
       "               'PHST': ['2024/08/03 00:00 [received]',\n",
       "                '2024/10/30 00:00 [revised]',\n",
       "                '2024/11/17 00:00 [accepted]',\n",
       "                '2025/02/27 05:02 [medline]',\n",
       "                '2024/11/28 00:24 [pubmed]',\n",
       "                '2024/11/27 19:29 [entrez]'],\n",
       "               'AID': ['S0022-3476(24)00522-5 [pii]',\n",
       "                '10.1016/j.jpeds.2024.114419 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Pediatr. 2025 Mar;278:114419. doi: 10.1016/j.jpeds.2024.114419. Epub 2024 Nov 26.'},\n",
       "              {'PMID': '39190269',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20250213',\n",
       "               'LR': '20250317',\n",
       "               'IS': '1439-0973 (Electronic) 0300-8126 (Print) 0300-8126 (Linking)',\n",
       "               'VI': '53',\n",
       "               'IP': '1',\n",
       "               'DP': '2025 Feb',\n",
       "               'TI': 'Management and outcome of cutaneous diphtheria in adolescent refugees in Germany, June 2022 - October 2023.',\n",
       "               'PG': '329-337',\n",
       "               'LID': '10.1007/s15010-024-02374-y [doi]',\n",
       "               'AB': 'OBJECTIVES: From September 2022 an increase in Corynebacterium diphtheriae (C. diphtheriae) infections was reported in Europe. Our study focuses on 31 adolescent and young adult refugees with cutaneous C. diphtheriae infections detected in Germany. We examined treatment regimens and outcomes to provide targeted insights into the management of this infection. METHODS: We distributed a standardized survey, focused on children and adolescents presenting to paediatric clinics through the German Paediatric Infectious Diseases Society (DGPI) and additional professional contacts in Germany. Data were extracted from routine medical documentation and reported anonymously. RESULTS: A total of 31 individuals with cutaneous C. diphtheriae infection were reported by 9 centres. Two of these showed diphtheria toxin (DT) related systemic symptoms and four exhibited systemic inflammation requiring complex management. The remaining 25 cases, with exclusively cutaneous manifestations, were afebrile. Treatment with topical antiseptics and systemic antibiotics, mainly aminopenicillin/beta-lactamase inhibitors (BLI) (35%) or clindamycin (25%), achieved eradication in all but two cases treated with aminopenicillin/BLI. Treatment duration varied between 5 and 17 days. CONCLUSIONS: In refugees presenting with chronic skin wounds, C. diphtheriae should be included into the differential diagnosis. Fever seems to be a valuable marker to differentiate severe cases with potentially DT-mediated sequelae from exclusively cutaneous diphtheria (CD). For afebrile CD, topical antiseptics and oral antibiotic therapy with clindamycin for 7 days, followed by clinical surveillance appears to be a safe treatment regimen. Patients with CD who present with fever or pharyngitis should be thoroughly investigated including blood and pharyngeal swab cultures.',\n",
       "               'CI': ['(c) 2024. The Author(s).'],\n",
       "               'FAU': ['Zink, Alicia',\n",
       "                'Hofer, Juliana',\n",
       "                'Schneider, Christian',\n",
       "                'Kessler, Franziska',\n",
       "                'Klenze, Hannes',\n",
       "                'Klauwer, Dietrich',\n",
       "                'Maleki, Klaudia',\n",
       "                'Muller, Andreas',\n",
       "                'Goretzki, Sarah',\n",
       "                'Wang, Shubei',\n",
       "                'Kobbe, Robin',\n",
       "                'Ramirez, Andrea Vanegas',\n",
       "                'Bode, Sebastian',\n",
       "                'Janda, Ales',\n",
       "                'Fressle, Roland',\n",
       "                'Remppis, Jonathan',\n",
       "                'Henneke, Philipp',\n",
       "                'Rieg, Siegbert',\n",
       "                'Berger, Anja',\n",
       "                'Sing, Andreas',\n",
       "                'Hufnagel, Markus',\n",
       "                'Spielberger, Benedikt D'],\n",
       "               'AU': ['Zink A',\n",
       "                'Hofer J',\n",
       "                'Schneider C',\n",
       "                'Kessler F',\n",
       "                'Klenze H',\n",
       "                'Klauwer D',\n",
       "                'Maleki K',\n",
       "                'Muller A',\n",
       "                'Goretzki S',\n",
       "                'Wang S',\n",
       "                'Kobbe R',\n",
       "                'Ramirez AV',\n",
       "                'Bode S',\n",
       "                'Janda A',\n",
       "                'Fressle R',\n",
       "                'Remppis J',\n",
       "                'Henneke P',\n",
       "                'Rieg S',\n",
       "                'Berger A',\n",
       "                'Sing A',\n",
       "                'Hufnagel M',\n",
       "                'Spielberger BD'],\n",
       "               'AD': ['Division for Paediatric Infectious Diseases and Rheumatology, Department of Paediatrics and Adolescent Medicine, University Medical Centre, Medical Faculty, University of Freiburg, Freiburg, Germany.',\n",
       "                'Institute for Medical Microbiology and Hygiene, University Medical Centre Freiburg, Freiburg, Germany.',\n",
       "                'Institute for Medical Microbiology and Hygiene, University Medical Centre Freiburg, Freiburg, Germany.',\n",
       "                'Centre for Child and Adolescent Health, Hegau-Bodensee Clinic Singen, Constance District Health Association, Singen, Germany.',\n",
       "                'Centre for Child and Adolescent Health, Hegau-Bodensee Clinic Singen, Constance District Health Association, Singen, Germany.',\n",
       "                'Centre for Child and Adolescent Health, Hegau-Bodensee Clinic Singen, Constance District Health Association, Singen, Germany.',\n",
       "                'Department of General Medicine and Health Services Research, Heidelberg University Hospital, Interdisciplinary Refugee Outpatient Clinic at the Patrick-Henry-Village State Initial Reception Centre, Heidelberg, Germany.',\n",
       "                'Initial Reception Centre of the State of Hesse, Giessen Regional Council, Giessen, Germany.',\n",
       "                'Clinic for Paediatrics I, Essen University Hospital, Essen, Germany.',\n",
       "                'Pediatrics 2: General and Special Pediatrics including Pediatric Infectious Diseases, Klinikum Stuttgart, Olgahospital, Stuttgart, Germany.',\n",
       "                'Institute for Infection Research and Vaccine Development, University Medical Centre Hamburg- Eppendorf, Hamburg, Germany.',\n",
       "                'Department of Infection Epidemiology, Bernhard Nocht Institute for Tropical Medicine (BNITM), Hamburg, Germany.',\n",
       "                'Bundeswehr Hospital Hamburg, Tropical Dermatology at the Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.',\n",
       "                'Department of Paediatrics and Adolescent Medicine, Ulm University Medical Centre, Ulm University, Ulm, Germany.',\n",
       "                'Department of Paediatrics and Adolescent Medicine, Ulm University Medical Centre, Ulm University, Ulm, Germany.',\n",
       "                'Paediatric and Adolescent Practice Dr Roland Fressle, Freiburg, Germany.',\n",
       "                \"Department of Neuropaediatrics, General Paediatrics, Diabetology, Endocrinology, Social Paediatrics, University Children's Hospital Tubingen, Tubingen, Germany.\",\n",
       "                'Institute of Tropical Medicine, Travel Medicine and Human Parasitology, University Hospital Tubingen, Tubingen, Germany.',\n",
       "                'Institute for Infection Prevention and Control, Medical Centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.',\n",
       "                'Department of Medicine II, Division of Infectious Diseases, Medical Centre-University of Freiburg, Faculty of Medicine, Freiburg, Germany.',\n",
       "                'Consultant Laboratory for Diphtheria, WHO Collaborating Centre for Diphtheria, Bavarian Health and Food Safety Authority, Oberschleissheim, Germany.',\n",
       "                'Consultant Laboratory for Diphtheria, WHO Collaborating Centre for Diphtheria, Bavarian Health and Food Safety Authority, Oberschleissheim, Germany.',\n",
       "                'Division for Paediatric Infectious Diseases and Rheumatology, Department of Paediatrics and Adolescent Medicine, University Medical Centre, Medical Faculty, University of Freiburg, Freiburg, Germany.',\n",
       "                'Division for Paediatric Infectious Diseases and Rheumatology, Department of Paediatrics and Adolescent Medicine, University Medical Centre, Medical Faculty, University of Freiburg, Freiburg, Germany. benedikt.spielberger@uniklinik-freiburg.de.',\n",
       "                'Department of Paediatrics and Adolescent Medicine, University Medical Centre, Medical Faculty, University of Freiburg, Mathildenstr. 1, 79106, Freiburg, Germany. benedikt.spielberger@uniklinik-freiburg.de.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20240827',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Infection',\n",
       "               'JT': 'Infection',\n",
       "               'JID': '0365307',\n",
       "               'RN': ['0 (Anti-Bacterial Agents)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Adolescent',\n",
       "                '*Diphtheria/drug therapy/diagnosis/microbiology',\n",
       "                'Germany',\n",
       "                '*Refugees/statistics & numerical data',\n",
       "                'Male',\n",
       "                'Female',\n",
       "                'Child',\n",
       "                '*Corynebacterium diphtheriae/isolation & purification/drug effects',\n",
       "                '*Anti-Bacterial Agents/therapeutic use',\n",
       "                'Young Adult',\n",
       "                'Skin Diseases, Bacterial/drug therapy/microbiology/diagnosis',\n",
       "                'Treatment Outcome'],\n",
       "               'PMC': 'PMC11825593',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Balkan route',\n",
       "                'Cutaneous diphtheria',\n",
       "                'Diphtheria',\n",
       "                'Minor refugee',\n",
       "                'Throat diphtheria',\n",
       "                'Toxigenic C. diphtheriae'],\n",
       "               'COIS': ['Declarations. Ethical approval: This survey and the retrospective analysis were',\n",
       "                'approved by the ethics committee of the University Medical Centre Freiburg',\n",
       "                '(CUDAAR, ID 22-1493-S1-retro). Use of artificial intelligence tools: No',\n",
       "                'artificial intelligence was used in generating the research data or the',\n",
       "                'manuscript. Conflict of interest: All authors declare that they have no known',\n",
       "                'competing financial interests or personal relationships that could have appeared',\n",
       "                'to influence the work reported in this paper.'],\n",
       "               'EDAT': '2024/08/27 12:46',\n",
       "               'MHDA': '2025/02/14 00:23',\n",
       "               'PMCR': ['2024/08/27'],\n",
       "               'CRDT': ['2024/08/27 11:17'],\n",
       "               'PHST': ['2024/06/27 00:00 [received]',\n",
       "                '2024/08/11 00:00 [accepted]',\n",
       "                '2025/02/14 00:23 [medline]',\n",
       "                '2024/08/27 12:46 [pubmed]',\n",
       "                '2024/08/27 11:17 [entrez]',\n",
       "                '2024/08/27 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s15010-024-02374-y [pii]',\n",
       "                '2374 [pii]',\n",
       "                '10.1007/s15010-024-02374-y [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Infection. 2025 Feb;53(1):329-337. doi: 10.1007/s15010-024-02374-y. Epub 2024 Aug 27.'},\n",
       "              {'PMID': '39078993',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20250303',\n",
       "               'LR': '20250303',\n",
       "               'IS': '2066-8643 (Electronic) 1844-4172 (Linking)',\n",
       "               'VI': '27',\n",
       "               'IP': '1',\n",
       "               'DP': '2025 Mar 2',\n",
       "               'TI': 'An [illustrative] update on pediatric emergency medicine ultrasound: part 2 - abdominal and urogenital applications.',\n",
       "               'PG': '63-72',\n",
       "               'LID': '10.11152/mu-4414 [doi]',\n",
       "               'AB': 'Emergency ultrasound, or point-of-care ultrasound (POCUS), has been established into daily patient care over the last decades. The use of abdominal and pelvic ultrasound in clinical practice has the potential to improve the efficiency and safety of pediatric emergency care. This article will provide a review of current applications of pediatric emergency abdominal and urogenital ultrasound, forming the second part of the series.',\n",
       "               'FAU': ['Dong, Yi',\n",
       "                'Hoffmann, Beatrice',\n",
       "                'Schwarz, Simone',\n",
       "                'Nourkami-Tutdibi, Nasenien',\n",
       "                'Huang, Yun-Lin',\n",
       "                'Chen, Sheng',\n",
       "                'Cekuolis, Andrius',\n",
       "                'Augustiniene, Rasa',\n",
       "                'Snelling, Peter J',\n",
       "                'Schreiber-Dietrich, Dagmar',\n",
       "                'Grevelding, Lara',\n",
       "                'Dietrich, Christoph F'],\n",
       "               'AU': ['Dong Y',\n",
       "                'Hoffmann B',\n",
       "                'Schwarz S',\n",
       "                'Nourkami-Tutdibi N',\n",
       "                'Huang YL',\n",
       "                'Chen S',\n",
       "                'Cekuolis A',\n",
       "                'Augustiniene R',\n",
       "                'Snelling PJ',\n",
       "                'Schreiber-Dietrich D',\n",
       "                'Grevelding L',\n",
       "                'Dietrich CF'],\n",
       "               'AD': ['Department of Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai.',\n",
       "                'Harvard Medical School, Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston.',\n",
       "                'Department of Neonatology and Pediatric Intensive Care Medicine, Sana Kliniken Duisburg GmbH, Duisburg.',\n",
       "                'Saarland University Medical Center, Hospital of General Pediatrics and Neonatology, Homburg/Saar.',\n",
       "                'Department of Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai.',\n",
       "                'Department of Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai.',\n",
       "                'Ultrasound Section, Department of Pediatric Radiology, Radiology and Nuclear Medicine Centre, Vilnius University Hospital Santaros Klinikos, Vilnius.',\n",
       "                'Ultrasound Section, Department of Pediatric Radiology, Radiology and Nuclear Medicine Centre, Vilnius University Hospital Santaros Klinikos, Vilnius.',\n",
       "                'Department of Emergency Medicine, Gold Coast University Hospital, Southport, Queensland.',\n",
       "                'Kliniken Hirslanden, Salem, Bern.',\n",
       "                'Department of Pediatrics, Division of Pneumology, Allergology, Infectious diseases and Gastroenterology, University Hospital, Frankfurt, Goethe University, Frankfurt.',\n",
       "                'Department Allgemeine Innere Medizin, Kliniken Hirslanden, Beau Site, Salem and Permanence, Bern. c.f.dietrich@googlemail.com.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'DEP': '20240729',\n",
       "               'PL': 'Romania',\n",
       "               'TA': 'Med Ultrason',\n",
       "               'JT': 'Medical ultrasonography',\n",
       "               'JID': '101522985',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*Ultrasonography/methods',\n",
       "                '*Abdomen/diagnostic imaging',\n",
       "                'Child',\n",
       "                'Urogenital System/diagnostic imaging',\n",
       "                'Point-of-Care Systems',\n",
       "                'Pediatric Emergency Medicine/methods',\n",
       "                'Female',\n",
       "                'Male'],\n",
       "               'EDAT': '2024/07/30 18:42',\n",
       "               'MHDA': '2025/03/04 00:22',\n",
       "               'CRDT': ['2024/07/30 14:33'],\n",
       "               'PHST': ['2025/03/04 00:22 [medline]',\n",
       "                '2024/07/30 18:42 [pubmed]',\n",
       "                '2024/07/30 14:33 [entrez]'],\n",
       "               'AID': ['10.11152/mu-4414 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Med Ultrason. 2025 Mar 2;27(1):63-72. doi: 10.11152/mu-4414. Epub 2024 Jul 29.'}],\n",
       "             '2024': [{'PMID': '39657677',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20241227',\n",
       "               'LR': '20241227',\n",
       "               'IS': '1097-4172 (Electronic) 0092-8674 (Linking)',\n",
       "               'VI': '187',\n",
       "               'IP': '26',\n",
       "               'DP': '2024 Dec 26',\n",
       "               'TI': 'Dual BACH1 regulation by complementary SCF-type E3 ligases.',\n",
       "               'PG': '7585-7602.e25',\n",
       "               'LID': 'S0092-8674(24)01322-9 [pii] 10.1016/j.cell.2024.11.006 [doi]',\n",
       "               'AB': 'Broad-complex, tramtrack, and bric-a-brac domain (BTB) and CNC homolog 1 (BACH1) is a key regulator of the cellular oxidative stress response and an oncogene that undergoes tight post-translational control by two distinct F-box ubiquitin ligases, SCF(FBXO22) and SCF(FBXL17). However, how both ligases recognize BACH1 under oxidative stress is unclear. In our study, we elucidate the mechanism by which FBXO22 recognizes a quaternary degron in a domain-swapped beta-sheet of the BACH1 BTB dimer. Cancer-associated mutations and cysteine modifications destabilize the degron and impair FBXO22 binding but simultaneously expose an otherwise shielded degron in the dimer interface, allowing FBXL17 to recognize BACH1 as a monomer. These findings shed light on a ligase switch mechanism that enables post-translational regulation of BACH1 by complementary ligases depending on the stability of its BTB domain. Our results provide mechanistic insights into the oxidative stress response and may spur therapeutic approaches for targeting oxidative stress-related disorders and cancer.',\n",
       "               'CI': ['Copyright (c) 2024 The Author(s). Published by Elsevier Inc. All rights reserved.'],\n",
       "               'FAU': ['Goretzki, Benedikt',\n",
       "                'Khoshouei, Maryam',\n",
       "                'Schroder, Martin',\n",
       "                'Penner, Patrick',\n",
       "                'Egger, Luca',\n",
       "                'Stephan, Christine',\n",
       "                'Argoti, Dayana',\n",
       "                'Dierlamm, Nele',\n",
       "                'Rada, Jimena Maria',\n",
       "                'Kapps, Sandra',\n",
       "                'Muller, Catrin Swantje',\n",
       "                'Thiel, Zacharias',\n",
       "                'Mutlu, Merve',\n",
       "                'Tschopp, Claude',\n",
       "                'Furkert, David',\n",
       "                'Freuler, Felix',\n",
       "                'Haenni, Simon',\n",
       "                'Tenaillon, Laurent',\n",
       "                'Knapp, Britta',\n",
       "                'Hinniger, Alexandra',\n",
       "                'Hoppe, Philipp',\n",
       "                'Schmidt, Enrico',\n",
       "                'Gutmann, Sascha',\n",
       "                'Iurlaro, Mario',\n",
       "                'Ryzhakov, Grigory',\n",
       "                'Fernandez, Cesar'],\n",
       "               'AU': ['Goretzki B',\n",
       "                'Khoshouei M',\n",
       "                'Schroder M',\n",
       "                'Penner P',\n",
       "                'Egger L',\n",
       "                'Stephan C',\n",
       "                'Argoti D',\n",
       "                'Dierlamm N',\n",
       "                'Rada JM',\n",
       "                'Kapps S',\n",
       "                'Muller CS',\n",
       "                'Thiel Z',\n",
       "                'Mutlu M',\n",
       "                'Tschopp C',\n",
       "                'Furkert D',\n",
       "                'Freuler F',\n",
       "                'Haenni S',\n",
       "                'Tenaillon L',\n",
       "                'Knapp B',\n",
       "                'Hinniger A',\n",
       "                'Hoppe P',\n",
       "                'Schmidt E',\n",
       "                'Gutmann S',\n",
       "                'Iurlaro M',\n",
       "                'Ryzhakov G',\n",
       "                'Fernandez C'],\n",
       "               'AD': ['Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland. Electronic address: bengoretzki@isomorphiclabs.com.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Global Discovery Chemistry, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Disease Area Oncology, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Global Discovery Chemistry, Novartis Biomedical Research, Emeryville, CA, USA.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Disease Area Immunology, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Disease Area Oncology, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Disease Area Immunology, Novartis Biomedical Research, Basel, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland. Electronic address: cesar.fernandez@novartis.com.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20241209',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Cell',\n",
       "               'JT': 'Cell',\n",
       "               'JID': '0413066',\n",
       "               'RN': ['0 (Basic-Leucine Zipper Transcription Factors)',\n",
       "                '0 (BACH1 protein, human)',\n",
       "                '0 (F-Box Proteins)',\n",
       "                'EC 2.3.2.27 (Ubiquitin-Protein Ligases)',\n",
       "                'EC 2.3.2.27 (SKP Cullin F-Box Protein Ligases)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['*Basic-Leucine Zipper Transcription Factors/metabolism/genetics',\n",
       "                'Humans',\n",
       "                '*Oxidative Stress',\n",
       "                'HEK293 Cells',\n",
       "                'F-Box Proteins/metabolism/chemistry',\n",
       "                'Ubiquitin-Protein Ligases/metabolism/chemistry',\n",
       "                'SKP Cullin F-Box Protein Ligases/metabolism',\n",
       "                'Models, Molecular',\n",
       "                'Animals'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['BACH1',\n",
       "                'Cullin-RING ligases',\n",
       "                'F-box',\n",
       "                'FBXL17',\n",
       "                'FBXO22',\n",
       "                'S-nitrosylation heme',\n",
       "                'cysteine modification',\n",
       "                'ligase switch',\n",
       "                'oxidative stress'],\n",
       "               'COIS': ['Declaration of interests All listed authors are or were employees and/or',\n",
       "                'shareholders of Novartis Pharma.'],\n",
       "               'EDAT': '2024/12/11 00:23',\n",
       "               'MHDA': '2024/12/28 11:43',\n",
       "               'CRDT': ['2024/12/10 18:41'],\n",
       "               'PHST': ['2024/03/08 00:00 [received]',\n",
       "                '2024/09/19 00:00 [revised]',\n",
       "                '2024/11/07 00:00 [accepted]',\n",
       "                '2024/12/28 11:43 [medline]',\n",
       "                '2024/12/11 00:23 [pubmed]',\n",
       "                '2024/12/10 18:41 [entrez]'],\n",
       "               'AID': ['S0092-8674(24)01322-9 [pii]',\n",
       "                '10.1016/j.cell.2024.11.006 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Cell. 2024 Dec 26;187(26):7585-7602.e25. doi: 10.1016/j.cell.2024.11.006. Epub 2024 Dec 9.'},\n",
       "              {'PMID': '39508042',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20241108',\n",
       "               'IS': '1663-9812 (Print) 1663-9812 (Electronic) 1663-9812 (Linking)',\n",
       "               'VI': '15',\n",
       "               'DP': '2024',\n",
       "               'TI': 'Case report: Acute liver failure during deferasirox therapy and the potential role of pharmacogenetics.',\n",
       "               'PG': '1477755',\n",
       "               'LID': '10.3389/fphar.2024.1477755 [doi] 1477755',\n",
       "               'AB': \"BACKGROUND AND AIMS: A number of case reports have documented the occurrence of acute hepatic and renal toxicity during treatment with deferasirox (DFX). The precise mechanisms underlying these adverse events remain unclear, with the time to toxicity varying considerably between patients-some experiencing it within weeks of treatment initiation, while others after several years. Recent studies have underscored the association of pharmacogenetic variants in genes responsible for the metabolism and clearance of DFX (ABCC2, ABCG2, and UGT1A1) in the development of toxicity. We present the case of an 8-year-old patient with beta thalassemia major who developed acute hepatic failure years after the initiation of DFX therapy. After ruling out the most likely causes, we performed a pharmacogenetic analysis, which suggested a possible link between the patient's genotype and the development of toxicity. METHODS: Sanger sequencing was performed for the most extensively studied single nucleotide polymorphisms (SNPs) studied associated with changes in transporter/enzyme function: ABCC2 rs717620 (c.-24C>T), rs2273697 (c.1249G>A), rs8187710 (c.4544G>A), rs369192412 (g.99781071delG); ABCG2 rs2231142 (c.421C>A); UGT1A1 *6 rs4148323 (c.211G>A), *28 rs3064744 (g.233760235TA[8]), *36 rs3064744 (g.233760235TA[6]) and *37 rs3064744 (g.233760235TA[9]). RESULTS: The patient is heterozygous for two ABCC2 variants, namely rs717620 (c.-24C>T) and rs2273697 (c.1249G>A). These variants have the potential to cause a reduction in transporter function, which could in turn result in decreased drug clearance and increased toxicity. DISCUSSION: The precise mechanism by which toxicity developed in this case remains unclear and is likely multifactorial. However, it is probable that the presence of SNPs in the gene ABCC2 played a substantial role. Our findings align with those of previously published reports of remarkably similar cases, where patients also exhibited genetic variants in the gene ABCC2.\",\n",
       "               'CI': ['Copyright (c) 2024 Garcia-Farina, Rink, Santarini, Westkemper, Dohna-Schwake and',\n",
       "                'Mohlendick.'],\n",
       "               'FAU': ['Garcia-Farina, Belen',\n",
       "                'Rink, Lydia',\n",
       "                'Santarini, Virginia',\n",
       "                'Westkemper, Marco',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Mohlendick, Birte'],\n",
       "               'AU': ['Garcia-Farina B',\n",
       "                'Rink L',\n",
       "                'Santarini V',\n",
       "                'Westkemper M',\n",
       "                'Dohna-Schwake C',\n",
       "                'Mohlendick B'],\n",
       "               'AD': ['Institute of Pharmacogenetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics III, Pediatric Hematology and Oncology, Cardiology, Pulmonology, University Hospital Essen, Essen, Germany.',\n",
       "                'Clinic of Pediatrics, Klinikum Dortmund, Dortmund, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, Essen, Germany.',\n",
       "                'Institute of Pharmacogenetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports', 'Journal Article'],\n",
       "               'DEP': '20241023',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Pharmacol',\n",
       "               'JT': 'Frontiers in pharmacology',\n",
       "               'JID': '101548923',\n",
       "               'PMC': 'PMC11538451',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['ABCC2',\n",
       "                'ABCG2',\n",
       "                'UGT1A1',\n",
       "                'beta thalassemia',\n",
       "                'deferasirox',\n",
       "                'liver failure',\n",
       "                'pharmacogenetic',\n",
       "                'toxicity'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2024/11/12 04:45',\n",
       "               'MHDA': '2024/11/12 04:46',\n",
       "               'PMCR': ['2024/10/23'],\n",
       "               'CRDT': ['2024/11/07 04:43'],\n",
       "               'PHST': ['2024/08/08 00:00 [received]',\n",
       "                '2024/09/23 00:00 [accepted]',\n",
       "                '2024/11/12 04:46 [medline]',\n",
       "                '2024/11/12 04:45 [pubmed]',\n",
       "                '2024/11/07 04:43 [entrez]',\n",
       "                '2024/10/23 00:00 [pmc-release]'],\n",
       "               'AID': ['1477755 [pii]', '10.3389/fphar.2024.1477755 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Pharmacol. 2024 Oct 23;15:1477755. doi: 10.3389/fphar.2024.1477755. eCollection 2024.'},\n",
       "              {'PMID': '39474686',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'In-Process',\n",
       "               'LR': '20241128',\n",
       "               'IS': '1524-4628 (Electronic) 0039-2499 (Print) 0039-2499 (Linking)',\n",
       "               'VI': '55',\n",
       "               'IP': '12',\n",
       "               'DP': '2024 Dec',\n",
       "               'TI': 'Ultrasound Localization Microscopy for the Assessment of Microvascular Circulation in Ischemic Perinatal Stroke.',\n",
       "               'PG': 'e323-e325',\n",
       "               'LID': '10.1161/STROKEAHA.124.048390 [doi]',\n",
       "               'FAU': ['Regensburger, Adrian P',\n",
       "                'Wachter, Felix',\n",
       "                'Denis, Louise',\n",
       "                'Mandelbaum, Henriette',\n",
       "                'Schey, Frauke',\n",
       "                'Buehler, Adrian',\n",
       "                'Siebenlist, Gregor',\n",
       "                'Schwarz, Simone',\n",
       "                'Schulz-Heise, Susanne',\n",
       "                'Rompel, Oliver',\n",
       "                'Trollmann, Regina',\n",
       "                'Woelfle, Joachim',\n",
       "                'Jungert, Jorg',\n",
       "                'Couture, Olivier',\n",
       "                'Reutter, Heiko',\n",
       "                'Hanslik, Gregor',\n",
       "                'Knieling, Ferdinand'],\n",
       "               'AU': ['Regensburger AP',\n",
       "                'Wachter F',\n",
       "                'Denis L',\n",
       "                'Mandelbaum H',\n",
       "                'Schey F',\n",
       "                'Buehler A',\n",
       "                'Siebenlist G',\n",
       "                'Schwarz S',\n",
       "                'Schulz-Heise S',\n",
       "                'Rompel O',\n",
       "                'Trollmann R',\n",
       "                'Woelfle J',\n",
       "                'Jungert J',\n",
       "                'Couture O',\n",
       "                'Reutter H',\n",
       "                'Hanslik G',\n",
       "                'Knieling F'],\n",
       "               'AUID': ['ORCID: 0000-0001-8244-1261',\n",
       "                'ORCID: 0000-0003-1010-050X',\n",
       "                'ORCID: 0000-0001-6395-7377',\n",
       "                'ORCID: 0009-0003-5269-9378',\n",
       "                'ORCID: 0000-0001-6930-1061',\n",
       "                'ORCID: 0000-0001-6031-8537',\n",
       "                'ORCID: 0000-0002-9132-6174',\n",
       "                'ORCID: 0000-0002-2048-1871',\n",
       "                'ORCID: 0000-0002-8683-1424',\n",
       "                'ORCID: 0000-0002-3591-5265',\n",
       "                'ORCID: 0000-0002-3535-2626'],\n",
       "               'AD': ['Department of Pediatrics and Adolescent Medicine (A.P.R., F.W., H.M., F.S., A.B., G.S., R.T., J.W., J.J., H.R., G.H., F.K.), University Hospital Erlangen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine (A.P.R., F.W., H.M., F.S., A.B., G.S., R.T., J.W., J.J., H.R., G.H., F.K.), University Hospital Erlangen, Germany.',\n",
       "                \"Laboratoire d'Imagerie Biomedicale, Sorbonne Universite, Centre National de la Recherche (CNRS), Institut National de la Sante et de la Recherche Medicale (INSERM), Paris, France (L.D., O.C.).\",\n",
       "                'Department of Pediatrics and Adolescent Medicine (A.P.R., F.W., H.M., F.S., A.B., G.S., R.T., J.W., J.J., H.R., G.H., F.K.), University Hospital Erlangen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine (A.P.R., F.W., H.M., F.S., A.B., G.S., R.T., J.W., J.J., H.R., G.H., F.K.), University Hospital Erlangen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine (A.P.R., F.W., H.M., F.S., A.B., G.S., R.T., J.W., J.J., H.R., G.H., F.K.), University Hospital Erlangen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine (A.P.R., F.W., H.M., F.S., A.B., G.S., R.T., J.W., J.J., H.R., G.H., F.K.), University Hospital Erlangen, Germany.',\n",
       "                'Department of Neonatology and Pediatric Intensive Care Medicine, Sana Clinics Duisburg, Germany (S.S.).',\n",
       "                'Institute of Radiology (S.S.-H., O.R.), University Hospital Erlangen, Germany.',\n",
       "                'Institute of Radiology (S.S.-H., O.R.), University Hospital Erlangen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine (A.P.R., F.W., H.M., F.S., A.B., G.S., R.T., J.W., J.J., H.R., G.H., F.K.), University Hospital Erlangen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine (A.P.R., F.W., H.M., F.S., A.B., G.S., R.T., J.W., J.J., H.R., G.H., F.K.), University Hospital Erlangen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine (A.P.R., F.W., H.M., F.S., A.B., G.S., R.T., J.W., J.J., H.R., G.H., F.K.), University Hospital Erlangen, Germany.',\n",
       "                \"Laboratoire d'Imagerie Biomedicale, Sorbonne Universite, Centre National de la Recherche (CNRS), Institut National de la Sante et de la Recherche Medicale (INSERM), Paris, France (L.D., O.C.).\",\n",
       "                'Department of Pediatrics and Adolescent Medicine (A.P.R., F.W., H.M., F.S., A.B., G.S., R.T., J.W., J.J., H.R., G.H., F.K.), University Hospital Erlangen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine (A.P.R., F.W., H.M., F.S., A.B., G.S., R.T., J.W., J.J., H.R., G.H., F.K.), University Hospital Erlangen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine (A.P.R., F.W., H.M., F.S., A.B., G.S., R.T., J.W., J.J., H.R., G.H., F.K.), University Hospital Erlangen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Letter'],\n",
       "               'DEP': '20241030',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Stroke',\n",
       "               'JT': 'Stroke',\n",
       "               'JID': '0235266',\n",
       "               'SB': 'IM',\n",
       "               'PMC': 'PMC11593985',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['diagnostic imaging',\n",
       "                'microcirculation',\n",
       "                'neonate',\n",
       "                'stroke',\n",
       "                'ultrasound'],\n",
       "               'COIS': ['Dr Couture is a co-inventor of ultrasound super-resolution patent (Patent',\n",
       "                'Cooperation Treaty [PCT])/FR2011/052810 and a co-founder of Resolve Stroke and',\n",
       "                'receives compensation from Bracco Imaging for consultant services. Dr Knieling',\n",
       "                'reports grants from the H2020 European Research Council, Bayerische',\n",
       "                'Forschungsstiftung, Sanofi-Aventis, and Siemens Healthcare and receives',\n",
       "                'compensation from iThera Medical GmbH for consultant services and travel support',\n",
       "                'from Sanofi-Aventis. The other authors report no conflicts.'],\n",
       "               'EDAT': '2024/10/30 06:22',\n",
       "               'MHDA': '2024/10/30 06:22',\n",
       "               'PMCR': ['2024/11/26'],\n",
       "               'CRDT': ['2024/10/30 05:03'],\n",
       "               'PHST': ['2024/10/30 06:22 [pubmed]',\n",
       "                '2024/10/30 06:22 [medline]',\n",
       "                '2024/10/30 05:03 [entrez]',\n",
       "                '2024/11/26 00:00 [pmc-release]'],\n",
       "               'AID': ['STROKE-2024-048390 [pii]',\n",
       "                '10.1161/STROKEAHA.124.048390 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Stroke. 2024 Dec;55(12):e323-e325. doi: 10.1161/STROKEAHA.124.048390. Epub 2024 Oct 30.'},\n",
       "              {'PMID': '39434912',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20241023',\n",
       "               'IS': '1664-1078 (Print) 1664-1078 (Electronic) 1664-1078 (Linking)',\n",
       "               'VI': '15',\n",
       "               'DP': '2024',\n",
       "               'TI': 'The effect of live-performed music therapy with physical contact in preterm infants on parental perceived stress and salivary cortisol levels.',\n",
       "               'PG': '1441824',\n",
       "               'LID': '10.3389/fpsyg.2024.1441824 [doi] 1441824',\n",
       "               'AB': \"INTRODUCTION: Parents of preterm infants face a stressful life event which might have long term impact on the parent-child relation as well as on the infant's cognitive and socio-emotional development. Both music therapy (MT) and physical contact (PC) are stress-reducing interventions for parents and preterm infants on the neonatal intensive care unit (NICU). Meanwhile, especially close PC is considered as standard care (SC) in most NICUs. However, the effect of live performed MT with PC on parental perceived stress and cortisol levels has barely been investigated. We hypothesized that MT with PC leads to reduced stress levels and lower salivary cortisol concentrations compared to SC in parents of preterm infants during the first 4 weeks after birth. METHODS: Randomized-controlled trial enrolling the parents of 99 preterm infants (MT n = 50, SC n = 49 infants). The infants received either MT with PC or SC only. Perceived stress was measured with the perceived stress questionnaire 20 (PSQ-20) after birth and 4 weeks later. Salivary cortisol levels were obtained and measured weekly after birth for 4 weeks. RESULTS: Forty-two mothers and eight fathers of the intervention group (MT with PC) as well as n = 43 mothers and n = 6 fathers of the control group (SC) were enrolled. For the intervention group, salivary cortisol was reduced 4 weeks after birth [mothers 5.5 nmol/l (confidence interval (CI) 3.6-7.5); fathers 8.3 (CI 7.2-9.4)] compared to the control group [mothers 10.3 nmol/l (CI 5.4-15.3); fathers 14.8 (CI 8.9-20.7)]. Overall perceived stress scores decreased in the intervention group (mothers -17.6; fathers -12.6) and increased in the control group (mothers +6.1; fathers +21.4) over 4 weeks. DISCUSSION: Live-performed MT with PC in preterm infants might be an effective, non-invasive intervention to reduce parental stress and cortisol levels. Future studies should investigate the long-term effects of this intervention on the parent-infant relation as well as on the infants' cognitive and socio-emotional development. CLINICAL TRIAL REGISTRATION: https://drks.de/search/en/trial/DRKS00025755 identifier [DRKS00025755].\",\n",
       "               'CI': ['Copyright (c) 2024 Dewan, Ader, Kleinbeck, Dathe, Schedlowski, Engler,',\n",
       "                'Felderhoff-Mueser, Bruns and Kobus.'],\n",
       "               'FAU': ['Dewan, Monia Vanessa',\n",
       "                'Ader, Miriam',\n",
       "                'Kleinbeck, Tim',\n",
       "                'Dathe, Anne-Kathrin',\n",
       "                'Schedlowski, Manfred',\n",
       "                'Engler, Harald',\n",
       "                'Felderhoff-Mueser, Ursula',\n",
       "                'Bruns, Nora',\n",
       "                'Kobus, Susann'],\n",
       "               'AU': ['Dewan MV',\n",
       "                'Ader M',\n",
       "                'Kleinbeck T',\n",
       "                'Dathe AK',\n",
       "                'Schedlowski M',\n",
       "                'Engler H',\n",
       "                'Felderhoff-Mueser U',\n",
       "                'Bruns N',\n",
       "                'Kobus S'],\n",
       "               'AD': ['Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Health and Nursing, Occupational Therapy, Ernst-Abbe-University of Applied Sciences Jena, Jena, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Institute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Institute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Center of Artistic Therapy, University Medicine Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20241007',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Psychol',\n",
       "               'JT': 'Frontiers in psychology',\n",
       "               'JID': '101550902',\n",
       "               'PMC': 'PMC11492995',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['NICU',\n",
       "                'cortisol',\n",
       "                'music therapy',\n",
       "                'parental stress',\n",
       "                'parents',\n",
       "                'preterm infant',\n",
       "                'stress reduction'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest. The author(s) declared that they were an editorial board',\n",
       "                'member of Frontiers, at the time of submission. This had no impact on the peer',\n",
       "                'review process and the final decision.'],\n",
       "               'EDAT': '2024/10/22 06:28',\n",
       "               'MHDA': '2024/10/22 06:29',\n",
       "               'PMCR': ['2024/10/07'],\n",
       "               'CRDT': ['2024/10/22 04:18'],\n",
       "               'PHST': ['2024/05/31 00:00 [received]',\n",
       "                '2024/09/11 00:00 [accepted]',\n",
       "                '2024/10/22 06:29 [medline]',\n",
       "                '2024/10/22 06:28 [pubmed]',\n",
       "                '2024/10/22 04:18 [entrez]',\n",
       "                '2024/10/07 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fpsyg.2024.1441824 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Psychol. 2024 Oct 7;15:1441824. doi: 10.3389/fpsyg.2024.1441824. eCollection 2024.'},\n",
       "              {'PMID': '39420822',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'Publisher',\n",
       "               'LR': '20241018',\n",
       "               'IS': '2066-8643 (Electronic) 1844-4172 (Linking)',\n",
       "               'DP': '2024 Sep 30',\n",
       "               'TI': 'How to perform Point of Care Ultrasound at resuscitation and when it is useful.',\n",
       "               'LID': '10.11152/mu-4439 [doi]',\n",
       "               'AB': 'Point of Care Ultrasound (POCUS) can be useful as a tool before, during and after the performance of cardiopulmonary resuscitation (CPR). Before or after resuscitation it can help with monitoring unstable hemodynamics, has the potential to identify reversible causes if patient deteriorates. During resuscitation POCUS can help detect potentially treatable causes of the cardiac arrest. Performance of POCUS while resuscitation requires experienced sonologists and a good team structure to embed the examination in advanced cardiovascular life support (ACLS) algorithms. This article gives an overview and tips about how to detect potential reversible causes of patient deterioration in all three phases of CPR. We describe some special situations in which resuscitation could take place. Further we give a comment about sonographic education of physicians and nonacademic medical staf.',\n",
       "               'FAU': ['Wastl, Daniel',\n",
       "                'Blaivas, Michael',\n",
       "                'Horn, Rudolf',\n",
       "                'Michels, Guido',\n",
       "                'Seibel, Armin',\n",
       "                'Schwarz, Simone',\n",
       "                'Hoffmann, Beatrice Hoffmann',\n",
       "                'Hoffmann, Oliver',\n",
       "                'Von Ow, Dieter',\n",
       "                'Dietrich, Christoph F'],\n",
       "               'AU': ['Wastl D',\n",
       "                'Blaivas M',\n",
       "                'Horn R',\n",
       "                'Michels G',\n",
       "                'Seibel A',\n",
       "                'Schwarz S',\n",
       "                'Hoffmann BH',\n",
       "                'Hoffmann O',\n",
       "                'Von Ow D',\n",
       "                'Dietrich CF'],\n",
       "               'AD': ['Hochtaunus Kliniken Bad Homburg.',\n",
       "                'University of South Carolina School of Medicine, Department of Medicine, Columbia, South Carolina.',\n",
       "                'Center da sanda Val Mustair, Sta. Maria.',\n",
       "                'Notfallzentrum. Krankenhaus der Barmherzigen Bruder Trier, Trier.',\n",
       "                'DRK Krankenhaus Kirchen, Interdisciplinary intensive care medicine.',\n",
       "                'Department of Neonatology and Pediatric Intensive Care Medicine, Sana Hospital Duisburg, Duisburg.',\n",
       "                'Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston MA, Harvard Medical School.',\n",
       "                'Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston MA, Harvard Medical School.',\n",
       "                'Department Allgemeine Innere Medizin (DAIM), Kliniken Hirslanden Beau Site, Salem und Permanence, Bern.',\n",
       "                'Department Allgemeine Innere Medizin (DAIM), Kliniken Hirslanden Beau Site, Salem und Permanence, Bern. c.f.dietrich@googlemail.com.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'DEP': '20240930',\n",
       "               'PL': 'Romania',\n",
       "               'TA': 'Med Ultrason',\n",
       "               'JT': 'Medical ultrasonography',\n",
       "               'JID': '101522985',\n",
       "               'SB': 'IM',\n",
       "               'EDAT': '2024/10/18 06:23',\n",
       "               'MHDA': '2024/10/18 06:23',\n",
       "               'CRDT': ['2024/10/18 03:53'],\n",
       "               'PHST': ['2024/10/18 06:23 [medline]',\n",
       "                '2024/10/18 06:23 [pubmed]',\n",
       "                '2024/10/18 03:53 [entrez]'],\n",
       "               'AID': ['10.11152/mu-4439 [doi]'],\n",
       "               'PST': 'aheadofprint',\n",
       "               'SO': 'Med Ultrason. 2024 Sep 30. doi: 10.11152/mu-4439.'},\n",
       "              {'PMID': '39420818',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'Publisher',\n",
       "               'LR': '20241018',\n",
       "               'IS': '2066-8643 (Electronic) 1844-4172 (Linking)',\n",
       "               'DP': '2024 Oct 17',\n",
       "               'TI': 'An [illustrative] update on pediatric emergency ultrasound: part 3 - cerebral, musculoskeletal and other applications.',\n",
       "               'LID': '10.11152/mu-4440 [doi]',\n",
       "               'AB': 'Point-of-care ultrasound (POCUS) plays an essential role in pediatric emergency medicine by improving diagnostics and procedural safety. The role of POCUS in the care of pediatric patients in the emergency department has expanded considerably in recent years. Cranial and musculoskeletal imaging has significant potential, yet POCUS has also become a vital tool for common procedures, such as central and difficult peripheral intravenous access. The purpose of this article is to provide an overview of pediatric POCUS applications for cranial, small parts (head, eyes, nose, throat, and soft tissue), musculoskeletal, and common procedural applications, forming the third part of the series.',\n",
       "               'FAU': ['Schwarz, Simone',\n",
       "                'Dong, Yi',\n",
       "                'Snelling, Peter J',\n",
       "                'Hoffmann, Beatrice',\n",
       "                'Nourkami-Tutdibi, Nasenien',\n",
       "                'Huang, Yun-Lin',\n",
       "                'Chen, Sheng',\n",
       "                'Cekuolis, Andrius',\n",
       "                'Augustiniene, Rasa',\n",
       "                'Schreiber-Dietrich, Dagmar',\n",
       "                'Grevelding, Lara',\n",
       "                'Dietrich, Christoph F'],\n",
       "               'AU': ['Schwarz S',\n",
       "                'Dong Y',\n",
       "                'Snelling PJ',\n",
       "                'Hoffmann B',\n",
       "                'Nourkami-Tutdibi N',\n",
       "                'Huang YL',\n",
       "                'Chen S',\n",
       "                'Cekuolis A',\n",
       "                'Augustiniene R',\n",
       "                'Schreiber-Dietrich D',\n",
       "                'Grevelding L',\n",
       "                'Dietrich CF'],\n",
       "               'AD': ['Department of Neonatology and Pediatric Intensive Care Medicine, Sana Hospital Duisburg GmbH, Duisburg.',\n",
       "                'Department of Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai.',\n",
       "                'Department of Emergency Medicine, Gold Coast University Hospital, Southport, Queensland.',\n",
       "                'Harvard Medical School, Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston.',\n",
       "                'Saarland University Medical Center, Hospital of General Pediatrics and Neonatology, Homburg/Saar.',\n",
       "                'Department of Neonatology and Pediatric Intensive Care Medicine, Sana Hospital Duisburg GmbH, Duisburg.',\n",
       "                'Department of Neonatology and Pediatric Intensive Care Medicine, Sana Hospital Duisburg GmbH, Duisburg.',\n",
       "                'Ultrasound Section, Department of Pediatric Radiology, Radiology and Nuclear Medicine Centre, Vilnius University Hospital Santaros Klinikos.',\n",
       "                'Ultrasound Section, Department of Pediatric Radiology, Radiology and Nuclear Medicine Centre, Vilnius University Hospital Santaros Klinikos.',\n",
       "                'Pediatrics, Kliniken Hirslanden, Salem, Bern.',\n",
       "                'Department of Pediatrics, Division of Pneumology, Allergology, Infectious diseases and Gastroenterology, University Hospital, Frankfurt, Goethe University, Frankfurt.',\n",
       "                'Department Allgemeine Innere Medizin, Kliniken Hirslanden, Beau Site, Salem and Permanence, Bern. c.f.dietrich@googlemail.com.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'DEP': '20241017',\n",
       "               'PL': 'Romania',\n",
       "               'TA': 'Med Ultrason',\n",
       "               'JT': 'Medical ultrasonography',\n",
       "               'JID': '101522985',\n",
       "               'SB': 'IM',\n",
       "               'EDAT': '2024/10/18 06:23',\n",
       "               'MHDA': '2024/10/18 06:23',\n",
       "               'CRDT': ['2024/10/18 03:53'],\n",
       "               'PHST': ['2024/10/18 06:23 [medline]',\n",
       "                '2024/10/18 06:23 [pubmed]',\n",
       "                '2024/10/18 03:53 [entrez]'],\n",
       "               'AID': ['10.11152/mu-4440 [doi]'],\n",
       "               'PST': 'aheadofprint',\n",
       "               'SO': 'Med Ultrason. 2024 Oct 17. doi: 10.11152/mu-4440.'},\n",
       "              {'PMID': '39402608',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20241015',\n",
       "               'LR': '20250318',\n",
       "               'IS': '1745-6215 (Electronic) 1745-6215 (Linking)',\n",
       "               'VI': '25',\n",
       "               'IP': '1',\n",
       "               'DP': '2024 Oct 14',\n",
       "               'TI': 'Telemedicine-based antibiotic stewardship program in pediatrics: study protocol of a stepped wedge cluster randomized trial-the TeleKasper study.',\n",
       "               'PG': '678',\n",
       "               'LID': '10.1186/s13063-024-08493-z [doi] 678',\n",
       "               'AB': 'BACKGROUND: Overuse and misuse of antibiotics is one of the driving factors of antimicrobial resistance, a growing global health threat. The use of antibiotics is particularly high in children. Even though the implementation of antibiotic stewardship programs (ASP) in pediatrics has been shown to reduce antibiotic use, this implementation has been limited to large university hospitals in Germany. Telemedicine applications might be an effective approach to implement ASP in non-university settings. METHODS: This protocol details the TeleKasper study (Telemedical Competence Network \"Antibiotic Stewardship in Pediatrics\"). Tele-Kasper is a stepped-wedge cluster-randomized trial that will be conducted across non-university children\\'s hospitals in Germany. The intervention consists of a telemedical consultation service in the form of a network in different German areas, using an app as a communication tool. The primary outcome will be a 20% reduction in overall antibiotic consumption measured using defined daily doses per 100 patient days. DISCUSSION: The TeleKasper study aims to implement and evaluate a prototype for a nationwide antibiotic stewardship program by telemedical means in pediatric departments in non-university hospitals in Germany to promote rational antibiotic use and improve medical care for infections. TRIAL REGISTRATION: German Clinical Trials Register (DRKS) DRKS00028534. Registered on 22nd of April 2022.',\n",
       "               'CI': ['(c) 2024. The Author(s).'],\n",
       "               'FAU': ['Diexer, Sophie',\n",
       "                'Ihling, Angelika',\n",
       "                'Gomes, Delphina',\n",
       "                'Moritz, Stefan',\n",
       "                'Simon, Arne',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Mikolajczyk, Rafael',\n",
       "                'Huebner, Johannes',\n",
       "                'von Both, Ulrich'],\n",
       "               'AU': ['Diexer S',\n",
       "                'Ihling A',\n",
       "                'Gomes D',\n",
       "                'Moritz S',\n",
       "                'Simon A',\n",
       "                'Dohna-Schwake C',\n",
       "                'Mikolajczyk R',\n",
       "                'Huebner J',\n",
       "                'von Both U'],\n",
       "               'AD': ['Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Medical Faculty, Interdisciplinary Centre for Health Sciences, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.',\n",
       "                'Section of Clinical Infectious Diseases, University Hospital Halle (Saale), Halle (Saale), Germany.',\n",
       "                'Institute of Social Pediatrics and Adolescent Medicine, Division of Pediatric Epidemiology, Ludwig-Maximilians-University Munich, Munich, Germany.',\n",
       "                \"Department of Paediatrics, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.\",\n",
       "                'Section of Clinical Infectious Diseases, University Hospital Halle (Saale), Halle (Saale), Germany.',\n",
       "                'Pediatric Oncology and Hematology, University Hospital Homburg Saar, Homburg, Germany.',\n",
       "                \"Department of Paediatrics I, Paediatric Intensive Care, Children's Hospital Essen, Essen, Germany.\",\n",
       "                'West German Centre for Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Medical Faculty, Interdisciplinary Centre for Health Sciences, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.',\n",
       "                \"Department of Paediatrics, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.\",\n",
       "                \"Department of Paediatrics, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University Munich, Munich, Germany. Ulrich.von.both@med.lmu.de.\",\n",
       "                'German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany. Ulrich.von.both@med.lmu.de.'],\n",
       "               'CN': ['TeleKasper Consortium'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Clinical Trial Protocol', 'Journal Article'],\n",
       "               'DEP': '20241014',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Trials',\n",
       "               'JT': 'Trials',\n",
       "               'JID': '101263253',\n",
       "               'RN': ['0 (Anti-Bacterial Agents)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*Antimicrobial Stewardship/methods',\n",
       "                '*Telemedicine',\n",
       "                '*Anti-Bacterial Agents/therapeutic use',\n",
       "                '*Randomized Controlled Trials as Topic',\n",
       "                'Child',\n",
       "                'Germany',\n",
       "                'Multicenter Studies as Topic',\n",
       "                'Pediatrics/methods/standards',\n",
       "                'Hospitals, Pediatric',\n",
       "                \"Practice Patterns, Physicians'/standards\",\n",
       "                'Child, Preschool'],\n",
       "               'PMC': 'PMC11476715',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Antimicrobial stewardship',\n",
       "                'Pediatrics',\n",
       "                'Randomized controlled trial',\n",
       "                'Telemedicine'],\n",
       "               'COIS': ['The authors declare that they have no competing interests.'],\n",
       "               'EDAT': '2024/10/15 00:20',\n",
       "               'MHDA': '2024/10/15 10:17',\n",
       "               'PMCR': ['2024/10/14'],\n",
       "               'CRDT': ['2024/10/14 23:50'],\n",
       "               'PHST': ['2024/04/12 00:00 [received]',\n",
       "                '2024/09/20 00:00 [accepted]',\n",
       "                '2024/10/15 10:17 [medline]',\n",
       "                '2024/10/15 00:20 [pubmed]',\n",
       "                '2024/10/14 23:50 [entrez]',\n",
       "                '2024/10/14 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1186/s13063-024-08493-z [pii]',\n",
       "                '8493 [pii]',\n",
       "                '10.1186/s13063-024-08493-z [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Trials. 2024 Oct 14;25(1):678. doi: 10.1186/s13063-024-08493-z.'},\n",
       "              {'PMID': '39337403',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20240928',\n",
       "               'LR': '20240930',\n",
       "               'IS': '1422-0067 (Electronic) 1422-0067 (Linking)',\n",
       "               'VI': '25',\n",
       "               'IP': '18',\n",
       "               'DP': '2024 Sep 13',\n",
       "               'TI': 'Characterization of the Immune-Modulating Properties of Different beta-Glucans on Myeloid Dendritic Cells.',\n",
       "               'LID': '10.3390/ijms25189914 [doi] 9914',\n",
       "               'AB': 'In allergen-specific immunotherapy, adjuvants are explored for modulating allergen-specific Th2 immune responses to re-establish clinical tolerance. One promising class of adjuvants are beta-glucans, which are naturally derived sugar structures and components of dietary fibers that activate C-type lectin (CLR)-, \"Toll\"-like receptors (TLRs), and complement receptors (CRs). We characterized the immune-modulating properties of six commercially available beta-glucans, using immunological (receptor activation, cytokine secretion, and T cell modulating potential) as well as metabolic parameters (metabolic state) in mouse bone marrow-derived myeloid dendritic cells (mDCs). All tested beta-glucans activated the CLR Dectin-1a, whereas TLR2 was predominantly activated by Zymosan. Further, the tested beta-glucans differentially induced mDC-derived cytokine secretion and activation of mDC metabolism. Subsequent analyses focusing on Zymosan, Zymosan depleted, beta-1,3 glucan, and beta-1,3 1,6 glucan revealed robust mDC activation with the upregulation of the cluster of differentiation 40 (CD40), CD80, CD86, and MHCII to different extents. beta-glucan-induced cytokine secretion was shown to be, in part, dependent on the activation of the intracellular Dectin-1 adapter molecule Syk. In co-cultures of mDCs with Th2-biased CD4(+) T cells isolated from birch allergen Bet v 1 plus aluminum hydroxide (Alum)-sensitized mice, these four beta-glucans suppressed allergen-induced IL-5 secretion, while only Zymosan and beta-1,3 glucan significantly suppressed allergen-induced interferon gamma (IFNgamma) secretion, suggesting the tested beta-glucans to have distinct effects on mDC T cell priming capacity. Our experiments indicate that beta-glucans have distinct immune-modulating properties, making them interesting adjuvants for future allergy treatment.',\n",
       "               'FAU': ['Rainer, Hannah',\n",
       "                'Goretzki, Alexandra',\n",
       "                'Lin, Yen-Ju',\n",
       "                'Schiller, Hannah Ruth',\n",
       "                'Krause, Maren',\n",
       "                'Doring, Sascha',\n",
       "                'Strecker, Daniel',\n",
       "                'Junker, Ann-Christine',\n",
       "                'Wolfheimer, Sonja',\n",
       "                'Toda, Masako',\n",
       "                'Scheurer, Stephan',\n",
       "                'Schulke, Stefan'],\n",
       "               'AU': ['Rainer H',\n",
       "                'Goretzki A',\n",
       "                'Lin YJ',\n",
       "                'Schiller HR',\n",
       "                'Krause M',\n",
       "                'Doring S',\n",
       "                'Strecker D',\n",
       "                'Junker AC',\n",
       "                'Wolfheimer S',\n",
       "                'Toda M',\n",
       "                'Scheurer S',\n",
       "                'Schulke S'],\n",
       "               'AD': ['Section Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Section Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Section Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Section Research Allergology, Division of Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Section Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Section Research Allergology, Division of Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Section Research Allergology, Division of Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Section Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Section Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Laboratory of Food and Biomolecular Science, Graduate School of Agricultural Science, Tohoku University, Sendai 980-8576, Japan.',\n",
       "                'Section Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Section Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Section Research Allergology, Division of Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.'],\n",
       "               'AUID': ['ORCID: 0000-0002-0761-9506',\n",
       "                'ORCID: 0000-0002-2859-562X',\n",
       "                'ORCID: 0000-0002-9674-5116'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['DFG SCHE637/4/German Research Foundation/',\n",
       "                'DFG SCHU2951/4/German Research Foundation/'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20240913',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Int J Mol Sci',\n",
       "               'JT': 'International journal of molecular sciences',\n",
       "               'JID': '101092791',\n",
       "               'RN': ['0 (beta-Glucans)',\n",
       "                '0 (Lectins, C-Type)',\n",
       "                '0 (Cytokines)',\n",
       "                '0 (dectin 1)',\n",
       "                '0 (Adjuvants, Immunologic)',\n",
       "                '9010-72-4 (Zymosan)',\n",
       "                '0 (Toll-Like Receptor 2)',\n",
       "                'EC 2.7.10.2 (Syk Kinase)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Animals',\n",
       "                '*Dendritic Cells/immunology/drug effects/metabolism',\n",
       "                '*beta-Glucans/pharmacology/chemistry',\n",
       "                'Mice',\n",
       "                '*Lectins, C-Type/metabolism',\n",
       "                '*Cytokines/metabolism',\n",
       "                'Adjuvants, Immunologic/pharmacology',\n",
       "                'Zymosan/pharmacology',\n",
       "                'Myeloid Cells/drug effects/immunology/metabolism',\n",
       "                'Toll-Like Receptor 2/metabolism',\n",
       "                'Mice, Inbred C57BL',\n",
       "                'Syk Kinase/metabolism'],\n",
       "               'PMC': 'PMC11433108',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['AIT', 'adjuvants', 'immune metabolism', 'beta-glucan'],\n",
       "               'COIS': ['The authors declare no conflict of interest.'],\n",
       "               'EDAT': '2024/09/28 22:43',\n",
       "               'MHDA': '2024/09/28 22:44',\n",
       "               'PMCR': ['2024/09/13'],\n",
       "               'CRDT': ['2024/09/28 01:16'],\n",
       "               'PHST': ['2024/08/22 00:00 [received]',\n",
       "                '2024/09/10 00:00 [revised]',\n",
       "                '2024/09/11 00:00 [accepted]',\n",
       "                '2024/09/28 22:44 [medline]',\n",
       "                '2024/09/28 22:43 [pubmed]',\n",
       "                '2024/09/28 01:16 [entrez]',\n",
       "                '2024/09/13 00:00 [pmc-release]'],\n",
       "               'AID': ['ijms25189914 [pii]',\n",
       "                'ijms-25-09914 [pii]',\n",
       "                '10.3390/ijms25189914 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Int J Mol Sci. 2024 Sep 13;25(18):9914. doi: 10.3390/ijms25189914.'},\n",
       "              {'PMID': '39288302',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20241002',\n",
       "               'LR': '20241002',\n",
       "               'IS': '1520-5126 (Electronic) 0002-7863 (Linking)',\n",
       "               'VI': '146',\n",
       "               'IP': '39',\n",
       "               'DP': '2024 Oct 2',\n",
       "               'TI': 'Oxadiazolines as Photoreleasable Labels for Drug Target Identification.',\n",
       "               'PG': '26759-26765',\n",
       "               'LID': '10.1021/jacs.4c06936 [doi]',\n",
       "               'AB': 'Photoaffinity labeling is a widely used technique for studying ligand-protein and protein-protein interactions. Traditional photoaffinity labels utilize nonspecific C-H bond insertion reactions mediated by a highly reactive intermediate. Despite being the most widely used photoaffinity labels, diazirines exhibit limited compatibility with downstream organic reactions and suffer from storage stability concerns. This study introduces oxadiazolines as innovative and complementary photoactivatable labels for addition to the toolbox and demonstrates their application in vitro and through in cellulo labeling experiments. Oxadiazolines can be easily synthesized from ketone moieties and cleaved with 302-330 nm light to cleanly liberate a diazo reactive moiety that can covalently modify nucleophilic amino acid residues. Notably, oxadiazolines are compatible with various organic reaction conditions and functional groups, allowing for the exploration of a large chemical space. Several known inhibitors featuring the oxadiazoline functionality were prepared without affecting their binding affinity. Furthermore, we confirmed the ability of oxadiazolines to form covalent bonds with proteins upon UV-irradiation, both in vitro and in cellulo, yielding comparable results to those of the matched diazirine compounds.',\n",
       "               'FAU': ['Bon, Corentin',\n",
       "                'Goretzki, Benedikt',\n",
       "                'Flamme, Marie',\n",
       "                'Shelton, Claude',\n",
       "                'Davis, Holly',\n",
       "                'Lima, Fabio',\n",
       "                'Garcia, Francisco',\n",
       "                'Brittain, Scott',\n",
       "                'Brocklehurst, Cara E'],\n",
       "               'AU': ['Bon C',\n",
       "                'Goretzki B',\n",
       "                'Flamme M',\n",
       "                'Shelton C',\n",
       "                'Davis H',\n",
       "                'Lima F',\n",
       "                'Garcia F',\n",
       "                'Brittain S',\n",
       "                'Brocklehurst CE'],\n",
       "               'AUID': ['ORCID: 0000-0002-6198-239X',\n",
       "                'ORCID: 0000-0003-2127-9568',\n",
       "                'ORCID: 0000-0002-0484-5540'],\n",
       "               'AD': ['Global Discovery Chemistry, Novartis Biomedical Research, Novartis Pharma AG, Basel 4056, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Novartis Pharma AG, Basel 4056, Switzerland.',\n",
       "                'Chemical and Analytical Development, Novartis Development, Novartis Pharma AG, Basel 4056, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Novartis Pharma AG, Cambridge, Massachusetts 02139, United States.',\n",
       "                'Global Discovery Chemistry, Novartis Biomedical Research, Novartis Pharma AG, Basel 4056, Switzerland.',\n",
       "                'Global Discovery Chemistry, Novartis Biomedical Research, Novartis Pharma AG, Basel 4056, Switzerland.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Novartis Pharma AG, Cambridge, Massachusetts 02139, United States.',\n",
       "                'Discovery Sciences, Novartis Biomedical Research, Novartis Pharma AG, Cambridge, Massachusetts 02139, United States.',\n",
       "                'Global Discovery Chemistry, Novartis Biomedical Research, Novartis Pharma AG, Basel 4056, Switzerland.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20240917',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Am Chem Soc',\n",
       "               'JT': 'Journal of the American Chemical Society',\n",
       "               'JID': '7503056',\n",
       "               'RN': ['0 (Oxadiazoles)', '0 (Photoaffinity Labels)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['*Oxadiazoles/chemistry/chemical synthesis',\n",
       "                '*Photoaffinity Labels/chemistry/chemical synthesis',\n",
       "                'Humans',\n",
       "                'Ultraviolet Rays',\n",
       "                'Molecular Structure',\n",
       "                'Photochemical Processes'],\n",
       "               'EDAT': '2024/09/17 23:43',\n",
       "               'MHDA': '2024/10/02 07:01',\n",
       "               'CRDT': ['2024/09/17 15:43'],\n",
       "               'PHST': ['2024/10/02 07:01 [medline]',\n",
       "                '2024/09/17 23:43 [pubmed]',\n",
       "                '2024/09/17 15:43 [entrez]'],\n",
       "               'AID': ['10.1021/jacs.4c06936 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Am Chem Soc. 2024 Oct 2;146(39):26759-26765. doi: 10.1021/jacs.4c06936. Epub 2024 Sep 17.'},\n",
       "              {'PMID': '39230104',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20241127',\n",
       "               'LR': '20241127',\n",
       "               'IS': '1799-7267 (Electronic) 1457-4969 (Linking)',\n",
       "               'VI': '113',\n",
       "               'IP': '4',\n",
       "               'DP': '2024 Dec',\n",
       "               'TI': 'Emergency surgery influences oncological outcome in small intestinal neuroendocrine tumors.',\n",
       "               'PG': '303-313',\n",
       "               'LID': '10.1177/14574969241271841 [doi]',\n",
       "               'AB': 'BACKGROUND AND AIMS: Patients with small intestinal neuroendocrine tumors (siNETs) frequently present emergently due to bowel ischemia or bowel obstruction. The influence of emergency surgery on the prognosis of siNET remains controversial. The aim of this study was to investigate the association between type of presentation (emergency/elective) and oncological outcome. METHODS: Clinicopathological data of patients who underwent bowel resection and were treated due to siNET at the Charite - Universitatsmedizin Berlin, Germany were analyzed retrospectively. RESULTS: A total of 165 patients underwent bowel resection for siNET. Of these, 22.4% (n = 37) were emergency and 77.6% (n = 128) were elective procedures. A preoperative known diagnosis was less common in patients with emergency surgery (48.6% vs 85.2%; p < 0.001) and complete resections of all tumor manifestations were performed less often (32.4% vs 50.8%; p = 0.049), while more completion operations had to be performed (24.3% vs 11.1%; p = 0.049). Overall survival (OS) and progression-free survival (PFS) of emergently operated patients were reduced (5-year OS: 85.2% vs 89.5% (p = 0.023); 5-year PFS: 26.7% versus 52.5% (p = 0.018)). In addition, emergency surgery was negatively associated with OS after multivariable regression analysis. CONCLUSION: Emergency surgery in siNET patients is associated with adverse oncological outcomes including shorter OS and PFS. Prevention of emergency conditions should be emphasized in advanced disease.',\n",
       "               'FAU': ['Butz, Frederike',\n",
       "                'Supper, Leonie',\n",
       "                'Reinhard, Lisa',\n",
       "                'Dukaczewska, Agata',\n",
       "                'Jann, Henning',\n",
       "                'Fehrenbach, Uli',\n",
       "                'Muller-Debus, Charlotte Friederike',\n",
       "                'Skachko, Tatiana',\n",
       "                'Pratschke, Johann',\n",
       "                'Goretzki, Peter E',\n",
       "                'Mogl, Martina T',\n",
       "                'Dobrindt, Eva M'],\n",
       "               'AU': ['Butz F',\n",
       "                'Supper L',\n",
       "                'Reinhard L',\n",
       "                'Dukaczewska A',\n",
       "                'Jann H',\n",
       "                'Fehrenbach U',\n",
       "                'Muller-Debus CF',\n",
       "                'Skachko T',\n",
       "                'Pratschke J',\n",
       "                'Goretzki PE',\n",
       "                'Mogl MT',\n",
       "                'Dobrindt EM'],\n",
       "               'AUID': ['ORCID: 0000-0002-5963-1558',\n",
       "                'ORCID: 0000-0002-3676-047X'],\n",
       "               'AD': ['Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Chariteplatz 1, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Hepatology and Gastroenterology, Campus Charite Mitte | Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Radiology, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20240904',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Scand J Surg',\n",
       "               'JT': 'Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society',\n",
       "               'JID': '101144297',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Male',\n",
       "                'Female',\n",
       "                '*Neuroendocrine Tumors/surgery/mortality/pathology',\n",
       "                'Middle Aged',\n",
       "                'Retrospective Studies',\n",
       "                'Aged',\n",
       "                '*Intestinal Neoplasms/surgery/mortality/pathology',\n",
       "                '*Intestine, Small/surgery/pathology',\n",
       "                'Adult',\n",
       "                'Treatment Outcome',\n",
       "                'Germany/epidemiology',\n",
       "                'Aged, 80 and over',\n",
       "                'Prognosis',\n",
       "                'Emergencies',\n",
       "                'Elective Surgical Procedures'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Small intestinal neuroendocrine tumors',\n",
       "                'emergency surgery',\n",
       "                'oncologic outcome'],\n",
       "               'COIS': ['Declaration of conflicting interestsThe author(s) declared no potential conflicts',\n",
       "                'of interest with respect to the research, authorship, and/or publication of this',\n",
       "                'article.'],\n",
       "               'EDAT': '2024/09/04 12:42',\n",
       "               'MHDA': '2024/11/27 12:37',\n",
       "               'CRDT': ['2024/09/04 08:23'],\n",
       "               'PHST': ['2024/11/27 12:37 [medline]',\n",
       "                '2024/09/04 12:42 [pubmed]',\n",
       "                '2024/09/04 08:23 [entrez]'],\n",
       "               'AID': ['10.1177/14574969241271841 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Scand J Surg. 2024 Dec;113(4):303-313. doi: 10.1177/14574969241271841. Epub 2024 Sep 4.'},\n",
       "              {'PMID': '39112809',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20240924',\n",
       "               'LR': '20250303',\n",
       "               'IS': '1867-0687 (Electronic) 1708-8569 (Print)',\n",
       "               'VI': '20',\n",
       "               'IP': '9',\n",
       "               'DP': '2024 Sep',\n",
       "               'TI': 'Feasibility, efficacy, and safety of animal-assisted activities with visiting dogs in inpatient pediatric oncology.',\n",
       "               'PG': '915-924',\n",
       "               'LID': '10.1007/s12519-024-00829-8 [doi]',\n",
       "               'AB': \"BACKGROUND: Childhood cancer entails a heavy burden for patients and their families. Recent advances in overall survival rates have increasingly brought long-term quality of life into focus. Animal-assisted activities (AAAs) have long been hypothesized to alleviate the burden on pediatric patients and their peers in the hospital setting. However, their use in inpatient pediatric oncology has been a sensitive issue mainly due to the fear of infections, resulting in a lack of studies. This study presents data on the feasibility, safety, and efficacy of AAAs from a single German center. METHODS: Between 2018 and 2022, 60 patients (median age = 10.3 years) diagnosed with malignancy and undergoing treatment were visited by an intervention dog (total visits = 100). Patients were screened for infections as per hospital policy, with additional microbiological testing performed based on symptoms. The dog was screened for human pathogens and zoonoses. Microbial data and hospitalizations were analyzed from two months prior to the first visit until two months after the last visit. Acceptance of being in the hospital, both with and without planned animal-assisted interventions and pre- and post-intervention state stress, were measured using a validated visual analogue scale (0-10). RESULTS: Patients benefited from AAAs, showing increased acceptance of being in the hospital (median: 7.25 vs. 4.50, P < 0.001) and decreased median state stress ratings one hour after the visit compared to one hour before the visit (1.00 vs. 4.25, P < 0.001). The intervention did not result in an increased number of infections or unplanned hospitalizations, and no zoonoses were detected. All microbial screening tests of the dog were negative. CONCLUSIONS: AAAs with visiting dogs in inpatient pediatric oncology are feasible and safe. Although they hold promise for enhancing patients' well-being, further prospective studies are needed. Supplementary file 2 (MP4 240076 KB).\",\n",
       "               'CI': ['(c) 2024. The Author(s).'],\n",
       "               'FAU': ['Steff, Katja',\n",
       "                'Grasemann, Maximilian',\n",
       "                'Ostermann, Kira',\n",
       "                'Goretzki, Sarah Christina',\n",
       "                'Rath, Peter-Michael',\n",
       "                'Reinhardt, Dirk',\n",
       "                'Schundeln, Michael M'],\n",
       "               'AU': ['Steff K',\n",
       "                'Grasemann M',\n",
       "                'Ostermann K',\n",
       "                'Goretzki SC',\n",
       "                'Rath PM',\n",
       "                'Reinhardt D',\n",
       "                'Schundeln MM'],\n",
       "               'AD': ['Pediatric Hematology and Oncology, Department of Pediatrics III, University of Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany.',\n",
       "                'Pediatric Hematology and Oncology, Department of Pediatrics III, University of Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany.',\n",
       "                'Department of Psychology, Medical School Hamburg, Hamburg, Germany.',\n",
       "                'Pediatric Hematology and Oncology, Department of Pediatrics III, University of Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany.',\n",
       "                'Pediatric Infectiology, Department of Pediatrics I, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Institute of Medical Microbiology, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Pediatric Hematology and Oncology, Department of Pediatrics III, University of Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany.',\n",
       "                'Pediatric Hematology and Oncology, Department of Pediatrics III, University of Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany. michael.schuendeln@uk-essen.de.'],\n",
       "               'AUID': ['ORCID: 0000-0002-7027-4483',\n",
       "                'ORCID: 0000-0001-7495-9060'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20240807',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'World J Pediatr',\n",
       "               'JT': 'World journal of pediatrics : WJP',\n",
       "               'JID': '101278599',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Dogs',\n",
       "                'Animals',\n",
       "                'Child',\n",
       "                'Male',\n",
       "                'Female',\n",
       "                '*Animal Assisted Therapy',\n",
       "                '*Neoplasms/therapy',\n",
       "                '*Feasibility Studies',\n",
       "                'Adolescent',\n",
       "                'Germany',\n",
       "                'Child, Preschool',\n",
       "                'Inpatients',\n",
       "                'Quality of Life'],\n",
       "               'PMC': 'PMC11422466',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Animal-assisted activities',\n",
       "                'Animal-assisted interventions',\n",
       "                'Animal-assisted therapy',\n",
       "                'Feasibility',\n",
       "                'Infection control',\n",
       "                'Inpatient pediatric oncology',\n",
       "                'Safety',\n",
       "                'Stress response',\n",
       "                'Therapy dog',\n",
       "                'Visiting dog'],\n",
       "               'COIS': ['No financial or non-financial benefits have been received or will be received',\n",
       "                'from any party related directly or indirectly to the subject of this article. The',\n",
       "                'authors have no conflict of interest to declare.'],\n",
       "               'EDAT': '2024/08/08 00:42',\n",
       "               'MHDA': '2024/09/25 00:44',\n",
       "               'PMCR': ['2024/08/07'],\n",
       "               'CRDT': ['2024/08/07 23:34'],\n",
       "               'PHST': ['2024/02/29 00:00 [received]',\n",
       "                '2024/06/24 00:00 [accepted]',\n",
       "                '2024/09/25 00:44 [medline]',\n",
       "                '2024/08/08 00:42 [pubmed]',\n",
       "                '2024/08/07 23:34 [entrez]',\n",
       "                '2024/08/07 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s12519-024-00829-8 [pii]',\n",
       "                '829 [pii]',\n",
       "                '10.1007/s12519-024-00829-8 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Pediatr. 2024 Sep;20(9):915-924. doi: 10.1007/s12519-024-00829-8. Epub 2024 Aug 7.'},\n",
       "              {'PMID': '39052290',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20240725',\n",
       "               'LR': '20250225',\n",
       "               'IS': '2574-3805 (Electronic) 2574-3805 (Linking)',\n",
       "               'VI': '7',\n",
       "               'IP': '7',\n",
       "               'DP': '2024 Jul 1',\n",
       "               'TI': 'Neonatal Sepsis Episodes and Retinopathy of Prematurity in Very Preterm Infants.',\n",
       "               'PG': 'e2423933',\n",
       "               'LID': '10.1001/jamanetworkopen.2024.23933 [doi] e2423933',\n",
       "               'AB': \"IMPORTANCE: Retinopathy of prematurity (ROP) is a major morbidity of preterm infants causing visual impairment, including blindness, for which timely treatment is vital and prevention is key. Increasing evidence suggests that exposure to neonatal sepsis contributes to ROP development. OBJECTIVE: To investigate the association between neonatal sepsis and ROP in 2 large-scale cohorts of preterm infants born at less than 29 weeks' gestation. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study was conducted using data from the German Neonatal Network (GNN) and Norwegian Neonatal Network (NNN). The GNN involves 68 and the NNN includes 21 level III neonatal intensive care units. Participants were infants born at a gestation of 22 weeks and 0 days to 28 weeks and 6 days and enrolled in the GNN between January 1, 2009, and December 31, 2022, and NNN between January 1, 2009, and December 31, 2018. Data were analyzed from February through September 2023. EXPOSURE: Single or multiple episodes of culture-proven sepsis. MAIN OUTCOMES AND MEASURES: Any ROP and treatment-warranted ROP. RESULTS: Among 12\\u202f794 infants in the GNN (6043 female [47.2%] and 6751 male [52.8%]; mean [SD] gestational age, 26.4 [1.5] weeks) and 1844 infants in the NNN (866 female [47.0%] and 978 male [53.0%]; mean [SD] gestational age, 25.6 [1.5] weeks), the mean (SD) birth weight was 848 (229) g and 807 (215) g, respectively. Any ROP was present in 6370 infants (49.8%) in GNN and 620 infants (33.6%) in NNN, and treatment-warranted ROP was present in 840 infants (6.6%) in GNN and 140 infants (7.6%) in NNN. In both cohorts, there were increasing rates of treatment-warranted ROP with each sepsis episode (no sepsis: 572 of 10\\u202f658 infants [5.4%] in GNN and 85 of 1492 infants (5.7%) in NNN; 1 episode: 190 of 1738 infants in GNN [10.9%] and 29 of 293 infants [9.9%] in NNN; 2 episodes: 53 of 314 infants in GNN [16.9%] and 13 of 49 infants [26.5%] in NNN; 3 episodes: 25 of 84 infants [29.8%] in GNN and 3 of 10 infants [30.0%] in NNN). After adjusting for multiple confounders in the GNN dataset, the number of sepsis episodes was associated with ROP and treatment-warranted ROP compared with 0 episodes (1 episode: adjusted odds ratio [aOR], 1.44 [95% CI, 1.27-1.63]; P < .001 and OR, 1.60 [95% CI, 1.31-1.96]; P < .001, respectively; 2 episodes: OR, 1.81 [95% CI, 1.35-2.42]; P < .001 and OR, 2.38 [95% CI, 1.68-3.37]; P < .001, respectively; 3 episodes: OR, 4.39 [95% CI, 2.19-8.78]; P < .001 and OR, 3.88 [95% CI, 2.29-6.55]; P < .001, respectively). These associations were confirmed for any ROP by propensity score matching (for example, the aOR with propensity score matching was 1.76 [95% CI, 1.54-2.02]; P < .001 for 1 episode vs 0 episodes and 1.58 [95% CI, 1.12-2.22]; P = .007 for 3 episodes vs 0 or 1 episode). In the NNN dataset, surgical NEC was associated with treatment-warranted ROP (multivariable analysis: aOR, 3.37 [95% CI, 1.78-6.37]; P < .001). CONCLUSIONS AND RELEVANCE: This study found that in the large-scale GNN cohort, recurrent culture-proven sepsis was associated with ROP and treatment-warranted ROP in infants born at less than 29 weeks.\",\n",
       "               'FAU': ['Glaser, Kirsten',\n",
       "                'Hartel, Christoph',\n",
       "                'Klingenberg, Claus',\n",
       "                'Herting, Egbert',\n",
       "                'Fortmann, Mats I',\n",
       "                'Speer, Christian P',\n",
       "                'Stensvold, Hans J',\n",
       "                'Huncikova, Zuzana',\n",
       "                'Ronnestad, Arild E',\n",
       "                'Nentwich, Martin M',\n",
       "                'Stahl, Andreas',\n",
       "                'Dammann, Olaf',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Glaser K',\n",
       "                'Hartel C',\n",
       "                'Klingenberg C',\n",
       "                'Herting E',\n",
       "                'Fortmann MI',\n",
       "                'Speer CP',\n",
       "                'Stensvold HJ',\n",
       "                'Huncikova Z',\n",
       "                'Ronnestad AE',\n",
       "                'Nentwich MM',\n",
       "                'Stahl A',\n",
       "                'Dammann O',\n",
       "                'Gopel W'],\n",
       "               'AD': [\"Division of Neonatology, Department of Women's and Children's Health, University of Leipzig Medical Center, Leipzig, Germany.\",\n",
       "                'Department of Pediatrics, University Hospital of Wurzburg, Wurzburg, Germany.',\n",
       "                'Paediatric Research Group, Faculty of Health Sciences, University of Tromso-Arctic University of Norway, Tromso, Norway.',\n",
       "                'Department of Pediatrics and Adolescence Medicine, University Hospital of North Norway, Tromso, Norway.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Wurzburg, Wurzburg, Germany.',\n",
       "                'Department of Neonatal Intensive Care, Clinic of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.',\n",
       "                'Paediatric Department, Stavanger University Hospital, Stavanger, Norway.',\n",
       "                'Department of Clinical Science, University of Bergen, Bergen, Norway.',\n",
       "                'Department of Neonatal Intensive Care, Clinic of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.',\n",
       "                'Medical Faculty, Institute for Clinical Medicine, University of Oslo, Oslo.',\n",
       "                'Department of Ophthalmology, University Hospital of Wurzburg, Wurzburg, Germany.',\n",
       "                'Department of Ophthalmology, University Medicine Greifswald, Greifswald, Germany.',\n",
       "                'Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts.',\n",
       "                'Department of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany.',\n",
       "                'Department of Neuromedicine and Movement Sciences, Norwegian University of Science and Technology, Trondheim, Norway.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network, the Norwegian Neonatal Network Investigators, and the',\n",
       "                'Infection, Inflammation, Immunology and Immunisation section of the European',\n",
       "                'Society for Paediatric Research'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20240701',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'JAMA Netw Open',\n",
       "               'JT': 'JAMA network open',\n",
       "               'JID': '101729235',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*Retinopathy of Prematurity/epidemiology',\n",
       "                'Infant, Newborn',\n",
       "                'Female',\n",
       "                'Male',\n",
       "                'Retrospective Studies',\n",
       "                '*Neonatal Sepsis/epidemiology',\n",
       "                'Germany/epidemiology',\n",
       "                'Infant, Extremely Premature',\n",
       "                'Norway/epidemiology',\n",
       "                'Intensive Care Units, Neonatal/statistics & numerical data',\n",
       "                'Gestational Age',\n",
       "                'Infant, Premature',\n",
       "                'Risk Factors'],\n",
       "               'PMC': 'PMC11273231',\n",
       "               'COIS': ['Conflict of Interest Disclosures: Dr Klingenberg reported receiving honoraria',\n",
       "                'from Chiesi outside the submitted work. Dr Herting reported receiving grants,',\n",
       "                'personal fees, travel support, and speaker honoraria from Chiesi during the',\n",
       "                'conduct of the study; support for other surfactant studies from Chiesi; and',\n",
       "                'personal fees and speaker honoraria from Pfizer, Merck Sharp and Dohme, Sanofi,',\n",
       "                'and AstraZeneca outside the submitted work; holding a patent with Chiesi for less',\n",
       "                'invasive surfactant therapy; and having membership on a board of the German',\n",
       "                'Research Foundation. Dr Fortmann reported receiving speaker honoraria from Chiesi',\n",
       "                'and Pfizer. Dr Nentwich reported receiving speaker honoraria from Novartis. Dr',\n",
       "                'Stahl reported receiving grants from Novartis, Bayer, and Roche and personal fees',\n",
       "                'from Novartis, Bayer, Alcon, Apellis, and Roche outside the submitted work. Dr',\n",
       "                'Gopel reported receiving personal fees from Chiesi and Abbott outside the',\n",
       "                'submitted work. No other disclosures were reported.'],\n",
       "               'FIR': ['Faust, Kirstin',\n",
       "                'Muller, Dirk',\n",
       "                'Thome, Ulrich',\n",
       "                'Guthmann, Florian',\n",
       "                'von der Wense, Axel',\n",
       "                'Wieg, Christian',\n",
       "                'Weller, Ursula',\n",
       "                'Hohn, Thomas',\n",
       "                'Olbertz, Dirk',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Rossi, Rainer',\n",
       "                'Teig, Norbert',\n",
       "                'Heitmann, Friedhelm',\n",
       "                'Heckmann, Matthias',\n",
       "                'Schmidtke, Susanne',\n",
       "                'Bohnhorst, Bettina',\n",
       "                'Kribs, Angela',\n",
       "                'Vochem, Matthias',\n",
       "                'Wellmann, Sven',\n",
       "                'Moller, Jens',\n",
       "                'Eichhorn, Joachim',\n",
       "                'Wintgens, Jurgen',\n",
       "                'Bottger, Ralf',\n",
       "                'Flugel, Markus',\n",
       "                'Hubert, Mechthild',\n",
       "                'Dordelmann, Michael',\n",
       "                'Hillebrand, Georg',\n",
       "                'Roll, Claudia',\n",
       "                'Jensen, Reinhard',\n",
       "                'Rudiger, Mario',\n",
       "                'Humberg, Alexander',\n",
       "                'Longardt, Ann Carolin',\n",
       "                'Schafer, Stefan',\n",
       "                'Schaible, Thomas',\n",
       "                'Franz, Axel',\n",
       "                'Hensel, Kay',\n",
       "                'Kunzmann, Steffen',\n",
       "                'Schmidt, Esther',\n",
       "                'Orlikowsky, Thorsten',\n",
       "                'Gerleve, Hubert',\n",
       "                'Depping, Nico',\n",
       "                'Haase, Roland',\n",
       "                'Hoppenz, Marc',\n",
       "                'Vilser, Daniel',\n",
       "                'Kuster, Helmut',\n",
       "                'Fuchs, Hans',\n",
       "                'Korner, Thorsten',\n",
       "                'Brune, Thomas',\n",
       "                'Muller, Andreas',\n",
       "                'Urlichs, Florian',\n",
       "                'Berghauser, Martin',\n",
       "                'Proquitte, Hans',\n",
       "                'Morhart, Patrick',\n",
       "                'Lindner, Wolfgang',\n",
       "                'Schlosser, Rolf',\n",
       "                'Schneider, Welfhard',\n",
       "                'Schroth, Michael',\n",
       "                'Rieger-Fackeldey, Esther',\n",
       "                'Dohle, Frank',\n",
       "                'Bauer, Jaqueline',\n",
       "                'Volkl, Thomas',\n",
       "                'Brevis Nunez, Francisco',\n",
       "                'Welsch, Michael',\n",
       "                'Kruger, Marcus'],\n",
       "               'IR': ['Faust K',\n",
       "                'Muller D',\n",
       "                'Thome U',\n",
       "                'Guthmann F',\n",
       "                'von der Wense A',\n",
       "                'Wieg C',\n",
       "                'Weller U',\n",
       "                'Hohn T',\n",
       "                'Olbertz D',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Rossi R',\n",
       "                'Teig N',\n",
       "                'Heitmann F',\n",
       "                'Heckmann M',\n",
       "                'Schmidtke S',\n",
       "                'Bohnhorst B',\n",
       "                'Kribs A',\n",
       "                'Vochem M',\n",
       "                'Wellmann S',\n",
       "                'Moller J',\n",
       "                'Eichhorn J',\n",
       "                'Wintgens J',\n",
       "                'Bottger R',\n",
       "                'Flugel M',\n",
       "                'Hubert M',\n",
       "                'Dordelmann M',\n",
       "                'Hillebrand G',\n",
       "                'Roll C',\n",
       "                'Jensen R',\n",
       "                'Rudiger M',\n",
       "                'Humberg A',\n",
       "                'Longardt AC',\n",
       "                'Schafer S',\n",
       "                'Schaible T',\n",
       "                'Franz A',\n",
       "                'Hensel K',\n",
       "                'Kunzmann S',\n",
       "                'Schmidt E',\n",
       "                'Orlikowsky T',\n",
       "                'Gerleve H',\n",
       "                'Depping N',\n",
       "                'Haase R',\n",
       "                'Hoppenz M',\n",
       "                'Vilser D',\n",
       "                'Kuster H',\n",
       "                'Fuchs H',\n",
       "                'Korner T',\n",
       "                'Brune T',\n",
       "                'Muller A',\n",
       "                'Urlichs F',\n",
       "                'Berghauser M',\n",
       "                'Proquitte H',\n",
       "                'Morhart P',\n",
       "                'Lindner W',\n",
       "                'Schlosser R',\n",
       "                'Schneider W',\n",
       "                'Schroth M',\n",
       "                'Rieger-Fackeldey E',\n",
       "                'Dohle F',\n",
       "                'Bauer J',\n",
       "                'Volkl T',\n",
       "                'Brevis Nunez F',\n",
       "                'Welsch M',\n",
       "                'Kruger M'],\n",
       "               'EDAT': '2024/07/26 12:41',\n",
       "               'MHDA': '2024/07/26 12:42',\n",
       "               'PMCR': ['2024/07/25'],\n",
       "               'CRDT': ['2024/07/25 11:34'],\n",
       "               'PHST': ['2024/07/26 12:42 [medline]',\n",
       "                '2024/07/26 12:41 [pubmed]',\n",
       "                '2024/07/25 11:34 [entrez]',\n",
       "                '2024/07/25 00:00 [pmc-release]'],\n",
       "               'AID': ['2821486 [pii]',\n",
       "                'zoi240749 [pii]',\n",
       "                '10.1001/jamanetworkopen.2024.23933 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'JAMA Netw Open. 2024 Jul 1;7(7):e2423933. doi: 10.1001/jamanetworkopen.2024.23933.'},\n",
       "              {'PMID': '39030994',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20240720',\n",
       "               'LR': '20240720',\n",
       "               'IS': '1399-3046 (Electronic) 1397-3142 (Linking)',\n",
       "               'VI': '28',\n",
       "               'IP': '5',\n",
       "               'DP': '2024 Aug',\n",
       "               'TI': 'Surgical Site Infections After Pediatric Liver Transplantation-Impact of a Change in Perioperative Prophylactic Antibiotic Protocol.',\n",
       "               'PG': 'e14830',\n",
       "               'LID': '10.1111/petr.14830 [doi]',\n",
       "               'AB': 'BACKGROUND: In spite of improved survival rates after pediatric liver transplantation, infections remain major contributors to perioperative morbidity and mortality. This study aimed to understand the impact of type and duration of perioperative antibiotic prophylaxis (PAP) on the occurrence of surgical site infections (SSIs). METHODS: In total, 125 patients who underwent liver transplantation between 2014 and 2020 were retrospectively included. Patients were categorized into two periods based on changes in the standard PAP regimen. Risk factors for SSIs were investigated, including the influence of PAP duration, antibiotic substances used, and abdominal patch placement using multivariable regression models. RESULTS: SSIs occurred in 23 (19%) of 119 analyzed patients and were not impacted by changes in the PAP regimen. The placement of an abdominal patch was a relevant risk factor for SSIs (odds ratio 3.81; 95% confidence interval [CI] 1.15-12.68). Longer PAP duration reduced the occurrence of SSIs by up to 4.6 percentage points (95% CI 0.0-9.1) per day, with its effect diminishing with longer duration. The choice of antibiotic substances for PAP changed after implementation of the new protocol, with a decline in vancomycin usage from 14% to 3%. CONCLUSION: The results of this study emphasize the need for evidence-based PAP regimens tailored to the unique needs of pediatric liver transplant recipients. The occurrence of SSIs remains complex and is influenced by various factors beyond the PAP regimen. Multicentric efforts to develop effective prevention strategies against SSIs in this vulnerable population are warranted.',\n",
       "               'CI': ['(c) 2024 The Author(s). Pediatric Transplantation published by Wiley Periodicals',\n",
       "                'LLC.'],\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Hauschild, Juliane',\n",
       "                'Lainka, Elke',\n",
       "                'Dohna-Schwake, Christian'],\n",
       "               'AU': ['Bruns N', 'Hauschild J', 'Lainka E', 'Dohna-Schwake C'],\n",
       "               'AUID': ['ORCID: 0000-0003-3809-1887',\n",
       "                'ORCID: 0000-0002-7624-2968',\n",
       "                'ORCID: 0000-0001-8973-5406'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                \"Department of Pediatrics II, Pediatric Gastroenterology, Hepatology and Liver Transplantation, University Children's Hospital, Essen, Germany.\",\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'Denmark',\n",
       "               'TA': 'Pediatr Transplant',\n",
       "               'JT': 'Pediatric transplantation',\n",
       "               'JID': '9802574',\n",
       "               'RN': ['0 (Anti-Bacterial Agents)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*Liver Transplantation/adverse effects',\n",
       "                '*Antibiotic Prophylaxis/methods',\n",
       "                'Retrospective Studies',\n",
       "                'Female',\n",
       "                '*Surgical Wound Infection/prevention & control/etiology/epidemiology',\n",
       "                'Male',\n",
       "                'Child',\n",
       "                'Child, Preschool',\n",
       "                '*Anti-Bacterial Agents/therapeutic use/administration & dosage',\n",
       "                'Risk Factors',\n",
       "                'Infant',\n",
       "                'Adolescent',\n",
       "                'Perioperative Care/methods',\n",
       "                'Clinical Protocols'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['abdominal patch',\n",
       "                'liver transplantation',\n",
       "                'perioperative antibiotic prophylaxis',\n",
       "                'surgical site infection'],\n",
       "               'EDAT': '2024/07/20 20:44',\n",
       "               'MHDA': '2024/07/20 20:45',\n",
       "               'CRDT': ['2024/07/20 07:14'],\n",
       "               'PHST': ['2024/06/21 00:00 [revised]',\n",
       "                '2024/02/20 00:00 [received]',\n",
       "                '2024/07/08 00:00 [accepted]',\n",
       "                '2024/07/20 20:45 [medline]',\n",
       "                '2024/07/20 20:44 [pubmed]',\n",
       "                '2024/07/20 07:14 [entrez]'],\n",
       "               'AID': ['10.1111/petr.14830 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Pediatr Transplant. 2024 Aug;28(5):e14830. doi: 10.1111/petr.14830.'},\n",
       "              {'PMID': '39002696',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20240911',\n",
       "               'LR': '20241022',\n",
       "               'IS': '1873-1570 (Electronic) 0300-9572 (Linking)',\n",
       "               'VI': '202',\n",
       "               'DP': '2024 Sep',\n",
       "               'TI': 'Short-term outcomes of asphyxiated neonates depending on requirement for transfer in the first 24 h of life.',\n",
       "               'PG': '110309',\n",
       "               'LID': 'S0300-9572(24)00203-X [pii] 10.1016/j.resuscitation.2024.110309 [doi]',\n",
       "               'AB': 'IMPORTANCE: In neonates with birth asphyxia (BA) and hypoxic-ischemic encephalopathy, therapeutic hypothermia (TH), initiated within six hours, is the only safe and established neuroprotective measure to prevent secondary brain injury. Infants born outside of TH centers have delayed access to cooling. OBJECTIVE: To compare in-hospital mortality, occurrence of seizures, and functional status at discharge in newborns with BA depending on postnatal transfer for treatment to another hospital within 24 h of admission (transferred (TN) versus non-transferred neonates (NTN)). DESIGN: Nationwide retrospective cohort study from a comprehensive hospital dataset using codes of the International Classification of Diseases, 10th modification (ICD-10). Clinical and outcome information was retrieved from diagnostic and procedural codes. Hierarchical multilevel logistic regression modeling was performed to quantify the effect of being postnatally transferred on target outcomes. SETTING: All discharges from German hospitals from 2016 to 2021. PARTICIPANTS: Full term neonates with birth asphyxia (ICD-10 code: P21) admitted to a pediatric department on their first day of life. EXPOSURES: Postnatal transfer to a pediatric department within 24 h of admission to an external hospital. MAIN OUTCOMES: In-hospital death; secondary outcomes: seizures and pediatric complex chronic conditions category (PCCC) >/= 2. RESULTS: Of 11,703,800 pediatric cases, 25,914 fulfilled the inclusion criteria. TNs had higher proportions of organ dysfunction, TH, organ replacement therapies, and neurological sequelae in spite of slightly lower proportions of maternal risk factors. In TNs, the adjusted odds ratios (OR) for death, seizures, and PCCC >/= 2 were 4.08 ((95% confidence interval 3.41-4.89), 2.99 (2.65-3.38), and 1.76 (1.52-2.05), respectively. A subgroup analysis among infants receiving TH (n = 3,283) found less pronounced adjusted ORs for death (1.67 (1.29-2.17)) and seizures (1.26 (1.07-1.48)) and inverse effects for PCCC >/= 2 (0.81 (0.64-1.02)) in TNs. CONCLUSION AND RELEVANCE: This comprehensive nationwide study found increased odds for adverse outcomes in neonates with BA who were transferred to another facility within 24 h of hospital admission. Closely linking obstetrical units to a pediatric department and balancing geographical coverage of different levels of care facilities might help to minimize risks for postnatal emergency transfer and optimize perinatal care.',\n",
       "               'CI': ['Copyright (c) 2024 The Author(s). Published by Elsevier B.V. All rights reserved.'],\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Feddahi, Nadia',\n",
       "                'Hojeij, Rayan',\n",
       "                'Rossi, Rainer',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Stein, Anja',\n",
       "                'Kobus, Susann',\n",
       "                'Stang, Andreas',\n",
       "                'Kowall, Bernd',\n",
       "                'Felderhoff-Muser, Ursula'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Feddahi N',\n",
       "                'Hojeij R',\n",
       "                'Rossi R',\n",
       "                'Dohna-Schwake C',\n",
       "                'Stein A',\n",
       "                'Kobus S',\n",
       "                'Stang A',\n",
       "                'Kowall B',\n",
       "                'Felderhoff-Muser U'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, Pediatric Neurology, and Pediatric Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; C-TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Electronic address: nora.bruns@uk-essen.de.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, Pediatric Neurology, and Pediatric Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; C-TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, Pediatric Neurology, and Pediatric Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; C-TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics, Vivantes Klinikum Neukoelln, Berlin, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, Pediatric Neurology, and Pediatric Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; C-TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, Pediatric Neurology, and Pediatric Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; C-TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, Pediatric Neurology, and Pediatric Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; C-TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, Pediatric Neurology, and Pediatric Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; C-TNBS, Centre for Translational Neuro- and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20240711',\n",
       "               'PL': 'Ireland',\n",
       "               'TA': 'Resuscitation',\n",
       "               'JT': 'Resuscitation',\n",
       "               'JID': '0332173',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*Asphyxia Neonatorum/therapy/complications',\n",
       "                'Infant, Newborn',\n",
       "                'Female',\n",
       "                'Male',\n",
       "                'Retrospective Studies',\n",
       "                '*Patient Transfer/statistics & numerical data',\n",
       "                '*Hospital Mortality',\n",
       "                'Germany/epidemiology',\n",
       "                '*Hypothermia, Induced/methods',\n",
       "                'Hypoxia-Ischemia, Brain/therapy/etiology',\n",
       "                'Seizures/etiology/epidemiology',\n",
       "                'Time-to-Treatment/statistics & numerical data'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Birth asphyxia',\n",
       "                'Hypothermia',\n",
       "                'Mortality',\n",
       "                'Outcome',\n",
       "                'Perinatal asphyxia',\n",
       "                'Referral',\n",
       "                'Transfer'],\n",
       "               'COIS': ['Declaration of competing interest The authors declare that they have no known',\n",
       "                'competing financial interests or personal relationships that could have appeared',\n",
       "                'to influence the work reported in this paper.'],\n",
       "               'EDAT': '2024/07/14 02:43',\n",
       "               'MHDA': '2024/09/12 00:42',\n",
       "               'CRDT': ['2024/07/13 19:26'],\n",
       "               'PHST': ['2024/03/25 00:00 [received]',\n",
       "                '2024/07/03 00:00 [revised]',\n",
       "                '2024/07/05 00:00 [accepted]',\n",
       "                '2024/09/12 00:42 [medline]',\n",
       "                '2024/07/14 02:43 [pubmed]',\n",
       "                '2024/07/13 19:26 [entrez]'],\n",
       "               'AID': ['S0300-9572(24)00203-X [pii]',\n",
       "                '10.1016/j.resuscitation.2024.110309 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Resuscitation. 2024 Sep;202:110309. doi: 10.1016/j.resuscitation.2024.110309. Epub 2024 Jul 11.'},\n",
       "              {'PMID': '38941879',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20240728',\n",
       "               'LR': '20240916',\n",
       "               'IS': '1532-2130 (Electronic) 1090-3798 (Linking)',\n",
       "               'VI': '51',\n",
       "               'DP': '2024 Jul',\n",
       "               'TI': 'The effect of live music therapy on white matter microstructure in very preterm infants - A randomized controlled trial.',\n",
       "               'PG': '132-139',\n",
       "               'LID': 'S1090-3798(24)00095-3 [pii] 10.1016/j.ejpn.2024.06.009 [doi]',\n",
       "               'AB': \"OBJECTIVE: Music therapy (MT) is proposed to enrich the acoustic environment of very preterm infants (VPT) on the neonatal intensive care unit during a vulnerable period of brain development. The objective of this study was to investigate the effect of MT on the white matter (WM) microstructure. It is hypothesized that MT affects WM integrity in VPT. METHODS: Randomized controlled trial enrolling infants born <32 weeks' gestation. Infants were randomized to MT or standard care. Live MT was provided twice weekly from the second postnatal week onwards by a trained music therapist. At term equivalent age, participants underwent a cranial magnetic resonance imaging scan including sequences for diffusion tensor imaging analysis. Differences in WM microstructure were assessed using tract based spatial statistics with fractional anisotropy. RESULTS: Of 80 infants enrolled, 42 were eligible for diffusion tensor imaging analysis (MT: n = 22, standard care: n = 20). While primary tract based spatial statistics analysis revealed no significant differences between groups, post hoc analysis with uncorrected p-values and a significance threshold of p < 0.01 revealed significant fractional anisotropy differences in several WM tracts including the bilateral superior longitudinal fasciculus, the left forceps minor and left fasciculus uncinatus, the corpus callosum, the left external capsule, and the right corticospinal tract. CONCLUSION: Post hoc analysis results suggest an effect of MT on WM integrity in VPT. Larger studies including long-term outcome are necessary to confirm these effects of MT on WM microstructure and to assess its impact on clinical neurodevelopment. CLINICAL TRIAL REGISTRATION: Clinical trial number DRKS00025753.\",\n",
       "               'CI': ['Copyright (c) 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.'],\n",
       "               'FAU': ['Dewan, Monia Vanessa',\n",
       "                'Jungilligens, Johannes',\n",
       "                'Kobus, Susann',\n",
       "                'Diezel, Marlis',\n",
       "                'Dathe, Anne-Kathrin',\n",
       "                'Schweiger, Bernd',\n",
       "                'Huning, Britta',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Bruns, Nora'],\n",
       "               'AU': ['Dewan MV',\n",
       "                'Jungilligens J',\n",
       "                'Kobus S',\n",
       "                'Diezel M',\n",
       "                'Dathe AK',\n",
       "                'Schweiger B',\n",
       "                'Huning B',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Bruns N'],\n",
       "               'AD': ['Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Center for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany. Electronic address: monia.dewan@uk-essen.de.',\n",
       "                'Department of Neurology, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Center for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Center for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Center for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany; Department of Health and Nursing, Occupational Therapy, Ernst-Abbe-University of Applied Sciences Jena, Germany.',\n",
       "                'Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Center for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Center for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Center for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Randomized Controlled Trial'],\n",
       "               'DEP': '20240622',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Eur J Paediatr Neurol',\n",
       "               'JT': 'European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society',\n",
       "               'JID': '9715169',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*White Matter/diagnostic imaging',\n",
       "                'Female',\n",
       "                'Male',\n",
       "                '*Diffusion Tensor Imaging/methods',\n",
       "                '*Music Therapy/methods',\n",
       "                'Infant, Newborn',\n",
       "                '*Infant, Extremely Premature',\n",
       "                'Infant, Premature'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Diffusion tensor imaging',\n",
       "                'Music therapy',\n",
       "                'Neurodevelopment',\n",
       "                'Preterm infants',\n",
       "                'Randomized controlled trial'],\n",
       "               'COIS': ['Declaration of competing interest On behalf of the authors of the manuscript \"The',\n",
       "                'effect of live music therapy on white matter microstructure in very preterm',\n",
       "                'infants - a randomized controlled trial\" there are no conflicts of interest to',\n",
       "                'declare.'],\n",
       "               'EDAT': '2024/06/29 00:42',\n",
       "               'MHDA': '2024/07/28 14:53',\n",
       "               'CRDT': ['2024/06/28 18:07'],\n",
       "               'PHST': ['2023/07/30 00:00 [received]',\n",
       "                '2024/05/31 00:00 [revised]',\n",
       "                '2024/06/20 00:00 [accepted]',\n",
       "                '2024/07/28 14:53 [medline]',\n",
       "                '2024/06/29 00:42 [pubmed]',\n",
       "                '2024/06/28 18:07 [entrez]'],\n",
       "               'AID': ['S1090-3798(24)00095-3 [pii]',\n",
       "                '10.1016/j.ejpn.2024.06.009 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Paediatr Neurol. 2024 Jul;51:132-139. doi: 10.1016/j.ejpn.2024.06.009. Epub 2024 Jun 22.'},\n",
       "              {'PMID': '38940604',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20241105',\n",
       "               'LR': '20241105',\n",
       "               'IS': '1469-8749 (Electronic) 0012-1622 (Linking)',\n",
       "               'VI': '66',\n",
       "               'IP': '12',\n",
       "               'DP': '2024 Dec',\n",
       "               'TI': 'Cerebral Doppler imaging in neonates: A guide for clinical application and diagnosis.',\n",
       "               'PG': '1570-1589',\n",
       "               'LID': '10.1111/dmcn.15998 [doi]',\n",
       "               'AB': 'Cranial ultrasound reliably diagnoses many neonatal brain disorders. Adding Doppler imaging expands the spectrum by providing information on the status of the vasculature and haemodynamics that may guide further diagnostic and clinical management. Doppler imaging may identify neonates with congenital or acquired vascular abnormalities such as perinatal stroke, sinuvenous thrombosis, vein of Galen malformation, dural sinus malformation, sinus pericranii, and developmental venous anomaly. These entities may need further investigation with complementary imaging modalities such as magnetic resonance imaging and magnetic resonance angiography, or conventional angiography. This review aims to help clinicians to improve their Doppler sonography knowledge and skills in order to use this helpful tool in neonates with neurological symptoms or suspected cerebral vascular abnormalities admitted to the neonatal intensive care unit.',\n",
       "               'CI': ['(c) 2024 Mac Keith Press.'],\n",
       "               'FAU': ['Horsch, Sandra',\n",
       "                'Schwarz, Simone',\n",
       "                'Arnaez, Juan',\n",
       "                'Steggerda, Sylke',\n",
       "                'Arena, Roberta',\n",
       "                'Govaert, Paul'],\n",
       "               'AU': ['Horsch S',\n",
       "                'Schwarz S',\n",
       "                'Arnaez J',\n",
       "                'Steggerda S',\n",
       "                'Arena R',\n",
       "                'Govaert P'],\n",
       "               'AUID': ['ORCID: 0000-0002-2412-7319',\n",
       "                'ORCID: 0000-0001-6930-1061',\n",
       "                'ORCID: 0000-0002-8603-4206',\n",
       "                'ORCID: 0000-0002-2011-4529'],\n",
       "               'AD': ['Department of Neonatology, Helios Klinikum Berlin Buch, Berlin, Germany.',\n",
       "                'Department of Neonatology and Pediatric Intensive Care Medicine, Sana Clinics, Duisburg, Germany.',\n",
       "                'Hospital Universitario de Burgos, Burgos, Spain.',\n",
       "                'Neonatal Neurology, NeNe Foundation, Madrid, Spain.',\n",
       "                'Department of Neonatology, Leiden University Medical Center, Leiden, the Netherlands.',\n",
       "                'Catholic University of the Sacred Heart, A. Gemelli Hospital, Rome, Italy.',\n",
       "                'Department of Neonatology, UZBrussel, Brussels, Belgium.',\n",
       "                'Department of Neonatology, ZNA Middelheim, Antwerp, Belgium.'],\n",
       "               'CN': ['EurUS.Brain group'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'DEP': '20240628',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Dev Med Child Neurol',\n",
       "               'JT': 'Developmental medicine and child neurology',\n",
       "               'JID': '0006761',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Infant, Newborn',\n",
       "                '*Ultrasonography, Doppler, Transcranial/methods',\n",
       "                'Brain Diseases/diagnostic imaging',\n",
       "                'Brain/diagnostic imaging/blood supply',\n",
       "                'Ultrasonography, Doppler'],\n",
       "               'FIR': ['Agut, Thais',\n",
       "                'Alarcon, Ana',\n",
       "                'Bartocci, Marco',\n",
       "                'Benavente-Fernandez, Isabel',\n",
       "                'Bravo, Maria Carmen',\n",
       "                'Cabanas, Fernando',\n",
       "                'Carreras, Nuria Blesa',\n",
       "                'Claris, Olivier',\n",
       "                'Dudink, Jeroen',\n",
       "                'Fumagalli, Monica',\n",
       "                'Garcia-Alix, Alfredo',\n",
       "                'Lubian-Lopez, Simon Pedro',\n",
       "                'Muhlbacher, Tobias',\n",
       "                'Parodi, Alessandro',\n",
       "                'Pellicer, Adelina',\n",
       "                'Ramenghi, Luca',\n",
       "                'Roehr, Charles C',\n",
       "                'Valverde, Eva'],\n",
       "               'IR': ['Agut T',\n",
       "                'Alarcon A',\n",
       "                'Bartocci M',\n",
       "                'Benavente-Fernandez I',\n",
       "                'Bravo MC',\n",
       "                'Cabanas F',\n",
       "                'Carreras NB',\n",
       "                'Claris O',\n",
       "                'Dudink J',\n",
       "                'Fumagalli M',\n",
       "                'Garcia-Alix A',\n",
       "                'Lubian-Lopez SP',\n",
       "                'Muhlbacher T',\n",
       "                'Parodi A',\n",
       "                'Pellicer A',\n",
       "                'Ramenghi L',\n",
       "                'Roehr CC',\n",
       "                'Valverde E'],\n",
       "               'EDAT': '2024/06/28 12:42',\n",
       "               'MHDA': '2024/11/05 18:21',\n",
       "               'CRDT': ['2024/06/28 09:12'],\n",
       "               'PHST': ['2024/04/30 00:00 [revised]',\n",
       "                '2023/08/15 00:00 [received]',\n",
       "                '2024/05/22 00:00 [accepted]',\n",
       "                '2024/11/05 18:21 [medline]',\n",
       "                '2024/06/28 12:42 [pubmed]',\n",
       "                '2024/06/28 09:12 [entrez]'],\n",
       "               'AID': ['10.1111/dmcn.15998 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Dev Med Child Neurol. 2024 Dec;66(12):1570-1589. doi: 10.1111/dmcn.15998. Epub 2024 Jun 28.'},\n",
       "              {'PMID': '38903601',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20240622',\n",
       "               'IS': '1662-4548 (Print) 1662-453X (Electronic) 1662-453X (Linking)',\n",
       "               'VI': '18',\n",
       "               'DP': '2024',\n",
       "               'TI': 'Association of bilaterally suppressed EEG amplitudes and outcomes in critically ill children.',\n",
       "               'PG': '1411151',\n",
       "               'LID': '10.3389/fnins.2024.1411151 [doi] 1411151',\n",
       "               'AB': 'BACKGROUND AND OBJECTIVES: Amplitude-integrated EEG (aEEG) is used to assess electrocortical activity in pediatric intensive care if (continuous) full channel EEG is unavailable but evidence regarding the meaning of suppressed aEEG amplitudes in children remains limited. This retrospective cohort study investigated the association of suppressed aEEG amplitudes in critically ill children with death or decline of neurological functioning at hospital discharge. METHODS: Two hundred and thirty-five EEGs derived from individual patients <18 years in the pediatric intensive care unit at the University Hospital Essen (Germany) between 04/2014 and 07/2021, were converted into aEEGs and amplitudes analyzed with respect to age-specific percentiles. Crude and adjusted odds ratios (OR) for death, and functional decline at hospital discharge in patients with bilateral suppression of the upper or lower amplitude below the 10th percentile were calculated. Sensitivity, specificity, positive (PPV) and negative predictive values (NPV) were assessed. RESULTS: The median time from neurological insult to EEG recording was 2 days. PICU admission occurred due to neurological reasons in 43% and patients had high overall disease severity. Thirty-three (14%) patients died and 68 (29%) had a functional decline. Amplitude suppression was observed in 48% (upper amplitude) and 57% (lower amplitude), with unilateral suppression less frequent than bilateral suppression. Multivariable regression analyses yielded crude ORs between 4.61 and 14.29 and adjusted ORs between 2.55 and 8.87 for death and functional decline if upper or lower amplitudes were bilaterally suppressed. NPVs for bilaterally non-suppressed amplitudes were above 95% for death and above 83% for pediatric cerebral performance category Scale (PCPC) decline, whereas PPVs ranged between 22 and 32% for death and 49-52% for PCPC decline. DISCUSSION: This study found a high prevalence of suppressed aEEG amplitudes in critically ill children. Bilaterally normal amplitudes predicted good outcomes, whereas bilateral suppression was associated with increased odds for death and functional decline. aEEG assessment may serve as an element for risk stratification of PICU patients if conventional EEG is unavailable with excellent negative predictive abilities but requires additional information to identify patients at risk for poor outcomes.',\n",
       "               'CI': ['Copyright (c) 2024 Paul, Greve, Hegemann, Gienger, Loffelhardt, Della Marina,',\n",
       "                'Felderhoff-Muser, Dohna-Schwake and Bruns.'],\n",
       "               'FAU': ['Paul, Luisa',\n",
       "                'Greve, Sandra',\n",
       "                'Hegemann, Johanna',\n",
       "                'Gienger, Sonja',\n",
       "                'Loffelhardt, Verena Tamara',\n",
       "                'Della Marina, Adela',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Bruns, Nora'],\n",
       "               'AU': ['Paul L',\n",
       "                'Greve S',\n",
       "                'Hegemann J',\n",
       "                'Gienger S',\n",
       "                'Loffelhardt VT',\n",
       "                'Della Marina A',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dohna-Schwake C',\n",
       "                'Bruns N'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, Pediatric Neurology, and Pediatric Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro-and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatric Cardiology/Congenital Cardiology, Heidelberg University Medical Center, Heidelberg, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, Pediatric Neurology, and Pediatric Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro-and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, Pediatric Neurology, and Pediatric Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro-and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, Pediatric Neurology, and Pediatric Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro-and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, Pediatric Neurology, and Pediatric Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro-and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, Pediatric Neurology, and Pediatric Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro-and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, Pediatric Neurology, and Pediatric Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro-and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, Pediatric Neurology, and Pediatric Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro-and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, Pediatric Neurology, and Pediatric Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro-and Behavioural Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20240605',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Neurosci',\n",
       "               'JT': 'Frontiers in neuroscience',\n",
       "               'JID': '101478481',\n",
       "               'PMC': 'PMC11188580',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['PCPC',\n",
       "                'amplitude suppression',\n",
       "                'amplitude-integrated EEG',\n",
       "                'children',\n",
       "                'mortality',\n",
       "                'neurocritical illness',\n",
       "                'outcome',\n",
       "                'pediatric intensive care unit'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest. The author(s) declared that they were an editorial board',\n",
       "                'member of Frontiers, at the time of submission. This had no impact on the peer',\n",
       "                'review process and the final decision.'],\n",
       "               'EDAT': '2024/06/21 06:42',\n",
       "               'MHDA': '2024/06/21 06:43',\n",
       "               'PMCR': ['2024/01/01'],\n",
       "               'CRDT': ['2024/06/21 04:21'],\n",
       "               'PHST': ['2024/04/02 00:00 [received]',\n",
       "                '2024/05/23 00:00 [accepted]',\n",
       "                '2024/06/21 06:43 [medline]',\n",
       "                '2024/06/21 06:42 [pubmed]',\n",
       "                '2024/06/21 04:21 [entrez]',\n",
       "                '2024/01/01 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fnins.2024.1411151 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Neurosci. 2024 Jun 5;18:1411151. doi: 10.3389/fnins.2024.1411151. eCollection 2024.'},\n",
       "              {'PMID': '38883338',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20240617',\n",
       "               'LR': '20240618',\n",
       "               'IS': '1612-3174 (Electronic) 1612-3174 (Linking)',\n",
       "               'VI': '22',\n",
       "               'DP': '2024',\n",
       "               'TI': 'Position statement on genuine physiotherapy research at German university hospitals.',\n",
       "               'PG': 'Doc06',\n",
       "               'LID': '10.3205/000332 [doi] Doc06',\n",
       "               'AB': 'In addition to patient care, physiotherapy is increasingly important in research at university hospitals. Genuine physiotherapy research plays a decisive role in this. This position statement describes the opportunities, benefits, framework conditions, challenges, and research priorities of genuine physiotherapy research at German university hospitals.',\n",
       "               'CI': ['Copyright (c) 2024 Klotz et al.'],\n",
       "               'FAU': ['Klotz, Susanne G R',\n",
       "                'Bokel, Andrea',\n",
       "                'Friderichs-Nedohibchenko, Maria',\n",
       "                'Stickdorn, Isabelle',\n",
       "                'Vogel, Barbara',\n",
       "                'Doods, Bernd',\n",
       "                'Feldmann, Franziska',\n",
       "                'Ghiazza, Mirko',\n",
       "                'Giehl, Markus',\n",
       "                'Hoberg, Annika',\n",
       "                'Jansen, Lynn',\n",
       "                'Kohlhofer, Daniel',\n",
       "                'Leonhardt, Ralf',\n",
       "                'Meier, Sebastian-Florian',\n",
       "                'Muller, Carina',\n",
       "                'Pannzek, Miriam',\n",
       "                'Schwarz, Simone',\n",
       "                'Traut, Martina',\n",
       "                'Urdahl, Maria'],\n",
       "               'AU': ['Klotz SGR',\n",
       "                'Bokel A',\n",
       "                'Friderichs-Nedohibchenko M',\n",
       "                'Stickdorn I',\n",
       "                'Vogel B',\n",
       "                'Doods B',\n",
       "                'Feldmann F',\n",
       "                'Ghiazza M',\n",
       "                'Giehl M',\n",
       "                'Hoberg A',\n",
       "                'Jansen L',\n",
       "                'Kohlhofer D',\n",
       "                'Leonhardt R',\n",
       "                'Meier SF',\n",
       "                'Muller C',\n",
       "                'Pannzek M',\n",
       "                'Schwarz S',\n",
       "                'Traut M',\n",
       "                'Urdahl M'],\n",
       "               'AD': ['Department of Physiotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.',\n",
       "                'Department of Rehabilitation and Sports Medicine, Hannover Medical School, Hannover, Germany.',\n",
       "                'Department for Physical Medicine, Charite - Universitatsmedizin Berlin, Germany.',\n",
       "                'Department of Therapeutic Health Professions, University Hospital Munster, Germany.',\n",
       "                'Physical Therapy, Department of Orthopedics and Sports Orthopedics, University Hospital rechts der Isar, Technical University of Munich, Germany.',\n",
       "                'Central Department of Physiotherapy, University Medical Center Gottingen, Georg August University, Gottingen, Germany.',\n",
       "                'Institute for Physiotherapy, University Medical Center Essen, Germany.',\n",
       "                'Central Physiotherapy Department, University Medical Center Freiburg, Germany.',\n",
       "                'Department of Physiotherapy, University Hospital Wurzburg, Germany.',\n",
       "                'Therapy Center, University Hospital Oldenburg AoR, Oldenburg, Germany.',\n",
       "                'Department of Physiotherapy, University Hospital RWTH Aachen, Germany.',\n",
       "                'Department of Physiotherapy and Occupational Therapy, University Hospital Augsburg, Germany.',\n",
       "                'Physical and Rehabilitative Medicine, University Hospital Erlangen, Germany.',\n",
       "                'Department of Physiotherapy and Occupational Therapy, University Hospital Regensburg, Germany.',\n",
       "                'Department of Physiotherapy, Ergotherapy, Logopedics and Physical Therapy, Universitatsmedizin Mannheim, Germany.',\n",
       "                'Department of Physiotherapy, Rostock University Medical Center, Rostock, Germany.',\n",
       "                'Central Facility for Physical Therapy and Rehabilitation, Leipzig University Hospital AoR, Leipzig, Germany.',\n",
       "                'Department of Physiotherapy, University Hospital Schleswig Holstein, Lubeck, Germany.',\n",
       "                'Department of Physiotherapy, University Hospital Schleswig Holstein, Kiel, Germany.'],\n",
       "               'CN': ['Network of Researching Physiotherapists at German University Hospitals'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20240527',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Ger Med Sci',\n",
       "               'JT': 'German medical science : GMS e-journal',\n",
       "               'JID': '101227686',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Germany',\n",
       "                '*Hospitals, University/standards',\n",
       "                'Humans',\n",
       "                'Physical Therapy Modalities/standards',\n",
       "                'Biomedical Research/standards',\n",
       "                'Physical Therapy Specialty/standards'],\n",
       "               'PMC': 'PMC11176936',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['genuine physiotherapy research',\n",
       "                'physiotherapy',\n",
       "                'profession',\n",
       "                'research',\n",
       "                'university hospital'],\n",
       "               'COIS': ['The authors declare that they have no competing interests'],\n",
       "               'EDAT': '2024/06/17 12:42',\n",
       "               'MHDA': '2024/06/17 12:43',\n",
       "               'PMCR': ['2024/05/27'],\n",
       "               'CRDT': ['2024/06/17 06:06'],\n",
       "               'PHST': ['2024/01/23 00:00 [received]',\n",
       "                '2024/06/17 12:43 [medline]',\n",
       "                '2024/06/17 12:42 [pubmed]',\n",
       "                '2024/06/17 06:06 [entrez]',\n",
       "                '2024/05/27 00:00 [pmc-release]'],\n",
       "               'AID': ['000332 [pii]', 'Doc06 [pii]', '10.3205/000332 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Ger Med Sci. 2024 May 27;22:Doc06. doi: 10.3205/000332. eCollection 2024.'},\n",
       "              {'PMID': '38811577',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20240529',\n",
       "               'LR': '20240606',\n",
       "               'IS': '2041-1723 (Electronic) 2041-1723 (Linking)',\n",
       "               'VI': '15',\n",
       "               'IP': '1',\n",
       "               'DP': '2024 May 29',\n",
       "               'TI': 'Small molecule induced STING degradation facilitated by the HECT ligase HERC4.',\n",
       "               'PG': '4584',\n",
       "               'LID': '10.1038/s41467-024-48922-w [doi] 4584',\n",
       "               'AB': \"Stimulator of interferon genes (STING) is a central component of the cytosolic nucleic acids sensing pathway and as such master regulator of the type I interferon response. Due to its critical role in physiology and its' involvement in a variety of diseases, STING has been a focus for drug discovery. Targeted protein degradation (TPD) has emerged as a promising pharmacology for targeting previously considered undruggable proteins by hijacking the cellular ubiquitin proteasome system (UPS) with small molecules. Here, we identify AK59 as a STING degrader leveraging HERC4, a HECT-domain E3 ligase. Additionally, our data reveals that AK59 is effective on the common pathological STING mutations, suggesting a potential clinical application of this mechanism. Thus, these findings introduce HERC4 to the fields of TPD and of compound-induced degradation of STING, suggesting potential therapeutic applications.\",\n",
       "               'CI': ['(c) 2024. The Author(s).'],\n",
       "               'FAU': ['Mutlu, Merve',\n",
       "                'Schmidt, Isabel',\n",
       "                'Morrison, Andrew I',\n",
       "                'Goretzki, Benedikt',\n",
       "                'Freuler, Felix',\n",
       "                'Begue, Damien',\n",
       "                'Simic, Oliver',\n",
       "                'Pythoud, Nicolas',\n",
       "                'Ahrne, Erik',\n",
       "                'Kapps, Sandra',\n",
       "                'Roest, Susan',\n",
       "                'Bonenfant, Debora',\n",
       "                'Jeanpierre, Delphine',\n",
       "                'Tran, Thi-Thanh-Thao',\n",
       "                'Maher, Rob',\n",
       "                'An, Shaojian',\n",
       "                'Rietsch, Amandine',\n",
       "                'Nigsch, Florian',\n",
       "                'Hofmann, Andreas',\n",
       "                'Reece-Hoyes, John',\n",
       "                'Parker, Christian N',\n",
       "                'Guerini, Danilo'],\n",
       "               'AU': ['Mutlu M',\n",
       "                'Schmidt I',\n",
       "                'Morrison AI',\n",
       "                'Goretzki B',\n",
       "                'Freuler F',\n",
       "                'Begue D',\n",
       "                'Simic O',\n",
       "                'Pythoud N',\n",
       "                'Ahrne E',\n",
       "                'Kapps S',\n",
       "                'Roest S',\n",
       "                'Bonenfant D',\n",
       "                'Jeanpierre D',\n",
       "                'Tran TT',\n",
       "                'Maher R',\n",
       "                'An S',\n",
       "                'Rietsch A',\n",
       "                'Nigsch F',\n",
       "                'Hofmann A',\n",
       "                'Reece-Hoyes J',\n",
       "                'Parker CN',\n",
       "                'Guerini D'],\n",
       "               'AUID': ['ORCID: 0000-0003-3680-4476',\n",
       "                'ORCID: 0009-0003-7029-4489',\n",
       "                'ORCID: 0009-0000-4144-9195',\n",
       "                'ORCID: 0000-0003-4729-1557',\n",
       "                'ORCID: 0000-0002-2919-8749',\n",
       "                'ORCID: 0000-0001-5450-6267'],\n",
       "               'AD': ['Novartis BioMedical Research, Basel, Switzerland. merve.koch@novartis.com.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology & Immunology, Amsterdam institute for Infection and Immunity, De Boelelaan, 1117, Amsterdam, The Netherlands.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Monte Rosa Therapeutics, Basel, Switzerland.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Novartis BioMedical Research, Cambridge, MA, USA.',\n",
       "                'Novartis BioMedical Research, Cambridge, MA, USA.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Novartis BioMedical Research, Cambridge, MA, USA.',\n",
       "                'Vector Biology, Cambridge, MA, USA.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.',\n",
       "                'Novartis BioMedical Research, Basel, Switzerland.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20240529',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Nat Commun',\n",
       "               'JT': 'Nature communications',\n",
       "               'JID': '101528555',\n",
       "               'RN': ['EC 2.3.2.27 (Ubiquitin-Protein Ligases)',\n",
       "                '0 (Membrane Proteins)',\n",
       "                '0 (STING1 protein, human)',\n",
       "                'EC 3.4.25.1 (Proteasome Endopeptidase Complex)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['*Ubiquitin-Protein Ligases/metabolism/genetics',\n",
       "                'Humans',\n",
       "                '*Membrane Proteins/metabolism/genetics',\n",
       "                '*Proteolysis/drug effects',\n",
       "                'HEK293 Cells',\n",
       "                'Animals',\n",
       "                'Mutation',\n",
       "                'Proteasome Endopeptidase Complex/metabolism',\n",
       "                'Ubiquitination'],\n",
       "               'PMC': 'PMC11137104',\n",
       "               'COIS': ['M.M., I.S., B.G., F.F., D.B., O.S., N.P., E.A., S.K., S.R., D.J., T.T., R.M.,',\n",
       "                'S.A., A.R., F.N., A.H., C.N.P., and D.G. are current employees and shareholders',\n",
       "                'of Novartis Pharma. A.I.M., D.Bo., and J.R.H. are former employees of Novartis',\n",
       "                'Pharma. D.Bo. is a current employee of Monte Rosa Therapeutics, Basel,',\n",
       "                'Switzerland., J.R.H. is a current employee of Vector Biology, Cambridge, MA, USA.'],\n",
       "               'EDAT': '2024/05/30 05:45',\n",
       "               'MHDA': '2024/05/30 05:46',\n",
       "               'PMCR': ['2024/05/29'],\n",
       "               'CRDT': ['2024/05/29 23:27'],\n",
       "               'PHST': ['2023/06/07 00:00 [received]',\n",
       "                '2024/05/16 00:00 [accepted]',\n",
       "                '2024/05/30 05:46 [medline]',\n",
       "                '2024/05/30 05:45 [pubmed]',\n",
       "                '2024/05/29 23:27 [entrez]',\n",
       "                '2024/05/29 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1038/s41467-024-48922-w [pii]',\n",
       "                '48922 [pii]',\n",
       "                '10.1038/s41467-024-48922-w [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Nat Commun. 2024 May 29;15(1):4584. doi: 10.1038/s41467-024-48922-w.'},\n",
       "              {'PMID': '38805622',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20241220',\n",
       "               'LR': '20241225',\n",
       "               'IS': '2066-8643 (Electronic) 1844-4172 (Linking)',\n",
       "               'VI': '26',\n",
       "               'IP': '4',\n",
       "               'DP': '2024 Dec 19',\n",
       "               'TI': 'An [illustrative] update on pediatric emergency medicine ultrasound: part 1 - trauma and thoracic applications.',\n",
       "               'PG': '393-404',\n",
       "               'LID': '10.11152/mu-4362 [doi]',\n",
       "               'AB': 'Point-of-care ultrasound (POCUS) plays an essential role in emergency medicine, providing a range of diagnostic and procedural modalities. It does not involve any ionizing radiation and can improve procedural accuracy and safety. The role of POCUS in the care of pediatric patients differs somewhat from that of adult patients, as there are a range of conditions specific to infants and children. The technical background of pediatric POCUS and its current applications for trauma and thoracic scanning are reviewed and illustrated in this first article of this series.',\n",
       "               'FAU': ['Dong, Yi',\n",
       "                'Schwarz, Simone',\n",
       "                'Hoffmann, Beatrice',\n",
       "                'Nourkami-Tutdibi, Nasenien',\n",
       "                'Huang, Yun-Lin',\n",
       "                'Chen, Sheng',\n",
       "                'Cekuolis, Andrius',\n",
       "                'Augustiniene, Rasa',\n",
       "                'Snelling, Peter J',\n",
       "                'Schreiber-Dietrich, Dagmar',\n",
       "                'Grevelding, Lara',\n",
       "                'Dietrich, Christoph F'],\n",
       "               'AU': ['Dong Y',\n",
       "                'Schwarz S',\n",
       "                'Hoffmann B',\n",
       "                'Nourkami-Tutdibi N',\n",
       "                'Huang YL',\n",
       "                'Chen S',\n",
       "                'Cekuolis A',\n",
       "                'Augustiniene R',\n",
       "                'Snelling PJ',\n",
       "                'Schreiber-Dietrich D',\n",
       "                'Grevelding L',\n",
       "                'Dietrich CF'],\n",
       "               'AD': ['Department of Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai.',\n",
       "                'Department of Neonatology and Pediatric Intensive Care Medicine, Sana Kliniken Duisburg GmbH, Duisburg.',\n",
       "                'Harvard Medical School, Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston.',\n",
       "                'Saarland University Medical Center, Hospital of General Pediatrics and Neonatology, Homburg/Saar.',\n",
       "                'Department of Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai.',\n",
       "                'Department of Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai.',\n",
       "                'Ultrasound Section, Department of Pediatric Radiology, Radiology and Nuclear Medicine Centre, Vilnius University Hospital Santaros Klinikos.',\n",
       "                'Ultrasound Section, Department of Pediatric Radiology, Radiology and Nuclear Medicine Centre, Vilnius University Hospital Santaros Klinikos.',\n",
       "                'Department of Emergency Medicine, Gold Coast University Hospital, Southport, Qld.',\n",
       "                'Kliniken Hirslanden, Salem, Bern.',\n",
       "                'Department of Pediatrics, Division of Pneumology, Allergology, Infectious diseases and Gastroenterology, University Hospital, Frankfurt, Goethe University, Frankfurt.',\n",
       "                'Department Allgemeine Innere Medizin, Kliniken Hirslanden, Beau Site, Salem and Permanence, Bern. c.f.dietrich@googlemail.com.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'DEP': '20240415',\n",
       "               'PL': 'Romania',\n",
       "               'TA': 'Med Ultrason',\n",
       "               'JT': 'Medical ultrasonography',\n",
       "               'JID': '101522985',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Child',\n",
       "                'Child, Preschool',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Pediatric Emergency Medicine/methods',\n",
       "                '*Point-of-Care Systems',\n",
       "                '*Thoracic Injuries/diagnostic imaging',\n",
       "                'Thorax/diagnostic imaging',\n",
       "                '*Ultrasonography/methods',\n",
       "                'Wounds and Injuries/diagnostic imaging'],\n",
       "               'EDAT': '2024/05/28 18:42',\n",
       "               'MHDA': '2024/12/20 18:20',\n",
       "               'CRDT': ['2024/05/28 14:52'],\n",
       "               'PHST': ['2024/12/20 18:20 [medline]',\n",
       "                '2024/05/28 18:42 [pubmed]',\n",
       "                '2024/05/28 14:52 [entrez]'],\n",
       "               'AID': ['10.11152/mu-4362 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Med Ultrason. 2024 Dec 19;26(4):393-404. doi: 10.11152/mu-4362. Epub 2024 Apr 15.'},\n",
       "              {'PMID': '38724933',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20240510',\n",
       "               'LR': '20240620',\n",
       "               'IS': '1471-2431 (Electronic) 1471-2431 (Linking)',\n",
       "               'VI': '24',\n",
       "               'IP': '1',\n",
       "               'DP': '2024 May 9',\n",
       "               'TI': 'Effects of an early transfer from incubator to a warming crib in very low birthweight preterm infants.',\n",
       "               'PG': '319',\n",
       "               'LID': '10.1186/s12887-024-04795-y [doi] 319',\n",
       "               'AB': 'PURPOSE: Very low birth weight infants are cared for postnatally in the incubator because of adverse consequences of hypothermia. Data on the optimal weight of transfer to a warming crib are rare. The aim of this study was to determine the course of temperature and body weight during a standardized transfer to a warming crib at a set weight. METHODS: Prospective intervention study in very low birthweight infants who were transferred from the incubator to a warming crib at a current weight between 1500 g and 1650 g. RESULTS: No infant had to be transferred back to an incubator. Length of hospital stay was equal compared to a historical cohort from the two years directly before the intervention. The intervention group showed an increase in the volume fed orally on the day after transfer to the warming crib, although this did not translate into an earlier discontinuation of gavage feedings. Compared to the historical group, infants in the intervention group could be transferred to an unheated crib at an earlier postmenstrual age and weight. CONCLUSIONS: Early transfer from the incubator to a warming crib between 1500 g and 1650 g is feasible and not associated with adverse short-term events or outcomes. TRIAL REGISTRATION: DRKS-IDDRKS00031832.',\n",
       "               'CI': ['(c) 2024. The Author(s).'],\n",
       "               'FAU': ['Greve, Sandra',\n",
       "                'Bruns, Nora',\n",
       "                'Dathe, Anne-Kathrin',\n",
       "                'Schuendeln, Michael M',\n",
       "                'Felderhoff-Mueser, Ursula',\n",
       "                'Stein, Anja'],\n",
       "               'AU': ['Greve S',\n",
       "                'Bruns N',\n",
       "                'Dathe AK',\n",
       "                'Schuendeln MM',\n",
       "                'Felderhoff-Mueser U',\n",
       "                'Stein A'],\n",
       "               'AUID': ['ORCID: 0000-0001-6957-9100'],\n",
       "               'AD': ['Department of Paediatrics I, Neonatology, Paediatric Intensive Care and Paediatric Neurology, Universitatsmedizin Essen, University of Duisburg-Essen, North-Rhine Westphalia, 45122, Essen, Germany. Sandra.greve@uk-essen.de.',\n",
       "                'Department of Paediatrics I, Neonatology, Paediatric Intensive Care and Paediatric Neurology, Universitatsmedizin Essen, University of Duisburg-Essen, North-Rhine Westphalia, 45122, Essen, Germany.',\n",
       "                'Department of Paediatrics I, Neonatology, Paediatric Intensive Care and Paediatric Neurology, Universitatsmedizin Essen, University of Duisburg-Essen, North-Rhine Westphalia, 45122, Essen, Germany.',\n",
       "                'Department of Health and Nursing, Occupational Therapy, Ernst-Abbe-University of Applied Sciences, Jena, Germany.',\n",
       "                'Department of Paediatrics III, Department of Pediatric Hematology and Oncology, Universitatsmedizin Essen, University of Duisburg-Essen, North-Rhine Westphalia, 45122, Essen, Germany.',\n",
       "                'Department of Paediatrics I, Neonatology, Paediatric Intensive Care and Paediatric Neurology, Universitatsmedizin Essen, University of Duisburg-Essen, North-Rhine Westphalia, 45122, Essen, Germany.',\n",
       "                'Department of Paediatrics I, Neonatology, Paediatric Intensive Care and Paediatric Neurology, Universitatsmedizin Essen, University of Duisburg-Essen, North-Rhine Westphalia, 45122, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Clinical Trial',\n",
       "                'Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20240509',\n",
       "               'PL': 'England',\n",
       "               'TA': 'BMC Pediatr',\n",
       "               'JT': 'BMC pediatrics',\n",
       "               'JID': '100967804',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Infant, Newborn',\n",
       "                '*Infant, Very Low Birth Weight',\n",
       "                'Prospective Studies',\n",
       "                '*Incubators, Infant',\n",
       "                'Male',\n",
       "                'Female',\n",
       "                '*Hypothermia/prevention & control/etiology',\n",
       "                'Infant, Premature',\n",
       "                'Length of Stay',\n",
       "                'Infant Equipment',\n",
       "                'Patient Transfer'],\n",
       "               'PMC': 'PMC11080167',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Incubator',\n",
       "                'Length of stay',\n",
       "                'Preterm infant',\n",
       "                'Thermoregulation',\n",
       "                'Warming crib'],\n",
       "               'COIS': ['The authors declare no competing interests.'],\n",
       "               'EDAT': '2024/05/10 00:42',\n",
       "               'MHDA': '2024/05/10 06:42',\n",
       "               'PMCR': ['2024/05/09'],\n",
       "               'CRDT': ['2024/05/09 23:41'],\n",
       "               'PHST': ['2023/06/26 00:00 [received]',\n",
       "                '2024/04/26 00:00 [accepted]',\n",
       "                '2024/05/10 06:42 [medline]',\n",
       "                '2024/05/10 00:42 [pubmed]',\n",
       "                '2024/05/09 23:41 [entrez]',\n",
       "                '2024/05/09 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1186/s12887-024-04795-y [pii]',\n",
       "                '4795 [pii]',\n",
       "                '10.1186/s12887-024-04795-y [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'BMC Pediatr. 2024 May 9;24(1):319. doi: 10.1186/s12887-024-04795-y.'},\n",
       "              {'PMID': '38606306',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20240413',\n",
       "               'IS': '1662-4548 (Print) 1662-453X (Electronic) 1662-453X (Linking)',\n",
       "               'VI': '18',\n",
       "               'DP': '2024',\n",
       "               'TI': 'COMFORTneo scale in preterm infants during live performed music therapy-Difference between close physical contact and hand touch contact.',\n",
       "               'PG': '1359769',\n",
       "               'LID': '10.3389/fnins.2024.1359769 [doi] 1359769',\n",
       "               'AB': \"There is evidence that music therapy combined with physical contact to parents stabilizes the vital signs of hospitalized preterm infants. Yet, there is no evidence for the difference between simple contact by touching the infant in the incubator or cod, or close physical contact during music therapy sessions (MT). Behavioral effects of the various forms of attention toward the infant during therapy need to be elucidated. Our study aimed to quantify the effects of hand touch contact (HTC) and close physical contact (CPC) during live performed MT in preterm infants regardless of gestational age on behavioral state (assessed via COMFORTneo scale) and vital signs. A maximum of ten live music therapy sessions were delivered three to four times a week until hospital discharge to 50 stable infants. Pre-, during- and post-therapy heart rates, respiratory rates, oxygen saturations and COMFORTneo scores were recorded for each session. A total of 486 sessions was performed with 243 sessions using HTC and CPC each. The mean gestational age was 33 + 3 weeks, with 27 (54%) infants being male. We observed lower COMFORTneo scores, heart and respiratory rates and higher oxygen saturation during and after live performed music therapy independent of the kind of physical contact than before therapy. While pre-therapy values were better in the CPC group for all four variables, a higher mean response on COMFORTneo scale and vital signs was observed for HTC (COMFORTneo score -5.5, heart rate -12.4 beats per min., respiratory rate -8.9 breaths per min, oxygen saturation + 1.5%) compared to CPC (COMFORTneo score -4.6, heart rate -9.6 beats per min., respiratory rate -7.0 breaths per min, oxygen saturation + 1.1%). Nonetheless, post-therapy values were better for all four measures in the CPC group. Regression modeling with correction for individual responses within each patient also yielded attenuated effects of MT in the CPC group compared to HTC, likely caused by the improved pre-therapy values. Live performed music therapy benefits preterm infants' vital signs and behavioral state. During CPC with a parent, the absolute therapeutic effect is attenuated but resulting post-therapy values are nonetheless better for both the COMFORTneo scale and vital signs.\",\n",
       "               'CI': ['Copyright (c) 2024 Kobus, Kleinbeck, Ader, Dewan, Dathe, Feddahi, Felderhoff-Mueser',\n",
       "                'and Bruns.'],\n",
       "               'FAU': ['Kobus, Susann',\n",
       "                'Kleinbeck, Tim',\n",
       "                'Ader, Miriam',\n",
       "                'Dewan, Monia Vanessa',\n",
       "                'Dathe, Anne-Kathrin',\n",
       "                'Feddahi, Nadia',\n",
       "                'Felderhoff-Mueser, Ursula',\n",
       "                'Bruns, Nora'],\n",
       "               'AU': ['Kobus S',\n",
       "                'Kleinbeck T',\n",
       "                'Ader M',\n",
       "                'Dewan MV',\n",
       "                'Dathe AK',\n",
       "                'Feddahi N',\n",
       "                'Felderhoff-Mueser U',\n",
       "                'Bruns N'],\n",
       "               'AD': ['Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Center of Artistic Therapy, University Medicine Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Health and Nursing, Occupational Therapy, Ernst-Abbe-University of Applied Sciences, Jena, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20240327',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Neurosci',\n",
       "               'JT': 'Frontiers in neuroscience',\n",
       "               'JID': '101478481',\n",
       "               'PMC': 'PMC11008230',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['NICU',\n",
       "                'Neonatology',\n",
       "                'behavioral state',\n",
       "                'close physical contact',\n",
       "                'hand touch contact',\n",
       "                'music therapy',\n",
       "                'neonatal intensive care unit',\n",
       "                'preterm infants'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2024/04/12 06:44',\n",
       "               'MHDA': '2024/04/12 06:45',\n",
       "               'PMCR': ['2024/01/01'],\n",
       "               'CRDT': ['2024/04/12 03:43'],\n",
       "               'PHST': ['2023/12/21 00:00 [received]',\n",
       "                '2024/03/14 00:00 [accepted]',\n",
       "                '2024/04/12 06:45 [medline]',\n",
       "                '2024/04/12 06:44 [pubmed]',\n",
       "                '2024/04/12 03:43 [entrez]',\n",
       "                '2024/01/01 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fnins.2024.1359769 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Neurosci. 2024 Mar 27;18:1359769. doi: 10.3389/fnins.2024.1359769. eCollection 2024.'},\n",
       "              {'PMID': '38592307',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20240411',\n",
       "               'IS': '2077-0383 (Print) 2077-0383 (Electronic) 2077-0383 (Linking)',\n",
       "               'VI': '13',\n",
       "               'IP': '5',\n",
       "               'DP': '2024 Mar 4',\n",
       "               'TI': 'Correlation of Comfort Score and Narcotrend Index during Procedural Sedation with Midazolam and Propofol in Children.',\n",
       "               'LID': '10.3390/jcm13051483 [doi] 1483',\n",
       "               'AB': 'Background/Objectives: Precise assessment of hypnotic depth in children during procedural sedation with preserved spontaneous breathing is challenging. The Narcotrendindex (NI) offers uninterrupted information by continuous electrocortical monitoring without the need to apply a stimulus with the risk of assessment-induced arousal. This study aimed to explore the correlation between NI and the Comfort Scale (CS) during procedural sedation with midazolam and propofol and to identify an NI target range for deep sedation. Methods: A prospective observational study was conducted on 176 children (6 months to 17.9 years) undergoing procedural sedation with midazolam premedication and continuous propofol infusion. Statistical analyses included Pearson correlation of NI and CS values, logistic regression, and receiver operating curves. Results: Median NI values varied with CS and age. The correlation coefficient between CS and NI was 0.50 and slightly higher in procedure-specific subgroup analyses. The optimal NI cut-off for deep sedation was between 50 and 60 depending on the analyzed subgroup and displayed high positive predictive values for sufficient sedation throughout. Conclusion: Our study found a moderate correlation between NI and CS, demonstrating reliable identification of adequately sedated patients.',\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Joist, Carolina A',\n",
       "                'Joist, Constantin M',\n",
       "                'Daniels, Anna',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Tschiedel, Eva'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Joist CA',\n",
       "                'Joist CM',\n",
       "                'Daniels A',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dohna-Schwake C',\n",
       "                'Tschiedel E'],\n",
       "               'AUID': ['ORCID: 0000-0003-3809-1887'],\n",
       "               'AD': ['Department of Pediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20240304',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'J Clin Med',\n",
       "               'JT': 'Journal of clinical medicine',\n",
       "               'JID': '101606588',\n",
       "               'PMC': 'PMC10932229',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Comfort scale',\n",
       "                'Narcotrend index',\n",
       "                'children',\n",
       "                'depth of sedation',\n",
       "                'midazolam',\n",
       "                'procedural sedation',\n",
       "                'propofol',\n",
       "                'sedation monitoring'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest. The manufacturer of the Narcotrend monitor provided two',\n",
       "                'monitors for the conduction of the study, but took no influence whatsoever on any',\n",
       "                'other part of the study (details in the section funding).'],\n",
       "               'EDAT': '2024/04/09 12:43',\n",
       "               'MHDA': '2024/04/09 12:44',\n",
       "               'PMCR': ['2024/03/04'],\n",
       "               'CRDT': ['2024/04/09 10:55'],\n",
       "               'PHST': ['2024/02/09 00:00 [received]',\n",
       "                '2024/02/28 00:00 [revised]',\n",
       "                '2024/03/02 00:00 [accepted]',\n",
       "                '2024/04/09 12:44 [medline]',\n",
       "                '2024/04/09 12:43 [pubmed]',\n",
       "                '2024/04/09 10:55 [entrez]',\n",
       "                '2024/03/04 00:00 [pmc-release]'],\n",
       "               'AID': ['jcm13051483 [pii]',\n",
       "                'jcm-13-01483 [pii]',\n",
       "                '10.3390/jcm13051483 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'J Clin Med. 2024 Mar 4;13(5):1483. doi: 10.3390/jcm13051483.'},\n",
       "              {'PMID': '38466975',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20240718',\n",
       "               'LR': '20240718',\n",
       "               'IS': '1556-3669 (Electronic) 1530-5627 (Linking)',\n",
       "               'VI': '30',\n",
       "               'IP': '7',\n",
       "               'DP': '2024 Jun',\n",
       "               'TI': 'Adaption of Follow-Up Visits for Preterm and High-Risk Children for Video Consultations.',\n",
       "               'PG': 'e2004-e2012',\n",
       "               'LID': '10.1089/tmj.2023.0594 [doi]',\n",
       "               'AB': \"Introduction: Structured and standardized follow-up care for preterm and high-risk infants enables an early detection of developmental deficits. The aim is to adapt the in-person follow-up to video consultation. Developmental delays can thus be identified at an early stage, independently of in-person contact. Methods: The adaptation of these follow-up to video consultation is presented descriptively, compared with the in-person consultation (similarities, differences, challenges, and limitations). Professionals's experiences with the adaption are described. Results: The experience of n = 267 video consultations for follow-up of children up to 6 years shows that an adaptation of the in-person consultation is necessary and possible. Prerequisite is a digital medium with a stable internet connection on both sides: the professional and the family, as well as a portal for video consultations with certified, encrypted data transmission. Among infants, testing is almost entirely parent guided. For older children, testing procedures have been adapted. A neurological examination is largely possible, while a general pediatric examination is omitted. A survey on professionals' (n = 7) experiences with video- and in-person consultations found that the rate of complete follow-up visits and the resources required for taking medical histories, personnel, and time remained constant for both approaches. All reported that the video consultation is generally suitable for identifying developmental delays in children up to an age of 6 years comparable with in-person consultations. One professional stated that the physical examination of children aged >/=1 year is impossible. Discussion: Video consultation is an alternative despite some limitations when an in-person consultation is impossible. Developmental delays can be identified, and therapies recommended.\",\n",
       "               'FAU': ['Dathe, Anne-Kathrin',\n",
       "                'Greve, Sandra',\n",
       "                'Teschler, Uta',\n",
       "                'Heuser-Spura, Katharina M',\n",
       "                'Cordier, Larissa',\n",
       "                'Albayrak, Bilge',\n",
       "                'Felderhoff-Mueser, Ursula',\n",
       "                'Huening, Britta M'],\n",
       "               'AU': ['Dathe AK',\n",
       "                'Greve S',\n",
       "                'Teschler U',\n",
       "                'Heuser-Spura KM',\n",
       "                'Cordier L',\n",
       "                'Albayrak B',\n",
       "                'Felderhoff-Mueser U',\n",
       "                'Huening BM'],\n",
       "               'AD': ['Department of Paediatrics I, Neonatology, Paediatric Intensive Care and Paediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Health and Nursing, Occupational Therapy, Ernst-Abbe-University of Applied Sciences, Jena, Germany.',\n",
       "                'Department of Paediatrics I, Neonatology, Paediatric Intensive Care and Paediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, Neonatology, Paediatric Intensive Care and Paediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, Neonatology, Paediatric Intensive Care and Paediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, Neonatology, Paediatric Intensive Care and Paediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, Neonatology, Paediatric Intensive Care and Paediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, Neonatology, Paediatric Intensive Care and Paediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, Neonatology, Paediatric Intensive Care and Paediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences, C-TNBS, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.'],\n",
       "               'AUID': ['ORCID: 0000-0001-6957-9100'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20240312',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Telemed J E Health',\n",
       "               'JT': 'Telemedicine journal and e-health : the official journal of the American Telemedicine Association',\n",
       "               'JID': '100959949',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Infant',\n",
       "                'Child, Preschool',\n",
       "                'Infant, Newborn',\n",
       "                '*Developmental Disabilities/diagnosis',\n",
       "                'Child',\n",
       "                'Female',\n",
       "                'Male',\n",
       "                'Infant, Premature',\n",
       "                'Videoconferencing',\n",
       "                'Telemedicine',\n",
       "                'Remote Consultation'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['development',\n",
       "                'follow-up',\n",
       "                'high-risk children',\n",
       "                'preterm children',\n",
       "                'telemedicine',\n",
       "                'video consultation'],\n",
       "               'EDAT': '2024/03/11 18:42',\n",
       "               'MHDA': '2024/07/18 18:43',\n",
       "               'CRDT': ['2024/03/11 16:53'],\n",
       "               'PHST': ['2024/07/18 18:43 [medline]',\n",
       "                '2024/03/11 18:42 [pubmed]',\n",
       "                '2024/03/11 16:53 [entrez]'],\n",
       "               'AID': ['10.1089/tmj.2023.0594 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Telemed J E Health. 2024 Jun;30(7):e2004-e2012. doi: 10.1089/tmj.2023.0594. Epub 2024 Mar 12.'},\n",
       "              {'PMID': '38451881',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20240516',\n",
       "               'LR': '20240516',\n",
       "               'IS': '1532-0987 (Electronic) 0891-3668 (Print) 0891-3668 (Linking)',\n",
       "               'VI': '43',\n",
       "               'IP': '6',\n",
       "               'DP': '2024 Jun 1',\n",
       "               'TI': 'Pediatric Community-Acquired Brain Abscesses: A Single-center Retrospective Study.',\n",
       "               'PG': 'e214-e217',\n",
       "               'LID': '10.1097/INF.0000000000004308 [doi]',\n",
       "               'AB': 'The European Society for Clinical Microbiology and Infectious Diseases recommends 3rd generation cephalosporins and metronidazole for empirical treatment of community-acquired brain abscesses. In 53 retrospectively analyzed pediatric patients with community-acquired brain abscesses at a German University Hospital Staphylococcus aureus was identified as a relevant pathogen (21%). Therefore, it may be reasonable to cover S. aureus when selecting empirical therapy.',\n",
       "               'CI': ['Copyright (c) 2024 The Author(s). Published by Wolters Kluwer Health, Inc.'],\n",
       "               'FAU': ['Lu, Kevin Hai-Ning',\n",
       "                'Bruns, Nora',\n",
       "                'Pentek, Christina',\n",
       "                'Della Marina, Adela',\n",
       "                'Gangfuss, Andrea',\n",
       "                'Kolbel, Heike',\n",
       "                'Dogan, Burcin',\n",
       "                'Dziobaka, Jan',\n",
       "                'Ahmadipour, Yahya',\n",
       "                'Damman, Philipp',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Goretzki, Sarah Christina'],\n",
       "               'AU': ['Lu KH',\n",
       "                'Bruns N',\n",
       "                'Pentek C',\n",
       "                'Della Marina A',\n",
       "                'Gangfuss A',\n",
       "                'Kolbel H',\n",
       "                'Dogan B',\n",
       "                'Dziobaka J',\n",
       "                'Ahmadipour Y',\n",
       "                'Damman P',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dohna-Schwake C',\n",
       "                'Goretzki SC'],\n",
       "               'AUID': ['ORCID: 0000-0002-5994-3826'],\n",
       "               'AD': ['From the Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology.',\n",
       "                'From the Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology.',\n",
       "                'From the Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology.',\n",
       "                'From the Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences C-TNBS.',\n",
       "                'From the Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences C-TNBS.',\n",
       "                'From the Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences C-TNBS.',\n",
       "                'From the Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology.',\n",
       "                'Institute of Medical Microbiology.',\n",
       "                'Department of Neurosurgery and Spine Surgery.',\n",
       "                'Department of Neurosurgery and Spine Surgery.',\n",
       "                'From the Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences C-TNBS.',\n",
       "                'From the Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences C-TNBS.',\n",
       "                'West German Centre for Infectious Diseases (WZI), University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'From the Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology.',\n",
       "                'Center for Translational Neuro- and Behavioural Sciences C-TNBS.',\n",
       "                'West German Centre for Infectious Diseases (WZI), University Hospital Essen, University Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20240305',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Pediatr Infect Dis J',\n",
       "               'JT': 'The Pediatric infectious disease journal',\n",
       "               'JID': '8701858',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Retrospective Studies',\n",
       "                '*Community-Acquired Infections/drug therapy/microbiology',\n",
       "                '*Brain Abscess/microbiology/drug therapy',\n",
       "                'Child',\n",
       "                'Male',\n",
       "                'Female',\n",
       "                '*Anti-Bacterial Agents/therapeutic use',\n",
       "                'Child, Preschool',\n",
       "                '*Staphylococcal Infections/drug therapy/microbiology',\n",
       "                'Adolescent',\n",
       "                '*Staphylococcus aureus/drug effects',\n",
       "                'Infant',\n",
       "                'Germany/epidemiology',\n",
       "                'Metronidazole/therapeutic use'],\n",
       "               'PMC': 'PMC11090509',\n",
       "               'COIS': ['The authors have no funding or conflicts of interest to disclose.'],\n",
       "               'EDAT': '2024/03/07 18:42',\n",
       "               'MHDA': '2024/05/16 18:42',\n",
       "               'PMCR': ['2024/05/13'],\n",
       "               'CRDT': ['2024/03/07 13:23'],\n",
       "               'PHST': ['2024/05/16 18:42 [medline]',\n",
       "                '2024/03/07 18:42 [pubmed]',\n",
       "                '2024/03/07 13:23 [entrez]',\n",
       "                '2024/05/13 00:00 [pmc-release]'],\n",
       "               'AID': ['00006454-990000000-00785 [pii]',\n",
       "                'PIDJ-24-52 [pii]',\n",
       "                '10.1097/INF.0000000000004308 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Pediatr Infect Dis J. 2024 Jun 1;43(6):e214-e217. doi: 10.1097/INF.0000000000004308. Epub 2024 Mar 5.'},\n",
       "              {'PMID': '38405592',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20240227',\n",
       "               'IS': '2296-2360 (Print) 2296-2360 (Electronic) 2296-2360 (Linking)',\n",
       "               'VI': '12',\n",
       "               'DP': '2024',\n",
       "               'TI': 'Current practice of intracranial pressure monitoring in children with severe traumatic brain injury-a nationwide prospective surveillance study in Germany.',\n",
       "               'PG': '1355771',\n",
       "               'LID': '10.3389/fped.2024.1355771 [doi] 1355771',\n",
       "               'AB': 'BACKGROUND: For management of severe traumatic brain injuries (sTBI) in children, the overall level of evidence to guide diagnostic and therapeutic procedures is low. Since 2016, international guidelines have subsequently suggested invasive intracranial pressure (ICP) monitoring in patients with initial Glasgow Coma Scale (GCS) </=8. In Germany, ICP monitoring was an individual case decision from 2011 until the 2022 update of the German pediatric TBI guideline. The aim of this study was to evaluate current clinical practice of invasive ICP monitoring in Germany in children <10 years with respect to guideline recommendations. METHODS: Anonymized clinical data on sTBI cases <10 years of age were collected in a nationwide prospective surveillance study via the German Pediatric Surveillance Unit ESPED from July 2019 until June 2022. Inclusion criteria for the surveillance study were sTBI (initial GCS </=8) or neurosurgery following TBI. For this analysis, only cases with GCS </=8 were subject to the present analysis. Descriptive analyses were performed to assess the proportion of ICP monitored patients and describe the cohort. RESULTS: Out of 217 reported cases, 102 cases met the inclusion criteria and thus qualified for ICP monitoring. Of these, 37 (36%) received ICP monitoring. Monitored patients were older, had lower median GCS values at presentation (4 vs. 5), higher mortality (32% vs. 22%), and were more frequently diagnosed with cerebral edema (68% vs. 37%). CONCLUSION: In children <10 years with sTBI, the present clinical management regarding ICP monitoring deviates from the current German national and international guidelines. The reasons remain unclear, with the low level of evidence in the field of ICP monitoring and the recency of changes in guideline recommendations as potential contributors. Prospective interventional studies should elucidate the benefit of ICP monitoring and ICP directed therapies to provide evidence-based recommendations on ICP monitoring.',\n",
       "               'CI': ['(c) 2024 Brensing, Greve, Hojeij, Dammann, Felderhoff-Muser, Dohna-Schwake and',\n",
       "                'Bruns.'],\n",
       "               'FAU': ['Brensing, Pia',\n",
       "                'Greve, Sandra',\n",
       "                'Hojeij, Rayan',\n",
       "                'Dammann, Philipp',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Bruns, Nora'],\n",
       "               'AU': ['Brensing P',\n",
       "                'Greve S',\n",
       "                'Hojeij R',\n",
       "                'Dammann P',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dohna-Schwake C',\n",
       "                'Bruns N'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20240209',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Pediatr',\n",
       "               'JT': 'Frontiers in pediatrics',\n",
       "               'JID': '101615492',\n",
       "               'PMC': 'PMC10884239',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['ICP',\n",
       "                'children',\n",
       "                'intracranial pressure monitoring',\n",
       "                'neuromonitoring',\n",
       "                'outcomes',\n",
       "                'severe traumatic brain injury'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest. The author(s) declared that they were an editorial board',\n",
       "                'member of Frontiers, at the time of submission. This had no impact on the peer',\n",
       "                'review process and the final decision.'],\n",
       "               'EDAT': '2024/02/26 06:43',\n",
       "               'MHDA': '2024/02/26 06:44',\n",
       "               'PMCR': ['2024/02/09'],\n",
       "               'CRDT': ['2024/02/26 04:46'],\n",
       "               'PHST': ['2023/12/14 00:00 [received]',\n",
       "                '2024/01/31 00:00 [accepted]',\n",
       "                '2024/02/26 06:44 [medline]',\n",
       "                '2024/02/26 06:43 [pubmed]',\n",
       "                '2024/02/26 04:46 [entrez]',\n",
       "                '2024/02/09 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fped.2024.1355771 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Pediatr. 2024 Feb 9;12:1355771. doi: 10.3389/fped.2024.1355771. eCollection 2024.'},\n",
       "              {'PMID': '38366304',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20240531',\n",
       "               'LR': '20240815',\n",
       "               'IS': '1439-0973 (Electronic) 0300-8126 (Print) 0300-8126 (Linking)',\n",
       "               'VI': '52',\n",
       "               'IP': '3',\n",
       "               'DP': '2024 Jun',\n",
       "               'TI': 'Outbreak of severe community-acquired bacterial infections among children in North Rhine-Westphalia (Germany), October to December 2022.',\n",
       "               'PG': '1099-1111',\n",
       "               'LID': '10.1007/s15010-023-02165-x [doi]',\n",
       "               'AB': \"PURPOSE: In late 2022, a surge of severe S. pyogenes infections was reported in several European countries. This study assessed hospitalizations and disease severity of community-acquired bacterial infections with S. pyogenes, S. pneumoniae, N. meningitidis, and H. influenzae among children in North Rhine-Westphalia (NRW), Germany, during the last quarter of 2022 compared to long-term incidences. METHODS: Hospital cases due to bacterial infections between October and December 2022 were collected in a multicenter study (MC) from 59/62 (95%) children's hospitals in NRW and combined with surveillance data (2016-2023) from the national reference laboratories for streptococci, N. meningitidis, and H. influenzae. Overall and pathogen-specific incidence rates (IR) from January 2016 to March 2023 were estimated via capture-recapture analyses. Expected annual deaths from the studied pathogens were calculated from national death cause statistics. RESULTS: In the MC study, 153 cases with high overall disease severity were reported with pneumonia being most common (59%, n = 91). IRs of bacterial infections declined at the beginning of the COVID-19 pandemic and massively surged to unprecedented levels in late 2022 and early 2023 (overall hospitalizations 3.5-fold), with S. pyogenes and S. pneumoniae as main drivers (18-fold and threefold). Observed deaths during the study period exceeded the expected number for the entire year in NRW by far (7 vs. 0.9). DISCUSSION: The unprecedented peak of bacterial infections and deaths in late 2022 and early 2023 was caused mainly by S. pyogenes and S. pneumoniae. Improved precautionary measures are needed to attenuate future outbreaks.\",\n",
       "               'CI': ['(c) 2024. The Author(s).'],\n",
       "               'FAU': ['Goretzki, Sarah C',\n",
       "                'van der Linden, Mark',\n",
       "                'Itzek, Andreas',\n",
       "                'Huhne, Tom',\n",
       "                'Adelmann, Roland O',\n",
       "                'Ala Eldin, Firas',\n",
       "                'Albarouni, Mohamed',\n",
       "                'Becker, Jan-Claudius',\n",
       "                'Berghauser, Martin A',\n",
       "                'Boesing, Thomas',\n",
       "                'Boeswald, Michael',\n",
       "                'Brasche, Milian',\n",
       "                'Brevis Nunez, Francisco',\n",
       "                'Camara, Rokya',\n",
       "                'Deibert, Clara',\n",
       "                'Dohle, Frank',\n",
       "                'Dolgner, Jorg',\n",
       "                'Dziobaka, Jan',\n",
       "                'Eifinger, Frank',\n",
       "                'Elting, Natalie',\n",
       "                'Endmann, Matthias',\n",
       "                'Engelmann, Guido',\n",
       "                'Frenzke, Holger',\n",
       "                'Gappa, Monika',\n",
       "                'Gharavi, Bahman',\n",
       "                'Goletz, Christine',\n",
       "                'Hahn, Eva',\n",
       "                'Heidenreich, Yvonne',\n",
       "                'Heimann, Konrad',\n",
       "                'Hensel, Kai O',\n",
       "                'Hoffmann, Hans-Georg',\n",
       "                'Hoppenz, Marc',\n",
       "                'Horneff, Gerd',\n",
       "                'Klassen, Helene',\n",
       "                'Koerner-Rettberg, Cordula',\n",
       "                'Langler, Alfred',\n",
       "                'Lenz, Pascal',\n",
       "                'Lohmeier, Klaus',\n",
       "                'Muller, Andreas',\n",
       "                'Niemann, Frank',\n",
       "                'Paulussen, Michael',\n",
       "                'Pentek, Falk',\n",
       "                'Perez, Ruy',\n",
       "                'Pingel, Markus',\n",
       "                'Repges, Philip',\n",
       "                'Rothoeft, Tobias',\n",
       "                'Rubo, Jochen',\n",
       "                'Schade, Herbert',\n",
       "                'Schmitz, Robert',\n",
       "                'Schonhoff, Peter',\n",
       "                'Schwade, Jan N',\n",
       "                'Schwarz, Tobias',\n",
       "                'Seiffert, Peter',\n",
       "                'Selzer, Georg',\n",
       "                'Spille, Uwe',\n",
       "                'Thiel, Carsten',\n",
       "                'Thimm, Ansgar',\n",
       "                'Urgatz, Bartholomaus',\n",
       "                'van den Heuvel, Alijda',\n",
       "                'van Hop, Tan',\n",
       "                'Giesen, Verena',\n",
       "                'Wirth, Stefan',\n",
       "                'Wollbrink, Thomas',\n",
       "                'Wuller, Daniel',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Lam, Thien-Tri',\n",
       "                'Claus, Heike',\n",
       "                'Bruns, Nora'],\n",
       "               'AU': ['Goretzki SC',\n",
       "                'van der Linden M',\n",
       "                'Itzek A',\n",
       "                'Huhne T',\n",
       "                'Adelmann RO',\n",
       "                'Ala Eldin F',\n",
       "                'Albarouni M',\n",
       "                'Becker JC',\n",
       "                'Berghauser MA',\n",
       "                'Boesing T',\n",
       "                'Boeswald M',\n",
       "                'Brasche M',\n",
       "                'Brevis Nunez F',\n",
       "                'Camara R',\n",
       "                'Deibert C',\n",
       "                'Dohle F',\n",
       "                'Dolgner J',\n",
       "                'Dziobaka J',\n",
       "                'Eifinger F',\n",
       "                'Elting N',\n",
       "                'Endmann M',\n",
       "                'Engelmann G',\n",
       "                'Frenzke H',\n",
       "                'Gappa M',\n",
       "                'Gharavi B',\n",
       "                'Goletz C',\n",
       "                'Hahn E',\n",
       "                'Heidenreich Y',\n",
       "                'Heimann K',\n",
       "                'Hensel KO',\n",
       "                'Hoffmann HG',\n",
       "                'Hoppenz M',\n",
       "                'Horneff G',\n",
       "                'Klassen H',\n",
       "                'Koerner-Rettberg C',\n",
       "                'Langler A',\n",
       "                'Lenz P',\n",
       "                'Lohmeier K',\n",
       "                'Muller A',\n",
       "                'Niemann F',\n",
       "                'Paulussen M',\n",
       "                'Pentek F',\n",
       "                'Perez R',\n",
       "                'Pingel M',\n",
       "                'Repges P',\n",
       "                'Rothoeft T',\n",
       "                'Rubo J',\n",
       "                'Schade H',\n",
       "                'Schmitz R',\n",
       "                'Schonhoff P',\n",
       "                'Schwade JN',\n",
       "                'Schwarz T',\n",
       "                'Seiffert P',\n",
       "                'Selzer G',\n",
       "                'Spille U',\n",
       "                'Thiel C',\n",
       "                'Thimm A',\n",
       "                'Urgatz B',\n",
       "                'van den Heuvel A',\n",
       "                'van Hop T',\n",
       "                'Giesen V',\n",
       "                'Wirth S',\n",
       "                'Wollbrink T',\n",
       "                'Wuller D',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dohna-Schwake C',\n",
       "                'Lam TT',\n",
       "                'Claus H',\n",
       "                'Bruns N'],\n",
       "               'AD': ['Department of Pediatrics I (Neonatology, Pediatric Intensive Care, Pediatric Neurology, and Pediatric Infectious Diseases), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'German Reference Laboratory for Streptococci, Department of Medical Microbiology, University Hospital RWTH Aachen, Aachen, Germany.',\n",
       "                'German Reference Laboratory for Streptococci, Department of Medical Microbiology, University Hospital RWTH Aachen, Aachen, Germany.',\n",
       "                'Department of Pediatrics I (Neonatology, Pediatric Intensive Care, Pediatric Neurology, and Pediatric Infectious Diseases), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of General Pediatrics, Klinikum Oberberg, Kreiskrankenhaus Gummersbach, Gummersbach, Germany.',\n",
       "                'Department of General Pediatrics, Helios Hospital Schwelm, Schwelm, Germany.',\n",
       "                'Department of General Pediatrics, Marien-Hospital Gelsenkirchen, Gelsenkirchen, Germany.',\n",
       "                'Department of Pediatrics, Agaplesion Hospital Hagen, Hagen, Germany.',\n",
       "                'Division of Pediatric Intensive Care, Department of Pediatrics, Florence Nightingale Hospital Kaiserswerth, Dusseldorf, Germany.',\n",
       "                'Division of Pediatric Intensive Care, Department of Pediatrics, Protestant Hospital Bethel, University of Bielefeld, Bielefeld, Germany.',\n",
       "                'Department of Pediatrics, Sankt Franziskus Hospital Munster, Munster, Germany.',\n",
       "                'Division of Neonatology, Department of Pediatrics, University Hospital, RWTH University of Aachen, Aachen, Germany.',\n",
       "                'Division of Pediatric Intensive Care, Department of Pediatrics, Sana Hospitals Duisburg, Duisburg, Germany.',\n",
       "                'Division of Neonatology, Department of Pediatrics and Adolescent Medicine, GFO Hospital Bonn, Bonn, Germany.',\n",
       "                'Department of General Pediatrics, DRK Hospital Kirchen, Kirchen, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, St. Vinzenz Hospital Paderborn, Paderborn, Germany.',\n",
       "                'Department of General Pediatrics, GFO Hospital Dinslaken, Dinslaken, Germany.',\n",
       "                'Department of Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Division of Pediatric Intensive Care, Department of Pediatrics, University Hospital, University of Cologne, Cologne, Germany.',\n",
       "                'Department of General Pediatrics, Evangelical Hospital Oberhausen, Oberhausen, Germany.',\n",
       "                'Department of General Pediatrics, St. Franziskus-Hospital Ahlen, Ahlen, Germany.',\n",
       "                'Department of General Pediatrics, Lukas-Hospital Neuss, Neuss, Germany.',\n",
       "                'Department of General Pediatrics, Markisch Hospital Ludenscheid, Ludenscheid, Germany.',\n",
       "                'Department of General Pediatrics, Evangelical Hospital Dusseldorf, Dusseldorf, Germany.',\n",
       "                'Department of General Pediatrics, Marien-Hospital Witten, Witten, Germany.',\n",
       "                'Department of General Pediatrics, Stadtische Kliniken Monchengladbach, Elisabeth-Hospital Rheydt, Monchengladbach, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine, Sankt Agnes Hospital, Bocholt, Germany.',\n",
       "                'Department of General Pediatrics, Hospital Soest gGmbH, Soest, Germany.',\n",
       "                'Division of Neonatology, Department of Pediatrics, University Hospital, RWTH University of Aachen, Aachen, Germany.',\n",
       "                'Division of Pediatric Intensive Care, Department of Pediatrics, Helios University Hospital Wuppertal, Witten/Herdecke University, Wuppertal, Germany.',\n",
       "                'Department of General Pediatrics, Mathias-Stiftung, Rheine, Germany.',\n",
       "                \"Division of Pediatric Intensive Care, Department of Pediatrics, Children's Hospital, Amsterdamer Str., Cologne, Germany.\",\n",
       "                'Department of Pediatrics, Asklepios Clinic Sankt Augustin GmbH, Sankt Augustin, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine, Hochsauerland Hospital, Arnsberg, Germany.',\n",
       "                'Department of General Pediatrics, Marien-Hospital gGmbH, Wesel, Germany.',\n",
       "                'Department of Pediatrics, Gemeinschaftskrankenhaus Herdecke, University of Witten/Herdecke, Herdecke, Germany.',\n",
       "                'Department of General Pediatrics, Hospital Leverkusen GmbH, Leverkusen, Germany.',\n",
       "                'Division of Neonatology and Pediatric Cardiology, Department of General Pediatrics, Heinrich Heine University, Dusseldorf, Germany.',\n",
       "                'Department of Neonatology and Pediatric Intensive Care Medicine, University of Bonn, Bonn, Germany.',\n",
       "                'Department of General Pediatrics, Marien-Hospital Gelsenkirchen, Gelsenkirchen, Germany.',\n",
       "                'Division of Oncology and Haematology, Department of General Pediatrics, Hospital of Children and Adolescents, University of Witten/Herdecke, Datteln, Germany.',\n",
       "                'Department of Pediatrics, Elisabeth-Hospital Essen, Essen, Germany.',\n",
       "                'Division of Pediatric Intensive Care, Department of Pediatrics, Helios Hospital Krefeld, Krefeld, Germany.',\n",
       "                'Department of General Pediatrics, DRK Hospital Siegen gGmbH, Siegen, Germany.',\n",
       "                'Department of General Pediatrics, Porz, Cologne, Germany.',\n",
       "                \"Division of Neonatology and Pediatric Intensive Care, University Children's Hospital, Ruhr University of Bochum, Bochum, Germany.\",\n",
       "                'Department of General Pediatrics, St. Antonius Hospital Kleve, Kleve, Germany.',\n",
       "                'Department of General Pediatrics, Hospital Mechernich GmbH, Mechernich, Germany.',\n",
       "                'Department of Pediatrics, Helios Clinic Duisburg, Duisburg, Germany.',\n",
       "                'Department of Pediatrics, Clemenshospital Munster, Munster, Germany.',\n",
       "                'Department of General Pediatrics, Evangelical Hospital Lippstadt, Lippstadt, Germany.',\n",
       "                'Department of General Pediatrics, Municipal Hospital Solingen, Solingen, Germany.',\n",
       "                'Department of Pediatrics, Helios Clinic Duisburg, Duisburg, Germany.',\n",
       "                'Division of Neonatology and Pediatric Intensive Care, Evangelical Hospital Hamm, Hamm, Germany.',\n",
       "                'Department of General Pediatrics, Herford, Germany.',\n",
       "                'Department of Pediatrics, St.-Clemens-Hospital Geldern, Geldern, Germany.',\n",
       "                'Department of General Pediatrics, Sana-Hospital Remscheid, Remscheid, Germany.',\n",
       "                'Department of General Pediatrics, AKH Hospital Viersen, Viersen, Germany.',\n",
       "                'Division of Pediatric Intensive Care, Department of Pediatrics, University Hospital Munster, Munster, Germany.',\n",
       "                'Department of General Pediatrics, Hospital Oberhausen Sterkrade gGmbH, Oberhausen, Germany.',\n",
       "                'Department of General Pediatrics, Bethanien Hospital Moers, Moers, Germany.',\n",
       "                'Department of Pediatrics, Helios Medical Center Niederberg, Velbert, Germany.',\n",
       "                'Division of Pediatric Intensive Care, Department of Pediatrics, Bergmannsheil Pediatric Hospital Gelsenkirchen Buer, Gelsenkirchen, Germany.',\n",
       "                'Department of Pediatrics and Adolescent Medicine, Christophorus Hospital, Coesfeld, Germany.',\n",
       "                'Department of Pediatrics I (Neonatology, Pediatric Intensive Care, Pediatric Neurology, and Pediatric Infectious Diseases), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I (Neonatology, Pediatric Intensive Care, Pediatric Neurology, and Pediatric Infectious Diseases), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'German National Reference Laboratory for Meningococci and Haemophilus Influenzae, Institute for Hygiene and Microbiology, University of Wurzburg, Wurzburg, Germany.',\n",
       "                'German National Reference Laboratory for Meningococci and Haemophilus Influenzae, Institute for Hygiene and Microbiology, University of Wurzburg, Wurzburg, Germany.',\n",
       "                'Department of Pediatrics I (Neonatology, Pediatric Intensive Care, Pediatric Neurology, and Pediatric Infectious Diseases), University Hospital Essen, University of Duisburg-Essen, Essen, Germany. nora.bruns@uk-essen.de.'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['1369-235/Robert Koch Institut/'],\n",
       "               'PT': ['Journal Article', 'Multicenter Study'],\n",
       "               'DEP': '20240216',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Infection',\n",
       "               'JT': 'Infection',\n",
       "               'JID': '0365307',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Germany/epidemiology',\n",
       "                '*Community-Acquired Infections/epidemiology/microbiology',\n",
       "                'Child',\n",
       "                'Child, Preschool',\n",
       "                'Infant',\n",
       "                '*Disease Outbreaks/statistics & numerical data',\n",
       "                'Adolescent',\n",
       "                'Female',\n",
       "                'Male',\n",
       "                'Hospitalization/statistics & numerical data',\n",
       "                'Bacterial Infections/epidemiology',\n",
       "                'Incidence',\n",
       "                'Infant, Newborn',\n",
       "                'Streptococcus pyogenes'],\n",
       "               'PMC': 'PMC11143032',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Bacterial infections',\n",
       "                'Children',\n",
       "                'Community acquired infections',\n",
       "                'Germany',\n",
       "                'Outbreak',\n",
       "                'Surveillance'],\n",
       "               'COIS': ['The other authors have no conflicts of interest to disclose.'],\n",
       "               'EDAT': '2024/02/17 12:42',\n",
       "               'MHDA': '2024/06/01 10:51',\n",
       "               'PMCR': ['2024/02/16'],\n",
       "               'CRDT': ['2024/02/17 00:14'],\n",
       "               'PHST': ['2023/10/07 00:00 [received]',\n",
       "                '2023/12/21 00:00 [accepted]',\n",
       "                '2024/06/01 10:51 [medline]',\n",
       "                '2024/02/17 12:42 [pubmed]',\n",
       "                '2024/02/17 00:14 [entrez]',\n",
       "                '2024/02/16 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s15010-023-02165-x [pii]',\n",
       "                '2165 [pii]',\n",
       "                '10.1007/s15010-023-02165-x [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Infection. 2024 Jun;52(3):1099-1111. doi: 10.1007/s15010-023-02165-x. Epub 2024 Feb 16.'},\n",
       "              {'PMID': '38326635',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20241127',\n",
       "               'LR': '20241130',\n",
       "               'IS': '2731-7056 (Electronic) 2731-7048 (Print) 2731-7048 (Linking)',\n",
       "               'VI': '64',\n",
       "               'IP': 'Suppl 1',\n",
       "               'DP': '2024 Nov',\n",
       "               'TI': 'Morphological chest CT changes in cystic fibrosis and massive hemoptysis.',\n",
       "               'PG': '76-85',\n",
       "               'LID': '10.1007/s00117-024-01266-4 [doi]',\n",
       "               'AB': 'BACKGROUND: Massive hemoptysis (MH) is a rare but potentially life-threatening condition of patients with mainly advanced cystic fibrosis (CF). Morphological lung changes are aggravated with disease progression. The aim of this study was to determine whether morphological lung changes differ between patients with CF (pwCF) who have MH and pwCF without MH. METHODS: Chest computed tomography (CT) scans of pwCF and MH acquired at a maximum of 4 months prior to MH (1/2008 to 2/2015) were evaluated for morphological changes and bronchial artery (BA) diameters. Lung lobes with MH were compared with lobes without MH and with matched control patients with end-stage CF and no hemoptysis using the Helbich scoring system. RESULTS: The study included 26 patients with MH (P(MH); 15 female, median age 29 years, interquartile range [IQR]: 25-33.75) and 17 matched control patients (11 male, median age 24 years, IQR: 19.5-30). No difference in Helbich score was detected between lobes with MH and matched control patients (p\\u202f= 0.051). Higher scores were detected in lobes with MH compared to lobes without MH in P(MH) (p\\u202f= 0.021), but no difference was detected in the subscores. The BA diameters were larger in P(MH) (p\\u202f= 0.02); 85% of P(MH) had unilateral MH, with 65% of MH involving only one or two lobes. CONCLUSION: Morphological changes are more severe in lobes with MH in the same patient, but there is no difference when compared with matched control patients. Besides abscess/sacculation, no specific changes for MH were identified. Other factors such as BA hypertrophy might play a pivotal role in the pathogenesis of MH in pwCF. Commonly used scores to evaluate chest CT in pwCF cannot be used to assess MH, and other factors, e.g., hypertrophied BA, not represented and not measured in these scores, might be more suitable for assessing the risk for MH.',\n",
       "               'CI': ['(c) 2024. The Author(s).'],\n",
       "               'FAU': ['Dohna, Martha',\n",
       "                'Kuhl, Hilmar',\n",
       "                'Sutharsan, Sivagurunathan',\n",
       "                'Bruns, Nora',\n",
       "                'Vo Chieu, Van Dai',\n",
       "                'Hellms, Susanne',\n",
       "                'Kornemann, Norman',\n",
       "                'Montag, Michael J'],\n",
       "               'AU': ['Dohna M',\n",
       "                'Kuhl H',\n",
       "                'Sutharsan S',\n",
       "                'Bruns N',\n",
       "                'Vo Chieu VD',\n",
       "                'Hellms S',\n",
       "                'Kornemann N',\n",
       "                'Montag MJ'],\n",
       "               'AD': ['Department of Diagnostic and Interventional Radiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. dohna.martha@mh-hannover.de.',\n",
       "                'Clinic for diagnostic and interventional Radiology, University Hospital Bonn, Bonn, Germany, Venusberg-Campus 1, 53127. dohna.martha@mh-hannover.de.',\n",
       "                'St. Bernhard-Hospital Kamp-Lintfort, Burgermeister-Schmelzing-Str. 90, 47475, Kamp-Lintfort, Germany.',\n",
       "                'Division of Cystic Fibrosis, Department of Pulmonary Medicine, University Medicine Essen -Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, University Medicine Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'St. Vicenz-Hospital Paderborn, Am Busdorf 2, 33098, Paderborn, Germany.',\n",
       "                'Department of Diagnostic and Interventional Radiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.',\n",
       "                'Department of Diagnostic and Interventional Radiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.',\n",
       "                'Clinic for Radiology, University Hospital Munster, Albert-Schweitzer-Campus 1, 48149, Munster, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'TT': 'Morphologische Veranderungen in der Thorax-CT bei zystischer Fibrose und massiven Hamoptysen.',\n",
       "               'DEP': '20240207',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Radiologie (Heidelb)',\n",
       "               'JT': 'Radiologie (Heidelberg, Germany)',\n",
       "               'JID': '9918384887306676',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*Hemoptysis/diagnostic imaging/etiology',\n",
       "                '*Cystic Fibrosis/complications/diagnostic imaging/pathology',\n",
       "                'Female',\n",
       "                'Male',\n",
       "                'Adult',\n",
       "                '*Tomography, X-Ray Computed',\n",
       "                'Young Adult',\n",
       "                'Retrospective Studies',\n",
       "                'Radiography, Thoracic',\n",
       "                'Case-Control Studies',\n",
       "                'Lung/diagnostic imaging/pathology'],\n",
       "               'PMC': 'PMC11602869',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Bronchial artery',\n",
       "                'Chest CT',\n",
       "                'Helbich scoring system',\n",
       "                'Morphological lung changes',\n",
       "                'Risk factor'],\n",
       "               'COIS': ['Declarations. Conflict of interest: M. Dohna, H. Kuhl, S. Sutharsan, N. Bruns,',\n",
       "                'V.D. Vo Chieu, S. Hellms, N. Kornemann and M.J. Montag declare that they have no',\n",
       "                'competing interests. This multicenter study has been approved by the ethics',\n",
       "                'committee of Aerztekammer Nordrhein according to  section sign 15 registry number 2016/181',\n",
       "                'and by the ethics committee of Medical School Hannover, registry number',\n",
       "                '10245_BO_K_2022 who also waived the need for informed consent from all patients.',\n",
       "                'All methods were carried out in accordance with relevant guidelines and',\n",
       "                'regulations. The supplement containing this article is not sponsored by industry.'],\n",
       "               'EDAT': '2024/02/08 00:41',\n",
       "               'MHDA': '2024/11/27 12:38',\n",
       "               'PMCR': ['2024/02/07'],\n",
       "               'CRDT': ['2024/02/07 23:29'],\n",
       "               'PHST': ['2023/08/07 00:00 [received]',\n",
       "                '2024/01/11 00:00 [accepted]',\n",
       "                '2024/11/27 12:38 [medline]',\n",
       "                '2024/02/08 00:41 [pubmed]',\n",
       "                '2024/02/07 23:29 [entrez]',\n",
       "                '2024/02/07 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s00117-024-01266-4 [pii]',\n",
       "                '1266 [pii]',\n",
       "                '10.1007/s00117-024-01266-4 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Radiologie (Heidelb). 2024 Nov;64(Suppl 1):76-85. doi: 10.1007/s00117-024-01266-4. Epub 2024 Feb 7.'},\n",
       "              {'PMID': '38254794',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20241023',\n",
       "               'IS': '2072-6694 (Print) 2072-6694 (Electronic) 2072-6694 (Linking)',\n",
       "               'VI': '16',\n",
       "               'IP': '2',\n",
       "               'DP': '2024 Jan 11',\n",
       "               'TI': 'Influence of Lymphatic, Microvascular and Perineural Invasion on Oncological Outcome in Patients with Neuroendocrine Tumors of the Small Intestine.',\n",
       "               'LID': '10.3390/cancers16020305 [doi] 305',\n",
       "               'AB': 'For the histopathological work-up of resected neuroendocrine tumors of the small intestine (siNET), the determination of lymphatic (LI), microvascular (VI) and perineural (PnI) invasion is recommended. Their association with poorer prognosis has already been demonstrated in many tumor entities. However, the influence of LI, VI and PnI in siNET has not been sufficiently described yet. A retrospective analysis of all patients treated for siNET at the ENETS Center of Excellence Charite-Universitatsmedizin Berlin, from 2010 to 2020 was performed (n = 510). Patients who did not undergo primary resection or had G3 tumors were excluded. In the entire cohort (n = 161), patients with LI, VI and PnI status had more distant metastases (48.0% vs. 71.4%, p = 0.005; 47.1% vs. 84.4%, p < 0.001; 34.2% vs. 84.7%, p < 0.001) and had lower rates of curative surgery (58.0% vs. 21.0%, p < 0.001; 48.3% vs. 16.7%, p < 0.001; 68.4% vs. 14.3%, p < 0.001). Progression-free survival was significantly reduced in patients with LI, VI or PnI compared to patients without. This was also demonstrated in patients who underwent curative surgery. Lymphatic, vascular and perineural invasion were associated with disease progression and recurrence in patients with siNET, and these should therefore be included in postoperative treatment considerations.',\n",
       "               'FAU': ['Butz, Frederike',\n",
       "                'Dukaczewska, Agata',\n",
       "                'Kunze, Catarina Alisa',\n",
       "                'Kromer, Janina Maren',\n",
       "                'Reinhard, Lisa',\n",
       "                'Jann, Henning',\n",
       "                'Fehrenbach, Uli',\n",
       "                'Muller-Debus, Charlotte Friederieke',\n",
       "                'Skachko, Tatiana',\n",
       "                'Pratschke, Johann',\n",
       "                'Goretzki, Peter E',\n",
       "                'Mogl, Martina T',\n",
       "                'Dobrindt, Eva Maria'],\n",
       "               'AU': ['Butz F',\n",
       "                'Dukaczewska A',\n",
       "                'Kunze CA',\n",
       "                'Kromer JM',\n",
       "                'Reinhard L',\n",
       "                'Jann H',\n",
       "                'Fehrenbach U',\n",
       "                'Muller-Debus CF',\n",
       "                'Skachko T',\n",
       "                'Pratschke J',\n",
       "                'Goretzki PE',\n",
       "                'Mogl MT',\n",
       "                'Dobrindt EM'],\n",
       "               'AUID': ['ORCID: 0000-0002-5963-1558',\n",
       "                'ORCID: 0009-0006-5473-5821',\n",
       "                'ORCID: 0000-0003-3622-3268',\n",
       "                'ORCID: 0000-0001-8997-4896',\n",
       "                'ORCID: 0000-0002-3676-047X',\n",
       "                'ORCID: 0000-0002-1616-9826'],\n",
       "               'AD': ['Department of Surgery, Campus Charite Mitte|Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte|Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Pathology, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte|Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte|Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Hepatology and Gastroenterology, Campus Charite Mitte|Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Radiology, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte|Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte|Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte|Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte|Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte|Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte|Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, 10117 Berlin, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20240111',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Cancers (Basel)',\n",
       "               'JT': 'Cancers',\n",
       "               'JID': '101526829',\n",
       "               'PMC': 'PMC10813650',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['lymphatic invasion',\n",
       "                'microvascular invasion',\n",
       "                'oncological outcome',\n",
       "                'perineural invasion',\n",
       "                'small-intestinal neuroendocrine tumors'],\n",
       "               'COIS': ['The authors declare no conflicts of interest.'],\n",
       "               'EDAT': '2024/01/23 06:43',\n",
       "               'MHDA': '2024/01/23 06:44',\n",
       "               'PMCR': ['2024/01/11'],\n",
       "               'CRDT': ['2024/01/23 01:04'],\n",
       "               'PHST': ['2023/12/18 00:00 [received]',\n",
       "                '2024/01/03 00:00 [revised]',\n",
       "                '2024/01/09 00:00 [accepted]',\n",
       "                '2024/01/23 06:44 [medline]',\n",
       "                '2024/01/23 06:43 [pubmed]',\n",
       "                '2024/01/23 01:04 [entrez]',\n",
       "                '2024/01/11 00:00 [pmc-release]'],\n",
       "               'AID': ['cancers16020305 [pii]',\n",
       "                'cancers-16-00305 [pii]',\n",
       "                '10.3390/cancers16020305 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Cancers (Basel). 2024 Jan 11;16(2):305. doi: 10.3390/cancers16020305.'},\n",
       "              {'PMID': '38172444',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20240320',\n",
       "               'LR': '20240322',\n",
       "               'IS': '1432-1076 (Electronic) 0340-6199 (Print) 0340-6199 (Linking)',\n",
       "               'VI': '183',\n",
       "               'IP': '3',\n",
       "               'DP': '2024 Mar',\n",
       "               'TI': 'Clinical recommendations for the inpatient management of lower respiratory tract infections in children and adolescents with severe neurological impairment in Germany.',\n",
       "               'PG': '987-999',\n",
       "               'LID': '10.1007/s00431-023-05401-6 [doi]',\n",
       "               'AB': 'Children and adolescents with severe neurological impairment (SNI) require specialized care due to their complex medical needs. In particular, these patients are often affected by severe and recurrent lower respiratory tract infections (LRTIs). These infections, including viral and bacterial etiology, pose a significant risk to these patients, often resulting in respiratory insufficiency and long-term impairments. Using expert consensus, we developed clinical recommendations on the management of LRTIs in children and adolescents with SNI. These recommendations emphasize comprehensive multidisciplinary care and antibiotic stewardship. Initial treatment should involve symptomatic care, including hydration, antipyretics, oxygen therapy, and respiratory support. In bacterial LRTIs, antibiotic therapy is initiated based on the severity of the infection, with aminopenicillin plus a beta-lactamase inhibitor recommended for community-acquired LRTIs and piperacillin-tazobactam for patients with chronic lung disease or tracheostomy. Ongoing management includes regular evaluations, adjustments to antibiotic therapy based on pathogen identification, and optimization of supportive care. Implementation of these recommendations aims to improve the diagnosis and treatment of LRTIs in children and adolescents with SNI. What is Known: * Children and adolescents with severe neurological impairment are particularly affected by severe and recurrent lower respiratory tract infections (LRTIs). * The indication and choice of antibiotic therapy for bacterial LRTI is often difficult because there are no evidence-based treatment recommendations for this heterogeneous but vulnerable patient population; the frequent overuse of broad-spectrum or reserve antibiotics in this patient population increases selection pressure for multidrug-resistant pathogens. What is New: * The proposed recommendations provide a crucial framework for focused diagnostics and treatment of LRTIs in children and adolescents with severe neurological impairment. * Along with recommendations for comprehensive and multidisciplinary therapy and antibiotic stewardship, ethical and palliative care aspects are taken into account.',\n",
       "               'CI': ['(c) 2024. The Author(s).'],\n",
       "               'FAU': ['Mauritz, Maximilian David',\n",
       "                'von Both, Ulrich',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Gille, Christian',\n",
       "                'Hasan, Carola',\n",
       "                'Huebner, Johannes',\n",
       "                'Hufnagel, Markus',\n",
       "                'Knuf, Markus',\n",
       "                'Liese, Johannes G',\n",
       "                'Renk, Hanna',\n",
       "                'Rudolph, Henriette',\n",
       "                'Schulze-Sturm, Ulf',\n",
       "                'Simon, Arne',\n",
       "                'Stehling, Florian',\n",
       "                'Tenenbaum, Tobias',\n",
       "                'Zernikow, Boris'],\n",
       "               'AU': ['Mauritz MD',\n",
       "                'von Both U',\n",
       "                'Dohna-Schwake C',\n",
       "                'Gille C',\n",
       "                'Hasan C',\n",
       "                'Huebner J',\n",
       "                'Hufnagel M',\n",
       "                'Knuf M',\n",
       "                'Liese JG',\n",
       "                'Renk H',\n",
       "                'Rudolph H',\n",
       "                'Schulze-Sturm U',\n",
       "                'Simon A',\n",
       "                'Stehling F',\n",
       "                'Tenenbaum T',\n",
       "                'Zernikow B'],\n",
       "               'AUID': ['ORCID: 0000-0002-9618-5307'],\n",
       "               'AD': [\"Paediatric Palliative Care Centre, Children's and Adolescents' Hospital, 45711, Datteln, Germany. m.mauritz@kinderklinik-datteln.de.\",\n",
       "                \"Department of Children's, Pain Therapy and Pediatric Palliative Care, Faculty of Health, School of Medicine , Herdecke University, 58448, WittenWitten, Germany. m.mauritz@kinderklinik-datteln.de.\",\n",
       "                \"Department of Infectious Diseases, Dr von Hauner Children's Hospital, LMU University Hospital, 80337, Munich, Germany.\",\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, 45147, Essen, Germany.',\n",
       "                \"Department of Neonatology, Heidelberg University Children's Hospital, 69120, Heidelberg, Germany.\",\n",
       "                \"Paediatric Palliative Care Centre, Children's and Adolescents' Hospital, 45711, Datteln, Germany.\",\n",
       "                \"Department of Children's, Pain Therapy and Pediatric Palliative Care, Faculty of Health, School of Medicine , Herdecke University, 58448, WittenWitten, Germany.\",\n",
       "                \"Department of Infectious Diseases, Dr von Hauner Children's Hospital, LMU University Hospital, 80337, Munich, Germany.\",\n",
       "                'Department of Paediatrics and Adolescent Medicine, Medical Faculty, University Medical Centre, University of Freiburg, 79106, Freiburg, Germany.',\n",
       "                'Department for Pediatric and Adolescent Medicine, Worms Clinic, 67550, Worms, Germany.',\n",
       "                'Department of Paediatrics, Division of Paediatric Infectious Diseases, University Hospital of Wuerzburg, 97080, Wurzburg, Germany.',\n",
       "                \"University Children's Hospital Tuebingen, 72076, Tuebingen, Germany.\",\n",
       "                'Department of Pediatrics, Goethe University Frankfurt, 60590, Frankfurt am Main, Germany.',\n",
       "                \"University Children's Hospital, University Medical Centre Hamburg-Eppendorf, 20246, Hamburg, Germany.\",\n",
       "                'Pediatric Oncology and Hematology, University Hospital Homburg Saar, 66421, Homburg/Saar, Germany.',\n",
       "                \"Department of Pediatric Pulmonology and Sleep Medicine, University Children's Hospital Essen, 45147, Essen, Germany.\",\n",
       "                'Clinic for Child and Adolescent Medicine, Sana Klinikum Lichtenberg, Academic Teaching Hospital, Charite-Universitatsmedizin, 10365, Berlin, Germany.',\n",
       "                \"Paediatric Palliative Care Centre, Children's and Adolescents' Hospital, 45711, Datteln, Germany.\",\n",
       "                \"Department of Children's, Pain Therapy and Pediatric Palliative Care, Faculty of Health, School of Medicine , Herdecke University, 58448, WittenWitten, Germany.\"],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'DEP': '20240103',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Eur J Pediatr',\n",
       "               'JT': 'European journal of pediatrics',\n",
       "               'JID': '7603873',\n",
       "               'RN': ['0 (Anti-Bacterial Agents)',\n",
       "                '157044-21-8 (Piperacillin, Tazobactam Drug Combination)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Child',\n",
       "                'Humans',\n",
       "                'Adolescent',\n",
       "                'Inpatients',\n",
       "                '*Respiratory Tract Infections/diagnosis/drug therapy',\n",
       "                'Anti-Bacterial Agents/therapeutic use',\n",
       "                'Piperacillin, Tazobactam Drug Combination/therapeutic use',\n",
       "                '*Bacterial Infections/drug therapy',\n",
       "                'Bacteria'],\n",
       "               'PMC': 'PMC10951000',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Antimicrobial stewardship',\n",
       "                'Lower respiratory tract infections',\n",
       "                'Pneumonia',\n",
       "                'Severe neurological impairment'],\n",
       "               'COIS': ['The authors declare no competing interests.'],\n",
       "               'EDAT': '2024/01/04 11:43',\n",
       "               'MHDA': '2024/03/20 06:45',\n",
       "               'PMCR': ['2024/01/03'],\n",
       "               'CRDT': ['2024/01/03 23:32'],\n",
       "               'PHST': ['2023/10/23 00:00 [received]',\n",
       "                '2023/12/19 00:00 [accepted]',\n",
       "                '2023/12/06 00:00 [revised]',\n",
       "                '2024/03/20 06:45 [medline]',\n",
       "                '2024/01/04 11:43 [pubmed]',\n",
       "                '2024/01/03 23:32 [entrez]',\n",
       "                '2024/01/03 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s00431-023-05401-6 [pii]',\n",
       "                '5401 [pii]',\n",
       "                '10.1007/s00431-023-05401-6 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Pediatr. 2024 Mar;183(3):987-999. doi: 10.1007/s00431-023-05401-6. Epub 2024 Jan 3.'},\n",
       "              {'PMID': '38108853',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20240131',\n",
       "               'LR': '20241023',\n",
       "               'IS': '1433-0458 (Electronic) 0017-6192 (Print) 0017-6192 (Linking)',\n",
       "               'VI': '72',\n",
       "               'IP': '2',\n",
       "               'DP': '2024 Feb',\n",
       "               'TI': '[Increased rate of complications of pediatric acute otitis media and sinusitis in 2022/2023].',\n",
       "               'PG': '83-89',\n",
       "               'LID': '10.1007/s00106-023-01393-9 [doi]',\n",
       "               'AB': \"BACKGROUND: Acute mastoiditis and orbital complications of acute rhinosinusitis are among the most common complications of pediatric infections in otolaryngology. OBJECTIVE: The aim of this study was to investigate the frequency of pediatric acute mastoiditis in the setting of acute otitis media as well as pediatric orbital complications in the setting of acute rhinosinusitis. Data from before the pandemic were compared to data after the end of the COVID-19 restrictions. MATERIALS AND METHODS: Included were hospitalized children who presented with acute mastoiditis from acute otitis media or with orbital complications from acute rhinosinusitis during the period from April 2017 to March 2023. Compared were three periods using descriptive statistics: April 2017 to March 2020 (before the pandemic in Germany), April 2020 to March 2022 (during the contact restrictions of the pandemic), and April 2022 to March 2023 (after the contact restrictions were lifted). RESULTS: A total of 102 children (43 with acute mastoiditis, 42%, and 59 with orbital complications of acute sinusitis, 58%) were included. During the 2022/2023 period, more than twice as many children with acute mastoiditis and approximately three times as many children with orbital complications of acute rhinosinusitis were hospitalized compared to the average of the periods 2017/2018, 2018/2019, and 2019/2020. In the 2021/2022 period, the number of these patients was below the average of previous years. CONCLUSION: This year's seasonal cluster of upper respiratory tract infections is associated with a higher-than-average incidence of orbital complications and mastoiditis.\",\n",
       "               'CI': ['(c) 2023. The Author(s).'],\n",
       "               'FAU': ['Voss, Noemi',\n",
       "                'Sadok, Nadia',\n",
       "                'Goretzki, Sarah',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Meyer, Moritz F',\n",
       "                'Mattheis, Stefan',\n",
       "                'Lang, Stephan',\n",
       "                'Stahr, Kerstin'],\n",
       "               'AU': ['Voss N',\n",
       "                'Sadok N',\n",
       "                'Goretzki S',\n",
       "                'Dohna-Schwake C',\n",
       "                'Meyer MF',\n",
       "                'Mattheis S',\n",
       "                'Lang S',\n",
       "                'Stahr K'],\n",
       "               'AD': ['Klinik fur Hals‑, Nasen‑, Ohrenheilkunde, Universitatsklinikum Essen (AoR), Hufelandstrasse 55, 45147, Essen, Deutschland. noemi.voss@uk-essen.de.',\n",
       "                'Klinik fur Hals‑, Nasen‑, Ohrenheilkunde, Universitatsklinikum Essen (AoR), Hufelandstrasse 55, 45147, Essen, Deutschland.',\n",
       "                'Zentrum fur Kinder- und Jugendmedizin, Universitatsklinikum Essen (AoR), Hufelandstrasse 55, 45147, Essen, Deutschland.',\n",
       "                'Zentrum fur Kinder- und Jugendmedizin, Universitatsklinikum Essen (AoR), Hufelandstrasse 55, 45147, Essen, Deutschland.',\n",
       "                'Klinik fur Hals‑, Nasen‑, Ohrenheilkunde, Universitatsklinikum Essen (AoR), Hufelandstrasse 55, 45147, Essen, Deutschland.',\n",
       "                'Klinik fur Hals‑, Nasen‑, Ohrenheilkunde, Universitatsklinikum Essen (AoR), Hufelandstrasse 55, 45147, Essen, Deutschland.',\n",
       "                'Klinik fur Hals‑, Nasen‑, Ohrenheilkunde, Universitatsklinikum Essen (AoR), Hufelandstrasse 55, 45147, Essen, Deutschland.',\n",
       "                'Klinik fur Hals‑, Nasen‑, Ohrenheilkunde, Universitatsklinikum Essen (AoR), Hufelandstrasse 55, 45147, Essen, Deutschland.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Haufung von Komplikationen der akuten Otitis media und Sinusitis bei Kindern 2022/2023.',\n",
       "               'DEP': '20231218',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'HNO',\n",
       "               'JT': 'HNO',\n",
       "               'JID': '2985099R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Child',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                '*Mastoiditis/epidemiology/complications',\n",
       "                '*Otitis Media/complications/epidemiology',\n",
       "                '*Sinusitis/complications/diagnosis/epidemiology',\n",
       "                '*Respiratory Tract Infections',\n",
       "                'Acute Disease',\n",
       "                'Retrospective Studies'],\n",
       "               'PMC': 'PMC10827887',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Acute mastoiditis',\n",
       "                'Acute rhinosinusitis',\n",
       "                'COVID-19',\n",
       "                'Orbital complications',\n",
       "                'Teenager'],\n",
       "               'EDAT': '2023/12/18 12:42',\n",
       "               'MHDA': '2024/01/31 06:42',\n",
       "               'PMCR': ['2023/12/18'],\n",
       "               'CRDT': ['2023/12/18 11:04'],\n",
       "               'PHST': ['2023/11/05 00:00 [accepted]',\n",
       "                '2024/01/31 06:42 [medline]',\n",
       "                '2023/12/18 12:42 [pubmed]',\n",
       "                '2023/12/18 11:04 [entrez]',\n",
       "                '2023/12/18 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s00106-023-01393-9 [pii]',\n",
       "                '1393 [pii]',\n",
       "                '10.1007/s00106-023-01393-9 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'HNO. 2024 Feb;72(2):83-89. doi: 10.1007/s00106-023-01393-9. Epub 2023 Dec 18.'},\n",
       "              {'PMID': '38015560',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20240216',\n",
       "               'LR': '20240216',\n",
       "               'IS': '2374-4243 (Electronic) 2374-4243 (Linking)',\n",
       "               'VI': '56',\n",
       "               'IP': '3',\n",
       "               'DP': '2024 Mar',\n",
       "               'TI': 'Targeted PCR of Mucorales in pediatric bronchoalveolar lavage samples indicates low prevalence of airway colonization and sample contamination.',\n",
       "               'PG': '255-258',\n",
       "               'LID': '10.1080/23744235.2023.2284357 [doi]',\n",
       "               'AB': 'Mucorales are a large order of ubiquitous saprophytic zygomycete fungi and act as opportunistic pathogens in humans. In pediatric patients, little is known about the role of Mucorales in airway colonization and infection or their role as contaminants of respiratory samples. Currently, polymerase chain reaction (PCR) is the most sensitive mode of detection Mucorales in clinical specimen. In this study, we aimed to determine the prevalence of Mucorales in bronchoalveolar lavage samples (BAL) from a large, diverse group of pediatric patients. We performed commercial Mucorales PCR (MucorGenius(R), Pathonostics, Maastricht, NL, USA) on 102 thawed BAL samples of 100 patients. Mucorales PCR was negative in all samples. Our data suggest that Mucorales spp. have a low prevalence in paediatric airways and do not frequently contaminate pediatric BAL samples.',\n",
       "               'FAU': ['Kavvalou, Alexandra',\n",
       "                'Stehling, Florian',\n",
       "                'Goretzki, Sarah Christina',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Rath, Peter-Michael',\n",
       "                'Steindor, Mathis'],\n",
       "               'AU': ['Kavvalou A',\n",
       "                'Stehling F',\n",
       "                'Goretzki SC',\n",
       "                'Dohna-Schwake C',\n",
       "                'Rath PM',\n",
       "                'Steindor M'],\n",
       "               'AD': [\"Department of Paediatric Pulmonology and Sleep Medicine, Children's Hospital, University of Duisburg-Essen, Essen, Germany.\",\n",
       "                \"Department of Paediatric Pulmonology and Sleep Medicine, Children's Hospital, University of Duisburg-Essen, Essen, Germany.\",\n",
       "                \"Department of Paediatric Infectious Diseases, Children's Hospital, University of Duisburg-Essen, Essen, Germany.\",\n",
       "                \"Department of Paediatric Infectious Diseases, Children's Hospital, University of Duisburg-Essen, Essen, Germany.\",\n",
       "                'Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                \"Department of Paediatric Pulmonology and Sleep Medicine, Children's Hospital, University of Duisburg-Essen, Essen, Germany.\"],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20231121',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Infect Dis (Lond)',\n",
       "               'JT': 'Infectious diseases (London, England)',\n",
       "               'JID': '101650235',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Child',\n",
       "                '*Mucorales/genetics',\n",
       "                'Prevalence',\n",
       "                'Bronchoalveolar Lavage Fluid/microbiology',\n",
       "                'Bronchoalveolar Lavage',\n",
       "                'Polymerase Chain Reaction'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Mucorales',\n",
       "                'PCR',\n",
       "                'bronchoalveolar lavage',\n",
       "                'paediatric',\n",
       "                'zygomycetes'],\n",
       "               'EDAT': '2023/11/28 12:42',\n",
       "               'MHDA': '2024/02/16 06:42',\n",
       "               'CRDT': ['2023/11/28 11:43'],\n",
       "               'PHST': ['2024/02/16 06:42 [medline]',\n",
       "                '2023/11/28 12:42 [pubmed]',\n",
       "                '2023/11/28 11:43 [entrez]'],\n",
       "               'AID': ['10.1080/23744235.2023.2284357 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Infect Dis (Lond). 2024 Mar;56(3):255-258. doi: 10.1080/23744235.2023.2284357. Epub 2023 Nov 21.'},\n",
       "              {'PMID': '37931914',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20241010',\n",
       "               'LR': '20241010',\n",
       "               'IS': '1438-8782 (Electronic) 0172-4614 (Linking)',\n",
       "               'VI': '45',\n",
       "               'IP': '5',\n",
       "               'DP': '2024 Oct',\n",
       "               'TI': 'Endoscopic ultrasound-guided ethanol ablation versus surgical resection of insulinomas.',\n",
       "               'PG': '519-527',\n",
       "               'LID': '10.1055/a-2204-5814 [doi]',\n",
       "               'AB': 'PURPOSE: Insulinoma is a rare tumor of the pancreas that can lead to hypoglycemia. To date, the standard therapy is surgical resection. After the first case report of successful endoscopic ultrasound-guided (EUS) ethanol injection 16 years ago, the need for establishing an alternative treatment method remains unchanged given the high morbidity rates of surgery and its unsuitability in some patients. MATERIALS AND METHODS: Here, we provide retrospective data from 33 insulinoma patients that were treated at our center between 2010 and 2021. Of these, 9 patients were treated with EUS-guided ethanol injection and 24 underwent pancreatic surgery. RESULTS: The ethanol group was older (ethanol: mean +/- SE 67.8+/-11.2 years vs. surgery: 52.3+/-15.7, p=0.014) with a higher Charlson Comorbidity Index (3.0 (1.0;4.0) vs. 1.0 (0.0;2.0), p=0.008). The lowest glucose values were similar between groups before (ethanol: 2.09+/-0.17 mmol/l vs. surgery: 1.81+/-0.08, p=0.158) and after (4.95+/-0.74 vs. 5.41+/-0.28, p=0.581) the respective treatments. Complications occurred more frequently in the surgery group (11 % vs. 54 %, p=0.026). One patient after prior partial pancreatectomy died postoperatively. The hospitalization time was significantly shorter in the ethanol group (4.78+/-0.78 days vs. 19.88+/-4.07, p<0.001). CONCLUSION: EUS-guided ethanol injection can be similarly effective for the treatment of hyperinsulinemic hypoglycemia compared with pancreatic surgery but seems to be associated with less severe complications. This implies the need for prospective randomized trials in insulinoma patients with a low risk for malignancy.',\n",
       "               'CI': ['Thieme. All rights reserved.'],\n",
       "               'FAU': ['Jurgensen, Christian',\n",
       "                'Eckart, Marius',\n",
       "                'Haberbosch, Linus',\n",
       "                'Tacke, Frank',\n",
       "                'Sandforth, Arvid',\n",
       "                'Birkenfeld, Andreas L',\n",
       "                'Overkamp, Dietrich',\n",
       "                'Daniels, Martin',\n",
       "                'Mogl, Martina',\n",
       "                'Goretzki, Peter',\n",
       "                'Strasburger, Christian',\n",
       "                'Mai, Knut',\n",
       "                'Spranger, Joachim',\n",
       "                'Jumpertz von Schwartzenberg, Reiner'],\n",
       "               'AU': ['Jurgensen C',\n",
       "                'Eckart M',\n",
       "                'Haberbosch L',\n",
       "                'Tacke F',\n",
       "                'Sandforth A',\n",
       "                'Birkenfeld AL',\n",
       "                'Overkamp D',\n",
       "                'Daniels M',\n",
       "                'Mogl M',\n",
       "                'Goretzki P',\n",
       "                'Strasburger C',\n",
       "                'Mai K',\n",
       "                'Spranger J',\n",
       "                'Jumpertz von Schwartzenberg R'],\n",
       "               'AD': ['Department of Hepatology and Gastroenterology, Charite University Medicine, Berlin, Germany.',\n",
       "                'Department of Hepatology and Gastroenterology, Charite University Medicine, Berlin, Germany.',\n",
       "                'Department of Endocrinology and Metabolic Diseases (including Lipid Metabolism), Charite University Medicine, Berlin, Germany.',\n",
       "                'Department of Hepatology and Gastroenterology, Charite University Medicine, Berlin, Germany.',\n",
       "                'Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, Eberhard-Karls University of Tubingen, Tubingen, Germany.',\n",
       "                'Institute of Diabetes Research and Metabolic Diseases (IDM), Helmholtz Center Munich, Neuherberg, Germany.',\n",
       "                'Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, Eberhard-Karls University of Tubingen, Tubingen, Germany.',\n",
       "                'Institute of Diabetes Research and Metabolic Diseases (IDM), Helmholtz Center Munich, Neuherberg, Germany.',\n",
       "                'Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, Eberhard-Karls University of Tubingen, Tubingen, Germany.',\n",
       "                'Department of Endocrinology and Metabolic Diseases (including Lipid Metabolism), Charite University Medicine, Berlin, Germany.',\n",
       "                'Department of Surgery, Charite University Medicine, Berlin, Germany.',\n",
       "                'Department of Surgery, Charite University Medicine, Berlin, Germany.',\n",
       "                'Department of Endocrinology and Metabolic Diseases (including Lipid Metabolism), Charite University Medicine, Berlin, Germany.',\n",
       "                'Department of Endocrinology and Metabolic Diseases (including Lipid Metabolism), Charite University Medicine, Berlin, Germany.',\n",
       "                'Department of Endocrinology and Metabolic Diseases (including Lipid Metabolism), Charite University Medicine, Berlin, Germany.',\n",
       "                'Berlin Institute of Health at Charite, Berlin, Germany.',\n",
       "                'Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, Eberhard-Karls University of Tubingen, Tubingen, Germany.',\n",
       "                'Institute of Diabetes Research and Metabolic Diseases (IDM), Helmholtz Center Munich, Neuherberg, Germany.',\n",
       "                'German Center for Diabetes Research, Munchen-Neuherberg, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['2124/Cluster of Excellence, Controlling Microbes to Fight Infection (CMFI),',\n",
       "                'University Tubingen, Germany/'],\n",
       "               'PT': ['Comparative Study', 'Journal Article'],\n",
       "               'TT': 'EUS-gesteuerte Alkoholablation versus chirurgische Resektion von Insulinomen.',\n",
       "               'DEP': '20231106',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Ultraschall Med',\n",
       "               'JT': 'Ultraschall in der Medizin (Stuttgart, Germany : 1980)',\n",
       "               'JID': '8303585',\n",
       "               'RN': ['3K9958V90M (Ethanol)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*Insulinoma/surgery/diagnostic imaging',\n",
       "                '*Ethanol/administration & dosage',\n",
       "                '*Pancreatic Neoplasms/surgery/diagnostic imaging',\n",
       "                'Male',\n",
       "                'Female',\n",
       "                'Middle Aged',\n",
       "                'Aged',\n",
       "                'Retrospective Studies',\n",
       "                '*Endosonography/methods',\n",
       "                'Adult',\n",
       "                'Postoperative Complications/diagnostic imaging',\n",
       "                'Ultrasonography, Interventional',\n",
       "                'Pancreatectomy/methods'],\n",
       "               'COIS': ['The authors declare that they have no conflict of interest.'],\n",
       "               'EDAT': '2023/11/07 00:42',\n",
       "               'MHDA': '2024/10/11 10:17',\n",
       "               'CRDT': ['2023/11/06 20:03'],\n",
       "               'PHST': ['2024/10/11 10:17 [medline]',\n",
       "                '2023/11/07 00:42 [pubmed]',\n",
       "                '2023/11/06 20:03 [entrez]'],\n",
       "               'AID': ['10.1055/a-2204-5814 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Ultraschall Med. 2024 Oct;45(5):519-527. doi: 10.1055/a-2204-5814. Epub 2023 Nov 6.'},\n",
       "              {'PMID': '37906988',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20240205',\n",
       "               'LR': '20241118',\n",
       "               'IS': '1661-7819 (Electronic) 1661-7800 (Print) 1661-7800 (Linking)',\n",
       "               'VI': '121',\n",
       "               'IP': '1',\n",
       "               'DP': '2024',\n",
       "               'TI': 'Aortic Steal Correlates with Acute Organ Dysfunction and Short-Term Outcomes in Neonates with Vein of Galen Malformation.',\n",
       "               'PG': '106-115',\n",
       "               'LID': '10.1159/000534132 [doi]',\n",
       "               'AB': 'INTRODUCTION: Vein of Galen aneurysmal malformation (VGAM) is a rare, congenital cerebrovascular malformation with high morbidity and mortality. Parameters to foresee clinical progression and allow individualized parent counseling are lacking. The aim of this study was to evaluate aortic steal measured by Doppler ultrasound as a prognostic parameter in these neonates. METHODS: A retrospective monocentric analysis of cardiac ultrasound exams before embolization in neonates with VGAM was conducted. Percentage of aortic steal measured by time-averaged maximum velocity above and below the zero flow baseline by pulsed Doppler ultrasound at the preductal aortic isthmus was calculated. Association of aortic steal with parameters of acute organ dysfunction (Bicetre neonatal evaluation score [BNES], neonatal multiple organ dysfunction score [NeoMODS]) and mortality and determination of correlation between aortic steal and cerebral damage on initial and follow-up cerebral magnetic resonance imaging (cMRI) were evaluated. RESULTS: Twelve neonates were included, of which 3 died. Per 10 percentage point increase of aortic steal, BNES decreased by 1.64 (95% confidence interval [CI]: 1.28-2.0) points and the maximum observed NeoMODS increased by 1.25 (CI: 0.94-1.57) points. The odds for mortality increased by 2.3 (CI: 1.14-13.67) per 10 percentage point increase of aortic steal. There was a correlation between aortic steal and cerebral damage at baseline (white matter rho [rho] = 0.34, gray matter rho = 0.81) and follow-up (white matter rho = 0.80, gray matter rho = 0.72). CONCLUSION: The degree of aortic steal in neonates with VGAM was highly associated with the severity of organ dysfunction, disease progression on cMRI, and mortality.',\n",
       "               'CI': ['(c) 2023 The Author(s). Published by S. Karger AG, Basel.'],\n",
       "               'FAU': ['Schwarz, Simone',\n",
       "                'Brevis Nunez, Francisco',\n",
       "                'Durr, Nikola R',\n",
       "                'Schlunz-Hendann, Martin',\n",
       "                'Brassel, Friedhelm',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Bruns, Nora'],\n",
       "               'AU': ['Schwarz S',\n",
       "                'Brevis Nunez F',\n",
       "                'Durr NR',\n",
       "                'Schlunz-Hendann M',\n",
       "                'Brassel F',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dohna-Schwake C',\n",
       "                'Bruns N'],\n",
       "               'AD': ['Department of Neonatology and Pediatric Intensive Care Medicine, Sana Clinics Duisburg, Duisburg, Germany.',\n",
       "                'Department of Neonatology and Pediatric Intensive Care Medicine, Sana Clinics Duisburg, Duisburg, Germany.',\n",
       "                'Clinic for Radiology and Neuroradiology, Sana Clinics Duisburg, Duisburg, Germany.',\n",
       "                'Clinic for Radiology and Neuroradiology, Sana Clinics Duisburg, Duisburg, Germany.',\n",
       "                'Clinic for Radiology and Neuroradiology, Sana Clinics Duisburg, Duisburg, Germany.',\n",
       "                'Centre for Pediatric Interventional Radiology/Neuroradiology and Interventional Treatment of Vascular Malformations, Sana Clinics Duisburg, Duisburg, Germany.',\n",
       "                'Department for Pediatrics I, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'TNBS, Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department for Pediatrics I, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'TNBS, Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department for Pediatrics I, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'TNBS, Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20231031',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Neonatology',\n",
       "               'JT': 'Neonatology',\n",
       "               'JID': '101286577',\n",
       "               'RN': ['Vein of Galen aneurysm'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Infant, Newborn',\n",
       "                'Humans',\n",
       "                '*Vein of Galen Malformations/complications/diagnostic imaging/therapy',\n",
       "                'Retrospective Studies',\n",
       "                'Multiple Organ Failure/etiology',\n",
       "                'Ultrasonography'],\n",
       "               'PMC': 'PMC10836749',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Aortic steal',\n",
       "                'Neonatal heart failure',\n",
       "                'Neonatal ultrasound',\n",
       "                'Ultrasound',\n",
       "                'Vein of Galen aneurysmal malformation'],\n",
       "               'COIS': ['Friedhelm Brassel declares the following competing interest: shareholder of the',\n",
       "                'company Bentley InnoMed GmbH, Hechingen, Germany. All other authors have no',\n",
       "                'conflicts of interest to declare.'],\n",
       "               'EDAT': '2023/11/01 00:42',\n",
       "               'MHDA': '2024/02/05 06:42',\n",
       "               'PMCR': ['2023/10/31'],\n",
       "               'CRDT': ['2023/10/31 19:26'],\n",
       "               'PHST': ['2023/07/28 00:00 [received]',\n",
       "                '2023/09/08 00:00 [accepted]',\n",
       "                '2024/02/05 06:42 [medline]',\n",
       "                '2023/11/01 00:42 [pubmed]',\n",
       "                '2023/10/31 19:26 [entrez]',\n",
       "                '2023/10/31 00:00 [pmc-release]'],\n",
       "               'AID': ['000534132 [pii]',\n",
       "                '534132 [pii]',\n",
       "                '10.1159/000534132 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Neonatology. 2024;121(1):106-115. doi: 10.1159/000534132. Epub 2023 Oct 31.'}],\n",
       "             '2022': [{'PMID': '36613052',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20230110',\n",
       "               'LR': '20230220',\n",
       "               'IS': '1660-4601 (Electronic) 1661-7827 (Print) 1660-4601 (Linking)',\n",
       "               'VI': '20',\n",
       "               'IP': '1',\n",
       "               'DP': '2022 Dec 30',\n",
       "               'TI': 'Music Therapy in Preterm Infants Reduces Maternal Distress.',\n",
       "               'LID': '10.3390/ijerph20010731 [doi] 731',\n",
       "               'AB': \"Preterm delivery is a stressful event for mothers, posing them at risk for post-traumatic stress reactions. This study examined the degree of depressive symptoms and post-traumatic stress in mothers of preterm infants born before 32 gestational weeks depending on whether the infant received music therapy in the neonatal intensive care unit (NICU) or not. We included 33 mothers of preterm infants enrolled in a previously described prospective randomized controlled trial, of whom 18 received music therapy (mean mothers' age 34.1 +/- 4.6 years) and 15 did not (mean mothers' age 29.6 +/- 4.2). The degree of depressive symptoms, anxiety and acute stress reactions of these mothers were measured by using the German version of the Center for Epidemiologic Studies Depression Scale (CES-D) and Impact of Events Scale-Revised (IES-R) one week after birth (T1) and at infants' hospital discharge (T2). 605 music therapy sessions with a mean duration of 24.2 +/- 8.6 min (range 10 to 50 min) were conducted two times a week from the second week of life (T1) until discharge (T2) to the infants from the intervention group. The infants from the control group received standard medical care without music therapy. The mean total CES-D score decreased from T1 (mean 34.7, 95% Confidence Interval (CI) 31.1-38.1) until T2 in all mothers (mean 16.3, 95% CI 12.6-20.1). Mothers whose infants received music therapy showed stronger declines of depressive and stress symptoms (with music therapy: CES-D mean difference of total score 25.7, 95% CI 20.0-31.3, IES-R mean difference of total score 1.7, 95% CI 0.9-2.5, IES-R mean difference of subcategory hyperarousal 10.2, 95% CI 6.2-14.3; without music therapy: CES-D mean difference of total score 9.5, 95% CI 3.8-15.3, IES-R mean difference of total score 0.1, 95% CI -1.0-1.2, IES-R mean difference of subcategory hyperarousal 1.6, 95% CI -4.7-7.9). Effect sizes were strong for CES-D, IES-R, and the hyperarousal subcategory, moderate for intrusion, and low for avoidance. These findings show that mothers of preterm infants are highly susceptible to supportive non-medical interventions such as music therapy to reduce psychological symptoms and distress during their infants' NICU stay.\",\n",
       "               'FAU': ['Kobus, Susann',\n",
       "                'Diezel, Marlis',\n",
       "                'Dewan, Monia Vanessa',\n",
       "                'Huening, Britta',\n",
       "                'Dathe, Anne-Kathrin',\n",
       "                'Marschik, Peter B',\n",
       "                'Felderhoff-Mueser, Ursula',\n",
       "                'Bruns, Nora'],\n",
       "               'AU': ['Kobus S',\n",
       "                'Diezel M',\n",
       "                'Dewan MV',\n",
       "                'Huening B',\n",
       "                'Dathe AK',\n",
       "                'Marschik PB',\n",
       "                'Felderhoff-Mueser U',\n",
       "                'Bruns N'],\n",
       "               'AUID': ['ORCID: 0000-0003-2223-402X',\n",
       "                'ORCID: 0000-0002-6815-5573',\n",
       "                'ORCID: 0000-0001-5351-3975',\n",
       "                'ORCID: 0000-0001-8932-0980',\n",
       "                'ORCID: 0000-0003-3809-1887'],\n",
       "               'AD': ['Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), Faculty of Medicine, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Center of Artistic Therapy, University Medicine Essen, 45147 Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), Faculty of Medicine, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), Faculty of Medicine, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), Faculty of Medicine, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), Faculty of Medicine, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Health and Nursing, Occupational Therapy, Ernst-Abbe-University of Applied Sciences Jena, 07745 Jena, Germany.',\n",
       "                'Child and Adolescent Psychiatry and Psychotherapy, University Medical Center Gottingen, 37075 Gottingen, Germany.',\n",
       "                'Leibniz ScienceCampus Primate Cognition, 37075 Gottingen, Germany.',\n",
       "                'iDN-Interdisciplinary Developmental Neuroscience, Division of Phoniatrics, Medical University of Graz, 8036 Graz, Austria.',\n",
       "                \"Center of Neurodevelopmental Disorders (KIND), Center for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institutet, 11330 Stockholm, Sweden.\",\n",
       "                'Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), Faculty of Medicine, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), Faculty of Medicine, University Duisburg-Essen, 45147 Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Randomized Controlled Trial',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20221230',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Int J Environ Res Public Health',\n",
       "               'JT': 'International journal of environmental research and public health',\n",
       "               'JID': '101238455',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Female',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Humans',\n",
       "                'Adult',\n",
       "                '*Infant, Premature',\n",
       "                '*Music Therapy',\n",
       "                'Prospective Studies',\n",
       "                'Mothers/psychology',\n",
       "                'Intensive Care Units, Neonatal'],\n",
       "               'PMC': 'PMC9819311',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['maternal distress', 'neonatology', 'preterm infants'],\n",
       "               'COIS': ['The authors have no conflicts of interest to declare.'],\n",
       "               'EDAT': '2023/01/09 06:00',\n",
       "               'MHDA': '2023/01/11 06:00',\n",
       "               'PMCR': ['2022/12/30'],\n",
       "               'CRDT': ['2023/01/08 01:16'],\n",
       "               'PHST': ['2022/11/24 00:00 [received]',\n",
       "                '2022/12/27 00:00 [revised]',\n",
       "                '2022/12/28 00:00 [accepted]',\n",
       "                '2023/01/08 01:16 [entrez]',\n",
       "                '2023/01/09 06:00 [pubmed]',\n",
       "                '2023/01/11 06:00 [medline]',\n",
       "                '2022/12/30 00:00 [pmc-release]'],\n",
       "               'AID': ['ijerph20010731 [pii]',\n",
       "                'ijerph-20-00731 [pii]',\n",
       "                '10.3390/ijerph20010731 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Int J Environ Res Public Health. 2022 Dec 30;20(1):731. doi: 10.3390/ijerph20010731.'},\n",
       "              {'PMID': '36533247',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20221222',\n",
       "               'IS': '2296-2360 (Print) 2296-2360 (Electronic) 2296-2360 (Linking)',\n",
       "               'VI': '10',\n",
       "               'DP': '2022',\n",
       "               'TI': 'Organizational characteristics of European pediatric onco-critical care: An international cross-sectional survey.',\n",
       "               'PG': '1024273',\n",
       "               'LID': '10.3389/fped.2022.1024273 [doi] 1024273',\n",
       "               'AB': \"BACKGROUND: Intensified treatment protocols have improved survival of pediatric oncology patients. However, these treatment protocols are associated with increased treatment-related morbidity requiring admission to pediatric intensive care unit (PICU). We aimed to describe the organizational characteristics and processes of care for this patient group across PICUs in Europe. METHODS: A web-based survey was sent to PICU directors or representative physicians between February and June 2021. RESULTS: Responses were obtained from 77 PICUs of 12 European countries. Organizational characteristics were similar across the different countries of Europe. The median number of PICU beds was 12 (IQR 8-16). The majority of the PICUs was staffed by pediatric intensivists and had a 24/7 intensivist coverage. Most PICUs had a nurse-to-patient ratio of 1:1 or 1:2. The median numbers of yearly planned and unplanned PICU admissions of pediatric cancer patients were 20 (IQR 10-45) and 10 (IQR 10-30, respectively. Oncology specific practices within PICU were less common in participating centres. This included implementation of oncology protocols in PICU (30%), daily rounds of PICU physicians on the wards (13%), joint mortality and morbidity meetings or complex patients' discussions (30% and 40%, respectively) and participation of parents during clinical rounds (40%). CONCLUSION: Our survey provides an overview on the delivery of critical care for oncology patients in PICU across European countries. Multidisciplinary care for these vulnerable and challenging patients remains complex and challenging. Future studies need to determine the effects of differences in PICU organization and processes of care on patients' outcome.\",\n",
       "               'CI': ['(c) 2022 Nielsen, Agbeko, Bate, Jordan, Dohna-Schwake, Potratz, Moscatelli,',\n",
       "                'Bottari, Pappachan, Witt, Crazzolara, Amigoni, Mizia-Malarz, Sanchez Martin,',\n",
       "                'Willems, van den Heuvel-Eibrink, Schlapbach and Wosten-van Asperen.'],\n",
       "               'FAU': ['Nielsen, Jeppe S A',\n",
       "                'Agbeko, Rachel',\n",
       "                'Bate, Jessica',\n",
       "                'Jordan, Iolanda',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Potratz, Jenny',\n",
       "                'Moscatelli, Andrea',\n",
       "                'Bottari, Gabriella',\n",
       "                'Pappachan, John',\n",
       "                'Witt, Volker',\n",
       "                'Crazzolara, Roman',\n",
       "                'Amigoni, Angela',\n",
       "                'Mizia-Malarz, Agniezka',\n",
       "                'Sanchez Martin, Maria',\n",
       "                'Willems, Jef',\n",
       "                'van den Heuvel-Eibrink, Marry M',\n",
       "                'Schlapbach, Luregn J',\n",
       "                'Wosten-van Asperen, Roelie M'],\n",
       "               'AU': ['Nielsen JSA',\n",
       "                'Agbeko R',\n",
       "                'Bate J',\n",
       "                'Jordan I',\n",
       "                'Dohna-Schwake C',\n",
       "                'Potratz J',\n",
       "                'Moscatelli A',\n",
       "                'Bottari G',\n",
       "                'Pappachan J',\n",
       "                'Witt V',\n",
       "                'Crazzolara R',\n",
       "                'Amigoni A',\n",
       "                'Mizia-Malarz A',\n",
       "                'Sanchez Martin M',\n",
       "                'Willems J',\n",
       "                'van den Heuvel-Eibrink MM',\n",
       "                'Schlapbach LJ',\n",
       "                'Wosten-van Asperen RM'],\n",
       "               'AD': ['Department of Neonatal and Pediatric Intensive Care, Rigshospitalet, Copenhagen, Denmark.',\n",
       "                \"Department of Pediatric Intensive Care Unit, Great North Children's Hospital & Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom.\",\n",
       "                \"Department of Pediatric Oncology, Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.\",\n",
       "                'Department of Pediatric Intensive Care, Hospital Sant Joan de Deu, University of Barcelona, Barcelona, Spain.',\n",
       "                'Department of Pediatric Intensive Care, University Hospital Essen, Essen, Germany.',\n",
       "                \"Department of General Pediatrics-Intensive Care Medicine, University Children's Hospital Munster, Munster, Germany.\",\n",
       "                'Department of Pediatric Intensive Care, Gaslini Hospital, Genova, Italy.',\n",
       "                'Department of Pediatric Intensive Care, Ospedale Pediatrico Bambino Gesu, IRCC, Rome, Italy.',\n",
       "                \"Department of Pediatric Intensive Care, Southampton Children's Hospital, Southamptom, United Kingdom.\",\n",
       "                \"Department of Pediatrics, St. Anna Children's Hospital, Medical University of Vienna, Southamptom, Austria.\",\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Unit, Medical University of Innsbruck, Innsbruck, Austria.',\n",
       "                \"Department of Pediatric Intensive Care, Department of Woman's and Child's Health, Padua University Hospital, Padua, Italy.\",\n",
       "                'Department of Pediatric Oncology, Hematology and Chemotherapy, Medical University of Silesia, Katowice, Poland.',\n",
       "                'Department of Pediatric Intensive Care, Hospital Universitario La Paz, Madrid, Spain.',\n",
       "                'Department of Pediatric Intensive Care, Ghent University Hospital, Ghent, Belgium.',\n",
       "                'Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.',\n",
       "                \"Department of Intensive Care and Neonatology, and Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland.\",\n",
       "                \"Department of Pediatric Intensive Care, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, Netherlands.\"],\n",
       "               'CN': ['POKER (PICU Oncology Kids in Europe Research group) research consortium of ESPNIC',\n",
       "                '(European Society of Paediatric & Neonatal Intensive Care)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20221201',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Pediatr',\n",
       "               'JT': 'Frontiers in pediatrics',\n",
       "               'JID': '101615492',\n",
       "               'PMC': 'PMC9751627',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['PICU',\n",
       "                'intensive care',\n",
       "                'oncology',\n",
       "                'organization',\n",
       "                'pediatric',\n",
       "                'structure'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest.'],\n",
       "               'FIR': ['Brierley, Joe',\n",
       "                'Nadel, Simon',\n",
       "                'Aziz, Omer',\n",
       "                'Worrall, Mark',\n",
       "                'McIntosh, Diana',\n",
       "                'Vieth, Simon',\n",
       "                'Tschiedel, Eva',\n",
       "                'Valla, Frederic',\n",
       "                'Remy, Solenn',\n",
       "                'Rizzati, Frida',\n",
       "                'Titieni, Andrea',\n",
       "                'Rossetti, Emanuele',\n",
       "                'Caramelli, Fabio',\n",
       "                'Mondardini, Maria Cristina',\n",
       "                'Montaguti, Alessia'],\n",
       "               'IR': ['Brierley J',\n",
       "                'Nadel S',\n",
       "                'Aziz O',\n",
       "                'Worrall M',\n",
       "                'McIntosh D',\n",
       "                'Vieth S',\n",
       "                'Tschiedel E',\n",
       "                'Valla F',\n",
       "                'Remy S',\n",
       "                'Rizzati F',\n",
       "                'Titieni A',\n",
       "                'Rossetti E',\n",
       "                'Caramelli F',\n",
       "                'Mondardini MC',\n",
       "                'Montaguti A'],\n",
       "               'EDAT': '2022/12/20 06:00',\n",
       "               'MHDA': '2022/12/20 06:01',\n",
       "               'PMCR': ['2022/12/01'],\n",
       "               'CRDT': ['2022/12/19 04:31'],\n",
       "               'PHST': ['2022/08/21 00:00 [received]',\n",
       "                '2022/10/31 00:00 [accepted]',\n",
       "                '2022/12/19 04:31 [entrez]',\n",
       "                '2022/12/20 06:00 [pubmed]',\n",
       "                '2022/12/20 06:01 [medline]',\n",
       "                '2022/12/01 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fped.2022.1024273 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Pediatr. 2022 Dec 1;10:1024273. doi: 10.3389/fped.2022.1024273. eCollection 2022.'},\n",
       "              {'PMID': '36518782',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20240908',\n",
       "               'IS': '2296-2360 (Print) 2296-2360 (Electronic) 2296-2360 (Linking)',\n",
       "               'VI': '10',\n",
       "               'DP': '2022',\n",
       "               'TI': 'Development of restrictive eating disorders in children and adolescents with long-COVID-associated smell and taste dysfunction.',\n",
       "               'PG': '1022669',\n",
       "               'LID': '10.3389/fped.2022.1022669 [doi] 1022669',\n",
       "               'AB': 'BACKGROUND: Absent or abnormal senses of smell and taste have been frequently reported during both acute and long COVID in adult patients. In contrast, pediatric patients who test positive for SARS-CoV-2 are often asymptomatic and the loss of smell and/or taste has been infrequently reported. After observing several young patients with COVID-associated anosmia and ageusia at our clinic, we decided to investigate the incidence of subsequent eating disorders in these patients and in SARS-CoV-2 positive patients who did not experience anosmia and ageusia during the same period. MATERIAL AND METHODS: A single-site retrospective cohort study of 84 pediatric patients with suspected long COVID who were treated in the Pediatric Infectious Diseases Outpatient Clinic at the University Hospital Essen were evaluated for persistent symptoms of COVID-19. Smell and taste dysfunction as well as eating behaviors were among the signs and symptoms analyzed in this study. RESULTS: 24 out of 84 children and adolescents described smell and taste dysfunction after confirmed or suspected SARS-CoV-2 infections. A large number of these patients (6 out of 24) demonstrated increased fixation on their eating behavior post-COVID and over time these patients developed anorexia nervosa. DISCUSSION/CONCLUSION: In this study we saw a possible association of long-lasting post-COVID smell and taste dysfunction with subsequent development of eating disorders. This observation is worrisome and merits further investigation by healthcare providers at multiple clinical sites.',\n",
       "               'CI': ['(c) 2022 Brasseler, Schonecker, Steindor, Della Marina, Bruns, Dogan,',\n",
       "                'Felderhoff-Muser, Hebebrand, Dohna-Schwake and Goretzki.'],\n",
       "               'FAU': ['Brasseler, Maire',\n",
       "                'Schonecker, Anne',\n",
       "                'Steindor, Mathis',\n",
       "                'Della Marina, Adela',\n",
       "                'Bruns, Nora',\n",
       "                'Dogan, Burcin',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Hebebrand, Johannes',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Goretzki, Sarah C'],\n",
       "               'AU': ['Brasseler M',\n",
       "                'Schonecker A',\n",
       "                'Steindor M',\n",
       "                'Della Marina A',\n",
       "                'Bruns N',\n",
       "                'Dogan B',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Hebebrand J',\n",
       "                'Dohna-Schwake C',\n",
       "                'Goretzki SC'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences C-TNBS, University Duisburg-Essen, Essen, Germany.',\n",
       "                'West German Centre for Infectious Diseases (WZI), University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics III, Pediatric Pulmonology and Sleep Medicine, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics III, Pediatric Pulmonology and Sleep Medicine, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences C-TNBS, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences C-TNBS, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'West German Centre for Infectious Diseases (WZI), University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences C-TNBS, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences C-TNBS, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department for Psychiatry, Psychosomatic Medicine and Psychotherapy of Children and Adolescents, LVR, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences C-TNBS, University Duisburg-Essen, Essen, Germany.',\n",
       "                'West German Centre for Infectious Diseases (WZI), University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Infectiology, Pediatric Neurology, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences C-TNBS, University Duisburg-Essen, Essen, Germany.',\n",
       "                'West German Centre for Infectious Diseases (WZI), University Hospital Essen, University Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20221124',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Pediatr',\n",
       "               'JT': 'Frontiers in pediatrics',\n",
       "               'JID': '101615492',\n",
       "               'PMC': 'PMC9743173',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['ageusia',\n",
       "                'anorexia',\n",
       "                'anosmia',\n",
       "                'eating disorder',\n",
       "                'pediatric long COVID'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2022/12/16 06:00',\n",
       "               'MHDA': '2022/12/16 06:01',\n",
       "               'PMCR': ['2022/11/24'],\n",
       "               'CRDT': ['2022/12/15 02:29'],\n",
       "               'PHST': ['2022/08/18 00:00 [received]',\n",
       "                '2022/10/10 00:00 [accepted]',\n",
       "                '2022/12/15 02:29 [entrez]',\n",
       "                '2022/12/16 06:00 [pubmed]',\n",
       "                '2022/12/16 06:01 [medline]',\n",
       "                '2022/11/24 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fped.2022.1022669 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Pediatr. 2022 Nov 24;10:1022669. doi: 10.3389/fped.2022.1022669. eCollection 2022.'},\n",
       "              {'PMID': '36472101',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20221207',\n",
       "               'LR': '20230106',\n",
       "               'IS': '2768-6698 (Electronic) 2768-6698 (Linking)',\n",
       "               'VI': '27',\n",
       "               'IP': '11',\n",
       "               'DP': '2022 Nov 8',\n",
       "               'TI': 'Next Generation Sequencing of Free Microbial DNA for Rapid Identification of Pathogens in Critically Ill Children with Systemic Inflammatory Response Syndrome (SIRS).',\n",
       "               'PG': '302',\n",
       "               'LID': '10.31083/j.fbl2711302 [doi]',\n",
       "               'AB': 'BACKGROUND: Infections, major surgeries, and hyperinflammatory syndromes are known to trigger Systemic Inflammatory Response Syndrome (SIRS). Discrimination between infectious and noninfectious inflammation often poses a challenge in chronically ill patients with multiple comorbidities. These patients are routinely treated with a variety of anti-infective medications before a pathogen is identified. With the goal of improving pathogen detection rates and interventions, we evaluated Next Generation Sequencing (NGS) as a highly sensitive and fast means of detecting free microbial DNA in a small amount of serum samples from children with ongoing SIRS. METHODS: We describe seven complex pediatric patients of SIRS or prolonged fever (>38.5  degrees C) >72 hours in which serum samples analyzed by NGS had a major impact on therapy. One patient was analyzed twice. RESULTS: In eight NGS there were six positive results (two bacterial, three viral, one fungal) which were subsequently confirmed by microbiological culture or polymerase chain reaction (PCR) in five of the six NGS. In five of the eight performed NGS, results led to a change of therapy: antibiotic therapy was discontinued in two, escalated in one, an initiated in another; in one an antiviral was administered. CONCLUSIONS: NGS may become a valuable addition to infectious disease diagnostics in cases of pediatric SIRS. However, NGS has not yet been validated as a diagnostic method in pediatric as a diagnostic method in pediatric patients and results should therefore be interpreted with caution. Multi-center NGS evaluation studies are currently being planned.',\n",
       "               'CI': ['(c) 2022 The Author(s). Published by IMR Press.'],\n",
       "               'FAU': ['Goretzki, Sarah C',\n",
       "                'Schafer, Miriam',\n",
       "                'Dogan, Burcin',\n",
       "                'Bruns, Nora',\n",
       "                'Tschiedel, Eva',\n",
       "                'Rath, Peter-Michael',\n",
       "                'Voigt, Sebastian',\n",
       "                'Grumaz, Silke',\n",
       "                'Horvatek, Petra',\n",
       "                'Schonberger, Stefan',\n",
       "                'Stehling, Florian',\n",
       "                'Brenner, Thorsten',\n",
       "                'Dohna-Schwake, Christian'],\n",
       "               'AU': ['Goretzki SC',\n",
       "                'Schafer M',\n",
       "                'Dogan B',\n",
       "                'Bruns N',\n",
       "                'Tschiedel E',\n",
       "                'Rath PM',\n",
       "                'Voigt S',\n",
       "                'Grumaz S',\n",
       "                'Horvatek P',\n",
       "                'Schonberger S',\n",
       "                'Stehling F',\n",
       "                'Brenner T',\n",
       "                'Dohna-Schwake C'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, Pediatric Infectious Diseases, Essen University Hospital, 45147 Essen, Germany.',\n",
       "                'West German Centre of Infectious Diseases (WZI), University Hospital Essen, 45147 Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, Pediatric Infectious Diseases, Essen University Hospital, 45147 Essen, Germany.',\n",
       "                'West German Centre of Infectious Diseases (WZI), University Hospital Essen, 45147 Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, Pediatric Infectious Diseases, Essen University Hospital, 45147 Essen, Germany.',\n",
       "                'West German Centre of Infectious Diseases (WZI), University Hospital Essen, 45147 Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, Pediatric Infectious Diseases, Essen University Hospital, 45147 Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, Pediatric Infectious Diseases, Essen University Hospital, 45147 Essen, Germany.',\n",
       "                'Institute of Medical Microbiology, University Medicine Essen, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Institute of Virology, University Medicine Essen, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Noscendo GmbH, Duisburg, 47198 Duisburg, Germany.',\n",
       "                'Noscendo GmbH, Duisburg, 47198 Duisburg, Germany.',\n",
       "                'Department of Pediatrics III, Pediatric Hematology and Oncology, Cardiology, Pulmonology, University Hospital Essen, 45147 Essen, Germany.',\n",
       "                'Department of Pediatrics III, Pediatric Hematology and Oncology, Cardiology, Pulmonology, University Hospital Essen, 45147 Essen, Germany.',\n",
       "                'Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, Pediatric Infectious Diseases, Essen University Hospital, 45147 Essen, Germany.',\n",
       "                'West German Centre of Infectious Diseases (WZI), University Hospital Essen, 45147 Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Singapore',\n",
       "               'TA': 'Front Biosci (Landmark Ed)',\n",
       "               'JT': 'Frontiers in bioscience (Landmark edition)',\n",
       "               'JID': '101612996',\n",
       "               'RN': ['9007-49-2 (DNA)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Child',\n",
       "                '*High-Throughput Nucleotide Sequencing/methods',\n",
       "                '*Systemic Inflammatory Response Syndrome/diagnosis',\n",
       "                'Critical Illness',\n",
       "                'Sequence Analysis, DNA',\n",
       "                'DNA'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['SIRS', 'children', 'next generation sequencing'],\n",
       "               'COIS': ['The authors declare no conflict of interest. Dr. Grumaz is a co-founder,',\n",
       "                'employee, and shareholder of Noscendo GmbH. Petra Horvatek is an employee of',\n",
       "                'Noscendo GmbH. No specific research funding was used for this research.'],\n",
       "               'EDAT': '2022/12/07 06:00',\n",
       "               'MHDA': '2023/01/07 06:00',\n",
       "               'CRDT': ['2022/12/06 03:30'],\n",
       "               'PHST': ['2022/07/27 00:00 [received]',\n",
       "                '2022/09/28 00:00 [revised]',\n",
       "                '2022/10/07 00:00 [accepted]',\n",
       "                '2022/12/06 03:30 [entrez]',\n",
       "                '2022/12/07 06:00 [pubmed]',\n",
       "                '2023/01/07 06:00 [medline]'],\n",
       "               'AID': ['S2768-6701(22)00658-X [pii]',\n",
       "                '10.31083/j.fbl2711302 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Front Biosci (Landmark Ed). 2022 Nov 8;27(11):302. doi: 10.31083/j.fbl2711302.'},\n",
       "              {'PMID': '36397043',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20221121',\n",
       "               'LR': '20221121',\n",
       "               'IS': '1471-2466 (Electronic) 1471-2466 (Linking)',\n",
       "               'VI': '22',\n",
       "               'IP': '1',\n",
       "               'DP': '2022 Nov 17',\n",
       "               'TI': 'Bronchial artery diameter in massive hemoptysis in cystic fibrosis.',\n",
       "               'PG': '424',\n",
       "               'LID': '10.1186/s12890-022-02233-2 [doi] 424',\n",
       "               'AB': 'BACKGROUND: Massive hemoptysis is a rare but potentially life-threatening condition of patients with cystic fibrosis (CF) and advanced pulmonary disease. Hypertrophied bronchial arteries are understood to cause massive hemoptysis when rupturing. Risk factors to predict massive hemoptysis are scarce and bronchial artery diameters are not part of any scoring system in follow-up of patients with CF. Aim of this study was to correlate bronchial artery diameter with massive hemoptysis in CF. METHODS: Bronchial artery and non-bronchial systemic artery diameters were measured in contrast enhanced computed tomography (CT) scans in patients with massive hemoptysis and compared to patients with end-stage CF and no history of hemoptysis. Demographic and clinical data and side of bronchial artery/non-bronchial systemic artery hypertrophy and coil embolization were documented. RESULTS: In this retrospective multicenter study 33 patients with massive hemoptysis were included for bronchial artery/non-bronchial systemic artery diameter measurements, (13 female, 20 male, median age 30 years (18-55)). Bronchial artery diameters were significantly larger in the case group than in the control group with median 4 mm (2.2-8.2 mm), and median 3 mm (1-7 mm), respectively (p = 0.002). Sensitivity of bronchial arteries >/= 3.5 mm to be associated with hemoptysis was 0.76 and specificity 0.71 with ROC creating an area under the curve of 0.719. If non-bronchial systemic arteries were present, they were considered culprit and embolized in 92% of cases. CONCLUSION: Bronchial arteries >/= 3.5 mm and presence of hypertrophied non-bronchial systemic arteries correlate with massive hemoptysis in patients with CF and might serve as risk predictor for massive hemoptysis. Therefore, in patients with advanced CF we propose CT scans to be carried out as CT angiography to search for bronchial arteries >/= 3.5 mm and for hypertrophied non-bronchial systemic arteries as possible risk factors for massive hemoptysis.',\n",
       "               'CI': ['(c) 2022. The Author(s).'],\n",
       "               'FAU': ['Dohna, Martha',\n",
       "                'Kuhl, Hilmar',\n",
       "                'Sutharsan, Sivagurunathan',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Vo Chieu, Van Dai',\n",
       "                'Hellms, Susanne',\n",
       "                'Kornemann, Norman',\n",
       "                'Renz, Diane M',\n",
       "                'Montag, Michael J'],\n",
       "               'AU': ['Dohna M',\n",
       "                'Kuhl H',\n",
       "                'Sutharsan S',\n",
       "                'Dohna-Schwake C',\n",
       "                'Vo Chieu VD',\n",
       "                'Hellms S',\n",
       "                'Kornemann N',\n",
       "                'Renz DM',\n",
       "                'Montag MJ'],\n",
       "               'AD': ['Department of Pediatric Radiology, Hannover Medical School, Institute of Diagnostic and Interventional Radiology, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. dohna.martha@mh-hannover.de.',\n",
       "                'St. Bernhard-Hospital Kamp-Lintfort, Burgermeister-Schmelzing-Str. 90, 47475, Kamp-Lintfort, Germany.',\n",
       "                'Division of Cystic Fibrosis, Department of Pulmonary Medicine, University Medicine Essen -Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, University Medicine Essen, Hufelandstr 55, 45147, Essen, Germany.',\n",
       "                'St. Vicenz-Hospital Paderborn, Am Busdorf 2, 33098, Paderborn, Germany.',\n",
       "                'Department of Pediatric Radiology, Hannover Medical School, Institute of Diagnostic and Interventional Radiology, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.',\n",
       "                'Department of Pediatric Radiology, Hannover Medical School, Institute of Diagnostic and Interventional Radiology, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.',\n",
       "                'Department of Pediatric Radiology, Hannover Medical School, Institute of Diagnostic and Interventional Radiology, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.',\n",
       "                'Clinic for Radiology, University Hospital Munster, Albert-Schweitzer-Campus 1, 48149, Munster, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Multicenter Study'],\n",
       "               'DEP': '20221117',\n",
       "               'PL': 'England',\n",
       "               'TA': 'BMC Pulm Med',\n",
       "               'JT': 'BMC pulmonary medicine',\n",
       "               'JID': '100968563',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Male',\n",
       "                'Female',\n",
       "                'Adult',\n",
       "                'Bronchial Arteries/diagnostic imaging',\n",
       "                '*Cystic Fibrosis/complications',\n",
       "                '*Embolization, Therapeutic/methods',\n",
       "                'Hemoptysis/etiology/therapy',\n",
       "                'Angiography/adverse effects/methods'],\n",
       "               'PMC': 'PMC9670530',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Bronchial artery diameter',\n",
       "                'Cystic fibrosis',\n",
       "                'Massive hemoptysis',\n",
       "                'Risk factor'],\n",
       "               'COIS': ['The authors declare that they have no competing interests.'],\n",
       "               'EDAT': '2022/11/19 06:00',\n",
       "               'MHDA': '2022/11/22 06:00',\n",
       "               'PMCR': ['2022/11/17'],\n",
       "               'CRDT': ['2022/11/18 00:09'],\n",
       "               'PHST': ['2022/08/21 00:00 [received]',\n",
       "                '2022/11/09 00:00 [accepted]',\n",
       "                '2022/11/18 00:09 [entrez]',\n",
       "                '2022/11/19 06:00 [pubmed]',\n",
       "                '2022/11/22 06:00 [medline]',\n",
       "                '2022/11/17 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1186/s12890-022-02233-2 [pii]',\n",
       "                '2233 [pii]',\n",
       "                '10.1186/s12890-022-02233-2 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'BMC Pulm Med. 2022 Nov 17;22(1):424. doi: 10.1186/s12890-022-02233-2.'},\n",
       "              {'PMID': '36327925',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20221215',\n",
       "               'LR': '20221220',\n",
       "               'IS': '1661-7819 (Electronic) 1661-7800 (Linking)',\n",
       "               'VI': '119',\n",
       "               'IP': '6',\n",
       "               'DP': '2022',\n",
       "               'TI': 'Recurrent Late-Onset Sepsis in Extremely Low Birth Weight Infants Is Associated with Motor Deficits in Early School Age.',\n",
       "               'PG': '695-702',\n",
       "               'LID': '10.1159/000525709 [doi]',\n",
       "               'AB': 'INTRODUCTION: Sepsis is regarded as a risk factor for brain injury in preterm infants. We herein hypothesize that extremely low birth weight infants (ELBWI, birth weight <1,000 g) having survived recurrent blood culture-proven late-onset sepsis (LOS) episodes are more likely to have an adverse long-term neurologic outcome. METHODS: In a large multicenter observational study of ELBWI </=28 6/7 weeks, we evaluated the impact of recurrent LOS (blood culture-proven, after day 7 of life) on development at 5-6 years. Neurodevelopment, behavior, and motor qualities were tested by blinded investigators. Univariate and logistic regression analyses were performed. RESULTS: The cohort consisted of 1343 ELBWI including 1,080 infants without LOS, 186 infants with one LOS, and 77 with recurrent LOS, i.e., 55 infants with two and 22 infants with three LOS episodes. After Bonferroni-Holm correction, multiple logistic regression analysis revealed recurrent sepsis to be significantly associated with adverse motor development (critical MABC-2 testing: 3.3 [1.5-7.3], p = 0.003, pB = 0.012), whereas no significant impact of recurrent LOS was found on intelligence quotient and behavioral difficulties. Odds of having critical motor testing results for infants with recurrent LOS were 1.7 times (95% confidence interval 1.4-2.3) that of infants with one LOS. CONCLUSION: Recurrent sepsis in preterm infants is associated with adverse long-term motor development. However, infants with recurrent infections are also more likely to have preterm-related complications, and reasons for a worse neurodevelopmental outcome remain to be elucidated.',\n",
       "               'CI': ['(c) 2022 S. Karger AG, Basel.'],\n",
       "               'FAU': ['Humberg, Alexander',\n",
       "                'Fortmann, Mats Ingmar',\n",
       "                'Spiegler, Juliane',\n",
       "                'Rausch, Tanja K',\n",
       "                'Siller, Bastian',\n",
       "                'Silwedel, Christine',\n",
       "                'Marissen, Janina',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang',\n",
       "                'Hartel, Christoph'],\n",
       "               'AU': ['Humberg A',\n",
       "                'Fortmann MI',\n",
       "                'Spiegler J',\n",
       "                'Rausch TK',\n",
       "                'Siller B',\n",
       "                'Silwedel C',\n",
       "                'Marissen J',\n",
       "                'Herting E',\n",
       "                'Gopel W',\n",
       "                'Hartel C'],\n",
       "               'AD': ['Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Wurzburg, Wurzburg, Germany.',\n",
       "                'Institute of Medical Biometry and Statistics, University of Lubeck, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Wurzburg, Wurzburg, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Wurzburg, Wurzburg, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Wurzburg, Wurzburg, Germany.'],\n",
       "               'CN': ['German Neonatal Network (GNN)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Multicenter Study',\n",
       "                'Observational Study'],\n",
       "               'DEP': '20221103',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Neonatology',\n",
       "               'JT': 'Neonatology',\n",
       "               'JID': '101286577',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Infant, Newborn',\n",
       "                'Humans',\n",
       "                '*Infant, Extremely Low Birth Weight',\n",
       "                '*Infant, Premature'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Extremely low birth weight infant',\n",
       "                'Motor skills',\n",
       "                'Neurodevelopment',\n",
       "                'Recurrent sepsis',\n",
       "                'Sepsis'],\n",
       "               'EDAT': '2022/11/04 06:00',\n",
       "               'MHDA': '2022/12/15 06:00',\n",
       "               'CRDT': ['2022/11/03 19:33'],\n",
       "               'PHST': ['2022/02/03 00:00 [received]',\n",
       "                '2022/06/17 00:00 [accepted]',\n",
       "                '2022/11/04 06:00 [pubmed]',\n",
       "                '2022/12/15 06:00 [medline]',\n",
       "                '2022/11/03 19:33 [entrez]'],\n",
       "               'AID': ['000525709 [pii]', '10.1159/000525709 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Neonatology. 2022;119(6):695-702. doi: 10.1159/000525709. Epub 2022 Nov 3.'},\n",
       "              {'PMID': '36293550',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20221028',\n",
       "               'LR': '20221030',\n",
       "               'IS': '1422-0067 (Electronic) 1422-0067 (Linking)',\n",
       "               'VI': '23',\n",
       "               'IP': '20',\n",
       "               'DP': '2022 Oct 21',\n",
       "               'TI': 'Role of Glycolysis and Fatty Acid Synthesis in the Activation and T Cell-Modulating Potential of Dendritic Cells Stimulated with a TLR5-Ligand Allergen Fusion Protein.',\n",
       "               'LID': '10.3390/ijms232012695 [doi] 12695',\n",
       "               'AB': 'Trained immune responses, based on metabolic and epigenetic changes in innate immune cells, are de facto innate immune memory and, therefore, are of great interest in vaccine development. In previous studies, the recombinant fusion protein rFlaA:Betv1, combining the adjuvant and toll-like receptor (TLR)5-ligand flagellin (FlaA) and the major birch pollen allergen Bet v 1 into a single molecule, significantly suppressed allergic sensitization in vivo while also changing the metabolism of myeloid dendritic cells (mDCs). Within this study, the immune-metabolic effects of rFlaA:Betv1 during mDC activation were elucidated. In line with results for other well-characterized TLR-ligands, rFlaA:Betv1 increased glycolysis while suppressing oxidative phosphorylation to different extents, making rFlaA:Betv1 a suitable model to study the immune-metabolic effects of TLR-adjuvanted vaccines. In vitro pretreatment of mDCs with cerulenin (inhibitor of fatty acid biosynthesis) led to a decrease in both rFlaA:Betv1-induced anti-inflammatory cytokine Interleukin (IL) 10 and T helper cell type (TH) 1-related cytokine IL-12p70, while the pro-inflammatory cytokine IL 1beta was unaffected. Interestingly, pretreatment with the glutaminase inhibitor BPTES resulted in an increase in IL-1beta, but decreased IL-12p70 secretion while leaving IL-10 unchanged. Inhibition of the glycolytic enzyme hexokinase-2 by 2-deoxyglucose led to a decrease in all investigated cytokines (IL-10, IL-12p70, and IL-1beta). Inhibitors of mitochondrial respiration had no effect on rFlaA:Betv1-induced IL-10 level, but either enhanced the secretion of IL-1beta (oligomycin) or decreased IL-12p70 (antimycin A). In extracellular flux measurements, mDCs showed a strongly enhanced glycolysis after rFlaA:Betv1 stimulation, which was slightly increased after respiratory shutdown using antimycin A. rFlaA:Betv1-stimulated mDCs secreted directly antimicrobial substances in a mTOR- and fatty acid metabolism-dependent manner. In co-cultures of rFlaA:Betv1-stimulated mDCs with CD4+ T cells, the suppression of Bet v 1-specific TH2 responses was shown to depend on fatty acid synthesis. The effector function of rFlaA:Betv1-activated mDCs mainly relies on glycolysis, with fatty acid synthesis also significantly contributing to rFlaA:Betv1-mediated cytokine secretion, the production of antimicrobial molecules, and the modulation of T cell responses.',\n",
       "               'FAU': ['Goretzki, Alexandra',\n",
       "                'Lin, Yen-Ju',\n",
       "                'Zimmermann, Jennifer',\n",
       "                'Rainer, Hannah',\n",
       "                'Junker, Ann-Christine',\n",
       "                'Wolfheimer, Sonja',\n",
       "                'Vieths, Stefan',\n",
       "                'Scheurer, Stephan',\n",
       "                'Schulke, Stefan'],\n",
       "               'AU': ['Goretzki A',\n",
       "                'Lin YJ',\n",
       "                'Zimmermann J',\n",
       "                'Rainer H',\n",
       "                'Junker AC',\n",
       "                'Wolfheimer S',\n",
       "                'Vieths S',\n",
       "                'Scheurer S',\n",
       "                'Schulke S'],\n",
       "               'AD': ['Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, 63225 Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, 63225 Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, 63225 Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, 63225 Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, 63225 Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, 63225 Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, 63225 Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, 63225 Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, 63225 Langen, Germany.'],\n",
       "               'AUID': ['ORCID: 0000-0002-0761-9506',\n",
       "                'ORCID: 0000-0002-2859-562X',\n",
       "                'ORCID: 0000-0002-9674-5116'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['DFG SCHU2951/4/Deutsche Forschungsgemeinschaft/',\n",
       "                'DFG SCHE637/4/Deutsche Forschungsgemeinschaft/'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20221021',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Int J Mol Sci',\n",
       "               'JT': 'International journal of molecular sciences',\n",
       "               'JID': '101092791',\n",
       "               'RN': ['0 (Toll-Like Receptor 5)',\n",
       "                '0 (Allergens)',\n",
       "                '130068-27-8 (Interleukin-10)',\n",
       "                '12777-81-0 (Flagellin)',\n",
       "                'EC 2.7.1.1 (Hexokinase)',\n",
       "                'EC 3.5.1.2 (Glutaminase)',\n",
       "                '0 (Ligands)',\n",
       "                '642-15-9 (Antimycin A)',\n",
       "                '17397-89-6 (Cerulenin)',\n",
       "                '0 (Recombinant Proteins)',\n",
       "                '0 (Cytokines)',\n",
       "                '0 (Adjuvants, Immunologic)',\n",
       "                '0 (Vaccines)',\n",
       "                '0 (Recombinant Fusion Proteins)',\n",
       "                'EC 2.7.11.1 (TOR Serine-Threonine Kinases)',\n",
       "                '9G2MP84A8W (Deoxyglucose)',\n",
       "                '0 (Oligomycins)',\n",
       "                '0 (Fatty Acids)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['*Toll-Like Receptor 5/metabolism',\n",
       "                'Allergens',\n",
       "                'Interleukin-10/metabolism',\n",
       "                'Flagellin/metabolism',\n",
       "                'Hexokinase/metabolism',\n",
       "                'Glutaminase/metabolism',\n",
       "                'Ligands',\n",
       "                'Antimycin A/metabolism/pharmacology',\n",
       "                'Cerulenin/metabolism/pharmacology',\n",
       "                'Dendritic Cells',\n",
       "                'Recombinant Proteins/metabolism',\n",
       "                'Cytokines/metabolism',\n",
       "                'Adjuvants, Immunologic/pharmacology',\n",
       "                '*Vaccines/metabolism',\n",
       "                'Recombinant Fusion Proteins/metabolism',\n",
       "                'Glycolysis',\n",
       "                'TOR Serine-Threonine Kinases/metabolism',\n",
       "                'Deoxyglucose/pharmacology',\n",
       "                'Oligomycins/pharmacology',\n",
       "                'Fatty Acids/metabolism'],\n",
       "               'PMC': 'PMC9604253',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Bet v 1',\n",
       "                'Warburg',\n",
       "                'allergy',\n",
       "                'flagellin',\n",
       "                'fusion protein',\n",
       "                'immune metabolism'],\n",
       "               'COIS': ['AG reports price money received from the German Society of Allergy and Clinical',\n",
       "                'Immunology (DGAKI) and the Organizing Committee of the World Immune Regulation',\n",
       "                'Meeting (WIRM) for abstracts and presentations relating to this publication. All',\n",
       "                'other authors have no conflict of interest to declare.'],\n",
       "               'EDAT': '2022/10/28 06:00',\n",
       "               'MHDA': '2022/10/29 06:00',\n",
       "               'PMCR': ['2022/10/21'],\n",
       "               'CRDT': ['2022/10/27 01:25'],\n",
       "               'PHST': ['2022/09/13 00:00 [received]',\n",
       "                '2022/10/14 00:00 [revised]',\n",
       "                '2022/10/15 00:00 [accepted]',\n",
       "                '2022/10/27 01:25 [entrez]',\n",
       "                '2022/10/28 06:00 [pubmed]',\n",
       "                '2022/10/29 06:00 [medline]',\n",
       "                '2022/10/21 00:00 [pmc-release]'],\n",
       "               'AID': ['ijms232012695 [pii]',\n",
       "                'ijms-23-12695 [pii]',\n",
       "                '10.3390/ijms232012695 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Int J Mol Sci. 2022 Oct 21;23(20):12695. doi: 10.3390/ijms232012695.'},\n",
       "              {'PMID': '36245724',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20221019',\n",
       "               'IS': '2296-2360 (Print) 2296-2360 (Electronic) 2296-2360 (Linking)',\n",
       "               'VI': '10',\n",
       "               'DP': '2022',\n",
       "               'TI': 'Administrative data in pediatric critical care research-Potential, challenges, and future directions.',\n",
       "               'PG': '1014094',\n",
       "               'LID': '10.3389/fped.2022.1014094 [doi] 1014094',\n",
       "               'AB': 'Heterogenous patient populations with small case numbers constitute a relevant barrier to research in pediatric critical care. Prospective studies bring along logistic barriers and-if interventional-ethical concerns. Therefore, retrospective observational investigations, mainly multicenter studies or analyses of registry data, prevail in the field of pediatric critical care research. Administrative health care data represent a possible alternative to overcome small case numbers and logistic barriers. However, their current use is limited by a lack of knowledge among clinicians about the availability and characteristics of these data sets, along with required expertise in the handling of large data sets. Specifically in the field of critical care research, difficulties to assess the severity of the acute disease and estimate organ dysfunction and outcomes pose additional challenges. In contrast, trauma research has shown that classification of injury severity from administrative data can be achieved and chronic disease scores have been developed for pediatric patients, nurturing confidence that the remaining obstacles can be overcome. Despite the undoubted challenges, interdisciplinary collaboration between clinicians and methodologic experts have resulted in impactful publications from across the world. Efforts to enable the estimation of organ dysfunction and measure outcomes after critical illness are the most urgent tasks to promote the use of administrative data in critical care. Clever analysis and linking of different administrative health care data sets carry the potential to advance observational research in pediatric critical care and ultimately improve clinical care for critically ill children.',\n",
       "               'CI': ['Copyright (c) 2022 Bruns, Sorg, Felderhoff-Muser, Dohna-Schwake and Stang.'],\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Sorg, Anna-Lisa',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Stang, Andreas'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Sorg AL',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dohna-Schwake C',\n",
       "                'Stang A'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Division of Pediatric Epidemiology, Institute of Social Pediatrics and Adolescent Medicine, Ludwig Maximilian University Munich, Munich, Germany.',\n",
       "                \"University Children's Hospital, Eberhard Karls University, Tubingen, Germany.\",\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20220928',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Pediatr',\n",
       "               'JT': 'Frontiers in pediatrics',\n",
       "               'JID': '101615492',\n",
       "               'PMC': 'PMC9554413',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['adjustment',\n",
       "                'administrative data',\n",
       "                'confounding',\n",
       "                'diagnose related groups',\n",
       "                'international classification of disease (ICD)',\n",
       "                'measurement of outcomes',\n",
       "                'pediatric critical care',\n",
       "                'severity of disease'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2022/10/18 06:00',\n",
       "               'MHDA': '2022/10/18 06:01',\n",
       "               'PMCR': ['2022/09/28'],\n",
       "               'CRDT': ['2022/10/17 04:19'],\n",
       "               'PHST': ['2022/08/08 00:00 [received]',\n",
       "                '2022/09/12 00:00 [accepted]',\n",
       "                '2022/10/17 04:19 [entrez]',\n",
       "                '2022/10/18 06:00 [pubmed]',\n",
       "                '2022/10/18 06:01 [medline]',\n",
       "                '2022/09/28 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fped.2022.1014094 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Pediatr. 2022 Sep 28;10:1014094. doi: 10.3389/fped.2022.1014094. eCollection 2022.'},\n",
       "              {'PMID': '36174765',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20221103',\n",
       "               'LR': '20221209',\n",
       "               'IS': '1089-8638 (Electronic) 0022-2836 (Linking)',\n",
       "               'VI': '434',\n",
       "               'IP': '22',\n",
       "               'DP': '2022 Nov 30',\n",
       "               'TI': 'The Disordered MAX N-terminus Modulates DNA Binding of the Transcription Factor MYC:MAX.',\n",
       "               'PG': '167833',\n",
       "               'LID': 'S0022-2836(22)00453-3 [pii] 10.1016/j.jmb.2022.167833 [doi]',\n",
       "               'AB': 'The intrinsically disordered protein MYC belongs to the family of basic helix-loop-helix leucine zipper (bHLH-LZ) transcription factors (TFs). In complex with its cognate binding partner MAX, MYC preferentially binds to E-Box promotor sequences where it controls fundamental cellular processes such as cell cycle progression, metabolism, and apoptosis. Intramolecular regulation of MYC:MAX has not yet been investigated in detail. In this work, we use Nuclear Magnetic Resonance (NMR) spectroscopy to identify and map interactions between the disordered MAX N-terminus and the MYC:MAX DNA binding domain (DBD). We find that this binding event is mainly driven by electrostatic interactions and that it is competitive with DNA binding. Using NMR spectroscopy and Surface Plasmon Resonance (SPR), we demonstrate that the MAX N-terminus serves to accelerate DNA binding kinetics of MYC:MAX and MAX:MAX dimers, while it simultaneously provides specificity for E-Box DNA. We also establish that these effects are further enhanced by Casein Kinase 2-mediated phosphorylation of two serine residues in the MAX N-terminus. Our work provides new insights how bHLH-LZ TFs are regulated by intramolecular interactions between disordered regions and the folded DNA binding domain.',\n",
       "               'CI': ['Copyright (c) 2022 Elsevier Ltd. All rights reserved.'],\n",
       "               'FAU': ['Schutz, Stefan',\n",
       "                'Bergsdorf, Christian',\n",
       "                'Goretzki, Benedikt',\n",
       "                'Lingel, Andreas',\n",
       "                'Renatus, Martin',\n",
       "                'Gossert, Alvar D',\n",
       "                'Jahnke, Wolfgang'],\n",
       "               'AU': ['Schutz S',\n",
       "                'Bergsdorf C',\n",
       "                'Goretzki B',\n",
       "                'Lingel A',\n",
       "                'Renatus M',\n",
       "                'Gossert AD',\n",
       "                'Jahnke W'],\n",
       "               'AD': ['Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland.',\n",
       "                'Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland.',\n",
       "                'Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland.',\n",
       "                'Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland.',\n",
       "                'Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland.',\n",
       "                'Department of Biology, ETH Zurich, CH-8093 Zurich, Switzerland.',\n",
       "                'Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland. Electronic address: wolfgang.jahnke@novartis.com.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20220927',\n",
       "               'PL': 'Netherlands',\n",
       "               'TA': 'J Mol Biol',\n",
       "               'JT': 'Journal of molecular biology',\n",
       "               'JID': '2985088R',\n",
       "               'RN': ['EC 2.7.11.1 (Casein Kinase II)',\n",
       "                '9007-49-2 (DNA)',\n",
       "                '0 (Intrinsically Disordered Proteins)',\n",
       "                '0 (Proto-Oncogene Proteins c-myc)',\n",
       "                '452VLY9402 (Serine)',\n",
       "                '0 (MAX protein, human)',\n",
       "                '0 (Basic Helix-Loop-Helix Leucine Zipper Transcription Factors)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Casein Kinase II/chemistry',\n",
       "                'DNA/chemistry',\n",
       "                '*Intrinsically Disordered Proteins/chemistry',\n",
       "                '*Proto-Oncogene Proteins c-myc/chemistry',\n",
       "                'Serine/chemistry',\n",
       "                'Protein Interaction Mapping',\n",
       "                '*Protein Interaction Domains and Motifs',\n",
       "                '*Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/chemistry',\n",
       "                'Protein Binding',\n",
       "                'Phosphorylation'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['E-Box',\n",
       "                'bHLH-LZ',\n",
       "                'intramolecular interaction',\n",
       "                'molecular mechanism',\n",
       "                'phosphorylation'],\n",
       "               'COIS': ['Conflict of interest statement The authors declare no conflict of interest.'],\n",
       "               'EDAT': '2022/09/30 06:00',\n",
       "               'MHDA': '2022/10/28 06:00',\n",
       "               'CRDT': ['2022/09/29 19:34'],\n",
       "               'PHST': ['2022/07/22 00:00 [received]',\n",
       "                '2022/09/05 00:00 [revised]',\n",
       "                '2022/09/17 00:00 [accepted]',\n",
       "                '2022/09/30 06:00 [pubmed]',\n",
       "                '2022/10/28 06:00 [medline]',\n",
       "                '2022/09/29 19:34 [entrez]'],\n",
       "               'AID': ['S0022-2836(22)00453-3 [pii]',\n",
       "                '10.1016/j.jmb.2022.167833 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Mol Biol. 2022 Nov 30;434(22):167833. doi: 10.1016/j.jmb.2022.167833. Epub 2022 Sep 27.'},\n",
       "              {'PMID': '36090865',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20220913',\n",
       "               'IS': '1664-2295 (Print) 1664-2295 (Electronic) 1664-2295 (Linking)',\n",
       "               'VI': '13',\n",
       "               'DP': '2022',\n",
       "               'TI': 'The impact of age and electrode position on amplitude-integrated EEGs in children from 1 month to 17 years of age.',\n",
       "               'PG': '952193',\n",
       "               'LID': '10.3389/fneur.2022.952193 [doi] 952193',\n",
       "               'AB': 'AIM: Amplitude-integrated electroencephalography (aEEG) is used to monitor electrocortical activity in critically ill children but age-specific reference values are lacking. We aimed to assess the impact of age and electrode position on aEEG amplitudes and derive normal values for pediatric aEEGs from neurologically healthy children. METHODS: Normal EEGs from awake children aged 1 month to 17 years (213 female, 237 male) without neurological disease or neuroactive medication were retrospectively converted into aEEGs. Two observers manually measured the upper and lower amplitude borders of the C3 - P3, C4 - P4, C3 - C4, P3 - P4, and Fp1 - Fp2 channels of the 10-20 system. Percentiles (10th, 25th, 50th, 75th, 90th) were calculated for each age group (<1 year, 1 year, 2-5 years, 6-9 years, 10-13 years, 14-17 years). RESULTS: Amplitude heights and curves differed between channels without sex-specific differences. During the first 2 years of life, upper and lower amplitudes of all but the Fp1-Fp2 channel increased and then declined until 17 years. The decline of the upper Fp1-Fp2 amplitude began at 4 years, while the lower amplitude declined from the 1st year of life. CONCLUSIONS: aEEG interpretation must account for age and electrode positions but not for sex in infants and children.',\n",
       "               'CI': ['Copyright (c) 2022 Greve, Loffelhardt, Della Marina, Felderhoff-Muser,',\n",
       "                'Dohna-Schwake and Bruns.'],\n",
       "               'FAU': ['Greve, Sandra',\n",
       "                'Loffelhardt, Verena Tamara',\n",
       "                'Della Marina, Adela',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Bruns, Nora'],\n",
       "               'AU': ['Greve S',\n",
       "                'Loffelhardt VT',\n",
       "                'Della Marina A',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dohna-Schwake C',\n",
       "                'Bruns N'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'C-TNBS, Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20220825',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Neurol',\n",
       "               'JT': 'Frontiers in neurology',\n",
       "               'JID': '101546899',\n",
       "               'PMC': 'PMC9452771',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['amplitude-integrated EEG',\n",
       "                'channel',\n",
       "                'electrode position',\n",
       "                'neuromonitoring',\n",
       "                'normal values',\n",
       "                'pediatric aEEG',\n",
       "                'pediatric intensive care',\n",
       "                'percentiles'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2022/09/13 06:00',\n",
       "               'MHDA': '2022/09/13 06:01',\n",
       "               'PMCR': ['2022/08/25'],\n",
       "               'CRDT': ['2022/09/12 03:51'],\n",
       "               'PHST': ['2022/05/24 00:00 [received]',\n",
       "                '2022/08/03 00:00 [accepted]',\n",
       "                '2022/09/12 03:51 [entrez]',\n",
       "                '2022/09/13 06:00 [pubmed]',\n",
       "                '2022/09/13 06:01 [medline]',\n",
       "                '2022/08/25 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fneur.2022.952193 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Neurol. 2022 Aug 25;13:952193. doi: 10.3389/fneur.2022.952193. eCollection 2022.'},\n",
       "              {'PMID': '36059475',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220908',\n",
       "               'LR': '20220914',\n",
       "               'IS': '1664-3224 (Electronic) 1664-3224 (Linking)',\n",
       "               'VI': '13',\n",
       "               'DP': '2022',\n",
       "               'TI': 'Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy.',\n",
       "               'PG': '916491',\n",
       "               'LID': '10.3389/fimmu.2022.916491 [doi] 916491',\n",
       "               'AB': 'BACKGROUND: Recently, bacterial components were shown to enhance immune responses by shifting immune cell metabolism towards glycolysis and lactic acid production, also known as the Warburg Effect. Currently, the effect of allergen products for immunotherapy (AIT) and commercial vaccines on immune cell metabolism is mostly unknown. OBJECTIVE: To investigate the effect of AIT products (adjuvanted with either MPLA or Alum) on myeloid dendritic cell (mDC) metabolism and activation. METHODS: Bone marrow-derived mDCs were stimulated with five allergoid-based AIT products (one adjuvanted with MPLA, four adjuvanted with Alum) and two MPLA-adjuvanted vaccines and analyzed for their metabolic activation, expression of cell surface markers, and cytokine secretion by ELISA. mDCs were pre-incubated with either immunological or metabolic inhibitors or cultured in glucose- or glutamine-free culture media and subsequently stimulated with the MPLA-containing AIT product (AIT product 1). mDCs were co-cultured with allergen-specific CD4+ T cells to investigate the contribution of metabolic pathways to the T cell priming capacity of mDCs stimulated with AIT product 1. RESULTS: Both the MPLA-containing AIT product 1 and commercial vaccines, but not the Alum-adjuvanted AIT products, activated Warburg metabolism and TNF-alpha secretion in mDCs. Further experiments focused on AIT product 1. Metabolic analysis showed that AIT product 1 increased glycolytic activity while also inducing the secretion of IL-1beta, IL-10, IL-12, and TNF-alpha. Both rapamycin (mTOR-inhibitor) and SP600125 (SAP/JNK MAPK-inhibitor) dose-dependently suppressed the AIT product 1-induced Warburg Effect, glucose consumption, IL-10-, and TNF-alpha secretion. Moreover, both glucose- and glutamine deficiency suppressed secretion of all investigated cytokines (IL-1beta, IL-10, and TNF-alpha). Glucose metabolism in mDCs was also critical for the (Th1-biased) T cell priming capacity of AIT product 1-stimulated mDCs, as inhibition of mTOR signaling abrogated their ability to induce Th1-responses. CONCLUSION: The AIT product and commercial vaccines containing the adjuvant MPLA were shown to modulate the induction of immune responses by changing the metabolic state of mDCs. Better understanding the mechanisms underlying the interactions between cell metabolism and immune responses will allow us to further improve vaccine development and AIT.',\n",
       "               'CI': ['Copyright (c) 2022 Zimmermann, Goretzki, Meier, Wolfheimer, Lin, Rainer, Krause,',\n",
       "                'Wedel, Spies, Fuhrer, Vieths, Scheurer and Schulke.'],\n",
       "               'FAU': ['Zimmermann, Jennifer',\n",
       "                'Goretzki, Alexandra',\n",
       "                'Meier, Clara',\n",
       "                'Wolfheimer, Sonja',\n",
       "                'Lin, Yen-Ju',\n",
       "                'Rainer, Hannah',\n",
       "                'Krause, Maren',\n",
       "                'Wedel, Saskia',\n",
       "                'Spies, Gerd',\n",
       "                'Fuhrer, Frank',\n",
       "                'Vieths, Stefan',\n",
       "                'Scheurer, Stephan',\n",
       "                'Schulke, Stefan'],\n",
       "               'AU': ['Zimmermann J',\n",
       "                'Goretzki A',\n",
       "                'Meier C',\n",
       "                'Wolfheimer S',\n",
       "                'Lin YJ',\n",
       "                'Rainer H',\n",
       "                'Krause M',\n",
       "                'Wedel S',\n",
       "                'Spies G',\n",
       "                'Fuhrer F',\n",
       "                'Vieths S',\n",
       "                'Scheurer S',\n",
       "                'Schulke S'],\n",
       "               'AD': ['Vice President s Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Vice President s Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Vice President s Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Vice President s Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Vice President s Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Vice President s Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Vice President s Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Vice President s Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Z6 Occupational Safety, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Division of Allergology, Batch Control and Allergen Analytics, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Vice President s Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Vice President s Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Vice President s Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20220817',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Immunol',\n",
       "               'JT': 'Frontiers in immunology',\n",
       "               'JID': '101560960',\n",
       "               'RN': ['0 (Adjuvants, Immunologic)',\n",
       "                '0 (Adjuvants, Pharmaceutic)',\n",
       "                '0 (Allergens)',\n",
       "                '0 (Immunologic Factors)',\n",
       "                '0 (Tumor Necrosis Factor-alpha)',\n",
       "                '0 (Vaccines)',\n",
       "                '130068-27-8 (Interleukin-10)',\n",
       "                'EC 2.7.11.1 (TOR Serine-Threonine Kinases)',\n",
       "                'IY9XDZ35W2 (Glucose)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adjuvants, Immunologic/pharmacology',\n",
       "                'Adjuvants, Pharmaceutic/metabolism/pharmacology',\n",
       "                '*Allergens',\n",
       "                'Dendritic Cells',\n",
       "                'Glucose/metabolism',\n",
       "                'Immunologic Factors/pharmacology',\n",
       "                'Immunotherapy',\n",
       "                'Interleukin-10',\n",
       "                'TOR Serine-Threonine Kinases/metabolism',\n",
       "                'Tumor Necrosis Factor-alpha/metabolism',\n",
       "                '*Vaccines/pharmacology'],\n",
       "               'PMC': 'PMC9430023',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['MPLA: monophosphoryl lipid A',\n",
       "                'Warburg Effect',\n",
       "                'allergen specific immunotherapy',\n",
       "                'immune metabolism',\n",
       "                'vaccine'],\n",
       "               'COIS': ['The authors are employees of the German Federal Institute for Vaccines and',\n",
       "                'Biomedicines. The Paul-Ehrlich-Institut (PEI) is an Agency of the German Federal',\n",
       "                'Ministry of Health. In relation to the present publication, the authors consider',\n",
       "                'themselves not having a conflict of interest. Opinions expressed in the paper are',\n",
       "                'personal views of the authors, not necessarily reflecting an official opinion of',\n",
       "                'the PEI or the German Federal Ministry of Health.'],\n",
       "               'EDAT': '2022/09/06 06:00',\n",
       "               'MHDA': '2022/09/09 06:00',\n",
       "               'PMCR': ['2022/01/01'],\n",
       "               'CRDT': ['2022/09/05 03:37'],\n",
       "               'PHST': ['2022/04/09 00:00 [received]',\n",
       "                '2022/07/18 00:00 [accepted]',\n",
       "                '2022/09/05 03:37 [entrez]',\n",
       "                '2022/09/06 06:00 [pubmed]',\n",
       "                '2022/09/09 06:00 [medline]',\n",
       "                '2022/01/01 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fimmu.2022.916491 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Immunol. 2022 Aug 17;13:916491. doi: 10.3389/fimmu.2022.916491. eCollection 2022.'},\n",
       "              {'PMID': '35987047',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220923',\n",
       "               'LR': '20221215',\n",
       "               'IS': '1872-6232 (Electronic) 0378-3782 (Linking)',\n",
       "               'VI': '173',\n",
       "               'DP': '2022 Oct',\n",
       "               'TI': 'Sleep problems in infancy and early school age in very preterm infants.',\n",
       "               'PG': '105656',\n",
       "               'LID': 'S0378-3782(22)00119-0 [pii] 10.1016/j.earlhumdev.2022.105656 [doi]',\n",
       "               'AB': \"BACKGROUND: Sleep plays an important role for psychological and physical health, especially in infants at high risk for long-term neurodevelopmental impairment such as preterm infants. OBJECTIVE: Our study aimed at determining risk factors for long-term sleep impairment in very-preterm (VPT; <32 weeks of gestation) infants. METHODS: Sleep problems were analyzed in an observational study in infants of the German Neonatal Network born between January 1st 2009 and December 31st 2014. Parental questionnaires of n = 2928 VPT children were evaluated regarding the child's sleep behavior at five years of age. Univariate and logistic regression analyses were used to identify risk factors for delayed sleep onset and hyperactivity/inattention (Strength and Difficulties Questionnaire). In a second cohort of n = 342 VPT infants, sleep habits were evaluated at toddlers age via the Infant Sleep Questionnaire. RESULTS: In our cohorts, 424/2928 (14.5 %) preterm children were diagnosed with delayed sleep onset at early school age while 57/342 (16.7 %) had sleep impairment in early infancy. Gestational age was not independently associated with sleep problems (i.e., early school age: OR 0.97, 95 % CI 0.9-1.1, p = 0.15). Notably, in both our cohorts, neonatal exposure to analgesics and sedatives was associated with a higher risk for sleep problems, i.e., early school age: exposure to sedatives: OR 1.31, 95%CI 1.02-1.7, p = 0.03. Sleep problems and drug exposure were both associated with hyperactivity/inattention. CONCLUSION: Sleep problems of VPT children are unrelated to gestational age which suggests rather individual risk factors. The significant neonatal exposure to analgesics and sedatives may contribute to long-term sleep impairment.\",\n",
       "               'CI': ['Copyright (c) 2022. Published by Elsevier B.V.'],\n",
       "               'FAU': ['Neitmann, Johanna',\n",
       "                'Hanke, Kathrin',\n",
       "                'Humberg, Alexander',\n",
       "                'Siller, Bastian',\n",
       "                'Spiegler, Juliane',\n",
       "                'Juhnke, Karla',\n",
       "                'Gilmore, Jessica',\n",
       "                'Odendahl, Rainer',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang',\n",
       "                'Hartel, Christoph',\n",
       "                'Fortmann, Ingmar'],\n",
       "               'AU': ['Neitmann J',\n",
       "                'Hanke K',\n",
       "                'Humberg A',\n",
       "                'Siller B',\n",
       "                'Spiegler J',\n",
       "                'Juhnke K',\n",
       "                'Gilmore J',\n",
       "                'Odendahl R',\n",
       "                'Herting E',\n",
       "                'Gopel W',\n",
       "                'Hartel C',\n",
       "                'Fortmann I'],\n",
       "               'AD': ['Department of Pediatrics, University of Luebeck, Luebeck, Germany.',\n",
       "                'Department of Pediatrics, University of Luebeck, Luebeck, Germany. Electronic address: kathrin.hanke@uksh.de.',\n",
       "                'Department of Pediatrics, University of Luebeck, Luebeck, Germany. Electronic address: alexander.humberg@uksh.de.',\n",
       "                'Department of Pediatrics, University of Luebeck, Luebeck, Germany. Electronic address: bastian.siller@uksh.de.',\n",
       "                'Department of Pediatrics, University Hospital of Wuerzburg, Wuerzburg, Germany. Electronic address: spiegler_j@ukw.de.',\n",
       "                'Department of Pediatrics, University of Luebeck, Luebeck, Germany.',\n",
       "                'Department of Pediatrics, University of Luebeck, Luebeck, Germany. Electronic address: jessica.gilmore@student.uni-luebeck.de.',\n",
       "                'Department of Pediatrics, University of Luebeck, Luebeck, Germany. Electronic address: info@kjm-klingenberg.de.',\n",
       "                'Department of Pediatrics, University of Luebeck, Luebeck, Germany. Electronic address: Egbert.herting@uksh.de.',\n",
       "                'Department of Pediatrics, University of Luebeck, Luebeck, Germany. Electronic address: Wolfgang.goepel@uksh.de.',\n",
       "                'Department of Pediatrics, University Hospital of Wuerzburg, Wuerzburg, Germany. Electronic address: Haertel_C1@ukw.de.',\n",
       "                'Department of Pediatrics, University of Luebeck, Luebeck, Germany. Electronic address: matsingmar.fortmann@uksh.de.'],\n",
       "               'CN': ['German Neonatal Network (GNN)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Observational Study',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20220815',\n",
       "               'PL': 'Ireland',\n",
       "               'TA': 'Early Hum Dev',\n",
       "               'JT': 'Early human development',\n",
       "               'JID': '7708381',\n",
       "               'RN': ['0 (Hypnotics and Sedatives)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Female',\n",
       "                'Fetal Growth Retardation',\n",
       "                'Humans',\n",
       "                'Hypnotics and Sedatives',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature',\n",
       "                '*Infant, Premature, Diseases',\n",
       "                'Infant, Very Low Birth Weight',\n",
       "                '*Sleep Wake Disorders/epidemiology'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Preterm infants',\n",
       "                'Sedatives',\n",
       "                'Sleep impairment',\n",
       "                'Sleep problems'],\n",
       "               'COIS': ['Declaration of competing interest The authors declare no conflict of interests.'],\n",
       "               'EDAT': '2022/08/21 06:00',\n",
       "               'MHDA': '2022/09/24 06:00',\n",
       "               'CRDT': ['2022/08/20 18:21'],\n",
       "               'PHST': ['2022/06/19 00:00 [received]',\n",
       "                '2022/08/10 00:00 [revised]',\n",
       "                '2022/08/10 00:00 [accepted]',\n",
       "                '2022/08/21 06:00 [pubmed]',\n",
       "                '2022/09/24 06:00 [medline]',\n",
       "                '2022/08/20 18:21 [entrez]'],\n",
       "               'AID': ['S0378-3782(22)00119-0 [pii]',\n",
       "                '10.1016/j.earlhumdev.2022.105656 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Early Hum Dev. 2022 Oct;173:105656. doi: 10.1016/j.earlhumdev.2022.105656. Epub 2022 Aug 15.'},\n",
       "              {'PMID': '35954880',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220815',\n",
       "               'LR': '20230308',\n",
       "               'IS': '1660-4601 (Electronic) 1661-7827 (Print) 1660-4601 (Linking)',\n",
       "               'VI': '19',\n",
       "               'IP': '15',\n",
       "               'DP': '2022 Aug 3',\n",
       "               'TI': \"Impact of Physical Contact on Preterm Infants' Vital Sign Response to Live Music Therapy.\",\n",
       "               'LID': '10.3390/ijerph19159524 [doi] 9524',\n",
       "               'AB': \"Evidence that music therapy stabilises vital parameters in preterm infants is growing, but the optimal setting for therapy is still under investigation. Our study aimed to quantify the effect of physical contact during live music therapy in preterm infants born < 32 weeks' gestational age (GA) on post-therapy vital sign values. Live music therapy was delivered twice-weekly until discharge from hospital to 40 stable infants < 32 weeks' GA. Baseline and post-therapy heart rate, respiratory rate, oxygen saturation and physical contact during each session were recorded. 159 sessions were performed with, and 444 sessions without, physical contact. Descriptive and multivariable regression analyses based on directed acyclic graphs were performed. The mean GA was 28.6 +/- 2.6 weeks, and 26 (65%) infants were male. Mean absolute values for heart and respiratory rates lowered during music therapy regardless of physical contact. The mean post-therapy SaO2 was higher compared to baseline values regardless of physical contact (mean differences -8.6 beats/min; -13.3 breaths/min and +2.0%). There were no clinically relevant changes in vital sign responses between therapy sessions, with or without physical contact, or adjusted post-therapy values for any of the studied vital signs. Physical contact caused better baseline and post-therapy vital sign values but did not enhance the vital sign response to music therapy. Thus, the effect of music therapy on preterm infants' vital signs is independent of physical contact and parents' presence during music therapy in the neonatal intensive care unit.\",\n",
       "               'FAU': ['Kobus, Susann',\n",
       "                'Diezel, Marlis',\n",
       "                'Dewan, Monia Vanessa',\n",
       "                'Huening, Britta',\n",
       "                'Dathe, Anne-Kathrin',\n",
       "                'Felderhoff-Mueser, Ursula',\n",
       "                'Bruns, Nora'],\n",
       "               'AU': ['Kobus S',\n",
       "                'Diezel M',\n",
       "                'Dewan MV',\n",
       "                'Huening B',\n",
       "                'Dathe AK',\n",
       "                'Felderhoff-Mueser U',\n",
       "                'Bruns N'],\n",
       "               'AUID': ['ORCID: 0000-0003-2223-402X',\n",
       "                'ORCID: 0000-0002-6815-5573',\n",
       "                'ORCID: 0000-0001-5351-3975',\n",
       "                'ORCID: 0000-0003-3809-1887'],\n",
       "               'AD': ['Department of Paediatrics I, University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), Faculty of Medicine, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), Faculty of Medicine, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), Faculty of Medicine, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), Faculty of Medicine, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), Faculty of Medicine, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Health and Nursing, Occupational Therapy, Ernst-Abbe-University of Applied Sciences Jena, 07745 Jena, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), Faculty of Medicine, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Centre for Translational Neuro- and Behavioural Sciences (C-TNBS), Faculty of Medicine, University of Duisburg-Essen, 45147 Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20220803',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Int J Environ Res Public Health',\n",
       "               'JT': 'International journal of environmental research and public health',\n",
       "               'JID': '101238455',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Female',\n",
       "                'Gestational Age',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature',\n",
       "                'Intensive Care Units, Neonatal',\n",
       "                'Male',\n",
       "                '*Music',\n",
       "                '*Music Therapy',\n",
       "                'Vital Signs'],\n",
       "               'PMC': 'PMC9368366',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['live music therapy',\n",
       "                'neonatal intensive care unit',\n",
       "                'physical contact',\n",
       "                'preterm infants',\n",
       "                'stabilisation',\n",
       "                'vital sign response'],\n",
       "               'COIS': ['The authors declare no conflict of interest.'],\n",
       "               'EDAT': '2022/08/13 06:00',\n",
       "               'MHDA': '2022/08/16 06:00',\n",
       "               'PMCR': ['2022/08/03'],\n",
       "               'CRDT': ['2022/08/12 01:08'],\n",
       "               'PHST': ['2022/06/22 00:00 [received]',\n",
       "                '2022/07/28 00:00 [revised]',\n",
       "                '2022/08/01 00:00 [accepted]',\n",
       "                '2022/08/12 01:08 [entrez]',\n",
       "                '2022/08/13 06:00 [pubmed]',\n",
       "                '2022/08/16 06:00 [medline]',\n",
       "                '2022/08/03 00:00 [pmc-release]'],\n",
       "               'AID': ['ijerph19159524 [pii]',\n",
       "                'ijerph-19-09524 [pii]',\n",
       "                '10.3390/ijerph19159524 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Int J Environ Res Public Health. 2022 Aug 3;19(15):9524. doi: 10.3390/ijerph19159524.'},\n",
       "              {'PMID': '35943742',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220811',\n",
       "               'LR': '20230421',\n",
       "               'IS': '2574-3805 (Electronic) 2574-3805 (Linking)',\n",
       "               'VI': '5',\n",
       "               'IP': '8',\n",
       "               'DP': '2022 Aug 1',\n",
       "               'TI': 'Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation.',\n",
       "               'PG': 'e2225810',\n",
       "               'LID': '10.1001/jamanetworkopen.2022.25810 [doi] e2225810',\n",
       "               'AB': \"IMPORTANCE: The inclusion of less invasive surfactant administration (LISA) in the care of preterm infants has been found to be beneficial for respiratory outcomes. Recently, the OPTIMIST trial found higher mortality rates in the subgroup of infants born at 25 to 26 weeks' gestational age (GA) who received surfactant treatment while spontaneously breathing. OBJECTIVE: To analyze outcomes among LISA-exposed, highly vulnerable babies born at less than 27 weeks' GA within the large-scale observational cohort of the German Neonatal Network. DESIGN, SETTING, AND PARTICIPANTS: In this cohort study of data from 68 tertiary level neonatal intensive care units in Germany of infants born between 22 weeks 0 days to 26 weeks 6 days of gestation between April 1, 2009, and December 31, 2020, short-term outcomes among infants receiving LISA vs infants not receiving LISA were compared. EXPOSURE: Use of LISA within the first 72 hours of life. MAIN OUTCOMES AND MEASURES: The main outcomes were rates of LISA use, use of mechanical ventilation within the first 72 hours (considered failure of LISA), and association of LISA with outcomes, including death from all causes, bronchopulmonary dysplasia (BPD), death and BPD combined, pneumothorax, retinopathy of prematurity, intracerebral hemorrhage, and periventricular leukomalacia. To address potential confounding factors, multivariate logistic regression models were used. RESULTS: A total of 6542 infants (3030 [46.3%] female and 3512 [53.7%] male; mean [SD] GA, 25.3 (1.1) weeks; mean [SD] birth weight, 715 [180] g) were analyzed; 2534 infants (38.7%) received LISA, which was most frequently given quasi-prophylactically during delivery room management. Among the infants who received LISA, 1357 (53.6%) did not require mechanical ventilation in the first 72 hours compared with 331 infants (8.3%) of 4008 who did not receive LISA. In a multivariate logistic regression model that adjusted for GA, small-for-GA status, sex, multiple birth, inborn status, antenatal steroid use, and maximum fraction of inspired oxygen in the first 12 hours of life, LISA was associated with reduced risks of all-cause death (odds ratio [OR], 0.74; 95% CI, 0.61-0.90; P = .002), BPD (OR, 0.69; 95% CI, 0.62-0.78; P < .001), and BPD or death (OR, 0.64; 95% CI, 0.57-0.72; P < .001) compared with infants without LISA exposure. CONCLUSIONS AND RELEVANCE: The results of this long-term multicenter cohort study suggest that LISA may be associated with reduced risks of adverse outcomes in extremely preterm infants.\",\n",
       "               'FAU': ['Hartel, Christoph',\n",
       "                'Herting, Egbert',\n",
       "                'Humberg, Alexander',\n",
       "                'Hanke, Kathrin',\n",
       "                'Mehler, Katrin',\n",
       "                'Keller, Titus',\n",
       "                'Mauer, Isabell',\n",
       "                'Frieauff, Eric',\n",
       "                'Meyer, Sascha',\n",
       "                'Thome, Ulrich H',\n",
       "                'Wieg, Christian',\n",
       "                'Schmidtke, Susanne',\n",
       "                'Kribs, Angela',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Hartel C',\n",
       "                'Herting E',\n",
       "                'Humberg A',\n",
       "                'Hanke K',\n",
       "                'Mehler K',\n",
       "                'Keller T',\n",
       "                'Mauer I',\n",
       "                'Frieauff E',\n",
       "                'Meyer S',\n",
       "                'Thome UH',\n",
       "                'Wieg C',\n",
       "                'Schmidtke S',\n",
       "                'Kribs A',\n",
       "                'Gopel W'],\n",
       "               'AD': ['Department of Paediatrics, University of Wurzburg, Wurzburg, Germany.',\n",
       "                'Department of Paediatrics, University Hospital Schleswig-Holstein/Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Paediatrics, University Hospital Schleswig-Holstein/Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Paediatrics, University Hospital Schleswig-Holstein/Campus Lubeck, Lubeck, Germany.',\n",
       "                'Division of Neonatology, Department of Paediatrics, University of Cologne, Cologne, Germany.',\n",
       "                'Division of Neonatology, Department of Paediatrics, University of Cologne, Cologne, Germany.',\n",
       "                'Department of Paediatrics, University of Wurzburg, Wurzburg, Germany.',\n",
       "                'Department of Paediatrics, University of Wurzburg, Wurzburg, Germany.',\n",
       "                \"Department of General Pediatrics and Neonatology, University Children's Hospital of Saarland, Homburg, Germany.\",\n",
       "                \"Division of Neonatology, Department of Women's and Children's Health, University Children's Hospital Leipzig, Leipzig, Germany.\",\n",
       "                \"Neonatology and Pediatric Intensive Care, Children's Hospital Aschaffenburg-Alzenau, Aschaffenburg, Germany.\",\n",
       "                'Division of Neonatology, Asklepios Hospital Hamburg-Barmbek, Hamburg, Germany.',\n",
       "                'Division of Neonatology, Department of Paediatrics, University of Cologne, Cologne, Germany.',\n",
       "                'Department of Paediatrics, University Hospital Schleswig-Holstein/Campus Lubeck, Lubeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Multicenter Study',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20220801',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'JAMA Netw Open',\n",
       "               'JT': 'JAMA network open',\n",
       "               'JID': '101729235',\n",
       "               'RN': ['0 (Pulmonary Surfactants)',\n",
       "                '0 (Surface-Active Agents)'],\n",
       "               'SB': 'IM',\n",
       "               'EIN': ['JAMA Netw Open. 2023 Apr 3;6(4):e2312619. doi:',\n",
       "                '10.1001/jamanetworkopen.2023.12619. PMID: 37083673'],\n",
       "               'MH': ['*Bronchopulmonary Dysplasia/epidemiology',\n",
       "                'Cohort Studies',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Extremely Premature',\n",
       "                'Infant, Newborn',\n",
       "                'Male',\n",
       "                'Pregnancy',\n",
       "                '*Pulmonary Surfactants/therapeutic use',\n",
       "                'Surface-Active Agents/therapeutic use'],\n",
       "               'PMC': 'PMC9364126',\n",
       "               'COIS': ['Conflict of Interest Disclosures: Dr Hartel reported receiving grants from the',\n",
       "                'Bundesministerium fur Bildung und Forschung (BMBF), Chiesi, and the Deutsche',\n",
       "                'Forschungs Gemeinschaft (DFG) during the conduct of the study. Dr Herting',\n",
       "                'reported receiving grants, personal fees, travel support, and speaker honoraria',\n",
       "                'from Chiesi during the conduct of the study; receiving support for other',\n",
       "                'surfactant studies from Chiesi; receiving personal fees and speaker honoraria',\n",
       "                'from Pfizer, Merck Sharp and Dohme, Sanofi, and AstraZeneca outside the submitted',\n",
       "                'work; holding a patent with Chiesi for less invasive surfactant therapy; and',\n",
       "                'having membership on a board of the DFG. Dr Hanke reported receiving nonfinancial',\n",
       "                'support for travel from Chiesi outside the submitted work. Dr Thome reported',\n",
       "                'receiving travel grants from Chiesi and Pfizer outside the submitted work. Dr',\n",
       "                'Kribs reported receiving grants from the BMBF during the conduct of the study and',\n",
       "                'personal fees from Chiesi outside the submitted work. Dr Gopel reported receiving',\n",
       "                'grants from the BMBF during the conduct of the study and personal fees from',\n",
       "                'Chiesi and Abbott outside the submitted work. No other disclosures were reported.'],\n",
       "               'FIR': ['Faust, Kirstin',\n",
       "                'Muller, Dirk',\n",
       "                'Gebauer, Corinna',\n",
       "                'Guthmann, Florian',\n",
       "                'von der Wense, Axel',\n",
       "                'Stangl, Oliver',\n",
       "                'Weller, Ursula',\n",
       "                'Hohn, Thomas',\n",
       "                'Olbertz, Dirk',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Rossi, Rainer',\n",
       "                'Teig, Norbert',\n",
       "                'Heitmann, Friedhelm',\n",
       "                'Heckmann, Matthias',\n",
       "                'Laux, Reinhard',\n",
       "                'Bohnhorst, Bettina',\n",
       "                'Roth, Bernd',\n",
       "                'Vochem, Matthias',\n",
       "                'Keller-Wackerbauer, Annette',\n",
       "                'Moller, Jens',\n",
       "                'Eichhorn, Joachim',\n",
       "                'Wintgens, Jurgen',\n",
       "                'Bottger, Ralf',\n",
       "                'Reese, Jochen',\n",
       "                'Hubert, Mechthild',\n",
       "                'Dordelmann, Michael',\n",
       "                'Hillebrand, Georg',\n",
       "                'Roll, Claudia',\n",
       "                'Jensen, Reinhard',\n",
       "                'Rudiger, Mario',\n",
       "                'Werner, Claudius',\n",
       "                'Longardt, Ann Carolin',\n",
       "                'Schafer, Stefan',\n",
       "                'Schaible, Thomas',\n",
       "                'Franz, Axel',\n",
       "                'Heldmann, Michael',\n",
       "                'Kunzmann, Steffen',\n",
       "                'Schmidt, Esther',\n",
       "                'Orlikowsky, Thorsten',\n",
       "                'Gerleve, Hubert',\n",
       "                'Depping, Nico',\n",
       "                'Haase, Roland',\n",
       "                'Hoppenz, Marc',\n",
       "                'Seeliger, Stephan',\n",
       "                'Kuster, Helmut',\n",
       "                'Fuchs, Hans',\n",
       "                'Korner, Thorsten',\n",
       "                'Brune, Thomas',\n",
       "                'Muller, Andreas',\n",
       "                'Urlichs, Florian',\n",
       "                'Berghauser, Martin',\n",
       "                'Proquitte, Hans',\n",
       "                'Morhart, Patrick',\n",
       "                'Lindner, Wolfgang',\n",
       "                'Schlosser, Rolf',\n",
       "                'Schneider, Welfhard',\n",
       "                'Schroth, Michael',\n",
       "                'Rieger-Fackeldey, Esther',\n",
       "                'Dohle, Frank',\n",
       "                'Sinnecker, Gernot',\n",
       "                'Volkl, Thomas',\n",
       "                'Brevis Nunez, Francisco',\n",
       "                'Welsch, Michael',\n",
       "                'Kruger, Marcus'],\n",
       "               'IR': ['Faust K',\n",
       "                'Muller D',\n",
       "                'Gebauer C',\n",
       "                'Guthmann F',\n",
       "                'von der Wense A',\n",
       "                'Stangl O',\n",
       "                'Weller U',\n",
       "                'Hohn T',\n",
       "                'Olbertz D',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Rossi R',\n",
       "                'Teig N',\n",
       "                'Heitmann F',\n",
       "                'Heckmann M',\n",
       "                'Laux R',\n",
       "                'Bohnhorst B',\n",
       "                'Roth B',\n",
       "                'Vochem M',\n",
       "                'Keller-Wackerbauer A',\n",
       "                'Moller J',\n",
       "                'Eichhorn J',\n",
       "                'Wintgens J',\n",
       "                'Bottger R',\n",
       "                'Reese J',\n",
       "                'Hubert M',\n",
       "                'Dordelmann M',\n",
       "                'Hillebrand G',\n",
       "                'Roll C',\n",
       "                'Jensen R',\n",
       "                'Rudiger M',\n",
       "                'Werner C',\n",
       "                'Longardt AC',\n",
       "                'Schafer S',\n",
       "                'Schaible T',\n",
       "                'Franz A',\n",
       "                'Heldmann M',\n",
       "                'Kunzmann S',\n",
       "                'Schmidt E',\n",
       "                'Orlikowsky T',\n",
       "                'Gerleve H',\n",
       "                'Depping N',\n",
       "                'Haase R',\n",
       "                'Hoppenz M',\n",
       "                'Seeliger S',\n",
       "                'Kuster H',\n",
       "                'Fuchs H',\n",
       "                'Korner T',\n",
       "                'Brune T',\n",
       "                'Muller A',\n",
       "                'Urlichs F',\n",
       "                'Berghauser M',\n",
       "                'Proquitte H',\n",
       "                'Morhart P',\n",
       "                'Lindner W',\n",
       "                'Schlosser R',\n",
       "                'Schneider W',\n",
       "                'Schroth M',\n",
       "                'Rieger-Fackeldey E',\n",
       "                'Dohle F',\n",
       "                'Sinnecker G',\n",
       "                'Volkl T',\n",
       "                'Brevis Nunez F',\n",
       "                'Welsch M',\n",
       "                'Kruger M'],\n",
       "               'EDAT': '2022/08/10 06:00',\n",
       "               'MHDA': '2022/08/12 06:00',\n",
       "               'PMCR': ['2022/08/09'],\n",
       "               'CRDT': ['2022/08/09 11:33'],\n",
       "               'PHST': ['2022/08/09 11:33 [entrez]',\n",
       "                '2022/08/10 06:00 [pubmed]',\n",
       "                '2022/08/12 06:00 [medline]',\n",
       "                '2022/08/09 00:00 [pmc-release]'],\n",
       "               'AID': ['2794980 [pii]',\n",
       "                'zoi220730 [pii]',\n",
       "                '10.1001/jamanetworkopen.2022.25810 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'JAMA Netw Open. 2022 Aug 1;5(8):e2225810. doi: 10.1001/jamanetworkopen.2022.25810.'},\n",
       "              {'PMID': '35923779',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20240901',\n",
       "               'IS': '2296-2360 (Print) 2296-2360 (Electronic) 2296-2360 (Linking)',\n",
       "               'VI': '10',\n",
       "               'DP': '2022',\n",
       "               'TI': 'Prevalence of osteopathologies in a single center cohort of survivors of childhood primary brain tumor.',\n",
       "               'PG': '913343',\n",
       "               'LID': '10.3389/fped.2022.913343 [doi] 913343',\n",
       "               'AB': 'BACKGROUND: Childhood primary brain tumors (CPBT) are the second largest group of childhood malignancies and associated with a high risk for endocrine late effects. OBJECTIVE: To assess endocrine late effects and their relevance for the development of osteopathologies in survivors. METHODS: This single center cross sectional study investigated data from 102 CPBT survivors with a mean age of 13.0 years and a mean age at diagnosis of 8.7 years. Clinical, biochemical, radiographic, and anamnestic data regarding endocrine and bone health were obtained at study visits. In addition, data regarding tumor stage and therapy was obtained by chart review. An expert opinion was applied to define presence of osteopathologies. RESULTS: Impaired bone health, defined by at least one pathological screening parameter, was present in 65% of patients. 27.5% were found to have overt osteopathologies per expert opinion. 37.8% displayed a severe vitamin D deficiency (25-OH vitamin D < 10 ng/ml) and 11% a secondary hyperparathyroidism. Patients with osteopathologies had lower 25-OH vitamin D levels compared to patients without osteopathologies. Multiple endocrine late effects were present: diabetes insipidus in 10.8%, aberrant pubertal development in 13.7%, central hypocortisolism in 14.9%, thyroid dysfunction in 23.8% and growth hormone deficiency in 21.8%. A total of 31.3% of survivors displayed any endocrinopathy. Tumors located near hypothalamic structures and patients who received irradiation had a higher likelihood of endocrine morbidity. CONCLUSION: This study indicates that endocrine deficiencies are common in pediatric survivors of CPBTs. Osteopathologies are present in this cohort. A prominent effect of hormonal deficiencies on bone health was not detected, possibly because patients were sufficiently treate for their endocrine conditions or indicating resilience of the childhood bone remodeling process. Vitamin D deficiency is frequent and should be treated as recommended.',\n",
       "               'CI': ['Copyright (c) 2022 Schundeln, Fritzemeier, Goretzki, Hauffa, Munteanu, Kiewert,',\n",
       "                'Hauffa, Fleischhack, Tippelt and Grasemann.'],\n",
       "               'FAU': ['Schundeln, Michael M',\n",
       "                'Fritzemeier, Sebastian',\n",
       "                'Goretzki, Sarah C',\n",
       "                'Hauffa, Pia K',\n",
       "                'Munteanu, Martin',\n",
       "                'Kiewert, Cordula',\n",
       "                'Hauffa, Berthold P',\n",
       "                'Fleischhack, Gudrun',\n",
       "                'Tippelt, Stephan',\n",
       "                'Grasemann, Corinna'],\n",
       "               'AU': ['Schundeln MM',\n",
       "                'Fritzemeier S',\n",
       "                'Goretzki SC',\n",
       "                'Hauffa PK',\n",
       "                'Munteanu M',\n",
       "                'Kiewert C',\n",
       "                'Hauffa BP',\n",
       "                'Fleischhack G',\n",
       "                'Tippelt S',\n",
       "                'Grasemann C'],\n",
       "               'AD': ['Pediatric Hematology and Oncology, Department of Pediatrics III, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Pediatric Hematology and Oncology, Department of Pediatrics III, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Pediatric Hematology and Oncology, Department of Pediatrics III, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Pediatric Hematology and Oncology, Department of Pediatrics III, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Pediatric Endocrinology and Diabetology, Department of Pediatrics II, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatric Endocrinology and Diabetology, Caritas Hospital, Bad Mergentheim, Germany.',\n",
       "                'Pediatric Endocrinology and Diabetology, Department of Pediatrics II, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Pediatric Endocrinology and Diabetology, Department of Pediatrics II, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Pediatric Hematology and Oncology, Department of Pediatrics III, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Pediatric Hematology and Oncology, Department of Pediatrics III, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics, Division of Rare Diseases, St. Josef-Hospital Bochum, Ruhr-University Bochum, Bochum, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20220718',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Pediatr',\n",
       "               'JT': 'Frontiers in pediatrics',\n",
       "               'JID': '101615492',\n",
       "               'PMC': 'PMC9339690',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['bone health',\n",
       "                'childhood malignancies',\n",
       "                'childhood primary brain tumors',\n",
       "                'osteopathologies',\n",
       "                'survivorship',\n",
       "                'vitamin D'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2022/08/05 06:00',\n",
       "               'MHDA': '2022/08/05 06:01',\n",
       "               'PMCR': ['2022/07/18'],\n",
       "               'CRDT': ['2022/08/04 02:24'],\n",
       "               'PHST': ['2022/04/05 00:00 [received]',\n",
       "                '2022/06/27 00:00 [accepted]',\n",
       "                '2022/08/04 02:24 [entrez]',\n",
       "                '2022/08/05 06:00 [pubmed]',\n",
       "                '2022/08/05 06:01 [medline]',\n",
       "                '2022/07/18 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fped.2022.913343 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Pediatr. 2022 Jul 18;10:913343. doi: 10.3389/fped.2022.913343. eCollection 2022.'},\n",
       "              {'PMID': '35705089',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220617',\n",
       "               'LR': '20220617',\n",
       "               'IS': '1438-9592 (Electronic) 0044-409X (Linking)',\n",
       "               'VI': '147',\n",
       "               'IP': '3',\n",
       "               'DP': '2022 Jun',\n",
       "               'TI': '[Differentiated Strategies for the Therapy of Liver Metastases in Gastro-entero-pancreatic Neuroendocrine Neoplasia].',\n",
       "               'PG': '270-280',\n",
       "               'LID': '10.1055/a-1830-8442 [doi]',\n",
       "               'AB': 'Neuroendocrine neoplasias comprise a heterogenous group of malignant tumours, mostly arising from the gastro-entero-pancreatic system (GEP). Most of these tumours develop from the small intestine and pancreas and the liver is the predominant site for distant metastases. Patients may be asymptomatic for a long time and liver metastases are frequently diagnosed by chance or during operations for bowel obstruction, for example, during emergency surgery. The only curative therapy consists in complete removal of primary and metastases. In case of metastatic disease, various treatment modalities need to be discussed in interdisciplinary tumour boards comprised of specialists from gastroenterology, (liver-)surgery, radiology, nuclear medicine, radiotherapy, pathology and endocrinology. By combining different therapies, even patients with progressive disease may reach long-term overall survival with good quality of life. The most important factors for decisions on therapy are individual factors like tumour grading, hormonal functionality, type of metastases and evolution of the disease. Adequate treatment of liver metastases comprises various surgical strategies as well as locally ablative radiological interventions and nuclear medical therapies, in complement to systemic treatments.',\n",
       "               'CI': ['Thieme. All rights reserved.'],\n",
       "               'FAU': ['Mogl, Martina T',\n",
       "                'Ollinger, Robert',\n",
       "                'Jann, Henning',\n",
       "                'Gebauer, Bernhard',\n",
       "                'Fehrenbach, Uli',\n",
       "                'Amthauer, Holger',\n",
       "                'Wetz, Christoph',\n",
       "                'Schmelzle, Moritz',\n",
       "                'Raschzok, Nathanael',\n",
       "                'Krenzien, Felix',\n",
       "                'Goretzki, Peter E',\n",
       "                'Pratschke, Johann',\n",
       "                'Schoening, Wenzel'],\n",
       "               'AU': ['Mogl MT',\n",
       "                'Ollinger R',\n",
       "                'Jann H',\n",
       "                'Gebauer B',\n",
       "                'Fehrenbach U',\n",
       "                'Amthauer H',\n",
       "                'Wetz C',\n",
       "                'Schmelzle M',\n",
       "                'Raschzok N',\n",
       "                'Krenzien F',\n",
       "                'Goretzki PE',\n",
       "                'Pratschke J',\n",
       "                'Schoening W'],\n",
       "               'AUID': ['ORCID: 0000-0002-3676-047X'],\n",
       "               'AD': ['Chirurgische Klinik Campus Charite Mitte | Campus Virchow-Klinikum, Charite Universitatsmedizin Berlin, Berlin, Deutschland.',\n",
       "                'Europaisches Metastasenzentrum Charite, Charite Universitatsmedizin-Berlin, Berlin, Deutschland.',\n",
       "                'Chirurgische Klinik Campus Charite Mitte | Campus Virchow-Klinikum, Charite Universitatsmedizin Berlin, Berlin, Deutschland.',\n",
       "                'Medizinische Klinik fur Hepatologie und Gastroenterologie, Charite Universitatsmedizin Berlin, Berlin, Deutschland.',\n",
       "                'Klinik fur Radiologie, Charite Universitatsmedizin Berlin, Berlin, Deutschland.',\n",
       "                'Klinik fur Radiologie, Charite Universitatsmedizin Berlin, Berlin, Deutschland.',\n",
       "                'Klinik fur Nuklearmedizin, Charite Universitatsmedizin Berlin, Berlin, Deutschland.',\n",
       "                'Klinik fur Nuklearmedizin, Charite Universitatsmedizin Berlin, Berlin, Deutschland.',\n",
       "                'Chirurgische Klinik Campus Charite Mitte | Campus Virchow-Klinikum, Charite Universitatsmedizin Berlin, Berlin, Deutschland.',\n",
       "                'Chirurgische Klinik Campus Charite Mitte | Campus Virchow-Klinikum, Charite Universitatsmedizin Berlin, Berlin, Deutschland.',\n",
       "                'Chirurgische Klinik Campus Charite Mitte | Campus Virchow-Klinikum, Charite Universitatsmedizin Berlin, Berlin, Deutschland.',\n",
       "                'Chirurgische Klinik Campus Charite Mitte | Campus Virchow-Klinikum, Charite Universitatsmedizin Berlin, Berlin, Deutschland.',\n",
       "                'Chirurgische Klinik Campus Charite Mitte | Campus Virchow-Klinikum, Charite Universitatsmedizin Berlin, Berlin, Deutschland.',\n",
       "                'Chirurgische Klinik Campus Charite Mitte | Campus Virchow-Klinikum, Charite Universitatsmedizin Berlin, Berlin, Deutschland.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'TT': 'Differenzierte Therapiestrategie bei Lebermetastasen gastro-entero-pankreatischer Neuroendokriner Neoplasien.',\n",
       "               'DEP': '20220615',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Zentralbl Chir',\n",
       "               'JT': 'Zentralblatt fur Chirurgie',\n",
       "               'JID': '0413645',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*Liver Neoplasms/secondary/surgery',\n",
       "                '*Neuroendocrine Tumors/diagnosis/surgery',\n",
       "                'Pancreas/pathology',\n",
       "                '*Pancreatic Neoplasms/diagnosis/surgery',\n",
       "                'Quality of Life'],\n",
       "               'COIS': ['Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht.'],\n",
       "               'EDAT': '2022/06/16 06:00',\n",
       "               'MHDA': '2022/06/18 06:00',\n",
       "               'CRDT': ['2022/06/15 18:42'],\n",
       "               'PHST': ['2022/06/15 18:42 [entrez]',\n",
       "                '2022/06/16 06:00 [pubmed]',\n",
       "                '2022/06/18 06:00 [medline]'],\n",
       "               'AID': ['10.1055/a-1830-8442 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Zentralbl Chir. 2022 Jun;147(3):270-280. doi: 10.1055/a-1830-8442. Epub 2022 Jun 15.'},\n",
       "              {'PMID': '35666427',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220928',\n",
       "               'LR': '20221122',\n",
       "               'IS': '1874-270X (Electronic) 1874-2718 (Print) 1874-270X (Linking)',\n",
       "               'VI': '16',\n",
       "               'IP': '2',\n",
       "               'DP': '2022 Oct',\n",
       "               'TI': 'Extent of intrinsic disorder and NMR chemical shift assignments of the distal N-termini from human TRPV1, TRPV2 and TRPV3 ion channels.',\n",
       "               'PG': '289-296',\n",
       "               'LID': '10.1007/s12104-022-10093-4 [doi]',\n",
       "               'AB': 'The mammalian Transient Receptor Potential Vanilloid (TRPV) channels are a family of six tetrameric ion channels localized at the plasma membrane. The group I members of the family, TRPV1 through TRPV4, are heat-activated and exhibit remarkable polymodality. The distal N-termini of group I TRPV channels contain large intrinsically disordered regions (IDRs), ranging from ~ 75 amino acids (TRPV2) to ~ 150 amino acids (TRPV4), the vast majority of which is invisible in the structural models published so far. These IDRs provide important binding sites for cytosolic partners, and their deletion is detrimental to channel activity and regulation. Recently, we reported the NMR backbone assignments of the distal TRPV4 N-terminus and noticed some discrepancies between the extent of disorder predicted solely based on protein sequence and from experimentally determined chemical shifts. Thus, for an analysis of the extent of disorder in the distal N-termini of all group I TRPV channels, we now report the NMR assignments for the human TRPV1, TRPV2 and TRPV3 IDRs.',\n",
       "               'CI': ['(c) 2022. The Author(s).'],\n",
       "               'FAU': ['Wiedemann, Christoph',\n",
       "                'Goretzki, Benedikt',\n",
       "                'Merz, Zoe N',\n",
       "                'Tebbe, Frederike',\n",
       "                'Schmitt, Pauline',\n",
       "                'Hellmich, Ute A'],\n",
       "               'AU': ['Wiedemann C',\n",
       "                'Goretzki B',\n",
       "                'Merz ZN',\n",
       "                'Tebbe F',\n",
       "                'Schmitt P',\n",
       "                'Hellmich UA'],\n",
       "               'AUID': ['ORCID: 0000-0003-4351-8857',\n",
       "                'ORCID: 0000-0002-7721-6657',\n",
       "                'ORCID: 0000-0001-6517-4915',\n",
       "                'ORCID: 0000-0003-4177-1672',\n",
       "                'ORCID: 0000-0001-7162-285X'],\n",
       "               'AD': ['Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, Humboldtstrasse 10, 07743, Jena, Germany.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, Humboldtstrasse 10, 07743, Jena, Germany.',\n",
       "                'Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe University, Max von Laue Str. 9, 60438, Frankfurt, Germany.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, Humboldtstrasse 10, 07743, Jena, Germany.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, Humboldtstrasse 10, 07743, Jena, Germany.',\n",
       "                'Department of Chemistry, Division Biochemistry, Johannes-Gutenberg-University Mainz, Johann-Joachim Becher-Weg 30, 55128, Mainz, Germany.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, Humboldtstrasse 10, 07743, Jena, Germany. ute.hellmich@uni-jena.de.',\n",
       "                'Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe University, Max von Laue Str. 9, 60438, Frankfurt, Germany. ute.hellmich@uni-jena.de.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20220606',\n",
       "               'PL': 'Netherlands',\n",
       "               'TA': 'Biomol NMR Assign',\n",
       "               'JT': 'Biomolecular NMR assignments',\n",
       "               'JID': '101472371',\n",
       "               'RN': ['0 (Amino Acids)',\n",
       "                '0 (TRPV Cation Channels)',\n",
       "                '0 (TRPV1 protein, human)',\n",
       "                '0 (TRPV2 protein, human)',\n",
       "                '0 (TRPV3 protein, human)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Amino Acid Sequence',\n",
       "                'Amino Acids',\n",
       "                'Animals',\n",
       "                '*Hot Temperature',\n",
       "                'Humans',\n",
       "                'Mammals/metabolism',\n",
       "                'Nuclear Magnetic Resonance, Biomolecular',\n",
       "                '*TRPV Cation Channels/chemistry/metabolism'],\n",
       "               'PMC': 'PMC9510099',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Intrinsically disordered protein',\n",
       "                'Ion channel',\n",
       "                'Regulatory domain',\n",
       "                'Structural dynamics',\n",
       "                'TRP vanilloid',\n",
       "                'Transient receptor potential'],\n",
       "               'COIS': ['The authors declare that they have no conflict of interest.'],\n",
       "               'EDAT': '2022/06/07 06:00',\n",
       "               'MHDA': '2022/09/28 06:00',\n",
       "               'PMCR': ['2022/06/06'],\n",
       "               'CRDT': ['2022/06/06 15:36'],\n",
       "               'PHST': ['2022/03/21 00:00 [received]',\n",
       "                '2022/05/12 00:00 [accepted]',\n",
       "                '2022/06/07 06:00 [pubmed]',\n",
       "                '2022/09/28 06:00 [medline]',\n",
       "                '2022/06/06 15:36 [entrez]',\n",
       "                '2022/06/06 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s12104-022-10093-4 [pii]',\n",
       "                '10093 [pii]',\n",
       "                '10.1007/s12104-022-10093-4 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Biomol NMR Assign. 2022 Oct;16(2):289-296. doi: 10.1007/s12104-022-10093-4. Epub 2022 Jun 6.'},\n",
       "              {'PMID': '35534988',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220802',\n",
       "               'LR': '20220829',\n",
       "               'IS': '1098-4275 (Electronic) 0031-4005 (Linking)',\n",
       "               'VI': '150',\n",
       "               'IP': '2',\n",
       "               'DP': '2022 Aug 1',\n",
       "               'TI': 'Pediatric ICU Admissions After Adolescent Suicide Attempts During the Pandemic.',\n",
       "               'LID': 'e2021055973 [pii] 10.1542/peds.2021-055973 [doi]',\n",
       "               'AB': \"BACKGROUND AND OBJECTIVES: The worldwide severe acute respiratory syndrome coronavirus 2 pandemic challenges adolescents' mental health. In this study, we aim to compare the number of pediatric ICU (PICU) admissions after suicide attempts during the first German lockdown and one year later during a second, prolonged lockdown with prepandemic years. METHODS: A retrospective multicenter study was conducted among 27 German PICUs. Cases <18 years admitted to the PICU because of accidents or injuries between March 16 and May 31 of 2017 to 2021 were identified based on International Classification of Diseases, 10th Revision codes (German modification) and patient data entered into a database. This study is a subset analysis on suicide attempts in adolescents aged 12 to 17.9 years. The Federal Statistics Office was queried for data on fatal suicides, which were available only for 2020 in adolescents aged 10 to 17.9 years. RESULTS: Total admissions and suicide attempts declined during the first lockdown in 2020 (standardized morbidity ratio 0.74 (95% confidence interval; 0.58-0.92) and 0.69 (0.43-1.04), respectively) and increased in 2021 (standardized morbidity ratio 2.14 [1.86-2.45] and 2.84 [2.29-3.49], respectively). Fatal suicide rates remained stable between 2017 to 2019 and 2020 (1.57 vs 1.48 per 100 000 adolescent years) with monthly numbers showing no clear trend during the course of 2020. CONCLUSIONS: This study shows a strong increase in serious suicide attempts among adolescents during the course of the pandemic in Germany. More research is needed to understand the relation between pandemic prevention measures and suicidal ideation to help implement mental health support for adolescents.\",\n",
       "               'CI': ['Copyright (c) 2022 by the American Academy of Pediatrics.'],\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Willemsen, Lea',\n",
       "                'Stang, Andreas',\n",
       "                'Kowall, Bernd',\n",
       "                'Holtkamp, Katharina',\n",
       "                'Kamp, Oliver',\n",
       "                'Dudda, Marcel',\n",
       "                'Hey, Florian',\n",
       "                'Hoffmann, Florian',\n",
       "                'Blankenburg, Judith',\n",
       "                'Eifinger, Frank',\n",
       "                'Fuchs, Hans',\n",
       "                'Haase, Roland',\n",
       "                'Baier, Jan',\n",
       "                'Andree, Clemens',\n",
       "                'Heldmann, Michael',\n",
       "                'Maldera, Vanessa',\n",
       "                'Potratz, Jenny',\n",
       "                'Kurz, Daniel',\n",
       "                'Mand, Nadine',\n",
       "                'Doerfel, Claus',\n",
       "                'Rothoeft, Tobias',\n",
       "                'Schultz, Michel',\n",
       "                'Ohlert, Manuel',\n",
       "                'Silkenbaumer, Katrin',\n",
       "                'Boesing, Thomas',\n",
       "                'Indraswari, Fithri',\n",
       "                'Niemann, Frank',\n",
       "                'Jahn, Peter',\n",
       "                'Merker, Michael',\n",
       "                'Braun, Nicole',\n",
       "                'Nunez, Francisco Brevis',\n",
       "                'Engler, Matthias',\n",
       "                'Heimann, Konrad',\n",
       "                'Brasche, Milian',\n",
       "                'Wolf, Gerhard',\n",
       "                'Freymann, Holger',\n",
       "                'Dercks, Martin',\n",
       "                'Hoppenz, Marc',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Willemsen L',\n",
       "                'Stang A',\n",
       "                'Kowall B',\n",
       "                'Holtkamp K',\n",
       "                'Kamp O',\n",
       "                'Dudda M',\n",
       "                'Hey F',\n",
       "                'Hoffmann F',\n",
       "                'Blankenburg J',\n",
       "                'Eifinger F',\n",
       "                'Fuchs H',\n",
       "                'Haase R',\n",
       "                'Baier J',\n",
       "                'Andree C',\n",
       "                'Heldmann M',\n",
       "                'Maldera V',\n",
       "                'Potratz J',\n",
       "                'Kurz D',\n",
       "                'Mand N',\n",
       "                'Doerfel C',\n",
       "                'Rothoeft T',\n",
       "                'Schultz M',\n",
       "                'Ohlert M',\n",
       "                'Silkenbaumer K',\n",
       "                'Boesing T',\n",
       "                'Indraswari F',\n",
       "                'Niemann F',\n",
       "                'Jahn P',\n",
       "                'Merker M',\n",
       "                'Braun N',\n",
       "                'Nunez FB',\n",
       "                'Engler M',\n",
       "                'Heimann K',\n",
       "                'Brasche M',\n",
       "                'Wolf G',\n",
       "                'Freymann H',\n",
       "                'Dercks M',\n",
       "                'Hoppenz M',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dohna-Schwake C'],\n",
       "               'AD': ['Department of Pediatrics I, Pediatric Intensive Care Medicine.',\n",
       "                'Department of Pediatrics I, Pediatric Intensive Care Medicine.',\n",
       "                'Institute of Medical Informatics, Biometry and Epidemiology.',\n",
       "                'Institute of Medical Informatics, Biometry and Epidemiology.',\n",
       "                'Department of Pediatrics I, Pediatric Intensive Care Medicine.',\n",
       "                'Department of Trauma, Hand and Reconstructive Surgery, University Medicine Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Trauma, Hand and Reconstructive Surgery, University Medicine Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                \"Pediatric Clinic and Pediatric Polyclinic at the Dr. von Haunerschen Children's Hospital, Interdisciplinary pediatric ICU - Pediatric Emergency Medicine, LMU Munich, Munich, Germany.\",\n",
       "                \"Pediatric Clinic and Pediatric Polyclinic at the Dr. von Haunerschen Children's Hospital, Interdisciplinary pediatric ICU - Pediatric Emergency Medicine, LMU Munich, Munich, Germany.\",\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital Dresden, University of Technology Dresden, Dresden, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital Freiburg, University of Freiburg, Freiburg, Germany.',\n",
       "                'Department of Pediatrics, Neonatology and Pediatric Intensive Care Medicine, University Hospital Halle, University of Halle, Halle, Germany.',\n",
       "                'Department of Pediatrics, Neonatology and Pediatric Intensive Care Medicine, University Hospital Halle, University of Halle, Halle, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Helios Hospital Krefeld, Krefeld, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Helios University Hospital Wuppertal, Wuppertal, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Helios University Hospital Wuppertal, Wuppertal, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital, Munster, Munster, Germany.',\n",
       "                'Department of Pediatrics 3, Pediatric Cardiology, Pediatric Intensive Care Medicine, Olgahospital Stuttgart, Stuttgart, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital Marburg, Philipps University of Marburg, Marburg, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital Jena, University of Jena, Jena, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Catholic Hospital Bochum, Ruhr-University of Bochum, Bochum, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Catholic Hospital Bochum, Ruhr-University of Bochum, Bochum, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Community Hospital Koblenz, Koblenz, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Protestant Hospital Bethel, University of Bielefeld, Bielefeld, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Protestant Hospital Bethel, University of Bielefeld, Bielefeld, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Hospital Fulda, Fulda, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Bergmannsheil and Pediatric Hospital Buer, Gelsenkirchen, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Hospital Leverkusen gGmbH, Leverkusen, Germany.',\n",
       "                'Department for Children and Adolescents, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.',\n",
       "                'Clinic of Pediatric Surgery, Klinikum Ernst von Bergmann, Potsdam, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Sana Hospitals Duisburg, Duisburg, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Sana Hospital Offenbach, Offenbach, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Hospital of Traunstein, Southeast Bavaria Hospitals, Traunstein, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Florence Nightingale Hospital, Dusseldorf, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Clemenshospital Munster, Munster, Germany.',\n",
       "                \"Department of Pediatrics, Pediatric Intensive Care Medicine, Cologne Hospitals, Children's Hospital Amsterdamer Str., Cologne, Germany.\",\n",
       "                'Department of Pediatrics I, Pediatric Intensive Care Medicine.',\n",
       "                'Department of Pediatrics I, Pediatric Intensive Care Medicine.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Multicenter Study',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Pediatrics',\n",
       "               'JT': 'Pediatrics',\n",
       "               'JID': '0376422',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                '*COVID-19/epidemiology',\n",
       "                'Child',\n",
       "                'Communicable Disease Control',\n",
       "                'Humans',\n",
       "                'Intensive Care Units, Pediatric',\n",
       "                'Pandemics',\n",
       "                'Suicidal Ideation',\n",
       "                '*Suicide, Attempted'],\n",
       "               'EDAT': '2022/05/11 06:00',\n",
       "               'MHDA': '2022/08/03 06:00',\n",
       "               'CRDT': ['2022/05/10 01:09'],\n",
       "               'PHST': ['2022/05/04 00:00 [accepted]',\n",
       "                '2022/05/11 06:00 [pubmed]',\n",
       "                '2022/08/03 06:00 [medline]',\n",
       "                '2022/05/10 01:09 [entrez]'],\n",
       "               'AID': ['187005 [pii]', '10.1542/peds.2021-055973 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Pediatrics. 2022 Aug 1;150(2):e2021055973. doi: 10.1542/peds.2021-055973.'},\n",
       "              {'PMID': '35451798',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220928',\n",
       "               'LR': '20221122',\n",
       "               'IS': '1874-270X (Electronic) 1874-2718 (Print) 1874-270X (Linking)',\n",
       "               'VI': '16',\n",
       "               'IP': '2',\n",
       "               'DP': '2022 Oct',\n",
       "               'TI': 'Backbone NMR assignments of the extensive human and chicken TRPV4 N-terminal intrinsically disordered regions as important players in ion channel regulation.',\n",
       "               'PG': '205-212',\n",
       "               'LID': '10.1007/s12104-022-10080-9 [doi]',\n",
       "               'AB': 'Transient receptor potential (TRP) channels are important pharmacological targets due to their ability to act as sensory transducers on the organismic and cellular level, as polymodal signal integrators and because of their role in numerous diseases. However, a detailed molecular understanding of the structural dynamics of TRP channels and their integration into larger cellular signalling networks remains challenging, in part due to the systematic absence of highly dynamic regions pivotal for channel regulation from available structures. In human TRP vanilloid 4 (TRPV4), a ubiquitously expressed homotetrameric cation channel involved in temperature, osmo- and mechano-sensation and in a multitude of (patho)physiological processes, the intrinsically disordered N-terminus encompasses 150 amino acids and thus represents > 17% of the entire channel sequence. Its deletion renders the channel significantly less excitable to agonists supporting a crucial role in TRPV4 activation and regulation. For a structural understanding and a comparison of its properties across species, we determined the NMR backbone assignments of the human and chicken TRPV4 N-terminal IDRs.',\n",
       "               'CI': ['(c) 2022. The Author(s).'],\n",
       "               'FAU': ['Goretzki, Benedikt',\n",
       "                'Tebbe, Frederike',\n",
       "                'Mitrovic, Sarah-Ana',\n",
       "                'Hellmich, Ute A'],\n",
       "               'AU': ['Goretzki B', 'Tebbe F', 'Mitrovic SA', 'Hellmich UA'],\n",
       "               'AD': ['Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry and Cluster of Excellence \"Balance of the Microverse\", Friedrich Schiller University Jena, Humboldtstrasse 10, 07443, Jena, Germany.',\n",
       "                'Center for Biomolecular Magnetic Resonance, Goethe-University, Max-von-Laue-Strasse 9, 60438, Frankfurt, Germany.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry and Cluster of Excellence \"Balance of the Microverse\", Friedrich Schiller University Jena, Humboldtstrasse 10, 07443, Jena, Germany.',\n",
       "                'Department of Chemistry, Division Biochemistry, Johannes-Gutenberg-University Mainz, Johann-Joachim Becher-Weg 30, 55128, Mainz, Germany.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry and Cluster of Excellence \"Balance of the Microverse\", Friedrich Schiller University Jena, Humboldtstrasse 10, 07443, Jena, Germany. ute.hellmich@uni-jena.de.',\n",
       "                'Center for Biomolecular Magnetic Resonance, Goethe-University, Max-von-Laue-Strasse 9, 60438, Frankfurt, Germany. ute.hellmich@uni-jena.de.'],\n",
       "               'AUID': ['ORCID: 0000-0001-7162-285X'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20220422',\n",
       "               'PL': 'Netherlands',\n",
       "               'TA': 'Biomol NMR Assign',\n",
       "               'JT': 'Biomolecular NMR assignments',\n",
       "               'JID': '101472371',\n",
       "               'RN': ['0 (Amino Acids)',\n",
       "                '0 (TRPV Cation Channels)',\n",
       "                '0 (TRPV4 protein, human)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Amino Acids',\n",
       "                'Animals',\n",
       "                '*Chickens/metabolism',\n",
       "                'Humans',\n",
       "                'Magnetic Resonance Spectroscopy',\n",
       "                'Nuclear Magnetic Resonance, Biomolecular',\n",
       "                '*TRPV Cation Channels/chemistry/metabolism'],\n",
       "               'PMC': 'PMC9027025',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Intrinsically disordered protein',\n",
       "                'Ion channel',\n",
       "                'Regulatory domain',\n",
       "                'Structural dynamics',\n",
       "                'TRP vanilloid',\n",
       "                'Transient receptor potential'],\n",
       "               'COIS': ['The authors declare that they have no conflict of interest.'],\n",
       "               'EDAT': '2022/04/23 06:00',\n",
       "               'MHDA': '2022/09/28 06:00',\n",
       "               'PMCR': ['2022/04/22'],\n",
       "               'CRDT': ['2022/04/22 12:08'],\n",
       "               'PHST': ['2022/01/14 00:00 [received]',\n",
       "                '2022/03/17 00:00 [accepted]',\n",
       "                '2022/04/23 06:00 [pubmed]',\n",
       "                '2022/09/28 06:00 [medline]',\n",
       "                '2022/04/22 12:08 [entrez]',\n",
       "                '2022/04/22 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s12104-022-10080-9 [pii]',\n",
       "                '10080 [pii]',\n",
       "                '10.1007/s12104-022-10080-9 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Biomol NMR Assign. 2022 Oct;16(2):205-212. doi: 10.1007/s12104-022-10080-9. Epub 2022 Apr 22.'},\n",
       "              {'PMID': '35386646',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20220408',\n",
       "               'IS': '2673-6101 (Electronic) 2673-6101 (Print) 2673-6101 (Linking)',\n",
       "               'VI': '3',\n",
       "               'DP': '2022',\n",
       "               'TI': 'Immune Metabolism-An Opportunity to Better Understand Allergic Pathology and Improve Treatment of Allergic Diseases?',\n",
       "               'PG': '825931',\n",
       "               'LID': '10.3389/falgy.2022.825931 [doi] 825931',\n",
       "               'FAU': ['Goretzki, Alexandra',\n",
       "                'Zimmermann, Jennifer',\n",
       "                'Lin, Yen-Ju',\n",
       "                'Schulke, Stefan'],\n",
       "               'AU': ['Goretzki A', 'Zimmermann J', 'Lin YJ', 'Schulke S'],\n",
       "               'AD': ['Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20220309',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Allergy',\n",
       "               'JT': 'Frontiers in allergy',\n",
       "               'JID': '9918227355906676',\n",
       "               'PMC': 'PMC8974690',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Warburg',\n",
       "                'allergy',\n",
       "                'immune effector molecules',\n",
       "                'immune metabolism',\n",
       "                'metabolic state'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2022/04/08 06:00',\n",
       "               'MHDA': '2022/04/08 06:01',\n",
       "               'PMCR': ['2022/03/09'],\n",
       "               'CRDT': ['2022/04/07 05:15'],\n",
       "               'PHST': ['2021/11/30 00:00 [received]',\n",
       "                '2022/01/25 00:00 [accepted]',\n",
       "                '2022/04/07 05:15 [entrez]',\n",
       "                '2022/04/08 06:00 [pubmed]',\n",
       "                '2022/04/08 06:01 [medline]',\n",
       "                '2022/03/09 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/falgy.2022.825931 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Allergy. 2022 Mar 9;3:825931. doi: 10.3389/falgy.2022.825931. eCollection 2022.'},\n",
       "              {'PMID': '35327736',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20220329',\n",
       "               'IS': '2227-9067 (Print) 2227-9067 (Electronic) 2227-9067 (Linking)',\n",
       "               'VI': '9',\n",
       "               'IP': '3',\n",
       "               'DP': '2022 Mar 4',\n",
       "               'TI': 'Impact of the First COVID Lockdown on Accident- and Injury-Related Pediatric Intensive Care Admissions in Germany-A Multicenter Study.',\n",
       "               'LID': '10.3390/children9030363 [doi] 363',\n",
       "               'AB': \"Children's and adolescents' lives drastically changed during COVID lockdowns worldwide. To compare accident- and injury-related admissions to pediatric intensive care units (PICU) during the first German COVID lockdown with previous years, we conducted a retrospective multicenter study among 37 PICUs (21.5% of German PICU capacities). A total of 1444 admissions after accidents or injuries during the first lockdown period and matched periods of 2017-2019 were reported and standardized morbidity ratios (SMR) were calculated. Total PICU admissions due to accidents/injuries declined from an average of 366 to 346 (SMR 0.95 (CI 0.85-1.05)). Admissions with trauma increased from 196 to 212 (1.07 (0.93-1.23). Traffic accidents and school/kindergarten accidents decreased (0.77 (0.57-1.02 and 0.26 (0.05-0.75)), whereas household and leisure accidents increased (1.33 (1.06-1.66) and 1.34 (1.06-1.67)). Less neurosurgeries and more visceral surgeries were performed (0.69 (0.38-1.16) and 2.09 (1.19-3.39)). Non-accidental non-suicidal injuries declined (0.73 (0.42-1.17)). Suicide attempts increased in adolescent boys (1.38 (0.51-3.02)), but decreased in adolescent girls (0.56 (0.32-0.79)). In summary, changed trauma mechanisms entailed different surgeries compared to previous years. We found no evidence for an increase in child abuse cases requiring intensive care. The increase in suicide attempts among boys demands investigation.\",\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Willemsen, Lea Y',\n",
       "                'Holtkamp, Katharina',\n",
       "                'Kamp, Oliver',\n",
       "                'Dudda, Marcel',\n",
       "                'Kowall, Bernd',\n",
       "                'Stang, Andreas',\n",
       "                'Hey, Florian',\n",
       "                'Blankenburg, Judith',\n",
       "                'Sabir, Hemmen',\n",
       "                'Eifinger, Frank',\n",
       "                'Fuchs, Hans',\n",
       "                'Haase, Roland',\n",
       "                'Andree, Clemens',\n",
       "                'Heldmann, Michael',\n",
       "                'Potratz, Jenny',\n",
       "                'Kurz, Daniel',\n",
       "                'Schumann, Anja',\n",
       "                'Muller-Knapp, Merle',\n",
       "                'Mand, Nadine',\n",
       "                'Doerfel, Claus',\n",
       "                'Dahlem, Peter',\n",
       "                'Rothoeft, Tobias',\n",
       "                'Ohlert, Manuel',\n",
       "                'Silkenbaumer, Katrin',\n",
       "                'Dohle, Frank',\n",
       "                'Indraswari, Fithri',\n",
       "                'Niemann, Frank',\n",
       "                'Jahn, Peter',\n",
       "                'Merker, Michael',\n",
       "                'Braun, Nicole',\n",
       "                'Brevis Nunez, Francisco',\n",
       "                'Engler, Matthias',\n",
       "                'Heimann, Konrad',\n",
       "                'Wolf, Gerhard K',\n",
       "                'Wulf, Dominik',\n",
       "                'Hankel, Saskia',\n",
       "                'Freymann, Holger',\n",
       "                'Allgaier, Nicolas',\n",
       "                'Knirsch, Felix',\n",
       "                'Dercks, Martin',\n",
       "                'Reinhard, Julia',\n",
       "                'Hoppenz, Marc',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Willemsen LY',\n",
       "                'Holtkamp K',\n",
       "                'Kamp O',\n",
       "                'Dudda M',\n",
       "                'Kowall B',\n",
       "                'Stang A',\n",
       "                'Hey F',\n",
       "                'Blankenburg J',\n",
       "                'Sabir H',\n",
       "                'Eifinger F',\n",
       "                'Fuchs H',\n",
       "                'Haase R',\n",
       "                'Andree C',\n",
       "                'Heldmann M',\n",
       "                'Potratz J',\n",
       "                'Kurz D',\n",
       "                'Schumann A',\n",
       "                'Muller-Knapp M',\n",
       "                'Mand N',\n",
       "                'Doerfel C',\n",
       "                'Dahlem P',\n",
       "                'Rothoeft T',\n",
       "                'Ohlert M',\n",
       "                'Silkenbaumer K',\n",
       "                'Dohle F',\n",
       "                'Indraswari F',\n",
       "                'Niemann F',\n",
       "                'Jahn P',\n",
       "                'Merker M',\n",
       "                'Braun N',\n",
       "                'Brevis Nunez F',\n",
       "                'Engler M',\n",
       "                'Heimann K',\n",
       "                'Wolf GK',\n",
       "                'Wulf D',\n",
       "                'Hankel S',\n",
       "                'Freymann H',\n",
       "                'Allgaier N',\n",
       "                'Knirsch F',\n",
       "                'Dercks M',\n",
       "                'Reinhard J',\n",
       "                'Hoppenz M',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dohna-Schwake C'],\n",
       "               'AUID': ['ORCID: 0000-0003-3809-1887',\n",
       "                'ORCID: 0000-0001-6641-5506',\n",
       "                'ORCID: 0000-0002-1029-5215',\n",
       "                'ORCID: 0000-0003-1758-6039',\n",
       "                'ORCID: 0000-0003-1303-3699',\n",
       "                'ORCID: 0000-0001-9286-556X',\n",
       "                'ORCID: 0000-0002-1327-5981',\n",
       "                'ORCID: 0000-0001-6403-7249',\n",
       "                'ORCID: 0000-0001-5973-3311',\n",
       "                'ORCID: 0000-0003-1814-6836',\n",
       "                'ORCID: 0000-0002-6295-1309',\n",
       "                'ORCID: 0000-0001-5932-8666'],\n",
       "               'AD': ['Department of Pediatrics I, Pediatric Intensive Care Medicine, University Medicine Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Pediatrics I, Pediatric Intensive Care Medicine, University Medicine Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Pediatrics I, Pediatric Intensive Care Medicine, University Medicine Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Trauma, Hand and Reconstructive Surgery, University Medicine Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Trauma, Hand and Reconstructive Surgery, University Medicine Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Institute of Medical Informatics, Biometry and Epidemiology, University Medicine Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Institute of Medical Informatics, Biometry and Epidemiology, University Medicine Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                \"Pediatric Clinic and Pediatric Polyclinic at the Dr. von Haunersches Children's Hospital, Interdisciplinary Pediatric Intensive Care Unit-Pediatric Emergency Medicine, LMU Munich, 80337 Munich, Germany.\",\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital Dresden, University of Technology Dresden, 01307 Dresden, Germany.',\n",
       "                'Department of Pediatrics, Neonatology and Pediatric Intensive Care Medicine, University Hospital Bonn, University of Bonn, 53127 Bonn, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital Freiburg, University of Freiburg, 79106 Freiburg, Germany.',\n",
       "                'Department of Pediatrics, Neonatology and Pediatric Intensive Care Medicine, University Hospital Halle, University of Halle, 06132 Halle, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Helios Hospital Krefeld, 47805 Krefeld, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Helios University Hospital Wuppertal, 42283 Wuppertal, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital, 48149 Munster, Germany.',\n",
       "                'Department of Pediatrics 3, Pediatric Cardiology, Pediatric Intensive Care Medicine, Olgahospital Stuttgart, 70174 Stuttgart, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Schwarzwald-Baar Hospital Villingen-Schwenningen, 78052 Villingen-Schwenningen, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital, University of Rostock, 18057 Rostock, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital, Philipps University of Marburg, 35043 Marburg, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital Jena, University of Jena, 07747 Jena, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Hospital Coburg, 96450 Coburg, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Catholic Hospital Bochum, Ruhr-University of Bochum, 44791 Bochum, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Community Hospital Koblenz, 56068 Koblenz, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Protestant Hospital Bethel, University of Bielefeld, 33615 Bielefeld, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, St. Vinzenz Hospital Paderborn, 33098 Paderborn, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Hospital Fulda, 36043 Fulda, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Bergmannsheil and Pediatric Hospital Buer, 45894 Gelsenkirchen, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Hospital Leverkusen GmbH, 51375 Leverkusen, Germany.',\n",
       "                'Department for Children and Adolescents, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, University Hospital Frankfurt, Goethe University, 60596 Frankfurt am Main, Germany.',\n",
       "                'Department of Surgery III, Pediatric Surgery, Ernst von Bergmann Hospital of Potsdam, 14467 Potsdam, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Sana Hospitals Duisburg, 47055 Duisburg, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Sana Hospital Offenbach, 63069 Offenbach, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital Aachen, RWTH Aachen University, 52074 Aachen, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Hospital of Traunstein, Southeast Bavaria Hospitals, 83278 Traunstein, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital Dusseldorf, Heinrich Heine University of Dusseldorf, 40225 Dusseldorf, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Surgery and Pediatric Intensive Care Medicine, Hospital of Dortmund, 44137 Dortmund, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Florence Nightingale Hospital, 40489 Dusseldorf, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, University Hospital Augsburg, University of Augsburg, 86156 Augsburg, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Sana Hospital Remscheid, 42859 Remscheid, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Clemenshospital Munster, 48153 Munster, Germany.',\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Medicine, Hospital Mittelbaden, 76532 Baden-Baden, Germany.',\n",
       "                \"Department of Pediatrics, Pediatric Intensive Care Medicine, Cologne Hospitals, Children's Hospital Amsterdamer Str., 50735 Cologne, Germany.\",\n",
       "                'Department of Pediatrics I, Pediatric Intensive Care Medicine, University Medicine Essen, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Department of Pediatrics I, Pediatric Intensive Care Medicine, University Medicine Essen, University of Duisburg-Essen, 45147 Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['IFORES/University of Duisburg-Essen/',\n",
       "                'n/a/Stiftung Universitatsmedizin Essen/'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20220304',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Children (Basel)',\n",
       "               'JT': 'Children (Basel, Switzerland)',\n",
       "               'JID': '101648936',\n",
       "               'PMC': 'PMC8947250',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['COVID',\n",
       "                'accident',\n",
       "                'injury',\n",
       "                'lockdown',\n",
       "                'pediatric intensive care',\n",
       "                'trauma'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2022/03/26 06:00',\n",
       "               'MHDA': '2022/03/26 06:01',\n",
       "               'PMCR': ['2022/03/04'],\n",
       "               'CRDT': ['2022/03/25 01:05'],\n",
       "               'PHST': ['2022/01/27 00:00 [received]',\n",
       "                '2022/03/02 00:00 [accepted]',\n",
       "                '2022/03/25 01:05 [entrez]',\n",
       "                '2022/03/26 06:00 [pubmed]',\n",
       "                '2022/03/26 06:01 [medline]',\n",
       "                '2022/03/04 00:00 [pmc-release]'],\n",
       "               'AID': ['children9030363 [pii]',\n",
       "                'children-09-00363 [pii]',\n",
       "                '10.3390/children9030363 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Children (Basel). 2022 Mar 4;9(3):363. doi: 10.3390/children9030363.'},\n",
       "              {'PMID': '35300980',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220426',\n",
       "               'LR': '20220716',\n",
       "               'IS': '1083-351X (Electronic) 0021-9258 (Print) 0021-9258 (Linking)',\n",
       "               'VI': '298',\n",
       "               'IP': '4',\n",
       "               'DP': '2022 Apr',\n",
       "               'TI': 'Multiubiquitination of TRPV4 reduces channel activity independent of surface localization.',\n",
       "               'PG': '101826',\n",
       "               'LID': 'S0021-9258(22)00266-6 [pii] 10.1016/j.jbc.2022.101826 [doi] 101826',\n",
       "               'AB': 'Ubiquitin (Ub)-mediated regulation of plasmalemmal ion channel activity canonically occurs via stimulation of endocytosis. Whether ubiquitination can modulate channel activity by alternative mechanisms remains unknown. Here, we show that the transient receptor potential vanilloid 4 (TRPV4) cation channel is multiubiquitinated within its cytosolic N-terminal and C-terminal intrinsically disordered regions (IDRs). Mutagenizing select lysine residues to block ubiquitination of the N-terminal but not C-terminal IDR resulted in a marked elevation of TRPV4-mediated intracellular calcium influx, without increasing cell surface expression levels. Conversely, enhancing TRPV4 ubiquitination via expression of an E3 Ub ligase reduced TRPV4 channel activity but did not decrease plasma membrane abundance. These results demonstrate Ub-dependent regulation of TRPV4 channel function independent of effects on plasma membrane localization. Consistent with ubiquitination playing a key negative modulatory role of the channel, gain-of-function neuropathy-causing mutations in the TRPV4 gene led to reduced channel ubiquitination in both cellular and Drosophila models of TRPV4 neuropathy, whereas increasing mutant TRPV4 ubiquitination partially suppressed channel overactivity. Together, these data reveal a novel mechanism via which ubiquitination of an intracellular flexible IDR domain modulates ion channel function independently of endocytic trafficking and identify a contributory role for this pathway in the dysregulation of TRPV4 channel activity by neuropathy-causing mutations.',\n",
       "               'CI': ['Copyright (c) 2022 The Authors. Published by Elsevier Inc. All rights reserved.'],\n",
       "               'FAU': ['Aisenberg, William H',\n",
       "                'McCray, Brett A',\n",
       "                'Sullivan, Jeremy M',\n",
       "                'Diehl, Erika',\n",
       "                'DeVine, Lauren R',\n",
       "                'Alevy, Jonathan',\n",
       "                'Bagnell, Anna M',\n",
       "                'Carr, Patrice',\n",
       "                'Donohue, Jack K',\n",
       "                'Goretzki, Benedikt',\n",
       "                'Cole, Robert N',\n",
       "                'Hellmich, Ute A',\n",
       "                'Sumner, Charlotte J'],\n",
       "               'AU': ['Aisenberg WH',\n",
       "                'McCray BA',\n",
       "                'Sullivan JM',\n",
       "                'Diehl E',\n",
       "                'DeVine LR',\n",
       "                'Alevy J',\n",
       "                'Bagnell AM',\n",
       "                'Carr P',\n",
       "                'Donohue JK',\n",
       "                'Goretzki B',\n",
       "                'Cole RN',\n",
       "                'Hellmich UA',\n",
       "                'Sumner CJ'],\n",
       "               'AD': ['Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.',\n",
       "                'Department of Chemistry, Biochemistry Section, Johannes Gutenberg-Universitat Mainz, Mainz, Germany.',\n",
       "                'Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.',\n",
       "                \"Institute of Organic Chemistry and Macromolecular Chemistry, Cluster of Excellence 'Balance of the Microverse', Friedrich-Schiller-Universitat, Jena, Germany; Center for Biomolecular Magnetic Resonance (BMRZ), Goethe-Universitat, Frankfurt am Main, Germany.\",\n",
       "                \"Institute of Organic Chemistry and Macromolecular Chemistry, Cluster of Excellence 'Balance of the Microverse', Friedrich-Schiller-Universitat, Jena, Germany.\",\n",
       "                \"Institute of Organic Chemistry and Macromolecular Chemistry, Cluster of Excellence 'Balance of the Microverse', Friedrich-Schiller-Universitat, Jena, Germany; Center for Biomolecular Magnetic Resonance (BMRZ), Goethe-Universitat, Frankfurt am Main, Germany.\",\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: csumner1@jhmi.edu.'],\n",
       "               'LA': ['eng'],\n",
       "               'SI': ['figshare/10.6084/m9.figshare.16990072.v1'],\n",
       "               'GR': ['F31 NS105404/NS/NINDS NIH HHS/United States',\n",
       "                'K08 NS102509/NS/NINDS NIH HHS/United States',\n",
       "                'R35 NS122306/NS/NINDS NIH HHS/United States',\n",
       "                'S10 OD023548/OD/NIH HHS/United States'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20220314',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Biol Chem',\n",
       "               'JT': 'The Journal of biological chemistry',\n",
       "               'JID': '2985121R',\n",
       "               'RN': ['0 (TRPV Cation Channels)',\n",
       "                '0 (Ubiquitin)',\n",
       "                'SY7Q814VUP (Calcium)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Animals',\n",
       "                'Calcium/metabolism',\n",
       "                'Cell Membrane/metabolism',\n",
       "                'Drosophila/genetics/metabolism',\n",
       "                'Humans',\n",
       "                'Mice',\n",
       "                'Mutation',\n",
       "                '*TRPV Cation Channels/genetics/metabolism',\n",
       "                'Ubiquitin/metabolism',\n",
       "                '*Ubiquitination'],\n",
       "               'PMC': 'PMC9010760',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Charcot-Marie-Tooth disease',\n",
       "                'NEDD4',\n",
       "                'TRPV4',\n",
       "                'channel activation',\n",
       "                'ion channel',\n",
       "                'plasma membrane',\n",
       "                'ubiquitination'],\n",
       "               'COIS': ['Conflict of interest The authors declare that they have no conflicts of interest',\n",
       "                'with the contents of this article.'],\n",
       "               'EDAT': '2022/03/19 06:00',\n",
       "               'MHDA': '2022/04/27 06:00',\n",
       "               'PMCR': ['2022/03/14'],\n",
       "               'CRDT': ['2022/03/18 05:38'],\n",
       "               'PHST': ['2021/08/25 00:00 [received]',\n",
       "                '2022/02/19 00:00 [revised]',\n",
       "                '2022/02/21 00:00 [accepted]',\n",
       "                '2022/03/19 06:00 [pubmed]',\n",
       "                '2022/04/27 06:00 [medline]',\n",
       "                '2022/03/18 05:38 [entrez]',\n",
       "                '2022/03/14 00:00 [pmc-release]'],\n",
       "               'AID': ['S0021-9258(22)00266-6 [pii]',\n",
       "                '101826 [pii]',\n",
       "                '10.1016/j.jbc.2022.101826 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Biol Chem. 2022 Apr;298(4):101826. doi: 10.1016/j.jbc.2022.101826. Epub 2022 Mar 14.'},\n",
       "              {'PMID': '35170874',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220503',\n",
       "               'LR': '20220531',\n",
       "               'IS': '2328-9503 (Electronic) 2328-9503 (Linking)',\n",
       "               'VI': '9',\n",
       "               'IP': '3',\n",
       "               'DP': '2022 Mar',\n",
       "               'TI': 'TRPV4 mutations causing mixed neuropathy and skeletal phenotypes result in severe gain of function.',\n",
       "               'PG': '375-391',\n",
       "               'LID': '10.1002/acn3.51523 [doi]',\n",
       "               'AB': 'OBJECTIVE: Distinct dominant mutations in the calcium-permeable ion channel TRPV4 (transient receptor potential vanilloid 4) typically cause nonoverlapping diseases of either the neuromuscular or skeletal systems. However, accumulating evidence suggests that some patients develop mixed phenotypes that include elements of both neuromuscular and skeletal disease. We sought to define the genetic and clinical features of these patients. METHODS: We report a 2-year-old with a novel R616G mutation in TRPV4 with a severe neuropathy phenotype and bilateral vocal cord paralysis. Interestingly, a different substitution at the same residue, R616Q, has been reported in families with isolated skeletal dysplasia. To gain insight into clinical features and potential genetic determinants of mixed phenotypes, we perform in-depth analysis of previously reported patients along with functional and structural assessment of selected mutations. RESULTS: We describe a wide range of neuromuscular and skeletal manifestations and highlight specific mutations that are more frequently associated with overlap syndromes. We find that mutations causing severe, mixed phenotypes have an earlier age of onset and result in more marked elevations of intracellular calcium, increased cytotoxicity, and reduced sensitivity to TRPV4 antagonism. Structural analysis of the two mutations with the most dramatic gain of ion channel function suggests that these mutants likely cause constitutive channel opening through disruption of the TRPV4 S5 transmembrane domain. INTERPRETATION: These findings demonstrate that the degree of baseline calcium elevation correlates with development of mixed phenotypes and sensitivity to pharmacologic channel inhibition, observations that will be critical for the design of future clinical trials for TRPV4 channelopathies.',\n",
       "               'CI': ['(c) 2022 The Authors. Annals of Clinical and Translational Neurology published by',\n",
       "                'Wiley Periodicals LLC on behalf of American Neurological Association.'],\n",
       "               'FAU': ['Taga, Arens',\n",
       "                'Peyton, Margo A',\n",
       "                'Goretzki, Benedikt',\n",
       "                'Gallagher, Thomas Q',\n",
       "                'Ritter, Ann',\n",
       "                'Harper, Amy',\n",
       "                'Crawford, Thomas O',\n",
       "                'Hellmich, Ute A',\n",
       "                'Sumner, Charlotte J',\n",
       "                'McCray, Brett A'],\n",
       "               'AU': ['Taga A',\n",
       "                'Peyton MA',\n",
       "                'Goretzki B',\n",
       "                'Gallagher TQ',\n",
       "                'Ritter A',\n",
       "                'Harper A',\n",
       "                'Crawford TO',\n",
       "                'Hellmich UA',\n",
       "                'Sumner CJ',\n",
       "                'McCray BA'],\n",
       "               'AD': ['Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USA.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USA.',\n",
       "                'Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, Jena, 07743, Germany.',\n",
       "                'Centre for Biomolecular Magnetic Resonance, Goethe-University, Frankfurt, 60438, Germany.',\n",
       "                \"Departments of Otolaryngology - Head & Neck Surgery & Pediatrics, Eastern Virginia Medical School, and Department of Pediatric Otolaryngology, Children's Hospital of the King's Daughters, Norfolk, Virginia, 23508, USA.\",\n",
       "                'Department of Neurosurgery, Virginia Commonwealth University Health System, Richmond, Virginia, 23298, USA.',\n",
       "                'Department of Neurology, Virginia Commonwealth University Health System, Richmond, Virginia, 23298, USA.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USA.',\n",
       "                'Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, Jena, 07743, Germany.',\n",
       "                'Centre for Biomolecular Magnetic Resonance, Goethe-University, Frankfurt, 60438, Germany.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USA.',\n",
       "                'The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USA.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USA.'],\n",
       "               'AUID': ['ORCID: 0000-0001-6581-9728'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['R35 NS122306/NS/NINDS NIH HHS/United States',\n",
       "                'K08 NS102509/NS/NINDS NIH HHS/United States'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Research Support, N.I.H., Extramural',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20220216',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Ann Clin Transl Neurol',\n",
       "               'JT': 'Annals of clinical and translational neurology',\n",
       "               'JID': '101623278',\n",
       "               'RN': ['0 (Calcium Channels)',\n",
       "                '0 (TRPV Cation Channels)',\n",
       "                '0 (TRPV4 protein, human)',\n",
       "                'SY7Q814VUP (Calcium)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Calcium',\n",
       "                'Calcium Channels/genetics',\n",
       "                'Gain of Function Mutation',\n",
       "                'Humans',\n",
       "                'Mutation',\n",
       "                '*Peripheral Nervous System Diseases/genetics',\n",
       "                'Phenotype',\n",
       "                '*TRPV Cation Channels/chemistry/genetics'],\n",
       "               'PMC': 'PMC8935273',\n",
       "               'COIS': ['The authors declare no conflicts of interest.'],\n",
       "               'EDAT': '2022/02/17 06:00',\n",
       "               'MHDA': '2022/05/04 06:00',\n",
       "               'PMCR': ['2022/02/16'],\n",
       "               'CRDT': ['2022/02/16 08:44'],\n",
       "               'PHST': ['2022/02/01 00:00 [revised]',\n",
       "                '2021/12/29 00:00 [received]',\n",
       "                '2022/02/02 00:00 [accepted]',\n",
       "                '2022/02/17 06:00 [pubmed]',\n",
       "                '2022/05/04 06:00 [medline]',\n",
       "                '2022/02/16 08:44 [entrez]',\n",
       "                '2022/02/16 00:00 [pmc-release]'],\n",
       "               'AID': ['ACN351523 [pii]', '10.1002/acn3.51523 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Ann Clin Transl Neurol. 2022 Mar;9(3):375-391. doi: 10.1002/acn3.51523. Epub 2022 Feb 16.'},\n",
       "              {'PMID': '35092500',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20220830',\n",
       "               'IS': '2110-5820 (Print) 2110-5820 (Electronic) 2110-5820 (Linking)',\n",
       "               'VI': '12',\n",
       "               'IP': '1',\n",
       "               'DP': '2022 Jan 29',\n",
       "               'TI': 'Role of extracorporeal membrane oxygenation in pediatric cancer patients: a systematic review and meta-analysis of observational studies.',\n",
       "               'PG': '8',\n",
       "               'LID': '10.1186/s13613-022-00983-0 [doi] 8',\n",
       "               'AB': 'BACKGROUND: The use of extracorporeal membrane oxygenation (ECMO) in pediatric patients with underlying malignancies remains controversial. However, in an era in which the survival rates for children with malignancies have increased significantly and several recent reports have demonstrated effective ECMO use in children with cancer, we aimed to estimate the outcome and complications of ECMO treatment in these children. METHODS: We searched MEDLINE, Embase and CINAHL databases for studies on the use ECMO in pediatric patients with an underlying malignancy from inception to September 2020. This review was conducted in adherence to Preferred Reporting Items for Systematic Review and Meta-Analysis statement. Study eligibility was independently assessed by two authors and disagreements resolved by a third author. Included studies were evaluated for quality using the Newcastle-Ottawa Scale (NOS). Random effects meta-analyses (DerSimonian and Laird) were performed. The primary outcomes were mortality during ECMO or hospital mortality. RESULTS: Thirteen retrospective, observational cohort studies were included, most of moderate quality (625 patients). The commonest indication for ECMO was severe respiratory failure (92%). Pooled mortality during ECMO was 55% (95% confidence interval [CI], 47-63%) and pooled hospital mortality was 60% (95% CI 54-67%). Although heterogeneity among the included studies was low, confidence intervals were large. In addition, the majority of the data were derived from registries with overlapping patients which were excluded for the meta-analyses to prevent resampling of the same participants across the included studies. Finally, there was a lack of consistent complications reporting among the studies. CONCLUSION: Significantly higher mortalities than in general PICU patients was reported with the use of ECMO in children with malignancies. Although these results need to be interpreted with caution due to the lack of granular data, they suggest that ECMO appears to represents a viable rescue option for selected patients with underlying malignancies. There is an urgent need for additional data to define patients for whom ECMO may provide benefit or harm.',\n",
       "               'CI': ['(c) 2022. The Author(s).'],\n",
       "               'FAU': ['Slooff, Valerie',\n",
       "                'Hoogendoorn, Rianne',\n",
       "                'Nielsen, Jeppe Sylvest Angaard',\n",
       "                'Pappachan, John',\n",
       "                'Amigoni, Angela',\n",
       "                'Caramelli, Fabio',\n",
       "                'Aziz, Omer',\n",
       "                'Wildschut, Enno',\n",
       "                'Verbruggen, Sascha',\n",
       "                'Crazzolara, Roman',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Potratz, Jenny',\n",
       "                'Willems, Jef',\n",
       "                'Llevadias, Judit',\n",
       "                'Moscatelli, Andrea',\n",
       "                'Montaguti, Alessia',\n",
       "                'Bottari, Gabriella',\n",
       "                'Di Nardo, Matteo',\n",
       "                'Schlapbach, Luregn',\n",
       "                'Wosten-van Asperen, Roelie'],\n",
       "               'AU': ['Slooff V',\n",
       "                'Hoogendoorn R',\n",
       "                'Nielsen JSA',\n",
       "                'Pappachan J',\n",
       "                'Amigoni A',\n",
       "                'Caramelli F',\n",
       "                'Aziz O',\n",
       "                'Wildschut E',\n",
       "                'Verbruggen S',\n",
       "                'Crazzolara R',\n",
       "                'Dohna-Schwake C',\n",
       "                'Potratz J',\n",
       "                'Willems J',\n",
       "                'Llevadias J',\n",
       "                'Moscatelli A',\n",
       "                'Montaguti A',\n",
       "                'Bottari G',\n",
       "                'Di Nardo M',\n",
       "                'Schlapbach L',\n",
       "                'Wosten-van Asperen R'],\n",
       "               'AD': [\"Department of Pediatric Intensive Care, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Lundlaan 6, 3584 EA, Utrecht, The Netherlands.\",\n",
       "                \"Department of Pediatric Intensive Care, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Lundlaan 6, 3584 EA, Utrecht, The Netherlands.\",\n",
       "                'Department of Neonatology and Pediatric Intensive Care, Rigshospitalet, Copenhagen, Denmark.',\n",
       "                'Pediatric Intensive Care Unit, University Hospital Southampton, Southampton, UK.',\n",
       "                \"Pediatric Intensive Care Unit, Department of Woman's and Child's Health, Padua University Hospital, Padua, Italy.\",\n",
       "                'Department of Woman, Child and Urological Diseases, Pediatric Intensive Care Unit, University-Hospital S. Orsola-Malpighi Policlinic, Bologna, Italy.',\n",
       "                \"Department of Pediatric Intensive Care, Royal Bristol Children's Hospital, Bristol, UK.\",\n",
       "                \"Intensive Care, Department of Pediatrics and Pediatric Surgery, Erasmus Medical Centre, Sophia Children's Hospital, Rotterdam, The Netherlands.\",\n",
       "                \"Intensive Care, Department of Pediatrics and Pediatric Surgery, Erasmus Medical Centre, Sophia Children's Hospital, Rotterdam, The Netherlands.\",\n",
       "                'Department of Pediatrics, Pediatric Intensive Care Unit, Medical University of Innsbruck, Innsbruck, Austria.',\n",
       "                'Department of Pediatric Intensive Care, Universitatsklinik Essen, Essen, Germany.',\n",
       "                \"Department of General Pediatrics-Intensive Care Medicine, University Children's Hospital Munster, Munster, Germany.\",\n",
       "                'Department of Pediatric Intensive Care, Ghent University Hospital, Ghent, Belgium.',\n",
       "                'Department of Pediatric Intensive Care, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.',\n",
       "                'Department of Pediatric Intensive Care, Gaslini Hospital, Genova, Italy.',\n",
       "                'Department of Pediatric Intensive Care, Gaslini Hospital, Genova, Italy.',\n",
       "                'Pediatric Intensive Care Unit, Ospedale Pediatrico Bambino Gesu, IRCC, Rome, Italy.',\n",
       "                'Pediatric Intensive Care Unit, Ospedale Pediatrico Bambino Gesu, IRCC, Rome, Italy.',\n",
       "                \"Pediatric and Neonatal Intensive Care Unit, Children's Research Centre, University Children's Hospital Zurich and University of Zurich, Zurich, Switzerland.\",\n",
       "                \"Department of Pediatric Intensive Care, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Lundlaan 6, 3584 EA, Utrecht, The Netherlands. r.m.vanasperen@umcutrecht.nl.\"],\n",
       "               'CN': ['POKER (PICU Oncology Kids in Europe Research group) research consortium of ESPNIC',\n",
       "                '(European Society of Paediatric Neonatal Intensive Care)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'DEP': '20220129',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Ann Intensive Care',\n",
       "               'JT': 'Annals of intensive care',\n",
       "               'JID': '101562873',\n",
       "               'PMC': 'PMC8800958',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Cancer',\n",
       "                'Extracorporeal membrane oxygenation',\n",
       "                'Meta-analysis',\n",
       "                'Outcomes',\n",
       "                'Pediatric intensive care unit',\n",
       "                'Systematic review'],\n",
       "               'COIS': ['The authors declared that they do not have a conflicting interest.'],\n",
       "               'EDAT': '2022/01/30 06:00',\n",
       "               'MHDA': '2022/01/30 06:01',\n",
       "               'PMCR': ['2022/01/29'],\n",
       "               'CRDT': ['2022/01/29 12:06'],\n",
       "               'PHST': ['2021/09/15 00:00 [received]',\n",
       "                '2022/01/13 00:00 [accepted]',\n",
       "                '2022/01/29 12:06 [entrez]',\n",
       "                '2022/01/30 06:00 [pubmed]',\n",
       "                '2022/01/30 06:01 [medline]',\n",
       "                '2022/01/29 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1186/s13613-022-00983-0 [pii]',\n",
       "                '983 [pii]',\n",
       "                '10.1186/s13613-022-00983-0 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Ann Intensive Care. 2022 Jan 29;12(1):8. doi: 10.1186/s13613-022-00983-0.'},\n",
       "              {'PMID': '35054103',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20220128',\n",
       "               'IS': '2077-0383 (Print) 2077-0383 (Electronic) 2077-0383 (Linking)',\n",
       "               'VI': '11',\n",
       "               'IP': '2',\n",
       "               'DP': '2022 Jan 14',\n",
       "               'TI': 'Hyperkalemia Following Parathyroidectomy in Patients with Renal Hyperparathyroidism-New Thresholds for Urgent Perioperative Dialysis.',\n",
       "               'LID': '10.3390/jcm11020409 [doi] 409',\n",
       "               'AB': 'Parathyroidectomy (PTX) is a mainstay of treating secondary hyperparathyroidism (SHPT) in patients with kidney failure in order to reduce the incidence of cardiovascular events (CVE), increase overall survival and improve quality of life. Perioperative hyperkalemia may lead to devastating cardiac complications. Distinct preoperative thresholds for serum potassium levels (SPL) were defined, but neither their usefulness nor consecutive risks are understood. This study compared the results and efficacy of different clinical procedures in preventing or treating perioperative hyperkalemia, including postoperative urgent hemodialysis (UHD). Methods: Patients from Charite-Universitatsmedizin Berlin and Rheinland Klinikum Lukaskrankenhaus, Neuss, undergoing PTX due to SHPT between 2008 and 2018 were analyzed retrospectively with regard to demographic parameters, surgery specific conditions and perioperative laboratory results. Comparisons of patient values from both centers with focus on perioperative hyperkalemia and the need for UHD were performed. Results: A total of 251 patients undergoing PTX for SHPT were included (Neuss: n = 121 (48%); Berlin: n = 130 (52%)). Perioperative hyperkalemia (SPL >/= 5.5 mmol/L) was noted in 134 patients (53%). UHD on the day of surgery was performed especially in patients with intraoperative hyperkalemia, in females (n = 40 (16%) vs. n = 27 (11%); p = 0.023), in obese patients (n = 27 (40%) vs. n = 50 (28%), p = 0.040) and more often in patients treated in Neuss (n = 42 (35%) vs. 25 (19%); p = 0.006). For patients treated in Neuss, the intraoperative hyperkalemia cut-off level above 5.75 mmol/L was the most predictive factor for UHD (n = 30 (71%) vs. n = 8 (10%); p < 0.001). Concerning secondary effects of hyperkalemia or UHD, no patient died within the postoperative period, and only three patients suffered from acute CVE, with SPL > 5.5 mmol/L measured in only one patient. Conclusion: Perioperative values could not predict postoperative hyperkalemia with the need for UHD. Previously defined cut-off levels for SPL should be reconsidered, especially for patients undergoing PTX. Early postoperative dialysis in patients with postoperative hyperkalemia can be performed with a low risk for complications and may be indicated for all patients with increased perioperative SPL.',\n",
       "               'FAU': ['Bures, Claudia',\n",
       "                'Uluk, Yasmin',\n",
       "                'Besmens, Mona',\n",
       "                'Akca, Aycan',\n",
       "                'Dobrindt, Eva-Maria',\n",
       "                'Pratschke, Johann',\n",
       "                'Goretzki, Peter',\n",
       "                'Mogl, Martina',\n",
       "                'Uluk, Deniz'],\n",
       "               'AU': ['Bures C',\n",
       "                'Uluk Y',\n",
       "                'Besmens M',\n",
       "                'Akca A',\n",
       "                'Dobrindt EM',\n",
       "                'Pratschke J',\n",
       "                'Goretzki P',\n",
       "                'Mogl M',\n",
       "                'Uluk D'],\n",
       "               'AD': ['Department of Surgery, Campus Mitte, Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Mitte, Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Rheinland Klinikum Lukaskrankenhaus Neuss, 41464 Neuss, Germany.',\n",
       "                'Department of Surgery, Rheinland Klinikum Lukaskrankenhaus Neuss, 41464 Neuss, Germany.',\n",
       "                'Department of Surgery, Campus Mitte, Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Mitte, Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Mitte, Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Mitte, Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, 10117 Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Mitte, Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, 10117 Berlin, Germany.'],\n",
       "               'AUID': ['ORCID: 0000-0002-1616-9826',\n",
       "                'ORCID: 0000-0002-3676-047X',\n",
       "                'ORCID: 0000-0001-6395-0845'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20220114',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'J Clin Med',\n",
       "               'JT': 'Journal of clinical medicine',\n",
       "               'JID': '101606588',\n",
       "               'PMC': 'PMC8777922',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['parathyroidectomy',\n",
       "                'perioperative hyperkalemia',\n",
       "                'secondary hyperparathyroidism',\n",
       "                'urgent dialysis'],\n",
       "               'COIS': ['The authors declare no conflict of interest.'],\n",
       "               'EDAT': '2022/01/22 06:00',\n",
       "               'MHDA': '2022/01/22 06:01',\n",
       "               'PMCR': ['2022/01/14'],\n",
       "               'CRDT': ['2022/01/21 01:07'],\n",
       "               'PHST': ['2021/12/11 00:00 [received]',\n",
       "                '2022/01/01 00:00 [revised]',\n",
       "                '2022/01/12 00:00 [accepted]',\n",
       "                '2022/01/21 01:07 [entrez]',\n",
       "                '2022/01/22 06:00 [pubmed]',\n",
       "                '2022/01/22 06:01 [medline]',\n",
       "                '2022/01/14 00:00 [pmc-release]'],\n",
       "               'AID': ['jcm11020409 [pii]',\n",
       "                'jcm-11-00409 [pii]',\n",
       "                '10.3390/jcm11020409 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'J Clin Med. 2022 Jan 14;11(2):409. doi: 10.3390/jcm11020409.'},\n",
       "              {'PMID': '34969942',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220429',\n",
       "               'LR': '20220429',\n",
       "               'IS': '0974-7559 (Electronic) 0019-6061 (Linking)',\n",
       "               'VI': '59',\n",
       "               'IP': '3',\n",
       "               'DP': '2022 Mar 15',\n",
       "               'TI': 'Breastfeeding and Readmission for Hyperbilirubinemia in Late Preterm and Term Infants in Beirut, Lebanon.',\n",
       "               'PG': '218-221',\n",
       "               'LID': 'S097475591600383 [pii]',\n",
       "               'AB': 'OBJECTIVE: To determine whether exclusive breastfeeding is associated with readmission of jaundiced newborns. METHODS: We retrieved medical records of 51 consecutive neonates >35 weeks with jaundice who were readmitted to the hospital, and compared to 164 controls. Data on gender, gestational age, birth weight, mode of delivery, feeding, bilirubin levels and breastfeeding counseling were analyzed. RESULTS: 24% babies were readmitted for hyperbilirubinemia reaching phototherapy level. Early term infants had significantly higher risk for readmission compared to term [OR (95% CI) 2.12 (0.99-4.53); P= 0.05]. The risk of readmission was lower amongst subjects receiving mixed/formula feeding [OR (95% CI) 0.51 (0.26-0.98); P=0.046] odds of readmission decreased for those feeding >8 times per day (OR (95% CI) 0.46 (0.23-0.91); P=0.016], and those who stayed in hospital for more than 2 days after birth [OR (95% CI) 0.95(0.93-0.97); P<0.001]. CONCLUSION: Ensuring feeding at least 8 times per day and keeping newborns beyond the first 24 hours decreases the chance of readmission.',\n",
       "               'FAU': ['Hanin, El Arab',\n",
       "                'Rayan, Hojeij',\n",
       "                'Hani, Tamim',\n",
       "                'Taleb, Jammal',\n",
       "                'Dany, Al Hamod',\n",
       "                'Lama, Charafeddine'],\n",
       "               'AU': ['Hanin EA',\n",
       "                'Rayan H',\n",
       "                'Hani T',\n",
       "                'Taleb J',\n",
       "                'Dany AH',\n",
       "                'Lama C'],\n",
       "               'AD': ['Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, American University of Beirut (AUB), Beirut, Lebanon.',\n",
       "                'Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, American University of Beirut (AUB), Beirut, Lebanon.',\n",
       "                'Department of Internal Medicine, Clinical Research Institute, Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.',\n",
       "                'Department of Pediatrics, Lebanese University, Beirut, Lebanon.',\n",
       "                'Department of Pediatrics, Balamand University, Beirut, Lebanon.',\n",
       "                'Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, American University of Beirut (AUB), Beirut, Lebanon. Correspondence to: Dr Lama Charafeddine, Associate Professor of Clinical Pediatrics and Neonatology, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, American University of Beirut (AUB), Beirut, Lebanon. lc12@aub.edu.lb.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20211229',\n",
       "               'PL': 'India',\n",
       "               'TA': 'Indian Pediatr',\n",
       "               'JT': 'Indian pediatrics',\n",
       "               'JID': '2985062R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['*Breast Feeding',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperbilirubinemia',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                '*Jaundice, Neonatal/epidemiology/therapy',\n",
       "                'Lebanon/epidemiology',\n",
       "                'Patient Readmission'],\n",
       "               'EDAT': '2022/01/01 06:00',\n",
       "               'MHDA': '2022/04/30 06:00',\n",
       "               'CRDT': ['2021/12/31 05:51'],\n",
       "               'PHST': ['2022/01/01 06:00 [pubmed]',\n",
       "                '2022/04/30 06:00 [medline]',\n",
       "                '2021/12/31 05:51 [entrez]'],\n",
       "               'AID': ['S097475591600383 [pii]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Indian Pediatr. 2022 Mar 15;59(3):218-221. Epub 2021 Dec 29.'},\n",
       "              {'PMID': '34877889',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220719',\n",
       "               'LR': '20220814',\n",
       "               'IS': '1557-9042 (Electronic) 0897-7151 (Print) 0897-7151 (Linking)',\n",
       "               'VI': '39',\n",
       "               'IP': '13-14',\n",
       "               'DP': '2022 Jul',\n",
       "               'TI': 'Functional Short-Term Outcomes and Mortality in Children with Severe Traumatic Brain Injury: Comparing Decompressive Craniectomy and Medical Management.',\n",
       "               'PG': '944-953',\n",
       "               'LID': '10.1089/neu.2021.0378 [doi]',\n",
       "               'AB': \"The effect of decompressive craniectomy (DC) on functional outcomes and mortality in children after severe head trauma is strongly debated. The lack of high-quality evidence poses a serious challenge to neurosurgeons' and pediatric intensive care physicians' decision making in critically ill children after head trauma. This study was conducted to compare DC and medical management in severely head-injured children with respect to short-term outcomes and mortality. Data on patients <18 years of age treated in Germany, Austria, and Switzerland during a 10-year period were extracted from TraumaRegister DGU((R)), forming a retrospective multi-center cohort study. Descriptive and multi-variable analyses were performed to compare outcomes and mortality after DC and medical management. Of 2507 patients, 402 (16.0%) received DC. Mortality was 20.6% after DC and 13.7% after medical management. Poor outcome (death or vegetative state) occurred in 27.6% after DC and in 16.1% after medical management. After risk adjustment by logistic regression modeling, the odds ratio was 1.56 (95% confidence interval 1.01-2.40) for poor outcome at intensive care unit discharge and 1.20 (0.74-1.95) for mortality after DC. In summary, DC was associated with increased odds for poor short-term outcomes in children with severe head trauma. This finding should temper enthusiasm for DC in children until a large randomized controlled trial has answered more precisely if DC in children is beneficial or increases rates of vegetative state.\",\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Kamp, Oliver',\n",
       "                'Lange, Kim',\n",
       "                'Lefering, Rolf',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dudda, Marcel',\n",
       "                'Dohna-Schwake, Christian'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Kamp O',\n",
       "                'Lange K',\n",
       "                'Lefering R',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dudda M',\n",
       "                'Dohna-Schwake C'],\n",
       "               'AD': ['Department of Pediatrics I, Hand and Reconstructive Surgery, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'TNBS, Center for Translational Neuro- and Behavioral Sciences, Hand and Reconstructive Surgery, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Trauma, Hand and Reconstructive Surgery, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Trauma, Hand and Reconstructive Surgery, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Faculty of Health, Institute for Research in Operative Medicine (IFOM), University of Witten/Herdecke, Cologne, Germany.',\n",
       "                'Department of Pediatrics I, Hand and Reconstructive Surgery, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'TNBS, Center for Translational Neuro- and Behavioral Sciences, Hand and Reconstructive Surgery, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Trauma, Hand and Reconstructive Surgery, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Hand and Reconstructive Surgery, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Multicenter Study',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Neurotrauma',\n",
       "               'JT': 'Journal of neurotrauma',\n",
       "               'JID': '8811626',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['*Brain Injuries, Traumatic/etiology/surgery',\n",
       "                'Child',\n",
       "                'Cohort Studies',\n",
       "                '*Craniocerebral Trauma/etiology',\n",
       "                '*Decompressive Craniectomy/methods',\n",
       "                'Humans',\n",
       "                'Persistent Vegetative State/etiology',\n",
       "                'Retrospective Studies',\n",
       "                'Treatment Outcome'],\n",
       "               'PMC': 'PMC9248344',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['TraumaRegister DGU(R)',\n",
       "                'children',\n",
       "                'decompressive craniectomy',\n",
       "                'mortality',\n",
       "                'outcomes',\n",
       "                'traumatic brain injury'],\n",
       "               'COIS': ['RL declares that his institution receives an ongoing support from AUC Akademie',\n",
       "                'der Unfallchirurgie, the data holder of TR-DGU, which includes statistical',\n",
       "                'support of data analysis from registry data. For the other authors, no competing',\n",
       "                'financial interests exist.'],\n",
       "               'EDAT': '2021/12/09 06:00',\n",
       "               'MHDA': '2022/07/20 06:00',\n",
       "               'PMCR': ['2022/06/28'],\n",
       "               'CRDT': ['2021/12/08 08:47'],\n",
       "               'PHST': ['2021/12/09 06:00 [pubmed]',\n",
       "                '2022/07/20 06:00 [medline]',\n",
       "                '2021/12/08 08:47 [entrez]',\n",
       "                '2022/06/28 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1089/neu.2021.0378 [pii]',\n",
       "                '10.1089/neu.2021.0378 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Neurotrauma. 2022 Jul;39(13-14):944-953. doi: 10.1089/neu.2021.0378.'},\n",
       "              {'PMID': '34873285',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220328',\n",
       "               'LR': '20230210',\n",
       "               'IS': '1530-0447 (Electronic) 0031-3998 (Print) 0031-3998 (Linking)',\n",
       "               'VI': '91',\n",
       "               'IP': '2',\n",
       "               'DP': '2022 Jan',\n",
       "               'TI': 'Antibiotics in critically ill children-a narrative review on different aspects of a rational approach.',\n",
       "               'PG': '440-446',\n",
       "               'LID': '10.1038/s41390-021-01878-9 [doi]',\n",
       "               'AB': 'Especially critically ill children are exposed to antibiotic overtreatment, mainly caused by the fear of missing out a severe bacterial infection. Potential adverse effects and selection of multi-drug resistant bacteria play minor roles in decision making. This narrative review first describes harm from antibiotics and second focuses on different aspects that could help to reduce antibiotic overtreatment without harming the patient: harm from antibiotic treatment, diagnostic approaches, role of biomarkers, timing of antibiotic therapy, empiric therapy, targeted therapy, and therapeutic drug monitoring. Wherever possible, we linked the described evidence to the current Surviving Sepsis Campaign guidelines. Antibiotic stewardship programs should help guiding antibiotic therapy for critically ill children. IMPACT: Critically ill children can be harmed by inadequate or overuse of antibiotics. Hemodynamically unstable children with a suspicion of infection should be immediately treated with broad-spectrum antibiotics. In contrast, in hemodynamically stable children with sepsis and organ dysfunction, a time frame of 3 h for proper diagnostics may be adequate before starting antibiotics if necessary. Less and more targeted antibiotic treatment can be achieved via antibiotic stewardship programs.',\n",
       "               'CI': ['(c) 2021. The Author(s).'],\n",
       "               'FAU': ['Bruns, Nora', 'Dohna-Schwake, Christian'],\n",
       "               'AU': ['Bruns N', 'Dohna-Schwake C'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. christian.dohna-schwake@uk-essen.de.',\n",
       "                'Westdeutsches Zentrum fur Infektiologie, University of Duisburg-Essen, Essen, Germany. christian.dohna-schwake@uk-essen.de.'],\n",
       "               'AUID': ['ORCID: 0000-0001-8973-5406'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                'Review'],\n",
       "               'DEP': '20211206',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Pediatr Res',\n",
       "               'JT': 'Pediatric research',\n",
       "               'JID': '0100714',\n",
       "               'RN': ['0 (Anti-Bacterial Agents)', '0 (Biomarkers)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Anti-Bacterial Agents/adverse effects/*therapeutic use',\n",
       "                'Antimicrobial Stewardship',\n",
       "                'Biomarkers/metabolism',\n",
       "                '*Critical Illness',\n",
       "                'Gastrointestinal Microbiome/drug effects',\n",
       "                'Humans',\n",
       "                'Sepsis/drug therapy'],\n",
       "               'PMC': 'PMC8816725',\n",
       "               'COIS': ['The authors declare no competing interests.'],\n",
       "               'EDAT': '2021/12/08 06:00',\n",
       "               'MHDA': '2022/03/29 06:00',\n",
       "               'PMCR': ['2021/12/06'],\n",
       "               'CRDT': ['2021/12/07 06:40'],\n",
       "               'PHST': ['2021/04/22 00:00 [received]',\n",
       "                '2021/11/13 00:00 [accepted]',\n",
       "                '2021/11/09 00:00 [revised]',\n",
       "                '2021/12/08 06:00 [pubmed]',\n",
       "                '2022/03/29 06:00 [medline]',\n",
       "                '2021/12/07 06:40 [entrez]',\n",
       "                '2021/12/06 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1038/s41390-021-01878-9 [pii]',\n",
       "                '1878 [pii]',\n",
       "                '10.1038/s41390-021-01878-9 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Pediatr Res. 2022 Jan;91(2):440-446. doi: 10.1038/s41390-021-01878-9. Epub 2021 Dec 6.'},\n",
       "              {'PMID': '34706565',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220309',\n",
       "               'LR': '20220309',\n",
       "               'IS': '1524-4628 (Electronic) 0039-2499 (Linking)',\n",
       "               'VI': '53',\n",
       "               'IP': '3',\n",
       "               'DP': '2022 Mar',\n",
       "               'TI': 'Natural Course of Cerebral Cavernous Malformations in Children: A Five-Year Follow-Up Study.',\n",
       "               'PG': '817-824',\n",
       "               'LID': '10.1161/STROKEAHA.121.035338 [doi]',\n",
       "               'AB': 'BACKGROUND AND PURPOSE: The purpose of this study was to investigate the natural course of cerebral cavernous malformations (CCM) in the pediatric population, with special emphasis on the risk of first and recurrent bleeding over a 5-year period. METHODS: Our institutional database was screened for patients with CCM treated between 2003 and 2020. Patients </=18 years of age with complete magnetic resonance imaging data set, clinical baseline characteristics, and >/=1 follow-up examination were included. Surgically treated individuals were censored after CCM removal. We assessed the impact of various parameters on first or recurrent intracerebral hemorrhage (ICH) at diagnosis using univariate and multivariate logistic regression adjusted for age and sex. Kaplan-Meier and Cox regression analyses were performed to determine the cumulative 5-year risk for (re)hemorrhage. RESULTS: One hundred twenty-nine pediatric patients with CCM were analyzed. Univariate logistic regression identified brain stem CCM (odds ratio, 3.15 [95% CI, 1.15-8.63]; P=0.026) and familial history of CCM (odds ratio, 2.47 [95% CI, 1.04-5.86]; P=0.041) as statistically significant predictors of ICH at diagnosis. Multivariate logistic regression confirmed this correlation (odds ratio, 3.62 [95% CI, 1.18-8.99]; P=0.022 and odds ratio, 2.53 [95% CI, 1.07-5.98]; P=0.035, respectively). Cox regression analysis identified ICH as mode of presentation (hazard ratio, 14.01 [95% CI, 1.80-110.39]; P=0.012) as an independent predictor for rehemorrhage during the 5-year follow-up. The cumulative 5-year risk of (re)bleeding was 15.9% (95% CI, 10.2%-23.6%) for the entire cohort, 30.2% (20.2%-42.3%) for pediatric patients with ICH at diagnosis, and 29.5% (95% CI, 13.9%-51.1%) for children with brain stem CCM. CONCLUSIONS: Pediatric patients with brain stem CCM and familial history of CCM have a higher risk of ICH as mode of presentation. During untreated 5-year follow-up, they revealed a similar risk of (re)hemorrhage compared to adult patients. The probability of (re)bleeding increases over time, especially in cases with ICH at presentation or brain stem localization.',\n",
       "               'FAU': ['Santos, Alejandro N',\n",
       "                'Rauschenbach, Laurel',\n",
       "                'Saban, Dino',\n",
       "                'Chen, Bixia',\n",
       "                'Herten, Annika',\n",
       "                'Dinger, Thiemo Florin',\n",
       "                'Li, Yan',\n",
       "                'Tippelt, Stephan',\n",
       "                'Della Marina, Adela',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Schmidt, Borge',\n",
       "                'Jabbarli, Ramazan',\n",
       "                'Wrede, Karsten H',\n",
       "                'Sure, Ulrich',\n",
       "                'Dammann, Philipp'],\n",
       "               'AU': ['Santos AN',\n",
       "                'Rauschenbach L',\n",
       "                'Saban D',\n",
       "                'Chen B',\n",
       "                'Herten A',\n",
       "                'Dinger TF',\n",
       "                'Li Y',\n",
       "                'Tippelt S',\n",
       "                'Della Marina A',\n",
       "                'Dohna-Schwake C',\n",
       "                'Schmidt B',\n",
       "                'Jabbarli R',\n",
       "                'Wrede KH',\n",
       "                'Sure U',\n",
       "                'Dammann P'],\n",
       "               'AUID': ['ORCID: 0000-0002-6616-5313',\n",
       "                'ORCID: 0000-0001-8348-4298',\n",
       "                'ORCID: 0000-0001-8645-3366',\n",
       "                'ORCID: 0000-0002-9698-4723',\n",
       "                'ORCID: 0000-0002-7009-9099',\n",
       "                'ORCID: 0000-0003-0737-6142',\n",
       "                'ORCID: 0000-0002-8356-6629',\n",
       "                'ORCID: 0000-0001-7076-3503',\n",
       "                'ORCID: 0000-0002-9073-1821'],\n",
       "               'AD': ['Department of Neurosurgery and Spine Surgery (A.N.S., L.R., D.S., B.C., A.H., T.F.D., R.J., K.H.W., U.S., P.D.), University Hospital Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery (A.N.S., L.R., D.S., B.C., A.H., T.F.D., R.J., K.H.W., U.S., P.D.), University Hospital Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery (A.N.S., L.R., D.S., B.C., A.H., T.F.D., R.J., K.H.W., U.S., P.D.), University Hospital Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery (A.N.S., L.R., D.S., B.C., A.H., T.F.D., R.J., K.H.W., U.S., P.D.), University Hospital Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery (A.N.S., L.R., D.S., B.C., A.H., T.F.D., R.J., K.H.W., U.S., P.D.), University Hospital Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery (A.N.S., L.R., D.S., B.C., A.H., T.F.D., R.J., K.H.W., U.S., P.D.), University Hospital Essen, Germany.',\n",
       "                'Institute of Diagnostic and Interventional Radiology and Neuroradiology (Y.L.), University Hospital Essen, Germany.',\n",
       "                'Department of Pediatrics (S.T., A.D.M., C.D.-S.), University Hospital Essen, Germany.',\n",
       "                'Department of Pediatrics (S.T., A.D.M., C.D.-S.), University Hospital Essen, Germany.',\n",
       "                'Department of Pediatrics (S.T., A.D.M., C.D.-S.), University Hospital Essen, Germany.',\n",
       "                'Institute for Medical Informatics, Biometry and Epidemiology (B.S.), University Hospital Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery (A.N.S., L.R., D.S., B.C., A.H., T.F.D., R.J., K.H.W., U.S., P.D.), University Hospital Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery (A.N.S., L.R., D.S., B.C., A.H., T.F.D., R.J., K.H.W., U.S., P.D.), University Hospital Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery (A.N.S., L.R., D.S., B.C., A.H., T.F.D., R.J., K.H.W., U.S., P.D.), University Hospital Essen, Germany.',\n",
       "                'Department of Neurosurgery and Spine Surgery (A.N.S., L.R., D.S., B.C., A.H., T.F.D., R.J., K.H.W., U.S., P.D.), University Hospital Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Clinical Trial', 'Journal Article'],\n",
       "               'DEP': '20211028',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Stroke',\n",
       "               'JT': 'Stroke',\n",
       "               'JID': '0235266',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                '*Cerebral Hemorrhage/diagnostic imaging/mortality/surgery',\n",
       "                'Child',\n",
       "                'Child, Preschool',\n",
       "                'Disease-Free Survival',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                '*Hemangioma, Cavernous, Central Nervous System/diagnostic imaging/mortality/surgery',\n",
       "                'Humans',\n",
       "                '*Magnetic Resonance Imaging',\n",
       "                'Male',\n",
       "                'Risk Factors',\n",
       "                'Survival Rate'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['brain stem',\n",
       "                'magnetic resonance imaging',\n",
       "                'pediatrics',\n",
       "                'population',\n",
       "                'risk factors'],\n",
       "               'EDAT': '2021/10/29 06:00',\n",
       "               'MHDA': '2022/03/11 06:00',\n",
       "               'CRDT': ['2021/10/28 05:24'],\n",
       "               'PHST': ['2021/10/29 06:00 [pubmed]',\n",
       "                '2022/03/11 06:00 [medline]',\n",
       "                '2021/10/28 05:24 [entrez]'],\n",
       "               'AID': ['10.1161/STROKEAHA.121.035338 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Stroke. 2022 Mar;53(3):817-824. doi: 10.1161/STROKEAHA.121.035338. Epub 2021 Oct 28.'},\n",
       "              {'PMID': '34619984',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220218',\n",
       "               'LR': '20220426',\n",
       "               'IS': '1524-4628 (Electronic) 0039-2499 (Linking)',\n",
       "               'VI': '53',\n",
       "               'IP': '2',\n",
       "               'DP': '2022 Feb',\n",
       "               'TI': 'Association of ApoE Genotypes and Recovery From Intracerebral Hemorrhage in Very Low Birth Weight Infants.',\n",
       "               'PG': '514-522',\n",
       "               'LID': '10.1161/STROKEAHA.120.033432 [doi]',\n",
       "               'AB': 'BACKGROUND AND PURPOSE: Associations of APOE genotypes with intracerebral hemorrhage (ICH) in preterm infants were previously described. In adults, APOE-epsilon4 genotype has been proposed as susceptibility factor for impaired recovery after cerebral insult. We here aim to determine APOE genotype-specific neurological consequences of neonatal ICH at school age. METHODS: In this multicenter observational cohort study, very low birth weight (<1500 g, <32 weeks gestational age) children were studied for cerebral palsy (CP) after ultrasound diagnosed ICH stratified by APOE genotype. Follow-up examination was done at the age of 5 to 6 years. Study personnel were blinded for perinatal information and complications. Participants were born between January 1, 2009 and December 31, 2013 and enrolled in the German Neonatal Network. Of 8022 infants primarily enrolled, 2467 children were invited for follow-up between January 1, 2014 and December 31, 2019. Univariate analyses and multivariate logistic regression models were used to assess the impact of APOE genotype (APOE-epsilon2, APOE-epsilon3, APOE-epsilon4) on CP after ICH. RESULTS: Two thousand two hundred fifteen children participated at follow-up, including 363 children with ultrasound diagnosed neonatal ICH. In univariate analyses of children with a history of ICH, APOE-epsilon3 carriers had lower frequencies of CP (n=33/250; 13.2 [95% CI, 9.4%-17.8%]), as compared to APOE-epsilon2 (n=15/63; 23.8 [14.6%-35.3%], P=0.037) and -epsilon4 carriers (n=31/107; 29.0 [21.0%-38.0%], P<0.001), respectively. Regression models revealed an association of APOE-epsilon4 genotype and CP development (odds ratio, 2.77 [1.44-5.32], P=0.002) after ICH. Notably, at low-grade ICH (grade I) APOE-epsilon4 expression resulted in an increased rate of CP (n=6/39; 15.4 [6.7-29.0]) in comparison to APOE-epsilon3 (n=2/105; 1.9 [0.4%-6.0%], P=0.002). CONCLUSIONS: APOE-epsilon4 carriers have an increased risk for long-term motor deficits after ICH. We assume an effect even after low-grade neonatal ICH, but more data are needed to clarify this issue.',\n",
       "               'FAU': ['Humberg, Alexander',\n",
       "                'Dzietko, Mark',\n",
       "                'Schulz, Soren',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Huning, Britta',\n",
       "                'Stein, Anja',\n",
       "                'Fortmann, Mats I',\n",
       "                'Marissen, Janina',\n",
       "                'Rausch, Tanja K',\n",
       "                'Herting, Egbert',\n",
       "                'Hartel, Christoph',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Humberg A',\n",
       "                'Dzietko M',\n",
       "                'Schulz S',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Huning B',\n",
       "                'Stein A',\n",
       "                'Fortmann MI',\n",
       "                'Marissen J',\n",
       "                'Rausch TK',\n",
       "                'Herting E',\n",
       "                'Hartel C',\n",
       "                'Gopel W'],\n",
       "               'AUID': ['ORCID: 0000-0002-1226-0016',\n",
       "                'ORCID: 0000-0002-3035-4841',\n",
       "                'ORCID: 0000-0002-6815-5573'],\n",
       "               'AD': ['Department of Pediatrics (A.H., S.S., M.I.F., T.K.R., E.H., W.G.), University Hospital of Schleswig-Holstein, Lubeck, Germany.',\n",
       "                'Department of Pediatrics I, University Duisburg-Essen, Germany (M.D., U.F-.M. B.H., A.S.).',\n",
       "                'Department of Pediatrics (A.H., S.S., M.I.F., T.K.R., E.H., W.G.), University Hospital of Schleswig-Holstein, Lubeck, Germany.',\n",
       "                'Department of Pediatrics I, University Duisburg-Essen, Germany (M.D., U.F-.M. B.H., A.S.).',\n",
       "                'Department of Pediatrics I, University Duisburg-Essen, Germany (M.D., U.F-.M. B.H., A.S.).',\n",
       "                'Department of Pediatrics I, University Duisburg-Essen, Germany (M.D., U.F-.M. B.H., A.S.).',\n",
       "                'Department of Pediatrics (A.H., S.S., M.I.F., T.K.R., E.H., W.G.), University Hospital of Schleswig-Holstein, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Wurzburg, Germany (J.M., C.H.).',\n",
       "                'Department of Pediatrics (A.H., S.S., M.I.F., T.K.R., E.H., W.G.), University Hospital of Schleswig-Holstein, Lubeck, Germany.',\n",
       "                'Institute of Medical Biometry and Statistics, University of Lubeck (T.K.R.), University Hospital of Schleswig-Holstein, Lubeck, Germany.',\n",
       "                'Department of Pediatrics (A.H., S.S., M.I.F., T.K.R., E.H., W.G.), University Hospital of Schleswig-Holstein, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Wurzburg, Germany (J.M., C.H.).',\n",
       "                'Department of Pediatrics (A.H., S.S., M.I.F., T.K.R., E.H., W.G.), University Hospital of Schleswig-Holstein, Lubeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network (GNN)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Multicenter Study',\n",
       "                'Observational Study',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20211008',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Stroke',\n",
       "               'JT': 'Stroke',\n",
       "               'JID': '0235266',\n",
       "               'RN': ['0 (ApoE protein, human)',\n",
       "                '0 (Apolipoprotein E3)',\n",
       "                '0 (Apolipoprotein E4)',\n",
       "                '0 (Apolipoproteins E)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Apolipoprotein E3/genetics',\n",
       "                'Apolipoprotein E4/genetics',\n",
       "                'Apolipoproteins E/*genetics',\n",
       "                'Cerebral Hemorrhage/complications/diagnostic imaging/*therapy',\n",
       "                'Child',\n",
       "                'Child, Preschool',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Genetic Predisposition to Disease',\n",
       "                'Genotype',\n",
       "                'Gestational Age',\n",
       "                'Heterozygote',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                '*Infant, Very Low Birth Weight',\n",
       "                'Male',\n",
       "                'Movement Disorders/epidemiology/etiology',\n",
       "                'Recovery of Function',\n",
       "                'Treatment Outcome',\n",
       "                'Ultrasonography'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['apolipoprotein',\n",
       "                'cerebral hemorrhage',\n",
       "                'cerebral palsy',\n",
       "                'gestational age',\n",
       "                'infants'],\n",
       "               'EDAT': '2021/10/09 06:00',\n",
       "               'MHDA': '2022/02/19 06:00',\n",
       "               'CRDT': ['2021/10/08 05:33'],\n",
       "               'PHST': ['2021/10/09 06:00 [pubmed]',\n",
       "                '2022/02/19 06:00 [medline]',\n",
       "                '2021/10/08 05:33 [entrez]'],\n",
       "               'AID': ['10.1161/STROKEAHA.120.033432 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Stroke. 2022 Feb;53(2):514-522. doi: 10.1161/STROKEAHA.120.033432. Epub 2021 Oct 8.'},\n",
       "              {'PMID': '34605998',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220209',\n",
       "               'LR': '20220824',\n",
       "               'IS': '1432-1076 (Electronic) 0340-6199 (Print) 0340-6199 (Linking)',\n",
       "               'VI': '181',\n",
       "               'IP': '2',\n",
       "               'DP': '2022 Feb',\n",
       "               'TI': 'Latency duration of preterm premature rupture of membranes and neonatal outcome: a retrospective single-center experience.',\n",
       "               'PG': '801-811',\n",
       "               'LID': '10.1007/s00431-021-04245-2 [doi]',\n",
       "               'AB': \"In preterm premature rupture of membranes (PPROM), a decision between early delivery with prematurity complications and pregnancy prolongation bearing the risk of chorioamnionitis has to be made. To define disadvantages of delayed prolongation, latency duration of PPROM in expectantly managed pregnancies was investigated. We included those PPROMs > 48 h leading to preterm birth prior 37 weeks' gestation and retrospectively analyzed 84 preterm infants fulfilling these criteria. The association between latency duration/appearance of PPROM and respiratory outcome (primary outcomes) and neurological outcome (secondary outcomes) was investigated. The study showed that latency duration of PPROM is not associated with clinical or histological chorioamnionitis (p = 0.275; p = 0.332). As the numerous clinical parameters show multicollinearity between each other, we performed a multiple regression analysis to consider this fact. Respiratory distress syndrome is significantly associated with gestational age at PPROM (p < 0.001), and surfactant application is significantly associated with PPROM duration (p = 0.014). The other respiratory parameters including steroids and diuretics therapy, bronchopulmonary dysplasia, and the neurological parameters (intraventricular hemorrhage, Bayley II testing at a corrected age of 24 months) were not significantly associated with PPROM duration or gestational age at PPROM diagnosis.Conclusion: Latency duration of PPROM was not associated with adverse neonatal outcome in expectantly and carefully managed pregnancies, but respiratory distress syndrome was pronounced. The observed effect of pronounced respiratory distress syndrome can be treated with surfactant preparations and was not followed by increased rate of bronchopulmonary dysplasia. What is Known: * In case of preterm premature rupture of membranes, a decision between pregnancy prolongation with the risk of chorioamnionitis and early delivery with prematurity complications has to be made. * Chorioamnionitis is a dangerous situation for the pregnant woman and the fetus. * Impaired neurodevelopmental outcome is strongly correlated with pronounced prematurity due to the increased rate of serious complications. What is New: * Respiratory distress syndrome is significantly associated with gestational age at PPROM, and surfactant application is significantly associated with PPROM duration. * Latency duration of PPROM is not associated with adverse respiratory neonatal outcome (therapy with continuous positive airway pressure, therapy with diuretics and/or steroids, bronchopulmonary dysplasia) in expectantly and carefully managed pregnancies. * Intraventricular hemorrhage and Bayley II testing at a corrected age of 24 months are not associated with latency duration of PPROM when pregnancies are carefully observed.\",\n",
       "               'CI': ['(c) 2021. The Author(s).'],\n",
       "               'FAU': ['Muller, Hanna',\n",
       "                'Stahling, Ann-Christin',\n",
       "                'Bruns, Nora',\n",
       "                'Weiss, Christel',\n",
       "                'Ai, Maria',\n",
       "                'Koninger, Angela',\n",
       "                'Felderhoff-Muser, Ursula'],\n",
       "               'AU': ['Muller H',\n",
       "                'Stahling AC',\n",
       "                'Bruns N',\n",
       "                'Weiss C',\n",
       "                'Ai M',\n",
       "                'Koninger A',\n",
       "                'Felderhoff-Muser U'],\n",
       "               'AD': ['Neonatology and Pediatric Intensive Care, Department of Pediatrics, University of Marburg, Baldingerstrasse, 35043, Marburg, Germany. Hanna.Mueller@med.uni-marburg.de.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany. Hanna.Mueller@med.uni-marburg.de.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Clinic for Urology and Pediatric Urology, Marien-Hospital Marl, KKRN GmbH, Hervester Str.57, 45768, Marl, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Department of Medical Statistics and Biomathematics, University Hospital Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Erlangen, University of Erlangen-Nurnberg, Loschgestr. 15, 91054, Erlangen, Germany.',\n",
       "                'Department of Gynecology and Obstetrics, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20211004',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Eur J Pediatr',\n",
       "               'JT': 'European journal of pediatrics',\n",
       "               'JID': '7603873',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Child, Preschool',\n",
       "                'Female',\n",
       "                '*Fetal Membranes, Premature Rupture/epidemiology',\n",
       "                'Gestational Age',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature',\n",
       "                'Pregnancy',\n",
       "                'Pregnancy Outcome',\n",
       "                '*Premature Birth',\n",
       "                'Retrospective Studies'],\n",
       "               'PMC': 'PMC8821059',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Chorioamnionitis',\n",
       "                'Neurological development',\n",
       "                'Preterm infant',\n",
       "                'Preterm premature rupture of membranes',\n",
       "                'Respiratory distress syndrome'],\n",
       "               'COIS': ['The authors declare no competing interests.'],\n",
       "               'EDAT': '2021/10/05 06:00',\n",
       "               'MHDA': '2022/02/10 06:00',\n",
       "               'PMCR': ['2021/10/04'],\n",
       "               'CRDT': ['2021/10/04 12:27'],\n",
       "               'PHST': ['2021/05/13 00:00 [received]',\n",
       "                '2021/08/27 00:00 [accepted]',\n",
       "                '2021/08/01 00:00 [revised]',\n",
       "                '2021/10/05 06:00 [pubmed]',\n",
       "                '2022/02/10 06:00 [medline]',\n",
       "                '2021/10/04 12:27 [entrez]',\n",
       "                '2021/10/04 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s00431-021-04245-2 [pii]',\n",
       "                '4245 [pii]',\n",
       "                '10.1007/s00431-021-04245-2 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Pediatr. 2022 Feb;181(2):801-811. doi: 10.1007/s00431-021-04245-2. Epub 2021 Oct 4.'}],\n",
       "             '2021': [{'PMID': '35153856',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20220501',\n",
       "               'IS': '1664-0640 (Print) 1664-0640 (Electronic) 1664-0640 (Linking)',\n",
       "               'VI': '12',\n",
       "               'DP': '2021',\n",
       "               'TI': 'What if... I Asked Cancer Patients About Psychological Distress? Barriers in Psycho-Oncological Screening From the Perspective of Nurses-A Qualitative Analysis.',\n",
       "               'PG': '786691',\n",
       "               'LID': '10.3389/fpsyt.2021.786691 [doi] 786691',\n",
       "               'AB': 'INTRODUCTION: Screening questionnaires to assess psychological distress in cancer patients are well-established, but in practice there are difficulties in implementation screening up to referral to psycho-oncology. Interdisciplinary collaboration between psycho-oncology, physicians, and nursing is very important to this process. However, there are barriers and obstacles on all sides. OBJECTIVE: The aim of this study is to capture in particular the barriers from the perspective of oncology nursing. MATERIALS AND METHODS: Semi-structured interviews with nursing experts (n = 15; n = 10 female; 24-62 years) from different oncology departments of three university hospitals in Germanys were conducted and qualitative content analysis was carried out by two raters. RESULTS: The Screening routine is variably well-integrated into daily clinical practice. Structural barriers such as time pressure and a lack of focus on mental distress in nursing are present. Barriers on the side of nurses are primarily a lack of knowledge and communication insecurities when dealing with patients. CONCLUSIONS: There is a need for training and implementation of a disciplinary screening approach. The structural and organizational barriers, which are a challenge for the successful screening process due to unfavorable interdisciplinary team communication and clinical daily structure, should be addressed in further studies. Implications for Practice: In order to establish an interdisciplinary screening process and to overcome the barriers, trainings to deal with knowledge deficits and insecurities seem to be useful.',\n",
       "               'CI': ['Copyright (c) 2022 Dreismann, Goretzki, Ginger and Zimmermann.'],\n",
       "               'FAU': ['Dreismann, Lara',\n",
       "                'Goretzki, Alina',\n",
       "                'Ginger, Viktoria',\n",
       "                'Zimmermann, Tanja'],\n",
       "               'AU': ['Dreismann L', 'Goretzki A', 'Ginger V', 'Zimmermann T'],\n",
       "               'AD': ['Department of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Hanover, Germany.',\n",
       "                'Department of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Hanover, Germany.',\n",
       "                'Department of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Hanover, Germany.',\n",
       "                'Department of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Hanover, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20220126',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Psychiatry',\n",
       "               'JT': 'Frontiers in psychiatry',\n",
       "               'JID': '101545006',\n",
       "               'PMC': 'PMC8825354',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['cancer nursing',\n",
       "                'distress',\n",
       "                'interdisciplinary work',\n",
       "                'psycho-oncology',\n",
       "                'qualitative research',\n",
       "                'screening'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2022/02/15 06:00',\n",
       "               'MHDA': '2022/02/15 06:01',\n",
       "               'PMCR': ['2022/01/26'],\n",
       "               'CRDT': ['2022/02/14 05:29'],\n",
       "               'PHST': ['2021/09/30 00:00 [received]',\n",
       "                '2021/12/06 00:00 [accepted]',\n",
       "                '2022/02/14 05:29 [entrez]',\n",
       "                '2022/02/15 06:00 [pubmed]',\n",
       "                '2022/02/15 06:01 [medline]',\n",
       "                '2022/01/26 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fpsyt.2021.786691 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Psychiatry. 2022 Jan 26;12:786691. doi: 10.3389/fpsyt.2021.786691. eCollection 2021.'},\n",
       "              {'PMID': '35127587',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20220501',\n",
       "               'IS': '2296-2360 (Print) 2296-2360 (Electronic) 2296-2360 (Linking)',\n",
       "               'VI': '9',\n",
       "               'DP': '2021',\n",
       "               'TI': 'Characterization of aEEG During Sleep and Wakefulness in Healthy Children.',\n",
       "               'PG': '773188',\n",
       "               'LID': '10.3389/fped.2021.773188 [doi] 773188',\n",
       "               'AB': 'INTRODUCTION: Interpretation of amplitude-integrated EEG (aEEG) is hindered by lacking knowledge on physiological background patterns in children. The aim of this study was to find out whether aEEG differs between wakefulness and sleep in children. METHODS: Forty continuous full-channel EEGs (cEEG) recorded during the afternoon and overnight in patients <18 years of age without pathologies or only solitary interictal epileptiform discharges were converted into aEEGs. Upper and lower amplitudes of the C3-C4, P3-P4, C3-P3, C4-P4, and Fp1-Fp2 channels were measured during wakefulness and sleep by two investigators and bandwidths (BW) calculated. Sleep states were assessed according to the American Academy of Sleep Medicine. Median and interquartile ranges (IQR) were calculated to compare the values of amplitudes and bandwidth between wakefulness and sleep. RESULTS: Median age was 9.9 years (IQR 6.1-14.7). All patients displayed continuous background patterns. Amplitudes and BW differed between wakefulness and sleep with median amplitude values of the C3-C4 channel 35 muV (IQR: 27-49) for the upper and 13 muV (10-19) for the lower amplitude. The BW was 29 muV (21-34). During sleep, episodes with high amplitudes [upper: 99 muV (71-125), lower: 35 muV (25-44), BW 63 muV (44-81)] corresponded to sleep states N2-N3. High amplitude-sections were interrupted by low amplitude-sections, which became the longer toward the morning [upper amplitude: 39 muV (30-51), lower: 16 muV (11-20), BW 23 muV (19-31)]. Low amplitude-sections were associated with sleep states REM, N1, and N2. With increasing age, amplitudes and bandwidths declined. CONCLUSION: aEEGs in non-critically ill children displayed a wide range of amplitudes and bandwidths. Amplitudes were low during wakefulness and light sleep and high during deep sleep. Interpretation of pediatric aEEG background patterns must take into account the state of wakefulness in in clinical practice and research.',\n",
       "               'CI': ['Copyright (c) 2022 Loffelhardt, Della Marina, Greve, Muller, Felderhoff-Muser,',\n",
       "                'Dohna-Schwake and Bruns.'],\n",
       "               'FAU': ['Loffelhardt, Verena T',\n",
       "                'Della Marina, Adela',\n",
       "                'Greve, Sandra',\n",
       "                'Muller, Hanna',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Bruns, Nora'],\n",
       "               'AU': ['Loffelhardt VT',\n",
       "                'Della Marina A',\n",
       "                'Greve S',\n",
       "                'Muller H',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dohna-Schwake C',\n",
       "                'Bruns N'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'TNBS, Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics, Neonatology and Pediatric Intensive Care, University of Marburg, Marburg, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'TNBS, Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'TNBS, Centre for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20220121',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Pediatr',\n",
       "               'JT': 'Frontiers in pediatrics',\n",
       "               'JID': '101615492',\n",
       "               'PMC': 'PMC8814596',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['amplitude-integrated EEG (aEEG)',\n",
       "                'antiepileptic drug (AED)',\n",
       "                'children',\n",
       "                'sleep',\n",
       "                'sleep states',\n",
       "                'wakefulness'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2022/02/08 06:00',\n",
       "               'MHDA': '2022/02/08 06:01',\n",
       "               'PMCR': ['2022/01/21'],\n",
       "               'CRDT': ['2022/02/07 05:34'],\n",
       "               'PHST': ['2021/09/09 00:00 [received]',\n",
       "                '2021/12/31 00:00 [accepted]',\n",
       "                '2022/02/07 05:34 [entrez]',\n",
       "                '2022/02/08 06:00 [pubmed]',\n",
       "                '2022/02/08 06:01 [medline]',\n",
       "                '2022/01/21 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fped.2021.773188 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Pediatr. 2022 Jan 21;9:773188. doi: 10.3389/fped.2021.773188. eCollection 2021.'},\n",
       "              {'PMID': '34943923',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220103',\n",
       "               'LR': '20240226',\n",
       "               'IS': '2073-4409 (Electronic) 2073-4409 (Linking)',\n",
       "               'VI': '10',\n",
       "               'IP': '12',\n",
       "               'DP': '2021 Dec 4',\n",
       "               'TI': 'The Fusion Protein rFlaA:Betv1 Modulates DC Responses by a p38-MAPK and COX2-Dependent Secretion of PGE(2) from Epithelial Cells.',\n",
       "               'LID': '10.3390/cells10123415 [doi] 3415',\n",
       "               'AB': 'Developing new adjuvants/vaccines and better understanding their mode-of-action is an important task. To specifically improve birch pollen allergy treatment, we designed a fusion protein consisting of major birch pollen allergen Betv1 conjugated to the TLR5-ligand flagellin (rFlaA:Betv1). This study investigates the immune-modulatory effects of rFlaA:Betv1 on airway epithelial cells. LA-4 mouse lung epithelial cells were stimulated with rFlaA:Betv1 in the presence/absence of various inhibitors with cytokine- and chemokine secretion quantified by ELISA and activation of intracellular signaling cascades demonstrated by Western blot (WB). Either LA-4 cells or LA-4-derived supernatants were co-cultured with BALB/c bone marrow-derived myeloid dendritic cells (mDCs). Compared to equimolar amounts of flagellin and Betv1 provided as a mixture, rFlaA:Betv1 induced higher secretion of IL-6 and the chemokines CCL2 and CCL20 from LA-4 cells and a pronounced MAPK- and NFkappaB-activation. Mechanistically, rFlaA:Betv1 was taken up more strongly and the induced cytokine production was inhibited by NFkappaB-inhibitors, while ERK- and p38-MAPK-inhibitors only suppressed IL-6 and CCL2 secretion. In co-cultures of LA-4 cells with mDCs, rFlaA:Betv1-stimulated LA-4 cells p38-MAPK- and COX2-dependently secreted PGE(2), which modulated DC responses by suppressing pro-inflammatory IL-12 and TNF-alpha secretion. Taken together, these results contribute to our understanding of the mechanisms underlying the strong immune-modulatory effects of flagellin-containing fusion proteins.',\n",
       "               'FAU': ['Lin, Yen-Ju',\n",
       "                'Flaczyk, Adam',\n",
       "                'Wolfheimer, Sonja',\n",
       "                'Goretzki, Alexandra',\n",
       "                'Jamin, Annette',\n",
       "                'Wangorsch, Andrea',\n",
       "                'Vieths, Stefan',\n",
       "                'Scheurer, Stephan',\n",
       "                'Schulke, Stefan'],\n",
       "               'AU': ['Lin YJ',\n",
       "                'Flaczyk A',\n",
       "                'Wolfheimer S',\n",
       "                'Goretzki A',\n",
       "                'Jamin A',\n",
       "                'Wangorsch A',\n",
       "                'Vieths S',\n",
       "                'Scheurer S',\n",
       "                'Schulke S'],\n",
       "               'AUID': ['ORCID: 0000-0002-0761-9506',\n",
       "                'ORCID: 0000-0002-5184-5455',\n",
       "                'ORCID: 0000-0002-2859-562X',\n",
       "                'ORCID: 0000-0002-9674-5116'],\n",
       "               'AD': ['Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['DFG SCHE637/4-1/Deutsche Forschungsgemeinschaft/',\n",
       "                'DFG SCHU2951/4/Deutsche Forschungsgemeinschaft/'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20211204',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Cells',\n",
       "               'JT': 'Cells',\n",
       "               'JID': '101600052',\n",
       "               'RN': ['0 (Chemokine CCL2)',\n",
       "                '0 (Chemokine CCL20)',\n",
       "                '0 (Chemokines)',\n",
       "                '0 (Interleukin-6)',\n",
       "                '0 (NF-kappa B)',\n",
       "                '0 (Recombinant Fusion Proteins)',\n",
       "                '0 (Toll-Like Receptor 5)',\n",
       "                'EC 1.14.99.1 (Cyclooxygenase 2)',\n",
       "                'EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases)',\n",
       "                'K7Q1JQR04M (Dinoprostone)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Animals',\n",
       "                'Cell Line',\n",
       "                'Chemokine CCL2/metabolism',\n",
       "                'Chemokine CCL20/metabolism',\n",
       "                'Chemokines/metabolism',\n",
       "                'Cyclooxygenase 2/*metabolism',\n",
       "                'Dendritic Cells/drug effects/*metabolism',\n",
       "                'Dinoprostone/*metabolism',\n",
       "                'Epithelial Cells/drug effects/*metabolism',\n",
       "                'Interleukin-6/metabolism',\n",
       "                'MAP Kinase Signaling System/drug effects',\n",
       "                'Mice, Inbred BALB C',\n",
       "                'Models, Biological',\n",
       "                'NF-kappa B/metabolism',\n",
       "                'Phosphorylation/drug effects',\n",
       "                'Recombinant Fusion Proteins/*pharmacology',\n",
       "                'Solubility',\n",
       "                'Toll-Like Receptor 5/metabolism',\n",
       "                'p38 Mitogen-Activated Protein Kinases/*metabolism',\n",
       "                'Mice'],\n",
       "               'PMC': 'PMC8700022',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Betv1',\n",
       "                'epithelial cells',\n",
       "                'flagellin',\n",
       "                'fusion protein',\n",
       "                'vaccine'],\n",
       "               'COIS': ['The authors have no conflict of interest to declare.'],\n",
       "               'EDAT': '2021/12/25 06:00',\n",
       "               'MHDA': '2022/01/04 06:00',\n",
       "               'PMCR': ['2021/12/04'],\n",
       "               'CRDT': ['2021/12/24 01:04'],\n",
       "               'PHST': ['2021/09/13 00:00 [received]',\n",
       "                '2021/11/26 00:00 [revised]',\n",
       "                '2021/12/02 00:00 [accepted]',\n",
       "                '2021/12/24 01:04 [entrez]',\n",
       "                '2021/12/25 06:00 [pubmed]',\n",
       "                '2022/01/04 06:00 [medline]',\n",
       "                '2021/12/04 00:00 [pmc-release]'],\n",
       "               'AID': ['cells10123415 [pii]',\n",
       "                'cells-10-03415 [pii]',\n",
       "                '10.3390/cells10123415 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Cells. 2021 Dec 4;10(12):3415. doi: 10.3390/cells10123415.'},\n",
       "              {'PMID': '34925372',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220209',\n",
       "               'LR': '20220209',\n",
       "               'IS': '1664-3224 (Electronic) 1664-3224 (Linking)',\n",
       "               'VI': '12',\n",
       "               'DP': '2021',\n",
       "               'TI': 'Immune Metabolism of IL-4-Activated B Cells and Th2 Cells in the Context of Allergic Diseases.',\n",
       "               'PG': '790658',\n",
       "               'LID': '10.3389/fimmu.2021.790658 [doi] 790658',\n",
       "               'AB': 'Over the last decades, the frequency of allergic disorders has steadily increased. Immunologically, allergies are caused by abnormal immune responses directed against otherwise harmless antigens derived from our environment. Two of the main cell types driving allergic sensitization and inflammation are IgE-producing plasma cells and Th2 cells. The acute activation of T and B cells, their differentiation into effector cells, as well as the formation of immunological memory are paralleled by distinct changes in cellular metabolism. Understanding the functional consequences of these metabolic changes is the focus of a new research field termed \"immune metabolism\". Currently, the contribution of metabolic changes in T and B cells to either the development or maintenance of allergies is not completely understood. Therefore, this mini review will introduce the fundamentals of energy metabolism, its connection to immune metabolism, and subsequently focus on the metabolic phenotypes of IL-4-activated B cells and Th2 cells.',\n",
       "               'CI': ['Copyright (c) 2021 Lin, Goretzki and Schulke.'],\n",
       "               'FAU': ['Lin, Yen-Ju',\n",
       "                'Goretzki, Alexandra',\n",
       "                'Schulke, Stefan'],\n",
       "               'AU': ['Lin YJ', 'Goretzki A', 'Schulke S'],\n",
       "               'AD': ['Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                'Review'],\n",
       "               'DEP': '20211201',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Immunol',\n",
       "               'JT': 'Frontiers in immunology',\n",
       "               'JID': '101560960',\n",
       "               'RN': ['207137-56-2 (Interleukin-4)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['B-Lymphocytes/*immunology/metabolism',\n",
       "                'Energy Metabolism',\n",
       "                'Germinal Center/metabolism',\n",
       "                'Humans',\n",
       "                'Hypersensitivity/*immunology/metabolism',\n",
       "                'Interleukin-4/*pharmacology',\n",
       "                'Lymphocyte Activation/*drug effects',\n",
       "                'Th2 Cells/*immunology/metabolism'],\n",
       "               'PMC': 'PMC8671807',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Warburg metabolism',\n",
       "                'allergies',\n",
       "                'fatty acid oxidation (FAO)',\n",
       "                'glycolysis',\n",
       "                'immune metabolism',\n",
       "                'metabolism',\n",
       "                'oxidative phosphorylation'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2021/12/21 06:00',\n",
       "               'MHDA': '2022/02/10 06:00',\n",
       "               'PMCR': ['2021/01/01'],\n",
       "               'CRDT': ['2021/12/20 06:06'],\n",
       "               'PHST': ['2021/10/07 00:00 [received]',\n",
       "                '2021/11/08 00:00 [accepted]',\n",
       "                '2021/12/20 06:06 [entrez]',\n",
       "                '2021/12/21 06:00 [pubmed]',\n",
       "                '2022/02/10 06:00 [medline]',\n",
       "                '2021/01/01 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fimmu.2021.790658 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Immunol. 2021 Dec 1;12:790658. doi: 10.3389/fimmu.2021.790658. eCollection 2021.'},\n",
       "              {'PMID': '34886539',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20211214',\n",
       "               'LR': '20211214',\n",
       "               'IS': '1660-4601 (Electronic) 1661-7827 (Print) 1660-4601 (Linking)',\n",
       "               'VI': '18',\n",
       "               'IP': '23',\n",
       "               'DP': '2021 Dec 5',\n",
       "               'TI': \"Parents' Perception of Family-Centered Music Therapy with Stable Preterm Infants.\",\n",
       "               'LID': '10.3390/ijerph182312813 [doi] 12813',\n",
       "               'AB': \"Premature birth places considerable demands on preterm infants and their families. Most of these infants are treated on a neonatal intensive care unit immediately after birth, leading to psychosocial stress for parents and making it more difficult to build a stable parent-child bond. We hypothesized that accompaniment with live music therapy by a music therapist supports the parents to get in contact with their child and to promote the parents' wellbeing. Preterm infants born at less than 32 gestational weeks received creative music therapy twice a week until discharge. At the time of discharge, the parents were asked to complete a Likert-style questionnaire to evaluate the music therapy. Six items related to socio-demographic characteristics, 4 items to observations on the infant and 10 items to personal perception. Of 40 preterm infants receiving music therapy, 32 (80%) parents completed the questionnaires. Thirty (94%) of these parents were able to relax during the music therapy session. Relaxation in their infants was observed by 29 (91%) during and by 28 (88%) after music therapy. Parents perceived music therapy as a positive change and enrichment during their infant's hospital stay. All parents were thankful for the music therapy they received. Music therapy supports the parents of preterm infants in the first time after birth until discharge from the hospital.\",\n",
       "               'FAU': ['Kobus, Susann',\n",
       "                'Diezel, Marlis',\n",
       "                'Huening, Britta',\n",
       "                'Dewan, Monia Vanessa',\n",
       "                'Felderhoff-Mueser, Ursula',\n",
       "                'Bruns, Nora'],\n",
       "               'AU': ['Kobus S',\n",
       "                'Diezel M',\n",
       "                'Huening B',\n",
       "                'Dewan MV',\n",
       "                'Felderhoff-Mueser U',\n",
       "                'Bruns N'],\n",
       "               'AUID': ['ORCID: 0000-0003-2223-402X',\n",
       "                'ORCID: 0000-0002-6815-5573',\n",
       "                'ORCID: 0000-0003-3809-1887'],\n",
       "               'AD': ['Clinic for Pediatrics I, Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Clinic for Pediatrics I, Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Clinic for Pediatrics I, Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Clinic for Pediatrics I, Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Clinic for Pediatrics I, Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Clinic for Pediatrics I, Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20211205',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Int J Environ Res Public Health',\n",
       "               'JT': 'International journal of environmental research and public health',\n",
       "               'JID': '101238455',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Female',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature',\n",
       "                'Intensive Care Units, Neonatal',\n",
       "                '*Music',\n",
       "                '*Music Therapy',\n",
       "                'Perception',\n",
       "                'Pregnancy'],\n",
       "               'PMC': 'PMC8657748',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['family',\n",
       "                'family-centered',\n",
       "                'music therapy',\n",
       "                'neonatal intensive care unit',\n",
       "                'parents',\n",
       "                'premature infants',\n",
       "                'preterm infants'],\n",
       "               'COIS': ['The authors have no conflict of interests to declare.'],\n",
       "               'EDAT': '2021/12/11 06:00',\n",
       "               'MHDA': '2021/12/15 06:00',\n",
       "               'PMCR': ['2021/12/05'],\n",
       "               'CRDT': ['2021/12/10 01:10'],\n",
       "               'PHST': ['2021/10/12 00:00 [received]',\n",
       "                '2021/11/23 00:00 [revised]',\n",
       "                '2021/12/03 00:00 [accepted]',\n",
       "                '2021/12/10 01:10 [entrez]',\n",
       "                '2021/12/11 06:00 [pubmed]',\n",
       "                '2021/12/15 06:00 [medline]',\n",
       "                '2021/12/05 00:00 [pmc-release]'],\n",
       "               'AID': ['ijerph182312813 [pii]',\n",
       "                'ijerph-18-12813 [pii]',\n",
       "                '10.3390/ijerph182312813 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Int J Environ Res Public Health. 2021 Dec 5;18(23):12813. doi: 10.3390/ijerph182312813.'},\n",
       "              {'PMID': '34685593',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20211213',\n",
       "               'LR': '20211214',\n",
       "               'IS': '2073-4409 (Electronic) 2073-4409 (Linking)',\n",
       "               'VI': '10',\n",
       "               'IP': '10',\n",
       "               'DP': '2021 Oct 1',\n",
       "               'TI': 'The Flagellin:Allergen Fusion Protein rFlaA:Betv1 Induces a MyD88- and MAPK-Dependent Activation of Glucose Metabolism in Macrophages.',\n",
       "               'LID': '10.3390/cells10102614 [doi] 2614',\n",
       "               'AB': 'TLR5 ligand flagellin-containing fusion proteins are potential vaccine candidates for many diseases. A recombinant fusion protein of flagellin A and the major birch pollen allergen Bet v 1 (rFlaA:Betv1) modulates immune responses in vitro and in vivo. We studied the effects of rFlaA:Betv1 on bone marrow-derived macrophages (BMDMs). BMDMs differentiated from BALB/c, C57BL/6, TLR5(-/-), or MyD88(-/-) mice were pre-treated with inhibitors, stimulated with rFlaA:Betv1 or respective controls, and analyzed for activation, cytokine secretion, metabolic state, RNA transcriptome, and modulation of allergen-specific Th2 responses. Stimulation of BMDMs with rFlaA:Betv1 resulted in MyD88-dependent production of IL-1beta, IL-6, TNF-alpha, IL-10, CD69 upregulation, and a pronounced shift towards glycolysis paralleled by activation of MAPK, NFkappaB, and mTOR signaling. Inhibition of either mTOR (rapamycin) or SAP/JNK-MAPK signaling (SP600125) resulted in dose-dependent metabolic suppression. In BMDM and T cell co-cultures, rFlaA:Betv1 stimulation suppressed rBet v 1-induced IL-5 and IL-13 secretion while inducing IFN-gamma production. mRNA-Seq analyses showed HIF-1a, JAK, STAT, phagosome, NLR, NFkappaB, TNF, TLR, and chemokine signaling to participate in the interplay of cell activation, glycolysis, and immune response. rFlaA:Betv1 strongly activated BMDMs, resulting in MyD88-, MAPK-, and mTOR-dependent enhancement of glucose metabolism. Our results suggest macrophages are important target cells to consider during restauration of allergen tolerance during AIT.',\n",
       "               'FAU': ['Lin, Yen-Ju',\n",
       "                'Papp, Garibald',\n",
       "                'Miskey, Csaba',\n",
       "                'Fiedler, Anna',\n",
       "                'Goretzki, Alexandra',\n",
       "                'Wolfheimer, Sonja',\n",
       "                'Zimmermann, Jennifer',\n",
       "                'Crauwels, Peter',\n",
       "                'Ivics, Zoltan',\n",
       "                'van Zandbergen, Ger',\n",
       "                'Vieths, Stefan',\n",
       "                'Scheurer, Stephan',\n",
       "                'Schulke, Stefan'],\n",
       "               'AU': ['Lin YJ',\n",
       "                'Papp G',\n",
       "                'Miskey C',\n",
       "                'Fiedler A',\n",
       "                'Goretzki A',\n",
       "                'Wolfheimer S',\n",
       "                'Zimmermann J',\n",
       "                'Crauwels P',\n",
       "                'Ivics Z',\n",
       "                'van Zandbergen G',\n",
       "                'Vieths S',\n",
       "                'Scheurer S',\n",
       "                'Schulke S'],\n",
       "               'AD': ['Vice Presidents Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Vice Presidents Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Medical Biotechnology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Vice Presidents Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Vice Presidents Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Vice Presidents Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Vice Presidents Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Immunology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Medical Biotechnology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Immunology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Institute of Immunology, University Medical Center of the Johannes Gutenberg University of Mainz, 55122 Mainz, Germany.',\n",
       "                'Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg-University Mainz, 55122 Mainz, Germany.',\n",
       "                'Vice Presidents Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Vice Presidents Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.',\n",
       "                'Vice Presidents Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.'],\n",
       "               'AUID': ['ORCID: 0000-0002-7566-9556',\n",
       "                'ORCID: 0000-0002-7803-6658',\n",
       "                'ORCID: 0000-0002-2859-562X',\n",
       "                'ORCID: 0000-0002-9674-5116'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['DFG SCHE637/4-1/Deutsche Forschungsgemeinschaft/',\n",
       "                'DFG SCHU2951/4/Deutsche Forschungsgemeinschaft/'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20211001',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Cells',\n",
       "               'JT': 'Cells',\n",
       "               'JID': '101600052',\n",
       "               'RN': ['0 (Allergens)',\n",
       "                '0 (Antigens, Bacterial)',\n",
       "                '0 (Antigens, Plant)',\n",
       "                '0 (Bacterial Proteins)',\n",
       "                '0 (Plant Proteins)',\n",
       "                '0 (Recombinant Fusion Proteins)',\n",
       "                '12777-81-0 (Flagellin)',\n",
       "                'IY9XDZ35W2 (Glucose)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Allergens/*immunology',\n",
       "                'Animals',\n",
       "                'Antigens, Bacterial/*immunology',\n",
       "                'Antigens, Plant/*immunology',\n",
       "                'Bacterial Proteins/immunology',\n",
       "                'Cells, Cultured',\n",
       "                'Flagellin/*immunology',\n",
       "                'Glucose/metabolism',\n",
       "                'Macrophages',\n",
       "                'Mice',\n",
       "                'Mice, Inbred BALB C',\n",
       "                'Mice, Inbred C57BL',\n",
       "                'Mice, Knockout',\n",
       "                'Plant Proteins/immunology',\n",
       "                'Pollen/immunology',\n",
       "                'Recombinant Fusion Proteins/*immunology'],\n",
       "               'PMC': 'PMC8534024',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Bet v 1',\n",
       "                'HIF-1a',\n",
       "                'TLR5',\n",
       "                'Warburg',\n",
       "                'allergen',\n",
       "                'flagellin',\n",
       "                'fusion protein',\n",
       "                'immune metabolism',\n",
       "                'metabolism'],\n",
       "               'COIS': ['The authors declare no conflict of interest.'],\n",
       "               'EDAT': '2021/10/24 06:00',\n",
       "               'MHDA': '2021/12/15 06:00',\n",
       "               'PMCR': ['2021/10/01'],\n",
       "               'CRDT': ['2021/10/23 01:22'],\n",
       "               'PHST': ['2021/06/22 00:00 [received]',\n",
       "                '2021/09/15 00:00 [revised]',\n",
       "                '2021/09/21 00:00 [accepted]',\n",
       "                '2021/10/23 01:22 [entrez]',\n",
       "                '2021/10/24 06:00 [pubmed]',\n",
       "                '2021/12/15 06:00 [medline]',\n",
       "                '2021/10/01 00:00 [pmc-release]'],\n",
       "               'AID': ['cells10102614 [pii]',\n",
       "                'cells-10-02614 [pii]',\n",
       "                '10.3390/cells10102614 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Cells. 2021 Oct 1;10(10):2614. doi: 10.3390/cells10102614.'},\n",
       "              {'PMID': '34660495',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20240403',\n",
       "               'IS': '2296-2360 (Print) 2296-2360 (Electronic) 2296-2360 (Linking)',\n",
       "               'VI': '9',\n",
       "               'DP': '2021',\n",
       "               'TI': 'Hospitalization and Morbidity Rates After Pediatric Traumatic Brain Injury: A Nation-Wide Population-Based Analysis.',\n",
       "               'PG': '747743',\n",
       "               'LID': '10.3389/fped.2021.747743 [doi] 747743',\n",
       "               'AB': 'Background: Even though traumatic brain injury (TBI) is a major cause of morbidity and mortality in children around the globe, population-based and nation-wide data to assess the burden of TBI is scarce. Methods:Based on diagnosis related groups from nation-wide hospital data, we extracted data on all TBI-related hospitalizations in children <18 years in Germany between 2014 and 2018. We calculated crude, age-specific and standardized incidence rates for hospitalizations, imaging, intracranial injury, neurosurgery, and mortality. Results:Out of 10.2 million hospitalizations, we identified 458,844 cases with TBI as primary or secondary diagnosis, resulting in a crude incidence rate of 687/100,000 child years (CY). Age-specific rates of computed tomography were below 30/100,000 CY until the age of 10 years and increased to 162/100,000 CY until 17 years of age. Intracranial injury was diagnosed in 2.7%, neurosurgery was performed in 0.7% of patients, and 0.7% were mechanically ventilated. Mortality was 0.67/100,000 CY (0.1%). Conclusions:Despite substantial hospitalization rates for pediatric TBI in Germany, the rates of imaging, the need for mechanical ventilation, neurosurgery and mortality were overall very low. Reasons for hospitalization and measures to reduce unnecessary admissions warrant further investigation.',\n",
       "               'CI': ['Copyright (c) 2021 Bruns, Trocchi, Felderhoff-Muser, Dohna-Schwake and Stang.'],\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Trocchi, Pietro',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Stang, Andreas'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Trocchi P',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dohna-Schwake C',\n",
       "                'Stang A'],\n",
       "               'AD': ['Department of Pediatrics I, Pediatric Intensive Care Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational and Behavioural Neurosciences (TNBS), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Institute for Medical Informatics, Biometry, and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Pediatric Intensive Care Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Translational and Behavioural Neurosciences (TNBS), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Pediatric Intensive Care Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Institute for Medical Informatics, Biometry, and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Epidemiology, School of Public Health, Boston University, Boston, MA, United States.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20210930',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Pediatr',\n",
       "               'JT': 'Frontiers in pediatrics',\n",
       "               'JID': '101615492',\n",
       "               'PMC': 'PMC8515415',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['epidemiology',\n",
       "                'hospitalization',\n",
       "                'incidence rates',\n",
       "                'morbidity',\n",
       "                'mortality',\n",
       "                'pediatric traumatic brain injury'],\n",
       "               'COIS': ['The authors declare that the research was conducted in the absence of any',\n",
       "                'commercial or financial relationships that could be construed as a potential',\n",
       "                'conflict of interest.'],\n",
       "               'EDAT': '2021/10/19 06:00',\n",
       "               'MHDA': '2021/10/19 06:01',\n",
       "               'PMCR': ['2021/09/30'],\n",
       "               'CRDT': ['2021/10/18 09:07'],\n",
       "               'PHST': ['2021/07/26 00:00 [received]',\n",
       "                '2021/09/03 00:00 [accepted]',\n",
       "                '2021/10/18 09:07 [entrez]',\n",
       "                '2021/10/19 06:00 [pubmed]',\n",
       "                '2021/10/19 06:01 [medline]',\n",
       "                '2021/09/30 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fped.2021.747743 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Pediatr. 2021 Sep 30;9:747743. doi: 10.3389/fped.2021.747743. eCollection 2021.'},\n",
       "              {'PMID': '34443994',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20210906',\n",
       "               'LR': '20210906',\n",
       "               'IS': '1660-4601 (Electronic) 1661-7827 (Print) 1660-4601 (Linking)',\n",
       "               'VI': '18',\n",
       "               'IP': '16',\n",
       "               'DP': '2021 Aug 4',\n",
       "               'TI': 'Music Therapy Is Effective during Sleep in Preterm Infants.',\n",
       "               'LID': '10.3390/ijerph18168245 [doi] 8245',\n",
       "               'AB': \"Recent research found evidence supporting music therapy for preterm infants to stabilize vital signs and possibly promote neurodevelopment. Even though preterm infants spend a considerable amount of time sleeping, the effectiveness of music therapy during sleep has not been studied. The aim of this study was to investigate the effect of music therapy on preterm infants' vital signs with respect to the state of wakefulness. The first 20 consecutive infants born with <32 weeks' gestational age (GA) from the intervention group of an ongoing randomized controlled trial received live music therapy twice a week until hospital discharge. The heart rate, respiratory rate, oxygen saturation, and state of wakefulness were recorded before and after therapy. We observed significantly lower heart and respiratory rates and higher oxygen saturation after live music therapy sessions in general (mean differences -4.9 beats per min; -7.0 breaths per min and +1.5%, respectively). When music therapy was applied during sleep, respiratory rates significantly lowered by 8.8 breaths per min and oxygen saturation increased by 1.6%, whereas in the awake state the vital parameters did not significantly change (heart rate -5.2 beats per min; respiratory rate +0.6 breaths per min and oxygen saturation +1.0%). Music therapy stabilized the respiratory rates and oxygen saturations in sleeping preterm infants.\",\n",
       "               'FAU': ['Kobus, Susann',\n",
       "                'Diezel, Marlis',\n",
       "                'Dewan, Monia Vanessa',\n",
       "                'Huening, Britta',\n",
       "                'Dathe, Anne-Kathrin',\n",
       "                'Felderhoff-Mueser, Ursula',\n",
       "                'Bruns, Nora'],\n",
       "               'AU': ['Kobus S',\n",
       "                'Diezel M',\n",
       "                'Dewan MV',\n",
       "                'Huening B',\n",
       "                'Dathe AK',\n",
       "                'Felderhoff-Mueser U',\n",
       "                'Bruns N'],\n",
       "               'AUID': ['ORCID: 0000-0003-2223-402X',\n",
       "                'ORCID: 0000-0001-5351-3975',\n",
       "                'ORCID: 0000-0003-3809-1887'],\n",
       "               'AD': ['Clinic for Pediatrics I, Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Clinic for Pediatrics I, Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Clinic for Pediatrics I, Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Clinic for Pediatrics I, Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Clinic for Pediatrics I, Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Clinic for Pediatrics I, Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.',\n",
       "                'Clinic for Pediatrics I, Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Randomized Controlled Trial',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20210804',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Int J Environ Res Public Health',\n",
       "               'JT': 'International journal of environmental research and public health',\n",
       "               'JID': '101238455',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Heart Rate',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature',\n",
       "                '*Music Therapy',\n",
       "                'Sleep',\n",
       "                'Vital Signs'],\n",
       "               'PMC': 'PMC8391215',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['music therapy',\n",
       "                'neonatal intensive care unit',\n",
       "                'premature infants',\n",
       "                'preterm infants',\n",
       "                'sleep'],\n",
       "               'COIS': ['The authors have no conflict of interests to declare.'],\n",
       "               'EDAT': '2021/08/28 06:00',\n",
       "               'MHDA': '2021/09/07 06:00',\n",
       "               'PMCR': ['2021/08/04'],\n",
       "               'CRDT': ['2021/08/27 01:18'],\n",
       "               'PHST': ['2021/06/27 00:00 [received]',\n",
       "                '2021/07/29 00:00 [revised]',\n",
       "                '2021/07/30 00:00 [accepted]',\n",
       "                '2021/08/27 01:18 [entrez]',\n",
       "                '2021/08/28 06:00 [pubmed]',\n",
       "                '2021/09/07 06:00 [medline]',\n",
       "                '2021/08/04 00:00 [pmc-release]'],\n",
       "               'AID': ['ijerph18168245 [pii]',\n",
       "                'ijerph-18-08245 [pii]',\n",
       "                '10.3390/ijerph18168245 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Int J Environ Res Public Health. 2021 Aug 4;18(16):8245. doi: 10.3390/ijerph18168245.'},\n",
       "              {'PMID': '34385150',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20211124',\n",
       "               'LR': '20211124',\n",
       "               'IS': '2052-4439 (Electronic) 2052-4439 (Linking)',\n",
       "               'VI': '8',\n",
       "               'IP': '1',\n",
       "               'DP': '2021 Aug',\n",
       "               'TI': 'Coil embolisation for massive haemoptysis in cystic fibrosis.',\n",
       "               'LID': '10.1136/bmjresp-2021-000985 [doi] e000985',\n",
       "               'AB': 'INTRODUCTION: Massive haemoptysis is a life-threatening event in advanced cystic fibrosis (CF) lung disease with bronchial artery embolisation (BAE) as standard of care treatment. The aim of our study was to scrutinise short-term and long-term outcomes of patients with CF and haemoptysis after BAE using coils. METHODS: We carried out a retrospective cohort study of 34 adult patients treated for massive haemoptysis with super selective bronchial artery coil embolisation (ssBACE) between January 2008 and February 2015. Embolisation protocol was restricted to the culprit vessel(s) and three lobes maximum. Demographic data, functional end-expiratory volume in 1 s in % predicted (FEV1% pred.) and body mass index before and after ssBACE, sputum colonisation, procedural data, time to transplant and time to death were documented. RESULTS: Patients treated with ssBACE showed significant improvement of FEV(1)% pred. after embolisation (p=0.004) with 72.8% alive 5 years post-ssBACE. Mean age of the patients was 29.9 years (+/-7.7). Mean FEV(1)% pred. was 45.7% (+/-20.1). Median survival to follow-up was 75 months (0-125). Severe complication rate was 0%, recanalisation rate 8.8% and 5-year-reintervention rate 58.8%. Chronic infection with Pseudomonas aeruginosa was found in 79.4%, Staphylococcus areus in 50% and Aspergillus fumigatus in 47.1%. DISCUSSION: ssBACE is a safe and effective treatment for massive haemoptysis in patients with CF with good results for controlling haemostasis and excellent short-term and long-term survival, especially in severely affected patients with FEV<40% pred. We think the data of our study support the use of coils and a protocol of careful and prudent embolisation.',\n",
       "               'CI': ['(c) Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No',\n",
       "                'commercial re-use. See rights and permissions. Published by BMJ.'],\n",
       "               'FAU': ['Dohna, Martha',\n",
       "                'Renz, Diane Miriam',\n",
       "                'Stehling, Florian',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Sutharsan, Sivagurunathan',\n",
       "                'Neurohr, Claus',\n",
       "                'Wirtz, Hubert',\n",
       "                'Eickmeier, Olaf',\n",
       "                'Grosse-Onnebrink, Jorg',\n",
       "                'Sauerbrey, Axel',\n",
       "                'Soditt, Volker',\n",
       "                'Poplawska, Krystyna',\n",
       "                'Wacker, Frank',\n",
       "                'Montag, Michael Johannes'],\n",
       "               'AU': ['Dohna M',\n",
       "                'Renz DM',\n",
       "                'Stehling F',\n",
       "                'Dohna-Schwake C',\n",
       "                'Sutharsan S',\n",
       "                'Neurohr C',\n",
       "                'Wirtz H',\n",
       "                'Eickmeier O',\n",
       "                'Grosse-Onnebrink J',\n",
       "                'Sauerbrey A',\n",
       "                'Soditt V',\n",
       "                'Poplawska K',\n",
       "                'Wacker F',\n",
       "                'Montag MJ'],\n",
       "               'AUID': ['ORCID: 0000-0002-2471-8530'],\n",
       "               'AD': ['Pediatric Radiology, Hannover Medical School, Hannover, Germany dohna.martha@mh-hannover.de.',\n",
       "                'Radiology, Hannover Medical School, Hannover, Germany.',\n",
       "                'Department of Pediatric Pulmonology and Sleep Medicine, University Hospital Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, Essen, Germany.',\n",
       "                'Ruhrlandklinik Pneumology, University Hospital Essen, Essen, Germany.',\n",
       "                'Robert-Bosch-Krankenhaus Klinik Schillerhohe, Gerlingen, Germany.',\n",
       "                'Department of Respiratory Medicine, University Hospital Leipzig, Leipzig, Germany.',\n",
       "                'Department of Pneumology, Hospital of the Goethe University Frankfurt, Frankfurt am Main, Germany.',\n",
       "                'Department of General Pediatrics, University Hospital Munster, Munster, Germany.',\n",
       "                'Pediatrics, HELIOS Klinikum Erfurt, Erfurt, Germany.',\n",
       "                'Pediatrics, Stadtisches Klinikum Solingen, Solingen, Germany.',\n",
       "                'Pediatrics, Johannes Gutenberg University Hospital Mainz, Mainz, Germany.',\n",
       "                'Radiology, Hannover Medical School, Hannover, Germany.',\n",
       "                'Department of Clinical Radiology, University Hospital Munster, Munster, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'England',\n",
       "               'TA': 'BMJ Open Respir Res',\n",
       "               'JT': 'BMJ open respiratory research',\n",
       "               'JID': '101638061',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Bronchial Arteries/diagnostic imaging',\n",
       "                '*Cystic Fibrosis/complications/therapy',\n",
       "                '*Embolization, Therapeutic',\n",
       "                'Hemoptysis/etiology/therapy',\n",
       "                'Humans',\n",
       "                'Retrospective Studies'],\n",
       "               'PMC': 'PMC8362706',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['cystic fibrosis', 'massive haemoptysis'],\n",
       "               'COIS': ['Competing interests: None declared.'],\n",
       "               'EDAT': '2021/08/14 06:00',\n",
       "               'MHDA': '2021/11/25 06:00',\n",
       "               'PMCR': ['2021/08/12'],\n",
       "               'CRDT': ['2021/08/13 06:12'],\n",
       "               'PHST': ['2021/05/08 00:00 [received]',\n",
       "                '2021/07/26 00:00 [accepted]',\n",
       "                '2021/08/13 06:12 [entrez]',\n",
       "                '2021/08/14 06:00 [pubmed]',\n",
       "                '2021/11/25 06:00 [medline]',\n",
       "                '2021/08/12 00:00 [pmc-release]'],\n",
       "               'AID': ['8/1/e000985 [pii]',\n",
       "                'bmjresp-2021-000985 [pii]',\n",
       "                '10.1136/bmjresp-2021-000985 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'BMJ Open Respir Res. 2021 Aug;8(1):e000985. doi: 10.1136/bmjresp-2021-000985.'},\n",
       "              {'PMID': '34160425',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20210701',\n",
       "               'LR': '20240812',\n",
       "               'IS': '1536-5964 (Electronic) 0025-7974 (Print) 0025-7974 (Linking)',\n",
       "               'VI': '100',\n",
       "               'IP': '25',\n",
       "               'DP': '2021 Jun 25',\n",
       "               'TI': 'Next-generation sequencing diagnostics of bacteremia in pediatric sepsis.',\n",
       "               'PG': 'e26403',\n",
       "               'LID': '10.1097/MD.0000000000026403 [doi] e26403',\n",
       "               'AB': 'INTRODUCTION: Sepsis and septic shock are the most severe forms of infection affecting predominantly elderly people, preterm and term neonates, and young infants. Even in high-income countries sepsis causes about 8% of admissions to pediatric intensive care units (PICUs). Early diagnosis, rapid anti-infective treatment, and prompt hemodynamic stabilization are crucial for patient survival. In this context, it is essential to identify the causative pathogen as soon as possible to optimize antimicrobial treatment. To date, culture-based diagnostic procedures (e.g., blood cultures) represent the standard of care. However, they have 2 major problems: on the one hand, in the case of very small sample volumes (and thus usually in children), they are not sufficiently sensitive. On the other hand, with a time-to-result of 2 to 5 days, blood cultures need a relatively long time for the anti-infective therapy to be calculated. To overcome these problems, culture-independent molecular diagnostic procedures such as unbiased sequence analysis of circulating cell-free DNA (cfDNA) from plasma samples of septic patients by next-generation sequencing (NGS) have been tested successfully in adult septic patients. However, these results still need to be transferred to the pediatric setting. METHODS: The Next GeneSiPS-Trial is a prospective, observational, non-interventional, multicenter study used to assess the diagnostic performance of an NGS-based approach for the identification of causative pathogens in (preterm and term) neonates (d1-d28, n = 50), infants (d29 to <1 yr, n = 50), and toddlers (1 yr to <5 yr, n = 50) with suspected or proven severe sepsis or septic shock (according to the pediatric sepsis definition) by the use of the quantitative sepsis indicating quantifier (SIQ) score in comparison to standard of care (culture-based) microbiological diagnostics. Potential changes in anti-infective treatment regimens based on these NGS results will be estimated retrospectively by a panel of 3 independent clinical specialists. DISCUSSION: Neonates, infants, and young children are significantly affected by sepsis. Fast and more sensitive diagnostic approaches are urgently needed. This prospective, observational, non-interventional, multicenter study seeks to evaluate an NGS-based approach in critically ill children suffering from sepsis. TRIAL REGISTRATION: DRKS-ID: DRKS00015705 (registered October 24, 2018). https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00015705.',\n",
       "               'CI': ['Copyright (c) 2021 the Author(s). Published by Wolters Kluwer Health, Inc.'],\n",
       "               'FAU': ['Schmoch, Thomas',\n",
       "                'Westhoff, Jens H',\n",
       "                'Decker, Sebastian O',\n",
       "                'Skarabis, Annabell',\n",
       "                'Hoffmann, Georg F',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Skolik, Caroline',\n",
       "                'Feisst, Manuel',\n",
       "                'Klose, Christina',\n",
       "                'Bruckner, Thomas',\n",
       "                'Luntz, Steffen',\n",
       "                'Weigand, Markus A',\n",
       "                'Sohn, Kai',\n",
       "                'Brenner, Thorsten'],\n",
       "               'AU': ['Schmoch T',\n",
       "                'Westhoff JH',\n",
       "                'Decker SO',\n",
       "                'Skarabis A',\n",
       "                'Hoffmann GF',\n",
       "                'Dohna-Schwake C',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Skolik C',\n",
       "                'Feisst M',\n",
       "                'Klose C',\n",
       "                'Bruckner T',\n",
       "                'Luntz S',\n",
       "                'Weigand MA',\n",
       "                'Sohn K',\n",
       "                'Brenner T'],\n",
       "               'AD': ['Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University Duisburg-Essen, Essen.',\n",
       "                'Department of Anesthesiology, Heidelberg University Hospital.',\n",
       "                \"Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg.\",\n",
       "                'Department of Anesthesiology, Heidelberg University Hospital.',\n",
       "                'Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University Duisburg-Essen, Essen.',\n",
       "                \"Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg.\",\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen.',\n",
       "                'Institute of Medical Biometry, University of Heidelberg.',\n",
       "                'Institute of Medical Biometry, University of Heidelberg.',\n",
       "                'Institute of Medical Biometry, University of Heidelberg.',\n",
       "                'Institute of Medical Biometry, University of Heidelberg.',\n",
       "                'Coordination Centre for Clinical Trials (KKS), Ruprecht-Karls-University, Heidelberg.',\n",
       "                'Department of Anesthesiology, Heidelberg University Hospital.',\n",
       "                'Fraunhofer Institute for Interfacial Engineering and Biotechnology, Stuttgart, Germany.',\n",
       "                'Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University Duisburg-Essen, Essen.'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['1DH2111010/Dietmar Hopp Stiftung/'],\n",
       "               'PT': ['Clinical Trial Protocol', 'Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Medicine (Baltimore)',\n",
       "               'JT': 'Medicine',\n",
       "               'JID': '2985248R',\n",
       "               'RN': ['0 (Anti-Bacterial Agents)', '0 (DNA, Bacterial)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Anti-Bacterial Agents/therapeutic use',\n",
       "                'Bacteremia/*diagnosis/drug therapy/microbiology',\n",
       "                'Bacteria/genetics/*isolation & purification',\n",
       "                'Blood Culture',\n",
       "                'Child, Preschool',\n",
       "                'DNA, Bacterial/isolation & purification',\n",
       "                'Early Diagnosis',\n",
       "                'Female',\n",
       "                '*High-Throughput Nucleotide Sequencing',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Intensive Care Units, Pediatric',\n",
       "                'Male',\n",
       "                'Molecular Diagnostic Techniques/*methods',\n",
       "                'Multicenter Studies as Topic',\n",
       "                'Observational Studies as Topic',\n",
       "                'Prospective Studies',\n",
       "                'Retrospective Studies',\n",
       "                'Severity of Illness Index',\n",
       "                'Shock, Septic/blood/*diagnosis/drug therapy/microbiology'],\n",
       "               'PMC': 'PMC8238315',\n",
       "               'COIS': ['The authors have no conflicts of interest to disclose.'],\n",
       "               'EDAT': '2021/06/24 06:00',\n",
       "               'MHDA': '2021/07/02 06:00',\n",
       "               'PMCR': ['2021/06/25'],\n",
       "               'CRDT': ['2021/06/23 12:20'],\n",
       "               'PHST': ['2021/05/26 00:00 [received]',\n",
       "                '2021/06/03 00:00 [accepted]',\n",
       "                '2021/06/23 12:20 [entrez]',\n",
       "                '2021/06/24 06:00 [pubmed]',\n",
       "                '2021/07/02 06:00 [medline]',\n",
       "                '2021/06/25 00:00 [pmc-release]'],\n",
       "               'AID': ['00005792-202106250-00048 [pii]',\n",
       "                'MD-D-21-03746 [pii]',\n",
       "                '10.1097/MD.0000000000026403 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Medicine (Baltimore). 2021 Jun 25;100(25):e26403. doi: 10.1097/MD.0000000000026403.'},\n",
       "              {'PMID': '33895584',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220125',\n",
       "               'LR': '20220125',\n",
       "               'IS': '1873-5150 (Electronic) 0887-8994 (Linking)',\n",
       "               'VI': '119',\n",
       "               'DP': '2021 Jun',\n",
       "               'TI': 'Epidemiology, Diagnostics, and Management of Vein of Galen Malformation.',\n",
       "               'PG': '50-55',\n",
       "               'LID': 'S0887-8994(21)00027-8 [pii] 10.1016/j.pediatrneurol.2021.02.007 [doi]',\n",
       "               'AB': 'BACKGROUND: Vein of Galen malformation (VGM) is a rare congenital intracerebral vascular malformation. The aim of this study was to gain reliable data about epidemiology; clinical manifestations; and pre-, peri- and postinterventional treatment strategies in Germany. METHODS: This prospective epidemiologic study was conducted by Erhebungseinheit fur Seltene Padiatrische Erkrankungen in Deutschland, a hospital-based German nationwide surveillance unit for rare pediatric diseases. Patients aged upto 18 years with a new diagnosis of VGM were prospectively included between January 1, 2014 and December 31, 2015. RESULTS: In the two-year study period, 30 individuals with newly diagnosed VGM were identified, resulting in an estimated annual incidence rate of VGM in Germany of at least 1: 58,100 live births. The main symptoms were age dependent. Neonates presented with mainly cardiac manifestations of high output failure; infants and older children mainly suffered from neurological complications. Of the patients with endovascular treatment 95% survived, but only 41% of these patients were discharged home without any complications. The Bicetre Neonatal Evaluation Score was a good predictor for poor outcome but could have led to palliative care in some patients with good outcome. CONCLUSIONS: The incidence of VGM in Germany is estimated to be 1:58,100 live births. The majority of patients were eligible for endovascular treatment. Nevertheless, due to side effects and long-term sequelae in the majority of patients, further improvement in care of children with VGM is needed.',\n",
       "               'CI': ['Copyright (c) 2021 Elsevier Inc. All rights reserved.'],\n",
       "               'FAU': ['Brevis Nunez, Francisco', 'Dohna-Schwake, Christian'],\n",
       "               'AU': ['Brevis Nunez F', 'Dohna-Schwake C'],\n",
       "               'AD': ['Department of Neonatology & Pediatric Intensive Care, Sana-Kliniken Duisburg GmbH, Duisburg, Germany. Electronic address: francisco.brevis@sana.de.',\n",
       "                'Department of Pediatrics I, University Medicine Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20210303',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Pediatr Neurol',\n",
       "               'JT': 'Pediatric neurology',\n",
       "               'JID': '8508183',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Child, Preschool',\n",
       "                'Endovascular Procedures',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Male',\n",
       "                'Prospective Studies',\n",
       "                'Vein of Galen Malformations/*diagnosis/*epidemiology/*therapy'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['BNES',\n",
       "                'Bicetre Neonatal Evaluation Score',\n",
       "                'Embolization',\n",
       "                'Endovascular treatment',\n",
       "                'VGM',\n",
       "                'Vein of Galen malformation'],\n",
       "               'EDAT': '2021/04/26 06:00',\n",
       "               'MHDA': '2022/01/27 06:00',\n",
       "               'CRDT': ['2021/04/25 20:41'],\n",
       "               'PHST': ['2020/10/25 00:00 [received]',\n",
       "                '2021/02/16 00:00 [revised]',\n",
       "                '2021/02/22 00:00 [accepted]',\n",
       "                '2021/04/26 06:00 [pubmed]',\n",
       "                '2022/01/27 06:00 [medline]',\n",
       "                '2021/04/25 20:41 [entrez]'],\n",
       "               'AID': ['S0887-8994(21)00027-8 [pii]',\n",
       "                '10.1016/j.pediatrneurol.2021.02.007 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Pediatr Neurol. 2021 Jun;119:50-55. doi: 10.1016/j.pediatrneurol.2021.02.007. Epub 2021 Mar 3.'},\n",
       "              {'PMID': '33811351',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20211115',\n",
       "               'LR': '20211115',\n",
       "               'IS': '1398-9995 (Electronic) 0105-4538 (Linking)',\n",
       "               'VI': '76',\n",
       "               'IP': '11',\n",
       "               'DP': '2021 Nov',\n",
       "               'TI': 'Immune metabolism in allergies, does it matter?-A review of immune metabolic basics and adaptations associated with the activation of innate immune cells in allergy.',\n",
       "               'PG': '3314-3331',\n",
       "               'LID': '10.1111/all.14843 [doi]',\n",
       "               'AB': 'Type I allergies are pathological, type 2 inflammatory immune responses against otherwise harmless environmental allergens that arise from complex interactions between different types of immune cells. Activated immune cells undergo extensive changes in phenotype and function to fulfill their effector functions. Hereby, activation, differentiation, proliferation, migration, and mounting of effector responses require metabolic reprogramming. While the metabolic changes associated with activation of dendritic cells, macrophages, and T cells are extensively studied, data about the metabolic phenotypes of the other cell types critically involved in allergic responses (epithelial cells, eosinophils, basophils, mast cells, and ILC2s) are rather limited. This review briefly covers the basics of cellular energy metabolism and its connection to immune cell function. In addition, it summarizes the current state of knowledge in terms of dendritic cell and macrophage metabolism and subsequently focuses on the metabolic changes associated with activation of epithelial cells, eosinophils, basophils, mast cells, as well as ILC2s in allergy. Interestingly, the innate key cell types in allergic inflammation were reported to change their metabolic phenotype during activation, shifting to either glycolysis (epithelial cells, M1 macrophages, DCs, eosinophils, basophils, acutely activated mast cells), oxidative phosphorylation (M2 macrophages, longer term activated mast cells), or fatty acid oxidation (ILC2s). Therefore, immune metabolism is of relevance in allergic diseases and its connection to immune cell effector function needs to be considered to better understand induction and maintenance of allergic responses. Further progress in this field will likely improve both our understanding of disease pathology and enable new treatment targets/strategies.',\n",
       "               'CI': ['(c) 2021 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.'],\n",
       "               'FAU': ['Goretzki, Alexandra',\n",
       "                'Lin, Yen-Ju',\n",
       "                'Schulke, Stefan'],\n",
       "               'AU': ['Goretzki A', 'Lin YJ', 'Schulke S'],\n",
       "               'AD': ['Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.',\n",
       "                'Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.'],\n",
       "               'AUID': ['ORCID: 0000-0002-9674-5116'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                'Review'],\n",
       "               'DEP': '20210506',\n",
       "               'PL': 'Denmark',\n",
       "               'TA': 'Allergy',\n",
       "               'JT': 'Allergy',\n",
       "               'JID': '7804028',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Basophils',\n",
       "                'Humans',\n",
       "                '*Hypersensitivity',\n",
       "                '*Immunity, Innate',\n",
       "                'Lymphocytes',\n",
       "                'Mast Cells'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['allergies',\n",
       "                'glycolysis',\n",
       "                'immune metabolism',\n",
       "                'metabolism',\n",
       "                'oxidative phosphorylation',\n",
       "                'warburg effect'],\n",
       "               'EDAT': '2021/04/04 06:00',\n",
       "               'MHDA': '2021/11/16 06:00',\n",
       "               'CRDT': ['2021/04/03 05:55'],\n",
       "               'PHST': ['2021/03/11 00:00 [revised]',\n",
       "                '2020/11/03 00:00 [received]',\n",
       "                '2021/03/28 00:00 [accepted]',\n",
       "                '2021/04/04 06:00 [pubmed]',\n",
       "                '2021/11/16 06:00 [medline]',\n",
       "                '2021/04/03 05:55 [entrez]'],\n",
       "               'AID': ['10.1111/all.14843 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Allergy. 2021 Nov;76(11):3314-3331. doi: 10.1111/all.14843. Epub 2021 May 6.'},\n",
       "              {'PMID': '33741410',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20211019',\n",
       "               'LR': '20211019',\n",
       "               'IS': '1089-8638 (Electronic) 0022-2836 (Linking)',\n",
       "               'VI': '433',\n",
       "               'IP': '17',\n",
       "               'DP': '2021 Aug 20',\n",
       "               'TI': 'Unstructural Biology of TRP Ion Channels: The Role of Intrinsically Disordered Regions in Channel Function and Regulation.',\n",
       "               'PG': '166931',\n",
       "               'LID': 'S0022-2836(21)00131-5 [pii] 10.1016/j.jmb.2021.166931 [doi]',\n",
       "               'AB': 'The first genuine high-resolution single particle cryo-electron microscopy structure of a membrane protein determined was a transient receptor potential (TRP) ion channel, TRPV1, in 2013. This methodical breakthrough opened up a whole new world for structural biology and ion channel aficionados alike. TRP channels capture the imagination due to the sheer endless number of tasks they carry out in all aspects of animal physiology. To date, structures of at least one representative member of each of the six mammalian TRP channel subfamilies as well as of a few non-mammalian families have been determined. These structures were instrumental for a better understanding of TRP channel function and regulation. However, all of the TRP channel structures solved so far are incomplete since they miss important information about highly flexible regions found mostly in the channel N- and C-termini. These intrinsically disordered regions (IDRs) can represent between a quarter to almost half of the entire protein sequence and act as important recruitment hubs for lipids and regulatory proteins. Here, we analyze the currently available TRP channel structures with regard to the extent of these \"missing\" regions and compare these findings to disorder predictions. We discuss select examples of intra- and intermolecular crosstalk of TRP channel IDRs with proteins and lipids as well as the effect of splicing and post-translational modifications, to illuminate their importance for channel function and to complement the prevalently discussed structural biology of these versatile and fascinating proteins with their equally relevant \\'unstructural\\' biology.',\n",
       "               'CI': ['Copyright (c) 2021 Elsevier Ltd. All rights reserved.'],\n",
       "               'FAU': ['Goretzki, Benedikt',\n",
       "                'Guhl, Charlotte',\n",
       "                'Tebbe, Frederike',\n",
       "                'Harder, Jean-Martin',\n",
       "                'Hellmich, Ute A'],\n",
       "               'AU': ['Goretzki B',\n",
       "                'Guhl C',\n",
       "                'Tebbe F',\n",
       "                'Harder JM',\n",
       "                'Hellmich UA'],\n",
       "               'AD': ['Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich-Schiller-University, Humboldtstrasse 10, 07743 Jena, Germany; Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe-University, Max-von-Laue-Strasse 9, 60438 Frankfurt, Germany.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich-Schiller-University, Humboldtstrasse 10, 07743 Jena, Germany; Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe-University, Max-von-Laue-Strasse 9, 60438 Frankfurt, Germany; TransMED - Mainz Research School of Translational Medicine, Johannes Gutenberg-University, University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich-Schiller-University, Humboldtstrasse 10, 07743 Jena, Germany; Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe-University, Max-von-Laue-Strasse 9, 60438 Frankfurt, Germany.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich-Schiller-University, Humboldtstrasse 10, 07743 Jena, Germany.',\n",
       "                'Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich-Schiller-University, Humboldtstrasse 10, 07743 Jena, Germany; Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe-University, Max-von-Laue-Strasse 9, 60438 Frankfurt, Germany; TransMED - Mainz Research School of Translational Medicine, Johannes Gutenberg-University, University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany; Cluster of Excellence Balance of the Microverse, Friedrich-Schiller-University, 07743 Jena, Germany. Electronic address: ute.hellmich@uni-jena.de.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                'Review'],\n",
       "               'DEP': '20210316',\n",
       "               'PL': 'Netherlands',\n",
       "               'TA': 'J Mol Biol',\n",
       "               'JT': 'Journal of molecular biology',\n",
       "               'JID': '2985088R',\n",
       "               'RN': ['0 (Lipids)',\n",
       "                '0 (Proteins)',\n",
       "                '0 (Transient Receptor Potential Channels)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Animals',\n",
       "                'Cryoelectron Microscopy/methods',\n",
       "                'Humans',\n",
       "                'Lipids/chemistry',\n",
       "                'Mammals/metabolism',\n",
       "                'Protein Processing, Post-Translational/physiology',\n",
       "                'Proteins/metabolism',\n",
       "                'RNA Splicing/physiology',\n",
       "                'Transient Receptor Potential Channels/*metabolism'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['TRP channel sensitization and inhibition',\n",
       "                'alternative splicing',\n",
       "                'disorder predictions',\n",
       "                'post-translational modification',\n",
       "                'protein and lipid interactions'],\n",
       "               'COIS': ['Declaration of Competing Interest The authors declare that they have no known',\n",
       "                'competing financial interests or personal relationships that could have appeared',\n",
       "                'to influence the work reported in this paper.'],\n",
       "               'EDAT': '2021/03/21 06:00',\n",
       "               'MHDA': '2021/10/21 06:00',\n",
       "               'CRDT': ['2021/03/20 05:59'],\n",
       "               'PHST': ['2021/01/10 00:00 [received]',\n",
       "                '2021/03/02 00:00 [revised]',\n",
       "                '2021/03/06 00:00 [accepted]',\n",
       "                '2021/03/21 06:00 [pubmed]',\n",
       "                '2021/10/21 06:00 [medline]',\n",
       "                '2021/03/20 05:59 [entrez]'],\n",
       "               'AID': ['S0022-2836(21)00131-5 [pii]',\n",
       "                '10.1016/j.jmb.2021.166931 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Mol Biol. 2021 Aug 20;433(17):166931. doi: 10.1016/j.jmb.2021.166931. Epub 2021 Mar 16.'},\n",
       "              {'PMID': '33675325',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20220113',\n",
       "               'LR': '20230914',\n",
       "               'IS': '1744-6880 (Electronic) 1744-6872 (Linking)',\n",
       "               'VI': '31',\n",
       "               'IP': '6',\n",
       "               'DP': '2021 Aug 1',\n",
       "               'TI': 'NAT2 polymorphisms as a cause of metamizole-induced agranulocytosis.',\n",
       "               'PG': '140-143',\n",
       "               'LID': '10.1097/FPC.0000000000000432 [doi]',\n",
       "               'AB': 'Metamizole is a widely prescribed NSAID with excellent analgesic and antipyretic properties. Although very effective, it is banned in some countries because of the risk for severe agranulocytosis. We here describe three patients with metamizole-associated agranulocytosis. Patient #1 suffered from agranulocytosis and tonsillitis followed by severe sepsis by Streptococcus pneumoniae and Epstein-Barr virus reactivation. Her dizygotic twin sister (patient #2) also suffered from agranulocytosis after a surgical intervention. Patient #3 initially had a tonsillitis and also developed neutropenia after metamizole intake. For all patients, pharmacogenetic diagnostic for the genes CYP2C9, CYP2C19 and NAT2, which are involved in metamizole metabolism and degradation of toxic metabolites, was initiated. Pharmacogenetic analysis revealed NAT2 slow acetylator phenotype in all three patients. Additionally, patient #2 is an intermediate metabolizer for CYP2C19 and patient #3 is a poor metabolizer for CYP2C9. Impairment of these enzymes causes a reduced degradation of toxic metabolites, for example, 4-methylaminoantipyrine (4-MAA) or 4-aminoantipyrine. The metabolite 4-MAA can complex with hemin, which is an early breakdown product during hemolysis. Hemolysis is often observed during invasive infections or after surgical procedures. It is known that the 4-MAA/hemin complex can induce cytotoxicity in the bone marrow and interrupt granulocyte maturation. In conclusion, metamizole-induced agranulocytosis most likely was a consequence of the underlying genetical predisposition, that is, polymorphisms in the genes NAT2, CYP2C9 and CYP2C19. Hemolysis may have increased the toxicity of metamizole metabolites.',\n",
       "               'CI': ['Copyright (c) 2021 Wolters Kluwer Health, Inc. All rights reserved.'],\n",
       "               'FAU': ['Radulovic, Ivana',\n",
       "                'Dogan, Burcin',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Schundeln, Michael M',\n",
       "                'Siffert, Winfried',\n",
       "                'Mohlendick, Birte'],\n",
       "               'AU': ['Radulovic I',\n",
       "                'Dogan B',\n",
       "                'Dohna-Schwake C',\n",
       "                'Schundeln MM',\n",
       "                'Siffert W',\n",
       "                'Mohlendick B'],\n",
       "               'AD': ['Department of Pediatrics III, Pediatric Hematology and Oncology, Cardiology, Pulmonology.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology.',\n",
       "                'Department of Pediatrics III, Pediatric Hematology and Oncology, Cardiology, Pulmonology.',\n",
       "                'Institute of Pharmacogenetics, University Hospital Essen, University of Duisburg-Essen, Germany.',\n",
       "                'Institute of Pharmacogenetics, University Hospital Essen, University of Duisburg-Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Pharmacogenet Genomics',\n",
       "               'JT': 'Pharmacogenetics and genomics',\n",
       "               'JID': '101231005',\n",
       "               'RN': ['0 (Anti-Inflammatory Agents, Non-Steroidal)',\n",
       "                '6429L0L52Y (Dipyrone)',\n",
       "                'EC 2.3.1.5 (Arylamine N-Acetyltransferase)',\n",
       "                'EC 2.3.1.5 (NAT2 protein, human)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Anti-Inflammatory Agents, Non-Steroidal/adverse effects',\n",
       "                '*Arylamine N-Acetyltransferase/genetics',\n",
       "                'Dipyrone/adverse effects',\n",
       "                '*Epstein-Barr Virus Infections',\n",
       "                'Female',\n",
       "                'Herpesvirus 4, Human',\n",
       "                'Humans',\n",
       "                '*Neutropenia'],\n",
       "               'EDAT': '2021/03/07 06:00',\n",
       "               'MHDA': '2022/01/14 06:00',\n",
       "               'CRDT': ['2021/03/06 12:05'],\n",
       "               'PHST': ['2021/03/07 06:00 [pubmed]',\n",
       "                '2022/01/14 06:00 [medline]',\n",
       "                '2021/03/06 12:05 [entrez]'],\n",
       "               'AID': ['01213011-202108000-00003 [pii]',\n",
       "                '10.1097/FPC.0000000000000432 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Pharmacogenet Genomics. 2021 Aug 1;31(6):140-143. doi: 10.1097/FPC.0000000000000432.'},\n",
       "              {'PMID': '33664271',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20210317',\n",
       "               'LR': '20210323',\n",
       "               'IS': '2041-1723 (Electronic) 2041-1723 (Linking)',\n",
       "               'VI': '12',\n",
       "               'IP': '1',\n",
       "               'DP': '2021 Mar 4',\n",
       "               'TI': 'Neuropathy-causing TRPV4 mutations disrupt TRPV4-RhoA interactions and impair neurite extension.',\n",
       "               'PG': '1444',\n",
       "               'LID': '10.1038/s41467-021-21699-y [doi] 1444',\n",
       "               'AB': 'TRPV4 is a cell surface-expressed calcium-permeable cation channel that mediates cell-specific effects on cellular morphology and function. Dominant missense mutations of TRPV4 cause distinct, tissue-specific diseases, but the pathogenic mechanisms are unknown. Mutations causing peripheral neuropathy localize to the intracellular N-terminal domain whereas skeletal dysplasia mutations are in multiple domains. Using an unbiased screen, we identified the cytoskeletal remodeling GTPase RhoA as a TRPV4 interactor. TRPV4-RhoA binding occurs via the TRPV4 N-terminal domain, resulting in suppression of TRPV4 channel activity, inhibition of RhoA activation, and extension of neurites in vitro. Neuropathy but not skeletal dysplasia mutations disrupt TRPV4-RhoA binding and cytoskeletal outgrowth. However, inhibition of RhoA restores neurite length in vitro and in a fly model of TRPV4 neuropathy. Together these results identify RhoA as a critical mediator of TRPV4-induced cell structure changes and suggest that disruption of TRPV4-RhoA binding may contribute to tissue-specific toxicity of TRPV4 neuropathy mutations.',\n",
       "               'FAU': ['McCray, Brett A',\n",
       "                'Diehl, Erika',\n",
       "                'Sullivan, Jeremy M',\n",
       "                'Aisenberg, William H',\n",
       "                'Zaccor, Nicholas W',\n",
       "                'Lau, Alexander R',\n",
       "                'Rich, Dominick J',\n",
       "                'Goretzki, Benedikt',\n",
       "                'Hellmich, Ute A',\n",
       "                'Lloyd, Thomas E',\n",
       "                'Sumner, Charlotte J'],\n",
       "               'AU': ['McCray BA',\n",
       "                'Diehl E',\n",
       "                'Sullivan JM',\n",
       "                'Aisenberg WH',\n",
       "                'Zaccor NW',\n",
       "                'Lau AR',\n",
       "                'Rich DJ',\n",
       "                'Goretzki B',\n",
       "                'Hellmich UA',\n",
       "                'Lloyd TE',\n",
       "                'Sumner CJ'],\n",
       "               'AUID': ['ORCID: 0000-0001-6581-9728',\n",
       "                'ORCID: 0000-0003-0002-3328',\n",
       "                'ORCID: 0000-0002-0540-3592',\n",
       "                'ORCID: 0000-0002-7721-6657',\n",
       "                'ORCID: 0000-0003-4756-3700',\n",
       "                'ORCID: 0000-0001-5088-6012'],\n",
       "               'AD': ['Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. bmccray3@jhmi.edu.',\n",
       "                'Department of Chemistry, Biochemistry Section, Johannes Gutenberg-Universitat Mainz, Mainz, Germany.',\n",
       "                'Center for Biomolecular Magnetic Resonance (BMRZ), Goethe-Universitat, Frankfurt am Main, Germany.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.',\n",
       "                'Department of Chemistry, Biochemistry Section, Johannes Gutenberg-Universitat Mainz, Mainz, Germany.',\n",
       "                'Center for Biomolecular Magnetic Resonance (BMRZ), Goethe-Universitat, Frankfurt am Main, Germany.',\n",
       "                'Department of Chemistry, Biochemistry Section, Johannes Gutenberg-Universitat Mainz, Mainz, Germany.',\n",
       "                'Center for Biomolecular Magnetic Resonance (BMRZ), Goethe-Universitat, Frankfurt am Main, Germany.',\n",
       "                \"Institute of Organic Chemistry and Macromolecular Chemistry, Cluster of Excellence 'Balance of the Microverse', Friedrich-Schiller-Universitat, Jena, Germany.\",\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.',\n",
       "                'The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.',\n",
       "                'Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. csumner1@jhmi.edu.',\n",
       "                'The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA. csumner1@jhmi.edu.'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['R01 NS094239/NS/NINDS NIH HHS/United States',\n",
       "                'R01 NS115475/NS/NINDS NIH HHS/United States',\n",
       "                'R01 NS082563/NS/NINDS NIH HHS/United States',\n",
       "                'F31 NS105404/NS/NINDS NIH HHS/United States',\n",
       "                'S10 OD023548/OD/NIH HHS/United States',\n",
       "                'K08 NS102509/NS/NINDS NIH HHS/United States',\n",
       "                'P40 OD018537/OD/NIH HHS/United States'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Research Support, N.I.H., Extramural',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                \"Research Support, U.S. Gov't, Non-P.H.S.\"],\n",
       "               'DEP': '20210304',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Nat Commun',\n",
       "               'JT': 'Nature communications',\n",
       "               'JID': '101528555',\n",
       "               'RN': ['0 (TRPV Cation Channels)',\n",
       "                '0 (TRPV4 protein, human)',\n",
       "                '124671-05-2 (RHOA protein, human)',\n",
       "                'EC 3.6.5.2 (rhoA GTP-Binding Protein)',\n",
       "                'SY7Q814VUP (Calcium)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Actin Cytoskeleton/metabolism',\n",
       "                'Animals',\n",
       "                'COS Cells',\n",
       "                'Calcium/metabolism',\n",
       "                'Cell Line',\n",
       "                'Chlorocebus aethiops',\n",
       "                'Drosophila',\n",
       "                'HEK293 Cells',\n",
       "                'Humans',\n",
       "                'Neurites/*metabolism',\n",
       "                'Peripheral Nervous System Diseases/*genetics',\n",
       "                'TRPV Cation Channels/*genetics/*metabolism',\n",
       "                'rhoA GTP-Binding Protein/*metabolism'],\n",
       "               'PMC': 'PMC7933254',\n",
       "               'COIS': ['The authors declare no competing interests.'],\n",
       "               'EDAT': '2021/03/06 06:00',\n",
       "               'MHDA': '2021/03/18 06:00',\n",
       "               'PMCR': ['2021/03/04'],\n",
       "               'CRDT': ['2021/03/05 05:59'],\n",
       "               'PHST': ['2020/05/13 00:00 [received]',\n",
       "                '2021/02/02 00:00 [accepted]',\n",
       "                '2021/03/05 05:59 [entrez]',\n",
       "                '2021/03/06 06:00 [pubmed]',\n",
       "                '2021/03/18 06:00 [medline]',\n",
       "                '2021/03/04 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1038/s41467-021-21699-y [pii]',\n",
       "                '21699 [pii]',\n",
       "                '10.1038/s41467-021-21699-y [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Nat Commun. 2021 Mar 4;12(1):1444. doi: 10.1038/s41467-021-21699-y.'},\n",
       "              {'PMID': '33613925',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20230919',\n",
       "               'IS': '2036-3605 (Print) 2036-3613 (Electronic) 2036-3605 (Linking)',\n",
       "               'VI': '13',\n",
       "               'DP': '2021',\n",
       "               'TI': 'Insulinoma in pregnancy (a case presentation and systematic review of the literature).',\n",
       "               'PG': '2036361320986647',\n",
       "               'LID': '10.1177/2036361320986647 [doi] 2036361320986647',\n",
       "               'AB': 'Insulinomas are rare, benign and functional tumors that coincidentally may become overt during pregnancy or in the post-partum period. As the general symptoms of a pregnancy might cover the clinical presentation, diagnosing remains challenging. We present one additional case of a post-partum insulinoma, combined with a systematic review of the literature to sum up relevant details in diagnosis and treatment. A systematic request of Pubmed/Medline was conducted using the following terms: \"insulinoma AND pregnancy\" and \"insulinoma\" for a second request of ClinicalTrials.gov. All publications concerning pregnant or post-partum women with insulinoma were included. Thirty-six cases could be identified for analysis. Each publication was reviewed for demographic, diagnostic and therapeutic data. The most frequent clinical signs were unconsciousness and neurological symptoms. 64.9% were diagnosed during early pregnancy and 35.1% post-partum. 91.9% underwent surgery with a third resected during pregnancy without severe influence on fetal or maternal outcome. Three patients died of metastatic disease or misdiagnosing, two of them miscarried. Insulinoma in pregnancy is rare but should be considered in case of unclear hyperinsulinemic hypoglycemia. Surgery can be performed during the second trimester or post-partum with promising outcome.',\n",
       "               'CI': ['(c) The Author(s) 2021.'],\n",
       "               'FAU': ['Dobrindt, Eva M',\n",
       "                'Mogl, Martina',\n",
       "                'Goretzki, Peter E',\n",
       "                'Pratschke, Johann',\n",
       "                'Dukaczewska, Agata K'],\n",
       "               'AU': ['Dobrindt EM',\n",
       "                'Mogl M',\n",
       "                'Goretzki PE',\n",
       "                'Pratschke J',\n",
       "                'Dukaczewska AK'],\n",
       "               'AUID': ['ORCID: 0000-0002-1616-9826'],\n",
       "               'AD': ['Department of Surgery, Campus Charite Mitte|Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin.',\n",
       "                'Department of Surgery, Campus Charite Mitte|Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin.',\n",
       "                'Department of Surgery, Campus Charite Mitte|Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin.',\n",
       "                'Department of Surgery, Campus Charite Mitte|Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin.',\n",
       "                'Department of Surgery, Campus Charite Mitte|Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'DEP': '20210207',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Rare Tumors',\n",
       "               'JT': 'Rare tumors',\n",
       "               'JID': '101526926',\n",
       "               'PMC': 'PMC7874339',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Insulinoma',\n",
       "                'MEN I',\n",
       "                'endogenous hyperinsulinism',\n",
       "                'hypoglycemia',\n",
       "                'neuroendocrine tumors'],\n",
       "               'COIS': ['Declaration of conflicting interests: The author(s) declared no potential',\n",
       "                'conflicts of interest with respect to the research, authorship, and/or',\n",
       "                'publication of this article.'],\n",
       "               'EDAT': '2021/02/23 06:00',\n",
       "               'MHDA': '2021/02/23 06:01',\n",
       "               'PMCR': ['2021/02/07'],\n",
       "               'CRDT': ['2021/02/22 05:55'],\n",
       "               'PHST': ['2020/09/23 00:00 [received]',\n",
       "                '2020/12/17 00:00 [accepted]',\n",
       "                '2021/02/22 05:55 [entrez]',\n",
       "                '2021/02/23 06:00 [pubmed]',\n",
       "                '2021/02/23 06:01 [medline]',\n",
       "                '2021/02/07 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1177_2036361320986647 [pii]',\n",
       "                '10.1177/2036361320986647 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Rare Tumors. 2021 Feb 7;13:2036361320986647. doi: 10.1177/2036361320986647. eCollection 2021.'},\n",
       "              {'PMID': '33497507',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20210825',\n",
       "               'IS': '1099-0496 (Electronic) 1099-0496 (Linking)',\n",
       "               'VI': '56',\n",
       "               'IP': '5',\n",
       "               'DP': '2021 May',\n",
       "               'TI': 'EVALI (E-cigarette or vaping product use associated lung injury): First case report of an adolescent in Europe.',\n",
       "               'PG': '1274-1275',\n",
       "               'LID': '10.1002/ppul.25265 [doi]',\n",
       "               'FAU': ['Schafer, Miriam',\n",
       "                'Steindor, Mathis',\n",
       "                'Stehling, Florian',\n",
       "                'Dohna-Schwake, Christian'],\n",
       "               'AU': ['Schafer M',\n",
       "                'Steindor M',\n",
       "                'Stehling F',\n",
       "                'Dohna-Schwake C'],\n",
       "               'AD': ['Department of Pediatrics, University Hospital of Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Essen, Essen, Germany.'],\n",
       "               'AUID': ['ORCID: 0000-0003-2724-5297',\n",
       "                'ORCID: 0000-0001-8973-5406'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Letter'],\n",
       "               'DEP': '20210126',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Pediatr Pulmonol',\n",
       "               'JT': 'Pediatric pulmonology',\n",
       "               'JID': '8510590',\n",
       "               'SB': 'IM',\n",
       "               'EDAT': '2021/01/27 06:00',\n",
       "               'MHDA': '2021/01/27 06:01',\n",
       "               'CRDT': ['2021/01/26 17:11'],\n",
       "               'PHST': ['2020/12/20 00:00 [revised]',\n",
       "                '2020/10/18 00:00 [received]',\n",
       "                '2021/01/07 00:00 [accepted]',\n",
       "                '2021/01/27 06:00 [pubmed]',\n",
       "                '2021/01/27 06:01 [medline]',\n",
       "                '2021/01/26 17:11 [entrez]'],\n",
       "               'AID': ['10.1002/ppul.25265 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Pediatr Pulmonol. 2021 May;56(5):1274-1275. doi: 10.1002/ppul.25265. Epub 2021 Jan 26.'},\n",
       "              {'PMID': '33363730',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20201229',\n",
       "               'IS': '2049-9450 (Print) 2049-9469 (Electronic) 2049-9450 (Linking)',\n",
       "               'VI': '14',\n",
       "               'IP': '1',\n",
       "               'DP': '2021 Jan',\n",
       "               'TI': 'A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.',\n",
       "               'PG': '20',\n",
       "               'LID': '10.3892/mco.2020.2182 [doi] 20',\n",
       "               'AB': 'Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with poorly differentiated tumors (NET G3) have a poor prognosis. Systemic treatment with cytotoxic chemotherapy is considered to be the treatment of choice. In patients that are refractory or intolerant to first-line therapy, experts recommend peptide receptor radionuclide therapy (PRRT) in tumors that express somatostatin receptors. Recently, combinations of PRRT and chemotherapy were tested in patients with NET. Available data have reported promising tumor control rates and an excellent toxicity profile in cases where PRRT had been administered with capecitabine/temozolomide, even when administered as salvage therapy. The current study reported an exceptional case of advanced NET G3 with severe toxicity upon receiving PRRT in combination with capecitabine/temozolomide as third line therapy. The patient developed a life-threatening neutropenic fever, fungal pneumonia and necrotizing mastitis 23 days after the first cycle of therapy was administered. However, the treatment led to a significant reduction in tumor size. A total of 5 months after treatment initiation, the patient was alive and in excellent clinical condition with sustained tumor response. In summary, the current study presented a rare case of high grade NET exhibiting an almost complete response to PRRT in combination capecitabine/temozolomide, despite facing unexpected severe toxicity.',\n",
       "               'CI': ['Copyright: (c) Ozdirik et al.'],\n",
       "               'FAU': ['Ozdirik, Burcin',\n",
       "                'Amthauer, Holger',\n",
       "                'Schatka, Imke',\n",
       "                'Goretzki, Peter E',\n",
       "                'Mogl, Martina T',\n",
       "                'Fehrenbach, Uli',\n",
       "                'Tacke, Frank',\n",
       "                'Jann, Henning',\n",
       "                'Roderburg, Christoph'],\n",
       "               'AU': ['Ozdirik B',\n",
       "                'Amthauer H',\n",
       "                'Schatka I',\n",
       "                'Goretzki PE',\n",
       "                'Mogl MT',\n",
       "                'Fehrenbach U',\n",
       "                'Tacke F',\n",
       "                'Jann H',\n",
       "                'Roderburg C'],\n",
       "               'AD': ['Department of Hepatology and Gastroenterology, Charite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin 13353, Germany.',\n",
       "                'Department of Nuclear Medicine, Charite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin 13353, Germany.',\n",
       "                'Department of Nuclear Medicine, Charite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin 13353, Germany.',\n",
       "                'Department of Surgery, Charite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin 13353, Germany.',\n",
       "                'Department of Surgery, Charite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin 13353, Germany.',\n",
       "                'Diagnostic and Interventional Radiology, Charite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin 13353, Germany.',\n",
       "                'Department of Hepatology and Gastroenterology, Charite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin 13353, Germany.',\n",
       "                'Department of Hepatology and Gastroenterology, Charite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin 13353, Germany.',\n",
       "                'Department of Hepatology and Gastroenterology, Charite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin 13353, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20201127',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Mol Clin Oncol',\n",
       "               'JT': 'Molecular and clinical oncology',\n",
       "               'JID': '101613422',\n",
       "               'PMC': 'PMC7725216',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['capecitabine',\n",
       "                'hematologic toxicity',\n",
       "                'neuroendocrine poorly differenciated tumors',\n",
       "                'peptide receptor radionuclide therapy',\n",
       "                'response',\n",
       "                'temozolomide'],\n",
       "               'EDAT': '2020/12/29 06:00',\n",
       "               'MHDA': '2020/12/29 06:01',\n",
       "               'PMCR': ['2020/11/27'],\n",
       "               'CRDT': ['2020/12/28 12:00'],\n",
       "               'PHST': ['2020/01/19 00:00 [received]',\n",
       "                '2020/08/28 00:00 [accepted]',\n",
       "                '2020/12/28 12:00 [entrez]',\n",
       "                '2020/12/29 06:00 [pubmed]',\n",
       "                '2020/12/29 06:01 [medline]',\n",
       "                '2020/11/27 00:00 [pmc-release]'],\n",
       "               'AID': ['MCO-0-0-02182 [pii]', '10.3892/mco.2020.2182 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Mol Clin Oncol. 2021 Jan;14(1):20. doi: 10.3892/mco.2020.2182. Epub 2020 Nov 27.'},\n",
       "              {'PMID': '33336889',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20211019',\n",
       "               'LR': '20211019',\n",
       "               'IS': '1099-0496 (Electronic) 1099-0496 (Linking)',\n",
       "               'VI': '56',\n",
       "               'IP': '5',\n",
       "               'DP': '2021 May',\n",
       "               'TI': 'Sedation for bronchoscopy in children: A prospective randomized double-blinded trial.',\n",
       "               'PG': '1221-1229',\n",
       "               'LID': '10.1002/ppul.25235 [doi]',\n",
       "               'AB': \"INTRODUCTION: In pediatric patients, flexible bronchoscopy requires deep sedation. Different sedation regimes are common, but only some of them include opioids. Due to their antitussive effect, the use of short-acting opioids may be beneficial for this particular indication, but additional respiratory depression may lead to an increase in adverse events. Here, we systematically compared sedation regimes in children undergoing flexible bronchoscopy with either propofol alone, or a combination of propofol and remifentanil. The primary outcome parameter was the frequency of coughing episodes during the intervention. Secondary outcome parameters were frequency and types of complications, patient satisfaction, examiner satisfaction, and recovery time after finishing the sedation. METHODS: Fifty children aged 1-17 years undergoing flexible bronchoscopy under deep sedation with propofol were randomly assigned to two groups: PR receiving propofol and remifentanil and PP receiving propofol only. Sedation depth was predefined as Comfort Score 10-13. RESULTS: We found significantly less coughing episodes ([med (IQR)] PR: 0.73 (0.28-2.45)/min; PP: 1.98 (1.26-3.12)/min; p = .010) and shorter recovery time in Group PR (PR: 13.5 (8-17.5) min; PP: 21.0 (14-27) min; p = .011). Examiner's satisfaction was higher in Group PR (PR: 10 (8-10); PP: 9 (7-9); p = .012). The number of adverse events, patient satisfaction, and required propofol dose during the intervention did not differ between groups. CONCLUSION: We suggest the combination of propofol with remifentanil instead of using propofol alone in pediatric procedural sedation for flexible bronchoscopy.\",\n",
       "               'CI': ['(c) 2020 The Authors. Pediatric Pulmonology published by Wiley Periodicals LLC.'],\n",
       "               'FAU': ['Tschiedel, Eva',\n",
       "                'Eckerland, Maximilian',\n",
       "                'Felderhoff-Mueser, Ursula',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Stehling, Florian'],\n",
       "               'AU': ['Tschiedel E',\n",
       "                'Eckerland M',\n",
       "                'Felderhoff-Mueser U',\n",
       "                'Dohna-Schwake C',\n",
       "                'Stehling F'],\n",
       "               'AUID': ['ORCID: 0000-0003-1790-6370',\n",
       "                'ORCID: 0000-0003-4620-2014',\n",
       "                'ORCID: 0000-0001-8973-5406'],\n",
       "               'AD': ['Department of Pediatrics I, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics III, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics III, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Randomized Controlled Trial',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20201229',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Pediatr Pulmonol',\n",
       "               'JT': 'Pediatric pulmonology',\n",
       "               'JID': '8510590',\n",
       "               'RN': ['0 (Hypnotics and Sedatives)',\n",
       "                'P10582JYYK (Remifentanil)',\n",
       "                'YI7VU623SF (Propofol)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['*Bronchoscopy',\n",
       "                'Child',\n",
       "                'Conscious Sedation/adverse effects',\n",
       "                'Humans',\n",
       "                'Hypnotics and Sedatives/adverse effects',\n",
       "                'Propofol/adverse effects',\n",
       "                'Prospective Studies',\n",
       "                'Remifentanil'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['bronchoscopy',\n",
       "                'child',\n",
       "                'propofol',\n",
       "                'remifentanil',\n",
       "                'sedation'],\n",
       "               'EDAT': '2020/12/19 06:00',\n",
       "               'MHDA': '2021/10/21 06:00',\n",
       "               'CRDT': ['2020/12/18 08:38'],\n",
       "               'PHST': ['2020/12/03 00:00 [revised]',\n",
       "                '2020/07/22 00:00 [received]',\n",
       "                '2020/12/15 00:00 [accepted]',\n",
       "                '2020/12/19 06:00 [pubmed]',\n",
       "                '2021/10/21 06:00 [medline]',\n",
       "                '2020/12/18 08:38 [entrez]'],\n",
       "               'AID': ['10.1002/ppul.25235 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Pediatr Pulmonol. 2021 May;56(5):1221-1229. doi: 10.1002/ppul.25235. Epub 2020 Dec 29.'},\n",
       "              {'PMID': '33210762',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20210514',\n",
       "               'LR': '20210514',\n",
       "               'IS': '1651-2227 (Electronic) 0803-5253 (Linking)',\n",
       "               'VI': '110',\n",
       "               'IP': '4',\n",
       "               'DP': '2021 Apr',\n",
       "               'TI': 'aEEG as a useful tool for neuromonitoring in critically ill children - Current evidence and knowledge gaps.',\n",
       "               'PG': '1132-1140',\n",
       "               'LID': '10.1111/apa.15676 [doi]',\n",
       "               'AB': 'AIM: Amplitude-integrated electroencephalography (aEEG) is used in children beyond neonatal age, but systematic investigations have been lacking. This mini-review summarised aEEG studies on children aged one month to 18 years, evaluated the usefulness of aEEG and identified knowledge gaps or limitations. METHODS: We searched the PubMed database for articles published in English up to September 2020, and 23 papers were identified. RESULTS: aEEG was frequently used to compensate for the absence of continuous full-channel EEG monitoring, particularly for detecting seizures. Interpreting background patterns was based on neonatal classifications, as reference values for older infants and children are lacking. It is possible that aEEG could predict outcomes after paediatric cardiac arrests and other conditions. Gaps in our knowledge exist with regard to normal values in healthy children and the effects of sedation on aEEG background patterns in children. CONCLUSION: The main application of aEEG was detecting and treating paediatric seizures. Further research should determine reference values and investigate the potential to predict outcome after critical events or in acute neurological disease. It is likely that aEEG will play a role in paediatric critical care in the future.',\n",
       "               'CI': ['(c)2020 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf',\n",
       "                'of Foundation Acta Paediatrica.'],\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian'],\n",
       "               'AU': ['Bruns N', 'Felderhoff-Muser U', 'Dohna-Schwake C'],\n",
       "               'AUID': ['ORCID: 0000-0003-3809-1887'],\n",
       "               'AD': ['Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Paediatrics I, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                'Review'],\n",
       "               'DEP': '20201219',\n",
       "               'PL': 'Norway',\n",
       "               'TA': 'Acta Paediatr',\n",
       "               'JT': 'Acta paediatrica (Oslo, Norway : 1992)',\n",
       "               'JID': '9205968',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Child',\n",
       "                '*Critical Illness',\n",
       "                '*Electroencephalography',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Monitoring, Physiologic',\n",
       "                'Seizures/diagnosis'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['amplitude-integrated electroencephalography',\n",
       "                'outcomes',\n",
       "                'paediatric',\n",
       "                'sedation',\n",
       "                'seizures'],\n",
       "               'EDAT': '2020/11/20 06:00',\n",
       "               'MHDA': '2021/05/15 06:00',\n",
       "               'CRDT': ['2020/11/19 08:47'],\n",
       "               'PHST': ['2020/05/25 00:00 [received]',\n",
       "                '2020/11/06 00:00 [revised]',\n",
       "                '2020/11/16 00:00 [accepted]',\n",
       "                '2020/11/20 06:00 [pubmed]',\n",
       "                '2021/05/15 06:00 [medline]',\n",
       "                '2020/11/19 08:47 [entrez]'],\n",
       "               'AID': ['10.1111/apa.15676 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Acta Paediatr. 2021 Apr;110(4):1132-1140. doi: 10.1111/apa.15676. Epub 2020 Dec 19.'},\n",
       "              {'PMID': '32810301',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20210514',\n",
       "               'LR': '20210514',\n",
       "               'IS': '1651-2227 (Electronic) 0803-5253 (Linking)',\n",
       "               'VI': '110',\n",
       "               'IP': '3',\n",
       "               'DP': '2021 Mar',\n",
       "               'TI': 'Aminoglycosides were associated with higher rates of surgical patent ductus arteriosus closure in preterm infants.',\n",
       "               'PG': '826-832',\n",
       "               'LID': '10.1111/apa.15541 [doi]',\n",
       "               'AB': \"AIM: In animal studies, aminoglycosides induced ductus arteriosus relaxation in a dose-dependent fashion. We tested the hypothesis that antibiotic treatment of preterm infants with aminoglycosides is associated with higher rates of surgical patent ductus arteriosus (PDA) closure. METHODS: Preterm infants (birthweight <1000 grams or gestational age <29 weeks) enrolled in 62 German neonatal intensive care units (NICUs) were analysed. NICUs were stratified according to the use of aminoglycosides as first-line antibiotics. RESULTS: Baseline data were not different when NICUs using aminoglycosides (n = 9965 infants) were compared to NICUs using other antibiotics (n = 1948 infants). Rates of surgical PDA closure were 5.9% for NICUs using aminoglycosides; 6.2% for units using gentamicin; and 5.0% for NICUs using tobramycin compared to 4.1% in NICUs using other antibiotics (P < .001, P < .001 and P = .140, respectively, Fisher's exact test). Indomethacin and ibuprofen use was more common in NICUs using aminoglycosides (41% vs 33%, P < .001, Fisher's exact test). Gentamicin trough levels were higher in NICUs with surgical closure rates above the mean (median 2.0 microg/mL, inter-quartile range 0.8-4.0 microg/mL vs 1.2 microg/mL, IQR 0.8-1.7, P < .001, Mann-Whitney U test). CONCLUSION: First-line antibiotic treatment of preterm infants with aminoglycosides was associated with higher rates of surgical PDA closure.\",\n",
       "               'CI': ['(c) 2020 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf',\n",
       "                'of Foundation Acta Paediatrica.'],\n",
       "               'FAU': ['Marissen, Janina',\n",
       "                'Erdmann, Harald',\n",
       "                'Bockenholt, Kai',\n",
       "                'Hoppenz, Marc',\n",
       "                'Rausch, Tanja K',\n",
       "                'Hartel, Christoph',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Marissen J',\n",
       "                'Erdmann H',\n",
       "                'Bockenholt K',\n",
       "                'Hoppenz M',\n",
       "                'Rausch TK',\n",
       "                'Hartel C',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AUID': ['ORCID: 0000-0002-1779-3508'],\n",
       "               'AD': ['Department of Paediatrics, University Hospital of Schleswig-Holstein, University of Luebeck, Luebeck, Germany.',\n",
       "                'Hospital Pharmacy Department, University Hospital of Schleswig-Holstein, University of Luebeck, Luebeck, Germany.',\n",
       "                \"Children's Hospital Amsterdamer Strasse, Cologne, Germany.\",\n",
       "                \"Children's Hospital Amsterdamer Strasse, Cologne, Germany.\",\n",
       "                'Department of Paediatrics, University Hospital of Schleswig-Holstein, University of Luebeck, Luebeck, Germany.',\n",
       "                'Institute of Medical Biometry and Statistics, University of Luebeck, Luebeck, Germany.',\n",
       "                'Department of Paediatrics, University Hospital of Schleswig-Holstein, University of Luebeck, Luebeck, Germany.',\n",
       "                'Department of Paediatrics, University of Wuerzburg, Wuerzburg, Germany.',\n",
       "                'Department of Paediatrics, University Hospital of Schleswig-Holstein, University of Luebeck, Luebeck, Germany.',\n",
       "                'Department of Paediatrics, University Hospital of Schleswig-Holstein, University of Luebeck, Luebeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20200907',\n",
       "               'PL': 'Norway',\n",
       "               'TA': 'Acta Paediatr',\n",
       "               'JT': 'Acta paediatrica (Oslo, Norway : 1992)',\n",
       "               'JID': '9205968',\n",
       "               'RN': ['0 (Aminoglycosides)',\n",
       "                '0 (Anti-Bacterial Agents)',\n",
       "                'WK2XYI10QM (Ibuprofen)',\n",
       "                'XXE1CET956 (Indomethacin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Aminoglycosides',\n",
       "                'Anti-Bacterial Agents',\n",
       "                '*Ductus Arteriosus, Patent/drug therapy/surgery',\n",
       "                'Humans',\n",
       "                'Ibuprofen',\n",
       "                'Indomethacin',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['aminoglycosides',\n",
       "                'extremely preterm infants',\n",
       "                'patent ductus arteriosus',\n",
       "                'surgical ligation'],\n",
       "               'EDAT': '2020/08/19 06:00',\n",
       "               'MHDA': '2021/05/15 06:00',\n",
       "               'CRDT': ['2020/08/19 06:00'],\n",
       "               'PHST': ['2020/05/16 00:00 [received]',\n",
       "                '2020/07/27 00:00 [revised]',\n",
       "                '2020/08/17 00:00 [accepted]',\n",
       "                '2020/08/19 06:00 [pubmed]',\n",
       "                '2021/05/15 06:00 [medline]',\n",
       "                '2020/08/19 06:00 [entrez]'],\n",
       "               'AID': ['10.1111/apa.15541 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Acta Paediatr. 2021 Mar;110(3):826-832. doi: 10.1111/apa.15541. Epub 2020 Sep 7.'}],\n",
       "             '2020': [{'PMID': '33261643',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20211006',\n",
       "               'LR': '20211006',\n",
       "               'IS': '1824-7288 (Electronic) 1720-8424 (Linking)',\n",
       "               'VI': '46',\n",
       "               'IP': '1',\n",
       "               'DP': '2020 Dec 1',\n",
       "               'TI': 'Iatrogenic severe hyperglycemia due to parenteral administration of glucose in children - a case series.',\n",
       "               'PG': '179',\n",
       "               'LID': '10.1186/s13052-020-00939-9 [doi] 179',\n",
       "               'AB': 'BACKGROUND: Iatrogenic severe hyperglycemia (ISH) caused by glucose-containing i.v. solution is a potentially fatal treatment error. The objective of this study was to investigate the causes, circumstances, course of disease, and complications of ISH > 300 mg/dl (16.7 mmol/l) in neonates and children. METHODS: We emailed a survey to 105 neonatal and pediatric intensive care units in Germany, Austria, and Switzerland, asking to retrospectively report cases of ISH. RESULTS: We received 11 reports about premature infants to children. Four patients (36%) had poor outcome: 2 died and 2 suffered persistent sequelae. The highest observed blood glucose was at median 983 mg/dl (54.6 mmol/l) (range 594-2240 mg/dl; 33.0-124.3 mmol/l) and median time to normoglycemia was 7 h (range 2-23). Blood glucose was higher and time to normoglycemia longer in patients with poor outcome. Invasive therapy was required in 73% (mechanical ventilation) and 50% (vasopressor therapy) of patients, respectively. Administration of insulin did not differ between outcome groups. Patients with poor outcome showed coma (100% vs. 40%) and seizures (75% vs. 29%) more frequently than those with good outcome. CONCLUSIONS: ISH is a severe condition with high morbidity and mortality. Further research to amplify the understanding of this condition is needed, but focus should largely be held on its prevention.',\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Grosse Lordemann, Anja',\n",
       "                'Rasche, Tobias',\n",
       "                'Meyburg, Jochen',\n",
       "                'Kruger, Marcus',\n",
       "                'Wieg, Christian',\n",
       "                'Gratopp, Alexander',\n",
       "                'Hoppenz, Marc',\n",
       "                'Heitmann, Friedhelm',\n",
       "                'Hoppen, Thomas',\n",
       "                'Loffler, Gunther',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Grosse Lordemann A',\n",
       "                'Rasche T',\n",
       "                'Meyburg J',\n",
       "                'Kruger M',\n",
       "                'Wieg C',\n",
       "                'Gratopp A',\n",
       "                'Hoppenz M',\n",
       "                'Heitmann F',\n",
       "                'Hoppen T',\n",
       "                'Loffler G',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dohna-Schwake C'],\n",
       "               'AUID': ['ORCID: 0000-0003-3809-1887'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care, and Pediatric Neurology, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany. nora.bruns@uk-essen.de.',\n",
       "                \"Emergency Department, Children's Hospital Hamburg-Altona, Bleickenallee 38, 22763, Hamburg, Germany.\",\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, and Pediatric Neurology, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Center for Childhood and Adolescent Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 672, 69120, Heidelberg, Germany.',\n",
       "                'Department of Neonatology, Munich Clinic Campus Harlaching and Schwabing, Sanatoriumsplatz 2, 81545, Munich, Germany.',\n",
       "                'Department of Neonatology and Pediatric Intensive Care, Klinikum Aschaffenburg, Am Hasenkopf, 63739, Aschaffenburg, Germany.',\n",
       "                'Division of Pediatric Emergency and Intensive Care Medicine, Charite University Medical Center, Augustenburger Platz 1, 13353, Berlin, Germany.',\n",
       "                \"Department of Neonatology and Pediatric Intensive Care Medicine, Children's Hospital, Amsterdamer Str. 59, 50735, Cologne, Germany.\",\n",
       "                'Department of Pediatrics, Klinikum Dortmund, Beurhausstr. 40, 44137, Dortmund, Germany.',\n",
       "                'Department of Pediatrics, Gemeinschaftsklinikum Mittelrhein, Koblenzer Str. 115-155, 56073, Koblenz, Germany.',\n",
       "                'Department of Pediatric and Neonatal Intensive Care, University Hospital of Saarland, Kirrberger Str. 100, 66421, Homburg, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, and Pediatric Neurology, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, and Pediatric Neurology, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['IFORES/Medizinische Fakultat, Universitat Duisburg-Essen/'],\n",
       "               'PT': ['Journal Article', 'Multicenter Study'],\n",
       "               'DEP': '20201201',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Ital J Pediatr',\n",
       "               'JT': 'Italian journal of pediatrics',\n",
       "               'JID': '101510759',\n",
       "               'RN': ['0 (Blood Glucose)',\n",
       "                '0 (Sweetening Agents)',\n",
       "                '0 (Vasoconstrictor Agents)',\n",
       "                'IY9XDZ35W2 (Glucose)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Blood Glucose/analysis',\n",
       "                'Europe/epidemiology',\n",
       "                'Female',\n",
       "                'Glucose/administration & dosage/*adverse effects',\n",
       "                'Humans',\n",
       "                'Hyperglycemia/*epidemiology/*etiology/therapy',\n",
       "                '*Iatrogenic Disease',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Infusions, Parenteral/*adverse effects',\n",
       "                'Intensive Care Units, Pediatric',\n",
       "                'Male',\n",
       "                'Respiration, Artificial/statistics & numerical data',\n",
       "                'Retrospective Studies',\n",
       "                'Sweetening Agents/administration & dosage/*adverse effects',\n",
       "                'Vasoconstrictor Agents/therapeutic use'],\n",
       "               'PMC': 'PMC7709336',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Administration',\n",
       "                'Glucose',\n",
       "                'Hyperglycemia',\n",
       "                'Iatrogenic',\n",
       "                'Parenteral feeding',\n",
       "                'Parenteral nutrition',\n",
       "                'Pediatric',\n",
       "                'Treatment error'],\n",
       "               'COIS': ['The authors declare that they have no competing interests.'],\n",
       "               'EDAT': '2020/12/03 06:00',\n",
       "               'MHDA': '2021/10/07 06:00',\n",
       "               'PMCR': ['2020/12/01'],\n",
       "               'CRDT': ['2020/12/02 05:21'],\n",
       "               'PHST': ['2020/07/06 00:00 [received]',\n",
       "                '2020/11/21 00:00 [accepted]',\n",
       "                '2020/12/02 05:21 [entrez]',\n",
       "                '2020/12/03 06:00 [pubmed]',\n",
       "                '2021/10/07 06:00 [medline]',\n",
       "                '2020/12/01 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1186/s13052-020-00939-9 [pii]',\n",
       "                '939 [pii]',\n",
       "                '10.1186/s13052-020-00939-9 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Ital J Pediatr. 2020 Dec 1;46(1):179. doi: 10.1186/s13052-020-00939-9.'},\n",
       "              {'PMID': '33162932',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20210526',\n",
       "               'LR': '20210526',\n",
       "               'IS': '1664-2392 (Print) 1664-2392 (Electronic) 1664-2392 (Linking)',\n",
       "               'VI': '11',\n",
       "               'DP': '2020',\n",
       "               'TI': \"Unusual Presentation of Polyautoimmunity and Renal Tubular Acidosis in an Adolescent With Hashimoto's Thyroiditis and Central Pontine Myelinolysis.\",\n",
       "               'PG': '548877',\n",
       "               'LID': '10.3389/fendo.2020.548877 [doi] 548877',\n",
       "               'AB': 'Background: Hashimoto\\'s thyroiditis is frequently associated with other autoimmune diseases and may include renal involvement. Case description: A 17-year-old female with previously diagnosed Hashimoto\\'s thyroiditis and vitiligo was admitted to a pediatric intensive care unit with hypokalemic paralysis and acidosis, after having suffered from recurrent muscular weakness for approximately one year. A few days later she developed central pontine myelinolysis. After initial stabilization she was also diagnosed with distal renal tubular acidosis (dRTA) and tubular proteinuria which can occur in Sjogren\\'s syndrome. Extended screening for autoimmune diseases additionally revealed celiac disease. Treatment with Prednisone and substitution of potassium quickly lead to the resolution of proteinuria and dRTA, but unilateral paralysis of the sixth nerve as a result of central pontine myelinolysis was irreversible. Conclusions: This is the rare case of polyautoimmunity including autoimmune thyroiditis, Sjogren\\'s syndrome, vitiligo and celiac disease in an adolescent with few disease-specific symptoms. The diagnoses were made via a complicating nephritis causing dRTA and proteinuria. Delay in diagnosis lead to permanent neurological damage. This case highlights the need for pediatricians to be aware of rare accompanying diseases and their complications in \"common\" pediatric autoimmune diseases like Hashimoto\\'s thyroiditis and celiac disease.',\n",
       "               'CI': ['Copyright (c) 2020 Bruns, Finkelberg, Al-Attrach, Hoyer and Buscher.'],\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Finkelberg, Ilja',\n",
       "                'Al-Attrach, Ibrahim',\n",
       "                'Hoyer, Peter F',\n",
       "                'Buscher, Rainer'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Finkelberg I',\n",
       "                'Al-Attrach I',\n",
       "                'Hoyer PF',\n",
       "                'Buscher R'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Duisburg, Germany.',\n",
       "                'Department of Pediatrics II, Pediatric Nephrology, University Hospital Essen, University Duisburg-Essen, Duisburg, Germany.',\n",
       "                'Department of Pediatrics II, Pediatric Nephrology, University Hospital Essen, University Duisburg-Essen, Duisburg, Germany.',\n",
       "                'Department of Pediatrics II, Pediatric Nephrology, University Hospital Essen, University Duisburg-Essen, Duisburg, Germany.',\n",
       "                'Department of Pediatrics II, Pediatric Nephrology, University Hospital Essen, University Duisburg-Essen, Duisburg, Germany.',\n",
       "                'Department of Pediatrics II, Pediatric Nephrology, University Hospital Essen, University Duisburg-Essen, Duisburg, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports',\n",
       "                'Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20201014',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Endocrinol (Lausanne)',\n",
       "               'JT': 'Frontiers in endocrinology',\n",
       "               'JID': '101555782',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Acidosis, Renal Tubular/*complications/immunology',\n",
       "                'Adolescent',\n",
       "                'Autoimmune Diseases/*complications',\n",
       "                'Celiac Disease/complications',\n",
       "                'Female',\n",
       "                'Hashimoto Disease/*complications',\n",
       "                'Humans',\n",
       "                'Myelinolysis, Central Pontine/*complications/immunology',\n",
       "                \"Sjogren's Syndrome/complications\",\n",
       "                'Vitiligo/complications'],\n",
       "               'PMC': 'PMC7591671',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': [\"Hashimoto's thyroiditis\",\n",
       "                \"Sjogren's syndrome\",\n",
       "                'autoimmune thyroiditis',\n",
       "                'case report',\n",
       "                'celiac disease',\n",
       "                'central pontine myelinolysis',\n",
       "                'distal renal tubular acidosis',\n",
       "                'hypokalemia'],\n",
       "               'EDAT': '2020/11/10 06:00',\n",
       "               'MHDA': '2021/05/27 06:00',\n",
       "               'PMCR': ['2020/01/01'],\n",
       "               'CRDT': ['2020/11/09 05:31'],\n",
       "               'PHST': ['2020/04/03 00:00 [received]',\n",
       "                '2020/09/01 00:00 [accepted]',\n",
       "                '2020/11/09 05:31 [entrez]',\n",
       "                '2020/11/10 06:00 [pubmed]',\n",
       "                '2021/05/27 06:00 [medline]',\n",
       "                '2020/01/01 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fendo.2020.548877 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Endocrinol (Lausanne). 2020 Oct 14;11:548877. doi: 10.3389/fendo.2020.548877. eCollection 2020.'},\n",
       "              {'PMID': '33117762',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20240802',\n",
       "               'IS': '2296-2360 (Print) 2296-2360 (Electronic) 2296-2360 (Linking)',\n",
       "               'VI': '8',\n",
       "               'DP': '2020',\n",
       "               'TI': 'More Than 500 Kids Could Be Saved Each Year! Ten Consensus Actions to Improve Quality of Pediatric Resuscitation in DACH-Countries (Austria, Germany, and Switzerland).',\n",
       "               'PG': '549710',\n",
       "               'LID': '10.3389/fped.2020.549710 [doi] 549710',\n",
       "               'AB': '* Quality and outcome of pediatric resuscitation often does not achieve recommended goals. * Quality improvement initiatives with the aim of better survival rates and decreased morbidity of resuscitated children are urgently needed. * These initiatives should include an action framework for a comprehensive, fundamental, and interprofessional reorientation of clinical and organizational structures concerning resuscitation and post-resuscitation care of children. * The authors of this DACH position statement suggest the implementation of 10 evidence-based actions (for out-of-hospital and in-house cardiac arrests) that should improve survival rates and decrease morbidity of resuscitated children with better neurological outcome and quality of life.',\n",
       "               'CI': ['Copyright (c) 2020 Jung, Brenner, Bachmann, Both, Cardona, Dohna-Schwake, Eich,',\n",
       "                'Eifinger, Huth, Heimberg, Landsleitner, Olivieri, Sasse, Weisner, Wagner, Warnke,',\n",
       "                'Ziegler, Boettiger, Nadkarni and Hoffmann.'],\n",
       "               'FAU': ['Jung, Philipp',\n",
       "                'Brenner, Sebastian',\n",
       "                'Bachmann, Iris',\n",
       "                'Both, Christian',\n",
       "                'Cardona, Francesco',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Eich, Christoph',\n",
       "                'Eifinger, Frank',\n",
       "                'Huth, Ralf',\n",
       "                'Heimberg, Ellen',\n",
       "                'Landsleitner, Bernd',\n",
       "                'Olivieri, Martin',\n",
       "                'Sasse, Michael',\n",
       "                'Weisner, Thomas',\n",
       "                'Wagner, Michael',\n",
       "                'Warnke, Gert',\n",
       "                'Ziegler, Bernhard',\n",
       "                'Boettiger, Bernd W',\n",
       "                'Nadkarni, Vinay',\n",
       "                'Hoffmann, Florian'],\n",
       "               'AU': ['Jung P',\n",
       "                'Brenner S',\n",
       "                'Bachmann I',\n",
       "                'Both C',\n",
       "                'Cardona F',\n",
       "                'Dohna-Schwake C',\n",
       "                'Eich C',\n",
       "                'Eifinger F',\n",
       "                'Huth R',\n",
       "                'Heimberg E',\n",
       "                'Landsleitner B',\n",
       "                'Olivieri M',\n",
       "                'Sasse M',\n",
       "                'Weisner T',\n",
       "                'Wagner M',\n",
       "                'Warnke G',\n",
       "                'Ziegler B',\n",
       "                'Boettiger BW',\n",
       "                'Nadkarni V',\n",
       "                'Hoffmann F'],\n",
       "               'AD': [\"University Children's Hospital, University Hospital Schleswig-Holstein, Lubeck, Germany.\",\n",
       "                'Neonatology and Pediatric Intensive Care, University Hospital Carl Gustav Carus, University of Dresden, Dresden, Germany.',\n",
       "                \"University Children's Hospital Zurich, Zurich, Switzerland.\",\n",
       "                \"University Children's Hospital Zurich, Zurich, Switzerland.\",\n",
       "                'Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics, Medical University of Vienna, Vienna, Austria.',\n",
       "                'Department of Pediatrics, University Medicine Essen, Essen, Germany.',\n",
       "                \"Department of Anaesthesia, Pediatric Intensive Care and Emergency Medicine, Auf der Bult Children's Hospital, Hanover, Germany.\",\n",
       "                \"Children's Hospital, Cologne, Germany.\",\n",
       "                \"University Children's Hospital, Mainz, Germany.\",\n",
       "                \"Department of Pediatric Cardiology, Pulmology and Intensive Care Medicine, University Children's Hospital, Tuebingen, Germany.\",\n",
       "                \"Children's Hospital, Nuremberg, Germany.\",\n",
       "                \"Dr. von Hauner University Children's Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.\",\n",
       "                \"University Children's Hospital, Medical School Hannover, Hanover, Germany.\",\n",
       "                \"University Children's Hospital, University Hospital Schleswig-Holstein, Lubeck, Germany.\",\n",
       "                'Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics, Medical University of Vienna, Vienna, Austria.',\n",
       "                \"University Children's Hospital Graz, Graz, Austria.\",\n",
       "                \"University Children's Hospital Salzburg, Salzburg, Austria.\",\n",
       "                'Department of Anaesthesiology and Intensive Care Medicine, Medical Faculty, University Hospital of Cologne, Cologne, Germany.',\n",
       "                \"Children's Hospital of Philadelphia, University of Pennsylvania Perlman School of Medicine, Philadelphia, PA, United States.\",\n",
       "                \"Dr. von Hauner University Children's Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.\"],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20201007',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Pediatr',\n",
       "               'JT': 'Frontiers in pediatrics',\n",
       "               'JID': '101615492',\n",
       "               'PMC': 'PMC7575775',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['cardiac arrest',\n",
       "                'cardiopulmonary resuscitation',\n",
       "                'children',\n",
       "                'patient safety',\n",
       "                'pediatric',\n",
       "                'quality improvement'],\n",
       "               'EDAT': '2020/10/30 06:00',\n",
       "               'MHDA': '2020/10/30 06:01',\n",
       "               'PMCR': ['2020/10/07'],\n",
       "               'CRDT': ['2020/10/29 05:53'],\n",
       "               'PHST': ['2020/04/07 00:00 [received]',\n",
       "                '2020/08/31 00:00 [accepted]',\n",
       "                '2020/10/29 05:53 [entrez]',\n",
       "                '2020/10/30 06:00 [pubmed]',\n",
       "                '2020/10/30 06:01 [medline]',\n",
       "                '2020/10/07 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fped.2020.549710 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Pediatr. 2020 Oct 7;8:549710. doi: 10.3389/fped.2020.549710. eCollection 2020.'},\n",
       "              {'PMID': '32907597',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20210618',\n",
       "               'LR': '20220531',\n",
       "               'IS': '1750-1172 (Electronic) 1750-1172 (Linking)',\n",
       "               'VI': '15',\n",
       "               'IP': '1',\n",
       "               'DP': '2020 Sep 9',\n",
       "               'TI': 'Further evidence for POMK as candidate gene for WWS with meningoencephalocele.',\n",
       "               'PG': '242',\n",
       "               'LID': '10.1186/s13023-020-01454-0 [doi] 242',\n",
       "               'AB': 'BACKGROUND: Walker-Warburg syndrome (WWS) is a rare form of alpha-dystroglycanopathy characterized by muscular dystrophy and severe malformations of the CNS and eyes. Bi-allelic pathogenic variants in POMK are the cause of a broad spectrum of alpha-dystroglycanopathies. POMK encodes protein-O-mannose kinase, which is required for proper glycosylation and function of the dystroglycan complex and is crucial for extracellular matrix composition. RESULTS: Here, we report on male monozygotic twins with severe CNS malformations (hydrocephalus, cortical malformation, hypoplastic cerebellum, and most prominently occipital meningocele), eye malformations and highly elevated creatine kinase, indicating the clinical diagnosis of a congenital muscular dystrophy (alpha-dystroglycanopathy). Both twins were found to harbor a homozygous nonsense mutation c.640C>T, p.214* in POMK, confirming the clinical diagnosis and supporting the concept that POMK mutations can be causative of WWS. CONCLUSION: Our combined data suggest a more important role for POMK in the pathogenesis of meningoencephalocele. Only eight different pathogenic POMK variants have been published so far, detected in eight families; only five showed the severe WWS phenotype, suggesting that POMK-associated WWS is an extremely rare disease. We expand the phenotypic and mutational spectrum of POMK-associated WWS and provide evidence of the broad phenotypic variability of POMK-associated disease.',\n",
       "               'FAU': ['Paul, Luisa',\n",
       "                'Rupprich, Katrin',\n",
       "                'Della Marina, Adela',\n",
       "                'Stein, Anja',\n",
       "                'Elgizouli, Magdeldin',\n",
       "                'Kaiser, Frank J',\n",
       "                'Schweiger, Bernd',\n",
       "                'Koninger, Angela',\n",
       "                'Iannaccone, Antonella',\n",
       "                'Hehr, Ute',\n",
       "                'Kolbel, Heike',\n",
       "                'Roos, Andreas',\n",
       "                'Schara-Schmidt, Ulrike',\n",
       "                'Kuechler, Alma'],\n",
       "               'AU': ['Paul L',\n",
       "                'Rupprich K',\n",
       "                'Della Marina A',\n",
       "                'Stein A',\n",
       "                'Elgizouli M',\n",
       "                'Kaiser FJ',\n",
       "                'Schweiger B',\n",
       "                'Koninger A',\n",
       "                'Iannaccone A',\n",
       "                'Hehr U',\n",
       "                'Kolbel H',\n",
       "                'Roos A',\n",
       "                'Schara-Schmidt U',\n",
       "                'Kuechler A'],\n",
       "               'AUID': ['ORCID: 0000-0002-6058-3274'],\n",
       "               'AD': ['Department of Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of General Pediatrics, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Institute of Human Genetics, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Institute of Human Genetics, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Radiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Obestetrics and Gynaecology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Obestetrics and Gynaecology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Center for Human Genetics, Regensburg, Germany / Department of Human Genetics, University of Regensburg, Regensburg, Germany.',\n",
       "                'Department of Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                \"Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, K1H 8L1, Canada.\",\n",
       "                'Department of Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Institute of Human Genetics, University Hospital Essen, University Duisburg-Essen, Essen, Germany. alma.kuechler@uk-essen.de.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports', 'Journal Article'],\n",
       "               'DEP': '20200909',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Orphanet J Rare Dis',\n",
       "               'JT': 'Orphanet journal of rare diseases',\n",
       "               'JID': '101266602',\n",
       "               'RN': ['EC 2.7.- (POMK protein, human)',\n",
       "                'EC 2.7.- (Protein Kinases)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Homozygote',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                '*Meningocele',\n",
       "                '*Muscular Dystrophies',\n",
       "                'Mutation',\n",
       "                '*Nervous System Malformations',\n",
       "                'Protein Kinases/*genetics',\n",
       "                'Twins, Monozygotic',\n",
       "                '*Walker-Warburg Syndrome'],\n",
       "               'PMC': 'PMC7488248',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Alpha-dystroglycanopathy',\n",
       "                'Congenital muscular dystrophy',\n",
       "                'Meningoencephalocele',\n",
       "                'POMK',\n",
       "                'Protein O-mannose kinase',\n",
       "                'Walker-Warburg syndrome'],\n",
       "               'COIS': ['The authors declare that they have no competing interests.'],\n",
       "               'EDAT': '2020/09/11 06:00',\n",
       "               'MHDA': '2021/06/22 06:00',\n",
       "               'PMCR': ['2020/09/09'],\n",
       "               'CRDT': ['2020/09/10 05:26'],\n",
       "               'PHST': ['2020/05/18 00:00 [received]',\n",
       "                '2020/06/29 00:00 [accepted]',\n",
       "                '2020/09/10 05:26 [entrez]',\n",
       "                '2020/09/11 06:00 [pubmed]',\n",
       "                '2021/06/22 06:00 [medline]',\n",
       "                '2020/09/09 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1186/s13023-020-01454-0 [pii]',\n",
       "                '1454 [pii]',\n",
       "                '10.1186/s13023-020-01454-0 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Orphanet J Rare Dis. 2020 Sep 9;15(1):242. doi: 10.1186/s13023-020-01454-0.'},\n",
       "              {'PMID': '32894267',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20201112',\n",
       "               'LR': '20201112',\n",
       "               'IS': '1940-087X (Electronic) 1940-087X (Linking)',\n",
       "               'IP': '162',\n",
       "               'DP': '2020 Aug 19',\n",
       "               'TI': 'How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children.',\n",
       "               'LID': '10.3791/61533 [doi]',\n",
       "               'AB': 'Near infrared spectroscopy (NIRS) calculates regional tissue oxygenation (rSO2) using the different absorption spectra of oxygenated and deoxygenated hemoglobin molecules. A probe placed on the skin emits light that is absorbed, scattered, and reflected by the underlying tissue. Detectors in the probe sense the amount of reflected light: this reflects the organ-specific ratio of oxygen supply and consumption - independent of pulsatile flow. Modern devices enable the simultaneous monitoring at different body sites. A rise or dip in the rSO2 curve visualizes changes in oxygen supply or demand before vital signs indicate them. The evolution of rSO2 values in relation to the starting point is more important for interpretation than are absolute values. A routine clinical application of NIRS is the surveillance of somatic and cerebral oxygenation during and after cardiac surgery. It is also administered in preterm infants at risk for necrotizing enterocolitis, newborns with hypoxic ischemic encephalopathy and a potential risk of impaired tissue oxygenation. In the future, NIRS could be increasingly used in multimodal neuromonitoring, or applied to monitor patients with other conditions (e.g., after resuscitation or traumatic brain injury).',\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Moosmann, Julia',\n",
       "                'Munch, Frank',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Woelfle, Joachim',\n",
       "                'Cesnjevar, Robert',\n",
       "                'Dittrich, Sven',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Muller, Hanna'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Moosmann J',\n",
       "                'Munch F',\n",
       "                'Dohna-Schwake C',\n",
       "                'Woelfle J',\n",
       "                'Cesnjevar R',\n",
       "                'Dittrich S',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Muller H'],\n",
       "               'AD': ['Department of Pediatrics I - Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen; Nora.Bruns@uk-essen.de.',\n",
       "                'Department of Pediatric Cardiology, University Hospital Erlangen, University of Erlangen-Nurnberg.',\n",
       "                'Department of Pediatric Cardiac Surgery, University Hospital Erlangen, University of Erlangen-Nurnberg.',\n",
       "                'Department of Pediatrics I - Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen.',\n",
       "                'Division of Neonatology and Pediatric Intensive Care, Department of Pediatrics, University Hospital Erlangen, University of Erlangen-Nurnberg.',\n",
       "                'Department of Pediatric Cardiac Surgery, University Hospital Erlangen, University of Erlangen-Nurnberg.',\n",
       "                'Department of Pediatric Cardiology, University Hospital Erlangen, University of Erlangen-Nurnberg.',\n",
       "                'Department of Pediatrics I - Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University of Duisburg-Essen.',\n",
       "                'Division of Neonatology and Pediatric Intensive Care, Department of Pediatrics, University Hospital Erlangen, University of Erlangen-Nurnberg.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                'Video-Audio Media'],\n",
       "               'DEP': '20200819',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Vis Exp',\n",
       "               'JT': 'Journal of visualized experiments : JoVE',\n",
       "               'JID': '101313252',\n",
       "               'RN': ['0 (Oxyhemoglobins)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Child',\n",
       "                '*Critical Illness',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Male',\n",
       "                'Oximetry/instrumentation/*methods',\n",
       "                'Oxygen Consumption/physiology',\n",
       "                'Oxyhemoglobins/analysis',\n",
       "                '*Spectroscopy, Near-Infrared'],\n",
       "               'EDAT': '2020/09/08 06:00',\n",
       "               'MHDA': '2020/11/13 06:00',\n",
       "               'CRDT': ['2020/09/07 12:11'],\n",
       "               'PHST': ['2020/09/07 12:11 [entrez]',\n",
       "                '2020/09/08 06:00 [pubmed]',\n",
       "                '2020/11/13 06:00 [medline]'],\n",
       "               'AID': ['10.3791/61533 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'J Vis Exp. 2020 Aug 19;(162). doi: 10.3791/61533.'},\n",
       "              {'PMID': '32661735',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20210524',\n",
       "               'LR': '20210524',\n",
       "               'IS': '1863-2300 (Electronic) 1863-2297 (Print) 1863-2297 (Linking)',\n",
       "               'VI': '42',\n",
       "               'IP': '4',\n",
       "               'DP': '2020 Aug',\n",
       "               'TI': 'Preterm birth and sustained inflammation: consequences for the neonate.',\n",
       "               'PG': '451-468',\n",
       "               'LID': '10.1007/s00281-020-00803-2 [doi]',\n",
       "               'AB': 'Almost half of all preterm births are caused or triggered by an inflammatory process at the feto-maternal interface resulting in preterm labor or rupture of membranes with or without chorioamnionitis (\"first inflammatory hit\"). Preterm babies have highly vulnerable body surfaces and immature organ systems. They are postnatally confronted with a drastically altered antigen exposure including hospital-specific microbes, artificial devices, drugs, nutritional antigens, and hypoxia or hyperoxia (\"second inflammatory hit\"). This is of particular importance to extremely preterm infants born before 28 weeks, as they have not experienced important \"third-trimester\" adaptation processes to tolerate maternal and self-antigens. Instead of a balanced adaptation to extrauterine life, the delicate co-regulation between immune defense mechanisms and immunosuppression (tolerance) to allow microbiome establishment is therefore often disturbed. Hence, preterm infants are predisposed to sepsis but also to several injurious conditions that can contribute to the onset or perpetuation of sustained inflammation (SI). This is a continuing challenge to clinicians involved in the care of preterm infants, as SI is regarded as a crucial mediator for mortality and the development of morbidities in preterm infants. This review will outline the (i) role of inflammation for short-term consequences of preterm birth and (ii) the effect of SI on organ development and long-term outcome.',\n",
       "               'FAU': ['Humberg, Alexander',\n",
       "                'Fortmann, Ingmar',\n",
       "                'Siller, Bastian',\n",
       "                'Kopp, Matthias Volkmar',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang',\n",
       "                'Hartel, Christoph'],\n",
       "               'AU': ['Humberg A',\n",
       "                'Fortmann I',\n",
       "                'Siller B',\n",
       "                'Kopp MV',\n",
       "                'Herting E',\n",
       "                'Gopel W',\n",
       "                'Hartel C'],\n",
       "               'AD': ['Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Ingmar Fortmann and Christoph Hartel (DZIF), Partner Site Hamburg-Lubeck-Borstel-Riems, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Bern, Bern, Switzerland.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany. haertel_c1@ukw.de.',\n",
       "                'Department of Pediatrics, University of Wurzburg, Josef-Schneider-Strasse 2, 97080, Wurzburg, Germany. haertel_c1@ukw.de.'],\n",
       "               'CN': ['German Neonatal Network, German Center for Lung Research and Priming Immunity at',\n",
       "                'the beginning of life (PRIMAL) Consortium'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                'Review'],\n",
       "               'DEP': '20200713',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Semin Immunopathol',\n",
       "               'JT': 'Seminars in immunopathology',\n",
       "               'JID': '101308769',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['*Chorioamnionitis/etiology',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature',\n",
       "                'Inflammation/etiology',\n",
       "                '*Obstetric Labor, Premature',\n",
       "                'Pregnancy',\n",
       "                '*Premature Birth/etiology'],\n",
       "               'PMC': 'PMC7508934',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Chronic pulmonary insufficiency of prematurity',\n",
       "                'Microbiome',\n",
       "                'Neurocognitive outcome',\n",
       "                'Preterm infants',\n",
       "                'Sepsis',\n",
       "                'Sustained inflammation'],\n",
       "               'COIS': ['Christoph Hartel is a lead principal investigator of the PRIMAL clinical study',\n",
       "                'investigating the effect of probiotics to prevent gut dysbiosis and inflammation',\n",
       "                'in preterm infants born at 28-32 weeks of gestation. All other authors have no',\n",
       "                'conflicts of interest relevant to this article to disclose.'],\n",
       "               'EDAT': '2020/07/15 06:00',\n",
       "               'MHDA': '2021/05/25 06:00',\n",
       "               'PMCR': ['2020/07/13'],\n",
       "               'CRDT': ['2020/07/15 06:00'],\n",
       "               'PHST': ['2020/05/22 00:00 [received]',\n",
       "                '2020/06/24 00:00 [accepted]',\n",
       "                '2020/07/15 06:00 [pubmed]',\n",
       "                '2021/05/25 06:00 [medline]',\n",
       "                '2020/07/15 06:00 [entrez]',\n",
       "                '2020/07/13 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s00281-020-00803-2 [pii]',\n",
       "                '803 [pii]',\n",
       "                '10.1007/s00281-020-00803-2 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Semin Immunopathol. 2020 Aug;42(4):451-468. doi: 10.1007/s00281-020-00803-2. Epub 2020 Jul 13.'},\n",
       "              {'PMID': '32634841',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20210305',\n",
       "               'LR': '20210305',\n",
       "               'IS': '1439-4413 (Electronic) 0012-0472 (Linking)',\n",
       "               'VI': '145',\n",
       "               'IP': '17',\n",
       "               'DP': '2020 Aug',\n",
       "               'TI': '[Thyroid nodules: The Guidelines of the American Thyroid Association from a European Perspective].',\n",
       "               'PG': '1227-1235',\n",
       "               'LID': '10.1055/a-1018-2767 [doi]',\n",
       "               'AB': 'In Germany and in other regions with former iodine deficiency, thyroid nodules and nodular goiter are still much more frequent than in the U.S.A. The American Thyroid Association (ATA) has published 2015 revised guidelines for patients with thyroid nodules and differentiated thyroid cancer. For evaluation of suspected thyroid nodules the authors describe high, intermediate, low and very low suspicion pattern and recommend further fine needle aspiration cytology, depending on the pattern and the size of the nodule. The high suspicion pattern includes irregular margins of the nodule, which may be an important criterion for malignancy of solitary nodules. In nodular goiters with multiple nodules grown together and without clear margins, frequently observed in former iodine deficiency regions, irregular margins may not be a significant criterion for malignancy. Another pattern, hypoechogenicity, which is frequently seen in benign nodules in former iodine deficiency areas, is also not a clear criterion for malignancy. Only strong hypoechogenicity may indicate malignancy. Another difference relates to the recommendation of scintigraphy that according to the guideline is restricted to patients with decreased TSH. In regions with former iodine deficiency, it has been demonstrated that thyroid autonomy may be present even if TSH is in the lower normal range. Therefore, in Germany scintigraphy is recommended for preoperative evaluation of all patients with thyroid nodules or nodular goiter.',\n",
       "               'CI': ['(c) Georg Thieme Verlag KG Stuttgart . New York.'],\n",
       "               'FAU': ['Derwahl, Karl Michael', 'Goretzki, Peter'],\n",
       "               'AU': ['Derwahl KM', 'Goretzki P'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'TT': 'Schilddrusenknoten: ATA-Leitlinie aus europaischer Sicht.',\n",
       "               'DEP': '20200707',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Dtsch Med Wochenschr',\n",
       "               'JT': 'Deutsche medizinische Wochenschrift (1946)',\n",
       "               'JID': '0006723',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Biopsy, Fine-Needle',\n",
       "                'Female',\n",
       "                'Germany',\n",
       "                'Goiter, Nodular/diagnosis/pathology',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Practice Guidelines as Topic',\n",
       "                'Radionuclide Imaging',\n",
       "                'Thyroid Gland/pathology',\n",
       "                '*Thyroid Nodule/diagnosis/epidemiology/pathology',\n",
       "                'United States'],\n",
       "               'COIS': ['Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht.'],\n",
       "               'EDAT': '2020/07/08 06:00',\n",
       "               'MHDA': '2021/03/06 06:00',\n",
       "               'CRDT': ['2020/07/08 06:00'],\n",
       "               'PHST': ['2020/07/08 06:00 [pubmed]',\n",
       "                '2021/03/06 06:00 [medline]',\n",
       "                '2020/07/08 06:00 [entrez]'],\n",
       "               'AID': ['10.1055/a-1018-2767 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Dtsch Med Wochenschr. 2020 Aug;145(17):1227-1235. doi: 10.1055/a-1018-2767. Epub 2020 Jul 7.'},\n",
       "              {'PMID': '32402458',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20210223',\n",
       "               'LR': '20210223',\n",
       "               'IS': '1873-2623 (Electronic) 0041-1345 (Linking)',\n",
       "               'VI': '52',\n",
       "               'IP': '10',\n",
       "               'DP': '2020 Dec',\n",
       "               'TI': 'Influence of Parathyroidectomy on Kidney Graft Function in Secondary and Tertiary Hyperparathyroidism.',\n",
       "               'PG': '3134-3143',\n",
       "               'LID': 'S0041-1345(19)31599-4 [pii] 10.1016/j.transproceed.2020.03.024 [doi]',\n",
       "               'AB': 'BACKGROUND: Timing of parathyroidectomy (PTX) remains controversial in candidates for kidney transplant with concomitant renal hyperparathyroidism (HPT). The aim of this retrospective study was to identify the influence of early vs late posttransplant PTX compared to pretransplant PTX on renal graft function and morbidity. METHODS: This single-center cohort study includes 57 patients with renal HPT and kidney transplantation treated between 2007 and 2017. Ninety-six patients had surgery for renal HPT between 2007 and 2017 as a consecutive sample. Group 1 (n = 30; tertiary HPT), group 2 (n = 66; secondary HPT). Of group 1, 4 patients were excluded for PTX before and after kidney transplantation. In group 2, 20 patients were excluded since they had not undergone kidney transplantation during follow-up. Twelve patients were excluded because of short follow-up (kidney transplantation in 2018), and 3 patients were excluded because of transplant failure within 90 days. Twenty-six patients underwent posttransplant PTX (10 patients within 12 months after transplant), and 31 patients had undergone PTX prior to kidney transplantation. Graft function, serum calcium concentrations, parathyroid hormone (PTH) levels, postoperative morbidity, and 90-day mortality were recorded. RESULTS: Median age was 53.1 years in group 1 and 49.1 years in group 2. Most patients were male (53.8% in group 1; 54.8% in group 2). Median preoperative PTH levels were significantly different with 331.6 pg/mL in group 1 and 667.5 pg/mL in group 2 (P = .003). Creatinine levels changed little from 1.4 mg/dL (range, 0.8-2.5) to 1.7 mg/dL (range, 0.7-7.3) in group 1, and no difference was seen between early or late PTX after transplantation. In group 2, creatinine levels were 8.5 mg/dL (range, 4.6-11.7) before PTX and 8.7 mg/dL (range, 5.1-11.9) after PTX. We saw no correlation between postoperative PTH and kidney function. Thirty-five patients with postoperative PTH < 15 pg/mL displayed a mean postoperative creatinine of 5.5 mg/dL (range, 4.3-6.8), similar to other patients. Both the 30-day and 90-day mortality rates were zero. CONCLUSIONS: PTX had no negative effect on graft function, whether performed before or after (early or late) kidney transplantation. Surgical cure of renal HPT should be performed as soon as possible to prevent secondary complications and can also be safely carried out early after transplantation.',\n",
       "               'CI': ['Copyright (c) 2020 Elsevier Inc. All rights reserved.'],\n",
       "               'FAU': ['Bures, Claudia',\n",
       "                'Seika, Philippa',\n",
       "                'Skachko, Tatjana',\n",
       "                'Dobrindt, Eva M',\n",
       "                'Rayes, Nada',\n",
       "                'Pratschke, Johann',\n",
       "                'Goretzki, Peter E',\n",
       "                'Mogl, Martina T'],\n",
       "               'AU': ['Bures C',\n",
       "                'Seika P',\n",
       "                'Skachko T',\n",
       "                'Dobrindt EM',\n",
       "                'Rayes N',\n",
       "                'Pratschke J',\n",
       "                'Goretzki PE',\n",
       "                'Mogl MT'],\n",
       "               'AD': ['Department of Surgery, Campus Charite Mitte, Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte, Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte, Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte, Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Berlin, Germany.',\n",
       "                'Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte, Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte, Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Berlin, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte, Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Berlin, Germany. Electronic address: Martina.mogl@charite.de.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20200511',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Transplant Proc',\n",
       "               'JT': 'Transplantation proceedings',\n",
       "               'JID': '0243532',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Cohort Studies',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism, Secondary/etiology/*surgery',\n",
       "                '*Kidney Failure, Chronic/complications/surgery',\n",
       "                '*Kidney Transplantation',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Parathyroidectomy/*methods',\n",
       "                'Retrospective Studies'],\n",
       "               'EDAT': '2020/05/14 06:00',\n",
       "               'MHDA': '2021/02/24 06:00',\n",
       "               'CRDT': ['2020/05/14 06:00'],\n",
       "               'PHST': ['2019/11/17 00:00 [received]',\n",
       "                '2020/02/20 00:00 [revised]',\n",
       "                '2020/03/12 00:00 [accepted]',\n",
       "                '2020/05/14 06:00 [pubmed]',\n",
       "                '2021/02/24 06:00 [medline]',\n",
       "                '2020/05/14 06:00 [entrez]'],\n",
       "               'AID': ['S0041-1345(19)31599-4 [pii]',\n",
       "                '10.1016/j.transproceed.2020.03.024 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Transplant Proc. 2020 Dec;52(10):3134-3143. doi: 10.1016/j.transproceed.2020.03.024. Epub 2020 May 11.'},\n",
       "              {'PMID': '32372309',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20210427',\n",
       "               'LR': '20210427',\n",
       "               'IS': '1435-2451 (Electronic) 1435-2443 (Linking)',\n",
       "               'VI': '405',\n",
       "               'IP': '2',\n",
       "               'DP': '2020 Mar',\n",
       "               'TI': 'Long-term outcome of surgical resection in patients with gastroenteropancreatic neuroendocrine neoplasia: results from a German nation-wide multi-centric registry.',\n",
       "               'PG': '145-154',\n",
       "               'LID': '10.1007/s00423-020-01868-1 [doi]',\n",
       "               'AB': 'BACKGROUND: Neuroendocrine neoplasia (NEN) are rare and heterogenous tumours. Few data exist on the impact of surgical therapy. MATERIALS AND METHODS: This is a retrospective analysis of prospectively collected data of gastroenteropancreatic NEN in the German NET-Registry (1999-2012). It focuses on patients without distant metastases (limited disease, LD, stage I-IIIB). RESULTS: Data of 2239 patients with NEN were recorded. Median age was 59 years, the gender ratio was 1:1.3 (f:m). A total of 986 patients (44%) had LD, and the 5-year survival rate (5 years) was 77% for all and 90% for patients with LD. A total of 1635 patients (73%) received a surgical therapy (1st to 6th line); the 5 and 10 ysr were 83/65% after and 59/35% without surgery for all patients (p < .001). The resection margins in the LD patients were 76%, 16%, and 3% for R0, R1 and R2, respectively. The 10 ysr was 84%, 59% and 42% for R0, R1 and R2 resections, respectively (p = .021 R0/R1, p < .001 R0/R2). The R0 resection rate was 75% for G1/G2 NET and 67% for G3 NEC. CONCLUSION: The rate of complete tumour resection (R0) in LD is independent of tumour grading, and R0 resection is the key determinant of long-term survival, as demonstrated by the 10 ysr. of 84%. All NEN patients with limited disease should be considered for operation, if possible, as the best 10-year survival is shown after an R0 resection.',\n",
       "               'FAU': ['Begum, Nehara',\n",
       "                'Maasberg, Sebastian',\n",
       "                'Pascher, Andreas',\n",
       "                'Plockinger, Ursula',\n",
       "                'Gress, Thomas M',\n",
       "                'Wurst, Christine',\n",
       "                'Weber, Frank',\n",
       "                'Raffel, Andreas',\n",
       "                'Krausch, Markus',\n",
       "                'Holzer, Katharina',\n",
       "                'Bartsch, Detlef K',\n",
       "                'Musholt, Thomas J',\n",
       "                'Keck, Tobias',\n",
       "                'Anlauf, Martin',\n",
       "                'Rinke, Anja',\n",
       "                'Pape, Ulrich-Frank',\n",
       "                'Goretzki, Peter E'],\n",
       "               'AU': ['Begum N',\n",
       "                'Maasberg S',\n",
       "                'Pascher A',\n",
       "                'Plockinger U',\n",
       "                'Gress TM',\n",
       "                'Wurst C',\n",
       "                'Weber F',\n",
       "                'Raffel A',\n",
       "                'Krausch M',\n",
       "                'Holzer K',\n",
       "                'Bartsch DK',\n",
       "                'Musholt TJ',\n",
       "                'Keck T',\n",
       "                'Anlauf M',\n",
       "                'Rinke A',\n",
       "                'Pape UF',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Department for General-, Visceral- and Minimalinvasive Surgery, Agaplesion Evangelisches Klinikum Schaumburg, Obernkirchen, Germany. nehara.begum@gmx.de.',\n",
       "                'Department for Internal Medicine and Gastroenterology, Asklepios Hospital St. Georg, Lohmuhlenstrasse 5, Hamburg, Germany.',\n",
       "                'Department of Hepatology and Gastroenterology, Campus Virchow Clinic, Charite, University Medicine Berlin, Berlin, Germany.',\n",
       "                'Department General-, Visceral- and Transplant Surgery, University Hospital Munster, Munster, Germany.',\n",
       "                'Centre of Metabollism: Endocrinology, Diabetes and Metabolism, Campus Virchow Clinic, Charite University-Medicine Berlin, Berlin, Germany.',\n",
       "                'Department of Gastroenterology and Endocrinology, University Hospital Marburg (UKGM), Marburg, Germany.',\n",
       "                'Department of Surgery, Klinikum Crailsheim, Crailsheim, Germany.',\n",
       "                'Department of General-, Visceral- and Transplantation Surgery, Division of Endocrine Surgery, Medical Faculty, University Duisburg-Essen, Duisburg, Germany.',\n",
       "                'Department for General-, Visceral- and Endocrine Surgery, Marienhospital Gelsenkirchen, Gelsenkirchen, Germany.',\n",
       "                'Department for General-, Visceral- and Endocrine Surgery, Marienhospital Gelsenkirchen, Gelsenkirchen, Germany.',\n",
       "                'Department of Visceral-, Thoracic- and Vascular Surgery, Section of Endocrine Surgery, University Hospital Marburg (UKGM), Marburg, Germany.',\n",
       "                'Department of Visceral-, Thoracic- and Vascular Surgery, University Hospital Marburg (UKGM), Marburg, Germany.',\n",
       "                'Department of General, Visceral and Transplantation Surgery, Section of Endocrine Surgery, University Medicine Mainz, Mainz, Germany.',\n",
       "                'Department of General Surgery, University Hospital Schleswig-Holstein, Lubeck, Germany.',\n",
       "                'Pathological Institute, Limburg, Germany.',\n",
       "                'Department of Gastroenterology and Endocrinology, University Hospital Marburg (UKGM), Marburg, Germany.',\n",
       "                'Department for Internal Medicine and Gastroenterology, Asklepios Hospital St. Georg, Lohmuhlenstrasse 5, Hamburg, Germany.',\n",
       "                'Department of Hepatology and Gastroenterology, Campus Virchow Clinic, Charite, University Medicine Berlin, Berlin, Germany.',\n",
       "                'Department of General, Visceral and Transplant Surgery, Section of Endocrine Surgery, Charite, University Medicine Berlin, Berlin, Germany.'],\n",
       "               'CN': ['German NET-Registry'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Multicenter Study'],\n",
       "               'DEP': '20200505',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Female',\n",
       "                'Gastrointestinal Neoplasms/mortality/pathology/*surgery',\n",
       "                'Germany',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Margins of Excision',\n",
       "                'Middle Aged',\n",
       "                'Neoplasm Staging',\n",
       "                'Neuroendocrine Tumors/mortality/pathology/*surgery',\n",
       "                'Pancreatic Neoplasms/mortality/pathology/*surgery',\n",
       "                'Registries',\n",
       "                'Retrospective Studies',\n",
       "                'Survival Rate',\n",
       "                'Treatment Outcome',\n",
       "                'Young Adult'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Net Registry',\n",
       "                'Resectional margin',\n",
       "                'Surgery in NEN',\n",
       "                'Tumour grading'],\n",
       "               'EDAT': '2020/05/07 06:00',\n",
       "               'MHDA': '2021/04/28 06:00',\n",
       "               'CRDT': ['2020/05/07 06:00'],\n",
       "               'PHST': ['2019/09/11 00:00 [received]',\n",
       "                '2020/03/22 00:00 [accepted]',\n",
       "                '2020/05/07 06:00 [pubmed]',\n",
       "                '2021/04/28 06:00 [medline]',\n",
       "                '2020/05/07 06:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00423-020-01868-1 [pii]',\n",
       "                '10.1007/s00423-020-01868-1 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 2020 Mar;405(2):145-154. doi: 10.1007/s00423-020-01868-1. Epub 2020 May 5.'},\n",
       "              {'PMID': '32278744',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20201222',\n",
       "               'LR': '20201222',\n",
       "               'IS': '2212-1692 (Electronic) 1875-9572 (Linking)',\n",
       "               'VI': '61',\n",
       "               'IP': '4',\n",
       "               'DP': '2020 Aug',\n",
       "               'TI': 'Postnatal serum creatinine is elevated in preterm infants with PPROM-induced anhydramnios.',\n",
       "               'PG': '414-419',\n",
       "               'LID': 'S1875-9572(20)30049-8 [pii] 10.1016/j.pedneo.2020.03.010 [doi]',\n",
       "               'AB': 'BACKGROUND: The reason for increased serum creatinine levels in preterm infants often remains unclear. We aimed to determine whether postnatal serum creatinine in preterm infants correlates with intake of amniotic fluid, represented by the amount of amniotic fluid after preterm premature rupture of membranes (PPROM). METHODS: 74 preterm infants with PPROM > 48 h duration were retrospectively studied. Postnatal creatinine concentration was determined at day 2-5, 10-17 and 26-33 of life and compared between infants with normal intrauterine amniotic volumes, oligohydramnios and anhydramnios. RESULTS: Mean gestational age of included patients was 29.7 weeks (range: 24.0-36.1 weeks) and mean birth weight was 1452 g (range: 560-2940 g). Serum creatinine concentration was similar at day 2-5 and day 10-17 of life between the three groups. We observed a significant decrease in creatinine concentration from day 2-5 to day 26-33 in infants with normal amniotic fluid volume and oligohydramnios (p = 0.0001 and p = 0.0071, respectively), but not in anhydramnios. On day 26-33 of life, infants with anhydramnios showed significantly higher creatinine levels compared to infants with normal amniotic fluid volume and oligohydramnios (p = 0.0211). CONCLUSION: Postnatal serum creatinine of preterm infants at day 26-33 of life is elevated in infants with PPROM-induced anhydramnios, but not in oligohydramnios.',\n",
       "               'CI': ['Copyright (c) 2020. Published by Elsevier B.V.'],\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Stahling, Ann-Christin',\n",
       "                'Greve, Sandra',\n",
       "                'Weiss, Christel',\n",
       "                'Koninger, Angela',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Muller, Hanna'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Stahling AC',\n",
       "                'Greve S',\n",
       "                'Weiss C',\n",
       "                'Koninger A',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Muller H'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany. Electronic address: Nora.Bruns@uk-essen.de.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany. Electronic address: acstaehling@gmail.com.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany. Electronic address: Sandra.greve@uk-essen.de.',\n",
       "                'Department for Medical Statistics and Biomathematics, University Hospital Mannheim, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany. Electronic address: christel.weiss@medma.uni-heidelberg.de.',\n",
       "                'Department of Gynecology and Obstetrics, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany. Electronic address: Angela.Koeninger@uk-essen.de.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany. Electronic address: Ursula.Felderhoff@uk-essen.de.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany; Division of Neonatology and Pediatric Intensive Care, Department of Pediatrics, University Hospital Erlangen, University of Erlangen-Nurnberg, Loschgestr. 15, 91054 Erlangen, Germany. Electronic address: Hanna.Mueller@uk-erlangen.de.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20200324',\n",
       "               'PL': 'Singapore',\n",
       "               'TA': 'Pediatr Neonatol',\n",
       "               'JT': 'Pediatrics and neonatology',\n",
       "               'JID': '101484755',\n",
       "               'RN': ['AYI8EX34EU (Creatinine)',\n",
       "                'Preterm Premature Rupture of the Membranes'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Amniotic Fluid',\n",
       "                'Creatinine/*blood',\n",
       "                'Female',\n",
       "                '*Fetal Membranes, Premature Rupture',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature/*blood',\n",
       "                'Oligohydramnios/*etiology',\n",
       "                'Pregnancy',\n",
       "                'Retrospective Studies'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['amniotic fluid',\n",
       "                'anhydramnios',\n",
       "                'preterm infant',\n",
       "                'preterm premature rupture of membranes',\n",
       "                'serum creatinine'],\n",
       "               'EDAT': '2020/04/13 06:00',\n",
       "               'MHDA': '2020/12/23 06:00',\n",
       "               'CRDT': ['2020/04/13 06:00'],\n",
       "               'PHST': ['2019/07/29 00:00 [received]',\n",
       "                '2020/02/04 00:00 [revised]',\n",
       "                '2020/03/18 00:00 [accepted]',\n",
       "                '2020/04/13 06:00 [pubmed]',\n",
       "                '2020/12/23 06:00 [medline]',\n",
       "                '2020/04/13 06:00 [entrez]'],\n",
       "               'AID': ['S1875-9572(20)30049-8 [pii]',\n",
       "                '10.1016/j.pedneo.2020.03.010 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Pediatr Neonatol. 2020 Aug;61(4):414-419. doi: 10.1016/j.pedneo.2020.03.010. Epub 2020 Mar 24.'},\n",
       "              {'PMID': '32110649',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20210201',\n",
       "               'IS': '2297-4725 (Print) 2297-475X (Electronic) 2297-4725 (Linking)',\n",
       "               'VI': '36',\n",
       "               'IP': '1',\n",
       "               'DP': '2020 Feb',\n",
       "               'TI': 'The Impact of Gender on Diagnosis and Treatment in Endocrine Surgery.',\n",
       "               'PG': '2',\n",
       "               'LID': '10.1159/000505502 [doi]',\n",
       "               'FAU': ['Goretzki, Peter E'],\n",
       "               'AU': ['Goretzki PE'],\n",
       "               'AD': ['Department of General, Visceral and Transplant Surgery, Charite - University Medicine Berlin, Berlin, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Editorial'],\n",
       "               'DEP': '20200114',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Visc Med',\n",
       "               'JT': 'Visceral medicine',\n",
       "               'JID': '101681546',\n",
       "               'PMC': 'PMC7036585',\n",
       "               'EDAT': '2020/02/29 06:00',\n",
       "               'MHDA': '2020/02/29 06:01',\n",
       "               'PMCR': ['2021/02/01'],\n",
       "               'CRDT': ['2020/02/29 06:00'],\n",
       "               'PHST': ['2019/12/17 00:00 [received]',\n",
       "                '2019/12/17 00:00 [accepted]',\n",
       "                '2020/02/29 06:00 [entrez]',\n",
       "                '2020/02/29 06:00 [pubmed]',\n",
       "                '2020/02/29 06:01 [medline]',\n",
       "                '2021/02/01 00:00 [pmc-release]'],\n",
       "               'AID': ['vis-0036-0002 [pii]', '10.1159/000505502 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Visc Med. 2020 Feb;36(1):2. doi: 10.1159/000505502. Epub 2020 Jan 14.'},\n",
       "              {'PMID': '32067100',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20210330',\n",
       "               'LR': '20240730',\n",
       "               'IS': '1432-1076 (Electronic) 0340-6199 (Print) 0340-6199 (Linking)',\n",
       "               'VI': '179',\n",
       "               'IP': '8',\n",
       "               'DP': '2020 Aug',\n",
       "               'TI': 'Two-year outcome data suggest that less invasive surfactant administration (LISA) is safe. Results from the follow-up of the randomized controlled AMV (avoid mechanical ventilation) study.',\n",
       "               'PG': '1309-1313',\n",
       "               'LID': '10.1007/s00431-020-03572-0 [doi]',\n",
       "               'AB': 'Less invasive surfactant administration (LISA) is a method to deliver surfactant to spontaneously breathing premature infants via a thin catheter. Here we report the two-year outcome from the AMV (avoid mechanical ventilation) study, the first randomized controlled trial on this mode of surfactant delivery. No statistically significant differences in weight, length or neurodevelopmental outcome (Bayley II scores) were found between the LISA intervention group (n = 95) and the control group (n = 84) that received standard treatment.Conclusion: No differences in outcome were observed at 2 years. LISA seems safe in that aspect. What is Known: * LISA is a method that is in increasing use for surfactant delivery to spontaneously breathing infants. LISA reduces the need for mechanical ventilation. What is New: * Outcome data at 2 years from the first randomized study with LISA raise no safety concerns in comparison to a group of infants that received standard treatment.',\n",
       "               'FAU': ['Herting, Egbert',\n",
       "                'Kribs, Angela',\n",
       "                'Hartel, Christoph',\n",
       "                'von der Wense, Axel',\n",
       "                'Weller, Ursula',\n",
       "                'Hoehn, Thomas',\n",
       "                'Vochem, Matthias',\n",
       "                'Moller, Jens',\n",
       "                'Wieg, Christian',\n",
       "                'Roth, Bernhard',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Herting E',\n",
       "                'Kribs A',\n",
       "                'Hartel C',\n",
       "                'von der Wense A',\n",
       "                'Weller U',\n",
       "                'Hoehn T',\n",
       "                'Vochem M',\n",
       "                'Moller J',\n",
       "                'Wieg C',\n",
       "                'Roth B',\n",
       "                'Gopel W'],\n",
       "               'AD': ['Department of Paediatrics, University Hospital of Schleswig-Holstein, University of Lubeck, Ratzeburger Allee 160, D-23538, Lubeck, Germany. egbert.herting@uksh.de.',\n",
       "                'Department of Neonatology, University of Cologne, Cologne, Germany.',\n",
       "                'Department of Paediatrics, University Hospital of Schleswig-Holstein, University of Lubeck, Ratzeburger Allee 160, D-23538, Lubeck, Germany.',\n",
       "                \"Department of Neonatology, Children's Hospital Hamburg-Altona, Hamburg, Germany.\",\n",
       "                'Department of Paediatrics, Evangelical Klinikum Bethel, Bielefeld, Germany.',\n",
       "                'Department of Paediatrics, University of Dusseldorf, Dusseldorf, Germany.',\n",
       "                'Department of Neonatology, Olgahospital Stuttgart, Stuttgart, Germany.',\n",
       "                'Department of Paediatrics, Saarbrucken General Hospital, Saarbrucken, Germany.',\n",
       "                \"Germany Children's Hospital Aschaffenburg-Alzenau, Aschaffenburg, Germany.\",\n",
       "                'Department of Neonatology, University of Cologne, Cologne, Germany.',\n",
       "                'Department of Paediatrics, University Hospital of Schleswig-Holstein, University of Lubeck, Ratzeburger Allee 160, D-23538, Lubeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network (GNN)'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['01ER0805 and 01ER1501/BMBF/'],\n",
       "               'PT': ['Journal Article', 'Randomized Controlled Trial'],\n",
       "               'DEP': '20200218',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Eur J Pediatr',\n",
       "               'JT': 'European journal of pediatrics',\n",
       "               'JID': '7603873',\n",
       "               'RN': ['0 (Pulmonary Surfactants)',\n",
       "                'Respiratory Distress Syndrome In Premature Infants'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Catheterization',\n",
       "                'Child, Preschool',\n",
       "                'Continuous Positive Airway Pressure',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Growth Disorders/diagnosis/etiology/*prevention & control',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature',\n",
       "                'Male',\n",
       "                'Neurodevelopmental Disorders/diagnosis/etiology/*prevention & control',\n",
       "                'Pulmonary Surfactants/*administration & dosage/therapeutic use',\n",
       "                'Respiration, Artificial/statistics & numerical data',\n",
       "                'Respiratory Distress Syndrome, Newborn/*drug therapy/therapy',\n",
       "                'Treatment Outcome'],\n",
       "               'PMC': 'PMC7351829',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['LISA - CPAP',\n",
       "                'Less invasive surfactant',\n",
       "                'Outcome',\n",
       "                'Premature infants'],\n",
       "               'COIS': ['Egbert Herting, Angela Kribs, Christoph Hartel and Wolfgang Gopel have received',\n",
       "                'study support, honoraria for presentations and travel support from Chiesi',\n",
       "                'Farmaceutici, a surfactant producer. Egbert Herting and Christoph Hartel served',\n",
       "                'as advisors for Draeger Medical, a company producing incubators, monitors and',\n",
       "                'ventilators.'],\n",
       "               'EDAT': '2020/02/19 06:00',\n",
       "               'MHDA': '2021/03/31 06:00',\n",
       "               'PMCR': ['2020/02/18'],\n",
       "               'CRDT': ['2020/02/19 06:00'],\n",
       "               'PHST': ['2019/09/27 00:00 [received]',\n",
       "                '2020/01/08 00:00 [accepted]',\n",
       "                '2019/12/20 00:00 [revised]',\n",
       "                '2020/02/19 06:00 [pubmed]',\n",
       "                '2021/03/31 06:00 [medline]',\n",
       "                '2020/02/19 06:00 [entrez]',\n",
       "                '2020/02/18 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s00431-020-03572-0 [pii]',\n",
       "                '3572 [pii]',\n",
       "                '10.1007/s00431-020-03572-0 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Pediatr. 2020 Aug;179(8):1309-1313. doi: 10.1007/s00431-020-03572-0. Epub 2020 Feb 18.'},\n",
       "              {'PMID': '32047169',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20201110',\n",
       "               'LR': '20210210',\n",
       "               'IS': '2045-2322 (Electronic) 2045-2322 (Linking)',\n",
       "               'VI': '10',\n",
       "               'IP': '1',\n",
       "               'DP': '2020 Feb 11',\n",
       "               'TI': 'Surgical necrotizing enterocolitis but not spontaneous intestinal perforation is associated with adverse neurological outcome at school age.',\n",
       "               'PG': '2373',\n",
       "               'LID': '10.1038/s41598-020-58761-6 [doi] 2373',\n",
       "               'AB': 'Gastrointestinal complications during the neonatal period, i.e. necrotizing enterocolitis (NEC) and spontaneous intestinal perforation (SIP), are associated with adverse short-term outcome in very-low-birthweight infants (VLBWI, <1500 g birth weight). However, little is known about the neurological outcome of survivors at school age. We analysed data of 2241 infants followed-up at the age of 6 years. To determine the effect of NEC and SIP on cognitive outcome in consideration of other important confounding factors, we used multivariable logistic regression models. In addition, infants with surgical diagnosis of NEC (n = 43) or SIP (n = 41) were compared to NEC (n = 43) or SIP (n = 41) negative controls using Mahalanobis distance matching. Infants with a history for NEC had a three times increased risk (RR 3.0 [1.8-4.2], p < 0.001) to develop IQ scores <85 while history of surgical SIP did not increase the relative risk for lower IQs at school age (RR 1.0 [0.4-2.1], p = 1.000). In a matched-cohort analysis, we confirmed that infants with surgical NEC had lower mean IQ results than unaffected controls (+/-SD) (85+/-17 vs. 94+/-14, p = 0.023) while no differences were found for history of SIP. Our results reflect that the different aetiology and inflammatory extent of NEC and SIP may lead to disparate neurodevelopment trajectories. Hence, our data suggest a potential role of early gut-brain axis distortion in infants with NEC which needs to be further explored.',\n",
       "               'FAU': ['Humberg, Alexander',\n",
       "                'Spiegler, Juliane',\n",
       "                'Fortmann, Mats Ingmar',\n",
       "                'Zemlin, Michael',\n",
       "                'Marissen, Janina',\n",
       "                'Swoboda, Isabelle',\n",
       "                'Rausch, Tanja K',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang',\n",
       "                'Hartel, Christoph'],\n",
       "               'AU': ['Humberg A',\n",
       "                'Spiegler J',\n",
       "                'Fortmann MI',\n",
       "                'Zemlin M',\n",
       "                'Marissen J',\n",
       "                'Swoboda I',\n",
       "                'Rausch TK',\n",
       "                'Herting E',\n",
       "                'Gopel W',\n",
       "                'Hartel C'],\n",
       "               'AD': ['Department of Paediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany. alexander.humberg@uksh.de.',\n",
       "                'Department of Paediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Paediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Paediatrics and Neonatology, Saarland University Medical Center, Homburg/Saar, Germany.',\n",
       "                'Department of Paediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Paediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Paediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Institute of Medical Biometry and Statistics, University of Lubeck, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Paediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Paediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.',\n",
       "                'Department of Paediatrics, University Hospital of Schleswig-Holstein, Campus Lubeck, Lubeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network (GNN)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20200211',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Sci Rep',\n",
       "               'JT': 'Scientific reports',\n",
       "               'JID': '101563288',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Child',\n",
       "                'Cognition',\n",
       "                'Developmental Disabilities/*epidemiology',\n",
       "                'Digestive System Surgical Procedures/*statistics & numerical data',\n",
       "                'Enterocolitis, Necrotizing/*epidemiology/surgery',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                '*Infant, Very Low Birth Weight',\n",
       "                'Intestinal Perforation/*epidemiology',\n",
       "                'Male'],\n",
       "               'PMC': 'PMC7012917',\n",
       "               'COIS': ['The authors declare no competing interests.'],\n",
       "               'FIR': ['Wieg, Christian',\n",
       "                'Kribs, Angela',\n",
       "                'von der Wense, Axel',\n",
       "                'Weller, Ursula',\n",
       "                'Hohn, Thomas',\n",
       "                'Olbertz, Dirk M',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Rossi, Rainer',\n",
       "                'Teig, Norbert',\n",
       "                'Heitmann, Friedhelm',\n",
       "                'Schmidtke, Susanne',\n",
       "                'Bohnhorst, Bettina',\n",
       "                'Vochem, Matthias',\n",
       "                'Michel, Holger',\n",
       "                'Moller, Jens',\n",
       "                'Eichhorn, Joachim G',\n",
       "                'Wintgens, Jurgen',\n",
       "                'Bottger, Ralf',\n",
       "                'Hubert, Mechthild',\n",
       "                'Dordelmann, Michael',\n",
       "                'Hillebrand, Georg',\n",
       "                'Roll, Claudia',\n",
       "                'Jensen, Reinhard',\n",
       "                'Rudiger, Mario',\n",
       "                'Sandkotter, Julia',\n",
       "                'Schafer, Stefan',\n",
       "                'Schaible, Thomas',\n",
       "                'Franz, Axel',\n",
       "                'Aydin, Malik',\n",
       "                'Ehlers, Silke',\n",
       "                'Werner, Claudius',\n",
       "                'Orlikowsky, Thorsten',\n",
       "                'Gerleve, Hubert',\n",
       "                'Schneider, Katja',\n",
       "                'Werner, Claudius',\n",
       "                'Bockenholt, Kai',\n",
       "                'Linnemann, Knud',\n",
       "                'Muller, Dirk',\n",
       "                'Gebauer, Corinna',\n",
       "                'Guthmann, Florian',\n",
       "                'Reese, Jochen',\n",
       "                'Haase, Roland',\n",
       "                'Seeliger, Stephan',\n",
       "                'Kuster, Helmut',\n",
       "                'Hentschel, Roland',\n",
       "                'Korner, Thorsten',\n",
       "                'Brune, Thomas',\n",
       "                'Muller, Andreas',\n",
       "                'Frank, Thomas',\n",
       "                'Berghauser, Martin Andree',\n",
       "                'Dawczynski, Kristin'],\n",
       "               'IR': ['Wieg C',\n",
       "                'Kribs A',\n",
       "                'von der Wense A',\n",
       "                'Weller U',\n",
       "                'Hohn T',\n",
       "                'Olbertz DM',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Rossi R',\n",
       "                'Teig N',\n",
       "                'Heitmann F',\n",
       "                'Schmidtke S',\n",
       "                'Bohnhorst B',\n",
       "                'Vochem M',\n",
       "                'Michel H',\n",
       "                'Moller J',\n",
       "                'Eichhorn JG',\n",
       "                'Wintgens J',\n",
       "                'Bottger R',\n",
       "                'Hubert M',\n",
       "                'Dordelmann M',\n",
       "                'Hillebrand G',\n",
       "                'Roll C',\n",
       "                'Jensen R',\n",
       "                'Rudiger M',\n",
       "                'Sandkotter J',\n",
       "                'Schafer S',\n",
       "                'Schaible T',\n",
       "                'Franz A',\n",
       "                'Aydin M',\n",
       "                'Ehlers S',\n",
       "                'Werner C',\n",
       "                'Orlikowsky T',\n",
       "                'Gerleve H',\n",
       "                'Schneider K',\n",
       "                'Werner C',\n",
       "                'Bockenholt K',\n",
       "                'Linnemann K',\n",
       "                'Muller D',\n",
       "                'Gebauer C',\n",
       "                'Guthmann F',\n",
       "                'Reese J',\n",
       "                'Haase R',\n",
       "                'Seeliger S',\n",
       "                'Kuster H',\n",
       "                'Hentschel R',\n",
       "                'Korner T',\n",
       "                'Brune T',\n",
       "                'Muller A',\n",
       "                'Frank T',\n",
       "                'Berghauser MA',\n",
       "                'Dawczynski K'],\n",
       "               'EDAT': '2020/02/13 06:00',\n",
       "               'MHDA': '2020/11/11 06:00',\n",
       "               'PMCR': ['2020/02/11'],\n",
       "               'CRDT': ['2020/02/13 06:00'],\n",
       "               'PHST': ['2019/09/09 00:00 [received]',\n",
       "                '2019/12/30 00:00 [accepted]',\n",
       "                '2020/02/13 06:00 [entrez]',\n",
       "                '2020/02/13 06:00 [pubmed]',\n",
       "                '2020/11/11 06:00 [medline]',\n",
       "                '2020/02/11 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1038/s41598-020-58761-6 [pii]',\n",
       "                '58761 [pii]',\n",
       "                '10.1038/s41598-020-58761-6 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Sci Rep. 2020 Feb 11;10(1):2373. doi: 10.1038/s41598-020-58761-6.'},\n",
       "              {'PMID': '32039124',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20200928',\n",
       "               'IS': '2296-2360 (Print) 2296-2360 (Electronic) 2296-2360 (Linking)',\n",
       "               'VI': '8',\n",
       "               'DP': '2020',\n",
       "               'TI': 'aEEG Use in Pediatric Critical Care-An Online Survey.',\n",
       "               'PG': '3',\n",
       "               'LID': '10.3389/fped.2020.00003 [doi] 3',\n",
       "               'AB': \"Background: Evidence supporting continuous EEG monitoring in pediatric intensive care is increasing, but continuous full-channel EEG is a scarce resource. Amplitude-integrated EEG (aEEG) monitors are broadly available in children's hospitals due to their use in neonatology and can easily be applied to older patients. Objective: The aim of this survey was to evaluate the use of amplitude-integrated EEG in German and Swiss pediatric intensive care units (PICUs). Design: An online survey was sent to German and Swiss PICUs that were identified via databases provided by the German Pediatric Association (DGKJ) and the Swiss Society of Intensive Care (SGI). The questionnaire contained 18 multiple choice questions including the PICU size and specialization, indications for aEEG use, perceived benefits from aEEG, and data storage. Main results: Forty-three (26%) PICUs filled out the questionnaire. Two thirds of all interviewed PICUs use aEEG in non-neonates. Main indications were neurological complications or disease and altered mental state. Features assessed were mostly seizures and side differences, less frequently height of amplitude and background pattern. Interpretation of raw EEG also played an important role. All interviewees would appreciate the establishment of reference values for toddlers and children. Conclusions: aEEG is used in a large proportion of the interviewed PICUs. The wide-spread use without validation of data generates the need for further evaluation of this technique and the establishment of reference values for non-neonates.\",\n",
       "               'CI': ['Copyright (c) 2020 Bruns, Felderhoff-Muser, Dohna-Schwake, Woelfle and Muller.'],\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Dohna-Schwake, Christian',\n",
       "                'Woelfle, Joachim',\n",
       "                'Muller, Hanna'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Dohna-Schwake C',\n",
       "                'Woelfle J',\n",
       "                'Muller H'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Division of Neonatology and Pediatric Intensive Care, Department of Pediatrics, University Hospital Erlangen, University of Erlangen-Nurnberg, Erlangen, Germany.',\n",
       "                'Division of Neonatology and Pediatric Intensive Care, Department of Pediatrics, University Hospital Erlangen, University of Erlangen-Nurnberg, Erlangen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20200124',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Front Pediatr',\n",
       "               'JT': 'Frontiers in pediatrics',\n",
       "               'JID': '101615492',\n",
       "               'PMC': 'PMC6992599',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['aEEG',\n",
       "                'amplitude-integrated EEG',\n",
       "                'continuous EEG',\n",
       "                'neuromonitoring',\n",
       "                'pediatric critical care',\n",
       "                'survey'],\n",
       "               'EDAT': '2020/02/11 06:00',\n",
       "               'MHDA': '2020/02/11 06:01',\n",
       "               'PMCR': ['2020/01/24'],\n",
       "               'CRDT': ['2020/02/11 06:00'],\n",
       "               'PHST': ['2019/10/11 00:00 [received]',\n",
       "                '2020/01/07 00:00 [accepted]',\n",
       "                '2020/02/11 06:00 [entrez]',\n",
       "                '2020/02/11 06:00 [pubmed]',\n",
       "                '2020/02/11 06:01 [medline]',\n",
       "                '2020/01/24 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3389/fped.2020.00003 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Front Pediatr. 2020 Jan 24;8:3. doi: 10.3389/fped.2020.00003. eCollection 2020.'},\n",
       "              {'PMID': '31786743',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20201217',\n",
       "               'LR': '20220625',\n",
       "               'IS': '1874-270X (Electronic) 1874-270X (Linking)',\n",
       "               'VI': '14',\n",
       "               'IP': '1',\n",
       "               'DP': '2020 Apr',\n",
       "               'TI': 'NMR assignments of a dynamically perturbed and dimerization inhibited N-terminal domain variant of a spider silk protein from E. australis.',\n",
       "               'PG': '67-71',\n",
       "               'LID': '10.1007/s12104-019-09922-w [doi]',\n",
       "               'AB': 'Web spiders use specialized glands to produce silk proteins, so-called spidroins, which assemble into extraordinarily tough silk fibers through tightly regulated phase and structural transitions. A crucial step in the polymerization of spidroins is the pH-triggered assembly of their N-terminal domains (NTDs) into tight dimers. Major ampullate spidroin NTDs contain an unusually high content of the amino acid methionine. We previously showed that the simultaneous mutation of the six hydrophobic core methionine residues to leucine in the NTD of the major ampullate spidroin 1 from Euprosthenops australis, a nursery web spider, yields a protein (L6-NTD) retaining a three-dimensional fold identical to the wildtype (WT) domain, yet with a significantly increased stability. Further, the dynamics of the L6-NTD are significantly reduced and the ability to dimerize is severely impaired compared to the WT domain. These properties lead to significant changes in the NMR spectra between WT and L6-NTD so that the previously available WT-NTD assignments cannot be transferred to the mutant protein. Here, we thus report the de novo NMR backbone and side chain assignments of the major ampullate spidroin 1 L6-NTD variant from E. australis as a prerequisite for obtaining further insights into protein structure and dynamics.',\n",
       "               'FAU': ['Goretzki, Benedikt',\n",
       "                'Heiby, Julia C',\n",
       "                'Hacker, Carolin',\n",
       "                'Neuweiler, Hannes',\n",
       "                'Hellmich, Ute A'],\n",
       "               'AU': ['Goretzki B',\n",
       "                'Heiby JC',\n",
       "                'Hacker C',\n",
       "                'Neuweiler H',\n",
       "                'Hellmich UA'],\n",
       "               'AUID': ['ORCID: 0000-0002-7721-6657',\n",
       "                'ORCID: 0000-0001-8191-8945',\n",
       "                'ORCID: 0000-0001-9951-0614',\n",
       "                'ORCID: 0000-0002-6657-001X',\n",
       "                'ORCID: 0000-0001-7162-285X'],\n",
       "               'AD': ['Institute for Pharmacy and Biochemistry, Johannes-Gutenberg-University Mainz, Johann-Joachim Becher-Weg 30, 55128, Mainz, Germany. begoretz@uni-mainz.de.',\n",
       "                'Center for Biomolecular Magnetic Resonance, Goethe-University, Max-von-Laue-Strasse 9, 60438, Frankfurt, Germany. begoretz@uni-mainz.de.',\n",
       "                'Department of Biotechnology & Biophysics, Julius-Maximilians-University Wurzburg, Am Hubland, 97074, Wurzburg, Germany.',\n",
       "                'Center for Biomolecular Magnetic Resonance, Goethe-University, Max-von-Laue-Strasse 9, 60438, Frankfurt, Germany.',\n",
       "                'Department of Biotechnology & Biophysics, Julius-Maximilians-University Wurzburg, Am Hubland, 97074, Wurzburg, Germany.',\n",
       "                'Institute for Pharmacy and Biochemistry, Johannes-Gutenberg-University Mainz, Johann-Joachim Becher-Weg 30, 55128, Mainz, Germany. u.hellmich@uni-mainz.de.',\n",
       "                'Center for Biomolecular Magnetic Resonance, Goethe-University, Max-von-Laue-Strasse 9, 60438, Frankfurt, Germany. u.hellmich@uni-mainz.de.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                \"Research Support, U.S. Gov't, Non-P.H.S.\"],\n",
       "               'DEP': '20191130',\n",
       "               'PL': 'Netherlands',\n",
       "               'TA': 'Biomol NMR Assign',\n",
       "               'JT': 'Biomolecular NMR assignments',\n",
       "               'JID': '101472371',\n",
       "               'RN': ['0 (spidroin 1)', '9007-76-5 (Fibroins)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Animals',\n",
       "                'Fibroins/*chemistry',\n",
       "                '*Nuclear Magnetic Resonance, Biomolecular',\n",
       "                'Protein Domains',\n",
       "                '*Protein Multimerization',\n",
       "                'Proton Magnetic Resonance Spectroscopy',\n",
       "                'Spiders/*metabolism'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Dimerization dynamics and plasticity',\n",
       "                'Hydrophobic core mutation',\n",
       "                'Major ampullate spidroin 1',\n",
       "                'Methionine',\n",
       "                'Spider silk'],\n",
       "               'EDAT': '2019/12/02 06:00',\n",
       "               'MHDA': '2020/12/18 06:00',\n",
       "               'CRDT': ['2019/12/02 06:00'],\n",
       "               'PHST': ['2019/10/14 00:00 [received]',\n",
       "                '2019/11/22 00:00 [accepted]',\n",
       "                '2019/12/02 06:00 [pubmed]',\n",
       "                '2020/12/18 06:00 [medline]',\n",
       "                '2019/12/02 06:00 [entrez]'],\n",
       "               'AID': ['10.1007/s12104-019-09922-w [pii]',\n",
       "                '10.1007/s12104-019-09922-w [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Biomol NMR Assign. 2020 Apr;14(1):67-71. doi: 10.1007/s12104-019-09922-w. Epub 2019 Nov 30.'},\n",
       "              {'PMID': '31724086',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20201118',\n",
       "               'LR': '20210819',\n",
       "               'IS': '1432-1076 (Electronic) 0340-6199 (Linking)',\n",
       "               'VI': '179',\n",
       "               'IP': '2',\n",
       "               'DP': '2020 Feb',\n",
       "               'TI': 'Correlation of lateral ventricular size and deep gray matter volume in MRI at term equivalent age with neurodevelopmental outcome at a corrected age of 24 months and with handedness in preterm infants.',\n",
       "               'PG': '271-278',\n",
       "               'LID': '10.1007/s00431-019-03496-4 [doi]',\n",
       "               'AB': 'The aim of this study was to correlate ventricular size and volumes of deep gray matter (DGM) in MRI at term equivalent age (TEA) with outcome at a corrected age of 24 months in preterm infants and with handedness. Seventy-three infants born before 32 weeks of gestation or with birth weight < 1500 g  were included in this retrospective analysis and measurement of lateral ventricles, and DGM was performed on MRI scans. The left lateral ventricle was significantly larger than the right lateral ventricle (p = 0.001). There was no correlation between volumes of the right and left ventricles and the DGM volume (p = 0.207 and p = 0.597, respectively), nor with the head circumference at TEA (p = 0.177 and p = 0.976, respectively). The total volume of both lateral ventricles did not correlate with Mental Develomental Index (MDI, p = 0.336) or Psychomotor Developmental Index (PDI, p = 0.650) score (Bayley Scales of Infant Development, BSID II). However, a correlation of total DGM volume with birth weight (p = 0.0001; r = 0.437), head circumference at TEA (p < 0.0001; r = 0.640), MDI (p = 0.029; r = 0.310), and PDI (p = 0.002; r = 0.456) was observed. No significant difference between right- and left-handed infants was seen in relation to volumes of both lateral ventricles and of DGM.Conclusion: DGM volume at TEA was significantly associated with the outcome at a corrected age of 24 months. Handedness did not correlate with DGM or lateral ventricle size.What is Known:* White matter injury as well as altered development of deep gray matter is associated with neurodevelopmental disability in preterm infants.* No study analyzed the association between deep gray matter volume or volumes of lateral ventricle and handedness in former preterm infants so far.What is New:* Volume of deep gray matter, but not lateral ventricular size was significantly associated with outcome at a corrected age of 24 months in preterm infants.* There was no correlation of handedness with volumes of lateral ventricular size or with deep gray matter volumes.',\n",
       "               'FAU': ['Storbeck, Tobias',\n",
       "                'Bruns, Nora',\n",
       "                'Weiss, Christel',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Muller, Hanna'],\n",
       "               'AU': ['Storbeck T',\n",
       "                'Bruns N',\n",
       "                'Weiss C',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Muller H'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Department of Medical Statistics and Biomathematics, University Hospital Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany. Hanna.Mueller@uk-erlangen.de.',\n",
       "                'Division of Neonatology and Pediatric Intensive Care, Department of Pediatrics, University Hospital Erlangen, University of Erlangen-Nurnberg, Loschgestrasse 15, 91054, Erlangen, Germany. Hanna.Mueller@uk-erlangen.de.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comparative Study', 'Journal Article'],\n",
       "               'DEP': '20191114',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Eur J Pediatr',\n",
       "               'JT': 'European journal of pediatrics',\n",
       "               'JID': '7603873',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Brain/growth & development',\n",
       "                'Child Development/physiology',\n",
       "                'Cohort Studies',\n",
       "                'Female',\n",
       "                'Functional Laterality',\n",
       "                'Germany',\n",
       "                'Gestational Age',\n",
       "                'Gray Matter/anatomy & histology/*diagnostic imaging',\n",
       "                'Hospitals, University',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature/*growth & development',\n",
       "                'Lateral Ventricles/*anatomy & histology/*diagnostic imaging',\n",
       "                'Magnetic Resonance Imaging/*methods',\n",
       "                'Male',\n",
       "                'Neurodevelopmental Disorders/*diagnostic imaging/physiopathology',\n",
       "                'Organ Size',\n",
       "                'Predictive Value of Tests',\n",
       "                'Retrospective Studies',\n",
       "                'Risk Assessment',\n",
       "                'Sex Factors',\n",
       "                'Term Birth'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Deep gray matter',\n",
       "                'Handedness',\n",
       "                'Immature preterm infants',\n",
       "                'MRI',\n",
       "                'Neurodevelopmental outcome',\n",
       "                'Ventricular size'],\n",
       "               'EDAT': '2019/11/15 06:00',\n",
       "               'MHDA': '2020/11/20 06:00',\n",
       "               'CRDT': ['2019/11/15 06:00'],\n",
       "               'PHST': ['2019/04/04 00:00 [received]',\n",
       "                '2019/10/02 00:00 [accepted]',\n",
       "                '2019/09/29 00:00 [revised]',\n",
       "                '2019/11/15 06:00 [pubmed]',\n",
       "                '2020/11/20 06:00 [medline]',\n",
       "                '2019/11/15 06:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00431-019-03496-4 [pii]',\n",
       "                '10.1007/s00431-019-03496-4 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Pediatr. 2020 Feb;179(2):271-278. doi: 10.1007/s00431-019-03496-4. Epub 2019 Nov 14.'},\n",
       "              {'PMID': '31693773',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20201002',\n",
       "               'LR': '20201002',\n",
       "               'IS': '1399-3062 (Electronic) 1398-2273 (Linking)',\n",
       "               'VI': '22',\n",
       "               'IP': '1',\n",
       "               'DP': '2020 Feb',\n",
       "               'TI': 'Bacterial infections in children after liver transplantation: A single-center surveillance study of 345 consecutive transplantations.',\n",
       "               'PG': 'e13208',\n",
       "               'LID': '10.1111/tid.13208 [doi]',\n",
       "               'AB': 'BACKGROUND: Infectious complications after pediatric liver transplantation frequently occur and are potentially serious. Data concerning strictly defined bacterial infections and their associated risk factors are lacking. METHODS: For the pediatric liver transplant postoperative period, we analyzed data from the nosocomial infection surveillance (2006-2015). RESULTS: A total of 235 bacterial infections in 162 transplantations (47%) occurred, including 32 bacterial pneumonia cases, 104 surgical site infections, 27 urinary tract infections, and 40 bloodstream infections. Sepsis was diagnosed in 127 cases (54%), severe sepsis in 22 (9%) cases, and septic shock in 41 (17%) cases. Thirty patients (9%) died, and septic shock was the leading cause of death. The carrier status of multi-drug resistant bacteria and a tacrolimus level >20 ng/mL were independent risk factors for surgical site infections and the occurrence of severe sepsis or septic shock. The length of mechanical ventilation was an independent risk factor for pneumonia and surgical site infection. CONCLUSION: Bacterial infections in the early postoperative period after pediatric liver transplantation are associated with high morbidity and mortality. Physicians involved in the medical care of these patients should be aware of the specific risk factors, and further development of prevention programs is highly recommended.',\n",
       "               'CI': ['(c) 2019 Wiley Periodicals, Inc.'],\n",
       "               'FAU': ['Dohna Schwake, Christian',\n",
       "                'Guiddir, Tamazoust',\n",
       "                'Cuzon, Gaelle',\n",
       "                'Benissa, Mohamed-Rida',\n",
       "                'Dubois, Cecile',\n",
       "                'Miatello, Jordi',\n",
       "                'Merchaoui, Zied',\n",
       "                'Durand, Philippe',\n",
       "                'Tissieres, Pierre'],\n",
       "               'AU': ['Dohna Schwake C',\n",
       "                'Guiddir T',\n",
       "                'Cuzon G',\n",
       "                'Benissa MR',\n",
       "                'Dubois C',\n",
       "                'Miatello J',\n",
       "                'Merchaoui Z',\n",
       "                'Durand P',\n",
       "                'Tissieres P'],\n",
       "               'AUID': ['ORCID: 0000-0001-8973-5406',\n",
       "                'ORCID: 0000-0002-8452-9918',\n",
       "                'ORCID: 0000-0001-5649-8635',\n",
       "                'ORCID: 0000-0001-5423-5532'],\n",
       "               'AD': ['Pediatric Intensive Care, Paris South University Hospitals AP-HP, Le Kremlin Bicetre, France.',\n",
       "                'Pediatric Intensive Care, Universitatsmedizin Essen, Essen, Germany.',\n",
       "                'Westdeutsches Zentrum fur Infektiologie, Universitatsmedizin Essen, Essen, Germany.',\n",
       "                'Pediatric Intensive Care, Paris South University Hospitals AP-HP, Le Kremlin Bicetre, France.',\n",
       "                'Laboratory of Microbiology, Paris South University Hospitals AP-HP, Le Kremlin-Bicetre, France.',\n",
       "                'Pediatric Intensive Care Unit, University Hospitals of Geneva, Geneva, Switzerland.',\n",
       "                'Pediatric Intensive Care, Paris South University Hospitals AP-HP, Le Kremlin Bicetre, France.',\n",
       "                'Pediatric Intensive Care, Paris South University Hospitals AP-HP, Le Kremlin Bicetre, France.',\n",
       "                'Institute of Integrative Biology of the Cell, CNRS, CEA, Univ. Paris Sud, Paris Saclay University, Gif sur Yvette, France.',\n",
       "                'Pediatric Intensive Care, Paris South University Hospitals AP-HP, Le Kremlin Bicetre, France.',\n",
       "                'Pediatric Intensive Care, Paris South University Hospitals AP-HP, Le Kremlin Bicetre, France.',\n",
       "                'Pediatric Intensive Care, Paris South University Hospitals AP-HP, Le Kremlin Bicetre, France.',\n",
       "                'Institute of Integrative Biology of the Cell, CNRS, CEA, Univ. Paris Sud, Paris Saclay University, Gif sur Yvette, France.'],\n",
       "               'CN': ['Bicetre Pediatric Liver Transplant Group'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20191209',\n",
       "               'PL': 'Denmark',\n",
       "               'TA': 'Transpl Infect Dis',\n",
       "               'JT': 'Transplant infectious disease : an official journal of the Transplantation Society',\n",
       "               'JID': '100883688',\n",
       "               'RN': ['0 (Immunosuppressive Agents)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Bacterial Infections/*etiology/mortality',\n",
       "                'Child',\n",
       "                'Child, Preschool',\n",
       "                'Epidemiological Monitoring',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Immunosuppressive Agents/administration & dosage',\n",
       "                'Liver Transplantation/*adverse effects',\n",
       "                'Male',\n",
       "                'Multivariate Analysis',\n",
       "                'Pneumonia/etiology/microbiology',\n",
       "                'Risk Factors',\n",
       "                'Sepsis/etiology/microbiology',\n",
       "                'Urinary Tract Infections/etiology/microbiology'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['children',\n",
       "                'liver transplantation',\n",
       "                'multi-resistant bacteria',\n",
       "                'nosocomial infection',\n",
       "                'sepsis'],\n",
       "               'EDAT': '2019/11/07 06:00',\n",
       "               'MHDA': '2020/10/03 06:00',\n",
       "               'CRDT': ['2019/11/07 06:00'],\n",
       "               'PHST': ['2019/05/20 00:00 [received]',\n",
       "                '2019/09/30 00:00 [revised]',\n",
       "                '2019/10/24 00:00 [accepted]',\n",
       "                '2019/11/07 06:00 [pubmed]',\n",
       "                '2020/10/03 06:00 [medline]',\n",
       "                '2019/11/07 06:00 [entrez]'],\n",
       "               'AID': ['10.1111/tid.13208 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Transpl Infect Dis. 2020 Feb;22(1):e13208. doi: 10.1111/tid.13208. Epub 2019 Dec 9.'},\n",
       "              {'PMID': '31039599',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20201102',\n",
       "               'LR': '20201102',\n",
       "               'IS': '1439-3646 (Electronic) 0947-7349 (Linking)',\n",
       "               'VI': '128',\n",
       "               'IP': '3',\n",
       "               'DP': '2020 Mar',\n",
       "               'TI': 'Early Postoperative Fasting Serum Glucose Levels are Useful in Depicting Future Diabetes Mellitus in Patients with Curative Insulinoma Surgery.',\n",
       "               'PG': '158-163',\n",
       "               'LID': '10.1055/a-0892-4157 [doi]',\n",
       "               'AB': 'BACKGROUND: Hyperglycemia has been reported in some patients after curative insulinoma resection but no systematic investigation of glucose metabolism has been shown in a larger cohort of these patients. Therefore, it is still unknown, whether long lasting hyperinsulinism in insulinoma patients induces insulin resistance, which may jeopardize the postoperative health status of these patients. METHODS: Early postoperative fasting serum glucose levels were measured in all insulinoma patients after curative tumor resection during the first 48 h, being operated between 2011 and 2018, retrospectively. RESULTS: Of 77 (100%) patients with benign, spontaneous occuring insulinoma 51 (66.2%) patients were operated on by tumor enucleation. In 15 (19.5%) patients a left pancreatic resection was performed and in 11 (14.3%) patients the pancreatic head or the middle console of pancreatic corpus were excised. In 32 (41.6%) cases the highest fasting postoperative glucose levels were measured between 140-200 mg/dl. In 16 (20.8%) patients the glucose serum levels reached values above 200 mg/dl and in 4 (5.2%) patients short term substitution with insulin was indicated. Only one (1.3%) of these patients developed diabetes mellitus with the need of ongoing insulin treatment. Major postoperative complications were registered in 31 of all 77 patients (40.3%) and in 9 of 16 patients (56.3%) with postoperative glucose levels above 200 mg/dl. This difference was not statistically significant. CONCLUSIONS: Early postoperative (first 48 h) fasting serum glucose levels in insulinoma patients showed significant hyperglycemia above 200 mg/dl in only few patients (20.8%) and chronic postoperative Diabetes mellitus developed in only one of 77 patients (<2%). Therefore, recovery of glucose metabolism after insulinoma resection is fast and medical intervention is not mandatory in most of these patients.',\n",
       "               'CI': ['(c) Georg Thieme Verlag KG Stuttgart . New York.'],\n",
       "               'FAU': ['Akca, Aycan',\n",
       "                'Starke, Achim A R',\n",
       "                'Dobek, Anna',\n",
       "                'Ulrich, Alexis',\n",
       "                'Goretzki, Peter E'],\n",
       "               'AU': ['Akca A',\n",
       "                'Starke AAR',\n",
       "                'Dobek A',\n",
       "                'Ulrich A',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Department of Endocrine Surgery, Lukaskrankenhaus Neuss, Neuss, Germany.',\n",
       "                'Insulinoma and GEP Tumor Center Neuss-Dusseldorf, Lukaskrankenhaus Neuss, Neuss, Germany.',\n",
       "                'Insulinoma and GEP Tumor Center Neuss-Dusseldorf, Lukaskrankenhaus Neuss, Neuss, Germany.',\n",
       "                'Department of Visceral Surgery, Lukaskrankenhaus Neuss, Neuss, Germany.',\n",
       "                'Department of Visceral Surgery, Lukaskrankenhaus Neuss, Neuss, Germany.',\n",
       "                'Insulinoma and GEP Tumor Center Neuss-Dusseldorf, Lukaskrankenhaus Neuss, Neuss, Germany.',\n",
       "                'Department of Endocrine Surgery, Charite Berlin, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20190430',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Exp Clin Endocrinol Diabetes',\n",
       "               'JT': 'Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association',\n",
       "               'JID': '9505926',\n",
       "               'RN': ['0 (Blood Glucose)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Blood Glucose/*metabolism',\n",
       "                '*Diabetes Mellitus/blood/etiology',\n",
       "                'Digestive System Surgical Procedures/adverse effects',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                '*Hyperglycemia/blood/etiology',\n",
       "                '*Insulinoma/blood/complications/surgery',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                '*Pancreatic Neoplasms/blood/complications/surgery',\n",
       "                '*Postoperative Complications/blood/etiology',\n",
       "                'Postoperative Period',\n",
       "                'Retrospective Studies',\n",
       "                'Young Adult'],\n",
       "               'COIS': ['The authors declare that they have no conflict of interest.'],\n",
       "               'EDAT': '2019/05/01 06:00',\n",
       "               'MHDA': '2020/11/03 06:00',\n",
       "               'CRDT': ['2019/05/01 06:00'],\n",
       "               'PHST': ['2019/05/01 06:00 [pubmed]',\n",
       "                '2020/11/03 06:00 [medline]',\n",
       "                '2019/05/01 06:00 [entrez]'],\n",
       "               'AID': ['10.1055/a-0892-4157 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Exp Clin Endocrinol Diabetes. 2020 Mar;128(3):158-163. doi: 10.1055/a-0892-4157. Epub 2019 Apr 30.'},\n",
       "              {'PMID': '30153748',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20210105',\n",
       "               'LR': '20210105',\n",
       "               'IS': '1476-4954 (Electronic) 1476-4954 (Linking)',\n",
       "               'VI': '33',\n",
       "               'IP': '8',\n",
       "               'DP': '2020 Apr',\n",
       "               'TI': 'Neurological outcome at 24 months corrected age of prematurely born infants after preterm premature rupture of membranes (PPROM) of at least 7 days: a two-center experience in Germany.',\n",
       "               'PG': '1315-1320',\n",
       "               'LID': '10.1080/14767058.2018.1517327 [doi]',\n",
       "               'AB': 'Objective: Preterm premature rupture of membranes (PPROM) is a risk factor for chorioamnionitis (CA) and injury to the fetal brain. However, prolongation of gestation prevents morbidity and decreases complications of prematurity. The current investigation is to define risk factors for the adverse neurological outcome from the influence of PPROM of at least 7 days.Methods: A case-control study included three groups of preterm infants born at the University Hospitals Bonn and Essen, Germany. The first group consisted of infants with PPROM of at least 7 days and no chorioamnionitis (CA) (PPROM group), the second included preterm infants with CA (CA group), and the third group consisted of infants without PPROM and CA (control group). The outcome was assessed using Bayley Scales of Infant Development at a corrected age of 24 months. Each group consisted of 20 corresponding infants with an identical birth weight and gestational age at birth.Results: There was no significant difference between the mental development index (MDI) and psychomotor development index (PDI) scores (mean +/- SD): the MDI score was 101 +/- 14 in the PPROM group, 98 +/- 12 in the CA group and 96 +/- 17 in the control group; the PDI score 96 +/- 10, 89 +/- 16, and 90 +/- 17, respectively. Multiple regression analysis revealed no significant influence of PPROM and CA on neurological outcome.Conclusions: PPROM of at least 7 days has no influence on neurodevelopmental outcome at a corrected age of 24 months when birth is initiated in the case of beginning CA.',\n",
       "               'FAU': ['Muller, Hanna',\n",
       "                'Storbeck, Tobias',\n",
       "                'Katzer, David',\n",
       "                'Bruns, Nora',\n",
       "                'Wossner-Stegmann, Gaby',\n",
       "                'Ai, Maria',\n",
       "                'Koninger, Angela',\n",
       "                'Muller, Andreas',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Bagci, Soyhan'],\n",
       "               'AU': ['Muller H',\n",
       "                'Storbeck T',\n",
       "                'Katzer D',\n",
       "                'Bruns N',\n",
       "                'Wossner-Stegmann G',\n",
       "                'Ai M',\n",
       "                'Koninger A',\n",
       "                'Muller A',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Bagci S'],\n",
       "               'AD': ['Division of Neonatology and Pediatric Intensive Care, Department of Pediatrics, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                \"Department of Neonatology and Pediatric Intensive Care, Children's Hospital, University of Bonn, Bonn, Germany.\",\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                \"Department of Neonatology and Pediatric Intensive Care, Children's Hospital, University of Bonn, Bonn, Germany.\",\n",
       "                'Department of Pediatric Surgery, University Hospital of Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany.',\n",
       "                'Department of Gynecology and Obstetrics, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                \"Department of Neonatology and Pediatric Intensive Care, Children's Hospital, University of Bonn, Bonn, Germany.\",\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.',\n",
       "                \"Department of Neonatology and Pediatric Intensive Care, Children's Hospital, University of Bonn, Bonn, Germany.\"],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Multicenter Study'],\n",
       "               'DEP': '20180925',\n",
       "               'PL': 'England',\n",
       "               'TA': 'J Matern Fetal Neonatal Med',\n",
       "               'JT': 'The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians',\n",
       "               'JID': '101136916',\n",
       "               'RN': ['0 (Anti-Bacterial Agents)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Anti-Bacterial Agents/therapeutic use',\n",
       "                'Birth Weight',\n",
       "                'Case-Control Studies',\n",
       "                'Chorioamnionitis/diagnosis/drug therapy/*epidemiology',\n",
       "                'Female',\n",
       "                'Fetal Membranes, Premature Rupture/*epidemiology',\n",
       "                'Germany',\n",
       "                'Gestational Age',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Premature/*growth & development',\n",
       "                'Pregnancy',\n",
       "                'Premature Birth/prevention & control',\n",
       "                'Risk Factors'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Chorioamnionitis',\n",
       "                'fetal brain',\n",
       "                'inflammation',\n",
       "                'neurodevelopmental outcome',\n",
       "                'prematurity'],\n",
       "               'EDAT': '2018/08/30 06:00',\n",
       "               'MHDA': '2021/01/06 06:00',\n",
       "               'CRDT': ['2018/08/30 06:00'],\n",
       "               'PHST': ['2018/08/30 06:00 [pubmed]',\n",
       "                '2021/01/06 06:00 [medline]',\n",
       "                '2018/08/30 06:00 [entrez]'],\n",
       "               'AID': ['10.1080/14767058.2018.1517327 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Matern Fetal Neonatal Med. 2020 Apr;33(8):1315-1320. doi: 10.1080/14767058.2018.1517327. Epub 2018 Sep 25.'}],\n",
       "             '2018': [{'PMID': '30357782',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20190927',\n",
       "               'LR': '20190927',\n",
       "               'IS': '1438-9592 (Electronic) 0044-409X (Linking)',\n",
       "               'VI': '143',\n",
       "               'IP': '5',\n",
       "               'DP': '2018 Oct',\n",
       "               'TI': '[Not Available].',\n",
       "               'PG': '451-454',\n",
       "               'LID': '10.1055/a-0623-8137 [doi]',\n",
       "               'FAU': ['Mogl, Martina T', 'Goretzki, Peter E'],\n",
       "               'AU': ['Mogl MT', 'Goretzki PE'],\n",
       "               'AD': ['Chirurgische Klinik, Campus Charite Mitte | Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin.',\n",
       "                'Chirurgische Klinik, Campus Charite Mitte | Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'TT': 'Stellenwert des Neuromonitorings in der Schilddrusenchirurgie.',\n",
       "               'DEP': '20181024',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Zentralbl Chir',\n",
       "               'JT': 'Zentralblatt fur Chirurgie',\n",
       "               'JID': '0413645',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Intraoperative Neurophysiological Monitoring/*methods',\n",
       "                'Postoperative Complications',\n",
       "                \"Practice Patterns, Physicians'\",\n",
       "                'Thyroid Diseases/*surgery',\n",
       "                'Thyroid Neoplasms/surgery',\n",
       "                'Vocal Cord Paralysis/*prevention & control'],\n",
       "               'COIS': ['Disclosure The authors report no conflicts of interest in this work.'],\n",
       "               'EDAT': '2018/10/26 06:00',\n",
       "               'MHDA': '2019/09/29 06:00',\n",
       "               'CRDT': ['2018/10/26 06:00'],\n",
       "               'PHST': ['2018/10/26 06:00 [entrez]',\n",
       "                '2018/10/26 06:00 [pubmed]',\n",
       "                '2019/09/29 06:00 [medline]'],\n",
       "               'AID': ['10.1055/a-0623-8137 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Zentralbl Chir. 2018 Oct;143(5):451-454. doi: 10.1055/a-0623-8137. Epub 2018 Oct 24.'},\n",
       "              {'PMID': '30304748',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20190814',\n",
       "               'LR': '20190814',\n",
       "               'IS': '1439-7803 (Electronic) 0044-2771 (Linking)',\n",
       "               'VI': '56',\n",
       "               'IP': '10',\n",
       "               'DP': '2018 Oct',\n",
       "               'TI': '[Neuroendocrine Neoplasia within the German NET Registry].',\n",
       "               'PG': '1237-1246',\n",
       "               'LID': '10.1055/a-0661-6099 [doi]',\n",
       "               'AB': 'Neuroendocrine neoplasias (NEN) comprise a rare tumor entity with heterogeneous biology, prognosis and therapeutic options. Together with the recent publication of the first German guidelines on diagnostics and therapy of NEN, an analysis of the German NET-registry cohort of the German Society of Endocrinology (DGE) was performed. For this purpose, 2686 cases were extracted and their patient characteristics (e. g., age, sex, histopathological characterization, grading and staging) were displayed and outcomes were calculated. Additionally, the systemic treatment reality in the two largest subgroups, small intestinal and pancreatic NEN, was analyzed within metastatic patients.Distribution of primary tumor localization, histopathological classification, disease stage and overall survival was comparable with results from international registry studies. In concordance with current guidelines, somatostatin analogues (SSA) and peptide-receptor-radionuclide-therapy (PRRT) were the most common therapeutic modalities in small intestinal NEN. In pancreatic NEN, chemotherapy was used in first line as often as SSA. In second line, chemotherapy was used as often as PRRT. WHO-classification of 2010 and TNM staging proved to be of prognostic relevance.The current analysis of the German NET-registry characterizes a multicentric, interdisciplinary cohort of NEN patients throughout Germany and it describes the applied systemic treatment modalities and overall outcome as well as the prognostic value of the WHO classification of 2010 and TNM staging.',\n",
       "               'CI': ['(c) Georg Thieme Verlag KG Stuttgart . New York.'],\n",
       "               'CN': ['Im Namen aller Teilnehmer/innen am Deutschen NET-Registers',\n",
       "                'Authors',\n",
       "                'Kollaboratoren:'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'TT': 'Neuroendokrine Neoplasien im deutschen NET-Register.',\n",
       "               'DEP': '20181010',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Z Gastroenterol',\n",
       "               'JT': 'Zeitschrift fur Gastroenterologie',\n",
       "               'JID': '0033370',\n",
       "               'MH': ['Female',\n",
       "                'Germany',\n",
       "                'Humans',\n",
       "                '*Intestinal Neoplasms/classification/epidemiology/therapy',\n",
       "                'Male',\n",
       "                '*Neuroendocrine Tumors/classification/epidemiology/therapy',\n",
       "                '*Pancreatic Neoplasms/classification/epidemiology/therapy',\n",
       "                'Prognosis',\n",
       "                'Registries'],\n",
       "               'COIS': ['Disclosure The authors report no conflicts of interest in this work.'],\n",
       "               'FIR': ['Maasberg, Sebastian',\n",
       "                'Pape, Ulrich-Frank',\n",
       "                'Fottner, Christian',\n",
       "                'Goretzki, Peter E',\n",
       "                'Anlauf, Martin',\n",
       "                'Horsch, Dieter',\n",
       "                'Cremer, Birgit',\n",
       "                'Schulte, Dominik M',\n",
       "                'Quietzsch, Detlef',\n",
       "                'Scheerer, Frank',\n",
       "                'Popperl, Gabriele',\n",
       "                'Poeppel, Thorsten D',\n",
       "                'Begum, Nehara',\n",
       "                'Grohe, Christian',\n",
       "                'Rinke, Anja',\n",
       "                'Plockinger, Ursula',\n",
       "                'Wiedenmann, Betram',\n",
       "                'Arnold, Rudolf',\n",
       "                'Neuhaus, Peter',\n",
       "                'Knapp, Wolfram H',\n",
       "                'Lehnert, Hendrick',\n",
       "                'Auernhammer, Christoph',\n",
       "                'Pavel, Marianne',\n",
       "                'von Weikersthal, Ludwig Fischer',\n",
       "                'Schmidt, Bernd',\n",
       "                'Klein, Harald H',\n",
       "                'Essler, Markus',\n",
       "                'Neumann, Jorg-Dietrich',\n",
       "                'Hamann, Susanne',\n",
       "                'Steffens, Frank',\n",
       "                'Demtroder, Frank',\n",
       "                'Krocher, Anke',\n",
       "                'Zoicas, Flavius',\n",
       "                'Lahner, Harald',\n",
       "                'Weber, Frank',\n",
       "                'Geissler, Michael',\n",
       "                'Raffel, Andreas',\n",
       "                'Krausch, Markus',\n",
       "                'Zimmermann, Patrick',\n",
       "                'Lerch, Markus M',\n",
       "                'Wirth, Thomas',\n",
       "                'Lang, Matthias',\n",
       "                'Ezziddin, Samer',\n",
       "                'Lammert, Frank',\n",
       "                'Bischoff, Marina',\n",
       "                'Altendorf-Hofmann, Annelore',\n",
       "                'Muller, Lothar',\n",
       "                'Hoffmeister, Albrecht',\n",
       "                'Klose, Silke',\n",
       "                'Musholt, Thomas J',\n",
       "                'Post, Stefan',\n",
       "                'Gertler, Ralf',\n",
       "                'Scheuerlein, Hubert',\n",
       "                'Bergmann, Tanja',\n",
       "                'Bisping, Guido',\n",
       "                'Knauerhase, Andreas',\n",
       "                'Rendenbach, Bernhard',\n",
       "                'Gross, Volker',\n",
       "                'Scheurlen, Michael',\n",
       "                'Monig, Heiner',\n",
       "                'Kudlich, Theodor',\n",
       "                'Grabowski, Patricia',\n",
       "                'Musholt, Thomas J',\n",
       "                'Watza, Felix',\n",
       "                'Scheidhauer, Klemens',\n",
       "                'Mobius, Elke'],\n",
       "               'IR': ['Maasberg S',\n",
       "                'Pape UF',\n",
       "                'Fottner C',\n",
       "                'Goretzki PE',\n",
       "                'Anlauf M',\n",
       "                'Horsch D',\n",
       "                'Cremer B',\n",
       "                'Schulte DM',\n",
       "                'Quietzsch D',\n",
       "                'Scheerer F',\n",
       "                'Popperl G',\n",
       "                'Poeppel TD',\n",
       "                'Begum N',\n",
       "                'Grohe C',\n",
       "                'Rinke A',\n",
       "                'Plockinger U',\n",
       "                'Wiedenmann B',\n",
       "                'Arnold R',\n",
       "                'Neuhaus P',\n",
       "                'Knapp WH',\n",
       "                'Lehnert H',\n",
       "                'Auernhammer C',\n",
       "                'Pavel M',\n",
       "                'von Weikersthal LF',\n",
       "                'Schmidt B',\n",
       "                'Klein HH',\n",
       "                'Essler M',\n",
       "                'Neumann JD',\n",
       "                'Hamann S',\n",
       "                'Steffens F',\n",
       "                'Demtroder F',\n",
       "                'Krocher A',\n",
       "                'Zoicas F',\n",
       "                'Lahner H',\n",
       "                'Weber F',\n",
       "                'Geissler M',\n",
       "                'Raffel A',\n",
       "                'Krausch M',\n",
       "                'Zimmermann P',\n",
       "                'Lerch MM',\n",
       "                'Wirth T',\n",
       "                'Lang M',\n",
       "                'Ezziddin S',\n",
       "                'Lammert F',\n",
       "                'Bischoff M',\n",
       "                'Altendorf-Hofmann A',\n",
       "                'Muller L',\n",
       "                'Hoffmeister A',\n",
       "                'Klose S',\n",
       "                'Musholt TJ',\n",
       "                'Post S',\n",
       "                'Gertler R',\n",
       "                'Scheuerlein H',\n",
       "                'Bergmann T',\n",
       "                'Bisping G',\n",
       "                'Knauerhase A',\n",
       "                'Rendenbach B',\n",
       "                'Gross V',\n",
       "                'Scheurlen M',\n",
       "                'Monig H',\n",
       "                'Kudlich T',\n",
       "                'Grabowski P',\n",
       "                'Musholt TJ',\n",
       "                'Watza F',\n",
       "                'Scheidhauer K',\n",
       "                'Mobius E'],\n",
       "               'IRAD': ['Med. Klinik m. S. Hepatologie u. Gastroenterologie, Universitatsmedizin Charite,',\n",
       "                'Campus Mitte, Berlin.',\n",
       "                'Med. Klinik m. S. Hepatologie u. Gastroenterologie, Universitatsmedizin Charite,',\n",
       "                'Campus Mitte, Berlin.',\n",
       "                'I. med. Klinik u. Poliklinik, Schwerpunkt Endokrinologie u. Stoffwechsel,',\n",
       "                'Universitatsmedizin Mainz.',\n",
       "                'Chirurgische Klinik I, Lukaskrankenhaus Neuss u. Chirurgische Klinik,',\n",
       "                'Universitatsmedizin Charite, Campus Virchow Klinikum, Berlin.',\n",
       "                'Uberregionale Gemeinschaftspraxis Pathologie, Limburg.',\n",
       "                'Klinik fur Innere Medizin, Gastroenterologie und Endokrinologie, Zentralklinik',\n",
       "                'Bad Berka.',\n",
       "                'Innere Klinik I - Onkologie, Hamatologie, klinische Infektiologie, klinische',\n",
       "                'Immunologie, Hamostaseologie, internistische Intensivmedizin, Uniklinik Koln.',\n",
       "                'Klinik fur Innere Medizin I mit Schwerpunkt Gastroenterologie, Hepatologie,',\n",
       "                'Pneumologie, internistische Intensivmedizin, Endokrinologie, Infektiologie,',\n",
       "                'Rheumatologie, Ernahrungs- und Altersmedizin, Universitatsklinikum',\n",
       "                'Schleswig-Holstein, Campus Kiel.',\n",
       "                'Onkologische Praxis Oelsnitz und Klinik fur Innere Medizin II Stollberg',\n",
       "                '/Erzgebirge.',\n",
       "                'Klinik fur Gastroenterologie und Hepatologie, stadtisches Klinikum',\n",
       "                'Munchen-Neuperlach, Munchen.',\n",
       "                'Klinik fur Nuklearmedizin, Klinikum Stuttgart.',\n",
       "                'Klinik fur Nuklearmedizin, Uniklinikum Essen.',\n",
       "                'Allgemein- und Viszeralchirurgie, Agaplesion Evangelisches Klinikum Schaumburg.',\n",
       "                'Evangelische Lungenklinik Berlin-Buch, Paul-Gerhardt Diakonie, Berlin-Buch.',\n",
       "                'Klinik f. Gastroenterologie, Endokrinologie, Stoffwechsel und klinische',\n",
       "                'Infektiologie, Universitatsklinikum Giessen Marburg, Standort Marburg.'],\n",
       "               'EDAT': '2018/10/12 06:00',\n",
       "               'MHDA': '2019/08/15 06:00',\n",
       "               'CRDT': ['2018/10/11 06:00'],\n",
       "               'PHST': ['2018/10/11 06:00 [entrez]',\n",
       "                '2018/10/12 06:00 [pubmed]',\n",
       "                '2019/08/15 06:00 [medline]'],\n",
       "               'AID': ['10.1055/a-0661-6099 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Z Gastroenterol. 2018 Oct;56(10):1237-1246. doi: 10.1055/a-0661-6099. Epub 2018 Oct 10.'},\n",
       "              {'PMID': '30291765',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20190320',\n",
       "               'LR': '20220410',\n",
       "               'IS': '1531-4995 (Electronic) 0023-852X (Linking)',\n",
       "               'VI': '128 Suppl 3',\n",
       "               'DP': '2018 Oct',\n",
       "               'TI': 'International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic data.',\n",
       "               'PG': 'S18-S27',\n",
       "               'LID': '10.1002/lary.27360 [doi]',\n",
       "               'AB': 'The purpose of this publication was to inform surgeons as to the modern state-of-the-art evidence-based guidelines for management of the recurrent laryngeal nerve invaded by malignancy through blending the domains of 1) surgical intraoperative information, 2) preoperative glottic function, and 3) intraoperative real-time electrophysiologic information. These guidelines generated by the International Neural Monitoring Study Group (INMSG) are envisioned to assist the clinical decision-making process involved in recurrent laryngeal nerve management during thyroid surgery by incorporating the important information domains of not only gross surgical findings but also intraoperative recurrent laryngeal nerve functional status and preoperative laryngoscopy findings. These guidelines are presented mainly through algorithmic workflow diagrams for convenience and the ease of application. These guidelines are published in conjunction with the INMSG Guidelines Part I: Staging Bilateral Thyroid Surgery With Monitoring Loss of Signal. Level of Evidence: 5 Laryngoscope, 128:S18-S27, 2018.',\n",
       "               'CI': ['(c) 2018 The American Laryngological, Rhinological and Otological Society, Inc.'],\n",
       "               'FAU': ['Wu, Che-Wei',\n",
       "                'Dionigi, Gianlorenzo',\n",
       "                'Barczynski, Marcin',\n",
       "                'Chiang, Feng-Yu',\n",
       "                'Dralle, Henning',\n",
       "                'Schneider, Rick',\n",
       "                'Al-Quaryshi, Zaid',\n",
       "                'Angelos, Peter',\n",
       "                'Brauckhoff, Katrin',\n",
       "                'Brooks, Jennifer A',\n",
       "                'Cernea, Claudio R',\n",
       "                'Chaplin, John',\n",
       "                'Chen, Amy Y',\n",
       "                'Davies, Louise',\n",
       "                'Diercks, Gill R',\n",
       "                'Duh, Quan Yang',\n",
       "                'Fundakowski, Christopher',\n",
       "                'Goretzki, Peter E',\n",
       "                'Hales, Nathan W',\n",
       "                'Hartl, Dana',\n",
       "                'Kamani, Dipti',\n",
       "                'Kandil, Emad',\n",
       "                'Kyriazidis, Natalia',\n",
       "                'Liddy, Whitney',\n",
       "                'Miyauchi, Akira',\n",
       "                'Orloff, Lisa',\n",
       "                'Rastatter, Jeff C',\n",
       "                'Scharpf, Joseph',\n",
       "                'Serpell, Jonathan',\n",
       "                'Shin, Jennifer J',\n",
       "                'Sinclair, Catherine F',\n",
       "                'Stack, Brendan C Jr',\n",
       "                'Tolley, Neil S',\n",
       "                'Slycke, Sam Van',\n",
       "                'Snyder, Samuel K',\n",
       "                'Urken, Mark L',\n",
       "                'Volpi, Erivelto',\n",
       "                'Witterick, Ian',\n",
       "                'Wong, Richard J',\n",
       "                'Woodson, Gayle',\n",
       "                'Zafereo, Mark',\n",
       "                'Randolph, Gregory W'],\n",
       "               'AU': ['Wu CW',\n",
       "                'Dionigi G',\n",
       "                'Barczynski M',\n",
       "                'Chiang FY',\n",
       "                'Dralle H',\n",
       "                'Schneider R',\n",
       "                'Al-Quaryshi Z',\n",
       "                'Angelos P',\n",
       "                'Brauckhoff K',\n",
       "                'Brooks JA',\n",
       "                'Cernea CR',\n",
       "                'Chaplin J',\n",
       "                'Chen AY',\n",
       "                'Davies L',\n",
       "                'Diercks GR',\n",
       "                'Duh QY',\n",
       "                'Fundakowski C',\n",
       "                'Goretzki PE',\n",
       "                'Hales NW',\n",
       "                'Hartl D',\n",
       "                'Kamani D',\n",
       "                'Kandil E',\n",
       "                'Kyriazidis N',\n",
       "                'Liddy W',\n",
       "                'Miyauchi A',\n",
       "                'Orloff L',\n",
       "                'Rastatter JC',\n",
       "                'Scharpf J',\n",
       "                'Serpell J',\n",
       "                'Shin JJ',\n",
       "                'Sinclair CF',\n",
       "                'Stack BC Jr',\n",
       "                'Tolley NS',\n",
       "                'Slycke SV',\n",
       "                'Snyder SK',\n",
       "                'Urken ML',\n",
       "                'Volpi E',\n",
       "                'Witterick I',\n",
       "                'Wong RJ',\n",
       "                'Woodson G',\n",
       "                'Zafereo M',\n",
       "                'Randolph GW'],\n",
       "               'AUID': ['ORCID: 0000-0003-1052-5348',\n",
       "                'ORCID: 0000-0003-0864-6087',\n",
       "                'ORCID: 0000-0002-2442-3281',\n",
       "                'ORCID: 0000-0003-2765-5413',\n",
       "                'ORCID: 0000-0001-5895-4403',\n",
       "                'ORCID: 0000-0002-9370-8547',\n",
       "                'ORCID: 0000-0003-2896-1615'],\n",
       "               'AD': ['Department of Otolaryngology-Head and Neck Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.',\n",
       "                'Division for Endocrine Surgery, Department of Human Pathology in Adulthood and Childhood \"G. Barresi\", University Hospital G. Martino, University of Messina, Messina, Italy.',\n",
       "                'Department of Endocrine Surgery, Jagiellonian University, Third Chair of General Surgery, Krakow, Poland.',\n",
       "                'Department of Otolaryngology-Head and Neck Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.',\n",
       "                'Department of General Surgery, University Hospital Halle, Halle/Saale, Germany.',\n",
       "                'Department of General, Visceral, and Vascular Surgery, Martin Luther University Halle-Wittenberg, Halle, Germany.',\n",
       "                'Department of Otolaryngology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, U.S.A.',\n",
       "                'Division of Endocrine Surgery, Department of Surgery, University of Chicago, Chicago, Illinois, U.S.A.',\n",
       "                'Department of Breast and Endocrine Surgery, Haukeland University Hospital, Bergen, Norway.',\n",
       "                'Department of Otolaryngology, Division of Thyroid and Parathyroid Surgery, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, U.S.A.',\n",
       "                'Department of Head and Neck Surgery, University of Sao Paulo Medical School, Sao Paulo, Brazil.',\n",
       "                'Department of Otolaryngology-Head and Neck Surgery, Gillies Hospital and Clinics, Epsom, New Zealand.',\n",
       "                'VA Endocrine Surgery, Department of Otolaryngology Emory University School of Medicine, Atlanta, GA, USA.',\n",
       "                'Outcomes Group, Veterans Affairs Medical Center, Norwich, Vermont, U.S.A.',\n",
       "                'Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, U.S.A.',\n",
       "                'Department of Surgery, University of California, San Francisco, San Francisco, California, U.S.A.',\n",
       "                'Department of Otolaryngology-Head and Neck Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, U.S.A.',\n",
       "                'P.G. Stadtische Kliniken Neuss Lukaskrankenhaus GmbH, Neuss, Nordrhein-Westfalen, DE.',\n",
       "                'Department of Otolaryngology, Uniformed Services of the Health Sciences, San Antonio, Texas, U.S.A.',\n",
       "                'San Antonio Head and Neck, San Antonio, Texas, U.S.A.',\n",
       "                'Department of Otolaryngology Head and Neck Surgery, Gustave Roussy Institute, Villejuif, France.',\n",
       "                'Department of Otolaryngology, Division of Thyroid and Parathyroid Surgery, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, U.S.A.',\n",
       "                'Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana, U.S.A.',\n",
       "                'Department of Otolaryngology, State University of New York Upstate Medical University, Syracuse, New York, U.S.A.',\n",
       "                'Department of Otolaryngology-Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, U.S.A.',\n",
       "                'Department of Surgery, Kuma Hospital, Kobe, Japan.',\n",
       "                'Department of Otolaryngology, Division of Head and Neck Surgery, Stanford University School of Medicine, Stanford, California, U.S.A.',\n",
       "                'Department of Otolaryngology-Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, U.S.A.',\n",
       "                'Department of Otolaryngology, Cleveland Clinic, Cleveland, Ohio, U.S.A.',\n",
       "                'Breast, Endocrine and General Surgery Unit, Alfred Hospital, Melbourne, Victoria, Australia.',\n",
       "                'Monash University School of Languages, Literatures, Cultures, and Linguistics, Clayton, Victoria, Australia.',\n",
       "                'Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts, U.S.A.',\n",
       "                'Department of Otolaryngology-Head and Neck Surgery, Mount Sinai Beth Israel, Icahn School of Medicine, New York, New York, U.S.A.',\n",
       "                'Department of Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.',\n",
       "                \"Department of Otolaryngology-Head and Neck Surgery, Imperial College Hospitals NHS Trust, St. Mary's Hospital, London, United Kingdom.\",\n",
       "                'Onze-Lieve-Vrouw Hospital Aalst, Brussels, Belgium.',\n",
       "                'Department of General Surgery, University of Texas Rio Grande Valley School of Medicine, Edinburg, Texas, U.S.A.',\n",
       "                'Department of Otolaryngology-Head and Neck Surgery, Mount Sinai Beth Israel, Icahn School of Medicine, New York, New York, U.S.A.',\n",
       "                'Clinics Hospital, University of Sao Paulo Medical School, Sao Paulo, Brazil.',\n",
       "                'Department of Otolaryngology, Mount Sinai Hospital, Toronto, Ontario, Canada.',\n",
       "                'Department of Surgery-Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, New York, U.S.A.',\n",
       "                '865 Indianola Drive, Merritt Island, Florida, U.S.A.',\n",
       "                'Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, Texas, U.S.A.',\n",
       "                'Department of Otolaryngology, Division of Thyroid and Parathyroid Surgery, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, U.S.A.',\n",
       "                'Division of Surgical Oncology, Endocrine Surgery Service, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Practice Guideline',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20181006',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Laryngoscope',\n",
       "               'JT': 'The Laryngoscope',\n",
       "               'JID': '8607378',\n",
       "               'SB': 'IM',\n",
       "               'CIN': ['Laryngoscope. 2019 Sep;129(9):E305. doi: 10.1002/lary.28056. PMID: 31070239',\n",
       "                'Laryngoscope. 2019 Sep;129(9):E306. doi: 10.1002/lary.28055. PMID: 31070243'],\n",
       "               'MH': ['Humans',\n",
       "                'Intraoperative Neurophysiological Monitoring/methods/*standards',\n",
       "                'Larynx/pathology/physiopathology',\n",
       "                'Neoplasm Invasiveness',\n",
       "                'Recurrent Laryngeal Nerve/physiopathology/*surgery',\n",
       "                'Recurrent Laryngeal Nerve Injuries/etiology/prevention & control',\n",
       "                'Thyroid Neoplasms/pathology/physiopathology/*surgery',\n",
       "                'Thyroidectomy/adverse effects/methods/*standards',\n",
       "                'Vocal Cord Paralysis/etiology/*prevention & control'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Thyroid malignancy',\n",
       "                'bilateral surgery',\n",
       "                'intraoperative neuromonitoring',\n",
       "                'invaded nerve',\n",
       "                'nerve preservation',\n",
       "                'nerve resection',\n",
       "                'only functional nerve',\n",
       "                'recurrent laryngeal nerve',\n",
       "                'thyroid surgery',\n",
       "                'vocal cord paralysis'],\n",
       "               'EDAT': '2018/10/07 06:00',\n",
       "               'MHDA': '2019/03/21 06:00',\n",
       "               'CRDT': ['2018/10/07 06:00'],\n",
       "               'PHST': ['2018/02/27 00:00 [received]',\n",
       "                '2018/04/22 00:00 [revised]',\n",
       "                '2018/05/24 00:00 [accepted]',\n",
       "                '2018/10/07 06:00 [pubmed]',\n",
       "                '2019/03/21 06:00 [medline]',\n",
       "                '2018/10/07 06:00 [entrez]'],\n",
       "               'AID': ['10.1002/lary.27360 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Laryngoscope. 2018 Oct;128 Suppl 3:S18-S27. doi: 10.1002/lary.27360. Epub 2018 Oct 6.'},\n",
       "              {'PMID': '30289983',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20190320',\n",
       "               'LR': '20190320',\n",
       "               'IS': '1531-4995 (Electronic) 0023-852X (Linking)',\n",
       "               'VI': '128 Suppl 3',\n",
       "               'DP': '2018 Oct',\n",
       "               'TI': 'International neural monitoring study group guideline 2018 part I: Staging bilateral thyroid surgery with monitoring loss of signal.',\n",
       "               'PG': 'S1-S17',\n",
       "               'LID': '10.1002/lary.27359 [doi]',\n",
       "               'AB': 'This publication offers modern, state-of-the-art International Neural Monitoring Study Group (INMSG) guidelines based on a detailed review of the recent monitoring literature. The guidelines outline evidence-based definitions of adverse electrophysiologic events, especially loss of signal, and their incorporation in surgical strategy. These recommendations are designed to reduce technique variations, enhance the quality of neural monitoring, and assist surgeons in the clinical decision-making process involved in surgical management of recurrent laryngeal nerve. The guidelines are published in conjunction with the INMSG Guidelines Part II, Optimal Recurrent Laryngeal Nerve Management for Invasive Thyroid Cancer-Incorporation of Surgical, Laryngeal, and Neural Electrophysiologic Data. Laryngoscope, 128:S1-S17, 2018.',\n",
       "               'CI': ['(c) 2018 The American Laryngological, Rhinological and Otological Society, Inc.'],\n",
       "               'FAU': ['Schneider, Rick',\n",
       "                'Randolph, Gregory W',\n",
       "                'Dionigi, Gianlorenzo',\n",
       "                'Wu, Che-Wei',\n",
       "                'Barczynski, Marcin',\n",
       "                'Chiang, Feng-Yu',\n",
       "                'Al-Quaryshi, Zaid',\n",
       "                'Angelos, Peter',\n",
       "                'Brauckhoff, Katrin',\n",
       "                'Cernea, Claudio R',\n",
       "                'Chaplin, John',\n",
       "                'Cheetham, Jonathan',\n",
       "                'Davies, Louise',\n",
       "                'Goretzki, Peter E',\n",
       "                'Hartl, Dana',\n",
       "                'Kamani, Dipti',\n",
       "                'Kandil, Emad',\n",
       "                'Kyriazidis, Natalia',\n",
       "                'Liddy, Whitney',\n",
       "                'Orloff, Lisa',\n",
       "                'Scharpf, Joseph',\n",
       "                'Serpell, Jonathan',\n",
       "                'Shin, Jennifer J',\n",
       "                'Sinclair, Catherine F',\n",
       "                'Singer, Michael C',\n",
       "                'Snyder, Samuel K',\n",
       "                'Tolley, Neil S',\n",
       "                'Van Slycke, Sam',\n",
       "                'Volpi, Erivelto',\n",
       "                'Witterick, Ian',\n",
       "                'Wong, Richard J',\n",
       "                'Woodson, Gayle',\n",
       "                'Zafereo, Mark',\n",
       "                'Dralle, Henning'],\n",
       "               'AU': ['Schneider R',\n",
       "                'Randolph GW',\n",
       "                'Dionigi G',\n",
       "                'Wu CW',\n",
       "                'Barczynski M',\n",
       "                'Chiang FY',\n",
       "                'Al-Quaryshi Z',\n",
       "                'Angelos P',\n",
       "                'Brauckhoff K',\n",
       "                'Cernea CR',\n",
       "                'Chaplin J',\n",
       "                'Cheetham J',\n",
       "                'Davies L',\n",
       "                'Goretzki PE',\n",
       "                'Hartl D',\n",
       "                'Kamani D',\n",
       "                'Kandil E',\n",
       "                'Kyriazidis N',\n",
       "                'Liddy W',\n",
       "                'Orloff L',\n",
       "                'Scharpf J',\n",
       "                'Serpell J',\n",
       "                'Shin JJ',\n",
       "                'Sinclair CF',\n",
       "                'Singer MC',\n",
       "                'Snyder SK',\n",
       "                'Tolley NS',\n",
       "                'Van Slycke S',\n",
       "                'Volpi E',\n",
       "                'Witterick I',\n",
       "                'Wong RJ',\n",
       "                'Woodson G',\n",
       "                'Zafereo M',\n",
       "                'Dralle H'],\n",
       "               'AD': ['Martin Luther University Halle-Wittenberg, Department of General, Visceral, and Vascular Surgery, Halle, Germany.',\n",
       "                'Division of Thyroid and Parathyroid Surgery, Department of Otolaryngology, Massachusetts Eye and Ear Harvard Medical School, Boston, Massachusetts.',\n",
       "                'Division of Surgical Oncology, Endocrine Surgery Service, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.',\n",
       "                'Division for Endocrine Surgery, at the Department of Human Pathology in Adulthood and Childhood \"G. Barresi,\" University Hospital G. Martino, University of Messina, Italy.',\n",
       "                'Kaohsiung Medical University Hospital, Kaohsiung Medical University, Otolaryngology-Head and Neck Surgery, Kaohsiung, Taiwan.',\n",
       "                'Jagiellonian University, Department of Endocrine Surgery, Third Chair of General Surgery, Krakow, Poland.',\n",
       "                'Kaohsiung Medical University Hospital, Kaohsiung Medical University, Otolaryngology-Head and Neck Surgery, Kaohsiung, Taiwan.',\n",
       "                'University of Iowa Hospitals and Clinics, Otolaryngology, Iowa City, Iowa.',\n",
       "                'University of Chicago, Division of Endocrine Surgery, Department of Surgery, Chicago, Illinois.',\n",
       "                'Haukeland Universitetssjukehus, Department of Breast and Endocrine Surgery, Bergen, Norway.',\n",
       "                'University of Sao Paulo Medical School, Department of Head and Neck Surgery, Sao Paulo, SP, Brazil.',\n",
       "                'Gillies Hospital & Clinics, Epsom, New Zealand.',\n",
       "                'Cornell University, Clinical Sciences, College of Veterinary Medicine, Ithaca, New York.',\n",
       "                'VA Outcomes Group at the Veterans Affairs Medical Center, Norwich, Vermont.',\n",
       "                'Stadtische Kliniken Neuss Lukaskrankenhaus GmbH, Neuss, Nordrhein-Westfalen, Germany.',\n",
       "                'Institut Gustave Roussy, Otolaryngology Head & Neck Surgery, Villejuif, France.',\n",
       "                'Division of Thyroid and Parathyroid Surgery, Department of Otolaryngology, Massachusetts Eye and Ear Harvard Medical School, Boston, Massachusetts.',\n",
       "                'Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana.',\n",
       "                'State University of New York Upstate Medical University, Otolaryngology, Syracuse, New York.',\n",
       "                'Northwestern University Feinberg School of Medicine Department of Psychiatry and Behavioral Sciences, Otolaryngology, Chicago, Illinois.',\n",
       "                'Stanford University School of Medicine, Otolaryngology, Division of Head and Neck Surgery, Stanford, California.',\n",
       "                'Cleveland Clinic, Otolaryngology, Cleveland, Ohio.',\n",
       "                'Alfred Hospital, Melbourne, Victoria, Australia.',\n",
       "                'Monash University School of Languages Literatures Cultures and Linguistics, Clayton, Victoria, Australia.',\n",
       "                'Harvard Medical School, Otolaryngology, Boston, Massachusetts.',\n",
       "                'Icahn School of Medicine at Mount Sinai, Otolaryngology, New York, New York.',\n",
       "                'Henry Ford Hospital, Otolaryngology-Head & Neck Surgery, Detroit, Michigan.',\n",
       "                'University of Texas Rio Grande Valley School of Medicine, Department of General Surgery, Edinburg, Texas.',\n",
       "                \"St. Mary's Hospital, Imperial College Hospitals NHS Trust, St. Mary's Hospital, London, United Kingdom.\",\n",
       "                'OLV Ziekenhuis Aalst, Brussels, Belgium.',\n",
       "                'Hospital das Clinicas-University of Sao Paulo Medical School, Sao Paulo, Brazil.',\n",
       "                'Mount Sinai Hospital, Department of Otolaryngology, Toronto, Ontario, Canada.',\n",
       "                'Memorial Sloan-Kettering Cancer Center, Department of Surgery, Head and Neck Service, New York, New York.',\n",
       "                '865 Indianola Dr, Merritt Island, Florida.',\n",
       "                'MD Anderson Cancer Center, Head and Neck Surgery, Houston, Texas, U.S.A.',\n",
       "                'Allgemeinchirurgie, Uniklinik Halle, Halle/Saale, Germany.'],\n",
       "               'AUID': ['ORCID: 0000-0003-0864-6087',\n",
       "                'ORCID: 0000-0003-1052-5348',\n",
       "                'ORCID: 0000-0002-2442-3281',\n",
       "                'ORCID: 0000-0003-2765-5413',\n",
       "                'ORCID: 0000-0001-5895-4403',\n",
       "                'ORCID: 0000-0002-9370-8547',\n",
       "                'ORCID: 0000-0002-8673-2637'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Practice Guideline',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                'Review'],\n",
       "               'DEP': '20181005',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Laryngoscope',\n",
       "               'JT': 'The Laryngoscope',\n",
       "               'JID': '8607378',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Intraoperative Complications/etiology/*prevention & control',\n",
       "                'Intraoperative Neurophysiological Monitoring/methods/*standards',\n",
       "                'Recurrent Laryngeal Nerve/*surgery',\n",
       "                'Recurrent Laryngeal Nerve Injuries/etiology/*prevention & control',\n",
       "                'Thyroid Gland/innervation/surgery',\n",
       "                'Thyroidectomy/adverse effects/methods/*standards',\n",
       "                'Vocal Cord Paralysis/etiology/*prevention & control'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['IONM',\n",
       "                'Thyroid surgery',\n",
       "                'bilateral thyroid surgery',\n",
       "                'intraoperative neural monitoring',\n",
       "                'laryngeal exam',\n",
       "                'loss of signal',\n",
       "                'staged surgery',\n",
       "                'vocal cord paralysis'],\n",
       "               'EDAT': '2018/10/06 06:00',\n",
       "               'MHDA': '2019/03/21 06:00',\n",
       "               'CRDT': ['2018/10/06 06:00'],\n",
       "               'PHST': ['2018/05/24 00:00 [accepted]',\n",
       "                '2018/10/06 06:00 [pubmed]',\n",
       "                '2019/03/21 06:00 [medline]',\n",
       "                '2018/10/06 06:00 [entrez]'],\n",
       "               'AID': ['10.1002/lary.27359 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Laryngoscope. 2018 Oct;128 Suppl 3:S1-S17. doi: 10.1002/lary.27359. Epub 2018 Oct 5.'},\n",
       "              {'PMID': '30280290',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20190410',\n",
       "               'LR': '20190410',\n",
       "               'IS': '1573-2606 (Electronic) 1389-9155 (Linking)',\n",
       "               'VI': '19',\n",
       "               'IP': '2',\n",
       "               'DP': '2018 Jun',\n",
       "               'TI': 'Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract.',\n",
       "               'PG': '169-178',\n",
       "               'LID': '10.1007/s11154-018-9469-9 [doi]',\n",
       "               'AB': 'The incidence of neuroendocrine tumors (NET) increases with age. Lately, the diagnosis of NET was mainly caused by early detection of small NET (<1 cm) in the rectum and stomach, which are depicted by chance during routine and prophylactic endoscopy. Also in patients with large and metastatic pancreatic and intestinal tumors thorough pathologic investigation with use of different immunohistologic markers discovers more neuroendocrine tumors with low differentiation grade (G2-G3) and more neuroendocrine carcinomas (NEC), nowadays, than in former times. While gastric and rectal NET are discovered as small (<1 cm in diameter) and mainly highly differentiated tumors, demonstrating lymph node metastases in less than 10% of the patients, the majority of pancreatic and small bowel NET have already metastasized at the time of diagnosis. This is of clinical importance, since tumor stage and differentiation grade not only influence prognosis but also surgical procedure and may define whether a combination of surgery with systemic biologic therapy, chemotherapy or local cytoreductive procedures may be used. The indication for surgery and the preferred surgical procedure will have to consider personal risk factors of each patient (i.e. general health, additional illnesses, etc.) and tumor specific factors (i.e. tumor stage, grade of differentiation, functional activity, mass and variety of loco regional as well as distant metastases etc.). Together they define, whether radical curative or only palliative surgery can be applied. Altogether surgery is the only cure for locally advanced NET and helps to increase quality of life and overall survival in many patients with metastatic neuroendocrine tumors. The question of cure versus palliative therapy sometimes only can be answered with time, however. Many different aspects and various questions concerning the indication and extent of surgery and the best therapeutic procedure are still unanswered. Therefore, a close multidisciplinary cooperation of colleagues involved in biochemical and localization diagnostics and those active in various treatment areas is warranted to search for the optimal strategy in each individual patient. How far genetic screening impacts survival remains to be seen. Since surgeons do have a central role in the treatment of NET patients, they have to understand the need for integration into such an interdisciplinary team.',\n",
       "               'FAU': ['Goretzki, Peter E',\n",
       "                'Mogl, Martina T',\n",
       "                'Akca, Aycan',\n",
       "                'Pratschke, Johann'],\n",
       "               'AU': ['Goretzki PE', 'Mogl MT', 'Akca A', 'Pratschke J'],\n",
       "               'AUID': ['ORCID: 0000-0001-8997-4896'],\n",
       "               'AD': ['Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany. Peter.goretzki@charite.de.',\n",
       "                'Leiter Arbeitsbereich endokrine Chirurgie, Chirurgische Klinik, Campus Charite Mitte | Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. Peter.goretzki@charite.de.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany.',\n",
       "                'Surgical Clinic 1, Lukaskrankenhaus Neuss, Preussenstrasse 84, 41456, Neuss, Germany.',\n",
       "                'Department of Surgery, Campus Charite Mitte | Campus Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Rev Endocr Metab Disord',\n",
       "               'JT': 'Reviews in endocrine & metabolic disorders',\n",
       "               'JID': '100940588',\n",
       "               'RN': ['Gastro-enteropancreatic neuroendocrine tumor'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Intestinal Neoplasms/*surgery',\n",
       "                '*Neoplasm Metastasis',\n",
       "                'Neuroendocrine Tumors/*surgery',\n",
       "                'Palliative Care/*methods',\n",
       "                'Pancreatic Neoplasms/*surgery',\n",
       "                'Stomach Neoplasms/*surgery'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Metastases',\n",
       "                'Neuroendocrine tumor',\n",
       "                'Pancreas',\n",
       "                'Small bowel',\n",
       "                'Surgery'],\n",
       "               'EDAT': '2018/10/04 06:00',\n",
       "               'MHDA': '2019/04/11 06:00',\n",
       "               'CRDT': ['2018/10/04 06:00'],\n",
       "               'PHST': ['2018/10/04 06:00 [pubmed]',\n",
       "                '2019/04/11 06:00 [medline]',\n",
       "                '2018/10/04 06:00 [entrez]'],\n",
       "               'AID': ['10.1007/s11154-018-9469-9 [pii]',\n",
       "                '10.1007/s11154-018-9469-9 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Rev Endocr Metab Disord. 2018 Jun;19(2):169-178. doi: 10.1007/s11154-018-9469-9.'},\n",
       "              {'PMID': '30244966',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20190918',\n",
       "               'LR': '20220408',\n",
       "               'IS': '1878-4186 (Electronic) 0969-2126 (Print) 0969-2126 (Linking)',\n",
       "               'VI': '26',\n",
       "               'IP': '12',\n",
       "               'DP': '2018 Dec 4',\n",
       "               'TI': 'Structural Basis of TRPV4 N Terminus Interaction with Syndapin/PACSIN1-3 and PIP(2).',\n",
       "               'PG': '1583-1593.e5',\n",
       "               'LID': 'S0969-2126(18)30290-9 [pii] 10.1016/j.str.2018.08.002 [doi]',\n",
       "               'AB': 'Transient receptor potential (TRP) channels are polymodally regulated ion channels. TRPV4 (vanilloid 4) is sensitized by PIP(2) and desensitized by Syndapin3/PACSIN3, which bind to the structurally uncharacterized TRPV4 N terminus. We determined the nuclear magnetic resonance structure of the Syndapin3/PACSIN3 SH3 domain in complex with the TRPV4 N-terminal proline-rich region (PRR), which binds as a class I polyproline II (PPII) helix. This PPII conformation is broken by a conserved proline in a cis conformation. Beyond the PPII, we find that the proximal TRPV4 N terminus is unstructured, a feature conserved across species thus explaining the difficulties in resolving it in previous structural studies. Syndapin/PACSIN SH3 domain binding leads to rigidification of both the PRR and the adjacent PIP(2) binding site. We determined the affinities of the TRPV4 N terminus for PACSIN1, 2, and 3 SH3 domains and PIP(2) and deduce a hierarchical interaction network where Syndapin/PACSIN binding influences the PIP(2) binding site but not vice versa.',\n",
       "               'CI': ['Copyright (c) 2018 Elsevier Ltd. All rights reserved.'],\n",
       "               'FAU': ['Goretzki, Benedikt',\n",
       "                'Glogowski, Nina A',\n",
       "                'Diehl, Erika',\n",
       "                'Duchardt-Ferner, Elke',\n",
       "                'Hacker, Carolin',\n",
       "                'Gaudet, Rachelle',\n",
       "                'Hellmich, Ute A'],\n",
       "               'AU': ['Goretzki B',\n",
       "                'Glogowski NA',\n",
       "                'Diehl E',\n",
       "                'Duchardt-Ferner E',\n",
       "                'Hacker C',\n",
       "                'Gaudet R',\n",
       "                'Hellmich UA'],\n",
       "               'AD': ['Institute for Pharmacy and Biochemistry, Johannes Gutenberg-Universitat Mainz, 55128 Mainz, Germany; Center for Biomolecular Magnetic Resonance (BMRZ), Goethe-Universitat, 60438 Frankfurt am Main, Germany.',\n",
       "                'Institute for Pharmacy and Biochemistry, Johannes Gutenberg-Universitat Mainz, 55128 Mainz, Germany; Center for Biomolecular Magnetic Resonance (BMRZ), Goethe-Universitat, 60438 Frankfurt am Main, Germany.',\n",
       "                'Institute for Pharmacy and Biochemistry, Johannes Gutenberg-Universitat Mainz, 55128 Mainz, Germany; Center for Biomolecular Magnetic Resonance (BMRZ), Goethe-Universitat, 60438 Frankfurt am Main, Germany.',\n",
       "                'Center for Biomolecular Magnetic Resonance (BMRZ), Goethe-Universitat, 60438 Frankfurt am Main, Germany; Institute for Molecular Biosciences, Goethe-Universitat, 60438 Frankfurt am Main, Germany.',\n",
       "                'Center for Biomolecular Magnetic Resonance (BMRZ), Goethe-Universitat, 60438 Frankfurt am Main, Germany; Institute for Molecular Biosciences, Goethe-Universitat, 60438 Frankfurt am Main, Germany.',\n",
       "                'Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA.',\n",
       "                'Institute for Pharmacy and Biochemistry, Johannes Gutenberg-Universitat Mainz, 55128 Mainz, Germany; Center for Biomolecular Magnetic Resonance (BMRZ), Goethe-Universitat, 60438 Frankfurt am Main, Germany. Electronic address: u.hellmich@uni-mainz.de.'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['R01 GM081340/GM/NIGMS NIH HHS/United States'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Research Support, N.I.H., Extramural',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20180920',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Structure',\n",
       "               'JT': 'Structure (London, England : 1993)',\n",
       "               'JID': '101087697',\n",
       "               'RN': ['0 (Adaptor Proteins, Signal Transducing)',\n",
       "                '0 (Phosphatidylinositol 4,5-Diphosphate)',\n",
       "                '0 (Phosphoproteins)',\n",
       "                '0 (TRPV Cation Channels)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adaptor Proteins, Signal Transducing/chemistry/*metabolism',\n",
       "                'Animals',\n",
       "                'Binding Sites',\n",
       "                'Chickens',\n",
       "                'Circular Dichroism',\n",
       "                'Humans',\n",
       "                'Magnetic Resonance Spectroscopy',\n",
       "                'Models, Molecular',\n",
       "                'Phosphatidylinositol 4,5-Diphosphate/*metabolism',\n",
       "                'Phosphoproteins/chemistry/metabolism',\n",
       "                'Protein Domains',\n",
       "                'TRPV Cation Channels/*chemistry/*metabolism'],\n",
       "               'PMC': 'PMC6281781',\n",
       "               'MID': ['NIHMS1503300'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['NMR',\n",
       "                'PACSIN',\n",
       "                'PIP(2)',\n",
       "                'SH3 domain',\n",
       "                'Syndapin',\n",
       "                'TRP channel',\n",
       "                'TRPV4',\n",
       "                'cis proline',\n",
       "                'class I',\n",
       "                'proline-rich region'],\n",
       "               'COIS': ['Competing financial interests: The authors declare no competing financial',\n",
       "                'interests.'],\n",
       "               'EDAT': '2018/09/25 06:00',\n",
       "               'MHDA': '2019/09/19 06:00',\n",
       "               'PMCR': ['2019/12/04'],\n",
       "               'CRDT': ['2018/09/25 06:00'],\n",
       "               'PHST': ['2018/06/05 00:00 [received]',\n",
       "                '2018/07/13 00:00 [revised]',\n",
       "                '2018/08/01 00:00 [accepted]',\n",
       "                '2018/09/25 06:00 [pubmed]',\n",
       "                '2019/09/19 06:00 [medline]',\n",
       "                '2018/09/25 06:00 [entrez]',\n",
       "                '2019/12/04 00:00 [pmc-release]'],\n",
       "               'AID': ['S0969-2126(18)30290-9 [pii]',\n",
       "                '10.1016/j.str.2018.08.002 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Structure. 2018 Dec 4;26(12):1583-1593.e5. doi: 10.1016/j.str.2018.08.002. Epub 2018 Sep 20.'},\n",
       "              {'PMID': '29890561',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20190814',\n",
       "               'LR': '20190814',\n",
       "               'IS': '1439-7803 (Electronic) 0044-2771 (Linking)',\n",
       "               'VI': '56',\n",
       "               'IP': '6',\n",
       "               'DP': '2018 Jun',\n",
       "               'TI': '[Practice guideline neuroendocrine tumors - AWMF-Reg. 021-27].',\n",
       "               'PG': '583-681',\n",
       "               'LID': '10.1055/a-0604-2924 [doi]',\n",
       "               'AB': 'This guideline was created for the first time and is intended as a practical aid for the diagnosis and therapy of neuroendocrine tumors. The aim is to represent the current state of science, promote the recognition of the disease and improve the treatment of patients. The guideline was created under the leadership of the DGVS and with participation of neighbouring scientific societies.',\n",
       "               'CI': ['(c) Georg Thieme Verlag KG Stuttgart . New York.'],\n",
       "               'CN': ['Deutsche Gesellschaft fur Gastroenterologie, Verdauungs- und',\n",
       "                'Stoffwechselkrankheiten (DGVS)',\n",
       "                'Netzwerk Neuroendokrine Tumoren (NeT) e.V. (Patientenvertretung)',\n",
       "                'Bundesorganisation Selbsthilfe NeuroEndokrine Tumoren e.V. (NET-sgh)',\n",
       "                '(Patientenvertretung)',\n",
       "                'Deutsche Gesellschaft fur Hamatologie und Medizinische Onkologie e.V. (DGHO), und',\n",
       "                'Arbeitsgemeinschaft Internistische Onkologie (AIO) der Deutschen',\n",
       "                'Krebsgesellschaft e.V',\n",
       "                'Deutsche Gesellschaft fur Allgemein- und Viszeralchirurgie e.V. (DGAV)',\n",
       "                'Deutsche Gesellschaft fur Chirurgie (DGCH)',\n",
       "                'Deutsche Gesellschaft fur Endoskopie und Bildgebende Verfahren (DGEBV)',\n",
       "                'Deutsche Gesellschaft fur Nuklearmedizin e.V. (DGNM)',\n",
       "                'Deutsche Gesellschaft fur Innere Medizin (DGIM)',\n",
       "                'Deutsche Gesellschaft fur Endokrinologie (DGE)',\n",
       "                'Deutsche Gesellschaft fur Palliativmedizin e.V. (DGP)',\n",
       "                'Deutsche Rontgengesellschaft e.V. (DRG)',\n",
       "                'Deutsche Gesellschaft fur Pathologie e.V./Bundesverband Deutscher Pathologen',\n",
       "                '(DGP/BDP)',\n",
       "                'Deutsche Gesellschaft fur interventionelle Radiologie (DGiR)',\n",
       "                'Authors',\n",
       "                'Collaborators:'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article', 'Practice Guideline'],\n",
       "               'TT': 'S2k-Leitlinie Neuroendokrine Tumore.',\n",
       "               'DEP': '20180611',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Z Gastroenterol',\n",
       "               'JT': 'Zeitschrift fur Gastroenterologie',\n",
       "               'JID': '0033370',\n",
       "               'MH': ['Germany',\n",
       "                'Humans',\n",
       "                '*Neuroendocrine Tumors/diagnosis/therapy'],\n",
       "               'COIS': ['Disclosure The authors report no conflicts of interest in this work.'],\n",
       "               'FIR': ['Rinke, Anja',\n",
       "                'Wiedenmann, Bertram',\n",
       "                'Auernhammer, Christoph',\n",
       "                'Bartenstein, Peter',\n",
       "                'Bartsch, Detlef K',\n",
       "                'Begum, Nehara',\n",
       "                'Faiss, Siegbert',\n",
       "                'Fottner, Christian',\n",
       "                'Gebauer, Bernhard',\n",
       "                'Goretzki, Peter',\n",
       "                'Lynen Jansen, Petra',\n",
       "                'Popperl, Gabriele',\n",
       "                'Scherubl, Hans',\n",
       "                'Weber, Matthias M',\n",
       "                'Gress, Thomas Mathias',\n",
       "                'Pavel, Marianne',\n",
       "                'Albert, Jorg',\n",
       "                'Alfke, Heiko',\n",
       "                'Amthauer, Holger',\n",
       "                'Anlauf, Martin',\n",
       "                'Arnold, Rudolf',\n",
       "                'Baum, Richard',\n",
       "                'Denecke, Timm',\n",
       "                'Ezziddin, Samer',\n",
       "                'Fendrich, Volker',\n",
       "                'Gniffke, Stefan',\n",
       "                'Haug, Alexander',\n",
       "                'Horsch, Dieter',\n",
       "                'Kegel, Thomas',\n",
       "                'Knoefel, Wolfram Trudo',\n",
       "                'Knosel, Thomas',\n",
       "                'Kratochwil, Clemens',\n",
       "                'Lahner, Harald',\n",
       "                'Lordick, Florian',\n",
       "                'Luster, Markus',\n",
       "                'Mahnken, Andreas',\n",
       "                'Mellar, Katharina',\n",
       "                'Monig, Heiner',\n",
       "                'Musholt, Thomas J',\n",
       "                'Nothacker, Monika',\n",
       "                'Pape, Ulrich-Frank',\n",
       "                'Pascher, Andreas',\n",
       "                'Poppel, Thorsten',\n",
       "                'Prasad, Vikas',\n",
       "                'Probst, Andreas',\n",
       "                'Scheidhauer, Klemens',\n",
       "                'Schneider, Dominik',\n",
       "                'Schott, Matthias',\n",
       "                'Schrader, Jorg',\n",
       "                'Seufferlein, Thomas',\n",
       "                'Sipos, Bence',\n",
       "                'Spitzweg, Christine',\n",
       "                'Steinmuller, Thomas',\n",
       "                'Trumm, Christoph',\n",
       "                'Wurst, Christine',\n",
       "                'Zorger, Niels'],\n",
       "               'IR': ['Rinke A',\n",
       "                'Wiedenmann B',\n",
       "                'Auernhammer C',\n",
       "                'Bartenstein P',\n",
       "                'Bartsch DK',\n",
       "                'Begum N',\n",
       "                'Faiss S',\n",
       "                'Fottner C',\n",
       "                'Gebauer B',\n",
       "                'Goretzki P',\n",
       "                'Lynen Jansen P',\n",
       "                'Popperl G',\n",
       "                'Scherubl H',\n",
       "                'Weber MM',\n",
       "                'Gress TM',\n",
       "                'Pavel M',\n",
       "                'Albert J',\n",
       "                'Alfke H',\n",
       "                'Amthauer H',\n",
       "                'Anlauf M',\n",
       "                'Arnold R',\n",
       "                'Baum R',\n",
       "                'Denecke T',\n",
       "                'Ezziddin S',\n",
       "                'Fendrich V',\n",
       "                'Gniffke S',\n",
       "                'Haug A',\n",
       "                'Horsch D',\n",
       "                'Kegel T',\n",
       "                'Knoefel WT',\n",
       "                'Knosel T',\n",
       "                'Kratochwil C',\n",
       "                'Lahner H',\n",
       "                'Lordick F',\n",
       "                'Luster M',\n",
       "                'Mahnken A',\n",
       "                'Mellar K',\n",
       "                'Monig H',\n",
       "                'Musholt TJ',\n",
       "                'Nothacker M',\n",
       "                'Pape UF',\n",
       "                'Pascher A',\n",
       "                'Poppel T',\n",
       "                'Prasad V',\n",
       "                'Probst A',\n",
       "                'Scheidhauer K',\n",
       "                'Schneider D',\n",
       "                'Schott M',\n",
       "                'Schrader J',\n",
       "                'Seufferlein T',\n",
       "                'Sipos B',\n",
       "                'Spitzweg C',\n",
       "                'Steinmuller T',\n",
       "                'Trumm C',\n",
       "                'Wurst C',\n",
       "                'Zorger N'],\n",
       "               'IRAD': ['Zentrum fur Neuroendokrine Tumore, Klinikum der Universitat Munchen Standort',\n",
       "                'Grosshadern, Munchen, Germany.',\n",
       "                'Klinik und Poliklinik fur Nuklearmedizin, Klinikum der Universitat Munchen',\n",
       "                'Standort Grosshadern, Munchen, Germany.',\n",
       "                'Klinik fur Viszeral-, Thorax- und Gefasschirurgie, Universitatsklinikum Marburg,',\n",
       "                'Germany.',\n",
       "                'Klinik fur Allgemein- und Viszeralchirurgie, Kreiskrankenhaus Stadthagen,',\n",
       "                'Germany.',\n",
       "                'Gastroenterologie, Asklepios Klinik Barmbek, Hamburg, Germany.',\n",
       "                'I. Medizinische Klinik und Poliklinik, Universitatsklinikum Mainz, Germany.',\n",
       "                'Klinik fur Strahlentherapie, Charite Campus Virchow-Klinikum, Berlin, Germany.',\n",
       "                'Allgemein-, Viszeral-, Gefass- und Thoraxchirurgie, Stadtische Kliniken Neuss -',\n",
       "                'Lukaskrankenhaus, Neuss, Germany.',\n",
       "                'Deutsche Gesellschaft fur Gastroenterologie, Verdauungs- und',\n",
       "                'Stoffwechselerkrankungen, Berlin, Germany.',\n",
       "                'Klinik fur Nuklearmedizin, Katharinenhospital Stuttgart, Germany.',\n",
       "                'Klinik fur Innere Medizin; Gastroenterol., GI Onkol. u. Infektiol., Vivantes',\n",
       "                'Klinikum Am Urban, Berlin, Germany.',\n",
       "                'I. Medizinische Klinik und Poliklinik, Universitatsklinikum Mainz, Germany.'],\n",
       "               'EDAT': '2018/06/12 06:00',\n",
       "               'MHDA': '2019/08/15 06:00',\n",
       "               'CRDT': ['2018/06/12 06:00'],\n",
       "               'PHST': ['2018/06/12 06:00 [entrez]',\n",
       "                '2018/06/12 06:00 [pubmed]',\n",
       "                '2019/08/15 06:00 [medline]'],\n",
       "               'AID': ['10.1055/a-0604-2924 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Z Gastroenterol. 2018 Jun;56(6):583-681. doi: 10.1055/a-0604-2924. Epub 2018 Jun 11.'},\n",
       "              {'PMID': '29876616',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20190620',\n",
       "               'LR': '20190620',\n",
       "               'IS': '1433-0385 (Electronic) 0009-4722 (Linking)',\n",
       "               'VI': '89',\n",
       "               'IP': '9',\n",
       "               'DP': '2018 Sep',\n",
       "               'TI': '[Update of the S2k guidelines : Surgical treatment of benign thyroid diseases].',\n",
       "               'PG': '699-709',\n",
       "               'LID': '10.1007/s00104-018-0653-y [doi]',\n",
       "               'AB': 'Thyroid resections represent one of the most common operations with 76,140 interventions in the year 2016 in Germany (source Destatis). These are predominantly benign thyroid gland diseases. Recommendations for the operative treatment of benign thyroid diseases were last published by the CAEK in 2010 as S2k guidelines (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. [AWMF] 003/002) against the background of increasingly more radical resection procedures. Hemithyroidectomy and thyroidectomy are routinely performed for benign thyroid disease in practice. The operation-specific risks show a clear increase with the extent of the resection. Therefore, weighing-up of the risk-indications ratio between unilateral lobectomy or thyroidectomy necessitates an independent evaluation of the indications for both sides. This principle in particular has been used to update the guidelines. In addition, the previously published recommendations of the CAEK for correct execution and consequences of intraoperative neuromonitoring were included into the guidelines, which in particular serve the aim to avoid bilateral recurrent laryngeal nerve paralysis. Moreover, the recommendations for the treatment of postoperative complications, such as hypoparathyroidism and postoperative infections were revised. The updated guidelines therefore represent the current state of the science as well as the resulting surgical practice.',\n",
       "               'FAU': ['Musholt, T J',\n",
       "                'Bockisch, A',\n",
       "                'Clerici, T',\n",
       "                'Dotzenrath, C',\n",
       "                'Dralle, H',\n",
       "                'Goretzki, P E',\n",
       "                'Hermann, M',\n",
       "                'Holzer, K',\n",
       "                'Karges, W',\n",
       "                'Krude, H',\n",
       "                'Kussmann, J',\n",
       "                'Lorenz, K',\n",
       "                'Luster, M',\n",
       "                'Niederle, B',\n",
       "                'Nies, C',\n",
       "                'Riss, P',\n",
       "                'Schabram, J',\n",
       "                'Schabram, P',\n",
       "                'Schmid, K W',\n",
       "                'Simon, D',\n",
       "                'Spitzweg, Ch',\n",
       "                'Steinmuller, Th',\n",
       "                'Trupka, A',\n",
       "                'Vorlander, C',\n",
       "                'Weber, T',\n",
       "                'Bartsch, D K'],\n",
       "               'AU': ['Musholt TJ',\n",
       "                'Bockisch A',\n",
       "                'Clerici T',\n",
       "                'Dotzenrath C',\n",
       "                'Dralle H',\n",
       "                'Goretzki PE',\n",
       "                'Hermann M',\n",
       "                'Holzer K',\n",
       "                'Karges W',\n",
       "                'Krude H',\n",
       "                'Kussmann J',\n",
       "                'Lorenz K',\n",
       "                'Luster M',\n",
       "                'Niederle B',\n",
       "                'Nies C',\n",
       "                'Riss P',\n",
       "                'Schabram J',\n",
       "                'Schabram P',\n",
       "                'Schmid KW',\n",
       "                'Simon D',\n",
       "                'Spitzweg C',\n",
       "                'Steinmuller T',\n",
       "                'Trupka A',\n",
       "                'Vorlander C',\n",
       "                'Weber T',\n",
       "                'Bartsch DK'],\n",
       "               'AD': ['Sektion Endokrine Chirurgie der Klinik fur Allgemein‑, Viszeral- und Transplantationschirurgie, Universitatsmedizin der Johannes Gutenberg Universitat Mainz, Langenbeckstr. 1, 55101, Mainz, Deutschland. Musholt@uni-mainz.de.',\n",
       "                'Klinik fur Nuklearmedizin, Universitatsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland.',\n",
       "                'Klinik fur Chirurgie, Kantonsspital St. Gallen, 9007, St. Gallen, Schweiz.',\n",
       "                'Klinik fur endokrine Chirurgie, Helios Universitatsklinikum Wuppertal, Heusnerstr. 40, 42283, Wuppertal, Deutschland.',\n",
       "                'Sektion Endokrine Chirurgie, Klinik fur Allgemein‑, Viszeral- und Transplantationschirurgie, Universitatsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland.',\n",
       "                'Chirurgische Klinik, Campus Charite Mitte/Campus Virchow Klinikum, Endokrine Chirurgie, Charite - Universitatsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Deutschland.',\n",
       "                '2. Chirurgische Abteilung, Krankenanstalt Rudolfstiftung, Marzstr. 80, 1150, Wien, Osterreich.',\n",
       "                'Sektion Endokrine Chirurgie der Viszeral‑, Thorax- u. Gefasschirurgie, Universitatsklinikum Marburg, Baldingerstr., 35043, Marburg, Deutschland.',\n",
       "                'Sektion Endokrinologie und Diabetologie - Medizinische Klinik III, Universitatsklinikum Aachen, RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland.',\n",
       "                'Klinik fur Padiatrie mit Schwerpunkt Endokrinologie und Diabetologie, Charite Berlin, Augustenburger Platz 1, 13353, Berlin, Deutschland.',\n",
       "                'Klinik fur Endokrine Chirurgie, Schon Klinik Hamburg-Eilbeck, Dehnhaide 120, 22081, Hamburg, Deutschland.',\n",
       "                'Klinik u. Poliklinik f. Allgem.-, Viszeral- u. Gefasschirurgie, Universitatsklinikum Halle, Ernst-Grube-Str. 40, 06120, Halle, Deutschland.',\n",
       "                'Nuklearmedizin, Universitatsklinikum Giessen und Marburg, GmbH, Standort Marburg, Baldingerstrass, 35041, Marburg, Deutschland.',\n",
       "                'Sektion Endokrine Chirurgie, Franziskus Spital, Nikolsdorfergasse 32, 1050, Wien, Osterreich.',\n",
       "                'Klinik fur Allg.- u. Viszeralchirurgie, Marienhospital Osnabruck, Bischofsstr. 1, 49074, Osnabruck, Deutschland.',\n",
       "                'Chirurgische Universitatsklinik, Wahringer Gurtel 18-20, 1090, Wien, Osterreich.',\n",
       "                'Klinik fur Endokrine Chirurgie, Asklepios Klinik Lich, Goethestr. 4, 35423, Lich, Deutschland.',\n",
       "                'Anwaltskanzlei Ratajczak & Partner, Heinrich-von-Stephan-Str. 25, 79100, Freiburg im Breisgau, Deutschland.',\n",
       "                'Pathologie, Universitatsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland.',\n",
       "                'Klinik f. Allg.- u. Viszeralchirurgie, Ev. Bethesda Krankenhaus Duisburg GmbH, Heerstr. 219, 47053, Duisburg, Deutschland.',\n",
       "                'Medizinische Klinik und Poliklinik II, LMU Klinikum der Universitat Munchen - Campus Grosshadern, Marchioninistr. 15, 81377, Munchen, Deutschland.',\n",
       "                'Chirurgische Abteilung, Zentrum f. Allg.- u. Viszeralchirurgie, DRK-Kliniken Westend, Spandauer Damm 130, 14050, Berlin, Deutschland.',\n",
       "                'Chirurgische Klinik, Klinikum Starnberg GmbH, Osswaldstr. 1, 82319, Starnberg, Deutschland.',\n",
       "                'Endokrine Chirurgie, Burgerhospital Frankfurt am Main, Nibelungenallee 37-41, 60318, Frankfurt am Main, Deutschland.',\n",
       "                'Klinik fur Endokrine Chirurgie, Katholisches Klinikum Mainz, An der Goldgrube 11, 55131, Mainz, Deutschland.',\n",
       "                'Klinik fur Visceral‑, Thorax- und Gefasschirurgie, Universitatsklinikum Giessen und Marburg, GmbH, Standort Marburg, Baldingerstrass, 35041, Marburg, Deutschland.'],\n",
       "               'CN': ['Leitliniengruppe der CAEK'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article', 'Practice Guideline', 'Review'],\n",
       "               'TT': 'Aktualisierung der S2k-Leitlinie : Operative Therapie benigner Schilddrusenerkrankungen.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Germany',\n",
       "                'Humans',\n",
       "                'Postoperative Complications',\n",
       "                'Retrospective Studies',\n",
       "                '*Thyroid Diseases/surgery',\n",
       "                '*Thyroidectomy',\n",
       "                'Vocal Cord Paralysis/etiology'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Germany',\n",
       "                'Hypoparathyroidism',\n",
       "                'Postoperative complications',\n",
       "                'Risk',\n",
       "                'Thyroid diseases',\n",
       "                'Thyroidectomy'],\n",
       "               'EDAT': '2018/06/08 06:00',\n",
       "               'MHDA': '2019/06/21 06:00',\n",
       "               'CRDT': ['2018/06/08 06:00'],\n",
       "               'PHST': ['2018/06/08 06:00 [pubmed]',\n",
       "                '2019/06/21 06:00 [medline]',\n",
       "                '2018/06/08 06:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00104-018-0653-y [pii]',\n",
       "                '10.1007/s00104-018-0653-y [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 2018 Sep;89(9):699-709. doi: 10.1007/s00104-018-0653-y.'},\n",
       "              {'PMID': '29789947',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20180926',\n",
       "               'LR': '20181114',\n",
       "               'IS': '1432-1076 (Electronic) 0340-6199 (Print) 0340-6199 (Linking)',\n",
       "               'VI': '177',\n",
       "               'IP': '8',\n",
       "               'DP': '2018 Aug',\n",
       "               'TI': 'Relationship between brain function (aEEG) and brain structure (MRI) and their predictive value for neurodevelopmental outcome of preterm infants.',\n",
       "               'PG': '1181-1189',\n",
       "               'LID': '10.1007/s00431-018-3166-2 [doi]',\n",
       "               'AB': 'To improve the prediction of neurodevelopmental outcome in very preterm infants, this study used the combination of amplitude-integrated electroencephalography (aEEG) within the first 72 h of life and cranial magnetic resonance imaging (MRI) at term equivalent age. A single-center cohort of 38 infants born before 32 weeks of gestation was subjected to both investigations. Structural measurements were performed on MRI. Multiple regression analysis was used to identify independent factors including functional and structural brain measurements associated with outcome at a corrected age of 24 months. aEEG parameters significantly correlated with MRI measurements. Reduced deep gray matter volume was associated with low Burdjalov Score on day 3 (p < 0.0001) and day 1-3 (p = 0.0012). The biparietal width and the transcerebellar diameter were related to Burdjalov Score on day 1 (p = 0.0111; p = 0.0002). The final multiple regression analysis revealed independent predictors of neurodevelopmental outcome: intraventricular hemorrhage (p = 0.0060) and interhemispheric distance (p = 0.0052) for mental developmental index; Burdjalov Score day 1 (p = 0.0201) and interhemispheric distance (p = 0.0142) for psychomotor developmental index. CONCLUSION: Functional aEEG parameters were associated with altered brain maturation on MRI. The combination of aEEG and MRI contributes to the prediction of outcome at 24 months. What is Known: * Prematurity remains a risk factor for impaired neurodevelopment. * aEEG is used to measure brain activity in preterm infants and cranial MRI is performed to identify structural gray and white matter abnormalities with impact on neurodevelopmental outcome. What is New: * aEEG parameters observed within the first 72 h of life were associated with altered deep gray matter volumes, biparietal width, and transcerebellar diameter at term equivalent age. * The combination of aEEG and MRI contributes to the prediction of neurodevelopmental outcome at 2 years of corrected age in very preterm infants.',\n",
       "               'FAU': ['Huning, Britta',\n",
       "                'Storbeck, Tobias',\n",
       "                'Bruns, Nora',\n",
       "                'Dransfeld, Frauke',\n",
       "                'Hobrecht, Julia',\n",
       "                'Karpienski, Julia',\n",
       "                'Sirin, Selma',\n",
       "                'Schweiger, Bernd',\n",
       "                'Weiss, Christel',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Muller, Hanna'],\n",
       "               'AU': ['Huning B',\n",
       "                'Storbeck T',\n",
       "                'Bruns N',\n",
       "                'Dransfeld F',\n",
       "                'Hobrecht J',\n",
       "                'Karpienski J',\n",
       "                'Sirin S',\n",
       "                'Schweiger B',\n",
       "                'Weiss C',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Muller H'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany. Tobias.Storbeck@uk-essen.de.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Department of Medical Statistics and Biomathematics, University Hospital Mannheim, University of Heidelberg, Ludolf-Krehl-Strasse 13-17, 68167, Mannheim, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Division of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nurnberg, Loschgestr. 15, 91054, Erlangen, Germany.'],\n",
       "               'AUID': ['ORCID: 0000-0002-3875-8023'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20180522',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Eur J Pediatr',\n",
       "               'JT': 'European journal of pediatrics',\n",
       "               'JID': '7603873',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Child, Preschool',\n",
       "                'Electroencephalography/*methods',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature',\n",
       "                'Infant, Premature, Diseases/*diagnostic imaging',\n",
       "                '*Magnetic Resonance Imaging',\n",
       "                'Male',\n",
       "                'Neurodevelopmental Disorders/*diagnostic imaging',\n",
       "                'Neuroimaging/*methods',\n",
       "                'Prognosis',\n",
       "                'Retrospective Studies'],\n",
       "               'PMC': 'PMC6061051',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Immature preterm infants',\n",
       "                'MRI',\n",
       "                'Neurodevelopmental outcome',\n",
       "                'aEEG'],\n",
       "               'COIS': ['The study was approved by the local ethics committee and in accordance with the',\n",
       "                '1964 Helsinki declaration and its later amendments or comparable ethical',\n",
       "                'standards. CONFLICT OF INTEREST: The authors declare that they have no conflict',\n",
       "                'of interest. No funds were received for this study.'],\n",
       "               'EDAT': '2018/05/24 06:00',\n",
       "               'MHDA': '2018/09/27 06:00',\n",
       "               'PMCR': ['2018/05/22'],\n",
       "               'CRDT': ['2018/05/24 06:00'],\n",
       "               'PHST': ['2018/01/08 00:00 [received]',\n",
       "                '2018/05/02 00:00 [accepted]',\n",
       "                '2018/04/30 00:00 [revised]',\n",
       "                '2018/05/24 06:00 [pubmed]',\n",
       "                '2018/09/27 06:00 [medline]',\n",
       "                '2018/05/24 06:00 [entrez]',\n",
       "                '2018/05/22 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s00431-018-3166-2 [pii]',\n",
       "                '3166 [pii]',\n",
       "                '10.1007/s00431-018-3166-2 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Pediatr. 2018 Aug;177(8):1181-1189. doi: 10.1007/s00431-018-3166-2. Epub 2018 May 22.'},\n",
       "              {'PMID': '29669680',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20190523',\n",
       "               'LR': '20190523',\n",
       "               'IS': '1866-0452 (Electronic) 1866-0452 (Linking)',\n",
       "               'VI': '115',\n",
       "               'IP': '13',\n",
       "               'DP': '2018 Mar 30',\n",
       "               'TI': 'In Reply.',\n",
       "               'PG': '221',\n",
       "               'LID': 'arztebl.2018.0221b [pii] 10.3238/arztebl.2018.0221b [doi]',\n",
       "               'FAU': ['Bartsch, Detlef K',\n",
       "                'Luster, Markus',\n",
       "                'Goretzki, Peter E'],\n",
       "               'AU': ['Bartsch DK', 'Luster M', 'Goretzki PE'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comment', 'Letter'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Dtsch Arztebl Int',\n",
       "               'JT': 'Deutsches Arzteblatt international',\n",
       "               'JID': '101475967',\n",
       "               'RN': ['9007-12-9 (Calcitonin)'],\n",
       "               'SB': 'IM',\n",
       "               'CON': ['Dtsch Arztebl Int. 2018 Mar 30;115(13):221. doi: 10.3238/arztebl.2018.0221a.',\n",
       "                'PMID: 29669679'],\n",
       "               'MH': ['*Calcitonin', '*Goiter, Nodular', 'Humans'],\n",
       "               'PMC': 'PMC5938437',\n",
       "               'EDAT': '2018/04/20 06:00',\n",
       "               'MHDA': '2019/05/24 06:00',\n",
       "               'PMCR': ['2018/03/01'],\n",
       "               'CRDT': ['2018/04/20 06:00'],\n",
       "               'PHST': ['2018/04/20 06:00 [entrez]',\n",
       "                '2018/04/20 06:00 [pubmed]',\n",
       "                '2019/05/24 06:00 [medline]',\n",
       "                '2018/03/01 00:00 [pmc-release]'],\n",
       "               'AID': ['arztebl.2018.0221b [pii]',\n",
       "                '10.3238/arztebl.2018.0221b [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Dtsch Arztebl Int. 2018 Mar 30;115(13):221. doi: 10.3238/arztebl.2018.0221b.'},\n",
       "              {'PMID': '29601449',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20190612',\n",
       "               'LR': '20190613',\n",
       "               'IS': '1532-0987 (Electronic) 0891-3668 (Linking)',\n",
       "               'VI': '37',\n",
       "               'IP': '11',\n",
       "               'DP': '2018 Nov',\n",
       "               'TI': 'Antifungal Treatment and Outcome in Very Low Birth Weight Infants: A Population-based Observational Study of the German Neonatal Network.',\n",
       "               'PG': '1165-1171',\n",
       "               'LID': '10.1097/INF.0000000000002001 [doi]',\n",
       "               'AB': 'BACKGROUND: The diagnostic proof of fungal infection in preterm infants is difficult. Antifungal treatment (AFT) is often initiated empirically when infants with suspected infection do not improve despite broad-spectrum antibiotic therapy. It was the aim of our study to determine the rate of exposure to empirical AFT in a large cohort of very low birth weight infants (VLBWI) of the German Neonatal Network and to address associated risks and outcomes. METHODS: The epidemiologic database consisted of n = 13,343 VLBWI born in 54 German Neonatal Network centers between 2009 and 2015. AFT was defined as number of neonates who got any dose of at least one of the following antifungal drugs: fluconazole, amphotericin B, voriconazole and caspofungin (denominator: number of infants enrolled in German Neonatal Network) for treatment (not prophylaxis) of (suspected) fungal infection. Univariate and logistic regression analyses were used to identify risk factors for exposure to AFT and associated short-term morbidities and long-term outcomes at 5-year follow-up. RESULTS: In our cohort, 724 out of 13,343 (5.4%) VLBWI were exposed to empiric AFT and had a mean gestational age of 25.7 (+/-2.1) weeks. Forty-four out of 13,343 (0.3%) had proven bloodstream infection with Candida spp. The main risk factors for exposure to AFT were gestational age, postnatal steroid treatment, need for abdominal surgery and use of carbapenems. Notably, AFT was associated with adverse outcomes such as bronchopulmonary dysplasia [adjusted odds ratio (OR): 1.9; 95% confidence interval (CI): 1.6-2.3; P < 0.001) and retinopathy of prematurity requiring intervention (adjusted OR: 1.69; 95% CI: 1.3-2.3; P <0.001) but not mortality. In the subgroup of infants available for 5-year follow-up (n = 895), exposure to AFT was associated with a risk for cerebral palsy (adjusted OR: 2.79; 95% CI: 1.11-7.04; P = 0.04) and intelligence quotient < 85 (adjusted OR: 2.07; 95% CI: 1.01-4.28; P = 0.049). CONCLUSIONS: A significant proportion of VLBWI is exposed to AFT, specifically those born <26 weeks. Exposed infants were found to have a higher risk for adverse outcomes, which may reflect their significant vulnerability in general. Given the observational design of our study, it remains unclear whether potential side effects of empirical or target AFT itself contribute to adverse outcome. Future studies need to include risk-based strategies and stewardship programs to restrict the use of antifungal management in VLBWI.',\n",
       "               'FAU': ['Fortmann, Ingmar',\n",
       "                'Hartz, Annika',\n",
       "                'Paul, Pia',\n",
       "                'Pulzer, Ferdinand',\n",
       "                'Muller, Andreas',\n",
       "                'Bottger, Ralf',\n",
       "                'Proquitte, Hans',\n",
       "                'Dawczynski, Kristin',\n",
       "                'Simon, Arne',\n",
       "                'Rupp, Jan',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang',\n",
       "                'Hartel, Christoph'],\n",
       "               'AU': ['Fortmann I',\n",
       "                'Hartz A',\n",
       "                'Paul P',\n",
       "                'Pulzer F',\n",
       "                'Muller A',\n",
       "                'Bottger R',\n",
       "                'Proquitte H',\n",
       "                'Dawczynski K',\n",
       "                'Simon A',\n",
       "                'Rupp J',\n",
       "                'Herting E',\n",
       "                'Gopel W',\n",
       "                'Hartel C'],\n",
       "               'AD': ['From the Department of Pediatrics, University of Lubeck, Germany.',\n",
       "                'From the Department of Pediatrics, University of Lubeck, Germany.',\n",
       "                'From the Department of Pediatrics, University of Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Leipzig, Germany.',\n",
       "                'Department of Neonatology, University of Bonn, Germany.',\n",
       "                'Department of Pediatrics, University of Magdeburg, Germany.',\n",
       "                'Department of Pediatrics, University of Jena, Germany.',\n",
       "                'Department of Pediatrics, University of Jena, Germany.',\n",
       "                'Department of Pediatric Oncology, Saar University Homburg, Germany.',\n",
       "                'Department of Infectious Diseases and Microbiology, University of Lubeck, Germany.',\n",
       "                'From the Department of Pediatrics, University of Lubeck, Germany.',\n",
       "                'From the Department of Pediatrics, University of Lubeck, Germany.',\n",
       "                'From the Department of Pediatrics, University of Lubeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Observational Study',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Pediatr Infect Dis J',\n",
       "               'JT': 'The Pediatric infectious disease journal',\n",
       "               'JID': '8701858',\n",
       "               'RN': ['0 (Antifungal Agents)', '8VZV102JFY (Fluconazole)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Antifungal Agents/*therapeutic use',\n",
       "                'Candida/drug effects',\n",
       "                'Candidiasis/drug therapy/mortality',\n",
       "                'Child, Preschool',\n",
       "                'Cohort Studies',\n",
       "                'Female',\n",
       "                'Fluconazole/therapeutic use',\n",
       "                'Follow-Up Studies',\n",
       "                'Germany/epidemiology',\n",
       "                'Gestational Age',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature, Diseases/drug therapy/*microbiology',\n",
       "                '*Infant, Very Low Birth Weight',\n",
       "                'Male',\n",
       "                'Mycoses/*drug therapy/epidemiology',\n",
       "                'Population Health',\n",
       "                'Risk Factors',\n",
       "                '*Treatment Outcome'],\n",
       "               'EDAT': '2018/03/31 06:00',\n",
       "               'MHDA': '2019/06/14 06:00',\n",
       "               'CRDT': ['2018/03/31 06:00'],\n",
       "               'PHST': ['2018/03/31 06:00 [pubmed]',\n",
       "                '2019/06/14 06:00 [medline]',\n",
       "                '2018/03/31 06:00 [entrez]'],\n",
       "               'AID': ['10.1097/INF.0000000000002001 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Pediatr Infect Dis J. 2018 Nov;37(11):1165-1171. doi: 10.1097/INF.0000000000002001.'},\n",
       "              {'PMID': '29345225',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20181211',\n",
       "               'LR': '20240606',\n",
       "               'IS': '1866-0452 (Electronic) 1866-0452 (Linking)',\n",
       "               'VI': '115',\n",
       "               'IP': '1-02',\n",
       "               'DP': '2018 Jan 8',\n",
       "               'TI': 'Indications for the Surgical Management of Benign Goiter in Adults.',\n",
       "               'PG': '1-7',\n",
       "               'LID': 'arztebl.2018.0001 [pii] 10.3238/arztebl.2018.0001 [doi]',\n",
       "               'AB': 'BACKGROUND: Thyroidectomy is still three to six times more common in Germany than in the USA, Great Britain, and the Scandinavian countries. Thus, the question is often asked whether thyroidectomy in Germany is being performed for the correct indications. METHODS: This review is based on studies and guidelines containing information on the indications for surgery in benign goiter and Graves\\' disease; these publications were retrieved by a systematic literature search in the Medline and Cochrane Library databases (1990-2016). The indications recommended here were determined by vote by the German Society for General and Visceral Surgery (Deutsche Gesellschaft fur Allgemein- und Viszeralchirurgie, DGAV). RESULTS: On the basis of the available evidence (levels 2-4), and in the absence of prospective studies, the indications for surgery in goiter include a well-founded suspicion of malignancy, local compressive symptoms, and, rarely, cosmesis. In hyperthyroid goiter and Graves\\' disease, surgery is a potential alternative to radio - iodine therapy, particularly if the volume of the thyroid gland exceeds 80 mL, in patients with advanced or active orbitopathy, and in female patients who are, or plan to be, pregnant. Large, asymptomatic, euthyroid nodular goiter without any suspicion of malignancy and scintigraphically \"cold\" nodules without any other evidence of malignancy are not indications for surgery. Thyroid operations of higher levels of difficulty (e.g., recurrent goiter, retrosternal extension, Graves\\' disease) should be carried out in institutions with special expertise in thyroid surgery. CONCLUSION: The decision to operate should be made on an interdisciplinary basis and in conformity with the relevant guidelines after all of the appropriate diagnostic studies have been performed. The radicality of any proposed surgical procedure should be weighed against its potential complications.',\n",
       "               'FAU': ['Bartsch, Detlef K',\n",
       "                'Luster, Markus',\n",
       "                'Buhr, Heinz J',\n",
       "                'Lorenz, Dietmar',\n",
       "                'Germer, Christoph-Thomas',\n",
       "                'Goretzki, Peter E'],\n",
       "               'AU': ['Bartsch DK',\n",
       "                'Luster M',\n",
       "                'Buhr HJ',\n",
       "                'Lorenz D',\n",
       "                'Germer CT',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Department of Visceral, Thoracic and Vascular Surgery, University Hospital of Giessen and Marburg; Marburg; Department of Nuclear Medicine, University Hospital of Giessen and Marburg; Marburg; German Society for General and Visceral Surgery, Berlin; Department of General and Visceral Surgery, Sana Klinikum Offenbach; Offenbach; Department of General, Visceral and Vascular Surgery, University Hospital of Wurzburg; Wurzburg; Department of General, Visceral and Endocrine Surgery, Lukaskrankenhaus Neuss; Neuss.'],\n",
       "               'CN': ['German Society for General and Visceral Surgery'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Dtsch Arztebl Int',\n",
       "               'JT': 'Deutsches Arzteblatt international',\n",
       "               'JID': '101475967',\n",
       "               'SB': 'IM',\n",
       "               'CIN': ['Dtsch Arztebl Int. 2018 Mar 30;115(13):221. doi: 10.3238/arztebl.2018.0221a.',\n",
       "                'PMID: 29669679'],\n",
       "               'EIN': ['Dtsch Arztebl Int. 2018 Mar;115(9):144. doi: 10.3238/arztebl.2018.0144. PMID:',\n",
       "                '31329757'],\n",
       "               'MH': ['Adult',\n",
       "                'Female',\n",
       "                'Goiter, Nodular/*surgery',\n",
       "                'Graves Disease/*surgery',\n",
       "                'Humans',\n",
       "                'Prospective Studies',\n",
       "                '*Thyroidectomy'],\n",
       "               'PMC': 'PMC5778395',\n",
       "               'EDAT': '2018/01/19 06:00',\n",
       "               'MHDA': '2018/12/12 06:00',\n",
       "               'PMCR': ['2018/01/01'],\n",
       "               'CRDT': ['2018/01/19 06:00'],\n",
       "               'PHST': ['2017/04/25 00:00 [received]',\n",
       "                '2017/04/25 00:00 [revised]',\n",
       "                '2017/09/22 00:00 [accepted]',\n",
       "                '2018/01/19 06:00 [entrez]',\n",
       "                '2018/01/19 06:00 [pubmed]',\n",
       "                '2018/12/12 06:00 [medline]',\n",
       "                '2018/01/01 00:00 [pmc-release]'],\n",
       "               'AID': ['arztebl.2018.0001 [pii]',\n",
       "                '10.3238/arztebl.2018.0001 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Dtsch Arztebl Int. 2018 Jan 8;115(1-02):1-7. doi: 10.3238/arztebl.2018.0001.'},\n",
       "              {'PMID': '29242949',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20190822',\n",
       "               'LR': '20190822',\n",
       "               'IS': '1433-0563 (Electronic) 0340-2592 (Linking)',\n",
       "               'VI': '57',\n",
       "               'IP': '2',\n",
       "               'DP': '2018 Feb',\n",
       "               'TI': '[Rare renal tumors].',\n",
       "               'PG': '193-197',\n",
       "               'LID': '10.1007/s00120-017-0553-7 [doi]',\n",
       "               'FAU': ['Akca, A',\n",
       "                'Otto, T',\n",
       "                'Hinsch, N',\n",
       "                'Lammers, B J',\n",
       "                'Starke, A A R',\n",
       "                'Goretzki, P E'],\n",
       "               'AU': ['Akca A',\n",
       "                'Otto T',\n",
       "                'Hinsch N',\n",
       "                'Lammers BJ',\n",
       "                'Starke AAR',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Klinik fur Allgemein‑, Visceral‑, Thorax‑, Gefass- und Endokrine Chirurgie, Lukaskrankenhaus Neuss, Preussenstr. 84, 41464, Neuss, Deutschland. aakca@lukasneuss.de.',\n",
       "                'Insulinom und GEP-NET-Zentrum Neuss, Neuss, Deutschland. aakca@lukasneuss.de.',\n",
       "                'Klinik fur Urologie, Lukaskrankenhaus Neuss, Neuss, Deutschland.',\n",
       "                'Institut fur Pathologie, Lukaskrankenhaus Neuss, Neuss, Deutschland.',\n",
       "                'Klinik fur Allgemein‑, Visceral‑, Thorax‑, Gefass- und Endokrine Chirurgie, Lukaskrankenhaus Neuss, Preussenstr. 84, 41464, Neuss, Deutschland.',\n",
       "                'Insulinom und GEP-NET-Zentrum Neuss, Neuss, Deutschland.',\n",
       "                'Insulinom und GEP-NET-Zentrum Neuss, Neuss, Deutschland.',\n",
       "                'Klinik fur Allgemein‑, Visceral‑, Thorax‑, Gefass- und Endokrine Chirurgie, Lukaskrankenhaus Neuss, Preussenstr. 84, 41464, Neuss, Deutschland.',\n",
       "                'Insulinom und GEP-NET-Zentrum Neuss, Neuss, Deutschland.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'TT': 'Seltene Tumoren der Niere.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Urologe A',\n",
       "               'JT': 'Der Urologe. Ausg. A',\n",
       "               'JID': '1304110',\n",
       "               'MH': ['*Carcinoma, Renal Cell', 'Humans', '*Kidney Neoplasms'],\n",
       "               'EDAT': '2017/12/16 06:00',\n",
       "               'MHDA': '2019/08/23 06:00',\n",
       "               'CRDT': ['2017/12/16 06:00'],\n",
       "               'PHST': ['2017/12/16 06:00 [pubmed]',\n",
       "                '2019/08/23 06:00 [medline]',\n",
       "                '2017/12/16 06:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00120-017-0553-7 [pii]',\n",
       "                '10.1007/s00120-017-0553-7 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Urologe A. 2018 Feb;57(2):193-197. doi: 10.1007/s00120-017-0553-7.'},\n",
       "              {'PMID': '29169190',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20180803',\n",
       "               'LR': '20190308',\n",
       "               'IS': '1439-4286 (Electronic) 0018-5043 (Linking)',\n",
       "               'VI': '50',\n",
       "               'IP': '1',\n",
       "               'DP': '2018 Jan',\n",
       "               'TI': 'Measurement of Basal Serum Calcitonin for the Diagnosis of Medullary Thyroid Cancer.',\n",
       "               'PG': '23-28',\n",
       "               'LID': '10.1055/s-0043-122237 [doi]',\n",
       "               'AB': 'Calcitonin (CT), a tumor marker for medullary thyroid cancer (MTC), can be stimulated with pentagastrin or calcium. Because of the unavailability of pentagastrin, basal CT measurement is frequently used for the preoperative diagnosis of MTC. The aim of the study was to define basal serum calcitonin (bCT) cut-off thresholds for diagnosing MTC. Within a retrospective analysis, 114 patients (51 males) were included fulfilling the criteria of an increased preoperative bCT level (>10 pg/ml) and the criteria of an available postoperative histology analysis. Based on a ROC plot analysis, the cut-off values for the diagnosis of MTC vs. non-malignancy (C cell hyperplasia and goiter) were identified. The most precise bCT thresholds for the identification of MTC were >/=46 pg/ml for males (sensitivity: 93.6%, specificity: 95.0%, PPV: 97%, NPV: 90%) and >/=35 pg/ml for females (sensitivity: 87.3%, specificity: 87.5%, PPV: 98%, NPV: 50%). Using these cut-offs, only 6% of male patients were not identified of having MTC, whereas 5% were false positive (having instead C cell hyperplasia). In females, the discrepancy was higher since 13% of female MTC patients were false negative by using the cut-off of >/=35 pg/ml, and 13% had false positive results (suffering from C cell hyperplasia). Gender-specific bCT cut-offs for the identification of MTC vs. C cell hyperplasia and non-malignancy were defined, which can be used in clinical routine. In female patients, however, the accuracy is much lower compared to males.',\n",
       "               'CI': ['(c) Georg Thieme Verlag KG Stuttgart . New York.'],\n",
       "               'FAU': ['Allelein, Stephanie',\n",
       "                'Ehlers, Margret',\n",
       "                'Morneau, Corinna',\n",
       "                'Schwartz, Katharina',\n",
       "                'Goretzki, Peter E',\n",
       "                'Seppel, Thomas',\n",
       "                'Feldkamp, Joachim',\n",
       "                'Krieg, Andreas',\n",
       "                'Knoefel, Wolfram Trudo',\n",
       "                'Kuebart, Anne',\n",
       "                'Haase, Matthias',\n",
       "                'Dringenberg, Till',\n",
       "                'Schmid, Christine',\n",
       "                'Schott, Matthias'],\n",
       "               'AU': ['Allelein S',\n",
       "                'Ehlers M',\n",
       "                'Morneau C',\n",
       "                'Schwartz K',\n",
       "                'Goretzki PE',\n",
       "                'Seppel T',\n",
       "                'Feldkamp J',\n",
       "                'Krieg A',\n",
       "                'Knoefel WT',\n",
       "                'Kuebart A',\n",
       "                'Haase M',\n",
       "                'Dringenberg T',\n",
       "                'Schmid C',\n",
       "                'Schott M'],\n",
       "               'AD': ['Division for Specific Endocrinology, Medical Faculty, University Hospital Duesseldorf, Duesseldorf, Germany.',\n",
       "                'Division for Specific Endocrinology, Medical Faculty, University Hospital Duesseldorf, Duesseldorf, Germany.',\n",
       "                'Division for Specific Endocrinology, Medical Faculty, University Hospital Duesseldorf, Duesseldorf, Germany.',\n",
       "                'Department of Surgery, Lukas Hospital, Neuss, Germany.',\n",
       "                'Department of Surgery, Lukas Hospital, Neuss, Germany.',\n",
       "                'Outpatient Clinic for Endocrinology, Moenchengladbach, Germany.',\n",
       "                'Department for Endocrinology and Diabetes, Municipal Hospital Bielefeld, Bielefeld, Germany.',\n",
       "                'Department of General, Visceral and Pediatric Surgery, Medical Faculty, University Hospital Duesseldorf, Duesseldorf, Germany.',\n",
       "                'Department of General, Visceral and Pediatric Surgery, Medical Faculty, University Hospital Duesseldorf, Duesseldorf, Germany.',\n",
       "                'Division for Specific Endocrinology, Medical Faculty, University Hospital Duesseldorf, Duesseldorf, Germany.',\n",
       "                'Division for Specific Endocrinology, Medical Faculty, University Hospital Duesseldorf, Duesseldorf, Germany.',\n",
       "                'Division for Specific Endocrinology, Medical Faculty, University Hospital Duesseldorf, Duesseldorf, Germany.',\n",
       "                'Division for Specific Endocrinology, Medical Faculty, University Hospital Duesseldorf, Duesseldorf, Germany.',\n",
       "                'Division for Specific Endocrinology, Medical Faculty, University Hospital Duesseldorf, Duesseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20171123',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Horm Metab Res',\n",
       "               'JT': 'Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme',\n",
       "               'JID': '0177722',\n",
       "               'RN': ['9007-12-9 (Calcitonin)', 'Thyroid cancer, medullary'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Calcitonin/*blood',\n",
       "                'Carcinoma, Neuroendocrine/*blood/*diagnosis',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperplasia',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'ROC Curve',\n",
       "                'Reference Values',\n",
       "                'Sensitivity and Specificity',\n",
       "                'Thyroid Neoplasms/*blood/*diagnosis'],\n",
       "               'COIS': ['Conflict of Interest: The authors declare that they have no conflict of interest.'],\n",
       "               'EDAT': '2017/11/24 06:00',\n",
       "               'MHDA': '2018/08/04 06:00',\n",
       "               'CRDT': ['2017/11/24 06:00'],\n",
       "               'PHST': ['2017/11/24 06:00 [pubmed]',\n",
       "                '2018/08/04 06:00 [medline]',\n",
       "                '2017/11/24 06:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-0043-122237 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Horm Metab Res. 2018 Jan;50(1):23-28. doi: 10.1055/s-0043-122237. Epub 2017 Nov 23.'}],\n",
       "             '2017': [{'PMID': '29024833',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20180627',\n",
       "               'LR': '20250103',\n",
       "               'IS': '1872-6232 (Electronic) 0378-3782 (Linking)',\n",
       "               'VI': '115',\n",
       "               'DP': '2017 Dec',\n",
       "               'TI': 'Health of VLBW infants in Germany at five years of age: What do parents describe?',\n",
       "               'PG': '88-92',\n",
       "               'LID': 'S0378-3782(17)30310-9 [pii] 10.1016/j.earlhumdev.2017.10.003 [doi]',\n",
       "               'AB': 'BACKGROUND: There are only few data on medical problems and utilization of health services of former very low birth weight (VLBW) children at preschool age. STUDY DESIGN: At five years of age parents of a cohort of VLBW children (N=862) received questionnaires, a medical interview and examination. The results were compared to the KIGGS cohort (Deutscher-Kinder-und Jugendgesundheitssurvey, N=777). RESULTS: Parents of the VLBW and KIGGS cohort reported a very good or good health in 95% in their children. When compared to the KIGGS cohort, families in the VLBW cohort had a lower social economic status. The VLBW cohort suffered more frequently from disabilities (9.6% vs. 1.4%), from chronic bronchitis (45% vs. 17%) and from recurrent pain (headaches (20% vs. 7%), ear (16% vs. 6%), throat (23% vs. 8%), tooth (10% vs. 3%)). The VLBW cohort received more specialized care (ophthalmologist, ENT, orthopaedics, paediatric neurologist). CONCLUSION: Families of VLBW children report a good health status in their children, but they utilized more specialized care. Higher rates of pain are reported in the VLBW cohort. Chronic bronchitis and various upper respiratory infections cause an increased morbidity in former VLBW children. Follow up programs are needed to develop optimal treatment and prevention strategies for these problems.',\n",
       "               'CI': ['Copyright (c) 2017 Elsevier B.V. All rights reserved.'],\n",
       "               'FAU': ['Spiegler, Juliane',\n",
       "                'Stichtenoth, Guido',\n",
       "                'Konig, Inke R',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Spiegler J',\n",
       "                'Stichtenoth G',\n",
       "                'Konig IR',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AD': ['Department of Paediatrics, University of Luebeck, Ratzeburger Allee 160, D-23538 Luebeck, Germany. Electronic address: uni@dr-spiegler.de.',\n",
       "                'Department of Paediatrics, University of Luebeck, Ratzeburger Allee 160, D-23538 Luebeck, Germany.',\n",
       "                'Institute of Medical Biometry and Statistics, University of Luebeck, Ratzeburger Allee 160, D-23538 Luebeck, Germany.',\n",
       "                'Department of Paediatrics, University of Luebeck, Ratzeburger Allee 160, D-23538 Luebeck, Germany.',\n",
       "                'Department of Paediatrics, University of Luebeck, Ratzeburger Allee 160, D-23538 Luebeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network (GNN)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20171009',\n",
       "               'PL': 'Ireland',\n",
       "               'TA': 'Early Hum Dev',\n",
       "               'JT': 'Early human development',\n",
       "               'JID': '7708381',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Bronchitis/epidemiology',\n",
       "                'Child',\n",
       "                'Children with Disabilities/statistics & numerical data',\n",
       "                'Eye Diseases/epidemiology',\n",
       "                'Female',\n",
       "                'Germany',\n",
       "                'Health Services/statistics & numerical data',\n",
       "                '*Health Status',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature/growth & development',\n",
       "                'Infant, Very Low Birth Weight/*growth & development',\n",
       "                'Male',\n",
       "                'Pain/epidemiology',\n",
       "                'Parents'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Chronic bronchitis',\n",
       "                'Infection',\n",
       "                'Pain',\n",
       "                'Utilization of health system',\n",
       "                'Very low birth weight'],\n",
       "               'EDAT': '2017/10/13 06:00',\n",
       "               'MHDA': '2018/06/28 06:00',\n",
       "               'CRDT': ['2017/10/13 06:00'],\n",
       "               'PHST': ['2017/06/26 00:00 [received]',\n",
       "                '2017/08/25 00:00 [revised]',\n",
       "                '2017/10/04 00:00 [accepted]',\n",
       "                '2017/10/13 06:00 [pubmed]',\n",
       "                '2018/06/28 06:00 [medline]',\n",
       "                '2017/10/13 06:00 [entrez]'],\n",
       "               'AID': ['S0378-3782(17)30310-9 [pii]',\n",
       "                '10.1016/j.earlhumdev.2017.10.003 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Early Hum Dev. 2017 Dec;115:88-92. doi: 10.1016/j.earlhumdev.2017.10.003. Epub 2017 Oct 9.'},\n",
       "              {'PMID': '28930990',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20180521',\n",
       "               'LR': '20181202',\n",
       "               'IS': '1940-087X (Electronic) 1940-087X (Linking)',\n",
       "               'IP': '127',\n",
       "               'DP': '2017 Sep 6',\n",
       "               'TI': 'Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates.',\n",
       "               'LID': '10.3791/55985 [doi] 55985',\n",
       "               'AB': 'Amplitude-integrated EEG (aEEG) is an easily accessible technique to monitor the electrocortical activity in preterm and term infants in neonatal intensive care units (NICUs). This method was first used to monitor newborns after asphyxia, providing information about future neurological outcomes. The aEEG is also helpful to select newborns who benefit from cooling. The aEEG monitoring of preterm infants is becoming more widespread, as various studies have shown that neurodevelopmental outcome is related to early aEEG tracings. Here, we demonstrate the application of the aEEG monitoring system and present typical patterns that depend upon gestational age and pathophysiological conditions. Furthermore, we mention pitfalls in the interpretation of the aEEG, as this method requires accurate fixation and localization of the electrodes. Additionally, the raw EEG can be used to detect neonatal seizures or to identify aEEG application problems. In conclusion, aEEG is a safe and generally well-tolerated method for the bedside monitoring of neonatal cerebral function; it can even provide information about long-term outcome.',\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Blumenthal, Susanne',\n",
       "                'Meyer, Irmgard',\n",
       "                'Klose-Verschuur, Susanne',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Muller, Hanna'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Blumenthal S',\n",
       "                'Meyer I',\n",
       "                'Klose-Verschuur S',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Muller H'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen; nora.bruns@uk-essen.de.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen; Division of Neonatology, Department of Pediatrics, University of Heidelberg.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Video-Audio Media'],\n",
       "               'DEP': '20170906',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Vis Exp',\n",
       "               'JT': 'Journal of visualized experiments : JoVE',\n",
       "               'JID': '101313252',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Electroencephalography/*methods',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature',\n",
       "                'Intensive Care Units, Neonatal',\n",
       "                'Monitoring, Physiologic/*methods',\n",
       "                'Seizures/*diagnosis'],\n",
       "               'PMC': 'PMC5752191',\n",
       "               'EDAT': '2017/09/21 06:00',\n",
       "               'MHDA': '2018/05/22 06:00',\n",
       "               'PMCR': ['2017/09/06'],\n",
       "               'CRDT': ['2017/09/21 06:00'],\n",
       "               'PHST': ['2017/09/21 06:00 [entrez]',\n",
       "                '2017/09/21 06:00 [pubmed]',\n",
       "                '2018/05/22 06:00 [medline]',\n",
       "                '2017/09/06 00:00 [pmc-release]'],\n",
       "               'AID': ['55985 [pii]', '10.3791/55985 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'J Vis Exp. 2017 Sep 6;(127):55985. doi: 10.3791/55985.'},\n",
       "              {'PMID': '28558032',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20170921',\n",
       "               'LR': '20191210',\n",
       "               'IS': '1932-6203 (Electronic) 1932-6203 (Linking)',\n",
       "               'VI': '12',\n",
       "               'IP': '5',\n",
       "               'DP': '2017',\n",
       "               'TI': 'The association of mannose-binding lectin 2 polymorphisms with outcome in very low birth weight infants.',\n",
       "               'PG': 'e0178032',\n",
       "               'LID': '10.1371/journal.pone.0178032 [doi] e0178032',\n",
       "               'AB': 'OBJECTIVES: Studies on the influence of mannose-binding lectin (MBL) deficiency on infection susceptibility in preterm infants have yielded controversial results. We investigated the association of genotype-based MBL levels with outcome in very-low-birth weight infants (VLBWI). METHODS: We genotyped 3 genetic variants of MBL2 (rs1800450, rs1800451, rs5030737) in 6878 VLBWI. MBL plasma levels were categorized as normal (wild type, A/A), low (heterozygotes, A/O) or undetectable (homozygotes, O/O). Primary outcome was the effect of genotype-based MBL2 levels on blood-culture proven and clinical sepsis during primary stay in hospital. We also evaluated burden of infection within 24 months after discharge. RESULTS: We found no association between MBL levels and sepsis risk in the whole cohort. Infants without measurable MBL levels born between 32 0/7 to 36 6/7 weeks of gestation, however, had a higher rate of Gram-negative sepsis than infants with normal or reduced MBL levels. In a follow-up investigation at 24 months (n = 1070 infants), infants without measurable MBL levels suffered more frequently from stomatitis and urinary tract infection. CONCLUSIONS: In a large cohort of VLBWI MBL2 deficiency had no major impact on infection risk unless children were born between 32 0/7 and 36 6/7 weeks of gestation.',\n",
       "               'FAU': ['Hartz, Annika',\n",
       "                'Pagel, Julia',\n",
       "                'Humberg, Alexander',\n",
       "                'Preuss, Michael',\n",
       "                'Schreiter, Lena',\n",
       "                'Rupp, Jan',\n",
       "                'Figge, Julia',\n",
       "                'Karsten, Christian M',\n",
       "                'Nurnberg, Peter',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang',\n",
       "                'Hartel, Christoph'],\n",
       "               'AU': ['Hartz A',\n",
       "                'Pagel J',\n",
       "                'Humberg A',\n",
       "                'Preuss M',\n",
       "                'Schreiter L',\n",
       "                'Rupp J',\n",
       "                'Figge J',\n",
       "                'Karsten CM',\n",
       "                'Nurnberg P',\n",
       "                'Herting E',\n",
       "                'Gopel W',\n",
       "                'Hartel C'],\n",
       "               'AUID': ['ORCID: 0000-0002-8785-2032'],\n",
       "               'AD': ['Department of Pediatrics, University Hospital Lubeck, Lubeck, Germany.',\n",
       "                'Institute of Systemic Inflammation Research, University Hospital Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital Lubeck, Lubeck, Germany.',\n",
       "                'Department of Infectious Diseases and Microbiology, University Hospital Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital Lubeck, Lubeck, Germany.',\n",
       "                'Institute for Medical Biometry and Statistics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital Lubeck, Lubeck, Germany.',\n",
       "                'Institute of Systemic Inflammation Research, University Hospital Lubeck, Lubeck, Germany.',\n",
       "                'Department of Infectious Diseases and Microbiology, University Hospital Lubeck, Lubeck, Germany.',\n",
       "                'Institute of Systemic Inflammation Research, University Hospital Lubeck, Lubeck, Germany.',\n",
       "                'Institute of Systemic Inflammation Research, University Hospital Lubeck, Lubeck, Germany.',\n",
       "                'Cologne Center for Genomics, Cologne, Germany.',\n",
       "                'Department of Pediatrics, University Hospital Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital Lubeck, Lubeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network (GNN)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20170530',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'PLoS One',\n",
       "               'JT': 'PloS one',\n",
       "               'JID': '101285081',\n",
       "               'RN': ['0 (Mannose-Binding Lectin)',\n",
       "                '0 (Mannose-Binding Lectins)',\n",
       "                'Mannose-Binding Protein Deficiency'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Cohort Studies',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                '*Infant, Very Low Birth Weight',\n",
       "                'Infections/complications',\n",
       "                'Mannose-Binding Lectin/deficiency/genetics',\n",
       "                'Mannose-Binding Lectins/*genetics',\n",
       "                'Metabolism, Inborn Errors/complications/genetics',\n",
       "                '*Polymorphism, Genetic'],\n",
       "               'PMC': 'PMC5448758',\n",
       "               'COIS': ['Competing Interests: The authors have declared that no competing interests exist.'],\n",
       "               'EDAT': '2017/05/31 06:00',\n",
       "               'MHDA': '2017/09/22 06:00',\n",
       "               'PMCR': ['2017/05/30'],\n",
       "               'CRDT': ['2017/05/31 06:00'],\n",
       "               'PHST': ['2017/01/25 00:00 [received]',\n",
       "                '2017/05/07 00:00 [accepted]',\n",
       "                '2017/05/31 06:00 [entrez]',\n",
       "                '2017/05/31 06:00 [pubmed]',\n",
       "                '2017/09/22 06:00 [medline]',\n",
       "                '2017/05/30 00:00 [pmc-release]'],\n",
       "               'AID': ['PONE-D-17-03307 [pii]',\n",
       "                '10.1371/journal.pone.0178032 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'PLoS One. 2017 May 30;12(5):e0178032. doi: 10.1371/journal.pone.0178032. eCollection 2017.'},\n",
       "              {'PMID': '28363188',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20180216',\n",
       "               'LR': '20180216',\n",
       "               'IS': '1872-7654 (Electronic) 0301-2115 (Linking)',\n",
       "               'VI': '212',\n",
       "               'DP': '2017 May',\n",
       "               'TI': 'Delivery mode and intraventricular hemorrhage risk in very-low-birth-weight infants: Observational data of the German Neonatal Network.',\n",
       "               'PG': '144-149',\n",
       "               'LID': 'S0301-2115(17)30143-4 [pii] 10.1016/j.ejogrb.2017.03.032 [doi]',\n",
       "               'AB': 'BACKGROUND: Very-low-birth-weight infants (VLBWI) are frequently delivered by cesarean section (CS). However, it is unclear at what gestational age the benefits of spontaneous delivery outweigh the perinatal risks, i.e. intraventricular hemorrhage (IVH) or death. OBJECTIVES: To assess the short-term outcome of VLBWI on IVH according to mode of delivery in a population-based cohort of the German Neonatal Network (GNN). STUDY DESIGN: A total cohort of 2203 singleton VLBWI with a birth weight <1500g and gestational age between 22 0/7 and 36 6/7 weeks born and discharged between 1st of January 2009 and 31st of December 2015 was available for analysis. VLBWI were stratified into three categories according to mode of delivery: (1) planned cesarean section (n=1381), (2) vaginal delivery (n=632) and (3) emergency cesarean section (n=190). Outcome was assessed in univariate and logistic regression analyses. RESULTS: Prevalence of IVH was significantly higher in the vaginal delivery (VD) (26.6%) and emergency CS group (31.1%) as compared to planned CS (17.2%), respectively. In a logistic regression analysis including known risk factors for IVH, vaginal delivery (OR 1.725 [1.325-2.202], p</=0.001) and emergency cesarean section (OR 1.916 [1.338-2.746], p</=0.001) were independently associated with IVH risk. In the subgroup of infants >30 weeks of gestation prevalence for IVH was not significantly different in VD and planned CS (5.3% vs. 4.4%). CONCLUSIONS: Our observational data demonstrate that elective cesarean section is associated with a reduced risk of IVH in preterm infants <30 weeks gestational age when presenting with preterm labor.',\n",
       "               'CI': ['Copyright (c) 2017 Elsevier B.V. All rights reserved.'],\n",
       "               'FAU': ['Humberg, Alexander',\n",
       "                'Hartel, Christoph',\n",
       "                'Paul, Pia',\n",
       "                'Hanke, Kathrin',\n",
       "                'Bossung, Verena',\n",
       "                'Hartz, Annika',\n",
       "                'Fasel, Laura',\n",
       "                'Rausch, Tanja K',\n",
       "                'Rody, Achim',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Humberg A',\n",
       "                'Hartel C',\n",
       "                'Paul P',\n",
       "                'Hanke K',\n",
       "                'Bossung V',\n",
       "                'Hartz A',\n",
       "                'Fasel L',\n",
       "                'Rausch TK',\n",
       "                'Rody A',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AD': ['Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Luebeck, Germany. Electronic address: alexander.humberg@uksh.de.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Luebeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Luebeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Luebeck, Germany.',\n",
       "                'Department of Obstetrics and Gynecology, University Hospital of Schleswig-Holstein, Campus Luebeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Luebeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Luebeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Luebeck, Germany; Institute of Medical Biometry and Statistics, University of Luebeck, University Medical Center of Schleswig-Holstein, Campus Luebeck, Germany.',\n",
       "                'Department of Obstetrics and Gynecology, University Hospital of Schleswig-Holstein, Campus Luebeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Luebeck, Germany.',\n",
       "                'Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Luebeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network (GNN)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Observational Study'],\n",
       "               'DEP': '20170322',\n",
       "               'PL': 'Ireland',\n",
       "               'TA': 'Eur J Obstet Gynecol Reprod Biol',\n",
       "               'JT': 'European journal of obstetrics, gynecology, and reproductive biology',\n",
       "               'JID': '0375672',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Cerebral Intraventricular Hemorrhage/*epidemiology',\n",
       "                'Cohort Studies',\n",
       "                'Delivery, Obstetric/adverse effects/*statistics & numerical data',\n",
       "                'Female',\n",
       "                'Germany/epidemiology',\n",
       "                'Gestational Age',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature',\n",
       "                'Infant, Premature, Diseases/epidemiology',\n",
       "                '*Infant, Very Low Birth Weight',\n",
       "                'Male',\n",
       "                'Obstetric Labor, Premature',\n",
       "                'Population Surveillance',\n",
       "                'Pregnancy',\n",
       "                'Prevalence',\n",
       "                'Regression Analysis',\n",
       "                'Risk Factors'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Cesarean section',\n",
       "                'Delivery mode',\n",
       "                'Premature labor',\n",
       "                'Spontaneous delivery',\n",
       "                'Vaginal delivery',\n",
       "                'Very-low-birth-weight infants'],\n",
       "               'EDAT': '2017/04/01 06:00',\n",
       "               'MHDA': '2018/02/17 06:00',\n",
       "               'CRDT': ['2017/04/01 06:00'],\n",
       "               'PHST': ['2017/01/20 00:00 [received]',\n",
       "                '2017/03/21 00:00 [accepted]',\n",
       "                '2017/04/01 06:00 [pubmed]',\n",
       "                '2018/02/17 06:00 [medline]',\n",
       "                '2017/04/01 06:00 [entrez]'],\n",
       "               'AID': ['S0301-2115(17)30143-4 [pii]',\n",
       "                '10.1016/j.ejogrb.2017.03.032 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Obstet Gynecol Reprod Biol. 2017 May;212:144-149. doi: 10.1016/j.ejogrb.2017.03.032. Epub 2017 Mar 22.'},\n",
       "              {'PMID': '27924356',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20170811',\n",
       "               'LR': '20181113',\n",
       "               'IS': '1432-1076 (Electronic) 0340-6199 (Print) 0340-6199 (Linking)',\n",
       "               'VI': '176',\n",
       "               'IP': '2',\n",
       "               'DP': '2017 Feb',\n",
       "               'TI': 'Comparison of two common aEEG classifications for the prediction of neurodevelopmental outcome in preterm infants.',\n",
       "               'PG': '163-171',\n",
       "               'LID': '10.1007/s00431-016-2816-5 [doi]',\n",
       "               'AB': 'Neurodevelopmental outcome after prematurity is crucial. The aim was to compare two amplitude-integrated EEG (aEEG) classifications (Hellstrom-Westas (HW), Burdjalov) for outcome prediction. We recruited 65 infants </=32 weeks gestational age with aEEG recordings within the first 72 h of life and Bayley testing at 24 months corrected age or death. Statistical analyses were performed for each 24 h section to determine whether very immature/depressed or mature/developed patterns predict survival/neurological outcome and to find predictors for mental development index (MDI) and psychomotor development index (PDI) at 24 months corrected age. On day 2, deceased infants showed no cycling in 80% (HW, p = 0.0140) and 100% (Burdjalov, p = 0.0041). The Burdjalov total score significantly differed between groups on day 2 (p = 0.0284) and the adapted Burdjalov total score on day 2 (p = 0.0183) and day 3 (p = 0.0472). Cycling on day 3 (HW; p = 0.0059) and background on day 3 (HW; p = 0.0212) are independent predictors for MDI (p = 0.0016) whereas no independent predictor for PDI was found (multiple regression analyses). CONCLUSION: Cycling in both classifications is a valuable tool to assess chance of survival. The classification by HW is also associated with long-term mental outcome. What is Known: *Neurodevelopmental outcome after preterm birth remains one of the major concerns in neonatology. *aEEG is used to measure brain activity and brain maturation in preterm infants. What is New: *The two common aEEG classifications and scoring systems described by Hellstrom-Westas and Burdjalov are valuable tools to predict neurodevelopmental outcome when performed within the first 72 h of life. *Both aEEG classifications are useful to predict chance of survival. The classification by Hellstrom-Westas can also predict long-term outcome at corrected age of 2 years.',\n",
       "               'FAU': ['Bruns, Nora',\n",
       "                'Dransfeld, Frauke',\n",
       "                'Huning, Britta',\n",
       "                'Hobrecht, Julia',\n",
       "                'Storbeck, Tobias',\n",
       "                'Weiss, Christel',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Muller, Hanna'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Dransfeld F',\n",
       "                'Huning B',\n",
       "                'Hobrecht J',\n",
       "                'Storbeck T',\n",
       "                'Weiss C',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Muller H'],\n",
       "               'AUID': ['ORCID: 0000-0003-3809-1887'],\n",
       "               'AD': ['Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany. Nora.Bruns@uk-essen.de.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Institute of Medical Statistics and Biomathematics, University Hospital Mannheim,, University of Heidelberg, Ludolf-Krehl-Strasse 13-17D, 68167, Mannheim, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Department of Pediatrics I, Neonatology, Pediatric Intensive Care, Pediatric Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.',\n",
       "                'Division of Neonatology, Department of Pediatrics, University of Heidelberg, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comparative Study',\n",
       "                'Journal Article',\n",
       "                'Multicenter Study'],\n",
       "               'DEP': '20161206',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Eur J Pediatr',\n",
       "               'JT': 'European journal of pediatrics',\n",
       "               'JID': '7603873',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Analysis of Variance',\n",
       "                'Brain/*physiology',\n",
       "                'Chi-Square Distribution',\n",
       "                '*Child Development',\n",
       "                'Child, Preschool',\n",
       "                'Electroencephalography/classification/*methods/statistics & numerical data',\n",
       "                'Female',\n",
       "                'Gestational Age',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                '*Infant, Premature',\n",
       "                'Intensive Care Units, Neonatal/statistics & numerical data',\n",
       "                'Male',\n",
       "                'Neurodevelopmental Disorders/diagnosis/mortality',\n",
       "                'Prognosis',\n",
       "                'Retrospective Studies',\n",
       "                'Sensitivity and Specificity',\n",
       "                'Statistics, Nonparametric'],\n",
       "               'PMC': 'PMC5243906',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Amplitude-integrated EEG',\n",
       "                'Mortality',\n",
       "                'Neurodevelopmental outcome',\n",
       "                'Preterm infant',\n",
       "                'aEEG'],\n",
       "               'COIS': ['Compliance with ethical standards The study was approved by the local ethics',\n",
       "                'committee and in accordance with the 1964 Helsinki declaration and its later',\n",
       "                'amendments or comparable ethical standards. Conflict of interest The authors',\n",
       "                'declare that they have no conflict of interest. No funds were received for this',\n",
       "                'study.'],\n",
       "               'EDAT': '2016/12/08 06:00',\n",
       "               'MHDA': '2017/08/12 06:00',\n",
       "               'PMCR': ['2016/12/06'],\n",
       "               'CRDT': ['2016/12/08 06:00'],\n",
       "               'PHST': ['2016/03/12 00:00 [received]',\n",
       "                '2016/11/17 00:00 [accepted]',\n",
       "                '2016/11/15 00:00 [revised]',\n",
       "                '2016/12/08 06:00 [pubmed]',\n",
       "                '2017/08/12 06:00 [medline]',\n",
       "                '2016/12/08 06:00 [entrez]',\n",
       "                '2016/12/06 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s00431-016-2816-5 [pii]',\n",
       "                '2816 [pii]',\n",
       "                '10.1007/s00431-016-2816-5 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Pediatr. 2017 Feb;176(2):163-171. doi: 10.1007/s00431-016-2816-5. Epub 2016 Dec 6.'},\n",
       "              {'PMID': '27509264',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20171207',\n",
       "               'LR': '20180108',\n",
       "               'IS': '1661-7819 (Electronic) 1661-7800 (Linking)',\n",
       "               'VI': '111',\n",
       "               'IP': '1',\n",
       "               'DP': '2017',\n",
       "               'TI': 'Glucocorticoid Receptor Gene Variants and Neonatal Outcome in Very-Low-Birth-Weight Preterm Infants.',\n",
       "               'PG': '22-29',\n",
       "               'AB': 'BACKGROUND: Induction of lung maturation by prenatal steroid treatment has become the standard of care for pregnant women at risk for preterm birth. In addition to the beneficial effects on lung maturation, prenatal steroids have been shown to reduce the incidence of neonatal death, necrotizing enterocolitis, sepsis, and intraventricular hemorrhage. However, little is known about the role of interindividual differences in corticoid sensitivity arising from polymorphisms in the glucocorticoid receptor (GR) gene. OBJECTIVES: To assess the impact of GR polymorphisms N363S (rs56149945), R23K (rs6190), and BclI (rs41423247) on neonatal outcome. METHODS: The GR polymorphisms N363S, R23K, and BclI were examined in 10,490 very-low-birth-weight (VLBW) preterm infants from 49 German tertiary level neonatal units (German Neonatal Network, GNN) with respect to neonatal outcome. RESULTS: Infants carrying the BclI genotype were at higher risk to develop bronchopulmonary dysplasia (BPD) (OR 1.12 per BclI allele, 95% CI: 1.02-1.23, p = 0.013) in a logistic regression model adjusted for gestational age, mechanical ventilation, and small for gestational age status. A similar relative risk was seen in the children (89.4%) who received antenatal betamethasone treatment (OR 1.16, 95% CI: 1.05-1.27, p = 0.003), whereas no such effect was detectable in infants without antenatal steroids. N363S and R23K did not show any stable association with neonatal outcome parameters. CONCLUSION: Except for a slightly higher risk of BPD in carriers of the GRBclI variant, the GR gene polymorphisms BclI, N363S, and R23K did not affect neonatal outcome parameters in this large multicenter cohort of VLBW preterm infants.',\n",
       "               'CI': ['(c) 2016 S. Karger AG, Basel.'],\n",
       "               'FAU': ['Schreiner, Christine',\n",
       "                'Schreiner, Felix',\n",
       "                'Hartel, Christoph',\n",
       "                'Heckmann, Matthias',\n",
       "                'Heep, Axel',\n",
       "                'Bartmann, Peter',\n",
       "                'Woelfle, Joachim',\n",
       "                'Muller, Andreas',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Schreiner C',\n",
       "                'Schreiner F',\n",
       "                'Hartel C',\n",
       "                'Heckmann M',\n",
       "                'Heep A',\n",
       "                'Bartmann P',\n",
       "                'Woelfle J',\n",
       "                'Muller A',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AD': [\"Department of Neonatology, Children's Hospital, University of Bonn, Bonn, Germany.\"],\n",
       "               'CN': ['German Neonatal Network, GNN'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Multicenter Study',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20160811',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Neonatology',\n",
       "               'JT': 'Neonatology',\n",
       "               'JID': '101286577',\n",
       "               'RN': ['0 (Glucocorticoids)',\n",
       "                '0 (Receptors, Glucocorticoid)',\n",
       "                '9842X06Q6M (Betamethasone)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Betamethasone/*therapeutic use',\n",
       "                'Bronchopulmonary Dysplasia/*drug therapy/*genetics',\n",
       "                'Female',\n",
       "                'Gestational Age',\n",
       "                'Glucocorticoids/*therapeutic use',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature',\n",
       "                'Infant, Very Low Birth Weight',\n",
       "                'Logistic Models',\n",
       "                'Polymorphism, Genetic',\n",
       "                'Pregnancy',\n",
       "                'Receptors, Glucocorticoid/*genetics',\n",
       "                'United Kingdom'],\n",
       "               'EDAT': '2016/08/11 06:00',\n",
       "               'MHDA': '2017/12/08 06:00',\n",
       "               'CRDT': ['2016/08/11 06:00'],\n",
       "               'PHST': ['2015/11/24 00:00 [received]',\n",
       "                '2016/05/18 00:00 [accepted]',\n",
       "                '2016/08/11 06:00 [pubmed]',\n",
       "                '2017/12/08 06:00 [medline]',\n",
       "                '2016/08/11 06:00 [entrez]'],\n",
       "               'AID': ['000446908 [pii]', '10.1159/000446908 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Neonatology. 2017;111(1):22-29. doi: 10.1159/000446908. Epub 2016 Aug 11.'}],\n",
       "             '2016': [{'PMID': '27923250',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20170313',\n",
       "               'LR': '20170313',\n",
       "               'IS': '1439-4286 (Electronic) 0018-5043 (Linking)',\n",
       "               'VI': '48',\n",
       "               'IP': '12',\n",
       "               'DP': '2016 Dec',\n",
       "               'TI': 'Clinical Evaluation of the First Automated Assay for the Detection of Stimulating TSH Receptor Autoantibodies.',\n",
       "               'PG': '795-801',\n",
       "               'AB': \"Until recently, stimulating TSH receptor autoantibodies (sTRAbs) could only be measured by bioassays. A new assay system, which directly detects sTRAb in sera by applying bridge technology, has been established and is now available as automated chemiluminescence (bridge) immunoassay. We evaluated the automated bridge assay in clinical routine and compared it with a conventional automated TRAb assay (competition assay). Altogether, 226 Graves' disease (GD), 57 autoimmune thyroiditis, 74 non-autoimmune nodular goiter and 49 thyroid cancer patients, as well as 41 healthy controls were retrospectively evaluated. ROC plot analysis based on sera of newly diagnosed GD patients revealed an area under curve of 0.99 (95% CI: 0.99-1.0) indicating a high assay sensitivity and specificity. The highest sensitivity (100%) and specificity (99%) were seen at a cut-off level of 0.55 IU/l. The calculated positive predictive value was 94%, whereas the negative was 100%. Applying a ROC plot-derived cut-off of>/=0.30 IU/l, derived from sera of GD patients already receiving antithyroid drug therapy for</=6 months, the sensitivity was 99% whereas the specificity was 98%. Detailed comparison of both assay systems used revealed a slightly different distribution of sTRAb and TRAb. Measurement of sTRAb during follow-up revealed a steady decline over one year of follow-up. In summary, our results demonstrate that the new automated bridge assay system for detecting sTRAb has a high sensitivity and specificity for diagnosing GD and to discriminate from other thyroid diseases, respectively. Our study, however, does not provide full evidence that the bridge assay is specific for sTRAb only.\",\n",
       "               'CI': ['(c) Georg Thieme Verlag KG Stuttgart . New York.'],\n",
       "               'FAU': ['Allelein, S',\n",
       "                'Ehlers, M',\n",
       "                'Goretzki, S',\n",
       "                'Hermsen, D',\n",
       "                'Feldkamp, J',\n",
       "                'Haase, M',\n",
       "                'Dringenberg, T',\n",
       "                'Schmid, C',\n",
       "                'Hautzel, H',\n",
       "                'Schott, M'],\n",
       "               'AU': ['Allelein S',\n",
       "                'Ehlers M',\n",
       "                'Goretzki S',\n",
       "                'Hermsen D',\n",
       "                'Feldkamp J',\n",
       "                'Haase M',\n",
       "                'Dringenberg T',\n",
       "                'Schmid C',\n",
       "                'Hautzel H',\n",
       "                'Schott M'],\n",
       "               'AD': ['Division for Specific Endocrinology, Medical Faculty, University of Dusseldorf, Dusseldorf, Germany.',\n",
       "                'Division for Specific Endocrinology, Medical Faculty, University of Dusseldorf, Dusseldorf, Germany.',\n",
       "                'Division for Specific Endocrinology, Medical Faculty, University of Dusseldorf, Dusseldorf, Germany.',\n",
       "                'Institute of Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University of Dusseldorf, Duesseldorf, Germany.',\n",
       "                'Department for Endocrinology and Diabetes, Municipal Hospital Bielefeld, Bielefeld, Germany.',\n",
       "                'Division for Specific Endocrinology, Medical Faculty, University of Dusseldorf, Dusseldorf, Germany.',\n",
       "                'Division for Specific Endocrinology, Medical Faculty, University of Dusseldorf, Dusseldorf, Germany.',\n",
       "                'Division for Specific Endocrinology, Medical Faculty, University of Dusseldorf, Dusseldorf, Germany.',\n",
       "                'Department for Nuclear Medicine, Medical Faculty, University of Dusseldorf, Dusseldorf, Germany.',\n",
       "                'Division for Specific Endocrinology, Medical Faculty, University of Dusseldorf, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20161206',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Horm Metab Res',\n",
       "               'JT': 'Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme',\n",
       "               'JID': '0177722',\n",
       "               'RN': ['0 (Autoantibodies)',\n",
       "                '0 (Receptors, Thyrotropin)',\n",
       "                'Q51BO43MG4 (Thyroxine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Autoantibodies/*biosynthesis',\n",
       "                'Automation',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Graves Disease/blood/diagnosis/immunology',\n",
       "                'Humans',\n",
       "                'Immunoassay/*methods',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'ROC Curve',\n",
       "                'Receptors, Thyrotropin/*immunology',\n",
       "                'Thyroxine/blood',\n",
       "                'Time Factors',\n",
       "                'Young Adult'],\n",
       "               'EDAT': '2016/12/07 06:00',\n",
       "               'MHDA': '2017/03/14 06:00',\n",
       "               'CRDT': ['2016/12/07 06:00'],\n",
       "               'PHST': ['2016/12/07 06:00 [entrez]',\n",
       "                '2016/12/07 06:00 [pubmed]',\n",
       "                '2017/03/14 06:00 [medline]'],\n",
       "               'AID': ['10.1055/s-0042-121012 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Horm Metab Res. 2016 Dec;48(12):795-801. doi: 10.1055/s-0042-121012. Epub 2016 Dec 6.'},\n",
       "              {'PMID': '26658808',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20170901',\n",
       "               'LR': '20181113',\n",
       "               'IS': '1435-2451 (Electronic) 1435-2443 (Print) 1435-2443 (Linking)',\n",
       "               'VI': '401',\n",
       "               'IP': '7',\n",
       "               'DP': '2016 Nov',\n",
       "               'TI': 'Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism.',\n",
       "               'PG': '943-951',\n",
       "               'AB': 'PURPOSE: Parathyroid carcinoma (PC) is remarkable for its rare occurrence and challenging diagnostics. PC accounts for 0.1-5 % cases of primary hyperparathyroidism (PHPT). The differentiation from benign tumours is difficult even by morphological criteria. To address these issues, we assessed the PC frequency in two separate European PHPT cohorts and evaluated the demographic, clinical, morphological and molecular background. METHODS: A retrospective study was carried out, using continuously maintained database (2005-2014) of PHPT patients from two tertiary referral university hospitals in Europe. The demographic, clinical data and frequency of PC among surgically treated PHPT was detected. Immunohistochemistry (IHC) was performed to detect parafibromin, representing protein product of HRPT2 gene and proliferation marker Ki-67. RESULTS: Both PHPT cohorts were characterised by close mean age values (58.6 and 58.0 years) and female predominance. The frequency of PC differed significantly between the cohorts: 2.1 vs. 0.3 %; p = 0.004. PC was characterised by invariable complete loss of parafibromin contrasting with parathyroid adenomas. The proliferation fraction was similar in both PC cohorts (10.6 and 11.0 %). PC showed significantly higher proliferation fraction than typical parathyroid adenomas (1.6 %), atypical adenomas (1.6 %) or adenomas featuring focal loss of parafibromin (2.2 %). CONCLUSIONS: PC frequency can range significantly between the two European cohorts. The differences can be attributable to selection bias of patients referred for surgery and are not caused by discordant definition of malignant parathyroid histology. Diffuse loss of parafibromin and increased proliferation fraction by Ki-67 are valuable adjuncts in PC diagnostics due to significant differences with various clinical and morphological subtypes of adenoma.',\n",
       "               'FAU': ['Ozolins, Arturs',\n",
       "                'Narbuts, Zenons',\n",
       "                'Vanags, Andrejs',\n",
       "                'Simtniece, Zane',\n",
       "                'Visnevska, Zane',\n",
       "                'Akca, Aycan',\n",
       "                'Wirowski, Denis',\n",
       "                'Gardovskis, Janis',\n",
       "                'Strumfa, Ilze',\n",
       "                'Goretzki, Peter E'],\n",
       "               'AU': ['Ozolins A',\n",
       "                'Narbuts Z',\n",
       "                'Vanags A',\n",
       "                'Simtniece Z',\n",
       "                'Visnevska Z',\n",
       "                'Akca A',\n",
       "                'Wirowski D',\n",
       "                'Gardovskis J',\n",
       "                'Strumfa I',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Department of Surgery, Riga Stradins University, Dzirciema Street 16, LV-1007, Riga, Latvia. arturs.ozolins@rsu.lv.',\n",
       "                'Department of Surgery, Riga Stradins University, Dzirciema Street 16, LV-1007, Riga, Latvia.',\n",
       "                'Department of Surgery, Riga Stradins University, Dzirciema Street 16, LV-1007, Riga, Latvia.',\n",
       "                'Department of Pathology, Riga Stradins University, Riga, Latvia.',\n",
       "                'Department of Surgery, Riga Stradins University, Dzirciema Street 16, LV-1007, Riga, Latvia.',\n",
       "                'Department of Surgery, Lukas Hospital, Neuss, Germany.',\n",
       "                'Department of Surgery, Lukas Hospital, Neuss, Germany.',\n",
       "                'Department of Surgery, Riga Stradins University, Dzirciema Street 16, LV-1007, Riga, Latvia.',\n",
       "                'Department of Pathology, Riga Stradins University, Riga, Latvia.',\n",
       "                'Department of Surgery, Lukas Hospital, Neuss, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20151211',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'RN': ['0 (CDC73 protein, human)',\n",
       "                '0 (Ki-67 Antigen)',\n",
       "                '0 (Tumor Suppressor Proteins)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/*diagnosis/*epidemiology/metabolism',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Cohort Studies',\n",
       "                'Europe',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism, Primary/*complications/metabolism/*pathology',\n",
       "                'Ki-67 Antigen/metabolism',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Parathyroid Neoplasms/*diagnosis/*epidemiology/metabolism',\n",
       "                'Prevalence',\n",
       "                'Tumor Suppressor Proteins/metabolism'],\n",
       "               'PMC': 'PMC5086340',\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Immunohistochemistry',\n",
       "                'Ki-67',\n",
       "                'Parafibromin',\n",
       "                'Parathyroid carcinoma',\n",
       "                'Primary hyperparathyroidism'],\n",
       "               'COIS': ['Compliance with ethical standards The study was performed in accordance with the',\n",
       "                'Declaration of Helsinki and permission of the Committee of Ethics, Riga Stradins',\n",
       "                'University (No. E-9(2), issued on May 5th, 2014). The present work was carried',\n",
       "                'out within the frames of scientific project Nr.',\n",
       "                '2013/0004/1DP/1.1.1.2.0/13/APIA/VIAA/ 020, supported by the European Social Fund',\n",
       "                '(ESF). This article does not contain any studies with human participants or',\n",
       "                'animals performed by any of the authors. Conflicts of interest None.'],\n",
       "               'EDAT': '2016/11/01 06:00',\n",
       "               'MHDA': '2017/09/02 06:00',\n",
       "               'PMCR': ['2015/12/11'],\n",
       "               'CRDT': ['2015/12/15 06:00'],\n",
       "               'PHST': ['2015/09/21 00:00 [received]',\n",
       "                '2015/11/29 00:00 [accepted]',\n",
       "                '2016/11/01 06:00 [pubmed]',\n",
       "                '2017/09/02 06:00 [medline]',\n",
       "                '2015/12/15 06:00 [entrez]',\n",
       "                '2015/12/11 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1007/s00423-015-1361-4 [pii]',\n",
       "                '1361 [pii]',\n",
       "                '10.1007/s00423-015-1361-4 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 2016 Nov;401(7):943-951. doi: 10.1007/s00423-015-1361-4. Epub 2015 Dec 11.'},\n",
       "              {'PMID': '27741007',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20170601',\n",
       "               'LR': '20220311',\n",
       "               'IS': '1528-1140 (Electronic) 0003-4932 (Linking)',\n",
       "               'VI': '264',\n",
       "               'IP': '5',\n",
       "               'DP': '2016 Nov',\n",
       "               'TI': 'Total Parathyroidectomy With Routine Thymectomy and Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism: Results of a Nonconfirmatory Multicenter Prospective Randomized Controlled Pilot Trial.',\n",
       "               'PG': '745-753',\n",
       "               'AB': 'OBJECTIVE: This randomized controlled multicenter pilot trial was conducted to find robust estimates for the rates of recurrence of 2 surgical strategies for secondary hyperparathyroidism (SHPT) within 36 months of follow-up. BACKGROUND: SHPT is a frequent consequence of chronic renal failure. Total parathyroidectomy with autotransplantation (TPTX+AT) and subtotal parathyroidectomy (SPTX) are the standard surgical procedures. Total parathyroidectomy alone (TPTX) might be a good alternative, as morbidity and recurrence rates are low according to small-scale retrospective studies. METHODS: The trial was performed as a nonconfirmatory randomized controlled pilot trial with 100 patients on long-term dialysis with otherwise uncontrollable SHPT to generate data on the rate of recurrent disease within a 3-year follow-up period after TPTX or TPTX+AT. Parathyroid hormone (PTH) and calcium levels, recurrent or persistent hyperparathyroidism, parathyroid reoperations, morbidity, and mortality were evaluated during a 3-year follow-up. RESULTS: A total of 52 patients underwent TPTX and 48 TPTX+AT. Patient characteristics, preoperative baseline data, duration of surgery (02:29 vs 02:47 hrs, P = 0.17) and mean hospital stay (10 +/- 7.1 vs 8 +/- 3.7 days, P = 0.11) did not differ significantly. Persistent SHPT developed in 1 TPTX and 2 TPTX+AT patients. None of the TPTX patients required delayed parathyroid AT to treat permanent hypoparathyroidism. Serum-calcium values were similar (2.1 +/- 0.3 vs 2.1 +/- 0.2, P = 0.95) whereas PTH rose by time in the TPTX+AT group and was significantly higher at the end of follow-up when compared with the TPTX group (31.7 +/- 43.6 vs 98.2 +/- 156.8, P = 0.02). Recurrent SHPT developed in 4 TPTX+AT and none of the TPTX patients. CONCLUSIONS: TPTX+AT and TPTX seem to be safe and equally effective for the treatment of otherwise uncontrollable SHPT. TPTX seems to suppress PTH more effectively and showed no recurrences after 3 years. The hypothesis that TPTX is superior to TPTX+AT referring to the rate of recurrent SHPT has to be tested in a large-scale confirmatory trial. Nevertheless, TPTX seems to be a feasible alternative therapeutic option for the surgical treatment of SHPT.',\n",
       "               'FAU': ['Schlosser, Katja',\n",
       "                'Bartsch, Detlef K',\n",
       "                'Diener, Markus K',\n",
       "                'Seiler, Christoph M',\n",
       "                'Bruckner, Tom',\n",
       "                'Nies, Christoph',\n",
       "                'Meyer, Moritz',\n",
       "                'Neudecker, Jens',\n",
       "                'Goretzki, Peter E',\n",
       "                'Glockzin, Gabriel',\n",
       "                'Konopke, Ralf',\n",
       "                'Rothmund, Matthias'],\n",
       "               'AU': ['Schlosser K',\n",
       "                'Bartsch DK',\n",
       "                'Diener MK',\n",
       "                'Seiler CM',\n",
       "                'Bruckner T',\n",
       "                'Nies C',\n",
       "                'Meyer M',\n",
       "                'Neudecker J',\n",
       "                'Goretzki PE',\n",
       "                'Glockzin G',\n",
       "                'Konopke R',\n",
       "                'Rothmund M'],\n",
       "               'AD': ['*Department for General, Visceral, and Vascular Surgery, Agaplesion Evangelisches Krankenhaus Mittelhessen, Giessen, Germany daggerDepartment for Visceral, Thoracic, and Vascular Surgery, University Hospital of Giessen and Marburg, Marburg, Germany double daggerDepartment for General, Visceral, and Transplantation Surgery, University Heidelberg, Heidelberg, Germany  section signInstitute of Medical Biometry and Informatics, University Heidelberg, Heidelberg, Germany  paragraph signDepartment for General and Visceral Surgery, Marienhospital Osnabruck, Osnabruck, Germany ||Department for General, Visceral, Vascular, and Thoracic Surgery, Universitatsmedizin Berlin, Charite Campus Mitte, Berlin, Germany **Department of Surgery, Lukaskrankenhaus Neuss, Neuss, Germany daggerdaggerDepartment of Surgery, University Medical Center Regensburg, Regensburg, Germany double daggerdouble daggerDepartment of Visceral, Thoracic, and Vascular Surgery, Carl Gustav Carus University Hospital, Dresden, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comparative Study',\n",
       "                'Journal Article',\n",
       "                'Multicenter Study',\n",
       "                'Randomized Controlled Trial'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Ann Surg',\n",
       "               'JT': 'Annals of surgery',\n",
       "               'JID': '0372354',\n",
       "               'SB': 'IM',\n",
       "               'CIN': ['Ann Surg. 2018 Dec;268(6):e62-e63. doi: 10.1097/SLA.0000000000002814. PMID:',\n",
       "                '29771721'],\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism, Secondary/etiology/*surgery',\n",
       "                'Kidney Failure, Chronic/complications',\n",
       "                'Length of Stay',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Parathyroid Glands/*transplantation',\n",
       "                '*Parathyroidectomy',\n",
       "                'Pilot Projects',\n",
       "                'Recurrence',\n",
       "                '*Thymectomy',\n",
       "                'Transplantation, Autologous',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '2016/10/16 06:00',\n",
       "               'MHDA': '2017/06/02 06:00',\n",
       "               'CRDT': ['2016/10/15 06:00'],\n",
       "               'PHST': ['2016/10/15 06:00 [entrez]',\n",
       "                '2016/10/16 06:00 [pubmed]',\n",
       "                '2017/06/02 06:00 [medline]'],\n",
       "               'AID': ['00000658-201611000-00010 [pii]',\n",
       "                '10.1097/SLA.0000000000001875 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Ann Surg. 2016 Nov;264(5):745-753. doi: 10.1097/SLA.0000000000001875.'},\n",
       "              {'PMID': '27143176',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20180209',\n",
       "               'LR': '20210625',\n",
       "               'IS': '1559-6834 (Electronic) 0899-823X (Linking)',\n",
       "               'VI': '37',\n",
       "               'IP': '8',\n",
       "               'DP': '2016 Aug',\n",
       "               'TI': 'Media Stories on NICU Outbreaks Lead to an Increased Prescription Rate of Third-Line Antibiotics in the Community of Neonatal Care.',\n",
       "               'PG': '924-930',\n",
       "               'LID': '10.1017/ice.2016.95 [doi]',\n",
       "               'AB': 'BACKGROUND Between 2010 and 2012, 3 outbreaks of nosocomial infections in German neonatal intensive care units (NICUs) attracted considerable public interest. Headlines on national television channels and in newspapers had important consequences for the involved institutions and a negative impact on the relationship between families and staff in many German NICUs. OBJECTIVE To determine whether NICU outbreaks reported in the media influenced provider behavior in the community of neonatal care and led to more third-line antibiotic prescribing. DESIGN Observational cohort study. METHODS To investigate secular trends, we evaluated data for very-low-birth-weight infants (VLBWIs, birth weight <1,500 g) enrolled in the German Neonatal Network (GNN) between 2009 and 2014 (N=10,253). For outbreak effects, we specifically analyzed data for VLBWIs discharged 6 months before (n=2,428) and 6 months after outbreaks (n=2,508). RESULTS The exposure of all VLBWIs to third-line antibiotics increased after outbreaks (19.4% before vs 22.5% after; P=.007). This trend particularly affected male infants (4.6% increase; P=.005) and infants with a birth weight between 1,000 and 1,499 g (3.5% increase; P=.001) In a logistic regression analysis, month of discharge as linear variable of time was associated with increased exposure to third-line antibiotics (odds ratio [OR], 1.01; 95% confidence interval [CI], 1.009-1.014; P<.001), and discharge within the 6-month period after outbreak reports independently contributed to this long-term trend (OR, 1.14; 95% CI, 1.017-1.270; P=.024). CONCLUSIONS Media reports directly affect medical practice, eg, overuse of third-line antibiotics. Future communication and management strategies must be based on objective dialogues between the scientific community and investigative journalists. Infect Control Hosp Epidemiol 2016;37:924-930.',\n",
       "               'FAU': ['Hartel, Christoph',\n",
       "                'Hartz, Annika',\n",
       "                'Bahr, Lina',\n",
       "                'Gille, Christian',\n",
       "                'Gortner, Ludwig',\n",
       "                'Simon, Arne',\n",
       "                'Orlikowsky, Thorsten',\n",
       "                'Muller, Andreas',\n",
       "                'Korner, Thorsten',\n",
       "                'Henneke, Philipp',\n",
       "                'Haase, Roland',\n",
       "                'Zemlin, Michael',\n",
       "                'Viemann, Dorothee',\n",
       "                'Gebauer, Corinna',\n",
       "                'Thome, Ulrich',\n",
       "                'Ziegler, Andreas',\n",
       "                'Rupp, Jan',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Hartel C',\n",
       "                'Hartz A',\n",
       "                'Bahr L',\n",
       "                'Gille C',\n",
       "                'Gortner L',\n",
       "                'Simon A',\n",
       "                'Orlikowsky T',\n",
       "                'Muller A',\n",
       "                'Korner T',\n",
       "                'Henneke P',\n",
       "                'Haase R',\n",
       "                'Zemlin M',\n",
       "                'Viemann D',\n",
       "                'Gebauer C',\n",
       "                'Thome U',\n",
       "                'Ziegler A',\n",
       "                'Rupp J',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AD': ['Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Neonatology University of Tubingen, Tubingen, Germany.',\n",
       "                'Department of Pediatrics at Saar University, Homburg, Germany.',\n",
       "                'Department of Pediatrics at Saar University, Homburg, Germany.',\n",
       "                'Department of Pediatrics, University of Aachen, Aachen, Germany.',\n",
       "                'Department of Pediatrics, University of Bonn, Bonn, Germany.',\n",
       "                \"Children's Hospital Links der Weser, Bremen, Germany.\",\n",
       "                'Center for Pediatrics and Adolescent Medicine and Center for Chronic Immunodeficiency, University Medical Center, Freiburg, Germany.',\n",
       "                'Department of Pediatrics, University of Halle, Halle, Germany.',\n",
       "                'Department of Pediatrics, University of Marburg, Marburg, Germany.',\n",
       "                'Department of Neonatology, Hanover Medical School, Hanover, Germany.',\n",
       "                'Department of Pediatrics, University of Leipzig, Leipzig, Germany.',\n",
       "                'Department of Pediatrics, University of Leipzig, Leipzig, Germany.',\n",
       "                'Institute of Medical Biometry and Statistics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Center for Clinical Trials, University of Lubeck, Lubeck, Germany.',\n",
       "                'School of Mathematics, Statistics and Computer Science, University of KwaZulu-Natal, Pietermaritzburg, South Africa.',\n",
       "                'Division of Molecular and Clinical Infectious Diseases, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Observational Study',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20160504',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Infect Control Hosp Epidemiol',\n",
       "               'JT': 'Infection control and hospital epidemiology',\n",
       "               'JID': '8804099',\n",
       "               'RN': ['0 (Anti-Bacterial Agents)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Anti-Bacterial Agents/*administration & dosage',\n",
       "                'Cohort Studies',\n",
       "                'Cross Infection/epidemiology',\n",
       "                '*Disease Outbreaks',\n",
       "                'Female',\n",
       "                'Germany/epidemiology',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                '*Intensive Care Units, Neonatal',\n",
       "                'Logistic Models',\n",
       "                'Male',\n",
       "                '*Mass Media',\n",
       "                \"*Practice Patterns, Physicians'\"],\n",
       "               'EDAT': '2016/05/05 06:00',\n",
       "               'MHDA': '2018/02/10 06:00',\n",
       "               'CRDT': ['2016/05/05 06:00'],\n",
       "               'PHST': ['2016/05/05 06:00 [entrez]',\n",
       "                '2016/05/05 06:00 [pubmed]',\n",
       "                '2018/02/10 06:00 [medline]'],\n",
       "               'AID': ['S0899823X16000957 [pii]', '10.1017/ice.2016.95 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Infect Control Hosp Epidemiol. 2016 Aug;37(8):924-930. doi: 10.1017/ice.2016.95. Epub 2016 May 4.'},\n",
       "              {'PMID': '26752461',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20161108',\n",
       "               'LR': '20180913',\n",
       "               'IS': '1536-4844 (Electronic) 1078-0998 (Linking)',\n",
       "               'VI': '22',\n",
       "               'IP': '2',\n",
       "               'DP': '2016 Feb',\n",
       "               'TI': 'NOD2 Loss-of-Function Mutations and Risks of Necrotizing Enterocolitis or Focal Intestinal Perforation in Very Low-birth-weight Infants.',\n",
       "               'PG': '249-56',\n",
       "               'LID': '10.1097/MIB.0000000000000658 [doi]',\n",
       "               'AB': 'BACKGROUND: NOD2 loss-of-function mutations, that is, R702W [rs2066844], G908R [rs2066845], and Leu1007fsinsC [rs5743293], have been linked to inflammatory bowel diseases. It is yet unknown whether these variants are also associated with necrotizing enterocolitis (NEC) or focal intestinal perforation (FIP) in infants of very low birth weight (VLBW). METHODS: To test this hypothesis, we genotyped 9082 VLBW infants with European ancestry enrolled in a prospective, population-based cohort study of the German Neonatal Network. We assessed the effect of the NOD2 gene variants on the risk for major morbidities of the gastrointestinal tract, that is, NEC/FIP requiring surgery in multivariable logistic regression analyses. RESULTS: In the whole cohort of VLBW infants, carriers of >/= 2 NOD2 variant alleles had an increased risk for NEC requiring surgery (odds ratio [OR], 3.57; 95% confidence interval [CI], 1.27-10.04; P = 0.03) and NEC or FIP requiring surgery (OR, 3.81; 95% CI, 1.70-8.51; P = 0.004) as compared with wild-type genotypes. In a multivariable logistic regression analysis including gestational age, birth weight, gender, multiple birth, and inborn delivery, the association between >/= 2 NOD2 variant alleles and NEC surgery (OR, 4.14; 95% CI, 1.41-12.12; P = 0.009), FIP surgery (OR, 3.50; 95% CI, 1.02-12.04; P = 0.047), and NEC or FIP surgery (OR, 4.10; 95% CI, 1.74-9.73; P = 0.001) proved to be independent. We also performed a regression analysis in the subgroup of infants with available information on Lactobacillus acidophilus/Bifidobacterium infantis probiotic supplementation (n = 3638). Although probiotics had a protective effect on NEC and NEC or FIP requiring surgery, the NOD2 variants had no significant impact in this subgroup. CONCLUSIONS: VLBW infants carrying >/= 2 NOD2 genetic risk factors of inflammatory bowel disease in adults have an increased risk for severe gastrointestinal complications, such as NEC requiring surgery. Therefore, infants might benefit from NOD2 genotyping followed by supplementation with probiotics. Replication studies are needed along with genome-wide arrays to allow risk-adapted prevention and therapeutic strategies.',\n",
       "               'FAU': ['Hartel, Christoph',\n",
       "                'Hartz, Annika',\n",
       "                'Pagel, Julia',\n",
       "                'Rupp, Jan',\n",
       "                'Stein, Anja',\n",
       "                'Kribs, Angela',\n",
       "                'Muller, Andreas',\n",
       "                'Haase, Roland',\n",
       "                'Gille, Christian',\n",
       "                'Bottger, Ralf',\n",
       "                'Kittel, Jochen',\n",
       "                'Jensen, Reinhard',\n",
       "                'Wieg, Christian',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Hartel C',\n",
       "                'Hartz A',\n",
       "                'Pagel J',\n",
       "                'Rupp J',\n",
       "                'Stein A',\n",
       "                'Kribs A',\n",
       "                'Muller A',\n",
       "                'Haase R',\n",
       "                'Gille C',\n",
       "                'Bottger R',\n",
       "                'Kittel J',\n",
       "                'Jensen R',\n",
       "                'Wieg C',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AD': [\"*Department of Neonatology, University Children's Hospital, Lubeck, Germany; daggerDepartment of Molecular and Clinical Infectious Diseases, University of Lubeck, Lubeck, Germany; double daggerDepartment of Neonatology, University Children's Hospital, Essen, Germany;  section signDepartment of Neonatology, University Children's Hospital, Cologne, Germany;  ||Department of Neonatology, University Children's Hospital, Bonn, Germany;  paragraph signDepartment of Neonatology, University Children's Hospital, Halle, Germany; **Department of Neonatology, University Children's Hospital, Tubingen, Germany; daggerdaggerDepartment of Neonatology, University Children's Hospital, Magdeburg, Germany; double daggerdouble daggerNeonatal Unit, Children's Hospital St. Hedwig, Regensburg, Germany;  section sign section signNeonatal Unit, Children's Hospital St. Hedwig, Heide, Germany; and  || ||Neonatal Unit, Children's Hospital St. Hedwig, Aschaffenburg, Germany.\"],\n",
       "               'CN': ['German Neonatal Network'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Inflamm Bowel Dis',\n",
       "               'JT': 'Inflammatory bowel diseases',\n",
       "               'JID': '9508162',\n",
       "               'RN': ['0 (NOD2 protein, human)',\n",
       "                '0 (Nod2 Signaling Adaptor Protein)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Enterocolitis, Necrotizing/drug therapy/epidemiology/*genetics',\n",
       "                'Follow-Up Studies',\n",
       "                'Germany/epidemiology',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Very Low Birth Weight',\n",
       "                'Intestinal Perforation/drug therapy/epidemiology/*genetics',\n",
       "                'Mutation/*genetics',\n",
       "                'Nod2 Signaling Adaptor Protein/*genetics',\n",
       "                'Probiotics/therapeutic use',\n",
       "                'Prognosis',\n",
       "                'Prospective Studies'],\n",
       "               'EDAT': '2016/01/12 06:00',\n",
       "               'MHDA': '2016/11/09 06:00',\n",
       "               'CRDT': ['2016/01/12 06:00'],\n",
       "               'PHST': ['2016/01/12 06:00 [entrez]',\n",
       "                '2016/01/12 06:00 [pubmed]',\n",
       "                '2016/11/09 06:00 [medline]'],\n",
       "               'AID': ['10.1097/MIB.0000000000000658 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Inflamm Bowel Dis. 2016 Feb;22(2):249-56. doi: 10.1097/MIB.0000000000000658.'},\n",
       "              {'PMID': '26621048',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20160601',\n",
       "               'LR': '20160126',\n",
       "               'IS': '1097-6833 (Electronic) 0022-3476 (Linking)',\n",
       "               'VI': '169',\n",
       "               'DP': '2016 Feb',\n",
       "               'TI': 'Does Breastmilk Influence the Development of Bronchopulmonary Dysplasia?',\n",
       "               'PG': '76-80.e4',\n",
       "               'LID': 'S0022-3476(15)01319-0 [pii] 10.1016/j.jpeds.2015.10.080 [doi]',\n",
       "               'AB': 'OBJECTIVE: To assess whether breastmilk feeding is associated with a reduced risk of bronchopulmonary dysplasia (BPD). Secondary outcome measures analyzed were retinopathy of prematurity (ROP) and necrotizing enterocolitis (NEC). STUDY DESIGN: In an ongoing multicenter cohort study, the data of 1433 very low birth weight infants born before 32 weeks of gestation and discharged in 2013 were analyzed. We compared growth and neonatal complications of infants who received breastmilk exclusively (N = 223) with those who received formula feedings exclusively (N = 239). Logistic regression models were estimated for BPD, ROP, and NEC using nutrition as an independent variable. The Firth logistic regression model and Lasso were used for sensitivity analyses. RESULTS: Exclusively breastmilk-fed infants gained less weight compared with formula-fed infants. SDS for weight decreased between birth and discharge (median (Q1-Q3): formula -0.9 (-1.4 to [-0.5]) vs breastmilk -1.1 (-1.7 to [-0.6])). Exclusive formula feeding of very low birth weight infants was associated with increased risks of BPD (OR 2.6) as well as NEC (OR 12.6) and ROP (OR 1.80) after controlling for known risk factors. CONCLUSIONS: Exclusive breastmilk feeding was associated with lower growth rates and a reduced risk of BPD as well as NEC and ROP.',\n",
       "               'CI': ['Copyright (c) 2016 Elsevier Inc. All rights reserved.'],\n",
       "               'FAU': ['Spiegler, Juliane',\n",
       "                'Preuss, Michael',\n",
       "                'Gebauer, Corinna',\n",
       "                'Bendiks, Meike',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Spiegler J',\n",
       "                'Preuss M',\n",
       "                'Gebauer C',\n",
       "                'Bendiks M',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AD': ['Department of Pediatrics, University of Lubeck, Lubeck, Germany. Electronic address: uni@dr-spiegler.de.',\n",
       "                'Institute of Medical Biometry and Statistics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Leipzig, Leipzig, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network (GNN)',\n",
       "                'German Neonatal Network GNN'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Multicenter Study',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20151125',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Pediatr',\n",
       "               'JT': 'The Journal of pediatrics',\n",
       "               'JID': '0375410',\n",
       "               'SB': 'IM',\n",
       "               'CIN': ['J Pediatr. 2016 Jun;173:267-8. doi: 10.1016/j.jpeds.2016.03.045. PMID: 27063807',\n",
       "                'J Pediatr. 2016 Jun;173:267. doi: 10.1016/j.jpeds.2016.03.036. PMID: 27063811',\n",
       "                'J Pediatr. 2016 Jul;174:279. doi: 10.1016/j.jpeds.2016.04.074. PMID: 27346515'],\n",
       "               'MH': ['Bronchopulmonary Dysplasia/*prevention & control',\n",
       "                'Cohort Studies',\n",
       "                'Enterocolitis, Necrotizing/*prevention & control',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Very Low Birth Weight',\n",
       "                'Male',\n",
       "                '*Milk, Human',\n",
       "                'Retinopathy of Prematurity/*prevention & control'],\n",
       "               'FIR': ['Bendiks, Meike',\n",
       "                'Berghauser, Martin A',\n",
       "                'Bockenholt, Kai',\n",
       "                'Bohnhorst, Bettina',\n",
       "                'Bottger, Ralf',\n",
       "                'Brune, Thomas',\n",
       "                'Dawczynski, Kristin',\n",
       "                'Dordelmann, Michael',\n",
       "                'Ehlers, Silke',\n",
       "                'Eichhorn, Joachim G',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Franz, Axel',\n",
       "                'Gebauer, Corinna',\n",
       "                'Gerleve, Hubert',\n",
       "                'Gopel, Wolfgang',\n",
       "                'Gortner, Ludwig',\n",
       "                'Haase, Roland',\n",
       "                'Heitmann, Friedhelm',\n",
       "                'Hentschel, Roland',\n",
       "                'Hepping, Nico',\n",
       "                'Hillebrand, Georg',\n",
       "                'Hohn, Thomas',\n",
       "                'Hornig-Franz, Isabelle',\n",
       "                'Hubert, Mechthild',\n",
       "                'Jenke, Andreas',\n",
       "                'Jensen, Rainer',\n",
       "                'Kannt, Olaf',\n",
       "                'Korner, Hans T',\n",
       "                'Kribs, Angela',\n",
       "                'Kuster, Helmut',\n",
       "                'Linnemann, Knud',\n",
       "                'Moller, Jens',\n",
       "                'Muller, Andreas',\n",
       "                'Muller, Dirk',\n",
       "                'Olbertz, Dirk M',\n",
       "                'Orlikowsky, Thorsten',\n",
       "                'Reese, Jochen',\n",
       "                'Roll, Claudia',\n",
       "                'Rossi, Rainer',\n",
       "                'Rudiger, Mario',\n",
       "                'Schaible, Thomas',\n",
       "                'Schiffmann, Jan-Holger',\n",
       "                'Schmidkte, Susanne',\n",
       "                'Seeliger, Stephan',\n",
       "                'Segerer, Hugo',\n",
       "                'Siegel, Jens',\n",
       "                'Teig, Norbert',\n",
       "                'Urlichs, Florian',\n",
       "                'von der Wense, Axel',\n",
       "                'Vochem, Matthias',\n",
       "                'Weller, Ursula',\n",
       "                'Wieg, Christian',\n",
       "                'Wintgens, Jurgen'],\n",
       "               'IR': ['Bendiks M',\n",
       "                'Berghauser MA',\n",
       "                'Bockenholt K',\n",
       "                'Bohnhorst B',\n",
       "                'Bottger R',\n",
       "                'Brune T',\n",
       "                'Dawczynski K',\n",
       "                'Dordelmann M',\n",
       "                'Ehlers S',\n",
       "                'Eichhorn JG',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Franz A',\n",
       "                'Gebauer C',\n",
       "                'Gerleve H',\n",
       "                'Gopel W',\n",
       "                'Gortner L',\n",
       "                'Haase R',\n",
       "                'Heitmann F',\n",
       "                'Hentschel R',\n",
       "                'Hepping N',\n",
       "                'Hillebrand G',\n",
       "                'Hohn T',\n",
       "                'Hornig-Franz I',\n",
       "                'Hubert M',\n",
       "                'Jenke A',\n",
       "                'Jensen R',\n",
       "                'Kannt O',\n",
       "                'Korner HT',\n",
       "                'Kribs A',\n",
       "                'Kuster H',\n",
       "                'Linnemann K',\n",
       "                'Moller J',\n",
       "                'Muller A',\n",
       "                'Muller D',\n",
       "                'Olbertz DM',\n",
       "                'Orlikowsky T',\n",
       "                'Reese J',\n",
       "                'Roll C',\n",
       "                'Rossi R',\n",
       "                'Rudiger M',\n",
       "                'Schaible T',\n",
       "                'Schiffmann JH',\n",
       "                'Schmidkte S',\n",
       "                'Seeliger S',\n",
       "                'Segerer H',\n",
       "                'Siegel J',\n",
       "                'Teig N',\n",
       "                'Urlichs F',\n",
       "                'von der Wense A',\n",
       "                'Vochem M',\n",
       "                'Weller U',\n",
       "                'Wieg C',\n",
       "                'Wintgens J'],\n",
       "               'EDAT': '2015/12/02 06:00',\n",
       "               'MHDA': '2016/06/02 06:00',\n",
       "               'CRDT': ['2015/12/02 06:00'],\n",
       "               'PHST': ['2015/05/12 00:00 [received]',\n",
       "                '2015/09/30 00:00 [revised]',\n",
       "                '2015/10/26 00:00 [accepted]',\n",
       "                '2015/12/02 06:00 [entrez]',\n",
       "                '2015/12/02 06:00 [pubmed]',\n",
       "                '2016/06/02 06:00 [medline]'],\n",
       "               'AID': ['S0022-3476(15)01319-0 [pii]',\n",
       "                '10.1016/j.jpeds.2015.10.080 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Pediatr. 2016 Feb;169:76-80.e4. doi: 10.1016/j.jpeds.2015.10.080. Epub 2015 Nov 25.'}],\n",
       "             '2015': [{'PMID': '26199082',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20151109',\n",
       "               'LR': '20150820',\n",
       "               'IS': '1468-2052 (Electronic) 1359-2998 (Linking)',\n",
       "               'VI': '100',\n",
       "               'IP': '5',\n",
       "               'DP': '2015 Sep',\n",
       "               'TI': 'Short-term outcome of very-low-birthweight infants with arterial hypotension in the first 24 h of life.',\n",
       "               'PG': 'F388-92',\n",
       "               'LID': '10.1136/archdischild-2014-306483 [doi]',\n",
       "               'AB': \"OBJECTIVE: To evaluate lowest mean arterial blood pressure during the first 24 h of life (minMAP(24)) in very-low-birthweight (VLBW) infants and to identify associations between hypotension and short-term outcome. DESIGN: Retrospective cohort analysis of the minMAP(24) of 4907 VLBW infants with a gestational age <32 weeks in correlation with clinical data. Hypotension was defined as minMAP(24) being lower than the median value of all patients of the same gestational age. RESULTS: MinMAP(24) values correlated with gestational age. Median minMAP(24) values of VLBW infants </=29 weeks' gestation were 1-2 mm Hg lower than gestational age in completed weeks. Hypotensive infants had a higher rate of intraventricular haemorrhage (IVH, 20.3% vs 15.9%, p<0.001), bronchopulmonary dysplasia (BPD, 19.2% vs 15.1%, p<0.001) and death (5.2% vs 3.0%, p<0.001). Multivariate logistic regression analyses, including potential confounders, confirmed these data. MinMAP(24) was an independent risk factor for IVH (OR 0.97/mm Hg, 95% CI 0.96 to 0.99, p=0.003), BPD (OR 0.96/mm Hg, 95% CI 0.94 to 0.98, p<0.001) and mortality (OR 0.94/mm Hg, 95% CI 0.90 to 0.98, p=0.003). CONCLUSIONS: Hypotension during the first 24 h of life is associated with adverse outcomes in VLBW infants. This underlines the need for randomised controlled trials on the use of vasoactive drugs in this vulnerable patient cohort.\",\n",
       "               'CI': ['Published by the BMJ Publishing Group Limited. For permission to use (where not',\n",
       "                'already granted under a licence) please go to',\n",
       "                'http://group.bmj.com/group/rights-licensing/permissions.'],\n",
       "               'FAU': ['Faust, Kirstin',\n",
       "                'Hartel, Christoph',\n",
       "                'Preuss, Michael',\n",
       "                'Rabe, Heike',\n",
       "                'Roll, Claudia',\n",
       "                'Emeis, Michael',\n",
       "                'Wieg, Christian',\n",
       "                'Szabo, Miklos',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Faust K',\n",
       "                'Hartel C',\n",
       "                'Preuss M',\n",
       "                'Rabe H',\n",
       "                'Roll C',\n",
       "                'Emeis M',\n",
       "                'Wieg C',\n",
       "                'Szabo M',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AD': ['Department of Paediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Paediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Institute of Medical Biometrics and Statistics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Academic Department of Paediatrics, Brighton & Sussex Medical School, Brighton, UK.',\n",
       "                \"Department of Neonatology, Vest Children's Hospital Datteln, University Witten/Herdecke, Datteln, Germany.\",\n",
       "                'Department of Neonatology, Vivantes Hospital, Berlin-Neukolln, Berlin, Germany.',\n",
       "                \"Department of Neonatology, Children's Hospital Aschaffenburg, Aschaffenburg, Germany.\",\n",
       "                'Department of Neonatology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.',\n",
       "                'Department of Paediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Paediatrics, University of Lubeck, Lubeck, Germany.'],\n",
       "               'CN': ['Neocirculation project and the German Neonatal Network (GNN)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Multicenter Study',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20150721',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Arch Dis Child Fetal Neonatal Ed',\n",
       "               'JT': 'Archives of disease in childhood. Fetal and neonatal edition',\n",
       "               'JID': '9501297',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Bronchopulmonary Dysplasia/complications',\n",
       "                'Cerebral Hemorrhage/complications',\n",
       "                'Gestational Age',\n",
       "                'Humans',\n",
       "                'Hypotension/*complications/diagnosis',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature',\n",
       "                '*Infant, Premature, Diseases/diagnosis/mortality',\n",
       "                '*Infant, Very Low Birth Weight',\n",
       "                'Prognosis',\n",
       "                'Retrospective Studies',\n",
       "                'Risk Factors'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Neonatology',\n",
       "                'blood pressure',\n",
       "                'hypotension',\n",
       "                'preterm infant'],\n",
       "               'EDAT': '2015/07/23 06:00',\n",
       "               'MHDA': '2015/11/10 06:00',\n",
       "               'CRDT': ['2015/07/23 06:00'],\n",
       "               'PHST': ['2014/03/26 00:00 [received]',\n",
       "                '2015/07/02 00:00 [accepted]',\n",
       "                '2015/07/23 06:00 [entrez]',\n",
       "                '2015/07/23 06:00 [pubmed]',\n",
       "                '2015/11/10 06:00 [medline]'],\n",
       "               'AID': ['archdischild-2014-306483 [pii]',\n",
       "                '10.1136/archdischild-2014-306483 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Arch Dis Child Fetal Neonatal Ed. 2015 Sep;100(5):F388-92. doi: 10.1136/archdischild-2014-306483. Epub 2015 Jul 21.'},\n",
       "              {'PMID': '26055002',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20151124',\n",
       "               'LR': '20150609',\n",
       "               'IS': '1090-3941 (Print) 1090-3941 (Linking)',\n",
       "               'VI': '26',\n",
       "               'DP': '2015 May',\n",
       "               'TI': 'Resection of Ileoinguinal and Ileohypogastric Nerves Combined with Gluing in Modified Lichtenstein Repair.',\n",
       "               'PG': '143-8',\n",
       "               'AB': 'We conducted a cohort trial to investigate the relevance of resection of the ilioinguinal and iliohypogastric nerves in combination with mesh fixation with BioGlue (CryoLife(R) Inc., Kennsaw, Georgia) in modified Lichtenstein repair to the development of chronic pain and hernia recurrence.1 In all, 430 patients underwent Lichtenstein repair. In 247 patients the mesh was fixed by means of glue, and in 183 patients it was fixed with conventional sutures. In all cases the inguinal nerves N. ilioinguinalis and N. iliohypogastricus were located and resected after identification to prevent nerve reaction to the mesh. The pain intensity was measured with a numeric analogous scale (NAS) 24 hours after surgery. All complications were recorded with a follow-up of up to 5 years. There was a significantly lower pain intensity level in the gluing group compared with the suture group 24 hours after surgery (0.016 t test). The level was 3.8+/-2.4 in bilateral hernia and 3.3+/-2.1 in unilateral hernia in the gluing group. It was 4.7+/-3.3 in unilateral and 3.7+/-2.2 in bilateral hernia in the suture group. The cut-suture time was lower in the gluing group. There were no severe pain syndromes (NAS>/=4) in the gluing group and only 1.1% in the suture group. There was a higher incidence of non-bacterial wound infections in the gluing group (3.6%) than in the suture group (1.1%). The rate of recurrence after 5 years amounted to 2.0% in the gluing group and 2.2% in the suture group. The technique of using BioGlue for mesh fixation combined with systematic nerve dissection reduces acute and chronic postoperative pain after modified Lichtenstein repair. Only 2 of 430 patients suffered from severe chronic pain. Combined gluing and systematic resection of the inguinal nerves is more comfortable than standard Lichtenstein repair.',\n",
       "               'FAU': ['Baer, Andreas',\n",
       "                'Bohnert, Nicholas',\n",
       "                'Goretzki, Peter E',\n",
       "                'Lammers, Bernhard J'],\n",
       "               'AU': ['Baer A', 'Bohnert N', 'Goretzki PE', 'Lammers BJ'],\n",
       "               'AD': ['Department of Colorectal and Hernia Surgery, Lukaskrankenhaus Neuss GmbH, Academic Teaching Hospital of Heinrich Heine University, Dusseldorf, Germany.',\n",
       "                'Department of Colorectal and Hernia Surgery, Lukaskrankenhaus Neuss GmbH, Academic Teaching Hospital of Heinrich Heine University, Dusseldorf, Germany.',\n",
       "                'Department of Colorectal and Hernia Surgery, Lukaskrankenhaus Neuss GmbH, Academic Teaching Hospital of Heinrich Heine University, Dusseldorf, Germany.',\n",
       "                'Department of Colorectal and Hernia Surgery, Lukaskrankenhaus Neuss GmbH, Academic Teaching Hospital of Heinrich Heine University, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Surg Technol Int',\n",
       "               'JT': 'Surgical technology international',\n",
       "               'JID': '9604509',\n",
       "               'RN': ['0 (Tissue Adhesives)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Abdomen/*innervation/surgery',\n",
       "                'Aged',\n",
       "                'Cohort Studies',\n",
       "                'Hernia, Inguinal/epidemiology/*surgery',\n",
       "                'Herniorrhaphy/adverse effects/*methods',\n",
       "                'Humans',\n",
       "                'Lumbosacral Plexus/*surgery',\n",
       "                'Middle Aged',\n",
       "                'Pain, Postoperative',\n",
       "                'Retrospective Studies',\n",
       "                'Sutures',\n",
       "                'Tissue Adhesives/adverse effects/*therapeutic use',\n",
       "                'Wound Closure Techniques'],\n",
       "               'EDAT': '2015/06/10 06:00',\n",
       "               'MHDA': '2015/12/15 06:00',\n",
       "               'CRDT': ['2015/06/10 06:00'],\n",
       "               'PHST': ['2015/06/10 06:00 [entrez]',\n",
       "                '2015/06/10 06:00 [pubmed]',\n",
       "                '2015/12/15 06:00 [medline]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Surg Technol Int. 2015 May;26:143-8.'},\n",
       "              {'PMID': '25875399',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20160822',\n",
       "               'LR': '20150909',\n",
       "               'IS': '1439-3824 (Electronic) 0300-8630 (Linking)',\n",
       "               'VI': '227',\n",
       "               'IP': '5',\n",
       "               'DP': '2015 Sep',\n",
       "               'TI': 'Electrocortical Activity at 7 Days of Life is Affected in Extremely Premature Infants with Patent Ductus Arteriosus.',\n",
       "               'PG': '264-8',\n",
       "               'LID': '10.1055/s-0035-1547309 [doi]',\n",
       "               'AB': 'BACKGROUND: The aim of this study was to determine whether the aEEG at 7 days of life is influenced by the presence of a PDA in non-sedated extremely low gestational age preterm infants. PATIENTS: We prospectively recruited infants born at less than 28 weeks of gestation between 11/2007 and 12/2009. METHOD: aEEGs were recorded at seven days of life and assessed by using the Burdjalov score and the electronically assessed lower border (eLBA). Kruskal-Wallis-Test and linear regression analysis were performed to determine how GA and a PDA affect the aEEG score and the eLBA. Using linear regression analysis we tested which components of the score are affected by a PDA. RESULTS: We recruited 44 infants with a GA of 26.5/7 (23.4/7-27.6/7) weeks and a birth weight of 837 (461-1230) g. The total sum of score points increased from 4 (1-6) to 8 (5-9) points in infants born at 23/24 weeks and 27 weeks of gestation, respectively. In infants with relevant PDA the aEEG scored lower with 8 (3-10) points compared to those with PDA: 5 (1-8) points. Linear regression analysis showed a positive influence of GA and a negative influence of a PDA on the total score. GA had a positive influence on SWC and the visually assessed LBA. A PDA had a negative influence on continuity. The eLBA increased from 4.61 (3.18-5.53) microV to 5.27 (3.38-6.51) microV in infants of 23/24 vs. 27 gestational weeks, but was not significantly influenced by a PDA. CONCLUSION: A PDA has a negative influence on the total Burdjalov score and continuity at 7 days of age in infants born at less than 28 weeks of gestation. The electrocortical disturbances may be the consequence of a diminished cerebral perfusion in the presence of a PDA.',\n",
       "               'CI': ['(c) Georg Thieme Verlag KG Stuttgart . New York.'],\n",
       "               'FAU': ['Bruns, N',\n",
       "                'Metze, B',\n",
       "                'Buhrer, C',\n",
       "                'Felderhoff-Muser, U',\n",
       "                'Huseman, D'],\n",
       "               'AU': ['Bruns N',\n",
       "                'Metze B',\n",
       "                'Buhrer C',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Huseman D'],\n",
       "               'AD': ['Department of Pediatrics I, University Hospital Essen, Essen, Germany.',\n",
       "                'Neonatology, Charite University Hospital Berlin, Berlin, Germany.',\n",
       "                'Neonatology, Charite University Hospital Berlin, Berlin, Germany.',\n",
       "                'Department of Pediatrics I, University Hospital Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics, Hospital Barnim, Eberswalde, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20150414',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Klin Padiatr',\n",
       "               'JT': 'Klinische Padiatrie',\n",
       "               'JID': '0326144',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Brain Damage, Chronic/diagnosis/physiopathology',\n",
       "                'Cerebral Cortex/blood supply/physiopathology',\n",
       "                'Ductus Arteriosus, Patent/diagnosis/*physiopathology',\n",
       "                '*Electrocorticography',\n",
       "                'Female',\n",
       "                'Gestational Age',\n",
       "                'Hemodynamics/physiology',\n",
       "                'Humans',\n",
       "                'Infant, Extremely Low Birth Weight/*physiology',\n",
       "                'Infant, Newborn',\n",
       "                'Male',\n",
       "                'Prognosis',\n",
       "                'Prospective Studies'],\n",
       "               'EDAT': '2015/04/16 06:00',\n",
       "               'MHDA': '2016/08/23 06:00',\n",
       "               'CRDT': ['2015/04/16 06:00'],\n",
       "               'PHST': ['2015/04/16 06:00 [entrez]',\n",
       "                '2015/04/16 06:00 [pubmed]',\n",
       "                '2016/08/23 06:00 [medline]'],\n",
       "               'AID': ['10.1055/s-0035-1547309 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Klin Padiatr. 2015 Sep;227(5):264-8. doi: 10.1055/s-0035-1547309. Epub 2015 Apr 14.'},\n",
       "              {'PMID': '25872910',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20160222',\n",
       "               'LR': '20181113',\n",
       "               'IS': '1476-5640 (Electronic) 0954-3007 (Linking)',\n",
       "               'VI': '69',\n",
       "               'IP': '6',\n",
       "               'DP': '2015 Jun',\n",
       "               'TI': 'Length and weight of very low birth weight infants in Germany at 2 years of age: does it matter at what age they start complementary food?',\n",
       "               'PG': '662-7',\n",
       "               'LID': '10.1038/ejcn.2015.54 [doi]',\n",
       "               'AB': 'BACKGROUND/OBJECTIVES: We analysed at what age parents start complementary food in very low birth weight infants, determined risk factors for early introduction of complementary food (post-term age) and analysed whether the age at introduction of complementary food influences height or weight at 2 years of age. SUBJECTS/METHODS: Parents of premature infants born in 2009-2011 answered questionnaires regarding introduction of complementary food in the first year of life (N=2262) and were followed up at a post-term age of 2 years (N=981). Length and weight were compared with full-term infants from the KiGGs study. Logistic and linear regression analyses were conducted to study predictors for early introduction of complementary food and the influence of age at introduction of complementary food on later height and weight. RESULTS: Average age at introduction of complementary food was 3.5 months post-term age. The lower the gestational age at birth, the earlier (post-term age) vegetables and meat were introduced. Age at introduction of complementary food was influenced by intrauterine growth restriction, gestational age at birth, maternal education and a developmental delay perceived by the parents. Length and weight at a post-term age of 2 years was not negatively influenced by early introduction of complementary food. CONCLUSIONS: VLBW infants are introduced to complementary food on average before a post-term age of 4 months. There was no negative effect of early introduction of complementary food on height and weight at 2 years of age.',\n",
       "               'FAU': ['Spiegler, J',\n",
       "                'Eisemann, N',\n",
       "                'Ehlers, S',\n",
       "                'Orlikowsky, T',\n",
       "                'Kannt, O',\n",
       "                'Herting, E',\n",
       "                'Gopel, W'],\n",
       "               'AU': ['Spiegler J',\n",
       "                'Eisemann N',\n",
       "                'Ehlers S',\n",
       "                'Orlikowsky T',\n",
       "                'Kannt O',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AD': ['Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Institute of Cancer Epidemiology, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Neonatology, Burgerhospital, Frankfurt, Germany.',\n",
       "                'Department of Neonatology, University of Aachen, Aachen, Germany.',\n",
       "                \"Children's Hospital, HELIOS Klinik Schwerin, Schwerin, Germany.\",\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.'],\n",
       "               'CN': ['GNN'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20150415',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Eur J Clin Nutr',\n",
       "               'JT': 'European journal of clinical nutrition',\n",
       "               'JID': '8804070',\n",
       "               'SB': 'IM',\n",
       "               'CIN': ['Eur J Clin Nutr. 2015 Jun;69(6):647-8. doi: 10.1038/ejcn.2015.70. PMID: 26036765'],\n",
       "               'MH': ['Body Height',\n",
       "                '*Child Development',\n",
       "                'Cohort Studies',\n",
       "                '*Diet/adverse effects',\n",
       "                '*Feeding Methods/adverse effects',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Germany',\n",
       "                'Growth Disorders/diet therapy/*prevention & control',\n",
       "                'Humans',\n",
       "                '*Infant Food',\n",
       "                '*Infant Nutritional Physiological Phenomena',\n",
       "                'Infant, Newborn',\n",
       "                '*Infant, Very Low Birth Weight',\n",
       "                'Male',\n",
       "                'Nutrition Policy',\n",
       "                'Parents',\n",
       "                'Patient Compliance',\n",
       "                'Surveys and Questionnaires',\n",
       "                'Weight Gain'],\n",
       "               'EDAT': '2015/04/16 06:00',\n",
       "               'MHDA': '2016/02/24 06:00',\n",
       "               'CRDT': ['2015/04/16 06:00'],\n",
       "               'PHST': ['2014/02/05 00:00 [received]',\n",
       "                '2015/02/19 00:00 [revised]',\n",
       "                '2015/03/09 00:00 [accepted]',\n",
       "                '2015/04/16 06:00 [entrez]',\n",
       "                '2015/04/16 06:00 [pubmed]',\n",
       "                '2016/02/24 06:00 [medline]'],\n",
       "               'AID': ['ejcn201554 [pii]', '10.1038/ejcn.2015.54 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Clin Nutr. 2015 Jun;69(6):662-7. doi: 10.1038/ejcn.2015.54. Epub 2015 Apr 15.'},\n",
       "              {'PMID': '25856083',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20160405',\n",
       "               'LR': '20190223',\n",
       "               'IS': '1932-6203 (Electronic) 1932-6203 (Linking)',\n",
       "               'VI': '10',\n",
       "               'IP': '4',\n",
       "               'DP': '2015',\n",
       "               'TI': 'Preterm prelabor rupture of membranes and outcome of very-low-birth-weight infants in the German Neonatal Network.',\n",
       "               'PG': 'e0122564',\n",
       "               'LID': '10.1371/journal.pone.0122564 [doi] e0122564',\n",
       "               'AB': 'OBJECTIVE: It was the aim of our study to evaluate the independent effect of preterm prelabor rupture of membranes (PPROM) as a cause of preterm delivery on mortality during primary hospital stay and significant morbidities in very-low-birth-weight (VLBW) infants < 32 weeks of gestation. DESIGN: Observational, epidemiological study design. SETTING: Population-based cohort, German Neonatal Network (GNN). POPULATION: 6102 VLBW infants were enrolled in GNN from 2009-2012, n=4120 fulfilled criteria for primary analysis (< 32 gestational weeks, no pre-eclampsia, HELLP (highly elevated liver enzymes and low platelets syndrome) or placental abruption as cause of preterm birth). METHODS: Multivariable logistic regression analyses included PPROM as potential risk factors for adverse outcomes and well established items such as gestational age in weeks, birth weight, antenatal steroids, center, inborn delivery, multiple birth, gender and being small-for-gestational-age. RESULTS: PPROM as cause of preterm delivery had no independent effect on the risk of early-onset sepsis, clinical sepsis and blood-culture proven sepsis, while gestational age proved to be the most important contributor to sepsis risk. The diagnosis of PPROM was associated with an increased risk for bronchopulmonary dysplasia (BPD; OR: 1.25, 95% CI: 1.02-1.55, p=0.03) but not with other major outcomes. CONCLUSIONS: The diagnosis of PPROM per se is not associated with adverse outcome in VLBW infants < 32 weeks apart from a moderately increased risk for BPD. Randomized controlled trials with primary neonatal outcomes are needed to determine which subgroup of VLBW infants benefit from expectant or intentional management of PPROM.',\n",
       "               'FAU': ['Hanke, Kathrin',\n",
       "                'Hartz, Annika',\n",
       "                'Manz, Maike',\n",
       "                'Bendiks, Meike',\n",
       "                'Heitmann, Friedhelm',\n",
       "                'Orlikowsky, Thorsten',\n",
       "                'Muller, Andreas',\n",
       "                'Olbertz, Dirk',\n",
       "                'Kuhn, Thomas',\n",
       "                'Siegel, Jens',\n",
       "                'von der Wense, Axel',\n",
       "                'Wieg, Christian',\n",
       "                'Kribs, Angela',\n",
       "                'Stein, Anja',\n",
       "                'Pagel, Julia',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang',\n",
       "                'Hartel, Christoph'],\n",
       "               'AU': ['Hanke K',\n",
       "                'Hartz A',\n",
       "                'Manz M',\n",
       "                'Bendiks M',\n",
       "                'Heitmann F',\n",
       "                'Orlikowsky T',\n",
       "                'Muller A',\n",
       "                'Olbertz D',\n",
       "                'Kuhn T',\n",
       "                'Siegel J',\n",
       "                'von der Wense A',\n",
       "                'Wieg C',\n",
       "                'Kribs A',\n",
       "                'Stein A',\n",
       "                'Pagel J',\n",
       "                'Herting E',\n",
       "                'Gopel W',\n",
       "                'Hartel C'],\n",
       "               'AD': ['Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                \"Department of Women's Health and Obstetrics University of Lubeck, Lubeck, Germany.\",\n",
       "                'Department of Pediatrics at University of Kiel, Kiel, Germany.',\n",
       "                \"Children's Hospital Dortmund, Dortmund, Germany.\",\n",
       "                'Department of Pediatrics, University of Aachen, Aachen, Germany.',\n",
       "                'Department of Pediatrics, University of Bonn, Bonn, Germany.',\n",
       "                \"Children's Hospital Rostock, Rostock, Germany.\",\n",
       "                \"Vivantes Children's Hospital Berlin-Neukolln, Berlin, Germany.\",\n",
       "                \"Children's Hospital Auf der Bult Hanover, Hanover, Germany.\",\n",
       "                \"Children's Hospital Hamburg-Altona, Hamburg, Germany.\",\n",
       "                \"Children's Hospital Aschaffenburg, Aschaffenburg, Germany.\",\n",
       "                'Department of Pediatrics, University of Cologne, Cologne, Germany.',\n",
       "                'Department of Pediatrics, University of Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University of Lubeck, Lubeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network (GNN)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20150409',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'PLoS One',\n",
       "               'JT': 'PloS one',\n",
       "               'JID': '101285081',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Cohort Studies',\n",
       "                'Female',\n",
       "                'Fetal Membranes, Premature Rupture/*epidemiology/*physiopathology',\n",
       "                'Germany/epidemiology',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Very Low Birth Weight/*physiology',\n",
       "                'Logistic Models',\n",
       "                'Mortality',\n",
       "                'Pregnancy',\n",
       "                'Premature Birth/*epidemiology/*etiology'],\n",
       "               'PMC': 'PMC4391753',\n",
       "               'COIS': ['Competing Interests: The authors have declared that no competing interests exist.'],\n",
       "               'FIR': ['Avenarius, Stefan',\n",
       "                'Bockenholt, Kai',\n",
       "                'Bohnhorst, Bettina',\n",
       "                'Dordelmann, Michael',\n",
       "                'Ehlers, Silke',\n",
       "                'Gerleve, Hubert',\n",
       "                'Gortner, Ludwig',\n",
       "                'Groneck, Peter',\n",
       "                'Hillebrand, Georg',\n",
       "                'Hoehn, Thomas',\n",
       "                'Hubert, Mechthild',\n",
       "                'Hummler, Helmut',\n",
       "                'Jenke, Andreas',\n",
       "                'Jensen, Reinhard',\n",
       "                'Kannt, Olaf',\n",
       "                'Kuster, Helmut',\n",
       "                'Laux, Reinhard',\n",
       "                'Lieser, Ursula',\n",
       "                'Mogel, Michael',\n",
       "                'Moller, Jens',\n",
       "                'Muller, Dirk',\n",
       "                'Reese, Jochen',\n",
       "                'Roll, Claudia',\n",
       "                'Schaible, Thomas',\n",
       "                'Seeliger, Stefan',\n",
       "                'Segerer, Hugo',\n",
       "                'Teig, Norbert',\n",
       "                'Weller, Ursula',\n",
       "                'Vochem, Matthias',\n",
       "                'Wintgens, Jurgen'],\n",
       "               'IR': ['Avenarius S',\n",
       "                'Bockenholt K',\n",
       "                'Bohnhorst B',\n",
       "                'Dordelmann M',\n",
       "                'Ehlers S',\n",
       "                'Gerleve H',\n",
       "                'Gortner L',\n",
       "                'Groneck P',\n",
       "                'Hillebrand G',\n",
       "                'Hoehn T',\n",
       "                'Hubert M',\n",
       "                'Hummler H',\n",
       "                'Jenke A',\n",
       "                'Jensen R',\n",
       "                'Kannt O',\n",
       "                'Kuster H',\n",
       "                'Laux R',\n",
       "                'Lieser U',\n",
       "                'Mogel M',\n",
       "                'Moller J',\n",
       "                'Muller D',\n",
       "                'Reese J',\n",
       "                'Roll C',\n",
       "                'Schaible T',\n",
       "                'Seeliger S',\n",
       "                'Segerer H',\n",
       "                'Teig N',\n",
       "                'Weller U',\n",
       "                'Vochem M',\n",
       "                'Wintgens J'],\n",
       "               'EDAT': '2015/04/10 06:00',\n",
       "               'MHDA': '2016/04/06 06:00',\n",
       "               'PMCR': ['2015/04/09'],\n",
       "               'CRDT': ['2015/04/10 06:00'],\n",
       "               'PHST': ['2014/09/28 00:00 [received]',\n",
       "                '2015/02/23 00:00 [accepted]',\n",
       "                '2015/04/10 06:00 [entrez]',\n",
       "                '2015/04/10 06:00 [pubmed]',\n",
       "                '2016/04/06 06:00 [medline]',\n",
       "                '2015/04/09 00:00 [pmc-release]'],\n",
       "               'AID': ['PONE-D-14-43091 [pii]',\n",
       "                '10.1371/journal.pone.0122564 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'PLoS One. 2015 Apr 9;10(4):e0122564. doi: 10.1371/journal.pone.0122564. eCollection 2015.'},\n",
       "              {'PMID': '25474712',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20151116',\n",
       "               'LR': '20181202',\n",
       "               'IS': '1651-2227 (Electronic) 0803-5253 (Linking)',\n",
       "               'VI': '104',\n",
       "               'IP': '3',\n",
       "               'DP': '2015 Mar',\n",
       "               'TI': 'Less invasive surfactant administration is associated with improved pulmonary outcomes in spontaneously breathing preterm infants.',\n",
       "               'PG': '241-6',\n",
       "               'LID': '10.1111/apa.12883 [doi]',\n",
       "               'AB': 'AIM: Providing less invasive surfactant administration (LISA) to spontaneously breathing preterm infants has been reported to reduce mechanical ventilation and bronchopulmonary dysplasia (BPD) in randomised controlled trials. This large cohort study compared these outcome measures between LISA-treated infants and controls. METHODS: Infants receiving LISA, who were born before 32 gestational weeks and enrolled in the German Neonatal Network, were matched to control infants by gestational age, umbilical cord pH, Apgar-score at 5 min, small for gestational age status, antenatal treatment with steroids, gender and highest supplemental oxygen during the first 12 h of life. Outcome data were compared with chi-square and Mann-Whitney U-tests and adjusted for multiple comparisons. RESULTS: Between 2009 and 2012, 1103 infants were treated with LISA at 37 centres. LISA infants had lower rates of mechanical ventilation (41% versus 62%, p < 0.001), postnatal dexamethasone treatment (2.5% versus 7%, p < 0.001), BPD (12% versus 18%, p = 0.001) and BPD or death (14% versus 21%, p < 0.001) than the controls. CONCLUSION: Surfactant treatment of spontaneously breathing infants was associated with lower rates of mechanical ventilation and BPD. Additional large-scale randomised controlled trials are needed to assess the possible long-term benefits of LISA.',\n",
       "               'CI': ['(c)2014 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.'],\n",
       "               'FAU': ['Gopel, Wolfgang',\n",
       "                'Kribs, Angela',\n",
       "                'Hartel, Christoph',\n",
       "                'Avenarius, Stefan',\n",
       "                'Teig, Norbert',\n",
       "                'Groneck, Peter',\n",
       "                'Olbertz, Dirk',\n",
       "                'Roll, Claudia',\n",
       "                'Vochem, Matthias',\n",
       "                'Weller, Ursula',\n",
       "                'von der Wense, Axel',\n",
       "                'Wieg, Christian',\n",
       "                'Wintgens, Jurgen',\n",
       "                'Preuss, Michael',\n",
       "                'Ziegler, Andreas',\n",
       "                'Roth, Bernhard',\n",
       "                'Herting, Egbert'],\n",
       "               'AU': ['Gopel W',\n",
       "                'Kribs A',\n",
       "                'Hartel C',\n",
       "                'Avenarius S',\n",
       "                'Teig N',\n",
       "                'Groneck P',\n",
       "                'Olbertz D',\n",
       "                'Roll C',\n",
       "                'Vochem M',\n",
       "                'Weller U',\n",
       "                'von der Wense A',\n",
       "                'Wieg C',\n",
       "                'Wintgens J',\n",
       "                'Preuss M',\n",
       "                'Ziegler A',\n",
       "                'Roth B',\n",
       "                'Herting E'],\n",
       "               'AD': ['Department of Pediatrics, University of Lubeck, Lubeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network (GNN)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Clinical Trial',\n",
       "                'Journal Article',\n",
       "                'Multicenter Study',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                'Video-Audio Media'],\n",
       "               'PL': 'Norway',\n",
       "               'TA': 'Acta Paediatr',\n",
       "               'JT': 'Acta paediatrica (Oslo, Norway : 1992)',\n",
       "               'JID': '9205968',\n",
       "               'RN': ['0 (Pulmonary Surfactants)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Bronchopulmonary Dysplasia/etiology/prevention & control',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature',\n",
       "                'Male',\n",
       "                'Matched-Pair Analysis',\n",
       "                'Prospective Studies',\n",
       "                'Pulmonary Surfactants/*administration & dosage/therapeutic use',\n",
       "                'Respiration',\n",
       "                'Respiration, Artificial/statistics & numerical data',\n",
       "                'Respiratory Distress Syndrome, Newborn/complications/*prevention & control',\n",
       "                'Treatment Outcome'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Bronchopulmonary dysplasia',\n",
       "                'Less invasive surfactant administration',\n",
       "                'Mechanical ventilation',\n",
       "                'Preterm infant',\n",
       "                'Spontaneous breathing'],\n",
       "               'EDAT': '2014/12/05 06:00',\n",
       "               'MHDA': '2015/11/17 06:00',\n",
       "               'CRDT': ['2014/12/05 06:00'],\n",
       "               'PHST': ['2014/03/05 00:00 [received]',\n",
       "                '2014/06/21 00:00 [revised]',\n",
       "                '2014/11/26 00:00 [accepted]',\n",
       "                '2014/12/05 06:00 [entrez]',\n",
       "                '2014/12/05 06:00 [pubmed]',\n",
       "                '2015/11/17 06:00 [medline]'],\n",
       "               'AID': ['10.1111/apa.12883 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Acta Paediatr. 2015 Mar;104(3):241-6. doi: 10.1111/apa.12883.'},\n",
       "              {'PMID': '25472649',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20160223',\n",
       "               'LR': '20150509',\n",
       "               'IS': '1534-4681 (Electronic) 1068-9265 (Linking)',\n",
       "               'VI': '22',\n",
       "               'IP': '6',\n",
       "               'DP': '2015',\n",
       "               'TI': 'Local recurrence in the neck and survival after thyroidectomy for metastatic renal cell carcinoma.',\n",
       "               'PG': '1798-805',\n",
       "               'LID': '10.1245/s10434-014-4266-5 [doi]',\n",
       "               'AB': 'BACKGROUND: Most investigations of thyroidectomy for metastatic renal cell carcinoma (RCC) are case studies or small series. This study was conducted to determine the contribution of clinical and histopathologic variables to local recurrence in the neck and overall survival after thyroidectomy for RCC metastases. METHODS: The medical records of 140 patients with thyroidectomy for metastatic RCC performed between 1979 and 2012 at 25 institutions in Germany and Austria were analyzed. RESULTS: The median interval between nephrectomy and thyroidectomy was 120 months. Concurrence of thyroid and pancreatic metastases was present in 23 % of the patients and concurrence of thyroid and adrenal metastases in 13 % of the patients. Clinical outcome data were available for 130 patients with a median follow-up period of 34 months. The 5-year overall survival rate was 46 %, and 28 % of patients developed a local neck recurrence at a median of 12 months after thyroidectomy. Multivariate analysis showed that invasion of adjacent cervical structures (hazard ratio [HR] 3.2; p = 0.001), patient age exceeding 70 years (HR 2.5; p = 0.004), and current or past evidence of metastases to nonendocrine organs (HR 2.4; p = 0.003) were independent determinants of inferior overall survival. Conversely, invasion of adjacent cervical structures (HR 12.1; p < 0.0001) and year of thyroidectomy (HR 5.7 before 2000; p < 0.0001) were shown to be independently associated with local recurrence in the neck by multivariate analysis. CONCLUSIONS: Although significant improvement of local disease control in patients with thyroid metastases of RCC has been achieved during the last decade, overall outcome continues to be poor for patients with locally invasive thyroid metastases.',\n",
       "               'FAU': ['Iesalnieks, Igors',\n",
       "                'Machens, Andreas',\n",
       "                'Bures, Claudia',\n",
       "                'Krenz, Detlef',\n",
       "                'Winter, Hauke',\n",
       "                'Vorlander, Christian',\n",
       "                'Bareck, Evelyne',\n",
       "                'Alesina, Pier F',\n",
       "                'Musholt, Thomas',\n",
       "                'Steinmuller, Thomas',\n",
       "                'Anthuber, Matthias',\n",
       "                'Goretzki, Peter',\n",
       "                'Trupka, Arnold',\n",
       "                'Mayr, Max',\n",
       "                'Weber, Theresia',\n",
       "                'Schlitt, Hans J',\n",
       "                'Dralle, Henning',\n",
       "                'Hermann, Michael',\n",
       "                'Agha, Ayman'],\n",
       "               'AU': ['Iesalnieks I',\n",
       "                'Machens A',\n",
       "                'Bures C',\n",
       "                'Krenz D',\n",
       "                'Winter H',\n",
       "                'Vorlander C',\n",
       "                'Bareck E',\n",
       "                'Alesina PF',\n",
       "                'Musholt T',\n",
       "                'Steinmuller T',\n",
       "                'Anthuber M',\n",
       "                'Goretzki P',\n",
       "                'Trupka A',\n",
       "                'Mayr M',\n",
       "                'Weber T',\n",
       "                'Schlitt HJ',\n",
       "                'Dralle H',\n",
       "                'Hermann M',\n",
       "                'Agha A'],\n",
       "               'AD': ['Department of Surgery, University of Regensburg, Regensburg, Germany, iesalnieks_igors@hotmail.com.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20141204',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Ann Surg Oncol',\n",
       "               'JT': 'Annals of surgical oncology',\n",
       "               'JID': '9420840',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Carcinoma, Renal Cell/mortality/pathology/*surgery',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                'Kidney Neoplasms/mortality/pathology/*surgery',\n",
       "                'Lymphatic Metastasis',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Neck/*pathology/surgery',\n",
       "                'Neoplasm Recurrence, Local/etiology/*mortality/pathology',\n",
       "                'Neoplasm Staging',\n",
       "                'Prognosis',\n",
       "                'Survival Rate',\n",
       "                'Thyroid Neoplasms/mortality/pathology/*surgery',\n",
       "                'Thyroidectomy/*adverse effects'],\n",
       "               'EDAT': '2014/12/05 06:00',\n",
       "               'MHDA': '2016/02/26 06:00',\n",
       "               'CRDT': ['2014/12/05 06:00'],\n",
       "               'PHST': ['2014/10/19 00:00 [received]',\n",
       "                '2014/12/05 06:00 [entrez]',\n",
       "                '2014/12/05 06:00 [pubmed]',\n",
       "                '2016/02/26 06:00 [medline]'],\n",
       "               'AID': ['10.1245/s10434-014-4266-5 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Ann Surg Oncol. 2015;22(6):1798-805. doi: 10.1245/s10434-014-4266-5. Epub 2014 Dec 4.'}],\n",
       "             '2014': [{'PMID': '25299063',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20150616',\n",
       "               'LR': '20211021',\n",
       "               'IS': '1932-6203 (Electronic) 1932-6203 (Linking)',\n",
       "               'VI': '9',\n",
       "               'IP': '10',\n",
       "               'DP': '2014',\n",
       "               'TI': 'Impairment of bone health in pediatric patients with hemolytic anemia.',\n",
       "               'PG': 'e108400',\n",
       "               'LID': '10.1371/journal.pone.0108400 [doi] e108400',\n",
       "               'AB': 'INTRODUCTION: Sickle cell anemia and thalassemia result in impaired bone health in both adults and youths. Children with other types of chronic hemolytic anemia may also display impaired bone health. STUDY DESIGN: To assess bone health in pediatric patients with chronic hemolytic anemia, a cross-sectional study was conducted involving 45 patients with different forms of hemolytic anemia (i.e., 17 homozygous sickle cell disease and 14 hereditary spherocytosis patients). Biochemical, radiographic and anamnestic parameters of bone health were assessed. RESULTS: Vitamin D deficiency with 25 OH-vitamin D serum levels below 20 ng/ml was a common finding (80.5%) in this cohort. Bone pain was present in 31% of patients. Analysis of RANKL, osteoprotegerin (OPG) and osteocalcin levels indicated an alteration in bone modeling with significantly elevated RANKL/OPG ratios (control: 0.08+0.07; patients: 0.26+0.2, P = 0.0007). Osteocalcin levels were found to be lower in patients compared with healthy controls (68.5+39.0 ng/ml vs. 118.0+36.6 ng/ml, P = 0.0001). Multiple stepwise regression analysis revealed a significant (P<0.025) influence of LDH (partial r2 = 0.29), diagnosis of hemolytic anemia (partial r2 = 0.05) and age (partial r2 = 0.03) on osteocalcin levels. Patients with homozygous sickle cell anemia were more frequently and more severely affected by impaired bone health than patients with hereditary spherocytosis. CONCLUSION: Bone health is impaired in pediatric patients with hemolytic anemia. In addition to endocrine alterations, an imbalance in the RANKL/OPG system and low levels of osteocalcin may contribute to this impairment.',\n",
       "               'FAU': ['Schundeln, Michael M',\n",
       "                'Goretzki, Sarah C',\n",
       "                'Hauffa, Pia K',\n",
       "                'Wieland, Regina',\n",
       "                'Bauer, Jens',\n",
       "                'Baeder, Lena',\n",
       "                'Eggert, Angelika',\n",
       "                'Hauffa, Berthold P',\n",
       "                'Grasemann, Corinna'],\n",
       "               'AU': ['Schundeln MM',\n",
       "                'Goretzki SC',\n",
       "                'Hauffa PK',\n",
       "                'Wieland R',\n",
       "                'Bauer J',\n",
       "                'Baeder L',\n",
       "                'Eggert A',\n",
       "                'Hauffa BP',\n",
       "                'Grasemann C'],\n",
       "               'AD': ['Department of Pediatric Hematology and Oncology, Kinderklinik III, Universitatsklinikum-Essen and the University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatric Hematology and Oncology, Kinderklinik III, Universitatsklinikum-Essen and the University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatric Hematology and Oncology, Kinderklinik III, Universitatsklinikum-Essen and the University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatric Hematology and Oncology, Kinderklinik III, Universitatsklinikum-Essen and the University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatric Endocrinology and Diabetology, Kinderklinik II, Universitatsklinikum-Essen and the University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatric Endocrinology and Diabetology, Kinderklinik II, Universitatsklinikum-Essen and the University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatrics, Division of Oncology and Hematology, Charite - Universitatsmedizin, Berlin, Germany.',\n",
       "                'Department of Pediatric Endocrinology and Diabetology, Kinderklinik II, Universitatsklinikum-Essen and the University of Duisburg-Essen, Essen, Germany.',\n",
       "                'Department of Pediatric Endocrinology and Diabetology, Kinderklinik II, Universitatsklinikum-Essen and the University of Duisburg-Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20141009',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'PLoS One',\n",
       "               'JT': 'PloS one',\n",
       "               'JID': '101285081',\n",
       "               'RN': ['0 (Osteoprotegerin)',\n",
       "                '0 (RANK Ligand)',\n",
       "                '104982-03-8 (Osteocalcin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Anemia, Hemolytic/*blood/*physiopathology',\n",
       "                'Bone Density/physiology',\n",
       "                'Bone and Bones/*physiopathology',\n",
       "                'Case-Control Studies',\n",
       "                'Child',\n",
       "                'Child, Preschool',\n",
       "                'Cross-Sectional Studies',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Male',\n",
       "                'Osteocalcin/blood',\n",
       "                'Osteoprotegerin/blood',\n",
       "                'RANK Ligand/blood'],\n",
       "               'PMC': 'PMC4191967',\n",
       "               'COIS': ['Competing Interests: The authors have declared that no competing interests exist.'],\n",
       "               'EDAT': '2014/10/10 06:00',\n",
       "               'MHDA': '2015/06/17 06:00',\n",
       "               'PMCR': ['2014/10/09'],\n",
       "               'CRDT': ['2014/10/10 06:00'],\n",
       "               'PHST': ['2014/05/15 00:00 [received]',\n",
       "                '2014/08/22 00:00 [accepted]',\n",
       "                '2014/10/10 06:00 [entrez]',\n",
       "                '2014/10/10 06:00 [pubmed]',\n",
       "                '2015/06/17 06:00 [medline]',\n",
       "                '2014/10/09 00:00 [pmc-release]'],\n",
       "               'AID': ['PONE-D-14-21696 [pii]',\n",
       "                '10.1371/journal.pone.0108400 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'PLoS One. 2014 Oct 9;9(10):e108400. doi: 10.1371/journal.pone.0108400. eCollection 2014.'},\n",
       "              {'PMID': '25155176',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20160318',\n",
       "               'LR': '20211021',\n",
       "               'IS': '1471-2431 (Electronic) 1471-2431 (Linking)',\n",
       "               'VI': '14',\n",
       "               'DP': '2014 Aug 26',\n",
       "               'TI': 'Mitochondrial mutation m.1555A>G as a risk factor for failed newborn hearing screening in a large cohort of preterm infants.',\n",
       "               'PG': '210',\n",
       "               'LID': '10.1186/1471-2431-14-210 [doi]',\n",
       "               'AB': 'BACKGROUND: The mitochondrial m.1555A>G mutation is associated with a high rate of permanent hearing loss, if aminoglycosides are given. Preterm infants have an increased risk of permanent hearing loss and are frequently treated with aminoglycoside antibiotics. METHODS: We genotyped preterm infants with a birth weight below 1500 grams who were prospectively enrolled in a large cohort study for the m.1555A>G mutation. Treatment with aminoglycoside antibiotics in combination with mitochondrial m.1555A>G mutation was tested as a predictor for failed hearing screening at discharge in a multivariate logistic regression analysis. RESULTS: 7056 infants were genotyped and analysed. Low birth weight was the most significant predictor of failed hearing screening (p = 7.3 x 10-10). 12 infants (0.2%) had the m.1555A>G-mutation. In a multivariable logistic regression analysis, the combination of aminoglycoside treatment with m.1555A>G-carrier status was associated with failed hearing screening (p = 0.0058). However, only 3 out of 10 preterm m.1555A>G-carriers who were exposed to aminoglycosides failed hearing screening. The m.1555A>G-mutation was detected in all mothers of m.1555A>G-positive children, but in none of 2993 maternal DNA-samples of m.1555A>G-negative infants. CONCLUSION: Antenatal screening for the m.1555A>G mutation by maternal genotyping of pregnant women with preterm labour might be a reasonable approach to identify infants who are at increased risk for permanent hearing loss. Additional studies are needed to estimate the relevance of cofactors like aminoglycoside plasma levels and birth weight and the amount of preterm m.1555A>G-carriers with permanent hearing loss.',\n",
       "               'FAU': ['Gopel, Wolfgang',\n",
       "                'Berkowski, Sandra',\n",
       "                'Preuss, Michael',\n",
       "                'Ziegler, Andreas',\n",
       "                'Kuster, Helmut',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Gortner, Ludwig',\n",
       "                'Mogel, Michael',\n",
       "                'Hartel, Christoph',\n",
       "                'Herting, Egbert'],\n",
       "               'AU': ['Gopel W',\n",
       "                'Berkowski S',\n",
       "                'Preuss M',\n",
       "                'Ziegler A',\n",
       "                'Kuster H',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Gortner L',\n",
       "                'Mogel M',\n",
       "                'Hartel C',\n",
       "                'Herting E'],\n",
       "               'AD': ['Department of Paediatrics, University of Lubeck, University Hospital of Schleswig Holstein, Ratzeburger Allee 160, G-23538 Lubeck, Germany. wolfgang.goepel@uksh.de.'],\n",
       "               'CN': ['German Neonatal Network'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Multicenter Study',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20140826',\n",
       "               'PL': 'England',\n",
       "               'TA': 'BMC Pediatr',\n",
       "               'JT': 'BMC pediatrics',\n",
       "               'JID': '100967804',\n",
       "               'RN': ['0 (Aminoglycosides)',\n",
       "                '0 (Anti-Bacterial Agents)',\n",
       "                '0 (DNA, Mitochondrial)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Aminoglycosides/administration & dosage/adverse effects',\n",
       "                'Anti-Bacterial Agents/administration & dosage/adverse effects',\n",
       "                'Cohort Studies',\n",
       "                'DNA, Mitochondrial/*genetics',\n",
       "                'Female',\n",
       "                'Hearing Loss/*diagnosis/genetics',\n",
       "                'Hearing Tests',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                '*Infant, Premature',\n",
       "                'Infant, Very Low Birth Weight',\n",
       "                'Male',\n",
       "                '*Mutation',\n",
       "                '*Neonatal Screening',\n",
       "                'Risk Factors'],\n",
       "               'PMC': 'PMC4236616',\n",
       "               'EDAT': '2014/08/27 06:00',\n",
       "               'MHDA': '2016/03/19 06:00',\n",
       "               'PMCR': ['2014/08/26'],\n",
       "               'CRDT': ['2014/08/27 06:00'],\n",
       "               'PHST': ['2014/02/25 00:00 [received]',\n",
       "                '2014/08/15 00:00 [accepted]',\n",
       "                '2014/08/27 06:00 [entrez]',\n",
       "                '2014/08/27 06:00 [pubmed]',\n",
       "                '2016/03/19 06:00 [medline]',\n",
       "                '2014/08/26 00:00 [pmc-release]'],\n",
       "               'AID': ['1471-2431-14-210 [pii]',\n",
       "                '10.1186/1471-2431-14-210 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'BMC Pediatr. 2014 Aug 26;14:210. doi: 10.1186/1471-2431-14-210.'},\n",
       "              {'PMID': '25116885',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'DCOM': '20140813',\n",
       "               'LR': '20211021',\n",
       "               'IS': '1999-4923 (Print) 1999-4923 (Electronic) 1999-4923 (Linking)',\n",
       "               'VI': '6',\n",
       "               'IP': '3',\n",
       "               'DP': '2014 Aug 11',\n",
       "               'TI': 'Encapsulated cells expressing a chemotherapeutic activating enzyme allow the targeting of subtoxic chemotherapy and are safe and efficacious: data from two clinical trials in pancreatic cancer.',\n",
       "               'PG': '447-66',\n",
       "               'LID': '10.3390/pharmaceutics6030447 [doi]',\n",
       "               'AB': 'Despite progress in the treatment of pancreatic cancer, there is still a need for improved therapies. In this manuscript, we report clinical experience with a new therapy for the treatment of pancreatic cancer involving the implantation of encapsulated cells over-expressing a cytochrome P450 enzyme followed by subsequent low-dose ifosfamide administrations as a means to target activated ifosfamide to the tumor. The safety and efficacy of the angiographic instillation of encapsulated allogeneic cells overexpressing cytochrome P450 in combination with low-dose systemic ifosfamide administration has now been evaluated in 27 patients in total. These patients were successfully treated in four centers by three different interventional radiologists, arguing strongly that the treatment can be successfully used in different centers. The safety of the intra-arterial delivery of the capsules and the lack of evidence that the patients developed an inflammatory or immune response to the encapsulated cells or encapsulation material was shown in all 27 patients. The ifosfamide dose of 1 g/m2/day used in the first trial was well tolerated by all patients. In contrast, the ifosfamide dose of 2 g/m2/day used in the second trial was poorly tolerated in most patients. Since the median survival in the first trial was 40 weeks and only 33 weeks in the second trial, this strongly suggests that there is no survival benefit to increasing the dose of ifosfamide, and indeed, a lower dose is beneficial for quality of life and the lack of side effects. This is supported by the one-year survival rate in the first trial being 38%, whilst that in the second trial was only 23%. However, taking the data from both trials together, a total of nine of the 27 patients were alive after one year, and two of these nine patients were alive for two years or more.',\n",
       "               'FAU': ['Lohr, J Matthias',\n",
       "                'Haas, Stephan L',\n",
       "                'Kroger, Jens C',\n",
       "                'Friess, Helmut M',\n",
       "                'Hoft, Raimund',\n",
       "                'Goretzki, Peter E',\n",
       "                'Peschel, Christian',\n",
       "                'Schweigert, Markus',\n",
       "                'Salmons, Brian',\n",
       "                'Gunzburg, Walter H'],\n",
       "               'AU': ['Lohr JM',\n",
       "                'Haas SL',\n",
       "                'Kroger JC',\n",
       "                'Friess HM',\n",
       "                'Hoft R',\n",
       "                'Goretzki PE',\n",
       "                'Peschel C',\n",
       "                'Schweigert M',\n",
       "                'Salmons B',\n",
       "                'Gunzburg WH'],\n",
       "               'AD': ['Gastrocentrum, Karolinska University Hospital, Halsovagen 1, SE-141 86 Stockholm, Sweden. matthias.lohr@ki.se.',\n",
       "                'Gastrocentrum, Karolinska University Hospital, Halsovagen 1, SE-141 86 Stockholm, Sweden. St.Haas@gmx.de.',\n",
       "                'Institute of Diagnostic und Interventional Radiology, University Medicine Rostock, Ernst-Heydemann-Strasse 6, D-18057 Rostock, Germany. jens-christian.kroeger@med.uni-rostock.de.',\n",
       "                'Department of Surgery, Klinikum rechts der Isar der Technischen Universitat Munchen, Ismaninger Strasse 22, D-81675 Munich, Germany. helmut@friess.cc.',\n",
       "                'Abteilung fur Gastroenterologie, Klinik und Poliklinik fur Innere Medizin, Universitat Rostock, Ernst-Heydemann-Strasse 6, D-18057 Rostock, Germany. Raimund.Hoeft@med.uni-rostock.de.',\n",
       "                'Chirurgische Klinik und Poliklinik, Medizinische Einrichtungen der Heinrich Heine Universitat, Moorenstrasse 5, D-40225 Dusseldorf, Germany. pgoretzki@lukasneuss.de.',\n",
       "                'Medizinische Klinik und Poliklinik, Klinikum Rechts der Isar der Technischen Universitat Munchen III, Ismaninger Strasse 22, D-81675 Munich, Germany. christian.peschel@lrz.tu-muenchen.de.',\n",
       "                'Medizinische Klinik (Onkologie/Hamatologie) Campus Mitte, Universitatsklinikum Charite II, Schumannstrasse 21/22, D-10098 Berlin, Germany. info@onkologie-hellersdorf.de.',\n",
       "                'Austrianova Singapore Pte Ltd, Centros, Biopolis, Singapore. salmons@sgaustria.com.',\n",
       "                'Austrianova Singapore Pte Ltd, Centros, Biopolis, Singapore. gunzburg@sgaustria.com.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'DEP': '20140811',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Pharmaceutics',\n",
       "               'JT': 'Pharmaceutics',\n",
       "               'JID': '101534003',\n",
       "               'PMC': 'PMC4190529',\n",
       "               'EDAT': '2014/08/15 06:00',\n",
       "               'MHDA': '2014/08/15 06:01',\n",
       "               'PMCR': ['2014/09/01'],\n",
       "               'CRDT': ['2014/08/14 06:00'],\n",
       "               'PHST': ['2014/03/24 00:00 [received]',\n",
       "                '2014/07/02 00:00 [revised]',\n",
       "                '2014/07/30 00:00 [accepted]',\n",
       "                '2014/08/14 06:00 [entrez]',\n",
       "                '2014/08/15 06:00 [pubmed]',\n",
       "                '2014/08/15 06:01 [medline]',\n",
       "                '2014/09/01 00:00 [pmc-release]'],\n",
       "               'AID': ['pharmaceutics6030447 [pii]',\n",
       "                'pharmaceutics-06-00447 [pii]',\n",
       "                '10.3390/pharmaceutics6030447 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Pharmaceutics. 2014 Aug 11;6(3):447-66. doi: 10.3390/pharmaceutics6030447.'},\n",
       "              {'PMID': '24880888',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20141016',\n",
       "               'LR': '20220330',\n",
       "               'IS': '1097-6833 (Electronic) 0022-3476 (Linking)',\n",
       "               'VI': '165',\n",
       "               'IP': '2',\n",
       "               'DP': '2014 Aug',\n",
       "               'TI': 'Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very low birth weight infants.',\n",
       "               'PG': '285-289.e1',\n",
       "               'LID': 'S0022-3476(14)00382-5 [pii] 10.1016/j.jpeds.2014.04.029 [doi]',\n",
       "               'AB': 'OBJECTIVE: To evaluate outcome data in an observational cohort of very low birth weight infants of the German Neonatal Network stratified to prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics. STUDY DESIGN: Within the observational period (September 1, 2010, until December 31, 2012, n=5351 infants) study centers were categorized into 3 groups based on their choice of Lactobacillus acidophilus/Bifidobacterium infantis use: (1) no prophylactic use (12 centers); (2 a/b) change of strategy nonuser to user during observational period (13 centers); and (3) use before start of observation (21 centers). Primary outcome data of all eligible infants were determined according to center-specific strategy. RESULTS: The use of probiotics was associated with a reduced risk for necrotizing enterocolitis surgery (group 1 vs group 3: 4.2 vs 2.6%, P=.028; change of strategy: 6.2 vs 4.0%, P<.001), any abdominal surgery, and hospital mortality. Infants treated with probiotics had improved weight gain/day, and probiotics had no effect on the risk of blood-culture confirmed sepsis. In a multivariable logistic regression analysis, probiotics were protective for necrotizing enterocolitis surgery (OR 0.58, 95% CI 0.37-0.91; P=.017), any abdominal surgery (OR 0.7, 95% CI 0.51-0.95; P=.02), and the combined outcome abdominal surgery and/or death (OR 0.43; 95% CI 0.33-0.56; P<.001). CONCLUSIONS: Our observational data support the use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics to reduce the risk for gastrointestinal morbidity but not sepsis in very low birth weight infants.',\n",
       "               'CI': ['Copyright (c) 2014 Elsevier Inc. All rights reserved.'],\n",
       "               'FAU': ['Hartel, Christoph',\n",
       "                'Pagel, Julia',\n",
       "                'Rupp, Jan',\n",
       "                'Bendiks, Meike',\n",
       "                'Guthmann, Florian',\n",
       "                'Rieger-Fackeldey, Esther',\n",
       "                'Heckmann, Matthias',\n",
       "                'Franz, Axel',\n",
       "                'Schiffmann, Jan-Holger',\n",
       "                'Zimmermann, Beate',\n",
       "                'Hepping, Nico',\n",
       "                'von der Wense, Axel',\n",
       "                'Wieg, Christian',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Hartel C',\n",
       "                'Pagel J',\n",
       "                'Rupp J',\n",
       "                'Bendiks M',\n",
       "                'Guthmann F',\n",
       "                'Rieger-Fackeldey E',\n",
       "                'Heckmann M',\n",
       "                'Franz A',\n",
       "                'Schiffmann JH',\n",
       "                'Zimmermann B',\n",
       "                'Hepping N',\n",
       "                'von der Wense A',\n",
       "                'Wieg C',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AD': ['Department of Pediatrics, University at Lubeck, Lubeck, Germany. Electronic address: christoph.haertel@uksh.de.',\n",
       "                'Department of Pediatrics, University at Lubeck, Lubeck, Germany.',\n",
       "                'Institute for Medical Microbiology and Hygiene of the University at Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University at Lubeck, Lubeck, Germany.',\n",
       "                'Department of Neonatology, University of Tubingen, Tubingen, Germany.',\n",
       "                \"Children's Hospitals Hannover Auf der Bult, Hannover, Germany.\",\n",
       "                'Department of Pediatrics at University of Munster, Munster, Germany.',\n",
       "                'Department of Pediatrics, University of Greifswald, Greifswald, Germany.',\n",
       "                \"Children's Hospital (Stadtisches Klinikum) Nurmberg, Nurnberg, Germany.\",\n",
       "                'Department of Pediatrics, GFO Hospitals Bonn, St. Marien Hospital, Bonn, Germany.',\n",
       "                'Department of Pediatrics, University at Lubeck, Lubeck, Germany.',\n",
       "                \"Department of Neonatology, Children's Hospital Hamburg-Altona, Hamburg-Altona, Germany.\",\n",
       "                'Department of Neonatology and Pediatric Intensive Care, Klinikum Aschaffenburg, Aschaffenburg, Germany.',\n",
       "                'Department of Pediatrics, University at Lubeck, Lubeck, Germany.',\n",
       "                'Department of Pediatrics, University at Lubeck, Lubeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Multicenter Study',\n",
       "                'Observational Study',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20140529',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Pediatr',\n",
       "               'JT': 'The Journal of pediatrics',\n",
       "               'JID': '0375410',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['*Bifidobacterium',\n",
       "                'Cohort Studies',\n",
       "                'Enterocolitis, Necrotizing/epidemiology/*prevention & control',\n",
       "                'Female',\n",
       "                'Germany',\n",
       "                'Hospital Mortality',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                '*Infant, Very Low Birth Weight',\n",
       "                '*Lactobacillus acidophilus',\n",
       "                'Male',\n",
       "                'Probiotics/*administration & dosage',\n",
       "                'Risk Factors',\n",
       "                'Treatment Outcome'],\n",
       "               'FIR': ['Avenarius, Stefan',\n",
       "                'Bockenholt, Kai',\n",
       "                'Bohnhorst, Bettina',\n",
       "                'Dordelmann, Michael',\n",
       "                'Ehlers, Silke',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Gebauer, Corinna',\n",
       "                'Gerleve, Hubert',\n",
       "                'Gortner, Ludwig',\n",
       "                'Groneck, Peter',\n",
       "                'Heitmann, Friedhelm',\n",
       "                'Hillebrand, Georg',\n",
       "                'Hohn, Thomas',\n",
       "                'Hubert, Mechthild',\n",
       "                'Hummler, Helmut',\n",
       "                'Jenke, Andreas',\n",
       "                'Jensen, Reinhard',\n",
       "                'Kannt, Olaf',\n",
       "                'Kribs, Angela',\n",
       "                'Kuster, Helmut',\n",
       "                'Laux, Reinhard',\n",
       "                'Lieser, Ursula',\n",
       "                'Mogel, Michael',\n",
       "                'Moller, Jens',\n",
       "                'Mller, Dirk',\n",
       "                'Nikischin, Werner',\n",
       "                'Olbertz, Dirk',\n",
       "                'Orlikowsky, Thorsten',\n",
       "                'Reese, Jochen',\n",
       "                'Roll, Claudia',\n",
       "                'Schaible, Thomas',\n",
       "                'Seelinger, Stefan',\n",
       "                'Segerer, Hugo',\n",
       "                'Teig, Norbert',\n",
       "                'Weller, Ursula',\n",
       "                'Vochem, Matthias',\n",
       "                'Wintgens, Jurgen'],\n",
       "               'IR': ['Avenarius S',\n",
       "                'Bockenholt K',\n",
       "                'Bohnhorst B',\n",
       "                'Dordelmann M',\n",
       "                'Ehlers S',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Gebauer C',\n",
       "                'Gerleve H',\n",
       "                'Gortner L',\n",
       "                'Groneck P',\n",
       "                'Heitmann F',\n",
       "                'Hillebrand G',\n",
       "                'Hohn T',\n",
       "                'Hubert M',\n",
       "                'Hummler H',\n",
       "                'Jenke A',\n",
       "                'Jensen R',\n",
       "                'Kannt O',\n",
       "                'Kribs A',\n",
       "                'Kuster H',\n",
       "                'Laux R',\n",
       "                'Lieser U',\n",
       "                'Mogel M',\n",
       "                'Moller J',\n",
       "                'Mller D',\n",
       "                'Nikischin W',\n",
       "                'Olbertz D',\n",
       "                'Orlikowsky T',\n",
       "                'Reese J',\n",
       "                'Roll C',\n",
       "                'Schaible T',\n",
       "                'Seelinger S',\n",
       "                'Segerer H',\n",
       "                'Teig N',\n",
       "                'Weller U',\n",
       "                'Vochem M',\n",
       "                'Wintgens J'],\n",
       "               'EDAT': '2014/06/02 06:00',\n",
       "               'MHDA': '2014/10/17 06:00',\n",
       "               'CRDT': ['2014/06/02 06:00'],\n",
       "               'PHST': ['2013/11/18 00:00 [received]',\n",
       "                '2014/01/28 00:00 [revised]',\n",
       "                '2014/04/15 00:00 [accepted]',\n",
       "                '2014/06/02 06:00 [entrez]',\n",
       "                '2014/06/02 06:00 [pubmed]',\n",
       "                '2014/10/17 06:00 [medline]'],\n",
       "               'AID': ['S0022-3476(14)00382-5 [pii]',\n",
       "                '10.1016/j.jpeds.2014.04.029 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Pediatr. 2014 Aug;165(2):285-289.e1. doi: 10.1016/j.jpeds.2014.04.029. Epub 2014 May 29.'},\n",
       "              {'PMID': '24867468',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20150914',\n",
       "               'LR': '20211021',\n",
       "               'IS': '1432-2323 (Electronic) 0364-2313 (Linking)',\n",
       "               'VI': '38',\n",
       "               'IP': '10',\n",
       "               'DP': '2014 Oct',\n",
       "               'TI': 'Postoperative vocal cord dysfunction despite normal intraoperative neuromonitoring: an unexpected complication with the risk of bilateral palsy.',\n",
       "               'PG': '2597-602',\n",
       "               'LID': '10.1007/s00268-014-2591-2 [doi]',\n",
       "               'AB': 'BACKGROUND: Intraoperative neuromonitoring (IONM) has become standard practice in thyroid surgery for many surgeons. It reduces the risk of vocal cord palsy in high-risk patients and has led to two-stage operations to prevent bilateral palsies. The specificity of detecting nerve injuries is not 100 %, leading to patients with vocal cord dysfunction (VCD) despite regular neuromonitoring (false-negative IONM). We aimed to evaluate possible risk factors for this phenomenon and its importance regarding bilateral palsies. METHODS: We performed a retrospective analysis of all patients with false-negative IONM. RESULTS: A total of 2152 patients (3426 nerves at risk) underwent surgery for benign disease between January 2008 and October 2010. Sensitivity for predicting VCD was 85.4 % and specificity 99.0 %. The positive predictive value was 68.0 % and the negative predictive value 99.6 %. We were not able to identify risk factors for false-negative IONM. We found four patients with delayed occurrence of VCD after regular IONM (1-8 weeks). We registered two patients with bilateral VCD after false negative IONM on the first side of bilateral resections (2/7) and four patients with bilateral palsy after correct IONM (4/1256). The relative risk for bilateral VCD between patients with false-negative IONM on the primary resection side and patients with correct IONM was 89.7. CONCLUSIONS: Although seldom, false-negative IONM is of clinical importance as it bears a high risk of bilateral VCD if it occurs on the first side of a bilateral resection. It can also have a latent occurrence after surgery.',\n",
       "               'FAU': ['Melin, Magnus',\n",
       "                'Schwarz, Katharina',\n",
       "                'Pearson, Marc D',\n",
       "                'Lammers, Bernhard J',\n",
       "                'Goretzki, Peter E'],\n",
       "               'AU': ['Melin M',\n",
       "                'Schwarz K',\n",
       "                'Pearson MD',\n",
       "                'Lammers BJ',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Department of General, Visceral, Endocrine, Thoracic, and Vascular Surgery, Lukaskrankenhaus GmbH Neuss, 84 Preussenstrasse, 41464, Neuss, Germany, mmelin@lukasneuss.de.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'SB': 'IM',\n",
       "               'CIN': ['World J Surg. 2014 Oct;38(10):2603-4. doi: 10.1007/s00268-014-2616-x. PMID:',\n",
       "                '24791671',\n",
       "                'World J Surg. 2015 Jun;39(6):1586. doi: 10.1007/s00268-014-2893-4. PMID: 25446483'],\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'False Negative Reactions',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                '*Monitoring, Intraoperative',\n",
       "                'Postoperative Period',\n",
       "                'Predictive Value of Tests',\n",
       "                'Retrospective Studies',\n",
       "                'Risk Factors',\n",
       "                'Thyroid Diseases/surgery',\n",
       "                'Thyroidectomy/*adverse effects',\n",
       "                'Vocal Cord Dysfunction/*etiology',\n",
       "                'Vocal Cord Paralysis/*etiology'],\n",
       "               'EDAT': '2014/05/29 06:00',\n",
       "               'MHDA': '2015/09/15 06:00',\n",
       "               'CRDT': ['2014/05/29 06:00'],\n",
       "               'PHST': ['2014/05/29 06:00 [entrez]',\n",
       "                '2014/05/29 06:00 [pubmed]',\n",
       "                '2015/09/15 06:00 [medline]'],\n",
       "               'AID': ['10.1007/s00268-014-2591-2 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 2014 Oct;38(10):2597-602. doi: 10.1007/s00268-014-2591-2.'},\n",
       "              {'PMID': '24671468',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20150114',\n",
       "               'LR': '20211021',\n",
       "               'IS': '1432-1963 (Electronic) 0172-8113 (Linking)',\n",
       "               'VI': '35',\n",
       "               'IP': '3',\n",
       "               'DP': '2014 May',\n",
       "               'TI': '[Neuroendocrine neoplasms of the distal jejunum and ileum].',\n",
       "               'PG': '283-93; quiz 294',\n",
       "               'LID': '10.1007/s00292-013-1888-5 [doi]',\n",
       "               'AB': 'Neuroendocrine neoplasms (NEN) of the distal jejunum and ileum derive from serotonin-producing enterochromaffin (EC) cells. Due to their low proliferation rate and their infiltrative growth, they are often discovered at an advanced disease stage when metastasis has already occurred. The biology of these tumours is different from other NEN of the digestive tract. In order to standardise and improve diagnosis and therapy, the guidelines for the diagnosis and clinical management of jejuno-ileal NEN as well as for the management of patients with liver and other distant metastases from NEN were revised by the European Neuroendocrine Tumour Society (ENETS) in 2012. This review focuses on aspects relevant for surgical pathology.',\n",
       "               'FAU': ['Anlauf, M',\n",
       "                'Sipos, B',\n",
       "                'Boeck, I',\n",
       "                'Baldus, S E',\n",
       "                'Heikaus, S',\n",
       "                'Krausch, M',\n",
       "                'Knoefel, W T',\n",
       "                'Begum, N',\n",
       "                'Goretzki, P',\n",
       "                'Schott, M',\n",
       "                'Auernhammer, C J',\n",
       "                'Cremer, B',\n",
       "                'Rinke, A',\n",
       "                'Ezziddin, S',\n",
       "                'Fottner, C',\n",
       "                'Popperl, G',\n",
       "                'Lahner, H',\n",
       "                'Horsch, D',\n",
       "                'Gabbert, H E',\n",
       "                'Komminoth, P',\n",
       "                'Perren, A',\n",
       "                'Kloppel, G',\n",
       "                'Wiedenmann, B',\n",
       "                'Pavel, M',\n",
       "                'Pape, U'],\n",
       "               'AU': ['Anlauf M',\n",
       "                'Sipos B',\n",
       "                'Boeck I',\n",
       "                'Baldus SE',\n",
       "                'Heikaus S',\n",
       "                'Krausch M',\n",
       "                'Knoefel WT',\n",
       "                'Begum N',\n",
       "                'Goretzki P',\n",
       "                'Schott M',\n",
       "                'Auernhammer CJ',\n",
       "                'Cremer B',\n",
       "                'Rinke A',\n",
       "                'Ezziddin S',\n",
       "                'Fottner C',\n",
       "                'Popperl G',\n",
       "                'Lahner H',\n",
       "                'Horsch D',\n",
       "                'Gabbert HE',\n",
       "                'Komminoth P',\n",
       "                'Perren A',\n",
       "                'Kloppel G',\n",
       "                'Wiedenmann B',\n",
       "                'Pavel M',\n",
       "                'Pape U'],\n",
       "               'AD': ['Institut fur Pathologie, Sektion fur Neuroendokrine Neoplasien, Endokrines Tumorzentrum und Deutsches NET-Register, Universitatsklinikum Dusseldorf, Dusseldorf, Deutschland, anlauf@patho-limburg.de.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article', 'Review'],\n",
       "               'TT': 'Neuroendokrine Neoplasien des distalen Jejunums und Ileums.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Pathologe',\n",
       "               'JT': 'Der Pathologe',\n",
       "               'JID': '8006541',\n",
       "               'RN': ['0 (Receptors, Somatostatin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Cell Proliferation',\n",
       "                'Diagnosis, Differential',\n",
       "                'Disease Progression',\n",
       "                'Enterochromaffin Cells/pathology',\n",
       "                'Humans',\n",
       "                'Ileal Neoplasms/*pathology/surgery',\n",
       "                'Ileum/pathology/surgery',\n",
       "                'Jejunal Neoplasms/*pathology/surgery',\n",
       "                'Jejunum/pathology/surgery',\n",
       "                'Neuroendocrine Tumors/*pathology/surgery',\n",
       "                'Practice Guidelines as Topic',\n",
       "                'Receptors, Somatostatin/analysis'],\n",
       "               'EDAT': '2014/03/29 06:00',\n",
       "               'MHDA': '2015/01/15 06:00',\n",
       "               'CRDT': ['2014/03/28 06:00'],\n",
       "               'PHST': ['2014/03/28 06:00 [entrez]',\n",
       "                '2014/03/29 06:00 [pubmed]',\n",
       "                '2015/01/15 06:00 [medline]'],\n",
       "               'AID': ['10.1007/s00292-013-1888-5 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Pathologe. 2014 May;35(3):283-93; quiz 294. doi: 10.1007/s00292-013-1888-5.'},\n",
       "              {'PMID': '24632475',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20160816',\n",
       "               'LR': '20181202',\n",
       "               'IS': '1879-176X (Electronic) 0300-5712 (Linking)',\n",
       "               'VI': '42',\n",
       "               'IP': '6',\n",
       "               'DP': '2014 Jun',\n",
       "               'TI': 'Prevalence of xerostomia and hyposalivation and their association with quality of life in elderly patients in dependence on dental status and prosthetic rehabilitation: a pilot study.',\n",
       "               'PG': '664-70',\n",
       "               'LID': 'S0300-5712(14)00084-0 [pii] 10.1016/j.jdent.2014.03.003 [doi]',\n",
       "               'AB': 'OBJECTIVES: The aims of this pilot study were to investigate the prevalence of xerostomia and hyposalivation and their impact on quality of life in a cohort of elderly patients including dental status and the character of potential prosthetic restorations as independent variables. METHODS: Patients aged 60 years or older without any objective or subjective need for prosthodontic treatment taking part in a regular recall programme were included in the trial. Quality of life was assessed using the German version of the GOHAI; prevalence and severity of xerostomia was investigated using the shortened version of the Xerostomia Inventory (XI). Stimulated salivary flow rate was determined using a sialometric approach. Dental status and the character of prosthetic restorations (no/fixed restorations and removable but tooth-supported dentures vs. gum-supported dentures) were assessed in a clinical examination by experienced dentists specialized in prosthodontic treatment. RESULTS: A total of 68 patients were included in the trial; a prevalence of xerostomia of 16% and a prevalence of hyposalivation of 31% were identified. The quality of life in the study cohort decreased significantly as a function of xerostomia severity but not salivary flow; moreover, a significant impact of the number of teeth/implants in the upper jaw and the presence of gum-supported dentures in both jaws on GOHAI scores could be identified. CONCLUSIONS: Within the limitations of a pilot study, the results support the assumption that the quality of life in elderly patients is particularly related to their subjective perception of xerostomia. A decline in salivary flow, the dental status and the character of prosthetic restorations appear to play a subordinate role for the quality of life in elderly patients. CLINICAL SIGNIFICANCE: The quality of life in elderly patients may be severely diminished due to an increased subjective perception of dry mouth. Dental treatment should focus on alleviating xerostomia, whereas the impact of dental status and prosthetic restoration appear to be subordinate.',\n",
       "               'CI': ['Copyright (c) 2014 Elsevier Ltd. All rights reserved.'],\n",
       "               'FAU': ['Hahnel, Sebastian',\n",
       "                'Schwarz, Simone',\n",
       "                'Zeman, Florian',\n",
       "                'Schafer, Lina',\n",
       "                'Behr, Michael'],\n",
       "               'AU': ['Hahnel S',\n",
       "                'Schwarz S',\n",
       "                'Zeman F',\n",
       "                'Schafer L',\n",
       "                'Behr M'],\n",
       "               'AD': ['Department of Prosthodontics, Regensburg University Medical Center, Regensburg, Germany. Electronic address: Sebastian.Hahnel@ukr.de.',\n",
       "                'Department of Prosthodontics, Regensburg University Medical Center, Regensburg, Germany.',\n",
       "                'Centre for Clinical Trials, Regensburg University Medical Center, Regensburg, Germany.',\n",
       "                'Department of Prosthodontics, Regensburg University Medical Center, Regensburg, Germany.',\n",
       "                'Department of Prosthodontics, Regensburg University Medical Center, Regensburg, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20140314',\n",
       "               'PL': 'England',\n",
       "               'TA': 'J Dent',\n",
       "               'JT': 'Journal of dentistry',\n",
       "               'JID': '0354422',\n",
       "               'RN': ['0 (Dental Implants)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Anxiety/psychology',\n",
       "                'Cohort Studies',\n",
       "                'Crowns/psychology/statistics & numerical data',\n",
       "                'Dental Implants/psychology/statistics & numerical data',\n",
       "                'Dental Prosthesis/*psychology/statistics & numerical data',\n",
       "                'Denture, Complete/psychology/statistics & numerical data',\n",
       "                'Denture, Partial, Fixed/psychology/statistics & numerical data',\n",
       "                'Denture, Partial, Removable/psychology/statistics & numerical data',\n",
       "                'Eating/physiology',\n",
       "                'Female',\n",
       "                'Geriatric Assessment',\n",
       "                'Humans',\n",
       "                'Interpersonal Relations',\n",
       "                'Male',\n",
       "                'Mastication/physiology',\n",
       "                'Middle Aged',\n",
       "                '*Oral Health',\n",
       "                'Pilot Projects',\n",
       "                '*Quality of Life',\n",
       "                'Saliva/metabolism',\n",
       "                'Secretory Rate/physiology',\n",
       "                'Speech/physiology',\n",
       "                'Xerostomia/*psychology'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Hyposalivation', 'Quality of life', 'Xerostomia'],\n",
       "               'EDAT': '2014/03/19 06:00',\n",
       "               'MHDA': '2016/08/17 06:00',\n",
       "               'CRDT': ['2014/03/18 06:00'],\n",
       "               'PHST': ['2013/09/23 00:00 [received]',\n",
       "                '2014/02/04 00:00 [revised]',\n",
       "                '2014/03/06 00:00 [accepted]',\n",
       "                '2014/03/18 06:00 [entrez]',\n",
       "                '2014/03/19 06:00 [pubmed]',\n",
       "                '2016/08/17 06:00 [medline]'],\n",
       "               'AID': ['S0300-5712(14)00084-0 [pii]',\n",
       "                '10.1016/j.jdent.2014.03.003 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Dent. 2014 Jun;42(6):664-70. doi: 10.1016/j.jdent.2014.03.003. Epub 2014 Mar 14.'},\n",
       "              {'PMID': '24306821',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20141014',\n",
       "               'LR': '20211021',\n",
       "               'IS': '1432-1262 (Electronic) 0179-1958 (Linking)',\n",
       "               'VI': '29',\n",
       "               'IP': '3',\n",
       "               'DP': '2014 Mar',\n",
       "               'TI': 'Functional long-term results after rectal cancer surgery--technique of the athermal mesorectal excision.',\n",
       "               'PG': '285-92',\n",
       "               'LID': '10.1007/s00384-013-1805-7 [doi]',\n",
       "               'AB': 'PURPOSE: The total mesorectal excision (TME), embedded in a multimodal therapeutic concept, is accepted as the standard therapy of the advanced adenocarcinoma of the middle and lower thirds. The thermal damages of the autonomous nerves in the little pelvis caused by dissection devices remains a large problem. For our patients, we use water-jet dissection (WJD)-aided TME with the intention to minimise the rate of bladder and sexual function disorders. METHODS: From October 2001 until June 2010, we recorded 125 patients with an adenocarcinoma of the middle and lower third of the rectum. Ninety deep anterior rectum resections and 35 abdominoperineal rectum extirpations by WJD were performed. Of the patients, 27.2 % received neoadjuvant radiochemotherapy. Bladder and sexual function disorders were assessed by International Prostate Symptom Score and International Index of Erectile Function. RESULTS: The median follow-up period was 46 (2-117) months. Considering a local recurrence rate of 9.6 %, the tumour-specific 5-year survival of the entire collective was 75.4 %. Long-term bladder function disorders showed in 6.0 % (4/64) and sexual function disorders in 25.0 % (9/36) of the male patients in the course of time. CONCLUSION: The specific advantage of the WJD technique is not only the facilitated dissection between the mesorectal fascia and the surrounding nervous structures in the little pelvis but also a completely athermal TME. The rate of bladder and sexual function disorders is an excellent result compared to that of international centres. Due to the size of the patient collective and the retrospective character of the study, further studies are necessary to validate the presented results.',\n",
       "               'FAU': ['Touloumtzidis, Aristotelis',\n",
       "                'Sostmann, Bjorn',\n",
       "                'Hilgers, Nicole',\n",
       "                'Renter, Marc A',\n",
       "                'Kuhn, Petra',\n",
       "                'Goretzki, Peter E',\n",
       "                'Lammers, Bernhard J'],\n",
       "               'AU': ['Touloumtzidis A',\n",
       "                'Sostmann B',\n",
       "                'Hilgers N',\n",
       "                'Renter MA',\n",
       "                'Kuhn P',\n",
       "                'Goretzki PE',\n",
       "                'Lammers BJ'],\n",
       "               'AD': ['Department of General Surgery, Stadtisches Klinikum, Lukaskrankenhaus Neuss, Neuss, Germany, ATouloumtzidis@web.de.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20131205',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Int J Colorectal Dis',\n",
       "               'JT': 'International journal of colorectal disease',\n",
       "               'JID': '8607899',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma/pathology/*surgery',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Autonomic Pathways/injuries',\n",
       "                'Chemoradiotherapy, Adjuvant',\n",
       "                'Dissection/*adverse effects/*methods',\n",
       "                'Fasciotomy',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Neoadjuvant Therapy',\n",
       "                'Pelvis/innervation',\n",
       "                'Rectal Neoplasms/pathology/*surgery',\n",
       "                'Rectum/*surgery',\n",
       "                'Retrospective Studies',\n",
       "                'Sexual Dysfunction, Physiological/*etiology',\n",
       "                'Survival Rate',\n",
       "                'Urination Disorders/*etiology'],\n",
       "               'EDAT': '2013/12/07 06:00',\n",
       "               'MHDA': '2014/10/15 06:00',\n",
       "               'CRDT': ['2013/12/06 06:00'],\n",
       "               'PHST': ['2013/11/20 00:00 [accepted]',\n",
       "                '2013/12/06 06:00 [entrez]',\n",
       "                '2013/12/07 06:00 [pubmed]',\n",
       "                '2014/10/15 06:00 [medline]'],\n",
       "               'AID': ['10.1007/s00384-013-1805-7 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Int J Colorectal Dis. 2014 Mar;29(3):285-92. doi: 10.1007/s00384-013-1805-7. Epub 2013 Dec 5.'},\n",
       "              {'PMID': '24263684',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20141021',\n",
       "               'LR': '20211021',\n",
       "               'IS': '1435-2451 (Electronic) 1435-2443 (Linking)',\n",
       "               'VI': '399',\n",
       "               'IP': '2',\n",
       "               'DP': '2014 Feb',\n",
       "               'TI': 'Multifocal papillary thyroid carcinoma--a consensus report of the European Society of Endocrine Surgeons (ESES).',\n",
       "               'PG': '141-54',\n",
       "               'LID': '10.1007/s00423-013-1145-7 [doi]',\n",
       "               'AB': 'BACKGROUND: Multifocal papillary thyroid carcinoma (MPTC) has been reported in literature in 18-87 % of cases. This paper aims to review controversies in the molecular pathogenesis, prognosis, and management of MPTC. METHODS: A review of English-language literature focusing on MPTC was carried out, and analyzed in an evidence-based perspective. Results were discussed at the 2013 Workshop of the European Society of Endocrine Surgeons devoted to surgery of thyroid carcinoma. RESULTS: Literature reports no prospective randomized studies; thus, a relatively low level of evidence may be achieved. CONCLUSIONS: MPTC could be the result of either true multicentricity or intrathyroidal metastasis from a single malignant focus. Radiation and familial nonmedullary thyroid carcinoma are conditions at risk of MPTC development. The prognostic importance of multifocal tumor growth in PTC remains controversial. Prognosis might be impaired in clinical MPTC but less or none in MPTC <1 cm. MPTC can be diagnosed preoperatively by FNAB and US, with low sensitivity for MPTC <1 cm. Total or near-total thyroidectomy is indicated to reduce the risk of local recurrence. Prophylactic central node dissection should be considered in patients with total tumor diameter >1 cm, or in cases with high number of cancer foci. Completion thyroidectomy might be necessary when MPTC is diagnosed after less than near-total thyroidectomy. Radioactive iodine ablation should be considered in selected patients with MPTC at increased risk of recurrence or metastatic spread.',\n",
       "               'FAU': ['Iacobone, Maurizio',\n",
       "                'Jansson, Svante',\n",
       "                'Barczynski, Marcin',\n",
       "                'Goretzki, Peter'],\n",
       "               'AU': ['Iacobone M', 'Jansson S', 'Barczynski M', 'Goretzki P'],\n",
       "               'AD': ['Minimally Invasive Endocrine Surgery Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Via Giustiniani 2, 35128, Padua, Italy, maurizio.iacobone@unipd.it.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Consensus Development Conference',\n",
       "                'Journal Article',\n",
       "                'Review'],\n",
       "               'DEP': '20131122',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma, Papillary/diagnosis/genetics/pathology/*surgery',\n",
       "                'Cell Transformation, Neoplastic/genetics/pathology',\n",
       "                'Chernobyl Nuclear Accident',\n",
       "                'Combined Modality Therapy',\n",
       "                'DNA Mutational Analysis',\n",
       "                'Disease Progression',\n",
       "                'Europe',\n",
       "                'Neck Dissection',\n",
       "                'Neoplasm Staging',\n",
       "                'Neoplasms, Multiple Primary/diagnosis/genetics/pathology/*surgery',\n",
       "                'Neoplasms, Radiation-Induced/diagnosis/genetics/pathology/surgery',\n",
       "                'Prognosis',\n",
       "                'Radiotherapy, Adjuvant',\n",
       "                'Risk Factors',\n",
       "                'Thyroid Neoplasms/diagnosis/genetics/pathology/*surgery',\n",
       "                'Thyroidectomy'],\n",
       "               'EDAT': '2013/11/23 06:00',\n",
       "               'MHDA': '2014/10/22 06:00',\n",
       "               'CRDT': ['2013/11/23 06:00'],\n",
       "               'PHST': ['2013/10/22 00:00 [received]',\n",
       "                '2013/11/10 00:00 [accepted]',\n",
       "                '2013/11/23 06:00 [entrez]',\n",
       "                '2013/11/23 06:00 [pubmed]',\n",
       "                '2014/10/22 06:00 [medline]'],\n",
       "               'AID': ['10.1007/s00423-013-1145-7 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 2014 Feb;399(2):141-54. doi: 10.1007/s00423-013-1145-7. Epub 2013 Nov 22.'},\n",
       "              {'PMID': '24077462',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'DCOM': '20140714',\n",
       "               'LR': '20131127',\n",
       "               'IS': '1477-9234 (Electronic) 1477-9226 (Linking)',\n",
       "               'VI': '43',\n",
       "               'IP': '1',\n",
       "               'DP': '2014 Jan 7',\n",
       "               'TI': 'Photophysics and electrochemistry of a platinum-acetylide disubstituted perylenediimide.',\n",
       "               'PG': '85-94',\n",
       "               'LID': '10.1039/c3dt50874a [doi]',\n",
       "               'AB': 'The synthesis and photophysical study of a perylene diimide (PDI) functionalised with platinum acetylide units of the type, trans-C identical withC-Pt(PBu3)2-C identical withC-Ph and comparison with a phenylacetylide substituted model compound are reported. The model compound demonstrates typical perylene absorption and photoluminescence spectra characteristic of singlet excited state formation and decay. The Pt-substitution, however, appears to induce spin-orbit coupling into the chromophore and giving rise to a triplet excited state which was confirmed by transient absorption measurements. This excited state is quenched by oxygen, leading to the formation of singlet oxygen in dichloromethane, recorded by time-resolved near-infrared luminescence measurements.',\n",
       "               'FAU': ['Llewellyn, Ben A',\n",
       "                'Slater, Anna G',\n",
       "                'Goretzki, Gudrun',\n",
       "                'Easun, Timothy L',\n",
       "                'Sun, Xue-Zhong',\n",
       "                'Davies, E Stephen',\n",
       "                'Argent, Stephen P',\n",
       "                'Lewis, William',\n",
       "                'Beeby, Andrew',\n",
       "                'George, Michael W',\n",
       "                'Champness, Neil R'],\n",
       "               'AU': ['Llewellyn BA',\n",
       "                'Slater AG',\n",
       "                'Goretzki G',\n",
       "                'Easun TL',\n",
       "                'Sun XZ',\n",
       "                'Davies ES',\n",
       "                'Argent SP',\n",
       "                'Lewis W',\n",
       "                'Beeby A',\n",
       "                'George MW',\n",
       "                'Champness NR'],\n",
       "               'AD': ['School of Chemistry, University of Nottingham, University Park, Nottingham, NG7 2RD, UK. Neil.Champness@nottingham.ac.uk Mike.George@nottingham.ac.uk.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Dalton Trans',\n",
       "               'JT': 'Dalton transactions (Cambridge, England : 2003)',\n",
       "               'JID': '101176026',\n",
       "               'EDAT': '2013/10/01 06:00',\n",
       "               'MHDA': '2013/10/01 06:01',\n",
       "               'CRDT': ['2013/10/01 06:00'],\n",
       "               'PHST': ['2013/10/01 06:00 [entrez]',\n",
       "                '2013/10/01 06:00 [pubmed]',\n",
       "                '2013/10/01 06:01 [medline]'],\n",
       "               'AID': ['10.1039/c3dt50874a [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Dalton Trans. 2014 Jan 7;43(1):85-94. doi: 10.1039/c3dt50874a.'},\n",
       "              {'PMID': '24063979',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20140203',\n",
       "               'LR': '20201113',\n",
       "               'IS': '1879-1220 (Electronic) 0960-0760 (Linking)',\n",
       "               'VI': '139',\n",
       "               'DP': '2014 Jan',\n",
       "               'TI': 'Hedgehog-signaling is upregulated in non-producing human adrenal adenomas and antagonism of hedgehog-signaling inhibits proliferation of NCI-H295R cells and an immortalized primary human adrenal cell line.',\n",
       "               'PG': '7-15',\n",
       "               'LID': 'S0960-0760(13)00181-7 [pii] 10.1016/j.jsbmb.2013.09.007 [doi]',\n",
       "               'AB': 'Hedgehog (Hh)-signaling pathway is important in embryonic development. Activation of Hh-signaling is associated with tumorigenesis. Recent studies demonstrate that Hh-signaling is involved in the development of the adrenal gland in mice and is important in regulating adrenal proliferation. We studied the expression of Sonic hedgehog (SHH), Smoothened (SMO), Patched1 (PTCH1) and GLI family zinc finger 1 (GLI1) in human adrenal and in adrenocortical tumors using immunohistochemistry and semi-quantitative reverse transcriptase-polymerase chain reaction. Modulation of GLI1 and SMO messenger ribonucleic acid (mRNA) expression was investigated with forskolin. The role of Hh-signaling was studied in NCI-H295R cells and in an immortalized primary cell line using the Hh-agonist smoothened agonist (SAG) and the Hh-antagonist cyclopamine. The Hh-pathway components SHH, GLI1, PTCH1 and SMO were detectable in all adrenal glands. While in cortisol-producing adenomas (CPA), Hh-signaling expression levels were comparable to that in normal adrenal cortex, a much higher mRNA expression of GLI1, SMO and SHH was observed in non-producing adenomas (NPA). Interestingly, stimulation of cultured adrenal cells with forskolin led to a decrease in expression of GLI1 and SMO mRNAs. Antagonism of Hh-signaling resulted in a lower proliferation rate of adrenocortical cells, while Hh-agonism had no significant effect on adrenal cell proliferation. Our data show Hh-signaling activity in adult adrenal glands. Activation of the PKA pathway results in lower expression of Hh-signaling proteins. This might explain the lower expression of the Hh components GLI1 and SMO in CPA in comparison to the higher expression in NPA. Hh-signaling might be involved in the tumorigenesis of NPA.',\n",
       "               'CI': ['Copyright (c) 2013 Elsevier Ltd. All rights reserved.'],\n",
       "               'FAU': ['Werminghaus, Pascal',\n",
       "                'Haase, Matthias',\n",
       "                'Hornsby, Peter J',\n",
       "                'Schinner, Sven',\n",
       "                'Schott, Matthias',\n",
       "                'Malendowicz, Ludwik K',\n",
       "                'Lammers, Bernhard J',\n",
       "                'Goretzki, Peter E',\n",
       "                'Muller-Mattheis, Volker',\n",
       "                'Markus Giessing',\n",
       "                'Willenberg, Holger S'],\n",
       "               'AU': ['Werminghaus P',\n",
       "                'Haase M',\n",
       "                'Hornsby PJ',\n",
       "                'Schinner S',\n",
       "                'Schott M',\n",
       "                'Malendowicz LK',\n",
       "                'Lammers BJ',\n",
       "                'Goretzki PE',\n",
       "                'Muller-Mattheis V',\n",
       "                'Markus Giessing',\n",
       "                'Willenberg HS'],\n",
       "               'AD': ['Department of Endocrinology and Diabetology, Medical Faculty, University of Dusseldorf, D-40225 Duesseldorf, Germany; Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Medical Faculty, University of Dusseldorf, D-40225 Duesseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20130921',\n",
       "               'PL': 'England',\n",
       "               'TA': 'J Steroid Biochem Mol Biol',\n",
       "               'JT': 'The Journal of steroid biochemistry and molecular biology',\n",
       "               'JID': '9015483',\n",
       "               'RN': ['0 (GLI1 protein, human)',\n",
       "                '0 (Hedgehog Proteins)',\n",
       "                '0 (PTCH1 protein, human)',\n",
       "                '0 (Patched Receptors)',\n",
       "                '0 (Patched-1 Receptor)',\n",
       "                '0 (Ptch1 protein, mouse)',\n",
       "                '0 (Receptors, Cell Surface)',\n",
       "                '0 (Receptors, G-Protein-Coupled)',\n",
       "                '0 (SHH protein, human)',\n",
       "                '0 (SMO protein, human)',\n",
       "                '0 (Smoothened Receptor)',\n",
       "                '0 (Transcription Factors)',\n",
       "                '0 (Zinc Finger Protein GLI1)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/*metabolism',\n",
       "                'Adrenal Cortex/metabolism/pathology',\n",
       "                'Adrenal Gland Neoplasms/*metabolism',\n",
       "                'Cell Line, Tumor',\n",
       "                '*Cell Proliferation',\n",
       "                'Gene Expression',\n",
       "                'Hedgehog Proteins/genetics/*metabolism',\n",
       "                'Humans',\n",
       "                'Patched Receptors',\n",
       "                'Patched-1 Receptor',\n",
       "                'Primary Cell Culture',\n",
       "                'Receptors, Cell Surface/genetics/metabolism',\n",
       "                'Receptors, G-Protein-Coupled/genetics/metabolism',\n",
       "                'Signal Transduction',\n",
       "                'Smoothened Receptor',\n",
       "                'Transcription Factors/genetics/metabolism',\n",
       "                'Up-Regulation',\n",
       "                'Zinc Finger Protein GLI1'],\n",
       "               'OTO': ['NOTNLM'],\n",
       "               'OT': ['Adrenal', 'GLI1', 'Hedgehog', 'SHH', 'Tumor'],\n",
       "               'EDAT': '2013/09/26 06:00',\n",
       "               'MHDA': '2014/02/04 06:00',\n",
       "               'CRDT': ['2013/09/26 06:00'],\n",
       "               'PHST': ['2013/03/06 00:00 [received]',\n",
       "                '2013/07/12 00:00 [revised]',\n",
       "                '2013/09/12 00:00 [accepted]',\n",
       "                '2013/09/26 06:00 [entrez]',\n",
       "                '2013/09/26 06:00 [pubmed]',\n",
       "                '2014/02/04 06:00 [medline]'],\n",
       "               'AID': ['S0960-0760(13)00181-7 [pii]',\n",
       "                '10.1016/j.jsbmb.2013.09.007 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Steroid Biochem Mol Biol. 2014 Jan;139:7-15. doi: 10.1016/j.jsbmb.2013.09.007. Epub 2013 Sep 21.'},\n",
       "              {'PMID': '24030351',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20150330',\n",
       "               'LR': '20140226',\n",
       "               'IS': '1532-0987 (Electronic) 0891-3668 (Linking)',\n",
       "               'VI': '33',\n",
       "               'IP': '3',\n",
       "               'DP': '2014 Mar',\n",
       "               'TI': 'Risk for late-onset blood-culture proven sepsis in very-low-birth weight infants born small for gestational age: a large multicenter study from the German Neonatal Network.',\n",
       "               'PG': '238-43',\n",
       "               'LID': '10.1097/INF.0000000000000031 [doi]',\n",
       "               'AB': 'BACKGROUND: It was the aim of this study to assess whether very-low-birth-weight (VLBW) infants born small for gestational age (SGA; birth weight less than 10th percentile) are at increased risk for late-onset sepsis. METHODS: This was a prospective, multicenter study of the German Neonatal Network including VLBW infants from 23 to < 32 weeks post menstrual age born 2009-2011. Outcomes were compared between VLBW infants born SGA (birth weight less than tenth percentile according to gestational age and gender) and non-SGA infants. The main outcome measure was at least 1 episode of late-onset sepsis defined as blood-culture-confirmed clinical sepsis occurring at >/= 72 hours of age. RESULTS: 5886 VLBW infants were included. In SGA infants (n = 692), an increased incidence of late-onset sepsis was noted compared with non-SGA infants (20.1% vs. 14.3 %, P < 0.001). This difference was only observed among infants with a gestational age of 27 to < 32 weeks and attributed to sepsis episodes with coagulase-negative staphylococci (12.8% vs. 8.3%, P < 0.001). Different treatment modalities (eg more frequent use of central venous lines) and longer duration of invasive therapies (parenteral nutrition, mechanical ventilation, hospitalization) may account for the increased sepsis risk with coagulase-negative staphylococci in our SGA cohort. In a multivariate logistic regression analysis, higher gestational age [per week; odds ratio (OR): 0.75, 95% confidence interval (CI): 0.72-0.78, P< 0.0001], treatment with antenatal steroids (OR: 0.7, 95% CI: 0.53-0.92, P = 0.01), German descendance (OR: 0.76, 95% CI: 0.63-0.91, P = 0.003) and prophylaxis with glycopeptide antibiotics (OR: 0.64, 95% CI: 0.47-0.87, P = 0.005) were shown to be protective against late-onset sepsis. In contrast, longer duration of parenteral nutrition (per day; OR: 1.016, 95% CI: 1.011-1.021, P < 0.0001) and SGA were found to be risk factors (OR: 1.31, 95% CI: 1.02-1.68, P= 0.03). CONCLUSIONS: SGA contributes to the risk of late-onset sepsis in VLBW infants. Future studies are needed to investigate the underlying pathophysiology to guide individualized preventive measures in this vulnerable subgroup.',\n",
       "               'FAU': ['Troger, Birte',\n",
       "                'Gopel, Wolfgang',\n",
       "                'Faust, Kirstin',\n",
       "                'Muller, Thilo',\n",
       "                'Jorch, Gerhard',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Gortner, Ludwig',\n",
       "                'Heitmann, Friedhelm',\n",
       "                'Hoehn, Thomas',\n",
       "                'Kribs, Angela',\n",
       "                'Laux, Reinhard',\n",
       "                'Roll, Claudia',\n",
       "                'Emeis, Michael',\n",
       "                'Mogel, Michael',\n",
       "                'Siegel, Jens',\n",
       "                'Vochem, Matthias',\n",
       "                'von der Wense, Axel',\n",
       "                'Wieg, Christian',\n",
       "                'Herting, Egbert',\n",
       "                'Hartel, Christoph'],\n",
       "               'AU': ['Troger B',\n",
       "                'Gopel W',\n",
       "                'Faust K',\n",
       "                'Muller T',\n",
       "                'Jorch G',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Gortner L',\n",
       "                'Heitmann F',\n",
       "                'Hoehn T',\n",
       "                'Kribs A',\n",
       "                'Laux R',\n",
       "                'Roll C',\n",
       "                'Emeis M',\n",
       "                'Mogel M',\n",
       "                'Siegel J',\n",
       "                'Vochem M',\n",
       "                'von der Wense A',\n",
       "                'Wieg C',\n",
       "                'Herting E',\n",
       "                'Hartel C'],\n",
       "               'AD': [\"From the *Department of Pediatrics, University of Lubeck, Lubeck; daggerDepartment of Pediatrics, University of Magdeburg, Magdeburg; double daggerDepartment of Pediatrics I, University Hospital Essen, University Duisburg, Essen;  section signDepartment of Pediatrics, University Homburg, Saar;  paragraph signDepartment of Neonatology, Children's Hospital, Dortmund;  ||Department of Pediatrics, University of Dusseldorf, Dusseldorf; **Department of Pediatrics, University of Cologne, Cologne; daggerdaggerDepartment of Neonatology, Asklepios Hospital Hamburg-Barmbek, Hamburg; double daggerdouble daggerDepartment of Neonatology, Vestische Children s Hospital, Datteln;  section sign section signDepartment of Neonatology, Vivantes Hospital Berlin-Neukolln, Berlin;  paragraph sign paragraph signDepartment of Pediatrics, Carl Gustav Carus University Dresden, Dresden;  || ||Department of Neonatology, Children s Hospital Hannover, Auf der Bult, Hannover; ***Department of Neonatology, Olgahospital Stuttgart; daggerdaggerdaggerDepartment of Neonatology, Children s Hospital Hamburg, Altona; and double daggerdouble daggerdouble daggerDepartment of Neonatology, Children s Hospital Aschaffenburg, Aschaffenburg, Germany.\"],\n",
       "               'CN': ['German Neonatal Network'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Pediatr Infect Dis J',\n",
       "               'JT': 'The Pediatric infectious disease journal',\n",
       "               'JID': '8701858',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Cohort Studies',\n",
       "                'Cross Infection/complications/*epidemiology/microbiology/mortality',\n",
       "                'Female',\n",
       "                'Fetal Growth Retardation/*epidemiology',\n",
       "                'Germany/epidemiology',\n",
       "                'Gestational Age',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature',\n",
       "                '*Infant, Very Low Birth Weight',\n",
       "                'Male',\n",
       "                'Risk Factors',\n",
       "                'Sepsis/complications/*epidemiology/microbiology/mortality'],\n",
       "               'EDAT': '2013/09/14 06:00',\n",
       "               'MHDA': '2015/03/31 06:00',\n",
       "               'CRDT': ['2013/09/14 06:00'],\n",
       "               'PHST': ['2013/09/14 06:00 [entrez]',\n",
       "                '2013/09/14 06:00 [pubmed]',\n",
       "                '2015/03/31 06:00 [medline]'],\n",
       "               'AID': ['10.1097/INF.0000000000000031 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Pediatr Infect Dis J. 2014 Mar;33(3):238-43. doi: 10.1097/INF.0000000000000031.'},\n",
       "              {'PMID': '23042103',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20150413',\n",
       "               'LR': '20140701',\n",
       "               'IS': '1438-9592 (Electronic) 0044-409X (Linking)',\n",
       "               'VI': '139',\n",
       "               'IP': '3',\n",
       "               'DP': '2014 Jun',\n",
       "               'TI': '[Neuroendocrine tumours of the GI tract--data from the German NET Registry].',\n",
       "               'PG': '276-83',\n",
       "               'LID': '10.1055/s-0032-1315199 [doi]',\n",
       "               'AB': 'BACKGROUND: Neuroendocrine tumours (NET) are rare and heterogeneous neoplasia. To obtain valid data on epidemiology, diagnostics, therapy, prognosis and risk factors is the aim of the German NET registry. PATIENTS AND METHODS: Data from 2009 histologically proven NET were collected from 35 NET centres between 1999 and 2010. Data collection has been performed prospectively since 2004. Results: Median follow-up was 34.5 months and median age at diagnosis 56.4 years. Primary tumour localisations were pancreas (34.2%), midgut (5.8%), stomach (6.5%), bowel (6.9%), duodenum (4.8%) and neuroendocrine CUP (12.6%). Synchronous metastases were seen in 46% and second malignancies in 12%. From 860 patients, 402 (46.7%) had functional tumours with the following hormone excess syndromes: carcinoid syndrome (19.1%; n = 164), persistent hyperinsulinaemic hypoglycaemia (17.7%; n = 152), Zollinger- Ellison syndrome (7.1%; n = 61), glucagonoma (0.7%; n = 15), Verner-Morrison syndrome (0.4%; n = 8) and somatostatinoma syndrome(0.1%; n = 2). Surgical therapy was performed in 78%, therapy with somatostatin receptor analogues(SSA) in 28%, peptide radioreceptor therapy (PRRT) in 19%, chemotherapy in 18% and interferon therapy in 6.5%. Only surgery was done in 47%, whereas 53% received a second therapy. General mortality rate during follow-up was 14.9%. The tumour-specific survival rates for 2, 5 and 10 years were 94, 85 and 70%. The 5-year survival is dependent on the surgical or non-surgical therapy (82 versus 61%, p < 0.001) and also on the primary tumour site (90/30% for midgut, 85/65% for pancreas, p < 0.001). Grading (G1, G2, G3) based on proliferation index Ki-67 recommended by the ENETS guidelines and WHO classification is highly correlated to the 5-year survival rate (88, 82, 33%, p < 0.001). CONCLUSION: The German NET registry provides valid multicentric data on NET in Germany. Surgical therapy is the most frequent and important therapy with good clinical outcome. In non-resectable, metastatic tumours, systemic therapies are common. Continuation and evaluation of the new WHO and TNM classifications for NET and their therapies will be a future focus of the registry.',\n",
       "               'FAU': ['Begum, N',\n",
       "                'Maasberg, S',\n",
       "                'Plockinger, U',\n",
       "                'Anlauf, M',\n",
       "                'Rinke, A',\n",
       "                'Popperl, G',\n",
       "                'Lehnert, H',\n",
       "                'Izbicki, J R',\n",
       "                'Krausch, M',\n",
       "                'Vashist, Y K',\n",
       "                'Raffel, A',\n",
       "                'Burk, C G',\n",
       "                'Hoffmann, J',\n",
       "                'Goretzki, P',\n",
       "                'Pape, U F'],\n",
       "               'AU': ['Begum N',\n",
       "                'Maasberg S',\n",
       "                'Plockinger U',\n",
       "                'Anlauf M',\n",
       "                'Rinke A',\n",
       "                'Popperl G',\n",
       "                'Lehnert H',\n",
       "                'Izbicki JR',\n",
       "                'Krausch M',\n",
       "                'Vashist YK',\n",
       "                'Raffel A',\n",
       "                'Burk CG',\n",
       "                'Hoffmann J',\n",
       "                'Goretzki P',\n",
       "                'Pape UF'],\n",
       "               'AD': ['Klinik fur Chirurgie, Universitatsklinikum Schleswig-Holstein, Campus Lubeck, Lubeck, Deutschland.',\n",
       "                'Medizinische Klinik m. S. Hepatologie & Gastroenterologie, Charite-Universitatsmedizin, Campus Virchow Klinikum, Berlin, Deutschland.',\n",
       "                'Interdisziplinares Stoffwechsel-Centrum, Charite-Universitatsmedizin, Berlin, Deutschland.',\n",
       "                'Institut fur Pathologie, Universitatsklinikum Dusseldorf, Dusseldorf, Deutschland.',\n",
       "                'Klinik fur Gastroenterologie, Endokrinologie und Stoffwechsel, Klinikum der Philipps-Universitat, Marburg, Deutschland.',\n",
       "                'Klinik fur Nuklearmedizin, Katharinenhospital, Stuttgart, Deutschland.',\n",
       "                'Medizinische Klinik I, Universitatsklinikum Schleswig-Holstein, Campus Lubeck, Lubeck, Deutschland.',\n",
       "                'Klinik und Poliklinik fur Allgemein-, Viszeral- und Thoraxchirurgie, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Deutschland.',\n",
       "                'Klinik fur Allgemein-, Viszeral- und Kinderchirurgie, Universitatsklinikum Dusseldorf, Dusseldorf, Deutschland.',\n",
       "                'Klinik und Poliklinik fur Allgemein-, Viszeral- und Thoraxchirurgie, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Deutschland.',\n",
       "                'Klinik fur Allgemein-, Viszeral- und Kinderchirurgie, Universitatsklinikum Dusseldorf, Dusseldorf, Deutschland.',\n",
       "                'Klinik fur Chirurgie, Universitatsklinikum Schleswig-Holstein, Campus Lubeck, Lubeck, Deutschland.',\n",
       "                'Chirurgische Klinik, Campus Grosshadern, Klinikum der Universitat , Munchen, Munchen, Deutschland.',\n",
       "                'Chirurgische Klinik I, Stadtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Deutschland.',\n",
       "                'Medizinische Klinik m. S. Hepatologie & Gastroenterologie, Charite-Universitatsmedizin, Campus Virchow Klinikum, Berlin, Deutschland.'],\n",
       "               'CN': ['Weitere Vertreter des deutschen NET-Registers'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Neuroendokrine Tumoren des Verdauungstrakts - Daten des deutschen NET-Registers.',\n",
       "               'DEP': '20121005',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Zentralbl Chir',\n",
       "               'JT': 'Zentralblatt fur Chirurgie',\n",
       "               'JID': '0413645',\n",
       "               'RN': ['0 (Hormones, Ectopic)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Combined Modality Therapy',\n",
       "                'Digestive System Neoplasms/*diagnosis/pathology/*surgery',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Hormones, Ectopic/*blood',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Neoplasm Grading',\n",
       "                'Neuroendocrine Tumors/*diagnosis/pathology/*surgery',\n",
       "                'Prognosis',\n",
       "                '*Registries',\n",
       "                'Syndrome',\n",
       "                'Young Adult'],\n",
       "               'FIR': ['Auernhammer, C',\n",
       "                'Bartsch, D K',\n",
       "                'Bechstein, W O',\n",
       "                'Buchler, M W',\n",
       "                'Daum, S',\n",
       "                'Fottner, C',\n",
       "                'Horsch, D',\n",
       "                'Hoffmeister, A',\n",
       "                'Klose, S',\n",
       "                'Kudlich, T',\n",
       "                'Lahner, H',\n",
       "                'Lerch, M M',\n",
       "                'Monig, H',\n",
       "                'Musholt, T',\n",
       "                'Nashan, B',\n",
       "                'Niedergethmann, M',\n",
       "                'Noe, S',\n",
       "                'Quitzsch, D',\n",
       "                'Scheerer, F',\n",
       "                'Schepp, W',\n",
       "                'Weber, F',\n",
       "                'Wurst, C'],\n",
       "               'IR': ['Auernhammer C',\n",
       "                'Bartsch DK',\n",
       "                'Bechstein WO',\n",
       "                'Buchler MW',\n",
       "                'Daum S',\n",
       "                'Fottner C',\n",
       "                'Horsch D',\n",
       "                'Hoffmeister A',\n",
       "                'Klose S',\n",
       "                'Kudlich T',\n",
       "                'Lahner H',\n",
       "                'Lerch MM',\n",
       "                'Monig H',\n",
       "                'Musholt T',\n",
       "                'Nashan B',\n",
       "                'Niedergethmann M',\n",
       "                'Noe S',\n",
       "                'Quitzsch D',\n",
       "                'Scheerer F',\n",
       "                'Schepp W',\n",
       "                'Weber F',\n",
       "                'Wurst C'],\n",
       "               'EDAT': '2012/10/09 06:00',\n",
       "               'MHDA': '2015/04/14 06:00',\n",
       "               'CRDT': ['2012/10/09 06:00'],\n",
       "               'PHST': ['2012/10/09 06:00 [entrez]',\n",
       "                '2012/10/09 06:00 [pubmed]',\n",
       "                '2015/04/14 06:00 [medline]'],\n",
       "               'AID': ['10.1055/s-0032-1315199 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Zentralbl Chir. 2014 Jun;139(3):276-83. doi: 10.1055/s-0032-1315199. Epub 2012 Oct 5.'}],\n",
       "             '2013': [{'PMID': '24337220',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20140915',\n",
       "               'LR': '20211021',\n",
       "               'IS': '1433-0385 (Electronic) 0009-4722 (Linking)',\n",
       "               'VI': '84',\n",
       "               'IP': '12',\n",
       "               'DP': '2013 Dec',\n",
       "               'TI': '[Intraoperative neuromonitoring in thyroid surgery. Recommendations of the Surgical Working Group for Endocrinology].',\n",
       "               'PG': '1049-56',\n",
       "               'LID': '10.1007/s00104-013-2656-z [doi]',\n",
       "               'FAU': ['Dralle, H',\n",
       "                'Lorenz, K',\n",
       "                'Schabram, P',\n",
       "                'Musholt, T J',\n",
       "                'Dotzenrath, C',\n",
       "                'Goretzki, P E',\n",
       "                'Kussmann, J',\n",
       "                'Niederle, B',\n",
       "                'Nies, C',\n",
       "                'Schabram, J',\n",
       "                'Scheuba, C',\n",
       "                'Simon, D',\n",
       "                'Steinmuller, T',\n",
       "                'Trupka, A'],\n",
       "               'AU': ['Dralle H',\n",
       "                'Lorenz K',\n",
       "                'Schabram P',\n",
       "                'Musholt TJ',\n",
       "                'Dotzenrath C',\n",
       "                'Goretzki PE',\n",
       "                'Kussmann J',\n",
       "                'Niederle B',\n",
       "                'Nies C',\n",
       "                'Schabram J',\n",
       "                'Scheuba C',\n",
       "                'Simon D',\n",
       "                'Steinmuller T',\n",
       "                'Trupka A'],\n",
       "               'AD': ['Klinik fur Allgemein-, Viszeral- und Gefasschirurgie, Medizinische Fakultat, Universitatsklinikum Halle, Ernst-Grube-Str. 40, 06097, Halle (Saale), Deutschland, henning.dralle@uk-halle.de.'],\n",
       "               'CN': ['Surgical Working Group for Endocrinology'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article', 'Practice Guideline'],\n",
       "               'TT': 'Intraoperatives Neuromonitoring in der Schilddrusenchirurgie. Empfehlungen der Chirurgischen Arbeitsgemeinschaft Endokrinologie.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Germany',\n",
       "                'Humans',\n",
       "                'Intraoperative Complications/*diagnosis/physiopathology/*prevention & control',\n",
       "                'Intraoperative Neurophysiological Monitoring/*methods',\n",
       "                'Prognosis',\n",
       "                'Recurrent Laryngeal Nerve/physiopathology',\n",
       "                'Recurrent Laryngeal Nerve Injuries/*diagnosis/physiopathology/*prevention & control',\n",
       "                '*Societies, Medical',\n",
       "                '*Specialties, Surgical',\n",
       "                'Thyroid Diseases/*surgery',\n",
       "                'Thyroid Gland/innervation',\n",
       "                'Vocal Cord Paralysis/diagnosis/physiopathology/prevention & control'],\n",
       "               'EDAT': '2013/12/18 06:00',\n",
       "               'MHDA': '2014/09/16 06:00',\n",
       "               'CRDT': ['2013/12/17 06:00'],\n",
       "               'PHST': ['2013/12/17 06:00 [entrez]',\n",
       "                '2013/12/18 06:00 [pubmed]',\n",
       "                '2014/09/16 06:00 [medline]'],\n",
       "               'AID': ['10.1007/s00104-013-2656-z [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 2013 Dec;84(12):1049-56. doi: 10.1007/s00104-013-2656-z.'},\n",
       "              {'PMID': '24073931',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20140425',\n",
       "               'LR': '20211021',\n",
       "               'IS': '2047-783X (Electronic) 0949-2321 (Print) 0949-2321 (Linking)',\n",
       "               'VI': '18',\n",
       "               'IP': '1',\n",
       "               'DP': '2013 Sep 28',\n",
       "               'TI': 'Is the covering of the resection margin after distal pancreatectomy advantageous?',\n",
       "               'PG': '33',\n",
       "               'LID': '10.1186/2047-783X-18-33 [doi]',\n",
       "               'AB': \"BACKGROUND: In recent years, many advances in pancreatic surgery have been achieved. Nevertheless, the rate of pancreatic fistula following pancreatic tail resection does not differ between various techniques, still reaching up to 30% in prospective multicentric studies. Taking into account contradictory results concerning the usefulness of covering resection margins after distal pancreatectomy, we sought to perform a systematic, retrospective analysis of patients that underwent distal pancreatectomy at our center. METHODS: We retrospectively analysed the data of 74 patients that underwent distal pancreatectomy between 2001 and 2011 at the community hospital in Neuss. Demographic factors, indications, postoperative complications, surgical or interventional revisions, and length of hospital stay were registered to compare the outcome of patients undergoing distal pancreatectomy with coverage of the resection margins vs. patients undergoing distal pancreatectomy without coverage of the resection margins. Differences between groups were calculated using Fisher's exact and Mann-Whitney U test. RESULTS: Main indications for pancreatic surgery were insulinoma (n=18, 24%), ductal adenocarcinoma (n=9, 12%), non-single-insulinoma-pancreatogenic-hypoglycemia-syndrome (NSIPHS) (n=8, 11%), and pancreatic cysts with pancreatitis (n=8, 11%). In 39 of 74 (53%) patients no postoperative complications were noted. In detail we found that 23/42 (55%) patients with coverage vs. 16/32 (50%) without coverage of the resection margins had no postoperative complications. The most common complications were pancreatic fistulas in eleven patients (15%), and postoperative bleeding in nine patients (12%). Pancreatic fistulas occurred in patients without coverage of the resection margins in 7/32 (22%) vs. 4/42 (1011%) with coverage are of the resection margins, yet without reaching statistical significance. Postoperative bleeding ensued with equal frequency in both groups (12% with coverage versus 13% without coverage of the resection margins). The reoperation rate was 8%. The hospital stay for patients without coverage was 13 days (5-60) vs. 17 days (8-60) for patients with coverage. CONCLUSIONS: The results show no significant difference in the fistula rate after covering of the resection margin after distal pancreatectomy, which contributes to the picture of an unsolved problem.\",\n",
       "               'FAU': ['Akca, Aycan',\n",
       "                'Goretzki, Peter E',\n",
       "                'Wirowski, Denis',\n",
       "                'Renter, Marc A',\n",
       "                'Bolke, Edwin',\n",
       "                'Matuschek, Christiane',\n",
       "                'Gerber, Peter Arne',\n",
       "                'Lammers, Bernhard J'],\n",
       "               'AU': ['Akca A',\n",
       "                'Goretzki PE',\n",
       "                'Wirowski D',\n",
       "                'Renter MA',\n",
       "                'Bolke E',\n",
       "                'Matuschek C',\n",
       "                'Gerber PA',\n",
       "                'Lammers BJ'],\n",
       "               'AD': ['Department of Visceral and Endocrine Surgery, Lukaskrankenhaus Neuss, Preussenstr, 84, Neuss, 41464, Germany. aakca@lukasneuss.de.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20130928',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Eur J Med Res',\n",
       "               'JT': 'European journal of medical research',\n",
       "               'JID': '9517857',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Child',\n",
       "                'Demography',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Pancreas/*pathology/*surgery',\n",
       "                '*Pancreatectomy/adverse effects',\n",
       "                'Pancreatic Fistula/etiology',\n",
       "                'Perioperative Care',\n",
       "                'Postoperative Complications/etiology',\n",
       "                'Young Adult'],\n",
       "               'PMC': 'PMC3849835',\n",
       "               'EDAT': '2013/10/01 06:00',\n",
       "               'MHDA': '2014/04/26 06:00',\n",
       "               'PMCR': ['2013/09/28'],\n",
       "               'CRDT': ['2013/10/01 06:00'],\n",
       "               'PHST': ['2012/11/21 00:00 [received]',\n",
       "                '2013/08/28 00:00 [accepted]',\n",
       "                '2013/10/01 06:00 [entrez]',\n",
       "                '2013/10/01 06:00 [pubmed]',\n",
       "                '2014/04/26 06:00 [medline]',\n",
       "                '2013/09/28 00:00 [pmc-release]'],\n",
       "               'AID': ['2047-783X-18-33 [pii]',\n",
       "                '10.1186/2047-783X-18-33 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'Eur J Med Res. 2013 Sep 28;18(1):33. doi: 10.1186/2047-783X-18-33.'},\n",
       "              {'PMID': '23877637',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20140722',\n",
       "               'LR': '20211021',\n",
       "               'IS': '1432-1076 (Electronic) 0340-6199 (Linking)',\n",
       "               'VI': '172',\n",
       "               'IP': '12',\n",
       "               'DP': '2013 Dec',\n",
       "               'TI': 'Use of analgesic and sedative drugs in VLBW infants in German NICUs from 2003-2010.',\n",
       "               'PG': '1633-9',\n",
       "               'LID': '10.1007/s00431-013-2095-3 [doi]',\n",
       "               'AB': \"Very low birth weight (VLBW) infants frequently receive analgesia and/or sedation for painful procedures and mechanical ventilation to avoid negative stress. Yet, concerns remain regarding potential adverse long-term effects of these drugs on VLBW infants' neurocognitive outcome. Recent studies have shown that less invasive surfactant application (LISA) and early nasal CPAP treatment reduce the need for mechanical ventilation and painful procedures. Therefore, these measures might also reduce the application of analgesic and/or sedative drugs in VLBW infants. To evaluate this hypothesis and to identify potential changes in analgesic treatment concepts in recent years, we retrospectively analyzed data on analgesia and sedation, respiratory support, and the method of surfactant application in VLBW infants enrolled in the German Neonatal Network (GNN) trial between 2003 and 2009 (period 1) and compared it with data from infants participating in GNN in 2010 (period 2). In both periods, about one third of all infants were treated with analgesic and/or sedative drugs using a wide variety of substances. The administration of novel drugs such as propofol, sufentanil, or intravenous paracetamol was higher in 2010 (6.7 vs. 12.2 %). Infants who were treated with CPAP only received significantly less analgesic/sedative medication than infants who were mechanically ventilated (12 vs. 65 %, p=<0.001). Similarly, infants treated with LISA received less analgesic or sedative drugs as compared to infants who received surfactant via endotracheal intubation (36 vs. 63 %, p=0.001). CONCLUSION: Although both avoidances of mechanical ventilation and less invasive surfactant application are associated with reduced analgesic or sedative treatment, the percentage of VLBW infants who received analgesia and/or sedation remained unchanged in Germany in recent years.\",\n",
       "               'FAU': ['Mehler, Katrin',\n",
       "                'Oberthuer, Andre',\n",
       "                'Haertel, Christoph',\n",
       "                'Herting, Egbert',\n",
       "                'Roth, Bernd',\n",
       "                'Goepel, Wolfgang'],\n",
       "               'AU': ['Mehler K',\n",
       "                'Oberthuer A',\n",
       "                'Haertel C',\n",
       "                'Herting E',\n",
       "                'Roth B',\n",
       "                'Goepel W'],\n",
       "               'AD': [\"Department of Neonatology, Children's Hospital, University of Cologne, Kerpenerstr. 62, 50937, Cologne, Germany, katrin.mehler@uk-koeln.de.\"],\n",
       "               'CN': ['German Neonatal Network (GNN)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comparative Study',\n",
       "                'Journal Article',\n",
       "                'Multicenter Study'],\n",
       "               'DEP': '20130723',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Eur J Pediatr',\n",
       "               'JT': 'European journal of pediatrics',\n",
       "               'JID': '7603873',\n",
       "               'RN': ['0 (Analgesics)',\n",
       "                '0 (Hypnotics and Sedatives)',\n",
       "                '0 (Pulmonary Surfactants)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Analgesics/*therapeutic use',\n",
       "                'Cohort Studies',\n",
       "                'Continuous Positive Airway Pressure/methods/*statistics & numerical data',\n",
       "                'Drug Utilization Review',\n",
       "                'Female',\n",
       "                'Germany',\n",
       "                'Humans',\n",
       "                'Hypnotics and Sedatives/*therapeutic use',\n",
       "                'Infant, Newborn',\n",
       "                '*Infant, Very Low Birth Weight',\n",
       "                'Intensive Care Units, Neonatal',\n",
       "                'Male',\n",
       "                'Pulmonary Surfactants/*therapeutic use',\n",
       "                'Respiration, Artificial/methods/*statistics & numerical data',\n",
       "                'Retrospective Studies',\n",
       "                'Statistics, Nonparametric'],\n",
       "               'EDAT': '2013/07/24 06:00',\n",
       "               'MHDA': '2014/07/23 06:00',\n",
       "               'CRDT': ['2013/07/24 06:00'],\n",
       "               'PHST': ['2013/04/20 00:00 [received]',\n",
       "                '2013/07/04 00:00 [accepted]',\n",
       "                '2013/07/24 06:00 [entrez]',\n",
       "                '2013/07/24 06:00 [pubmed]',\n",
       "                '2014/07/23 06:00 [medline]'],\n",
       "               'AID': ['10.1007/s00431-013-2095-3 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Pediatr. 2013 Dec;172(12):1633-9. doi: 10.1007/s00431-013-2095-3. Epub 2013 Jul 23.'},\n",
       "              {'PMID': '23840443',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20171016',\n",
       "               'LR': '20211021',\n",
       "               'IS': '1932-6203 (Electronic) 1932-6203 (Linking)',\n",
       "               'VI': '8',\n",
       "               'IP': '6',\n",
       "               'DP': '2013',\n",
       "               'TI': 'Polymorphisms in FTO and MAF Genes and Birth Weight, BMI, Ponderal Index, Weight Gain in a Large Cohort of Infants with a Birth Weight below 1500 Grams.',\n",
       "               'PG': 'e66331',\n",
       "               'LID': '10.1371/journal.pone.0066331 [doi] e66331',\n",
       "               'AB': 'BACKGROUND: The FTO gene, located on chromosome 16q12.2, and the MAF gene, located on chromosome 16q22-23, were identified as genes harboring common variants with an impact on obesity predisposition. We studied the association of common variants with birth weight, gain of body weight, body mass index (BMI), Ponderal index and relevant neonatal outcomes in a large German cohort of infants with a birth weight below 1500 grams. METHODS: The single nucleotide polymorphisms rs9939609 (FTO gene) and rs1424233 (MAF gene) were genotyped using allelic discrimination assays in a prospective multicenter cohort study conducted in 15 neonatal intensive care units in Germany from September 2003 until January 2008. DNA samples were extracted from buccal swabs according to standard protocols. RESULTS: 1946 infants were successfully genotyped at FTO and 2149 infants at MAF. Allele frequencies were not significantly different from other European cohorts. The polymorphisms were in Hardy-Weinberg equilibrium. The polymorphisms did not show associations with birth weight, BMI and Ponderal Index at discharge, and weight gain, neither testing for a dominant, additive nor for a recessive model. DISCUSSION: Since an association of the polymorphisms with weight gain has been demonstrated in multiple populations, the lack of association in a population of preterm infants with regular tube feeding after birth and highly controlled feeding volumes provides evidence for the hypothesis that these polymorphisms affect food intake behavior and hunger rather than metabolism and energy consumption.',\n",
       "               'FAU': ['Haller, Sebastian',\n",
       "                'Spiegler, Juliane',\n",
       "                'Hemmelmann, Claudia',\n",
       "                'Kuster, Helmut',\n",
       "                'Vochem, Matthias',\n",
       "                'Moller, Jens',\n",
       "                'Muller, Dirk',\n",
       "                'Kribs, Angela',\n",
       "                'Hoehn, Thomas',\n",
       "                'Hartel, Christoph',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Haller S',\n",
       "                'Spiegler J',\n",
       "                'Hemmelmann C',\n",
       "                'Kuster H',\n",
       "                'Vochem M',\n",
       "                'Moller J',\n",
       "                'Muller D',\n",
       "                'Kribs A',\n",
       "                'Hoehn T',\n",
       "                'Hartel C',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AD': ['Department of Pediatrics, University of Lubeck, Lubeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Multicenter Study',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20130626',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'PLoS One',\n",
       "               'JT': 'PloS one',\n",
       "               'JID': '101285081',\n",
       "               'RN': ['0 (MAF protein, human)',\n",
       "                '0 (Proto-Oncogene Proteins c-maf)',\n",
       "                'EC 1.14.11.33 (Alpha-Ketoglutarate-Dependent Dioxygenase FTO)',\n",
       "                'EC 1.14.11.33 (FTO protein, human)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Alpha-Ketoglutarate-Dependent Dioxygenase FTO/*genetics',\n",
       "                '*Body Mass Index',\n",
       "                'Cohort Studies',\n",
       "                'Critical Care',\n",
       "                '*Energy Metabolism',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                '*Infant, Very Low Birth Weight',\n",
       "                'Male',\n",
       "                'Prospective Studies',\n",
       "                'Proto-Oncogene Proteins c-maf/*genetics',\n",
       "                'Weight Gain'],\n",
       "               'PMC': 'PMC3694095',\n",
       "               'COIS': ['Competing Interests: The authors have declared that no competing interests exist.'],\n",
       "               'EDAT': '2013/07/11 06:00',\n",
       "               'MHDA': '2013/07/11 06:01',\n",
       "               'PMCR': ['2013/06/26'],\n",
       "               'CRDT': ['2013/07/11 06:00'],\n",
       "               'PHST': ['2013/01/14 00:00 [received]',\n",
       "                '2013/05/03 00:00 [accepted]',\n",
       "                '2013/07/11 06:00 [entrez]',\n",
       "                '2013/07/11 06:00 [pubmed]',\n",
       "                '2013/07/11 06:01 [medline]',\n",
       "                '2013/06/26 00:00 [pmc-release]'],\n",
       "               'AID': ['PONE-D-13-02172 [pii]',\n",
       "                '10.1371/journal.pone.0066331 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'PLoS One. 2013 Jun 26;8(6):e66331. doi: 10.1371/journal.pone.0066331. Print 2013.'},\n",
       "              {'PMID': '23512418',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20140117',\n",
       "               'LR': '20130612',\n",
       "               'IS': '1439-3646 (Electronic) 0947-7349 (Linking)',\n",
       "               'VI': '121',\n",
       "               'IP': '6',\n",
       "               'DP': '2013 Jun',\n",
       "               'TI': 'Failed surgery in primary hyperparathyroidism - what has changed with time.',\n",
       "               'PG': '323-8',\n",
       "               'LID': '10.1055/s-0033-1334876 [doi]',\n",
       "               'AB': 'Advanced preoperative imaging of parathyroid adenomas and intraoperative parathyroid hormone determination optimized the results in the surgical treatment of primary hyperparathyroidism patients. We asked, whether reasons for failure have changed during the last 25 years.We retrospectively analyzed operations for persistent primary hyperparathyroidism in our department between 2001 and 2011 (n=67), and compared these results to our experience between 1986 and 2001 (n=80).From 2001 to 2011, 765 primary hyperparathyroidism patients were operated on at our department. All but 4 patients were cured (761/765, 99.5%). 67 operations were performed for persistent primary hyperparathyroidism. Main reasons for failure were a misdiagnosed sporadic multiple gland disease in our own patients (18/29, 62.1%), and an undetected solitary adenoma in patients referred to us after -initial operation in another hospital (22/38, 57.9%) (statistically significant). From 1986 to 2001 (1 105 primary hyperparathyroidism patients), main indications for re-operation due to persistent disease were an undiagnosed sporadic multiple gland disease in our own patients (15/24, 62.5%), and a missed solitary adenoma in patients being operated on primarily somewhere else (38/56, 67.9%) (statistically significant).Comparing our experience in 147 patients with persistent primary hyperparathyroidism being operated on between 2001-2011 and 1986-2001, not much has changed with the modern armamentarium of improved preoperative imaging or intraoperative biochemical control. Whereas sporadic multiple gland disease was the most common reason for unsuccessful surgery in experienced hands, other units mainly failed due to an undetected solitary adenoma. Re-operations for persistent primary hyperparathyroidism performed by us were successful in 93.8% (2001-2011) and 96.0% (1986-2001), respectively.',\n",
       "               'CI': ['(c) J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart . New York.'],\n",
       "               'FAU': ['Wirowski, D',\n",
       "                'Goretzki, P E',\n",
       "                'Schwarz, K',\n",
       "                'Lammers, B J',\n",
       "                'Dotzenrath, C',\n",
       "                'Roher, H-D'],\n",
       "               'AU': ['Wirowski D',\n",
       "                'Goretzki PE',\n",
       "                'Schwarz K',\n",
       "                'Lammers BJ',\n",
       "                'Dotzenrath C',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Department of Visceral and Endocrine Surgery, Lukaskrankenhaus Neuss, Neuss, Germany. dwirowski@lukasneuss.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comparative Study', 'Journal Article'],\n",
       "               'DEP': '20130319',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Exp Clin Endocrinol Diabetes',\n",
       "               'JT': 'Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association',\n",
       "               'JID': '9505926',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/metabolism/*pathology/*surgery',\n",
       "                'Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism/metabolism/*pathology/*surgery',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Parathyroid Neoplasms/metabolism/*pathology/*surgery',\n",
       "                'Preoperative Care',\n",
       "                'Retrospective Studies',\n",
       "                'Treatment Failure'],\n",
       "               'EDAT': '2013/03/21 06:00',\n",
       "               'MHDA': '2014/01/18 06:00',\n",
       "               'CRDT': ['2013/03/21 06:00'],\n",
       "               'PHST': ['2013/03/21 06:00 [entrez]',\n",
       "                '2013/03/21 06:00 [pubmed]',\n",
       "                '2014/01/18 06:00 [medline]'],\n",
       "               'AID': ['10.1055/s-0033-1334876 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Exp Clin Endocrinol Diabetes. 2013 Jun;121(6):323-8. doi: 10.1055/s-0033-1334876. Epub 2013 Mar 19.'},\n",
       "              {'PMID': '23456424',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20130911',\n",
       "               'LR': '20220321',\n",
       "               'IS': '1435-2451 (Electronic) 1435-2443 (Linking)',\n",
       "               'VI': '398',\n",
       "               'IP': '3',\n",
       "               'DP': '2013 Mar',\n",
       "               'TI': 'German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.',\n",
       "               'PG': '347-75',\n",
       "               'LID': '10.1007/s00423-013-1057-6 [doi]',\n",
       "               'AB': 'INTRODUCTION: Over the past years, the incidence of thyroid cancer has surged not only in Germany but also in other countries of the Western hemisphere. This surge was first and foremost due to an increase of prognostically favorable (\"low risk\") papillary thyroid microcarcinomas, for which limited surgical procedures are often sufficient without loss of oncological benefit. These developments called for an update of the previous practice guideline to detail the surgical treatment options that are available for the various disease entities and tumor stages. METHODS: The present German Association of Endocrine Surgeons practice guideline was developed on the basis of clinical evidence considering current national and international treatment recommendations through a formal expert consensus process in collaboration with the German Societies of General and Visceral Surgery, Endocrinology, Nuclear Medicine, Pathology, Radiooncology, Oncological Hematology, and a German thyroid cancer patient support organization. RESULTS: The practice guideline for the surgical management of malignant thyroid tumors includes recommendations regarding preoperative workup; classification of locoregional nodes and terminology of surgical procedures; frequency, clinical, and histopathological features of occult and clinically apparent papillary, follicular, poorly differentiated, undifferentiated, and sporadic and hereditary medullary thyroid cancers, thyroid lymphoma and thyroid metastases from primaries outside the thyroid gland; extent of thyroidectomy; extent of lymph node dissection; aerodigestive tract resection; postoperative follow-up and surgery for recurrence and distant metastases. CONCLUSION: These evidence-based recommendations for surgical therapy reflect various \"treatment corridors\" that are best discussed within multidisciplinary teams and the patient considering tumor type, stage, progression, and inherent surgical risk.',\n",
       "               'FAU': ['Dralle, Henning',\n",
       "                'Musholt, Thomas J',\n",
       "                'Schabram, Jochen',\n",
       "                'Steinmuller, Thomas',\n",
       "                'Frilling, Andreja',\n",
       "                'Simon, Dietmar',\n",
       "                'Goretzki, Peter E',\n",
       "                'Niederle, Bruno',\n",
       "                'Scheuba, Christian',\n",
       "                'Clerici, Thomas',\n",
       "                'Hermann, Michael',\n",
       "                'Kussmann, Jochen',\n",
       "                'Lorenz, Kerstin',\n",
       "                'Nies, Christoph',\n",
       "                'Schabram, Peter',\n",
       "                'Trupka, Arnold',\n",
       "                'Zielke, Andreas',\n",
       "                'Karges, Wolfram',\n",
       "                'Luster, Markus',\n",
       "                'Schmid, Kurt W',\n",
       "                'Vordermark, Dirk',\n",
       "                'Schmoll, Hans-Joachim',\n",
       "                'Muhlenberg, Reinhard',\n",
       "                'Schober, Otmar',\n",
       "                'Rimmele, Harald',\n",
       "                'Machens, Andreas'],\n",
       "               'AU': ['Dralle H',\n",
       "                'Musholt TJ',\n",
       "                'Schabram J',\n",
       "                'Steinmuller T',\n",
       "                'Frilling A',\n",
       "                'Simon D',\n",
       "                'Goretzki PE',\n",
       "                'Niederle B',\n",
       "                'Scheuba C',\n",
       "                'Clerici T',\n",
       "                'Hermann M',\n",
       "                'Kussmann J',\n",
       "                'Lorenz K',\n",
       "                'Nies C',\n",
       "                'Schabram P',\n",
       "                'Trupka A',\n",
       "                'Zielke A',\n",
       "                'Karges W',\n",
       "                'Luster M',\n",
       "                'Schmid KW',\n",
       "                'Vordermark D',\n",
       "                'Schmoll HJ',\n",
       "                'Muhlenberg R',\n",
       "                'Schober O',\n",
       "                'Rimmele H',\n",
       "                'Machens A'],\n",
       "               'AD': ['Department of General, Visceral and Vascular Surgery, Martin Luther University Halle-Wittenberg, Ernst-Grube-Strasse 40, 06097, Halle, Saale, Germany. henning.dralle@uk-halle.de'],\n",
       "               'CN': ['German Societies of General and Visceral Surgery; Endocrinology; Nuclear',\n",
       "                'Medicine; Pathology; Radiooncology; Oncological Hematology; and the German',\n",
       "                'Thyroid Cancer Patient Support Organization Ohne Schilddruse leben e.V'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'DEP': '20130303',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Endocrine Surgical Procedures/standards',\n",
       "                'Germany',\n",
       "                'Guideline Adherence',\n",
       "                'Humans',\n",
       "                'Lymph Node Excision/methods/standards',\n",
       "                'Lymph Nodes/*pathology',\n",
       "                'Neoplasm Staging',\n",
       "                '*Practice Guidelines as Topic',\n",
       "                'Societies, Medical/standards',\n",
       "                'Thyroid Neoplasms/pathology/*surgery',\n",
       "                'Thyroidectomy/methods/*standards',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '2013/03/05 06:00',\n",
       "               'MHDA': '2013/09/12 06:00',\n",
       "               'CRDT': ['2013/03/05 06:00'],\n",
       "               'PHST': ['2013/01/27 00:00 [received]',\n",
       "                '2013/01/30 00:00 [accepted]',\n",
       "                '2013/03/05 06:00 [entrez]',\n",
       "                '2013/03/05 06:00 [pubmed]',\n",
       "                '2013/09/12 06:00 [medline]'],\n",
       "               'AID': ['10.1007/s00423-013-1057-6 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 2013 Mar;398(3):347-75. doi: 10.1007/s00423-013-1057-6. Epub 2013 Mar 3.'},\n",
       "              {'PMID': '23400353',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20131211',\n",
       "               'LR': '20130614',\n",
       "               'IS': '1432-0711 (Electronic) 0932-0067 (Linking)',\n",
       "               'VI': '288',\n",
       "               'IP': '1',\n",
       "               'DP': '2013 Jul',\n",
       "               'TI': 'Pregnancy risk factors for very premature delivery: what role do hypertension, obesity and diabetes play?',\n",
       "               'PG': '57-64',\n",
       "               'LID': '10.1007/s00404-013-2739-6 [doi]',\n",
       "               'AB': 'PURPOSE: Very premature delivery is a major cause of infant morbidity and mortality. Obesity, diabetes and pregnancy hypertension are known risk factors for pregnancy complications. The study aimed to scrutinize differences of pregnancy complications in a cohort of very premature deliveries compared to a national group. METHODS: In a multicenter study performed between January 2009 and December 2010 including 1,577 very low birth weight (VLBW) infants, we compared parental reported pregnancy problems of VLBW infants with a national cohort (KIGGS). We compared reported pregnancy complications to reasons for premature delivery and neonatal outcome within the group of VLBW infants. RESULTS: While parents of the national cohort reported pregnancy-induced hypertension in 8 %, parents of VLBW infants reported this complication more frequently (27 %). Mothers of the national cohort were significantly younger (1 year), suffered less from obesity, anaemia, diabetes. Regression analysis showed that hypertension (OR = 5.11) and advanced maternal age (OR = 1.03) increased the risk for premature birth. Women with hypertension were likely to experience a clinically indicated premature delivery, had more VLBW infants with a moderate growth restriction, but less multiples and their infants had less intraventricular haemorrhages grade 3 or 4. Otherwise, neonatal outcome was correlated with gestational age but not with the pregnancy complications diabetes, hypertension or obesity. CONCLUSION: Premature birth seems to be correlated to gestational hypertension and associated problems in about (1/4) of VLBW infants. Further studies should focus on preventing and treating gestational hypertension to avoid premature delivery and associated neonatal morbidity.',\n",
       "               'FAU': ['Spiegler, Juliane',\n",
       "                'Stichtenoth, G',\n",
       "                'Weichert, J',\n",
       "                'Konig, I R',\n",
       "                'Schlaud, M',\n",
       "                'V D Wense, A',\n",
       "                'Olbertz, D',\n",
       "                'Gurth, H',\n",
       "                'Schiffmann, J-H',\n",
       "                'Bohnhorst, B',\n",
       "                'Gortner, L',\n",
       "                'Herting, E',\n",
       "                'Gopel, W'],\n",
       "               'AU': ['Spiegler J',\n",
       "                'Stichtenoth G',\n",
       "                'Weichert J',\n",
       "                'Konig IR',\n",
       "                'Schlaud M',\n",
       "                'V D Wense A',\n",
       "                'Olbertz D',\n",
       "                'Gurth H',\n",
       "                'Schiffmann JH',\n",
       "                'Bohnhorst B',\n",
       "                'Gortner L',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AD': ['Department of Pediatrics, University of Lubeck, Ratzeburger Allee 160, 23538 Luebeck, Germany. uni@dr-spiegler.de'],\n",
       "               'CN': ['German Neonatal Network, GNN'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Multicenter Study',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20130212',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Arch Gynecol Obstet',\n",
       "               'JT': 'Archives of gynecology and obstetrics',\n",
       "               'JID': '8710213',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Case-Control Studies',\n",
       "                'Diabetes Mellitus/*epidemiology',\n",
       "                'Female',\n",
       "                'Germany/epidemiology',\n",
       "                'Gestational Age',\n",
       "                'Humans',\n",
       "                'Hypertension/*epidemiology',\n",
       "                'Infant, Newborn',\n",
       "                '*Infant, Very Low Birth Weight',\n",
       "                'Obesity/*epidemiology',\n",
       "                'Odds Ratio',\n",
       "                'Pregnancy',\n",
       "                'Premature Birth/*epidemiology',\n",
       "                'Regression Analysis',\n",
       "                'Risk Factors'],\n",
       "               'EDAT': '2013/02/13 06:00',\n",
       "               'MHDA': '2013/12/16 06:00',\n",
       "               'CRDT': ['2013/02/13 06:00'],\n",
       "               'PHST': ['2012/11/05 00:00 [received]',\n",
       "                '2013/01/21 00:00 [accepted]',\n",
       "                '2013/02/13 06:00 [entrez]',\n",
       "                '2013/02/13 06:00 [pubmed]',\n",
       "                '2013/12/16 06:00 [medline]'],\n",
       "               'AID': ['10.1007/s00404-013-2739-6 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Arch Gynecol Obstet. 2013 Jul;288(1):57-64. doi: 10.1007/s00404-013-2739-6. Epub 2013 Feb 12.'},\n",
       "              {'PMID': '23325061',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20130627',\n",
       "               'LR': '20211021',\n",
       "               'IS': '1433-0458 (Electronic) 0017-6192 (Linking)',\n",
       "               'VI': '61',\n",
       "               'IP': '1',\n",
       "               'DP': '2013 Jan',\n",
       "               'TI': '[Surgical therapy for thyroid gland malignancies].',\n",
       "               'PG': '71-81; quiz 82',\n",
       "               'LID': '10.1007/s00106-012-2639-2 [doi]',\n",
       "               'AB': \"Surgical therapy for thyroid neoplasms is based on tumor histology and comprises stage-adapted procedures with a high degree of inter-individual variability. This can range from waiting and monitoring, to extensive multivisceral surgery. Grouping together histologically different types of malignancies leads to false assumptions when gauging the radicality of surgery necessary in each particular case. Surgical therapy requires not only an understanding of the biological behavior of the tumor and the risk that it or the therapy poses to the patient, but also knowledge of a wide surgical spectrum of limited and complex resection procedures in the neck and thorax region. The following recommendations are based primarily on the guidelines of the Surgical Working Group for Endocrinology of the German Society for General and Visceral Surgery as well as on the authors' own experience and, where indicated, the guidelines of other working groups.\",\n",
       "               'FAU': ['Goretzki, P E', 'Schwarz, K', 'Lammers, B'],\n",
       "               'AU': ['Goretzki PE', 'Schwarz K', 'Lammers B'],\n",
       "               'AD': ['Chirurgische Klinik 1, Lukas-Krankenhaus-GmbH Neuss, Preussenstr. 84, 41456, Neuss, Deutschland. pgoretzki@lukasneuss.de'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article', 'Review'],\n",
       "               'TT': 'Chirurgie der Schilddrusenmalignome.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'HNO',\n",
       "               'JT': 'HNO',\n",
       "               'JID': '2985099R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Combined Modality Therapy',\n",
       "                'Cross-Cultural Comparison',\n",
       "                'Cross-Sectional Studies',\n",
       "                'Female',\n",
       "                'Goiter, Nodular/classification/epidemiology/pathology/surgery',\n",
       "                'Guideline Adherence',\n",
       "                'Humans',\n",
       "                'Lymph Node Excision/methods',\n",
       "                'Lymphatic Metastasis/pathology',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Neoplasm Invasiveness',\n",
       "                'Neoplasm Recurrence, Local/classification/epidemiology/pathology/surgery',\n",
       "                'Neoplasm Staging',\n",
       "                'Reoperation',\n",
       "                'Thyroid Neoplasms/classification/epidemiology/pathology/*surgery',\n",
       "                'Thyroidectomy/*methods',\n",
       "                'Tomography, X-Ray Computed',\n",
       "                'Ultrasonography',\n",
       "                'Young Adult'],\n",
       "               'EDAT': '2013/01/18 06:00',\n",
       "               'MHDA': '2013/06/29 06:00',\n",
       "               'CRDT': ['2013/01/18 06:00'],\n",
       "               'PHST': ['2013/01/18 06:00 [entrez]',\n",
       "                '2013/01/18 06:00 [pubmed]',\n",
       "                '2013/06/29 06:00 [medline]'],\n",
       "               'AID': ['10.1007/s00106-012-2639-2 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'HNO. 2013 Jan;61(1):71-81; quiz 82. doi: 10.1007/s00106-012-2639-2.'},\n",
       "              {'PMID': '23266151',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20131017',\n",
       "               'LR': '20151119',\n",
       "               'IS': '1872-6232 (Electronic) 0378-3782 (Linking)',\n",
       "               'VI': '89',\n",
       "               'IP': '5',\n",
       "               'DP': '2013 May',\n",
       "               'TI': 'Very low birth weight infants after discharge: What do parents describe?',\n",
       "               'PG': '343-7',\n",
       "               'LID': 'S0378-3782(12)00275-7 [pii] 10.1016/j.earlhumdev.2012.11.007 [doi]',\n",
       "               'AB': 'BACKGROUND: Morbidity and mortality in Very Low Birth Weight (VLBW) infants during their hospital stay have been well described. However, there are insufficient data regarding health problems after discharge. STUDY DESIGN: In a multicenter study performed between January 2009 and December 2010 including 2493 VLBW infants, questionnaires were sent out to all participating parents in the first year of life. We compared the parental reported health of VLBW infants with a national cohort (KIGGS). RESULTS: The reported health of VLBW infants born after 29 weeks of gestation was identical to term infants. Even in the group of infants born before 24 weeks of gestation health was regarded as very good or good in >70% of cases. However, parents described a delayed development in >50% increasing to >70% with lower gestational age. In the first year of life VLBW infants have an increased risk of visual and hearing problems. Bronchitis was more frequent in VLBW infants but there were no differences in other infections typical for that age group. VLBW infants had less sleeping problems. No gender differences were described. CONCLUSION: VLBW infants in our study require slightly more medical care compared to their peers. However, medical problems are relatively small compared to the developmental needs as perceived by their parents. Therefore, close follow-up and advice by specialists in infant development are needed.',\n",
       "               'CI': ['Copyright (c) 2012 Elsevier Ltd. All rights reserved.'],\n",
       "               'FAU': ['Spiegler, Juliane',\n",
       "                'Schlaud, Martin',\n",
       "                'Konig, Inke R',\n",
       "                'Teig, Norbert',\n",
       "                'Hubert, Mechthild',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Spiegler J',\n",
       "                'Schlaud M',\n",
       "                'Konig IR',\n",
       "                'Teig N',\n",
       "                'Hubert M',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AD': ['Department of Pediatrics, University of Luebeck, Ratzeburger Allee 160, D-23538 Luebeck, Germany. uni@dr-spiegler.de'],\n",
       "               'CN': ['German Neonatal Network, GNN'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comparative Study',\n",
       "                'Journal Article',\n",
       "                'Multicenter Study',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20121223',\n",
       "               'PL': 'Ireland',\n",
       "               'TA': 'Early Hum Dev',\n",
       "               'JT': 'Early human development',\n",
       "               'JID': '7708381',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Developmental Disabilities/*epidemiology',\n",
       "                'Germany/epidemiology',\n",
       "                '*Health Status',\n",
       "                'Humans',\n",
       "                'Infant',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Very Low Birth Weight/*physiology',\n",
       "                'Parents',\n",
       "                'Statistics, Nonparametric',\n",
       "                'Surveys and Questionnaires'],\n",
       "               'EDAT': '2012/12/26 06:00',\n",
       "               'MHDA': '2013/10/18 06:00',\n",
       "               'CRDT': ['2012/12/26 06:00'],\n",
       "               'PHST': ['2012/09/26 00:00 [received]',\n",
       "                '2012/11/24 00:00 [revised]',\n",
       "                '2012/11/27 00:00 [accepted]',\n",
       "                '2012/12/26 06:00 [entrez]',\n",
       "                '2012/12/26 06:00 [pubmed]',\n",
       "                '2013/10/18 06:00 [medline]'],\n",
       "               'AID': ['S0378-3782(12)00275-7 [pii]',\n",
       "                '10.1016/j.earlhumdev.2012.11.007 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Early Hum Dev. 2013 May;89(5):343-7. doi: 10.1016/j.earlhumdev.2012.11.007. Epub 2012 Dec 23.'},\n",
       "              {'PMID': '23179319',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20130911',\n",
       "               'LR': '20220321',\n",
       "               'IS': '1435-2451 (Electronic) 1435-2443 (Linking)',\n",
       "               'VI': '398',\n",
       "               'IP': '3',\n",
       "               'DP': '2013 Mar',\n",
       "               'TI': 'IONM-guided goiter surgery leading to two-stage thyroidectomy--indication and results.',\n",
       "               'PG': '411-8',\n",
       "               'LID': '10.1007/s00423-012-1032-7 [doi]',\n",
       "               'AB': 'PURPOSE: Intraoperative neuromonitoring (IONM) in thyroid surgery allows for changing the operative strategy during bilateral procedures to avoid bilateral recurrent laryngeal nerve palsy (RLNP). While this strategy is comprehendible for the surgeon, the question remains, whether it is always necessary. METHODS: Two thousand five hundred forty-six patients underwent surgery with IONM between January 2008 and October 2010 (4,012 nerves at risk). We performed a retrospective review of all patients after thyroid surgery. In 98 cases, signal loss occurred on the primary side. Of these patients, 64 required bilateral surgery. We proceeded with the contralateral surgery in 24 cases. Forty operations were ended unilaterally. The second operation was performed on 18 patients in total, 16 after confirmation of primarily intact (n = 8) or recovered vocal cord function (n = 8) and twice under persisting dysfunction. Patient satisfaction was evaluated using a five-point scale. RESULTS: We have shown a significant difference (p = 0.017) in the rate of bilateral RLNP when signal loss on the primary side resulted in termination of the procedure compared to continuation. Our evaluation of patient satisfaction did not show a significant difference when comparing the two-stage operation to other procedures. CONCLUSIONS: We have shown a significant difference in the rate of bilateral RLNP when comparing termination and continuation of a bilateral procedure after primary IONM signal loss. We strongly recommend a two-stage thyroidectomy after signal loss on the primary side of resection in benign bilateral goiter surgery.',\n",
       "               'FAU': ['Melin, Magnus',\n",
       "                'Schwarz, Katharina',\n",
       "                'Lammers, Bernhard J',\n",
       "                'Goretzki, Peter E'],\n",
       "               'AU': ['Melin M', 'Schwarz K', 'Lammers BJ', 'Goretzki PE'],\n",
       "               'AD': ['Department of General Surgery, Endocrine Surgery, Abdominal Surgery, Thorax Surgery, Vascular Surgery, Colorectal and Hernia Surgery, Lukaskrankenhaus GmbH, Preussenstrasse 84, 41464 Neuss, Germany. mmelin@lukasneuss.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comparative Study', 'Journal Article'],\n",
       "               'DEP': '20121123',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Cohort Studies',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Goiter, Nodular/pathology/*surgery',\n",
       "                'Humans',\n",
       "                'Intraoperative Complications/prevention & control',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Monitoring, Intraoperative/*methods',\n",
       "                '*Neural Conduction',\n",
       "                'Predictive Value of Tests',\n",
       "                'Recurrent Laryngeal Nerve Injuries/*prevention & control',\n",
       "                'Retrospective Studies',\n",
       "                'Risk Assessment',\n",
       "                'Sensitivity and Specificity',\n",
       "                'Thyroidectomy/*methods',\n",
       "                'Treatment Outcome',\n",
       "                'Young Adult'],\n",
       "               'EDAT': '2012/11/28 06:00',\n",
       "               'MHDA': '2013/09/12 06:00',\n",
       "               'CRDT': ['2012/11/27 06:00'],\n",
       "               'PHST': ['2012/07/16 00:00 [received]',\n",
       "                '2012/11/06 00:00 [accepted]',\n",
       "                '2012/11/27 06:00 [entrez]',\n",
       "                '2012/11/28 06:00 [pubmed]',\n",
       "                '2013/09/12 06:00 [medline]'],\n",
       "               'AID': ['10.1007/s00423-012-1032-7 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 2013 Mar;398(3):411-8. doi: 10.1007/s00423-012-1032-7. Epub 2012 Nov 23.'},\n",
       "              {'PMID': '23007384',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20130604',\n",
       "               'LR': '20220318',\n",
       "               'IS': '1435-2451 (Electronic) 1435-2443 (Linking)',\n",
       "               'VI': '398',\n",
       "               'IP': '1',\n",
       "               'DP': '2013 Jan',\n",
       "               'TI': 'Cinacalcet effects on the perioperative course of patients with secondary hyperparathyroidism.',\n",
       "               'PG': '131-8',\n",
       "               'LID': '10.1007/s00423-012-1005-x [doi]',\n",
       "               'AB': 'PURPOSE: Since its registration in 2004, the calcimimetic agent cinacalcet has been established as an alternative treatment for secondary hyperparathyroidism (SHPT). Working by allosteric activation of the calcium-sensing receptor, cinacalcet can lower parathyroid hormone (PTH) and calcium (Ca) in patients with SHPT. The influence of calcimimetics on the perioperative course has been unclear so far. METHODS: We retrospectively analyzed the data of patients with primary operation for SHPT between 2004 and 2011, comparing the perioperative course of patients with and without preoperative cinacalcet treatment. RESULTS: Fifty-six patients had cinacalcet therapy, and 54 patients had no calcimimetic medication prior to surgery. Gender, age, hemodialysis, and medical treatment were similar in both groups. Also, PTH levels were similar preoperatively and postoperatively (preoperative, 1,249 +/- 676 vs. 1,196 +/- 601 pg/ml; postoperative, 86 +/- 220 vs. 62 +/- 91 pg/ml). Patients with cinacalcet preoperatively had significant lower Ca levels preoperatively (2.49 +/- 0.25 vs. 2.61 +/- 0.24 mmol/l) and postoperatively (1.75 +/- 0.37 vs. 1.86 +/- 0.35 mmol/l) and had a higher rate of oral Ca substitution postoperatively (93 vs. 74 %). The risk for postoperative persistent disease was slightly higher in these patients compared to those without preoperative cinacalcet therapy (5 vs. 0 %, not significant). CONCLUSIONS: In our experience, cinacalcet did not alter the perioperative course in SHPT patients.',\n",
       "               'FAU': ['Wirowski, Denis',\n",
       "                'Goretzki, Peter E',\n",
       "                'Schwarz, Katharina',\n",
       "                'Lammers, Bernhard J'],\n",
       "               'AU': ['Wirowski D', 'Goretzki PE', 'Schwarz K', 'Lammers BJ'],\n",
       "               'AD': ['Department of Visceral and Endocrine Surgery, Lukaskrankenhaus Neuss, Preussenstr. 84, 41464 Neuss, Germany. dwirowski@lukasneuss.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comparative Study', 'Journal Article'],\n",
       "               'DEP': '20120925',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'RN': ['0 (Calcimimetic Agents)',\n",
       "                '0 (Naphthalenes)',\n",
       "                '0 (Parathyroid Hormone)',\n",
       "                'SY7Q814VUP (Calcium)',\n",
       "                'UAZ6V7728S (Cinacalcet)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Calcimimetic Agents/*therapeutic use',\n",
       "                'Calcium/blood/therapeutic use',\n",
       "                'Cinacalcet',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism, Secondary/blood/diagnosis/*surgery',\n",
       "                'Hypocalcemia/blood',\n",
       "                'Kidney Transplantation',\n",
       "                'Length of Stay',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Naphthalenes/*therapeutic use',\n",
       "                'Parathyroid Hormone/blood',\n",
       "                '*Parathyroidectomy',\n",
       "                'Postoperative Complications/*blood/diagnosis',\n",
       "                'Preoperative Care',\n",
       "                'Retrospective Studies',\n",
       "                'Thyroidectomy'],\n",
       "               'EDAT': '2012/09/26 06:00',\n",
       "               'MHDA': '2013/06/05 06:00',\n",
       "               'CRDT': ['2012/09/26 06:00'],\n",
       "               'PHST': ['2012/03/03 00:00 [received]',\n",
       "                '2012/09/10 00:00 [accepted]',\n",
       "                '2012/09/26 06:00 [entrez]',\n",
       "                '2012/09/26 06:00 [pubmed]',\n",
       "                '2013/06/05 06:00 [medline]'],\n",
       "               'AID': ['10.1007/s00423-012-1005-x [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 2013 Jan;398(1):131-8. doi: 10.1007/s00423-012-1005-x. Epub 2012 Sep 25.'},\n",
       "              {'PMID': '22580937',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20130305',\n",
       "               'LR': '20130108',\n",
       "               'IS': '1528-1140 (Electronic) 0003-4932 (Linking)',\n",
       "               'VI': '257',\n",
       "               'IP': '2',\n",
       "               'DP': '2013 Feb',\n",
       "               'TI': 'Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1.',\n",
       "               'PG': '308-14',\n",
       "               'LID': '10.1097/SLA.0b013e3182536339 [doi]',\n",
       "               'AB': 'OBJECTIVE: To evaluate the outcome of pancreaticoduodenectomy (PD) versus non-PD resections for the treatment of gastrinoma in multiple endocrine neoplasia type 1. BACKGROUND: Gastrinoma in MEN1 is considered a rarely curable disease and its management is highly controversial both for timing and extent of surgery. METHODS: Clinical characteristics, complications and outcomes of 27 prospectively collected MEN1 patients with biochemically proven gastrinoma, who underwent surgery, were analyzed with special regard to the gastrinoma type and the initial operative procedure. RESULTS: Twenty-two (81%) patients with gastrinoma in MEN1 had duodenal gastrinomas and 5 patients (19%) had pancreatic gastrinomas. At the time of diagnosis, 21 (77%) gastrinomas were malignant (18 duodenal, 3 pancreatic), but distant metastases were only present in 4 (15%) patients. Patients with pancreatic gastrinomas underwent either distal pancreatic resections or gastrinoma enucleation with lymphadenectomy, 2 patients also had synchronous resections of liver metastases. One of these patients was biochemically cured after a median of 136 (77-312) months. Thirteen patients with duodenal gastrinomas underwent PD resections (group 1, partial PD [n = 11], total PD [n = 2]), whereas 9 patients had no-PD resections (group 2) as initial operative procedure. Perioperative morbidity and mortality, including postoperative diabetes, differed not significantly between groups (P > 0.5). All patients of group 1 and 5 of 9 (55%) patients of group 2 had a negative secretin test at hospital discharge. However, after a median follow-up of 136 (3-276) months, 12 (92%) patients of group 1 were still normogastrinemic compared to only 3 of 9 (33%) patients of group 2 (P = 0.023). Three (33%) patients of group 2 had to undergo up to 3 reoperations for recurrent or metastatic disease compared to none of group 1. CONCLUSIONS: Duodenal gastrinoma in MEN1 should be considered a surgically curable disease. PD seems to be the adequate approach to this disease, providing a high cure rate and acceptable morbidity compared to non-PD resections.',\n",
       "               'FAU': ['Lopez, Caroline L',\n",
       "                'Falconi, Massimo',\n",
       "                'Waldmann, Jens',\n",
       "                'Boninsegna, Letizia',\n",
       "                'Fendrich, Volker',\n",
       "                'Goretzki, Peter K',\n",
       "                'Langer, Peter',\n",
       "                'Kann, Peter H',\n",
       "                'Partelli, Stefano',\n",
       "                'Bartsch, Detlef K'],\n",
       "               'AU': ['Lopez CL',\n",
       "                'Falconi M',\n",
       "                'Waldmann J',\n",
       "                'Boninsegna L',\n",
       "                'Fendrich V',\n",
       "                'Goretzki PK',\n",
       "                'Langer P',\n",
       "                'Kann PH',\n",
       "                'Partelli S',\n",
       "                'Bartsch DK'],\n",
       "               'AD': ['Department of Surgery, Philipps-University, Marburg, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Ann Surg',\n",
       "               'JT': 'Annals of surgery',\n",
       "               'JID': '0372354',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Disease-Free Survival',\n",
       "                'Duodenal Neoplasms/etiology/mortality/*surgery',\n",
       "                'Female',\n",
       "                'Gastrinoma/etiology/mortality/*surgery',\n",
       "                'Humans',\n",
       "                'Kaplan-Meier Estimate',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Multiple Endocrine Neoplasia Type 1/complications',\n",
       "                '*Pancreaticoduodenectomy',\n",
       "                'Young Adult'],\n",
       "               'EDAT': '2012/05/15 06:00',\n",
       "               'MHDA': '2013/03/06 06:00',\n",
       "               'CRDT': ['2012/05/15 06:00'],\n",
       "               'PHST': ['2012/05/15 06:00 [entrez]',\n",
       "                '2012/05/15 06:00 [pubmed]',\n",
       "                '2013/03/06 06:00 [medline]'],\n",
       "               'AID': ['10.1097/SLA.0b013e3182536339 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Ann Surg. 2013 Feb;257(2):308-14. doi: 10.1097/SLA.0b013e3182536339.'}],\n",
       "             '2012': [{'PMID': '22853920',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20120920',\n",
       "               'LR': '20120802',\n",
       "               'IS': '1832-4274 (Print) 1832-4274 (Linking)',\n",
       "               'VI': '15',\n",
       "               'IP': '4',\n",
       "               'DP': '2012 Aug',\n",
       "               'TI': 'Causes of delivery and outcomes of very preterm twins stratified to zygosity.',\n",
       "               'PG': '532-6',\n",
       "               'LID': '10.1017/thg.2012.33 [doi]',\n",
       "               'AB': \"The increasing rates of preterm birth among twins implicate that solid data on associated risks and outcomes are required. Assessment of zygosity is often based on clinical criteria (evaluation of placenta; same gender, birth weight discordance as surrogate criteria for monochorionic/monozygotic twins). The aim of this study was to compare clinical versus genetic assessment of zygosity and to compare causes of preterm delivery as well as outcome data of very-low-birth-weight (VLBW; birth weight <1,500 g) twins stratified to zygosity. In a multicenter study, we selected n=176 sets of same gender twins and determined zygosity genetically. In a subgroup of 123 sets of twins, the attending physicians at the study centers were asked to document the parameter 'zygosity' (monozygotic/dizygotic) on the basis of their clinical judgment. Concordance between genetic and clinical assessment was 62.7% for monozygotic twins and 88.9% for dizygotic twins, respectively. Outcome parameters (death, BPD, ROP, NEC, IVH) were comparable in both groups. Genetically dizygotic twins were significantly more often born due to intrauterine infection (33% vs. 20% in monozygotic twins, p<.01) and antenatal antibiotics were more frequently given to mothers of dizygotic twins (62% vs. 47% in monozygotic twins, p<.01). Obstetric complications such as twin-twin-transfusion-syndrome were only seen in monozygotic twins as expected. The unexpected increase of antenatal antibiotic treatment and birth due to intrauterine infection in dizygotic twins should be confirmed in additional VLBW twin-cohorts.\",\n",
       "               'FAU': ['Spiegler, Juliane',\n",
       "                'Hartel, Christoph',\n",
       "                'Schulz, Lena',\n",
       "                'von Wurmb-Schwark, Nicole',\n",
       "                'Hoehn, Thomas',\n",
       "                'Kribs, Angela',\n",
       "                'Kuster, Helmut',\n",
       "                'Siegel, Jens',\n",
       "                'Wieg, Christian',\n",
       "                'Weichert, Jan',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Spiegler J',\n",
       "                'Hartel C',\n",
       "                'Schulz L',\n",
       "                'von Wurmb-Schwark N',\n",
       "                'Hoehn T',\n",
       "                'Kribs A',\n",
       "                'Kuster H',\n",
       "                'Siegel J',\n",
       "                'Wieg C',\n",
       "                'Weichert J',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AD': ['Department of Pediatrics, University Hospital of Schleswig-Holstein, Luebeck, Germany. uni@dr-spiegler.de'],\n",
       "               'CN': ['German Neonatal Network (GNN)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Multicenter Study'],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Twin Res Hum Genet',\n",
       "               'JT': 'Twin research and human genetics : the official journal of the International Society for Twin Studies',\n",
       "               'JID': '101244624',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Female',\n",
       "                'Gestational Age',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                '*Infant, Premature',\n",
       "                'Infant, Very Low Birth Weight',\n",
       "                'Male',\n",
       "                'Pregnancy',\n",
       "                'Pregnancy Complications',\n",
       "                'Pregnancy Outcome',\n",
       "                '*Pregnancy, Twin',\n",
       "                'Premature Birth/*etiology',\n",
       "                'Risk Factors',\n",
       "                '*Twins, Dizygotic',\n",
       "                '*Twins, Monozygotic'],\n",
       "               'EDAT': '2012/08/03 06:00',\n",
       "               'MHDA': '2012/09/21 06:00',\n",
       "               'CRDT': ['2012/08/03 06:00'],\n",
       "               'PHST': ['2012/08/03 06:00 [entrez]',\n",
       "                '2012/08/03 06:00 [pubmed]',\n",
       "                '2012/09/21 06:00 [medline]'],\n",
       "               'AID': ['S1832427412000333 [pii]', '10.1017/thg.2012.33 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Twin Res Hum Genet. 2012 Aug;15(4):532-6. doi: 10.1017/thg.2012.33.'},\n",
       "              {'PMID': '22768043',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20121127',\n",
       "               'LR': '20211021',\n",
       "               'IS': '1932-6203 (Electronic) 1932-6203 (Linking)',\n",
       "               'VI': '7',\n",
       "               'IP': '6',\n",
       "               'DP': '2012',\n",
       "               'TI': 'Epidemic microclusters of blood-culture proven sepsis in very-low-birth weight infants: experience of the German Neonatal Network.',\n",
       "               'PG': 'e38304',\n",
       "               'LID': '10.1371/journal.pone.0038304 [doi] e38304',\n",
       "               'AB': \"INTRODUCTION: We evaluated blood culture-proven sepsis episodes occurring in microclusters in very-low-birth-weight infants born in the German Neonatal Network (GNN) during 2009-2010. METHODS: Thirty-seven centers participated in GNN; 23 centers enrolled >/=50 VLBW infants in the study period. Data quality was approved by on-site monitoring. Microclusters of sepsis were defined as occurrence of at least two blood-culture proven sepsis events in different patients of one center within 3 months with the same bacterial species. For microcluster analysis, we selected sepsis episodes with typically cross-transmitted bacteria of high clinical significance including gram-negative rods and Enterococcus spp. RESULTS: In our cohort, 12/2110 (0.6%) infants were documented with an early-onset sepsis and 235 late-onset sepsis episodes (>/=72 h of age) occurred in 203/2110 (9.6%) VLBW infants. In 182/235 (77.4%) late-onset sepsis episodes gram-positive bacteria were documented, while coagulase negative staphylococci were found to be the most predominant pathogens (48.5%, 95%CI: 42.01-55.01). Candida spp. and gram-negative bacilli caused 10/235 (4.3%, 95%CI: 1.68% -6.83%) and 43/235 (18.5%) late-onset sepsis episodes, respectively. Eleven microclusters of blood-culture proven sepsis were detected in 7 hospitals involving a total 26 infants. 16/26 cluster patients suffered from Klebsiella spp. sepsis. The median time interval between the first patient's Klebsiella spp. sepsis and cluster cases was 14.1 days (interquartile range: 1-27 days). First patients in the cluster, their linked cases and sporadic sepsis events did not show significant differences in short term outcome parameters. DISCUSSION: Microclusters of infection are an important phenomenon for late-onset sepsis. Most gram-negative cluster infections occur within 30 days after the first patient was diagnosed and Klebsiella spp. play a major role. It is essential to monitor epidemic microclusters of sepsis in surveillance networks to adapt clinical practice, inform policy and further improve quality of care.\",\n",
       "               'FAU': ['Hartel, Christoph',\n",
       "                'Faust, Kirstin',\n",
       "                'Avenarius, Stefan',\n",
       "                'Bohnhorst, Bettina',\n",
       "                'Emeis, Michael',\n",
       "                'Gebauer, Corinna',\n",
       "                'Groneck, Peter',\n",
       "                'Heitmann, Friedhelm',\n",
       "                'Hoehn, Thomas',\n",
       "                'Hubert, Mechthild',\n",
       "                'Kribs, Angela',\n",
       "                'Kuster, Helmut',\n",
       "                'Laux, Reinhard',\n",
       "                'Mogel, Michael',\n",
       "                'Muller, Dirk',\n",
       "                'Olbertz, Dirk',\n",
       "                'Roll, Claudia',\n",
       "                'Siegel, Jens',\n",
       "                'Stein, Anja',\n",
       "                'Vochem, Matthias',\n",
       "                'Weller, Ursula',\n",
       "                'von der Wense, Axel',\n",
       "                'Wieg, Christian',\n",
       "                'Wintgens, Jurgen',\n",
       "                'Hemmelmann, Claudia',\n",
       "                'Simon, Arne',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Hartel C',\n",
       "                'Faust K',\n",
       "                'Avenarius S',\n",
       "                'Bohnhorst B',\n",
       "                'Emeis M',\n",
       "                'Gebauer C',\n",
       "                'Groneck P',\n",
       "                'Heitmann F',\n",
       "                'Hoehn T',\n",
       "                'Hubert M',\n",
       "                'Kribs A',\n",
       "                'Kuster H',\n",
       "                'Laux R',\n",
       "                'Mogel M',\n",
       "                'Muller D',\n",
       "                'Olbertz D',\n",
       "                'Roll C',\n",
       "                'Siegel J',\n",
       "                'Stein A',\n",
       "                'Vochem M',\n",
       "                'Weller U',\n",
       "                'von der Wense A',\n",
       "                'Wieg C',\n",
       "                'Wintgens J',\n",
       "                'Hemmelmann C',\n",
       "                'Simon A',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AD': ['Department of Pediatrics at the University of Lubeck, Lubeck, Germany. haertel@paedia.ukl.mu-luebeck.de'],\n",
       "               'CN': ['German Neonatal Network (GNN)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20120629',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'PLoS One',\n",
       "               'JT': 'PloS one',\n",
       "               'JID': '101285081',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Cluster Analysis',\n",
       "                'Cohort Studies',\n",
       "                'Female',\n",
       "                'Germany/epidemiology',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Very Low Birth Weight/*blood',\n",
       "                'Male',\n",
       "                'Sepsis/*blood/*epidemiology/microbiology',\n",
       "                'Treatment Outcome'],\n",
       "               'PMC': 'PMC3387163',\n",
       "               'COIS': ['Competing Interests: The authors have declared that no competing interests exist.'],\n",
       "               'FIR': ['Teig, Norbert',\n",
       "                'Heckmann, Matthias',\n",
       "                'Gortner, Ludwig',\n",
       "                'Nikischin, Werner',\n",
       "                'Rieger-Fackeldey, Esther',\n",
       "                'Dordelmann, Michael',\n",
       "                'Ehlers, Silke',\n",
       "                'Jensen, Reinhard',\n",
       "                'Hien, Steffen',\n",
       "                'Schiffmann, Holger',\n",
       "                'Segerer, Hugo',\n",
       "                'Moller, Jens',\n",
       "                'Kannt, Olaf'],\n",
       "               'IR': ['Teig N',\n",
       "                'Heckmann M',\n",
       "                'Gortner L',\n",
       "                'Nikischin W',\n",
       "                'Rieger-Fackeldey E',\n",
       "                'Dordelmann M',\n",
       "                'Ehlers S',\n",
       "                'Jensen R',\n",
       "                'Hien S',\n",
       "                'Schiffmann H',\n",
       "                'Segerer H',\n",
       "                'Moller J',\n",
       "                'Kannt O'],\n",
       "               'EDAT': '2012/07/07 06:00',\n",
       "               'MHDA': '2012/12/10 06:00',\n",
       "               'PMCR': ['2012/06/29'],\n",
       "               'CRDT': ['2012/07/07 06:00'],\n",
       "               'PHST': ['2012/03/27 00:00 [received]',\n",
       "                '2012/05/07 00:00 [accepted]',\n",
       "                '2012/07/07 06:00 [entrez]',\n",
       "                '2012/07/07 06:00 [pubmed]',\n",
       "                '2012/12/10 06:00 [medline]',\n",
       "                '2012/06/29 00:00 [pmc-release]'],\n",
       "               'AID': ['PONE-D-12-08879 [pii]',\n",
       "                '10.1371/journal.pone.0038304 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'PLoS One. 2012;7(6):e38304. doi: 10.1371/journal.pone.0038304. Epub 2012 Jun 29.'},\n",
       "              {'PMID': '22657106',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20130322',\n",
       "               'LR': '20211021',\n",
       "               'IS': '1472-6807 (Electronic) 1472-6807 (Linking)',\n",
       "               'VI': '12',\n",
       "               'DP': '2012 Jun 1',\n",
       "               'TI': 'Conservation and divergence between cytoplasmic and muscle-specific actin capping proteins: insights from the crystal structure of cytoplasmic Cap32/34 from Dictyostelium discoideum.',\n",
       "               'PG': '12',\n",
       "               'LID': '10.1186/1472-6807-12-12 [doi]',\n",
       "               'AB': 'BACKGROUND: Capping protein (CP), also known as CapZ in muscle cells and Cap32/34 in Dictyostelium discoideum, plays a major role in regulating actin filament dynamics. CP is a ubiquitously expressed heterodimer comprising an alpha- and beta-subunit. It tightly binds to the fast growing end of actin filaments, thereby functioning as a \"cap\" by blocking the addition and loss of actin subunits. Vertebrates contain two somatic variants of CP, one being primarily found at the cell periphery of non-muscle tissues while the other is mainly localized at the Z-discs of skeletal muscles. RESULTS: To elucidate structural and functional differences between cytoplasmic and sarcomercic CP variants, we have solved the atomic structure of Cap32/34 (32=beta- and 34=alpha-subunit) from the cellular slime mold Dictyostelium at 2.2 A resolution and compared it to that of chicken muscle CapZ. The two homologs display a similar overall arrangement including the attached alpha-subunit C-terminus (alpha-tentacle) and the flexible beta-tentacle. Nevertheless, the structures exhibit marked differences suggesting considerable structural flexibility within the alpha-subunit. In the alpha-subunit we observed a bending motion of the beta-sheet region located opposite to the position of the C-terminal beta-tentacle towards the antiparallel helices that interconnect the heterodimer. Recently, a two domain twisting attributed mainly to the beta-subunit has been reported. At the hinge of these two domains Cap32/34 contains an elongated and highly flexible loop, which has been reported to be important for the interaction of cytoplasmic CP with actin and might contribute to the more dynamic actin-binding of cytoplasmic compared to sarcomeric CP (CapZ). CONCLUSIONS: The structure of Cap32/34 from Dictyostelium discoideum allowed a detailed analysis and comparison between the cytoplasmic and sarcomeric variants of CP. Significant structural flexibility could particularly be found within the alpha-subunit, a loop region in the beta-subunit, and the surface of the alpha-globule where the amino acid differences between the cytoplasmic and sarcomeric mammalian CP are located. Hence, the crystal structure of Cap32/34 raises the possibility of different binding behaviours of the CP variants toward the barbed end of actin filaments, a feature, which might have arisen from adaptation to different environments.',\n",
       "               'FAU': ['Eckert, Christian',\n",
       "                'Goretzki, Agnieszka',\n",
       "                'Faberova, Maria',\n",
       "                'Kollmar, Martin'],\n",
       "               'AU': ['Eckert C', 'Goretzki A', 'Faberova M', 'Kollmar M'],\n",
       "               'AD': ['Abteilung NMR basierte Strukturbiologie, Max-Planck-Institut fur Biophysikalische Chemie, Am Fassberg 11, D-37077, Gottingen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20120601',\n",
       "               'PL': 'England',\n",
       "               'TA': 'BMC Struct Biol',\n",
       "               'JT': 'BMC structural biology',\n",
       "               'JID': '101088689',\n",
       "               'RN': ['0 (Actin Capping Proteins)',\n",
       "                '0 (CapZ Actin Capping Protein)',\n",
       "                '0 (Lipids)',\n",
       "                '0 (Microfilament Proteins)',\n",
       "                '0 (Protein Subunits)',\n",
       "                '0 (Protozoan Proteins)',\n",
       "                '0 (cap32-34 protein, Dictyostelium)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Actin Capping Proteins/*chemistry',\n",
       "                'Amino Acid Sequence',\n",
       "                'Animals',\n",
       "                'Binding Sites',\n",
       "                'CapZ Actin Capping Protein/chemistry',\n",
       "                'Chickens',\n",
       "                '*Conserved Sequence',\n",
       "                'Crystallography, X-Ray',\n",
       "                'Cytoplasm/*metabolism',\n",
       "                'Dictyostelium/*chemistry',\n",
       "                'Lipids',\n",
       "                'Microfilament Proteins/*chemistry',\n",
       "                'Models, Molecular',\n",
       "                'Molecular Sequence Data',\n",
       "                'Muscles/*metabolism',\n",
       "                'Organ Specificity',\n",
       "                'Protein Binding',\n",
       "                'Protein Structure, Secondary',\n",
       "                'Protein Subunits/chemistry/metabolism',\n",
       "                'Protozoan Proteins/*chemistry',\n",
       "                'Sequence Alignment'],\n",
       "               'PMC': 'PMC3472329',\n",
       "               'EDAT': '2012/06/05 06:00',\n",
       "               'MHDA': '2013/03/23 06:00',\n",
       "               'PMCR': ['2012/06/01'],\n",
       "               'CRDT': ['2012/06/05 06:00'],\n",
       "               'PHST': ['2012/03/01 00:00 [received]',\n",
       "                '2012/05/10 00:00 [accepted]',\n",
       "                '2012/06/05 06:00 [entrez]',\n",
       "                '2012/06/05 06:00 [pubmed]',\n",
       "                '2013/03/23 06:00 [medline]',\n",
       "                '2012/06/01 00:00 [pmc-release]'],\n",
       "               'AID': ['1472-6807-12-12 [pii]',\n",
       "                '10.1186/1472-6807-12-12 [doi]'],\n",
       "               'PST': 'epublish',\n",
       "               'SO': 'BMC Struct Biol. 2012 Jun 1;12:12. doi: 10.1186/1472-6807-12-12.'},\n",
       "              {'PMID': '22334829',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20120918',\n",
       "               'LR': '20211021',\n",
       "               'IS': '1866-0452 (Electronic) 1866-0452 (Linking)',\n",
       "               'VI': '109',\n",
       "               'IP': '4',\n",
       "               'DP': '2012 Jan',\n",
       "               'TI': 'Correspondence (letter to the editor): Incomplete picture.',\n",
       "               'PG': '66; author reply 66-7',\n",
       "               'LID': '10.3238/arztebl.2012.0066a [doi]',\n",
       "               'FAU': ['Starke, Achim A R',\n",
       "                'Goretzki, Peter E',\n",
       "                'Saddig, Christiane'],\n",
       "               'AU': ['Starke AA', 'Goretzki PE', 'Saddig C'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comment', 'Letter'],\n",
       "               'DEP': '20120127',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Dtsch Arztebl Int',\n",
       "               'JT': 'Deutsches Arzteblatt international',\n",
       "               'JID': '101475967',\n",
       "               'SB': 'IM',\n",
       "               'CON': ['Dtsch Arztebl Int. 2011 May;108(18):305-12. doi: 10.3238/arztebl.2011.0305. PMID:',\n",
       "                '21629514'],\n",
       "               'MH': ['Gastrointestinal Neoplasms/*diagnosis/*therapy',\n",
       "                'Humans',\n",
       "                'Neuroendocrine Tumors/*diagnosis/*therapy'],\n",
       "               'PMC': 'PMC3278750',\n",
       "               'EDAT': '2012/02/16 06:00',\n",
       "               'MHDA': '2012/09/19 06:00',\n",
       "               'PMCR': ['2012/01/01'],\n",
       "               'CRDT': ['2012/02/16 06:00'],\n",
       "               'PHST': ['2012/02/16 06:00 [entrez]',\n",
       "                '2012/02/16 06:00 [pubmed]',\n",
       "                '2012/09/19 06:00 [medline]',\n",
       "                '2012/01/01 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3238/arztebl.2012.0066a [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Dtsch Arztebl Int. 2012 Jan;109(4):66; author reply 66-7. doi: 10.3238/arztebl.2012.0066a. Epub 2012 Jan 27.'},\n",
       "              {'PMID': '22290318',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20120711',\n",
       "               'LR': '20211021',\n",
       "               'IS': '1432-1289 (Electronic) 0020-9554 (Linking)',\n",
       "               'VI': '53',\n",
       "               'IP': '2',\n",
       "               'DP': '2012 Feb',\n",
       "               'TI': '[Surgery for neuroendocrine tumors of the gastroenteropancreatic system (GEP-NET)].',\n",
       "               'PG': '152-60',\n",
       "               'LID': '10.1007/s00108-011-2917-1 [doi]',\n",
       "               'AB': 'Surgical treatment is still the only curative treatment proven for patients with neuroendocrine tumors (NET) of the gastroenteropancreatic system. In addition to the therapy of incidental findings, the treatment of NET with variable aggressiveness and often good long-term prognosis requires a thorough preoperative assessment and a surgical procedure that is based on each individual case. Treatment can be surgery alone (if the disease is locally confined) or can be combined with other therapies. Early NET of the stomach and rectum can be cured endoscopically without further diagnostics, while early findings of the appendix can be treated by an appendectomy. Functionally active pancreatic NET and NET of the small intestine are often preoperatively diagnosed based on symptoms. Thus, it is possible to refer the patient to a NET center, if necessary. Stratification of the necessary treatment combination can be made early. An alternative to radical surgical treatment is the operative reduction of the tumor size and hormone production in metastasized NET, which can lead to improved life expectancy and quality of life. Combination with other treatment forms is absolutely necessary in these patients. It has been proven useful to divide the large group of NET based on the different tumor locations, hormone activity, and the degree of differentiation of the tumor. Early forms, locoregionally limited tumor stages, and tumor stages with distant metastases are considered separately.',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Starke, A',\n",
       "                'Akca, A',\n",
       "                'Lammers, B J'],\n",
       "               'AU': ['Goretzki PE', 'Starke A', 'Akca A', 'Lammers BJ'],\n",
       "               'AD': ['Chirurgische Klinik I, Lukaskrankenhaus GmbH Neuss und Insulinoma und GEP-NET Tumorzentrum Neuss-Dusseldorf, Preussenstrasse 84, Neuss. pgoretzki@lukasneuss.de'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Chirurgie neuroendokriner Tumoren des gastroenteropankreatischen Systems (GEP-NET).',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Internist (Berl)',\n",
       "               'JT': 'Der Internist',\n",
       "               'JID': '0264620',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Digestive System Surgical Procedures/*methods',\n",
       "                'Gastrointestinal Neoplasms/*surgery',\n",
       "                'Humans',\n",
       "                'Neuroendocrine Tumors/*surgery',\n",
       "                'Pancreatectomy/*methods',\n",
       "                'Pancreatic Neoplasms/*surgery',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '2012/02/01 06:00',\n",
       "               'MHDA': '2012/07/12 06:00',\n",
       "               'CRDT': ['2012/02/01 06:00'],\n",
       "               'PHST': ['2012/02/01 06:00 [entrez]',\n",
       "                '2012/02/01 06:00 [pubmed]',\n",
       "                '2012/07/12 06:00 [medline]'],\n",
       "               'AID': ['10.1007/s00108-011-2917-1 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Internist (Berl). 2012 Feb;53(2):152-60. doi: 10.1007/s00108-011-2917-1.'},\n",
       "              {'PMID': '22145626',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20120620',\n",
       "               'LR': '20171213',\n",
       "               'IS': '1651-2227 (Electronic) 0803-5253 (Linking)',\n",
       "               'VI': '101',\n",
       "               'IP': '4',\n",
       "               'DP': '2012 Apr',\n",
       "               'TI': 'ATP-binding cassette member A3 (E292V) gene mutation and pulmonary morbidity in very-low-birth-weight infants.',\n",
       "               'PG': '380-3',\n",
       "               'LID': '10.1111/j.1651-2227.2011.02553.x [doi]',\n",
       "               'AB': 'AIM: ATP-binding cassette member A 3 (ABCA3) plays a critical role for the transport of surfactant phospholipids into the lamellar bodies of type II alveolar epithelial cells. Term infants carrying the E292V missense mutation of the gene encoding ABCA3 are likely to develop respiratory distress syndrome, and the mutation has also been linked to interstitial lung disease in paediatric patients. The aim of this study was to investigate the association of the E292V genotype with pulmonary morbidity in a large cohort of very-low-birth-weight (VLBW) infants. METHODS: We performed a genetic association study with a prospective, population-based multi-centre cohort of 3177 VLBW infants born in 16 German study centres between 2003 and 2009 (German Neonatal Network). The ABCA3 genotype was determined by restriction fragment length polymorphism-PCR in genomic DNA samples derived from buccal swabs. RESULTS: In a large cohort of 3177 VLBW infants, 11 individuals were found to be heterozygote for the E292V mutation (0.34%). After stratification according to ABCA3 genotype, no differences were noted for clinical characteristics, necessary treatments and neonatal pulmonary outcomes. CONCLUSIONS: Within the size limits of our study cohort, the ABCA3 missense mutation E292V had no remarkable effect on pulmonary outcome in VLBW infants. Present results do not rule out the possibility that E292V phenotype is associated with minor difference in the morbidity.',\n",
       "               'CI': ['(c) 2011 The Author(s)/Acta Paediatrica (c) 2011 Foundation Acta Paediatrica.'],\n",
       "               'FAU': ['Hartel, Christoph',\n",
       "                'Felderhoff-Muser, Ursula',\n",
       "                'Gebauer, Corinna',\n",
       "                'Hoehn, Thomas',\n",
       "                'Kribs, Angela',\n",
       "                'Laux, Reinhard',\n",
       "                'Moller, Jens',\n",
       "                'Segerer, Hugo',\n",
       "                'Teig, Norbert',\n",
       "                'von der Wense, Axel',\n",
       "                'Wieg, Christian',\n",
       "                'Stichtenoth, Guido',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Hartel C',\n",
       "                'Felderhoff-Muser U',\n",
       "                'Gebauer C',\n",
       "                'Hoehn T',\n",
       "                'Kribs A',\n",
       "                'Laux R',\n",
       "                'Moller J',\n",
       "                'Segerer H',\n",
       "                'Teig N',\n",
       "                'von der Wense A',\n",
       "                'Wieg C',\n",
       "                'Stichtenoth G',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AD': ['Department of Pediatrics, University at Lubeck, Lubeck, Germany. haertel@paedia.ukl.mu-luebeck.de'],\n",
       "               'CN': ['German Neonatal Network (GNN)'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20120109',\n",
       "               'PL': 'Norway',\n",
       "               'TA': 'Acta Paediatr',\n",
       "               'JT': 'Acta paediatrica (Oslo, Norway : 1992)',\n",
       "               'JID': '9205968',\n",
       "               'RN': ['0 (ABCA3 protein, human)',\n",
       "                '0 (ATP-Binding Cassette Transporters)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['ATP-Binding Cassette Transporters/*genetics',\n",
       "                'Female',\n",
       "                'Genetic Association Studies',\n",
       "                'Genetic Predisposition to Disease',\n",
       "                'Genotype',\n",
       "                'Germany/epidemiology',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                '*Infant, Very Low Birth Weight',\n",
       "                'Lung Diseases, Interstitial/epidemiology/*genetics',\n",
       "                'Male',\n",
       "                'Morbidity',\n",
       "                'Mutation, Missense',\n",
       "                'Prospective Studies',\n",
       "                'Respiratory Distress Syndrome, Newborn/epidemiology/*genetics'],\n",
       "               'EDAT': '2011/12/08 06:00',\n",
       "               'MHDA': '2012/06/21 06:00',\n",
       "               'CRDT': ['2011/12/08 06:00'],\n",
       "               'PHST': ['2011/12/08 06:00 [entrez]',\n",
       "                '2011/12/08 06:00 [pubmed]',\n",
       "                '2012/06/21 06:00 [medline]'],\n",
       "               'AID': ['10.1111/j.1651-2227.2011.02553.x [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Acta Paediatr. 2012 Apr;101(4):380-3. doi: 10.1111/j.1651-2227.2011.02553.x. Epub 2012 Jan 9.'},\n",
       "              {'PMID': '21365536',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20120807',\n",
       "               'LR': '20181201',\n",
       "               'IS': '1438-9592 (Electronic) 0044-409X (Linking)',\n",
       "               'VI': '137',\n",
       "               'IP': '1',\n",
       "               'DP': '2012 Feb',\n",
       "               'TI': '[Continuous intraoperative neuromonitoring of the recurrent laryngeal nerve in thyroid surgery (CIONM) - Where are we now? An update to the European Symposium of Continuous Neuromonitoring in Thyroid Surgery].',\n",
       "               'PG': '88-90',\n",
       "               'LID': '10.1055/s-0030-1262697 [doi]',\n",
       "               'FAU': ['Schneider, R',\n",
       "                'Lamade, W',\n",
       "                'Hermann, M',\n",
       "                'Goretzki, P',\n",
       "                'Timmermann, W',\n",
       "                'Hauss, J',\n",
       "                'Leinung, S'],\n",
       "               'AU': ['Schneider R',\n",
       "                'Lamade W',\n",
       "                'Hermann M',\n",
       "                'Goretzki P',\n",
       "                'Timmermann W',\n",
       "                'Hauss J',\n",
       "                'Leinung S'],\n",
       "               'AD': ['Universitatsklinikum Leipzig, Klinik fur Viszeral-, Transplantations-, Thorax- und Gefasschirurgie, Leipzig, Deutschland. ricksch@web.de'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Congress'],\n",
       "               'TT': 'Kontinuierliches intraoperatives Neuromonitoring des N. laryngeus recurrens in der Schilddrusenchirurgie (CIONM) - Wo stehen wir? Ein Update zum Europaischen Symposium Kontinuierliches Neuromonitoring in der Schilddrusenchirurgie.',\n",
       "               'DEP': '20110301',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Zentralbl Chir',\n",
       "               'JT': 'Zentralblatt fur Chirurgie',\n",
       "               'JID': '0413645',\n",
       "               'SB': 'IM',\n",
       "               'CIN': ['Zentralbl Chir. 2012 Feb;137(1):91. doi: 10.1055/s-0030-1262774. PMID: 21365538'],\n",
       "               'MH': ['Electric Stimulation/instrumentation',\n",
       "                'Electrodes',\n",
       "                'Europe',\n",
       "                'Humans',\n",
       "                'Intraoperative Complications/physiopathology/*prevention & control',\n",
       "                'Monitoring, Intraoperative/instrumentation/*methods',\n",
       "                'Recurrent Laryngeal Nerve/physiopathology',\n",
       "                'Recurrent Laryngeal Nerve Injuries/physiopathology/*prevention & control',\n",
       "                '*Thyroidectomy',\n",
       "                'Vagus Nerve/physiopathology'],\n",
       "               'EDAT': '2011/03/03 06:00',\n",
       "               'MHDA': '2012/08/08 06:00',\n",
       "               'CRDT': ['2011/03/03 06:00'],\n",
       "               'PHST': ['2011/03/03 06:00 [entrez]',\n",
       "                '2011/03/03 06:00 [pubmed]',\n",
       "                '2012/08/08 06:00 [medline]'],\n",
       "               'AID': ['10.1055/s-0030-1262697 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Zentralbl Chir. 2012 Feb;137(1):88-90. doi: 10.1055/s-0030-1262697. Epub 2011 Mar 1.'}],\n",
       "             '2011': [{'PMID': '22504966',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20191120',\n",
       "               'IS': '1090-3941 (Print) 1090-3941 (Linking)',\n",
       "               'VI': '21',\n",
       "               'DP': '2011 Dec',\n",
       "               'TI': 'Evaluation of Biocompatibility of Alloplastic Materials: Development of a Tissue Culture In Vitro Test System.',\n",
       "               'PG': '21-7',\n",
       "               'AB': 'Optimized biocompatibility is a major requirement for alloplastic materials currently applied in surgical approaches for hernia, incontinence, and prolapse situations. Tissue ingrowth/adherence and formation of connective tissue seem to have important influence in mesh incorporation at the implant site. In an in vitro approach we randomly investigated 7 different mesh types currently used in surgeries with various indications with regard to their adherence performance. Using a tissue culture approach, meshes were incubated with tissue representative of fibroblasts, muscle cells, and endothelial cells originating from 10 different patients. After 6 weeks, the meshes were assessed microscopically and a ranking of their adherence performance was established. Tissue culture was successful in 100% of the probes. We did not remark on interindividual differences concerning the growth and adherence performance after incubation with the different meshes in the investigated 10 patients. The ranking was consistent in all patients. In this test system, PVDF Dynamesh(R) (FEG Textiltechnik, Aachen, Germany) was the mesh with the best growth-in score. The test system was feasible and reproducible. Pore size seems to be a predictor of adherence performance. The test system may be a helpful tool for further investigations, and the predictive value should be assessed in further in vitro and in vivo experiments.',\n",
       "               'FAU': ['Gerullis, Holger',\n",
       "                'Georgas, Evangelos',\n",
       "                'Eimer, Christoph',\n",
       "                'Goretzki, Peter E',\n",
       "                'Lammers, Bernhard J',\n",
       "                'Klosterhalfen, Bernd',\n",
       "                'Boros, Mihaly',\n",
       "                'Wishahi, Mohamed',\n",
       "                'Heusch, Gerd',\n",
       "                'Otto, Thomas'],\n",
       "               'AU': ['Gerullis H',\n",
       "                'Georgas E',\n",
       "                'Eimer C',\n",
       "                'Goretzki PE',\n",
       "                'Lammers BJ',\n",
       "                'Klosterhalfen B',\n",
       "                'Boros M',\n",
       "                'Wishahi M',\n",
       "                'Heusch G',\n",
       "                'Otto T'],\n",
       "               'AD': ['Consultant, Department of Urology, Lukas Hospital, Neuss, Germany.',\n",
       "                'Department of Urology, Lukas Hospital, Neuss, Germany.',\n",
       "                'Department of Urology, Lukas Hospital, Neuss, Germany.',\n",
       "                'Department of General Surgery, Lukas Hospital, Neuss, Germany.',\n",
       "                'Department of General Surgery, Lukas Hospital, Neuss, Germany.',\n",
       "                'German Centre for Implant-Pathology, Duren, Germany.',\n",
       "                'Department of Experimental Surgery, University of Szeged, Szeged, Hungary.',\n",
       "                'Department of Urology, Theodor Bilharz Research Institute, Cairo, Egypt.',\n",
       "                'Institute for Pathophysiology, University of Essen, Essen, Germany.',\n",
       "                'Department of Urology, Lukas Hospital, Neuss, Germany, Oncologist, West German Cancer Center, University of Essen, Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Surg Technol Int',\n",
       "               'JT': 'Surgical technology international',\n",
       "               'JID': '9604509',\n",
       "               'SB': 'IM',\n",
       "               'EDAT': '2012/04/17 06:00',\n",
       "               'MHDA': '2012/04/17 06:01',\n",
       "               'CRDT': ['2012/04/17 06:00'],\n",
       "               'PHST': ['2012/04/17 06:00 [entrez]',\n",
       "                '2012/04/17 06:00 [pubmed]',\n",
       "                '2012/04/17 06:01 [medline]'],\n",
       "               'AID': ['sti21/21 [pii]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Surg Technol Int. 2011 Dec;21:21-7.'},\n",
       "              {'PMID': '22132974',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20120321',\n",
       "               'LR': '20221207',\n",
       "               'IS': '1532-2335 (Electronic) 1525-7770 (Linking)',\n",
       "               'VI': '30',\n",
       "               'IP': '12',\n",
       "               'DP': '2011 Dec',\n",
       "               'TI': 'Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells.',\n",
       "               'PG': '1190-6',\n",
       "               'LID': '10.1080/15257770.2011.596497 [doi]',\n",
       "               'AB': 'Digalloylresveratrol (DIG) is a newly synthesized agent aimed to combine the biological effects of the natural compounds, gallic acid and resveratrol, which both are free radical scavengers exhibiting anticancer activity. In this study, we investigated the effects of DIG on the growth of human HL-60 leukemia cells and on the colony formation of human BxPC-3 and PANC-1 pancreatic cancer cells. DIG was applied alone and in combination with arabinofuranosylcytosine (Ara-C) or difluorodeoxycytidine (dFdC), depending on the cell line employed. All IC(50) values observed were in the low micromolar range rendering DIG a promising antitumor compound in vitro. Considering the combination experiments, DIG yielded additive effects with Ara-C in HL-60 cells and-to a lesser extent-with dFdC in BxPC-3 and PANC-1 cells. Owing to our results, DIG may be further investigated in vitro and in animals.',\n",
       "               'FAU': ['Saiko, Philipp',\n",
       "                'Graser, Geraldine',\n",
       "                'Madlener, Sibylle',\n",
       "                'Schwarz, Simone',\n",
       "                'Krupitza, Georg',\n",
       "                'Jaeger, Walter',\n",
       "                'Somepalli, Venkateswarlu',\n",
       "                'Golakoti, Trimurtulu',\n",
       "                'Fritzer-Szekeres, Monika',\n",
       "                'Szekeres, Thomas'],\n",
       "               'AU': ['Saiko P',\n",
       "                'Graser G',\n",
       "                'Madlener S',\n",
       "                'Schwarz S',\n",
       "                'Krupitza G',\n",
       "                'Jaeger W',\n",
       "                'Somepalli V',\n",
       "                'Golakoti T',\n",
       "                'Fritzer-Szekeres M',\n",
       "                'Szekeres T'],\n",
       "               'AD': ['Department of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, General Hospital of Vienna, Vienna, Austria.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Nucleosides Nucleotides Nucleic Acids',\n",
       "               'JT': 'Nucleosides, nucleotides & nucleic acids',\n",
       "               'JID': '100892832',\n",
       "               'RN': ['0 (Stilbenes)',\n",
       "                '0 (digalloylresveratrol)',\n",
       "                '04079A1RDZ (Cytarabine)',\n",
       "                '0W860991D6 (Deoxycytidine)',\n",
       "                '632XD903SP (Gallic Acid)',\n",
       "                '0 (Gemcitabine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Antineoplastic Combined Chemotherapy Protocols/pharmacology/*therapeutic use',\n",
       "                'Cell Proliferation/drug effects',\n",
       "                'Cytarabine/chemistry/pharmacology/therapeutic use',\n",
       "                'Deoxycytidine/*analogs & derivatives/chemistry/pharmacology/therapeutic use',\n",
       "                'Gallic Acid/*analogs & derivatives/chemistry/pharmacology/therapeutic use',\n",
       "                'HL-60 Cells',\n",
       "                'Humans',\n",
       "                'Leukemia/*drug therapy/pathology',\n",
       "                'Pancreatic Neoplasms/*drug therapy/pathology',\n",
       "                'Stilbenes/chemistry/pharmacology/*therapeutic use',\n",
       "                'Tumor Stem Cell Assay',\n",
       "                'Gemcitabine'],\n",
       "               'EDAT': '2011/12/03 06:00',\n",
       "               'MHDA': '2012/03/22 06:00',\n",
       "               'CRDT': ['2011/12/03 06:00'],\n",
       "               'PHST': ['2011/12/03 06:00 [entrez]',\n",
       "                '2011/12/03 06:00 [pubmed]',\n",
       "                '2012/03/22 06:00 [medline]'],\n",
       "               'AID': ['10.1080/15257770.2011.596497 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1190-6. doi: 10.1080/15257770.2011.596497.'},\n",
       "              {'PMID': '21963186',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20111207',\n",
       "               'LR': '20220409',\n",
       "               'IS': '1474-547X (Electronic) 0140-6736 (Linking)',\n",
       "               'VI': '378',\n",
       "               'IP': '9803',\n",
       "               'DP': '2011 Nov 5',\n",
       "               'TI': 'Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.',\n",
       "               'PG': '1627-34',\n",
       "               'LID': '10.1016/S0140-6736(11)60986-0 [doi]',\n",
       "               'AB': 'BACKGROUND: Surfactant is usually given to mechanically ventilated preterm infants via an endotracheal tube to treat respiratory distress syndrome. We tested a new method of surfactant application to spontaneously breathing preterm infants to avoid mechanical ventilation. METHOD: In a parallel-group, randomised controlled trial, 220 preterm infants with a gestational age between 26 and 28 weeks and a birthweight less than 1.5 kg were enrolled in 12 German neonatal intensive care units. Infants were independently randomised in a 1:1 ratio with variable block sizes, to standard treatment or intervention, and randomisation was stratified according to centre and multiple birth status. Masking was not possible. Infants were stabilised with continuous positive airway pressure and received rescue intubation if necessary. In the intervention group, infants received surfactant treatment during spontaneous breathing via a thin catheter inserted into the trachea by laryngoscopy if they needed a fraction of inspired oxygen more than 0.30. The primary endpoint was need for any mechanical ventilation, or being not ventilated but having a partial pressure of carbon dioxide more than 65 mm Hg (8.6 kPa) or a fraction of inspired oxygen more than 0.60, or both, for more than 2 h between 25 h and 72 h of age. Analysis was by intention to treat. This study is registered, number ISRCTN05025922. FINDINGS: 108 infants were assigned to the intervention group and 112 infants to the standard treatment group. All infants were analysed. On day 2 or 3 after birth, 30 (28%) infants in the intervention group were mechanically ventilated versus 51 (46%) in the standard treatment group (number needed to treat 6, 95% CI 3-20, absolute risk reduction 0.18, 95% CI 0.30-0.05, p=0.008). 36 (33%) infants in the intervention group were mechanically ventilated during their stay in the hospital compared with 82 (73%) in the standard treatment group (number needed to treat: 3, 95% CI 2-4, p<0.0001). The intervention group had significantly fewer median days on mechanical ventilation, (0 days. IQR 0-3 vs 2 days, 0-5) and a lower need for oxygen therapy at 28 days (30 infants [30%] vs 49 infants [45%], p=0.032) compared with the standard treatment group. We recorded no differences between groups for mortality (seven deaths in the intervention group vs five in the standard treatment group) and serious adverse events (21 vs 28). INTERPRETATION: The application of surfactant via a thin catheter to spontaneously breathing preterm infants receiving continuous positive airway pressure reduces the need for mechanical ventilation. FUNDING: German Ministry of Research and Technology, University of Lubeck, and Chiesi Pharmaceuticals.',\n",
       "               'CI': ['Copyright A(c) 2011 Elsevier Ltd. All rights reserved.'],\n",
       "               'FAU': ['Gopel, Wolfgang',\n",
       "                'Kribs, Angela',\n",
       "                'Ziegler, Andreas',\n",
       "                'Laux, Reinhard',\n",
       "                'Hoehn, Thomas',\n",
       "                'Wieg, Christian',\n",
       "                'Siegel, Jens',\n",
       "                'Avenarius, Stefan',\n",
       "                'von der Wense, Axel',\n",
       "                'Vochem, Matthias',\n",
       "                'Groneck, Peter',\n",
       "                'Weller, Ursula',\n",
       "                'Moller, Jens',\n",
       "                'Hartel, Christoph',\n",
       "                'Haller, Sebastian',\n",
       "                'Roth, Bernhard',\n",
       "                'Herting, Egbert'],\n",
       "               'AU': ['Gopel W',\n",
       "                'Kribs A',\n",
       "                'Ziegler A',\n",
       "                'Laux R',\n",
       "                'Hoehn T',\n",
       "                'Wieg C',\n",
       "                'Siegel J',\n",
       "                'Avenarius S',\n",
       "                'von der Wense A',\n",
       "                'Vochem M',\n",
       "                'Groneck P',\n",
       "                'Weller U',\n",
       "                'Moller J',\n",
       "                'Hartel C',\n",
       "                'Haller S',\n",
       "                'Roth B',\n",
       "                'Herting E'],\n",
       "               'AD': ['University of Lubeck, Lubeck, Germany.'],\n",
       "               'CN': ['German Neonatal Network'],\n",
       "               'LA': ['eng'],\n",
       "               'SI': ['ISRCTN/ISRCTN05025922'],\n",
       "               'PT': ['Journal Article',\n",
       "                'Multicenter Study',\n",
       "                'Randomized Controlled Trial',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20110929',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Lancet',\n",
       "               'JT': 'Lancet (London, England)',\n",
       "               'JID': '2985213R',\n",
       "               'RN': ['0 (Pulmonary Surfactants)',\n",
       "                '142M471B3J (Carbon Dioxide)',\n",
       "                'S88TT14065 (Oxygen)'],\n",
       "               'SB': 'IM',\n",
       "               'CIN': ['Lancet. 2011 Nov 5;378(9803):1607-8. doi: 10.1016/S0140-6736(11)61339-1. PMID:',\n",
       "                '21963185',\n",
       "                'Lancet. 2012 Apr 28;379(9826):1589; author reply 1589-90. doi:',\n",
       "                '10.1016/S0140-6736(12)60676-X. PMID: 22541580'],\n",
       "               'MH': ['Administration, Inhalation',\n",
       "                'Carbon Dioxide/metabolism',\n",
       "                'Catheters',\n",
       "                'Continuous Positive Airway Pressure',\n",
       "                'Female',\n",
       "                'Heart Rate',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                '*Infant, Premature',\n",
       "                'Intensive Care Units, Neonatal',\n",
       "                'Male',\n",
       "                'Oxygen/blood',\n",
       "                'Oxygen Inhalation Therapy/statistics & numerical data',\n",
       "                'Pulmonary Surfactants/*administration & dosage',\n",
       "                'Respiration, Artificial/*statistics & numerical data',\n",
       "                'Respiratory Distress Syndrome, Newborn/*therapy'],\n",
       "               'FIR': ['Konig, I R',\n",
       "                'Stichtenoth, G',\n",
       "                'Bendiks, M',\n",
       "                'Kattner, E',\n",
       "                'Strahleck, T',\n",
       "                'Mehler, K',\n",
       "                'Hunseler, C',\n",
       "                'Hadzik, B',\n",
       "                'Moser, Katja',\n",
       "                'Buder, K',\n",
       "                'Lenze, S',\n",
       "                'Raedler, E',\n",
       "                'Gudowius, P',\n",
       "                'Anhalt, D',\n",
       "                'Teig, N',\n",
       "                'Nikischin, W',\n",
       "                'Rudiger, M',\n",
       "                'Katalinic, A'],\n",
       "               'IR': ['Konig IR',\n",
       "                'Stichtenoth G',\n",
       "                'Bendiks M',\n",
       "                'Kattner E',\n",
       "                'Strahleck T',\n",
       "                'Mehler K',\n",
       "                'Hunseler C',\n",
       "                'Hadzik B',\n",
       "                'Moser K',\n",
       "                'Buder K',\n",
       "                'Lenze S',\n",
       "                'Raedler E',\n",
       "                'Gudowius P',\n",
       "                'Anhalt D',\n",
       "                'Teig N',\n",
       "                'Nikischin W',\n",
       "                'Rudiger M',\n",
       "                'Katalinic A'],\n",
       "               'EDAT': '2011/10/04 06:00',\n",
       "               'MHDA': '2011/12/13 00:00',\n",
       "               'CRDT': ['2011/10/04 06:00'],\n",
       "               'PHST': ['2011/10/04 06:00 [entrez]',\n",
       "                '2011/10/04 06:00 [pubmed]',\n",
       "                '2011/12/13 00:00 [medline]'],\n",
       "               'AID': ['S0140-6736(11)60986-0 [pii]',\n",
       "                '10.1016/S0140-6736(11)60986-0 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Lancet. 2011 Nov 5;378(9803):1627-34. doi: 10.1016/S0140-6736(11)60986-0. Epub 2011 Sep 29.'},\n",
       "              {'PMID': '21656454',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20110815',\n",
       "               'LR': '20110609',\n",
       "               'IS': '1439-4413 (Electronic) 0012-0472 (Linking)',\n",
       "               'VI': '136',\n",
       "               'IP': '24',\n",
       "               'DP': '2011 Jun',\n",
       "               'TI': '[Diagnostics and treatment in functional pancreatic neuroendocrine tumours].',\n",
       "               'PG': '1319-30',\n",
       "               'LID': '10.1055/s-0031-1280554 [doi]',\n",
       "               'AB': 'Pancreatic neuroendocrine tumours (PNET) are rare entities with an annual incidence of < 100,000. About 1 - 2 % of pancreatic neoplasias are neuroendocrine tumours. About one third of these tumours secrete biologically active substances that lead to development of specific clinical syndromes. PNET may occur sporadically or in association with hereditary syndromes, such as multiple endocrine neoplasia type 1 (MEN1). Among the functional PNET, insulinomas and gastrinomas are the most common entities. In contrast, vasoactive intetinale peptide (VIP)-secreting tumours, glucagonomas, serotonin-secreting carcinoid tumors, and tumours with secretion of ectopic hormones, such as calcitonin, are extremely rare. Once diagnosis has been established on the basis of clinical and laboratory findings, localization of the source of pathologic hormone secretion is warranted. Imaging methods frequently used for localization of PNET comprise anatomical imaging modalities, computed tomography, and magnetic resonance imaging, endoscopic ultrasound, selective arterial catheterization with hepatic venous sampling, DTPA-octreotid scintigraphy and DOTA-D-Phe(1)-Tyr(3)-octreotid positron emission tomography. Therapy is based on the specific tumour entity and the extent of the disease. In the majority of patients, even in the case of malignant disease, a surgical approach is warranted, eventually combined with a medical treatment.',\n",
       "               'CI': ['(c) Georg Thieme Verlag KG Stuttgart . New York.'],\n",
       "               'FAU': ['Mussig, K',\n",
       "                'Dudziak, K',\n",
       "                'Horger, M',\n",
       "                'Anlauf, M',\n",
       "                'Goretzki, P E'],\n",
       "               'AU': ['Mussig K',\n",
       "                'Dudziak K',\n",
       "                'Horger M',\n",
       "                'Anlauf M',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Klinik fur Innere Medizin mit Gastroenterologie und Onkologie, Florence-Nightingale-Krankenhaus, Kaiserswerther Diakonie, Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Case Reports',\n",
       "                'English Abstract',\n",
       "                'Journal Article',\n",
       "                'Review'],\n",
       "               'TT': 'Diagnostik und Therapie bei funktionell aktiven pankreatischen neuroendokrinen Tumoren.',\n",
       "               'DEP': '20110607',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Dtsch Med Wochenschr',\n",
       "               'JT': 'Deutsche medizinische Wochenschrift (1946)',\n",
       "               'JID': '0006723',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Diagnosis, Differential',\n",
       "                'Fasting',\n",
       "                'Female',\n",
       "                'Gastrinoma/diagnosis/pathology/therapy',\n",
       "                'Glucagonoma/diagnosis/pathology/therapy',\n",
       "                'Humans',\n",
       "                'Hypoglycemia/etiology',\n",
       "                'Insulinoma/diagnosis/pathology/therapy',\n",
       "                'Malignant Carcinoid Syndrome/diagnosis/pathology/therapy',\n",
       "                'Multiple Endocrine Neoplasia Type 1/diagnosis/pathology/therapy',\n",
       "                'Neoplasm Staging',\n",
       "                'Neuroectodermal Tumors, Primitive/*diagnosis/pathology/therapy',\n",
       "                'Pancreatic Neoplasms/*diagnosis/pathology/therapy',\n",
       "                'Prognosis',\n",
       "                'Somatostatinoma/diagnosis/pathology/therapy',\n",
       "                'Tomography, Spiral Computed',\n",
       "                'Vipoma/diagnosis/pathology/therapy'],\n",
       "               'EDAT': '2011/06/10 06:00',\n",
       "               'MHDA': '2011/08/16 06:00',\n",
       "               'CRDT': ['2011/06/10 06:00'],\n",
       "               'PHST': ['2011/06/10 06:00 [entrez]',\n",
       "                '2011/06/10 06:00 [pubmed]',\n",
       "                '2011/08/16 06:00 [medline]'],\n",
       "               'AID': ['10.1055/s-0031-1280554 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Dtsch Med Wochenschr. 2011 Jun;136(24):1319-30. doi: 10.1055/s-0031-1280554. Epub 2011 Jun 7.'},\n",
       "              {'PMID': '21424798',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20111114',\n",
       "               'LR': '20211020',\n",
       "               'IS': '1435-2451 (Electronic) 1435-2443 (Linking)',\n",
       "               'VI': '396',\n",
       "               'IP': '5',\n",
       "               'DP': '2011 Jun',\n",
       "               'TI': 'German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease.',\n",
       "               'PG': '639-49',\n",
       "               'LID': '10.1007/s00423-011-0774-y [doi]',\n",
       "               'AB': 'INTRODUCTION: Benign thyroid disorders are among the most common diseases in Germany, affecting around 15 million people and leading to more than 100,000 thyroid surgeries per year. Since the first German guidelines for the surgical treatment of benign goiter were published in 1998, abundant new information has become available, significantly shifting surgical strategy towards more radical interventions. Additionally, minimally invasive techniques have been developed and gained wide usage. These circumstances demanded a revision of the guidelines. METHODS: Based on a review of relevant recent guidelines from other groups and additional literature, unpublished data, and clinical experience, the German Association of Endocrine Surgeons formulated new recommendations on the surgical treatment of benign thyroid diseases. These guidelines were developed through a formal expert consensus process and in collaboration with the German societies of Nuclear Medicine, Endocrinology, Pathology, and Phoniatrics & Pedaudiology as well as two patient organizations. Consensus was achieved through several moderated conferences of surgical experts and representatives of the collaborating medical societies and patient organizations. RESULTS: The revised guidelines for the surgical treatment of benign thyroid diseases include recommendations regarding the preoperative assessment necessary to determine when surgery is indicated. Recommendations regarding the extent of resection, surgical techniques, and perioperative management are also given in order to optimize patient outcomes. CONCLUSIONS: Evidence-based recommendations for the surgical treatment of benign thyroid diseases have been created to aid the surgeon and to support optimal patient care, based on current knowledge. These recommendations comply with the Association of the Scientific Medical Societies in Germany requirements for S2k guidelines.',\n",
       "               'FAU': ['Musholt, Thomas J',\n",
       "                'Clerici, Thomas',\n",
       "                'Dralle, Henning',\n",
       "                'Frilling, Andreja',\n",
       "                'Goretzki, Peter E',\n",
       "                'Hermann, Michael M',\n",
       "                'Kussmann, Jochen',\n",
       "                'Lorenz, Kerstin',\n",
       "                'Nies, Christoph',\n",
       "                'Schabram, Jochen',\n",
       "                'Schabram, Peter',\n",
       "                'Scheuba, Christian',\n",
       "                'Simon, Dietmar',\n",
       "                'Steinmuller, Thomas',\n",
       "                'Trupka, Arnold W',\n",
       "                'Wahl, Robert A',\n",
       "                'Zielke, Andreas',\n",
       "                'Bockisch, Andreas',\n",
       "                'Karges, Wolfram',\n",
       "                'Luster, Markus',\n",
       "                'Schmid, Kurt W'],\n",
       "               'AU': ['Musholt TJ',\n",
       "                'Clerici T',\n",
       "                'Dralle H',\n",
       "                'Frilling A',\n",
       "                'Goretzki PE',\n",
       "                'Hermann MM',\n",
       "                'Kussmann J',\n",
       "                'Lorenz K',\n",
       "                'Nies C',\n",
       "                'Schabram J',\n",
       "                'Schabram P',\n",
       "                'Scheuba C',\n",
       "                'Simon D',\n",
       "                'Steinmuller T',\n",
       "                'Trupka AW',\n",
       "                'Wahl RA',\n",
       "                'Zielke A',\n",
       "                'Bockisch A',\n",
       "                'Karges W',\n",
       "                'Luster M',\n",
       "                'Schmid KW'],\n",
       "               'AD': ['Section of Endocrine Surgery, Clinic of General and Abdominal Surgery, University Medical Center, Gutenberg University-Mainz, Langenbeckstr. 1, 55101, Mainz, Germany. musholt@uni-mainz.de'],\n",
       "               'CN': ['Interdisciplinary Task Force Guidelines of the German Association of Endocrine',\n",
       "                'Surgeons'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Consensus Development Conference',\n",
       "                'Journal Article',\n",
       "                'Practice Guideline'],\n",
       "               'DEP': '20110322',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Biopsy, Fine-Needle/standards',\n",
       "                'Cost-Benefit Analysis/standards',\n",
       "                '*Endocrinology',\n",
       "                'Evidence-Based Medicine/standards',\n",
       "                'Frozen Sections/standards',\n",
       "                'Germany',\n",
       "                'Goiter/diagnosis/pathology/*surgery',\n",
       "                'Goiter, Nodular/diagnosis/pathology/surgery',\n",
       "                'Humans',\n",
       "                'Minimally Invasive Surgical Procedures/standards',\n",
       "                'Postoperative Care/standards',\n",
       "                'Quality Assurance, Health Care/standards',\n",
       "                '*Societies, Medical',\n",
       "                '*Specialties, Surgical',\n",
       "                'Thyroid Diseases/diagnosis/pathology/*surgery',\n",
       "                'Thyroid Gland/pathology',\n",
       "                'Thyroidectomy/methods/standards'],\n",
       "               'EDAT': '2011/03/23 06:00',\n",
       "               'MHDA': '2011/11/15 06:00',\n",
       "               'CRDT': ['2011/03/23 06:00'],\n",
       "               'PHST': ['2011/01/18 00:00 [received]',\n",
       "                '2011/03/01 00:00 [accepted]',\n",
       "                '2011/03/23 06:00 [entrez]',\n",
       "                '2011/03/23 06:00 [pubmed]',\n",
       "                '2011/11/15 06:00 [medline]'],\n",
       "               'AID': ['10.1007/s00423-011-0774-y [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 2011 Jun;396(5):639-49. doi: 10.1007/s00423-011-0774-y. Epub 2011 Mar 22.'},\n",
       "              {'PMID': '21403810',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20110809',\n",
       "               'LR': '20211020',\n",
       "               'IS': '1866-0452 (Electronic) 1866-0452 (Linking)',\n",
       "               'VI': '108',\n",
       "               'IP': '8',\n",
       "               'DP': '2011 Feb',\n",
       "               'TI': 'Hormone replacement after thyroid and parathyroid surgery: Importance of postoperative hypocalcemia.',\n",
       "               'PG': '133; author reply 134',\n",
       "               'LID': '10.3238/arztebl.2011.0133b [doi]',\n",
       "               'FAU': ['Wirowski, Denis',\n",
       "                'Schwarz, Katharina',\n",
       "                'Lammers, Bernhard J',\n",
       "                'Goretzki, Peter E'],\n",
       "               'AU': ['Wirowski D', 'Schwarz K', 'Lammers BJ', 'Goretzki PE'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comment', 'Letter'],\n",
       "               'DEP': '20110225',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Dtsch Arztebl Int',\n",
       "               'JT': 'Deutsches Arzteblatt international',\n",
       "               'JID': '101475967',\n",
       "               'RN': ['0 (Parathyroid Hormone)', '9679TC07X4 (Iodine)'],\n",
       "               'SB': 'IM',\n",
       "               'CON': ['Dtsch Arztebl Int. 2010 Nov;107(47):827-34. doi: 10.3238/arztebl.2010.0827. PMID:',\n",
       "                '21173898'],\n",
       "               'MH': ['Drug Administration Schedule',\n",
       "                'Hormone Replacement Therapy/*methods',\n",
       "                'Humans',\n",
       "                'Hypocalcemia/*drug therapy/*etiology',\n",
       "                'Hypothyroidism/blood/*drug therapy',\n",
       "                'Iodine/administration & dosage',\n",
       "                'Parathyroid Diseases/blood/*surgery',\n",
       "                'Parathyroid Hormone/blood/therapeutic use',\n",
       "                'Parathyroidectomy/*adverse effects',\n",
       "                'Thyroid Diseases/blood/*surgery',\n",
       "                'Thyroidectomy'],\n",
       "               'PMC': 'PMC3055262',\n",
       "               'EDAT': '2011/03/16 06:00',\n",
       "               'MHDA': '2011/08/10 06:00',\n",
       "               'PMCR': ['2011/02/01'],\n",
       "               'CRDT': ['2011/03/16 06:00'],\n",
       "               'PHST': ['2011/03/16 06:00 [entrez]',\n",
       "                '2011/03/16 06:00 [pubmed]',\n",
       "                '2011/08/10 06:00 [medline]',\n",
       "                '2011/02/01 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3238/arztebl.2011.0133b [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Dtsch Arztebl Int. 2011 Feb;108(8):133; author reply 134. doi: 10.3238/arztebl.2011.0133b. Epub 2011 Feb 25.'},\n",
       "              {'PMID': '21374546',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20111109',\n",
       "               'LR': '20161125',\n",
       "               'IS': '1439-3646 (Electronic) 0947-7349 (Linking)',\n",
       "               'VI': '119',\n",
       "               'IP': '7',\n",
       "               'DP': '2011 Jul',\n",
       "               'TI': 'Extra-adrenal pheochromocytoma in the organ of Zuckerkandl: diagnosis and treatment strategies.',\n",
       "               'PG': '436-9',\n",
       "               'LID': '10.1055/s-0030-1270511 [doi]',\n",
       "               'AB': 'Pheochromocytoma (PHEO) and paraganglioma (PGL) are rare catecholamine-secreting neuroendocrine tumors arising from chromaffin tissue and can occur within the adrenal medulla (PHEO) or extra-adrenal sites (PGL). The most common site for PGL is the organ of Zuckerkandl, extra-adrenal chromaffin tissue near the origin of the inferior mesenteric artery.We here present 2 patients with extra-adrenal PGL in the organ of Zuckerkandl, located by iodine-123-metaiodobenzylguanadine ( (123)I-MIBG) scintigraphy and thereafter treated surgically or with iodine-131-metaiodobenzylguanadine ( (131)I-MIBG). First, in a 15-year-old boy with clinical suspicion of PHEO, the diagnosis was established by biochemical evaluation and confirmed by further imaging studies, including CT and (123)I-MIBG, as PGL in the Zuckerkandl organ. The tumor was completely resected by laparotomy. Second, in a 70-year-old woman presenting with progressive hypertension and palpitations, MR and (123)I-MIBG revealed a singular tumor lesion with abnormal (123)I-MIBG uptake in the Zuckerkandl organ. Due to severe general vascular disease, surgery was not performed and instead the patient underwent (131)I-MIBG therapy. The patient showed a good symptomatic response with improvement of symptoms and no relevant side-effects of therapy.',\n",
       "               'CI': ['(c) J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart . New York.'],\n",
       "               'FAU': ['Kahraman, D',\n",
       "                'Goretzki, P E',\n",
       "                'Szangolies, M',\n",
       "                'Schade, H',\n",
       "                'Schmidt, M',\n",
       "                'Kobe, C'],\n",
       "               'AU': ['Kahraman D',\n",
       "                'Goretzki PE',\n",
       "                'Szangolies M',\n",
       "                'Schade H',\n",
       "                'Schmidt M',\n",
       "                'Kobe C'],\n",
       "               'AD': ['Department of Nuclear Medicine, University of Cologne, Germany. deniz.kahraman@uk-koeln.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports', 'Journal Article'],\n",
       "               'DEP': '20110303',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Exp Clin Endocrinol Diabetes',\n",
       "               'JT': 'Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association',\n",
       "               'JID': '9505926',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adrenal Gland Neoplasms/*diagnostic imaging/*therapy',\n",
       "                'Aged',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Laparoscopy/methods',\n",
       "                'Male',\n",
       "                '*Para-Aortic Bodies',\n",
       "                'Pheochromocytoma/diagnostic imaging/*therapy',\n",
       "                'Radionuclide Imaging/methods'],\n",
       "               'EDAT': '2011/03/05 06:00',\n",
       "               'MHDA': '2011/11/10 06:00',\n",
       "               'CRDT': ['2011/03/05 06:00'],\n",
       "               'PHST': ['2011/03/05 06:00 [entrez]',\n",
       "                '2011/03/05 06:00 [pubmed]',\n",
       "                '2011/11/10 06:00 [medline]'],\n",
       "               'AID': ['10.1055/s-0030-1270511 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Exp Clin Endocrinol Diabetes. 2011 Jul;119(7):436-9. doi: 10.1055/s-0030-1270511. Epub 2011 Mar 3.'},\n",
       "              {'PMID': '21317641',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20110818',\n",
       "               'LR': '20220311',\n",
       "               'IS': '1530-0293 (Electronic) 0090-3493 (Linking)',\n",
       "               'VI': '39',\n",
       "               'IP': '5',\n",
       "               'DP': '2011 May',\n",
       "               'TI': 'Tumor necrosis factor-alpha promoter -308 G/A polymorphism and susceptibility to sepsis in very-low-birth-weight infants.',\n",
       "               'PG': '1190-5',\n",
       "               'LID': '10.1097/CCM.0b013e31820ead07 [doi]',\n",
       "               'AB': 'OBJECTIVES: To determine whether the tumor necrosis factor-alpha -308 G/A polymorphism is associated with blood culture-proven sepsis in two large cohorts of very-low-birth-weight infants. DESIGN: Genetic association studies. SETTING: Prospective, population-based, multicentered cohort of 1944 very-low-birth-weight infants born in 14 German study centers between 2003 and 2008 and 976 mothers, and a second prospective cohort of 926 very-low-birth-weight infants born in 2009 (German Neonatal Network). MEASUREMENTS AND MAIN RESULTS: In cohort I, 344 of 1944 (18.2%) very-low-birth-weight infants had at least one episode of blood culture-proven sepsis develop. The sepsis incidence stratified to genotype was 19.3% for G/G, 15.8% for G/A, 10.0% for A/A genotype (Cochrane-Armitage trend test: G/G vs. G/A: odds ratio, 1.32; 95% confidence interval, 1.03-1.71; G/G vs. A/A: odds ratio, 1.74; 95% confidence interval, 1.06-2.91; p = .03). There was a trend for association of tumor necrosis factor-alpha -308 A/G genotype with late-onset sepsis episodes (incidence: 17.2% for G/G, 12.5% for G/A, 10.0% for A/A genotype; Cochrane-Armitage trend test: G/G vs. G/A: odds ratio, 1.43; 95% confidence interval, 1.09-1.9; G/G vs. A/A: odds ratio, 2.05; 95% confidence interval, 1.19-3.56; p = .009). However, after adjustment for multiple testing, no significant associations were found. Furthermore, the genotype of the investigated 976 mothers had no impact on sepsis risk for their very-low-birth-weight infants. We additionally studied a second prospective cohort of 926 very-low-birth-weight infants and found no associations with sepsis risk. CONCLUSIONS: No association was found between the tumor necrosis factor-alpha -308 G/A polymorphism blood culture-proven sepsis in two large cohorts of very-low-birth-weight infants. A recent meta-analysis demonstrated that the tumor necrosis factor-alpha -308 A allele is associated with higher sepsis risk in adult cohorts. Thus, potential differences between adults and infants need to be incorporated in future study designs evaluating risk profiles for sepsis.',\n",
       "               'FAU': ['Hartel, Christoph',\n",
       "                'Hemmelmann, Claudia',\n",
       "                'Faust, Kirstin',\n",
       "                'Gebauer, Corinna',\n",
       "                'Hoehn, Thomas',\n",
       "                'Kribs, Angela',\n",
       "                'Laux, Reinhard',\n",
       "                'Nikischin, Werner',\n",
       "                'Segerer, Hugo',\n",
       "                'Teig, Norbert',\n",
       "                'von der Wense, Axel',\n",
       "                'Wieg, Christian',\n",
       "                'Herting, Egbert',\n",
       "                'Gopel, Wolfgang'],\n",
       "               'AU': ['Hartel C',\n",
       "                'Hemmelmann C',\n",
       "                'Faust K',\n",
       "                'Gebauer C',\n",
       "                'Hoehn T',\n",
       "                'Kribs A',\n",
       "                'Laux R',\n",
       "                'Nikischin W',\n",
       "                'Segerer H',\n",
       "                'Teig N',\n",
       "                'von der Wense A',\n",
       "                'Wieg C',\n",
       "                'Herting E',\n",
       "                'Gopel W'],\n",
       "               'AD': ['Department of Pediatrics and Institute of Medical Biometry and Statistics, University at Lubeck, Germany. haertel@paedia.ukl.mu-luebeck.de'],\n",
       "               'CN': ['German Neonatal Network'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comparative Study',\n",
       "                'Journal Article',\n",
       "                'Multicenter Study',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Crit Care Med',\n",
       "               'JT': 'Critical care medicine',\n",
       "               'JID': '0355501',\n",
       "               'RN': ['0 (Tumor Necrosis Factor-alpha)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Cohort Studies',\n",
       "                'Confidence Intervals',\n",
       "                'Disease Susceptibility',\n",
       "                'Enzyme-Linked Immunosorbent Assay',\n",
       "                'Female',\n",
       "                'Flow Cytometry',\n",
       "                'Germany',\n",
       "                'Hospital Mortality/trends',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Newborn, Diseases/blood/*genetics/mortality',\n",
       "                '*Infant, Very Low Birth Weight',\n",
       "                'Intensive Care Units, Neonatal',\n",
       "                'Male',\n",
       "                'Odds Ratio',\n",
       "                '*Polymorphism, Genetic',\n",
       "                'Prognosis',\n",
       "                'Promoter Regions, Genetic/genetics',\n",
       "                'Prospective Studies',\n",
       "                'Risk Assessment',\n",
       "                'Sepsis/blood/*genetics/mortality',\n",
       "                'Survival Analysis',\n",
       "                'Tumor Necrosis Factor-alpha/*genetics/metabolism'],\n",
       "               'EDAT': '2011/02/15 06:00',\n",
       "               'MHDA': '2011/08/19 06:00',\n",
       "               'CRDT': ['2011/02/15 06:00'],\n",
       "               'PHST': ['2011/02/15 06:00 [entrez]',\n",
       "                '2011/02/15 06:00 [pubmed]',\n",
       "                '2011/08/19 06:00 [medline]'],\n",
       "               'AID': ['10.1097/CCM.0b013e31820ead07 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Crit Care Med. 2011 May;39(5):1190-5. doi: 10.1097/CCM.0b013e31820ead07.'}],\n",
       "             '2010': [{'PMID': '21082555',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20120816',\n",
       "               'LR': '20101118',\n",
       "               'IS': '1090-3941 (Print) 1090-3941 (Linking)',\n",
       "               'VI': '20',\n",
       "               'DP': '2010 Oct',\n",
       "               'TI': 'Water-jet dissection in rectal cancer surgery: surgical and oncological outcomes.',\n",
       "               'PG': '115-23',\n",
       "               'AB': 'These days the treatment of rectal cancer remains an encounter for various medical disciplines. A key position in the whole concept of therapy is still taken by surgery itself. To facilitate the advantages of the total mesorectal excision (TME) we used the water-jet dissector (WJD) in our surgical routine. Our object was to analyze perioperative data as well as oncological long-term results following WJD-assisted rectal resection. MATERIALS AND METHODS: A total of 226 patients underwent surgery for rectal cancer in our center between October 2001 and June 2009. A retrospective review was performed of all WJD-assisted rectal resections during this time. One hundred and five patients with adenocarcinoma of the lower and middle rectum were operated on by 7 surgeons according to the concept of TME. Seventy-six patients underwent a low anterior resection, 29 patients an abdominoperineal resection. Twenty-eight patients received preoperative radiochemotherapy. The median follow-up period amounted to 35 (2-96) months. Survival rates were calculated using the Kaplan-Meier method. RESULTS: Anastomotic leakage occurred in 5.7%, wound healing disturbance (including perineal wound infections) in 29.5%, intra-abdominal infections in 7.6% and urinary tract infections in 7.6%. Postoperative bladder dysfunction (requiring catheterization) occurred in 1.9%. Postoperative 30-day mortality was 0%, 60-day mortality 1%. The rate of local recurrence (including three patients who refused postoperative radiochemotherapy) was 8.5%. Cancer-specific survival at 5 years was 74% and differed significantly by stage. CONCLUSIONS: The particular advance of the WJD is the facile development of the embryological plane between the mesorectal fascia and the surrounding pelvic nerves. Without harming one of them, maximum radicality and excellent autonomic nerve preservation can be achieved. The WJD is a technique with acceptable postoperative morbidity and low mortality. Local control and survival are comparable to other surgical centers in international literature.',\n",
       "               'FAU': ['Touloumtzidis, Aristotelis',\n",
       "                'Kuhn, Petra',\n",
       "                'Goretzki, Peter E',\n",
       "                'Lammers, Bernhard J'],\n",
       "               'AU': ['Touloumtzidis A',\n",
       "                'Kuhn P',\n",
       "                'Goretzki PE',\n",
       "                'Lammers BJ'],\n",
       "               'AD': ['Department of General Surgery, Abdominal Surgery, Thorax and Vascular Surgery, Coloproctology, and Hernia Surgery, Stadtisches Klinikum, Lukaskrankenhaus, Neuss, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Surg Technol Int',\n",
       "               'JT': 'Surgical technology international',\n",
       "               'JID': '9604509',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Dissection/*methods/*mortality',\n",
       "                'Equipment Design',\n",
       "                'Female',\n",
       "                'Germany/epidemiology',\n",
       "                'Humans',\n",
       "                'Hydrostatic Pressure',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Prevalence',\n",
       "                'Rectal Neoplasms/*mortality/*surgery',\n",
       "                'Risk Assessment',\n",
       "                'Risk Factors',\n",
       "                'Survival Analysis',\n",
       "                'Survival Rate',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '2010/11/18 06:00',\n",
       "               'MHDA': '2012/08/17 06:00',\n",
       "               'CRDT': ['2010/11/18 06:00'],\n",
       "               'PHST': ['2010/11/18 06:00 [entrez]',\n",
       "                '2010/11/18 06:00 [pubmed]',\n",
       "                '2012/08/17 06:00 [medline]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Surg Technol Int. 2010 Oct;20:115-23.'},\n",
       "              {'PMID': '20830282',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20110125',\n",
       "               'LR': '20211020',\n",
       "               'IS': '1866-0452 (Electronic) 1866-0452 (Linking)',\n",
       "               'VI': '107',\n",
       "               'IP': '33',\n",
       "               'DP': '2010 Aug',\n",
       "               'TI': 'Substantial deficiencies.',\n",
       "               'PG': '573; author reply 574',\n",
       "               'LID': '10.3238/arztebl.2010.0573a [doi]',\n",
       "               'FAU': ['Goretzki, Peter',\n",
       "                'Lammers, Bernhard',\n",
       "                'Touloumtzidis, Aristotelis',\n",
       "                'Otto, Thomas'],\n",
       "               'AU': ['Goretzki P', 'Lammers B', 'Touloumtzidis A', 'Otto T'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comment', 'Letter'],\n",
       "               'DEP': '20100820',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Dtsch Arztebl Int',\n",
       "               'JT': 'Deutsches Arzteblatt international',\n",
       "               'JID': '101475967',\n",
       "               'SB': 'IM',\n",
       "               'CON': ['Dtsch Arztebl Int. 2010 Feb;107(8):123-30. doi: 10.3238/arztebl.2010.0123. PMID:',\n",
       "                '20300220'],\n",
       "               'MH': ['Comorbidity',\n",
       "                'Female',\n",
       "                'Germany/epidemiology',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Postoperative Complications/*mortality',\n",
       "                'Prevalence',\n",
       "                'Quality of Life',\n",
       "                'Rectal Neoplasms/*mortality/*surgery',\n",
       "                'Sexual Dysfunction, Physiological/*mortality',\n",
       "                'Treatment Outcome'],\n",
       "               'PMC': 'PMC2936048',\n",
       "               'EDAT': '2010/09/11 06:00',\n",
       "               'MHDA': '2011/01/28 06:00',\n",
       "               'PMCR': ['2010/08/01'],\n",
       "               'CRDT': ['2010/09/11 06:00'],\n",
       "               'PHST': ['2010/09/11 06:00 [entrez]',\n",
       "                '2010/09/11 06:00 [pubmed]',\n",
       "                '2011/01/28 06:00 [medline]',\n",
       "                '2010/08/01 00:00 [pmc-release]'],\n",
       "               'AID': ['10.3238/arztebl.2010.0573a [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Dtsch Arztebl Int. 2010 Aug;107(33):573; author reply 574. doi: 10.3238/arztebl.2010.0573a. Epub 2010 Aug 20.'},\n",
       "              {'PMID': '20648406',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20100916',\n",
       "               'LR': '20141113',\n",
       "               'IS': '1439-4413 (Electronic) 0012-0472 (Linking)',\n",
       "               'VI': '135',\n",
       "               'IP': '30',\n",
       "               'DP': '2010 Jul',\n",
       "               'TI': '[Insulinoma associated with pregnancy].',\n",
       "               'PG': '1484-6',\n",
       "               'LID': '10.1055/s-0030-1262436 [doi]',\n",
       "               'AB': 'HISTORY AND CLINICAL FINDINGS: A 42-year-old woman was found by her husband with unconsciousness and seizure at night three weeks after delivery of her fifth child. At a blood glucose level of 25 mg/dl, she received an intravenous infusion of glucose by the called emergency physician, leading to a rapid improvement of her symptoms. INVESTIGATION AND DIAGNOSIS: The following examination showed a low basal blood glucose level as well as pathological levels of insulin and C-peptide. These findings together with the Whipple trias (hypoglycaemia, neurological symptoms and rapid improvement after infusion of glucose) were highly suspicious of an insulinoma. Whereas CT, MRI and DOTATOC-PET were negative, endoscopic ultrasound showed a mass of 13 mm in the tail of the pancreas. TREATMENT AND COURSE: The tumour was resected from the tail of the pancreas by laparoscopic enucleation. Histological examination revealed an endocrine tumour (insulinoma) of the pancreas. Postoperative blood glucose levels were within the normal range. The patient and her healthy newborn child could be dismissed from hospital on the third day after surgery. CONCLUSION: Despite its rarity, an insulinoma represents an important differential diagnosis of hypoglycaemia during and right after pregnancy.',\n",
       "               'CI': ['Georg Thieme Verlag KG Stuttgart, New York.'],\n",
       "               'FAU': ['Akca, A',\n",
       "                'Mann, K',\n",
       "                'Starke, A',\n",
       "                'Lammers, B J',\n",
       "                'Goretzki, P E'],\n",
       "               'AU': ['Akca A',\n",
       "                'Mann K',\n",
       "                'Starke A',\n",
       "                'Lammers BJ',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Chirurgische Klinik I, Lukaskrankenhaus Neuss. AAkca@lukasneuss.de'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Case Reports', 'English Abstract', 'Journal Article'],\n",
       "               'TT': 'Postpartales Insulinom.',\n",
       "               'DEP': '20100720',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Dtsch Med Wochenschr',\n",
       "               'JT': 'Deutsche medizinische Wochenschrift (1946)',\n",
       "               'JID': '0006723',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Insulinoma/*diagnosis/*surgery',\n",
       "                'Pancreatic Neoplasms/*diagnosis/*surgery',\n",
       "                'Pregnancy',\n",
       "                'Pregnancy Complications, Neoplastic/*diagnosis/*surgery',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '2010/07/22 06:00',\n",
       "               'MHDA': '2010/09/18 06:00',\n",
       "               'CRDT': ['2010/07/22 06:00'],\n",
       "               'PHST': ['2010/07/22 06:00 [entrez]',\n",
       "                '2010/07/22 06:00 [pubmed]',\n",
       "                '2010/09/18 06:00 [medline]'],\n",
       "               'AID': ['10.1055/s-0030-1262436 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Dtsch Med Wochenschr. 2010 Jul;135(30):1484-6. doi: 10.1055/s-0030-1262436. Epub 2010 Jul 20.'},\n",
       "              {'PMID': '20560122',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20101029',\n",
       "               'LR': '20151119',\n",
       "               'IS': '1438-9592 (Electronic) 0044-409X (Linking)',\n",
       "               'VI': '135',\n",
       "               'IP': '3',\n",
       "               'DP': '2010 Jun',\n",
       "               'TI': '[Pancreatic hyperinsulinism--changes of the clinical picture and importance of differences in sporadic disease course (experience with 144 patients operated in the period 1986-2009)].',\n",
       "               'PG': '218-25',\n",
       "               'LID': '10.1055/s-0030-1247316 [doi]',\n",
       "               'AB': 'The diagnoses of pancreatogenic hyperinsulinism and insulinoma (benign or malignant) were almost synonomously used during the last decades. Only familial forms of hyperinsulinism, i. e., in patients with multiple endocrine neoplasia type 1 were separately discussed. The surgical literature concentrated on technical questions, comparing open and minimal invasive techniques. The clinical diagnosis of patients with pancreatogenic hypo-glycaemia syndrome (NIPHS) and the pathological diagnosis of insulinomatosis has now opened up new questions in the diagnosis and therapy of pancreatogenic hyperinsulinism. On the basis of our experience from 144 patients operated on for pancreatogenic hyperinsulinism during the last 22 years with 16 NIPHS patients and with the help of the relevant literature, we explain the prerequisites that surgical therapy has to fulfil in the treatment of patients with pancreatogenic hyperinsulinism today.',\n",
       "               'FAU': ['Goretzki, P',\n",
       "                'Starke, A',\n",
       "                'Lammers, B',\n",
       "                'Schwarz, K',\n",
       "                'Roher, H-D'],\n",
       "               'AU': ['Goretzki P',\n",
       "                'Starke A',\n",
       "                'Lammers B',\n",
       "                'Schwarz K',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Stadtische Kliniken Neuss, Lukaskrankenhaus GmbH, Chirurgische Klinik I, Neuss, Deutschland. pgoretzki@lukasneuss.de'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article', 'Review'],\n",
       "               'TT': 'Pankreatischer Hyperinsulinismus--Wandel des Krankheitsbildes mit spezifischen Unterschieden auch bei sporadischen Erkrankungsformen (Eigene Erfahrung an 144 operierten Patienten von 1986-2009).',\n",
       "               'DEP': '20100617',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Zentralbl Chir',\n",
       "               'JT': 'Zentralblatt fur Chirurgie',\n",
       "               'JID': '0413645',\n",
       "               'RN': ['SY7Q814VUP (Calcium)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Calcium',\n",
       "                'Cooperative Behavior',\n",
       "                'Diagnosis, Differential',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Glucose Tolerance Test',\n",
       "                'Humans',\n",
       "                'Hyperinsulinism/*diagnosis/*surgery',\n",
       "                'Hypoglycemia/diagnosis/surgery',\n",
       "                'Insulinoma/*diagnosis/*surgery',\n",
       "                'Interdisciplinary Communication',\n",
       "                'Laparoscopy',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Minimally Invasive Surgical Procedures/methods',\n",
       "                'Multiple Endocrine Neoplasia Type 1/*diagnosis/*surgery',\n",
       "                'Nesidioblastosis/*diagnosis/*surgery',\n",
       "                'Pancreatectomy/methods',\n",
       "                'Pancreatic Diseases/*diagnosis/*surgery',\n",
       "                'Pancreatic Neoplasms/*diagnosis/*surgery',\n",
       "                'Postoperative Complications/etiology/surgery',\n",
       "                'Reoperation',\n",
       "                'Retrospective Studies',\n",
       "                'Young Adult'],\n",
       "               'EDAT': '2010/06/19 06:00',\n",
       "               'MHDA': '2010/10/30 06:00',\n",
       "               'CRDT': ['2010/06/19 06:00'],\n",
       "               'PHST': ['2010/06/19 06:00 [entrez]',\n",
       "                '2010/06/19 06:00 [pubmed]',\n",
       "                '2010/10/30 06:00 [medline]'],\n",
       "               'AID': ['10.1055/s-0030-1247316 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Zentralbl Chir. 2010 Jun;135(3):218-25. doi: 10.1055/s-0030-1247316. Epub 2010 Jun 17.'},\n",
       "              {'PMID': '20473996',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20100610',\n",
       "               'LR': '20100517',\n",
       "               'IS': '1365-2168 (Electronic) 0007-1323 (Linking)',\n",
       "               'VI': '97',\n",
       "               'IP': '6',\n",
       "               'DP': '2010 Jun',\n",
       "               'TI': 'Diagnosis and treatment of small follicular thyroid carcinomas.',\n",
       "               'PG': '839-44',\n",
       "               'LID': '10.1002/bjs.6969 [doi]',\n",
       "               'AB': 'BACKGROUND: Follicular thyroid microcarcinomas (mFTCs) of 10 mm or less in size rarely manifest clinically and their clinical significance is controversial. This study assessed their characteristics and incidence, and analysed treatment modalities used for mFTC. METHODS: Members of the German Association of Endocrine Surgeons were asked to review patients with mFTC operated on between 1990 and 2005. RESULTS: Data for 90 patients from 26 institutions were reported. Histopathological slides were available for re-evaluation in 35 patients. Most initial diagnoses had to be revised because of incorrect size assessment or incorrect diagnosis (benign adenoma, papillary thyroid carcinoma (PTC), follicular variant of PTC). The diagnosis of mFTC was confirmed in only four patients. As a result of the incorrect histopathological diagnosis, unnecessary completion thyroidectomy and radioiodine ablation were performed in 17 and 20 patients respectively. The incidence of mFTC was calculated to be 0.12 per million population per year. CONCLUSION: mFTC is exceptionally rare. Such tumours are overdiagnosed, resulting in unnecessary treatment associated with avoidable morbidity. Histopathological re-evaluation by an experienced pathologist is recommended before embarking on further treatments when a diagnosis of mFTC is made.',\n",
       "               'FAU': ['Clerici, T',\n",
       "                'Kolb, W',\n",
       "                'Beutner, U',\n",
       "                'Bareck, E',\n",
       "                'Dotzenrath, C',\n",
       "                'Kull, C',\n",
       "                'Niederle, B'],\n",
       "               'AU': ['Clerici T',\n",
       "                'Kolb W',\n",
       "                'Beutner U',\n",
       "                'Bareck E',\n",
       "                'Dotzenrath C',\n",
       "                'Kull C',\n",
       "                'Niederle B'],\n",
       "               'AD': ['Department of Surgery, Kantonsspital St Gallen, St Gallen, Switzerland.'],\n",
       "               'CN': ['German Association of Endocrine Surgeons'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Multicenter Study'],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Br J Surg',\n",
       "               'JT': 'The British journal of surgery',\n",
       "               'JID': '0372553',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma, Follicular/*pathology/surgery',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Austria',\n",
       "                'Female',\n",
       "                'Germany',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Neoplasm Recurrence, Local/pathology',\n",
       "                'Switzerland',\n",
       "                'Thyroid Neoplasms/*pathology/*surgery',\n",
       "                'Thyroidectomy',\n",
       "                'Tumor Burden'],\n",
       "               'FIR': ['Kaserer, K',\n",
       "                'Perren, A',\n",
       "                'Schmid, K W',\n",
       "                'Koberle-Wuhrer, R',\n",
       "                'Wenzl, E',\n",
       "                'Asari, R',\n",
       "                'Klinge, U',\n",
       "                'Muller, G',\n",
       "                'Kroell, K P',\n",
       "                'Blankenburg, C',\n",
       "                'Voss, H',\n",
       "                'Cupisti, K',\n",
       "                'Witte, J',\n",
       "                'Knoefel, W T',\n",
       "                'Simon, D',\n",
       "                'Lienenluke, R H',\n",
       "                'Vorlander, C',\n",
       "                'Wacha, H',\n",
       "                'Schabram, J',\n",
       "                'Lorenz, K',\n",
       "                'Dralle, H',\n",
       "                'Wojciechowski, B',\n",
       "                'Kussmann, J',\n",
       "                'Weber, Y',\n",
       "                'Schurmann, G',\n",
       "                'Goretzki, P E',\n",
       "                'Ulitzer, H',\n",
       "                'Eberle, A',\n",
       "                'Mayer, M',\n",
       "                'Stabenow, R',\n",
       "                'Stegmaier, C',\n",
       "                'Buhlmann, R',\n",
       "                'Schlumpf, R',\n",
       "                'Triponez, F',\n",
       "                'Ess, S M'],\n",
       "               'IR': ['Kaserer K',\n",
       "                'Perren A',\n",
       "                'Schmid KW',\n",
       "                'Koberle-Wuhrer R',\n",
       "                'Wenzl E',\n",
       "                'Asari R',\n",
       "                'Klinge U',\n",
       "                'Muller G',\n",
       "                'Kroell KP',\n",
       "                'Blankenburg C',\n",
       "                'Voss H',\n",
       "                'Cupisti K',\n",
       "                'Witte J',\n",
       "                'Knoefel WT',\n",
       "                'Simon D',\n",
       "                'Lienenluke RH',\n",
       "                'Vorlander C',\n",
       "                'Wacha H',\n",
       "                'Schabram J',\n",
       "                'Lorenz K',\n",
       "                'Dralle H',\n",
       "                'Wojciechowski B',\n",
       "                'Kussmann J',\n",
       "                'Weber Y',\n",
       "                'Schurmann G',\n",
       "                'Goretzki PE',\n",
       "                'Ulitzer H',\n",
       "                'Eberle A',\n",
       "                'Mayer M',\n",
       "                'Stabenow R',\n",
       "                'Stegmaier C',\n",
       "                'Buhlmann R',\n",
       "                'Schlumpf R',\n",
       "                'Triponez F',\n",
       "                'Ess SM'],\n",
       "               'EDAT': '2010/05/18 06:00',\n",
       "               'MHDA': '2010/06/11 06:00',\n",
       "               'CRDT': ['2010/05/18 06:00'],\n",
       "               'PHST': ['2010/05/18 06:00 [entrez]',\n",
       "                '2010/05/18 06:00 [pubmed]',\n",
       "                '2010/06/11 06:00 [medline]'],\n",
       "               'AID': ['10.1002/bjs.6969 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Br J Surg. 2010 Jun;97(6):839-44. doi: 10.1002/bjs.6969.'},\n",
       "              {'PMID': '20143072',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20100914',\n",
       "               'LR': '20220331',\n",
       "               'IS': '1432-2323 (Electronic) 0364-2313 (Linking)',\n",
       "               'VI': '34',\n",
       "               'IP': '6',\n",
       "               'DP': '2010 Jun',\n",
       "               'TI': 'The impact of intraoperative neuromonitoring (IONM) on surgical strategy in bilateral thyroid diseases: is it worth the effort?',\n",
       "               'PG': '1274-84',\n",
       "               'LID': '10.1007/s00268-009-0353-3 [doi]',\n",
       "               'AB': 'BACKGROUND: Intraoperative nerve monitoring (IONM) of the recurrent laryngeal nerve and the vagal nerve can detect nonfunctioning nerves (recurrent laryngeal nerve palsy, RLNP) that are visibly intact. The use of IONM is questionable, however, as we still lack evidence that it reduces the rate of postoperative nerve injuries. Since negative IONM results after thyroid dissection of the first side could change our surgical strategy and thus could prevent patients from bilateral RLNP, we questioned whether IONM results are reliable enough to base changes in surgical strategy and whether this has any effect on surgical outcome. METHODS: We retrospectively analyzed the data of 1333 consecutive patients with suggested benign bilateral thyroid disease who had been operated on under a defined protocol, including the use of a specific IONM technique (tube electrodes and stimulation of the vagal nerve and the inferior recurrent nerve before and after thyroid resection), between January 1, 2006 and December 31, 2008. RESULTS: In four patients the IONM system did not work, two nerves had not been found, and in eight patients the tube had to be readjusted. Of five permanent nerve injuries, four were visible during surgery and one was suspected. Sensitivity of IONM in detecting temporary nerve injuries of macroscopically normal-appearing nerves was 93%. Specificity was 75-83% at first side of dissection and 55-67% at the second side, with an overall specificity of 77%. In 11 of 13 patients (85%) with known nerve injury (preexisting or visible) and in 20 of 36 patients (56%) with negative IONM stimulation at the first side of dissection, the surgical strategy was changed (specific surgeon or restricted resection) with no postoperative bilateral RLNP. This was in contrast to 3 of 18 (17%) bilateral RLNP (p < 0.05), when surgeons were not aware of a preexisting or highly likely nerve injury at the first side of thyroid dissection. CONCLUSIONS: Failed IONM stimulation of the vagal or recurrent laryngeal nerve after resection of the first thyroid lobe is specific enough to reconsider the surgical strategy in patients with bilateral thyroid disease to surely prevent bilateral RLNP.',\n",
       "               'FAU': ['Goretzki, Peter E',\n",
       "                'Schwarz, Katharina',\n",
       "                'Brinkmann, Jurgen',\n",
       "                'Wirowski, Denis',\n",
       "                'Lammers, Bernhard J'],\n",
       "               'AU': ['Goretzki PE',\n",
       "                'Schwarz K',\n",
       "                'Brinkmann J',\n",
       "                'Wirowski D',\n",
       "                'Lammers BJ'],\n",
       "               'AD': ['Surgical Department 1, Insulinoma GEP Tumor Center Neuss-Dusseldorf, Lukaskrankenhaus Neuss, Preussenstr. 84, 41456, Neuss, Germany. pgoretzki@lukasneuss.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Child',\n",
       "                'Electric Stimulation',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Monitoring, Intraoperative/*methods',\n",
       "                'Retrospective Studies',\n",
       "                'Sensitivity and Specificity',\n",
       "                'Thyroid Diseases/*surgery',\n",
       "                '*Vagus Nerve',\n",
       "                'Vocal Cord Paralysis/*prevention & control'],\n",
       "               'EDAT': '2010/02/10 06:00',\n",
       "               'MHDA': '2010/09/15 06:00',\n",
       "               'CRDT': ['2010/02/10 06:00'],\n",
       "               'PHST': ['2010/02/10 06:00 [entrez]',\n",
       "                '2010/02/10 06:00 [pubmed]',\n",
       "                '2010/09/15 06:00 [medline]'],\n",
       "               'AID': ['10.1007/s00268-009-0353-3 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 2010 Jun;34(6):1274-84. doi: 10.1007/s00268-009-0353-3.'},\n",
       "              {'PMID': '20135656',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'DCOM': '20100707',\n",
       "               'LR': '20100412',\n",
       "               'IS': '1521-3773 (Electronic) 1433-7851 (Linking)',\n",
       "               'VI': '49',\n",
       "               'IP': '10',\n",
       "               'DP': '2010 Mar 1',\n",
       "               'TI': 'Supramolecular assemblies formed on an epitaxial graphene superstructure.',\n",
       "               'PG': '1794-9',\n",
       "               'LID': '10.1002/anie.200905503 [doi]',\n",
       "               'FAU': ['Pollard, Andrew J',\n",
       "                'Perkins, Edward W',\n",
       "                'Smith, Nicholas A',\n",
       "                'Saywell, Alex',\n",
       "                'Goretzki, Gudrun',\n",
       "                'Phillips, Anna G',\n",
       "                'Argent, Stephen P',\n",
       "                'Sachdev, Hermann',\n",
       "                'Muller, Frank',\n",
       "                'Hufner, Stefan',\n",
       "                'Gsell, Stefan',\n",
       "                'Fischer, Martin',\n",
       "                'Schreck, Matthias',\n",
       "                'Osterwalder, Jurg',\n",
       "                'Greber, Thomas',\n",
       "                'Berner, Simon',\n",
       "                'Champness, Neil R',\n",
       "                'Beton, Peter H'],\n",
       "               'AU': ['Pollard AJ',\n",
       "                'Perkins EW',\n",
       "                'Smith NA',\n",
       "                'Saywell A',\n",
       "                'Goretzki G',\n",
       "                'Phillips AG',\n",
       "                'Argent SP',\n",
       "                'Sachdev H',\n",
       "                'Muller F',\n",
       "                'Hufner S',\n",
       "                'Gsell S',\n",
       "                'Fischer M',\n",
       "                'Schreck M',\n",
       "                'Osterwalder J',\n",
       "                'Greber T',\n",
       "                'Berner S',\n",
       "                'Champness NR',\n",
       "                'Beton PH'],\n",
       "               'AD': ['School of Physics & Astronomy, University of Nottingham, Nottingham, NG7 2RD UK.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Angew Chem Int Ed Engl',\n",
       "               'JT': 'Angewandte Chemie (International ed. in English)',\n",
       "               'JID': '0370543',\n",
       "               'EDAT': '2010/02/06 06:00',\n",
       "               'MHDA': '2010/02/06 06:01',\n",
       "               'CRDT': ['2010/02/06 06:00'],\n",
       "               'PHST': ['2010/02/06 06:00 [entrez]',\n",
       "                '2010/02/06 06:00 [pubmed]',\n",
       "                '2010/02/06 06:01 [medline]'],\n",
       "               'AID': ['10.1002/anie.200905503 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Angew Chem Int Ed Engl. 2010 Mar 1;49(10):1794-9. doi: 10.1002/anie.200905503.'},\n",
       "              {'PMID': '20017490',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'DCOM': '20100601',\n",
       "               'LR': '20100310',\n",
       "               'IS': '1520-5827 (Electronic) 0743-7463 (Linking)',\n",
       "               'VI': '26',\n",
       "               'IP': '6',\n",
       "               'DP': '2010 Mar 16',\n",
       "               'TI': 'Solubilized derivatives of perylenetetracarboxylic dianhydride (PTCDA) adsorbed on highly oriented pyrolytic graphite.',\n",
       "               'PG': '3972-4',\n",
       "               'LID': '10.1021/la903335v [doi]',\n",
       "               'AB': 'The effect on 2D molecular crystallization caused by the addition of propylthioether side groups to the 3,4,9,10-perylenetetracarboxylic dianhydride (PTCDA) molecule is investigated using scanning tunneling microscopy (STM). The molecule was deposited from 1-phenyloctane onto highly oriented pyrolytic graphite (HOPG) and imaged at the liquid-solid interface. We observe a different structure to previously reported arrangements of PTCDA due to the presence of the propylthioether side groups which inhibits the formation of the herringbone phase. A model, supported by calculations based on density functional theory, is proposed in which molecules form rows stabilized by hydrogen bonding.',\n",
       "               'FAU': ['Russell, James C',\n",
       "                'Blunt, Matthew O',\n",
       "                'Goretzki, Gudrun',\n",
       "                'Phillips, Anna G',\n",
       "                'Champness, Neil R',\n",
       "                'Beton, Peter H'],\n",
       "               'AU': ['Russell JC',\n",
       "                'Blunt MO',\n",
       "                'Goretzki G',\n",
       "                'Phillips AG',\n",
       "                'Champness NR',\n",
       "                'Beton PH'],\n",
       "               'AD': ['School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K..'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Langmuir',\n",
       "               'JT': 'Langmuir : the ACS journal of surfaces and colloids',\n",
       "               'JID': '9882736',\n",
       "               'EDAT': '2009/12/19 06:00',\n",
       "               'MHDA': '2009/12/19 06:01',\n",
       "               'CRDT': ['2009/12/19 06:00'],\n",
       "               'PHST': ['2009/12/19 06:00 [entrez]',\n",
       "                '2009/12/19 06:00 [pubmed]',\n",
       "                '2009/12/19 06:01 [medline]'],\n",
       "               'AID': ['10.1021/la903335v [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langmuir. 2010 Mar 16;26(6):3972-4. doi: 10.1021/la903335v.'}],\n",
       "             '2009': [{'PMID': '19825962',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20100111',\n",
       "               'LR': '20220408',\n",
       "               'IS': '1557-3265 (Electronic) 1078-0432 (Linking)',\n",
       "               'VI': '15',\n",
       "               'IP': '20',\n",
       "               'DP': '2009 Oct 15',\n",
       "               'TI': 'Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients.',\n",
       "               'PG': '6378-85',\n",
       "               'LID': '10.1158/1078-0432.CCR-09-1237 [doi]',\n",
       "               'AB': 'PURPOSE: Six pheochromocytoma susceptibility genes causing distinct syndromes have been identified; approximately one of three of all pheochromocytoma patients carry a predisposing germline mutation. When four major genes (VHL, RET, SDHB, SDHD) are analyzed in a clinical laboratory, costs are approximately $3,400 per patient. The aim of the study is to systematically obtain a robust algorithm to identify who should be genetically tested, and to determine the order in which genes should be tested. EXPERIMENTAL DESIGN: DNA from 989 apparently nonsyndromic patients were scanned for germline mutations in the genes VHL, RET, SDHB, SDHC, and SDHD. Clinical parameters were analyzed as potential predictors for finding mutations by multiple logistic regression, validated by bootstrapping. Cost reduction was calculated between prioritized gene testing compared with that for all genes. RESULTS: Of 989 apparently nonsyndromic pheochromocytoma cases, 187 (19%) harbored germline mutations. Predictors for presence of mutation are age <45 years, multiple pheochromocytoma, extra-adrenal location, and previous head and neck paraganglioma. If we used the presence of any one predictor as indicative of proceeding with gene testing, then 342 (34.6%) patients would be excluded, and only 8 carriers (4.3%) would be missed. We were also able to statistically model the priority of genes to be tested given certain clinical features. E.g., for patients with prior head and neck paraganglioma, the priority would be SDHD>SDHB>RET>VHL. Using the clinical predictor algorithm to prioritize gene testing and order, a 44.7% cost reduction in diagnostic process can be achieved. CONCLUSIONS: Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.',\n",
       "               'FAU': ['Erlic, Zoran',\n",
       "                'Rybicki, Lisa',\n",
       "                'Peczkowska, Mariola',\n",
       "                'Golcher, Henriette',\n",
       "                'Kann, Peter H',\n",
       "                'Brauckhoff, Michael',\n",
       "                'Mussig, Karsten',\n",
       "                'Muresan, Michaela',\n",
       "                'Schaffler, Andreas',\n",
       "                'Reisch, Nicole',\n",
       "                'Schott, Matthias',\n",
       "                'Fassnacht, Martin',\n",
       "                'Opocher, Giuseppe',\n",
       "                'Klose, Silke',\n",
       "                'Fottner, Christian',\n",
       "                'Forrer, Flavio',\n",
       "                'Plockinger, Ursula',\n",
       "                'Petersenn, Stephan',\n",
       "                'Zabolotny, Dimitry',\n",
       "                'Kollukch, Oleg',\n",
       "                'Yaremchuk, Svetlana',\n",
       "                'Januszewicz, Andrzej',\n",
       "                'Walz, Martin K',\n",
       "                'Eng, Charis',\n",
       "                'Neumann, Hartmut P H'],\n",
       "               'AU': ['Erlic Z',\n",
       "                'Rybicki L',\n",
       "                'Peczkowska M',\n",
       "                'Golcher H',\n",
       "                'Kann PH',\n",
       "                'Brauckhoff M',\n",
       "                'Mussig K',\n",
       "                'Muresan M',\n",
       "                'Schaffler A',\n",
       "                'Reisch N',\n",
       "                'Schott M',\n",
       "                'Fassnacht M',\n",
       "                'Opocher G',\n",
       "                'Klose S',\n",
       "                'Fottner C',\n",
       "                'Forrer F',\n",
       "                'Plockinger U',\n",
       "                'Petersenn S',\n",
       "                'Zabolotny D',\n",
       "                'Kollukch O',\n",
       "                'Yaremchuk S',\n",
       "                'Januszewicz A',\n",
       "                'Walz MK',\n",
       "                'Eng C',\n",
       "                'Neumann HP'],\n",
       "               'AD': ['Department of Nephrology, Section of Preventive Medicine, Albert-Ludwigs-University, Hugstetter Strasse 55, Freiburg, Germany.'],\n",
       "               'CN': ['European-American Pheochromocytoma Study Group'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20091013',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Clin Cancer Res',\n",
       "               'JT': 'Clinical cancer research : an official journal of the American Association for Cancer Research',\n",
       "               'JID': '9502500',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adrenal Gland Neoplasms/*diagnosis/*genetics',\n",
       "                'Algorithms',\n",
       "                'Family Health',\n",
       "                'Female',\n",
       "                'Genetic Carrier Screening',\n",
       "                'Genetic Predisposition to Disease',\n",
       "                '*Genetic Testing/economics',\n",
       "                'Head and Neck Neoplasms/complications',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Mutation',\n",
       "                'Paraganglioma/complications',\n",
       "                'Pheochromocytoma/*diagnosis/economics/*genetics'],\n",
       "               'FIR': ['Alexander',\n",
       "                'Allolio',\n",
       "                'Anlauf',\n",
       "                'Arlt',\n",
       "                'Arnold',\n",
       "                'Bachmann',\n",
       "                'Baumeister',\n",
       "                'Behrend',\n",
       "                'Bertram',\n",
       "                'Beyer',\n",
       "                'Beyersdorf',\n",
       "                'Bergmann',\n",
       "                'Bierkamp',\n",
       "                'Bloch',\n",
       "                'Boehncke',\n",
       "                'Bojunga',\n",
       "                'Bosse',\n",
       "                'Bootz',\n",
       "                'Borany',\n",
       "                'Borch',\n",
       "                'Bornstein',\n",
       "                'Brauckhoff',\n",
       "                'Brietzke',\n",
       "                'Buchler',\n",
       "                'Callies',\n",
       "                'Caspari',\n",
       "                'Cupisty',\n",
       "                'Demtroder',\n",
       "                'Desiderato',\n",
       "                'Dickert',\n",
       "                'Diefenbach',\n",
       "                'Roos',\n",
       "                'Dietz',\n",
       "                'Dorr',\n",
       "                'Donauer',\n",
       "                'Dost',\n",
       "                'Dralle',\n",
       "                'Dupuis',\n",
       "                'Ebbinghaus',\n",
       "                'Egli',\n",
       "                'Eisenhofer',\n",
       "                'Engert',\n",
       "                'Fade',\n",
       "                'Falk',\n",
       "                'Fassbinder',\n",
       "                'Feldkamp',\n",
       "                'Finke',\n",
       "                'Fischer',\n",
       "                'Fischer',\n",
       "                'Fritze',\n",
       "                'Frilling',\n",
       "                'Furtwangler',\n",
       "                'Gal',\n",
       "                'Garbrecht',\n",
       "                'Gerke',\n",
       "                'Glien',\n",
       "                'Gotte',\n",
       "                'Goretzki',\n",
       "                'Graubner',\n",
       "                'Grotz',\n",
       "                'Haag',\n",
       "                'Hagen',\n",
       "                'Hahner',\n",
       "                'Harsch',\n",
       "                'Hartung',\n",
       "                'Hauch',\n",
       "                'Happ',\n",
       "                'Hauschild',\n",
       "                'Hecht',\n",
       "                'Hector',\n",
       "                'Hehmann',\n",
       "                'Hehr',\n",
       "                'Heidemann',\n",
       "                'Heidemann',\n",
       "                'Heins',\n",
       "                'Hempel',\n",
       "                'Heppner',\n",
       "                'Herbach',\n",
       "                'Herlan',\n",
       "                'Hetzer',\n",
       "                'Hirsch',\n",
       "                'Hofmeier',\n",
       "                'Hofmockel',\n",
       "                'Holbeck',\n",
       "                'Hopt',\n",
       "                'Host',\n",
       "                'Hudelmayer',\n",
       "                'Isermann',\n",
       "                'Iwen',\n",
       "                'Jacobs',\n",
       "                'Jarzab',\n",
       "                'Jocham',\n",
       "                'Jurgens',\n",
       "                'Judy',\n",
       "                'Junginger',\n",
       "                'Jurdi',\n",
       "                'Justl',\n",
       "                'Kabisch',\n",
       "                'Karaa',\n",
       "                'Kavelage',\n",
       "                'Kindler',\n",
       "                'Kisters',\n",
       "                'Kirste',\n",
       "                'Klein-Franke',\n",
       "                'Klingebiel',\n",
       "                'Koch',\n",
       "                'Koster',\n",
       "                'Kornely',\n",
       "                'Kramer',\n",
       "                'Kremens',\n",
       "                'Krone',\n",
       "                'Krumme',\n",
       "                'Kuhn',\n",
       "                'Kusterer',\n",
       "                'Lampe',\n",
       "                'Lamster',\n",
       "                'Lederbogen',\n",
       "                'Lee',\n",
       "                'Leisner',\n",
       "                'Lindemann',\n",
       "                'Lohmann',\n",
       "                'Lossner',\n",
       "                'Lohofener',\n",
       "                'Lorenz',\n",
       "                'Luckhoff',\n",
       "                'Luft',\n",
       "                'Macazhavy',\n",
       "                'Malyar',\n",
       "                'Mann',\n",
       "                'Meyer',\n",
       "                'Meyer',\n",
       "                'Mitter',\n",
       "                'Mittler',\n",
       "                'Moller',\n",
       "                'Monig',\n",
       "                'Nawroth',\n",
       "                'Netzer',\n",
       "                'Neumann',\n",
       "                'Niebling',\n",
       "                'Niedermeyer',\n",
       "                'Niemeyer',\n",
       "                'Nies',\n",
       "                'Noah',\n",
       "                'Normann',\n",
       "                'Opitz',\n",
       "                'Otto',\n",
       "                'Patsch',\n",
       "                'Pasedag',\n",
       "                'Pavel',\n",
       "                'Pavenstadt',\n",
       "                'Peter',\n",
       "                'Petzold',\n",
       "                'Pfaffle',\n",
       "                'Pichl',\n",
       "                'Pielken',\n",
       "                'Plingen',\n",
       "                'Ploner',\n",
       "                'Pohl',\n",
       "                'Quante',\n",
       "                'Racasan',\n",
       "                'Reichhardt',\n",
       "                'Reincke',\n",
       "                'Reissenweber',\n",
       "                'Reschke',\n",
       "                'Reuter',\n",
       "                'Rieg',\n",
       "                'Riel',\n",
       "                'Ritter',\n",
       "                'Roher',\n",
       "                'Rohrer',\n",
       "                'Roth',\n",
       "                'Rudolph',\n",
       "                'Rudolph',\n",
       "                'Ruckauer',\n",
       "                'Schafer',\n",
       "                'Schafer',\n",
       "                'Schellong',\n",
       "                'Scherbaum',\n",
       "                'Schlottmann',\n",
       "                'Schmidt',\n",
       "                'Schmid',\n",
       "                'Schmitz',\n",
       "                'Schoninger',\n",
       "                'Schogohl',\n",
       "                'Scholz',\n",
       "                'Schott',\n",
       "                'Schulze',\n",
       "                'Schumann',\n",
       "                'Schumm-Drager',\n",
       "                'Schweinfest',\n",
       "                'Seppel',\n",
       "                'Seufert',\n",
       "                'Siegler',\n",
       "                'Sievers',\n",
       "                'Simon',\n",
       "                'Sieverts',\n",
       "                'Slisko',\n",
       "                'Sommer',\n",
       "                'Speicher',\n",
       "                'Stahl',\n",
       "                'Stephan',\n",
       "                'Stoll',\n",
       "                'Tan',\n",
       "                'Trupka',\n",
       "                'Unger',\n",
       "                'Vogelsang',\n",
       "                'Wahl',\n",
       "                'Walter',\n",
       "                'Weber',\n",
       "                'Weber',\n",
       "                'Wehinger',\n",
       "                'Weisbrod',\n",
       "                'Wenzel',\n",
       "                'Wiegand',\n",
       "                'Wiiwer',\n",
       "                'Willenberg',\n",
       "                'Wilms',\n",
       "                'Yuce',\n",
       "                'Zimmerhackl',\n",
       "                'Zimmermann',\n",
       "                'Zumkeller',\n",
       "                'zur Muhlen',\n",
       "                'Fauth',\n",
       "                'Winquist',\n",
       "                'Bello',\n",
       "                'MacGregor',\n",
       "                'Bockenhauer',\n",
       "                'Schulte',\n",
       "                'Aittomaki',\n",
       "                'Paronen',\n",
       "                'Valimaki',\n",
       "                'Virkamaki',\n",
       "                'Brunaud',\n",
       "                'Klein',\n",
       "                'Limacher',\n",
       "                'Pigny',\n",
       "                'Weryha',\n",
       "                'Zamboulis',\n",
       "                'Regev',\n",
       "                'Glase',\n",
       "                'Falcioni',\n",
       "                'Riegler',\n",
       "                'Schiavi',\n",
       "                'Stanzial',\n",
       "                'Heimdal',\n",
       "                'Laurent',\n",
       "                'Milos',\n",
       "                'Fuentes',\n",
       "                'Rovia',\n",
       "                'Ramme',\n",
       "                'Wallin',\n",
       "                'Angst',\n",
       "                'Mohaupt',\n",
       "                'Muller',\n",
       "                'Pichert',\n",
       "                'Preiswerk',\n",
       "                'Sanssonnens',\n",
       "                'Stettler',\n",
       "                'Sulzer',\n",
       "                'Unger',\n",
       "                'Unger',\n",
       "                'Huseyn',\n",
       "                'Kollkh',\n",
       "                'Yaremchuk',\n",
       "                'Uckun-Kitapci'],\n",
       "               'IR': ['Alexander',\n",
       "                'Allolio',\n",
       "                'Anlauf',\n",
       "                'Arlt',\n",
       "                'Arnold',\n",
       "                'Bachmann',\n",
       "                'Baumeister',\n",
       "                'Behrend',\n",
       "                'Bertram',\n",
       "                'Beyer',\n",
       "                'Beyersdorf',\n",
       "                'Bergmann',\n",
       "                'Bierkamp',\n",
       "                'Bloch',\n",
       "                'Boehncke',\n",
       "                'Bojunga',\n",
       "                'Bosse',\n",
       "                'Bootz',\n",
       "                'Borany',\n",
       "                'Borch',\n",
       "                'Bornstein',\n",
       "                'Brauckhoff',\n",
       "                'Brietzke',\n",
       "                'Buchler',\n",
       "                'Callies',\n",
       "                'Caspari',\n",
       "                'Cupisty',\n",
       "                'Demtroder',\n",
       "                'Desiderato',\n",
       "                'Dickert',\n",
       "                'Diefenbach',\n",
       "                'Roos',\n",
       "                'Dietz',\n",
       "                'Dorr',\n",
       "                'Donauer',\n",
       "                'Dost',\n",
       "                'Dralle',\n",
       "                'Dupuis',\n",
       "                'Ebbinghaus',\n",
       "                'Egli',\n",
       "                'Eisenhofer',\n",
       "                'Engert',\n",
       "                'Fade',\n",
       "                'Falk',\n",
       "                'Fassbinder',\n",
       "                'Feldkamp',\n",
       "                'Finke',\n",
       "                'Fischer',\n",
       "                'Fischer',\n",
       "                'Fritze',\n",
       "                'Frilling',\n",
       "                'Furtwangler',\n",
       "                'Gal',\n",
       "                'Garbrecht',\n",
       "                'Gerke',\n",
       "                'Glien',\n",
       "                'Gotte',\n",
       "                'Goretzki',\n",
       "                'Graubner',\n",
       "                'Grotz',\n",
       "                'Haag',\n",
       "                'Hagen',\n",
       "                'Hahner',\n",
       "                'Harsch',\n",
       "                'Hartung',\n",
       "                'Hauch',\n",
       "                'Happ',\n",
       "                'Hauschild',\n",
       "                'Hecht',\n",
       "                'Hector',\n",
       "                'Hehmann',\n",
       "                'Hehr',\n",
       "                'Heidemann',\n",
       "                'Heidemann',\n",
       "                'Heins',\n",
       "                'Hempel',\n",
       "                'Heppner',\n",
       "                'Herbach',\n",
       "                'Herlan',\n",
       "                'Hetzer',\n",
       "                'Hirsch',\n",
       "                'Hofmeier',\n",
       "                'Hofmockel',\n",
       "                'Holbeck',\n",
       "                'Hopt',\n",
       "                'Host',\n",
       "                'Hudelmayer',\n",
       "                'Isermann',\n",
       "                'Iwen',\n",
       "                'Jacobs',\n",
       "                'Jarzab',\n",
       "                'Jocham',\n",
       "                'Jurgens',\n",
       "                'Judy',\n",
       "                'Junginger',\n",
       "                'Jurdi',\n",
       "                'Justl',\n",
       "                'Kabisch',\n",
       "                'Karaa',\n",
       "                'Kavelage',\n",
       "                'Kindler',\n",
       "                'Kisters',\n",
       "                'Kirste',\n",
       "                'Klein-Franke',\n",
       "                'Klingebiel',\n",
       "                'Koch',\n",
       "                'Koster',\n",
       "                'Kornely',\n",
       "                'Kramer',\n",
       "                'Kremens',\n",
       "                'Krone',\n",
       "                'Krumme',\n",
       "                'Kuhn',\n",
       "                'Kusterer',\n",
       "                'Lampe',\n",
       "                'Lamster',\n",
       "                'Lederbogen',\n",
       "                'Lee',\n",
       "                'Leisner',\n",
       "                'Lindemann',\n",
       "                'Lohmann',\n",
       "                'Lossner',\n",
       "                'Lohofener',\n",
       "                'Lorenz',\n",
       "                'Luckhoff',\n",
       "                'Luft',\n",
       "                'Macazhavy',\n",
       "                'Malyar',\n",
       "                'Mann',\n",
       "                'Meyer',\n",
       "                'Meyer',\n",
       "                'Mitter',\n",
       "                'Mittler',\n",
       "                'Moller',\n",
       "                'Monig',\n",
       "                'Nawroth',\n",
       "                'Netzer',\n",
       "                'Neumann',\n",
       "                'Niebling',\n",
       "                'Niedermeyer',\n",
       "                'Niemeyer',\n",
       "                'Nies',\n",
       "                'Noah',\n",
       "                'Normann',\n",
       "                'Opitz',\n",
       "                'Otto',\n",
       "                'Patsch',\n",
       "                'Pasedag',\n",
       "                'Pavel',\n",
       "                'Pavenstadt',\n",
       "                'Peter',\n",
       "                'Petzold',\n",
       "                'Pfaffle',\n",
       "                'Pichl',\n",
       "                'Pielken',\n",
       "                'Plingen',\n",
       "                'Ploner',\n",
       "                'Pohl',\n",
       "                'Quante',\n",
       "                'Racasan',\n",
       "                'Reichhardt',\n",
       "                'Reincke',\n",
       "                'Reissenweber',\n",
       "                'Reschke',\n",
       "                'Reuter',\n",
       "                'Rieg',\n",
       "                'Riel',\n",
       "                'Ritter',\n",
       "                'Roher',\n",
       "                'Rohrer',\n",
       "                'Roth',\n",
       "                'Rudolph',\n",
       "                'Rudolph',\n",
       "                'Ruckauer',\n",
       "                'Schafer',\n",
       "                'Schafer',\n",
       "                'Schellong',\n",
       "                'Scherbaum',\n",
       "                'Schlottmann',\n",
       "                'Schmidt',\n",
       "                'Schmid',\n",
       "                'Schmitz',\n",
       "                'Schoninger',\n",
       "                'Schogohl',\n",
       "                'Scholz',\n",
       "                'Schott',\n",
       "                'Schulze',\n",
       "                'Schumann',\n",
       "                'Schumm-Drager',\n",
       "                'Schweinfest',\n",
       "                'Seppel',\n",
       "                'Seufert',\n",
       "                'Siegler',\n",
       "                'Sievers',\n",
       "                'Simon',\n",
       "                'Sieverts',\n",
       "                'Slisko',\n",
       "                'Sommer',\n",
       "                'Speicher',\n",
       "                'Stahl',\n",
       "                'Stephan',\n",
       "                'Stoll',\n",
       "                'Tan',\n",
       "                'Trupka',\n",
       "                'Unger',\n",
       "                'Vogelsang',\n",
       "                'Wahl',\n",
       "                'Walter',\n",
       "                'Weber',\n",
       "                'Weber',\n",
       "                'Wehinger',\n",
       "                'Weisbrod',\n",
       "                'Wenzel',\n",
       "                'Wiegand',\n",
       "                'Wiiwer',\n",
       "                'Willenberg',\n",
       "                'Wilms',\n",
       "                'Yuce',\n",
       "                'Zimmerhackl',\n",
       "                'Zimmermann',\n",
       "                'Zumkeller',\n",
       "                'zur Muhlen',\n",
       "                'Fauth',\n",
       "                'Winquist',\n",
       "                'Bello',\n",
       "                'MacGregor',\n",
       "                'Bockenhauer',\n",
       "                'Schulte',\n",
       "                'Aittomaki',\n",
       "                'Paronen',\n",
       "                'Valimaki',\n",
       "                'Virkamaki',\n",
       "                'Brunaud',\n",
       "                'Klein',\n",
       "                'Limacher',\n",
       "                'Pigny',\n",
       "                'Weryha',\n",
       "                'Zamboulis',\n",
       "                'Regev',\n",
       "                'Glase',\n",
       "                'Falcioni',\n",
       "                'Riegler',\n",
       "                'Schiavi',\n",
       "                'Stanzial',\n",
       "                'Heimdal',\n",
       "                'Laurent',\n",
       "                'Milos',\n",
       "                'Fuentes',\n",
       "                'Rovia',\n",
       "                'Ramme',\n",
       "                'Wallin',\n",
       "                'Angst',\n",
       "                'Mohaupt',\n",
       "                'Muller',\n",
       "                'Pichert',\n",
       "                'Preiswerk',\n",
       "                'Sanssonnens',\n",
       "                'Stettler',\n",
       "                'Sulzer',\n",
       "                'Unger',\n",
       "                'Unger',\n",
       "                'Huseyn',\n",
       "                'Kollkh',\n",
       "                'Yaremchuk',\n",
       "                'Uckun-Kitapci'],\n",
       "               'EDAT': '2009/10/15 06:00',\n",
       "               'MHDA': '2010/01/12 06:00',\n",
       "               'CRDT': ['2009/10/15 06:00'],\n",
       "               'PHST': ['2009/10/15 06:00 [entrez]',\n",
       "                '2009/10/15 06:00 [pubmed]',\n",
       "                '2010/01/12 06:00 [medline]'],\n",
       "               'AID': ['1078-0432.CCR-09-1237 [pii]',\n",
       "                '10.1158/1078-0432.CCR-09-1237 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Clin Cancer Res. 2009 Oct 15;15(20):6378-85. doi: 10.1158/1078-0432.CCR-09-1237. Epub 2009 Oct 13.'},\n",
       "              {'PMID': '19799381',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'DCOM': '20100119',\n",
       "               'LR': '20091026',\n",
       "               'IS': '1520-510X (Electronic) 0020-1669 (Linking)',\n",
       "               'VI': '48',\n",
       "               'IP': '21',\n",
       "               'DP': '2009 Nov 2',\n",
       "               'TI': 'Building multistate redox-active architectures using metal-complex functionalized perylene bis-imides.',\n",
       "               'PG': '10264-74',\n",
       "               'LID': '10.1021/ic901379d [doi]',\n",
       "               'AB': 'A series of multistate redox-active architectures has been synthesized, structurally characterized, and their optical and redox properties investigated. Specifically, two redox-active ferrocene or cobalt-dithiolene moieties have been introduced to the \"bay\" region of perylene-bisimides. Three of these disubstituted perylene-bisimide species have been structurally characterized by single crystal X-ray diffraction, confirming the twisted nature of the central perylene core. The first isomeric pair of disubstituted perylene-bisimide isomers, N,N\\'-di-(n-butyl)-1,7-diferrocenyl-perylene-3,4:9,10-tetracarboxylic acid bisimide (2) and N,N\\'-di-(n-butyl)-1,6-diferrocenyl-perylene-3,4:9,10-tetracarboxylic acid bisimide (3), structurally characterized by single crystal X-ray diffraction are reported and compared. Structural characterization of the cobalt-dithiolene substituted perylene-bisimide, N,N\\'-di-(n-butyl)-1,7-dicyclopentadienyl-cobalt(II)-dithiolenyl-perylene-3,4:9,10-tetracarboxylic acid bisimide (4), reveals the expected twisting of the perylene core and confirms the ene-dithiolate geometry of the cobalt dithiolene moiety. Cyclic voltammetry measurements, coupled with spectroelectrochemcial and electron paramagnetic resonance studies, of 1-4, where 1 is N,N\\'-di-(n-butyl)-1,7-diethynylferrocenyl-perylene-3,4:9,10-tetracarboxylic acid bisimide, reveal the two anticipated perylene-bisimide based reductions. In addition, for the ferrocene substituted compounds, 1-3, a single reversible two-electron oxidation is seen with only a small degree of communication between the ferrocene groups observed in the 1,6-isomer where the two ferrocene groups are attached to the same naphthyl moiety. In the case of 4, two reversible reductions associated with the cobalt-dithiolene moieties are observed, confirming communication across the reduced perylene core.',\n",
       "               'FAU': ['Goretzki, Gudrun',\n",
       "                'Davies, E Stephen',\n",
       "                'Argent, Stephen P',\n",
       "                'Warren, John E',\n",
       "                'Blake, Alexander J',\n",
       "                'Champness, Neil R'],\n",
       "               'AU': ['Goretzki G',\n",
       "                'Davies ES',\n",
       "                'Argent SP',\n",
       "                'Warren JE',\n",
       "                'Blake AJ',\n",
       "                'Champness NR'],\n",
       "               'AD': ['School of Chemistry, University of Nottingham, University Park, Nottingham NG7 2RD, UK.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Inorg Chem',\n",
       "               'JT': 'Inorganic chemistry',\n",
       "               'JID': '0366543',\n",
       "               'EDAT': '2009/10/06 06:00',\n",
       "               'MHDA': '2009/10/06 06:01',\n",
       "               'CRDT': ['2009/10/06 06:00'],\n",
       "               'PHST': ['2009/10/06 06:00 [entrez]',\n",
       "                '2009/10/06 06:00 [pubmed]',\n",
       "                '2009/10/06 06:01 [medline]'],\n",
       "               'AID': ['10.1021/ic901379d [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Inorg Chem. 2009 Nov 2;48(21):10264-74. doi: 10.1021/ic901379d.'},\n",
       "              {'PMID': '19579199',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20120816',\n",
       "               'LR': '20090706',\n",
       "               'IS': '1090-3941 (Print) 1090-3941 (Linking)',\n",
       "               'VI': '18',\n",
       "               'DP': '2009 Apr',\n",
       "               'TI': 'Less pain intensity after lichtenstein-repair by using BioGlue for mesh fixation.',\n",
       "               'PG': '125-8',\n",
       "               'AB': 'A pre-trial was conducted to investigate the reliability of using the surgical adhesive, BioGlue (CryoLife(R), Inc., Kennesaw, Georgia, USA) for mesh fixation in Lichtenstein repair of inguinal hernia. From February to August 2008, 60 patients with unilateral inguinal hernia underwent a Lichtenstein repair. In 30 of the patients, BioGlue was used for mesh fixation and in the other 30 cases a conventional suture was used. The patients were sorted into two groups (BioGlue-group and suture-group). No differences were noted in demographic characteristics. The main criteria for dropout were incarceration, relapse, operation, and/or scrotal hernia. Twenty-four hours postoperative, pain intensity was measured with a numeric analogous scale (NAS) that reached from 0 (no pain) to 10 (heavy pain). The pain intensity in the BioGlue-group was 2.4 points and 4.3 points in the suture-group. The cut-suture time was 30 minutes in the BioGlue-group and 56 minutes in the suture-group. In the first nine months, no relapses, no mesh infections, nor serom-formations were reported; however, one superficial wound infection did occur in the BioGlue-group. Lichtenstein-repair using BioGlue for mesh-fixation is a safe, new method without early recurrences and less pain-intensity in relation to suture-supported Lichtenstein repair.',\n",
       "               'FAU': ['Bar, Andreas',\n",
       "                'Sauer, Thorsten',\n",
       "                'Bohnert, Nicholas',\n",
       "                'Goretzki, Peter E',\n",
       "                'Lammers, Bernhard J'],\n",
       "               'AU': ['Bar A',\n",
       "                'Sauer T',\n",
       "                'Bohnert N',\n",
       "                'Goretzki PE',\n",
       "                'Lammers BJ'],\n",
       "               'AD': ['Department of General Surgery, Abdominal Surgery, Thorax and Vascular Surgery, Coloproctology, and Hernia Surgery, Lukaskrankenhaus GmbH, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Controlled Clinical Trial', 'Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Surg Technol Int',\n",
       "               'JT': 'Surgical technology international',\n",
       "               'JID': '9604509',\n",
       "               'RN': ['0 (Bio-glue)', '0 (Proteins)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Female',\n",
       "                'Hernia, Inguinal/complications/*surgery',\n",
       "                'Herniorrhaphy/*adverse effects/*instrumentation/methods',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Pain, Postoperative/*etiology/*prevention & control',\n",
       "                'Prosthesis Implantation/methods',\n",
       "                'Proteins/*therapeutic use',\n",
       "                'Surgical Mesh/*adverse effects',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '2009/07/07 09:00',\n",
       "               'MHDA': '2012/08/17 06:00',\n",
       "               'CRDT': ['2009/07/07 09:00'],\n",
       "               'PHST': ['2009/07/07 09:00 [entrez]',\n",
       "                '2009/07/07 09:00 [pubmed]',\n",
       "                '2012/08/17 06:00 [medline]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Surg Technol Int. 2009 Apr;18:125-8.'},\n",
       "              {'PMID': '19579193',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20120816',\n",
       "               'LR': '20090706',\n",
       "               'IS': '1090-3941 (Print) 1090-3941 (Linking)',\n",
       "               'VI': '18',\n",
       "               'DP': '2009 Apr',\n",
       "               'TI': 'Implementing the general use of dissection devices in thyroid surgery from prospective randomized trial to daily use.',\n",
       "               'PG': '86-92',\n",
       "               'AB': 'Routine use of vascular sealing and dissecting devices was implemented in our Tertiary Center of Endocrine Surgery with a high volume of thyroid operations. Beginning with a prospective randomized trial on 82 patients that compared thyroid surgery with assistance of a new, high-frequency-powered electrothermal device (Precise, Covidien, Boulder, Colorado) to conventional thyroid surgery, approximately 30% of operation time was saved in the group using the device. Surgeons were then free to decide whether to use LigaSure (Precise), an ultrasonic device (Focus, Ethicon Endo Surgery, Cincinnati, Ohio), or the classic tie-and-knotting procedure. This change of procedure resulted in an increase of surgery with devices, when compared to classic procedures from 20.2% to 98.4%, during a period of 5 years with 2,591 patients. The equal results of device-supported thyroid surgery were demonstrated when 100 consecutive patients with Precise and Focus were compared, by measuring time of surgery (-36% or 43 min) and postoperative morbidity. The authors advocate the use of vascular sealing and dissecting devices for thyroid operations and, especially, for surgical units with high operative frequency.',\n",
       "               'FAU': ['Goretzki, Peter E',\n",
       "                'Schwarz, Katharina',\n",
       "                'Lammers, Berhard J'],\n",
       "               'AU': ['Goretzki PE', 'Schwarz K', 'Lammers BJ'],\n",
       "               'AD': ['Department of General Surgery, Abdominal Surgery, Coloproctology, and Hernia Surgery, Lukaskrankenhaus, Neuss, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Randomized Controlled Trial'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Surg Technol Int',\n",
       "               'JT': 'Surgical technology international',\n",
       "               'JID': '9604509',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Equipment Design',\n",
       "                'Equipment Failure Analysis',\n",
       "                'Germany/epidemiology',\n",
       "                'Humans',\n",
       "                'Suture Techniques/*instrumentation/*statistics & numerical data',\n",
       "                'Thyroidectomy/*instrumentation/*statistics & numerical data',\n",
       "                'Treatment Outcome',\n",
       "                'Ultrasonic Surgical Procedures/*instrumentation/*statistics & numerical data',\n",
       "                'Workload/*statistics & numerical data'],\n",
       "               'EDAT': '2009/07/07 09:00',\n",
       "               'MHDA': '2012/08/17 06:00',\n",
       "               'CRDT': ['2009/07/07 09:00'],\n",
       "               'PHST': ['2009/07/07 09:00 [entrez]',\n",
       "                '2009/07/07 09:00 [pubmed]',\n",
       "                '2012/08/17 06:00 [medline]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Surg Technol Int. 2009 Apr;18:86-92.'},\n",
       "              {'PMID': '19533167',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20091104',\n",
       "               'LR': '20211020',\n",
       "               'IS': '1435-2451 (Electronic) 1435-2443 (Linking)',\n",
       "               'VI': '394',\n",
       "               'IP': '5',\n",
       "               'DP': '2009 Sep',\n",
       "               'TI': 'Does multiple gland disease in primary hyperparathyroidism correlate with age or sex?',\n",
       "               'PG': '885-90',\n",
       "               'LID': '10.1007/s00423-009-0521-9 [doi]',\n",
       "               'AB': 'PURPOSE: Paediatric primary hyperparathyroidism (PHPT) patients suffer more often from multiple gland disease (MGD) than adults. The question occurs whether MGD in adult PHPT patients also correlates with age or sex and whether familial PHPT plays a decisive role. This is significant, as it would influence our decision for a focused approach or the bilateral cervical exploration. MATERIALS AND METHODS: We retrospectively analysed 465 consecutive PHPT patients who underwent surgery in our department between September 2001 and December 2008. RESULTS: PHPT patients aged 40 years or younger suffered significantly more often from MGD than older patients (22.9% versus 11.0%). If familial PHPT disorders, which were more common in young patients, were excluded, the divergence between these two groups vanished (12.5% versus 10.0%). There was no statistical significant difference in the frequency of MGD between men (12.2%) and women (12.3%). CONCLUSIONS: If familial PHPT can be ruled out, the frequency of MGD in adult PHPT patients does not correlate with age or with sex. Therefore, age and sex do not imply specific surgical approaches in adult PHPT patients.',\n",
       "               'FAU': ['Wirowski, Denis',\n",
       "                'Lammers, Bernhard J',\n",
       "                'Pohl, Peter',\n",
       "                'Schwarz, Katharina',\n",
       "                'Goretzki, Peter E'],\n",
       "               'AU': ['Wirowski D',\n",
       "                'Lammers BJ',\n",
       "                'Pohl P',\n",
       "                'Schwarz K',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Department of Visceral and Endocrine Surgery, Lukaskrankenhaus Neuss, Preussenstr. 84, 41464, Neuss, Germany. denis.wirowski@t-online.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20090617',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/complications/genetics/*pathology/surgery',\n",
       "                'Adolescent',\n",
       "                'Adult',\n",
       "                'Age Factors',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism, Primary/*etiology',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Parathyroid Neoplasms/complications/genetics/*pathology/surgery',\n",
       "                'Sex Factors',\n",
       "                'Young Adult'],\n",
       "               'EDAT': '2009/06/18 09:00',\n",
       "               'MHDA': '2009/11/05 06:00',\n",
       "               'CRDT': ['2009/06/18 09:00'],\n",
       "               'PHST': ['2009/04/09 00:00 [received]',\n",
       "                '2009/06/03 00:00 [accepted]',\n",
       "                '2009/06/18 09:00 [entrez]',\n",
       "                '2009/06/18 09:00 [pubmed]',\n",
       "                '2009/11/05 06:00 [medline]'],\n",
       "               'AID': ['10.1007/s00423-009-0521-9 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 2009 Sep;394(5):885-90. doi: 10.1007/s00423-009-0521-9. Epub 2009 Jun 17.'},\n",
       "              {'PMID': '19294612',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20090803',\n",
       "               'LR': '20151119',\n",
       "               'IS': '1439-4286 (Electronic) 0018-5043 (Linking)',\n",
       "               'VI': '41',\n",
       "               'IP': '5',\n",
       "               'DP': '2009 May',\n",
       "               'TI': 'Nestin as a marker in the classification of adrenocortical tumors.',\n",
       "               'PG': '397-401',\n",
       "               'LID': '10.1055/s-0029-1202788 [doi]',\n",
       "               'AB': 'Expression of the intermediate filament, nestin, was long believed to be restricted to neuroectodermal stem cells. However, nestin expression has recently been detected in several tumors. Since adrenocortical carcinoma, a tumor entity still very difficult to classify, may gain the ability to aberrantly express neuroectodermal proteins including chromogranin A and synaptophysin, we asked the question whether nestin might also be detected in adrenocortical carcinomas, and if so, whether it might serve as a tool for clinical pathology. Therefore, we studied the expression of nestin in normal adrenal glands, adrenocortical adenomas, and adrenocortical cancers using specific immunohistochemistry and semi-quantitative reverse transcriptase-polymerase chain reaction. Immunostaining was nestin-positive in 1 out of 9 normal adrenal glands (11%), 2 out of 20 adrenocortical adenomas (10%), and 13 out of 16 adrenocortical carcinomas (81%). Expression of nestin mRNA could be detected in all microdissected tissues, independently of their grade of dedifferentiation. We conclude that our findings provide further evidence that nestin, as a marker, is not restricted to neuronal stem cells and nestin expression is worth to be studied in adrenocortical tumors.',\n",
       "               'FAU': ['Lachenmayer, A',\n",
       "                'Lichtenauer, U D',\n",
       "                'Cox, T',\n",
       "                'Schott, M',\n",
       "                'Malendowicz, L K',\n",
       "                'Goretzki, P E',\n",
       "                'Cupisti, K',\n",
       "                'Scherbaum, W A',\n",
       "                'Bornstein, S R',\n",
       "                'Willenberg, H S'],\n",
       "               'AU': ['Lachenmayer A',\n",
       "                'Lichtenauer UD',\n",
       "                'Cox T',\n",
       "                'Schott M',\n",
       "                'Malendowicz LK',\n",
       "                'Goretzki PE',\n",
       "                'Cupisti K',\n",
       "                'Scherbaum WA',\n",
       "                'Bornstein SR',\n",
       "                'Willenberg HS'],\n",
       "               'AD': ['Department of General, Visceral and Pediatric Surgery, University Hospital Dusseldorf, Dusseldorf 40225, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20090317',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Horm Metab Res',\n",
       "               'JT': 'Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme',\n",
       "               'JID': '0177722',\n",
       "               'RN': ['0 (Biomarkers, Tumor)',\n",
       "                '0 (Intermediate Filament Proteins)',\n",
       "                '0 (NES protein, human)',\n",
       "                '0 (Nerve Tissue Proteins)',\n",
       "                '0 (Nestin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adrenal Cortex Neoplasms/genetics/metabolism/*pathology',\n",
       "                'Adrenal Glands/metabolism',\n",
       "                'Adrenocortical Adenoma/*classification/genetics/metabolism/pathology',\n",
       "                'Adrenocortical Carcinoma/genetics/metabolism/*pathology',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Biomarkers, Tumor/genetics/*metabolism',\n",
       "                'Female',\n",
       "                'Gene Expression',\n",
       "                'Humans',\n",
       "                'Intermediate Filament Proteins/genetics/*metabolism',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Nerve Tissue Proteins/genetics/*metabolism',\n",
       "                'Nestin'],\n",
       "               'EDAT': '2009/03/19 09:00',\n",
       "               'MHDA': '2009/08/04 09:00',\n",
       "               'CRDT': ['2009/03/19 09:00'],\n",
       "               'PHST': ['2009/03/19 09:00 [entrez]',\n",
       "                '2009/03/19 09:00 [pubmed]',\n",
       "                '2009/08/04 09:00 [medline]'],\n",
       "               'AID': ['10.1055/s-0029-1202788 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Horm Metab Res. 2009 May;41(5):397-401. doi: 10.1055/s-0029-1202788. Epub 2009 Mar 17.'},\n",
       "              {'PMID': '19138159',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20090227',\n",
       "               'LR': '20151119',\n",
       "               'IS': '0743-7463 (Print) 0743-7463 (Linking)',\n",
       "               'VI': '25',\n",
       "               'IP': '2',\n",
       "               'DP': '2009 Jan 20',\n",
       "               'TI': 'Self-assembly of a pyridine-terminated thiol monolayer on Au(111).',\n",
       "               'PG': '959-67',\n",
       "               'LID': '10.1021/la802966s [doi]',\n",
       "               'AB': 'Self-assembled monolayers (SAMs) of 3-(4-pyridine-4-yl-phenyl)-propane-1-thiol (PyP3) on Au(111)/mica have been studied by scanning tunneling microscopy (STM), polarization-modulated infrared reflection absorption spectroscopy (PM-IRRAS), high-resolution X-ray photoemission spectroscopy (HRXPS), and near-edge X-ray absorption fine structure (NEXAFS) spectroscopy. The quality of the SAM is found to be strongly dependent on the solvent. Substantial gold corrosion is observed if pure ethanol is used. In contrast, highly ordered and densely packed SAMs are formed from acetonitrile or a KOH/ethanol mixture. The structure is described by a 2 radical3 x radical3 unit cell with the aromatic moiety oriented nearly perpendicular to the surface. The PyP3 films form with the pyridine moiety deprotonated. Variation of pH allows reversible protonation without measurable damage of the SAM.',\n",
       "               'FAU': ['Silien, Christophe',\n",
       "                'Buck, Manfred',\n",
       "                'Goretzki, Gudrun',\n",
       "                'Lahaye, Dorothee',\n",
       "                'Champness, Neil R',\n",
       "                'Weidner, Tobias',\n",
       "                'Zharnikov, Michael'],\n",
       "               'AU': ['Silien C',\n",
       "                'Buck M',\n",
       "                'Goretzki G',\n",
       "                'Lahaye D',\n",
       "                'Champness NR',\n",
       "                'Weidner T',\n",
       "                'Zharnikov M'],\n",
       "               'AD': ['EaStChem School of Chemistry, University of St. Andrews, North Haugh, St. Andrews KY16 9ST, UK. cjcs@st-andrews.ac.uk'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Langmuir',\n",
       "               'JT': 'Langmuir : the ACS journal of surfaces and colloids',\n",
       "               'JID': '9882736',\n",
       "               'RN': ['0 (3-(4-pyridine-4-yl-phenyl)-propane-1-thiol)',\n",
       "                '0 (Aluminum Silicates)',\n",
       "                '0 (Membranes, Artificial)',\n",
       "                '0 (Pyridines)',\n",
       "                '0 (Sulfhydryl Compounds)',\n",
       "                '7440-57-5 (Gold)',\n",
       "                'V8A1AW0880 (mica)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Aluminum Silicates/chemistry',\n",
       "                'Gold/*chemistry',\n",
       "                '*Membranes, Artificial',\n",
       "                'Microscopy, Scanning Tunneling',\n",
       "                'Molecular Structure',\n",
       "                'Particle Size',\n",
       "                'Pyridines/chemical synthesis/*chemistry',\n",
       "                'Spectrum Analysis',\n",
       "                'Sulfhydryl Compounds/chemical synthesis/*chemistry',\n",
       "                'Surface Properties',\n",
       "                'X-Rays'],\n",
       "               'EDAT': '2009/01/14 09:00',\n",
       "               'MHDA': '2009/02/28 09:00',\n",
       "               'CRDT': ['2009/01/14 09:00'],\n",
       "               'PHST': ['2009/01/14 09:00 [entrez]',\n",
       "                '2009/01/14 09:00 [pubmed]',\n",
       "                '2009/02/28 09:00 [medline]'],\n",
       "               'AID': ['10.1021/la802966s [pii]', '10.1021/la802966s [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langmuir. 2009 Jan 20;25(2):959-67. doi: 10.1021/la802966s.'},\n",
       "              {'PMID': '19096808',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20091028',\n",
       "               'LR': '20211020',\n",
       "               'IS': '1433-0385 (Electronic) 0009-4722 (Linking)',\n",
       "               'VI': '80',\n",
       "               'IP': '2',\n",
       "               'DP': '2009 Feb',\n",
       "               'TI': '[Indication and performance of endocrine surgery. The significance of molecular genetic examination].',\n",
       "               'PG': '122-9',\n",
       "               'LID': '10.1007/s00104-008-1615-6 [doi]',\n",
       "               'AB': 'The molecular genetic changes from certain endocrine tumors are already understood, reflecting as they do the etiology of these sporadic familial disorders. This already has clinical consequences to the treatment of familial endocrine tumors, which often appear in the course of syndromatic disorders. These consequences consist in slight changes to surgical technique, the search for other active and usually endocrinal tumors, and examination of family members for other gene carriers (of disease-specific mutations) and the most suitable prophylactic tumor therapy. In contrast, for sporadic endocrine tumors there exists far less clinically relevant knowledge. Starting with anamnesis and clinical findings of active endocrine tumors, we discuss the current possibilities for molecular genetic determination of disease-specific mutations (germline and tumor DNA) and their effect on surgical procedure.',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Wirowski, D',\n",
       "                'Schwarz, K',\n",
       "                'Pohl, P',\n",
       "                'Bohner, H',\n",
       "                'Starke, A',\n",
       "                'Lammers, B J'],\n",
       "               'AU': ['Goretzki PE',\n",
       "                'Wirowski D',\n",
       "                'Schwarz K',\n",
       "                'Pohl P',\n",
       "                'Bohner H',\n",
       "                'Starke A',\n",
       "                'Lammers BJ'],\n",
       "               'AD': ['Chirurgische Klinik 1, Stadtisches Lukaskrankenhaus Neuss und Insulinoma und GEP-Tumor Center Neuss-Dusseldorf, Preussenstrasse 84, Neuss, Germany. pgoretzki@lukasneuss.de'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'TT': 'Indikation und Durchfuhrung endokrin-chirurgischer Operationen. Bedeutung molekulargenetischer Untersuchungen.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'RN': ['0 (DNA, Neoplasm)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['DNA Mutational Analysis',\n",
       "                'DNA, Neoplasm/genetics',\n",
       "                'Endocrine Gland Neoplasms/diagnosis/*genetics/*surgery',\n",
       "                'Genetic Carrier Screening',\n",
       "                'Genetic Testing',\n",
       "                'Germ-Line Mutation',\n",
       "                'Humans',\n",
       "                'Palliative Care',\n",
       "                'Prognosis',\n",
       "                'Syndrome'],\n",
       "               'RF': '35',\n",
       "               'EDAT': '2008/12/20 09:00',\n",
       "               'MHDA': '2009/10/29 06:00',\n",
       "               'CRDT': ['2008/12/20 09:00'],\n",
       "               'PHST': ['2008/12/20 09:00 [entrez]',\n",
       "                '2008/12/20 09:00 [pubmed]',\n",
       "                '2009/10/29 06:00 [medline]'],\n",
       "               'AID': ['10.1007/s00104-008-1615-6 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 2009 Feb;80(2):122-9. doi: 10.1007/s00104-008-1615-6.'}],\n",
       "             '2008': [{'PMID': '18855454',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'DCOM': '20090109',\n",
       "               'LR': '20081114',\n",
       "               'IS': '1520-6904 (Electronic) 0022-3263 (Linking)',\n",
       "               'VI': '73',\n",
       "               'IP': '22',\n",
       "               'DP': '2008 Nov 21',\n",
       "               'TI': 'Bis-morpholine-substituted perylene bisimides: impact of isomeric arrangement on electrochemical and spectroelectrochemical properties.',\n",
       "               'PG': '8808-14',\n",
       "               'LID': '10.1021/jo801557e [doi]',\n",
       "               'AB': \"The synthesis and separation of the 1,6- and 1,7- isomers of N,N'-bis(n-butyl)dimorpholino-3,4:9,10-perylenetetracarboxylic acid bisimide are reported. Investigations of the electrochemical and spectroscopic, in particular, spectroelectrochemical, properties of the two isomers reveal a sequence of electrochemically and chemically reversible redox processes for both isomers. Importantly, the 1,7-isomer of N,N'-bis(n-butyl)dimorpholino-3,4:9,10-perylenetetracarboxylic acid bisimide was observed to undergo a two-electron oxidation process, which contrasts with the behavior of both the corresponding 1,6-isomer and other related amino-substituted perylene bis-imide species.\",\n",
       "               'FAU': ['Goretzki, Gudrun',\n",
       "                'Davies, E Stephen',\n",
       "                'Argent, Stephen P',\n",
       "                'Alsindi, Wassim Z',\n",
       "                'Blake, Alexander J',\n",
       "                'Warren, John E',\n",
       "                'McMaster, Jonathan',\n",
       "                'Champness, Neil R'],\n",
       "               'AU': ['Goretzki G',\n",
       "                'Davies ES',\n",
       "                'Argent SP',\n",
       "                'Alsindi WZ',\n",
       "                'Blake AJ',\n",
       "                'Warren JE',\n",
       "                'McMaster J',\n",
       "                'Champness NR'],\n",
       "               'AD': ['School of Chemistry, University of Nottingham, University Park, Nottingham NG7 2RD, UK.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20081015',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Org Chem',\n",
       "               'JT': 'The Journal of organic chemistry',\n",
       "               'JID': '2985193R',\n",
       "               'EDAT': '2008/10/16 09:00',\n",
       "               'MHDA': '2008/10/16 09:01',\n",
       "               'CRDT': ['2008/10/16 09:00'],\n",
       "               'PHST': ['2008/10/16 09:00 [pubmed]',\n",
       "                '2008/10/16 09:01 [medline]',\n",
       "                '2008/10/16 09:00 [entrez]'],\n",
       "               'AID': ['10.1021/jo801557e [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Org Chem. 2008 Nov 21;73(22):8808-14. doi: 10.1021/jo801557e. Epub 2008 Oct 15.'},\n",
       "              {'PMID': '18666294',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20081014',\n",
       "               'LR': '20131121',\n",
       "               'IS': '0947-6539 (Print) 0947-6539 (Linking)',\n",
       "               'VI': '14',\n",
       "               'IP': '25',\n",
       "               'DP': '2008',\n",
       "               'TI': 'Functionalized supramolecular nanoporous arrays for surface templating.',\n",
       "               'PG': '7600-7',\n",
       "               'LID': '10.1002/chem.200800476 [doi]',\n",
       "               'AB': 'Controlled self-assembly and chemical tailoring of bimolecular networks on surfaces is demonstrated using structural derivatives of 3,4:9,10-perylenetetracarboxylic diimide (PTCDI) combined with melamine (1,3,5-triazine-2,4,6-triamine). Two functionalised PTCDI derivatives have been synthesised, Br(2)-PTCDI and di(propylthio)-PTCDI, through attachment of chemical side groups to the perylene core. Self-assembled structures formed by these molecules on a Ag-Si(111)sqrt3 x sqrt3R30 degrees surface were studied with a room-temperature scanning tunneling microscope under ultrahigh vacuum conditions. It is shown that the introduction of side groups can have a significant effect upon both the structures formed, notably in the case of di(propylthio)-PTCDI which forms a previously unreported unimolecular hexagonal arrangement, and their entrapment behaviour. These results demonstrate a new route of functionalisation for network pores, opening up the possibility of designing nanostructured surface structures with chemical selectivity and applications in nanostructure templating.',\n",
       "               'FAU': ['Perdigao, Luis M A',\n",
       "                'Saywell, Alex',\n",
       "                'Fontes, Giselle N',\n",
       "                'Staniec, Paul A',\n",
       "                'Goretzki, Gudrun',\n",
       "                'Phillips, Anna G',\n",
       "                'Champness, Neil R',\n",
       "                'Beton, Peter H'],\n",
       "               'AU': ['Perdigao LM',\n",
       "                'Saywell A',\n",
       "                'Fontes GN',\n",
       "                'Staniec PA',\n",
       "                'Goretzki G',\n",
       "                'Phillips AG',\n",
       "                'Champness NR',\n",
       "                'Beton PH'],\n",
       "               'AD': ['School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, UK.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chemistry',\n",
       "               'JT': 'Chemistry (Weinheim an der Bergstrasse, Germany)',\n",
       "               'JID': '9513783',\n",
       "               'RN': ['0 (Macromolecular Substances)',\n",
       "                '0 (Triazines)',\n",
       "                '3M4G523W1G (Silver)',\n",
       "                '5QD5427UN7 (Perylene)',\n",
       "                'N3GP2YSD88 (melamine)',\n",
       "                'Z4152N8IUI (Silicon)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Macromolecular Substances/chemistry',\n",
       "                'Molecular Structure',\n",
       "                'Nanostructures/*chemistry',\n",
       "                'Particle Size',\n",
       "                'Perylene/*analogs & derivatives/chemical synthesis/chemistry',\n",
       "                'Porosity',\n",
       "                'Silicon/chemistry',\n",
       "                'Silver/chemistry',\n",
       "                'Surface Properties',\n",
       "                'Temperature',\n",
       "                'Triazines/*chemistry'],\n",
       "               'EDAT': '2008/07/31 09:00',\n",
       "               'MHDA': '2008/10/15 09:00',\n",
       "               'CRDT': ['2008/07/31 09:00'],\n",
       "               'PHST': ['2008/07/31 09:00 [pubmed]',\n",
       "                '2008/10/15 09:00 [medline]',\n",
       "                '2008/07/31 09:00 [entrez]'],\n",
       "               'AID': ['10.1002/chem.200800476 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chemistry. 2008;14(25):7600-7. doi: 10.1002/chem.200800476.'},\n",
       "              {'PMID': '18578615',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20081002',\n",
       "               'LR': '20161124',\n",
       "               'IS': '1050-7256 (Print) 1050-7256 (Linking)',\n",
       "               'VI': '18',\n",
       "               'IP': '6',\n",
       "               'DP': '2008 Jun',\n",
       "               'TI': 'A left nonrecurrent inferior laryngeal nerve in a patient with right-sided aorta, truncus arteriosus communis, and an aberrant left innominate artery.',\n",
       "               'PG': '647-9',\n",
       "               'LID': '10.1089/thy.2007.0284 [doi]',\n",
       "               'AB': 'The identification and prevention of injury to the inferior laryngeal nerve is one of the main issues in thyroid surgery. Sound knowledge of anatomic variants of the nerve is of major importance. In rare cases the nerve does not run the recurrent way and it is therefore difficult to identify the nerve. Abnormal developments of the aortic arch during embryogenesis include malformation of the great vessels and can be the reason for anatomic abnormalities. A cause for a nonrecurrent nerve on the right side is the so-called lusorian artery, a right retroesophageal subclavian artery. Left-sided nonrecurrent nerves are seldom if ever documented. Only two cases have been published so far of patients with situs inversus viscerum, where left nonrecurrent nerves were associated with inverse, left-sided lusorian arteries.',\n",
       "               'FAU': ['Fellmer, Peter T',\n",
       "                'Bohner, Hinrich',\n",
       "                'Wolf, Achim',\n",
       "                'Roher, Hans-Dietrich',\n",
       "                'Goretzki, Peter E'],\n",
       "               'AU': ['Fellmer PT',\n",
       "                'Bohner H',\n",
       "                'Wolf A',\n",
       "                'Roher HD',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Department of Visceral-, Transplant-, Thorax- and Vascular Surgery, University of Leipzig, Leipzig, Germany. peter.fellmer@uniklinik-leipzig.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports', 'Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Thyroid',\n",
       "               'JT': 'Thyroid : official journal of the American Thyroid Association',\n",
       "               'JID': '9104317',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Angiography',\n",
       "                'Aorta/*abnormalities',\n",
       "                'Aorta, Thoracic/abnormalities/diagnostic imaging',\n",
       "                'Aortography',\n",
       "                'Brachiocephalic Trunk/*abnormalities/diagnostic imaging',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                'Laryngeal Nerves/*abnormalities',\n",
       "                'Truncus Arteriosus/*abnormalities/diagnostic imaging'],\n",
       "               'EDAT': '2008/06/27 09:00',\n",
       "               'MHDA': '2008/10/03 09:00',\n",
       "               'CRDT': ['2008/06/27 09:00'],\n",
       "               'PHST': ['2008/06/27 09:00 [pubmed]',\n",
       "                '2008/10/03 09:00 [medline]',\n",
       "                '2008/06/27 09:00 [entrez]'],\n",
       "               'AID': ['10.1089/thy.2007.0284 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Thyroid. 2008 Jun;18(6):647-9. doi: 10.1089/thy.2007.0284.'},\n",
       "              {'PMID': '18578610',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20081002',\n",
       "               'LR': '20220311',\n",
       "               'IS': '1050-7256 (Print) 1050-7256 (Linking)',\n",
       "               'VI': '18',\n",
       "               'IP': '6',\n",
       "               'DP': '2008 Jun',\n",
       "               'TI': \"Thyroid metastases of renal cell carcinoma: clinical course in 45 patients undergoing surgery. Assessment of factors affecting patients' survival.\",\n",
       "               'PG': '615-24',\n",
       "               'LID': '10.1089/thy.2007.0343 [doi]',\n",
       "               'AB': 'BACKGROUND: Metastases of renal cell carcinoma (RCC) to the thyroid gland are uncommon. There is no clear consensus regarding the role of surgery in metastatic disease to the thyroid since most clinical studies include small numbers of patients. Also, risk factors associated with disease progression following thyroidectomy are not yet defined. We examined the determinants of the outcome in patients undergoing surgery for thyroid metastases of RCC. METHODS: The medical records of 45 patients undergoing resection of thyroid metastases of RCC at 15 institutions in Germany and Austria were reviewed retrospectively. The outcome parameters assessed were overall survival and tumor-related survival. Factors associated with disease progression following thyroid surgery have been calculated. RESULTS: The overall 5-year survival rate following thyroid metastasectomy was 51%. Nineteen patients died during the study: 14 of disseminated disease and 5 of non-tumor-related causes. In the multivariate analysis, the prognosis was significantly worse in patients older than > or = 70 years and in patients who had undergone nephrectomy for metastases in the contralateral kidney during the course of the disease. Nine patients developed a thyroid recurrence following surgery. No local disease relapse occurred if resection margins were documented to be free of the tumor. Of the 45 patients with thyroid metastases, 14 (31%) developed pancreatic metastases during the course of disease. Ten of these patients also underwent pancreatic surgery with a 5-year survival rate of 43% in this subgroup. CONCLUSIONS: The overall survival of patients undergoing thyroidectomy for metastases of RCC is affected rather by general health status than by tumor-related factors. There is a significant coincidence of thyroid and pancreatic metastases of RCC.',\n",
       "               'FAU': ['Iesalnieks, Igors',\n",
       "                'Winter, Hauke',\n",
       "                'Bareck, Evelyne',\n",
       "                'Sotiropoulos, Georgios C',\n",
       "                'Goretzki, Peter E',\n",
       "                'Klinkhammer-Schalke, Monika',\n",
       "                'Brockner, Stefan',\n",
       "                'Trupka, Arnold',\n",
       "                'Anthuber, Matthias',\n",
       "                'Rupprecht, Holger',\n",
       "                'Raab, Maximilian',\n",
       "                'Meyer, Willibald',\n",
       "                'Reichmann, Florian',\n",
       "                'Kastel, Manfred',\n",
       "                'Mayr, Max',\n",
       "                'Braun, Wolfgang',\n",
       "                'Schlitt, Hans J',\n",
       "                'Agha, Ayman'],\n",
       "               'AU': ['Iesalnieks I',\n",
       "                'Winter H',\n",
       "                'Bareck E',\n",
       "                'Sotiropoulos GC',\n",
       "                'Goretzki PE',\n",
       "                'Klinkhammer-Schalke M',\n",
       "                'Brockner S',\n",
       "                'Trupka A',\n",
       "                'Anthuber M',\n",
       "                'Rupprecht H',\n",
       "                'Raab M',\n",
       "                'Meyer W',\n",
       "                'Reichmann F',\n",
       "                'Kastel M',\n",
       "                'Mayr M',\n",
       "                'Braun W',\n",
       "                'Schlitt HJ',\n",
       "                'Agha A'],\n",
       "               'AD': ['Department of Surgery, University of Regensburg, Regensburg, Germany. igors.iesalnieks@klinik.uni-regensburg.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Multicenter Study'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Thyroid',\n",
       "               'JT': 'Thyroid : official journal of the American Thyroid Association',\n",
       "               'JID': '9104317',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Aged',\n",
       "                'Carcinoma, Renal Cell/diagnosis/*secondary/*surgery',\n",
       "                'Disease Progression',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                'Kaplan-Meier Estimate',\n",
       "                'Kidney Neoplasms/*pathology',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Multivariate Analysis',\n",
       "                'Neoplasm Recurrence, Local/radiotherapy',\n",
       "                'Prognosis',\n",
       "                'Retrospective Studies',\n",
       "                'Thyroid Neoplasms/diagnosis/*secondary/*surgery',\n",
       "                'Thyroidectomy'],\n",
       "               'EDAT': '2008/06/27 09:00',\n",
       "               'MHDA': '2008/10/03 09:00',\n",
       "               'CRDT': ['2008/06/27 09:00'],\n",
       "               'PHST': ['2008/06/27 09:00 [pubmed]',\n",
       "                '2008/10/03 09:00 [medline]',\n",
       "                '2008/06/27 09:00 [entrez]'],\n",
       "               'AID': ['10.1089/thy.2007.0343 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Thyroid. 2008 Jun;18(6):615-24. doi: 10.1089/thy.2007.0343.'},\n",
       "              {'PMID': '18523916',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20081105',\n",
       "               'LR': '20220318',\n",
       "               'IS': '0947-7349 (Print) 0947-7349 (Linking)',\n",
       "               'VI': '116',\n",
       "               'IP': '8',\n",
       "               'DP': '2008 Aug',\n",
       "               'TI': 'Presentation of 6 cases with parathyroid cysts and discussion of the literature.',\n",
       "               'PG': '501-6',\n",
       "               'LID': '10.1055/s-2008-1058084 [doi]',\n",
       "               'AB': 'INTRODUCTION: Cystic lesions of the parathyroid glands are uncommon, and rare are those that cause primary hyperparathyroidism. Preoperative diagnosis can be challenging and some of these tumors might be misinterpreted as parathyroid carcinoma. With an expertise of more than 1700 patients operated on primary hyperparathyroidism, we present six cases with cystic degeneration of a parathyroid gland causing primary hyperparathyroidism in five patients. CASE REPORTS: A woman at the age of 67 presented with hypercalcaemic crisis due to persistent primary hyperparathyroidism after an operation four years ago. As cervical exploration was unsuccessful, sternotomy was performed and a cystic adenoma of a parathyroid gland could be resected from the anterior mediastinum. The second patient - a 63-year-old female with severe hypercalcaemic crisis, operated on under suspicion of a parathyroid carcinoma - had a functional cyst of the parathyroid gland with a parathyroid hormone level of 700,000 pg/ml in the aspirated fluid. Third, operation on a 70-year-old woman with a benign euthyreot goiter and the laboratory findings of primary hyperparathyroidism revealed a cystic adenoma adjacent to the thyroid gland, whose aspirate had a parathyroid hormone level of 1,500,000 pg/ml. In the fourth case of a 67-year-old female with an adenoma of the right inferior parathyroid gland localized by ultrasonography, the cystic parathyroid adenoma was operated on by video-assistance. A cystic structure in the upper mediastinum was diagnosed in the fifth patient, a 66-year-old woman. It was suspected to be a thyroid cyst at the left-lower pole of the thyroid gland. After hemithyroidectomy pathological evaluation revealed a large parathyroid cyst. The last case of a 56-year-old male illustrates the extensive preoperative work-up of a patient with primary hyperparathyroidism who was preoperatively diagnosed as having a thyroid cyst. Final histopathological examination exposed multiple gland disease with a parathyroid adenoma as well as a cystic parathyroid gland. DISCUSSION: Cystic adenomas of the parathyroid glands are often misdiagnosed as thyroid cysts or - in the case of extremely elevated parathyroid hormone levels - even as parathyroid carcinoma. The routine preoperative diagnostic tools, such as ultrasonography or (99m)Tc-sestamibi-scintigraphy, cannot clearly distinguish between these entities and might be jeopardized by mediastinal localization, which is not uncommon in parathyroid adenomas with cystic degeneration.',\n",
       "               'FAU': ['Wirowski, D',\n",
       "                'Wicke, C',\n",
       "                'Bohner, H',\n",
       "                'Lammers, B J',\n",
       "                'Pohl, P',\n",
       "                'Schwarz, K',\n",
       "                'Goretzki, P E'],\n",
       "               'AU': ['Wirowski D',\n",
       "                'Wicke C',\n",
       "                'Bohner H',\n",
       "                'Lammers BJ',\n",
       "                'Pohl P',\n",
       "                'Schwarz K',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Department of Surgery, Lukaskrankenhaus Neuss, Neuss, Germany. denis.wirowski@t-online.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports', 'Journal Article'],\n",
       "               'DEP': '20080401',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Exp Clin Endocrinol Diabetes',\n",
       "               'JT': 'Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association',\n",
       "               'JID': '9505926',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Aged',\n",
       "                'Cysts/*pathology/*surgery',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism/etiology/pathology/*surgery',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Parathyroid Diseases/*pathology/*surgery'],\n",
       "               'EDAT': '2008/06/05 09:00',\n",
       "               'MHDA': '2008/11/06 09:00',\n",
       "               'CRDT': ['2008/06/05 09:00'],\n",
       "               'PHST': ['2008/06/05 09:00 [pubmed]',\n",
       "                '2008/11/06 09:00 [medline]',\n",
       "                '2008/06/05 09:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-2008-1058084 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Exp Clin Endocrinol Diabetes. 2008 Aug;116(8):501-6. doi: 10.1055/s-2008-1058084. Epub 2008 Apr 1.'},\n",
       "              {'PMID': '18392315',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20080811',\n",
       "               'LR': '20191110',\n",
       "               'IS': '0029-5566 (Print) 0029-5566 (Linking)',\n",
       "               'VI': '47',\n",
       "               'IP': '2',\n",
       "               'DP': '2008',\n",
       "               'TI': '[Routine measurement of serum calcitonin in patients with nodular thyroid disorders?].',\n",
       "               'PG': '65-72',\n",
       "               'AB': 'In spite of the fact that the German Society of Endocrinology has recommended calcitonin as screening-parameter the majority of physicians in Germany do not routinely use calcitonin in patients with thyroid nodules to exclude medullary thyroid cancer (MTC). The future revision of the recommendation should describe reference values for each commercially available assay, separately for men and women (basal and after pentagastrin-stimulation), and should define sonomorphological inclusion criteria. The epidemiological database of the prevalence of MTC is controversial and the specificity of basal elevated calcitonin levels is limited up to the 5-fold of the upper reference level. If renal insufficiency, bacterial infection, and an alcohol- or drug-induced stimulation of calcitonin is excluded, hypercalcitoninaemia should be confirmed by a second measurement (if necessary using another assay). Stimulation of calcitonin by use of pentagastrin is mandatory prior to the decision on thyroidectomy. A stimulated calcitonin level < 100 pg/ml justifies \"wait and see\". If stimulated calcitonin levels range between 100 and 200 pg/ml or higher, the differentiation between C-cell hyperplasia and MTC remains uncertain, especially in men. The implementation of calcitonin-screening requires the definition of sonographic inclusion criteria and validation of each assay. Additional pre-requisites are excellent logistic (short period between blood sampling and start of the laboratory test), knowledge of differential diagnoses, knowledge of the consumption of drugs and alcohol, availability of pentagastrin-testing and of moleculargenetic testing with full information to the patients and sufficient time before the decision on surgery is made. All this and the choice of a skilled surgeon, experienced in thyroidectomy and lymphadenectomy with a low rate of local complications are the rationale to recommend calcitonin-screening primarily in centers for thyroid disorders.',\n",
       "               'FAU': ['Dietlein, M',\n",
       "                'Wieler, H',\n",
       "                'Schmidt, M',\n",
       "                'Schwab, R',\n",
       "                'Goretzki, P E',\n",
       "                'Schicha, H'],\n",
       "               'AU': ['Dietlein M',\n",
       "                'Wieler H',\n",
       "                'Schmidt M',\n",
       "                'Schwab R',\n",
       "                'Goretzki PE',\n",
       "                'Schicha H'],\n",
       "               'AD': ['Klinik und Poliklinik fur Nuklearmedizin der Universitat zu Koln, Koln, Germany. markus.dietlein@uni-koeln.de'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Calcitonin-Screening bei der Knotenstruma?',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Nuklearmedizin',\n",
       "               'JT': 'Nuklearmedizin. Nuclear medicine',\n",
       "               'JID': '7609387',\n",
       "               'RN': ['0 (Biomarkers, Tumor)', '9007-12-9 (Calcitonin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Biomarkers, Tumor/blood',\n",
       "                'Brain Stem Neoplasms/blood/*diagnosis',\n",
       "                'Calcitonin/*blood',\n",
       "                'Humans',\n",
       "                'Mass Screening/methods',\n",
       "                'Reproducibility of Results',\n",
       "                'Thyroid Diseases/*blood',\n",
       "                'Thyroid Neoplasms/blood/*diagnosis'],\n",
       "               'EDAT': '2008/04/09 09:00',\n",
       "               'MHDA': '2008/08/12 09:00',\n",
       "               'CRDT': ['2008/04/09 09:00'],\n",
       "               'PHST': ['2008/04/09 09:00 [pubmed]',\n",
       "                '2008/08/12 09:00 [medline]',\n",
       "                '2008/04/09 09:00 [entrez]'],\n",
       "               'AID': ['08020065 [pii]', '10.3413/nukmed-0125 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Nuklearmedizin. 2008;47(2):65-72. doi: 10.3413/nukmed-0125.'},\n",
       "              {'PMID': '18303959',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20080618',\n",
       "               'LR': '20130520',\n",
       "               'IS': '1050-7256 (Print) 1050-7256 (Linking)',\n",
       "               'VI': '18',\n",
       "               'IP': '3',\n",
       "               'DP': '2008 Mar',\n",
       "               'TI': 'Is it meaningful to preserve a palsied recurrent laryngeal nerve?',\n",
       "               'PG': '363-6',\n",
       "               'LID': '10.1089/thy.2007.0124 [doi]',\n",
       "               'AB': \"Surgeons may assume intuitively that preservation of a palsied recurrent laryngeal nerve (RLN) in patients with preoperative vocal cord paralysis is not meaningful. Here we present our experience in four cases with preoperative vocal cord paralysis, and show that preservation of a palsied RLN may be important in maintaining patients' voice. PATIENTS: Case 1 is a 54-year-old woman who suffered from a recurrent thyroid cancer disease and right vocal cord paralysis. She was subjected to resection of a locoregional lymph node metastasis on the right paratracheal groove. The right RLN was infiltrated by tumor and was sacrificed during surgery. Surprisingly, her voice weakened postoperatively. Evaluation of the patient showed immobility and mild atrophy of right vocal cord. Cases 2, 3, and 4 are patients with preoperative unilateral vocal cord paralysis and undergoing thyroid or parathyroid surgery. In these three patients, the palsied RLNs were identified and carefully preserved during surgery. These palsied RLNs and ipsilateral vagus nerves were tested with intraoperative neuromonitoring, and an evoked electromyographic activity was elicited. Postoperative evaluation of these three patients showed a steady state of voice and immobility without atrophy of vocal cords. CONCLUSION: Even on a palsied RLN, a positive electrophysiological response may still be yielded by intraoperative neuromonitoring. This means that there may retain residual innervations in laryngeal muscles. To prevent atrophy of a paralyzed vocal cord, further injury to a palsied RLN should be avoided. Even the palsied nerve should be saved whenever possible.\",\n",
       "               'FAU': ['Chi, Shun Yu',\n",
       "                'Lammers, Bernhard',\n",
       "                'Boehner, Hinrich',\n",
       "                'Pohl, Peter',\n",
       "                'Goretzki, Peter E'],\n",
       "               'AU': ['Chi SY',\n",
       "                'Lammers B',\n",
       "                'Boehner H',\n",
       "                'Pohl P',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Department of Surgery, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Taiwan, No. 123 Ta-pei Road, 833 Niao-sung Hsiang, Kaohsiung, Taiwan.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports', 'Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Thyroid',\n",
       "               'JT': 'Thyroid : official journal of the American Thyroid Association',\n",
       "               'JID': '9104317',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Aged',\n",
       "                'Atrophy',\n",
       "                'Electromyography',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Postoperative Complications/pathology/physiopathology/prevention & control',\n",
       "                'Recovery of Function',\n",
       "                'Recurrent Laryngeal Nerve/physiology/*surgery',\n",
       "                '*Recurrent Laryngeal Nerve Injuries',\n",
       "                'Vocal Cord Paralysis/pathology/*physiopathology/*surgery',\n",
       "                'Vocal Cords/innervation/pathology/physiopathology',\n",
       "                'Voice/*physiology'],\n",
       "               'EDAT': '2008/02/29 09:00',\n",
       "               'MHDA': '2008/06/19 09:00',\n",
       "               'CRDT': ['2008/02/29 09:00'],\n",
       "               'PHST': ['2008/02/29 09:00 [pubmed]',\n",
       "                '2008/06/19 09:00 [medline]',\n",
       "                '2008/02/29 09:00 [entrez]'],\n",
       "               'AID': ['10.1089/thy.2007.0124 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Thyroid. 2008 Mar;18(3):363-6. doi: 10.1089/thy.2007.0124.'},\n",
       "              {'PMID': '18259806',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20081010',\n",
       "               'LR': '20211020',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '32',\n",
       "               'IP': '5',\n",
       "               'DP': '2008 May',\n",
       "               'TI': 'Differentiation of insulin secretion patterns in insulinoma.',\n",
       "               'PG': '918-29',\n",
       "               'LID': '10.1007/s00268-007-9450-3 [doi]',\n",
       "               'AB': 'BACKGROUND: In patients with insulinoma, biochemical proof of inappropriately elevated insulin secretion during hypoglycemia is required prior to surgery. Because circulating insulin levels usually vary widely, we have used the combined OGTT-fasting test to define new normative criteria for a retrospective systematic analysis. METHODS: We retrospectively analyzed insulin concentrations from OGTT-fasting tests of 64 patients with surgically removed insulinomas. In addition, the response to intravenous somatostatin infusions was estimated. Normative criteria were defined to obtain comparable estimates of insulin concentrations: basal, glucose-stimulated maximum, postglucose plateau, and secretory bursts. RESULTS: Three types of insulin secretion patterns were identified: (1) the autonomous secretion pattern (type 1, N=17) with basal and post-OGTT plateau insulin concentrations of approximately 50 mU/L, suppression after OGTT by 41%, virtual absence of distinctive secretory bursts, and resistance to somatostatin-mediated suppression (25 %); (2) the inadequate suppression pattern (type 2, N=28) with moderately elevated basal and post-OGTT insulin concentrations of approximately 20 mU/L, suppression after OGTT by 73%, absence of secretory bursts, and incomplete somatostatin-induced suppression (56 %); (3) the late-burst secretion pattern (type 3, N=19) with similar basal and post-OGTT insulin concentrations of 17 mU/L, suppression after OGTT by 76%, true insulin bursts of Delta 13+/-11 mU/L (184%), and nearly complete somatostatin-induced suppression by 64%. CONCLUSIONS: By means of a new normative analysis of the combined OGTT-fasting test, three different patterns of insulin secretion can be described in patients with insulinoma: the autonomous secretion type, the inadequate suppression type, and the late-burst secretion type.',\n",
       "               'FAU': ['Saddig, Christiane',\n",
       "                'Goretzki, Peter E',\n",
       "                'Starke, Achim A R'],\n",
       "               'AU': ['Saddig C', 'Goretzki PE', 'Starke AA'],\n",
       "               'AD': ['Department of Oncology and Hematology, Kliniken Essen-Mitte, Henricistrasse 92, 45136 Essen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'RN': ['0 (Blood Glucose)',\n",
       "                '0 (Insulin)',\n",
       "                '51110-01-1 (Somatostatin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Blood Glucose/metabolism',\n",
       "                'Case-Control Studies',\n",
       "                'Female',\n",
       "                'Glucose Tolerance Test',\n",
       "                'Humans',\n",
       "                'Insulin/blood/*metabolism',\n",
       "                'Insulin Secretion',\n",
       "                'Insulinoma/blood/*metabolism/pathology',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Pancreatic Neoplasms/blood/*metabolism/pathology',\n",
       "                'Somatostatin'],\n",
       "               'EDAT': '2008/02/09 09:00',\n",
       "               'MHDA': '2008/10/11 09:00',\n",
       "               'CRDT': ['2008/02/09 09:00'],\n",
       "               'PHST': ['2008/02/09 09:00 [pubmed]',\n",
       "                '2008/10/11 09:00 [medline]',\n",
       "                '2008/02/09 09:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00268-007-9450-3 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 2008 May;32(5):918-29. doi: 10.1007/s00268-007-9450-3.'},\n",
       "              {'PMID': '18097130',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20080208',\n",
       "               'LR': '20090203',\n",
       "               'IS': '1423-0194 (Electronic) 0028-3835 (Linking)',\n",
       "               'VI': '87',\n",
       "               'IP': '1',\n",
       "               'DP': '2008',\n",
       "               'TI': 'Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma.',\n",
       "               'PG': '31-9',\n",
       "               'FAU': ['Ramage, John K',\n",
       "                'Goretzki, Peter E',\n",
       "                'Manfredi, Riccardo',\n",
       "                'Komminoth, Paul',\n",
       "                'Ferone, Diego',\n",
       "                'Hyrdel, Rudolf',\n",
       "                'Kaltsas, Gregory',\n",
       "                'Kelestimur, Fahrettin',\n",
       "                'Kvols, Larry',\n",
       "                'Scoazec, Jean-Yves',\n",
       "                'Garcia, M I Sevilla',\n",
       "                'Caplin, Martyn E'],\n",
       "               'AU': ['Ramage JK',\n",
       "                'Goretzki PE',\n",
       "                'Manfredi R',\n",
       "                'Komminoth P',\n",
       "                'Ferone D',\n",
       "                'Hyrdel R',\n",
       "                'Kaltsas G',\n",
       "                'Kelestimur F',\n",
       "                'Kvols L',\n",
       "                'Scoazec JY',\n",
       "                'Garcia MI',\n",
       "                'Caplin ME'],\n",
       "               'AD': ['Department of Gastroenterology, North Hampshire Hospital, Basingstoke, UK.'],\n",
       "               'CN': ['Frascati Consensus Conference participants'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20071121',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Neuroendocrinology',\n",
       "               'JT': 'Neuroendocrinology',\n",
       "               'JID': '0035665',\n",
       "               'SB': 'IM',\n",
       "               'CIN': ['Neuroendocrinology. 2008;88(3):157-8; author reply 158-9. doi: 10.1159/000158560.',\n",
       "                'PMID: 18849621'],\n",
       "               'MH': ['Carcinoma/*therapy',\n",
       "                'Colonic Neoplasms/*therapy',\n",
       "                '*Consensus',\n",
       "                'Guidelines as Topic/*standards',\n",
       "                'Humans',\n",
       "                'Rectal Neoplasms/*therapy'],\n",
       "               'EDAT': '2007/12/22 09:00',\n",
       "               'MHDA': '2008/02/09 09:00',\n",
       "               'CRDT': ['2007/12/22 09:00'],\n",
       "               'PHST': ['2007/12/22 09:00 [pubmed]',\n",
       "                '2008/02/09 09:00 [medline]',\n",
       "                '2007/12/22 09:00 [entrez]'],\n",
       "               'AID': ['000111036 [pii]', '10.1159/000111036 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Neuroendocrinology. 2008;87(1):31-9. doi: 10.1159/000111036. Epub 2007 Nov 21.'},\n",
       "              {'PMID': '17879074',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20081104',\n",
       "               'LR': '20220716',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '79',\n",
       "               'IP': '6',\n",
       "               'DP': '2008 Jun',\n",
       "               'TI': '[Abdominal preoperation. No contraindication for laparoscopic transabdominal adrenalectomy].',\n",
       "               'PG': '571-5',\n",
       "               'AB': 'Benign adrenal gland tumors smaller than 6 cm are nowadays the indication for minimally invasive surgery. Until now there has been no significant difference between retroperitoneoscopic and transabdominal adrenalectomy. Intestinal adhesions could be a contraindication against transabdominal laparoscopic adrenalectomy, and therefore the retroperitoneoscopic approach could be an advantage in these cases. A prospective study concerning this question has not been published yet. Our clinical investigation here includes 114 adrenalectomies during the last 5 years. We show that in any case of abdominal preoperation, laparoscopic adrenalectomy can be performed by transabdominal approach and without conversion to open surgery. Discussed are the different indications for laparoscopic adrenalectomy, operating time, conversion rate to open surgery, and amount and type of abdominal preoperation. We compared patients with and without abdominal preoperations.',\n",
       "               'FAU': ['Pohl, P P',\n",
       "                'Meyer, A',\n",
       "                'Lammers, B J',\n",
       "                'Goretzki, P E'],\n",
       "               'AU': ['Pohl PP', 'Meyer A', 'Lammers BJ', 'Goretzki PE'],\n",
       "               'AD': ['Klinik fur Allgemein-, Visceral-, Gefass- und Thoraxchirurgie, Stadtische Kliniken Neuss,Lukaskrankenhaus-GmbH, Preussenstrasse 84, 41464, Neuss, Deutschland. P.Pohl2@gmx.de'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Comparative Study', 'Journal Article'],\n",
       "               'TT': 'Abdominelle Voroperationen. Keine Kontraindikation fur eine laparoskopische transabdominelle Adrenalektomie.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Abdomen/*surgery',\n",
       "                'Adolescent',\n",
       "                'Adrenal Gland Neoplasms/*surgery',\n",
       "                '*Adrenalectomy/methods',\n",
       "                'Adrenocortical Adenoma/*surgery',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Carcinoma/*surgery',\n",
       "                'Contraindications',\n",
       "                'Cushing Syndrome/*surgery',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                '*Laparoscopy/methods',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Minimally Invasive Surgical Procedures/methods',\n",
       "                'Pheochromocytoma/*surgery',\n",
       "                'Postoperative Complications/etiology',\n",
       "                'Reoperation',\n",
       "                'Tissue Adhesions/complications/surgery'],\n",
       "               'EDAT': '2007/09/20 09:00',\n",
       "               'MHDA': '2008/11/05 09:00',\n",
       "               'CRDT': ['2007/09/20 09:00'],\n",
       "               'PHST': ['2007/09/20 09:00 [pubmed]',\n",
       "                '2008/11/05 09:00 [medline]',\n",
       "                '2007/09/20 09:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00104-007-1400-y [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 2008 Jun;79(6):571-5. doi: 10.1007/s00104-007-1400-y.'}],\n",
       "             '2007': [{'PMID': '17853334',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20071113',\n",
       "               'LR': '20070913',\n",
       "               'IS': '0947-7349 (Print) 0947-7349 (Linking)',\n",
       "               'VI': '115',\n",
       "               'IP': '8',\n",
       "               'DP': '2007 Sep',\n",
       "               'TI': 'Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1.',\n",
       "               'PG': '509-17',\n",
       "               'AB': 'BACKGROUND: Multiple-endocrine-neoplasia-type-1 (MEN1) is an autosomal-dominant inherited disorder characterized by the combined occurrence of primary hyperparathyroidism (pHPT), gastroenteropancreatic neuroendocrine tumors (GEP), adenomas of the pituitary gland (APA), adrenal cortical tumors (ADR) and other tumors. As the tumors appear in an unpredictable schedule, uncertainty about screening programs is persisting. OBJECTIVE: To optimize screening and to analyze possible differences in sporadic versus familial cases. METHODS: We analyzed data of 419 individuals including 306 MEN-1 patients (138 isolated and168 familial cases out of 102 unrelated families). RESULTS: A total of 683 tumors occurred consisting of 273 pHPT, 138 APA, 166 GEP, 57 ADR, 24 thymic- and bronchial-carcinoids as well as 25 neoplasms of other tissues. The age-related penetrance was determined as 10%, 35%, 67%, 81% and 100% at 20, 30, 40, 50 and 65 years respectively. Although pHPT being the most frequent first manifestation (41%), also GEP (22%) or APA (21%) were found to be the first presentation. APA occurred significantly more frequent (p<0,05) in isolated (n=138) than in familial (n=168) cases, whereas GEP showed a tendency to occur more often in familial cases. Genotype/phenotype correlation in 140 clinically affected MEN-1 cases showed a tendency for truncating mutations, especially nonsense mutations to be associated to GEP and carcinoids of the lungs and thymus. CONCLUSION: In view of the morbidity and frequency in familial cases an effective screening programme should aim at an early diagnosis of GEP particularly when truncating, especially nonsense mutations are found.',\n",
       "               'FAU': ['Schaaf, L',\n",
       "                'Pickel, J',\n",
       "                'Zinner, K',\n",
       "                'Hering, U',\n",
       "                'Hofler, M',\n",
       "                'Goretzki, P E',\n",
       "                'Spelsberg, F',\n",
       "                'Raue, F',\n",
       "                'von zur Muhlen, A',\n",
       "                'Gerl, H',\n",
       "                'Hensen, J',\n",
       "                'Bartsch, D K',\n",
       "                'Rothmund, M',\n",
       "                'Schneyer, U',\n",
       "                'Dralle, H',\n",
       "                'Engelbach, M',\n",
       "                'Karges, W',\n",
       "                'Stalla, G K',\n",
       "                'Hoppner, W'],\n",
       "               'AU': ['Schaaf L',\n",
       "                'Pickel J',\n",
       "                'Zinner K',\n",
       "                'Hering U',\n",
       "                'Hofler M',\n",
       "                'Goretzki PE',\n",
       "                'Spelsberg F',\n",
       "                'Raue F',\n",
       "                'von zur Muhlen A',\n",
       "                'Gerl H',\n",
       "                'Hensen J',\n",
       "                'Bartsch DK',\n",
       "                'Rothmund M',\n",
       "                'Schneyer U',\n",
       "                'Dralle H',\n",
       "                'Engelbach M',\n",
       "                'Karges W',\n",
       "                'Stalla GK',\n",
       "                'Hoppner W'],\n",
       "               'AD': ['Endocrinology and Clinical Chemistry, Max-Planck-Institute of Psychiatry, Kraepelinstrasse 10, 80804 Munich, Germany. schaaf@mpipsykl.mpg.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Exp Clin Endocrinol Diabetes',\n",
       "               'JT': 'Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association',\n",
       "               'JID': '9505926',\n",
       "               'RN': ['9007-49-2 (DNA)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Age of Onset',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Child',\n",
       "                'DNA/blood/genetics',\n",
       "                'Female',\n",
       "                'Genotype',\n",
       "                'Germany/epidemiology',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Mass Screening/*methods',\n",
       "                'Middle Aged',\n",
       "                'Multiple Endocrine Neoplasia Type 1/*epidemiology/genetics',\n",
       "                'Nuclear Family',\n",
       "                'Phenotype',\n",
       "                'Polymerase Chain Reaction'],\n",
       "               'EDAT': '2007/09/14 09:00',\n",
       "               'MHDA': '2007/11/14 09:00',\n",
       "               'CRDT': ['2007/09/14 09:00'],\n",
       "               'PHST': ['2007/09/14 09:00 [pubmed]',\n",
       "                '2007/11/14 09:00 [medline]',\n",
       "                '2007/09/14 09:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-2007-970160 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Exp Clin Endocrinol Diabetes. 2007 Sep;115(8):509-17. doi: 10.1055/s-2007-970160.'},\n",
       "              {'PMID': '17590169',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20080501',\n",
       "               'LR': '20070920',\n",
       "               'IS': '0300-0664 (Print) 0300-0664 (Linking)',\n",
       "               'VI': '67',\n",
       "               'IP': '4',\n",
       "               'DP': '2007 Oct',\n",
       "               'TI': 'Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.',\n",
       "               'PG': '613-22',\n",
       "               'AB': 'OBJECTIVE: In multiple endocrine neoplasia type 1 (MEN1), age-related tumour penetrance according to the type of MEN1 germline mutation has not been investigated in-depth. This study was conducted to examine whether carriers of out-of-frame/truncating and in-frame MEN1 mutations differ in age-related tumour penetrance. DESIGN: A multicentre study with biochemical, hormonal and radiological screening for MEN1-associated tumours. PATIENTS: A total of 258 MEN1 carriers from six major German tertiary referral centres averaging 43 years of age at last follow-up. MEASUREMENTS: Main outcome measure was time to first diagnosis of MEN1-associated tumours. RESULTS: Independent of the year of birth and observation period, time to first tumour diagnosis did not vary much by the type of MEN1 germline mutation or endocrine organ system, and perhaps not even by the type of endocrine tumour when the amount of time was considered by which the diagnosis probably has been advanced through the manifestation of hormonal symptoms. Parathyroid hyperplasia and adenomas developed almost twice as often as enteropancreatic and pituitary tumours (77%vs. 49-32%), and more than five to sevenfold as often as adrenal cortical tumours and carcinoids (77%vs. 15-10%), reaching penetrance rates of up to 90%, 60%, 40%, 26% and 17%, respectively. The heterogeneity of tumour penetrance was marked, ranging from 9 years to 25 years for the earliest, and from 68 years to 77 years for the latest tumour manifestation. CONCLUSIONS: Because of our inability of predicting tumour penetrance and malignant transformation individually, life-long follow-up of MEN1 carriers is warranted to prevent tumour morbidity.',\n",
       "               'FAU': ['Machens, Andreas',\n",
       "                'Schaaf, Ludwig',\n",
       "                'Karges, Wolfram',\n",
       "                'Frank-Raue, Karin',\n",
       "                'Bartsch, Detlef K',\n",
       "                'Rothmund, Matthias',\n",
       "                'Schneyer, Ulrich',\n",
       "                'Goretzki, Peter',\n",
       "                'Raue, Friedhelm',\n",
       "                'Dralle, Henning'],\n",
       "               'AU': ['Machens A',\n",
       "                'Schaaf L',\n",
       "                'Karges W',\n",
       "                'Frank-Raue K',\n",
       "                'Bartsch DK',\n",
       "                'Rothmund M',\n",
       "                'Schneyer U',\n",
       "                'Goretzki P',\n",
       "                'Raue F',\n",
       "                'Dralle H'],\n",
       "               'AD': ['Department of General, Visceral and Vascular Surgery, Martin-Luther-University, Halle (Saale), Germany. AndreasMachens@aol.com'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Multicenter Study'],\n",
       "               'DEP': '20070621',\n",
       "               'PL': 'England',\n",
       "               'TA': 'Clin Endocrinol (Oxf)',\n",
       "               'JT': 'Clinical endocrinology',\n",
       "               'JID': '0346653',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Aging/*genetics',\n",
       "                'Analysis of Variance',\n",
       "                'Child',\n",
       "                'Female',\n",
       "                '*Germ-Line Mutation',\n",
       "                'Heterozygote',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Multiple Endocrine Neoplasia Type 1/diagnosis/*genetics/mortality',\n",
       "                '*Penetrance'],\n",
       "               'EDAT': '2007/06/26 09:00',\n",
       "               'MHDA': '2008/05/02 09:00',\n",
       "               'CRDT': ['2007/06/26 09:00'],\n",
       "               'PHST': ['2007/06/26 09:00 [pubmed]',\n",
       "                '2008/05/02 09:00 [medline]',\n",
       "                '2007/06/26 09:00 [entrez]'],\n",
       "               'AID': ['CEN2934 [pii]',\n",
       "                '10.1111/j.1365-2265.2007.02934.x [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Clin Endocrinol (Oxf). 2007 Oct;67(4):613-22. doi: 10.1111/j.1365-2265.2007.02934.x. Epub 2007 Jun 21.'}],\n",
       "             '2006': [{'PMID': '17312380',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20070327',\n",
       "               'LR': '20220409',\n",
       "               'IS': '0028-3835 (Print) 0028-3835 (Linking)',\n",
       "               'VI': '84',\n",
       "               'IP': '3',\n",
       "               'DP': '2006',\n",
       "               'TI': 'Well-differentiated pancreatic nonfunctioning tumors/carcinoma.',\n",
       "               'PG': '196-211',\n",
       "               'FAU': ['Falconi, Massimo',\n",
       "                'Plockinger, Ursula',\n",
       "                'Kwekkeboom, Dik J',\n",
       "                'Manfredi, Riccardo',\n",
       "                'Korner, Meike',\n",
       "                'Kvols, Larry',\n",
       "                'Pape, Ulrich F',\n",
       "                'Ricke, Jens',\n",
       "                'Goretzki, Peter E',\n",
       "                'Wildi, Stefan',\n",
       "                'Steinmuller, Thomas',\n",
       "                'Oberg, Kjell',\n",
       "                'Scoazec, Jean-Yves'],\n",
       "               'AU': ['Falconi M',\n",
       "                'Plockinger U',\n",
       "                'Kwekkeboom DJ',\n",
       "                'Manfredi R',\n",
       "                'Korner M',\n",
       "                'Kvols L',\n",
       "                'Pape UF',\n",
       "                'Ricke J',\n",
       "                'Goretzki PE',\n",
       "                'Wildi S',\n",
       "                'Steinmuller T',\n",
       "                'Oberg K',\n",
       "                'Scoazec JY'],\n",
       "               'AD': ['Department of Surgery, University of Verona, Verona, Italy. massimo.falconi@univr.it'],\n",
       "               'CN': ['Frascati Consensus Conference',\n",
       "                'European Neuroendocrine Tumor Society'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Consensus Development Conference',\n",
       "                'Guideline',\n",
       "                'Journal Article'],\n",
       "               'DEP': '20070220',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Neuroendocrinology',\n",
       "               'JT': 'Neuroendocrinology',\n",
       "               'JID': '0035665',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Carcinoma/*diagnosis/epidemiology/*therapy',\n",
       "                'Pancreatic Neoplasms/*diagnosis/epidemiology/*therapy'],\n",
       "               'RF': '171',\n",
       "               'EDAT': '2007/02/22 09:00',\n",
       "               'MHDA': '2007/03/28 09:00',\n",
       "               'CRDT': ['2007/02/22 09:00'],\n",
       "               'PHST': ['2007/02/22 09:00 [pubmed]',\n",
       "                '2007/03/28 09:00 [medline]',\n",
       "                '2007/02/22 09:00 [entrez]'],\n",
       "               'AID': ['000098012 [pii]', '10.1159/000098012 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Neuroendocrinology. 2006;84(3):196-211. doi: 10.1159/000098012. Epub 2007 Feb 20.'},\n",
       "              {'PMID': '17102072',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20061212',\n",
       "               'LR': '20181201',\n",
       "               'IS': '0077-8923 (Print) 0077-8923 (Linking)',\n",
       "               'VI': '1073',\n",
       "               'DP': '2006 Aug',\n",
       "               'TI': 'A case of catecholamine and glucocorticoid excess syndrome due to a corticotropin-secreting paraganglioma.',\n",
       "               'PG': '52-8',\n",
       "               'AB': 'We present a case of a 61-year-old female patient with ectopic corticotropin (ACTH) syndrome, hypopituitarism, and catecholamine excess due to a paraganglioma at the inferior pole of the left kidney. In this article we discuss the hormonal findings in the patient and its consequences, the pitfalls of the endocrine workup, and the results of our immunohistological and molecular studies in more detail.',\n",
       "               'FAU': ['Willenberg, Holger S',\n",
       "                'Feldkamp, Joachim',\n",
       "                'Lehmann, Reiner',\n",
       "                'Schott, Matthias',\n",
       "                'Goretzki, Peter E',\n",
       "                'Scherbaum, Werner A'],\n",
       "               'AU': ['Willenberg HS',\n",
       "                'Feldkamp J',\n",
       "                'Lehmann R',\n",
       "                'Schott M',\n",
       "                'Goretzki PE',\n",
       "                'Scherbaum WA'],\n",
       "               'AD': ['Department of Endocrinology, Diabetes and Rheumatology, University Hospital Dusseldorf, Moorenstr. 5, D-40225 Dusseldorf, Germany. Holger.Willenberg@uni-duesseldorf.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports',\n",
       "                'Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Ann N Y Acad Sci',\n",
       "               'JT': 'Annals of the New York Academy of Sciences',\n",
       "               'JID': '7506858',\n",
       "               'RN': ['0 (Catecholamines)',\n",
       "                '0 (Glucocorticoids)',\n",
       "                '9002-60-2 (Adrenocorticotropic Hormone)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adrenocorticotropic Hormone/*metabolism',\n",
       "                'Catecholamines/*blood/metabolism',\n",
       "                'Female',\n",
       "                'Glucocorticoids/*blood/metabolism',\n",
       "                'Humans',\n",
       "                'Magnetic Resonance Imaging',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Paraganglioma/*diagnosis/diagnostic imaging/metabolism',\n",
       "                'Tomography, X-Ray Computed',\n",
       "                'Ultrasonography'],\n",
       "               'EDAT': '2006/11/15 09:00',\n",
       "               'MHDA': '2006/12/13 09:00',\n",
       "               'CRDT': ['2006/11/15 09:00'],\n",
       "               'PHST': ['2006/11/15 09:00 [pubmed]',\n",
       "                '2006/12/13 09:00 [medline]',\n",
       "                '2006/11/15 09:00 [entrez]'],\n",
       "               'AID': ['1073/1/52 [pii]', '10.1196/annals.1353.006 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Ann N Y Acad Sci. 2006 Aug;1073:52-8. doi: 10.1196/annals.1353.006.'},\n",
       "              {'PMID': '16819338',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20060810',\n",
       "               'LR': '20111117',\n",
       "               'IS': '0147-5185 (Print) 0147-5185 (Linking)',\n",
       "               'VI': '30',\n",
       "               'IP': '7',\n",
       "               'DP': '2006 Jul',\n",
       "               'TI': 'Coincidence of insulinoma with nesidioblastosis or false diagnosis in 2 of 15 patients?',\n",
       "               'PG': '919-20; author reply 920-1',\n",
       "               'FAU': ['Goretzki, Peter E', 'Starkel, Achim'],\n",
       "               'AU': ['Goretzki PE', 'Starkel A'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comment', 'Letter'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Am J Surg Pathol',\n",
       "               'JT': 'The American journal of surgical pathology',\n",
       "               'JID': '7707904',\n",
       "               'RN': ['0 (Insulin)'],\n",
       "               'SB': 'IM',\n",
       "               'CON': ['Am J Surg Pathol. 2005 Apr;29(4):524-33. doi: 10.1097/01.pas.0000151617.14598.ae.',\n",
       "                'PMID: 15767809'],\n",
       "               'MH': ['Cell Nucleus/pathology',\n",
       "                'Diagnostic Errors',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperinsulinism/complications/*pathology',\n",
       "                'Hypoglycemia/complications/*pathology',\n",
       "                'Insulin/blood',\n",
       "                'Insulinoma/complications/metabolism/*pathology',\n",
       "                'Islets of Langerhans/metabolism/*pathology',\n",
       "                'Male',\n",
       "                'Nesidioblastosis/complications/metabolism/*pathology',\n",
       "                'Pancreatic Neoplasms/complications/metabolism/*pathology'],\n",
       "               'EDAT': '2006/07/05 09:00',\n",
       "               'MHDA': '2006/08/11 09:00',\n",
       "               'CRDT': ['2006/07/05 09:00'],\n",
       "               'PHST': ['2006/07/05 09:00 [pubmed]',\n",
       "                '2006/08/11 09:00 [medline]',\n",
       "                '2006/07/05 09:00 [entrez]'],\n",
       "               'AID': ['00000478-200607000-00021 [pii]',\n",
       "                '10.1097/01.pas.0000209857.13035.ee [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Am J Surg Pathol. 2006 Jul;30(7):919-20; author reply 920-1. doi: 10.1097/01.pas.0000209857.13035.ee.'},\n",
       "              {'PMID': '16800538',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'DCOM': '20070723',\n",
       "               'LR': '20060627',\n",
       "               'IS': '1520-6106 (Print) 1520-5207 (Linking)',\n",
       "               'VI': '110',\n",
       "               'IP': '25',\n",
       "               'DP': '2006 Jun 29',\n",
       "               'TI': 'Dianhydride-amine hydrogen bonded perylene tetracarboxylic dianhydride and tetraaminobenzene rows.',\n",
       "               'PG': '12207-10',\n",
       "               'AB': 'We have investigated the coadsorption of perylene tetracarboxylic dianhydride (PTCDA) and tetraaminobenzene (TAB) on the Ag/Si(111)-square root(3) x square root(3) R30 degree surface using scanning tunneling microscopy. At room temperature, PTCDA islands with square and herringbone ordering are formed which, on exposure to TAB, are converted into an intermixed phase in which PTCDA and TAB form alternating rows. From our images, we determine the relative placement of TAB and PTCDA molecules and conclude that the row structure is stabilized by hydrogen bonding between dianhydride and diamine groups. We confirm that this hydrogen bonding junction is stable using ab initio calculations and show that the proposed geometry is consistent with calculated intermolecular dimensions.',\n",
       "               'FAU': ['Ma, J',\n",
       "                'Rogers, B L',\n",
       "                'Humphry, M J',\n",
       "                'Ring, D J',\n",
       "                'Goretzki, G',\n",
       "                'Champness, N R',\n",
       "                'Beton, P H'],\n",
       "               'AU': ['Ma J',\n",
       "                'Rogers BL',\n",
       "                'Humphry MJ',\n",
       "                'Ring DJ',\n",
       "                'Goretzki G',\n",
       "                'Champness NR',\n",
       "                'Beton PH'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Letter'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Phys Chem B',\n",
       "               'JT': 'The journal of physical chemistry. B',\n",
       "               'JID': '101157530',\n",
       "               'EDAT': '2006/06/28 09:00',\n",
       "               'MHDA': '2006/06/28 09:01',\n",
       "               'CRDT': ['2006/06/28 09:00'],\n",
       "               'PHST': ['2006/06/28 09:00 [pubmed]',\n",
       "                '2006/06/28 09:01 [medline]',\n",
       "                '2006/06/28 09:00 [entrez]'],\n",
       "               'AID': ['10.1021/jp057304y [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Phys Chem B. 2006 Jun 29;110(25):12207-10. doi: 10.1021/jp057304y.'},\n",
       "              {'PMID': '16555022',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20061019',\n",
       "               'LR': '20181113',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '30',\n",
       "               'IP': '5',\n",
       "               'DP': '2006 May',\n",
       "               'TI': 'Islet hyperplasia in adults: challenge to preoperatively diagnose non-insulinoma pancreatogenic hypoglycemia syndrome.',\n",
       "               'PG': '670-9',\n",
       "               'AB': 'BACKGROUND: Pancreatic hyperfunctional islet hyperplasia in adults has been more and more frequently described in the literature. Postprandial neuroglycopenia, a negative normal fasting test, negative pancreatic imaging results, and positive intra-arterial calcium stimulation of serum insulin are characteristic. In affected patients the term non-insulinoma pancreatogenic hypoglycemia syndrome (NIPHS) was proposed. MATERIALS AND METHODS/PATIENTS: We also encountered fasting hypoglycemia in such patients and therefore evaluated clinical and biochemical data in patients with NIPHS (n = 11), patients with insulinoma (n = 70), and patients in whom hypoglycemia was ruled out (n = 70). RESULTS: Patients with NIPHS were younger (median age: 41 years; range: 18-66) and mostly non-obese (median body mass index/BMI: 22.2 kg/m2; range: 19-39) compared with patients with an insulinoma (median age: 50 years; median: BMI 26.1 kg/m2). During an oral glucose tolerance test (OGTT) followed by a standard fasting test, neuroglycopenia was observed postprandially with a mean minimal blood glucose level of 36 +/- 9 mg/dl in 7 out of 11 patients. Spontaneous hypoglycemia during the fast was 38 +/- 5 mg/dl in 8 out of 11 patients. The corresponding insulin levels were 9.2 +/- 9.8 mU/l (OGTT) and 6.8 +/- 5.4 mU/l (fasting), significantly lower than in patients with insulinoma (P < 0.001), but not different from patients without hypoglycemia (P = 0.05). After pancreatic resection 8 patients (73%) were cured with enduring euglycemia. Pathohistological islet abnormalities with hyperplasia, hypertrophy, and microadenomatosis were confirmed in all patients. CONCLUSION: In patients with postprandial and/or fasting neuroglycopenia NIPHS may be suspected when insulin levels are low but inadequately suppressed and localization studies failed to show a distinct pancreatic tumor.',\n",
       "               'FAU': ['Starke, Achim',\n",
       "                'Saddig, Christiane',\n",
       "                'Kirch, Barbara',\n",
       "                'Tschahargane, Cyrus',\n",
       "                'Goretzki, Peter'],\n",
       "               'AU': ['Starke A',\n",
       "                'Saddig C',\n",
       "                'Kirch B',\n",
       "                'Tschahargane C',\n",
       "                'Goretzki P'],\n",
       "               'AD': ['Insulinoma and GEP Tumor Center Neuss-Dusseldorf, Lukaskrankenhaus Neuss, Preussenstrasse 84, Neuss, 41464, Germany. starkea@uni-duessel-dorf.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'RN': ['0 (Blood Glucose)'],\n",
       "               'SB': 'IM',\n",
       "               'CIN': ['World J Surg. 2007 Feb;31(2):442-3; author reply 444-5. doi:',\n",
       "                '10.1007/s00268-006-0581-8. PMID: 17171485'],\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Blood Glucose/analysis',\n",
       "                'Diagnosis, Differential',\n",
       "                'Female',\n",
       "                'Glucose Tolerance Test',\n",
       "                'Humans',\n",
       "                'Hyperplasia/complications',\n",
       "                'Hypoglycemia/diagnosis/*etiology',\n",
       "                'Insulinoma/diagnosis',\n",
       "                'Islets of Langerhans/*pathology',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Pancreatic Diseases/complications/*diagnosis',\n",
       "                'Pancreatic Neoplasms/diagnosis'],\n",
       "               'EDAT': '2006/03/24 09:00',\n",
       "               'MHDA': '2006/10/20 09:00',\n",
       "               'CRDT': ['2006/03/24 09:00'],\n",
       "               'PHST': ['2006/03/24 09:00 [pubmed]',\n",
       "                '2006/10/20 09:00 [medline]',\n",
       "                '2006/03/24 09:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00268-005-0543-6 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 2006 May;30(5):670-9. doi: 10.1007/s00268-005-0543-6.'}],\n",
       "             '2005': [{'PMID': '16207897',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20051102',\n",
       "               'LR': '20051117',\n",
       "               'IS': '0021-972X (Print) 0021-972X (Linking)',\n",
       "               'VI': '90',\n",
       "               'IP': '10',\n",
       "               'DP': '2005 Oct',\n",
       "               'TI': 'Letter Re: Id1 gene expression in hyperplastic and neoplastic thyroid tissues.',\n",
       "               'PG': '5906',\n",
       "               'FAU': ['Rao, Annavarapu Srinivas',\n",
       "                'Goretzki, Peter E',\n",
       "                'Kohrle, Josef',\n",
       "                'Brabant, Georg'],\n",
       "               'AU': ['Rao AS', 'Goretzki PE', 'Kohrle J', 'Brabant G'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comment', 'Letter'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Clin Endocrinol Metab',\n",
       "               'JT': 'The Journal of clinical endocrinology and metabolism',\n",
       "               'JID': '0375362',\n",
       "               'RN': ['0 (ID1 protein, human)',\n",
       "                '0 (Inhibitor of Differentiation Protein 1)',\n",
       "                '0 (Repressor Proteins)',\n",
       "                '0 (Transcription Factors)'],\n",
       "               'SB': 'IM',\n",
       "               'CON': ['J Clin Endocrinol Metab. 2004 Jun;89(6):2905-8. doi: 10.1210/jc.2003-031828.',\n",
       "                'PMID: 15181075'],\n",
       "               'MH': ['*Cell Line, Tumor',\n",
       "                'Gene Expression Regulation, Neoplastic/*genetics',\n",
       "                'Humans',\n",
       "                'Inhibitor of Differentiation Protein 1',\n",
       "                'Neoplasm Metastasis/genetics/pathology',\n",
       "                'Repressor Proteins/biosynthesis/*genetics',\n",
       "                'Thyroid Neoplasms/*genetics/metabolism/pathology',\n",
       "                'Transcription Factors/biosynthesis/*genetics'],\n",
       "               'EDAT': '2005/10/07 09:00',\n",
       "               'MHDA': '2005/11/03 09:00',\n",
       "               'CRDT': ['2005/10/07 09:00'],\n",
       "               'PHST': ['2005/10/07 09:00 [pubmed]',\n",
       "                '2005/11/03 09:00 [medline]',\n",
       "                '2005/10/07 09:00 [entrez]'],\n",
       "               'AID': ['jc.2005-0952 [pii]', '10.1210/jc.2005-0952 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Clin Endocrinol Metab. 2005 Oct;90(10):5906. doi: 10.1210/jc.2005-0952.'},\n",
       "              {'PMID': '16088423',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20060112',\n",
       "               'LR': '20181113',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '29',\n",
       "               'IP': '9',\n",
       "               'DP': '2005 Sep',\n",
       "               'TI': 'Do Germans keep patients too long in hospital? A prospective randomized trial.',\n",
       "               'PG': '1189-93',\n",
       "               'AB': \"Cost-effectiveness reduces hospital stay for all patients with thyroid surgery but lacks information on medical comparability and patients' fulfilled expectations. The aim of this study was to assess if a hospital stay of 2 days after thyroid surgery had a negative influence on the medical quality or on health-related quality of life. In a controlled prospective randomized trial with 238 patients, a postoperative hospital stay of 2 days was compared to one longer than 2 days. The postoperative medical investigation included serum calcium levels, laryngeal nerve function, and suction drainage volume. Health-related quality of life was assessed on the day of admission before the operation and again 14 days after discharge. Fourteen days after discharge patients were also asked about their subjective health. Despite the study design, it was necessary, for ethical reasons, to let the patients decide when to leave the hospital. In the 2-day study group, 56.6% of the patients preferred hospitalization for more than 2 days (most choosing 3 days). Medical reasons were hyperthyroidism (p < 0.02) and postoperative hypocalcemia (p < 0.03). In the control group 28% left the hospital after 2 days. Only 35% of the patients left the hospital at the second postoperative day, but 60% of these patient supported this shorter hospitalization. Health-related quality of life and self-rated health was significantly higher in patients leaving the hospital on the second postoperative day. A 2-day hospital stay after thyroid surgery is possible and does not show medical or health-related quality of life disadvantages in patients with an uncomplicated postoperative course who consider themselves healthy.\",\n",
       "               'FAU': ['Dotzenrath, Cornelia M E',\n",
       "                'Cupisti, Kenko',\n",
       "                'Raffel, Andreas',\n",
       "                'Aust, Birgit',\n",
       "                'Yang, Quh',\n",
       "                'Kruger, Bjorn',\n",
       "                'Ohmann, Christian',\n",
       "                'Roher, Hans Dietrich',\n",
       "                'Goretzki, Peter E'],\n",
       "               'AU': ['Dotzenrath CM',\n",
       "                'Cupisti K',\n",
       "                'Raffel A',\n",
       "                'Aust B',\n",
       "                'Yang Q',\n",
       "                'Kruger B',\n",
       "                'Ohmann C',\n",
       "                'Roher HD',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Department of Surgery, Heinrich-Heine University, Moorenstrasse 5, Dusseldorf 40225, Germany. dotzenr@uni-duesseldorf.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Randomized Controlled Trial'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Chi-Square Distribution',\n",
       "                'Cost-Benefit Analysis',\n",
       "                'Female',\n",
       "                'Germany',\n",
       "                'Goiter/*surgery',\n",
       "                'Humans',\n",
       "                'Length of Stay/*statistics & numerical data',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Patient Discharge/*statistics & numerical data',\n",
       "                'Prospective Studies',\n",
       "                'Quality of Life',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '2005/08/10 09:00',\n",
       "               'MHDA': '2006/01/13 09:00',\n",
       "               'CRDT': ['2005/08/10 09:00'],\n",
       "               'PHST': ['2005/08/10 09:00 [pubmed]',\n",
       "                '2006/01/13 09:00 [medline]',\n",
       "                '2005/08/10 09:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00268-005-7742-z [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 2005 Sep;29(9):1189-93. doi: 10.1007/s00268-005-7742-z.'},\n",
       "              {'PMID': '15989483',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20050919',\n",
       "               'LR': '20151119',\n",
       "               'IS': '1084-9785 (Print) 1084-9785 (Linking)',\n",
       "               'VI': '20',\n",
       "               'IP': '3',\n",
       "               'DP': '2005 Jun',\n",
       "               'TI': 'Radiosynoviorthesis in osteoarthritis and other disorders with concomitant synovitis in comparison to rheumatoid arthritis.',\n",
       "               'PG': '349-55',\n",
       "               'AB': 'AIM: The aim of this study was to evaluate the effectiveness of radiosynoviorthesis (RSO) in osteoarthritis and other disorders with concomitant synovitis versus rheumatoid arthritis by means of a standardized questionnaire. METHODS: Eight-hundred and three RSO treatments were monitored in 691 patients by seven centers in three countries, using standardized questionnaires. Patients were assigned to three groups according to their age (20-40, 41-60, and 61-80 years). Additionally, the data was analyzed separately for patients with rheumatoid arthritis (group A) and those with osteoarthritis, psoriasis arthritis, pigmental villonodular synovitis, or persistent effusions after joint replacement (group B). RESULTS: Quality of life improved in 78% of group A and 59% of group B (p < 0.01). Ameliorations of joint pain, swelling/effusion, or flexibility were found in 80% of group A and 56% of group B (p < 0.01). The response rate was similar for small- and large-sized joints in group A, but was significantly higher for large-sized joints in group B (p < 0.01). The positive effects on joint pain, swelling/effusion, or flexibility lasted longer in group A (p < 0.01). Repeated RSOs were as effective as initial RSOs. The clinical outcome was not influenced by age, gender, or transient immobilization for 48 hours after RSO. CONCLUSION: Although slightly more efficient in rheumatoid arthritis, RSO represents an effective treatment option also in osteoarthritis and other disorders with concomitant synovitis.',\n",
       "               'FAU': ['Rau, Harald',\n",
       "                'Franke, Christian',\n",
       "                'Goretzki, Gunter',\n",
       "                'Spitz, Jorg'],\n",
       "               'AU': ['Rau H', 'Franke C', 'Goretzki G', 'Spitz J'],\n",
       "               'AD': ['Praxis fur Nuklearmedizin, Wiesbaden, Germany. H.Rau@em.uni-frankfurt.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Clinical Trial',\n",
       "                'Comparative Study',\n",
       "                'Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Cancer Biother Radiopharm',\n",
       "               'JT': 'Cancer biotherapy & radiopharmaceuticals',\n",
       "               'JID': '9605408',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Arthritis, Rheumatoid/pathology/*radiotherapy',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Osteoarthritis/*complications/pathology/*radiotherapy',\n",
       "                'Quality of Life',\n",
       "                'Surveys and Questionnaires',\n",
       "                'Synovitis/*complications/pathology/*radiotherapy',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '2005/07/02 09:00',\n",
       "               'MHDA': '2005/09/20 09:00',\n",
       "               'CRDT': ['2005/07/02 09:00'],\n",
       "               'PHST': ['2005/07/02 09:00 [pubmed]',\n",
       "                '2005/09/20 09:00 [medline]',\n",
       "                '2005/07/02 09:00 [entrez]'],\n",
       "               'AID': ['10.1089/cbr.2005.20.349 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Cancer Biother Radiopharm. 2005 Jun;20(3):349-55. doi: 10.1089/cbr.2005.20.349.'},\n",
       "              {'PMID': '15937683',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20051107',\n",
       "               'LR': '20181113',\n",
       "               'IS': '0340-2592 (Print) 0340-2592 (Linking)',\n",
       "               'VI': '44',\n",
       "               'IP': '7',\n",
       "               'DP': '2005 Jul',\n",
       "               'TI': '[New aspects in hernia surgery].',\n",
       "               'PG': '774-9',\n",
       "               'AB': 'In the last 10 years in Germany we have seen a lot of hernia repairs using mesh.Meta-analysis shows the advantages of using meshes in hernia surgery; recurrence rates in inguinal hernia surgery are less than 3% in studies. There is some discussion about minimally invasive surgery in Germany.In incisional hernia surgery there is no discussion about using meshes. The role of minimally invasive surgery has not yet been defined.',\n",
       "               'FAU': ['Lammers, B J', 'Goretzki, P E', 'Otto, T'],\n",
       "               'AU': ['Lammers BJ', 'Goretzki PE', 'Otto T'],\n",
       "               'AD': ['Klinik fur Allgemeine, Viszeral-, Thorax- und Gefasschirurgie, Lukaskrankenhaus, Neuss. blammers@lukasneuss.de'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract',\n",
       "                'Journal Article',\n",
       "                'Meta-Analysis',\n",
       "                'Review'],\n",
       "               'TT': 'Aktuelle Aspekte der Hernienchirurgie.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Urologe A',\n",
       "               'JT': 'Der Urologe. Ausg. A',\n",
       "               'JID': '1304110',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Clinical Trials as Topic',\n",
       "                'Germany/epidemiology',\n",
       "                'Hernia, Hiatal/*epidemiology/*surgery',\n",
       "                'Humans',\n",
       "                'Incidence',\n",
       "                'Internationality',\n",
       "                'Minimally Invasive Surgical Procedures/*instrumentation/methods/*statistics & numerical data/trends',\n",
       "                'Practice Guidelines as Topic',\n",
       "                \"Practice Patterns, Physicians'\",\n",
       "                'Risk Assessment/*methods',\n",
       "                'Risk Factors',\n",
       "                '*Surgical Mesh',\n",
       "                'Treatment Outcome'],\n",
       "               'RF': '34',\n",
       "               'EDAT': '2005/06/07 09:00',\n",
       "               'MHDA': '2005/11/08 09:00',\n",
       "               'CRDT': ['2005/06/07 09:00'],\n",
       "               'PHST': ['2005/06/07 09:00 [pubmed]',\n",
       "                '2005/11/08 09:00 [medline]',\n",
       "                '2005/06/07 09:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00120-005-0845-1 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Urologe A. 2005 Jul;44(7):774-9. doi: 10.1007/s00120-005-0845-1.'},\n",
       "              {'PMID': '15880279',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20051207',\n",
       "               'LR': '20181113',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '29',\n",
       "               'IP': '6',\n",
       "               'DP': '2005 Jun',\n",
       "               'TI': 'Malignant metastatic insulinoma-postoperative treatment and follow-up.',\n",
       "               'PG': '789-93',\n",
       "               'AB': 'The rarity of malignant insulinoma limits reports on therapeutic strategies and outcome. The treatment and follow-up of 10 patients, all presenting an insulinoma with metastatic disease of the liver and newly diagnosed between 1992 and 2002, is reported. Pancreatic surgery with successful removal of the primary tumor preferentially located in the tail was performed in 7 women and 3 men, median age 55 years (range 36-82 years). If appropriate, 5 patients underwent additional hepatic surgery and lymph node resections. Liver metastases as the major cause of postoperatively persistent hypoglycemia were subsequently treated by repeated transarterial hepatic chemoembolization and chemoperfusion protocols using high-dose transhepatic streptozocin perfusions (3-4 g per session). The current median survival time for all 10 patients is 2.6 years (range: 1.6-9.7 years). Six patients are currently alive with a median survival of 3.7 years (1.7-9.7 years), five of them with stable disease and free of hypoglycemia. Four patients died after a median survival of 1.8 years (range: 1.6-7.5 years) from complications of unmanageable hypoglycemia. It is concluded that the necessity to treat debiliating and life-threatening hypoglycemia in metastatic malignant insulinoma warrants the option of radical endocrine surgery in combination with extended and repeated postoperative chemoembolization of liver metastases.',\n",
       "               'FAU': ['Starke, Achim',\n",
       "                'Saddig, Christiane',\n",
       "                'Mansfeld, Lothar',\n",
       "                'Koester, Rainer',\n",
       "                'Tschahargane, Cyrus',\n",
       "                'Czygan, Peter',\n",
       "                'Goretzki, Peter'],\n",
       "               'AU': ['Starke A',\n",
       "                'Saddig C',\n",
       "                'Mansfeld L',\n",
       "                'Koester R',\n",
       "                'Tschahargane C',\n",
       "                'Czygan P',\n",
       "                'Goretzki P'],\n",
       "               'AD': ['Insulinoma & GEP-Tumor Center, Department of Internal Medicine, Heinrich-Heine-University, Moorenstrasse 5, 40225, Dusseldorf, Germany. starkea@uni-duesseldorf.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'RN': ['0 (Antibiotics, Antineoplastic)',\n",
       "                '5W494URQ81 (Streptozocin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Antibiotics, Antineoplastic/administration & dosage/*therapeutic use',\n",
       "                'Dose-Response Relationship, Drug',\n",
       "                'Embolization, Therapeutic',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Hepatectomy',\n",
       "                'Humans',\n",
       "                'Hypoglycemia/etiology/*prevention & control',\n",
       "                'Infusions, Intra-Arterial',\n",
       "                'Insulinoma/complications/*secondary/*therapy',\n",
       "                'Liver Neoplasms/complications/*secondary/*therapy',\n",
       "                'Lymph Node Excision',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Pancreatectomy',\n",
       "                'Pancreatic Neoplasms/complications/*pathology/surgery',\n",
       "                'Retrospective Studies',\n",
       "                'Streptozocin/administration & dosage/*therapeutic use'],\n",
       "               'EDAT': '2005/05/10 09:00',\n",
       "               'MHDA': '2005/12/13 09:00',\n",
       "               'CRDT': ['2005/05/10 09:00'],\n",
       "               'PHST': ['2005/05/10 09:00 [pubmed]',\n",
       "                '2005/12/13 09:00 [medline]',\n",
       "                '2005/05/10 09:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00268-005-7743-y [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 2005 Jun;29(6):789-93. doi: 10.1007/s00268-005-7743-y.'},\n",
       "              {'PMID': '15874945',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20050524',\n",
       "               'LR': '20121003',\n",
       "               'IS': '0741-5214 (Print) 0741-5214 (Linking)',\n",
       "               'VI': '41',\n",
       "               'IP': '4',\n",
       "               'DP': '2005 Apr',\n",
       "               'TI': 'Monitoring of the hypoglossal nerve during general anesthesia.',\n",
       "               'PG': '734',\n",
       "               'FAU': ['Bohner, Hinrich',\n",
       "                'Terorde, Nils',\n",
       "                'Goretzki, Peter E'],\n",
       "               'AU': ['Bohner H', 'Terorde N', 'Goretzki PE'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comment', 'Letter'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Vasc Surg',\n",
       "               'JT': 'Journal of vascular surgery',\n",
       "               'JID': '8407742',\n",
       "               'SB': 'IM',\n",
       "               'CON': ['J Vasc Surg. 2002 Mar;35(3):627. doi: 10.1067/mva.2002.119234. PMID: 11877730'],\n",
       "               'MH': ['*Anesthesia, General',\n",
       "                'Carotid Arteries/surgery',\n",
       "                'Humans',\n",
       "                'Hypoglossal Nerve/*physiopathology',\n",
       "                'Monitoring, Intraoperative/*methods'],\n",
       "               'EDAT': '2005/05/06 09:00',\n",
       "               'MHDA': '2005/05/25 09:00',\n",
       "               'CRDT': ['2005/05/06 09:00'],\n",
       "               'PHST': ['2005/05/06 09:00 [pubmed]',\n",
       "                '2005/05/25 09:00 [medline]',\n",
       "                '2005/05/06 09:00 [entrez]'],\n",
       "               'AID': ['S0741521404017094 [pii]',\n",
       "                '10.1016/j.jvs.2004.12.035 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Vasc Surg. 2005 Apr;41(4):734. doi: 10.1016/j.jvs.2004.12.035.'},\n",
       "              {'PMID': '15870131',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20050809',\n",
       "               'LR': '20120604',\n",
       "               'IS': '0021-972X (Print) 0021-972X (Linking)',\n",
       "               'VI': '90',\n",
       "               'IP': '7',\n",
       "               'DP': '2005 Jul',\n",
       "               'TI': 'Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.',\n",
       "               'PG': '4063-7',\n",
       "               'AB': 'CONTEXT: Primary hyperparathyroidism (HPT) presents as a part of inherited syndromes such as multiple endocrine neoplasia (MEN) types 1 and 2. In patients with MEN1, parathyroid hyperplasia or multiple adenomas occur in approximately 90-95%. MEN2A-related HPT is characterized by a mild hypercalcemia, which is mostly asymptomatic. OBJECTIVE: Here we present a family with coexistence of MEN1 gene mutation and RET mutation. RESULTS: Six family members carrying MEN1 gene mutation IVS5 + 1G>A only, one family member with RET mutation Y791F, and three family members with both MEN1 gene and RET mutation were studied. The key to diagnosis was recurrent HPT in a young male carrying RET mutation Y791F, a mutation not likely to give rise to recurrent HPT. CONCLUSION: MEN1 gene mutation and RET codon 791 mutation in the same patient did not affect the typical phenotype of MEN1 or MEN2, and also the course of diseases seems to be unchanged. The reason may be that both mutations, although contributing to tumor pathogenesis, do not interact and induce a worsening of the cancer syndromes.',\n",
       "               'FAU': ['Frank-Raue, Karin',\n",
       "                'Rondot, Susanne',\n",
       "                'Hoeppner, Wolfgang',\n",
       "                'Goretzki, Peter',\n",
       "                'Raue, Friedhelm',\n",
       "                'Meng, Wieland'],\n",
       "               'AU': ['Frank-Raue K',\n",
       "                'Rondot S',\n",
       "                'Hoeppner W',\n",
       "                'Goretzki P',\n",
       "                'Raue F',\n",
       "                'Meng W'],\n",
       "               'AD': ['karin.frankraue@raue-endokrinologie.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20050503',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Clin Endocrinol Metab',\n",
       "               'JT': 'The Journal of clinical endocrinology and metabolism',\n",
       "               'JID': '0375362',\n",
       "               'RN': ['0 (MEN1 protein, human)',\n",
       "                '0 (Oncogene Proteins)',\n",
       "                '0 (Proto-Oncogene Proteins)',\n",
       "                'EC 2.7.10.1 (Proto-Oncogene Proteins c-ret)',\n",
       "                'EC 2.7.10.1 (RET protein, human)',\n",
       "                'EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases)'],\n",
       "               'SB': 'IM',\n",
       "               'EIN': ['J Clin Endocrinol Metab. 2005 Oct;90(10):5575'],\n",
       "               'MH': ['Adult',\n",
       "                'Female',\n",
       "                '*Genes, Tumor Suppressor',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism/*genetics',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Multiple Endocrine Neoplasia Type 1/*genetics',\n",
       "                'Multiple Endocrine Neoplasia Type 2a/*genetics',\n",
       "                'Multiple Endocrine Neoplasia Type 2b/*genetics',\n",
       "                '*Mutation',\n",
       "                'Oncogene Proteins/*genetics',\n",
       "                'Proto-Oncogene Proteins/*genetics',\n",
       "                'Proto-Oncogene Proteins c-ret',\n",
       "                '*Proto-Oncogenes',\n",
       "                'Receptor Protein-Tyrosine Kinases/*genetics',\n",
       "                'Recurrence'],\n",
       "               'EDAT': '2005/05/05 09:00',\n",
       "               'MHDA': '2005/08/10 09:00',\n",
       "               'CRDT': ['2005/05/05 09:00'],\n",
       "               'PHST': ['2005/05/05 09:00 [pubmed]',\n",
       "                '2005/08/10 09:00 [medline]',\n",
       "                '2005/05/05 09:00 [entrez]'],\n",
       "               'AID': ['jc.2004-1759 [pii]', '10.1210/jc.2004-1759 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Clin Endocrinol Metab. 2005 Jul;90(7):4063-7. doi: 10.1210/jc.2004-1759. Epub 2005 May 3.'},\n",
       "              {'PMID': '15697249',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'DCOM': '20060612',\n",
       "               'LR': '20050208',\n",
       "               'IS': '0743-7463 (Print) 0743-7463 (Linking)',\n",
       "               'VI': '21',\n",
       "               'IP': '4',\n",
       "               'DP': '2005 Feb 15',\n",
       "               'TI': 'Photochemical hydrosilylation of 11-undecenyltriethylammonium bromide with hydrogen-terminated Si surfaces for the development of robust microcantilever sensors for Cr(VI).',\n",
       "               'PG': '1139-42',\n",
       "               'AB': 'We report a novel approach to the design and development of microcantilever sensors in which photochemical hydrosilylation is used to modify the microcantilever surface. This process enables individual microcantilevers in multicantilever array chips to be modified separately by focusing the activating UV light sequentially on each particular cantilever. Photochemical hydrosilylation of 11-undecenyltriethylammonium bromide with hydrogen-terminated silicon microcantilever surfaces was carried out to yield a robust quaternary ammonium terminated organic monolayer suitable for chromate detection. The surface functionalities retain their affinity toward Cr(VI), and the organic monolayer is dense enough to generate significant surface stress upon subsequent adsorption of chromate ions from aqueous solutions.',\n",
       "               'FAU': ['Boiadjiev, V I',\n",
       "                'Brown, G M',\n",
       "                'Pinnaduwage, L A',\n",
       "                'Goretzki, G',\n",
       "                'Bonnesen, P V',\n",
       "                'Thundat, T'],\n",
       "               'AU': ['Boiadjiev VI',\n",
       "                'Brown GM',\n",
       "                'Pinnaduwage LA',\n",
       "                'Goretzki G',\n",
       "                'Bonnesen PV',\n",
       "                'Thundat T'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Letter'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Langmuir',\n",
       "               'JT': 'Langmuir : the ACS journal of surfaces and colloids',\n",
       "               'JID': '9882736',\n",
       "               'EDAT': '2005/02/09 09:00',\n",
       "               'MHDA': '2005/02/09 09:01',\n",
       "               'CRDT': ['2005/02/09 09:00'],\n",
       "               'PHST': ['2005/02/09 09:00 [pubmed]',\n",
       "                '2005/02/09 09:01 [medline]',\n",
       "                '2005/02/09 09:00 [entrez]'],\n",
       "               'AID': ['10.1021/la047852n [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langmuir. 2005 Feb 15;21(4):1139-42. doi: 10.1021/la047852n.'}],\n",
       "             '2004': [{'PMID': '15188407',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20041123',\n",
       "               'LR': '20061115',\n",
       "               'IS': '1615-9853 (Print) 1615-9853 (Linking)',\n",
       "               'VI': '4',\n",
       "               'IP': '5',\n",
       "               'DP': '2004 May',\n",
       "               'TI': 'Convenient and versatile subcellular extraction procedure, that facilitates classical protein expression profiling and functional protein analysis.',\n",
       "               'PG': '1397-405',\n",
       "               'AB': 'Standardized sample preparation to reduce proteome complexity facilitates subsequent proteome analysis. Here we describe a robust sequential extraction method that enables simple fractionation of proteins in their native state according to their subcellular localization, yielding four subproteomes enriched in (a) cytosolic; (b) membrane and membrane organelle-localized; (c) soluble and DNA-associated nuclear and (d) cytoskeletal proteins. Efficiency and selectivity is demonstrated by morphological-, two-dimensional electrophoresis image-, immunological- as well as enzymatic-analysis. In pilot studies, subcellular redistribution of regulatory proteins was successfully measured.',\n",
       "               'FAU': ['Abdolzade-Bavil, Afsaneh',\n",
       "                'Hayes, Scott',\n",
       "                'Goretzki, Lothar',\n",
       "                'Kroger, Michaela',\n",
       "                'Anders, Jonas',\n",
       "                'Hendriks, Robertus'],\n",
       "               'AU': ['Abdolzade-Bavil A',\n",
       "                'Hayes S',\n",
       "                'Goretzki L',\n",
       "                'Kroger M',\n",
       "                'Anders J',\n",
       "                'Hendriks R'],\n",
       "               'AD': ['Merck, Life Science Products R&D, Darmstadt, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comparative Study',\n",
       "                'Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Proteomics',\n",
       "               'JT': 'Proteomics',\n",
       "               'JID': '101092707',\n",
       "               'RN': ['0 (Cytoskeletal Proteins)',\n",
       "                '0 (DNA-Binding Proteins)',\n",
       "                '0 (Enzymes)',\n",
       "                '0 (Membrane Proteins)',\n",
       "                '0 (NF-kappa B)',\n",
       "                '0 (Proteins)',\n",
       "                '0 (Proteome)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Blotting, Western',\n",
       "                'Cell Fractionation/*methods/*standards',\n",
       "                'Cell Line, Tumor',\n",
       "                'Cell Nucleus/chemistry',\n",
       "                'Cells/drug effects',\n",
       "                'Cytoskeletal Proteins/chemistry',\n",
       "                'Cytosol/chemistry',\n",
       "                'DNA-Binding Proteins/chemistry',\n",
       "                'Electrophoresis, Gel, Two-Dimensional',\n",
       "                'Electrophoresis, Polyacrylamide Gel',\n",
       "                'Enzymes/analysis/metabolism',\n",
       "                'Humans',\n",
       "                'Isoelectric Focusing',\n",
       "                'Membrane Proteins/chemistry/isolation & purification',\n",
       "                'Microscopy, Fluorescence',\n",
       "                'NF-kappa B/pharmacology',\n",
       "                'Organelles/chemistry',\n",
       "                'Pilot Projects',\n",
       "                'Proteins/*metabolism',\n",
       "                'Proteome/*analysis',\n",
       "                'Sensitivity and Specificity',\n",
       "                'Subcellular Fractions/*chemistry'],\n",
       "               'EDAT': '2004/06/10 05:00',\n",
       "               'MHDA': '2004/12/16 09:00',\n",
       "               'CRDT': ['2004/06/10 05:00'],\n",
       "               'PHST': ['2004/06/10 05:00 [pubmed]',\n",
       "                '2004/12/16 09:00 [medline]',\n",
       "                '2004/06/10 05:00 [entrez]'],\n",
       "               'AID': ['10.1002/pmic.200300710 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Proteomics. 2004 May;4(5):1397-405. doi: 10.1002/pmic.200300710.'},\n",
       "              {'PMID': '15168031',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20050218',\n",
       "               'LR': '20181113',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '75',\n",
       "               'IP': '11',\n",
       "               'DP': '2004 Nov',\n",
       "               'TI': '[Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery].',\n",
       "               'PG': '1088-97',\n",
       "               'AB': 'INTRODUCTION: The incidence of adenocarcinoma of the esophagogastric junction (AEG) is increasing worldwide, and classification systems and resection procedures are being controversially discussed. METHODS AND PATIENTS: We report on 225 AEG patients undergoing primary resection in our unit (1986-2000) with a special focus on perioperative morbidity, mortality, and long-term prognosis under consideration of the AEG type (Siewert classification) and operative procedure performed (subtotal esophagectomy with proximal gastric resection in AEG I, total gastrectomy with distal esophageal resection in AEG II and AEG III). RESULTS: Types I, II, and III carcinomas were found in 32%, 42%, and 26% of the patients, respectively, with R(0) resections in 65%, 69%, and 51% ( P=0.039). The overall 5-year survival rates were 29%, 31%, and 14% ( P=0.068), respectively; in R(0)-resected patients, they were 40%, 41%, and 27% ( P=0.771). In univariate analysis, the TNM classification ( P<0.001), R classification ( P<0.001), and tumor stage ( P<0.001) were relevant prognostic factors. In multivariate analysis, only the R classification ( P=0.003), LN ratio ( P=0.012), and N stage ( P=0.027) were independent prognostic factors. In 35 of 177 patients resected with curative intent, R(0) resections could not be achieved, mainly because of residual tumor in the circumferential plane (22/35=63%). Only in 37% of cases (13/35) was the R(1) situation due to exclusive positive oral or aboral resection margins. Therefore, in only 7% of all patients resected with curative intent (13/177) did the question arise of whether the R(1) resection could have been avoided by a different surgical approach. Surgical, pulmonary, and cardiac complications were found in 33%, 26%, and 10%, respectively. The mortality within 30 days was 4%. CONCLUSIONS: Failure of R(0) resection in patients treated with curative intent is mostly caused by residual tumor in the circumferential plane. Therefore, different surgical approaches with varying oral and aboral resection margins are of minor importance for reducing the frequency of R(1) resections. Downstaging of tumors by neoadjuvant treatment may increase the R(0) resection rate.',\n",
       "               'FAU': ['Bosing, N M',\n",
       "                'Heise, J W',\n",
       "                'Goretzki, P E',\n",
       "                'Sarbia, M',\n",
       "                'Roher, H-D'],\n",
       "               'AU': ['Bosing NM',\n",
       "                'Heise JW',\n",
       "                'Goretzki PE',\n",
       "                'Sarbia M',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Klinikum der Heinrich-Heine-Universitat Dusseldorf, Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Comparative Study',\n",
       "                'English Abstract',\n",
       "                'Journal Article'],\n",
       "               'TT': 'Ergebnisse der primar chirurgischen Therapie beim Adenokarzinom des osophagogastralen Ubergangs.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma/mortality/pathology/*surgery',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Esophageal Neoplasms/mortality/pathology/*surgery',\n",
       "                'Esophagectomy',\n",
       "                '*Esophagogastric Junction/pathology',\n",
       "                'Female',\n",
       "                'Gastrectomy',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Multivariate Analysis',\n",
       "                'Postoperative Complications',\n",
       "                'Prognosis',\n",
       "                'Stomach Neoplasms/mortality/pathology/*surgery',\n",
       "                'Survival Analysis'],\n",
       "               'EDAT': '2004/05/29 05:00',\n",
       "               'MHDA': '2005/02/19 09:00',\n",
       "               'CRDT': ['2004/05/29 05:00'],\n",
       "               'PHST': ['2004/05/29 05:00 [pubmed]',\n",
       "                '2005/02/19 09:00 [medline]',\n",
       "                '2004/05/29 05:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00104-004-0840-x [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 2004 Nov;75(11):1088-97. doi: 10.1007/s00104-004-0840-x.'},\n",
       "              {'PMID': '15145028',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20041019',\n",
       "               'LR': '20051116',\n",
       "               'IS': '0960-7404 (Print) 0960-7404 (Linking)',\n",
       "               'VI': '13',\n",
       "               'IP': '1',\n",
       "               'DP': '2004 Jul',\n",
       "               'TI': 'Therapeutic strategy of papillary cystic and solid neoplasm (PCSN): a rare non-endocrine tumor of the pancreas in children.',\n",
       "               'PG': '1-6',\n",
       "               'AB': 'Papillary-cystic and solid neoplasm (PCSN) are rare tumors. Two personal observations and a review of the literature are presented with a total of 44 pediatric patients in addition to a total of 67 published cases in the review of Cohen (Pediatr. Surg. Int. 6 (1991) 128) and Snadjauf (Eur. J. Pediatr. Surg. 9 (1999) 416). Overall, PCSN shows a clear predominance in females and only occasionally occurs in males. Typically they grow to a large tumor mass with minimal symptoms. Their histologic and immunocytologic characteristics cause diagnostic difficulties, especially on frozen sections of small biopsies. The tumors are assumed to origin from pluripotent stem cells and present as tumors of low malignancy with a favorable prognosis. Nevertheless 10 children have been reported to develop metastases, 5 have demonstrated an invasive growth pattern and 4 local recurrence. But only two of the 111 pediatric cases have died from their tumor burden. Treatment of choice is a complete surgical resection, which is true for the primary tumor and for metastases as well as local recurrences. In our 2 patients one had spleen-conserving left pancreatic resection and one mesopancreatectomy with roux-en-y-reconstruction leading to long-term cure. Adjuvant therapy in curative resected patients is unnecessary and does not appear to improve prognosis.',\n",
       "               'FAU': ['Raffel, A',\n",
       "                'Cupisti, K',\n",
       "                'Krausch, M',\n",
       "                'Braunstein, S',\n",
       "                'Trobs, B',\n",
       "                'Goretzki, P E',\n",
       "                'Willnow, U'],\n",
       "               'AU': ['Raffel A',\n",
       "                'Cupisti K',\n",
       "                'Krausch M',\n",
       "                'Braunstein S',\n",
       "                'Trobs B',\n",
       "                'Goretzki PE',\n",
       "                'Willnow U'],\n",
       "               'AD': ['Department of General and Trauma Surgery, Heinrich-Heine-University Dusseldorf, Moorenstrasse 5, Dusseldorf 40005, Germany. raffel@med.uni-duesseldorf.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports', 'Journal Article', 'Review'],\n",
       "               'PL': 'Netherlands',\n",
       "               'TA': 'Surg Oncol',\n",
       "               'JT': 'Surgical oncology',\n",
       "               'JID': '9208188',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Carcinoma, Papillary/diagnosis/*therapy',\n",
       "                'Child',\n",
       "                'Child, Preschool',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Pancreatic Cyst/diagnosis/*therapy',\n",
       "                'Pancreatic Neoplasms/diagnosis/*therapy'],\n",
       "               'RF': '57',\n",
       "               'EDAT': '2004/05/18 05:00',\n",
       "               'MHDA': '2004/10/20 09:00',\n",
       "               'CRDT': ['2004/05/18 05:00'],\n",
       "               'PHST': ['2004/05/18 05:00 [pubmed]',\n",
       "                '2004/10/20 09:00 [medline]',\n",
       "                '2004/05/18 05:00 [entrez]'],\n",
       "               'AID': ['S0960740403000756 [pii]',\n",
       "                '10.1016/j.suronc.2003.09.003 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Surg Oncol. 2004 Jul;13(1):1-6. doi: 10.1016/j.suronc.2003.09.003.'},\n",
       "              {'PMID': '15138657',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20041025',\n",
       "               'LR': '20181113',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '75',\n",
       "               'IP': '7',\n",
       "               'DP': '2004 Jul',\n",
       "               'TI': '[Economic restraints shorten the length of hospital stay: thyroid operation as a model case].',\n",
       "               'PG': '702-5',\n",
       "               'AB': 'INTRODUCTION: Decreasing the length of stay is a possible means of cost control in the medical system. Therefore we performed a study to test the feasibility of reducing hospital stay to 2 days after thyroid operation. METHODS: In a controlled prospective trial, 238 patients were randomly assigned to group A (2 days of stay) or group B (more than 2 days). Studied were medical standard, practicability, patient acceptance, and quality of life. RESULTS: Of those in group A, 56.6% did not leave the hospital at the scheduled 2nd day post operation. Reasons were preoperative hyperthyroidism ( P<0.011), postoperative hypocalcemia ( P<0.03), or unspecific disturbances. In group B, 28% of the patients left before the established borderline of 3-4 days, and only 35% left on the 2nd postoperative day. CONCLUSION: Reduced length of stay has no negative influence on medical standards. The quality of life of patients leaving the hospital on the 2nd postoperative day was significantly higher. Reducing hospital stay after thyroid operation to 2 postoperative days is desirable and possible without a loss in quality of care, except in case of postoperative complications or unspecific complaints.',\n",
       "               'FAU': ['Raffel, A',\n",
       "                'Cupisti, K',\n",
       "                'Dotzenrath, B',\n",
       "                'Kruger, B',\n",
       "                'Ohmann, C',\n",
       "                'Schulte, K M',\n",
       "                'Goretzki, P E',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Raffel A',\n",
       "                'Cupisti K',\n",
       "                'Dotzenrath B',\n",
       "                'Kruger B',\n",
       "                'Ohmann C',\n",
       "                'Schulte KM',\n",
       "                'Goretzki PE',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Universitatsklinikum Dusseldorf. raffel@med.uni-duesseldorf.de'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Clinical Trial',\n",
       "                'Comparative Study',\n",
       "                'English Abstract',\n",
       "                'Journal Article',\n",
       "                'Randomized Controlled Trial'],\n",
       "               'TT': 'Okonomische Zwange fuhren zur Reduktion der stationaren VerweildauerBeispiel: Schilddrusenoperation.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Cost Savings/statistics & numerical data',\n",
       "                'Female',\n",
       "                'Germany',\n",
       "                'Humans',\n",
       "                'Length of Stay/*economics',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'National Health Programs/*economics',\n",
       "                'Patient Satisfaction',\n",
       "                'Postoperative Complications/economics/etiology',\n",
       "                'Quality Assurance, Health Care/economics',\n",
       "                'Quality of Life',\n",
       "                'Thyroid Diseases/economics/*surgery',\n",
       "                'Thyroidectomy/*economics'],\n",
       "               'EDAT': '2004/05/13 05:00',\n",
       "               'MHDA': '2004/10/27 09:00',\n",
       "               'CRDT': ['2004/05/13 05:00'],\n",
       "               'PHST': ['2004/05/13 05:00 [pubmed]',\n",
       "                '2004/10/27 09:00 [medline]',\n",
       "                '2004/05/13 05:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00104-003-0811-7 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 2004 Jul;75(7):702-5. doi: 10.1007/s00104-003-0811-7.'},\n",
       "              {'PMID': '15031775',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20041021',\n",
       "               'LR': '20041117',\n",
       "               'IS': '0947-7349 (Print) 0947-7349 (Linking)',\n",
       "               'VI': '112',\n",
       "               'IP': '2',\n",
       "               'DP': '2004 Feb',\n",
       "               'TI': 'Pheochromocytoma during pregnancy: laparoscopic and conventional surgical treatment of two cases.',\n",
       "               'PG': '98-101',\n",
       "               'AB': 'Pheochromocytoma is a rare entity. When it presents during pregnancy, rapid recognition and diagnosis are crucial in order to avoid the maternal and fetal morbidity and mortality associated with severe, uncontrolled hypertension. Difficulties arise from the differential diagnosis of pre-eclampsia. We report two patients operated on for pheochromocytoma during pregnancy. The first patient developed new-onset hypertension in early pregnancy. Prior to presentation, there had been non-specific signs of endocrine disorder, namely a mild diabetes, but no hypertension requiring medication. The second patient sought medical care for irregular heartbeat, shortness of breath, and fatigue during the 6th week of pregnancy. She was found to be hypertensive; diagnostic evaluation revealed substantially increased catecholamine levels. The diagnosis was made by elevated urinary catecholamines and by MRI scan as well as ultrasonography, both of which demonstrated an adrenal mass. Both patients underwent surgical extirpation of the affected adrenal gland. The procedure was performed laparoscopically in the case of the second patient. Pre-operatively, both patients were pre-treated with alpha-blockade followed by secondary beta-blockade. Patient two also received methyldopa for control of hypertension. Both patients were readily weaned from antihypertensive medications post-operatively, with complete resolution of hypertension within a few hours. Each pregnancy progressed normally to term.',\n",
       "               'FAU': ['Wolf, A',\n",
       "                'Goretzki, P E',\n",
       "                'Rohrborn, A',\n",
       "                'Feldkamp, J',\n",
       "                'Simon, D',\n",
       "                'Scherbaum, W A',\n",
       "                'Roher, H-D'],\n",
       "               'AU': ['Wolf A',\n",
       "                'Goretzki PE',\n",
       "                'Rohrborn A',\n",
       "                'Feldkamp J',\n",
       "                'Simon D',\n",
       "                'Scherbaum WA',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Department of General and Visceral Surgery, Heinrich Heine University, Dusseldorf, Germany. roehborn@med.uni-duesseldorf.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports', 'Journal Article'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Exp Clin Endocrinol Diabetes',\n",
       "               'JT': 'Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association',\n",
       "               'JID': '9505926',\n",
       "               'RN': ['0 (Catecholamines)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adrenal Gland Neoplasms/blood/complications/diagnosis/*surgery',\n",
       "                'Catecholamines/urine',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hypertension/etiology',\n",
       "                '*Laparoscopy',\n",
       "                'Magnetic Resonance Imaging',\n",
       "                'Pheochromocytoma/blood/complications/diagnosis/*surgery',\n",
       "                'Pregnancy',\n",
       "                'Pregnancy Complications, Neoplastic/blood/diagnosis/*surgery',\n",
       "                'Treatment Outcome',\n",
       "                'Ultrasonography'],\n",
       "               'EDAT': '2004/03/20 05:00',\n",
       "               'MHDA': '2004/10/22 09:00',\n",
       "               'CRDT': ['2004/03/20 05:00'],\n",
       "               'PHST': ['2004/03/20 05:00 [pubmed]',\n",
       "                '2004/10/22 09:00 [medline]',\n",
       "                '2004/03/20 05:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-2004-815764 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Exp Clin Endocrinol Diabetes. 2004 Feb;112(2):98-101. doi: 10.1055/s-2004-815764.'},\n",
       "              {'PMID': '15029266',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20040701',\n",
       "               'LR': '20191108',\n",
       "               'IS': '0029-5566 (Print) 0029-5566 (Linking)',\n",
       "               'VI': '43',\n",
       "               'IP': '2',\n",
       "               'DP': '2004 Mar',\n",
       "               'TI': '[Multicenter study of radiosynoviorthesis. Clinical outcome in osteoarthritis and other disorders with concomitant synovitis in comparison with rheumatoid arthritis].',\n",
       "               'PG': '57-62',\n",
       "               'AB': 'AIM: Evaluation of the effectiveness of radiosynoviorthesis (RSO) in osteoarthritis and other disorders with concomitant synovitis versus rheumatoid arthritis by means of a standardized questionnaire. PATIENTS, METHODS: 803 RSO treatments were monitored in 691 patients by standardized questionnaires of 7 centers in 3 countries. Patients were assigned to 3 groups according to their age (20-40, 41-60, 61-80 years). Additionally, the data were analyzed separately for patients with rheumatoid arthritis (group A) and those with osteoarthritis, psoriasis arthritis, pigmental villonodular synovitis or persistent effusions after joint replacement (group B). RESULTS: Ameliorations of joint pain, swelling/effusion or flexibility were found in 80% of group A and 56% of group B (p >0.01). Quality of life improved in 78% of group A and 59% of group B (p >0.01). The response rate was similar for small- and large-sized joints in group A, but significantly higher for large-sized joints in group B (p >0.01). The positive effects on joint pain, swelling/effusion or flexibility lasted longer in group A (p >0.01). Repeated RSOs were as effective as initial ones. The clinical outcome was neither influenced by age, nor gender, nor transient immobilisation for 48 hours after RSO. CONCLUSION: Although slightly more efficient in rheumatoid arthritis, RSO represents an effective treatment option also in osteoarthritis and other disorders with concomitant synovitis.',\n",
       "               'FAU': ['Rau, H',\n",
       "                'Lohmann, K',\n",
       "                'Franke, C',\n",
       "                'Goretzki, G',\n",
       "                'Lemb, M A',\n",
       "                'Muller, J',\n",
       "                'Panholzer, P J',\n",
       "                'Stelling, E',\n",
       "                'Spitz, J'],\n",
       "               'AU': ['Rau H',\n",
       "                'Lohmann K',\n",
       "                'Franke C',\n",
       "                'Goretzki G',\n",
       "                'Lemb MA',\n",
       "                'Muller J',\n",
       "                'Panholzer PJ',\n",
       "                'Stelling E',\n",
       "                'Spitz J'],\n",
       "               'AD': ['Praxis fur Nuklearmedizin, Stadtischen Klinikum Wiesbaden, Ludwig-Erhard-Str. 100, 65199 Wiesbaden.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Comparative Study',\n",
       "                'English Abstract',\n",
       "                'Journal Article',\n",
       "                'Multicenter Study'],\n",
       "               'TT': 'Multizenterstudie zur Radiosynoviorthese: klinische Ergebnisse bei aktivierten Arthrosen und anderen Gelenkerkrankungen mit chronischer Synovialitis im Vergleich zur rheumatoiden Arthritis.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Nuklearmedizin',\n",
       "               'JT': 'Nuklearmedizin. Nuclear medicine',\n",
       "               'JID': '7609387',\n",
       "               'RN': ['0 (Radioisotopes)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Arthritis, Psoriatic/radiotherapy',\n",
       "                'Arthritis, Rheumatoid/radiotherapy',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Joint Prosthesis/adverse effects',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Osteoarthritis/radiotherapy',\n",
       "                'Pain',\n",
       "                'Quality of Life',\n",
       "                'Radioisotopes/*therapeutic use',\n",
       "                'Synovitis/physiopathology/*radiotherapy',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '2004/03/19 05:00',\n",
       "               'MHDA': '2004/07/02 05:00',\n",
       "               'CRDT': ['2004/03/19 05:00'],\n",
       "               'PHST': ['2004/03/19 05:00 [pubmed]',\n",
       "                '2004/07/02 05:00 [medline]',\n",
       "                '2004/03/19 05:00 [entrez]'],\n",
       "               'AID': ['04020057 [pii]', '10.1267/nukl04020057 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Nuklearmedizin. 2004 Mar;43(2):57-62. doi: 10.1267/nukl04020057.'}],\n",
       "             '2003': [{'PMID': '14690006',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20040408',\n",
       "               'LR': '20190917',\n",
       "               'IS': '0936-6555 (Print) 0936-6555 (Linking)',\n",
       "               'VI': '15',\n",
       "               'IP': '8',\n",
       "               'DP': '2003 Dec',\n",
       "               'TI': 'Spindle epithelial tumour with thymus-like differentiation (SETTLE) of the thyroid gland with widespread metastases in a 13-year-old girl.',\n",
       "               'PG': '490-5',\n",
       "               'FAU': ['Raffel, A',\n",
       "                'Cupisti, K',\n",
       "                'Rees, M',\n",
       "                'Janig, U',\n",
       "                'Bernbeck, B',\n",
       "                'Jazbec, J',\n",
       "                'Goretzki, P E',\n",
       "                'Gobel, U'],\n",
       "               'AU': ['Raffel A',\n",
       "                'Cupisti K',\n",
       "                'Rees M',\n",
       "                'Janig U',\n",
       "                'Bernbeck B',\n",
       "                'Jazbec J',\n",
       "                'Goretzki PE',\n",
       "                'Gobel U'],\n",
       "               'AD': ['Department of Pediatric Haematology and Oncology, Heinrich-Heine-University, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports', 'Journal Article', 'Review'],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Clin Oncol (R Coll Radiol)',\n",
       "               'JT': 'Clinical oncology (Royal College of Radiologists (Great Britain))',\n",
       "               'JID': '9002902',\n",
       "               'RN': ['68238-35-7 (Keratins)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Diagnosis, Differential',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Immunohistochemistry',\n",
       "                'Keratins/analysis',\n",
       "                'Lymphatic Metastasis',\n",
       "                'Neoplasms, Glandular and Epithelial/*pathology',\n",
       "                'Thymus Gland/chemistry/*pathology/radiation effects',\n",
       "                'Thyroid Neoplasms/*pathology'],\n",
       "               'RF': '17',\n",
       "               'EDAT': '2003/12/24 05:00',\n",
       "               'MHDA': '2004/04/09 05:00',\n",
       "               'CRDT': ['2003/12/24 05:00'],\n",
       "               'PHST': ['2003/12/24 05:00 [pubmed]',\n",
       "                '2004/04/09 05:00 [medline]',\n",
       "                '2003/12/24 05:00 [entrez]'],\n",
       "               'AID': ['S0936-6555(03)00153-5 [pii]',\n",
       "                '10.1016/s0936-6555(03)00153-5 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Clin Oncol (R Coll Radiol). 2003 Dec;15(8):490-5. doi: 10.1016/s0936-6555(03)00153-5.'},\n",
       "              {'PMID': '12818837',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20030815',\n",
       "               'LR': '20080215',\n",
       "               'IS': '0361-803X (Print) 0361-803X (Linking)',\n",
       "               'VI': '181',\n",
       "               'IP': '1',\n",
       "               'DP': '2003 Jul',\n",
       "               'TI': 'Angiographic ablation of an ectopic mediastinal hyperplastic parathyroid gland using a left internal mammary artery coronary bypass.',\n",
       "               'PG': '95-7',\n",
       "               'FAU': ['Ernst, S',\n",
       "                'Cupisti, K',\n",
       "                'Kemper, J',\n",
       "                'Dotzenrath, C',\n",
       "                'Goretzki, P E',\n",
       "                'Furst, G'],\n",
       "               'AU': ['Ernst S',\n",
       "                'Cupisti K',\n",
       "                'Kemper J',\n",
       "                'Dotzenrath C',\n",
       "                'Goretzki PE',\n",
       "                'Furst G'],\n",
       "               'AD': ['Department of Diagnostic Radiology, University of Duesseldorf, Moorenstr. 5, D-40225 Duesseldorf, Germany. stefan.ernst@mkh-bgl.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports', 'Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'AJR Am J Roentgenol',\n",
       "               'JT': 'AJR. American journal of roentgenology',\n",
       "               'JID': '7708173',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Angiography',\n",
       "                'Choristoma/*therapy',\n",
       "                '*Embolization, Therapeutic',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism/therapy',\n",
       "                '*Internal Mammary-Coronary Artery Anastomosis',\n",
       "                'Male',\n",
       "                'Mediastinal Diseases/*therapy',\n",
       "                'Middle Aged',\n",
       "                '*Parathyroid Glands'],\n",
       "               'EDAT': '2003/06/24 05:00',\n",
       "               'MHDA': '2003/08/16 05:00',\n",
       "               'CRDT': ['2003/06/24 05:00'],\n",
       "               'PHST': ['2003/06/24 05:00 [pubmed]',\n",
       "                '2003/08/16 05:00 [medline]',\n",
       "                '2003/06/24 05:00 [entrez]'],\n",
       "               'AID': ['10.2214/ajr.181.1.1810095 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'AJR Am J Roentgenol. 2003 Jul;181(1):95-7. doi: 10.2214/ajr.181.1.1810095.'},\n",
       "              {'PMID': '12747776',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20030623',\n",
       "               'LR': '20211203',\n",
       "               'IS': '0022-2623 (Print) 0022-2623 (Linking)',\n",
       "               'VI': '46',\n",
       "               'IP': '11',\n",
       "               'DP': '2003 May 22',\n",
       "               'TI': '3D QSAR analyses-guided rational design of novel ligands for the (alpha4)2(beta2)3 nicotinic acetylcholine receptor.',\n",
       "               'PG': '2031-48',\n",
       "               'AB': 'Three-dimensional quantitative structure-activity relationship methods, the comparative molecular field analysis (CoMFA) and the comparative molecular similarity indices analysis (CoMSIA), were applied using a training set of 45 ligands of the (alpha4)2(beta2)3 nicotinic acetylcholine receptor (nAChR). All compounds are related to (-)-epibatidine, (-)-cytisine, (+)-anatoxin-a, and (-)-ferruginine, and additionally, novel diazabicyclo[4.2.1]nonane- and quinuclidin-2-ene-based structures were included. Their biological data have been determined by utilizing the same experimental protocol. Statistically reliable models of good predictive power (CoMFA r2 = 0.928, q2 = 0.692, no. of components = 3; CoMSIA r2 = 0.899, q2 = 0.701, no. of components = 3) were achieved. The results obtained were graphically interpreted in terms of field contribution maps. Hence, physicochemical determinants of binding, such as steric and electrostatic and, for the first time, hydrophobic, hydrogen bond donor, and hydrogen bond acceptor properties, were mapped back onto the molecular structures of a set of nAChR modulators. In particular, changes in the binding affinity of the modulators as a result of modifications in the aromatic ring systems could be rationalized by the steric, electrostatic, hydrophobic, and hydrogen bond acceptor properties. These results were used to guide the rational design of new nAChR ligands such as 48-52 and 54, which were subsequently synthesized for the first time and tested. Key steps of our synthetic approaches were successfully applied Stille and Suzuki cross-coupling reactions. Predictive r2 values of 0.614 and 0.660 for CoMFA and CoMSIA, respectively, obtained for 22 in part previously unknown ligands for the (alpha4)2(beta2)3 subtype, demonstrate the high quality of the 3D QSAR models.',\n",
       "               'FAU': ['Gohlke, Holger',\n",
       "                'Schwarz, Simone',\n",
       "                'Gundisch, Daniela',\n",
       "                'Tilotta, Maria Cristina',\n",
       "                'Weber, Alexander',\n",
       "                'Wegge, Thomas',\n",
       "                'Seitz, Gunther'],\n",
       "               'AU': ['Gohlke H',\n",
       "                'Schwarz S',\n",
       "                'Gundisch D',\n",
       "                'Tilotta MC',\n",
       "                'Weber A',\n",
       "                'Wegge T',\n",
       "                'Seitz G'],\n",
       "               'AD': ['Institut fur Pharmazeutische Chemie der Philipps-Universitat Marburg, Marbacher Weg 6, D-35032 Marburg, Germany. gohlke@scripps.edu'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Med Chem',\n",
       "               'JT': 'Journal of medicinal chemistry',\n",
       "               'JID': '9716531',\n",
       "               'RN': ['0 (Alkaloids)',\n",
       "                '0 (Azocines)',\n",
       "                '0 (Bacterial Toxins)',\n",
       "                '0 (Bridged Bicyclo Compounds, Heterocyclic)',\n",
       "                '0 (Cyanobacteria Toxins)',\n",
       "                '0 (Ligands)',\n",
       "                '0 (Marine Toxins)',\n",
       "                '0 (Microcystins)',\n",
       "                '0 (Protein Subunits)',\n",
       "                '0 (Pyridines)',\n",
       "                '0 (Quinolizines)',\n",
       "                '0 (Receptors, Nicotinic)',\n",
       "                '0 (Tropanes)',\n",
       "                '0 (ferruginine)',\n",
       "                '53S5U404NU (cytisine)',\n",
       "                '80023A73NK (anatoxin a)',\n",
       "                'M6K314F1XX (epibatidine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Alkaloids/chemistry',\n",
       "                'Animals',\n",
       "                'Azocines',\n",
       "                'Bacterial Toxins/chemistry',\n",
       "                'Binding, Competitive',\n",
       "                'Bridged Bicyclo Compounds, Heterocyclic/*chemical synthesis/chemistry/pharmacology',\n",
       "                'Cyanobacteria Toxins',\n",
       "                'Drug Design',\n",
       "                'In Vitro Techniques',\n",
       "                'Ligands',\n",
       "                'Marine Toxins/chemistry',\n",
       "                'Microcystins',\n",
       "                'Models, Molecular',\n",
       "                'Prosencephalon/metabolism',\n",
       "                'Protein Subunits',\n",
       "                'Pyridines/chemistry',\n",
       "                'Quantitative Structure-Activity Relationship',\n",
       "                'Quinolizines',\n",
       "                'Radioligand Assay',\n",
       "                'Rats',\n",
       "                'Rats, Sprague-Dawley',\n",
       "                'Receptors, Nicotinic/*metabolism',\n",
       "                'Stereoisomerism',\n",
       "                'Tropanes'],\n",
       "               'EDAT': '2003/05/16 05:00',\n",
       "               'MHDA': '2003/06/24 05:00',\n",
       "               'CRDT': ['2003/05/16 05:00'],\n",
       "               'PHST': ['2003/05/16 05:00 [pubmed]',\n",
       "                '2003/06/24 05:00 [medline]',\n",
       "                '2003/05/16 05:00 [entrez]'],\n",
       "               'AID': ['10.1021/jm020859m [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Med Chem. 2003 May 22;46(11):2031-48. doi: 10.1021/jm020859m.'},\n",
       "              {'PMID': '12536330',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20030605',\n",
       "               'LR': '20161020',\n",
       "               'IS': '1435-2443 (Print) 1435-2443 (Linking)',\n",
       "               'VI': '387',\n",
       "               'IP': '9-10',\n",
       "               'DP': '2003 Jan',\n",
       "               'TI': 'Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients.',\n",
       "               'PG': '348-54',\n",
       "               'AB': 'BACKGROUND: Subtotal parathyroidectomy (SPTX) and total parathyroidectomy with autotransplantation (TPTX and AT) are standard procedures in the treatment of renal autonomous hyperparathyroidism. In contrast to primary hyperparathyroidism, the persistence/recurrence rate is reported of up to 12.0%. PATIENTS AND METHODS: Between 1986 and 2000 we operated on 304 patients with renal autonomous hyperparathyroidism including 14 patients who were admitted after a primary operation in an outside hospital. Mean observation period was 51.4+/-38.9 months. RESULTS: The overall persistence/recurrence rate in our patients was 9.0% (26/290). After SPTX, excluding patients with an incomplete operation, it was 3.7%, and after TPTX and AT it was 6.0%. Reasons for developing recurrent or persistent disease in these patients were removal of less than 3.5 glands ( n=12), hyperplastic autograft ( n=5), and supernumerary gland ( n=4). After the first reoperation 7 patients (26.9%) had persistent or recurrent disease. CONCLUSIONS: An incomplete primary operation caused by missed cervical glands was the major reason for persistent ( n=8) or recurrent ( n=4) disease after different operative strategies in renal autonomous hyperparathyroidism.',\n",
       "               'FAU': ['Dotzenrath, C',\n",
       "                'Cupisti, K',\n",
       "                'Goretzki, E',\n",
       "                'Mondry, A',\n",
       "                'Vossough, A',\n",
       "                'Grabensee, B',\n",
       "                'Roher, H-D'],\n",
       "               'AU': ['Dotzenrath C',\n",
       "                'Cupisti K',\n",
       "                'Goretzki E',\n",
       "                'Mondry A',\n",
       "                'Vossough A',\n",
       "                'Grabensee B',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Department of Surgery, Heinrich Heine University Dusseldorf, Dusseldorf, Germany. dotzenr@uni-duesseldorf.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20021214',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism, Secondary/epidemiology/etiology/*surgery',\n",
       "                'Incidence',\n",
       "                'Kidney Failure, Chronic/*complications',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Parathyroidectomy/adverse effects/*methods',\n",
       "                'Postoperative Complications',\n",
       "                'Recurrence',\n",
       "                'Reoperation',\n",
       "                'Retrospective Studies',\n",
       "                'Risk Assessment',\n",
       "                'Risk Factors',\n",
       "                'Severity of Illness Index',\n",
       "                'Transplantation, Autologous',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '2003/01/22 04:00',\n",
       "               'MHDA': '2003/06/06 05:00',\n",
       "               'CRDT': ['2003/01/22 04:00'],\n",
       "               'PHST': ['2002/02/11 00:00 [received]',\n",
       "                '2002/08/26 00:00 [accepted]',\n",
       "                '2003/01/22 04:00 [pubmed]',\n",
       "                '2003/06/06 05:00 [medline]',\n",
       "                '2003/01/22 04:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00423-002-0322-x [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 2003 Jan;387(9-10):348-54. doi: 10.1007/s00423-002-0322-x. Epub 2002 Dec 14.'}],\n",
       "             '1998': [{'PMID': '14518281',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20031103',\n",
       "               'LR': '20201208',\n",
       "               'IS': '0942-2854 (Print) 0942-2854 (Linking)',\n",
       "               'VI': '115',\n",
       "               'IP': 'Suppl I',\n",
       "               'DP': '1998',\n",
       "               'TI': '[Tumor necrosis factor-alpha (TNF-alpha) gene polymorphism in surgical intensive care patients with SIRS].',\n",
       "               'PG': '387-90',\n",
       "               'AB': 'Biallelic polymorphism in the promotor region of the TNF-alpha gene have been associated with variation in TNF-alpha production. We determined the TNFA polymorphism (position--308) and related these data to plasma cytokine levels of TNF alpha, IL6, IL6R and IL8 in patients with SIRS and sepsis. Although there seems to be a different cytokine secretion pattern for both allelic groups (TNFA1 and TNFA2), a clear risk group could not be determined. It still remains unclear whether there is a genetic factor that influences the development of sepsis and multi organ failure.',\n",
       "               'FAU': ['Dumon, K',\n",
       "                'Rossbach, C',\n",
       "                'Harms, B',\n",
       "                'Gorelov, V',\n",
       "                'Gross-Weege, W',\n",
       "                'Schneider, E M',\n",
       "                'Goretzki, P E',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Dumon K',\n",
       "                'Rossbach C',\n",
       "                'Harms B',\n",
       "                'Gorelov V',\n",
       "                'Gross-Weege W',\n",
       "                'Schneider EM',\n",
       "                'Goretzki PE',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Heinrich-Heine Universitat, Moorenstrasse 5, 40225 Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'TT': 'Tumornekrosefaktor-alpha (TNF-alpha) Gen-Polymorphismus bei chirurgischen Intensivpatienten mit SIRS.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir Suppl Kongressbd',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress',\n",
       "               'JID': '9200456',\n",
       "               'RN': ['0 (Adaptor Proteins, Signal Transducing)',\n",
       "                '0 (Cytokines)',\n",
       "                '0 (Proteins)',\n",
       "                '0 (TNFAIP1 protein, human)',\n",
       "                '0 (TNFAIP2 protein, human)',\n",
       "                '0 (Tumor Necrosis Factor-alpha)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adaptor Proteins, Signal Transducing',\n",
       "                'Alleles',\n",
       "                '*Critical Care',\n",
       "                'Cytokines/blood/genetics',\n",
       "                'Enzyme-Linked Immunosorbent Assay',\n",
       "                'Gene Frequency/genetics',\n",
       "                'Genetic Carrier Screening',\n",
       "                'Homozygote',\n",
       "                'Humans',\n",
       "                'Polymorphism, Genetic/*genetics',\n",
       "                'Prognosis',\n",
       "                'Promoter Regions, Genetic/genetics',\n",
       "                'Proteins/genetics',\n",
       "                'Shock, Septic/genetics/immunology',\n",
       "                'Systemic Inflammatory Response Syndrome/*genetics/immunology',\n",
       "                'Tumor Necrosis Factor-alpha/*genetics'],\n",
       "               'EDAT': '2003/10/02 05:00',\n",
       "               'MHDA': '2003/11/05 05:00',\n",
       "               'CRDT': ['2003/10/02 05:00'],\n",
       "               'PHST': ['2003/10/02 05:00 [pubmed]',\n",
       "                '2003/11/05 05:00 [medline]',\n",
       "                '2003/10/02 05:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir Suppl Kongressbd. 1998;115(Suppl I):387-90.'},\n",
       "              {'PMID': '9931912',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19990407',\n",
       "               'LR': '20161124',\n",
       "               'IS': '0942-2854 (Print) 0942-2854 (Linking)',\n",
       "               'VI': '115',\n",
       "               'DP': '1998',\n",
       "               'TI': '[Protein expression of hMSH2 and hMLH1 in HNPCC: evaluation of a prescreening method].',\n",
       "               'PG': '1461-3',\n",
       "               'AB': 'We show that immunohistochemistry for hMSH2 and hMLH1 is an easy and reproducible routine procedure. The interpretation of the staining results is unequivocal and investigator-independent. It is now necessary to validate the specificity and sensitivity of the method in a multicenter study with tumors of known mutations. As a consequence perhaps MIN testing may be replaced by immunohistochemistry as a first-line pretesting for HNPCC, reducing cost and time required.',\n",
       "               'FAU': ['Vossen, S',\n",
       "                'Moslein, G',\n",
       "                'Katzer, M',\n",
       "                'Gabbert, H E',\n",
       "                'Muller, W',\n",
       "                'Wirtz, C',\n",
       "                'Goretzki, P E',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Vossen S',\n",
       "                'Moslein G',\n",
       "                'Katzer M',\n",
       "                'Gabbert HE',\n",
       "                'Muller W',\n",
       "                'Wirtz C',\n",
       "                'Goretzki PE',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Abteilung fur Allgemeine und Unfallchirurgie, Heinrich-Heine-Universitat, Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'TT': 'Untersuchung der Proteinexpression von hMSH2 und hMLH1 bei HNPCC: Evaluation einer Prescreening-Methode.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir Suppl Kongressbd',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress',\n",
       "               'JID': '9200456',\n",
       "               'RN': ['0 (Adaptor Proteins, Signal Transducing)',\n",
       "                '0 (Carrier Proteins)',\n",
       "                '0 (DNA-Binding Proteins)',\n",
       "                '0 (MLH1 protein, human)',\n",
       "                '0 (Neoplasm Proteins)',\n",
       "                '0 (Nuclear Proteins)',\n",
       "                '0 (Proto-Oncogene Proteins)',\n",
       "                'EC 3.6.1.3 (MSH2 protein, human)',\n",
       "                'EC 3.6.1.3 (MutL Protein Homolog 1)',\n",
       "                'EC 3.6.1.3 (MutS Homolog 2 Protein)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adaptor Proteins, Signal Transducing',\n",
       "                'Adult',\n",
       "                'Carrier Proteins',\n",
       "                '*DNA-Binding Proteins',\n",
       "                'Female',\n",
       "                '*Genetic Testing',\n",
       "                'Humans',\n",
       "                'Immunoenzyme Techniques',\n",
       "                'Male',\n",
       "                'MutL Protein Homolog 1',\n",
       "                'MutS Homolog 2 Protein',\n",
       "                'Neoplasm Proteins/*genetics',\n",
       "                'Nuclear Proteins',\n",
       "                'Proto-Oncogene Proteins/*genetics',\n",
       "                'Sensitivity and Specificity'],\n",
       "               'EDAT': '1999/02/05 00:00',\n",
       "               'MHDA': '1999/02/05 00:01',\n",
       "               'CRDT': ['1999/02/05 00:00'],\n",
       "               'PHST': ['1999/02/05 00:00 [pubmed]',\n",
       "                '1999/02/05 00:01 [medline]',\n",
       "                '1999/02/05 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir Suppl Kongressbd. 1998;115:1461-3.'},\n",
       "              {'PMID': '9931786',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19990407',\n",
       "               'LR': '20080220',\n",
       "               'IS': '0942-2854 (Print) 0942-2854 (Linking)',\n",
       "               'VI': '115',\n",
       "               'DP': '1998',\n",
       "               'TI': '[Surgical procedure for hyperthyroidism in children and adolescents].',\n",
       "               'PG': '1048-50',\n",
       "               'AB': 'The high recurrence rate of hyperthyroidism after drug therapy in Graves disease and the high incidence of differentiated thyroid cancer in autonomously functioning thyroid nodules are the most common indications for surgical treatment in children and adolescents (less than 18 years old). Between April 1986 and March 1998, 101 adolescents were operated on: 24 children (23.8%) for Graves disease, 9 adolescents (8.9%) for autonomously functioning thyroid nodules. Surgery for hyperthyroidism is recommended in children and adolescents because of the low morbidity, the guarantee that this approach will successfully treat hyperthyroidism and the necessity for histological exploration.',\n",
       "               'FAU': ['Witte, J', 'Goretzki, P E', 'Roher, H D'],\n",
       "               'AU': ['Witte J', 'Goretzki PE', 'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemeine und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Operatives Vorgehen bei Hyperthyreosen von Kindern und Jugendlichen.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir Suppl Kongressbd',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress',\n",
       "               'JID': '9200456',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Child',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperthyroidism/pathology/*surgery',\n",
       "                'Male',\n",
       "                'Precancerous Conditions/pathology/*surgery',\n",
       "                'Prognosis',\n",
       "                'Thyroid Gland/pathology',\n",
       "                '*Thyroidectomy'],\n",
       "               'EDAT': '1999/02/05 00:00',\n",
       "               'MHDA': '1999/02/05 00:01',\n",
       "               'CRDT': ['1999/02/05 00:00'],\n",
       "               'PHST': ['1999/02/05 00:00 [pubmed]',\n",
       "                '1999/02/05 00:01 [medline]',\n",
       "                '1999/02/05 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir Suppl Kongressbd. 1998;115:1048-50.'},\n",
       "              {'PMID': '9931619',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19990407',\n",
       "               'LR': '20080220',\n",
       "               'IS': '0942-2854 (Print) 0942-2854 (Linking)',\n",
       "               'VI': '115',\n",
       "               'DP': '1998',\n",
       "               'TI': '[Pelvic exenteration from the surgical viewpoint].',\n",
       "               'PG': '246-9',\n",
       "               'AB': 'Pelvic exenteration (PE) is associated with specific problems in the indication of excision and reconstructive surgery. Indication are colorectal cancer or cervical cancer recurrence. In each case intensive and early cooperation of gynecologist, surgeon and urologist is warranted. Thus, PE is indicated in some T3 N1 and T4 rectal carcinoma patients without distant metastases and may be superior to chemotherapy. In cervix carcinoma recurrence, PE with or without intestinal reconstruction is of specific importance. While intestinal reconstruction may improve the quality of life in R0 resected patients we reluctantly perform this in noncurative treated patients, since their expected survival time is limited and reconstructive surgery in these pretreated patients (radiation and surgery) increases the risk of morbidity.',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Goebell, P J',\n",
       "                'Vogel, T',\n",
       "                'Schnurch, H G',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Goretzki PE',\n",
       "                'Goebell PJ',\n",
       "                'Vogel T',\n",
       "                'Schnurch HG',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie und Klinik fur Frauenheilkunde, Heinriche-Heine Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Die pelvine Exenteration aus chirurgischer Sicht.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir Suppl Kongressbd',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress',\n",
       "               'JID': '9200456',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Anastomosis, Surgical',\n",
       "                'Colorectal Neoplasms/mortality/pathology/*surgery',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Middle Aged',\n",
       "                'Neoplasm Recurrence, Local/mortality/pathology/*surgery',\n",
       "                'Neoplasm Staging',\n",
       "                '*Patient Care Team',\n",
       "                '*Pelvic Exenteration',\n",
       "                'Prognosis',\n",
       "                'Reoperation',\n",
       "                'Survival Rate',\n",
       "                'Uterine Cervical Neoplasms/mortality/pathology/*surgery'],\n",
       "               'EDAT': '1999/02/05 00:00',\n",
       "               'MHDA': '1999/02/05 00:01',\n",
       "               'CRDT': ['1999/02/05 00:00'],\n",
       "               'PHST': ['1999/02/05 00:00 [pubmed]',\n",
       "                '1999/02/05 00:01 [medline]',\n",
       "                '1999/02/05 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir Suppl Kongressbd. 1998;115:246-9.'},\n",
       "              {'PMID': '9931611',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19990407',\n",
       "               'LR': '20080220',\n",
       "               'IS': '0942-2854 (Print) 0942-2854 (Linking)',\n",
       "               'VI': '115',\n",
       "               'DP': '1998',\n",
       "               'TI': '[Geographical differences of thyroid carcinoma and basic molecular principles].',\n",
       "               'PG': '200-2',\n",
       "               'AB': 'Geographical differences have been demonstrated for the cancer incidence and histology of differentiated thyroid cancer. Iodine intake and specific external noxes, such as nitrosamine ingestion or external radiation are important factors. It is still questionable whether histologically identical differentiated thyroid cancers are prognostically different in low and rich iodine areas. Despite increased knowledge of molecular and genetic changes in differentiated cancer, the present therapy is primarily related to patient age, tumor stage and histology.',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Witte, J',\n",
       "                'Dotzenrath, C',\n",
       "                'Schulte, K M',\n",
       "                'Simon, D',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Goretzki PE',\n",
       "                'Witte J',\n",
       "                'Dotzenrath C',\n",
       "                'Schulte KM',\n",
       "                'Simon D',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Heinrich-Heine Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Geographische Differenzen des Schilddrusenkarzinoms und molekulare Grundlagen.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir Suppl Kongressbd',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress',\n",
       "               'JID': '9200456',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Cell Transformation, Neoplastic/genetics',\n",
       "                'Germany',\n",
       "                'Goiter, Endemic/complications/*epidemiology/genetics',\n",
       "                'Humans',\n",
       "                'Prognosis',\n",
       "                'Risk Factors',\n",
       "                'Thyroid Gland/pathology',\n",
       "                'Thyroid Neoplasms/*epidemiology/etiology/genetics'],\n",
       "               'EDAT': '1999/02/05 00:00',\n",
       "               'MHDA': '1999/02/05 00:01',\n",
       "               'CRDT': ['1999/02/05 00:00'],\n",
       "               'PHST': ['1999/02/05 00:00 [pubmed]',\n",
       "                '1999/02/05 00:01 [medline]',\n",
       "                '1999/02/05 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir Suppl Kongressbd. 1998;115:200-2.'},\n",
       "              {'PMID': '9841744',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19990104',\n",
       "               'LR': '20211203',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '22',\n",
       "               'IP': '12',\n",
       "               'DP': '1998 Dec',\n",
       "               'TI': 'Genetic and biochemical screening for endocrine disease.',\n",
       "               'PG': '1202-7',\n",
       "               'AB': 'The development of biochemical and genetic screening tests for inherited endocrine diseases has dramatically changed our approach to surgical patients with endocrine tumors. Among more than 1800 patients with endocrine tumors and a possible inherited disease operated on between 1986 and 1997, there were 6.1% to 7.3% who were found to have a familial disease associated with familial medullary thyroid cancer, (MTC), multiple endocrine neoplasia type IIa (MEN-IIa), MEN-IIb, or MEN-I. Genetic testing for the RET proto-oncogene is therefore recommended for all patients with MTC, and testing for the MEN-I gene is recommended in patients with suspected MEN-I and in specific clinical subgroups with an increased probability of endocrine tumor heredity. Early treatment based on early diagnosis by genetic testing appears to improve survival and to decrease morbidity in these patients.',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Hoppner, W',\n",
       "                'Dotzenrath, C',\n",
       "                'Clark, O H',\n",
       "                'Simon, D',\n",
       "                'Cupisti, K',\n",
       "                'Schulte, H',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Goretzki PE',\n",
       "                'Hoppner W',\n",
       "                'Dotzenrath C',\n",
       "                'Clark OH',\n",
       "                'Simon D',\n",
       "                'Cupisti K',\n",
       "                'Schulte H',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Chirurgische Klinik A, Heinrich-Heine-Universitat Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'RN': ['0 (Biomarkers)',\n",
       "                '0 (MAS1 protein, human)',\n",
       "                '0 (Proto-Oncogene Mas)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Biomarkers',\n",
       "                'Endocrine System Diseases/*diagnosis',\n",
       "                '*Genetic Testing',\n",
       "                'Humans',\n",
       "                'Multiple Endocrine Neoplasia Type 1/*diagnosis',\n",
       "                'Multiple Endocrine Neoplasia Type 2a/*diagnosis',\n",
       "                'Pedigree',\n",
       "                'Proto-Oncogene Mas',\n",
       "                'Thyroid Neoplasms/diagnosis'],\n",
       "               'EDAT': '1998/12/05 00:00',\n",
       "               'MHDA': '1998/12/05 00:01',\n",
       "               'CRDT': ['1998/12/05 00:00'],\n",
       "               'PHST': ['1998/12/05 00:00 [pubmed]',\n",
       "                '1998/12/05 00:01 [medline]',\n",
       "                '1998/12/05 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/s002689900545 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 1998 Dec;22(12):1202-7. doi: 10.1007/s002689900545.'},\n",
       "              {'PMID': '9820815',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19990126',\n",
       "               'LR': '20190501',\n",
       "               'IS': '0264-6021 (Print) 1470-8728 (Electronic) 0264-6021 (Linking)',\n",
       "               'VI': '336 ( Pt 2)',\n",
       "               'IP': 'Pt 2',\n",
       "               'DP': '1998 Dec 1',\n",
       "               'TI': 'Low-density-lipoprotein-receptor-related protein (LRP) interacts with a GTP-binding protein.',\n",
       "               'PG': '381-6',\n",
       "               'AB': 'The low-density-lipoprotein-receptor-related protein (LRP) binds and internalizes numerous ligands, including lipoproteins, proteinase-inhibitor complexes and others. We have shown previously that LRP-mediated ligand internalization is dependent on cAMP-dependent protein kinase (PKA) activity. Here, we investigated whether ligation of LRP increases the intracellular cAMP level and PKA activity via a stimulatory GTP-binding protein. Treatment of LRP-expressing cell lines with the LRP ligands lactoferrin or urokinase-type plasminogen activator caused a significant elevation in cAMP and stimulated PKA activity in a dose-dependent manner. Addition of the 39 kDa receptor-associated protein (RAP), an antagonist for ligand interactions with LRP, blocked the lactoferrin-induced increase in PKA activity, demonstrating a requirement for ligand binding to LRP. Incubation of cell membrane fractions with lactoferrin increased GTPase activity in a time- and dose-dependent manner, and treatment with LRP ligands suppressed cholera-toxin-mediated ADP-ribosylation of the Gsalpha subunit of a heterotrimeric G-protein. Affinity precipitation of LRP with RAP resulted in co-precipitation of two isoforms of Gsalpha from detergent extracts. We thus conclude that LRP is a signalling receptor that associates directly with a stimulatory heterotrimeric G-protein and activates a downstream PKA-dependent pathway.',\n",
       "               'FAU': ['Goretzki, L', 'Mueller, B M'],\n",
       "               'AU': ['Goretzki L', 'Mueller BM'],\n",
       "               'AD': ['The Scripps Research Institute, Department of Immunology, 10550 N. Torrey Pines Road, IMM13, La Jolla, CA 92037, USA.'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['CA59692/CA/NCI NIH HHS/United States'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                \"Research Support, U.S. Gov't, P.H.S.\"],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Biochem J',\n",
       "               'JT': 'The Biochemical journal',\n",
       "               'JID': '2984726R',\n",
       "               'RN': ['0 (Low Density Lipoprotein Receptor-Related Protein-1)',\n",
       "                '0 (Plasminogen Activator Inhibitor 1)',\n",
       "                '0 (Receptors, Immunologic)',\n",
       "                '9012-63-9 (Cholera Toxin)',\n",
       "                'E0399OZS9N (Cyclic AMP)',\n",
       "                'EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases)',\n",
       "                'EC 3.4.21.- (Lactoferrin)',\n",
       "                'EC 3.6.1.- (GTP Phosphohydrolases)',\n",
       "                'EC 3.6.1.- (GTP-Binding Proteins)',\n",
       "                'EC 3.6.5.1 (GTP-Binding Protein alpha Subunits, Gs)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Cholera Toxin/pharmacology',\n",
       "                'Cyclic AMP/metabolism',\n",
       "                'Cyclic AMP-Dependent Protein Kinases/drug effects/metabolism',\n",
       "                'GTP Phosphohydrolases/metabolism',\n",
       "                'GTP-Binding Protein alpha Subunits, Gs/metabolism',\n",
       "                'GTP-Binding Proteins/drug effects/*metabolism',\n",
       "                'Humans',\n",
       "                'Lactoferrin/pharmacology',\n",
       "                'Low Density Lipoprotein Receptor-Related Protein-1',\n",
       "                'Plasminogen Activator Inhibitor 1/pharmacology',\n",
       "                'Receptors, Immunologic/drug effects/genetics/*metabolism',\n",
       "                'Signal Transduction'],\n",
       "               'PMC': 'PMC1219882',\n",
       "               'EDAT': '1998/11/20 00:00',\n",
       "               'MHDA': '1998/11/20 00:01',\n",
       "               'PMCR': ['1999/06/01'],\n",
       "               'CRDT': ['1998/11/20 00:00'],\n",
       "               'PHST': ['1998/11/20 00:00 [pubmed]',\n",
       "                '1998/11/20 00:01 [medline]',\n",
       "                '1998/11/20 00:00 [entrez]',\n",
       "                '1999/06/01 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1042/bj3360381 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Biochem J. 1998 Dec 1;336 ( Pt 2)(Pt 2):381-6. doi: 10.1042/bj3360381.'},\n",
       "              {'PMID': '9808321',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19990105',\n",
       "               'LR': '20090219',\n",
       "               'IS': '0018-5043 (Print) 0018-5043 (Linking)',\n",
       "               'VI': '30',\n",
       "               'IP': '9',\n",
       "               'DP': '1998 Sep',\n",
       "               'TI': 'Rare loss of heterozygosity of the MTS1 and MTS2 tumor suppressor genes in differentiated human thyroid cancer.',\n",
       "               'PG': '549-54',\n",
       "               'AB': \"Loss of heterozygosity (LOH) of the MTS1 (p16) tumor suppressor gene has been reported to occur frequently in thyroid cancer cell lines. In order to determine the frequency of LOH for these multiple tumor suppressor genes, we used microsatellite markers IFNA and D9S171 to perform differential quantitative polymerase chain reaction. Tumor DNA was isolated from native sections of tumor tissue. Control DNA was isolated from blood. PCR products were separated on 6% polyacrylamide sequencing gels and quantified according to peak height and area. Analysis was informative in 70% of cases for both markers, and in 88% for at least one out of both. LOH was found in 3 out of 35 informative patients (8.6%) with papillary thyroid cancer, in 1 out of 7 patients with follicular thyroid cancer (14.2%), and in 0 out of 18 medullary cancers (0%). No LOH was found in 11 informative patients with multinodular goitre, 7 with follicular adenoma, 4 with Graves' disease, and 6 with other thyroid disease. 75% of LOH was found in T1 and T2 stages, it was not more frequent in patients with lymphonodular metastasis. The low frequency of LOH in these types of thyroid cancer argues against a role of loss of heterozygosity at the MTS 1 and 2 gene locus in the development of differentiated thyroid neoplasia.\",\n",
       "               'FAU': ['Schulte, K M',\n",
       "                'Staudt, S',\n",
       "                'Niederacher, D',\n",
       "                'Finken-Eigen, M',\n",
       "                'Kohrer, K',\n",
       "                'Goretzki, P E',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Schulte KM',\n",
       "                'Staudt S',\n",
       "                'Niederacher D',\n",
       "                'Finken-Eigen M',\n",
       "                'Kohrer K',\n",
       "                'Goretzki PE',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Dept. of General and Trauma Surgery, Heinrich Heine University, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Horm Metab Res',\n",
       "               'JT': 'Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme',\n",
       "               'JID': '0177722',\n",
       "               'RN': ['0 (CDKN2B protein, human)',\n",
       "                '0 (Carrier Proteins)',\n",
       "                '0 (Cell Cycle Proteins)',\n",
       "                '0 (Cyclin-Dependent Kinase Inhibitor p15)',\n",
       "                '0 (Cyclin-Dependent Kinase Inhibitor p16)',\n",
       "                '0 (DNA, Neoplasm)',\n",
       "                '0 (DNA, Satellite)',\n",
       "                '0 (Enzyme Inhibitors)',\n",
       "                '0 (Tumor Suppressor Proteins)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/*genetics/metabolism',\n",
       "                'Alleles',\n",
       "                'Carcinoma, Papillary, Follicular/genetics/metabolism',\n",
       "                'Carrier Proteins/*genetics',\n",
       "                '*Cell Cycle Proteins',\n",
       "                'Cell Differentiation/genetics',\n",
       "                'Cyclin-Dependent Kinase Inhibitor p15',\n",
       "                'Cyclin-Dependent Kinase Inhibitor p16/*genetics',\n",
       "                'DNA, Neoplasm/analysis',\n",
       "                'DNA, Satellite/analysis',\n",
       "                'Enzyme Inhibitors/*metabolism',\n",
       "                'Gene Expression Regulation, Enzymologic',\n",
       "                'Gene Expression Regulation, Neoplastic',\n",
       "                'Genes, Tumor Suppressor/*physiology',\n",
       "                'Heterozygote',\n",
       "                'Humans',\n",
       "                'Thyroid Neoplasms/*genetics/metabolism',\n",
       "                '*Tumor Suppressor Proteins'],\n",
       "               'EDAT': '1998/11/10 00:00',\n",
       "               'MHDA': '1998/11/10 00:01',\n",
       "               'CRDT': ['1998/11/10 00:00'],\n",
       "               'PHST': ['1998/11/10 00:00 [pubmed]',\n",
       "                '1998/11/10 00:01 [medline]',\n",
       "                '1998/11/10 00:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-2007-978930 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Horm Metab Res. 1998 Sep;30(9):549-54. doi: 10.1055/s-2007-978930.'},\n",
       "              {'PMID': '9792464',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19990108',\n",
       "               'LR': '20161124',\n",
       "               'IS': '0947-7349 (Print) 0947-7349 (Linking)',\n",
       "               'VI': '106',\n",
       "               'IP': '4',\n",
       "               'DP': '1998',\n",
       "               'TI': 'Regulation of the HGF-receptor c-met in the thyroid gland.',\n",
       "               'PG': '310-8',\n",
       "               'AB': 'HGF (hepatocyte growth factor) has been characterised as an important mitogen and motogen in many epithelial cells. The biological and clinical significance of HGF and its receptor c-met in the thyroid is currently under study. Overexpression of c-met is an important feature of papillary thyroid cancer. We developed a quantitative differential RT-PCR method in order to examine HGF-receptor regulation using RNA of about 50 cells per analysis. Experiments were performed in three spontaneously transformed follicular thyroid cancer (FTC) cell lines FTC-133, 236, and 238, 7 primary cultures derived from multinodular goitres, one from Graves disease and 1 from papillary thyroid cancer (PTC). TGF-alpha and to a minor degree HGF were shown to induce a marked up-regulation of the receptor whereas bovine TSH, NaI, dbcAMP or basic FGF had no apparent effect. We conclude that expression of the HGF-receptor is under control of paracrine growth factors activating tyrosine-kinase-dependent pathways. We could demonstrate a minor stimulation of thyroid cell proliferation by HGF in presence but not in absence of 10% fetal calf serum.',\n",
       "               'FAU': ['Schulte, K M',\n",
       "                'Antoch, G',\n",
       "                'Ellrichmann, M',\n",
       "                'Finken-Eigen, M',\n",
       "                'Kohrer, K',\n",
       "                'Simon, D',\n",
       "                'Goretzki, P E',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Schulte KM',\n",
       "                'Antoch G',\n",
       "                'Ellrichmann M',\n",
       "                'Finken-Eigen M',\n",
       "                'Kohrer K',\n",
       "                'Simon D',\n",
       "                'Goretzki PE',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Dept. for General and Trauma Surgery, Heinrich Heine University, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Exp Clin Endocrinol Diabetes',\n",
       "               'JT': 'Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association',\n",
       "               'JID': '9505926',\n",
       "               'RN': ['0 (Culture Media)',\n",
       "                '0 (Growth Substances)',\n",
       "                '0 (Receptors, Cell Surface)',\n",
       "                '67256-21-7 (Hepatocyte Growth Factor)',\n",
       "                '9007-49-2 (DNA)',\n",
       "                'EC 2.7.10.1 (RON protein)',\n",
       "                'EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Carcinoma, Papillary/metabolism',\n",
       "                'Cells, Cultured',\n",
       "                'Culture Media',\n",
       "                'DNA/biosynthesis',\n",
       "                'Female',\n",
       "                'Goiter/metabolism',\n",
       "                'Growth Substances/pharmacology',\n",
       "                'Hepatocyte Growth Factor/*metabolism',\n",
       "                'Humans',\n",
       "                'Immunohistochemistry',\n",
       "                'Kinetics',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Receptor Protein-Tyrosine Kinases/*biosynthesis',\n",
       "                'Receptors, Cell Surface/*biosynthesis',\n",
       "                'Reverse Transcriptase Polymerase Chain Reaction',\n",
       "                'Thyroid Gland/*metabolism',\n",
       "                'Thyroid Neoplasms/metabolism'],\n",
       "               'EDAT': '1998/10/29 00:00',\n",
       "               'MHDA': '1998/10/29 00:01',\n",
       "               'CRDT': ['1998/10/29 00:00'],\n",
       "               'PHST': ['1998/10/29 00:00 [pubmed]',\n",
       "                '1998/10/29 00:01 [medline]',\n",
       "                '1998/10/29 00:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-0029-1211991 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Exp Clin Endocrinol Diabetes. 1998;106(4):310-8. doi: 10.1055/s-0029-1211991.'},\n",
       "              {'PMID': '9677513',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19981001',\n",
       "               'LR': '20191024',\n",
       "               'IS': '0020-9554 (Print) 0020-9554 (Linking)',\n",
       "               'VI': '39',\n",
       "               'IP': '6',\n",
       "               'DP': '1998 Jun',\n",
       "               'TI': '[Significance of oncogenes in development and prognosis of differentiated thyroid gland carcinomas].',\n",
       "               'PG': '584-7',\n",
       "               'FAU': ['Goretzki, P E', 'Schulte, K M'],\n",
       "               'AU': ['Goretzki PE', 'Schulte KM'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Heinrich-Heine-Universitat, Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'TT': 'Bedeutung von Onkogenen in Entstehung und Prognose von differenzierten Schilddrusenkarzinomen.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Internist (Berl)',\n",
       "               'JT': 'Der Internist',\n",
       "               'JID': '0264620',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma, Papillary/genetics',\n",
       "                'Carcinoma/genetics',\n",
       "                'Cell Transformation, Neoplastic/*genetics',\n",
       "                'DNA Mutational Analysis',\n",
       "                'Gene Expression Regulation, Neoplastic/physiology',\n",
       "                'Genes, Tumor Suppressor/genetics',\n",
       "                'Humans',\n",
       "                'Oncogenes/*genetics',\n",
       "                'Thyroid Neoplasms/*genetics',\n",
       "                'Tumor Cells, Cultured'],\n",
       "               'RF': '41',\n",
       "               'EDAT': '1998/07/25 00:00',\n",
       "               'MHDA': '1998/07/25 00:01',\n",
       "               'CRDT': ['1998/07/25 00:00'],\n",
       "               'PHST': ['1998/07/25 00:00 [pubmed]',\n",
       "                '1998/07/25 00:01 [medline]',\n",
       "                '1998/07/25 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/s001080050215 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Internist (Berl). 1998 Jun;39(6):584-7. doi: 10.1007/s001080050215.'},\n",
       "              {'PMID': '9673563',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19980807',\n",
       "               'LR': '20190826',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '22',\n",
       "               'IP': '8',\n",
       "               'DP': '1998 Aug',\n",
       "               'TI': 'Therapeutic management of rare malignant pancreatic tumors in children.',\n",
       "               'PG': '879-82',\n",
       "               'AB': 'Malignant pancreatic tumors in children are rare. The major problem for the clinician is a lack of experience and of accepted therapeutic strategies. Malignant pancreatic tumors in children show a pattern different from that in adults. In infants, especially pancreatoblastomas, solid cystic tumors of females, and endocrine carcinomas of the pancreas must be expected. We report our experience in three patients with malignant pancreatic tumors (one pancreatoblastoma and two malignant endocrine pancreatic carcinomas) and review the present literature with a focus on the typical clinical and biologic features and the presently recommended therapeutic strategies. Pancreatoblastomas and solid cystic tumors are mainly found in the head of the pancreas. Fibrotic capsules with rare, late metastases are characteristics of these tumors, indicating total resection to be an important therapeutic procedure. Pancreatoblastomas should additionally be treated with chemotherapy (ADM, IFO, cis-PL, VP16). Endocrine carcinomas of the pancreas (malignant gastrinomas and malignant insulinomas) should also primarily be treated with radical surgery, including extensive lymph node dissection. In case of distant metastases, local resection (liver) or somatostatin in combination with chemotherapy (streptozocin in the case of malignant insulinomas) may be used.',\n",
       "               'FAU': ['Vossen, S',\n",
       "                'Goretzki, P E',\n",
       "                'Goebel, U',\n",
       "                'Willnow, U'],\n",
       "               'AU': ['Vossen S', 'Goretzki PE', 'Goebel U', 'Willnow U'],\n",
       "               'AD': ['Department of General and Pediatric Surgery, Heinrich-Heine-Universitat, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports', 'Journal Article', 'Review'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Child, Preschool',\n",
       "                'Combined Modality Therapy',\n",
       "                'Fatal Outcome',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                'Insulinoma/pathology/*therapy',\n",
       "                'Male',\n",
       "                'Pancreatic Neoplasms/pathology/*therapy'],\n",
       "               'RF': '32',\n",
       "               'EDAT': '1998/07/23 00:00',\n",
       "               'MHDA': '1998/07/23 00:01',\n",
       "               'CRDT': ['1998/07/23 00:00'],\n",
       "               'PHST': ['1998/07/23 00:00 [pubmed]',\n",
       "                '1998/07/23 00:01 [medline]',\n",
       "                '1998/07/23 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/s002689900486 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 1998 Aug;22(8):879-82. doi: 10.1007/s002689900486.'},\n",
       "              {'PMID': '9633109',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19980710',\n",
       "               'LR': '20181113',\n",
       "               'IS': '0962-8452 (Print) 1471-2954 (Electronic) 0962-8452 (Linking)',\n",
       "               'VI': '265',\n",
       "               'IP': '1399',\n",
       "               'DP': '1998 May 22',\n",
       "               'TI': 'Chance and risk of controlling rabies in large-scale and long-term immunized fox populations.',\n",
       "               'PG': '839-46',\n",
       "               'AB': 'The large-scale immunization of European fox populations against rabies is currently under the microscope for reducing the considerable expenditure without putting public health at risk. Empirical knowledge is inadequate to interpret the lasting sporadic incidences and, therefore, to verify the final success of the immunization campaigns. By using a proven simulation model we show that rabies can persist on a very low level in the form of spatio-temporal moving infection clusters within a highly immunized fox population. We found further: (i) the existence of a threshold after which the chance of eradicating the disease by vaccination increases clearly, and (ii) that at least six years of 70% mean immunization rate are required to guarantee a likely success.',\n",
       "               'FAU': ['Tischendorf, L',\n",
       "                'Thulke, H H',\n",
       "                'Staubach, C',\n",
       "                'Muller, M S',\n",
       "                'Jeltsch, F',\n",
       "                'Goretzki, J',\n",
       "                'Selhorst, T',\n",
       "                'Muller, T',\n",
       "                'Schluter, H',\n",
       "                'Wissel, C'],\n",
       "               'AU': ['Tischendorf L',\n",
       "                'Thulke HH',\n",
       "                'Staubach C',\n",
       "                'Muller MS',\n",
       "                'Jeltsch F',\n",
       "                'Goretzki J',\n",
       "                'Selhorst T',\n",
       "                'Muller T',\n",
       "                'Schluter H',\n",
       "                'Wissel C'],\n",
       "               'AD': ['Department of Ecological Modelling, Centre for Environmental Research Ltd., Leipzig, Germany. luti@oesa.ufz.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Proc Biol Sci',\n",
       "               'JT': 'Proceedings. Biological sciences',\n",
       "               'JID': '101245157',\n",
       "               'RN': ['0 (Rabies Vaccines)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Animals',\n",
       "                'Computer Simulation',\n",
       "                '*Foxes',\n",
       "                'Models, Immunological',\n",
       "                'Rabies/prevention & control/*veterinary',\n",
       "                'Rabies Vaccines/*administration & dosage',\n",
       "                'Time Factors'],\n",
       "               'PMC': 'PMC1689058',\n",
       "               'EDAT': '1998/06/20 00:00',\n",
       "               'MHDA': '1998/06/20 00:01',\n",
       "               'PMCR': ['2000/05/22'],\n",
       "               'CRDT': ['1998/06/20 00:00'],\n",
       "               'PHST': ['1998/06/20 00:00 [pubmed]',\n",
       "                '1998/06/20 00:01 [medline]',\n",
       "                '1998/06/20 00:00 [entrez]',\n",
       "                '2000/05/22 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1098/rspb.1998.0368 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Proc Biol Sci. 1998 May 22;265(1399):839-46. doi: 10.1098/rspb.1998.0368.'},\n",
       "              {'PMID': '9606279',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19980713',\n",
       "               'LR': '20190826',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '22',\n",
       "               'IP': '7',\n",
       "               'DP': '1998 Jul',\n",
       "               'TI': 'Reoperative surgery for organic hyperinsulinism: indications and operative strategy.',\n",
       "               'PG': '666-71; discussion 671-2',\n",
       "               'AB': 'Organic hyperinsulinism has a good chance of cure by operation, although patients with diffuse or multiple disease run a high risk of recurrence or persistence of disease. Surgical management and outcome in these patients are presented and discussed. Between 1986 and April 1997 a total of 62 patients were operated on for organic hyperinsulinism [solitary 48, multiple 3, multiple endocrine neoplasia type I (MEN-I) 2, diffuse 4, malignant 5]. Persistence or recurrence occurred in 10 patients (16%). Among the six that persisted, four were malignant and two benign. All four of those that recurred were benign. Patients with benign disease presented with multiple tumors (n = 3), MEN-I syndrome (n = 1), and diffuse/nodular hyperplasia (n = 2). The duration between diagnosis and reintervention ranged from 1 to 10 years. Preoperative diagnosis was able to localize tumors in three patients (computed tomography 1, angiography 2, calcium stimulation 1). Operative procedures were multiple enucleations in two patients with sporadic disease, subtotal resection plus enucleation in the case of MEN-I syndrome, subtotal resection for diffuse hyperplasia, left resection for adenomatosis, and tumor extirpation after multiple previous operations. Long-term clinical and biochemical cure was achieved in five of six patients (mean follow-up 5 years). Octreotide therapy shows good symptomatic control in the patient with operative failure. Reintervention for organic hyperinsulinism is successful (80% cure) and requires preoperative imaging and individual surgical management.',\n",
       "               'FAU': ['Simon, D',\n",
       "                'Starke, A',\n",
       "                'Goretzki, P E',\n",
       "                'Roeher, H D'],\n",
       "               'AU': ['Simon D', 'Starke A', 'Goretzki PE', 'Roeher HD'],\n",
       "               'AD': ['Department of Surgery, Heinrich Heine University, Moorenstrasse 5, D-40225 Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports', 'Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Child',\n",
       "                'Child, Preschool',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperinsulinism/*etiology/*surgery',\n",
       "                'Insulinoma/*complications',\n",
       "                'Male',\n",
       "                'Methods',\n",
       "                'Middle Aged',\n",
       "                'Multiple Endocrine Neoplasia Type 1/*complications',\n",
       "                'Pancreatic Neoplasms/*complications',\n",
       "                'Recurrence',\n",
       "                'Reoperation'],\n",
       "               'EDAT': '1998/06/20 00:00',\n",
       "               'MHDA': '1998/06/20 00:01',\n",
       "               'CRDT': ['1998/06/20 00:00'],\n",
       "               'PHST': ['1998/06/20 00:00 [pubmed]',\n",
       "                '1998/06/20 00:01 [medline]',\n",
       "                '1998/06/20 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/s002689900450 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 1998 Jul;22(7):666-71; discussion 671-2. doi: 10.1007/s002689900450.'},\n",
       "              {'PMID': '9597930',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19980630',\n",
       "               'LR': '20190826',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '22',\n",
       "               'IP': '6',\n",
       "               'DP': '1998 Jun',\n",
       "               'TI': 'Redifferentiation therapy with retinoids: therapeutic option for advanced follicular and papillary thyroid carcinoma.',\n",
       "               'PG': '569-74',\n",
       "               'AB': 'During the course of tumor progression the differentiated morphologic and functional characteristics of differentiated thyroid carcinomas (DTC) disappear. This corresponds to more aggressive growth, metastatic spread, and loss of iodine uptake. Experimental data give strong evidence that differentiated functions of iodine metabolism can be reinduced by retinoic acids. Results of a study performed in patients with advanced DTC are presented. Twenty patients with DTC (eight follicular, seven papillary, five oxyphilic) were selected for treatment with retinoic acid 1.5 mg/kg body weight/day over 5 weeks. All patients had advanced tumor stages with prior operative and radioiodine treatment. Extensive tumor invasion, distant metastatic spread, or insufficient or no radioiodine uptake precluded any conventional therapeutic option. The aim was to assess the changes under retinoid treatment. Iodine uptake increased in eight patients (three follicular, three papillary, two oxyphilic). Thyroglobulin (TG) as parameter for tumor mass and differentiation increased in 12 (63%) patients, decreased in 6 (32%), and did not change in 1 (5%). Retinoids do have an effect on differentiation status of DTC, reinducing iodine uptake in 50% of patients. TG levels do not always parallel a response in iodine uptake.',\n",
       "               'FAU': ['Simon, D',\n",
       "                'Koehrle, J',\n",
       "                'Reiners, C',\n",
       "                'Boerner, A R',\n",
       "                'Schmutzler, C',\n",
       "                'Mainz, K',\n",
       "                'Goretzki, P E',\n",
       "                'Roeher, H D'],\n",
       "               'AU': ['Simon D',\n",
       "                'Koehrle J',\n",
       "                'Reiners C',\n",
       "                'Boerner AR',\n",
       "                'Schmutzler C',\n",
       "                'Mainz K',\n",
       "                'Goretzki PE',\n",
       "                'Roeher HD'],\n",
       "               'AD': ['Department of Surgery, Heinrich-Heine-University, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'RN': ['0 (Retinoids)',\n",
       "                '9010-34-8 (Thyroglobulin)',\n",
       "                '9679TC07X4 (Iodine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma, Follicular/*drug therapy/metabolism/pathology',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Carcinoma, Papillary/*drug therapy/metabolism/pathology',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Iodine/metabolism',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Retinoids/*therapeutic use',\n",
       "                'Thyroglobulin/analysis',\n",
       "                'Thyroid Neoplasms/*drug therapy/metabolism/pathology'],\n",
       "               'EDAT': '1998/05/23 00:00',\n",
       "               'MHDA': '1998/05/23 00:01',\n",
       "               'CRDT': ['1998/05/23 00:00'],\n",
       "               'PHST': ['1998/05/23 00:00 [pubmed]',\n",
       "                '1998/05/23 00:01 [medline]',\n",
       "                '1998/05/23 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/s002689900436 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 1998 Jun;22(6):569-74. doi: 10.1007/s002689900436.'},\n",
       "              {'PMID': '9579574',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19980519',\n",
       "               'LR': '20190708',\n",
       "               'IS': '0020-7136 (Print) 0020-7136 (Linking)',\n",
       "               'VI': '76',\n",
       "               'IP': '3',\n",
       "               'DP': '1998 May 4',\n",
       "               'TI': 'Functional retinoid and thyroid hormone receptors in human thyroid-carcinoma cell lines and tissues.',\n",
       "               'PG': '368-76',\n",
       "               'AB': 'Thyroid carcinomas no longer accessible to radio-iodide or TSH-suppressive T4 therapy, due to loss of thyroid-specific functions, might be sufficiently re-differentiated by retinoic acid (RA) to be treated by conventional methods again. To help evaluate the feasibility of RA re-differentiation therapy in thyroid carcinomas, we examined the functionality of RA receptors (RARs/RXRs), central RA signal mediators, in human thyroid-carcinoma cell lines as model systems. [3H]-RA binding assays with nuclear extracts from follicular thyroid-carcinoma cell lines FTC-133 and -238 revealed high-affinity binding sites for RA. Electrophoretic mobility shift and super-shift assays using a DR2 (\"direct repeat\" 2) RA response element demonstrated DNA-binding of RARalpha, RARgamma, RXRalpha and RXRbeta in nuclear extracts of FTC-133 and anaplastic HTh74 cells. Use of a DR5 RA response element revealed no difference in DNA binding. In supershift assays with a DR4 T3 response element, we found DNA-binding by TRalpha1, TRalpha2, and TRbeta. Northern-blot analysis showed low expression of RXRbeta mRNA in FTC-133 and of TRalpha1 mRNA in FTC-133 and FTC-238 cells. Using RT-PCR, we detected mRNA for RARalpha, RARbeta, RARgamma, RXRalpha, and RXRbeta in the 4 cell lines and in human thyroid-carcinoma samples. RARbeta mRNA was reduced in FTC-238 cells and RXRbeta mRNA was decreased in anaplastic C643 cells and 9 of 12 tumor samples. Differential RA regulation of RA-receptor-mRNA expression was observed in the various cell lines. Thus, RA and T3 nuclear receptors are present in thyroid-carcinoma cell lines or tissues, albeit with cell-line and tumor-dependent variations; in the cell lines, they were shown to be functional with respect to DNA and/or ligand binding.',\n",
       "               'FAU': ['schmutzler, C',\n",
       "                'Brtko, J',\n",
       "                'Winzer, R',\n",
       "                'Jakobs, T C',\n",
       "                'Meissner-Weigl, J',\n",
       "                'Simon, D',\n",
       "                'Goretzki, P E',\n",
       "                'Kohrle, J'],\n",
       "               'AU': ['schmutzler C',\n",
       "                'Brtko J',\n",
       "                'Winzer R',\n",
       "                'Jakobs TC',\n",
       "                'Meissner-Weigl J',\n",
       "                'Simon D',\n",
       "                'Goretzki PE',\n",
       "                'Kohrle J'],\n",
       "               'AD': ['Klinische Forschergruppe, Medizinische Poliklinik, Universitat Wurzburg, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Int J Cancer',\n",
       "               'JT': 'International journal of cancer',\n",
       "               'JID': '0042124',\n",
       "               'RN': ['0 (Neoplasm Proteins)',\n",
       "                '0 (RNA, Messenger)',\n",
       "                '0 (Receptors, Retinoic Acid)',\n",
       "                '0 (Receptors, Thyroid Hormone)',\n",
       "                '5688UTC01R (Tretinoin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Carcinoma/*metabolism',\n",
       "                'Feasibility Studies',\n",
       "                'Humans',\n",
       "                'Neoplasm Proteins/*metabolism',\n",
       "                'Polymerase Chain Reaction',\n",
       "                'RNA, Messenger/*metabolism',\n",
       "                'Receptors, Retinoic Acid/*metabolism',\n",
       "                'Receptors, Thyroid Hormone/*metabolism',\n",
       "                'Thyroid Neoplasms/*metabolism',\n",
       "                'Tretinoin/metabolism',\n",
       "                'Tumor Cells, Cultured'],\n",
       "               'EDAT': '1998/05/14 02:03',\n",
       "               'MHDA': '2000/06/20 09:00',\n",
       "               'CRDT': ['1998/05/14 02:03'],\n",
       "               'PHST': ['1998/05/14 02:03 [pubmed]',\n",
       "                '2000/06/20 09:00 [medline]',\n",
       "                '1998/05/14 02:03 [entrez]'],\n",
       "               'AID': ['10.1002/(SICI)1097-0215(19980504)76:3<368::AID-IJC14>3.0.CO;2-7 [pii]',\n",
       "                '10.1002/(sici)1097-0215(19980504)76:3<368::aid-ijc14>3.0.co;2-7 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Int J Cancer. 1998 May 4;76(3):368-76. doi: 10.1002/(sici)1097-0215(19980504)76:3<368::aid-ijc14>3.0.co;2-7.'},\n",
       "              {'PMID': '9562814',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19980623',\n",
       "               'LR': '20080610',\n",
       "               'IS': '1661-8157 (Print) 1661-8157 (Linking)',\n",
       "               'VI': '87',\n",
       "               'IP': '11',\n",
       "               'DP': '1998 Mar 11',\n",
       "               'TI': '[From limited to extensive radical operation in thyroid carcinoma].',\n",
       "               'PG': '383-8',\n",
       "               'AB': 'The incidence of malignant thyroid tumors in Germany is about 1-2 cases per 100,000 inhabitants and year with a preponderance of female to male 3:1. Thus malignant thyroid tumors are rare and account for about 0.5% to 1% of all malignancies. Special consideration, however, has to be paid to the fact, that thyroid lesions associated with the risk of malignancy are much more frequent. Therefore identification of patients with particular risk for thyroid malignancy out of the 15% to 20% of the German population with thyroid lesions has to be the main scope. Prognosis of differentiated thyroid carcinomas is excellent and requires operative procedures adapted to histological tumor type and tumor stage. Hemithyroidectomy for small papillary tumors can be as adequate as total thyroidectomy including bilateral neck dissection plus mediastinal lymph node dissection in medullary thyroid carcinoma. Generally radical resection of tumor is the aim. Palliative modalities in distant metastatic disease or undifferentiated tumors are indicated to optimize additive or adjuvant therapy resp. to improve prognosis.',\n",
       "               'FAU': ['Simon, D', 'Goretzki, P E', 'Roher, H D'],\n",
       "               'AU': ['Simon D', 'Goretzki PE', 'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemeine und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article', 'Review'],\n",
       "               'TT': 'Von limitierter bis erweiterter Radikalitat der Operation beim Schilddrusenkarzinom.',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Praxis (Bern 1994)',\n",
       "               'JT': 'Praxis',\n",
       "               'JID': '101468093',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Female',\n",
       "                'Humans',\n",
       "                'Lymphatic Metastasis',\n",
       "                'Male',\n",
       "                'Neck Dissection/*methods',\n",
       "                'Neoplasm Staging',\n",
       "                'Palliative Care',\n",
       "                'Prognosis',\n",
       "                'Thyroid Neoplasms/classification/pathology/*surgery',\n",
       "                'Thyroidectomy/*methods'],\n",
       "               'RF': '35',\n",
       "               'EDAT': '1998/05/01 00:00',\n",
       "               'MHDA': '1998/05/01 00:01',\n",
       "               'CRDT': ['1998/05/01 00:00'],\n",
       "               'PHST': ['1998/05/01 00:00 [pubmed]',\n",
       "                '1998/05/01 00:01 [medline]',\n",
       "                '1998/05/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Praxis (Bern 1994). 1998 Mar 11;87(11):383-8.'},\n",
       "              {'PMID': '9528832',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19980415',\n",
       "               'LR': '20190607',\n",
       "               'IS': '0007-0920 (Print) 1532-1827 (Electronic) 0007-0920 (Linking)',\n",
       "               'VI': '77',\n",
       "               'IP': '6',\n",
       "               'DP': '1998 Mar',\n",
       "               'TI': 'Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma.',\n",
       "               'PG': '903-6',\n",
       "               'AB': 'Ret/PTC oncogene has been described with a frequency of 2.5-30% in papillary thyroid carcinomas. We examined the expression of ret/PTC in 99 German papillary thyroid carcinomas, including two recently described new variants of ret/PTC3 and identified eight ret/PTC-positive tumours (8%) but none with the new variants.',\n",
       "               'FAU': ['Mayr, B',\n",
       "                'Potter, E',\n",
       "                'Goretzki, P',\n",
       "                'Ruschoff, J',\n",
       "                'Dietmaier, W',\n",
       "                'Hoang-Vu, C',\n",
       "                'Dralle, H',\n",
       "                'Brabant, G'],\n",
       "               'AU': ['Mayr B',\n",
       "                'Potter E',\n",
       "                'Goretzki P',\n",
       "                'Ruschoff J',\n",
       "                'Dietmaier W',\n",
       "                'Hoang-Vu C',\n",
       "                'Dralle H',\n",
       "                'Brabant G'],\n",
       "               'AD': ['Abteilung Klinische Endokrinologie, Medizinische Hochschule Hannover, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Br J Cancer',\n",
       "               'JT': 'British journal of cancer',\n",
       "               'JID': '0370635',\n",
       "               'RN': ['0 (Drosophila Proteins)',\n",
       "                '0 (NCOA4 protein, human)',\n",
       "                '0 (Nuclear Receptor Coactivators)',\n",
       "                '0 (Oncogene Proteins)',\n",
       "                '0 (Oncogene Proteins, Fusion)',\n",
       "                '0 (Proto-Oncogene Proteins)',\n",
       "                '0 (Transcription Factors)',\n",
       "                'EC 2.7.10.1 (Protein-Tyrosine Kinases)',\n",
       "                'EC 2.7.10.1 (Proto-Oncogene Proteins c-ret)',\n",
       "                'EC 2.7.10.1 (RET protein, human)',\n",
       "                'EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases)',\n",
       "                'EC 2.7.10.1 (Ret protein, Drosophila)',\n",
       "                'EC 2.7.10.1 (ret-PTC fusion oncoproteins, human)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Artificial Gene Fusion',\n",
       "                'Carcinoma, Papillary/genetics/*metabolism',\n",
       "                '*Drosophila Proteins',\n",
       "                'Germany',\n",
       "                'Humans',\n",
       "                'Nuclear Receptor Coactivators',\n",
       "                'Oncogene Proteins/*biosynthesis',\n",
       "                'Oncogene Proteins, Fusion',\n",
       "                'Oncogenes',\n",
       "                'Polymerase Chain Reaction',\n",
       "                'Protein-Tyrosine Kinases',\n",
       "                'Proto-Oncogene Proteins/*biosynthesis',\n",
       "                'Proto-Oncogene Proteins c-ret',\n",
       "                'Proto-Oncogenes',\n",
       "                'Receptor Protein-Tyrosine Kinases/*biosynthesis',\n",
       "                'Sequence Deletion',\n",
       "                'Thyroid Neoplasms/genetics/*metabolism',\n",
       "                '*Transcription Factors'],\n",
       "               'PMC': 'PMC2150093',\n",
       "               'EDAT': '1998/04/07 00:00',\n",
       "               'MHDA': '1998/04/07 00:01',\n",
       "               'CRDT': ['1998/04/07 00:00'],\n",
       "               'PHST': ['1998/04/07 00:00 [pubmed]',\n",
       "                '1998/04/07 00:01 [medline]',\n",
       "                '1998/04/07 00:00 [entrez]'],\n",
       "               'AID': ['10.1038/bjc.1998.149 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Br J Cancer. 1998 Mar;77(6):903-6. doi: 10.1038/bjc.1998.149.'}],\n",
       "             '2002': [{'PMID': '12362047',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20021213',\n",
       "               'LR': '20190503',\n",
       "               'IS': '1468-6244 (Electronic) 0022-2593 (Print) 0022-2593 (Linking)',\n",
       "               'VI': '39',\n",
       "               'IP': '10',\n",
       "               'DP': '2002 Oct',\n",
       "               'TI': 'Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and the Baltic States.',\n",
       "               'PG': 'E65',\n",
       "               'FAU': ['Kurzawski, G',\n",
       "                'Suchy, J',\n",
       "                'Kladny, J',\n",
       "                'Safranow, K',\n",
       "                'Jakubowska, A',\n",
       "                'Elsakov, P',\n",
       "                'Kucinskas, V',\n",
       "                'Gardovski, J',\n",
       "                'Irmejs, A',\n",
       "                'Sibul, H',\n",
       "                'Huzarski, T',\n",
       "                'Byrski, T',\n",
       "                'Debniak, T',\n",
       "                'Cybulski, C',\n",
       "                'Gronwald, J',\n",
       "                'Oszurek, O',\n",
       "                'Clark, J',\n",
       "                'Gozdz, S',\n",
       "                'Niepsuj, S',\n",
       "                'Slomski, R',\n",
       "                'Plawski, A',\n",
       "                'Lacka-Wojciechowska, A',\n",
       "                'Rozmiarek, A',\n",
       "                'Fiszer-Maliszewska, L',\n",
       "                'Bebenek, M',\n",
       "                'Sorokin, D',\n",
       "                'Stawicka, M',\n",
       "                'Godlewski, D',\n",
       "                'Richter, P',\n",
       "                'Brozek, I',\n",
       "                'Wysocka, B',\n",
       "                'Jawien, A',\n",
       "                'Banaszkiewicz, Z',\n",
       "                'Kowalczyk, J',\n",
       "                'Czudowska, D',\n",
       "                'Goretzki, P E',\n",
       "                'Moeslein, G',\n",
       "                'Lubinski, J'],\n",
       "               'AU': ['Kurzawski G',\n",
       "                'Suchy J',\n",
       "                'Kladny J',\n",
       "                'Safranow K',\n",
       "                'Jakubowska A',\n",
       "                'Elsakov P',\n",
       "                'Kucinskas V',\n",
       "                'Gardovski J',\n",
       "                'Irmejs A',\n",
       "                'Sibul H',\n",
       "                'Huzarski T',\n",
       "                'Byrski T',\n",
       "                'Debniak T',\n",
       "                'Cybulski C',\n",
       "                'Gronwald J',\n",
       "                'Oszurek O',\n",
       "                'Clark J',\n",
       "                'Gozdz S',\n",
       "                'Niepsuj S',\n",
       "                'Slomski R',\n",
       "                'Plawski A',\n",
       "                'Lacka-Wojciechowska A',\n",
       "                'Rozmiarek A',\n",
       "                'Fiszer-Maliszewska L',\n",
       "                'Bebenek M',\n",
       "                'Sorokin D',\n",
       "                'Stawicka M',\n",
       "                'Godlewski D',\n",
       "                'Richter P',\n",
       "                'Brozek I',\n",
       "                'Wysocka B',\n",
       "                'Jawien A',\n",
       "                'Banaszkiewicz Z',\n",
       "                'Kowalczyk J',\n",
       "                'Czudowska D',\n",
       "                'Goretzki PE',\n",
       "                'Moeslein G',\n",
       "                'Lubinski J'],\n",
       "               'AD': ['Hereditary Cancer Centre, Department of Genetics and Pathology, Pomeranian Academy of Medicine, Szczecin, Poland. gkurz@sci.pam.szczecin.pl'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'England',\n",
       "               'TA': 'J Med Genet',\n",
       "               'JT': 'Journal of medical genetics',\n",
       "               'JID': '2985087R',\n",
       "               'RN': ['0 (Adaptor Proteins, Signal Transducing)',\n",
       "                '0 (Carrier Proteins)',\n",
       "                '0 (DNA-Binding Proteins)',\n",
       "                '0 (MLH1 protein, human)',\n",
       "                '0 (Neoplasm Proteins)',\n",
       "                '0 (Nuclear Proteins)',\n",
       "                '0 (Proto-Oncogene Proteins)',\n",
       "                'EC 3.6.1.3 (MSH2 protein, human)',\n",
       "                'EC 3.6.1.3 (MutL Protein Homolog 1)',\n",
       "                'EC 3.6.1.3 (MutS Homolog 2 Protein)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adaptor Proteins, Signal Transducing',\n",
       "                'Baltic States/epidemiology',\n",
       "                'Carrier Proteins',\n",
       "                'Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics',\n",
       "                'DNA Mutational Analysis/*methods',\n",
       "                '*DNA-Binding Proteins',\n",
       "                'Germ-Line Mutation/*genetics',\n",
       "                'Humans',\n",
       "                'MutL Protein Homolog 1',\n",
       "                'MutS Homolog 2 Protein',\n",
       "                'Neoplasm Proteins/*genetics',\n",
       "                'Nuclear Proteins',\n",
       "                'Poland/epidemiology',\n",
       "                'Proto-Oncogene Proteins/*genetics'],\n",
       "               'PMC': 'PMC1734972',\n",
       "               'EDAT': '2002/10/04 04:00',\n",
       "               'MHDA': '2002/12/17 04:00',\n",
       "               'PMCR': ['2005/10/01'],\n",
       "               'CRDT': ['2002/10/04 04:00'],\n",
       "               'PHST': ['2002/10/04 04:00 [pubmed]',\n",
       "                '2002/12/17 04:00 [medline]',\n",
       "                '2002/10/04 04:00 [entrez]',\n",
       "                '2005/10/01 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1136/jmg.39.10.e65 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Med Genet. 2002 Oct;39(10):E65. doi: 10.1136/jmg.39.10.e65.'},\n",
       "              {'PMID': '12242984',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20021204',\n",
       "               'LR': '20190922',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '73',\n",
       "               'IP': '7',\n",
       "               'DP': '2002 Jul',\n",
       "               'TI': '[Kasabach-Merritt syndrome in giant hemangioma of the liver. A case report].',\n",
       "               'PG': '729-32',\n",
       "               'AB': 'Kasabach-Merritt-syndrome is rare coagulation disorder with consumption coagulopathy caused by vascular malformations. We report the case of a 44-year-old woman with repeated severe bleeding complications after small and medium sized operations with normal results in the tests of plasmatic coagulation. After discovery of a giant hemangioma of the liver the diagnosis was established. Activation of coagulation was stopped preoperatively by i.v.-heparinization and curative treatment by right-sided hemihepatectomy followed.',\n",
       "               'FAU': ['Vogel, T',\n",
       "                'Lammers, B',\n",
       "                'von Herbay, A',\n",
       "                'Kunz, B M E',\n",
       "                'Donner, A J',\n",
       "                'Furst, G',\n",
       "                'Goretzki, P E'],\n",
       "               'AU': ['Vogel T',\n",
       "                'Lammers B',\n",
       "                'von Herbay A',\n",
       "                'Kunz BM',\n",
       "                'Donner AJ',\n",
       "                'Furst G',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Universitatsklinikum Dusseldorf, Moorenstrasse 5, 40225 Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Case Reports', 'English Abstract', 'Journal Article'],\n",
       "               'TT': 'Kasabach-Merritt-Syndrom bei Riesenhamangiom der Leber. Ein Fallbericht.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'RN': ['9005-49-6 (Heparin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Angiography, Digital Subtraction',\n",
       "                'Blood Coagulation Tests',\n",
       "                'Disseminated Intravascular Coagulation/*etiology/pathology/prevention & control',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Hemangioma/*complications/diagnosis/pathology/surgery',\n",
       "                'Heparin/administration & dosage',\n",
       "                'Hepatectomy',\n",
       "                'Humans',\n",
       "                'Liver/pathology',\n",
       "                'Liver Neoplasms/*complications/diagnosis/pathology/surgery',\n",
       "                'Postoperative Hemorrhage/*etiology/pathology/prevention & control',\n",
       "                'Premedication',\n",
       "                'Reoperation',\n",
       "                'Syndrome',\n",
       "                'Thrombocytopenia/*etiology/pathology/prevention & control',\n",
       "                'Tomography, X-Ray Computed'],\n",
       "               'EDAT': '2002/09/24 06:00',\n",
       "               'MHDA': '2002/12/05 04:00',\n",
       "               'CRDT': ['2002/09/24 06:00'],\n",
       "               'PHST': ['2002/09/24 06:00 [pubmed]',\n",
       "                '2002/12/05 04:00 [medline]',\n",
       "                '2002/09/24 06:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00104-002-0445-1 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 2002 Jul;73(7):729-32. doi: 10.1007/s00104-002-0445-1.'},\n",
       "              {'PMID': '12173071',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20030124',\n",
       "               'LR': '20131121',\n",
       "               'IS': '0018-5043 (Print) 0018-5043 (Linking)',\n",
       "               'VI': '34',\n",
       "               'IP': '6',\n",
       "               'DP': '2002 Jun',\n",
       "               'TI': 'Effects of the putatively oncogenic protein kinase Calpha D294G mutation on enzymatic activity and cell growth and its occurrence in human thyroid neoplasias.',\n",
       "               'PG': '311-7',\n",
       "               'AB': 'A point mutation of protein kinase Calpha (PKCalpha) has been described in pituitary adenomas and in follicular adenomas and thyroid carcinomas. The mutation results in an exchange of aspartic acid into a glycine of the amino acid 294 of PKCalpha, which is located adjacent to the Ca (2+)-binding hinge region and has been proposed as an activation inhibitor. To investigate its biochemical sequelae, we constructed the mutated enzyme and expressed it in human embryonic kidney cells (HEK). The K M of the purified enzyme for Ca (2+) and its K M for the substrate MBP 4 - 14 was not altered by the mutation. Translocation of PKCalpha to HEK cell membranes upon activation was not changed and the mutant potently inhibited cell proliferation upon 5-fold stable overexpression in HEK cells. Thus, loss of function in mutated PKCalpha was excluded. A screen for the mutation using a restriction assay with a sensitivity of at least 8 % for the mutated DNA did not show any mutation in 11 carcinoma and 13 adenomatous thyroid samples. We conclude that the A294G mutation of PKCalpha does not detectably affect its biochemical properties in vitro or in vivo, and is at least rare in thyroid neoplasias, in Germany.',\n",
       "               'FAU': ['Assert, R',\n",
       "                'Kotter, R',\n",
       "                'Schiemann, U',\n",
       "                'Goretzki, P',\n",
       "                'Pfeiffer, A F H'],\n",
       "               'AU': ['Assert R',\n",
       "                'Kotter R',\n",
       "                'Schiemann U',\n",
       "                'Goretzki P',\n",
       "                'Pfeiffer AF'],\n",
       "               'AD': ['German Institute of Human Nutrition, Potsdam-Rehbrucke, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Horm Metab Res',\n",
       "               'JT': 'Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme',\n",
       "               'JID': '0177722',\n",
       "               'RN': ['0 (Isoenzymes)',\n",
       "                'EC 2.7.11.13 (PRKCA protein, human)',\n",
       "                'EC 2.7.11.13 (Protein Kinase C)',\n",
       "                'EC 2.7.11.13 (Protein Kinase C-alpha)',\n",
       "                'NI40JAQ945 (Tetradecanoylphorbol Acetate)',\n",
       "                'SY7Q814VUP (Calcium)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Biological Transport/drug effects',\n",
       "                'Blotting, Western',\n",
       "                'Calcium/metabolism',\n",
       "                '*Cell Division',\n",
       "                'Cell Line',\n",
       "                'Cell Membrane/enzymology',\n",
       "                'Cytosol/enzymology',\n",
       "                'Embryo, Mammalian',\n",
       "                'Humans',\n",
       "                'Isoenzymes/*genetics/metabolism',\n",
       "                'Kidney',\n",
       "                'Kinetics',\n",
       "                'Mutagenesis, Site-Directed',\n",
       "                '*Mutation',\n",
       "                'Polymerase Chain Reaction',\n",
       "                'Protein Kinase C/*genetics/metabolism',\n",
       "                'Protein Kinase C-alpha',\n",
       "                'Tetradecanoylphorbol Acetate/pharmacology',\n",
       "                'Thyroid Neoplasms/*enzymology/*pathology',\n",
       "                'Transfection'],\n",
       "               'EDAT': '2002/08/13 10:00',\n",
       "               'MHDA': '2003/01/25 04:00',\n",
       "               'CRDT': ['2002/08/13 10:00'],\n",
       "               'PHST': ['2002/08/13 10:00 [pubmed]',\n",
       "                '2003/01/25 04:00 [medline]',\n",
       "                '2002/08/13 10:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-2002-33259 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Horm Metab Res. 2002 Jun;34(6):311-7. doi: 10.1055/s-2002-33259.'},\n",
       "              {'PMID': '12045860',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20021203',\n",
       "               'LR': '20041117',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '26',\n",
       "               'IP': '8',\n",
       "               'DP': '2002 Aug',\n",
       "               'TI': 'Importance of lymph node metastases in follicular thyroid cancer.',\n",
       "               'PG': '1017-22',\n",
       "               'AB': \"There are many concepts of risk and prognostic factor analysis for differentiated thyroid cancer. The prognostic role of lymph node metastases in follicular thyroid cancer (FTC), however, is still controversial. We performed a retrospective trial in 186 patients with FTC (124 women, 62 men; mean follow-up 5.5 years) questioning whether lymph node metastases and radical thyroid surgery with neck dissection contribute to the prognosis of FTC. Univariate analysis demonstrated that lymph node metastasesp <0.005), tumor size (p <0.005), tumor stage (p <0.005), distant metastases p = 0.0063), and gender (p = 0.003) are significant prognostic factors for recurrence (Kaplan-Meier). Tumor size (p = 0.004), lymph node metastases p = 0.0478), and distant metastases p = 0.0064) influenced mortality. Age and extent of surgery were not significant for recurrence nor was gender for mortality. Multivariate analysis (Cox regression test) characterized tumor size (p <0.005) and lymph node metastases p = 0.004) as prognostic factors for recurrence of FTC. No significant difference was detected between patients being treated by thyroidectomy when compared to patients treated by thyroidectomy plus neck dissection in relation to recurrence. Our data demonstrate lymph node metastases to be a significant prognostic factor for recurrence of FTC and the patient's survival. We advocate thyroidectomy plus central lymph node dissection as the basic surgical strategy. For T3 and T4 tumors, unilateral modified neck dissection is an all but optional procedure. Whether radical surgery with thyroidectomy plus neck dissection has an impact on survival remains questionable.\",\n",
       "               'FAU': ['Witte, Jurgen',\n",
       "                'Goretzki, Peter E',\n",
       "                'Dieken, Jan',\n",
       "                'Simon, Dietmar',\n",
       "                'Roher, Hans D'],\n",
       "               'AU': ['Witte J',\n",
       "                'Goretzki PE',\n",
       "                'Dieken J',\n",
       "                'Simon D',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Department of General and Trauma Surgery, Heinrich-Heine-University, Moorenstrasse 5, 40225 Dusseldorf, Germany. witte-bonn@t-online.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20020606',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma, Follicular/mortality/secondary/*surgery',\n",
       "                'Adult',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                '*Lymph Node Excision',\n",
       "                '*Lymphatic Metastasis',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Multivariate Analysis',\n",
       "                'Neoplasm Recurrence, Local/prevention & control',\n",
       "                'Prognosis',\n",
       "                'Thyroid Neoplasms/mortality/pathology/*surgery',\n",
       "                'Thyroidectomy'],\n",
       "               'EDAT': '2002/06/05 10:00',\n",
       "               'MHDA': '2002/12/04 04:00',\n",
       "               'CRDT': ['2002/06/05 10:00'],\n",
       "               'PHST': ['2002/06/05 10:00 [pubmed]',\n",
       "                '2002/12/04 04:00 [medline]',\n",
       "                '2002/06/05 10:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00268-002-6668-y [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 2002 Aug;26(8):1017-22. doi: 10.1007/s00268-002-6668-y. Epub 2002 Jun 6.'},\n",
       "              {'PMID': '12016472',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20021203',\n",
       "               'LR': '20220331',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '26',\n",
       "               'IP': '8',\n",
       "               'DP': '2002 Aug',\n",
       "               'TI': 'Adrenal involvement in multiple endocrine neoplasia type 1.',\n",
       "               'PG': '891-6',\n",
       "               'AB': 'Adrenal lesions belong to the spectrum of multiple endocrine neoplasia type 1 (MEN-1) syndrome. However, the prevalence of adrenal involvement, the characteristics, and the clinical management of adrenal lesions have not yet been clearly defined. A total of 66 patients with confirmed MEN1 germline mutations and 1 additional patient with typical manifestations in three organ systems were monitored in a regular screening program that included evaluation of the adrenals (median follow-up 96 months; range 12 to 300 months). Age at the diagnosis of MEN-1 and of adrenal tumors and the clinical characteristics, genotype, treatment, and follow-up of adrenal disease were analyzed. Adrenal lesions were identified in 18 of 67 (26.8%) MEN-1 patients and were diagnosed 5 years later than MEN-1. The median tumor diameter at diagnosis was 3.0 cm (range 1.2-15.0 cm), with most tumors being 3 cm or smaller. Eight patients had bilateral tumors. Ten patients had nonfunctional benign tumors, three had benign adrenal Cushing syndrome, and one patient had a pheochromocytoma. Four patients developed adrenocortical carcinomas (ACCs), three of which were functional. Nine adrenalectomies and one subtotal adrenalectomy were performed in six patients. Three patients with ACC died owing to the tumor. Patients with mutations in exons 2 and 10 developed adrenal tumors significantly more often than patients with other mutations (p <0.01). Adrenal tumors are a common feature of MEN-1 but occur later in the course of the disease. The lesions are often small and nonfunctional and can therefore be managed by close surveillance; others have significant malignant potential and should be considered for surgery when they are 3 cm or larger.',\n",
       "               'FAU': ['Langer, Peter',\n",
       "                'Cupisti, Kenko',\n",
       "                'Bartsch, Detlef K',\n",
       "                'Nies, Christoph',\n",
       "                'Goretzki, Peter E',\n",
       "                'Rothmund, Matthias',\n",
       "                'Roher, Hans D'],\n",
       "               'AU': ['Langer P',\n",
       "                'Cupisti K',\n",
       "                'Bartsch DK',\n",
       "                'Nies C',\n",
       "                'Goretzki PE',\n",
       "                'Rothmund M',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Department of Surgery, Philipps-University Hospital, Baldingerstrasse, D-35043 Marburg, Germany. langerp@mailer.uni-marburg.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'DEP': '20020521',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adrenal Gland Neoplasms/*complications/genetics/pathology',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Exons/genetics',\n",
       "                'Female',\n",
       "                'Genotype',\n",
       "                'Germ-Line Mutation',\n",
       "                'Humans',\n",
       "                'Introns/genetics',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Multiple Endocrine Neoplasia Type 1/*complications/genetics/pathology',\n",
       "                'Phenotype',\n",
       "                'Prevalence'],\n",
       "               'EDAT': '2002/05/23 10:00',\n",
       "               'MHDA': '2002/12/04 04:00',\n",
       "               'CRDT': ['2002/05/23 10:00'],\n",
       "               'PHST': ['2002/05/23 10:00 [pubmed]',\n",
       "                '2002/12/04 04:00 [medline]',\n",
       "                '2002/05/23 10:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00268-002-6492-4 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 2002 Aug;26(8):891-6. doi: 10.1007/s00268-002-6492-4. Epub 2002 May 21.'},\n",
       "              {'PMID': '11855986',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20020325',\n",
       "               'LR': '20190710',\n",
       "               'IS': '0022-2623 (Print) 0022-2623 (Linking)',\n",
       "               'VI': '45',\n",
       "               'IP': '5',\n",
       "               'DP': '2002 Feb 28',\n",
       "               'TI': 'Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165.',\n",
       "               'PG': '1064-72',\n",
       "               'AB': 'As part of our program aimed at optimizing therapeutic effects over toxic effects (as observed in the naturally occurring nicotinic acetylcholine receptor modulators (-)-nicotine, (-)-epibatidine, (-)-ferruginine, and (+)-anatoxin-a), we investigated the bioisosteric potential of diazines in the field of (+)-anatoxin-a-type structures. In the series of diazine analogues of deschloro-UB-165 (DUB-165, 6), bioisosteric replacement of the 3-pyridyl pharmacophoric element by a 4-pyridazinyl, 5-pyrimidinyl, or 2-pyrazinyl moiety resulted in novel nAChR ligands 7, 8, and 9. A palladium-catalyzed Suzuki cross-coupling of the 3-diethylboranylpyridine (14) and a Stille cross-coupling of the corresponding tributylstannyl diazines 15-17 with the vinyl triflate 13 of the N-protected 9-azabicyclo[4.2.1]nonan-2-one 12 constitute the key steps in the syntheses of these enantiopure anatoxinoids 6-9. Studies of the in vitro affinity for (alpha4)(2)(beta2)(3), alpha3(beta)4, and alpha7 nAChR subtypes by radioligand binding assays demonstrated that the diazine analogues 7-9 can be considered as pharmacologically attractive bioisosteres of DUB-165 (6) but with different effects on the binding affinity with regard to the diazine moiety. The pyrimidine-containing bioisostere 8 turned out to be the most active diazine analogue, which interacts potently (K(i) = 0.14 nM) with the (alpha4)(2)(beta2)(3) subtype and differentiates significantly among the nAChR subtypes investigated. The nitrogens in this anatoxinoid 8 show by far the most negative atomic charges (calculated using the AM1 Hamiltonian). This qualitatively correlates with the highest binding affinity observed for 8 for all subtypes under consideration.',\n",
       "               'FAU': ['Gohlke, Holger',\n",
       "                'Gundisch, Daniela',\n",
       "                'Schwarz, Simone',\n",
       "                'Seitz, Gunther',\n",
       "                'Tilotta, Maria Cristina',\n",
       "                'Wegge, Thomas'],\n",
       "               'AU': ['Gohlke H',\n",
       "                'Gundisch D',\n",
       "                'Schwarz S',\n",
       "                'Seitz G',\n",
       "                'Tilotta MC',\n",
       "                'Wegge T'],\n",
       "               'AD': ['Institut fur Pharmazeutische Chemie der Philipps-Universitat Marburg, Marbacher Weg 6, D-35032 Marburg, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Med Chem',\n",
       "               'JT': 'Journal of medicinal chemistry',\n",
       "               'JID': '9716531',\n",
       "               'RN': ['0 ((2-chloro-5-pyridyl)-9-azabicyclo(4.2.1)non-2-ene)',\n",
       "                '0 (2-(pyrimidin-5-yl)-9-azabicyclo(4.2.1)non-2-ene)',\n",
       "                '0 (Bridged Bicyclo Compounds, Heterocyclic)',\n",
       "                '0 (Bridged-Ring Compounds)',\n",
       "                '0 (Ligands)',\n",
       "                '0 (Nicotinic Agonists)',\n",
       "                '0 (Pyrazines)',\n",
       "                '0 (Pyridazines)',\n",
       "                '0 (Pyridines)',\n",
       "                '0 (Pyrimidines)',\n",
       "                '0 (Receptors, Nicotinic)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adrenal Glands/metabolism',\n",
       "                'Animals',\n",
       "                'Binding, Competitive',\n",
       "                'Brain/metabolism',\n",
       "                'Bridged Bicyclo Compounds, Heterocyclic/*chemical synthesis/chemistry/pharmacology',\n",
       "                'Bridged-Ring Compounds/*chemistry/pharmacology',\n",
       "                'In Vitro Techniques',\n",
       "                'Ligands',\n",
       "                'Nicotinic Agonists/*chemical synthesis/chemistry/pharmacology',\n",
       "                'Pyrazines/*chemical synthesis/chemistry/pharmacology',\n",
       "                'Pyridazines/*chemical synthesis/chemistry/pharmacology',\n",
       "                'Pyridines/*chemistry/pharmacology',\n",
       "                'Pyrimidines/*chemical synthesis/chemistry/pharmacology',\n",
       "                'Radioligand Assay',\n",
       "                'Rats',\n",
       "                'Rats, Sprague-Dawley',\n",
       "                'Receptors, Nicotinic/*metabolism',\n",
       "                'Stereoisomerism',\n",
       "                'Structure-Activity Relationship',\n",
       "                'Swine'],\n",
       "               'EDAT': '2002/02/22 10:00',\n",
       "               'MHDA': '2002/03/26 10:01',\n",
       "               'CRDT': ['2002/02/22 10:00'],\n",
       "               'PHST': ['2002/02/22 10:00 [pubmed]',\n",
       "                '2002/03/26 10:01 [medline]',\n",
       "                '2002/02/22 10:00 [entrez]'],\n",
       "               'AID': ['jm010936y [pii]', '10.1021/jm010936y [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Med Chem. 2002 Feb 28;45(5):1064-72. doi: 10.1021/jm010936y.'},\n",
       "              {'PMID': '11819104',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20020320',\n",
       "               'LR': '20220408',\n",
       "               'IS': '1435-2443 (Print) 1435-2443 (Linking)',\n",
       "               'VI': '386',\n",
       "               'IP': '7',\n",
       "               'DP': '2002 Jan',\n",
       "               'TI': 'Therapy of suspected intrathoracic parathyroid adenomas. Experiences using open transthoracic approach and video-assisted thoracoscopic surgery.',\n",
       "               'PG': '488-93',\n",
       "               'AB': 'BACKGROUND AND AIMS: Ectopic mediastinal parathyroid adenoma as a cause of primary hyperparathyroidism (pHPT) can normally be resected from conventional collar incision. In rare cases with adenomas deeper in the chest, a transthoracic approach is necessary. PATIENTS/METHODS: We report our experience of 19 patients with suspected mediastinal parathyroid adenomas from a total of 1035 patients with pHPT who were operated on between 1986 and 2000 using an open approach (sternotomy or thoracotomy) or video-assisted mediastinal or thoracoscopic surgery (VAMS/VATS). RESULTS: Fourteen patients underwent an open approach with a success rate of 71% (10 of 14). Four patients remained hypercalcaemic. There were four complications in three patients: three permanent recurrent nerve palsies and one chylus fistula, requiring further surgery. VATS was successful in three of four patients with conversion to sternal splitting because of a false-negative frozen section in one patient. Another patient had parathyroid adenoma retrosternally which could not be resected by means of VAMS and had to be excised using a transsternal approach. There were no complications of minimal invasive procedures. All five patients were normocalcaemic after the operation. CONCLUSION: Ectopic parathyroid adenomas not resectable by means of a collar incision are rare causes of pHPT and comprise 1.25% of all patients with pHPT in our series. For these patients, VATS revealed an alternative to conventional open procedures. In questionable cases, however, the collar incision should precede the VATS procedure.',\n",
       "               'FAU': ['Cupisti, Kenko',\n",
       "                'Dotzenrath, Cornelia',\n",
       "                'Simon, Dietmar',\n",
       "                'Roher, Hans-Dietrich',\n",
       "                'Goretzki, Peter E'],\n",
       "               'AU': ['Cupisti K',\n",
       "                'Dotzenrath C',\n",
       "                'Simon D',\n",
       "                'Roher HD',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Universitatsklinikum, Heinrich-Heine-Universitat Dusseldorf, Moorenstrasse 5, 40225 Dusseldorf, Germany. cupisti@uni-duesseldorf.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20011114',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/complications/*pathology/*surgery',\n",
       "                'Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Child',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism/etiology/*pathology/*surgery',\n",
       "                'Male',\n",
       "                'Mediastinal Neoplasms/complications/*pathology/*surgery',\n",
       "                '*Mediastinoscopy',\n",
       "                'Middle Aged',\n",
       "                'Parathyroid Neoplasms/complications/*pathology/*surgery',\n",
       "                '*Thoracic Surgery, Video-Assisted',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '2002/01/31 10:00',\n",
       "               'MHDA': '2002/03/21 10:01',\n",
       "               'CRDT': ['2002/01/31 10:00'],\n",
       "               'PHST': ['2001/03/08 00:00 [received]',\n",
       "                '2001/09/18 00:00 [accepted]',\n",
       "                '2002/01/31 10:00 [pubmed]',\n",
       "                '2002/03/21 10:01 [medline]',\n",
       "                '2002/01/31 10:00 [entrez]'],\n",
       "               'AID': ['10.1007/s00423-001-0254-x [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 2002 Jan;386(7):488-93. doi: 10.1007/s00423-001-0254-x. Epub 2001 Nov 14.'},\n",
       "              {'PMID': '11738601',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20020312',\n",
       "               'LR': '20190901',\n",
       "               'IS': '0968-0896 (Print) 0968-0896 (Linking)',\n",
       "               'VI': '10',\n",
       "               'IP': '1',\n",
       "               'DP': '2002 Jan',\n",
       "               'TI': 'Syntheses and evaluation of pyridazine and pyrimidine containing bioisosteres of (+/-)-pyrido[3.4-b]homotropane and pyrido-[3.4-b]tropane as novel nAChR ligands.',\n",
       "               'PG': '1-9',\n",
       "               'AB': \"Bioisosteric replacement of the pyridine pharmacophoric element in (+/-)-pyrido[3.4-b]homotropane (PHT) and pyrido[3.4-b]tropane with the pyridazine and pyrimidine nucleus resulted in hitherto unknown nAChR ligands such as 5-8. Inverse type Diels-Alder reactions constitute the key steps in the new routes to the pyridazine- or pyrimidine-annulated bioisosteres. The enantiopure (+)-2-tropinone (11) from the 'chiral pool' is transformed to the ring-expanded silyl enol ether 12 and to the enamine 15. Both proved to be highly dienophilic species in the inverse type [4+2] cycloaddition reactions with the 1,2,4,5-tetrazines 13 and 16a,b or with the 1,3,5-triazine 19 to provide the enantiopure target compounds 5-7. In the same way the racemic pyrimidine-annulated species 8 was obtained from 3-tropanone 21. The new ligands were tested for their in vitro affinity for (alpha4)2(beta2)3 and alpha7* nAChR subtype. In comparison to PHT, well known to exhibit affinity for agonist binding sites in rat brain approximately equivalent to that of (+)-anatoxin-a (1), replacement of the pyridine by the bioisosteric pyridazine resulted in 30-fold lower affinity at the (alpha4)2(beta2)3 subtype. The annulated diazinotropanes 6-8, ligands with ferruginine-like structures more or less retained the affinity of (-)-norferruginine (3) except of compound 7. Remarkably, all of the novel ligands are devoid of affinity at the alpha7* subtype.\",\n",
       "               'FAU': ['Gundisch, Daniela',\n",
       "                'Kampchen, Thomas',\n",
       "                'Schwarz, Simone',\n",
       "                'Seitz, Gunther',\n",
       "                'Siegl, Johanna',\n",
       "                'Wegge, Thomas'],\n",
       "               'AU': ['Gundisch D',\n",
       "                'Kampchen T',\n",
       "                'Schwarz S',\n",
       "                'Seitz G',\n",
       "                'Siegl J',\n",
       "                'Wegge T'],\n",
       "               'AD': ['Department of Pharmaceutical Chemistry, Rhein.Friedr.Wilh. University, Kreuzbergweg 26, D-53115, Bonn, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Bioorg Med Chem',\n",
       "               'JT': 'Bioorganic & medicinal chemistry',\n",
       "               'JID': '9413298',\n",
       "               'RN': ['0 (Ligands)',\n",
       "                '0 (Pyridazines)',\n",
       "                '0 (Pyridines)',\n",
       "                '0 (Pyrimidines)',\n",
       "                '0 (Receptors, Nicotinic)',\n",
       "                '0 (Tropanes)',\n",
       "                '0 (pyrido(3,4-b)norhomotropane)',\n",
       "                '449GLA0653 (pyridazine)',\n",
       "                'K8CXK5Q32L (pyrimidine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Ligands',\n",
       "                'Molecular Structure',\n",
       "                'Pyridazines/*chemistry',\n",
       "                'Pyridines/*chemical synthesis/chemistry/metabolism',\n",
       "                'Pyrimidines/*chemistry',\n",
       "                'Receptors, Nicotinic/*metabolism',\n",
       "                'Spectrum Analysis',\n",
       "                'Tropanes/*chemical synthesis/chemistry/metabolism'],\n",
       "               'EDAT': '2001/12/12 10:00',\n",
       "               'MHDA': '2002/03/13 10:01',\n",
       "               'CRDT': ['2001/12/12 10:00'],\n",
       "               'PHST': ['2001/12/12 10:00 [pubmed]',\n",
       "                '2002/03/13 10:01 [medline]',\n",
       "                '2001/12/12 10:00 [entrez]'],\n",
       "               'AID': ['S0968089601002589 [pii]',\n",
       "                '10.1016/s0968-0896(01)00258-9 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Bioorg Med Chem. 2002 Jan;10(1):1-9. doi: 10.1016/s0968-0896(01)00258-9.'}],\n",
       "             '2001': [{'PMID': '11760344',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20020125',\n",
       "               'LR': '20191025',\n",
       "               'IS': '0177-5537 (Print) 0177-5537 (Linking)',\n",
       "               'VI': '104',\n",
       "               'IP': '11',\n",
       "               'DP': '2001 Nov',\n",
       "               'TI': '[Congenital diaphragmatic hernia in a polytrauma patient].',\n",
       "               'PG': '1107-10',\n",
       "               'AB': 'A case of congenital, bilateral, diaphragmatic hernia in a patient with multiple trauma after a motor accident is presented. No anamnestic information was available because of the need for intubation at the accident site. After the insertion of bilateral chest tubes because of left sided pneumothorax and right sided haematopneumothorax a mediastinal mass became apparent. A CT scan revealed a bilateral diaphragmatic hernia. Problems and therapy of this condition as well as differentiation between congenital and traumatic hernias are discussed in this case report. A mediastinal mass of unknown origin in multiple trauma patients suggests the presence of traumatic diaphragmatic hernia. Diagnostic signs suggesting congenital hernia as compared to acute traumatic hernia are: unilateral or bilateral localisation in the dorsal muscular part of the diaphragm and non-suspicious appearance of parenchymal abdominal organs in relation to the size of the hernia. Diaphragmatic hernias reduce the vital and functional residual capacity of the lungs, possibly leading to respiratory complications and infections.',\n",
       "               'FAU': ['Harms, J M',\n",
       "                'Bohner, H',\n",
       "                'Wenserski, F',\n",
       "                'Rohrborn, A',\n",
       "                'Muller, E',\n",
       "                'Goretzki, P E'],\n",
       "               'AU': ['Harms JM',\n",
       "                'Bohner H',\n",
       "                'Wenserski F',\n",
       "                'Rohrborn A',\n",
       "                'Muller E',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Klinik fur Allgemeine und Unfallchirurgie, Heinrich-Heine-Universitat, Moorenstrasse 5, 40225 Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Case Reports', 'Journal Article'],\n",
       "               'TT': 'Angeborene beidseitige Zwerchfellhernie bei einem polytraumatisierten Patienten.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Unfallchirurg',\n",
       "               'JT': 'Der Unfallchirurg',\n",
       "               'JID': '8502736',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Aged',\n",
       "                'Diagnosis, Differential',\n",
       "                'Hemothorax/*diagnostic imaging',\n",
       "                'Hernia, Diaphragmatic/diagnostic imaging',\n",
       "                'Hernia, Diaphragmatic, Traumatic/diagnostic imaging',\n",
       "                '*Hernias, Diaphragmatic, Congenital',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Multiple Trauma/*diagnostic imaging',\n",
       "                'Pneumothorax/*diagnostic imaging',\n",
       "                '*Tomography, X-Ray Computed'],\n",
       "               'EDAT': '2002/01/05 10:00',\n",
       "               'MHDA': '2002/01/26 10:01',\n",
       "               'CRDT': ['2002/01/05 10:00'],\n",
       "               'PHST': ['2002/01/05 10:00 [pubmed]',\n",
       "                '2002/01/26 10:01 [medline]',\n",
       "                '2002/01/05 10:00 [entrez]'],\n",
       "               'AID': ['10.1007/s001130170027 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Unfallchirurg. 2001 Nov;104(11):1107-10. doi: 10.1007/s001130170027.'},\n",
       "              {'PMID': '11568851',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20020109',\n",
       "               'LR': '20041117',\n",
       "               'IS': '1058-4838 (Print) 1058-4838 (Linking)',\n",
       "               'VI': '33',\n",
       "               'IP': '9',\n",
       "               'DP': '2001 Nov 1',\n",
       "               'TI': 'The microbiology of postoperative peritonitis.',\n",
       "               'PG': '1513-9',\n",
       "               'AB': 'Postoperative peritonitis carries a higher risk of complications and mortality than does community-acquired disease. Little, however, is known about the specific microbiology of this condition. To gain insight into this problem, the microbiological findings of 67 patients with postoperative peritonitis were compared with those of 68 patients with community-acquired peritonitis. In a comparison of postoperative peritonitis with community-acquired disease, the number of isolates of enterococci (23 versus 6) and Enterobacter species (13 versus 4) were increased and the number of isolates of Escherichia coli (21 versus 42) were reduced. Antibiotic therapy before reintervention increased the number of resistant organisms at relaparotomy (33% versus 8%). The in vitro efficacy of the primary antibiotic or combination of drugs did not affect mortality rates (40% versus 38% after effective and ineffective treatment, respectively). Thus, the microbiology of postoperative peritonitis differs significantly from that of community-acquired disease, and specific antibiotic therapy is required, despite the doubtful impact on survival.',\n",
       "               'FAU': ['Roehrborn, A',\n",
       "                'Thomas, L',\n",
       "                'Potreck, O',\n",
       "                'Ebener, C',\n",
       "                'Ohmann, C',\n",
       "                'Goretzki, P E',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Roehrborn A',\n",
       "                'Thomas L',\n",
       "                'Potreck O',\n",
       "                'Ebener C',\n",
       "                'Ohmann C',\n",
       "                'Goretzki PE',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Department of General and Trauma Surgery, Heinrich Heine University, Dusseldorf, Germany. roehrborn@med.uni-duesseldorf.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'DEP': '20010924',\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Clin Infect Dis',\n",
       "               'JT': 'Clinical infectious diseases : an official publication of the Infectious Diseases Society of America',\n",
       "               'JID': '9203213',\n",
       "               'RN': ['0 (Anti-Bacterial Agents)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Anti-Bacterial Agents/therapeutic use',\n",
       "                'Humans',\n",
       "                'Peritonitis/drug therapy/*microbiology',\n",
       "                'Surgical Wound Infection/drug therapy/*microbiology'],\n",
       "               'EDAT': '2001/09/25 10:00',\n",
       "               'MHDA': '2002/01/10 10:01',\n",
       "               'CRDT': ['2001/09/25 10:00'],\n",
       "               'PHST': ['2001/01/17 00:00 [received]',\n",
       "                '2001/05/14 00:00 [revised]',\n",
       "                '2001/09/25 10:00 [pubmed]',\n",
       "                '2002/01/10 10:01 [medline]',\n",
       "                '2001/09/25 10:00 [entrez]'],\n",
       "               'AID': ['CID010091 [pii]', '10.1086/323333 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Clin Infect Dis. 2001 Nov 1;33(9):1513-9. doi: 10.1086/323333. Epub 2001 Sep 24.'},\n",
       "              {'PMID': '11549657',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20011011',\n",
       "               'LR': '20171116',\n",
       "               'IS': '0021-972X (Print) 0021-972X (Linking)',\n",
       "               'VI': '86',\n",
       "               'IP': '9',\n",
       "               'DP': '2001 Sep',\n",
       "               'TI': 'Soluble Fas is increased in hyperthyroidism independent of the underlying thyroid disease.',\n",
       "               'PG': '4250-3',\n",
       "               'AB': \"In Hashimoto's thyroiditis, Fas-induced apoptosis is one of the mechanisms leading to cell destruction, whereas thyroid tissue in Graves' disease is prevented from it. The soluble form of the Fas molecule produced by alternative splicing prevents from apoptosis. We measured soluble Fas in the sera of 112 patients with Graves' disease, 21 patients with toxic goiter, and 24 patients with subclinical hyperthyroidism due to suppressive therapy with levothyroxine after near-total resection of the thyroid gland for nodular goiter. Soluble Fas was increased in thyrotoxic patients, toxic goiter, and patients with subclinical hyperthyroidism. Decreased levels of soluble Fas were found in euthyroid patients with Graves' disease after surgery, whereas soluble Fas was normal in euthyroid patients with Graves' disease receiving antithyroid drug treatment and in patients in stable remission. There was a good correlation between soluble Fas with free T(3) (r = 0.6) and free T(4) (r = 0.5). Our results show that soluble Fas is increased in hyperthyroidism independent of the underlying thyroid disease.\",\n",
       "               'FAU': ['Feldkamp, J',\n",
       "                'Pascher, E',\n",
       "                'Schott, M',\n",
       "                'Goretzki, P',\n",
       "                'Seissler, J',\n",
       "                'Scherbaum, W A'],\n",
       "               'AU': ['Feldkamp J',\n",
       "                'Pascher E',\n",
       "                'Schott M',\n",
       "                'Goretzki P',\n",
       "                'Seissler J',\n",
       "                'Scherbaum WA'],\n",
       "               'AD': ['Department of Endocrinology, Heinrich Heine University, D-40225 Dusseldorf, Germany. feldkamj@uni-duesseldorf.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Clinical Trial', 'Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Clin Endocrinol Metab',\n",
       "               'JT': 'The Journal of clinical endocrinology and metabolism',\n",
       "               'JID': '0375362',\n",
       "               'RN': ['0 (Receptors, Thyrotropin)',\n",
       "                '0 (fas Receptor)',\n",
       "                '06LU7C9H1V (Triiodothyronine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Apoptosis/drug effects',\n",
       "                'Disease Progression',\n",
       "                'Female',\n",
       "                'Graves Disease/*blood',\n",
       "                'Humans',\n",
       "                'Hyperthyroidism/*blood',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Receptors, Thyrotropin/metabolism',\n",
       "                'Thyrotoxicosis/metabolism',\n",
       "                'Triiodothyronine/blood',\n",
       "                'fas Receptor/*metabolism'],\n",
       "               'EDAT': '2001/09/11 10:00',\n",
       "               'MHDA': '2001/10/12 10:01',\n",
       "               'CRDT': ['2001/09/11 10:00'],\n",
       "               'PHST': ['2001/09/11 10:00 [pubmed]',\n",
       "                '2001/10/12 10:01 [medline]',\n",
       "                '2001/09/11 10:00 [entrez]'],\n",
       "               'AID': ['10.1210/jcem.86.9.7834 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Clin Endocrinol Metab. 2001 Sep;86(9):4250-3. doi: 10.1210/jcem.86.9.7834.'},\n",
       "              {'PMID': '11417985',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20010726',\n",
       "               'LR': '20161124',\n",
       "               'IS': '0748-7983 (Print) 0748-7983 (Linking)',\n",
       "               'VI': '27',\n",
       "               'IP': '4',\n",
       "               'DP': '2001 Jun',\n",
       "               'TI': 'Parathyroid carcinoma: problems in diagnosis and the need for radical surgery even in recurrent disease.',\n",
       "               'PG': '383-9',\n",
       "               'AB': 'INTRODUCTION: From 1986 to 1999 we operated on 963 patients with primary hyperparathyroidism (pHPT). METHODS AND RESULTS: Parathyroid carcinoma was diagnosed clinically and histologically in four patients (0.4%). In two of these patients diagnosis of parathyroid cancer was delayed by misinterpretation of the histopathology leading to an autotransplantation of malignant parathyroid tissue in one case. In two patients multivisceral surgery was performed: beside thyroidectomy, neck dissection, tracheal wall resection and resection of the muscular layer of the oesophagus one patient received oesophagectomy and gastric transposition and one patient a lung wedge resection. Both patients had a temporary palliation of tumour-associated symptoms after multivisceral surgery. The first patient died 2 years after oesophagectomy and 12 years after primary diagnosis from local tumour recurrence and cachexia. The second patient is living with tumour recurrence presenting a serum calcium level of 4.2 mmol/l (normal range 2.0 to 2.5 mol/l) and multiple brown tumours 2 years after lung resection and 6 years after the primary diagnosis. CONCLUSIONS: We conclude that parathyroid carcinomas, being difficult to diagnose, warrant radical surgery, including multivisceral resection to prolong survival and reduce tumour and hypercalcaemia associated symptoms.',\n",
       "               'CI': ['Copyright Harcourt Publishers Limited.'],\n",
       "               'FAU': ['Dotzenrath, C',\n",
       "                'Goretzki, P E',\n",
       "                'Sarbia, M',\n",
       "                'Cupisti, K',\n",
       "                'Feldkamp, J',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Dotzenrath C',\n",
       "                'Goretzki PE',\n",
       "                'Sarbia M',\n",
       "                'Cupisti K',\n",
       "                'Feldkamp J',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Department of Surgery, Heinrich Heine-University Dusseldorf, Dusseldorf, Germany. dotzenr@uni-duesseldorf.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports', 'Journal Article'],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Eur J Surg Oncol',\n",
       "               'JT': 'European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology',\n",
       "               'JID': '8504356',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Diagnosis, Differential',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism/*etiology',\n",
       "                'Immunohistochemistry',\n",
       "                'Magnetic Resonance Imaging',\n",
       "                'Male',\n",
       "                'Parathyroid Neoplasms/complications/*diagnosis/diagnostic imaging/pathology/*surgery',\n",
       "                'Surgical Procedures, Operative/methods',\n",
       "                'Tomography, Emission-Computed',\n",
       "                'Tomography, X-Ray Computed',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '2001/06/22 10:00',\n",
       "               'MHDA': '2001/07/28 10:01',\n",
       "               'CRDT': ['2001/06/22 10:00'],\n",
       "               'PHST': ['2001/06/22 10:00 [pubmed]',\n",
       "                '2001/07/28 10:01 [medline]',\n",
       "                '2001/06/22 10:00 [entrez]'],\n",
       "               'AID': ['S0748-7983(01)91122-9 [pii]',\n",
       "                '10.1053/ejso.2001.1122 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Surg Oncol. 2001 Jun;27(4):383-9. doi: 10.1053/ejso.2001.1122.'},\n",
       "              {'PMID': '11405089',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20020401',\n",
       "               'LR': '20191104',\n",
       "               'IS': '1435-2443 (Print) 1435-2443 (Linking)',\n",
       "               'VI': '386',\n",
       "               'IP': '1',\n",
       "               'DP': '2001 Feb',\n",
       "               'TI': 'Is there any consensus in diagnostic and operative strategy with respect to medullary thyroid cancer? A questionnaire answered by 73 endocrine surgical units.',\n",
       "               'PG': '47-52',\n",
       "               'AB': 'BACKGROUND: The purpose of this investigation was to analyze the individual diagnostic and operative strategy in the treatment of medullary thyroid carcinoma (MTC) in international specialized centers and to assess whether standard procedures are carried out in practice everywhere. METHODS: A questionnaire concerning diagnosis and treatment of patients with primary, persistent, or recurrent sporadic or familial MTC was sent to 263 members of the International Association of Endocrine Surgeons. RESULTS: Primary treatment of MTC does not show significant differences for patients with sporadic or familial disease (Chi-square, n.s.), and standard procedures are performed in only 25-40% of patients. Computed tomography scan is the most common localization procedure in persistent or recurrent disease (52-72%), followed by scintigraphy (43-71%), ultrasonography (41-56%), and magnetic resonance imaging (31-49%). In case of negative localization studies, 68-86% of colleagues do not recommend reoperation. In symptomatic patients with stage-IV tumors, however, 84% of colleagues advocate reoperation to provide relief from the tumor burden. CONCLUSIONS: Even with experienced endocrine surgeons, a consensus to uni- and/or bilateral neck dissection in primary MTC is lacking. The majority of authors supports at least total thyroidectomy with central lymph-node dissection. In recurrent disease, there is a general tendency to reoperate in case of positive localization studies and in case of symptomatic disease.',\n",
       "               'FAU': ['Dotzenrath, C',\n",
       "                'Goretzki, P E',\n",
       "                'Cupisti, K',\n",
       "                'Simon, D',\n",
       "                'Witte, J',\n",
       "                'Yang, Q',\n",
       "                'Ohmann, C',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Dotzenrath C',\n",
       "                'Goretzki PE',\n",
       "                'Cupisti K',\n",
       "                'Simon D',\n",
       "                'Witte J',\n",
       "                'Yang Q',\n",
       "                'Ohmann C',\n",
       "                'Roher HD'],\n",
       "               'AD': ['St. Antonius Kliniken, Marienheim, Hardtstr. 46, D-42107 Wuppertal, Germany. Dotzenr@uni-duesseldorf.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Carcinoma, Medullary/*diagnosis/*surgery',\n",
       "                'Humans',\n",
       "                \"Practice Patterns, Physicians'\",\n",
       "                'Surgery Department, Hospital',\n",
       "                '*Surveys and Questionnaires',\n",
       "                'Thyroid Neoplasms/*diagnosis/*surgery'],\n",
       "               'EDAT': '2001/06/19 10:00',\n",
       "               'MHDA': '2002/04/02 10:01',\n",
       "               'CRDT': ['2001/06/19 10:00'],\n",
       "               'PHST': ['2001/06/19 10:00 [pubmed]',\n",
       "                '2002/04/02 10:01 [medline]',\n",
       "                '2001/06/19 10:00 [entrez]'],\n",
       "               'AID': ['10.1007/s004230000186 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 2001 Feb;386(1):47-52. doi: 10.1007/s004230000186.'},\n",
       "              {'PMID': '11316400',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20010830',\n",
       "               'LR': '20141120',\n",
       "               'IS': '1102-4151 (Print) 1102-4151 (Linking)',\n",
       "               'VI': '167',\n",
       "               'IP': '3',\n",
       "               'DP': '2001 Mar',\n",
       "               'TI': 'Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential?',\n",
       "               'PG': '173-8',\n",
       "               'AB': 'OBJECTIVE: To analyse our long term results in patients operated on for primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa. DESIGN: Retrospective (data collection) and prospective (follow-up) analysis. SETTING: University hospital, Germany. SUBJECTS: 39 patients with MEN type I-associated and 7 patients with MEN-type-IIa-associated primary hyperparathyroidism. INTERVENTIONS: Subtotal parathyroidectomy (n = 25 with MEN I and 1 with MEN IIa), total parathyroidectomy and autotransplantation (one in each group) and removal of only enlarged glands (13 with MEN type I and 5 with MEN type IIa). MAIN OUTCOME MEASUREMENTS: Recurrence rate of hyperparathyroidism and permanent hypocalcaemia postoperatively. RESULTS: Subtotal parathyroidectomy in patients with MEN type I gave a significantly lower recurrence rate than removal of only enlarged glands (3/25 compared with 3/13, log rank, p = 0.04). Permanent hypocalcaemia developed in 3/25 compared with 3/13, respectively. 2/5 patients with MEN type IIa developed recurrences after removal of only enlarged glands and the rate was higher than expected. CONCLUSIONS: A more extensive operation is essential for patients with MEN type I; the rate of permanent hypocalcaemia is not increased, but the recurrence rate is reduced. Patients with MEN type IIa should be treated by excision of enlarged glands alone, but this may be extended to subtotal parathyroidectomy in patients with severe symptoms.',\n",
       "               'FAU': ['Dotzenrath, C',\n",
       "                'Cupisti, K',\n",
       "                'Goretzki, P E',\n",
       "                'Yang, Q',\n",
       "                'Simon, D',\n",
       "                'Ohmann, C',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Dotzenrath C',\n",
       "                'Cupisti K',\n",
       "                'Goretzki PE',\n",
       "                'Yang Q',\n",
       "                'Simon D',\n",
       "                'Ohmann C',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Department of Surgery, Heinrich Heine University Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Eur J Surg',\n",
       "               'JT': 'The European journal of surgery = Acta chirurgica',\n",
       "               'JID': '9105264',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/complications',\n",
       "                'Adenoma, Islet Cell/complications',\n",
       "                'Adrenal Cortex Neoplasms/complications',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hypercalcemia/etiology',\n",
       "                'Hyperparathyroidism/*complications/*surgery',\n",
       "                'Hypocalcemia/etiology',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Multiple Endocrine Neoplasia Type 1/*complications',\n",
       "                'Multiple Endocrine Neoplasia Type 2a/*complications',\n",
       "                'Pancreatic Neoplasms/complications',\n",
       "                'Parathyroidectomy/*methods',\n",
       "                'Pituitary Neoplasms/complications',\n",
       "                'Reoperation',\n",
       "                'Retrospective Studies',\n",
       "                'Secondary Prevention'],\n",
       "               'EDAT': '2001/04/24 10:00',\n",
       "               'MHDA': '2001/08/31 10:01',\n",
       "               'CRDT': ['2001/04/24 10:00'],\n",
       "               'PHST': ['2001/04/24 10:00 [pubmed]',\n",
       "                '2001/08/31 10:01 [medline]',\n",
       "                '2001/04/24 10:00 [entrez]'],\n",
       "               'AID': ['10.1080/110241501750099294 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Surg. 2001 Mar;167(3):173-8. doi: 10.1080/110241501750099294.'},\n",
       "              {'PMID': '11260859',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20010405',\n",
       "               'LR': '20190906',\n",
       "               'IS': '0171-5216 (Print) 0171-5216 (Linking)',\n",
       "               'VI': '127',\n",
       "               'IP': '3',\n",
       "               'DP': '2001',\n",
       "               'TI': 'Clinical management of malignant adrenal tumors.',\n",
       "               'PG': '143-55',\n",
       "               'AB': 'Malignant primary adrenal tumors are rare forms of cancer with an estimated incidence of two to ten new cases per one million inhabitants per year. The 5-year survival rate for adrenocortical carcinoma is approximately 35%, whereas the 10-year survival rate of malignant pheochromocytoma reaches 40%. Clinical studies support repeated surgery as the mainstay of treatment, either with curative or palliative intention. For adrenocortical carcinoma, adjunctive treatment with oral mitotane leads to well-documented improvement of survival. Rare malignant pheochromocytomas with distant metastases are preferably treated by 131I-MIBG. Chemotherapy is reserved for unresectable tumors without sufficient response to mitotane or 131I-MIBG, respectively. Cisplatin and etoposide as single therapy, or in combination with doxorubicin or etoposide, appear to be effective in adrenocortical carcinoma. Malignant pheochromocytoma may be treated with vincristine, dacarbazine, and cyclophosphamide. Treatment with octreotide is currently being evaluated. Radiotherapy is indicated if unresectable tumor masses cause local symptoms. If symptoms of endocrine activity are not sufficiently controlled by measures aiming at tumor mass reduction, specific inhibitors of hormone synthesis or action are available. Ketoconazole is widely used for adrenocortical carcinoma, and phenoxybenzamine and metyrosine are available for malignant pheochromocytoma. This review provides guidelines for rational disease management based on still scanty clinical evidence.',\n",
       "               'FAU': ['Kopf, D', 'Goretzki, P E', 'Lehnert, H'],\n",
       "               'AU': ['Kopf D', 'Goretzki PE', 'Lehnert H'],\n",
       "               'AD': ['Department of Endocrinology and Metabolism, Otto von Guericke University Magdeburg, Leipziger Strasse 44, 39120 Magdeburg, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'J Cancer Res Clin Oncol',\n",
       "               'JT': 'Journal of cancer research and clinical oncology',\n",
       "               'JID': '7902060',\n",
       "               'RN': ['0 (Antineoplastic Agents)',\n",
       "                '0 (Antineoplastic Agents, Hormonal)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adrenal Cortex Neoplasms/diagnosis/therapy',\n",
       "                'Adrenal Gland Neoplasms/*diagnosis/drug therapy/epidemiology/radiotherapy/surgery/*therapy',\n",
       "                'Adrenocortical Carcinoma/diagnosis/therapy',\n",
       "                'Antineoplastic Agents/*therapeutic use',\n",
       "                'Antineoplastic Agents, Hormonal/therapeutic use',\n",
       "                'Antineoplastic Combined Chemotherapy Protocols/therapeutic use',\n",
       "                'Combined Modality Therapy',\n",
       "                'Diagnosis, Differential',\n",
       "                'Humans',\n",
       "                'Pheochromocytoma/diagnosis/therapy'],\n",
       "               'RF': '125',\n",
       "               'EDAT': '2001/03/23 10:00',\n",
       "               'MHDA': '2001/04/06 10:01',\n",
       "               'CRDT': ['2001/03/23 10:00'],\n",
       "               'PHST': ['2001/03/23 10:00 [pubmed]',\n",
       "                '2001/04/06 10:01 [medline]',\n",
       "                '2001/03/23 10:00 [entrez]'],\n",
       "               'AID': ['10.1007/s004320000170 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Cancer Res Clin Oncol. 2001;127(3):143-55. doi: 10.1007/s004320000170.'},\n",
       "              {'PMID': '11216010',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20010426',\n",
       "               'LR': '20061115',\n",
       "               'IS': '1438-3276 (Print) 1438-3276 (Linking)',\n",
       "               'VI': '143',\n",
       "               'IP': '1-2',\n",
       "               'DP': '2001 Jan 11',\n",
       "               'TI': '[When is total thyroidectomy indicated? What applies in thyroid carcinoma: radical surgery according to findings].',\n",
       "               'PG': '32-4',\n",
       "               'AB': 'Today, surgical treatment of thyroid carcinoma is oriented to the underlying histology and the extent of the tumourous process. Total thyroidectomy with postoperative radioiodine treatment represents only one of the spectrum of possibilities that ranges from limited to extended radical interventional procedures. Such an individualized operative strategy should be applied not only for the primary intervention, but also for locoregional tumour recurrence and confirmed distant metastases, with the aim of keeping operative morbidity to a minimum.',\n",
       "               'FAU': ['Goretzki, P E', 'Witte, J'],\n",
       "               'AU': ['Goretzki PE', 'Witte J'],\n",
       "               'AD': ['Klinik fur Allgemeine und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Wann ist die totale Thyreoidektomie angezeigt? Beim Schilddrusen-Ca. gilt: Radikalitat je nach Befund.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'MMW Fortschr Med',\n",
       "               'JT': 'MMW Fortschritte der Medizin',\n",
       "               'JID': '100893959',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Neoplasm Invasiveness',\n",
       "                'Neoplasm Staging',\n",
       "                'Prognosis',\n",
       "                'Thyroid Gland/pathology',\n",
       "                'Thyroid Neoplasms/pathology/*surgery',\n",
       "                '*Thyroidectomy'],\n",
       "               'EDAT': '2001/02/24 12:00',\n",
       "               'MHDA': '2001/05/01 10:01',\n",
       "               'CRDT': ['2001/02/24 12:00'],\n",
       "               'PHST': ['2001/02/24 12:00 [pubmed]',\n",
       "                '2001/05/01 10:01 [medline]',\n",
       "                '2001/02/24 12:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'MMW Fortschr Med. 2001 Jan 11;143(1-2):32-4.'},\n",
       "              {'PMID': '11150038',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20010208',\n",
       "               'LR': '20190915',\n",
       "               'IS': '0039-6060 (Print) 0039-6060 (Linking)',\n",
       "               'VI': '129',\n",
       "               'IP': '1',\n",
       "               'DP': '2001 Jan',\n",
       "               'TI': 'Malignant endocrine tumors in patients with MEN 1 disease.',\n",
       "               'PG': '91-5',\n",
       "               'AB': 'BACKGROUND: In contrast with multiple endocrine neoplasia type 2, malignancies are of minor importance in multiple endocrine neoplasia type 1 (MEN 1) syndrome. METHODS: The data for 42 patients with MEN 1 syndrome were evaluated. Twelve patients (29%) had 1 or more associated malignancies: malignant gastrinoma (1 patient), neuroendocrine tumors of the thymus (2 patients), neuroendocrine tumors of the lung (3 patients), neuroendocrine tumor of the ileum (1 patient), adrenocortical carcinomas (2 patients), and a combination of neuroendocrine tumors of thymus, lung or pancreas (3 patients). RESULTS: Despite suspected MEN 1 syndrome in 7 patients, malignancies were detected late in 4 patients and could not be resected curatively. The survival rates for 5 years and 10 years after operation of the malignant tumor were 66% +/- 14% (SE) and 33% +/- 15% (SE), respectively. CONCLUSIONS: In patients at risk for the MEN 1 syndrome, genetic screening is indispensable. Gene carriers have to be followed up closely with hormone analysis and routine examination of the thorax, pancreas, and adrenal glands to detect malignancies as early as possible.',\n",
       "               'FAU': ['Dotzenrath, C',\n",
       "                'Goretzki, P E',\n",
       "                'Cupisti, K',\n",
       "                'Yang, Q',\n",
       "                'Simon, D',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Dotzenrath C',\n",
       "                'Goretzki PE',\n",
       "                'Cupisti K',\n",
       "                'Yang Q',\n",
       "                'Simon D',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Department of Surgery, Heinrich-Heine Universitat, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Surgery',\n",
       "               'JT': 'Surgery',\n",
       "               'JID': '0417347',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Female',\n",
       "                'Gastrinoma/genetics/surgery',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism/genetics',\n",
       "                'Lung Neoplasms/genetics/surgery',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Multiple Endocrine Neoplasia Type 1/genetics/pathology/*surgery',\n",
       "                'Mutation',\n",
       "                'Pancreatic Neoplasms/genetics/surgery',\n",
       "                'Thymus Neoplasms/genetics/surgery'],\n",
       "               'EDAT': '2001/01/10 11:00',\n",
       "               'MHDA': '2001/03/03 10:01',\n",
       "               'CRDT': ['2001/01/10 11:00'],\n",
       "               'PHST': ['2001/01/10 11:00 [pubmed]',\n",
       "                '2001/03/03 10:01 [medline]',\n",
       "                '2001/01/10 11:00 [entrez]'],\n",
       "               'AID': ['S0039606001457229 [pii]',\n",
       "                '10.1067/msy.2001.109500 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Surgery. 2001 Jan;129(1):91-5. doi: 10.1067/msy.2001.109500.'},\n",
       "              {'PMID': '11115561',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20010301',\n",
       "               'LR': '20051116',\n",
       "               'IS': '1021-335X (Print) 1021-335X (Linking)',\n",
       "               'VI': '8',\n",
       "               'IP': '1',\n",
       "               'DP': '2001 Jan-Feb',\n",
       "               'TI': 'Follicular thyroid cancer cells: a model of metastatic tumor in vitro (review).',\n",
       "               'PG': '3-8',\n",
       "               'AB': 'We used a thyroid metastatic tumor model to analyze some of the mechanisms of invasion and metastasis in culture. Chronic TSH stimulation (thyroid stimulating hormone) was associated with enhanced tumor proliferation and aggressiveness. We present a unique metastatic tumor model including three follicular thyroid cancer cell lines using a human primary tumor and two metastases of the same patient. They contain thyroglobulin, have intact thyroid functions and response to TSH. Investigating growth factor sensitivity we found that the amplitude of stimulation or inhibition of invasion was significantly smaller in both metastatic cell lines. Unstimulated cells of the lung metastasis had the highest basal invasive potential, but were only minimally affected by the stimulation of growth factors. In contrast, the parental cell line had the lowest basal invasiveness, but was considerably stimulated by growth factors.',\n",
       "               'FAU': ['Hoelting, T', 'Goretzki, P E', 'Duh, Q Y'],\n",
       "               'AU': ['Hoelting T', 'Goretzki PE', 'Duh QY'],\n",
       "               'AD': ['Department of Surgery, University of Heidelberg, D-69120 Heidelberg, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'PL': 'Greece',\n",
       "               'TA': 'Oncol Rep',\n",
       "               'JT': 'Oncology reports',\n",
       "               'JID': '9422756',\n",
       "               'RN': ['0 (Transforming Growth Factor alpha)',\n",
       "                '0 (Transforming Growth Factor beta)',\n",
       "                '62229-50-9 (Epidermal Growth Factor)',\n",
       "                '9002-71-5 (Thyrotropin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma, Follicular/genetics/metabolism/*pathology/secondary',\n",
       "                'Aneuploidy',\n",
       "                'Animals',\n",
       "                'Cell Differentiation',\n",
       "                'Chromosomes, Human, Pair 13/ultrastructure',\n",
       "                'Chromosomes, Human, Pair 5/ultrastructure',\n",
       "                'Chromosomes, Human, Pair 7/ultrastructure',\n",
       "                'Epidermal Growth Factor/pharmacology',\n",
       "                'Flow Cytometry',\n",
       "                'Humans',\n",
       "                'Lymphatic Metastasis',\n",
       "                'Mice',\n",
       "                'Mice, Nude',\n",
       "                'Neoplasm Invasiveness',\n",
       "                'Neoplasm Metastasis/*pathology',\n",
       "                'Neoplasm Transplantation',\n",
       "                'Thyroid Neoplasms/genetics/metabolism/*pathology',\n",
       "                'Thyrotropin/pharmacology/toxicity',\n",
       "                'Transforming Growth Factor alpha/pharmacology',\n",
       "                'Transforming Growth Factor beta/pharmacology',\n",
       "                'Translocation, Genetic',\n",
       "                'Transplantation, Heterologous',\n",
       "                'Tumor Cells, Cultured/drug effects/metabolism/pathology/transplantation'],\n",
       "               'RF': '17',\n",
       "               'EDAT': '2000/12/15 11:00',\n",
       "               'MHDA': '2001/03/07 10:01',\n",
       "               'CRDT': ['2000/12/15 11:00'],\n",
       "               'PHST': ['2000/12/15 11:00 [pubmed]',\n",
       "                '2001/03/07 10:01 [medline]',\n",
       "                '2000/12/15 11:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Oncol Rep. 2001 Jan-Feb;8(1):3-8.'}],\n",
       "             '2000': [{'PMID': '11201009',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20010322',\n",
       "               'LR': '20211203',\n",
       "               'IS': '1435-2443 (Print) 1435-2443 (Linking)',\n",
       "               'VI': '385',\n",
       "               'IP': '8',\n",
       "               'DP': '2000 Dec',\n",
       "               'TI': 'Surgical treatment of postoperative, incidentally diagnosed small sporadic C-cell carcinomas of the thyroid.',\n",
       "               'PG': '526-30',\n",
       "               'AB': 'BACKGROUND AND AIMS: The surgical strategy in small sporadic C-cell carcinomas of the thyroid that are incidentally diagnosed after goiter resection for benign disease is controversial. It remains unclear whether a completion thyroidectomy should be performed in every case. PATIENTS AND METHODS: We present nine patients who were operated on between October 1992 and October 1997 in whom an unexpected, small sporadic C-cell carcinoma (seven with pT1, two with pT2) was found in the postoperative histology. RESULTS: All patients were calcitonin negative and there were no signs of the disease being inherited (no familial history, negative RET proto-oncogene). No patient underwent a completion thyroidectomy. All patients had a follow-up with pentagastrin-stimulated calcitonin and carcinoembryonic antigen (CEA) 3 months, 6 months and annually after the operation. No patient became calcitonin positive or showed any other signs of tumor recurrence after a follow-up period of 2-7 years. CONCLUSION: A completion thyroidectomy is not necessary in small sporadic C-cell carcinoma that is incidentally diagnosed after resection for benign disease if there is no sign of familial cancer and if calcitonin is negative. A close follow-up is necessary.',\n",
       "               'FAU': ['Cupisti, K',\n",
       "                'Simon, D',\n",
       "                'Wolf, A',\n",
       "                'Gerharz, C D',\n",
       "                'Goretzki, P E',\n",
       "                'Dotzenrath, C',\n",
       "                'Witte, J',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Cupisti K',\n",
       "                'Simon D',\n",
       "                'Wolf A',\n",
       "                'Gerharz CD',\n",
       "                'Goretzki PE',\n",
       "                'Dotzenrath C',\n",
       "                'Witte J',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemein und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'RN': ['0 (Carcinoembryonic Antigen)',\n",
       "                '0 (MAS1 protein, human)',\n",
       "                '0 (Proto-Oncogene Mas)',\n",
       "                '9007-12-9 (Calcitonin)',\n",
       "                'EF0NX91490 (Pentagastrin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Calcitonin/blood/*drug effects',\n",
       "                'Carcinoembryonic Antigen/blood',\n",
       "                'Carcinoma, Medullary/*diagnosis/immunology/pathology/surgery/therapy',\n",
       "                'Diagnosis, Differential',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Immunohistochemistry',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Pentagastrin/pharmacology',\n",
       "                'Prognosis',\n",
       "                'Proto-Oncogene Mas',\n",
       "                'Retrospective Studies',\n",
       "                'Thyroid Diseases/pathology/surgery',\n",
       "                'Thyroid Neoplasms/*diagnosis/immunology/pathology/surgery/therapy',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '2001/02/24 12:00',\n",
       "               'MHDA': '2001/03/27 10:01',\n",
       "               'CRDT': ['2001/02/24 12:00'],\n",
       "               'PHST': ['2001/02/24 12:00 [pubmed]',\n",
       "                '2001/03/27 10:01 [medline]',\n",
       "                '2001/02/24 12:00 [entrez]'],\n",
       "               'AID': ['10.1007/s004230000166 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 2000 Dec;385(8):526-30. doi: 10.1007/s004230000166.'},\n",
       "              {'PMID': '11190613',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20010315',\n",
       "               'LR': '20171116',\n",
       "               'IS': '0044-409X (Print) 0044-409X (Linking)',\n",
       "               'VI': '125',\n",
       "               'IP': '12',\n",
       "               'DP': '2000',\n",
       "               'TI': '[Stomach saving duodenopancreatectomy. Indications and contraindications. The most important surgical steps].',\n",
       "               'PG': '961-5',\n",
       "               'AB': \"Discussion on pylorus-preserving pancreatoduodenectomy (PPPD) in case of ductal adenocarcinoma is controversal. Aim of the present study was the comparison of survival in patients resected by the classic Whipple operation (Whipple) or the pylorus-preserving procedure. From April 1986 to June 1998 all patients operated for proven diagnosis of ductal pancreatic cancer were documented prospectively concerning patient's characteristics, kind of surgery, complications and histopathological staging according to the UICC-classification of 1992. During the observation period 100 patients underwent pancreatoduodenectomy, 38 cases as Whipple, 62 as PPPD. Average of age was 59.9 +/- 10.3 years without significant differences. Mortality was 6.0% in total, 5.5% post Whipple, and 6.5% post PPPD. Eighty-three percent of the resected specimen were node positive. The median survival time was 9.9 and 10.5 months, 5-year survival 2.6% and 10%, respectively without significant differences. Actually, only node positive patients reached 5-year survival. Even better survival figures following PPPD than after classic Whipple procedure make the pylorus-preserving procedure the standard operation in ductal cancer of the pancreatic head. Distal gastric resection is only mandatory in case of tumor involvement of the duodenopancreatic angle. Since only node negative cases survived 5 years, extensive surgery exceeding anatomical pancreatic head resection does not appear to be beneficial.\",\n",
       "               'FAU': ['Roher, H D', 'Heise, J W', 'Goretzki, P E'],\n",
       "               'AU': ['Roher HD', 'Heise JW', 'Goretzki PE'],\n",
       "               'AD': ['Klinik fur Allgemeine und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'TT': 'Die magenerhaltende Duodenopankreatektomie. Indikation und Kontraindikation. Die wichtigsten operativen Schritte.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Zentralbl Chir',\n",
       "               'JT': 'Zentralblatt fur Chirurgie',\n",
       "               'JID': '0413645',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma/mortality/pathology/*surgery',\n",
       "                'Aged',\n",
       "                'Contraindications',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Lymphatic Metastasis',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Neoplasm Staging',\n",
       "                'Pancreatic Neoplasms/mortality/pathology/*surgery',\n",
       "                '*Pancreaticoduodenectomy',\n",
       "                'Prognosis',\n",
       "                'Pyloric Antrum/*surgery',\n",
       "                'Stomach/*surgery',\n",
       "                'Survival Rate'],\n",
       "               'EDAT': '2001/02/24 12:00',\n",
       "               'MHDA': '2001/03/17 10:01',\n",
       "               'CRDT': ['2001/02/24 12:00'],\n",
       "               'PHST': ['2001/02/24 12:00 [pubmed]',\n",
       "                '2001/03/17 10:01 [medline]',\n",
       "                '2001/02/24 12:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-2000-10073 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Zentralbl Chir. 2000;125(12):961-5. doi: 10.1055/s-2000-10073.'},\n",
       "              {'PMID': '11077584',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20010109',\n",
       "               'LR': '20190921',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '71',\n",
       "               'IP': '10',\n",
       "               'DP': '2000 Oct',\n",
       "               'TI': '[\"Field cancerization\"--an additional phenomenon in development of colon tumors? K-ras codon 12 mutations in normal colonic mucosa of patients with colorectal neoplasms].',\n",
       "               'PG': '1230-4; discussion 1234-5',\n",
       "               'AB': 'INTRODUCTION: The c-K-ras2-gene (K-ras) encodes the p21ras protein, which participates in the transduction of mitogenic signals from the cell surface to the nucleus. About 40-50% of colorectal cancers bear a point mutation of the K-ras codon 12 within exon I, leading to activation of the K-ras oncogene. METHODS: Using a polymerase chain reaction (PCR)-based two-step restriction fragment length polymorphism (2sRFLP)-technique, we assessed the frequency of point mutations in the first or second base of K-ras codon 12 in patients suffering from colorectal carcinoma, adenoma, and their normal colon mucosa, respectively. RESULTS: Similar to other investigators, we found mutations in 7 out of 17 (41%) colorectal carcinomas and 1 out of 4 (25%) adenomas. Using this very sensitive 2sRFLP technique (detection level = 0.2% of mutated cells), we were able to find K-ras codon 12 mutations in normal mucosa in 4 out of 18 (22.2%) patients with colorectal neoplasia. CONCLUSIONS: This result can be explained by the phenomenon of \"field cancerization\" or by a local micrometastasis of K-ras-positive tumor cells.',\n",
       "               'FAU': ['Aivado, M',\n",
       "                'Gynes, M',\n",
       "                'Gorelov, V',\n",
       "                'Schmidt, W U',\n",
       "                'Roher, H D',\n",
       "                'Goretzki, P E'],\n",
       "               'AU': ['Aivado M',\n",
       "                'Gynes M',\n",
       "                'Gorelov V',\n",
       "                'Schmidt WU',\n",
       "                'Roher HD',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Heinrich Heine-Universitat Dusseldorf. alvesai@uni-duesseldorf.de'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract',\n",
       "                'Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'TT': '\"Field cancerization\"--ein zusatzliches Phanomen in der Entwicklung von Colontumoren? K-ras-Codon-12-Mutationen in normaler Colonmucosa von Patienten mit colorectalen Neoplasien.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'RN': ['0 (Codon)',\n",
       "                'EC 3.6.5.2 (HRAS protein, human)',\n",
       "                'EC 3.6.5.2 (Proto-Oncogene Proteins p21(ras))'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma/*genetics/pathology',\n",
       "                'Adenoma/*genetics/pathology',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Biopsy',\n",
       "                'Cell Transformation, Neoplastic/*genetics/pathology',\n",
       "                '*Codon',\n",
       "                'Colorectal Neoplasms/*genetics/pathology',\n",
       "                'Exons',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Intestinal Mucosa/pathology',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Point Mutation/*genetics',\n",
       "                'Polymerase Chain Reaction',\n",
       "                'Polymorphism, Restriction Fragment Length',\n",
       "                'Proto-Oncogene Proteins p21(ras)/*genetics'],\n",
       "               'EDAT': '2000/11/15 11:00',\n",
       "               'MHDA': '2001/02/28 10:01',\n",
       "               'CRDT': ['2000/11/15 11:00'],\n",
       "               'PHST': ['2000/11/15 11:00 [pubmed]',\n",
       "                '2001/02/28 10:01 [medline]',\n",
       "                '2000/11/15 11:00 [entrez]'],\n",
       "               'AID': ['10.1007/s001040051207 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 2000 Oct;71(10):1230-4; discussion 1234-5. doi: 10.1007/s001040051207.'},\n",
       "              {'PMID': '11038198',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20001221',\n",
       "               'LR': '20190826',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '24',\n",
       "               'IP': '11',\n",
       "               'DP': '2000 Nov',\n",
       "               'TI': \"Surgery for Graves' disease: total versus subtotal thyroidectomy-results of a prospective randomized trial.\",\n",
       "               'PG': '1303-11',\n",
       "               'AB': \"The effect of surgery on Graves' orbitopathy (GO) is still controversial. Retrospective analyses of many authors (including our own group) demonstrated GO improvement after subtotal thyroid resection in up to 70% of operated patients, so the question arose whether total thyroidectomy could add anything to this pronounced positive effect on GO. We therefore performed a prospective randomized trial on 150 patients with Graves' disease (125 women, 25 men; mean thyroid volume 80.5 ml) comparing three surgical procedures (bilateral subtotal thyroid resection-total remnant < 4 ml; unilateral hemithyroidectomy with contralateral subtotal thyroid resection-remnant < 4 ml; total thyroidectomy) and their effect on postoperative GO changes, postoperative thyroid-stimulating hormone receptor (TSH-R) antibody titers, and postoperative complication rates. After a period of at least 6 months (6-36 months) GO had improved in 71% to 74% of all patients regardless of whether total or subtotal thyroidectomy was performed. TSH-R antibody titers showed no differences for the three surgical groups. Postoperative recurrent hyperthyroidism occurred in two patients with subtotal resections, and early postoperative hypoparathyroidism was more frequently detected in patients with total thyroidectomy than in those with subtotal thyroid resection (28% vs. 12%; p < 0.002). In respect to possible postoperative hypoparathyroidism and a lack of difference in postoperative GO changes, we do not advocate total thyroidectomy for patients with Graves' disease and Graves' orbitopathy but prefer radical subtotal thyroid resection with a remnant of less than 4 ml.\",\n",
       "               'FAU': ['Witte, J',\n",
       "                'Goretzki, P E',\n",
       "                'Dotzenrath, C',\n",
       "                'Simon, D',\n",
       "                'Felis, P',\n",
       "                'Neubauer, M',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Witte J',\n",
       "                'Goretzki PE',\n",
       "                'Dotzenrath C',\n",
       "                'Simon D',\n",
       "                'Felis P',\n",
       "                'Neubauer M',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Department of Surgery, Heinrich Heine University Dusseldorf, Moorenstrasse 5, D-40225 Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Clinical Trial',\n",
       "                'Comparative Study',\n",
       "                'Journal Article',\n",
       "                'Randomized Controlled Trial'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Child',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Graves Disease/diagnosis/*surgery',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Postoperative Complications',\n",
       "                'Prospective Studies',\n",
       "                'Reference Values',\n",
       "                'Statistics, Nonparametric',\n",
       "                'Thyroid Function Tests',\n",
       "                'Thyroidectomy/adverse effects/*methods',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '2000/10/19 11:00',\n",
       "               'MHDA': '2001/02/28 10:01',\n",
       "               'CRDT': ['2000/10/19 11:00'],\n",
       "               'PHST': ['2000/10/19 11:00 [pubmed]',\n",
       "                '2001/02/28 10:01 [medline]',\n",
       "                '2000/10/19 11:00 [entrez]'],\n",
       "               'AID': ['10.1007/s002680010216 [pii]',\n",
       "                '10.1007/s002680010216 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 2000 Nov;24(11):1303-11. doi: 10.1007/s002680010216.'},\n",
       "              {'PMID': '11026704',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20010117',\n",
       "               'LR': '20191104',\n",
       "               'IS': '1435-2443 (Print) 1435-2443 (Linking)',\n",
       "               'VI': '385',\n",
       "               'IP': '5',\n",
       "               'DP': '2000 Aug',\n",
       "               'TI': 'Therapeutic experience of 65 cases with organic hyperinsulinism.',\n",
       "               'PG': '329-36',\n",
       "               'AB': 'INTRODUCTION: The treatment for insulinoma is enucleation or resection, which are associated with various degrees of morbidity, including fistulas, pseudocysts, and necessity for reoperations. PATIENTS: We evaluated the outcome of 65 patients operated on for organic hyperinsulinism at an experienced university hospital (Department of Surgery, Heinrich-Heine University, Dusseldorf, Germany) between 1990 and 1998. Procedures included enucleation (n=37), left-sided resection (n=19), combination of enucleation from the head and left-sided resection (n=4), subtotal left pancreatectomy (n=2), and pancreaticoduodenectomy (n=3). RESULTS: In 47 out of the 65 patients (72%), the expected benign solitary insulinoma was found. Seven patients had malignant tumors and another eight had multiple tumors (including two with multiple endocrine neoplasia type 1 (MEN-1)), and three had nesidioblastosis. In total, 20 patients (31%) developed postoperative drainage of high amylase containing fluid, which in all but three cases resolved with conservative therapy. The three patients who developed fistulas and the three patients who developed pseudocysts underwent reoperative surgery. Seventeen (41%) of the patients who underwent enucleation (10 from the pancreatic head; 50%) and six (25%) of the resected patients demonstrated these complications. Postoperative glucose metabolism was normalized in all patients. CONCLUSION: Resection, especially in the head of the pancreas, demonstrates lower complication rates than enucleation. We propose resection for tumors that are large, malignant, situated close to pancreatic duct, and are multiple, including in MEN-1. For tumors in the head, pancreaticoduodenectomy may be an occasional choice.',\n",
       "               'FAU': ['Hellman, P',\n",
       "                'Goretzki, P',\n",
       "                'Simon, D',\n",
       "                'Dotzenrath, C',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Hellman P',\n",
       "                'Goretzki P',\n",
       "                'Simon D',\n",
       "                'Dotzenrath C',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Department of Surgery, Heinrich-Heine University, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Diagnosis, Differential',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperinsulinism/*etiology',\n",
       "                'Insulinoma/*diagnosis/diagnostic imaging/pathology/*surgery',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Multiple Endocrine Neoplasia Type 1/diagnosis/surgery',\n",
       "                '*Pancreatectomy/adverse effects/methods',\n",
       "                'Pancreatic Diseases/diagnosis/surgery',\n",
       "                'Pancreatic Neoplasms/complications/*diagnosis/diagnostic imaging/pathology/*surgery',\n",
       "                '*Pancreaticoduodenectomy/adverse effects/methods',\n",
       "                'Radiography',\n",
       "                'Recurrence',\n",
       "                'Retrospective Studies',\n",
       "                'Survival Analysis',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '2000/10/12 11:00',\n",
       "               'MHDA': '2001/02/28 10:01',\n",
       "               'CRDT': ['2000/10/12 11:00'],\n",
       "               'PHST': ['2000/10/12 11:00 [pubmed]',\n",
       "                '2001/02/28 10:01 [medline]',\n",
       "                '2000/10/12 11:00 [entrez]'],\n",
       "               'AID': ['10.1007/s004230000148 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 2000 Aug;385(5):329-36. doi: 10.1007/s004230000148.'},\n",
       "              {'PMID': '11016473',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20001018',\n",
       "               'LR': '20220321',\n",
       "               'IS': '0748-7983 (Print) 0748-7983 (Linking)',\n",
       "               'VI': '26',\n",
       "               'IP': '5',\n",
       "               'DP': '2000 Aug',\n",
       "               'TI': 'Gastric cancer: which patients benefit from systematic lymphadenectomy?',\n",
       "               'PG': '498-505',\n",
       "               'AB': 'AIMS: The purpose of this study was to evaluate the value of systematic lymphadenectomy (SLA) in curative resected gastric cancer patients with respect to long-term survival, peri-operative morbidity and mortality. METHODS: We reviewed our prospectively gathered database of 309 resected gastric cancer patients and analysed the outcome of 185 R0-resected patients (60%) with respect to peri-operative morbidity, mortality and long-term survival by comparing 81 patients resected with SLA (D2-group) versus 104 patients resected without SLA (D1-group). RESULTS: Overall 5-year survival rates of R0-resected patients (n = 173; exclusion of peri-operative mortality) amounted to 49% and did not differ significantly between D2- and D1-groups (53% vs 47%); P=0.344). Nevertheless, subgroups of patients taking a benefit from SLA could be defined. Gastric cancer patients without LN metastases (pTx pN0; n=78) and patients with LN metastases only in perigastric lymph nodes (pTx pN1; n=34) showed a significantly better long-term prognosis when SLA was performed (84% vs 51%; P=0.001). Regarding peri-operative morbidity (38% vs 39%) and mortality (6% in each case) we could not find any differences between the D2- and D1-groups. CONCLUSIONS: We conclude that SLA is able to improve long-term survival for some tumour stages. Therefore SLA should be recommended as a standard procedure in all gastric cancer patients resected with curative intention.',\n",
       "               'FAU': ['Bosing, N M', 'Goretzki, P E', 'Roher, H D'],\n",
       "               'AU': ['Bosing NM', 'Goretzki PE', 'Roher HD'],\n",
       "               'AD': ['Department of General and Trauma Surgery, Heinrich Heine University, Dusseldorf, Federal Republic Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Eur J Surg Oncol',\n",
       "               'JT': 'European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology',\n",
       "               'JID': '8504356',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                '*Lymph Node Excision/methods',\n",
       "                'Lymphatic Metastasis',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Prognosis',\n",
       "                'Prospective Studies',\n",
       "                'Reoperation',\n",
       "                'Risk Factors',\n",
       "                'Stomach Neoplasms/mortality/*surgery',\n",
       "                'Survival Analysis',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '2000/10/04 11:00',\n",
       "               'MHDA': '2000/10/21 11:01',\n",
       "               'CRDT': ['2000/10/04 11:00'],\n",
       "               'PHST': ['2000/10/04 11:00 [pubmed]',\n",
       "                '2000/10/21 11:01 [medline]',\n",
       "                '2000/10/04 11:00 [entrez]'],\n",
       "               'AID': ['S0748798399909307 [pii]',\n",
       "                '10.1053/ejso.1999.0930 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Surg Oncol. 2000 Aug;26(5):498-505. doi: 10.1053/ejso.1999.0930.'},\n",
       "              {'PMID': '10889192',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20001013',\n",
       "               'LR': '20210209',\n",
       "               'IS': '0021-9258 (Print) 0021-9258 (Linking)',\n",
       "               'VI': '275',\n",
       "               'IP': '37',\n",
       "               'DP': '2000 Sep 15',\n",
       "               'TI': 'Binding of the NG2 proteoglycan to kringle domains modulates the functional properties of angiostatin and plasmin(ogen).',\n",
       "               'PG': '28625-33',\n",
       "               'AB': 'Interactions of the developmentally regulated chondroitin sulfate proteoglycan NG2 with human plasminogen and kringle domain-containing plasminogen fragments have been analyzed by solid-phase immunoassays and by surface plasmon resonance. In immunoassays, the core protein of NG2 binds specifically and saturably to plasminogen, which consists of five kringle domains and a serine protease domain, and to angiostatin, which contains plasminogen kringle domains 1-3. Apparent dissociation constants for these interactions range from 12 to 75 nm. Additional evidence for NG2 interaction with kringle domains comes from its binding to plasminogen kringle domain 4 and to miniplasminogen (kringle domain 5 plus the protease domain) with apparent dissociation constants in the 18-71 nm range. Inhibition of plasminogen and angiostatin binding to NG2 by 6-aminohexanoic acid suggests that lysine binding sites are involved in kringle interaction with NG2. The interaction of NG2 with plasminogen and angiostatin has very interesting functional consequences. 1) Soluble NG2 significantly enhances the activation of plasminogen by urokinase type plasminogen activator. 2) The antagonistic effect of angiostatin on endothelial cell proliferation is inhibited by soluble NG2. Both of these effects of NG2 should make the proteoglycan a positive regulator of the cell migration and proliferation required for angiogenesis.',\n",
       "               'FAU': ['Goretzki, L', 'Lombardo, C R', 'Stallcup, W B'],\n",
       "               'AU': ['Goretzki L', 'Lombardo CR', 'Stallcup WB'],\n",
       "               'AD': ['The Burnham Institute, La Jolla Cancer Research Center, La Jolla, California 92037, USA.'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['R01 AR44400/AR/NIAMS NIH HHS/United States',\n",
       "                'R01 NS21990/NS/NINDS NIH HHS/United States',\n",
       "                'T32 CA09579/CA/NCI NIH HHS/United States'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, U.S. Gov't, P.H.S.\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Biol Chem',\n",
       "               'JT': 'The Journal of biological chemistry',\n",
       "               'JID': '2985121R',\n",
       "               'RN': ['0 (Antigens)',\n",
       "                '0 (Peptide Fragments)',\n",
       "                '0 (Proteoglycans)',\n",
       "                '0 (chondroitin sulfate proteoglycan 4)',\n",
       "                '86090-08-6 (Angiostatins)',\n",
       "                '9001-91-6 (Plasminogen)',\n",
       "                'EC 3.4.21.73 (Urokinase-Type Plasminogen Activator)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Angiostatins',\n",
       "                'Animals',\n",
       "                'Antigens/metabolism/*pharmacology',\n",
       "                'Cell Division/drug effects',\n",
       "                'Cells, Cultured',\n",
       "                'Endothelium, Vascular/cytology/drug effects',\n",
       "                'Humans',\n",
       "                '*Kringles',\n",
       "                'Mice',\n",
       "                'Mice, Inbred BALB C',\n",
       "                'Peptide Fragments/*physiology',\n",
       "                'Plasminogen/*physiology',\n",
       "                'Proteoglycans/metabolism/*pharmacology',\n",
       "                'Rabbits',\n",
       "                'Urokinase-Type Plasminogen Activator/physiology'],\n",
       "               'EDAT': '2000/07/13 11:00',\n",
       "               'MHDA': '2000/10/21 11:01',\n",
       "               'CRDT': ['2000/07/13 11:00'],\n",
       "               'PHST': ['2000/07/13 11:00 [pubmed]',\n",
       "                '2000/10/21 11:01 [medline]',\n",
       "                '2000/07/13 11:00 [entrez]'],\n",
       "               'AID': ['S0021-9258(19)61241-X [pii]',\n",
       "                '10.1074/jbc.M002290200 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Biol Chem. 2000 Sep 15;275(37):28625-33. doi: 10.1074/jbc.M002290200.'},\n",
       "              {'PMID': '10865035',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20000906',\n",
       "               'LR': '20190826',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '24',\n",
       "               'IP': '8',\n",
       "               'DP': '2000 Aug',\n",
       "               'TI': 'Growth regulation of thyroid and thyroid tumors in humans.',\n",
       "               'PG': '913-22',\n",
       "               'AB': 'In a study of growth regulation of the human thyroid gland and thyroid tumors we investigated the impact of iodine and that of the thyroid-specific growth-stimulating hormone TSH. Further studies included locally active growth factors such as the epidermal growth factor, insulin-like growth factor, and tissue transforming growth factors alpha and beta. In addition to studies of growth regulation by the various growth factors in mostly normal thyrocytes, the impact of tumor-specific mutations in oncogenes and tumor-suppressor genes was investigated. The results demonstrated distinct changes in tissue specificity and sensitivity to external stimuli. This rather complex view on thyrocyte growth regulation may be confusing, but it describes the biologic reality more precisely. Increased knowledge of the regulatory processes may lead to the development of new tumor- and patient-specific therapeutic approaches, especially for preventing benign goiter recurrence and for treating follicular and papillary thyroid cancers.',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Simon, D',\n",
       "                'Dotzenrath, C',\n",
       "                'Schulte, K M',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Goretzki PE',\n",
       "                'Simon D',\n",
       "                'Dotzenrath C',\n",
       "                'Schulte KM',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemeine und Unfallchirurgie, Heinrich-Heine-Universitat, Moorenstrasse 5, D-40225 Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                'Review'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'RN': ['9002-71-5 (Thyrotropin)', '9679TC07X4 (Iodine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Genes, Tumor Suppressor/physiology',\n",
       "                'Humans',\n",
       "                'Iodine/physiology',\n",
       "                'Proto-Oncogenes/physiology',\n",
       "                'Thyroid Gland/*growth & development/metabolism',\n",
       "                'Thyroid Neoplasms/metabolism/*pathology',\n",
       "                'Thyrotropin/physiology'],\n",
       "               'RF': '88',\n",
       "               'EDAT': '2000/06/24 11:00',\n",
       "               'MHDA': '2000/09/09 11:01',\n",
       "               'CRDT': ['2000/06/24 11:00'],\n",
       "               'PHST': ['2000/06/24 11:00 [pubmed]',\n",
       "                '2000/09/09 11:01 [medline]',\n",
       "                '2000/06/24 11:00 [entrez]'],\n",
       "               'AID': ['10.1007/s002680010174 [pii]',\n",
       "                '10.1007/s002680010174 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 2000 Aug;24(8):913-22. doi: 10.1007/s002680010174.'},\n",
       "              {'PMID': '10822340',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20000803',\n",
       "               'LR': '20250103',\n",
       "               'IS': '1359-4184 (Print) 1359-4184 (Linking)',\n",
       "               'VI': '5',\n",
       "               'IP': '2',\n",
       "               'DP': '2000 Mar',\n",
       "               'TI': 'Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function.',\n",
       "               'PG': '137-41',\n",
       "               'AB': \"Corticotropin-releasing hormone (CRH) is the principal regulator of the hypothalamic-pituitary-adrenal (HPA) axis and an activator of the sympathoadrenal (SA) and systemic sympathetic (SS) systems. Mental disorders, including major depression and, more recently, Alzheimer's disease have been associated with dysregulation of the HPA axis and the SA/SS systems. Treatment of rats or monkeys with the novel CRH receptor type 1 (CRH-R1) antagonist antalarmin inhibits the HPA and/or the SA/SS axes. This is the first study to examine the potential direct effect of antalarmin on human adrenal function. Adrenocortical and adrenomedullary cells were characterized by double-immunohistochemistry with anti-17 alpha hydroxylase (cortical cells) and anti-chromogranin A (chromaffin cells). Expression of CRH, ACTH, CRH type I and type II receptor mRNA were analyzed by reverse-transcription (RT) PCR. Human adrenal cortical and/or chromaffin cells in co-culture were incubated with CRH, antalarmin, and both CRH and antalarmin in vitro. Exposure of these cells to corticotropin or vehicle medium served as positive and negative controls, respectively. Cortical and chromaffin tissues were interwoven in the human adrenals, and both in situ and in the co-culture system the endocrine cell types were in close cellular contact. ACTH, CRH, and CRH-R1 and CRH-R2 mRNAs were expressed in the human adrenal as determined by RT-PCR. CRH (10-8 M) led to a moderate increase of cortisol release (145.7 +/- 20.0%) from cortical and chromaffin adrenal cells in co-culture. This effect corresponded to 41.8% of the maximal increase induced by ACTH (10-8 M). The action of CRH was completely inhibited by antalarmin. CRH, ACTH, and both CRH-R1 and CRH-R2 mRNAs are expressed in the adult human adrenal gland. CRH stimulates cortisol production in cortical and chromaffin cell co-cultures. This effect is blocked by antalarmin, a selective CRH-R1 receptor antagonist, suggesting that CRH-R1 receptors are involved in an intraadrenal CRH/ACTH control system in humans.\",\n",
       "               'FAU': ['Willenberg, H S',\n",
       "                'Bornstein, S R',\n",
       "                'Hiroi, N',\n",
       "                'Path, G',\n",
       "                'Goretzki, P E',\n",
       "                'Scherbaum, W A',\n",
       "                'Chrousos, G P'],\n",
       "               'AU': ['Willenberg HS',\n",
       "                'Bornstein SR',\n",
       "                'Hiroi N',\n",
       "                'Path G',\n",
       "                'Goretzki PE',\n",
       "                'Scherbaum WA',\n",
       "                'Chrousos GP'],\n",
       "               'AD': ['Diabetes Research Institute at the University of Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Mol Psychiatry',\n",
       "               'JT': 'Molecular psychiatry',\n",
       "               'JID': '9607835',\n",
       "               'RN': ['0 (CRF receptor type 2)',\n",
       "                '0 (Pyrimidines)',\n",
       "                '0 (Pyrroles)',\n",
       "                '0 (Receptors, Corticotropin-Releasing Hormone)',\n",
       "                '0 (antalarmin)',\n",
       "                '5CLY6W2H1M (CRF Receptor, Type 1)',\n",
       "                '9002-60-2 (Adrenocorticotropic Hormone)',\n",
       "                '9015-71-8 (Corticotropin-Releasing Hormone)',\n",
       "                'WI4X0X7BPJ (Hydrocortisone)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adrenal Cortex/cytology/drug effects/*metabolism',\n",
       "                'Adrenal Medulla/cytology/drug effects/*metabolism',\n",
       "                'Adrenocorticotropic Hormone/pharmacology',\n",
       "                'Adult',\n",
       "                'Animals',\n",
       "                'Cell Line',\n",
       "                'Cells, Cultured',\n",
       "                'Chromaffin Cells/cytology/drug effects/metabolism',\n",
       "                'Coculture Techniques',\n",
       "                'Corticotropin-Releasing Hormone/*genetics/pharmacology',\n",
       "                'Gene Expression Regulation/*drug effects',\n",
       "                'Haplorhini',\n",
       "                'Humans',\n",
       "                'Hydrocortisone/metabolism',\n",
       "                'Pituitary Gland/drug effects/metabolism',\n",
       "                'Pyrimidines/*pharmacology',\n",
       "                'Pyrroles/*pharmacology',\n",
       "                'Rats',\n",
       "                'Receptors, Corticotropin-Releasing Hormone/*antagonists & inhibitors/*genetics',\n",
       "                'Reverse Transcriptase Polymerase Chain Reaction',\n",
       "                'Transcription, Genetic/drug effects',\n",
       "                'CRF Receptor, Type 1'],\n",
       "               'EDAT': '2000/05/24 09:00',\n",
       "               'MHDA': '2000/08/06 11:00',\n",
       "               'CRDT': ['2000/05/24 09:00'],\n",
       "               'PHST': ['2000/05/24 09:00 [pubmed]',\n",
       "                '2000/08/06 11:00 [medline]',\n",
       "                '2000/05/24 09:00 [entrez]'],\n",
       "               'AID': ['10.1038/sj.mp.4000720 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Mol Psychiatry. 2000 Mar;5(2):137-41. doi: 10.1038/sj.mp.4000720.'},\n",
       "              {'PMID': '10759881',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20000531',\n",
       "               'LR': '20190826',\n",
       "               'IS': '0014-2972 (Print) 0014-2972 (Linking)',\n",
       "               'VI': '30',\n",
       "               'IP': '4',\n",
       "               'DP': '2000 Apr',\n",
       "               'TI': 'Lack of MEN1 gene mutations in 27 sporadic insulinomas.',\n",
       "               'PG': '325-9',\n",
       "               'AB': 'BACKGROUND: Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant familial cancer syndrome characterized by tumours of the parathyroids, anterior pituitary gland and endocrine pancreas. Since the cloning of the MEN1 gene (encoding menin) on chromosome 11q13 by Chandrasekharappa et al. in 1997, it has become possible to identify mutations that are responsible. We examined whether MEN1 gene mutations are present in sporadic insulinomas, a rare sporadic tumour that is seen more frequently in patients with the MEN 1 syndrome. PATIENTS AND METHODS: We sequenced the coding part of the MEN1 gene (exons 2-10) in tumour tissue of 27 patients suffering from an insulinoma (24 benign, three malignant). To validate our methods we also examined tumour tissue from five patients with primary hyperparathyroidism (HPT) at a younger age and/or multiple gland disease, with increased risk of MEN 1. RESULTS: We found no mutations in the nine coding exons of the MEN1 gene in the insulinoma tissues. We could confirm three benign polymorphisms (S145S, R171Q, D418D) reported previously. In the control patients we found two new point mutations (one mis-sense, one non-sense mutation) and one deletion. CONCLUSION: Mutations of the MEN1 gene do not play an important role in the pathogenesis of sporadic insulinomas. Therefore genetic screening is not cost effective in sporadic insulinoma patients without other indicators of MEN 1. Patients with primary HPT at a younger age and/or multiple gland disease should be screened for MEN1 gene mutations.',\n",
       "               'FAU': ['Cupisti, K',\n",
       "                'Hoppner, W',\n",
       "                'Dotzenrath, C',\n",
       "                'Simon, D',\n",
       "                'Berndt, I',\n",
       "                'Roher, H D',\n",
       "                'Goretzki, P E'],\n",
       "               'AU': ['Cupisti K',\n",
       "                'Hoppner W',\n",
       "                'Dotzenrath C',\n",
       "                'Simon D',\n",
       "                'Berndt I',\n",
       "                'Roher HD',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Heinrich-Heine-University, Dusseldorf; Institute for Hormone and Fertility Research at the University of Hamburg, Hamburg, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Eur J Clin Invest',\n",
       "               'JT': 'European journal of clinical investigation',\n",
       "               'JID': '0245331',\n",
       "               'RN': ['0 (MEN1 protein, human)',\n",
       "                '0 (Neoplasm Proteins)',\n",
       "                '0 (Proto-Oncogene Proteins)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Amino Acid Substitution',\n",
       "                'Chromosome Mapping',\n",
       "                '*Chromosomes, Human, Pair 11',\n",
       "                'Exons',\n",
       "                'Female',\n",
       "                '*Genes, Tumor Suppressor',\n",
       "                'Genetic Carrier Screening',\n",
       "                'Genetic Predisposition to Disease',\n",
       "                'Homozygote',\n",
       "                'Humans',\n",
       "                'Insulinoma/*genetics/surgery',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Multiple Endocrine Neoplasia Type 1/*genetics',\n",
       "                'Neoplasm Proteins/*genetics',\n",
       "                'Pancreatic Neoplasms/*genetics/surgery',\n",
       "                '*Proto-Oncogene Proteins',\n",
       "                'Reproducibility of Results'],\n",
       "               'EDAT': '2000/04/12 09:00',\n",
       "               'MHDA': '2000/06/03 09:00',\n",
       "               'CRDT': ['2000/04/12 09:00'],\n",
       "               'PHST': ['2000/04/12 09:00 [pubmed]',\n",
       "                '2000/06/03 09:00 [medline]',\n",
       "                '2000/04/12 09:00 [entrez]'],\n",
       "               'AID': ['eci620 [pii]',\n",
       "                '10.1046/j.1365-2362.2000.00620.x [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Clin Invest. 2000 Apr;30(4):325-9. doi: 10.1046/j.1365-2362.2000.00620.x.'}],\n",
       "             '1999': [{'PMID': '10612479',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '20000127',\n",
       "               'LR': '20151119',\n",
       "               'IS': '0947-7349 (Print) 0947-7349 (Linking)',\n",
       "               'VI': '107',\n",
       "               'IP': '8',\n",
       "               'DP': '1999',\n",
       "               'TI': 'cAMP-synthesis in a medullary thyroid carcinoma cell line: response to adrenergic agents and prostaglandines.',\n",
       "               'PG': '488-95',\n",
       "               'AB': \"Calcitonin secretion by C-cells is mediated through intracellular 3'5'-cyclic adenosine monophosphate (cAMP) and calcium signaling. Calcitonin release stimulation tests may take advantage of both signaling cascades in screening for medullary thyroid carcinomas (MTC). To elucidate the regulation of the adenylyl cyclase system we have determined cAMP levels of a calcitonin-expressing MTC cell line (RG) after exposure to adrenergic agents and prostaglandines. In early passages (20-30) cAMP concentrations were significantly elevated in RG cells after exposure to beta-adrenergic agents and prostaglandines E1 and E2. In advanced passages (60-80) the beta-adrenergic response was no longer detectable and adrenergic receptors were uncoupled from the adenylyl cyclase complex; while the effect of prostaglandines E1 and E2 remained unaffected. Preincubation with dexamethasone, in a process requiring protein new synthesis, re-established the adrenergic response in later passages, indicating that RG cells dedifferentiated in culture over time. Our in vitro findings suggest that MTC cell dedifferentiation may be accompanied by adrenergic receptor-uncoupling from the adenylate cyclase system and that this process may be reversed by dexamethasone incubation.\",\n",
       "               'FAU': ['Mertens, P R', 'Goretzki, P E', 'Keck, E'],\n",
       "               'AU': ['Mertens PR', 'Goretzki PE', 'Keck E'],\n",
       "               'AD': ['Medical Clinic II, RWTH Aachen, Germany. petermert@aol.com'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Exp Clin Endocrinol Diabetes',\n",
       "               'JT': 'Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association',\n",
       "               'JID': '9505926',\n",
       "               'RN': ['0 (Adrenergic Agonists)',\n",
       "                '0 (PTGER1 protein, human)',\n",
       "                '0 (Prostaglandins)',\n",
       "                '0 (Receptors, Adrenergic)',\n",
       "                '0 (Receptors, Prostaglandin E)',\n",
       "                '0 (Receptors, Prostaglandin E, EP1 Subtype)',\n",
       "                '9007-12-9 (Calcitonin)',\n",
       "                'E0399OZS9N (Cyclic AMP)',\n",
       "                'EC 4.6.1.1 (Adenylyl Cyclases)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenylyl Cyclases/metabolism',\n",
       "                'Adrenergic Agonists/*pharmacology',\n",
       "                'Calcitonin/metabolism',\n",
       "                'Carcinoma, Medullary/*metabolism',\n",
       "                'Cell Differentiation',\n",
       "                'Cyclic AMP/*biosynthesis',\n",
       "                'Enzyme Activation',\n",
       "                'Humans',\n",
       "                'Prostaglandins/*pharmacology',\n",
       "                'Receptors, Adrenergic/metabolism',\n",
       "                'Receptors, Prostaglandin E/metabolism',\n",
       "                'Receptors, Prostaglandin E, EP1 Subtype',\n",
       "                'Thyroid Neoplasms/*metabolism',\n",
       "                'Tumor Cells, Cultured'],\n",
       "               'EDAT': '1999/12/28 00:00',\n",
       "               'MHDA': '1999/12/28 00:01',\n",
       "               'CRDT': ['1999/12/28 00:00'],\n",
       "               'PHST': ['1999/12/28 00:00 [pubmed]',\n",
       "                '1999/12/28 00:01 [medline]',\n",
       "                '1999/12/28 00:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-0029-1232557 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Exp Clin Endocrinol Diabetes. 1999;107(8):488-95. doi: 10.1055/s-0029-1232557.'},\n",
       "              {'PMID': '10501664',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19991207',\n",
       "               'LR': '20220331',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '70',\n",
       "               'IP': '9',\n",
       "               'DP': '1999 Sep',\n",
       "               'TI': '[Complications in thyroid surgery. Incidence and therapy].',\n",
       "               'PG': '999-1010',\n",
       "               'AB': \"Developments in thyroid surgery during the last 20 years have reduced the number of complications significantly with rates from the literature of less than 1 % of laryngeal nerve paralysis and hypoparathyroidism. Specific problems are connected, however, with patients presenting with recurrent goitres, requiring extended operations for Graves' disease and for malignant diseases. Our own experience in almost 6,000 operations during the last 12 years confirms the results from the literature with regard to more complicated thyroid surgery. Thus, laryngeal nerve paralysis in recurrent thyroid surgery is between 2 and 8 %, depending on the extent of surgery, which is necessary. In surgical treatment of hyperthyroidism, permanent laryngeal nerve paralysis may be reduced to less than 1 %, while hypoparathyroidism is still a severe problem in patients with Graves' disease, and due to the necessity for an extensive operation is approximately 2 % in all cases. The same is true for patients with thyroid malignancies who suffer from permanent laryngeal nerve paralysis in 2-5 % and permanent hypoparathyroidism in 1-4 %, the range related to primary, secondary completion, or recurrent operation. The danger of postoperative bleeding still deserves special attention because it may be followed by life-threatening acute asphyxia. It is essential that surgeons also take care of all operative consequences at least by recommending additional treatment.\",\n",
       "               'FAU': ['Roher, H D',\n",
       "                'Goretzki, P E',\n",
       "                'Hellmann, P',\n",
       "                'Witte, J'],\n",
       "               'AU': ['Roher HD', 'Goretzki PE', 'Hellmann P', 'Witte J'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Chirurgische Klinik und Poliklinik, Medizinische Einrichtungen der Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article', 'Review'],\n",
       "               'TT': 'Risiken und Komplikationen der Schilddrusenchirurgie. Haufigkeit und Therapie.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Hypoparathyroidism/etiology',\n",
       "                'Postoperative Complications/*etiology',\n",
       "                'Postoperative Hemorrhage/etiology',\n",
       "                'Recurrent Laryngeal Nerve Injuries',\n",
       "                'Risk Factors',\n",
       "                'Thyroid Diseases/*surgery',\n",
       "                'Thyroid Neoplasms/*surgery',\n",
       "                '*Thyroidectomy',\n",
       "                'Vocal Cord Paralysis/etiology'],\n",
       "               'RF': '38',\n",
       "               'EDAT': '1999/09/29 00:00',\n",
       "               'MHDA': '1999/09/29 00:01',\n",
       "               'CRDT': ['1999/09/29 00:00'],\n",
       "               'PHST': ['1999/09/29 00:00 [pubmed]',\n",
       "                '1999/09/29 00:01 [medline]',\n",
       "                '1999/09/29 00:00 [entrez]'],\n",
       "               'AID': ['90700999.104 [pii]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 1999 Sep;70(9):999-1010.'},\n",
       "              {'PMID': '10388537',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19990825',\n",
       "               'LR': '20131121',\n",
       "               'IS': '0014-4827 (Print) 0014-4827 (Linking)',\n",
       "               'VI': '250',\n",
       "               'IP': '1',\n",
       "               'DP': '1999 Jul 10',\n",
       "               'TI': 'Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.',\n",
       "               'PG': '231-40',\n",
       "               'AB': 'Urokinase-type plasminogen activator (uPA) and its receptor (uPAR) participate in matrix degradation and cell migration by focusing proteolysis and functioning as a signaling ligand/receptor complex. uPAR, anchored by a lipid moiety in the membrane, is thought to require a transmembrane adapter to transduce signals into the cytoplasm. To study uPAR signaling, we transfected the prostate carcinoma cell line LNCaP, which does not express endogenous uPA or uPAR, with a uPAR encoding cDNA, resulting in high-level surface expression. We studied migration of these cells on fibronectin, which is mediated by the integrin alpha5beta1. Ligation of uPAR with uPA or its amino-terminal fragment enhanced haptotactic migration to fibronectin. In cells on fibronectin, but not on poly-l-lysine, ligation of uPAR also resulted in tyrosine phosphorylation of several proteins, including two proteins involved in integrin signaling, focal adhesion kinase and the crk-associated substrate p130(Cas). Furthermore, after uPAR ligation, uPAR was co-immunoprecipitated with beta1 integrins from the detergent-insoluble fraction of cell lysates. Thus, our data suggest that uPAR occupancy results in an interaction between uPAR and integrins and a potentiation of integrin-mediated signaling, which leads to enhanced cell migration.',\n",
       "               'CI': ['Copyright 1999 Academic Press.'],\n",
       "               'FAU': ['Yebra, M',\n",
       "                'Goretzki, L',\n",
       "                'Pfeifer, M',\n",
       "                'Mueller, B M'],\n",
       "               'AU': ['Yebra M', 'Goretzki L', 'Pfeifer M', 'Mueller BM'],\n",
       "               'AD': ['Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road, IMM13, La Jolla, California, 92037, USA.'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['CA59692/CA/NCI NIH HHS/United States'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                \"Research Support, U.S. Gov't, P.H.S.\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Exp Cell Res',\n",
       "               'JT': 'Experimental cell research',\n",
       "               'JID': '0373226',\n",
       "               'RN': ['0 (BCAR1 protein, human)',\n",
       "                '0 (Cell Adhesion Molecules)',\n",
       "                '0 (Crk-Associated Substrate Protein)',\n",
       "                '0 (Fibronectins)',\n",
       "                '0 (PLAUR protein, human)',\n",
       "                '0 (Phosphoproteins)',\n",
       "                '0 (Proteins)',\n",
       "                '0 (Receptors, Cell Surface)',\n",
       "                '0 (Receptors, Fibronectin)',\n",
       "                '0 (Receptors, Urokinase Plasminogen Activator)',\n",
       "                '0 (Retinoblastoma-Like Protein p130)',\n",
       "                '42HK56048U (Tyrosine)',\n",
       "                'EC 2.7.10.1 (Protein-Tyrosine Kinases)',\n",
       "                'EC 2.7.10.2 (Focal Adhesion Kinase 1)',\n",
       "                'EC 2.7.10.2 (Focal Adhesion Protein-Tyrosine Kinases)',\n",
       "                'EC 2.7.10.2 (PTK2 protein, human)',\n",
       "                'EC 3.4.21.73 (Urokinase-Type Plasminogen Activator)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Cell Adhesion',\n",
       "                'Cell Adhesion Molecules/metabolism',\n",
       "                'Cell Movement/*physiology',\n",
       "                'Crk-Associated Substrate Protein',\n",
       "                'Fibronectins/metabolism',\n",
       "                'Focal Adhesion Kinase 1',\n",
       "                'Focal Adhesion Protein-Tyrosine Kinases',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Phosphoproteins/metabolism',\n",
       "                'Phosphorylation',\n",
       "                'Prostatic Neoplasms',\n",
       "                'Protein-Tyrosine Kinases/metabolism',\n",
       "                '*Proteins',\n",
       "                'Receptors, Cell Surface/genetics/*metabolism',\n",
       "                'Receptors, Fibronectin/*metabolism',\n",
       "                'Receptors, Urokinase Plasminogen Activator',\n",
       "                'Retinoblastoma-Like Protein p130',\n",
       "                '*Signal Transduction',\n",
       "                'Transfection',\n",
       "                'Tumor Cells, Cultured',\n",
       "                'Tyrosine/metabolism',\n",
       "                'Urokinase-Type Plasminogen Activator/*metabolism'],\n",
       "               'EDAT': '1999/07/02 00:00',\n",
       "               'MHDA': '1999/07/02 00:01',\n",
       "               'CRDT': ['1999/07/02 00:00'],\n",
       "               'PHST': ['1999/07/02 00:00 [pubmed]',\n",
       "                '1999/07/02 00:01 [medline]',\n",
       "                '1999/07/02 00:00 [entrez]'],\n",
       "               'AID': ['S0014-4827(99)94510-X [pii]',\n",
       "                '10.1006/excr.1999.4510 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Exp Cell Res. 1999 Jul 10;250(1):231-40. doi: 10.1006/excr.1999.4510.'},\n",
       "              {'PMID': '10367631',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19990720',\n",
       "               'LR': '20191103',\n",
       "               'IS': '1435-2443 (Print) 1435-2443 (Linking)',\n",
       "               'VI': '384',\n",
       "               'IP': '1',\n",
       "               'DP': '1999 Feb',\n",
       "               'TI': 'Expression of wild-type ret, ret/PTC and ret/PTC variants in papillary thyroid carcinoma in Germany.',\n",
       "               'PG': '54-9',\n",
       "               'AB': 'INTRODUCTION: Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy. Although the clinical course is usually rather benign, a subset of tumors is more aggressive. The ret/PTC oncogene was found only in PTC, with varying frequencies of up to 30%. Recently, two new variants of ret/PTC could be identified in post-Chernobyl PTCs, which raised the possibility that the prevalence of ret/PTC in non-radiation-induced PTCs might be higher than previously described. Normal thyroid cells do not express wild-type ret, but there is evidence that ret activation from any cause, including wild-type ret, occurs in more than a half of papillary tumors. METHODS: We used reverse transcription polymerase chain reaction and sequencing to examine wild-type ret and all five forms of ret/PTC known today in 99 PTCs from Hannover, Dusseldorf, Halle and Regensburg. Our method could also detect other variants within the known breakpoint regions. The presence of the ret tyrosine-kinase domain was examined by immunohistochemistry. RESULTS: Seven PTC1-positive tumors and one PTC3-positive tumor (8%), but none with the new variants or other variants of PTC1, 2 or 3 could be detected. Of 43 tumors examined, 20 showed expression of wild-type ret mRNA and staining of ret protein located predominantly to the cell membrane. CONCLUSION: Variants of ret/PTC do not substantially contribute to non-radiation-related ret/PTC-positive tumors, and the prevalence of ret/PTC in Germany is low in contrast to the high rate of wild-type ret expression. Thus, expression of wild-type ret should be examined for pathogenic, prognostic and possible therapeutic implications.',\n",
       "               'FAU': ['Mayr, B',\n",
       "                'Potter, E',\n",
       "                'Goretzki, P',\n",
       "                'Ruschoff, J',\n",
       "                'Dietmaier, W',\n",
       "                'Hoang-Vu, C',\n",
       "                'Dralle, H',\n",
       "                'Brabant, G'],\n",
       "               'AU': ['Mayr B',\n",
       "                'Potter E',\n",
       "                'Goretzki P',\n",
       "                'Ruschoff J',\n",
       "                'Dietmaier W',\n",
       "                'Hoang-Vu C',\n",
       "                'Dralle H',\n",
       "                'Brabant G'],\n",
       "               'AD': ['Abteilung Klinische Endokrinologie, Medizinische Hochschule Hannover, Germany. Mayr.Bernhard@MH-Hannover.de'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'RN': ['0 (Proto-Oncogene Proteins)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Carcinoma, Papillary/epidemiology/*genetics',\n",
       "                'Genetic Variation',\n",
       "                'Germany/epidemiology',\n",
       "                'Humans',\n",
       "                'Immunohistochemistry',\n",
       "                'Proto-Oncogene Proteins/analysis',\n",
       "                '*Proto-Oncogenes',\n",
       "                'Thyroid Neoplasms/epidemiology/*genetics'],\n",
       "               'EDAT': '1999/06/15 00:00',\n",
       "               'MHDA': '1999/06/15 00:01',\n",
       "               'CRDT': ['1999/06/15 00:00'],\n",
       "               'PHST': ['1999/06/15 00:00 [pubmed]',\n",
       "                '1999/06/15 00:01 [medline]',\n",
       "                '1999/06/15 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/s004230050174 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 1999 Feb;384(1):54-9. doi: 10.1007/s004230050174.'},\n",
       "              {'PMID': '10367623',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19990720',\n",
       "               'LR': '20220408',\n",
       "               'IS': '1435-2443 (Print) 1435-2443 (Linking)',\n",
       "               'VI': '384',\n",
       "               'IP': '1',\n",
       "               'DP': '1999 Feb',\n",
       "               'TI': 'Studies of oncogenes and tumor-suppressor genes in human thyroid carcinomas, and their clinical implications.',\n",
       "               'PG': '1-8',\n",
       "               'AB': 'INTRODUCTION AND DISCUSSION: Molecular genetic investigations relating to thyroid cancer have started to gain clinical importance, with discovery of the tumor-specific oncogenes PTC 1-3 in papillary thyroid cancer and the syndrome-specific mutations of the RET protooncogene in MEN-2a, MEN-2b and familial MTC patients. Furthermore, the thyroid-specific sodium-iodine symporter, causing iodine accumulation in thyroid tissue, has been cloned and now offers studies to enhance iodine and radioiodine uptake in thyroid cancer, which could soon prove to be clinically applicable.',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Dotzenrath, C',\n",
       "                'Simon, D',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Goretzki PE', 'Dotzenrath C', 'Simon D', 'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Heinrich Heine Universitat Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Surg',\n",
       "               'JT': \"Langenbeck's archives of surgery\",\n",
       "               'JID': '9808285',\n",
       "               'RN': ['0 (Carcinogens)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['*Carcinogens',\n",
       "                '*Genes, Tumor Suppressor',\n",
       "                'Humans',\n",
       "                'Thyroid Neoplasms/*genetics'],\n",
       "               'RF': '97',\n",
       "               'EDAT': '1999/06/15 00:00',\n",
       "               'MHDA': '1999/06/15 00:01',\n",
       "               'CRDT': ['1999/06/15 00:00'],\n",
       "               'PHST': ['1999/06/15 00:00 [pubmed]',\n",
       "                '1999/06/15 00:01 [medline]',\n",
       "                '1999/06/15 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/s004230050166 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Surg. 1999 Feb;384(1):1-8. doi: 10.1007/s004230050166.'},\n",
       "              {'PMID': '10358027',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19990706',\n",
       "               'LR': '20210209',\n",
       "               'IS': '0021-9258 (Print) 0021-9258 (Linking)',\n",
       "               'VI': '274',\n",
       "               'IP': '24',\n",
       "               'DP': '1999 Jun 11',\n",
       "               'TI': 'High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan.',\n",
       "               'PG': '16831-7',\n",
       "               'AB': 'NG2 is a transmembrane chondroitin sulfate proteoglycan that is expressed by immature progenitor cells in several developmental lineages and by some types of malignant cells. In vitro studies have suggested that NG2 participates in growth factor activation of the platelet-derived growth factor-alpha receptor. In this study the ability of recombinant NG2 core protein to interact with several different growth factors (epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF)-AA, PDGF-BB, vascular endothelial growth factor (VEGF)165 and transforming growth factor (TGF)-beta1) was investigated using two different assay systems: enzyme-linked immunosorbent assay-type solid-phase binding and an optical biosensor (BIAcore) system. High-affinity binding of bFGF and PDGF-AA to the core protein of NG2 could be demonstrated with both types of assays. Using both the BIAcore software analysis program and nonlinear regression analysis of the solid phase binding data, KD values in the low nanomolar range were obtained for binding of each of these growth factors to NG2. The results further indicate that NG2 contains at least two binding sites for each of these two growth factors. PDGF-BB, TGF-beta1, VEGF, and EGF exhibited little or no binding to NG2 in either type of assay. These data suggest that NG2 can have an important role in organizing and presenting some types of mitogenic growth factors at the cell surface.',\n",
       "               'FAU': ['Goretzki, L',\n",
       "                'Burg, M A',\n",
       "                'Grako, K A',\n",
       "                'Stallcup, W B'],\n",
       "               'AU': ['Goretzki L', 'Burg MA', 'Grako KA', 'Stallcup WB'],\n",
       "               'AD': ['The Burnham Institute Cancer Research Center, La Jolla, California 92037, USA. goretzki@ljcrf.edu'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['F32 CA72220/CA/NCI NIH HHS/United States',\n",
       "                'F32 HL09541/HL/NHLBI NIH HHS/United States',\n",
       "                'R01 NS21990/NS/NINDS NIH HHS/United States',\n",
       "                'etc.'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, U.S. Gov't, P.H.S.\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Biol Chem',\n",
       "               'JT': 'The Journal of biological chemistry',\n",
       "               'JID': '2985121R',\n",
       "               'RN': ['0 (Antigens)',\n",
       "                '0 (Peptide Fragments)',\n",
       "                '0 (Platelet-Derived Growth Factor)',\n",
       "                '0 (Proteoglycans)',\n",
       "                '0 (Receptors, Fibroblast Growth Factor)',\n",
       "                '0 (Recombinant Proteins)',\n",
       "                '0 (chondroitin sulfate proteoglycan 4)',\n",
       "                '0 (platelet-derived growth factor A)',\n",
       "                '103107-01-3 (Fibroblast Growth Factor 2)',\n",
       "                'EC 2.7.10.1 (Receptor, Platelet-Derived Growth Factor alpha)',\n",
       "                'EC 2.7.10.1 (Receptors, Platelet-Derived Growth Factor)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Antigens/genetics/*metabolism',\n",
       "                'Fibroblast Growth Factor 2/*metabolism',\n",
       "                'Peptide Fragments/genetics/metabolism',\n",
       "                'Platelet-Derived Growth Factor/*metabolism',\n",
       "                'Protein Binding',\n",
       "                'Proteoglycans/genetics/*metabolism',\n",
       "                'Receptor, Platelet-Derived Growth Factor alpha',\n",
       "                'Receptors, Fibroblast Growth Factor/metabolism',\n",
       "                'Receptors, Platelet-Derived Growth Factor/metabolism',\n",
       "                'Recombinant Proteins/metabolism',\n",
       "                'Surface Plasmon Resonance'],\n",
       "               'EDAT': '1999/06/08 00:00',\n",
       "               'MHDA': '1999/06/08 00:01',\n",
       "               'CRDT': ['1999/06/08 00:00'],\n",
       "               'PHST': ['1999/06/08 00:00 [pubmed]',\n",
       "                '1999/06/08 00:01 [medline]',\n",
       "                '1999/06/08 00:00 [entrez]'],\n",
       "               'AID': ['S0021-9258(19)72848-8 [pii]',\n",
       "                '10.1074/jbc.274.24.16831 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Biol Chem. 1999 Jun 11;274(24):16831-7. doi: 10.1074/jbc.274.24.16831.'},\n",
       "              {'PMID': '20654484',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'DCOM': '20121002',\n",
       "               'LR': '20190918',\n",
       "               'IS': '0887-2333 (Print) 0887-2333 (Linking)',\n",
       "               'VI': '13',\n",
       "               'IP': '2',\n",
       "               'DP': '1999 Apr',\n",
       "               'TI': 'An in vitro model for peroxisome proliferation utilizing primary hepatocytes in sandwich culture.',\n",
       "               'PG': '265-73',\n",
       "               'AB': 'Peroxisome proliferators comprise a group of structurally diverse chemicals which share as a common biologic effect the induction of peroxisomal fatty acid degrading enzymes. Concomitantly, the number and size of peroxisomes within hepatocytes increases. Following chronic administration some peroxisome proliferators act as non-genotoxic hepatocarcinogens in susceptible species such as rodents. To establish an in vitro model for the toxicological investigation of peroxisome proliferation, primary hepatocytes of rats, dogs and humans were cultivated in an organotypic cell culture model (sandwich model). By employing a panel of diverse compounds in this model a graded response was observed in the induction of carnitine acetyl transferase (CAT), the activity of which was determined as an endpoint. The following results were obtained in the order of decreasing inducing potential for rat hepatocytes: FOE 3798>nafenopin>fenofibrate (<clofibrate>ciprofibrate>bezafibrate DEHP approximately ETYA>DEHA. Induction of CAT activity was generally higher than reported in earlier cell culture systems, probably reflecting the effect of the extracellular matrix provided by the collagen gel sandwich. In parallel, transcription of the rat CYP4A1 gene was induced by a similar order of magnitude as measured by TaqMan RT-PCR. In accordance with literature data, human and dog hepatocytes did not display such a strong and graded response but rather were not susceptible to this effect. In addition, (3)H-thymidine incorporation data demonstrated that nafenopin was able to induce DNA synthesis in rat hepatocytes whereas it did not in human hepatocytes.',\n",
       "               'FAU': ['Hildebrand, H',\n",
       "                'Schmidt, U',\n",
       "                'Kempka, G',\n",
       "                'Jacob, R',\n",
       "                'Ahr, H J',\n",
       "                'Ebener, C',\n",
       "                'Goretzki, P E',\n",
       "                'Bader, A'],\n",
       "               'AU': ['Hildebrand H',\n",
       "                'Schmidt U',\n",
       "                'Kempka G',\n",
       "                'Jacob R',\n",
       "                'Ahr HJ',\n",
       "                'Ebener C',\n",
       "                'Goretzki PE',\n",
       "                'Bader A'],\n",
       "               'AD': ['Bayer AG, Toxikologie, D-42096 Wuppertal, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Toxicol In Vitro',\n",
       "               'JT': 'Toxicology in vitro : an international journal published in association with BIBRA',\n",
       "               'JID': '8712158',\n",
       "               'EDAT': '1999/04/01 00:00',\n",
       "               'MHDA': '1999/04/01 00:01',\n",
       "               'CRDT': ['2010/07/27 06:00'],\n",
       "               'PHST': ['1998/09/13 00:00 [accepted]',\n",
       "                '2010/07/27 06:00 [entrez]',\n",
       "                '1999/04/01 00:00 [pubmed]',\n",
       "                '1999/04/01 00:01 [medline]'],\n",
       "               'AID': ['S0887-2333(98)00078-2 [pii]',\n",
       "                '10.1016/s0887-2333(98)00078-2 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Toxicol In Vitro. 1999 Apr;13(2):265-73. doi: 10.1016/s0887-2333(98)00078-2.'}],\n",
       "             '1997': [{'PMID': '9217325',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19970929',\n",
       "               'LR': '20220215',\n",
       "               'IS': '0021-9533 (Print) 0021-9533 (Linking)',\n",
       "               'VI': '110 ( Pt 12)',\n",
       "               'DP': '1997 Jun',\n",
       "               'TI': 'Receptor-mediated endocytosis of urokinase-type plasminogen activator is regulated by cAMP-dependent protein kinase.',\n",
       "               'PG': '1395-402',\n",
       "               'AB': 'Internalization of the urokinase-type plasminogen activator (uPA) requires two receptors, the uPA receptor (uPAR) and the low density lipoprotein receptor-related protein (LRP)/alpha2-macroglobulin (alpha2M) receptor. Here, we address whether protein kinases are involved in the internalization of uPA by human melanoma cells. Initially, we found that the internalization of uPA was significantly inhibited by the serine/threonine protein kinase inhibitors staurosporine, K-252a and H-89, but not by the tyrosine kinase inhibitors, genistein and lavendustin A. Internalization of uPA was also inhibited by a pseudosubstrate peptide for cAMP-dependent protein kinase (PKA), but not by a pseudosubstrate peptide for protein kinase C. We confirmed a requirement for PKA-activity and implicated a specific isoform by using an antisense oligonucleotide against the regulatory subunit RI alpha of PKA which suppresses PKA-I activity. Exposure of cells to this oligonucleotide led to a specific, dose-dependent decrease in RI alpha protein and to a significant inhibition in the rate of uPA internalization. We further demonstrate that treatment of melanoma cells with either H-89 or PKA RI alpha antisense oligonucleotides also resulted in a decreased internalization of two other ligands of LRP, activated alpha2M and lactoferrin, indicating that PKA activity is associated with LRP. Finally, we demonstrate that PKA activity is also required for the internalization of transferrin, but not for the internalization of the epidermal growth factor or adenovirus 2, suggesting that in melanoma cells, PKA activity is not generally required for clathrin-mediated endocytosis, but is rather associated with specific internalization receptors.',\n",
       "               'FAU': ['Goretzki, L', 'Mueller, B M'],\n",
       "               'AU': ['Goretzki L', 'Mueller BM'],\n",
       "               'AD': ['The Scripps Research Institute, Department of Immunology, La Jolla, CA 92037, USA.'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['CA59692/CA/NCI NIH HHS/United States'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                \"Research Support, U.S. Gov't, P.H.S.\"],\n",
       "               'PL': 'England',\n",
       "               'TA': 'J Cell Sci',\n",
       "               'JT': 'Journal of cell science',\n",
       "               'JID': '0052457',\n",
       "               'RN': ['0 (Carbazoles)',\n",
       "                '0 (Enzyme Inhibitors)',\n",
       "                '0 (Indole Alkaloids)',\n",
       "                '0 (Indoles)',\n",
       "                '0 (Isoflavones)',\n",
       "                '0 (Isoquinolines)',\n",
       "                '0 (Low Density Lipoprotein Receptor-Related Protein-1)',\n",
       "                '0 (Maleimides)',\n",
       "                '0 (Naphthalenes)',\n",
       "                '0 (Phenols)',\n",
       "                '0 (Receptors, Immunologic)',\n",
       "                '0 (Sulfonamides)',\n",
       "                '3Y0G32G2RV (lavendustin A)',\n",
       "                '62229-50-9 (Epidermal Growth Factor)',\n",
       "                '97161-97-2 (staurosporine aglycone)',\n",
       "                'DH2M523P0H (Genistein)',\n",
       "                'EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases)',\n",
       "                'EC 2.7.11.13 (Protein Kinase C)',\n",
       "                'EC 3.4.21.- (Lactoferrin)',\n",
       "                'EC 3.4.21.73 (Urokinase-Type Plasminogen Activator)',\n",
       "                'H88EPA0A3N (Staurosporine)',\n",
       "                'I271P23G24 (calphostin C)',\n",
       "                'M876330O56 (N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide)',\n",
       "                'MBK3OO5K8T (bisindolylmaleimide)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoviruses, Human/metabolism',\n",
       "                'Carbazoles/pharmacology',\n",
       "                'Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors/*metabolism',\n",
       "                'Dose-Response Relationship, Drug',\n",
       "                'Endocytosis/*physiology',\n",
       "                'Enzyme Inhibitors/pharmacology',\n",
       "                'Epidermal Growth Factor/metabolism',\n",
       "                'Genistein',\n",
       "                'Humans',\n",
       "                'Indole Alkaloids',\n",
       "                'Indoles/pharmacology',\n",
       "                'Isoflavones/pharmacology',\n",
       "                'Isoquinolines/pharmacology',\n",
       "                'Lactoferrin/metabolism',\n",
       "                'Low Density Lipoprotein Receptor-Related Protein-1',\n",
       "                'Maleimides/pharmacology',\n",
       "                'Melanoma/enzymology',\n",
       "                'Naphthalenes/pharmacology',\n",
       "                'Phenols/pharmacology',\n",
       "                'Protein Kinase C/antagonists & inhibitors/metabolism',\n",
       "                'Receptors, Immunologic/*metabolism',\n",
       "                'Signal Transduction/physiology',\n",
       "                'Staurosporine/pharmacology',\n",
       "                '*Sulfonamides',\n",
       "                'Tumor Cells, Cultured/drug effects',\n",
       "                'Urokinase-Type Plasminogen Activator/*metabolism'],\n",
       "               'EDAT': '1997/06/01 00:00',\n",
       "               'MHDA': '1997/06/01 00:01',\n",
       "               'CRDT': ['1997/06/01 00:00'],\n",
       "               'PHST': ['1997/06/01 00:00 [pubmed]',\n",
       "                '1997/06/01 00:01 [medline]',\n",
       "                '1997/06/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1242/jcs.110.12.1395 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Cell Sci. 1997 Jun;110 ( Pt 12):1395-402. doi: 10.1242/jcs.110.12.1395.'},\n",
       "              {'PMID': '9100614',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19970506',\n",
       "               'LR': '20190607',\n",
       "               'IS': '0021-972X (Print) 0021-972X (Linking)',\n",
       "               'VI': '82',\n",
       "               'IP': '4',\n",
       "               'DP': '1997 Apr',\n",
       "               'TI': 'ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?',\n",
       "               'PG': '1306-7',\n",
       "               'FAU': ['Mayr, B',\n",
       "                'Brabant, G',\n",
       "                'Goretzki, P',\n",
       "                'Ruschoff, J',\n",
       "                'Dietmaier, W',\n",
       "                'Dralle, H'],\n",
       "               'AU': ['Mayr B',\n",
       "                'Brabant G',\n",
       "                'Goretzki P',\n",
       "                'Ruschoff J',\n",
       "                'Dietmaier W',\n",
       "                'Dralle H'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comment', 'Letter'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Clin Endocrinol Metab',\n",
       "               'JT': 'The Journal of clinical endocrinology and metabolism',\n",
       "               'JID': '0375362',\n",
       "               'RN': ['0 (Drosophila Proteins)',\n",
       "                '0 (Proto-Oncogene Proteins)',\n",
       "                'EC 2.7.10.1 (Proto-Oncogene Proteins c-ret)',\n",
       "                'EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases)',\n",
       "                'EC 2.7.10.1 (Ret protein, Drosophila)'],\n",
       "               'SB': 'IM',\n",
       "               'CON': ['J Clin Endocrinol Metab. 1996 Sep;81(9):3360-5. doi: 10.1210/jcem.81.9.8784097.',\n",
       "                'PMID: 8784097'],\n",
       "               'MH': ['Carcinoma/*genetics',\n",
       "                '*Drosophila Proteins',\n",
       "                '*Gene Rearrangement',\n",
       "                'Humans',\n",
       "                'Neoplasm Metastasis/genetics',\n",
       "                '*Oncogenes',\n",
       "                'Proto-Oncogene Proteins/*genetics',\n",
       "                'Proto-Oncogene Proteins c-ret',\n",
       "                'Receptor Protein-Tyrosine Kinases/*genetics',\n",
       "                'Thyroid Neoplasms/*genetics'],\n",
       "               'EDAT': '1997/04/01 00:00',\n",
       "               'MHDA': '1997/04/01 00:01',\n",
       "               'CRDT': ['1997/04/01 00:00'],\n",
       "               'PHST': ['1997/04/01 00:00 [pubmed]',\n",
       "                '1997/04/01 00:01 [medline]',\n",
       "                '1997/04/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1210/jcem.82.4.3891-5 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Clin Endocrinol Metab. 1997 Apr;82(4):1306-7. doi: 10.1210/jcem.82.4.3891-5.'},\n",
       "              {'PMID': '9165076',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19970815',\n",
       "               'LR': '20191102',\n",
       "               'IS': '1431-6730 (Print) 1431-6730 (Linking)',\n",
       "               'VI': '378',\n",
       "               'IP': '3-4',\n",
       "               'DP': '1997 Mar-Apr',\n",
       "               'TI': 'Inhibition of the interaction of urokinase-type plasminogen activator (uPA) with its receptor (uPAR) by synthetic peptides.',\n",
       "               'PG': '231-7',\n",
       "               'AB': 'Focusing of the serine protease urokinase-type plasminogen activator (uPA) to the cell surface via interaction with its specific receptor (uPAR, CD87) is an important step for tumor cell invasion and metastasis. The ability of a synthetic peptide derived from the uPAR-binding region of uPA (comprising amino acids 16-32 of uPA; uPA(16-32)) to inhibit binding of fluorescently labeled uPA to uPAR on human promyeloid U937 cells was assessed by quantitative flow cytofluorometric analysis (FACS) and compared to the inhibitory capacities of other synthetic peptides known to interfere with uPA/uPAR-interaction. An about 3000-fold molar excess of uPA(16-32) resulted in 50% inhibition of pro-uPA binding to cell surface-associated uPAR. Using a solid-phase uPA-ligand binding assay employing recombinant soluble uPAR coated to microtiter plates, the minimal binding region of wild-type uPA was determined. The linear peptide uPA(19-31) and its more stable disulfide-bridged cyclic form (cyclo(19,31)uPA(19-31)) displayed uPAR-binding activity whereas other peptides such as uPA(18-30), uPA(20-32) or uPA(20-30) did not react with uPAR. Cyclic peptide derivatives of cyclo(19,31)uPA(19-31) in which certain amino acids were deleted and/or replaced by other amino acids as well as uPAR-derived wild-type peptides did also not inhibit uPA/uPAR-interaction. Therefore, the present investigations identified cyclo(19,31)uPA(19-31) as a potential lead structure for the development of uPA-peptide analogues to block uPA/uPAR-interaction.',\n",
       "               'FAU': ['Burgle, M',\n",
       "                'Koppitz, M',\n",
       "                'Riemer, C',\n",
       "                'Kessler, H',\n",
       "                'Konig, B',\n",
       "                'Weidle, U H',\n",
       "                'Kellermann, J',\n",
       "                'Lottspeich, F',\n",
       "                'Graeff, H',\n",
       "                'Schmitt, M',\n",
       "                'Goretzki, L',\n",
       "                'Reuning, U',\n",
       "                'Wilhelm, O',\n",
       "                'Magdolen, V'],\n",
       "               'AU': ['Burgle M',\n",
       "                'Koppitz M',\n",
       "                'Riemer C',\n",
       "                'Kessler H',\n",
       "                'Konig B',\n",
       "                'Weidle UH',\n",
       "                'Kellermann J',\n",
       "                'Lottspeich F',\n",
       "                'Graeff H',\n",
       "                'Schmitt M',\n",
       "                'Goretzki L',\n",
       "                'Reuning U',\n",
       "                'Wilhelm O',\n",
       "                'Magdolen V'],\n",
       "               'AD': ['Institut fur Organische Chemie und Biochemie der Technischen Universitat Munchen, Garching, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Biol Chem',\n",
       "               'JT': 'Biological chemistry',\n",
       "               'JID': '9700112',\n",
       "               'RN': ['0 (Ligands)',\n",
       "                '0 (PLAUR protein, human)',\n",
       "                '0 (Peptides)',\n",
       "                '0 (Receptors, Cell Surface)',\n",
       "                '0 (Receptors, Urokinase Plasminogen Activator)',\n",
       "                'EC 3.4.21.73 (Urokinase-Type Plasminogen Activator)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Amino Acid Sequence',\n",
       "                'Chromatography, High Pressure Liquid',\n",
       "                'Flow Cytometry',\n",
       "                'Humans',\n",
       "                'Ligands',\n",
       "                'Mass Spectrometry',\n",
       "                'Molecular Sequence Data',\n",
       "                'Peptides/chemical synthesis/isolation & purification/*pharmacology',\n",
       "                'Receptors, Cell Surface/*antagonists & inhibitors/metabolism',\n",
       "                'Receptors, Urokinase Plasminogen Activator',\n",
       "                'Tumor Cells, Cultured',\n",
       "                'Urokinase-Type Plasminogen Activator/*antagonists & inhibitors/metabolism'],\n",
       "               'EDAT': '1997/03/01 00:00',\n",
       "               'MHDA': '1997/03/01 00:01',\n",
       "               'CRDT': ['1997/03/01 00:00'],\n",
       "               'PHST': ['1997/03/01 00:00 [pubmed]',\n",
       "                '1997/03/01 00:01 [medline]',\n",
       "                '1997/03/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1515/bchm.1997.378.3-4.231 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Biol Chem. 1997 Mar-Apr;378(3-4):231-7. doi: 10.1515/bchm.1997.378.3-4.231.'},\n",
       "              {'PMID': '9050920',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19970325',\n",
       "               'LR': '20190722',\n",
       "               'IS': '0340-6717 (Print) 0340-6717 (Linking)',\n",
       "               'VI': '99',\n",
       "               'IP': '3',\n",
       "               'DP': '1997 Mar',\n",
       "               'TI': 'Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.',\n",
       "               'PG': '342-9',\n",
       "               'AB': 'Various genetic loci harboring oncogenes, tumor suppressor genes, and genes for calcium receptors have been implicated in the development of parathyroid tumors. We have carried out loss of heterozygosity (LOH) studies in chromosomes 1p, 1q, 3q, 6q, 11q, 13q, 15q, and X in a total of 89 benign parathyroid tumors. Of these, 28 were sporadic parathyroid adenomas from patients with no family history of the disease, 41 were secondary parathyroid tumors, 5 were from patients with a history of previous irradiation to the neck, 12 were from patients with a family history of hyperparathyroidism, and 3 were parathyroid tumors related to multiple endocrine neoplasia type 1 (MEN1). In addition, we determined the chromosomal localization of a second putative calcium-sensing receptor, CaS, for inclusion in the LOH studies. Based on analysis of somatic cell hybrids and fluorescent in situ hybridization to metaphase chromsomes, the gene for CaS was mapped to chromosomal region 2q21-q22. The following results were obtained from the LOH studies: (1) out of the 24 tumors that showed LOH, only 4 had more than one chromosomal region involved, (2) in the tumors from uremic patients, LOH of chromosome 3q was detected in a subset of the tumors, (3) LOH of the MEN1 region at 11q13 was the most common abnormality found in both MEN1-related and sporadic parathyroid tumours but was not a feature of the other forms of parathyroid tumors, (4) LOH in 1p and 6q was not as frequent as previously reported, and (5) tumor suppressor genes in 1q and X might have played a role, particularly on the X chromosome, in the case of familial parathyroid adenomas. We therefore conclude that the tumorigenesis of familial, sporadic, and uremic hyperparathyroidism involves different genetic triggers in a non-progressive pattern.',\n",
       "               'FAU': ['Farnebo, F',\n",
       "                'Teh, B T',\n",
       "                'Dotzenrath, C',\n",
       "                'Wassif, W S',\n",
       "                'Svensson, A',\n",
       "                'White, I',\n",
       "                'Betz, R',\n",
       "                'Goretzki, P',\n",
       "                'Sandelin, K',\n",
       "                'Farnebo, L O',\n",
       "                'Larsson, C'],\n",
       "               'AU': ['Farnebo F',\n",
       "                'Teh BT',\n",
       "                'Dotzenrath C',\n",
       "                'Wassif WS',\n",
       "                'Svensson A',\n",
       "                'White I',\n",
       "                'Betz R',\n",
       "                'Goretzki P',\n",
       "                'Sandelin K',\n",
       "                'Farnebo LO',\n",
       "                'Larsson C'],\n",
       "               'AD': ['Department of Molecular Medicine, Karolinska Hospital, Stockholm, Sweden. ffa@gen.ks.se'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Hum Genet',\n",
       "               'JT': 'Human genetics',\n",
       "               'JID': '7613873',\n",
       "               'RN': ['0 (Calcium-Binding Proteins)', '0 (Receptors, LDL)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/complications/genetics',\n",
       "                'Autoradiography',\n",
       "                'Calcium-Binding Proteins/*genetics',\n",
       "                '*Chromosome Deletion',\n",
       "                'Chromosome Mapping',\n",
       "                'Chromosomes, Human, Pair 2',\n",
       "                'Female',\n",
       "                'Heterozygote',\n",
       "                'Humans',\n",
       "                'Hybrid Cells',\n",
       "                'Hyperparathyroidism/complications/*genetics',\n",
       "                'Hyperparathyroidism, Secondary/genetics',\n",
       "                'In Situ Hybridization, Fluorescence',\n",
       "                'Male',\n",
       "                'Multiple Endocrine Neoplasia Type 1/complications/genetics',\n",
       "                'Neoplasms/genetics',\n",
       "                'Parathyroid Neoplasms/complications/*genetics/secondary',\n",
       "                'Receptors, LDL/*genetics',\n",
       "                'Uremia/complications'],\n",
       "               'EDAT': '1997/03/01 00:00',\n",
       "               'MHDA': '1997/03/01 00:01',\n",
       "               'CRDT': ['1997/03/01 00:00'],\n",
       "               'PHST': ['1997/03/01 00:00 [pubmed]',\n",
       "                '1997/03/01 00:01 [medline]',\n",
       "                '1997/03/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/s004390050369 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Hum Genet. 1997 Mar;99(3):342-9. doi: 10.1007/s004390050369.'},\n",
       "              {'PMID': '9156979',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19970522',\n",
       "               'LR': '20190920',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '68',\n",
       "               'IP': '2',\n",
       "               'DP': '1997 Feb',\n",
       "               'TI': '[Surgical therapy of neuroendocrine tumors of the thymus].',\n",
       "               'PG': '136-40',\n",
       "               'AB': \"Neuroendocrine tumors of the thymus, also known as thymic carcinoids, are rare tumors of the anterior mediastinum. They occur sporadically or in association with MEN I syndrome. We present five patients (four male, one female; age of first manifestation 19-53 years) who were operated on at our hospital between 1984 and 1995 for neuroendocrine thymic tumors. A hormone-producing tumor presented with Cushing's syndrome in two patients. Two patients had MEN I syndrome. Only in the female patient the primary tumor was confined to the thymus. We found lymph node metastases in three patients and a distant metastasis in one. The neuroendocrine tumors have a high rate of local recurrences and thus we performed 11 operations using a transthoracic or transsternal approach. Since there was no operative mortality and adjuvant therapies are of limited value, we recommend surgery even in case of recurrence.\",\n",
       "               'FAU': ['Cupisti, K',\n",
       "                'Dotzenrath, C',\n",
       "                'Simon, D',\n",
       "                'Goretzki, P E',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Cupisti K',\n",
       "                'Dotzenrath C',\n",
       "                'Simon D',\n",
       "                'Goretzki PE',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemein und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Case Reports', 'Journal Article'],\n",
       "               'TT': 'Chirurgische Therapie neuroendokriner Tumoren des Thymus.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Carcinoid Tumor/diagnostic imaging/pathology/*surgery',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Lymph Node Excision',\n",
       "                'Lymph Nodes/pathology',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Multiple Endocrine Neoplasia Type 1/diagnostic imaging/pathology/surgery',\n",
       "                'Neoplasm Recurrence, Local/diagnostic imaging/pathology/surgery',\n",
       "                'Prognosis',\n",
       "                'Reoperation',\n",
       "                'Thymectomy',\n",
       "                'Thymus Gland/pathology',\n",
       "                'Thymus Neoplasms/diagnostic imaging/pathology/*surgery',\n",
       "                'Tomography, X-Ray Computed'],\n",
       "               'EDAT': '1997/02/01 00:00',\n",
       "               'MHDA': '1997/02/01 00:01',\n",
       "               'CRDT': ['1997/02/01 00:00'],\n",
       "               'PHST': ['1997/02/01 00:00 [pubmed]',\n",
       "                '1997/02/01 00:01 [medline]',\n",
       "                '1997/02/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/s001040050163 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 1997 Feb;68(2):136-40. doi: 10.1007/s001040050163.'},\n",
       "              {'PMID': '9156976',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19970522',\n",
       "               'LR': '20190920',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '68',\n",
       "               'IP': '2',\n",
       "               'DP': '1997 Feb',\n",
       "               'TI': '[Special diagnostic and therapeutic aspects of insulinoma].',\n",
       "               'PG': '116-21',\n",
       "               'AB': 'Insulinomas are rare tumors and account for 90% of all endocrine pancreatic tumors. They typically present as a solitary tumor, but may occur in multiple sites (e.g. multiple endocrine neoplasia type I) or as a malignant disease in 10% of cases and rarely as nesidioblastosis or islet cell adenomatosis. Neuroglucopenic symptoms lead to the diagnosis; inadequate high insulin and C-peptide secretion with hypoglycemia in the fasting test confirm the diagnosis. Preoperative localization is not necessary prior to the first operation. The standard operation is enucleation, or depending on size and location, resection. The treatment of multiple tumors and islet cell hyperplasia with a high risk of recurrence is problematic. Subtotal resection plus enucleation seems to be better than selective tumor resection. In malignant insulinomas, mostly presenting with liver metastases, aggressive surgical therapy with hepatectomy and debulking, chemoembolization and systemic chemotherapy are the modalities of choice.',\n",
       "               'FAU': ['Roher, H D', 'Simon, D', 'Starke, A', 'Goretzki, P E'],\n",
       "               'AU': ['Roher HD', 'Simon D', 'Starke A', 'Goretzki PE'],\n",
       "               'AD': ['Klinik fur Allgemeine und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Case Reports',\n",
       "                'English Abstract',\n",
       "                'Journal Article',\n",
       "                'Review'],\n",
       "               'TT': 'Spezielle diagnostische und therapeutische Aspekte beim Insulinom.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Chemotherapy, Adjuvant',\n",
       "                'Combined Modality Therapy',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Insulinoma/diagnosis/pathology/*surgery',\n",
       "                'Male',\n",
       "                'Multiple Endocrine Neoplasia Type 1/diagnosis/pathology/surgery',\n",
       "                'Pancreas/pathology',\n",
       "                'Pancreatectomy',\n",
       "                'Pancreatic Neoplasms/diagnosis/pathology/*surgery'],\n",
       "               'RF': '25',\n",
       "               'EDAT': '1997/02/01 00:00',\n",
       "               'MHDA': '1997/02/01 00:01',\n",
       "               'CRDT': ['1997/02/01 00:00'],\n",
       "               'PHST': ['1997/02/01 00:00 [pubmed]',\n",
       "                '1997/02/01 00:01 [medline]',\n",
       "                '1997/02/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/s001040050160 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 1997 Feb;68(2):116-21. doi: 10.1007/s001040050160.'},\n",
       "              {'PMID': '9574440',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19980603',\n",
       "               'LR': '20151119',\n",
       "               'IS': '0942-2854 (Print) 0942-2854 (Linking)',\n",
       "               'VI': '114',\n",
       "               'DP': '1997',\n",
       "               'TI': '[Does rationing of intensive care beds lead to premature ward return with preventable complications?].',\n",
       "               'PG': '1396-7',\n",
       "               'AB': 'Readmission to the surgical intensive care unit was necessary in 105 of 2269 patients (4.6%) who were discharged between 1991 and 1995. Mortality was 20% Cardiopulmonary reasons during the first 72 h after initial discharge were rare [33 patients (1.4%)].',\n",
       "               'FAU': ['Ebener, C',\n",
       "                'Goretzki, P E',\n",
       "                'Grabitz, K',\n",
       "                'Elbertzhagen, D',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Ebener C',\n",
       "                'Goretzki PE',\n",
       "                'Grabitz K',\n",
       "                'Elbertzhagen D',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemein und Unfallchirurgie, Heinrich-Heine Universitat, Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Fuhrt die Rationierung verfugbarer Intensivbetten zu verfruhter Verlegung mit vermeidbaren Komplikationen?',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir Suppl Kongressbd',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress',\n",
       "               'JID': '9200456',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Cause of Death',\n",
       "                'Cost-Benefit Analysis',\n",
       "                'Critical Care/*economics',\n",
       "                'Germany',\n",
       "                'Health Care Rationing/*economics',\n",
       "                'Hospital Bed Capacity/*economics',\n",
       "                'Hospital Mortality',\n",
       "                'Humans',\n",
       "                'Patient Readmission/economics',\n",
       "                'Postoperative Complications/*economics/mortality/prevention & control',\n",
       "                'Risk Factors'],\n",
       "               'EDAT': '1997/01/01 00:00',\n",
       "               'MHDA': '1998/05/09 00:01',\n",
       "               'CRDT': ['1997/01/01 00:00'],\n",
       "               'PHST': ['1997/01/01 00:00 [pubmed]',\n",
       "                '1998/05/09 00:01 [medline]',\n",
       "                '1997/01/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir Suppl Kongressbd. 1997;114:1396-7.'},\n",
       "              {'PMID': '9574360',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19980603',\n",
       "               'LR': '20080220',\n",
       "               'IS': '0942-2854 (Print) 0942-2854 (Linking)',\n",
       "               'VI': '114',\n",
       "               'DP': '1997',\n",
       "               'TI': '[Does decreased preoperative diagnosis in goiter surgery present special challenges for the surgeon? What stays indispensible? What is superfluous?].',\n",
       "               'PG': '1145-7',\n",
       "               'AB': 'Patient history, clinical examination, basal TSH, and ultrasound are the crucial factors for the indication of surgical treatment of the goiter. In our study, additional scintiscan failed to locate additional nodules found by intraoperative digital examination of the thyroid in 10.3%, and therefore leads to no additional security in determining the extent of thyroid resection (exception: autonomous goiter). Intraoperative inspection and palpation of both thyroid lobes remains the most important factor in preventing goiter recurrence.',\n",
       "               'FAU': ['Witte, J', 'Goretzki, P E', 'Roher, H D'],\n",
       "               'AU': ['Witte J', 'Goretzki PE', 'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemeine und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Stellt eine Verringerung der praoperativen Diagnostik in der Strumachirurgie besondere Anforderungen an den Chirurgen? Was bleibt unverzichtbar? Was ist uberflussig?',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir Suppl Kongressbd',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress',\n",
       "               'JID': '9200456',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Diagnosis, Differential',\n",
       "                'Diagnostic Imaging',\n",
       "                '*Diagnostic Tests, Routine',\n",
       "                'Humans',\n",
       "                'Retrospective Studies',\n",
       "                'Sensitivity and Specificity',\n",
       "                'Thyroid Diseases/diagnosis/etiology/*surgery',\n",
       "                'Thyroid Function Tests',\n",
       "                'Thyroid Neoplasms/diagnosis/etiology/*surgery',\n",
       "                '*Thyroidectomy'],\n",
       "               'EDAT': '1997/01/01 00:00',\n",
       "               'MHDA': '1998/05/09 00:01',\n",
       "               'CRDT': ['1997/01/01 00:00'],\n",
       "               'PHST': ['1997/01/01 00:00 [pubmed]',\n",
       "                '1998/05/09 00:01 [medline]',\n",
       "                '1997/01/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir Suppl Kongressbd. 1997;114:1145-7.'},\n",
       "              {'PMID': '9574162',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19980603',\n",
       "               'LR': '20080220',\n",
       "               'IS': '0942-2854 (Print) 0942-2854 (Linking)',\n",
       "               'VI': '114',\n",
       "               'DP': '1997',\n",
       "               'TI': '[Instrumental diagnosis for therapeutic decisions--what is possible and desirable, what is essential and what is superfluous--in goiter surgery].',\n",
       "               'PG': '387-90',\n",
       "               'AB': 'In addition to patient history and clinical examination, the basis of thyroid diagnosis consists of bTSH measurement and ultrasound to provide information on function and morphology. Solitary nodules have to be differentiated into \"cold\" and \"hot\" by scintigraphy. For cold nodules, FNA cytology is strongly recommended. Immunogenic hyperthyroidism is proven by positive TRAK measurement. Thyroidal autonomy requires suppressive scintigraphy for morphologic guidance. Special imaging procedures like CT and MRT are reserved for special situations of retrosternal extension.',\n",
       "               'FAU': ['Roher, H D', 'Simon, D', 'Goretzki, P E'],\n",
       "               'AU': ['Roher HD', 'Simon D', 'Goretzki PE'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Medizinische Einrichtungen, Heinrich-Heine-Universitat, Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Apparative Diagnostik zur Therapieentscheidung--was ist moglich und wunschenswert, was unverzichtbar und was uberflussig--in der Strumachirurgie.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir Suppl Kongressbd',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress',\n",
       "               'JID': '9200456',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Diagnosis, Differential',\n",
       "                '*Diagnostic Imaging',\n",
       "                'Germany',\n",
       "                'Goiter, Nodular/diagnosis/etiology/*surgery',\n",
       "                'Graves Disease/diagnosis/etiology/surgery',\n",
       "                'Humans',\n",
       "                'Quality Assurance, Health Care',\n",
       "                'Thyroid Function Tests',\n",
       "                'Thyroid Neoplasms/diagnosis/etiology/*surgery'],\n",
       "               'EDAT': '1997/01/01 00:00',\n",
       "               'MHDA': '1997/01/01 00:01',\n",
       "               'CRDT': ['1997/01/01 00:00'],\n",
       "               'PHST': ['1997/01/01 00:00 [pubmed]',\n",
       "                '1997/01/01 00:01 [medline]',\n",
       "                '1997/01/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir Suppl Kongressbd. 1997;114:387-90.'},\n",
       "              {'PMID': '9574114',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19980603',\n",
       "               'LR': '20080220',\n",
       "               'IS': '0942-2854 (Print) 0942-2854 (Linking)',\n",
       "               'VI': '114',\n",
       "               'DP': '1997',\n",
       "               'TI': '[Guidelines in oncologic surgery--malignant thyroid tumors].',\n",
       "               'PG': '142-5',\n",
       "               'AB': 'Guidelines for a highly effective radical treatment protocol of thyroid cancer are based on its histopathological classification. The bases are total thyroidectomy, including the central lymph node compartment parathyroidal and paratracheal, extended to uni- or bilateral cervical lymph node dissection in case of clinical manifestation or very advanced tumor stage. Postoperative control or treatment by radioiodine is obligatory for all differentiated thyroid carcinoma. Reoperative surgery is useful for locoregional recurrence. Limited unilateral thyroid surgery is only justified in selected cases of primary tumors less than 1 cm diameter in a low-risk patient group.',\n",
       "               'FAU': ['Roher, H D', 'Simon, D', 'Goretzki, P E'],\n",
       "               'AU': ['Roher HD', 'Simon D', 'Goretzki PE'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Medizinische Einrichtungen der Heinrich-Heine-Universitat, Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Leitlinien Onkologische Chirurgie--Maligne Schilddrusentumoren.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir Suppl Kongressbd',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress',\n",
       "               'JID': '9200456',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Combined Modality Therapy',\n",
       "                'Germany',\n",
       "                'Humans',\n",
       "                'Lymph Node Excision',\n",
       "                'Neoplasm Recurrence, Local/diagnosis/pathology/surgery',\n",
       "                'Neoplasm Staging',\n",
       "                'Practice Guidelines as Topic',\n",
       "                '*Quality Assurance, Health Care',\n",
       "                'Radiotherapy, Adjuvant',\n",
       "                'Reoperation',\n",
       "                'Thyroid Neoplasms/diagnosis/pathology/*surgery',\n",
       "                'Thyroidectomy'],\n",
       "               'EDAT': '1997/01/01 00:00',\n",
       "               'MHDA': '1998/05/09 00:01',\n",
       "               'CRDT': ['1997/01/01 00:00'],\n",
       "               'PHST': ['1997/01/01 00:00 [pubmed]',\n",
       "                '1998/05/09 00:01 [medline]',\n",
       "                '1997/01/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir Suppl Kongressbd. 1997;114:142-5.'},\n",
       "              {'PMID': '9498199',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19980422',\n",
       "               'LR': '20190822',\n",
       "               'IS': '0023-8236 (Print) 0023-8236 (Linking)',\n",
       "               'VI': '382',\n",
       "               'IP': '6',\n",
       "               'DP': '1997',\n",
       "               'TI': '[Results of selective venous site-specific catheterization in occult C-cell carcinoma of the thyroid gland].',\n",
       "               'PG': '295-301',\n",
       "               'AB': 'BACKGROUND: Medullary thyroid carcinoma (MTC) can--even in recurrent cases--only be treated surgically. Therefore, preoperative localization of the tumor is essential. METHODS: From April 1986 through April 1997, 137 patients with MTC were operated on at our clinic. In 22 patients with recurrent tumor which had not been radiologically localized, 28 selective venous catheterizations (SVC) with determination of calcitonin levels were carried out. RESULTS: In 23 examinations a suspected tumor could be identified (nine cervical unilateral, seven mediastinal, four cervical unilateral and mediastinal, one cervical bilateral and mediastinal, one liver, one cervical unilateral and liver). In 18 cases surgery was performed for recurrence (nine cervical revisions, one mediastinal dissection, six cervicomediastinal dissections, two laparotomies). In 15 of 18 cases, tumor tissue was found in the previously suspected area. In ten cases serum calcitonin levels dropped postoperatively by 6%-75%. A normalization of the hormone level was achieved only once by yet another operation. During further follow-up, five of the reoperated patients died from their disease. The other 17 patients are being followed up, whereby calcitonin levels are elevated but there is no clinical or radiological evidence of tumor. CONCLUSIONS: Although in the patient cohort presented a normalization of serum calcitonin could be achieved only once, the authors consider SVC useful because it is the only means of localization of tumor tissue in cases of negative radiologic studies and therefore allows a planned approach to the operation procedure in these cases.',\n",
       "               'FAU': ['Cupisti, K',\n",
       "                'Simon, D',\n",
       "                'Dotzenrath, C',\n",
       "                'Goretzki, P E',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Cupisti K',\n",
       "                'Simon D',\n",
       "                'Dotzenrath C',\n",
       "                'Goretzki PE',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf, Germany.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Ergebnisse des selektiven venosen Etagenkatheters (SVK) beim okkulten C-Zell-Karzinom der Schilddruse.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie',\n",
       "               'JID': '0204167',\n",
       "               'RN': ['0 (Hormones, Ectopic)', '9007-12-9 (Calcitonin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Calcitonin/*blood',\n",
       "                'Carcinoma, Medullary/*diagnosis/pathology/surgery',\n",
       "                '*Catheters, Indwelling',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Hormones, Ectopic/*blood',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Neck Dissection',\n",
       "                'Neoplasm, Residual/*diagnosis/pathology/surgery',\n",
       "                'Reoperation',\n",
       "                'Retrospective Studies',\n",
       "                'Thyroid Neoplasms/*diagnosis/pathology/surgery',\n",
       "                'Thyroidectomy',\n",
       "                'Veins'],\n",
       "               'EDAT': '1997/01/01 00:00',\n",
       "               'MHDA': '1998/03/14 00:01',\n",
       "               'CRDT': ['1997/01/01 00:00'],\n",
       "               'PHST': ['1997/01/01 00:00 [pubmed]',\n",
       "                '1998/03/14 00:01 [medline]',\n",
       "                '1997/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/s004230050070 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir. 1997;382(6):295-301. doi: 10.1007/s004230050070.'},\n",
       "              {'PMID': '9439918',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19980218',\n",
       "               'LR': '20051117',\n",
       "               'IS': '0947-7349 (Print) 0947-7349 (Linking)',\n",
       "               'VI': '105 Suppl 4',\n",
       "               'DP': '1997',\n",
       "               'TI': 'Surgery for Graves disease in childhood and adolescence.',\n",
       "               'PG': '58-60',\n",
       "               'AB': 'Children and adolescents with thyroid disorders are predominantly treated by pediatricians and pediatric endocrinologists. Surgery for thyroid disorders still represents the third frequent operation in adults in Germany, but is seldomly indicated in children. Thus children and adolescents make up for 1.3% of all our patients and of these 89 patients only 21 (23.6%) suffered from Graves disease. Nevertheless surgery for Graves disease in children and adolescence is recommended because medical therapy has proven a high rate of recurrences in children and because radioiodine is only reluctantly applied to children, at least in Germany.',\n",
       "               'FAU': ['Witte, J', 'Goretzki, P E', 'Roher, H D'],\n",
       "               'AU': ['Witte J', 'Goretzki PE', 'Roher HD'],\n",
       "               'AD': ['Department of General and Trauma Surgery, University Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Exp Clin Endocrinol Diabetes',\n",
       "               'JT': 'Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association',\n",
       "               'JID': '9505926',\n",
       "               'RN': ['0 (Antithyroid Agents)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Antithyroid Agents/therapeutic use',\n",
       "                'Child',\n",
       "                'Female',\n",
       "                'Graves Disease/*surgery',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Postoperative Complications',\n",
       "                'Thyroidectomy'],\n",
       "               'RF': '15',\n",
       "               'EDAT': '1997/01/01 00:00',\n",
       "               'MHDA': '1998/01/24 00:01',\n",
       "               'CRDT': ['1997/01/01 00:00'],\n",
       "               'PHST': ['1997/01/01 00:00 [pubmed]',\n",
       "                '1998/01/24 00:01 [medline]',\n",
       "                '1997/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-0029-1211935 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Exp Clin Endocrinol Diabetes. 1997;105 Suppl 4:58-60. doi: 10.1055/s-0029-1211935.'},\n",
       "              {'PMID': '9334115',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19971015',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0044-409X (Print) 0044-409X (Linking)',\n",
       "               'VI': '122',\n",
       "               'IP': '6',\n",
       "               'DP': '1997',\n",
       "               'TI': '[Conventional operation for therapy of incidentaloma].',\n",
       "               'PG': '473-6',\n",
       "               'AB': 'AIM: The increasing detection rate of incidentalomas imposes not only the question about the necessity of treatment but also with introduction of laparoscopic adrenalectomy the question about operative strategy. Own patients and literature are analysed and discussed. PATIENTS: Between 1985 and 1996 203 patients have been operated on for adrenal disease including 21 patients with incidentaloma. RESULTS: Biochemical analysis revealed latent hormonal activity in 9 patients. All patients were operated conventionally. Pathohistology demonstrated 1 adrenal carcinoma, 9 adrenocortical adenomas, 2 myelolipomas, 2 adrenal cysts, 2 nodular hyperplasias and 5 pheochromocytomas. Postoperative morbidity was 5% and mortality 0%. CONCLUSION: Small and hormonally latent active tumors can be operated laparoscopically or conventionally via dorsal approach. In case of suspected malignancy conventional operation is the more reliable procedure.',\n",
       "               'FAU': ['Simon, D', 'Goretzki, P E', 'Roher, H D'],\n",
       "               'AU': ['Simon D', 'Goretzki PE', 'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemeine und Unfallchirurgie, Heinrich-Heinc-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article', 'Review'],\n",
       "               'TT': 'Konventionelle Operation zur Therapie des Inzidentaloms.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Zentralbl Chir',\n",
       "               'JT': 'Zentralblatt fur Chirurgie',\n",
       "               'JID': '0413645',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adrenal Gland Neoplasms/diagnosis/mortality/*surgery',\n",
       "                '*Adrenalectomy',\n",
       "                'Adrenocortical Adenoma/diagnosis/mortality/*surgery',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Diagnosis, Differential',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                '*Laparoscopy',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Paraneoplastic Endocrine Syndromes/diagnosis/mortality/surgery',\n",
       "                'Pheochromocytoma/diagnosis/mortality/*surgery',\n",
       "                'Precancerous Conditions/diagnosis/mortality/*surgery',\n",
       "                'Survival Rate'],\n",
       "               'RF': '29',\n",
       "               'EDAT': '1997/01/01 00:00',\n",
       "               'MHDA': '1997/10/23 00:01',\n",
       "               'CRDT': ['1997/01/01 00:00'],\n",
       "               'PHST': ['1997/01/01 00:00 [pubmed]',\n",
       "                '1997/10/23 00:01 [medline]',\n",
       "                '1997/01/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Zentralbl Chir. 1997;122(6):473-6.'},\n",
       "              {'PMID': '9334114',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19971015',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0044-409X (Print) 0044-409X (Linking)',\n",
       "               'VI': '122',\n",
       "               'IP': '6',\n",
       "               'DP': '1997',\n",
       "               'TI': '[Surgical concept in sporadic and familial pheochromocytoma].',\n",
       "               'PG': '467-72',\n",
       "               'AB': \"A retrospective analysis of 61 patients operated upon sporadic and familial pheochromocytomas demonstrates the changes in diagnosis and therapy. Familial pheochromocytomas make up for 28% of all patients and in 13% tumor malignancy was diagnosed. Patients had suffered from endocrine crises in 21% preoperatively but only in 3% intra- and postoperatively. CT was confirmed to visualize more tumors than US or MIBG (> 90%) preoperatively. Operative strategy was based on tumor-size and tumor-localization but increasing importance of endoscopic procedures is conceded. Postoperative complications are rare (infection 8%; Addison's crisis 5%) and life threatening complications (bleeding, post op death) as well as tumor persistence or recurrence almost exclusively occur in patients with malignant disease. Altogether the main changes are the early diagnosis of especially familial disease and the use of endoscopic procedures in the treatment of patients with small benign pheochromocytomas.\",\n",
       "               'FAU': ['Goretzki, P E', 'Simon, D', 'Roher, H D'],\n",
       "               'AU': ['Goretzki PE', 'Simon D', 'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Operatives Konzept beim sporadischen und familiaren Phaochromozytom.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Zentralbl Chir',\n",
       "               'JT': 'Zentralblatt fur Chirurgie',\n",
       "               'JID': '0413645',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adrenal Gland Neoplasms/genetics/mortality/*surgery',\n",
       "                'Adrenalectomy',\n",
       "                'Endoscopy',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                'Neoplastic Syndromes, Hereditary/genetics/mortality/surgery',\n",
       "                'Pheochromocytoma/genetics/mortality/*surgery',\n",
       "                'Postoperative Complications/etiology/mortality',\n",
       "                'Retrospective Studies',\n",
       "                'Risk Factors',\n",
       "                'Survival Rate'],\n",
       "               'EDAT': '1997/01/01 00:00',\n",
       "               'MHDA': '1997/10/23 00:01',\n",
       "               'CRDT': ['1997/01/01 00:00'],\n",
       "               'PHST': ['1997/01/01 00:00 [pubmed]',\n",
       "                '1997/10/23 00:01 [medline]',\n",
       "                '1997/01/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Zentralbl Chir. 1997;122(6):467-72.'},\n",
       "              {'PMID': '9221636',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19970715',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0044-409X (Print) 0044-409X (Linking)',\n",
       "               'VI': '122',\n",
       "               'IP': '4',\n",
       "               'DP': '1997',\n",
       "               'TI': '[Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].',\n",
       "               'PG': '259-65',\n",
       "               'AB': 'Surgical therapy of differentiated thyroid cancer (DTC) includes thyroidectomy plus central lymph node dissection and postoperative radioiodine therapy. In cases of lymph node metastasis, T3/T4 tumors and C-cell-carcinoma (after thyroidectomy) uni- or bilateral modified radical lymph node dissection of the neck (neck dissection) and of the mediastinum is recommended. The importance of lymph node metastasis for prognosis of survival in papillary, follicular and C-cell-carcinoma is discussed controversial, however. Even the kind of surgical radicality is questioned. Thus a metaanalysis of 35 studies in 29 independent publications from a pool of 2186 studies was performed. Univariate analysis demonstrates lymph node metastasis as a negative prognostic factor in papillary carcinoma with a 3.25/2.97, in follicular carcinoma with a 7.62/4.0 and in C-cell-carcinoma with a 3.33/3.37 higher probability of mortality 5 and 10 years after operation. Modification of the present surgical therapy can therefore only be accepted after univariate and multivariate analysis of all prognostic factors (age, sex, cell type, tumor extent, lymph node- and distant metastasis) and after it has proven superiority to the present strategy in prospective randomised trials.',\n",
       "               'FAU': ['Witte, J',\n",
       "                'Schlotmann, U',\n",
       "                'Simon, D',\n",
       "                'Dotzenrath, C',\n",
       "                'Ohmann, C',\n",
       "                'Goretzki, P E'],\n",
       "               'AU': ['Witte J',\n",
       "                'Schlotmann U',\n",
       "                'Simon D',\n",
       "                'Dotzenrath C',\n",
       "                'Ohmann C',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Klinik fur Allgemeine- und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article', 'Meta-Analysis'],\n",
       "               'TT': 'Bedeutung der Lymphknotenmetastasen differenzierter Schilddrusenkarzinome und C-Zell-Karzinome fur deren Prognose--eine Metaanalyse.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Zentralbl Chir',\n",
       "               'JT': 'Zentralblatt fur Chirurgie',\n",
       "               'JID': '0413645',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma, Follicular/mortality/*pathology/surgery',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Carcinoma, Medullary/mortality/*pathology/surgery',\n",
       "                'Carcinoma, Papillary/mortality/*pathology/surgery',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Lymph Node Excision',\n",
       "                'Lymphatic Metastasis',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Neoplasm Staging',\n",
       "                'Prognosis',\n",
       "                'Survival Rate',\n",
       "                'Thyroid Neoplasms/mortality/*pathology/surgery',\n",
       "                'Thyroidectomy'],\n",
       "               'EDAT': '1997/01/01 00:00',\n",
       "               'MHDA': '1997/01/01 00:01',\n",
       "               'CRDT': ['1997/01/01 00:00'],\n",
       "               'PHST': ['1997/01/01 00:00 [pubmed]',\n",
       "                '1997/01/01 00:01 [medline]',\n",
       "                '1997/01/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Zentralbl Chir. 1997;122(4):259-65.'},\n",
       "              {'PMID': '8943171',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19970409',\n",
       "               'LR': '20190826',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '21',\n",
       "               'IP': '1',\n",
       "               'DP': '1997 Jan',\n",
       "               'TI': 'Iodide or L-thyroxine to prevent recurrent goiter in an iodine-deficient area: prospective sonographic study.',\n",
       "               'PG': '10-4',\n",
       "               'AB': 'In a randomized study, prevention of goiter recurrence with L-thyroxine was compared with pure iodide substitution after thyroid surgery for nodular goiter in an iodine-deficient area. Altogether 107 patients were followed up for 52 weeks after thyroid resection. The thyroid volume was determined sonographically. Free thyroxine, total thyroxine, thyrotropin, thyroglobulin, and antibodies to thyroglobulin and thyroid peroxidase were measured. The thyroid volume decreased slightly over the course of a year in the two therapy groups. There was no significant difference between the two groups. Recurrences were seen with both L-thyroxine medication and iodide substitution. The thyroglobulin levels fell significantly over the 52-week follow-up period in the iodide group. Antibody formation was not observed under iodine substitution. In an area of iodine deficiency, substitution with iodide is just as effective as medicating the patients with L-thyroxine for preventing recurrences.',\n",
       "               'FAU': ['Feldkamp, J',\n",
       "                'Seppel, T',\n",
       "                'Becker, A',\n",
       "                'Klisch, A',\n",
       "                'Schlaghecke, R',\n",
       "                'Goretzki, P E',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Feldkamp J',\n",
       "                'Seppel T',\n",
       "                'Becker A',\n",
       "                'Klisch A',\n",
       "                'Schlaghecke R',\n",
       "                'Goretzki PE',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Department of Endocrinology, Heinrich-Heine-University, Moorenstrasse 5, D-40225 Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Clinical Trial',\n",
       "                'Comparative Study',\n",
       "                'Journal Article',\n",
       "                'Randomized Controlled Trial'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'RN': ['0 (Thyroid Hormones)',\n",
       "                '1C4QK22F9J (Potassium Iodide)',\n",
       "                'Q51BO43MG4 (Thyroxine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Female',\n",
       "                'Goiter/*prevention & control/surgery',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Potassium Iodide/*therapeutic use',\n",
       "                'Prospective Studies',\n",
       "                'Recurrence',\n",
       "                'Statistics, Nonparametric',\n",
       "                'Thyroid Gland/diagnostic imaging/surgery',\n",
       "                'Thyroid Hormones/blood',\n",
       "                'Thyroxine/*therapeutic use',\n",
       "                'Ultrasonography'],\n",
       "               'EDAT': '1997/01/01 00:00',\n",
       "               'MHDA': '1997/01/01 00:01',\n",
       "               'CRDT': ['1997/01/01 00:00'],\n",
       "               'PHST': ['1997/01/01 00:00 [pubmed]',\n",
       "                '1997/01/01 00:01 [medline]',\n",
       "                '1997/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/s002689900186 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 1997 Jan;21(1):10-4. doi: 10.1007/s002689900186.'}],\n",
       "             '1996': [{'PMID': '8957499',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19970110',\n",
       "               'LR': '20190914',\n",
       "               'IS': '0039-6060 (Print) 0039-6060 (Linking)',\n",
       "               'VI': '120',\n",
       "               'IP': '6',\n",
       "               'DP': '1996 Dec',\n",
       "               'TI': 'A frequent mutation/polymorphism in tumor suppressor gene INK4B (MTS-2) in papillary and medullary thyroid cancer.',\n",
       "               'PG': '1081-8',\n",
       "               'AB': \"BACKGROUND: Structural genetic changes of tumor suppressor genes MTS-1/INK4A and MTS-2/INK4B were demonstrated in a variety of human cancers but not in thyroid cancer until now. METHODS: Because MTS-2 encodes the tumor suppressor p15, a protein related to the transforming growth factor-beta inhibition of many epithelial cells such as thyrocytes, we investigated MTS-1 and MTS-2 genes in 87 thyroid cancers (29 papillary, 26 follicular, 31 medullary, and 1 anaplastic), 8 goiters, and 38 control DNAs by using a semiquantitative polymerase chain reaction technique. RESULTS: We failed to demonstrate homozygous deletions of MTS-1 and MTS-2 in thyroid tumors, but we demonstrated a highly frequent base pair exchange of the MTS-2 gene 27 codons upstream the 5' end of exon 2. This genetic change formerly described as polymorphism was found to a lesser degree (15%), in control DNA when compared with papillary thyroid cancer and medullary thyroid cancer (35% and 32%, respectively), and it paralleled a higher prevalence of extensive lymph node metastases in thyroid cancer (p < 0.01). In addition, we could demonstrate that genetic changes at site 27 upstream the 5' end of exon 2 were harbored as somatic mutations in 2 of 10 thyroid cancers with simultaneously investigated corresponding control tissue. CONCLUSIONS: We conclude that base pair exchange at this site most likely has biologic importance for the tumor suppressor p15 and may contribute to tumorigenesis and lymphatic spread of differentiated and medullary thyroid cancer.\",\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Gorelov, V',\n",
       "                'Dotzenrath, C',\n",
       "                'Witte, J',\n",
       "                'Roeher, H D'],\n",
       "               'AU': ['Goretzki PE',\n",
       "                'Gorelov V',\n",
       "                'Dotzenrath C',\n",
       "                'Witte J',\n",
       "                'Roeher HD'],\n",
       "               'AD': ['Klinik fuer Allgemein- und Unfallchirurgie, Heinrich Heine Universitaet Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['CA-91-32/CA/NCI NIH HHS/United States'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                \"Research Support, U.S. Gov't, P.H.S.\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Surgery',\n",
       "               'JT': 'Surgery',\n",
       "               'JID': '0417347',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Carcinoma/*genetics',\n",
       "                'Carcinoma, Medullary/*genetics',\n",
       "                'Carcinoma, Papillary/*genetics',\n",
       "                '*Genes, Tumor Suppressor',\n",
       "                'Humans',\n",
       "                '*Mutation',\n",
       "                'Polymerase Chain Reaction',\n",
       "                '*Polymorphism, Genetic',\n",
       "                'Thyroid Neoplasms/*genetics'],\n",
       "               'EDAT': '1996/12/01 00:00',\n",
       "               'MHDA': '1996/12/01 00:01',\n",
       "               'CRDT': ['1996/12/01 00:00'],\n",
       "               'PHST': ['1996/12/01 00:00 [pubmed]',\n",
       "                '1996/12/01 00:01 [medline]',\n",
       "                '1996/12/01 00:00 [entrez]'],\n",
       "               'AID': ['S0039-6060(96)80059-6 [pii]',\n",
       "                '10.1016/s0039-6060(96)80059-6 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Surgery. 1996 Dec;120(6):1081-8. doi: 10.1016/s0039-6060(96)80059-6.'},\n",
       "              {'PMID': '8872463',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19970108',\n",
       "               'LR': '20190512',\n",
       "               'IS': '0964-6906 (Print) 0964-6906 (Linking)',\n",
       "               'VI': '5',\n",
       "               'IP': '9',\n",
       "               'DP': '1996 Sep',\n",
       "               'TI': 'Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer.',\n",
       "               'PG': '1245-52',\n",
       "               'AB': 'To date, at least four genes involved in DNA mismatch repair, hMSH2, hMLH1, hPMS1 and hPMS2, have been demonstrated to be altered in the germline of patients with hereditary nonpolyposis colorectal cancer (HNPCC). Additionally, defective mismatch repair is thought to account for the observation of microsatellite instability (MIN) in tumors from these patients. The genetic defect responsible for the MIN+ phenotype in sporadic colorectal cancer, however, has yet to be clearly delineated. In order to better understand the role of somatic and germline alterations within hMSH2 and hMLH1 in the process of colorectal tumorigenesis, we examined the entire coding regions of both of these genes in seven patients with MIN+ sporadic colorectal cancer, 19 patients with familial colorectal cancer, and 20 patients meeting the strict Amsterdam criteria for HNPCC. Thirteen germline, two somatic, and four neutral alterations were identified. The two somatic mutations occurred in patients having familial cancer, while the germline mutations were distributed among one sporadic (14%), three familial (16%), and nine HNPCC (45%) cases. All patients with identified mutations in the mismatch repair genes, whose tumors were available for analysis, demonstrated MIN. On the other hand, we could not identify mutations in the subset of clinically defined HNPCC patients with MIN negative tumors nor in the majority (6/7) of MIN+ sporadic tumors.',\n",
       "               'FAU': ['Moslein, G',\n",
       "                'Tester, D J',\n",
       "                'Lindor, N M',\n",
       "                'Honchel, R',\n",
       "                'Cunningham, J M',\n",
       "                'French, A J',\n",
       "                'Halling, K C',\n",
       "                'Schwab, M',\n",
       "                'Goretzki, P',\n",
       "                'Thibodeau, S N'],\n",
       "               'AU': ['Moslein G',\n",
       "                'Tester DJ',\n",
       "                'Lindor NM',\n",
       "                'Honchel R',\n",
       "                'Cunningham JM',\n",
       "                'French AJ',\n",
       "                'Halling KC',\n",
       "                'Schwab M',\n",
       "                'Goretzki P',\n",
       "                'Thibodeau SN'],\n",
       "               'AD': ['Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Hum Mol Genet',\n",
       "               'JT': 'Human molecular genetics',\n",
       "               'JID': '9208958',\n",
       "               'RN': ['0 (Adaptor Proteins, Signal Transducing)',\n",
       "                '0 (Carrier Proteins)',\n",
       "                '0 (DNA, Satellite)',\n",
       "                '0 (DNA-Binding Proteins)',\n",
       "                '0 (MLH1 protein, human)',\n",
       "                '0 (Neoplasm Proteins)',\n",
       "                '0 (Nuclear Proteins)',\n",
       "                '0 (Proto-Oncogene Proteins)',\n",
       "                'EC 3.6.1.3 (MSH2 protein, human)',\n",
       "                'EC 3.6.1.3 (MutL Protein Homolog 1)',\n",
       "                'EC 3.6.1.3 (MutS Homolog 2 Protein)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adaptor Proteins, Signal Transducing',\n",
       "                'Adult',\n",
       "                'Carrier Proteins',\n",
       "                'Colorectal Neoplasms/*genetics',\n",
       "                'DNA Mutational Analysis',\n",
       "                'DNA, Satellite/*genetics',\n",
       "                '*DNA-Binding Proteins',\n",
       "                'Humans',\n",
       "                'Microsatellite Repeats/*genetics',\n",
       "                'Middle Aged',\n",
       "                'MutL Protein Homolog 1',\n",
       "                'MutS Homolog 2 Protein',\n",
       "                'Neoplasm Proteins/*genetics',\n",
       "                'Nuclear Proteins',\n",
       "                'Proto-Oncogene Proteins/*genetics'],\n",
       "               'EDAT': '1996/09/01 00:00',\n",
       "               'MHDA': '2000/03/29 09:00',\n",
       "               'CRDT': ['1996/09/01 00:00'],\n",
       "               'PHST': ['1996/09/01 00:00 [pubmed]',\n",
       "                '2000/03/29 09:00 [medline]',\n",
       "                '1996/09/01 00:00 [entrez]'],\n",
       "               'AID': ['6w0083 [pii]', '10.1093/hmg/5.9.1245 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Hum Mol Genet. 1996 Sep;5(9):1245-52. doi: 10.1093/hmg/5.9.1245.'},\n",
       "              {'PMID': '8784068',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19961016',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0021-972X (Print) 0021-972X (Linking)',\n",
       "               'VI': '81',\n",
       "               'IP': '9',\n",
       "               'DP': '1996 Sep',\n",
       "               'TI': 'Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors?',\n",
       "               'PG': '3194-6',\n",
       "               'AB': 'Allelic loss of the retinoblastoma tumor suppressor gene has recently been shown to be highly specific for parathyroid carcinoma. It has been proposed that this genetic abnormality may have diagnostic and prognostic implications for parathyroid carcinoma, but to date no further studies are available to substantiate these findings. In the present study, three cases of atypical recurrent hyperparathyroidism were examined: a patient with parathyroid carcinoma and an autotransplanted adenoma that progressed into carcinoma, a patient with recurrent juvenile hyperparathyroidism, and a patient with severe recurrent secondary hyperparathyroid disease due to rapidly growing autotransplant. Six pairs each of sporadic parathyroid adenoma and secondary parathyroid disease were also studied for comparison. Allelic losses of RB and D13S71 at 13q14 was found in the parathyroid carcinoma and the corresponding autotransplant that had previously been considered benign tissue and in the case of recurrent juvenile hyperparathyroidism, but not in any of the other tumors. Our findings support the findings of the previous study that RB or 13q loss is specific for parathyroid tumors with increased aggressiveness and might be of clinical significance.',\n",
       "               'FAU': ['Dotzenrath, C',\n",
       "                'Teh, B T',\n",
       "                'Farnebo, F',\n",
       "                'Cupisti, K',\n",
       "                'Svensson, A',\n",
       "                'Toell, A',\n",
       "                'Goretzki, P',\n",
       "                'Larsson, C'],\n",
       "               'AU': ['Dotzenrath C',\n",
       "                'Teh BT',\n",
       "                'Farnebo F',\n",
       "                'Cupisti K',\n",
       "                'Svensson A',\n",
       "                'Toell A',\n",
       "                'Goretzki P',\n",
       "                'Larsson C'],\n",
       "               'AD': ['Department of Surgery, Heinrich Heine Universitat, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports',\n",
       "                'Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Clin Endocrinol Metab',\n",
       "               'JT': 'The Journal of clinical endocrinology and metabolism',\n",
       "               'JID': '0375362',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/*genetics',\n",
       "                'Adult',\n",
       "                '*Alleles',\n",
       "                'Child',\n",
       "                'Chromosomes, Human, Pair 13',\n",
       "                'Female',\n",
       "                '*Genes, Retinoblastoma',\n",
       "                'Heterozygote',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism/etiology',\n",
       "                'Middle Aged',\n",
       "                'Mutation',\n",
       "                'Parathyroid Neoplasms/complications/*genetics',\n",
       "                'Prognosis'],\n",
       "               'EDAT': '1996/09/01 00:00',\n",
       "               'MHDA': '1996/09/01 00:01',\n",
       "               'CRDT': ['1996/09/01 00:00'],\n",
       "               'PHST': ['1996/09/01 00:00 [pubmed]',\n",
       "                '1996/09/01 00:01 [medline]',\n",
       "                '1996/09/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1210/jcem.81.9.8784068 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Clin Endocrinol Metab. 1996 Sep;81(9):3194-6. doi: 10.1210/jcem.81.9.8784068.'},\n",
       "              {'PMID': '8678963',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19961105',\n",
       "               'LR': '20190826',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '20',\n",
       "               'IP': '7',\n",
       "               'DP': '1996 Sep',\n",
       "               'TI': 'Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma.',\n",
       "               'PG': '860-6; discussion 866',\n",
       "               'AB': 'Total thyroidectomy has become the routine procedure for treatment of differentiated thyroid carcinoma. However, the necessity of unilateral or bilateral neck dissection is far less standardized. Our usual procedure has been to perform a routine neck dissection in T4 tumors and in all other tumor stages only in the presence of positive diagnostic or intraoperative findings. The results concerning regional tumor recurrence in cervical lymph nodes subsequent to thyroidectomy are studied and discussed. Between April 1986 and December 1992 a group of 252 patients were operated on for differentiated thyroid carcinoma (DTC) (176 papillary, 76 follicular). Postoperative treatment included radioiodine therapy as a rule in all patients more than stage T1, and follow-up encompassed thyroglobulin measurements, cervical ultrasonography, and radioiodine scintigraphy. After a mean follow-up of 6.9 years, 77 (31%) of the patients underwent reoperation because of regional tumor recurrence [46 of 176 (26%) papillary, 31 of 76 (41%) follicular]. In papillary thyroid cancer a significant difference could be demonstrated between patients with thyroidectomy only versus thyroidectomy plus neck dissection in all tumor stages (T2, 13 of 29 (45%) versus 1 of 34 (3%); T3, 10 of 13 (77%) versus 4 of 11 (36%); T4, 6 of 8 (75%) versus 6 of 18 (33%) (p < 0.0001). Similar results could be achieved for follicular thyroid cancer, showing statistical significance with regard to operative procedure (p < 0.009). Our experience demonstrates a positive correlation of regional tumor recurrence with increasing tumor stage for both histologic tumor types. The high rate of regional recurrence justifies a more radical approach, including neck dissection at the initial operation. The impact on survival, however, must be proved by further evaluation.',\n",
       "               'FAU': ['Simon, D', 'Goretzki, P E', 'Witte, J', 'Roher, H D'],\n",
       "               'AU': ['Simon D', 'Goretzki PE', 'Witte J', 'Roher HD'],\n",
       "               'AD': ['Department of Surgery, Heinrich Heine University Dusseldorf, Moorenstrasse 5, D-40225 Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'RN': ['0 (Iodine Radioisotopes)', '9010-34-8 (Thyroglobulin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma, Follicular/diagnostic imaging/pathology/*surgery',\n",
       "                'Adult',\n",
       "                'Carcinoma, Papillary/diagnostic imaging/pathology/*surgery',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                'Incidence',\n",
       "                'Intraoperative Care',\n",
       "                'Iodine Radioisotopes/therapeutic use',\n",
       "                'Lymph Node Excision/*methods',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Neck/diagnostic imaging',\n",
       "                'Neoplasm Recurrence, Local/diagnostic imaging/*pathology',\n",
       "                'Neoplasm Staging',\n",
       "                'Postoperative Care',\n",
       "                'Radionuclide Imaging',\n",
       "                'Reoperation',\n",
       "                'Survival Rate',\n",
       "                'Thyroglobulin/analysis',\n",
       "                'Thyroid Neoplasms/pathology/*surgery',\n",
       "                'Thyroidectomy/*methods',\n",
       "                'Ultrasonography'],\n",
       "               'EDAT': '1996/09/01 00:00',\n",
       "               'MHDA': '1996/09/01 00:01',\n",
       "               'CRDT': ['1996/09/01 00:00'],\n",
       "               'PHST': ['1996/09/01 00:00 [pubmed]',\n",
       "                '1996/09/01 00:01 [medline]',\n",
       "                '1996/09/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/s002689900131 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 1996 Sep;20(7):860-6; discussion 866. doi: 10.1007/s002689900131.'},\n",
       "              {'PMID': '8685860',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19960822',\n",
       "               'LR': '20080212',\n",
       "               'IS': '0040-5930 (Print) 0040-5930 (Linking)',\n",
       "               'VI': '53',\n",
       "               'IP': '5',\n",
       "               'DP': '1996 May',\n",
       "               'TI': '[Endocrine pancreatic tumors].',\n",
       "               'PG': '408-12',\n",
       "               'AB': 'Endocrine active islet cell tumors of the pancreas are rare and become clinically evident mainly by symptoms of hormone over-production (hypoglycemia, gastric ulcer disease, diarrhea etc.). The tumors may occur sporadically or in connection with the familial MEN-I syndrome. Diagnosis is verified biochemically and does not need further localization studies. Localization studies are important, however, intraoperatively and in detecting persistent or recurrent tumor disease. Principally endocrine pancreatic tumors are excised selectively with exception of MEN-I patients and patients suffering from \"Nesidioblastosis\", where subtotal resections of the pancreas are indicated. In case of malignant metastatic endocrine pancreatic tumors palliative therapies (surgery, embolization, chemotherapy, therapy of hormone excess etc.) are demanded to improve the quality of life in these patients, since they may survive for years despite their tumor burden.',\n",
       "               'FAU': ['Goretzki, P E', 'Simon, D', 'Starke, A', 'Roher, H D'],\n",
       "               'AU': ['Goretzki PE', 'Simon D', 'Starke A', 'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Heinrich-Heine-Universitat, Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article', 'Review'],\n",
       "               'TT': 'Endokrine Pankreastumoren.',\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Ther Umsch',\n",
       "               'JT': 'Therapeutische Umschau. Revue therapeutique',\n",
       "               'JID': '0407224',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma, Islet Cell/*diagnosis/surgery',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                'Multiple Endocrine Neoplasia Type 1/*diagnosis/surgery',\n",
       "                'Pancreatic Neoplasms/*diagnosis/*surgery',\n",
       "                'Postoperative Care'],\n",
       "               'RF': '18',\n",
       "               'EDAT': '1996/05/01 00:00',\n",
       "               'MHDA': '1996/05/01 00:01',\n",
       "               'CRDT': ['1996/05/01 00:00'],\n",
       "               'PHST': ['1996/05/01 00:00 [pubmed]',\n",
       "                '1996/05/01 00:01 [medline]',\n",
       "                '1996/05/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Ther Umsch. 1996 May;53(5):408-12.'},\n",
       "              {'PMID': '8647121',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19960725',\n",
       "               'LR': '20190620',\n",
       "               'IS': '0014-2956 (Print) 0014-2956 (Linking)',\n",
       "               'VI': '237',\n",
       "               'IP': '3',\n",
       "               'DP': '1996 May 1',\n",
       "               'TI': 'Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator.',\n",
       "               'PG': '743-51',\n",
       "               'AB': 'The amino-terminal fragment of human uPA (ATF; amino acids 1-135), which contains the binding site for the uPA receptor (uPAR, CD87) was expressed in the yeast Saccharomyces cerevisiae. Recombinant yeast ATF, modified and extended by an amino-terminal in-frame insertion of a His6 tract, was purified from total protein extracts by nickel chelate affinity chromatography and shown to be functionally active since it efficiently competes with uPA for binding to cell-surface-associated uPAR. The ATF expression plasmid served as a template for the construction of a series of site-directed mutants in order to define those amino acids that are important for binding to uPAR. All mutant ATF proteins but one (deletion of Ser26) were expressed in a stable form (about 20-30 ng/mg total protein) and the binding capacity of each mutant was tested by a uPA-ligand binding assay employing recombinant uPAR immobilized to a microtiter plate. Each of the 11 amino acids of loop B of the binding region of uPA (amino acids 20-30) were individually substituted with alanine. Lys23, Tyr24, Phe25, IIe28, and Trp30 were important determinants for uPAR binding. A systematic alanine scan was also performed with chemically synthesized linear peptides spanning amino acids 14-32 of ATF. Comparable results to those with the yeast ATF mutants were obtained. In a different set of experiments, those amino acids of the uPAR-binding region of uPA that are only conserved between man and baboon but not in other species were altered: whereas substitution of Thr18 by alanine or Asn32 by serine had hardly any effect, replacement of Asn22 by tyrosine and Trp30 by arginine (both positions are strictly conserved in other mammals) led to ATF variants incapable of interacting with human uPAR. Deletion of either Val20, Ser21, Lys23, His29 or Val20 plus Ser21, respectively, also generated non-reactive ATF mutants. Finally, Lys23 in ATF was substituted with certain amino acids: whereas the replacement of Lys23 by alanine, histidine or glutamine generated ATF variants with moderate uPAR-binding activity, the introduction of a negatively charged amino acid (exchange of Lys23 by glutamic acid) completely abolished uPAR-binding activity. The results presented for the ATF mutants and uPA-derived peptides may provide clues necessary to establish the nature of the physical interaction of uPA with its receptor and may help to develop uPA-derived peptide analogues as potential therapeutic agents to block tumor cell-associated uPA/uPAR interaction.',\n",
       "               'FAU': ['Magdolen, V',\n",
       "                'Rettenberger, P',\n",
       "                'Koppitz, M',\n",
       "                'Goretzki, L',\n",
       "                'Kessler, H',\n",
       "                'Weidle, U H',\n",
       "                'Konig, B',\n",
       "                'Graeff, H',\n",
       "                'Schmitt, M',\n",
       "                'Wilhelm, O'],\n",
       "               'AU': ['Magdolen V',\n",
       "                'Rettenberger P',\n",
       "                'Koppitz M',\n",
       "                'Goretzki L',\n",
       "                'Kessler H',\n",
       "                'Weidle UH',\n",
       "                'Konig B',\n",
       "                'Graeff H',\n",
       "                'Schmitt M',\n",
       "                'Wilhelm O'],\n",
       "               'AD': ['Frauenklinik der Technischen Universitat Munchen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Eur J Biochem',\n",
       "               'JT': 'European journal of biochemistry',\n",
       "               'JID': '0107600',\n",
       "               'RN': ['0 (PLAUR protein, human)',\n",
       "                '0 (Peptide Fragments)',\n",
       "                '0 (Receptors, Cell Surface)',\n",
       "                '0 (Receptors, Urokinase Plasminogen Activator)',\n",
       "                '0 (Recombinant Proteins)',\n",
       "                'EC 3.4.21.73 (Urokinase-Type Plasminogen Activator)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Amino Acid Sequence',\n",
       "                'Animals',\n",
       "                'Binding Sites/genetics',\n",
       "                'Escherichia coli/genetics',\n",
       "                'Humans',\n",
       "                'Molecular Sequence Data',\n",
       "                'Mutagenesis, Site-Directed',\n",
       "                'Papio',\n",
       "                'Peptide Fragments/chemistry/genetics/metabolism',\n",
       "                'Point Mutation',\n",
       "                'Protein Structure, Secondary',\n",
       "                'Receptors, Cell Surface/*metabolism',\n",
       "                'Receptors, Urokinase Plasminogen Activator',\n",
       "                'Recombinant Proteins/chemistry/genetics/metabolism',\n",
       "                'Saccharomyces cerevisiae/genetics',\n",
       "                'Sequence Deletion',\n",
       "                'Urokinase-Type Plasminogen Activator/chemistry/*genetics/*metabolism'],\n",
       "               'EDAT': '1996/05/01 00:00',\n",
       "               'MHDA': '1996/05/01 00:01',\n",
       "               'CRDT': ['1996/05/01 00:00'],\n",
       "               'PHST': ['1996/05/01 00:00 [pubmed]',\n",
       "                '1996/05/01 00:01 [medline]',\n",
       "                '1996/05/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1111/j.1432-1033.1996.0743p.x [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Biochem. 1996 May 1;237(3):743-51. doi: 10.1111/j.1432-1033.1996.0743p.x.'},\n",
       "              {'PMID': '9101829',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19970417',\n",
       "               'LR': '20080220',\n",
       "               'IS': '0942-2854 (Print) 0942-2854 (Linking)',\n",
       "               'VI': '113',\n",
       "               'DP': '1996',\n",
       "               'TI': '[Is total thyroidectomy and lymph node excision as therapy of differentiated thyroid gland carcinomas in childhood justified?].',\n",
       "               'PG': '196-8',\n",
       "               'AB': 'The extent of radical resection of differentiated thyroid carcinomas in children (< 18 years) is discussed controversially because of good prognosis, on the one hand, but a high rate of lymph node metastases, greater tumor size, lung metastases and tumor recurrences on the other. Because of our data we advocate thyroidectomy, cervical lymph node dissection and postoperative 131J-therapy as the treatment of choice in patients with manifest disease in order of further detection and/or treatment of lung metastases. Limited radicality (i.e. hemithyroidectomy) should be reserved for children with small and occult tumors.',\n",
       "               'FAU': ['Witte, J', 'Goretzki, P E', 'Simon, D', 'Roher, H D'],\n",
       "               'AU': ['Witte J', 'Goretzki PE', 'Simon D', 'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemeine und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Ist die totale Thyreoidektomie und Lymphknotendissektion zur Therapie differenzierter Schilddrusenkarzinome im Kindesalter angezeigt?',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir Suppl Kongressbd',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress',\n",
       "               'JID': '9200456',\n",
       "               'RN': ['0 (Iodine Radioisotopes)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma, Follicular/mortality/pathology/radiotherapy/*surgery',\n",
       "                'Adenocarcinoma, Papillary/mortality/pathology/radiotherapy/*surgery',\n",
       "                'Adolescent',\n",
       "                'Child',\n",
       "                'Child, Preschool',\n",
       "                'Combined Modality Therapy',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Iodine Radioisotopes/therapeutic use',\n",
       "                '*Lymph Node Excision',\n",
       "                'Lymphatic Metastasis',\n",
       "                'Male',\n",
       "                'Neoplasm Staging',\n",
       "                'Radiotherapy, Adjuvant',\n",
       "                'Thyroid Neoplasms/mortality/pathology/radiotherapy/*surgery',\n",
       "                '*Thyroidectomy'],\n",
       "               'EDAT': '1996/01/01 00:00',\n",
       "               'MHDA': '1996/01/01 00:01',\n",
       "               'CRDT': ['1996/01/01 00:00'],\n",
       "               'PHST': ['1996/01/01 00:00 [pubmed]',\n",
       "                '1996/01/01 00:01 [medline]',\n",
       "                '1996/01/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir Suppl Kongressbd. 1996;113:196-8.'},\n",
       "              {'PMID': '8981014',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19970320',\n",
       "               'LR': '20051116',\n",
       "               'IS': '0947-7349 (Print) 0947-7349 (Linking)',\n",
       "               'VI': '104 Suppl 4',\n",
       "               'DP': '1996',\n",
       "               'TI': 'Molecular genetics of primary and secondary hyperparathyroidism.',\n",
       "               'PG': '105-7',\n",
       "               'AB': 'Hyperparathyroidism (HPT) can be caused by solitary parathyroid adenomas and carcinomas, and primary and secondary multiglandular parathyroid disease. Primary HPT is also a feature of several hereditary diseases e.g. multiple endocrine neoplasia type 1 and type 2A (MEN1 and 2A), familial hypocalciuric hyperparathyroidism (FHH), the HPT-jaw tumor syndrome (HPT-JT), and familial isolated HPT. Summarizing data from the literature and our own observations, various genetic abnormalities are observed in the pathogenesis of HPT. These include chromosomal deletions of the MEN1 locus on 11q in sporadic and MEN1 associated primary HPT, of RB1 on 13q in carcinomas, and of the FHH gene located on 3q in sporadic primary and secondary HPT. Genetic material is also lost from chromosomes 1p, 6q, 15q and X suggesting loss of yet unidentified tumor suppressor genes in these regions. In addition the HRPT2 gene on 1q, as well as the proto-oncogenes RET on 10q and PRAD1 on 11q are associated with a subset of parathyroid tumors.',\n",
       "               'FAU': ['Dotzenrath, C',\n",
       "                'Goretzki, P E',\n",
       "                'Farnebo, F',\n",
       "                'Teh, B T',\n",
       "                'Weber, G',\n",
       "                'Roher, H D',\n",
       "                'Larsson, C'],\n",
       "               'AU': ['Dotzenrath C',\n",
       "                'Goretzki PE',\n",
       "                'Farnebo F',\n",
       "                'Teh BT',\n",
       "                'Weber G',\n",
       "                'Roher HD',\n",
       "                'Larsson C'],\n",
       "               'AD': ['Department of Surgery, Heinrich-Heine University, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Exp Clin Endocrinol Diabetes',\n",
       "               'JT': 'Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association',\n",
       "               'JID': '9505926',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Gene Deletion',\n",
       "                'Genes, Tumor Suppressor',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism/*genetics',\n",
       "                'Hyperparathyroidism, Secondary/*genetics',\n",
       "                'Multiple Endocrine Neoplasia Type 1/genetics',\n",
       "                'Multiple Endocrine Neoplasia Type 2a/genetics'],\n",
       "               'RF': '13',\n",
       "               'EDAT': '1996/01/01 00:00',\n",
       "               'MHDA': '1996/01/01 00:01',\n",
       "               'CRDT': ['1996/01/01 00:00'],\n",
       "               'PHST': ['1996/01/01 00:00 [pubmed]',\n",
       "                '1996/01/01 00:01 [medline]',\n",
       "                '1996/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-0029-1211714 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:105-7. doi: 10.1055/s-0029-1211714.'},\n",
       "              {'PMID': '8981013',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19970320',\n",
       "               'LR': '20081121',\n",
       "               'IS': '0947-7349 (Print) 0947-7349 (Linking)',\n",
       "               'VI': '104 Suppl 4',\n",
       "               'DP': '1996',\n",
       "               'TI': 'INT-2 gene amplification in differentiated human thyroid cancer.',\n",
       "               'PG': '101-4',\n",
       "               'AB': 'Oncogene amplification is frequent in many epithelial tumors and often associated with advanced tumor progression. In different epithelial neoplasias it helps to provide prognostic information on individual patients. The present study was performed to evaluate the hitherto unknown prevalence of INT-2 gene amplification and its potential usefulness as prognostic marker in patients with human thyroid cancer. We used differential quantitative polymerase chain reaction and fluorescent DNA technique as a reliable method to detect low copy-number amplification of oncogenes from archival carcinoma specimens. Sequences from the int-2 gene and the single copy gamma-interferon gene were amplified simultaneously by PCR and quantified on a fluorescence activated sequencer. Native tumor tissue from 63 patients with differentiated thyroid cancer (43 papillary, 3 oncocytary, and 17 follicular) and from 12 goiters was analyzed by differential quantitative polymerase chain reaction. The study group contained many far advanced tumors. 40% of tumors were recurrent, 35% were staged T4 tumors and 70% presented with lymph node metastases. The prevalence of INT-2 amplification was 12% for follicular and 7% for papillary carcinomas. In goiter tissue no amplification was found. Amplification was only 2-4fold in positive cases. Low grade amplification is of no apparent importance in differentiated thyroid cancer.',\n",
       "               'FAU': ['Schulte, K M',\n",
       "                'Niederacher, D',\n",
       "                'An, H X',\n",
       "                'Staudt, S',\n",
       "                'Simon, D',\n",
       "                'Beckmann, M W',\n",
       "                'Goretzki, P E'],\n",
       "               'AU': ['Schulte KM',\n",
       "                'Niederacher D',\n",
       "                'An HX',\n",
       "                'Staudt S',\n",
       "                'Simon D',\n",
       "                'Beckmann MW',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Department of General Surgery, Heinrich-Heine-University, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Exp Clin Endocrinol Diabetes',\n",
       "               'JT': 'Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association',\n",
       "               'JID': '9505926',\n",
       "               'RN': ['0 (FGF3 protein, human)',\n",
       "                '0 (Fibroblast Growth Factor 3)',\n",
       "                '0 (Proto-Oncogene Proteins)',\n",
       "                '62031-54-3 (Fibroblast Growth Factors)',\n",
       "                '82115-62-6 (Interferon-gamma)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/genetics',\n",
       "                'Adult',\n",
       "                'Carcinoma, Papillary/genetics',\n",
       "                'Cell Differentiation',\n",
       "                'Fibroblast Growth Factor 3',\n",
       "                'Fibroblast Growth Factors/*genetics',\n",
       "                '*Gene Amplification',\n",
       "                'Humans',\n",
       "                'Interferon-gamma/genetics',\n",
       "                'Middle Aged',\n",
       "                'Polymerase Chain Reaction',\n",
       "                'Prognosis',\n",
       "                'Proto-Oncogene Proteins/*genetics',\n",
       "                'Thyroid Neoplasms/*genetics'],\n",
       "               'EDAT': '1996/01/01 00:00',\n",
       "               'MHDA': '1996/01/01 00:01',\n",
       "               'CRDT': ['1996/01/01 00:00'],\n",
       "               'PHST': ['1996/01/01 00:00 [pubmed]',\n",
       "                '1996/01/01 00:01 [medline]',\n",
       "                '1996/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-0029-1211713 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:101-4. doi: 10.1055/s-0029-1211713.'},\n",
       "              {'PMID': '8908604',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19970227',\n",
       "               'LR': '20190822',\n",
       "               'IS': '0385-5600 (Print) 0385-5600 (Linking)',\n",
       "               'VI': '40',\n",
       "               'IP': '9',\n",
       "               'DP': '1996',\n",
       "               'TI': 'A modified PCR-based method for rapid non-radioactive detection of clinically important pathogens.',\n",
       "               'PG': '611-6',\n",
       "               'AB': 'We have devised a sensitive and rapid method for the detection of several bacterial pathogens in clinical specimens using PCR. This method has been named Direct Labeling and Detection Procedure (DLDP) and is based on the direct incorporation of a nonradioactive digoxigenin label (DIG-11-dUTP) into a microbial species-specific gene fragment during amplification. Following amplification, the resulting PCR products are cleansed of nonincorporated DIG-11-dUTP, spotted onto a nylon membrane, fixed by UV-crosslinking and the labeled DNA is visualized by digoxigenin detection reagents. Using cultivated reference bacteria (Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa) we were able to demonstrate a rapid and sensitive detection of < 20 CFU of bacteria in human secretions (sputum, urine, mucous). The present study suggests that DLDP can be used as a reliable method for indication of bacteria in clinical or environmental specimens with the proviso that the selected corresponding oligonucleotide primers provide amplification of strong species-specific genes.',\n",
       "               'FAU': ['Gorelov, V N',\n",
       "                'Dumon, K',\n",
       "                'Barteneva, N S',\n",
       "                'Roher, H D',\n",
       "                'Goretzki, P E'],\n",
       "               'AU': ['Gorelov VN',\n",
       "                'Dumon K',\n",
       "                'Barteneva NS',\n",
       "                'Roher HD',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Department of Surgery A, Heinrich Heine University, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Australia',\n",
       "               'TA': 'Microbiol Immunol',\n",
       "               'JT': 'Microbiology and immunology',\n",
       "               'JID': '7703966',\n",
       "               'RN': ['0 (DNA, Bacterial)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Bacteria/*isolation & purification',\n",
       "                'Bacterial Infections/*microbiology/urine',\n",
       "                'DNA, Bacterial/genetics/isolation & purification',\n",
       "                'Humans',\n",
       "                'Methicillin Resistance',\n",
       "                'Mucus/microbiology',\n",
       "                'Polymerase Chain Reaction/*methods',\n",
       "                'Pseudomonas aeruginosa/isolation & purification',\n",
       "                'Reproducibility of Results',\n",
       "                'Sputum/microbiology',\n",
       "                'Staphylococcus aureus/isolation & purification',\n",
       "                'Streptococcus pneumoniae/isolation & purification'],\n",
       "               'EDAT': '1996/01/01 00:00',\n",
       "               'MHDA': '1996/01/01 00:01',\n",
       "               'CRDT': ['1996/01/01 00:00'],\n",
       "               'PHST': ['1996/01/01 00:00 [pubmed]',\n",
       "                '1996/01/01 00:01 [medline]',\n",
       "                '1996/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1111/j.1348-0421.1996.tb01117.x [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Microbiol Immunol. 1996;40(9):611-6. doi: 10.1111/j.1348-0421.1996.tb01117.x.'},\n",
       "              {'PMID': '8851671',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19961216',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '67',\n",
       "               'IP': '1',\n",
       "               'DP': '1996 Jan',\n",
       "               'TI': \"[Ulcer surgery '96--choice of methods in an emergency].\",\n",
       "               'PG': '20-5',\n",
       "               'AB': 'Understanding of peptic ulcer disease has dramatically changed within the last years. Today ulcer disease can be considered as a chronic infection. Based on this new pathophysiological concept treatment policies for ulcer bleeding and perforation have to be revised. For ulcer bleeding the standard procedure consists of a diagnostic emergency endoscopy and endoscopic treatment based on the bleeding activity. Patients with recurrent bleeding during hospital stay carry an increased risk for death. More than 50% of these patients have to be operated, nearly 25% die during hospital stay. For that reason an early elective operation can be recommended in patients with a high risk for further bleeding. This includes patients with arterial bleeding (Forrest Ia) and with a vissible vessel (Forrest IIa) with an additional risk (e. g. posterior wall of the duodenum, lesser curvature). All other bleeding activities can primarily treated conservatively. Because of an effective medical treatment of the ulcer disease with eradication, the operation should be restricted to ulcer excision and ulcer oversewing in bleeding or perforated gastric ulcer and duodenotomy, ulcer ligation and extraluminal ligature in bleeding duodenum ulcer and excision and oversewing with pyloroplasty in perforated duodenal ulcer. More definite surgery is not reasonable and should be avoided. With treatment policies based on early elective operation in high risk groups and medical treatment in the other patients a mortality of 5% or less can be achieved.',\n",
       "               'FAU': ['Roher, H D', 'Imhof, M', 'Goretzki, P E', 'Ohmann, C'],\n",
       "               'AU': ['Roher HD', 'Imhof M', 'Goretzki PE', 'Ohmann C'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article', 'Review'],\n",
       "               'TT': \"Ulcus '96--Methodenwahl im Notfall.\",\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Duodenal Ulcer/mortality/surgery',\n",
       "                '*Emergencies',\n",
       "                'Germany',\n",
       "                'Humans',\n",
       "                'Peptic Ulcer Hemorrhage/mortality/*surgery',\n",
       "                'Peptic Ulcer Perforation/mortality/*surgery',\n",
       "                'Stomach Ulcer/mortality/surgery',\n",
       "                'Survival Rate',\n",
       "                'Treatment Outcome'],\n",
       "               'RF': '28',\n",
       "               'EDAT': '1996/01/01 00:00',\n",
       "               'MHDA': '1996/01/01 00:01',\n",
       "               'CRDT': ['1996/01/01 00:00'],\n",
       "               'PHST': ['1996/01/01 00:00 [pubmed]',\n",
       "                '1996/01/01 00:01 [medline]',\n",
       "                '1996/01/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 1996 Jan;67(1):20-5.'},\n",
       "              {'PMID': '8717175',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19961112',\n",
       "               'LR': '20190821',\n",
       "               'IS': '0023-8236 (Print) 0023-8236 (Linking)',\n",
       "               'VI': '381',\n",
       "               'IP': '1',\n",
       "               'DP': '1996',\n",
       "               'TI': '[Results of surgical therapy in renal hyperparathyroidism. Follow-up of 143 patients].',\n",
       "               'PG': '46-50',\n",
       "               'AB': 'Subtotal parathyroidectomy (SPTX) and total parathyroidectomy with autotransplantation (PTX and AT) are now equivalent and challenging surgical procedures, that now involve very low morbidity even in patients with serious secondary illness. In most cases, either brings about a significant amelioration of quality of life. It is rare for the illness to persist after such an operation. In most cases, this is the case only after an inadequate primary operation. An actual recurrence of the illness after at least 6 months is a much more serious problem and cannot usually be attributed to an inadequate operation. Our experience is based on operations performed in 143 patients and a follow-up of up to 8 years. In 68.7% of cases there was a noticeable improvement of bone pain immediately after the operation. This rate fell to 61.5% during subsequent years. Comparable results could not be achieved with any drug therapy. After SPTX the recurrence rate was 4.5%, and after PTX and AT, 5.5%. This is comparable to the results cited in the literature.',\n",
       "               'FAU': ['Dotzenrath, C', 'Goretzki, P E', 'Roher, H D'],\n",
       "               'AU': ['Dotzenrath C', 'Goretzki PE', 'Roher HD'],\n",
       "               'AD': ['Abteilung fur Allgemein- und Unfallchirurgie, Heinrich-Heine-Universitat, Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'TT': 'Ergebnisse der operativen therapie beim renalen hyperparathyreoidismus. Verkaufsbeobachtungen bei 143 patienten.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie',\n",
       "               'JID': '0204167',\n",
       "               'SB': 'IM',\n",
       "               'CIN': ['Langenbecks Arch Surg. 2003 Jan;387(9-10):392-4. doi: 10.1007/s00423-002-0338-2.',\n",
       "                'PMID: 12536336'],\n",
       "               'MH': ['Chronic Kidney Disease-Mineral and Bone Disorder/*surgery',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism/*surgery',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Pain Measurement',\n",
       "                'Parathyroid Glands/*transplantation',\n",
       "                '*Parathyroidectomy',\n",
       "                'Postoperative Complications/*etiology',\n",
       "                'Prospective Studies',\n",
       "                'Quality of Life',\n",
       "                'Recurrence',\n",
       "                'Transplantation, Autologous',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '1996/01/01 00:00',\n",
       "               'MHDA': '1996/01/01 00:01',\n",
       "               'CRDT': ['1996/01/01 00:00'],\n",
       "               'PHST': ['1996/01/01 00:00 [pubmed]',\n",
       "                '1996/01/01 00:01 [medline]',\n",
       "                '1996/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF00184255 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir. 1996;381(1):46-50. doi: 10.1007/BF00184255.'},\n",
       "              {'PMID': '8698744',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19960905',\n",
       "               'LR': '20190905',\n",
       "               'IS': '0171-5216 (Print) 0171-5216 (Linking)',\n",
       "               'VI': '122',\n",
       "               'IP': '8',\n",
       "               'DP': '1996',\n",
       "               'TI': 'Distribution of Gs-alpha activating mutations in human thyroid tumors measured by subcloning.',\n",
       "               'PG': '453-7',\n",
       "               'AB': 'In the search for the prevalence and distribution pattern of Gs-alpha gene mutations in differentiated thyroid tumors we examined 66 tumor tissue samples for the presence of mutations at \"hot-spot\" codons 201 and 227 using methods based on the polymerase chain reaction, subcloning and sequencing. The prevailing type of single-base substitution at codon 201 (71.4%) corresponded to the replacement of the wild-type sequence CGT (Arg) with TGT (Cys). The fragments of the Gs-alpha gene, including codon 201 or 227 from five follicular carcinomas and one follicular adenoma, were subcloned in Escherichia coli and it was found that the proportion of alleles with mutated codon 201 varied from 3.2% to 43%. Sequencing of the corresponding region has confirmed preliminary data indicating that the single-base changes CGT (Arg) to TGT (Cys) or CGT to CAT (His) occurred. There was only a weak correlation between the prevalence of cells bearing a mutation in the Gs-alpha gene and the level of Gs-alpha protein expression in the corresponding thyroid tumors.',\n",
       "               'FAU': ['Gorelov, V N',\n",
       "                'Gyenes, M',\n",
       "                'Neser, F',\n",
       "                'Roher, H D',\n",
       "                'Goretzki, P E'],\n",
       "               'AU': ['Gorelov VN',\n",
       "                'Gyenes M',\n",
       "                'Neser F',\n",
       "                'Roher HD',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Genlabor of Surgery Clinick A, Heinrich-Heine University of Dusseldorf, Gebaude, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'J Cancer Res Clin Oncol',\n",
       "               'JT': 'Journal of cancer research and clinical oncology',\n",
       "               'JID': '7902060',\n",
       "               'RN': ['0 (Codon)',\n",
       "                '9007-49-2 (DNA)',\n",
       "                'EC 3.6.1.- (GTP-Binding Proteins)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Base Sequence',\n",
       "                'Cloning, Molecular',\n",
       "                'Codon',\n",
       "                'DNA/chemistry',\n",
       "                'Escherichia coli/genetics',\n",
       "                'Female',\n",
       "                'GTP-Binding Proteins/*genetics',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Molecular Sequence Data',\n",
       "                '*Mutation',\n",
       "                'Thyroid Neoplasms/*genetics'],\n",
       "               'EDAT': '1996/01/01 00:00',\n",
       "               'MHDA': '1996/01/01 00:01',\n",
       "               'CRDT': ['1996/01/01 00:00'],\n",
       "               'PHST': ['1996/01/01 00:00 [pubmed]',\n",
       "                '1996/01/01 00:01 [medline]',\n",
       "                '1996/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF01187156 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Cancer Res Clin Oncol. 1996;122(8):453-7. doi: 10.1007/BF01187156.'}],\n",
       "             '1995': [{'PMID': '8582162',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19960315',\n",
       "               'LR': '20190607',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '66',\n",
       "               'IP': '12',\n",
       "               'DP': '1995 Dec',\n",
       "               'TI': '[Preventive radical surgery of C-cell carcinoma in MEN-II syndrome based on genetic screening].',\n",
       "               'PG': '1196-202',\n",
       "               'AB': 'Between April 1986 and July 1995 121 patients have been operated on for C-cell carcinoma with 70 (57.9%) patients presenting a sporadic type and 51 (42.1%) a hereditary type of disease (46/38% MEN IIa and 5/4.1% MEN IIb). Indication for operation in patients with familial disease (MEN II) was in 9 patients (18%) detection of a mutation in the ret protooncogen (group I), in 27 patients (53%) a pathologic biochemical screening (pentagastrin stimulation) (group II), and in 15 patients (29%) the first manifestation in a family (index) (group III). Distribution of stages showed a stage I (T1 N0 M0) in 8/9 (89%) in group I, in 17/27 (63%) in group II, and in 0/15 in group III. In 8 from 9 patients with genetic indication a multifocal microcarcinoma and in one patient a cell-cell hyperplasia could be demonstrated. Accordingly the rate of curative operations with postoperative normalization of basal and pentagastrin stimulated calcitonin levels was 100% (9/9) in group I, 59% (16/27) in group II, and 7% (1/15) in group III. The mean age was 14 (median 12) years in group I, 26 (median 24) years in group II, and 43 (median 40) years in group III). In patients with presymptomatic screening (genetic and biochemical) a thyroidectomy including lymph node dissection of the central compartment was performed as a standard procedure. Postoperative complication rate showed a recurrent nerve palsy of 0 in group I and 4% in group II and a hypoparathyroidism of 0 in group I and 4% in group II. The detection of a mutation correlated with positive histological findings of the disease in all patients. The prophylactic radical operation on the basis of a genetic screening proved to be a safe procedure with curative intention. The early age of manifestation underlines the importance of the genetic screening and the early indication for operation.',\n",
       "               'FAU': ['Roher, H D',\n",
       "                'Simon, D',\n",
       "                'Goretzki, P E',\n",
       "                'Hoppner, W',\n",
       "                'Lederbogen, S',\n",
       "                'Seppel, T'],\n",
       "               'AU': ['Roher HD',\n",
       "                'Simon D',\n",
       "                'Goretzki PE',\n",
       "                'Hoppner W',\n",
       "                'Lederbogen S',\n",
       "                'Seppel T'],\n",
       "               'AD': ['Klinik fur Allgemeine und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'TT': 'Die prophylaktische Radikaloperation des C-Zell-Carcinoms beim MEN-II-Syndrom auf der Grundlage des genetischen Screening.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'RN': ['0 (Drosophila Proteins)',\n",
       "                '0 (Proto-Oncogene Proteins)',\n",
       "                'EC 2.7.10.1 (Proto-Oncogene Proteins c-ret)',\n",
       "                'EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases)',\n",
       "                'EC 2.7.10.1 (Ret protein, Drosophila)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Carcinoma, Medullary/genetics/pathology/prevention & control/*surgery',\n",
       "                'Child',\n",
       "                'Child, Preschool',\n",
       "                'DNA Mutational Analysis',\n",
       "                '*Drosophila Proteins',\n",
       "                'Female',\n",
       "                'Gene Expression Regulation, Neoplastic/physiology',\n",
       "                '*Genetic Testing',\n",
       "                'Humans',\n",
       "                'Lymph Node Excision',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Multiple Endocrine Neoplasia Type 2a/genetics/pathology/prevention & control/*surgery',\n",
       "                'Neoplasm Staging',\n",
       "                'Postoperative Complications/etiology',\n",
       "                'Proto-Oncogene Proteins/genetics',\n",
       "                'Proto-Oncogene Proteins c-ret',\n",
       "                'Receptor Protein-Tyrosine Kinases/genetics',\n",
       "                'Thyroid Gland/pathology',\n",
       "                'Thyroid Neoplasms/genetics/pathology/prevention & control/*surgery',\n",
       "                'Thyroidectomy'],\n",
       "               'EDAT': '1995/12/01 00:00',\n",
       "               'MHDA': '1995/12/01 00:01',\n",
       "               'CRDT': ['1995/12/01 00:00'],\n",
       "               'PHST': ['1995/12/01 00:00 [pubmed]',\n",
       "                '1995/12/01 00:01 [medline]',\n",
       "                '1995/12/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 1995 Dec;66(12):1196-202.'},\n",
       "              {'PMID': '8590627',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19960403',\n",
       "               'LR': '20190920',\n",
       "               'IS': '0177-3593 (Print) 0177-3593 (Linking)',\n",
       "               'VI': '376',\n",
       "               'IP': '10',\n",
       "               'DP': '1995 Oct',\n",
       "               'TI': 'A competitive chromogenic assay to study the functional interaction of urokinase-type plasminogen activator with its receptor.',\n",
       "               'PG': '587-94',\n",
       "               'AB': 'Urokinase-type plasminogen activator (uPA) converts plasminogen to plasmin which degrades various extracellular matrix components. uPA is focused to the cell surface via binding to a specific receptor (uPAR, also termed CD87). uPAR-bound uPA mediates pericellular proteolysis in a variety of biological processes, e.g. cell migration, tissue remodeling and tumor invasion. We have developed a competitive microtiter plate-based chromogenic assay which allows the analysis of uPA/uPAR interaction. The plates are coated with recombinant uPAR expressed in Chinese hamster ovary (CHO) cells. Proteolytically active uPA (HMW-uPA) is added to the microtiter plate-attached uPAR. The amount of receptor-bound uPA is then determined indirectly via addition of plasminogen, which is activated to plasmin, followed by cleavage of a plasmin-specific chromogenic substrate. Substances interfering with binding of HMW-uPA to uPAR diminish the generation of plasmin, as indicated by a reduction of cleaved chromogenic substrate. This assay was used to analyze the inhibitory capacity of a variety of proteins and peptides, respectively, on the uPA/uPAR interaction: i) uPAR and uPAR-variants expressed in CHO cells, yeast or E. coli, ii) the aminoterminal fragment (ATF) of human uPA or yeast recombinant pro-uPA, iii) synthetic peptides derived from the sequence of the uPAR-binding region of uPA, and iv) antibodies directed against uPAR. This assay may be helpful in identifying uPA and uPAR analogues or antagonists which efficiently block uPA/uPAR interaction.',\n",
       "               'FAU': ['Rettenberger, P',\n",
       "                'Wilhelm, O',\n",
       "                'Oi, H',\n",
       "                'Weidle, U H',\n",
       "                'Goretzki, L',\n",
       "                'Koppitz, M',\n",
       "                'Lottspeich, F',\n",
       "                'Konig, B',\n",
       "                'Pessara, U',\n",
       "                'Kramer, M D'],\n",
       "               'AU': ['Rettenberger P',\n",
       "                'Wilhelm O',\n",
       "                'Oi H',\n",
       "                'Weidle UH',\n",
       "                'Goretzki L',\n",
       "                'Koppitz M',\n",
       "                'Lottspeich F',\n",
       "                'Konig B',\n",
       "                'Pessara U',\n",
       "                'Kramer MD',\n",
       "                'et al.'],\n",
       "               'AD': ['Frauenklinik, Technischen Universitat Munchen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Biol Chem Hoppe Seyler',\n",
       "               'JT': 'Biological chemistry Hoppe-Seyler',\n",
       "               'JID': '8503054',\n",
       "               'RN': ['0 (Antibodies, Monoclonal)',\n",
       "                '0 (Chromogenic Compounds)',\n",
       "                '0 (PLAUR protein, human)',\n",
       "                '0 (Receptors, Cell Surface)',\n",
       "                '0 (Receptors, Urokinase Plasminogen Activator)',\n",
       "                '0 (Recombinant Proteins)',\n",
       "                'EC 3.4.21.73 (Urokinase-Type Plasminogen Activator)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Amino Acid Sequence',\n",
       "                'Animals',\n",
       "                'Antibodies, Monoclonal',\n",
       "                'CHO Cells',\n",
       "                'Chromogenic Compounds',\n",
       "                'Cricetinae',\n",
       "                'Escherichia coli/metabolism',\n",
       "                'Humans',\n",
       "                'Molecular Sequence Data',\n",
       "                'Plasmids/genetics',\n",
       "                'Receptors, Cell Surface/antagonists & inhibitors/chemistry/*metabolism',\n",
       "                'Receptors, Urokinase Plasminogen Activator',\n",
       "                'Recombinant Proteins/chemistry/metabolism/pharmacology',\n",
       "                'Saccharomyces cerevisiae/genetics/metabolism',\n",
       "                'Urokinase-Type Plasminogen Activator/chemistry/*metabolism/pharmacology'],\n",
       "               'EDAT': '1995/10/01 00:00',\n",
       "               'MHDA': '1995/10/01 00:01',\n",
       "               'CRDT': ['1995/10/01 00:00'],\n",
       "               'PHST': ['1995/10/01 00:00 [pubmed]',\n",
       "                '1995/10/01 00:01 [medline]',\n",
       "                '1995/10/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1515/bchm3.1995.376.10.587 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Biol Chem Hoppe Seyler. 1995 Oct;376(10):587-94. doi: 10.1515/bchm3.1995.376.10.587.'},\n",
       "              {'PMID': '8529444',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19960129',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '66',\n",
       "               'IP': '10',\n",
       "               'DP': '1995 Oct',\n",
       "               'TI': '[Differentiated thyroid gland carcinomas in \"autonomous adenomas\" in childhood].',\n",
       "               'PG': '1018-20',\n",
       "               'AB': 'Thyroid surgery is seldomly indicated in childhood and adolescence mainly because of suspicious nodules or proven carcinoma. Indications for operation in Graves disease and focal autonomy are discussed controversially, however. In a retrospective case control study two of our 6 patients up to 18 years demonstrated differentiated thyroid cancer with focal autonomy in the autonomous nodule. Other studies show similar results. Thyroid surgery is therefore warranted in all children and adolescents with focal thyroid autonomy.',\n",
       "               'FAU': ['Muller, A',\n",
       "                'Goretzki, P',\n",
       "                'Witte, J',\n",
       "                'Gerharz, P',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Muller A',\n",
       "                'Goretzki P',\n",
       "                'Witte J',\n",
       "                'Gerharz P',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemeine und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Case Reports', 'English Abstract', 'Journal Article'],\n",
       "               'TT': 'Differenzierte Schilddrusencarcinome in \"autonomen Adenomen\" im Kindesalter.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma, Follicular/pathology/*surgery',\n",
       "                'Adenoma/pathology/*surgery',\n",
       "                'Adolescent',\n",
       "                'Carcinoma, Papillary/pathology/*surgery',\n",
       "                'Child',\n",
       "                'Diagnosis, Differential',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Neoplasm Staging',\n",
       "                'Thyroid Gland/pathology',\n",
       "                'Thyroid Neoplasms/pathology/*surgery',\n",
       "                'Thyroid Nodule/pathology/*surgery',\n",
       "                'Thyroidectomy'],\n",
       "               'EDAT': '1995/10/01 00:00',\n",
       "               'MHDA': '1995/10/01 00:01',\n",
       "               'CRDT': ['1995/10/01 00:00'],\n",
       "               'PHST': ['1995/10/01 00:00 [pubmed]',\n",
       "                '1995/10/01 00:01 [medline]',\n",
       "                '1995/10/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 1995 Oct;66(10):1018-20.'},\n",
       "              {'PMID': '7554100',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19951031',\n",
       "               'LR': '20171116',\n",
       "               'IS': '0263-6484 (Print) 0263-6484 (Linking)',\n",
       "               'VI': '13',\n",
       "               'IP': '3',\n",
       "               'DP': '1995 Sep',\n",
       "               'TI': 'N-3 but not N-6 fatty acids reduce the expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells.',\n",
       "               'PG': '211-6',\n",
       "               'AB': 'CD36, a multifunctional adhesion receptor e.g. for thrombospondin and collagen, as well as a scavenger receptor for oxidized low density lipoprotein, is expressed e.g. on platelets and monocytes. By this dual role it might be involved in early steps of atherosclerosis like the recruitment of monocytes and formation of foam cells. We therefore studied the effects of n-3 fatty acids on CD36 expression in human monocytic cells. Incorporation of eicosapentaenoic acid (EPA, C20:5n-3) and docosahexaenoic acid (DHA, C22:6n-3) into cellular phospholipids resulted in a significant reduction of CD36 expression at the mRNA and protein level, whereas arachidonic acid (AA, C20: 4n-6) and linoleic acid (LA, C18:2n-6) tended to increase CD36 expression compared to the control. This specific down-regulation of CD36 by n-3 fatty acids in cells involved in the initiation and progression of atherogenesis and inflammation, represents a further mechanism that may contribute to the beneficial effects of n-3 polyunsaturated fatty acids (PUFA) in these disorders.',\n",
       "               'FAU': ['Pietsch, A',\n",
       "                'Weber, C',\n",
       "                'Goretzki, M',\n",
       "                'Weber, P C',\n",
       "                'Lorenz, R L'],\n",
       "               'AU': ['Pietsch A',\n",
       "                'Weber C',\n",
       "                'Goretzki M',\n",
       "                'Weber PC',\n",
       "                'Lorenz RL'],\n",
       "               'AD': ['Institut fur Prophylaxe der Kreislaufkrankheiten, Ludwig-Maximilians-Universitat Munchen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Cell Biochem Funct',\n",
       "               'JT': 'Cell biochemistry and function',\n",
       "               'JID': '8305874',\n",
       "               'RN': ['0 (CD36 Antigens)',\n",
       "                '0 (DNA Primers)',\n",
       "                '0 (Fatty Acids, Omega-3)',\n",
       "                '0 (Fatty Acids, Omega-6)',\n",
       "                '0 (Fatty Acids, Unsaturated)',\n",
       "                '0 (Linoleic Acids)',\n",
       "                '0 (Membrane Proteins)',\n",
       "                '0 (RNA, Messenger)',\n",
       "                '0 (Receptors, Immunologic)',\n",
       "                '0 (Receptors, Lipoprotein)',\n",
       "                '0 (Receptors, Scavenger)',\n",
       "                '0 (Scarb1 protein, mouse)',\n",
       "                '0 (Scavenger Receptors, Class B)',\n",
       "                '25167-62-8 (Docosahexaenoic Acids)',\n",
       "                '27YG812J1I (Arachidonic Acid)',\n",
       "                '9KJL21T0QJ (Linoleic Acid)',\n",
       "                'AAN7QOV9EA (Eicosapentaenoic Acid)',\n",
       "                'N762921K75 (Nitrogen)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Arachidonic Acid/metabolism/pharmacology',\n",
       "                'Base Sequence',\n",
       "                'CD36 Antigens/*biosynthesis/drug effects/genetics',\n",
       "                'Cell Adhesion',\n",
       "                'Cell Line',\n",
       "                'DNA Primers',\n",
       "                'Docosahexaenoic Acids/metabolism/pharmacology',\n",
       "                'Eicosapentaenoic Acid/metabolism/pharmacology',\n",
       "                'Fatty Acids, Omega-3/*pharmacology',\n",
       "                'Fatty Acids, Omega-6',\n",
       "                'Fatty Acids, Unsaturated/*pharmacology',\n",
       "                'Humans',\n",
       "                'Linoleic Acid',\n",
       "                'Linoleic Acids/metabolism/pharmacology',\n",
       "                '*Membrane Proteins',\n",
       "                'Molecular Sequence Data',\n",
       "                'Monocytes/drug effects/*metabolism',\n",
       "                'Nitrogen/chemistry',\n",
       "                'RNA, Messenger/metabolism',\n",
       "                'Receptors, Immunologic/drug effects',\n",
       "                '*Receptors, Lipoprotein',\n",
       "                'Receptors, Scavenger',\n",
       "                'Scavenger Receptors, Class B'],\n",
       "               'EDAT': '1995/09/01 00:00',\n",
       "               'MHDA': '1995/09/01 00:01',\n",
       "               'CRDT': ['1995/09/01 00:00'],\n",
       "               'PHST': ['1995/09/01 00:00 [pubmed]',\n",
       "                '1995/09/01 00:01 [medline]',\n",
       "                '1995/09/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1002/cbf.290130312 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Cell Biochem Funct. 1995 Sep;13(3):211-6. doi: 10.1002/cbf.290130312.'},\n",
       "              {'PMID': '9816040',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19990218',\n",
       "               'LR': '20220227',\n",
       "               'IS': '1078-0432 (Print) 1078-0432 (Linking)',\n",
       "               'VI': '1',\n",
       "               'IP': '7',\n",
       "               'DP': '1995 Jul',\n",
       "               'TI': 'Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer.',\n",
       "               'PG': '741-6',\n",
       "               'AB': 'The lysosomal cysteine proteases cathepsin B and cathepsin L have been implicated in tumor spread and metastasis. To evaluate the prognostic impact of these proteases for disease-free survival and overall survival in breast cancer, the antigen content of cathepsin B and cathepsin L was determined using ELISA in tumor cytosol fractions of 167 breast cancer patients and in cytosols of 29 benign breast tissue specimens. Median values of 856 ng versus 76 ng cathepsin B/mg protein and of 428 ng versus 56 ng cathepsin L/mg protein were found in tumor versus benign cytosol fractions. A positive correlation between cathepsin B and cathepsin L (r = 0.32, P = 0.0000, Spearman test) was found. Cathepsin L was inversely correlated to hormone receptor status (P = 0.0014, Mann-Whitney U test) and to the presence of tumor necrosis (P = 0.009, Mann-Whitney U test). There were no correlations of cathepsin B or cathepsin L to tumor size, axillary lymph node status, age, menopausal status, tumor grading, and vessel invasion. To perform univariate analyses of disease-free survival, optimal cutoff points were determined by isotonic regression and classification and regression trees analysis. Patients with a high content of cathepsin B (>1092 ng/mg protein) or cathepsin L (>376 ng/mg protein) in their primary tumors had a statistically significantly higher risk of recurrence than patients with a low content of cathepsin B or cathepsin L (5-year disease-free survival: cathepsin B, 70% versus 52%, P = 0.04; cathepsin L, 83% versus 52%, P = 0.0002). Median follow-up was 39 (range, 6-73) months. Multivariate analysis for disease-free survival showed that cathepsin L is a strong and independent prognostic factor with a prognostic impact comparable to that of axillary lymph node status and grading. We conclude that both cathepsin B and cathepsin L may serve as prognostic factors for tumor recurrence in human breast cancer. These data underline the significance of tumor-associated proteolysis for invasion and metastasis.',\n",
       "               'FAU': ['Thomssen, C',\n",
       "                'Schmitt, M',\n",
       "                'Goretzki, L',\n",
       "                'Oppelt, P',\n",
       "                'Pache, L',\n",
       "                'Dettmar, P',\n",
       "                'Janicke, F',\n",
       "                'Graeff, H'],\n",
       "               'AU': ['Thomssen C',\n",
       "                'Schmitt M',\n",
       "                'Goretzki L',\n",
       "                'Oppelt P',\n",
       "                'Pache L',\n",
       "                'Dettmar P',\n",
       "                'Janicke F',\n",
       "                'Graeff H'],\n",
       "               'AD': ['Frauenklinik, Institut fur Medizinische Statistik und Epidemiologie, der Technischen Universitat Munchen, Klinikum rechts der Isar, Ismaninger Strasse 22, 81675 Munich, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Clin Cancer Res',\n",
       "               'JT': 'Clinical cancer research : an official journal of the American Association for Cancer Research',\n",
       "               'JID': '9502500',\n",
       "               'RN': ['094ZI81Y45 (Tamoxifen)',\n",
       "                'EC 3.4.- (Cathepsins)',\n",
       "                'EC 3.4.- (Endopeptidases)',\n",
       "                'EC 3.4.22.- (Cysteine Endopeptidases)',\n",
       "                'EC 3.4.22.1 (Cathepsin B)',\n",
       "                'EC 3.4.22.15 (CTSL protein, human)',\n",
       "                'EC 3.4.22.15 (Cathepsin L)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Antineoplastic Combined Chemotherapy Protocols/therapeutic use',\n",
       "                'Breast Neoplasms/drug therapy/*enzymology/mortality/*pathology/surgery',\n",
       "                'Cathepsin B/*analysis',\n",
       "                'Cathepsin L',\n",
       "                'Cathepsins/*analysis',\n",
       "                'Chemotherapy, Adjuvant',\n",
       "                'Cysteine Endopeptidases',\n",
       "                '*Endopeptidases',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                'Lymphatic Metastasis',\n",
       "                'Middle Aged',\n",
       "                'Multivariate Analysis',\n",
       "                'Neoplasm Invasiveness',\n",
       "                'Neoplasm Metastasis',\n",
       "                'Predictive Value of Tests',\n",
       "                'Prognosis',\n",
       "                'Regression Analysis',\n",
       "                'Survival Analysis',\n",
       "                'Tamoxifen/therapeutic use',\n",
       "                'Time Factors'],\n",
       "               'EDAT': '1995/07/01 00:00',\n",
       "               'MHDA': '1998/11/17 00:01',\n",
       "               'CRDT': ['1995/07/01 00:00'],\n",
       "               'PHST': ['1995/07/01 00:00 [pubmed]',\n",
       "                '1998/11/17 00:01 [medline]',\n",
       "                '1995/07/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Clin Cancer Res. 1995 Jul;1(7):741-6.'},\n",
       "              {'PMID': '7642736',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19950921',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0021-7697 (Print) 0021-7697 (Linking)',\n",
       "               'VI': '132',\n",
       "               'IP': '5',\n",
       "               'DP': '1995 May',\n",
       "               'TI': '[Current aspects of surgery of the parathyroid glands].',\n",
       "               'PG': '270-4',\n",
       "               'AB': \"Diagnosis and treatment of primary hyperparathyroidism has changed substantially during recent years. Routine serum calcium measurements and development of specific as well as sensitive PTH assays made primary hyperparathyroidism the most prevalent diagnosis of hypercalcaemia in the normal population. With increasing numbers of asymptomatic patients secondary complications are reduced but the demands made on surgeon's technical skill are much higher. In view of our experience in 329 patients with primary hyperparathyroidism during the last six years and a success rate of 98% we refrain from any localisation technique and advocate visualisation of all four glands.\",\n",
       "               'FAU': ['Dotzenrath, C',\n",
       "                'Goretzki, P E',\n",
       "                'Simon, D',\n",
       "                'Witte, J',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Dotzenrath C',\n",
       "                'Goretzki PE',\n",
       "                'Simon D',\n",
       "                'Witte J',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Clinique de Chirurgie Generale et Traumatologique, Universite Heinrich Heine, Dusseldorf.'],\n",
       "               'LA': ['fre'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Aspects actuels de la chirurgie des parathyroides.',\n",
       "               'PL': 'France',\n",
       "               'TA': 'J Chir (Paris)',\n",
       "               'JT': 'Journal de chirurgie',\n",
       "               'JID': '0374754',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/*complications/surgery',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism/etiology/*surgery',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Parathyroid Neoplasms/*complications/surgery',\n",
       "                'Recurrence',\n",
       "                'Reoperation'],\n",
       "               'EDAT': '1995/05/01 00:00',\n",
       "               'MHDA': '1995/05/01 00:01',\n",
       "               'CRDT': ['1995/05/01 00:00'],\n",
       "               'PHST': ['1995/05/01 00:00 [pubmed]',\n",
       "                '1995/05/01 00:01 [medline]',\n",
       "                '1995/05/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Chir (Paris). 1995 May;132(5):270-4.'},\n",
       "              {'PMID': '7588568',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19951129',\n",
       "               'LR': '20191023',\n",
       "               'IS': '0173-0835 (Print) 0173-0835 (Linking)',\n",
       "               'VI': '16',\n",
       "               'IP': '5',\n",
       "               'DP': '1995 May',\n",
       "               'TI': 'Expression of the human urokinase-type plasminogen activator receptor in E. coli and Chinese hamster ovary cells: purification of the recombinant proteins and generation of polyclonal antibodies in chicken.',\n",
       "               'PG': '813-6',\n",
       "               'AB': 'The receptor for urokinase-type plasminogen activator (uPAR) may contribute to the invasive and metastatic capacity of tumor cells by focusing the serine protease urokinase-type plasminogen activator (uPA) to the cell surface. uPA activates plasminogen to plasmin which in turn degrades extracellular matrix proteins or activates other proteases. Mature uPAR is a heavily glycosylated protein of about 284 amino acids attached to the plasma membrane via a glycosyl-phosphatidylinositol (GPI) anchor. A set of different polyclonal uPAR antibodies has been generated in order to investigate the role of uPAR in tumor spreading in more detail. For this purpose, uPAR (lacking the GPI anchor) was expressed in E. coli and Chinese hamster ovary (CHO) cells. Recombinant uPAR from E. coli (corresponding to amino acids 1-284 of human uPAR) was expressed with an N-terminal histidine-tag insertion and purified by nickel chelate affinity chromatography. Soluble uPAR, synthesized by CHO cells (corresponding to amino acids 1-277 of human uPAR), was isolated by ligand (uPA) affinity chromatography. Expression in E. coli led to a nonglycosylated form of uPAR, whereas uPAR produced by CHO cells seemed to be glycosylated to a similar extent as the naturally occurring human form of uPAR (as analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis). Prior to immunization the N-termini of the recombinant uPAR variants were determined by amino acid sequence analysis. Polyclonal antibodies were generated in chickens and purified from egg yolk. The reaction patterns of these antibodies were analyzed by Western blot analyses and flow cytofluorometry.',\n",
       "               'FAU': ['Magdolen, V',\n",
       "                'Rettenberger, P',\n",
       "                'Lopens, A',\n",
       "                'Oi, H',\n",
       "                'Lottspeich, F',\n",
       "                'Kellermann, J',\n",
       "                'Creutzburg, S',\n",
       "                'Goretzki, L',\n",
       "                'Weidle, U H',\n",
       "                'Wilhelm, O'],\n",
       "               'AU': ['Magdolen V',\n",
       "                'Rettenberger P',\n",
       "                'Lopens A',\n",
       "                'Oi H',\n",
       "                'Lottspeich F',\n",
       "                'Kellermann J',\n",
       "                'Creutzburg S',\n",
       "                'Goretzki L',\n",
       "                'Weidle UH',\n",
       "                'Wilhelm O',\n",
       "                'et al.'],\n",
       "               'AD': ['Klinische Forschergruppe, Frauenklinik der Technischen Universitat Munchen, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Electrophoresis',\n",
       "               'JT': 'Electrophoresis',\n",
       "               'JID': '8204476',\n",
       "               'RN': ['0 (Antibodies)',\n",
       "                '0 (PLAUR protein, human)',\n",
       "                '0 (Receptors, Cell Surface)',\n",
       "                '0 (Receptors, Urokinase Plasminogen Activator)',\n",
       "                '0 (Recombinant Fusion Proteins)',\n",
       "                'EC 3.4.21.73 (Urokinase-Type Plasminogen Activator)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Amino Acid Sequence',\n",
       "                'Animals',\n",
       "                'Antibodies/*immunology/isolation & purification',\n",
       "                'Base Sequence',\n",
       "                'CHO Cells',\n",
       "                'Chickens',\n",
       "                'Chromatography, Affinity',\n",
       "                'Cloning, Molecular',\n",
       "                'Cricetinae',\n",
       "                'Escherichia coli',\n",
       "                'Glycosylation',\n",
       "                'Humans',\n",
       "                'Molecular Sequence Data',\n",
       "                'Receptors, Cell Surface/analysis/*genetics/immunology',\n",
       "                'Receptors, Urokinase Plasminogen Activator',\n",
       "                'Recombinant Fusion Proteins/analysis/genetics/immunology',\n",
       "                'Tumor Cells, Cultured',\n",
       "                '*Urokinase-Type Plasminogen Activator'],\n",
       "               'EDAT': '1995/05/01 00:00',\n",
       "               'MHDA': '1995/05/01 00:01',\n",
       "               'CRDT': ['1995/05/01 00:00'],\n",
       "               'PHST': ['1995/05/01 00:00 [pubmed]',\n",
       "                '1995/05/01 00:01 [medline]',\n",
       "                '1995/05/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1002/elps.11501601134 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Electrophoresis. 1995 May;16(5):813-6. doi: 10.1002/elps.11501601134.'},\n",
       "              {'PMID': '7533818',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19950413',\n",
       "               'LR': '20190516',\n",
       "               'IS': '0741-5400 (Print) 0741-5400 (Linking)',\n",
       "               'VI': '57',\n",
       "               'IP': '3',\n",
       "               'DP': '1995 Mar',\n",
       "               'TI': 'Retinoic acid inhibits basal and interferon-gamma-induced expression of intercellular adhesion molecule 1 in monocytic cells.',\n",
       "               'PG': '401-6',\n",
       "               'AB': 'Retinoic acid (RA) and 1,25-(OH)2-vitamin D3 (1,25-D3) induced U937 cell maturation into distinct monocytic phenotypes, as demonstrated by up-regulation of CD23 by RA and CD14 by 1,25-D3. Differentiation by RA but not by 1,25-D3 was associated with reduction of basal and complete suppression of interferon-gamma (IFN-gamma)-stimulated intercellular adhesion molecule 1 (ICAM-1) expression. Induction of cyclooxygenase activity by RA and attenuation of basal ICAM-1 expression exhibited similar kinetics. Treatment with indomethacin prevented and prostaglandin E2 (PGE2), dibutyryl-cAMP, or forskolin mimicked reduction of basal ICAM-1 expression by RA, indicating that this effect of RA is mediated by PGE2 synthesis and subsequent cAMP elevation. In contrast, suppression of IFN-gamma-induced ICAM-1 expression by RA was only partly reversible by indomethacin, suggesting that inhibition of IFN-gamma stimulation was not completely due to cyclooxygenase induction. RA did not always counter-act IFN-gamma, as it cooperated with IFN-gamma in down-regulating very late activation antigen 4. Specific polymerase chain reaction and Northern blotting of ICAM-1 mRNA revealed that RA suppressed ICAM-1 induction by IFN-gamma at the transcriptional level. RA also blocked ICAM-1 induction by IFN-gamma in isolated human blood monocytes. In conclusion, inhibition of basal and stimulated ICAM-1 expression in monocytic cells may provide a mechanism for beneficial anti-inflammatory effects of retinoids.',\n",
       "               'FAU': ['Weber, C',\n",
       "                'Calzada-Wack, J C',\n",
       "                'Goretzki, M',\n",
       "                'Pietsch, A',\n",
       "                'Johnson, J P',\n",
       "                'Ziegler-Heitbrock, H W'],\n",
       "               'AU': ['Weber C',\n",
       "                'Calzada-Wack JC',\n",
       "                'Goretzki M',\n",
       "                'Pietsch A',\n",
       "                'Johnson JP',\n",
       "                'Ziegler-Heitbrock HW'],\n",
       "               'AD': ['Institut fur Prophylaxe der Kreislaufkrankheiten, University of Munich, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'England',\n",
       "               'TA': 'J Leukoc Biol',\n",
       "               'JT': 'Journal of leukocyte biology',\n",
       "               'JID': '8405628',\n",
       "               'RN': ['0 (Antigens, CD)',\n",
       "                '0 (Antigens, Differentiation, Myelomonocytic)',\n",
       "                '0 (Lipopolysaccharide Receptors)',\n",
       "                '0 (RNA, Messenger)',\n",
       "                '0 (Receptors, IgE)',\n",
       "                '126547-89-5 (Intercellular Adhesion Molecule-1)',\n",
       "                '1F7A44V6OU (Colforsin)',\n",
       "                '37H9VM9WZL (Calcimycin)',\n",
       "                '5688UTC01R (Tretinoin)',\n",
       "                '63X7MBT2LQ (Bucladesine)',\n",
       "                '82115-62-6 (Interferon-gamma)',\n",
       "                'EC 1.14.99.1 (Prostaglandin-Endoperoxide Synthases)',\n",
       "                'FXC9231JVH (Calcitriol)',\n",
       "                'K7Q1JQR04M (Dinoprostone)',\n",
       "                'XXE1CET956 (Indomethacin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Antigens, CD/metabolism',\n",
       "                'Antigens, Differentiation, Myelomonocytic/metabolism',\n",
       "                'Bucladesine/pharmacology',\n",
       "                'Calcimycin/pharmacology',\n",
       "                'Calcitriol/pharmacology',\n",
       "                'Cell Differentiation/drug effects',\n",
       "                'Cell Line',\n",
       "                'Colforsin/pharmacology',\n",
       "                'Dinoprostone/biosynthesis/pharmacology',\n",
       "                'Enzyme Induction',\n",
       "                'Gene Expression/drug effects',\n",
       "                'Humans',\n",
       "                'Indomethacin/pharmacology',\n",
       "                'Intercellular Adhesion Molecule-1/*metabolism',\n",
       "                'Interferon-gamma/*pharmacology',\n",
       "                'Lipopolysaccharide Receptors',\n",
       "                'Monocytes/*metabolism',\n",
       "                'Prostaglandin-Endoperoxide Synthases/metabolism',\n",
       "                'RNA, Messenger/genetics/metabolism',\n",
       "                'Receptors, IgE/metabolism',\n",
       "                'Tretinoin/*pharmacology'],\n",
       "               'EDAT': '1995/03/01 00:00',\n",
       "               'MHDA': '1995/03/01 00:01',\n",
       "               'CRDT': ['1995/03/01 00:00'],\n",
       "               'PHST': ['1995/03/01 00:00 [pubmed]',\n",
       "                '1995/03/01 00:01 [medline]',\n",
       "                '1995/03/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1002/jlb.57.3.401 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Leukoc Biol. 1995 Mar;57(3):401-6. doi: 10.1002/jlb.57.3.401.'},\n",
       "              {'PMID': '8536054',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19960208',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0947-7349 (Print) 0947-7349 (Linking)',\n",
       "               'VI': '103',\n",
       "               'IP': '5',\n",
       "               'DP': '1995',\n",
       "               'TI': 'Molecular analysis of mutations in thyroid tumors with TGGE.',\n",
       "               'PG': '275-9',\n",
       "               'AB': 'Immunohistochemical demonstration of overexpression of the p53 protein indicates a mutational alteration of the gene. Our own investigations of 59 differentiated thyroid carcinomas revealed an overexpression in 15% of the tumors. A correlation to unfavourable tumor prognosis was found (stage I and II: 0/11 (0%); stage III: 4/26 (14%); stage IV: 5/22 (23%)). For screening of one out of more than 300 possible mutations temperature gradient gel electrophoresis was employed. Analysis of the highly-conserved regions of the p53 gene (exon 5 to 8) could demonstrate a mutation in only 1 out of 31 differentiated thyroid carcinomas. The question arises whether accumulation of the protein is due to a mutational event or rather other molecular mechanisms.',\n",
       "               'FAU': ['Simon, D',\n",
       "                'Goretzki, P E',\n",
       "                'Schafer, C',\n",
       "                'Gorelov, V',\n",
       "                'Ebeling, B',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Simon D',\n",
       "                'Goretzki PE',\n",
       "                'Schafer C',\n",
       "                'Gorelov V',\n",
       "                'Ebeling B',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Department of Surgery, Heinrich Heine University Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                'Review'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Exp Clin Endocrinol Diabetes',\n",
       "               'JT': 'Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association',\n",
       "               'JID': '9505926',\n",
       "               'RN': ['0 (Molecular Probes)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma, Follicular/*genetics',\n",
       "                'Base Sequence',\n",
       "                'Carcinoma, Medullary/*genetics',\n",
       "                'Carcinoma, Papillary/*genetics',\n",
       "                'Electrophoresis, Polyacrylamide Gel/*methods',\n",
       "                'Exons',\n",
       "                'Humans',\n",
       "                'Molecular Probes/genetics',\n",
       "                'Molecular Sequence Data',\n",
       "                '*Mutation',\n",
       "                'Polymerase Chain Reaction',\n",
       "                'Temperature',\n",
       "                'Thyroid Neoplasms/*genetics',\n",
       "                'Thyroid Nodule/genetics'],\n",
       "               'RF': '36',\n",
       "               'EDAT': '1995/01/01 00:00',\n",
       "               'MHDA': '1995/01/01 00:01',\n",
       "               'CRDT': ['1995/01/01 00:00'],\n",
       "               'PHST': ['1995/01/01 00:00 [pubmed]',\n",
       "                '1995/01/01 00:01 [medline]',\n",
       "                '1995/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-0029-1211363 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Exp Clin Endocrinol Diabetes. 1995;103(5):275-9. doi: 10.1055/s-0029-1211363.'},\n",
       "              {'PMID': '7751320',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19950622',\n",
       "               'LR': '20190904',\n",
       "               'IS': '0171-5216 (Print) 0171-5216 (Linking)',\n",
       "               'VI': '121',\n",
       "               'IP': '4',\n",
       "               'DP': '1995',\n",
       "               'TI': 'Overexpression of Gs alpha subunit in thyroid tumors bearing a mutated Gs alpha gene.',\n",
       "               'PG': '219-24',\n",
       "               'AB': 'Point mutations occurring at codon 201 of the gene coding for the alpha subunit of the stimulatory G protein impair intrinsic GTPase activity and lead to a constitutive activation of adenylate cyclase. We have examined thyroid follicular and papillary carcinomas and follicular adenomas and found samples that bear this mutation at codon 201 of the Gs alpha gene. Both mutation-positive and mutation-negative tissue samples were investigated for the level of Gs alpha expression relative to a pool of normal thyroid tissue, using immunoblotting against two (mid-region-specific and C-end-specific) antipeptide antibodies. Using 8000 g and 100,000 g membrane fractions of homogenized tissues we have demonstrated that the Gs alpha proteins in normal ad neoplastic thyroid tissues are represented by three isoforms: 43 kDa, 45 kDa and 52 kDa. We have quantified and compared the amount of Gs alpha protein and find it is overexpressed in mutation-bearing tissue samples.',\n",
       "               'FAU': ['Gorelov, V N',\n",
       "                'Dumon, K',\n",
       "                'Barteneva, N S',\n",
       "                'Palm, D',\n",
       "                'Roher, H D',\n",
       "                'Goretzki, P E'],\n",
       "               'AU': ['Gorelov VN',\n",
       "                'Dumon K',\n",
       "                'Barteneva NS',\n",
       "                'Palm D',\n",
       "                'Roher HD',\n",
       "                'Goretzki PE'],\n",
       "               'AD': ['Department of Surgery A, Heinrich-Heine-University, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comparative Study',\n",
       "                'Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'J Cancer Res Clin Oncol',\n",
       "               'JT': 'Journal of cancer research and clinical oncology',\n",
       "               'JID': '7902060',\n",
       "               'RN': ['0 (Codon)',\n",
       "                '0 (Macromolecular Substances)',\n",
       "                '0 (Peptide Fragments)',\n",
       "                'EC 3.6.1.- (GTP-Binding Proteins)'],\n",
       "               'SB': 'IM',\n",
       "               'GS': ['Gs&agr;'],\n",
       "               'MH': ['Amino Acid Sequence',\n",
       "                'Animals',\n",
       "                'Antibody Specificity',\n",
       "                'Carcinoma, Papillary/*genetics',\n",
       "                'Carcinoma, Papillary, Follicular/*genetics',\n",
       "                'Cell Membrane/chemistry',\n",
       "                'Codon',\n",
       "                'GTP-Binding Proteins/biosynthesis/*genetics/immunology',\n",
       "                'Gene Expression',\n",
       "                'Humans',\n",
       "                'Immunoblotting',\n",
       "                'Macromolecular Substances',\n",
       "                'Molecular Sequence Data',\n",
       "                'Peptide Fragments/immunology',\n",
       "                '*Point Mutation',\n",
       "                'Rabbits',\n",
       "                'Subcellular Fractions',\n",
       "                'Thyroid Gland/metabolism/physiology',\n",
       "                'Thyroid Neoplasms/*genetics/metabolism'],\n",
       "               'EDAT': '1995/01/01 00:00',\n",
       "               'MHDA': '1995/01/01 00:01',\n",
       "               'CRDT': ['1995/01/01 00:00'],\n",
       "               'PHST': ['1995/01/01 00:00 [pubmed]',\n",
       "                '1995/01/01 00:01 [medline]',\n",
       "                '1995/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF01366965 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Cancer Res Clin Oncol. 1995;121(4):219-24. doi: 10.1007/BF01366965.'}],\n",
       "             '1994': [{'PMID': '7860679',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19950323',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0021-7697 (Print) 0021-7697 (Linking)',\n",
       "               'VI': '131',\n",
       "               'IP': '10',\n",
       "               'DP': '1994 Oct',\n",
       "               'TI': '[Surgical treatment of esophageal perforations].',\n",
       "               'PG': '440-4',\n",
       "               'AB': 'Spontaneous and iatrogenic esophageal perforations continue to present life threatening gastroenterologic emergencies. The results in 17 patients being treated between 1986 and 1992 are presented. In respect to localisation of the perforation, the underlying nature of the disease and the condition of the patient an early suture and wrap in all patients with benign diseases and an early esophagectomy in patients with esophageal cancer was aspired. 11 patients having been treated this way survived whereas 3 of six patients with extensive tumour burden and reduced physical state who had been treated conservatively died during the hospital stay. Thus early diagnosis and operative treatment of esophageal perforations improves patients outcome significantly.',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Horstmann, O',\n",
       "                'Verreet, P R',\n",
       "                'Rohr, H D'],\n",
       "               'AU': ['Goretzki PE', 'Horstmann O', 'Verreet PR', 'Rohr HD'],\n",
       "               'AD': ['Clinique de Chirurgie Generale et Traumatologique, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['fre'],\n",
       "               'PT': ['English Abstract', 'Journal Article', 'Review'],\n",
       "               'TT': 'Traitement chirurgical des perforations oesophagiennes.',\n",
       "               'PL': 'France',\n",
       "               'TA': 'J Chir (Paris)',\n",
       "               'JT': 'Journal de chirurgie',\n",
       "               'JID': '0374754',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Drainage',\n",
       "                'Endoscopy, Digestive System/*adverse effects',\n",
       "                'Esophageal Neoplasms/*complications',\n",
       "                'Esophageal Perforation/etiology/*surgery',\n",
       "                'Esophagectomy',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged'],\n",
       "               'RF': '20',\n",
       "               'EDAT': '1994/10/01 00:00',\n",
       "               'MHDA': '1994/10/01 00:01',\n",
       "               'CRDT': ['1994/10/01 00:00'],\n",
       "               'PHST': ['1994/10/01 00:00 [pubmed]',\n",
       "                '1994/10/01 00:01 [medline]',\n",
       "                '1994/10/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Chir (Paris). 1994 Oct;131(10):440-4.'},\n",
       "              {'PMID': '7725746',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19950519',\n",
       "               'LR': '20190825',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '18',\n",
       "               'IP': '4',\n",
       "               'DP': '1994 Jul-Aug',\n",
       "               'TI': 'Diminished expression of the alpha 5 beta 1 integrin (fibronectin receptor) by invasive clones of a human follicular thyroid cancer cell line.',\n",
       "               'PG': '569-75; discussion 575-6',\n",
       "               'AB': 'Altered adhesion plaques have been observed in transformed cell lines and are associated with enhanced metastatic potential. The prototypical adhesion plaque is formed by alpha 5 beta 1 fibronectin receptors (FnRs) interacting with the cellular actin network. We have found differences in the actin networks of noninvasive (FTC-133) and invasive (FTC-236, FTC-238) clones of a human follicular thyroid cancer cell line. Furthermore, thyroid-stimulating hormone (TSH) induces stress fibers in FTC-133. In order to investigate differences in adhesion plaques, expression of fibronectin (FN) and its receptor by these cells was analyzed. For these studies FTC-133, FTC-236, and FTC-238 were cultured in serum-depleted DME-H21 medium for 24 hours before the addition of TSH 30 mU/ml. No quantitative differences were noted in FN expression on Western blot in either the conditioned medium or cellular extracts. Western blots and immunohistochemical studies indicated that TSH induced secretion of FN only in FTC-133. Flow cytometry with an alpha 5 antibody demonstrated a 52% and 45% reduction (p < 0.01) in expression of FnR by FTC-236 and FTC-238, respectively, compared to FTC-133; this finding was supported by immunohistochemistry results. TSH treatment did not alter FnR expression. From these studies, we conclude that invasive clones of FTC decrease their expression of FnRs without changing their expression of FN. Furthermore, TSH treatment may promote FN secretion by FTC-133, although it does not seem to affect FnR or absolute FN expression. The diminished expression of FnR adhesion plaques may enhance metastatic potential in some follicular thyroid cancers.',\n",
       "               'FAU': ['Demeure, M J',\n",
       "                'Doffek, K M',\n",
       "                'Rezaee, M',\n",
       "                'Goretzki, P E',\n",
       "                'Wilson, S D'],\n",
       "               'AU': ['Demeure MJ',\n",
       "                'Doffek KM',\n",
       "                'Rezaee M',\n",
       "                'Goretzki PE',\n",
       "                'Wilson SD'],\n",
       "               'AD': ['Department of Surgery, Medical College of Wisconsin, Milwaukee 53226, USA.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'RN': ['0 (Receptors, Peptide)',\n",
       "                '0 (fibrin receptor)',\n",
       "                '9001-31-4 (Fibrin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma, Follicular/*chemistry',\n",
       "                'Blotting, Western',\n",
       "                'Cell Line',\n",
       "                'Clone Cells',\n",
       "                'Fibrin/analysis',\n",
       "                'Flow Cytometry',\n",
       "                'Humans',\n",
       "                'Immunohistochemistry',\n",
       "                'Receptors, Peptide/*analysis',\n",
       "                'Thyroid Neoplasms/*chemistry',\n",
       "                'Tumor Cells, Cultured'],\n",
       "               'EDAT': '1994/07/01 00:00',\n",
       "               'MHDA': '1994/07/01 00:01',\n",
       "               'CRDT': ['1994/07/01 00:00'],\n",
       "               'PHST': ['1994/07/01 00:00 [pubmed]',\n",
       "                '1994/07/01 00:01 [medline]',\n",
       "                '1994/07/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF00353767 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 1994 Jul-Aug;18(4):569-75; discussion 575-6. doi: 10.1007/BF00353767.'},\n",
       "              {'PMID': '7725741',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19950519',\n",
       "               'LR': '20190825',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '18',\n",
       "               'IP': '4',\n",
       "               'DP': '1994 Jul-Aug',\n",
       "               'TI': 'Significance of P53 in human thyroid tumors.',\n",
       "               'PG': '535-40; discussion 540-1',\n",
       "               'AB': 'Mutational changes in the p53 tumor suppressor gene are the most frequent genetic alterations in human malignant tumors. Studies have shown a correlation of p53 expression in breast cancer with tumor prognosis. In contrast to mutational activation of ras and GSP in thyroid tumors, little is known about the role of p53 in thyroid tumor development. Therefore thyroid tumors and thyroid tumor cell lines were studied for the presence of p53 mutations. Snap-frozen tissues from 57 differentiated thyroid carcinomas (DTCs) and 5 goiters were studied by immunohistochemical methods. A panel of six antibodies (pAb 240, 421, 1620, 1801, DO7, and CM1) was employed by using the ABC technique. Five cell lines from DTCs (FTC133, 236, 238, PTC337, MTC164) were examined by the same technique. Additionally, genomic DNA from the cells was amplified by the polymerase chain reaction (PCR) and the PCR product studied for p53 mutations (R273H) by mutation-specific oligonucleotide hybridization (MOH) and temperature gradient gel electrophoresis (TGGE) for the p53 exon 8. None of the benign thyroid tumors and 7 of 57 (12%) DTCs strongly express p53 with a heterogeneous distribution in the tumor tissue. All seven patients have metastatic disease or dedifferentiated tumors G3 (three of seven). CM1 was positive in two cell lines (FTC-133, PTC-337), questionable in FTC-238, and negative in FTC-236 and MTC-164. All three follicular cell lines, however, and the original tumor tissue showed the same p53 mutation (R273H) in MOH analysis and TGGE. P53 mutations are rare in thyroid tumors, but the presence of p53 mutations indicates a poor prognosis.(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "               'FAU': ['Simon, D',\n",
       "                'Goretzki, P E',\n",
       "                'Gorelev, V',\n",
       "                'Ebling, B',\n",
       "                'Reishaus, E',\n",
       "                'Lyons, J',\n",
       "                'Haubruck, H',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Simon D',\n",
       "                'Goretzki PE',\n",
       "                'Gorelev V',\n",
       "                'Ebling B',\n",
       "                'Reishaus E',\n",
       "                'Lyons J',\n",
       "                'Haubruck H',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Department of Surgery, Heinrich-Heine-University Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Base Sequence',\n",
       "                'Cell Line',\n",
       "                '*Genes, p53',\n",
       "                'Humans',\n",
       "                'Molecular Sequence Data',\n",
       "                'Mutation',\n",
       "                'Neoplasm Metastasis',\n",
       "                'Polymerase Chain Reaction',\n",
       "                'Prognosis',\n",
       "                'Thyroid Neoplasms/*genetics'],\n",
       "               'EDAT': '1994/07/01 00:00',\n",
       "               'MHDA': '1994/07/01 00:01',\n",
       "               'CRDT': ['1994/07/01 00:00'],\n",
       "               'PHST': ['1994/07/01 00:00 [pubmed]',\n",
       "                '1994/07/01 00:01 [medline]',\n",
       "                '1994/07/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF00353758 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 1994 Jul-Aug;18(4):535-40; discussion 540-1. doi: 10.1007/BF00353758.'},\n",
       "              {'PMID': '8166707',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19940523',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0006-291X (Print) 0006-291X (Linking)',\n",
       "               'VI': '200',\n",
       "               'IP': '1',\n",
       "               'DP': '1994 Apr 15',\n",
       "               'TI': 'A method to increase the sensitivity of mutation specific oligonucleotide hybridization using asymmetric polymerase-chain reaction (PCR).',\n",
       "               'PG': '365-9',\n",
       "               'AB': 'We propose a simple and reliable method to increase the sensitivity of mutation specific oligonucleotide hybridization (MSOH) at least 2.5 times, when it is used to detect mutations in samples of DNA from tumor tissues. The method is based on using single stranded (ss) DNA, amplified by asymmetric PCR, as a target for MSOH analysis. During the first step, genomic DNA, isolated from tissue samples, has to be amplified by \"standard\", symmetric PCR, with sense and antisense primers in equimolar concentration. This amplification can be performed in a diminished volume of reaction mixture. In the second step obtained double stranded (ds) PCR DNA-product can be used as a template for asymmetric PCR, using only a single primer. The ss DNA must be complementary to the set of mutation specific oligonucleotides. By this innovation we have been able to clarify questionable results of MSOH using ds DNA as a target. Comparing MSOH from ss DNA to that from ds DNA, the observed rate of Gs-alpha mutations in thyroid tumor tissue samples increased to 16.7% (14/66) from 6% (4/66).',\n",
       "               'FAU': ['Gorelov, V N', 'Roher, H D', 'Goretzki, P E'],\n",
       "               'AU': ['Gorelov VN', 'Roher HD', 'Goretzki PE'],\n",
       "               'AD': ['Department of Surgery A, Heinrich-Heine-University, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Biochem Biophys Res Commun',\n",
       "               'JT': 'Biochemical and biophysical research communications',\n",
       "               'JID': '0372516',\n",
       "               'RN': ['0 (Codon)',\n",
       "                '0 (DNA Primers)',\n",
       "                '0 (DNA, Neoplasm)',\n",
       "                '0 (DNA, Single-Stranded)',\n",
       "                '0 (Oligonucleotides, Antisense)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Base Sequence',\n",
       "                'Codon/*genetics',\n",
       "                '*DNA Primers',\n",
       "                'DNA, Neoplasm/*genetics/isolation & purification',\n",
       "                'DNA, Single-Stranded/chemistry/genetics',\n",
       "                'Humans',\n",
       "                'Molecular Sequence Data',\n",
       "                'Nucleic Acid Hybridization',\n",
       "                'Oligonucleotides, Antisense',\n",
       "                '*Point Mutation',\n",
       "                'Polymerase Chain Reaction/*methods',\n",
       "                'Thyroid Neoplasms/*genetics'],\n",
       "               'EDAT': '1994/04/15 00:00',\n",
       "               'MHDA': '1994/04/15 00:01',\n",
       "               'CRDT': ['1994/04/15 00:00'],\n",
       "               'PHST': ['1994/04/15 00:00 [pubmed]',\n",
       "                '1994/04/15 00:01 [medline]',\n",
       "                '1994/04/15 00:00 [entrez]'],\n",
       "               'AID': ['S0006-291X(84)71457-4 [pii]',\n",
       "                '10.1006/bbrc.1994.1457 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Biochem Biophys Res Commun. 1994 Apr 15;200(1):365-9. doi: 10.1006/bbrc.1994.1457.'},\n",
       "              {'PMID': '7934579',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19941117',\n",
       "               'LR': '20190821',\n",
       "               'IS': '0023-8236 (Print) 0023-8236 (Linking)',\n",
       "               'VI': '379',\n",
       "               'IP': '4',\n",
       "               'DP': '1994',\n",
       "               'TI': '[Surgical strategy in persistence and recurrence in surgery of primary hyperparathyroidism].',\n",
       "               'PG': '218-23',\n",
       "               'AB': 'Persisting hypercalcemia after surgery for primary hyperparathyroidism is a challenge for the surgeon: once non-parathyroid causes for the hypercalcemia have been excluded the only remaining possible causes are ineffective surgery and a failed surgery. Between 1986 and 1994, 414 patients with primary hyperparathyroidism were operated upon, 32 of whom presented with persisting hypercalcemia; 24 of these patients had their first operation in another hospital. The cause for persisting hypercalcemia was a single adenoma in 27 patients (84%), double adenoma in 2 patients and primary hyperplasia in 2 patients. In 1 patient an unsuccessful revision operation was performed. In 17 patients the parathyroid glands had an atypical position. There were 11 patients who presented with recurrent hyperplasia. The reasons for recurrence were double adenoma in 2 patients and hyperplasia in 8 cases (73%). In 1 patient no pathologic gland was found. Although preoperative localization studies were positive in only 32%, the overall surgical success rate fortunately amounted to a satisfactory 95%.',\n",
       "               'FAU': ['Dotzenrath, C', 'Goretzki, P E', 'Roher, H D'],\n",
       "               'AU': ['Dotzenrath C', 'Goretzki PE', 'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Operative Strategie bei Persistenz und Rezidiv in der Chirurgie des primaren Hyperparathyreoidismus.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie',\n",
       "               'JID': '0204167',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/etiology/*surgery',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                'Hypercalcemia/etiology/*surgery',\n",
       "                'Hyperparathyroidism/etiology/*surgery',\n",
       "                'Hyperplasia',\n",
       "                'Male',\n",
       "                'Multiple Endocrine Neoplasia Type 1/pathology/surgery',\n",
       "                'Multiple Endocrine Neoplasia Type 2a/pathology/surgery',\n",
       "                'Neoplasm Recurrence, Local/etiology/*surgery',\n",
       "                'Neoplasms, Second Primary/etiology/*surgery',\n",
       "                'Parathyroid Glands/pathology',\n",
       "                'Parathyroid Neoplasms/etiology/*surgery',\n",
       "                'Parathyroidectomy',\n",
       "                'Postoperative Complications/etiology/*surgery',\n",
       "                'Reoperation'],\n",
       "               'EDAT': '1994/01/01 00:00',\n",
       "               'MHDA': '1994/01/01 00:01',\n",
       "               'CRDT': ['1994/01/01 00:00'],\n",
       "               'PHST': ['1994/01/01 00:00 [pubmed]',\n",
       "                '1994/01/01 00:01 [medline]',\n",
       "                '1994/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF00186361 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir. 1994;379(4):218-23. doi: 10.1007/BF00186361.'}],\n",
       "             '1993': [{'PMID': '8256225',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19940107',\n",
       "               'LR': '20100324',\n",
       "               'IS': '0039-6060 (Print) 0039-6060 (Linking)',\n",
       "               'VI': '114',\n",
       "               'IP': '6',\n",
       "               'DP': '1993 Dec',\n",
       "               'TI': 'Persistent hypertension after successful adrenal operation.',\n",
       "               'PG': '1189-95',\n",
       "               'AB': \"BACKGROUND: Up to 80% of patients with adrenocortical tumors comprising Conn's or Cushing's syndrome and patients with pheochromocytomas suffer from hypertension. Its implications in cardiovascular disease and its impact on quality of life make it the most important aim in therapeutic efforts. The aim of our study was to assess the long-term results in postoperative blood pressure after adrenalectomy and to evaluate potential risk factors for persistent hypertension. METHODS: Forty four patients with adrenal hypertension operated on between April 1986 and April 1991 underwent follow-up consisting of exact history, hormonal analysis, and adrenal imaging. RESULTS: Forty three patients were reexamined, which showed 11 patients (26%) with hypertension at dismissal from hospital and 17 patients (40%) with hypertension after a median of 2 years. Except for two recurrent tumors in adrenocortical carcinoma all patients were surgically cured. Antihypertensive medication could be reduced in 13 of 17 patients with persistent hypertension. Persistent hypertension did not correlate with the degree of preoperative blood pressure elevation, age, and gender, but it did correlate strongly with history of hypertension. Patients with normal blood pressure level after operation had a mean history of 5.7 years versus 11.5 years in patients with persistent hypertension (p < 0.03). CONCLUSIONS: The success of surgical treatment for adrenal hypertension strongly depends on early diagnosis and surgical intervention.\",\n",
       "               'FAU': ['Simon, D',\n",
       "                'Goretzki, P E',\n",
       "                'Lollert, A',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Simon D', 'Goretzki PE', 'Lollert A', 'Roher HD'],\n",
       "               'AD': ['Department of Surgery, Heinrich-Heine University, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Surgery',\n",
       "               'JT': 'Surgery',\n",
       "               'JID': '0417347',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/surgery',\n",
       "                'Adolescent',\n",
       "                'Adrenal Cortex Neoplasms/surgery',\n",
       "                'Adrenal Glands/pathology/*surgery',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Blood Pressure',\n",
       "                'Child',\n",
       "                'Cushing Syndrome/surgery',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperplasia',\n",
       "                'Hypertension/*etiology/physiopathology',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Postoperative Complications',\n",
       "                'Postoperative Period',\n",
       "                'Risk Factors'],\n",
       "               'EDAT': '1993/12/01 00:00',\n",
       "               'MHDA': '1993/12/01 00:01',\n",
       "               'CRDT': ['1993/12/01 00:00'],\n",
       "               'PHST': ['1993/12/01 00:00 [pubmed]',\n",
       "                '1993/12/01 00:01 [medline]',\n",
       "                '1993/12/01 00:00 [entrez]'],\n",
       "               'AID': ['0039-6060(93)90343-C [pii]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Surgery. 1993 Dec;114(6):1189-95.'},\n",
       "              {'PMID': '7524636',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19941206',\n",
       "               'LR': '20161021',\n",
       "               'IS': '1121-7596 (Print) 1121-7596 (Linking)',\n",
       "               'VI': '5',\n",
       "               'IP': '3',\n",
       "               'DP': '1993 Dec',\n",
       "               'TI': 'Principals of limited or radical surgery for differentiated thyroid cancer.',\n",
       "               'PG': '93-6',\n",
       "               'AB': 'Since the late sixties standard total thyroidectomy with or without selective radical neck dissection depending on the extent of the disease has become the routine surgical procedure for differentiated thyroid carcinoma (DTC;-papillary, follicular). This strategy has contributed remarkably to the increase of cure rates for various reasons. Only recently, in the last decade, has limited radicality with only unilateral lobectomy (= hemithyroidectomy) with or without partial contralateral resection been advocated as being sufficient for selected early tumor stages. We have analyzed a series of 252 patients, 174 (69%) being papillary and 78 (31%) follicular. Primary operation was done in 117 patients (46%) while 135 patients (54%) underwent reoperative surgery at this institution for either completion of radicality or because of loco-regional recurrence. From our evaluation we draw the conclusion that limited radicality (unilateral operation or subtotal) is justified only in pT-1-tumors in younger age (< 45 yrs) in order to avoid recurrence and unnecessary reoperation. On the other hand generous indication for reoperation is justified with the overall chance of almost 60% cure rate. All adjuvant treatment, mainly radioiodine should be applied thereafter.',\n",
       "               'FAU': ['Roeher, H D', 'Simon, D', 'Witte, J', 'Goretzki, P E'],\n",
       "               'AU': ['Roeher HD', 'Simon D', 'Witte J', 'Goretzki PE'],\n",
       "               'AD': ['Department of Surgery, Heinrich-Heine-University, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'Italy',\n",
       "               'TA': 'Thyroidology',\n",
       "               'JT': 'Thyroidology',\n",
       "               'JID': '9100266',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma, Follicular/*surgery',\n",
       "                'Adult',\n",
       "                'Carcinoma, Papillary/*surgery',\n",
       "                'Humans',\n",
       "                'Lymph Node Excision',\n",
       "                'Middle Aged',\n",
       "                'Neoplasm Recurrence, Local',\n",
       "                'Reoperation',\n",
       "                'Thyroid Neoplasms/*surgery',\n",
       "                'Thyroidectomy/*methods'],\n",
       "               'EDAT': '1993/12/01 00:00',\n",
       "               'MHDA': '1993/12/01 00:01',\n",
       "               'CRDT': ['1993/12/01 00:00'],\n",
       "               'PHST': ['1993/12/01 00:00 [pubmed]',\n",
       "                '1993/12/01 00:01 [medline]',\n",
       "                '1993/12/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Thyroidology. 1993 Dec;5(3):93-6.'},\n",
       "              {'PMID': '8402050',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19931101',\n",
       "               'LR': '20220311',\n",
       "               'IS': '0007-1323 (Print) 0007-1323 (Linking)',\n",
       "               'VI': '80',\n",
       "               'IP': '8',\n",
       "               'DP': '1993 Aug',\n",
       "               'TI': 'Surgical reintervention for differentiated thyroid cancer.',\n",
       "               'PG': '1009-12',\n",
       "               'AB': 'Reoperation was performed in 110 of 185 patients with a differentiated thyroid carcinoma. In 25 patients (23 per cent) the indication for reintervention was a large thyroid remnant and in the other 85 (77 per cent) persistent or recurrent cancer was suspected. In 32 (29 per cent) of the 110 patients undergoing reoperation no evidence of cancer tissue was found. Tumour tissue in 33 patients (30 per cent) was resectable. Of 45 patients (41 per cent) with residual tumour after operation 24 showed only occult thyroid carcinoma with a raised serum thyroglobulin level. Eight of 21 patients with macroscopically persistent tumour died from the disease during a mean follow-up of 2.3 years. In 13 of 38 patients the investigated recurrent tumours were histologically less differentiated than the primary lesions, stressing the importance of total tumour clearance. The treatment of choice for persistent and recurrent differentiated thyroid carcinoma is surgical reintervention, if feasible, before radioiodine and radiation therapy are considered.',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Simon, D',\n",
       "                'Frilling, A',\n",
       "                'Witte, J',\n",
       "                'Reiners, C',\n",
       "                'Grussendorf, M',\n",
       "                'Horster, F A',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Goretzki PE',\n",
       "                'Simon D',\n",
       "                'Frilling A',\n",
       "                'Witte J',\n",
       "                'Reiners C',\n",
       "                'Grussendorf M',\n",
       "                'Horster FA',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemeine und Unfallchirurgie, Heinrich Heine Universitat, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Br J Surg',\n",
       "               'JT': 'The British journal of surgery',\n",
       "               'JID': '0372553',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma, Follicular/pathology/*surgery',\n",
       "                'Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Carcinoma, Papillary/pathology/*surgery',\n",
       "                'Child',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Neoplasm Recurrence, Local/surgery',\n",
       "                'Neoplasm Staging',\n",
       "                'Reoperation',\n",
       "                'Thyroid Neoplasms/pathology/*surgery',\n",
       "                'Treatment Outcome'],\n",
       "               'EDAT': '1993/08/01 00:00',\n",
       "               'MHDA': '1993/08/01 00:01',\n",
       "               'CRDT': ['1993/08/01 00:00'],\n",
       "               'PHST': ['1993/08/01 00:00 [pubmed]',\n",
       "                '1993/08/01 00:01 [medline]',\n",
       "                '1993/08/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1002/bjs.1800800826 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Br J Surg. 1993 Aug;80(8):1009-12. doi: 10.1002/bjs.1800800826.'},\n",
       "              {'PMID': '8154661',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19940512',\n",
       "               'LR': '20051116',\n",
       "               'IS': '0003-469X (Print) 0003-469X (Linking)',\n",
       "               'VI': '64',\n",
       "               'IP': '4',\n",
       "               'DP': '1993 Jul-Aug',\n",
       "               'TI': 'Renal hyperparathyroidism following kidney transplantation.',\n",
       "               'PG': '381-4',\n",
       "               'FAU': ['Dotzenrath, C', 'Goretzki, P E', 'Roher, H D'],\n",
       "               'AU': ['Dotzenrath C', 'Goretzki PE', 'Roher HD'],\n",
       "               'AD': ['Department of surgery, Heinrich Heine University Dusseldorf.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'PL': 'Italy',\n",
       "               'TA': 'Ann Ital Chir',\n",
       "               'JT': 'Annali italiani di chirurgia',\n",
       "               'JID': '0372343',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                '*Hyperparathyroidism/diagnosis/epidemiology/physiopathology/surgery',\n",
       "                'Incidence',\n",
       "                '*Kidney Transplantation',\n",
       "                'Parathyroidectomy',\n",
       "                'Postoperative Care',\n",
       "                '*Postoperative Complications/diagnosis/epidemiology/physiopathology/surgery'],\n",
       "               'RF': '28',\n",
       "               'EDAT': '1993/07/01 00:00',\n",
       "               'MHDA': '1993/07/01 00:01',\n",
       "               'CRDT': ['1993/07/01 00:00'],\n",
       "               'PHST': ['1993/07/01 00:00 [pubmed]',\n",
       "                '1993/07/01 00:01 [medline]',\n",
       "                '1993/07/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Ann Ital Chir. 1993 Jul-Aug;64(4):381-4.'},\n",
       "              {'PMID': '8385451',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19930503',\n",
       "               'LR': '20141120',\n",
       "               'IS': '0006-291X (Print) 0006-291X (Linking)',\n",
       "               'VI': '191',\n",
       "               'IP': '3',\n",
       "               'DP': '1993 Mar 31',\n",
       "               'TI': 'Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: growth inhibition by cAMP.',\n",
       "               'PG': '1131-8',\n",
       "               'AB': 'The role of TSH and its receptor in controlling growth of thyroid carcinomas is far from well understood. In order to study this subject further we established a new human thyroid carcinoma cell line. We transfected human thyroid carcinoma cells lacking an endogenous TSH receptor with the human TSH receptor cDNA. Transfected cells, designated HTC-TSHr, expressed the TSH receptor mRNA and synthesized a functional TSH receptor with a TSH binding affinity in the order of magnitude of normal thyroid cells. In response to TSH stimulation HTC-TSHr cells accumulated cAMP, indicating a functional TSH receptor-adenylate cyclase system. However, HTC-TSHr cells did not concentrate iodide and lacked thyroglobulin immunoreactivity, although they did express low amounts of thyroglobulin mRNA. Proliferation of HTC-TSHr cells was inhibited by dibutyryl-cAMP and forskolin and also by TSH via the re-expressed TSH receptor.',\n",
       "               'FAU': ['Derwahl, M',\n",
       "                'Kuemmel, M',\n",
       "                'Goretzki, P',\n",
       "                'Schatz, H',\n",
       "                'Broecker, M'],\n",
       "               'AU': ['Derwahl M',\n",
       "                'Kuemmel M',\n",
       "                'Goretzki P',\n",
       "                'Schatz H',\n",
       "                'Broecker M'],\n",
       "               'AD': ['Laboratory of Experimental Endocrinology, Clinic of Internal Medicine, University of Bochum, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Biochem Biophys Res Commun',\n",
       "               'JT': 'Biochemical and biophysical research communications',\n",
       "               'JID': '0372516',\n",
       "               'RN': ['0 (Oligodeoxyribonucleotides)',\n",
       "                '0 (RNA, Messenger)',\n",
       "                '0 (Receptors, Thyrotropin)',\n",
       "                '1F7A44V6OU (Colforsin)',\n",
       "                '63X7MBT2LQ (Bucladesine)',\n",
       "                '9002-71-5 (Thyrotropin)',\n",
       "                '9010-34-8 (Thyroglobulin)',\n",
       "                'E0399OZS9N (Cyclic AMP)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Base Sequence',\n",
       "                'Bucladesine/pharmacology',\n",
       "                'Cell Division',\n",
       "                'Colforsin/pharmacology',\n",
       "                'Cyclic AMP/*physiology',\n",
       "                'Gene Expression',\n",
       "                'Humans',\n",
       "                'In Vitro Techniques',\n",
       "                'Molecular Sequence Data',\n",
       "                'Oligodeoxyribonucleotides/chemistry',\n",
       "                'RNA, Messenger/genetics',\n",
       "                'Receptors, Thyrotropin/*metabolism',\n",
       "                'Thyroglobulin/genetics',\n",
       "                'Thyroid Neoplasms/*metabolism/pathology',\n",
       "                'Thyrotropin/*metabolism',\n",
       "                'Transfection',\n",
       "                'Tumor Cells, Cultured'],\n",
       "               'EDAT': '1993/03/31 00:00',\n",
       "               'MHDA': '1993/03/31 00:01',\n",
       "               'CRDT': ['1993/03/31 00:00'],\n",
       "               'PHST': ['1993/03/31 00:00 [pubmed]',\n",
       "                '1993/03/31 00:01 [medline]',\n",
       "                '1993/03/31 00:00 [entrez]'],\n",
       "               'AID': ['S0006-291X(83)71334-3 [pii]',\n",
       "                '10.1006/bbrc.1993.1334 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Biochem Biophys Res Commun. 1993 Mar 31;191(3):1131-8. doi: 10.1006/bbrc.1993.1334.'},\n",
       "              {'PMID': '8382511',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19930401',\n",
       "               'LR': '20190515',\n",
       "               'IS': '0007-0920 (Print) 1532-1827 (Electronic) 0007-0920 (Linking)',\n",
       "               'VI': '67',\n",
       "               'IP': '3',\n",
       "               'DP': '1993 Mar',\n",
       "               'TI': 'Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion.',\n",
       "               'PG': '537-44',\n",
       "               'AB': 'Single-chain urokinase-type plasminogen activator (pro-uPA) is bound to a specific surface receptor on ovarian cancer HOC-I cells that is incompletely saturated. Saturation of uncovered receptors by uPA polypeptides with intact amino-terminal fragment (ATF) derived from pro-uPA by limited proteolysis (human leucocyte elastase [HLE] or V8 protease) has been studied. HOC-I cells preferentially invaded reconstituted basement membranes in a time- and plasminogen-dependent manner. This process was inhibitable by preincubation with uPA polypeptides in the medium at levels which suggested that complete saturation of cell surface uPA receptors occurred. This result indicates that occupation of uPA receptors by enzymatically inactive uPA fragments or prevention of rebinding of pro-uPA synthesised by tumour cells to the receptors specifically reduces the invasion of the tumour cells through basement membranes in vitro.',\n",
       "               'FAU': ['Kobayashi, H',\n",
       "                'Ohi, H',\n",
       "                'Shinohara, H',\n",
       "                'Sugimura, M',\n",
       "                'Fujii, T',\n",
       "                'Terao, T',\n",
       "                'Schmitt, M',\n",
       "                'Goretzki, L',\n",
       "                'Chucholowski, N',\n",
       "                'Janicke, F'],\n",
       "               'AU': ['Kobayashi H',\n",
       "                'Ohi H',\n",
       "                'Shinohara H',\n",
       "                'Sugimura M',\n",
       "                'Fujii T',\n",
       "                'Terao T',\n",
       "                'Schmitt M',\n",
       "                'Goretzki L',\n",
       "                'Chucholowski N',\n",
       "                'Janicke F',\n",
       "                'et al.'],\n",
       "               'AD': ['Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Shizuoka, Japan.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Br J Cancer',\n",
       "               'JT': 'British journal of cancer',\n",
       "               'JID': '0370635',\n",
       "               'RN': ['0 (PLAUR protein, human)',\n",
       "                '0 (Peptide Fragments)',\n",
       "                '0 (Receptors, Cell Surface)',\n",
       "                '0 (Receptors, Urokinase Plasminogen Activator)',\n",
       "                'EC 3.4.21.36 (Pancreatic Elastase)',\n",
       "                'EC 3.4.21.37 (Leukocyte Elastase)',\n",
       "                'EC 3.4.21.73 (Urokinase-Type Plasminogen Activator)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Cell Movement/drug effects',\n",
       "                'Electrophoresis, Polyacrylamide Gel',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Leukocyte Elastase',\n",
       "                'Molecular Weight',\n",
       "                '*Neoplasm Invasiveness',\n",
       "                'Ovarian Neoplasms/metabolism/*pathology',\n",
       "                'Pancreatic Elastase/pharmacology',\n",
       "                'Peptide Fragments/chemistry/isolation & purification/*metabolism',\n",
       "                'Receptors, Cell Surface/chemistry/drug effects/*metabolism',\n",
       "                'Receptors, Urokinase Plasminogen Activator',\n",
       "                'Tumor Cells, Cultured',\n",
       "                'Urokinase-Type Plasminogen Activator/chemistry/drug effects/*metabolism'],\n",
       "               'PMC': 'PMC1968269',\n",
       "               'EDAT': '1993/03/01 00:00',\n",
       "               'MHDA': '1993/03/01 00:01',\n",
       "               'CRDT': ['1993/03/01 00:00'],\n",
       "               'PHST': ['1993/03/01 00:00 [pubmed]',\n",
       "                '1993/03/01 00:01 [medline]',\n",
       "                '1993/03/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1038/bjc.1993.99 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Br J Cancer. 1993 Mar;67(3):537-44. doi: 10.1038/bjc.1993.99.'},\n",
       "              {'PMID': '8474295',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19930520',\n",
       "               'LR': '20190821',\n",
       "               'IS': '0023-8236 (Print) 0023-8236 (Linking)',\n",
       "               'VI': '378',\n",
       "               'IP': '2',\n",
       "               'DP': '1993',\n",
       "               'TI': '[Surgical therapy of secondary hyperparathyroidism after kidney transplantation].',\n",
       "               'PG': '121-4',\n",
       "               'AB': 'Between April 1986 and January 1992, a total of 22 patients with chronic renal failure were operated on for secondary hyperparathyroidism after kidney transplantation, and 21 of these patients were normocalcemic postoperatively. In 1 patient three reductions of autotransplanted parathyroid tissue were performed and this patient was still hypercalcemic postoperatively, with a serum calcium of 2.65 mmol/l. The renal function was not impaired by parathyroidectomy. In 9 of the 22 patients subtotal parathyroidectomy was indicated within 4 months after renal transplantation because of serum calcium levels over 3.0 mmol/l or severe clinical symptoms. Subtotal parathyroidectomy is indicated in patients with secondary hyperparathyroidism after renal transplantation with a serum calcium over 3.0 mmol/l and severe clinical symptoms and also in patients with slightly elevated serum calcium levels after an observation period of up to 12 months.',\n",
       "               'FAU': ['Dotzenrath, C', 'Goretzki, P E', 'Roher, H D'],\n",
       "               'AU': ['Dotzenrath C', 'Goretzki PE', 'Roher HD'],\n",
       "               'AD': ['Klinik fur Allgemein- und Unfallchirurgie, Heinrich-Heine-Universitat, Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Operative Therapie des sekundaren Hyperparathyreoidismus nach Nierentransplantation.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie',\n",
       "               'JID': '0204167',\n",
       "               'RN': ['0 (Parathyroid Hormone)',\n",
       "                'EC 3.1.3.1 (Alkaline Phosphatase)',\n",
       "                'SY7Q814VUP (Calcium)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Alkaline Phosphatase/blood',\n",
       "                'Calcium/blood',\n",
       "                'Female',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism, Secondary/blood/*surgery',\n",
       "                'Kidney Failure, Chronic/blood/*surgery',\n",
       "                'Kidney Function Tests',\n",
       "                'Kidney Transplantation/*physiology',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Parathyroid Hormone/blood',\n",
       "                '*Parathyroidectomy',\n",
       "                'Postoperative Complications/*surgery',\n",
       "                'Reoperation'],\n",
       "               'EDAT': '1993/01/01 00:00',\n",
       "               'MHDA': '1993/01/01 00:01',\n",
       "               'CRDT': ['1993/01/01 00:00'],\n",
       "               'PHST': ['1993/01/01 00:00 [pubmed]',\n",
       "                '1993/01/01 00:01 [medline]',\n",
       "                '1993/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF00202121 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir. 1993;378(2):121-4. doi: 10.1007/BF00202121.'},\n",
       "              {'PMID': '8094664',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19930325',\n",
       "               'LR': '20151119',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '64',\n",
       "               'IP': '1',\n",
       "               'DP': '1993 Jan',\n",
       "               'TI': '[Experience with presymptomatic screening of patients with C cell carcinoma of the thyroid gland].',\n",
       "               'PG': '28-35',\n",
       "               'AB': 'Presymptomatic screening of medullary thyroid carcinoma in MEN 2A families enables the early diagnosis of this tumor burdened by significant morbidity. Biochemical screening consists of basal and stimulated serum calcitonin evaluation. Genetic screening is based on DNA analysis using linked DNA markers. Thyroidectomy at an occult tumor stage may provide curative treatment. Calcitonin measurement was carried out in 58 apparently unaffected family members at risk of 11 MEN 2A patients. In 9 individuals calcitonin elevation was detected. All 9 underwent thyroidectomy. Histological examination confirmed medullary thyroid carcinoma in 8 patients and in 1 case C-cell-hyperplasia. Postoperatively 8 patients (89%) are clinically and biochemically tumor-free (mean follow-up 30 months). DNA screening results in one affected family are presented. DNA analysis allowed the recognition of one apparently unaffected individual at risk as MEN 2A gene carrier. One family member at risk was scored as not carrying the gene and may be excluded from further screening.',\n",
       "               'FAU': ['Frilling, A',\n",
       "                'Roher, H D',\n",
       "                'Ponder, B A',\n",
       "                'Goretzki, P E',\n",
       "                'Schlaghecke, R',\n",
       "                'Reiners, C'],\n",
       "               'AU': ['Frilling A',\n",
       "                'Roher HD',\n",
       "                'Ponder BA',\n",
       "                'Goretzki PE',\n",
       "                'Schlaghecke R',\n",
       "                'Reiners C'],\n",
       "               'AD': ['Abteilung fur Allgemeine und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Erfahrungen mit prasymptomatischem Screening bei Patienten mit C-Zell-Carcinom der Schilddruse.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'RN': ['0 (Biomarkers, Tumor)',\n",
       "                '0 (Carcinoembryonic Antigen)',\n",
       "                '9007-12-9 (Calcitonin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Biomarkers, Tumor/blood',\n",
       "                'Calcitonin/blood',\n",
       "                'Carcinoembryonic Antigen/blood',\n",
       "                'Carcinoma/diagnosis/*genetics/surgery',\n",
       "                'Female',\n",
       "                '*Genetic Testing',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Multiple Endocrine Neoplasia/diagnosis/*genetics/surgery',\n",
       "                'Pedigree',\n",
       "                'Thyroid Function Tests',\n",
       "                'Thyroid Neoplasms/diagnosis/*genetics/surgery'],\n",
       "               'EDAT': '1993/01/01 00:00',\n",
       "               'MHDA': '1993/01/01 00:01',\n",
       "               'CRDT': ['1993/01/01 00:00'],\n",
       "               'PHST': ['1993/01/01 00:00 [pubmed]',\n",
       "                '1993/01/01 00:01 [medline]',\n",
       "                '1993/01/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 1993 Jan;64(1):28-35.'}],\n",
       "             '1992': [{'PMID': '1294589',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19930412',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0021-7697 (Print) 0021-7697 (Linking)',\n",
       "               'VI': '129',\n",
       "               'IP': '10',\n",
       "               'DP': '1992 Oct',\n",
       "               'TI': '[Surgical treatment of carcinoid tumors of the intestine].',\n",
       "               'PG': '449-55',\n",
       "               'AB': 'Carcinoid tumours arise from the neuroendocrine system and present a characteristic morphological picture. They occur in almost every organ, predilected sites are the appendix and the small intestine. Prognosis depends on the primary localization and tumour size. Carcinoids of the appendix and rectum are mostly small and thus have a good prognosis. Growth of bronchial, stomach and small intestinal carcinoids is aggressive and implicates a high percentage of metastatic disease. First choice therapy is the surgical removal of the tumour. Depending on tumour size surgical treatment includes fulguration, local excision and oncologic radical resection up to extended organ extirpation. Reoperation and repeated surgery have good chances to be successful concerning tumour remission and improvement of the carcinoid syndrome. Additive treatment comprises in particular somatostatin therapy and, in some cases, chemotherapy.',\n",
       "               'FAU': ['Simon, D',\n",
       "                'Goretzki, P E',\n",
       "                'Branscheid, D',\n",
       "                'Roher, J D'],\n",
       "               'AU': ['Simon D', 'Goretzki PE', 'Branscheid D', 'Roher JD'],\n",
       "               'AD': ['Departement de Chirurgie Generale et Traumatologique, Clinique Chirurgicale Universitaire de Dusseldorf.'],\n",
       "               'LA': ['fre'],\n",
       "               'PT': ['English Abstract', 'Journal Article', 'Review'],\n",
       "               'TT': \"Traitement chirurgical des tumeurs carcinoides de l'intestin.\",\n",
       "               'PL': 'France',\n",
       "               'TA': 'J Chir (Paris)',\n",
       "               'JT': 'Journal de chirurgie',\n",
       "               'JID': '0374754',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Appendiceal Neoplasms/diagnosis/pathology/*surgery',\n",
       "                'Bronchial Neoplasms/diagnosis/pathology/surgery',\n",
       "                'Carcinoid Tumor/diagnosis/pathology/*surgery',\n",
       "                'Humans',\n",
       "                'Intestinal Neoplasms/diagnosis/pathology/*surgery',\n",
       "                'Prognosis',\n",
       "                'Rectal Neoplasms/diagnosis/pathology/surgery',\n",
       "                'Stomach Neoplasms/diagnosis/pathology/surgery',\n",
       "                'Thymus Neoplasms/diagnosis/pathology/surgery'],\n",
       "               'RF': '33',\n",
       "               'EDAT': '1992/10/01 00:00',\n",
       "               'MHDA': '1992/10/01 00:01',\n",
       "               'CRDT': ['1992/10/01 00:00'],\n",
       "               'PHST': ['1992/10/01 00:00 [pubmed]',\n",
       "                '1992/10/01 00:01 [medline]',\n",
       "                '1992/10/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Chir (Paris). 1992 Oct;129(10):449-55.'},\n",
       "              {'PMID': '1413827',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19921104',\n",
       "               'LR': '20190824',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '16',\n",
       "               'IP': '4',\n",
       "               'DP': '1992 Jul-Aug',\n",
       "               'TI': 'Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications.',\n",
       "               'PG': '576-81; discussion 581-2',\n",
       "               'AB': 'Activating mutations of ras-genes (Kirsten-ras, Harvey-ras, N-ras) and genes encoding for the alpha subunit of G-proteins (Gs, Gi2, Gi3, Go, Gz) were assessed in 32 differentiated thyroid cancer (DTC) tissues from German (n = 22) and American (n = 10) patients. Gs-protein (GSP) and/or ras mutations were found in 69% of all tissues with a heterogeneous distribution pattern. An increased prevalence could be demonstrated in metastatic (8 of 9 mutation positive) when compared to localized disease (13 of 23 mutation positive) (p less than 0.001) and in patients greater than 50 years of age (16 of 18 mutation positive), when compared to younger patients (6 of 14 mutation positive) (p less than 0.001). No activating mutations were found on H-ras and K-ras genes nor on genes encoding for the alpha subunits of Gi2, Gi3, Go, and Gz. Differentiated thyroid cancer tissue from German patients revealed a higher prevalence for GSP mutations (73%) than did DTC from American patients (20%) (p less than 0.001). We demonstrated a high frequency of ras and GSP mutations in DTC and suggest that these mutations may contribute to our basic understanding of this disease and might initiate a new search for more rational and individualized therapeutic approaches in patients with DTC.',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Lyons, J',\n",
       "                'Stacy-Phipps, S',\n",
       "                'Rosenau, W',\n",
       "                'Demeure, M',\n",
       "                'Clark, O H',\n",
       "                'McCormick, F',\n",
       "                'Roher, H D',\n",
       "                'Bourne, H R'],\n",
       "               'AU': ['Goretzki PE',\n",
       "                'Lyons J',\n",
       "                'Stacy-Phipps S',\n",
       "                'Rosenau W',\n",
       "                'Demeure M',\n",
       "                'Clark OH',\n",
       "                'McCormick F',\n",
       "                'Roher HD',\n",
       "                'Bourne HR'],\n",
       "               'AD': ['Department of Pharmacology, University of California, San Francisco.'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['CA42032/CA/NCI NIH HHS/United States'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                \"Research Support, U.S. Gov't, P.H.S.\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'RN': ['EC 3.6.1.- (GTP-Binding Proteins)'],\n",
       "               'SB': 'IM',\n",
       "               'GS': ['GSP', 'ras'],\n",
       "               'MH': ['Base Sequence',\n",
       "                'GTP-Binding Proteins/*genetics',\n",
       "                'Genes, ras/*genetics',\n",
       "                'Humans',\n",
       "                'Molecular Sequence Data',\n",
       "                '*Mutation',\n",
       "                'Thyroid Neoplasms/*genetics',\n",
       "                'Tumor Cells, Cultured'],\n",
       "               'EDAT': '1992/07/01 00:00',\n",
       "               'MHDA': '1992/07/01 00:01',\n",
       "               'CRDT': ['1992/07/01 00:00'],\n",
       "               'PHST': ['1992/07/01 00:00 [pubmed]',\n",
       "                '1992/07/01 00:01 [medline]',\n",
       "                '1992/07/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF02067325 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 1992 Jul-Aug;16(4):576-81; discussion 581-2. doi: 10.1007/BF02067325.'},\n",
       "              {'PMID': '1384245',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19921104',\n",
       "               'LR': '20190824',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '16',\n",
       "               'IP': '4',\n",
       "               'DP': '1992 Jul-Aug',\n",
       "               'TI': 'Invasion by cultured human follicular thyroid cancer correlates with increased beta 1 integrins and production of proteases.',\n",
       "               'PG': '770-6',\n",
       "               'AB': \"A recognized model of tumor invasion requires cells to adhere to epithelial basement membrane and extracellular matrix components triggering release of proteases thus allowing cancer cells to invade the substrate. This adhesion is mediated by beta 1 integrins, a family of receptors to substrates such as collagen, laminin, and fibronectin. In order to study tumor invasion in follicular thyroid cancer (FTC), we used cell lines derived from a single patient's FTC primary tumor (FTC-133), neck lymph node metastases (FTC-236), and lung metastases (FTC-238). In vitro invasion as determined by the ability of the tumor cells to penetrate Matrigel was assessed by scanning electron microscopy. FTC-133 did not invade, FTC-236 was moderately invasive, and FTC-238 was highly invasive. Immunoprecipation with a monoclonal antibody to beta 1 integrin subunits and SDS-PAGE showed increased synthesis and flow cytometry showed increased expression of this subunit in FTC-236 and FTC-238 compared to FTC-133. Proteolytic activity was assessed by gelatin zymography. FTC-238 cell extract and conditioned media exhibited a more complex array of proteases consistent with activated type I collagenase and stromelysin compared to the less invasive clones, however 72 and 92 kd gelatinases consistent with type IV collagenases were present in the conditioned media from all three lines. In conclusion, in vitro invasion parallels in vivo metastasis by the source cells in the FTC-133/236/238 cell-lines. The ability to invade basement membrane preparation correlates with increased synthesis and expression of beta 1 integrins and activation of tumor proteases.\",\n",
       "               'FAU': ['Demeure, M J',\n",
       "                'Damsky, C H',\n",
       "                'Elfman, F',\n",
       "                'Goretzki, P E',\n",
       "                'Wong, M G',\n",
       "                'Clark, O H'],\n",
       "               'AU': ['Demeure MJ',\n",
       "                'Damsky CH',\n",
       "                'Elfman F',\n",
       "                'Goretzki PE',\n",
       "                'Wong MG',\n",
       "                'Clark OH'],\n",
       "               'AD': ['Department of Surgery, University of California, San Francisco.'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['CA42032/CA/NCI NIH HHS/United States'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                \"Research Support, U.S. Gov't, Non-P.H.S.\",\n",
       "                \"Research Support, U.S. Gov't, P.H.S.\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'RN': ['0 (Integrin beta1)',\n",
       "                '0 (Integrins)',\n",
       "                'EC 3.4.- (Endopeptidases)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma/metabolism/*pathology',\n",
       "                'Endopeptidases/*biosynthesis',\n",
       "                'Humans',\n",
       "                'Integrin beta1',\n",
       "                'Integrins/*biosynthesis',\n",
       "                'Microscopy, Electron, Scanning',\n",
       "                'Neoplasm Invasiveness/*pathology',\n",
       "                'Neoplasm Metastasis/*pathology',\n",
       "                'Thyroid Neoplasms/metabolism/*pathology',\n",
       "                'Tumor Cells, Cultured'],\n",
       "               'EDAT': '1992/07/01 00:00',\n",
       "               'MHDA': '1992/07/01 00:01',\n",
       "               'CRDT': ['1992/07/01 00:00'],\n",
       "               'PHST': ['1992/07/01 00:00 [pubmed]',\n",
       "                '1992/07/01 00:01 [medline]',\n",
       "                '1992/07/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF02067383 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 1992 Jul-Aug;16(4):770-6. doi: 10.1007/BF02067383.'},\n",
       "              {'PMID': '1551416',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19920430',\n",
       "               'LR': '20240109',\n",
       "               'IS': '0014-5793 (Print) 0014-5793 (Linking)',\n",
       "               'VI': '297',\n",
       "               'IP': '1-2',\n",
       "               'DP': '1992 Feb 3',\n",
       "               'TI': 'Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L.',\n",
       "               'PG': '112-8',\n",
       "               'AB': 'Increased levels of both the cysteine protease, cathepsin L, and the serine protease, uPA (urokinase-type plasminogen activator), are present in solid tumors and are correlated with malignancy. uPA is released by tumor cells as an inactive single-chain proenzyme (pro-uPA) which has to be activated by proteolytic cleavage. We analyzed in detail the action of the cysteine protease, cathepsin L, on recombinant human pro-uPA. Enzymatic assays, SDS-PAGE and Western blot analysis revealed that cathepsin L is a potent activator of pro-uPA. As determined by N-terminal amino acid sequence analysis, activation of pro-uPA by cathepsin L is achieved by cleavage of the Lys158-Ile159 peptide bond, a common activation site of serine proteases such as plasmin and kallikrein. Similar to cathepsin B (Kobayashi et al., J. Biol. Chem. (1991) 266, 5147-5152) cleavage of pro-uPA by cathepsin L was most effective at acidic pH (molar ratio of cathepsin L to pro-uPA of 1:2,000). Nevertheless, even at pH 7.0, pro-uPA was activated by cathepsin L, although a 10-fold higher concentration of cathepsin L was required. As tumor cells may produce both pro-uPA and cathepsin L, implications for the activation of tumor cell-derived pro-uPA by cathepsin L may be considered. Different pathways of activation of pro-uPA in tumor tissues may coexist: (i) autocatalytic intrinsic activation of pro-uPA; (ii) activation by serine proteases (plasmin, kallikrein, Factor XIIa); and (iii) activation by cysteine proteases (cathepsin B and L).',\n",
       "               'FAU': ['Goretzki, L',\n",
       "                'Schmitt, M',\n",
       "                'Mann, K',\n",
       "                'Calvete, J',\n",
       "                'Chucholowski, N',\n",
       "                'Kramer, M',\n",
       "                'Gunzler, W A',\n",
       "                'Janicke, F',\n",
       "                'Graeff, H'],\n",
       "               'AU': ['Goretzki L',\n",
       "                'Schmitt M',\n",
       "                'Mann K',\n",
       "                'Calvete J',\n",
       "                'Chucholowski N',\n",
       "                'Kramer M',\n",
       "                'Gunzler WA',\n",
       "                'Janicke F',\n",
       "                'Graeff H'],\n",
       "               'AD': ['Frauenklinik der Technischen Universitat Munchen, Klinikum rechts der Isar, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'England',\n",
       "               'TA': 'FEBS Lett',\n",
       "               'JT': 'FEBS letters',\n",
       "               'JID': '0155157',\n",
       "               'RN': ['0 (Enzyme Precursors)',\n",
       "                '0 (Recombinant Proteins)',\n",
       "                'EC 3.4.- (Cathepsins)',\n",
       "                'EC 3.4.- (Endopeptidases)',\n",
       "                'EC 3.4.21.73 (Urokinase-Type Plasminogen Activator)',\n",
       "                'EC 3.4.22.- (Cysteine Endopeptidases)',\n",
       "                'EC 3.4.22.15 (CTSL protein, human)',\n",
       "                'EC 3.4.22.15 (Cathepsin L)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Amino Acid Sequence',\n",
       "                'Blotting, Western',\n",
       "                'Cathepsin L',\n",
       "                'Cathepsins/*metabolism',\n",
       "                'Chromatography, High Pressure Liquid',\n",
       "                'Cysteine Endopeptidases',\n",
       "                'Electrophoresis, Polyacrylamide Gel',\n",
       "                '*Endopeptidases',\n",
       "                'Enzyme Activation',\n",
       "                'Enzyme Precursors/*metabolism',\n",
       "                'Humans',\n",
       "                'Hydrolysis',\n",
       "                'Molecular Sequence Data',\n",
       "                'Recombinant Proteins/metabolism',\n",
       "                'Urokinase-Type Plasminogen Activator/*metabolism'],\n",
       "               'EDAT': '1992/02/03 00:00',\n",
       "               'MHDA': '1992/02/03 00:01',\n",
       "               'CRDT': ['1992/02/03 00:00'],\n",
       "               'PHST': ['1992/02/03 00:00 [pubmed]',\n",
       "                '1992/02/03 00:01 [medline]',\n",
       "                '1992/02/03 00:00 [entrez]'],\n",
       "               'AID': ['0014-5793(92)80339-I [pii]',\n",
       "                '10.1016/0014-5793(92)80339-i [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'FEBS Lett. 1992 Feb 3;297(1-2):112-8. doi: 10.1016/0014-5793(92)80339-i.'},\n",
       "              {'PMID': '1321752',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19920824',\n",
       "               'LR': '20190706',\n",
       "               'IS': '0300-5127 (Print) 0300-5127 (Linking)',\n",
       "               'VI': '20',\n",
       "               'IP': '1',\n",
       "               'DP': '1992 Feb',\n",
       "               'TI': 'Flow cytofluorometry in tumour cell receptor analysis. Survey of the literature and recent developments concerning the urokinase-type plasminogen activator (uPA).',\n",
       "               'PG': '208-16',\n",
       "               'FAU': ['Chucholowski, N',\n",
       "                'Schmitt, M',\n",
       "                'Goretzki, L',\n",
       "                'Schuren, E',\n",
       "                'Moniwa, N',\n",
       "                'Weidle, U',\n",
       "                'Kramer, M',\n",
       "                'Wagner, B',\n",
       "                'Janicke, F',\n",
       "                'Graeff, H'],\n",
       "               'AU': ['Chucholowski N',\n",
       "                'Schmitt M',\n",
       "                'Goretzki L',\n",
       "                'Schuren E',\n",
       "                'Moniwa N',\n",
       "                'Weidle U',\n",
       "                'Kramer M',\n",
       "                'Wagner B',\n",
       "                'Janicke F',\n",
       "                'Graeff H'],\n",
       "               'AD': ['Frauenklinik, Technischen Universitat Munchen, Klinikum rechts der Isar, FRG.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Biochem Soc Trans',\n",
       "               'JT': 'Biochemical Society transactions',\n",
       "               'JID': '7506897',\n",
       "               'RN': ['0 (PLAUR protein, human)',\n",
       "                '0 (Receptors, Cell Surface)',\n",
       "                '0 (Receptors, Urokinase Plasminogen Activator)',\n",
       "                '0 (Recombinant Proteins)',\n",
       "                'EC 3.4.- (Endopeptidases)',\n",
       "                'EC 3.4.21.73 (Urokinase-Type Plasminogen Activator)',\n",
       "                'I223NX31W9 (Fluorescein-5-isothiocyanate)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Animals',\n",
       "                'Endopeptidases/*metabolism',\n",
       "                'Flow Cytometry/methods',\n",
       "                'Fluorescein-5-isothiocyanate',\n",
       "                'Humans',\n",
       "                'Models, Biological',\n",
       "                'Neoplasms/*enzymology/pathology',\n",
       "                'Receptors, Cell Surface/*analysis/metabolism',\n",
       "                'Receptors, Urokinase Plasminogen Activator',\n",
       "                'Recombinant Proteins/metabolism',\n",
       "                'Urokinase-Type Plasminogen Activator/analysis/*metabolism'],\n",
       "               'RF': '72',\n",
       "               'EDAT': '1992/02/01 00:00',\n",
       "               'MHDA': '1992/02/01 00:01',\n",
       "               'CRDT': ['1992/02/01 00:00'],\n",
       "               'PHST': ['1992/02/01 00:00 [pubmed]',\n",
       "                '1992/02/01 00:01 [medline]',\n",
       "                '1992/02/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1042/bst0200208 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Biochem Soc Trans. 1992 Feb;20(1):208-16. doi: 10.1042/bst0200208.'},\n",
       "              {'PMID': '1468509',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19930122',\n",
       "               'LR': '20051116',\n",
       "               'IS': '0232-7384 (Print) 0232-7384 (Linking)',\n",
       "               'VI': '100',\n",
       "               'IP': '1-2',\n",
       "               'DP': '1992',\n",
       "               'TI': 'G-protein mutations in thyroid tumors.',\n",
       "               'PG': '14-6',\n",
       "               'AB': 'Tissue specific G-protein mutations have been found in differentiated thyroid cancer with a higher prevalence in tumors from German than from American patients. Since activating mutations of Gs are principally comparable to chronic TSH stimulation of these tumor-thyrocytes such mutations may predict changes in tumor development and patient prognosis. The fundamental background and recent results of studies on mutational activation of G-proteins are presented.',\n",
       "               'FAU': ['Goretzki, P E', 'Simon, D', 'Roher, H D'],\n",
       "               'AU': ['Goretzki PE', 'Simon D', 'Roher HD'],\n",
       "               'AD': ['Department of Surgery, Heinrich-Heine-University Dusseldorf/Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Exp Clin Endocrinol',\n",
       "               'JT': 'Experimental and clinical endocrinology',\n",
       "               'JID': '8302802',\n",
       "               'RN': ['EC 3.6.1.- (GTP-Binding Proteins)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['GTP-Binding Proteins/*genetics/physiology',\n",
       "                'Humans',\n",
       "                '*Mutation',\n",
       "                'Thyroid Neoplasms/*genetics'],\n",
       "               'RF': '11',\n",
       "               'EDAT': '1992/01/01 00:00',\n",
       "               'MHDA': '1992/01/01 00:01',\n",
       "               'CRDT': ['1992/01/01 00:00'],\n",
       "               'PHST': ['1992/01/01 00:00 [pubmed]',\n",
       "                '1992/01/01 00:01 [medline]',\n",
       "                '1992/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-0029-1211167 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Exp Clin Endocrinol. 1992;100(1-2):14-6. doi: 10.1055/s-0029-1211167.'}],\n",
       "             '1991': [{'PMID': '1685044',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19920220',\n",
       "               'LR': '20220408',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '15',\n",
       "               'IP': '6',\n",
       "               'DP': '1991 Nov-Dec',\n",
       "               'TI': 'Management of primary hyperparathyroidism caused by multiple gland disease.',\n",
       "               'PG': '693-7',\n",
       "               'AB': 'Multiple gland parathyroid disease is the pathological finding in primary hyperparathyroidism (HPT) in about 10% to 20% of all patients and in approximately a third of all patients with persistent or recurrent disease. The variability of multiple gland disease spans from 2 adenomas to diffuse hyperplasia in patients with multiple endocrine neoplasia type 1. This variability calls into question the proposed common pathophysiologic background in all of these cases. As primary treatment of multiple gland primary HPT, subtotal parathyroidectomy and thymectomy or total parathyroidectomy and heterotopic autotransplantation including thymectomy can be equally advocated. Recurrent hyperparathyroidism frequently occurs in cases of diffuse parathyroid hyperplasia. This must be considered especially in patient follow up and before each surgical procedure. Thus, a defined but adaptable therapeutic regimen might prevent permanent hypoparathyroidism and persistent hyperparathyroidism.',\n",
       "               'FAU': ['Goretzki, P E', 'Dotzenrath, C', 'Roeher, H D'],\n",
       "               'AU': ['Goretzki PE', 'Dotzenrath C', 'Roeher HD'],\n",
       "               'AD': ['Department of Surgery, Heinrich-Heine-Universitat, Dusseldorf, Federal Republic of Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Hyperparathyroidism/diagnosis/*etiology/therapy',\n",
       "                'Multiple Endocrine Neoplasia/*complications',\n",
       "                'Parathyroidectomy',\n",
       "                'Recurrence'],\n",
       "               'EDAT': '1991/11/01 00:00',\n",
       "               'MHDA': '1991/11/01 00:01',\n",
       "               'CRDT': ['1991/11/01 00:00'],\n",
       "               'PHST': ['1991/11/01 00:00 [pubmed]',\n",
       "                '1991/11/01 00:01 [medline]',\n",
       "                '1991/11/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF01665302 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 1991 Nov-Dec;15(6):693-7. doi: 10.1007/BF01665302.'},\n",
       "              {'PMID': '1923534',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19911101',\n",
       "               'LR': '20051117',\n",
       "               'IS': '0950-9232 (Print) 0950-9232 (Linking)',\n",
       "               'VI': '6',\n",
       "               'IP': '9',\n",
       "               'DP': '1991 Sep',\n",
       "               'TI': 'Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours.',\n",
       "               'PG': '1693-7',\n",
       "               'AB': 'The p53 gene has been implicated as a tumour suppressor, with mutations occurring in many carcinomas, such as colon, breast and lung. We have sequenced exons 5, 7 and 8 containing conserved gene regions in the only available differentiated thyroid follicular carcinoma cell line and found a mutation at position 273, Arg----His, with no normal allele present. The same mutation was also present in DNA from the tumour of origin. However immunohistochemical analysis of 129 human thyroid tumours using a panel of p53 antibodies was unequivocally negative. Southern blotting in 20 cases failed to demonstrate any deletion or rearrangement, and direct genomic sequencing of 20 carcinomas showed normal DNA sequence for exons 5, 7 and 8. Thus p53 abnormalities may not be important in human thyroid carcinogenesis, in contrast to colon, breast and lung. However, the FTC 133 cell line was only established after 132 unsuccessful attempts with other differentiated thyroid follicular tumours. Since this line and the corresponding tumour of origin have a p53 mutation, we propose that p53 mutation may confer on thyroid follicular tumour cells the ability to grow in culture. This has potential applications for the future development of thyroid carcinoma cell lines.',\n",
       "               'FAU': ['Wright, P A',\n",
       "                'Lemoine, N R',\n",
       "                'Goretzki, P E',\n",
       "                'Wyllie, F S',\n",
       "                'Bond, J',\n",
       "                'Hughes, C',\n",
       "                'Roher, H D',\n",
       "                'Williams, E D',\n",
       "                'Wynford-Thomas, D'],\n",
       "               'AU': ['Wright PA',\n",
       "                'Lemoine NR',\n",
       "                'Goretzki PE',\n",
       "                'Wyllie FS',\n",
       "                'Bond J',\n",
       "                'Hughes C',\n",
       "                'Roher HD',\n",
       "                'Williams ED',\n",
       "                'Wynford-Thomas D'],\n",
       "               'AD': ['CRC Thyroid Tumour Biology Research Group, Department of Pathology, University of Wales College of Medicine, Cardiff, UK.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Oncogene',\n",
       "               'JT': 'Oncogene',\n",
       "               'JID': '8711562',\n",
       "               'RN': ['0 (Antibodies, Monoclonal)',\n",
       "                '0 (DNA, Neoplasm)',\n",
       "                '0 (Oligodeoxyribonucleotides)',\n",
       "                '0 (Tumor Suppressor Protein p53)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Antibodies, Monoclonal',\n",
       "                'Base Sequence',\n",
       "                'Blotting, Southern',\n",
       "                'Carcinoma/*genetics/pathology',\n",
       "                'Carcinoma, Papillary/*genetics/pathology',\n",
       "                'Cell Differentiation',\n",
       "                'Cell Line',\n",
       "                'DNA, Neoplasm/genetics',\n",
       "                '*Exons',\n",
       "                '*Genes, p53',\n",
       "                'Homozygote',\n",
       "                'Humans',\n",
       "                'Immunohistochemistry',\n",
       "                'Molecular Sequence Data',\n",
       "                '*Mutation',\n",
       "                'Oligodeoxyribonucleotides',\n",
       "                'Polymerase Chain Reaction/methods',\n",
       "                'Thyroid Neoplasms/*genetics/pathology',\n",
       "                'Tumor Suppressor Protein p53/analysis'],\n",
       "               'EDAT': '1991/09/01 00:00',\n",
       "               'MHDA': '1991/09/01 00:01',\n",
       "               'CRDT': ['1991/09/01 00:00'],\n",
       "               'PHST': ['1991/09/01 00:00 [pubmed]',\n",
       "                '1991/09/01 00:01 [medline]',\n",
       "                '1991/09/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Oncogene. 1991 Sep;6(9):1693-7.'},\n",
       "              {'PMID': '1724574',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19920408',\n",
       "               'LR': '20131121',\n",
       "               'IS': '0094-6176 (Print) 0094-6176 (Linking)',\n",
       "               'VI': '17',\n",
       "               'IP': '3',\n",
       "               'DP': '1991 Jul',\n",
       "               'TI': 'Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cells.',\n",
       "               'PG': '291-302',\n",
       "               'AB': 'Flow cytofluorometric protocols (FACScan) are described for the rapid and quantitative real-time analysis of binding of FITC-pro-u-PA to cell surface receptors (u-PAR) on living, resting, and also on PMA-stimulated human monocytic U937 cells. Binding of pro-u-PA was visualized by CLSM. This fairly new technique is superior over conventional fluorescence microscopy and is an alternative to electron microscopic approaches. Both flow cytofluorometry and confocal laser scanning microscopy allow the analysis quantitatively and with high-sensitivity binding of FITC-pro-u-PA to single suspended or adherent cells. By CLSM u-PA/u-PAR were found to be located in heterogeneously distributed discrete patches at the cell surface on U937 and not inside the cell. This is in agreement with previous studies by Hansen et al, who applied radioiodinated u-PA and electron microscopy to locate u-PAR on microvilli of fixed U937 cells. By flow cytofluorometry, it was possible to quantify the time-dependent and temperature-dependent binding of FITC-pro-u-PA to living single U937. Apparent saturation of u-PAR was achieved at 5 nM FITC-pro-u-PA for both nonstimulated and PMA-stimulated U937 cells. Half saturation of u-PAR was also determined. Nonstimulated U937 was 0.7 nM, and PMA-stimulated U937 was 1.1 nM of FITC-pro-u-PA. This increase in half-saturation concentration in PMA-stimulated cells is paralleled by a steep increase in binding sites (3.6-fold). The use of fluoresceinated reference beads is recommended to verify changes in affinity and binding sites. Using CLSM or flow cytofluorometry, it is also possible to study the structure relationship of u-PA/u-PAR in the presence of competitive binding analogues or inhibitors. Fluorescence techniques will also permit the identification of u-PAR-positive cells in blood, ascitic fluid, or biopsies obtained from cancer patients.',\n",
       "               'FAU': ['Schmitt, M',\n",
       "                'Chucholowski, N',\n",
       "                'Busch, E',\n",
       "                'Hellmann, D',\n",
       "                'Wagner, B',\n",
       "                'Goretzki, L',\n",
       "                'Janicke, F',\n",
       "                'Gunzler, W A',\n",
       "                'Graeff, H'],\n",
       "               'AU': ['Schmitt M',\n",
       "                'Chucholowski N',\n",
       "                'Busch E',\n",
       "                'Hellmann D',\n",
       "                'Wagner B',\n",
       "                'Goretzki L',\n",
       "                'Janicke F',\n",
       "                'Gunzler WA',\n",
       "                'Graeff H'],\n",
       "               'AD': ['Frauenklinik der Technischen Universitat Munchen, Klinikum rechts der Isar, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Semin Thromb Hemost',\n",
       "               'JT': 'Seminars in thrombosis and hemostasis',\n",
       "               'JID': '0431155',\n",
       "               'RN': ['0 (Antibodies, Monoclonal)',\n",
       "                '0 (Enzyme Precursors)',\n",
       "                '0 (Epitopes)',\n",
       "                '0 (Fluorescent Dyes)',\n",
       "                '0 (PLAUR protein, human)',\n",
       "                '0 (Peptide Fragments)',\n",
       "                '0 (Receptors, Cell Surface)',\n",
       "                '0 (Receptors, Urokinase Plasminogen Activator)',\n",
       "                '0 (urokinase-type plasminogen activator (17-34))',\n",
       "                'EC 3.4.- (Endopeptidases)',\n",
       "                'EC 3.4.21.73 (Urokinase-Type Plasminogen Activator)',\n",
       "                'EC 3.4.24.- (Metalloendopeptidases)',\n",
       "                'EC 3.4.24.33 (endoproteinase Asp-N)',\n",
       "                'I223NX31W9 (Fluorescein-5-isothiocyanate)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Amino Acid Sequence',\n",
       "                'Antibodies, Monoclonal',\n",
       "                'Endopeptidases',\n",
       "                'Enzyme Precursors/chemical synthesis',\n",
       "                'Epitopes/immunology',\n",
       "                'Flow Cytometry',\n",
       "                '*Fluorescein-5-isothiocyanate',\n",
       "                '*Fluorescent Dyes',\n",
       "                'Hydrogen-Ion Concentration',\n",
       "                'Lasers',\n",
       "                'Metalloendopeptidases',\n",
       "                'Microscopy/methods',\n",
       "                'Molecular Sequence Data',\n",
       "                'Peptide Fragments/chemical synthesis',\n",
       "                'Receptors, Cell Surface/*metabolism',\n",
       "                'Receptors, Urokinase Plasminogen Activator',\n",
       "                'Structure-Activity Relationship',\n",
       "                'Tumor Cells, Cultured',\n",
       "                'Urokinase-Type Plasminogen Activator/chemical synthesis/*metabolism'],\n",
       "               'EDAT': '1991/07/01 00:00',\n",
       "               'MHDA': '1991/07/01 00:01',\n",
       "               'CRDT': ['1991/07/01 00:00'],\n",
       "               'PHST': ['1991/07/01 00:00 [pubmed]',\n",
       "                '1991/07/01 00:01 [medline]',\n",
       "                '1991/07/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-2007-1002623 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Semin Thromb Hemost. 1991 Jul;17(3):291-302. doi: 10.1055/s-2007-1002623.'},\n",
       "              {'PMID': '1915647',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19911112',\n",
       "               'LR': '20051117',\n",
       "               'IS': '0232-7384 (Print) 0232-7384 (Linking)',\n",
       "               'VI': '97',\n",
       "               'IP': '2-3',\n",
       "               'DP': '1991 May',\n",
       "               'TI': 'Surgery for immunogenic hyperthyroidism.',\n",
       "               'PG': '292-6',\n",
       "               'FAU': ['Roher, H D',\n",
       "                'Horster, F A',\n",
       "                'Frilling, A',\n",
       "                'Goretzki, P E',\n",
       "                'Witte, J'],\n",
       "               'AU': ['Roher HD',\n",
       "                'Horster FA',\n",
       "                'Frilling A',\n",
       "                'Goretzki PE',\n",
       "                'Witte J'],\n",
       "               'AD': ['Department of Surgery, Heinrich-Heine-University, Dusseldorf, Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Exp Clin Endocrinol',\n",
       "               'JT': 'Experimental and clinical endocrinology',\n",
       "               'JID': '8302802',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Graves Disease/*surgery',\n",
       "                'Humans',\n",
       "                'Hyperthyroidism/surgery',\n",
       "                'Preoperative Care',\n",
       "                'Risk Factors',\n",
       "                'Thyroidectomy/adverse effects'],\n",
       "               'EDAT': '1991/05/01 00:00',\n",
       "               'MHDA': '1991/05/01 00:01',\n",
       "               'CRDT': ['1991/05/01 00:00'],\n",
       "               'PHST': ['1991/05/01 00:00 [pubmed]',\n",
       "                '1991/05/01 00:01 [medline]',\n",
       "                '1991/05/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-0029-1211080 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Exp Clin Endocrinol. 1991 May;97(2-3):292-6. doi: 10.1055/s-0029-1211080.'},\n",
       "              {'PMID': '1820969',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19920811',\n",
       "               'LR': '20190813',\n",
       "               'IS': '0303-7207 (Print) 0303-7207 (Linking)',\n",
       "               'VI': '76',\n",
       "               'IP': '1-3',\n",
       "               'DP': '1991 Apr',\n",
       "               'TI': 'Correlated abnormalities of transforming growth factor-beta 1 response and p53 expression in thyroid epithelial cell transformation.',\n",
       "               'PG': '13-21',\n",
       "               'AB': \"Using the thyroid follicular cell as a model for multi-stage carcinogenesis, we have investigated the role of two potential negative growth regulators ('anti-oncogenes') in epithelial tumour progression--transforming growth factor-beta 1 (TGF beta 1) and p53. Normal follicular cells, as expected, showed marked growth inhibition in response to TGF beta 1. Adenoma cells were equally inhibited. In contrast, spontaneously and SV40-immortalised follicular cell lines showing features of malignant transformation (notably loss of growth factor dependence) had lost all responsiveness to TGF beta 1, accompanied by a partial loss of its receptors. p53 protein was below detectable limits in normal and in adenoma cells but in contrast very high levels were observed in all three transformed lines. In the SV40-immortalised cells, this was expected in view of the known stabilising effect of the viral large T protein. In the spontaneous line we found strong evidence for point mutation of p53, which is known to have the same effect. Both mechanisms result in loss of p53 tumour suppressor function despite increased protein content. We conclude that loss of inhibition by TGF beta and inactivation of p53 are important steps in in vitro immortalisation and/or in vivo tumour progression in human thyroid follicular cells, and speculate that p53 may mediate or be required for the inhibitory signal normally induced by TGF beta 1.\",\n",
       "               'FAU': ['Wyllie, F S',\n",
       "                'Dawson, T',\n",
       "                'Bond, J A',\n",
       "                'Goretzki, P',\n",
       "                'Game, S',\n",
       "                'Prime, S',\n",
       "                'Wynford-Thomas, D'],\n",
       "               'AU': ['Wyllie FS',\n",
       "                'Dawson T',\n",
       "                'Bond JA',\n",
       "                'Goretzki P',\n",
       "                'Game S',\n",
       "                'Prime S',\n",
       "                'Wynford-Thomas D'],\n",
       "               'AD': ['Department of Pathology, University of Wales College of Medicine, Heath Park, Cardiff, U.K.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Ireland',\n",
       "               'TA': 'Mol Cell Endocrinol',\n",
       "               'JT': 'Molecular and cellular endocrinology',\n",
       "               'JID': '7500844',\n",
       "               'RN': ['0 (Culture Media)',\n",
       "                '0 (Transforming Growth Factor beta)',\n",
       "                '0 (Tumor Suppressor Protein p53)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/*metabolism',\n",
       "                'Cell Division',\n",
       "                '*Cell Transformation, Neoplastic',\n",
       "                'Cells, Cultured',\n",
       "                'Culture Media',\n",
       "                'Epithelium/metabolism',\n",
       "                'Humans',\n",
       "                'Immunohistochemistry',\n",
       "                'Precipitin Tests',\n",
       "                'Thyroid Gland/metabolism',\n",
       "                'Thyroid Neoplasms/*metabolism',\n",
       "                'Transforming Growth Factor beta/metabolism/*physiology',\n",
       "                'Tumor Cells, Cultured',\n",
       "                'Tumor Suppressor Protein p53/metabolism/*physiology'],\n",
       "               'EDAT': '1991/04/01 00:00',\n",
       "               'MHDA': '1991/04/01 00:01',\n",
       "               'CRDT': ['1991/04/01 00:00'],\n",
       "               'PHST': ['1991/04/01 00:00 [pubmed]',\n",
       "                '1991/04/01 00:01 [medline]',\n",
       "                '1991/04/01 00:00 [entrez]'],\n",
       "               'AID': ['0303-7207(91)90255-Q [pii]',\n",
       "                '10.1016/0303-7207(91)90255-q [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Mol Cell Endocrinol. 1991 Apr;76(1-3):13-21. doi: 10.1016/0303-7207(91)90255-q.'},\n",
       "              {'PMID': '1900515',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19910417',\n",
       "               'LR': '20210210',\n",
       "               'IS': '0021-9258 (Print) 0021-9258 (Linking)',\n",
       "               'VI': '266',\n",
       "               'IP': '8',\n",
       "               'DP': '1991 Mar 15',\n",
       "               'TI': 'Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).',\n",
       "               'PG': '5147-52',\n",
       "               'AB': 'Action of purified human cathepsin B on recombinant single-chain urokinase-type plasminogen activator (pro-uPA) generated enzymatically active two-chain uPA (HMW-uPA), which was indistinguishable by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot from plasmin-generated HMW-uPA and from elastase- or thrombin-generated inactive two-chain urokinase-type plasminogen activator. Preincubation of cathepsin B with E-64 (transepoxysuccinyl-L-leucylamino- (4-guanidino)butane, a potent inhibitor for cathepsin B) prior to the addition of pro-uPA prevented the activation of pro-uPA. The cleavage site within the cathepsin B-treated urokinase-type plasminogen activator (uPA) molecule, determined by N-terminal amino acid sequence analysis, is located between Lys158 and Ile159. Pro-uPA is cleaved by cathepsin B at the same peptide bond that is cleaved by plasmin or kallikrein. Binding of cathepsin B-activated pro-uPA to the uPA receptor on U937 cells did not differ from that of enzymatically inactive pro-uPA, indicating an intact receptor-binding region within the growth factor-like domain of the cathepsin B-treated uPA molecule. Not only soluble but also tumor cell receptor-bound pro-uPA could be efficiently cleaved by cathepsin B to generate enzymatically active two-chain uPA. Thus, cathepsin B can substitute for plasmin in the proteolytic activation of pro-uPA to enzymatically active HMW-uPA. In contrast, no significant activation of pro-uPA by cathepsin D was observed. As tumor cells may produce both pro-uPA and cathepsin B, implications for the activation of tumor cell-derived pro-uPA by cellular proteases may be considered.',\n",
       "               'FAU': ['Kobayashi, H',\n",
       "                'Schmitt, M',\n",
       "                'Goretzki, L',\n",
       "                'Chucholowski, N',\n",
       "                'Calvete, J',\n",
       "                'Kramer, M',\n",
       "                'Gunzler, W A',\n",
       "                'Janicke, F',\n",
       "                'Graeff, H'],\n",
       "               'AU': ['Kobayashi H',\n",
       "                'Schmitt M',\n",
       "                'Goretzki L',\n",
       "                'Chucholowski N',\n",
       "                'Calvete J',\n",
       "                'Kramer M',\n",
       "                'Gunzler WA',\n",
       "                'Janicke F',\n",
       "                'Graeff H'],\n",
       "               'AD': ['Frauenklinik der Technischen Universitat Munchen im Klinikum rechts der Isar, Federal Republic of Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Biol Chem',\n",
       "               'JT': 'The Journal of biological chemistry',\n",
       "               'JID': '2985121R',\n",
       "               'RN': ['0 (Enzyme Precursors)',\n",
       "                'EC 3.4.21.- (Plasminogen Activators)',\n",
       "                'EC 3.4.21.73 (Urokinase-Type Plasminogen Activator)',\n",
       "                'EC 3.4.22.1 (Cathepsin B)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Blotting, Western',\n",
       "                'Cathepsin B/*metabolism',\n",
       "                'Chromatography, High Pressure Liquid',\n",
       "                'Electrophoresis, Polyacrylamide Gel',\n",
       "                'Enzyme Activation',\n",
       "                'Enzyme Precursors/*metabolism',\n",
       "                'Flow Cytometry',\n",
       "                'Humans',\n",
       "                'Hydrolysis',\n",
       "                'Plasminogen Activators/*metabolism',\n",
       "                'Tumor Cells, Cultured/metabolism',\n",
       "                'Urokinase-Type Plasminogen Activator/*metabolism'],\n",
       "               'EDAT': '1991/03/15 00:00',\n",
       "               'MHDA': '1991/03/15 00:01',\n",
       "               'CRDT': ['1991/03/15 00:00'],\n",
       "               'PHST': ['1991/03/15 00:00 [pubmed]',\n",
       "                '1991/03/15 00:01 [medline]',\n",
       "                '1991/03/15 00:00 [entrez]'],\n",
       "               'AID': ['S0021-9258(19)67767-7 [pii]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Biol Chem. 1991 Mar 15;266(8):5147-52.'},\n",
       "              {'PMID': '1709844',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19910628',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '62',\n",
       "               'IP': '3',\n",
       "               'DP': '1991 Mar',\n",
       "               'TI': '[Morphology and function-based surgery in different forms of hyperthyroidism].',\n",
       "               'PG': '176-81',\n",
       "               'FAU': ['Roher, H D',\n",
       "                'Horster, F A',\n",
       "                'Frilling, A',\n",
       "                'Goretzki, P E'],\n",
       "               'AU': ['Roher HD', 'Horster FA', 'Frilling A', 'Goretzki PE'],\n",
       "               'AD': ['Abteilung fur Allgemeine und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Comparative Study', 'Journal Article'],\n",
       "               'TT': 'Morphologie und funktionsgerechte Chirurgie verschiedener Hyperthyreoseformen.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'RN': ['0 (Antithyroid Agents)', '0 (Iodine Radioisotopes)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/physiopathology/surgery',\n",
       "                'Antithyroid Agents/therapeutic use',\n",
       "                'Graves Disease/pathology/physiopathology/surgery',\n",
       "                'Humans',\n",
       "                'Hyperthyroidism/pathology/physiopathology/*surgery',\n",
       "                'Iodine Radioisotopes/therapeutic use',\n",
       "                'Thyroid Gland/pathology/physiopathology',\n",
       "                'Thyroid Neoplasms/physiopathology/surgery',\n",
       "                'Thyroiditis, Autoimmune/physiopathology/surgery'],\n",
       "               'EDAT': '1991/03/01 00:00',\n",
       "               'MHDA': '1991/03/01 00:01',\n",
       "               'CRDT': ['1991/03/01 00:00'],\n",
       "               'PHST': ['1991/03/01 00:00 [pubmed]',\n",
       "                '1991/03/01 00:01 [medline]',\n",
       "                '1991/03/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 1991 Mar;62(3):176-81.'},\n",
       "              {'PMID': '1801751',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19920423',\n",
       "               'LR': '20161123',\n",
       "               'IS': '0232-766X (Print) 0232-766X (Linking)',\n",
       "               'VI': '50',\n",
       "               'IP': '4-6',\n",
       "               'DP': '1991',\n",
       "               'TI': 'Biological and clinical relevance of the urokinase-type plasminogen activator (uPA) in breast cancer.',\n",
       "               'PG': '731-41',\n",
       "               'AB': 'Tumor cell invasion and metastasis is a multifactorial process, which at each step may require the action of proteolytic enzymes such as collagenases, cathepsins, plasmin, or plasminogen activators. An enzymatically inactive proenzyme form of the urokinase-type plasminogen activator (pro-uPA) is secreted by tumor cells which may be converted to an enzymatically active two-chain uPA-molecule (HMW-uPA) by plasmin-like enzymes. Action of proteases on pro-uPA may generate the enzymatically active or inactive high-molecular-weight form of uPA (HMW-uPA). Some proteases (plasmin, cathepsin B and L, kallikrein, trypsin or thermolysin) activate pro-uPA by cleaving the peptide bond Lys158 and IIe159. Other proteases (elastase, thrombin) cleave pro-uPA at different positions to yield enzymatically inactive HMW-uPA. HMW-uPA may be split into the enzymatically active LMW-uPA and the enzymatically inactive ATF (amino terminal fragment). ATF may be cleaved between peptide sequence 20 and 40 within the receptor binding domain of uPA (GFD). Such impaired ATF does not bind to uPA-receptors. Action of the bacterial endoproteinase Asp-N from Pseudomonas fragi mutant on pro-uPA or HMW-uPA, however, generates intact ATF which efficiently competes for binding of HMW-uPA or pro-uPA to receptors on tumor cells. High uPA-antigen content (pro-uPA, HMW-uPA, or LMW-uPA) in breast cancer tissue (not in plasma) indicates an elevated risk for the patient of recurrences and shorter overall survival. Thus pro-uPA/uPA-antigen content in breast cancer tissue serves as an independent prognostic parameter for the outcome of the disease. Cathepsin D is also an independent prognostic factor for recurrences and overall survival. High content of cathepsin D in breast cancer tumors is, however, not correlated with elevated levels of pro-uPA/uPA indicating that synthesis and release of cathepsin D and pro-uPA/uPA are independent events.',\n",
       "               'FAU': ['Schmitt, M',\n",
       "                'Goretzki, L',\n",
       "                'Janicke, F',\n",
       "                'Calvete, J',\n",
       "                'Eulitz, M',\n",
       "                'Kobayashi, H',\n",
       "                'Chucholowski, N',\n",
       "                'Graeff, H'],\n",
       "               'AU': ['Schmitt M',\n",
       "                'Goretzki L',\n",
       "                'Janicke F',\n",
       "                'Calvete J',\n",
       "                'Eulitz M',\n",
       "                'Kobayashi H',\n",
       "                'Chucholowski N',\n",
       "                'Graeff H'],\n",
       "               'AD': ['Frauenklinik, Technischen Universitat Munchen, Klinikum rechts der Isar, FRG.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Biomed Biochim Acta',\n",
       "               'JT': 'Biomedica biochimica acta',\n",
       "               'JID': '8304435',\n",
       "               'RN': ['0 (Enzyme Precursors)',\n",
       "                '0 (Peptide Fragments)',\n",
       "                '0 (Recombinant Proteins)',\n",
       "                'EC 3.4.21.- (Plasminogen Activators)',\n",
       "                'EC 3.4.21.73 (Urokinase-Type Plasminogen Activator)',\n",
       "                'U5NH2JV64T (saruplase)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Binding Sites',\n",
       "                'Breast Neoplasms/*enzymology/secondary',\n",
       "                'Enzyme Precursors/metabolism',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Neoplasm Invasiveness',\n",
       "                'Peptide Fragments/metabolism',\n",
       "                'Plasminogen Activators/metabolism',\n",
       "                'Prognosis',\n",
       "                'Recombinant Proteins',\n",
       "                'Urokinase-Type Plasminogen Activator/*metabolism'],\n",
       "               'EDAT': '1991/01/01 00:00',\n",
       "               'MHDA': '1991/01/01 00:01',\n",
       "               'CRDT': ['1991/01/01 00:00'],\n",
       "               'PHST': ['1991/01/01 00:00 [pubmed]',\n",
       "                '1991/01/01 00:01 [medline]',\n",
       "                '1991/01/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Biomed Biochim Acta. 1991;50(4-6):731-41.'}],\n",
       "             '1990': [{'PMID': '2247845',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19910108',\n",
       "               'LR': '20131121',\n",
       "               'IS': '0039-6060 (Print) 0039-6060 (Linking)',\n",
       "               'VI': '108',\n",
       "               'IP': '6',\n",
       "               'DP': '1990 Dec',\n",
       "               'TI': 'Actin architecture of cultured human thyroid cancer cells: predictor of differentiation?',\n",
       "               'PG': '986-92; discussion 992-3',\n",
       "               'AB': 'The actin cytoskeleton is important for cell structure and motility. A disordered actin architecture has been correlated with a high metastatic potential in melanoma, fibrosarcoma, and colon cancer models. Thyrotropin is known to induce growth and differentiation in cultured thyroid cells, whereas the carcinogenic phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA) causes dedifferentiation and malignant transformation in many cell lines. We therefore assessed the effect of thyrotropin and TPA on the actin architecture of FTC-133 human follicular thyroid cancer cells in continuous culture. Staining of filamentous actin with rhodamine phalloidin showed that 1 mU/ml or 30 mU/ml thyrotropin-induced actin polymerization was detectable at 1 hour but more notable at 24 hours. Similarly TPA (0.008 to 10 mumol/L) caused rapid actin fiber disruption and redistribution to the cell periphery. Secondary antibody staining for alpha-actinin, a protein that binds and crosslinks actin, was more prominent after treatment with thyrotropin but decreased after TPA. These findings indicate that the actin cytoskeleton has a dynamic response to trophic factors. Thyrotropin promoted actin polymerization, but TPA caused depolymerization. These effects may correlate with cellular alpha-actinin levels. Actin architecture may therefore reflect the state of differentiation of thyroid tumor cells.',\n",
       "               'FAU': ['Demeure, M J',\n",
       "                'Hughes-Fulford, M',\n",
       "                'Goretzki, P E',\n",
       "                'Duh, Q Y',\n",
       "                'Clark, O H'],\n",
       "               'AU': ['Demeure MJ',\n",
       "                'Hughes-Fulford M',\n",
       "                'Goretzki PE',\n",
       "                'Duh QY',\n",
       "                'Clark OH'],\n",
       "               'AD': ['Surgical Service Veterans Administration Medical Center, San Francisco, CA 94121.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Surgery',\n",
       "               'JT': 'Surgery',\n",
       "               'JID': '0417347',\n",
       "               'RN': ['0 (Actins)',\n",
       "                '9002-71-5 (Thyrotropin)',\n",
       "                'NI40JAQ945 (Tetradecanoylphorbol Acetate)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Actin Cytoskeleton/metabolism/ultrastructure',\n",
       "                'Actins/*metabolism',\n",
       "                'Cell Differentiation',\n",
       "                'Forecasting',\n",
       "                'Humans',\n",
       "                'Tetradecanoylphorbol Acetate/pharmacology',\n",
       "                'Thyroid Neoplasms/*metabolism/pathology/ultrastructure',\n",
       "                'Thyrotropin/pharmacology',\n",
       "                'Time Factors',\n",
       "                'Tumor Cells, Cultured/drug effects'],\n",
       "               'OID': ['NASA: 91062858'],\n",
       "               'EDAT': '1990/12/01 00:00',\n",
       "               'MHDA': '1990/12/01 00:01',\n",
       "               'CRDT': ['1990/12/01 00:00'],\n",
       "               'PHST': ['1990/12/01 00:00 [pubmed]',\n",
       "                '1990/12/01 00:01 [medline]',\n",
       "                '1990/12/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Surgery. 1990 Dec;108(6):986-92; discussion 992-3.'},\n",
       "              {'PMID': '2238668',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19901219',\n",
       "               'LR': '20190824',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '14',\n",
       "               'IP': '5',\n",
       "               'DP': '1990 Sep-Oct',\n",
       "               'TI': 'West Germany: still an underdeveloped country in the diagnosis and early treatment of primary hyperparathyroidism?',\n",
       "               'PG': '660-1; discussion 662',\n",
       "               'AB': 'Early diagnosis of asymptomatic patients with primary hyperparathyroidism (primary HPT) has been achieved in Scandinavia, the United States of America, and the United Kingdom during the last 20 years. Comparable results have been reported from some medical centers from West Germany; however, clinical manifestations were pronounced and patient symptoms were high in our population with primary HPT (N = 128) operated on at the University of Dusseldorf from April, 1986 to July, 1989. Only 19 patients (14.8%) were asymptomatic while the others suffered from nephrolithiasis (39%), osteopathy (32%), gastrointestinal disturbances (28.9%), and depression (11.7%). In 46 (35.9%) of our patients, the duration of these clinical symptoms exceeded 10 years, in 27 patients (21%) 15 years, and in 12 patients (9.3%) even 25 years. We, therefore, conclude that primary HPT is still a grossly underdiagnosed illness in parts of West Germany, presently, with patients suffering from severe clinical symptoms for more than 1-2 decades before definitive treatment.',\n",
       "               'FAU': ['Dotzenrath, C', 'Goretzki, P E', 'Roher, H D'],\n",
       "               'AU': ['Dotzenrath C', 'Goretzki PE', 'Roher HD'],\n",
       "               'AD': ['Department of Surgery, Medical Center Heinrich-Heine University Dusseldorf, Federal Republic of Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Aged, 80 and over',\n",
       "                'Female',\n",
       "                'Germany, West',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism/complications/*diagnosis/surgery',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Retrospective Studies',\n",
       "                'Surveys and Questionnaires'],\n",
       "               'EDAT': '1990/09/01 00:00',\n",
       "               'MHDA': '1990/09/01 00:01',\n",
       "               'CRDT': ['1990/09/01 00:00'],\n",
       "               'PHST': ['1990/09/01 00:00 [pubmed]',\n",
       "                '1990/09/01 00:01 [medline]',\n",
       "                '1990/09/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF01658820 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 1990 Sep-Oct;14(5):660-1; discussion 662. doi: 10.1007/BF01658820.'},\n",
       "              {'PMID': '2338059',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19900615',\n",
       "               'LR': '20131121',\n",
       "               'IS': '0012-0472 (Print) 0012-0472 (Linking)',\n",
       "               'VI': '115',\n",
       "               'IP': '19',\n",
       "               'DP': '1990 May 11',\n",
       "               'TI': '[Subtotal thyroid gland resection as therapy for thyrotoxic crises].',\n",
       "               'PG': '735-9',\n",
       "               'AB': 'Thyrotoxic crises occurred in six patients (four women aged 51, 63, 72 and 76 years; two men aged 52 and 63 years). In four patients the crisis was triggered by a contrast medium containing iodine, and in one by amiodarone. The cause of the crisis in the 51-year-old woman remained uncertain. After a latent period of up to two months, T3 and T4 concentrations rose in all the patients, and abnormal findings such as tachycardia, increased blood pressure, dehydration, tremor, restlessness, hallucinations and coma ensued. Because of ineffective conservative treatment, five patients underwent subtotal thyroidectomy. In all five the symptoms and signs of hyperthyroidism were promptly relieved, and the postoperative course was uneventful. The 76-year-old woman was considered unfit for surgery because of her cardiac condition, and she died of left ventricular failure resistant to therapy.',\n",
       "               'FAU': ['Frilling, A',\n",
       "                'Goretzki, P E',\n",
       "                'Horster, F A',\n",
       "                'Grussendorf, M',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Frilling A',\n",
       "                'Goretzki PE',\n",
       "                'Horster FA',\n",
       "                'Grussendorf M',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Abteilung fur Allgemeine und Unfallchirurgie, Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Case Reports', 'English Abstract', 'Journal Article'],\n",
       "               'TT': 'Subtotale Schilddrusenresektion als Therapiekonzept bei thyreotoxischer Krise.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Dtsch Med Wochenschr',\n",
       "               'JT': 'Deutsche medizinische Wochenschrift (1946)',\n",
       "               'JID': '0006723',\n",
       "               'RN': ['0 (Contrast Media)',\n",
       "                '06LU7C9H1V (Triiodothyronine)',\n",
       "                '9679TC07X4 (Iodine)',\n",
       "                'N3RQ532IUT (Amiodarone)',\n",
       "                'Q51BO43MG4 (Thyroxine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Aged',\n",
       "                'Amiodarone/adverse effects',\n",
       "                'Contrast Media',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Iodine/adverse effects',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Thyroid Crisis/chemically induced/*surgery',\n",
       "                '*Thyroidectomy',\n",
       "                'Thyroxine/blood',\n",
       "                'Triiodothyronine/blood'],\n",
       "               'EDAT': '1990/05/11 00:00',\n",
       "               'MHDA': '1990/05/11 00:01',\n",
       "               'CRDT': ['1990/05/11 00:00'],\n",
       "               'PHST': ['1990/05/11 00:00 [pubmed]',\n",
       "                '1990/05/11 00:01 [medline]',\n",
       "                '1990/05/11 00:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-2008-1065074 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Dtsch Med Wochenschr. 1990 May 11;115(19):735-9. doi: 10.1055/s-2008-1065074.'},\n",
       "              {'PMID': '2368450',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19900816',\n",
       "               'LR': '20190824',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '14',\n",
       "               'IP': '3',\n",
       "               'DP': '1990 May-Jun',\n",
       "               'TI': 'The influence of surgery on endocrine ophthalmopathy.',\n",
       "               'PG': '442-5; discussion 445-6',\n",
       "               'AB': \"Since the pathogenesis of endocrine ophthalmopathy is unclear, there has been little agreement on the treatment of the disease. The influence of thyroid surgery on endocrine ophthalmopathy is controversial. To evaluate the effect of thyroid surgery on the course of the disease, we developed a special ophthalmopathy index. As a standard procedure, subtotal thyroidectomy with thyroid remnants of 3-5 g was performed. A total of 176 patients with Graves' disease underwent the above treatment between 1986 and 1988. In 78 patients suffering from concomitant endocrine ophthalmopathy, ocular status was examined prior to operation and postoperatively. The history of endocrine ophthalmopathy had been present less than 2 years preoperatively in 74% of the patients. Follow-up ranged from 6 to 36 months. Postoperatively, 54 (69%) patients showed a marked improvement of their eye symptoms. In 18 (23%), there was no change and, in 6 (8%) patients, the severity of the eye symptoms increased after the operation. As a result of these data, a cautious and preliminary conclusion may be justified--that subtotal thyroidectomy may have a positive effect on endocrine ophthalmopathy.\",\n",
       "               'FAU': ['Frilling, A',\n",
       "                'Goretzki, P E',\n",
       "                'Grussendorf, M',\n",
       "                'Erbsloh, M',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Frilling A',\n",
       "                'Goretzki PE',\n",
       "                'Grussendorf M',\n",
       "                'Erbsloh M',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Department of Surgery, University of Dusseldorf, Federal Republic of Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Aged',\n",
       "                'Autoimmune Diseases/*complications',\n",
       "                'Eye Diseases/*complications',\n",
       "                'Female',\n",
       "                'Graves Disease/*surgery',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Prospective Studies',\n",
       "                '*Thyroidectomy'],\n",
       "               'EDAT': '1990/05/01 00:00',\n",
       "               'MHDA': '1990/05/01 00:01',\n",
       "               'CRDT': ['1990/05/01 00:00'],\n",
       "               'PHST': ['1990/05/01 00:00 [pubmed]',\n",
       "                '1990/05/01 00:01 [medline]',\n",
       "                '1990/05/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF01658552 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 1990 May-Jun;14(3):442-5; discussion 445-6. doi: 10.1007/BF01658552.'},\n",
       "              {'PMID': '2347271',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19900711',\n",
       "               'LR': '20041117',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '61',\n",
       "               'IP': '4',\n",
       "               'DP': '1990 Apr',\n",
       "               'TI': '[Acute pancreatitis as the initial manifestation of primary hyperparathyroidism in children].',\n",
       "               'PG': '329-30',\n",
       "               'FAU': ['Dotzenrath, C',\n",
       "                'Raunest, J',\n",
       "                'Goretzki, P E',\n",
       "                'Schmitt-Graff, A',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Dotzenrath C',\n",
       "                'Raunest J',\n",
       "                'Goretzki PE',\n",
       "                'Schmitt-Graff A',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Chirurgische Klinik A, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Case Reports', 'Journal Article'],\n",
       "               'TT': 'Akute Pankreatitis als Erstmanifestation eines primaren Hyperparathyreoidismus im Kindesalter.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'RN': ['0 (Parathyroid Hormone)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Acute Disease',\n",
       "                'Adenoma/complications/surgery',\n",
       "                'Child',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism/*complications',\n",
       "                'Pancreatitis/*etiology',\n",
       "                'Parathyroid Hormone/blood',\n",
       "                'Parathyroid Neoplasms/complications/surgery'],\n",
       "               'EDAT': '1990/04/01 00:00',\n",
       "               'MHDA': '1990/04/01 00:01',\n",
       "               'CRDT': ['1990/04/01 00:00'],\n",
       "               'PHST': ['1990/04/01 00:00 [pubmed]',\n",
       "                '1990/04/01 00:01 [medline]',\n",
       "                '1990/04/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 1990 Apr;61(4):329-30.'},\n",
       "              {'PMID': '2389645',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19900924',\n",
       "               'LR': '20131121',\n",
       "               'IS': '0303-8173 (Print) 0303-8173 (Linking)',\n",
       "               'VI': '17 Suppl 1',\n",
       "               'DP': '1990',\n",
       "               'TI': '[Iodine-induced crisis in thyroid autonomy: a surgical emergency].',\n",
       "               'PG': '86-7',\n",
       "               'FAU': ['Frilling, A', 'Goretzki, P E', 'Roher, H D'],\n",
       "               'AU': ['Frilling A', 'Goretzki PE', 'Roher HD'],\n",
       "               'AD': ['Abteilung fur Allgemeine und Unfallchirurgie, Heinrich-Heine Universitat, Dusseldorf, BRD.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Case Reports', 'Journal Article'],\n",
       "               'TT': 'Jodinduzierte Krise bei Schilddrusenautonomie: Ein chirurgischer Notfall.',\n",
       "               'PL': 'Austria',\n",
       "               'TA': 'Acta Med Austriaca',\n",
       "               'JT': 'Acta medica Austriaca',\n",
       "               'JID': '7501997',\n",
       "               'RN': ['9679TC07X4 (Iodine)', 'N3RQ532IUT (Amiodarone)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Amiodarone/adverse effects',\n",
       "                'Angiography/adverse effects',\n",
       "                '*Emergencies',\n",
       "                'Humans',\n",
       "                'Iodine/*adverse effects',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Postoperative Complications/etiology',\n",
       "                'Thyroid Crisis/chemically induced/*surgery',\n",
       "                'Thyroidectomy/*methods'],\n",
       "               'EDAT': '1990/01/01 00:00',\n",
       "               'MHDA': '1990/01/01 00:01',\n",
       "               'CRDT': ['1990/01/01 00:00'],\n",
       "               'PHST': ['1990/01/01 00:00 [pubmed]',\n",
       "                '1990/01/01 00:01 [medline]',\n",
       "                '1990/01/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Acta Med Austriaca. 1990;17 Suppl 1:86-7.'},\n",
       "              {'PMID': '2280648',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19910308',\n",
       "               'LR': '20190820',\n",
       "               'IS': '0023-8236 (Print) 0023-8236 (Linking)',\n",
       "               'VI': '375',\n",
       "               'IP': '6',\n",
       "               'DP': '1990',\n",
       "               'TI': '[Progress in the diagnosis and therapy of C cell carcinoma of the thyroid gland].',\n",
       "               'PG': '333-9',\n",
       "               'AB': 'Between 1986 and 1989 172 patients were operated on thyroid cancer. Twenty-nine (17%) of them had a medullary carcinoma. In 20 of these patients (69%) the carcinoma occurred in a sporadic and in 9 (31%) patients in a familial form. Eighteen patients (62%) had to be operated because of tumor recurrence and in 4 of them additional surgery was necessary because of distant metastases. Due to tumor recurrence 7 patients underwent multiple operations during the above period. Adequate first operation was performed only in 6 patients (33%). Based on family screening a carcinoma was diagnosed in 4 patients in its occult stage. Diagnostic methods include biochemical and imaging methods. Calcitonin is the most sensitive tumor marker. Basal and stimulated serum calcitonin analysis provides a very efficient method to detect medullary carcinoma in early tumor stage and to treat the disease curatively. DNA-analysis improves early diagnosis of persons at risk.',\n",
       "               'FAU': ['Frilling, A', 'Goretzki, P E', 'Roher, H D'],\n",
       "               'AU': ['Frilling A', 'Goretzki PE', 'Roher HD'],\n",
       "               'AD': ['Abteilung fur Allgemeine und Unfallchirurgie, Heinrich-Heine-Universitat, Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Comparative Study',\n",
       "                'English Abstract',\n",
       "                'Journal Article'],\n",
       "               'TT': 'Fortschritte in der Diagnostik und Therapie des C-Zell-Karzinoms der Schilddruse.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie',\n",
       "               'JID': '0204167',\n",
       "               'RN': ['0 (Biomarkers, Tumor)',\n",
       "                '0 (Carcinoembryonic Antigen)',\n",
       "                'EF0NX91490 (Pentagastrin)',\n",
       "                'SY7Q814VUP (Calcium)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma/diagnosis/therapy',\n",
       "                'Biomarkers, Tumor',\n",
       "                'Calcium',\n",
       "                'Carcinoembryonic Antigen/analysis',\n",
       "                'Carcinoma/*diagnosis/*therapy',\n",
       "                'Carcinoma, Papillary/diagnosis/therapy',\n",
       "                'Humans',\n",
       "                'Pentagastrin',\n",
       "                'Prognosis',\n",
       "                'Thyroid Neoplasms/*diagnosis/*therapy'],\n",
       "               'EDAT': '1990/01/01 00:00',\n",
       "               'MHDA': '1990/01/01 00:01',\n",
       "               'CRDT': ['1990/01/01 00:00'],\n",
       "               'PHST': ['1990/01/01 00:00 [pubmed]',\n",
       "                '1990/01/01 00:01 [medline]',\n",
       "                '1990/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF00185215 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir. 1990;375(6):333-9. doi: 10.1007/BF00185215.'},\n",
       "              {'PMID': '2195806',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19900813',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0044-409X (Print) 0044-409X (Linking)',\n",
       "               'VI': '115',\n",
       "               'IP': '7',\n",
       "               'DP': '1990',\n",
       "               'TI': '[Therapeutic strategy and prognosis of malignant struma].',\n",
       "               'PG': '389-97',\n",
       "               'AB': 'The systematic application of combined treatment modalities including surgery, radiotherapy and suppressive hormone administration is based on a biologically relevant histomorphologic tumour classification. Although the principle of an aggressive therapeutic approach is still valid meantime a limited radicality has proven equally successful for selected early cases. On the other hand an even extended radical strategy is followed by repeated surgery for local recurrencies and metastatic lesions.',\n",
       "               'FAU': ['Roher, H D', 'Goretzki, P E', 'Frilling, A'],\n",
       "               'AU': ['Roher HD', 'Goretzki PE', 'Frilling A'],\n",
       "               'AD': ['Klinik fur Allgemeine und Unfallchirurgie, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article', 'Review'],\n",
       "               'TT': 'Therapeutische Strategie und Prognose der Struma maligna.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Zentralbl Chir',\n",
       "               'JT': 'Zentralblatt fur Chirurgie',\n",
       "               'JID': '0413645',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Combined Modality Therapy',\n",
       "                'Humans',\n",
       "                'Neoplasm Recurrence, Local/*surgery',\n",
       "                'Postoperative Complications/*etiology',\n",
       "                'Prognosis',\n",
       "                'Thyroid Neoplasms/*surgery',\n",
       "                '*Thyroidectomy'],\n",
       "               'RF': '11',\n",
       "               'EDAT': '1990/01/01 00:00',\n",
       "               'MHDA': '1990/01/01 00:01',\n",
       "               'CRDT': ['1990/01/01 00:00'],\n",
       "               'PHST': ['1990/01/01 00:00 [pubmed]',\n",
       "                '1990/01/01 00:01 [medline]',\n",
       "                '1990/01/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Zentralbl Chir. 1990;115(7):389-97.'},\n",
       "              {'PMID': '2173080',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19901204',\n",
       "               'LR': '20220408',\n",
       "               'IS': '0080-0015 (Print) 0080-0015 (Linking)',\n",
       "               'VI': '118',\n",
       "               'DP': '1990',\n",
       "               'TI': 'Growth regulation of normal thyroids and thyroid tumors in man.',\n",
       "               'PG': '48-63',\n",
       "               'AB': 'Our studies using thyrocyte membranes from different human thyroid tissues, monolayer cultures of human thyrocytes, and the permanant cell line FTC-133 demonstrate the stimulatory effect of TSH on metabolism, DNA synthesis, and cell growth in human thyrocytes. Up- and down-regulation of cAMP cell content fails to show direct effects on DNA synthesis and cell growth in primary thyrocyte cultures in man. Increased AC responsiveness to TSH in adenomatous human thyroid tissues, when compared to normal thyroids of the same patient (p less than 0.005), is thus of only questionable importance for thyroid tumor growth. The permanant cell line FTC-133 was established from differentiated follicular human thyroid cancer cells. FTC-133 cells proved to be of particular usefulness in assessing growth regulation of human thyroid tissue. These cells could be propagated in serum free medium, showed thyroglobulin immunoreactivity and EGF receptors, lacked any fibroblast contamination, and responded to TSH and local active growth factors such as EGF and IGF with a stimulated [3H]thymidine incorporation. The latter could be shown in primary cell cultures of normal and pathological human thyrocytes as well. Additional to the stimulatory effect of TSH and IGF on [3H]thymidine incorporation, these substances show an additive effect when incubated simultaneously. Locally active growth factors and endocrine growth stimulation by TSH therefore act synergistically on thyrocyte growth in human thyrocyte cultures. Whether the TSH effect on cell growth is related to its stimulation of AC remains as yet questionable.',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Frilling, A',\n",
       "                'Simon, D',\n",
       "                'Roeher, H D'],\n",
       "               'AU': ['Goretzki PE', 'Frilling A', 'Simon D', 'Roeher HD'],\n",
       "               'AD': ['Abteilung fur Allgemeine- und Unfallchirurgie, Chirurgische Universitatsklinik Dusseldorf, FRG.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Recent Results Cancer Res',\n",
       "               'JT': 'Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer',\n",
       "               'JID': '0044671',\n",
       "               'RN': ['62229-50-9 (Epidermal Growth Factor)',\n",
       "                '63X7MBT2LQ (Bucladesine)',\n",
       "                '9002-71-5 (Thyrotropin)',\n",
       "                '9007-49-2 (DNA)',\n",
       "                'EC 4.6.1.1 (Adenylyl Cyclases)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenylyl Cyclases/analysis/physiology',\n",
       "                'Bucladesine/pharmacology',\n",
       "                'Cell Division/drug effects',\n",
       "                'DNA/biosynthesis',\n",
       "                'Epidermal Growth Factor/pharmacology',\n",
       "                'Humans',\n",
       "                'Thyroid Gland/cytology/*growth & development',\n",
       "                'Thyroid Neoplasms/*pathology',\n",
       "                'Thyrotropin/pharmacology'],\n",
       "               'EDAT': '1990/01/01 00:00',\n",
       "               'MHDA': '1990/01/01 00:01',\n",
       "               'CRDT': ['1990/01/01 00:00'],\n",
       "               'PHST': ['1990/01/01 00:00 [pubmed]',\n",
       "                '1990/01/01 00:01 [medline]',\n",
       "                '1990/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/978-3-642-83816-3_6 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Recent Results Cancer Res. 1990;118:48-63. doi: 10.1007/978-3-642-83816-3_6.'}],\n",
       "             '1989': [{'PMID': '2758893',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19890908',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '60',\n",
       "               'IP': '6',\n",
       "               'DP': '1989 Jun',\n",
       "               'TI': '[Various strategies in the diagnosis and therapy of thyroid gland cancer. Results of a survey].',\n",
       "               'PG': '398-402',\n",
       "               'AB': 'In a questionnaire we compared generally adviced therapeutical and technical procedures in patients with thyroid carcinomas with the actually favorized strategy of the clinically active surgeons. At present, sonography and cytology are not favored as preoperative diagnostic tools by the questioned surgeons. Hemithyreoidectomy as primary procedure in suspicious nodules is performed only seldomly. In the treatment of thyroid carcinoma total thyroidectomy is the accepted procedure and the possibility of restricted radicality in the treatment of papillary thyroid carcinomas has gained wide acknowledgement. Most surgeons prefer to visualize the recurrent nerve and at least one or two parathyroid glands. Autotransplantation of parathyroid glands with insufficient blood supply is considered only seldomly.',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Frilling, A',\n",
       "                'Ohmann, C',\n",
       "                'Wins, L',\n",
       "                'Grussendorf, M',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Goretzki PE',\n",
       "                'Frilling A',\n",
       "                'Ohmann C',\n",
       "                'Wins L',\n",
       "                'Grussendorf M',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Chirurgische Klinik A, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Unterschiedliche Strategien in Diagnostik und Therapie des Schilddrusencarcinoms. Ergebnis einer Umfrage.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma/diagnosis/*surgery',\n",
       "                'Carcinoma/diagnosis/*surgery',\n",
       "                'Carcinoma, Papillary/diagnosis/*surgery',\n",
       "                'Diagnosis, Differential',\n",
       "                'Humans',\n",
       "                'Neck Dissection',\n",
       "                'Thyroid Diseases/surgery',\n",
       "                'Thyroid Neoplasms/diagnosis/*surgery',\n",
       "                '*Thyroidectomy'],\n",
       "               'EDAT': '1989/06/01 00:00',\n",
       "               'MHDA': '1989/06/01 00:01',\n",
       "               'CRDT': ['1989/06/01 00:00'],\n",
       "               'PHST': ['1989/06/01 00:00 [pubmed]',\n",
       "                '1989/06/01 00:01 [medline]',\n",
       "                '1989/06/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 1989 Jun;60(6):398-402.'},\n",
       "              {'PMID': '2667906',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19890908',\n",
       "               'LR': '20051116',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '60',\n",
       "               'IP': '6',\n",
       "               'DP': '1989 Jun',\n",
       "               'TI': '[Intrathoracic struma].',\n",
       "               'PG': '384-90',\n",
       "               'FAU': ['Roher, H D',\n",
       "                'Goretzki, P E',\n",
       "                'Wahl, R A',\n",
       "                'Frilling, A'],\n",
       "               'AU': ['Roher HD', 'Goretzki PE', 'Wahl RA', 'Frilling A'],\n",
       "               'AD': ['Chirurgische Klinik A, Heinrich-Heine-Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'TT': 'Intrathorakale Struma.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Goiter, Substernal/diagnosis/*surgery',\n",
       "                'Humans',\n",
       "                'Postoperative Complications/*etiology',\n",
       "                'Thyroid Neoplasms/surgery',\n",
       "                'Thyroidectomy/*methods'],\n",
       "               'RF': '20',\n",
       "               'EDAT': '1989/06/01 00:00',\n",
       "               'MHDA': '1989/06/01 00:01',\n",
       "               'CRDT': ['1989/06/01 00:00'],\n",
       "               'PHST': ['1989/06/01 00:00 [pubmed]',\n",
       "                '1989/06/01 00:01 [medline]',\n",
       "                '1989/06/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 1989 Jun;60(6):384-90.'},\n",
       "              {'PMID': '2652183',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19890608',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0033-832X (Print) 0033-832X (Linking)',\n",
       "               'VI': '29',\n",
       "               'IP': '3',\n",
       "               'DP': '1989 Mar',\n",
       "               'TI': '[Indications for and basic principles of the surgical treatment of thyroid diseases].',\n",
       "               'PG': '119-24',\n",
       "               'AB': 'Surgical treatment is indicated for patients with nodular goiter if malignancy seems possible, if there are mechanical reasons, or on request from the patient. In patients with goiter and hyperthyroidism, surgery and radioiodine are alternatives. In contrast, thyroid autonomy always requires surgery. The treatment of patients suffering from differentiated thyroid cancer includes thyroidectomy and radioiodine, and in those with anaplastic thyroid cancer external radiation and surgery should be performed. Apart from the classic indications and surgical procedures, in recent years selective resection of multinodular goiter, more conservative surgery of small papillary thyroid cancer and surgical treatment of iodine-induced thyrotoxicosis have become established.',\n",
       "               'FAU': ['Roher, H D', 'Goretzki, P E', 'Frilling, A'],\n",
       "               'AU': ['Roher HD', 'Goretzki PE', 'Frilling A'],\n",
       "               'AD': ['Klinik fur Allgemeine und Unfallchirurgie, Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article', 'Review'],\n",
       "               'TT': 'Indikation und Grundzuge der chirurgischen Therapie von Schilddrusenerkrankungen.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Radiologe',\n",
       "               'JT': 'Der Radiologe',\n",
       "               'JID': '0401257',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Humans',\n",
       "                'Thyroid Diseases/*surgery',\n",
       "                'Thyroid Neoplasms/*surgery',\n",
       "                'Thyroidectomy/adverse effects'],\n",
       "               'RF': '31',\n",
       "               'EDAT': '1989/03/01 00:00',\n",
       "               'MHDA': '1989/03/01 00:01',\n",
       "               'CRDT': ['1989/03/01 00:00'],\n",
       "               'PHST': ['1989/03/01 00:00 [pubmed]',\n",
       "                '1989/03/01 00:01 [medline]',\n",
       "                '1989/03/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Radiologe. 1989 Mar;29(3):119-24.'},\n",
       "              {'PMID': '2591630',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19900125',\n",
       "               'LR': '20191029',\n",
       "               'IS': '0250-3751 (Print) 0250-3751 (Linking)',\n",
       "               'VI': '20',\n",
       "               'DP': '1989',\n",
       "               'TI': \"Effect of near total thyroidectomy on ophthalmopathy in patients with Graves' disease.\",\n",
       "               'PG': '86-90',\n",
       "               'FAU': ['Grussendorf, M',\n",
       "                'Inanc, Y',\n",
       "                'Goretzki, P E',\n",
       "                'Roher, H D',\n",
       "                'Horster, F A',\n",
       "                'Kruskemper, H L'],\n",
       "               'AU': ['Grussendorf M',\n",
       "                'Inanc Y',\n",
       "                'Goretzki PE',\n",
       "                'Roher HD',\n",
       "                'Horster FA',\n",
       "                'Kruskemper HL'],\n",
       "               'AD': ['Medizinische Klinik C, University of Dusseldorf, FRG.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'Switzerland',\n",
       "               'TA': 'Dev Ophthalmol',\n",
       "               'JT': 'Developments in ophthalmology',\n",
       "               'JID': '8010321',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Goiter/complications/radiotherapy/surgery',\n",
       "                'Graves Disease/complications/radiotherapy/*surgery',\n",
       "                'Humans',\n",
       "                'Prospective Studies',\n",
       "                'Thyroid Function Tests',\n",
       "                '*Thyroidectomy'],\n",
       "               'EDAT': '1989/01/01 00:00',\n",
       "               'MHDA': '1989/01/01 00:01',\n",
       "               'CRDT': ['1989/01/01 00:00'],\n",
       "               'PHST': ['1989/01/01 00:00 [pubmed]',\n",
       "                '1989/01/01 00:01 [medline]',\n",
       "                '1989/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1159/000417923 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Dev Ophthalmol. 1989;20:86-90. doi: 10.1159/000417923.'},\n",
       "              {'PMID': '2576942',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19900816',\n",
       "               'LR': '20041117',\n",
       "               'IS': '0018-0416 (Print) 0018-0416 (Linking)',\n",
       "               'VI': '37',\n",
       "               'IP': '3-4',\n",
       "               'DP': '1989',\n",
       "               'TI': 'The importance of screening for medullary thyroid carcinoma in families of patients with MEN 2.',\n",
       "               'PG': '122-3',\n",
       "               'AB': 'Family screening for medullary thyroid cancer (MTC) is important for detecting members of multiple endocrine neoplasia type 2 (MEN 2) families who may be gene carriers but show no clinical evidence of the disease. Most members of our MEN 2 families are screened yearly by measuring basal and pentagastrin-stimulated calcitonin (CT) levels. A 15-year-old first-degree relative of an affected member of the D-kindred showed a normal basal and an elevated stimulated CT level. Clinical examination, ultrasonography, and scintigraphy were normal. Thyroidectomy and bilateral neck dissection revealed a multicentric MTC with no lymph node involvement. In the O-kindred we detected elevated basal and/or stimulated CT levels in three asymptomatic first-degree relatives. At surgery we found a small multicentric MTC in one family member, C-cell hyperplasia in another member, and bilateral lymph node metastases in one member who had been previously thyroidectomized. Basal and stimulated CT estimations in MEN 2 family members provide an effective method for detecting MTC in early, treatable stages.',\n",
       "               'FAU': ['Frilling, A',\n",
       "                'Goretzki, P E',\n",
       "                'Bastian, L',\n",
       "                'Roeher, H D'],\n",
       "               'AU': ['Frilling A', 'Goretzki PE', 'Bastian L', 'Roeher HD'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Case Reports', 'Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Henry Ford Hosp Med J',\n",
       "               'JT': 'Henry Ford Hospital medical journal',\n",
       "               'JID': '0122304',\n",
       "               'RN': ['0 (Carcinoembryonic Antigen)',\n",
       "                '9007-12-9 (Calcitonin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adrenal Gland Neoplasms/genetics',\n",
       "                'Adult',\n",
       "                'Calcitonin/blood',\n",
       "                'Carcinoembryonic Antigen/blood',\n",
       "                'Carcinoma/*genetics',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Multiple Endocrine Neoplasia/*genetics',\n",
       "                'Pheochromocytoma/genetics',\n",
       "                'Thyroid Neoplasms/*genetics'],\n",
       "               'EDAT': '1989/01/01 00:00',\n",
       "               'MHDA': '1989/01/01 00:01',\n",
       "               'CRDT': ['1989/01/01 00:00'],\n",
       "               'PHST': ['1989/01/01 00:00 [pubmed]',\n",
       "                '1989/01/01 00:01 [medline]',\n",
       "                '1989/01/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Henry Ford Hosp Med J. 1989;37(3-4):122-3.'}],\n",
       "             '1988': [{'PMID': '3200284',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19890123',\n",
       "               'LR': '20190824',\n",
       "               'IS': '0028-4793 (Print) 0028-4793 (Linking)',\n",
       "               'VI': '319',\n",
       "               'IP': '25',\n",
       "               'DP': '1988 Dec 22',\n",
       "               'TI': \"Thyroid-stimulating antibodies of Graves' disease in thyroid cancer.\",\n",
       "               'PG': '1669-70',\n",
       "               'FAU': ['Roher, H D', 'Goretzki, P E', 'Frilling, A'],\n",
       "               'AU': ['Roher HD', 'Goretzki PE', 'Frilling A'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Letter'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'N Engl J Med',\n",
       "               'JT': 'The New England journal of medicine',\n",
       "               'JID': '0255562',\n",
       "               'RN': ['0 (Autoantibodies)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Autoantibodies/*immunology',\n",
       "                'Graves Disease/complications/*immunology',\n",
       "                'Humans',\n",
       "                'Thyroid Gland/*immunology',\n",
       "                'Thyroid Neoplasms/*etiology'],\n",
       "               'EDAT': '1988/12/22 00:00',\n",
       "               'MHDA': '1988/12/22 00:01',\n",
       "               'CRDT': ['1988/12/22 00:00'],\n",
       "               'PHST': ['1988/12/22 00:00 [pubmed]',\n",
       "                '1988/12/22 00:01 [medline]',\n",
       "                '1988/12/22 00:00 [entrez]'],\n",
       "               'AID': ['10.1056/nejm198812223192514 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'N Engl J Med. 1988 Dec 22;319(25):1669-70. doi: 10.1056/nejm198812223192514.'},\n",
       "              {'PMID': '2458922',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19881122',\n",
       "               'LR': '20240109',\n",
       "               'IS': '0014-2956 (Print) 0014-2956 (Linking)',\n",
       "               'VI': '176',\n",
       "               'IP': '3',\n",
       "               'DP': '1988 Oct 1',\n",
       "               'TI': 'A new siliconized-glass fiber as support for protein-chemical analysis of electroblotted proteins.',\n",
       "               'PG': '509-19',\n",
       "               'AB': 'A new hydrophobic glass-fiber support is presented, which is well suited to the electrophoretic transfer of proteins from polyacrylamide gels and subsequent protein-chemical analysis. Modified glass-fiber sheets are easily prepared by chemical reaction of the surface with poly(methyl-3,3,3-trifluoropropylsiloxane) in trifluoroacetic acid. The modification is stable during electroblotting, amino acid sequence analysis and hydrolysis. The siliconized glass fiber exhibits a high protein-binding capacity, allows the application of well-established staining procedures, and does not interfere with the analytical methods of modern protein chemistry at the low picomole level. Samples separated by electrophoresis and immobilized on hydrophobic supports fail to exhibit any detectable contamination in amino acid sequence analysis hence allowing the high performance of the available protein-chemical methods to be exploited.',\n",
       "               'FAU': ['Eckerskorn, C',\n",
       "                'Mewes, W',\n",
       "                'Goretzki, H',\n",
       "                'Lottspeich, F'],\n",
       "               'AU': ['Eckerskorn C', 'Mewes W', 'Goretzki H', 'Lottspeich F'],\n",
       "               'AD': ['Max-Planck-Institut fur Biochemie, Genzentrum, Martinsried, Federal Republic of Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Eur J Biochem',\n",
       "               'JT': 'European journal of biochemistry',\n",
       "               'JID': '0107600',\n",
       "               'RN': ['0 (Amino Acids)',\n",
       "                '0 (Dimethylpolysiloxanes)',\n",
       "                '0 (Membranes, Artificial)',\n",
       "                '0 (Proteins)',\n",
       "                '0 (Silicones)',\n",
       "                '0 (fiberglass)',\n",
       "                '25791-89-3 (polymethyl-3,3,3-trifluoropropylsiloxane)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Amino Acid Sequence',\n",
       "                'Amino Acids/analysis',\n",
       "                'Blotting, Western',\n",
       "                '*Dimethylpolysiloxanes',\n",
       "                'Electrophoresis, Polyacrylamide Gel/*methods',\n",
       "                '*Glass',\n",
       "                'Immunochemistry',\n",
       "                'Membranes, Artificial',\n",
       "                'Proteins/*analysis',\n",
       "                '*Silicones',\n",
       "                'Staining and Labeling'],\n",
       "               'EDAT': '1988/10/01 00:00',\n",
       "               'MHDA': '1988/10/01 00:01',\n",
       "               'CRDT': ['1988/10/01 00:00'],\n",
       "               'PHST': ['1988/10/01 00:00 [pubmed]',\n",
       "                '1988/10/01 00:01 [medline]',\n",
       "                '1988/10/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1111/j.1432-1033.1988.tb14308.x [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Eur J Biochem. 1988 Oct 1;176(3):509-19. doi: 10.1111/j.1432-1033.1988.tb14308.x.'},\n",
       "              {'PMID': '3188552',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19881219',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0043-5341 (Print) 0043-5341 (Linking)',\n",
       "               'VI': '138',\n",
       "               'IP': '18',\n",
       "               'DP': '1988 Sep 30',\n",
       "               'TI': '[Persistent postoperative hyperthyroidism--a surgical problem].',\n",
       "               'PG': '450-1',\n",
       "               'AB': \"The rate of persistent or recurrent hyperthyroidism after surgical treatment of Graves' disease correlates with the size of a thyroid remnant. Reoperation should be viewed as a last resort because of a high complication rate. A subtotal thyroidectomy with a thyroid remnant of 5 to 8 g is recommended.\",\n",
       "               'FAU': ['Frilling, A', 'Goretzki, P E', 'Roher, H D'],\n",
       "               'AU': ['Frilling A', 'Goretzki PE', 'Roher HD'],\n",
       "               'AD': ['Chirurgischen Universitatsklinik Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Persistierende postoperative Hyperthyreose--ein chirurgisches Problem.',\n",
       "               'PL': 'Austria',\n",
       "               'TA': 'Wien Med Wochenschr',\n",
       "               'JT': 'Wiener medizinische Wochenschrift (1946)',\n",
       "               'JID': '8708475',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Graves Disease/*surgery',\n",
       "                'Humans',\n",
       "                'Hyperthyroidism/*surgery',\n",
       "                'Postoperative Complications/*surgery',\n",
       "                'Recurrence',\n",
       "                'Reoperation',\n",
       "                '*Thyroidectomy'],\n",
       "               'EDAT': '1988/09/30 00:00',\n",
       "               'MHDA': '1988/09/30 00:01',\n",
       "               'CRDT': ['1988/09/30 00:00'],\n",
       "               'PHST': ['1988/09/30 00:00 [pubmed]',\n",
       "                '1988/09/30 00:01 [medline]',\n",
       "                '1988/09/30 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Wien Med Wochenschr. 1988 Sep 30;138(18):450-1.'},\n",
       "              {'PMID': '2897041',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19880623',\n",
       "               'LR': '20190611',\n",
       "               'IS': '0140-6736 (Print) 0140-6736 (Linking)',\n",
       "               'VI': '1',\n",
       "               'IP': '8596',\n",
       "               'DP': '1988 May 28',\n",
       "               'TI': 'Classical versus lower segment caesarean section for very-low-birthweight infants.',\n",
       "               'PG': '1227',\n",
       "               'FAU': ['Dietl, J A', 'Goretzki, K', 'Hirsch, H A'],\n",
       "               'AU': ['Dietl JA', 'Goretzki K', 'Hirsch HA'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Letter'],\n",
       "               'PL': 'England',\n",
       "               'TA': 'Lancet',\n",
       "               'JT': 'Lancet (London, England)',\n",
       "               'JID': '2985213R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Cesarean Section/*methods',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                '*Infant, Low Birth Weight',\n",
       "                'Infant, Newborn',\n",
       "                'Pregnancy'],\n",
       "               'EDAT': '1988/05/28 00:00',\n",
       "               'MHDA': '1988/05/28 00:01',\n",
       "               'CRDT': ['1988/05/28 00:00'],\n",
       "               'PHST': ['1988/05/28 00:00 [pubmed]',\n",
       "                '1988/05/28 00:01 [medline]',\n",
       "                '1988/05/28 00:00 [entrez]'],\n",
       "               'AID': ['S0140-6736(88)92048-X [pii]',\n",
       "                '10.1016/s0140-6736(88)92048-x [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Lancet. 1988 May 28;1(8596):1227. doi: 10.1016/s0140-6736(88)92048-x.'},\n",
       "              {'PMID': '3407198',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19880922',\n",
       "               'LR': '20131121',\n",
       "               'IS': '0043-5325 (Print) 0043-5325 (Linking)',\n",
       "               'VI': '100',\n",
       "               'IP': '11',\n",
       "               'DP': '1988 May 27',\n",
       "               'TI': '[Acute abdomen in unrecognized hyperparathyroidism].',\n",
       "               'PG': '373-5',\n",
       "               'AB': 'The incidence of acute abdomen in patients with unrecognised hyperparathyroidism (HPT) was investigated in 61 patients with primary and 15 patients with secondary HPT, operated on at the Surgical University Department in Dusseldorf between 4/86 and 10/87. In seven patients (9%) an acute abdomen occurred preoperatively (bleeding ulcer n = 3, ulcer perforation n = 1, acute pancreatitis n = 3). Recurrent gastrointestinal disease was observed in 20 of the 76 Patients (28%). The fast and surprising clinical recovery of patients with pancreatitis and HPT after operation of the HPT support the assumption of a causal relation between hyperparathyroidism and pancreatitis. The importance of hypercalcaemia and HPT as causative factors in gastrointestinal ulcers, remains uncertain, however. Possible acute abdominal emergencies in the clinical course of primary hyperparathyroidism support the indication for early operation.',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Becker, H',\n",
       "                'Dotzenrath, C',\n",
       "                'Grussendorf, M',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Goretzki PE',\n",
       "                'Becker H',\n",
       "                'Dotzenrath C',\n",
       "                'Grussendorf M',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Chirurgische Klinik, Universitat Dusseldorf, Bundesrepublik Deutschland.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Case Reports', 'English Abstract', 'Journal Article'],\n",
       "               'TT': 'Das akute Abdomen beim nichterkannten Hyperparathyreoidismus.',\n",
       "               'PL': 'Austria',\n",
       "               'TA': 'Wien Klin Wochenschr',\n",
       "               'JT': 'Wiener klinische Wochenschrift',\n",
       "               'JID': '21620870R',\n",
       "               'RN': ['SY7Q814VUP (Calcium)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Abdomen, Acute/*etiology',\n",
       "                'Adenoma/complications/surgery',\n",
       "                'Calcium/blood',\n",
       "                'Diagnosis, Differential',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism/*complications',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Pancreatitis/etiology',\n",
       "                'Parathyroid Neoplasms/complications/surgery',\n",
       "                'Peptic Ulcer Hemorrhage/etiology'],\n",
       "               'EDAT': '1988/05/27 00:00',\n",
       "               'MHDA': '1988/05/27 00:01',\n",
       "               'CRDT': ['1988/05/27 00:00'],\n",
       "               'PHST': ['1988/05/27 00:00 [pubmed]',\n",
       "                '1988/05/27 00:01 [medline]',\n",
       "                '1988/05/27 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Wien Klin Wochenschr. 1988 May 27;100(11):373-5.'},\n",
       "              {'PMID': '3407195',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19880922',\n",
       "               'LR': '20131121',\n",
       "               'IS': '0043-5325 (Print) 0043-5325 (Linking)',\n",
       "               'VI': '100',\n",
       "               'IP': '11',\n",
       "               'DP': '1988 May 27',\n",
       "               'TI': '[Subtotal thyroidectomy as a superior therapeutic principle in the treatment of endocrine ophthalmopathy: a comparison with retrobulbar irradiation and thyrostatic therapy alone].',\n",
       "               'PG': '355-7',\n",
       "               'AB': \"In order to investigate the influence of near total thyroidectomy on the course of endocrine ophthalmopathy (E.O.) in patients with Graves' disease, 29 patients with goitre and E.O. were classified before and after (up to 18 months) operation by use of a special ophthalmopathy index. 14 patients without goitre served as controls; they get only antithyroid drug treatment (ADT) (E.O. I and II, n = 7) or additional retoorbital irradiation (E.O. III and IV, n = 7, linear accelerator, 20 Gray). 20 out of 29 operated patients showed an improvement in the E.O., 4 a deterioration, 5 were unchanged. 3 out of 7 not operated patients with mild E.O. showed an amelioration during ADT, 4 no change. Additional radiotherapy in 7 patients with severe E.O. caused an improvement in the clinical condition of 3 patients, 3 patients deteriorated and 1 patient showed no change. It is concluded that adequate near total thyroidectomy has a positive effect on the clinical course of E.O. in patients with Graves' disease and E.O.\",\n",
       "               'FAU': ['Grussendorf, M',\n",
       "                'Horster, F A',\n",
       "                'Inanc, Y',\n",
       "                'Goretzki, P E',\n",
       "                'Roher, H D',\n",
       "                'Kruskemper, H L'],\n",
       "               'AU': ['Grussendorf M',\n",
       "                'Horster FA',\n",
       "                'Inanc Y',\n",
       "                'Goretzki PE',\n",
       "                'Roher HD',\n",
       "                'Kruskemper HL'],\n",
       "               'AD': ['Medizinische Klinik, Universitat Dusseldorf, Bundesrepublik Deutschland.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Comparative Study',\n",
       "                'English Abstract',\n",
       "                'Journal Article'],\n",
       "               'TT': 'Subtotale Thyreoidektomie als uberlegenes Therapieprinzip bei der Behandlung der endokrinen Ophthalmopathie: Ein Vergleich mit Retrobulbarbestrahlung bzw. alleiniger thyreostatischer Therapie.',\n",
       "               'PL': 'Austria',\n",
       "               'TA': 'Wien Klin Wochenschr',\n",
       "               'JT': 'Wiener klinische Wochenschrift',\n",
       "               'JID': '21620870R',\n",
       "               'RN': ['554Z48XN5E (Methimazole)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Follow-Up Studies',\n",
       "                'Graves Disease/drug therapy/radiotherapy/*surgery',\n",
       "                'Humans',\n",
       "                'Methimazole/*administration & dosage',\n",
       "                'Orbit/*radiation effects',\n",
       "                '*Thyroidectomy'],\n",
       "               'EDAT': '1988/05/27 00:00',\n",
       "               'MHDA': '1988/05/27 00:01',\n",
       "               'CRDT': ['1988/05/27 00:00'],\n",
       "               'PHST': ['1988/05/27 00:00 [pubmed]',\n",
       "                '1988/05/27 00:01 [medline]',\n",
       "                '1988/05/27 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Wien Klin Wochenschr. 1988 May 27;100(11):355-7.'},\n",
       "              {'PMID': '2900582',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19880922',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0043-5325 (Print) 0043-5325 (Linking)',\n",
       "               'VI': '100',\n",
       "               'IP': '11',\n",
       "               'DP': '1988 May 27',\n",
       "               'TI': '[Reinterventions for hyperparathyroidism in multiple endocrine adenopathy].',\n",
       "               'PG': '364-6',\n",
       "               'AB': 'Six out of a series of 10 patients with hyperparathyroidism associated with an MEA type I syndrome were treated by subtotal parathyroidectomy with resulting normocalcaemia over a follow-up time of one to 7 years. Three patients with repeated previously unsuccessful operations underwent total parathyroidectomy with simultaneous autotransplantation. The first type of operation remains our first choice, while the radical approach with forearm transplantation is reserved only for recurrent surgery for various reasons.',\n",
       "               'FAU': ['Roher, H D', 'Goretzki, P E', 'Dotzenrath, C'],\n",
       "               'AU': ['Roher HD', 'Goretzki PE', 'Dotzenrath C'],\n",
       "               'AD': ['Chirurgische Universitatsklinik, Dusseldorf, Bundesrepublik Deutschland.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Rezidiveingriffe wegen Hyperparathyreoidismus bei multipler endokriner Adenopathie.',\n",
       "               'PL': 'Austria',\n",
       "               'TA': 'Wien Klin Wochenschr',\n",
       "               'JT': 'Wiener klinische Wochenschrift',\n",
       "               'JID': '21620870R',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism/*surgery',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Multiple Endocrine Neoplasia/*surgery',\n",
       "                'Parathyroid Glands/surgery/transplantation',\n",
       "                'Parathyroid Neoplasms/*surgery',\n",
       "                'Postoperative Complications/*surgery',\n",
       "                'Reoperation',\n",
       "                'Thymectomy'],\n",
       "               'EDAT': '1988/05/27 00:00',\n",
       "               'MHDA': '1988/05/27 00:01',\n",
       "               'CRDT': ['1988/05/27 00:00'],\n",
       "               'PHST': ['1988/05/27 00:00 [pubmed]',\n",
       "                '1988/05/27 00:01 [medline]',\n",
       "                '1988/05/27 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Wien Klin Wochenschr. 1988 May 27;100(11):364-6.'},\n",
       "              {'PMID': '2900580',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19880922',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0043-5325 (Print) 0043-5325 (Linking)',\n",
       "               'VI': '100',\n",
       "               'IP': '11',\n",
       "               'DP': '1988 May 27',\n",
       "               'TI': '[Reintervention in C-cell carcinoma].',\n",
       "               'PG': '348-51',\n",
       "               'AB': 'Cervical re-exploration in persistent medullary thyroid cancer usually fails to normalize serum calcitonin levels, which is the most sensitive criterion of tumour-free status (2 out of 21 patients in our re-exploration series). Positive lymph nodes - even at an early tumour stage - seem much more important (postoperative normal serum calcitonin: 86% in the occult tumour group, 71% in patients with palpable primary tumour and negative lymph nodes, as opposed to only 18% with a palpable cervical mass and positive lymph nodes). However, local re-exploration in case of persistent medullary thyroid cancer seems to offer a possible curative chance for the control of recurrence, especially after inadequate primary surgery. In cases without visible distant metastases a marked reduction in serum calcitonin level may be expected (21% of the preoperative level for stages N1 and N2 and 16% for stage N3 on average). In patients with elevated calcitonin levels after stimulation as sole indicator of persistent tumour the indication for reoperation should be handled cautiously. Thus, in 3 out of 5 patients with occult medullary thyroid cancer diagnosed only on the basis of venous sampling who were subjected to multiple cervical re-explorations, distant metastases were subsequently found during follow-up.',\n",
       "               'FAU': ['Wahl, R A',\n",
       "                'Goretzki, P E',\n",
       "                'Branscheid, D',\n",
       "                'Vietmeier, P',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Wahl RA',\n",
       "                'Goretzki PE',\n",
       "                'Branscheid D',\n",
       "                'Vietmeier P',\n",
       "                'Roher HD'],\n",
       "               'AD': ['Chirurgische Klinik, Burgerhospital Frankfurt, Bundesrepublik Deutschland.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Reintervention beim C-Zell-Karzinom.',\n",
       "               'PL': 'Austria',\n",
       "               'TA': 'Wien Klin Wochenschr',\n",
       "               'JT': 'Wiener klinische Wochenschrift',\n",
       "               'JID': '21620870R',\n",
       "               'RN': ['9007-12-9 (Calcitonin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Calcitonin/blood',\n",
       "                'Carcinoma/blood/*surgery',\n",
       "                'Follow-Up Studies',\n",
       "                'Humans',\n",
       "                'Lymphatic Metastasis',\n",
       "                'Multiple Endocrine Neoplasia/surgery',\n",
       "                'Neoplasm Recurrence, Local/blood/*surgery',\n",
       "                'Thyroid Neoplasms/blood/*surgery'],\n",
       "               'EDAT': '1988/05/27 00:00',\n",
       "               'MHDA': '1988/05/27 00:01',\n",
       "               'CRDT': ['1988/05/27 00:00'],\n",
       "               'PHST': ['1988/05/27 00:00 [pubmed]',\n",
       "                '1988/05/27 00:01 [medline]',\n",
       "                '1988/05/27 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Wien Klin Wochenschr. 1988 May 27;100(11):348-51.'},\n",
       "              {'PMID': '3359872',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19880603',\n",
       "               'LR': '20131121',\n",
       "               'IS': '0009-4722 (Print) 0009-4722 (Linking)',\n",
       "               'VI': '59',\n",
       "               'IP': '2',\n",
       "               'DP': '1988 Feb',\n",
       "               'TI': '[Echinococcus cyst of the thyroid gland. A case report].',\n",
       "               'PG': '106-7',\n",
       "               'FAU': ['Dotzenrath, C', 'Burring, K F', 'Goretzki, P E'],\n",
       "               'AU': ['Dotzenrath C', 'Burring KF', 'Goretzki PE'],\n",
       "               'AD': ['Chirurgische Klinik, Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Case Reports', 'Journal Article'],\n",
       "               'TT': 'Die Echinococcuscyste der Schilddruse. Eine Fallbeschreibung.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chirurg',\n",
       "               'JT': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "               'JID': '16140410R',\n",
       "               'RN': ['81G6I5V05I (Mebendazole)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Combined Modality Therapy',\n",
       "                'Echinococcosis/pathology/*surgery',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Mebendazole/administration & dosage',\n",
       "                'Thyroid Diseases/pathology/*surgery',\n",
       "                'Thyroid Gland/pathology'],\n",
       "               'EDAT': '1988/02/01 00:00',\n",
       "               'MHDA': '1988/02/01 00:01',\n",
       "               'CRDT': ['1988/02/01 00:00'],\n",
       "               'PHST': ['1988/02/01 00:00 [pubmed]',\n",
       "                '1988/02/01 00:01 [medline]',\n",
       "                '1988/02/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chirurg. 1988 Feb;59(2):106-7.'},\n",
       "              {'PMID': '3350321',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19880512',\n",
       "               'LR': '20061115',\n",
       "               'IS': '0016-5751 (Print) 0016-5751 (Linking)',\n",
       "               'VI': '48',\n",
       "               'IP': '1',\n",
       "               'DP': '1988 Jan',\n",
       "               'TI': '[Fetal outcome following cesarean section in premature labor. Isthmocorpus longitudinal section or isthmian transverse section?].',\n",
       "               'PG': '13-5',\n",
       "               'AB': 'Little is known about the comparative safety of the isthmocorporal versus the low transverse uterine incision for Caesarean delivery of the very low birthweight infant. To address this question, the fetal outcome of 59 deliveries by isthmocorporal incision and 76 by low transverse incision were analysed. The incidences of a 5-min-Apgar score of 6 or lower and UA-pH were not significantly different. No correlation was evident between early intraventricular hemorrhage and type of incision. The number of neonatal deaths weighing less than 1000 g associated with vertical incision (27%) was lower than that associated with the low transverse incision (47%). Nevertheless the difference was not statistically significant. The decision for the type of incision should be made intraoperatively by an experienced surgeon. This factor is probably more important than the choice of a particular incision.',\n",
       "               'FAU': ['Dietl, J',\n",
       "                'Dannecker, G',\n",
       "                'Goretzki, K',\n",
       "                'Hirsch, H A'],\n",
       "               'AU': ['Dietl J', 'Dannecker G', 'Goretzki K', 'Hirsch HA'],\n",
       "               'AD': ['Universitats-Frauenklinik Tubingen.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Comparative Study',\n",
       "                'English Abstract',\n",
       "                'Journal Article'],\n",
       "               'TT': '\"Fetal outcome\" nach Sektio bei der fruhen Fruhgeburt. Isthmokorporaler Langsschnitt oder isthmischer Querschnitt?',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Geburtshilfe Frauenheilkd',\n",
       "               'JT': 'Geburtshilfe und Frauenheilkunde',\n",
       "               'JID': '0370732',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Apgar Score',\n",
       "                'Birth Weight',\n",
       "                'Cerebral Hemorrhage/*etiology',\n",
       "                'Cesarean Section/*methods',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Infant, Newborn',\n",
       "                'Infant, Premature, Diseases/*etiology',\n",
       "                'Obstetric Labor, Premature/*surgery',\n",
       "                'Postoperative Complications/*etiology',\n",
       "                'Pregnancy',\n",
       "                'Risk Factors'],\n",
       "               'EDAT': '1988/01/01 00:00',\n",
       "               'MHDA': '1988/01/01 00:01',\n",
       "               'CRDT': ['1988/01/01 00:00'],\n",
       "               'PHST': ['1988/01/01 00:00 [pubmed]',\n",
       "                '1988/01/01 00:01 [medline]',\n",
       "                '1988/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1055/s-2008-1035687 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Geburtshilfe Frauenheilkd. 1988 Jan;48(1):13-5. doi: 10.1055/s-2008-1035687.'},\n",
       "              {'PMID': '3210848',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19890223',\n",
       "               'LR': '20190820',\n",
       "               'IS': '0023-8236 (Print) 0023-8236 (Linking)',\n",
       "               'VI': '373',\n",
       "               'IP': '6',\n",
       "               'DP': '1988',\n",
       "               'TI': '[Autotransplantation of parathyroid gland tissue--on the indications for total parathyroidectomy with autotransplantation].',\n",
       "               'PG': '323-4',\n",
       "               'FAU': ['Goretzki, P E'],\n",
       "               'AU': ['Goretzki PE'],\n",
       "               'AD': ['Abteilung fur Allgemeine- und Unfallchirurgie, Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'TT': 'Autotransplantation von Epithelkorperchengewebe--zur Indikation der totalen Parathyreoidektomie mit Autotransplantation.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie',\n",
       "               'JID': '0204167',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/*surgery',\n",
       "                'Humans',\n",
       "                'Hyperparathyroidism/*surgery',\n",
       "                'Parathyroid Glands/surgery/*transplantation',\n",
       "                'Parathyroid Neoplasms/*surgery'],\n",
       "               'EDAT': '1988/01/01 00:00',\n",
       "               'MHDA': '1988/01/01 00:01',\n",
       "               'CRDT': ['1988/01/01 00:00'],\n",
       "               'PHST': ['1988/01/01 00:00 [pubmed]',\n",
       "                '1988/01/01 00:01 [medline]',\n",
       "                '1988/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF01272550 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir. 1988;373(6):323-4. doi: 10.1007/BF01272550.'}],\n",
       "             '1987': [{'PMID': '3686343',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19880107',\n",
       "               'LR': '20220318',\n",
       "               'IS': '0039-6060 (Print) 0039-6060 (Linking)',\n",
       "               'VI': '102',\n",
       "               'IP': '6',\n",
       "               'DP': '1987 Dec',\n",
       "               'TI': 'Nerve growth factor (NGF) sensitizes human medullary thyroid carcinoma (hMTC) cells for cytostatic therapy in vitro.',\n",
       "               'PG': '1035-42',\n",
       "               'AB': 'Medullary thyroid carcinoma (hMTC) cells were established from nine patients with MTC disease to initiate a new approach of adjuvant medical therapy in these patients. We measured calcitonin (CT) secretion, DNA synthesis, and cell proliferation in vitro and their response to various substances. Nerve growth factor (NGF) (0.01 to 10 micrograms/ml), glucagon (0.01 to 100 micrograms/ml), and isoproterenol (4 to 500 micrograms/ml) stimulated CT secretion and DNA synthesis in hMTC cells. Other substances, calcium (1.0 to 15 mmol), pentagastrin (1.0 to 50 mumol), dibutyryl-cyclic-adenosine-monophosphate (1.0 to 100 mumol), and phorbol ester TPA (1.0 to 100 nmol), stimulated CT secretion but not DNA synthesis. In addition, NGF enhanced cell proliferation of hMTC cells 2- to 3- fold and caused an increased sensitivity of these cells for chemotherapy in vitro. Thus 0.5 microgram/ml doxorubicin (half-maximal effective dose) induced a cell death rate of up to 32.8%, which was enhanced by preincubation with NGF to 68.1% (1.0 microgram/ml, NGF) and to 100% (10.0 micrograms/ml, NGF), respectively. Pulsative stimulation of APUD cell carcinomas with NGF may therefore improve the response rate of these tumors to chemotherapy, which would be of significant clinical importance for patients with residual postoperative MTC tissue.',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Wahl, R A',\n",
       "                'Becker, R',\n",
       "                'Koller, C',\n",
       "                'Branscheid, D',\n",
       "                'Grussendorf, M',\n",
       "                'Roeher, H D'],\n",
       "               'AU': ['Goretzki PE',\n",
       "                'Wahl RA',\n",
       "                'Becker R',\n",
       "                'Koller C',\n",
       "                'Branscheid D',\n",
       "                'Grussendorf M',\n",
       "                'Roeher HD'],\n",
       "               'AD': ['Department of Surgery and Endocrinology, University Duesseldorf, West Germany.'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Surgery',\n",
       "               'JT': 'Surgery',\n",
       "               'JID': '0417347',\n",
       "               'RN': ['0 (Antineoplastic Agents)',\n",
       "                '0 (DNA, Neoplasm)',\n",
       "                '0 (Nerve Growth Factors)',\n",
       "                '9007-12-9 (Calcitonin)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Antineoplastic Agents/*therapeutic use',\n",
       "                'Calcitonin/metabolism',\n",
       "                'Carcinoma/*drug therapy/metabolism',\n",
       "                'Cell Division/drug effects',\n",
       "                'DNA, Neoplasm/biosynthesis',\n",
       "                'Drug Synergism',\n",
       "                'Humans',\n",
       "                'In Vitro Techniques',\n",
       "                'Nerve Growth Factors/*therapeutic use',\n",
       "                'Thyroid Neoplasms/*drug therapy/metabolism',\n",
       "                'Tumor Cells, Cultured/drug effects'],\n",
       "               'EDAT': '1987/12/01 00:00',\n",
       "               'MHDA': '1987/12/01 00:01',\n",
       "               'CRDT': ['1987/12/01 00:00'],\n",
       "               'PHST': ['1987/12/01 00:00 [pubmed]',\n",
       "                '1987/12/01 00:01 [medline]',\n",
       "                '1987/12/01 00:00 [entrez]'],\n",
       "               'AID': ['0039-6060(87)90332-1 [pii]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Surgery. 1987 Dec;102(6):1035-42.'},\n",
       "              {'PMID': '9942447',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'PubMed-not-MEDLINE',\n",
       "               'LR': '20191120',\n",
       "               'IS': '0163-1829 (Print) 0163-1829 (Linking)',\n",
       "               'VI': '36',\n",
       "               'IP': '13',\n",
       "               'DP': '1987 Nov 1',\n",
       "               'TI': 'Observation of carboxylic groups in the lattice of sintered Ba2YCu3O7-y high-Tc superconductors.',\n",
       "               'PG': '7148-7150',\n",
       "               'FAU': ['Parmigiani, F',\n",
       "                'Chiarello, G',\n",
       "                'Ripamonti, N',\n",
       "                'Goretzki, H',\n",
       "                'Roll, U'],\n",
       "               'AU': ['Parmigiani F',\n",
       "                'Chiarello G',\n",
       "                'Ripamonti N',\n",
       "                'Goretzki H',\n",
       "                'Roll U'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Phys Rev B Condens Matter',\n",
       "               'JT': 'Physical review. B, Condensed matter',\n",
       "               'JID': '9878217',\n",
       "               'EDAT': '1987/11/01 00:00',\n",
       "               'MHDA': '1999/02/11 00:00',\n",
       "               'CRDT': ['1987/11/01 00:00'],\n",
       "               'PHST': ['1987/11/01 00:00 [pubmed]',\n",
       "                '1999/02/11 00:00 [medline]',\n",
       "                '1987/11/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1103/physrevb.36.7148 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Phys Rev B Condens Matter. 1987 Nov 1;36(13):7148-7150. doi: 10.1103/physrevb.36.7148.'},\n",
       "              {'PMID': '3551146',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19870514',\n",
       "               'LR': '20220317',\n",
       "               'IS': '0039-6109 (Print) 0039-6109 (Linking)',\n",
       "               'VI': '67',\n",
       "               'IP': '2',\n",
       "               'DP': '1987 Apr',\n",
       "               'TI': 'Management of goiter and thyroid nodules in an area of endemic goiter.',\n",
       "               'PG': '233-49',\n",
       "               'AB': 'This article discusses the diagnostic and therapeutic measures we have used during the past five years to treat 861 patients from an edemic goiter area with various thyroid disorders. The similarities and differences between these patients, with nontoxic goiter, toxic goiter, and thyroid cancer, were compared with those seen in patients with thyroid problems who live in iodine-rich areas.',\n",
       "               'FAU': ['Roher, H D', 'Goretzki, P E'],\n",
       "               'AU': ['Roher HD', 'Goretzki PE'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', 'Review'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Surg Clin North Am',\n",
       "               'JT': 'The Surgical clinics of North America',\n",
       "               'JID': '0074243',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['*Disease Reservoirs',\n",
       "                'Goiter/*diagnosis/surgery',\n",
       "                'Graves Disease/diagnosis/surgery',\n",
       "                'Humans',\n",
       "                'Hyperthyroidism/diagnosis/surgery',\n",
       "                'Preoperative Care',\n",
       "                'Thyroid Neoplasms/*diagnosis/surgery',\n",
       "                'Thyroidectomy'],\n",
       "               'RF': '66',\n",
       "               'EDAT': '1987/04/01 00:00',\n",
       "               'MHDA': '1987/04/01 00:01',\n",
       "               'CRDT': ['1987/04/01 00:00'],\n",
       "               'PHST': ['1987/04/01 00:00 [pubmed]',\n",
       "                '1987/04/01 00:01 [medline]',\n",
       "                '1987/04/01 00:00 [entrez]'],\n",
       "               'AID': ['S0039-6109(16)44181-2 [pii]',\n",
       "                '10.1016/s0039-6109(16)44181-2 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Surg Clin North Am. 1987 Apr;67(2):233-49. doi: 10.1016/s0039-6109(16)44181-2.'},\n",
       "              {'PMID': '3669824',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19871203',\n",
       "               'LR': '20190820',\n",
       "               'IS': '0023-8236 (Print) 0023-8236 (Linking)',\n",
       "               'VI': '371',\n",
       "               'IP': '2',\n",
       "               'DP': '1987',\n",
       "               'TI': '[Surgery of metastases of differentiated thyroid cancers].',\n",
       "               'PG': '103-13',\n",
       "               'AB': '84 (19.5%) of 431 patients with differentiated thyroid cancer developed distant metastases in bone and parenchymal organs. 78% of primary bone metastases and only 21% of primary lung metastases were treated operatively. High survival rates of 33-60% at 5 years supported the necessity of surgical interventions primarily in bone metastases to prevent early morbidity due to pathological fractures. Even in case of questionable increase in survival rate surgery of metastases from differentiated thyroid carcinomas doubtlessly improves the quality of life in these patients.',\n",
       "               'FAU': ['Roher, H D', 'Goretzki, P E', 'Wahl, R A'],\n",
       "               'AU': ['Roher HD', 'Goretzki PE', 'Wahl RA'],\n",
       "               'AD': ['Zentrum Operative Medizin I, Klinik fur Allgemeine und Unfallchirurgie der Medizinischen Einrichtungen, Universitat Dusseldorf.'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Case Reports', 'English Abstract', 'Journal Article'],\n",
       "               'TT': 'Chirurgie der Metastasen differenzierter Schilddrusencarcinome.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie',\n",
       "               'JID': '0204167',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma/*surgery',\n",
       "                'Aged',\n",
       "                'Carcinoma/*surgery',\n",
       "                'Carcinoma, Papillary/*surgery',\n",
       "                'Combined Modality Therapy',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Neoplasm Metastasis',\n",
       "                'Thyroid Neoplasms/*surgery',\n",
       "                'Thyroidectomy'],\n",
       "               'EDAT': '1987/01/01 00:00',\n",
       "               'MHDA': '1987/01/01 00:01',\n",
       "               'CRDT': ['1987/01/01 00:00'],\n",
       "               'PHST': ['1987/01/01 00:00 [pubmed]',\n",
       "                '1987/01/01 00:01 [medline]',\n",
       "                '1987/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF01251902 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir. 1987;371(2):103-13. doi: 10.1007/BF01251902.'},\n",
       "              {'PMID': '3475914',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19870921',\n",
       "               'LR': '20191029',\n",
       "               'IS': '0300-9750 (Print) 0300-9750 (Linking)',\n",
       "               'VI': '281',\n",
       "               'DP': '1987',\n",
       "               'TI': 'Pathophysiological and clinical implications of thyroid growth-stimulating immunoglobulins: evidence for their intrathyroidal production.',\n",
       "               'PG': '334-41',\n",
       "               'AB': \"Thyroid growth-stimulating immunoglobulins are responsible for goitre formation not only in Graves' and Hashimoto's disease but also (partly) in simple goitre, especially in recurrent cases. TGI are antibodies, the TSH receptor, however, appears not to be the antigenic site in simple goitre. In our own studies two TGI assay systems ([3H]thymidine incorporation into isolated porcine thyroid follicles and into FRTL-5 cells) gave comparable results. TGI was found in 20 out of 72 patients with simple goitre (27%) coming from an endemic goitre area (biased by selection, i.e. certainly including sporadic forms) and in 10 out of 26 patients (38%) with recurrent goitre. TGI levels were higher in thyroidal venous blood compared to cubital blood (simultaneously drawn during surgery) indicating an intrathyroidal production of TGI. Thyroid growth-blocking antibodies as estimated in the FRTL-5 cell assay in one of our patients might be of significance not only in primary myxoedema but also for congenital hypothyroidism.\",\n",
       "               'FAU': ['Schatz, H', 'Ludwig, I', 'Wiss, F', 'Goretzki, P E'],\n",
       "               'AU': ['Schatz H', 'Ludwig I', 'Wiss F', 'Goretzki PE'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'Denmark',\n",
       "               'TA': 'Acta Endocrinol Suppl (Copenh)',\n",
       "               'JT': 'Acta endocrinologica. Supplementum',\n",
       "               'JID': '0370313',\n",
       "               'RN': ['0 (Immunoglobulins)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Animals',\n",
       "                'Cell Division',\n",
       "                'Graves Disease/*immunology/physiopathology',\n",
       "                'Humans',\n",
       "                'Immunoglobulins/*immunology',\n",
       "                'Swine',\n",
       "                'Thyroid Gland/cytology/*immunology/physiopathology',\n",
       "                'Thyroiditis, Autoimmune/*immunology/physiopathology'],\n",
       "               'EDAT': '1987/01/01 00:00',\n",
       "               'MHDA': '1987/01/01 00:01',\n",
       "               'CRDT': ['1987/01/01 00:00'],\n",
       "               'PHST': ['1987/01/01 00:00 [pubmed]',\n",
       "                '1987/01/01 00:01 [medline]',\n",
       "                '1987/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1530/acta.0.114s334 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Acta Endocrinol Suppl (Copenh). 1987;281:334-41. doi: 10.1530/acta.0.114s334.'},\n",
       "              {'PMID': '3475910',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19870921',\n",
       "               'LR': '20191029',\n",
       "               'IS': '0300-9750 (Print) 0300-9750 (Linking)',\n",
       "               'VI': '281',\n",
       "               'DP': '1987',\n",
       "               'TI': 'Adenylate cyclase stimulation and [3H]thymidine incorporation in human thyroid tissues and thyrocyte cultures: the effect of IgG preparation from patients with different thyroid disorders.',\n",
       "               'PG': '281-7',\n",
       "               'AB': \"Primary cell cultures of normal and adenomatous human thyroid tissues were incubated with TSH or ammonium sulphate precipited IGG fractions (1 mg/ml) of sera from patients with different thyroid diseases (Graves' disease: active n = 7 in remission n = 12; thyroid autonomy n = 39; simple euthyroid goitre n = 15) and were compared to controls (n = 26). [3H]thymidine incorporation in primary thyrocyte cultures demonstrated a typical bell shape curve after incubation with EGF and TSH with a maximal effect at 10-100 microIU/ml. This effect, however, was inconsistent and positive only in 2 of 7 primary cultures. Only TSH positive cultures were used for IgG studies. 16-28% of IGG fractions from sera of thyroid patients caused high (more than X + 5 SD of controls) stimulation of [3H]thymidine incorporation. Dose response curves of IgG fractions of 19 additional patients (Graves' disease in remission n = 15; thyroid autonomy n = 4) showed an increase in [3H]thymidine incorporation at 0.1 mg protein/ml for 10 patients and at low concentrations of 10-5 mg/ml for 5 patients. There was a good correlation (r = 0.72) (P less than 0.0001) between positive findings in TSH-binding inhibition (TBII) and AC-stimulation (TSI) IGG fractions but none between stimulation of [3H]thymidine incorporation and any other thyroid specific immunoglobulin nor thyroid function nor any other available data. Immunoglobulins stimulating [3H]thymidine incorporation differ therefore from TBII and TSI. The growth effect of these immunoglobulins, however, has yet to be determined.\",\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'West, M',\n",
       "                'Koob, R',\n",
       "                'Koller, C',\n",
       "                'Joseph, K',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Goretzki PE',\n",
       "                'West M',\n",
       "                'Koob R',\n",
       "                'Koller C',\n",
       "                'Joseph K',\n",
       "                'Roher HD'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Denmark',\n",
       "               'TA': 'Acta Endocrinol Suppl (Copenh)',\n",
       "               'JT': 'Acta endocrinologica. Supplementum',\n",
       "               'JID': '0370313',\n",
       "               'RN': ['0 (Immunoglobulin G)',\n",
       "                'EC 4.6.1.1 (Adenylyl Cyclases)',\n",
       "                'VC2W18DGKR (Thymidine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/pathology',\n",
       "                'Adenylyl Cyclases/*metabolism',\n",
       "                'Cells, Cultured',\n",
       "                '*DNA Replication',\n",
       "                'Goiter/*immunology',\n",
       "                'Humans',\n",
       "                '*Immunoglobulin G',\n",
       "                'Thymidine/metabolism',\n",
       "                'Thyroid Gland/*cytology/immunology/metabolism',\n",
       "                'Thyroid Neoplasms/pathology'],\n",
       "               'EDAT': '1987/01/01 00:00',\n",
       "               'MHDA': '1987/01/01 00:01',\n",
       "               'CRDT': ['1987/01/01 00:00'],\n",
       "               'PHST': ['1987/01/01 00:00 [pubmed]',\n",
       "                '1987/01/01 00:01 [medline]',\n",
       "                '1987/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1530/acta.0.114s281 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Acta Endocrinol Suppl (Copenh). 1987;281:281-7. doi: 10.1530/acta.0.114s281.'},\n",
       "              {'PMID': '3475909',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19870921',\n",
       "               'LR': '20191029',\n",
       "               'IS': '0300-9750 (Print) 0300-9750 (Linking)',\n",
       "               'VI': '281',\n",
       "               'DP': '1987',\n",
       "               'TI': 'Thyrotropin (TSH) stimulates cell growth and DNA synthesis in monolayer cultures of human thyrocytes independent of the adenylate-cyclase system.',\n",
       "               'PG': '273-80',\n",
       "               'AB': 'Monolayer cultures of human thyrocytes from normal thyroids (n = 13), thyroid adenomas (n = 8), differentiated (n = 7), poorly and undifferentiated (n = 5) thyroid cancers as well as thyroid cancer metastases (n = 2) were established to assess the significance of TSH and cAMP on cell growth and DNA synthesis. Cell growth was stimulated by 0.1 IU bTSH/ml and inhibited by 1.0 IU bTSH/ml (P less than 0.01), while dibutyryl-cAMP (dbcAMP) failed to show any effect on cell growth at the concentrations (10-5; 10-3 mol/l), tested. Neither did the adenylate-cyclase inhibitor dideoxy-adenosine (ddA) (2 X 10-5 mol/l) stimulate thyrocyte growth. DNA synthesis, however, measured indirectly by [3H]thymidine incorporation, was stimulated not only by TSH 2-12-fold, but also by ddA 1.3-7-fold (P less than 0.01), and was not affected by dbcAMP. TSH had no effect on [3H]thymidine incorporation in fibroblasts and c-cells from c-cell carcinomas. The stimulatory effect of TSH on thyrocyte growth and DNA synthesis was unpredictable in thyrocytes from cancerous tissues (n = 14) with no obvious correlation to tumour differentiation or stage. Thus, we showed that TSH is a promotor for cell growth and DNA synthesis in monolayer cultures of human thyrocytes from normal and adenomatous human thyroid tissues with no obvious correlation to the AC system. This TSH effect is unpredictable, however, in thyrocytes from human thyroid cancer.',\n",
       "               'FAU': ['Goretzki, P E', 'Koob, R', 'Koller, C', 'Roher, H D'],\n",
       "               'AU': ['Goretzki PE', 'Koob R', 'Koller C', 'Roher HD'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Denmark',\n",
       "               'TA': 'Acta Endocrinol Suppl (Copenh)',\n",
       "               'JT': 'Acta endocrinologica. Supplementum',\n",
       "               'JID': '0370313',\n",
       "               'RN': ['9002-71-5 (Thyrotropin)',\n",
       "                'EC 4.6.1.1 (Adenylyl Cyclases)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/pathology',\n",
       "                'Adenylyl Cyclases/*physiology',\n",
       "                'Cell Division/drug effects',\n",
       "                'Cells, Cultured',\n",
       "                'DNA Replication/*drug effects',\n",
       "                'Humans',\n",
       "                'Neoplasm Metastasis',\n",
       "                'Thyroid Gland/*cytology/drug effects/pathology',\n",
       "                'Thyroid Neoplasms/pathology',\n",
       "                'Thyrotropin/*pharmacology'],\n",
       "               'EDAT': '1987/01/01 00:00',\n",
       "               'MHDA': '1987/01/01 00:01',\n",
       "               'CRDT': ['1987/01/01 00:00'],\n",
       "               'PHST': ['1987/01/01 00:00 [pubmed]',\n",
       "                '1987/01/01 00:01 [medline]',\n",
       "                '1987/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1530/acta.0.114s273 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Acta Endocrinol Suppl (Copenh). 1987;281:273-80. doi: 10.1530/acta.0.114s273.'}],\n",
       "             '1986': [{'PMID': '3024342',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19861229',\n",
       "               'LR': '20131121',\n",
       "               'IS': '0039-6060 (Print) 0039-6060 (Linking)',\n",
       "               'VI': '100',\n",
       "               'IP': '6',\n",
       "               'DP': '1986 Dec',\n",
       "               'TI': 'The effect of thyrotropin and cAMP on DNA synthesis and cell growth of human thyrocytes in monolayer culture.',\n",
       "               'PG': '1053-61',\n",
       "               'AB': \"Monolayer cultures of human thyrocytes from normal tissue (n = 10), and adenomas (n = 7), differentiated (n = 4), poorly differentiated (n = 2), and undifferentiated (n = 3) thyroid cancers were established to assess the significance of thyrotropin (TSH) and cAMP (adenosine 3',5'-cyclic monophosphate) on cell growth and DNA (deoxyribonucleic acid) synthesis. Cell growth of thyrocytes from normal and adenomatous tissues increased more rapidly (p less than 0.01) after TSH (0.1 IU/ml) was added but was unaffected by cAMP (10(-4) mol/L). In these cells, TSH also enhanced DNA synthesis twofold to twelvefold (p less than 0.01). The adenylate cyclase (AC) inhibitor, 2',3' dideoxyadenosine (ddA), increased DNA synthesis 1.3 to 6 times at a concentration of 2 X 10(-4) mol, whereas the membrane/passable cAMP analogue, dibutyryl-cAMP, and the AC stimulator, forskolin, failed to show any effect on DNA synthesis up to a concentration of 10(-5) mol/L (p less than NS). When administered simultaneously, TSH (1/2 maximum) and ddA (20 mumol) had no cumulative effect on DNA synthesis (p = NS). TSH stimulation in cancerous thyroid tissue (n = 11) demonstrated a lack of TSH response in seven of 11 monolayer cultures with no apparent correlation to cancer differentiation, patient age, or sex. Thus TSH was demonstrated to stimulate DNA synthesis and cell growth of human thyrocytes in monolayer cultures independent of the AC system. However, the TSH effect on cell growth and DNA synthesis was unpredictable in thyrocytes from cancerous tissues.\",\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Koob, R',\n",
       "                'Koller, T',\n",
       "                'Simon, R',\n",
       "                'Branscheid, D',\n",
       "                'Clark, O H',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Goretzki PE',\n",
       "                'Koob R',\n",
       "                'Koller T',\n",
       "                'Simon R',\n",
       "                'Branscheid D',\n",
       "                'Clark OH',\n",
       "                'Roher HD'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comparative Study',\n",
       "                'Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Surgery',\n",
       "               'JT': 'Surgery',\n",
       "               'JID': '0417347',\n",
       "               'RN': ['0 (Deoxyadenosines)',\n",
       "                '1F7A44V6OU (Colforsin)',\n",
       "                '4Q86AH641A (Dideoxyadenosine)',\n",
       "                '9002-71-5 (Thyrotropin)',\n",
       "                '9007-49-2 (DNA)',\n",
       "                'E0399OZS9N (Cyclic AMP)',\n",
       "                'VC2W18DGKR (Thymidine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/metabolism',\n",
       "                'Cells, Cultured',\n",
       "                'Colforsin/pharmacology',\n",
       "                'Cyclic AMP/*pharmacology',\n",
       "                'DNA/biosynthesis/*drug effects',\n",
       "                'Deoxyadenosines/analogs & derivatives/pharmacology',\n",
       "                'Dideoxyadenosine',\n",
       "                'Dose-Response Relationship, Drug',\n",
       "                'Humans',\n",
       "                'Thymidine/metabolism',\n",
       "                'Thyroid Gland/cytology/*drug effects/metabolism',\n",
       "                'Thyroid Neoplasms/metabolism',\n",
       "                'Thyrotropin/*pharmacology',\n",
       "                'Time Factors'],\n",
       "               'EDAT': '1986/12/01 00:00',\n",
       "               'MHDA': '1986/12/01 00:01',\n",
       "               'CRDT': ['1986/12/01 00:00'],\n",
       "               'PHST': ['1986/12/01 00:00 [pubmed]',\n",
       "                '1986/12/01 00:01 [medline]',\n",
       "                '1986/12/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Surgery. 1986 Dec;100(6):1053-61.'},\n",
       "              {'PMID': '3536478',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19870114',\n",
       "               'LR': '20220511',\n",
       "               'IS': '0261-4189 (Print) 1460-2075 (Electronic) 0261-4189 (Linking)',\n",
       "               'VI': '5',\n",
       "               'IP': '10',\n",
       "               'DP': '1986 Oct',\n",
       "               'TI': 'Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins.',\n",
       "               'PG': '2495-502',\n",
       "               'AB': 'A pool of synthetic oligonucleotides was used to identify the gene encoding tetanus toxin on a 75-kbp plasmid from a toxigenic non-sporulating strain of Clostridium tetani. The nucleotide sequence contained a single open reading frame coding for 1315 amino acids corresponding to a polypeptide with a mol. wt of 150,700. In the mature toxin molecule, proline (2) and serine (458) formed the N termini of the 52,288 mol. wt light chain and the 98,300 mol. wt heavy chain, respectively. Cysteine (467) was involved in the disulfide linkage between the two subchains. The amino acid sequences of the tetanus toxin revealed striking homologies with the partial amino acid sequences of botulinum toxins A, B, and E, indicating that the neurotoxins from C. tetani and C. botulinum are derived from a common ancestral gene. Overlapping peptides together covering the entire tetanus toxin molecule were synthesized in Escherichia coli and identified by monoclonal antibodies. The promoter of the toxin gene was localized in a region extending 322 bp upstream from the ATG codon and was shown to be functional in E. coli.',\n",
       "               'FAU': ['Eisel, U',\n",
       "                'Jarausch, W',\n",
       "                'Goretzki, K',\n",
       "                'Henschen, A',\n",
       "                'Engels, J',\n",
       "                'Weller, U',\n",
       "                'Hudel, M',\n",
       "                'Habermann, E',\n",
       "                'Niemann, H'],\n",
       "               'AU': ['Eisel U',\n",
       "                'Jarausch W',\n",
       "                'Goretzki K',\n",
       "                'Henschen A',\n",
       "                'Engels J',\n",
       "                'Weller U',\n",
       "                'Hudel M',\n",
       "                'Habermann E',\n",
       "                'Niemann H'],\n",
       "               'LA': ['eng'],\n",
       "               'SI': ['GENBANK/X04436'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'England',\n",
       "               'TA': 'EMBO J',\n",
       "               'JT': 'The EMBO journal',\n",
       "               'JID': '8208664',\n",
       "               'RN': ['0 (Macromolecular Substances)',\n",
       "                '0 (Tetanus Toxin)',\n",
       "                'EC 3.4.24.69 (Botulinum Toxins)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Amino Acid Sequence',\n",
       "                'Base Sequence',\n",
       "                'Botulinum Toxins/*genetics',\n",
       "                'Clostridium tetani/*genetics',\n",
       "                'Escherichia coli/*genetics',\n",
       "                'Macromolecular Substances',\n",
       "                'Nucleic Acid Hybridization',\n",
       "                'Sequence Homology, Nucleic Acid',\n",
       "                'Tetanus Toxin/*genetics'],\n",
       "               'PMC': 'PMC1167145',\n",
       "               'EDAT': '1986/10/01 00:00',\n",
       "               'MHDA': '1986/10/01 00:01',\n",
       "               'PMCR': ['1987/10/01'],\n",
       "               'CRDT': ['1986/10/01 00:00'],\n",
       "               'PHST': ['1986/10/01 00:00 [pubmed]',\n",
       "                '1986/10/01 00:01 [medline]',\n",
       "                '1986/10/01 00:00 [entrez]',\n",
       "                '1987/10/01 00:00 [pmc-release]'],\n",
       "               'AID': ['10.1002/j.1460-2075.1986.tb04527.x [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'EMBO J. 1986 Oct;5(10):2495-502. doi: 10.1002/j.1460-2075.1986.tb04527.x.'},\n",
       "              {'PMID': '3519777',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19860714',\n",
       "               'LR': '20190723',\n",
       "               'IS': '0022-1759 (Print) 0022-1759 (Linking)',\n",
       "               'VI': '90',\n",
       "               'IP': '1',\n",
       "               'DP': '1986 Jun 10',\n",
       "               'TI': 'Screening for bacterial Fc-receptor activity on nitrocellulose membranes.',\n",
       "               'PG': '47-50',\n",
       "               'AB': 'Fc receptors released from staphylococci and streptococci could be readily detected by direct cultivation of the bacteria on nitrocellulose membranes or by microfiltration of their culture supernatants. The nitrocellulose membranes used in both assays were subsequently treated with human immunoglobulin (Ig) G. The reactions of the Fc receptor with IgG could be demonstrated by use of the respective peroxidase-labelled antibodies against IgG. The resulting color formation, which indicated Fc-receptor activity of the bacterial culture, closely corresponded to the 125I-labelled IgG-binding reactivity.',\n",
       "               'FAU': ['Lammler, C',\n",
       "                'Schaufuss, P',\n",
       "                'Goretzki, K',\n",
       "                'Blobel, H'],\n",
       "               'AU': ['Lammler C', 'Schaufuss P', 'Goretzki K', 'Blobel H'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Netherlands',\n",
       "               'TA': 'J Immunol Methods',\n",
       "               'JT': 'Journal of immunological methods',\n",
       "               'JID': '1305440',\n",
       "               'RN': ['0 (Immunoglobulin G)',\n",
       "                '0 (Membranes, Artificial)',\n",
       "                '0 (Receptors, Fc)',\n",
       "                '9004-70-0 (Collodion)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Collodion',\n",
       "                'Immunoenzyme Techniques',\n",
       "                'Immunoglobulin G/immunology',\n",
       "                'Membranes, Artificial',\n",
       "                'Receptors, Fc/*analysis/immunology',\n",
       "                'Staphylococcus/*analysis',\n",
       "                'Streptococcus/*analysis',\n",
       "                'Ultrafiltration'],\n",
       "               'EDAT': '1986/06/10 00:00',\n",
       "               'MHDA': '1986/06/10 00:01',\n",
       "               'CRDT': ['1986/06/10 00:00'],\n",
       "               'PHST': ['1986/06/10 00:00 [pubmed]',\n",
       "                '1986/06/10 00:01 [medline]',\n",
       "                '1986/06/10 00:00 [entrez]'],\n",
       "               'AID': ['0022-1759(86)90381-9 [pii]',\n",
       "                '10.1016/0022-1759(86)90381-9 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Immunol Methods. 1986 Jun 10;90(1):47-50. doi: 10.1016/0022-1759(86)90381-9.'},\n",
       "              {'PMID': '3807517',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19870318',\n",
       "               'LR': '20190820',\n",
       "               'IS': '0023-8236 (Print) 0023-8236 (Linking)',\n",
       "               'VI': '369',\n",
       "               'DP': '1986',\n",
       "               'TI': '[The cold thyroid nodule].',\n",
       "               'PG': '191-4',\n",
       "               'AB': 'A \"cold\" thyroid nodule basically always carries the risk of being \"malignant\". Scintigraphy and sonography can not differentiate between benign and malignant. The best means to discriminate the risk of \"cold nodules\" is by way of fine needle aspiration biopsy. In general the operative indication for \"cold\" nodules can be generous. In high suspicion the best surgical strategy is \"hemithyroidectomy\" as primary operation.',\n",
       "               'FAU': ['Roher, H D', 'Goretzki, P'],\n",
       "               'AU': ['Roher HD', 'Goretzki P'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Der \"kalte\" Schilddrusenknoten.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie',\n",
       "               'JID': '0204167',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Biopsy, Needle',\n",
       "                'Diagnosis, Differential',\n",
       "                'Humans',\n",
       "                'Thyroid Diseases/pathology/*surgery',\n",
       "                'Thyroid Gland/pathology',\n",
       "                'Thyroid Neoplasms/pathology/surgery'],\n",
       "               'EDAT': '1986/01/01 00:00',\n",
       "               'MHDA': '1986/01/01 00:01',\n",
       "               'CRDT': ['1986/01/01 00:00'],\n",
       "               'PHST': ['1986/01/01 00:00 [pubmed]',\n",
       "                '1986/01/01 00:01 [medline]',\n",
       "                '1986/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF01274350 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir. 1986;369:191-4. doi: 10.1007/BF01274350.'}],\n",
       "             '1985': [{'PMID': '3903336',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19851209',\n",
       "               'LR': '20190711',\n",
       "               'IS': '0023-2173 (Print) 0023-2173 (Linking)',\n",
       "               'VI': '63',\n",
       "               'IP': '17',\n",
       "               'DP': '1985 Sep 2',\n",
       "               'TI': 'Thyroid function after surgery for autonomous and non-autonomous nodular endemic goitre--effect of iodide-substitution.',\n",
       "               'PG': '812-20',\n",
       "               'AB': 'The aim of this study was to evaluate the influence of postoperative iodide-substitution on the function of thyroid remnants of different quality and quantity in order to define the appropriate prophylaxis (iodide or thyroid hormone) to prevent recurrent goitre. In a prospective, randomized clinical trial, the following patients were examined: group I: simple, non-autonomous nodular goitre, bilateral thyroidectomy (n = 40); group II: simple, non-autonomous nodular goitre, \"selective\" (unilateral) thyroidectomy (n = 40); group III: autonomous nodular goitre, bilateral thyroidectomy (n = 40); group IV: autonomous nodular goitre, \"selective\" (unilateral) thyroidectomy (n = 35). The following parameters were measured 6 and 12 weeks postoperatively. Serum-total-T4, -T3, -TSH, TRH-test, 99mTc-Thyroid-Uptake (TcTU). Six weeks postoperatively the 4 groups were separately randomized into controls and treatment groups, who received 200 micrograms iodide/day orally. Six weeks postoperatively, patients in group I had lower T4 levels and both basal and stimulated TSH were higher than in the other groups, however no significant differences were observed in T3, T4/T3 ratio and TcTU. Twelve weeks postoperatively patients from groups I, II and III, who had been treated with iodide, had lower T3 and TcTU values but higher T4 and T4/T3 than the appropriate controls. Basal and stimulated TSH showed no differences between controls and iodide-treated patients in these groups. In group IV, T4 and T3 showed a tendency to elevation (n.s.), and basal and stimulated TSH as well as TcTU were lower in patients with iodide.(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "               'FAU': ['Wahl, R A',\n",
       "                'Joseph, K',\n",
       "                'Bogner, E',\n",
       "                'Ohmann, C',\n",
       "                'Goretzki, P',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Wahl RA',\n",
       "                'Joseph K',\n",
       "                'Bogner E',\n",
       "                'Ohmann C',\n",
       "                'Goretzki P',\n",
       "                'Roher HD'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Clinical Trial',\n",
       "                'Journal Article',\n",
       "                'Randomized Controlled Trial'],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Klin Wochenschr',\n",
       "               'JT': 'Klinische Wochenschrift',\n",
       "               'JID': '2985205R',\n",
       "               'RN': ['0 (Thyroid Hormones)', '9679TC07X4 (Iodine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Clinical Trials as Topic',\n",
       "                'Combined Modality Therapy',\n",
       "                'Goiter, Endemic/*surgery',\n",
       "                'Goiter, Nodular/*surgery',\n",
       "                'Humans',\n",
       "                'Iodine/*therapeutic use',\n",
       "                'Postoperative Complications/blood',\n",
       "                'Recurrence',\n",
       "                '*Thyroid Function Tests',\n",
       "                'Thyroid Hormones/blood',\n",
       "                '*Thyroidectomy'],\n",
       "               'EDAT': '1985/09/02 00:00',\n",
       "               'MHDA': '1985/09/02 00:01',\n",
       "               'CRDT': ['1985/09/02 00:00'],\n",
       "               'PHST': ['1985/09/02 00:00 [pubmed]',\n",
       "                '1985/09/02 00:01 [medline]',\n",
       "                '1985/09/02 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF01732286 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Klin Wochenschr. 1985 Sep 2;63(17):812-20. doi: 10.1007/BF01732286.'},\n",
       "              {'PMID': '4057698',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19851203',\n",
       "               'LR': '20190919',\n",
       "               'IS': '0047-1909 (Print) 0047-1909 (Linking)',\n",
       "               'VI': '15',\n",
       "               'IP': '4',\n",
       "               'DP': '1985 Jul',\n",
       "               'TI': 'Low T3 syndrome in patients following major surgery.',\n",
       "               'PG': '285-90',\n",
       "               'AB': 'Time sequence and specificity of thyroid hormones and biochemical parameters were investigated in patients following major surgery. Serum concentration of triiodothyronine decreases significantly following operation, with a biphasic regression. There is a reciprocal change in serum reverse triiodothyronine levels, but serum thyroxine levels show no significant change after operation. The significant decrease in serum concentration of alpha-2-macroglobulin and antithrombin III during and after surgery is the result of consumption of these inhibitors because the reciprocal change in serum concentration of elastase-like protease has been recognized. According to the change of curvilinear regression of serum triiodothyronine levels, 14 patients were grouped into 3. The patients for whom the curvilinear regression resembled a polynomial of degree 3 and 2 had a good prognosis, but the remaining 4 with no significant curvilinear regression had major complications and 2 died. It is meaningful that the postoperative change of triiodothyronine levels relates to the clinical outcome, to some degree.',\n",
       "               'FAU': ['Tsuchiya, A',\n",
       "                'Goretzki, P E',\n",
       "                'Gramse, M',\n",
       "                'Joseph, K',\n",
       "                'Wahl, R A'],\n",
       "               'AU': ['Tsuchiya A',\n",
       "                'Goretzki PE',\n",
       "                'Gramse M',\n",
       "                'Joseph K',\n",
       "                'Wahl RA'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Japan',\n",
       "               'TA': 'Jpn J Surg',\n",
       "               'JT': 'The Japanese journal of surgery',\n",
       "               'JID': '1302176',\n",
       "               'RN': ['06LU7C9H1V (Triiodothyronine)',\n",
       "                '5817-39-0 (Triiodothyronine, Reverse)',\n",
       "                'Q51BO43MG4 (Thyroxine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adult',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Prognosis',\n",
       "                '*Surgical Procedures, Operative',\n",
       "                'Syndrome',\n",
       "                'Thyroxine/blood',\n",
       "                'Time Factors',\n",
       "                'Triiodothyronine/*blood/deficiency',\n",
       "                'Triiodothyronine, Reverse/blood'],\n",
       "               'EDAT': '1985/07/01 00:00',\n",
       "               'MHDA': '1985/07/01 00:01',\n",
       "               'CRDT': ['1985/07/01 00:00'],\n",
       "               'PHST': ['1985/07/01 00:00 [pubmed]',\n",
       "                '1985/07/01 00:01 [medline]',\n",
       "                '1985/07/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF02469919 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Jpn J Surg. 1985 Jul;15(4):285-90. doi: 10.1007/BF02469919.'},\n",
       "              {'PMID': '3838608',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19850508',\n",
       "               'LR': '20190824',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '9',\n",
       "               'IP': '1',\n",
       "               'DP': '1985 Feb',\n",
       "               'TI': 'Indication for operation of patients with autonomously functioning thyroid tissue in endemic goiter areas.',\n",
       "               'PG': '149-55',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Wahl, R A',\n",
       "                'Branscheid, D',\n",
       "                'Joseph, K',\n",
       "                'Tsuchiya, A',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Goretzki PE',\n",
       "                'Wahl RA',\n",
       "                'Branscheid D',\n",
       "                'Joseph K',\n",
       "                'Tsuchiya A',\n",
       "                'Roher HD'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adult',\n",
       "                'Female',\n",
       "                'Goiter, Endemic/*complications',\n",
       "                'Goiter, Nodular/complications',\n",
       "                'Graves Disease/etiology',\n",
       "                'Humans',\n",
       "                'Hyperthyroidism/*etiology',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Postoperative Complications',\n",
       "                'Thyroid Diseases/complications/etiology/*surgery'],\n",
       "               'EDAT': '1985/02/01 00:00',\n",
       "               'MHDA': '1985/02/01 00:01',\n",
       "               'CRDT': ['1985/02/01 00:00'],\n",
       "               'PHST': ['1985/02/01 00:00 [pubmed]',\n",
       "                '1985/02/01 00:01 [medline]',\n",
       "                '1985/02/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF01656269 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 1985 Feb;9(1):149-55. doi: 10.1007/BF01656269.'},\n",
       "              {'PMID': '2982058',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19850306',\n",
       "               'LR': '20190817',\n",
       "               'IS': '0022-4804 (Print) 0022-4804 (Linking)',\n",
       "               'VI': '38',\n",
       "               'IP': '2',\n",
       "               'DP': '1985 Feb',\n",
       "               'TI': 'Estrogen and thyroid-stimulating hormone (TSH) receptors in neoplastic and nonneoplastic human thyroid tissue.',\n",
       "               'PG': '89-96',\n",
       "               'AB': 'Estrogen-binding receptors (ER) and thyroid-stimulating hormone (TSH) receptors were observed in the cytosol and in a membrane particulate fraction, respectively, in most neoplastic and nonneoplastic human thyroid tissues. Fourteen of 15 thyroid neoplasms and 6 of 15 nonneoplastic thyroid specimens had estrogen receptors (assuming the sensitivity of our estrogen receptor assay is 0.2 fmole/mg protein), and 14 of 15 thyroid neoplasms and 11 of 15 nonneoplastic thyroid specimens had a high affinity, low capacity TSH receptor. Neoplastic thyroid tissue had more ER (2.35 +/- 0.70/fmole/mg protein) than nonneoplastic thyroid tissue (0.57 +/- 0.181/fmole/mg protein) removed from the same patients (P less than 0.05). The Kd for ER did not differ in nonneoplastic (0.41 +/- 0.090 nM) and neoplastic (0.311 +/- 0.048 nM) thyroid tissue. The number of TSH receptors was comparable in neoplastic (0.609 +/- 0.191 pmole/mg protein) and in nonneoplastic (0.765 +/- 0.181 pmole/mg protein) thyroid tissue removed from the same patients who had the ER studies. The maximal adenylate cyclase response to TSH was greater in the neoplastic (147 +/- 26.9 pmole/mg protein/30 min) than in nonneoplastic thyroid tissue (32.8 +/- 6.69 pmole/mg protein/30 min) (P less than 0.001) suggesting a greater metabolic responsiveness of the neoplastic thyroid tissue to TSH. No correlation was evident, however, between the number of estrogen and TSH receptors in nonneoplastic and neoplastic thyroid tissue (r = 0.226). This study demonstrates that neoplastic human thyroid tissues have both estrogen receptors and TSH receptors. The neoplastic tissue also has a greater AC response to TSH than nonneoplastic thyroid tissue.',\n",
       "               'FAU': ['Clark, O H',\n",
       "                'Gerend, P L',\n",
       "                'Davis, M',\n",
       "                'Goretzki, P E',\n",
       "                'Hoffman, P G Jr'],\n",
       "               'AU': ['Clark OH',\n",
       "                'Gerend PL',\n",
       "                'Davis M',\n",
       "                'Goretzki PE',\n",
       "                'Hoffman PG Jr'],\n",
       "               'LA': ['eng'],\n",
       "               'GR': ['1 P30 HD 11979/HD/NICHD NIH HHS/United States'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, U.S. Gov't, Non-P.H.S.\",\n",
       "                \"Research Support, U.S. Gov't, P.H.S.\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Surg Res',\n",
       "               'JT': 'The Journal of surgical research',\n",
       "               'JID': '0376340',\n",
       "               'RN': ['0 (Receptors, Cell Surface)',\n",
       "                '0 (Receptors, Estrogen)',\n",
       "                '9002-71-5 (Thyrotropin)',\n",
       "                'EC 4.6.1.1 (Adenylyl Cyclases)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma/*analysis/enzymology',\n",
       "                'Adenylyl Cyclases/metabolism',\n",
       "                'Adult',\n",
       "                'Aged',\n",
       "                'Female',\n",
       "                'Humans',\n",
       "                'Male',\n",
       "                'Middle Aged',\n",
       "                'Receptors, Cell Surface/*analysis',\n",
       "                'Receptors, Estrogen/*analysis',\n",
       "                'Thyroid Diseases/enzymology/*metabolism',\n",
       "                'Thyroid Gland/*analysis/enzymology',\n",
       "                'Thyroid Neoplasms/*analysis/enzymology',\n",
       "                'Thyrotropin/*analysis'],\n",
       "               'EDAT': '1985/02/01 00:00',\n",
       "               'MHDA': '2001/03/28 10:01',\n",
       "               'CRDT': ['1985/02/01 00:00'],\n",
       "               'PHST': ['1985/02/01 00:00 [pubmed]',\n",
       "                '2001/03/28 10:01 [medline]',\n",
       "                '1985/02/01 00:00 [entrez]'],\n",
       "               'AID': ['0022-4804(85)90012-5 [pii]',\n",
       "                '10.1016/0022-4804(85)90012-5 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Surg Res. 1985 Feb;38(2):89-96. doi: 10.1016/0022-4804(85)90012-5.'},\n",
       "              {'PMID': '4058200',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19851219',\n",
       "               'LR': '20190820',\n",
       "               'IS': '0023-8236 (Print) 0023-8236 (Linking)',\n",
       "               'VI': '366',\n",
       "               'DP': '1985',\n",
       "               'TI': '[Radicality principles in operations on malignant thyroid tumors].',\n",
       "               'PG': '61-8',\n",
       "               'AB': 'Different concepts are required by different tumors: anaplastic carcinomas rarely are accessible to curative surgery, but tumor reduction gives sense in combined concepts. In follicular carcinomas general (\"near\"-) total thyroidectomy + radioiodine + hormonal suppressive therapy is recommended, with respect to the high incidence of distant metastases even in low 1 degree Tu-stages. Papillary carcinomas allow a stage related procedure with exceptions from total thyroidectomy: no reintervention for \"occult\" carcinomas and-in patients under 40 years of age-hemithyroidectomy for intrathyroid tumors without regional metastases. In C-Cell-carcinomas total thyroidectomy has to be accompanied by lymph-node dissections of various extent, depending on familiary or sporadic type and tumor-stage.',\n",
       "               'FAU': ['Wahl, R A',\n",
       "                'Goretzki, P E',\n",
       "                'Joseph, K',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Wahl RA', 'Goretzki PE', 'Joseph K', 'Roher HD'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['English Abstract', 'Journal Article'],\n",
       "               'TT': 'Radikalitatsprinzipien bei der Operation maligner Schilddrusentumoren.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Langenbecks Arch Chir',\n",
       "               'JT': 'Langenbecks Archiv fur Chirurgie',\n",
       "               'JID': '0204167',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenocarcinoma/surgery',\n",
       "                'Carcinoma/surgery',\n",
       "                'Carcinoma, Papillary/surgery',\n",
       "                'Combined Modality Therapy',\n",
       "                'Humans',\n",
       "                'Lymph Node Excision',\n",
       "                'Prognosis',\n",
       "                'Thyroid Neoplasms/*surgery',\n",
       "                'Thyroidectomy/*methods'],\n",
       "               'EDAT': '1985/01/01 00:00',\n",
       "               'MHDA': '1985/01/01 00:01',\n",
       "               'CRDT': ['1985/01/01 00:00'],\n",
       "               'PHST': ['1985/01/01 00:00 [pubmed]',\n",
       "                '1985/01/01 00:01 [medline]',\n",
       "                '1985/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF01836607 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Langenbecks Arch Chir. 1985;366:61-8. doi: 10.1007/BF01836607.'},\n",
       "              {'PMID': '3897815',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19851010',\n",
       "               'LR': '20191022',\n",
       "               'IS': '0300-8584 (Print) 0300-8584 (Linking)',\n",
       "               'VI': '174',\n",
       "               'IP': '3',\n",
       "               'DP': '1985',\n",
       "               'TI': 'Enzymatic hydrolysis of tetanus toxin by intrinsic and extrinsic proteases. Characterization of the fragments by monoclonal antibodies.',\n",
       "               'PG': '139-50',\n",
       "               'AB': 'Enzymatic fragments of tetanus toxin were characterized by immunoblotting using a set of previously characterized antibodies (Ahnert-Hilger et al. (1983) and a set of novel antibodies. The selected antibodies recognized the light chain, fragment C (beta 1), and the complementary piece (beta 2) of the heavy chain when blotted on nitrocellulose. All toxin preparations contained intrinsic esteroprotease activity which became manifest in the presence of urea. The main split product was a fragment (MW 100 000) reacting with anti-fragment C and anti-beta 2 antibodies. Toxicity does not depend on this protease activity. Some crude preparations of tetanus toxin contain another split product (MW 47 000) which resembles fragment C. The main product of papain hydrolysis is fragment C, which appears as a double band under nonreducing conditions but is homogeneous when reduced. Chymotryptic digestion hydrolyses the heavy chain well but leaves the light chain largely intact. Tetanus toxin is very resistant against trypsin as compared with other proteases, although this enzyme splits numerous different links. Our data show the usefulness of immunoblotting with monoclonal antibodies in analytical work with tetanus toxin, and the relevance of intrinsic proteases.',\n",
       "               'FAU': ['Goretzki, K', 'Habermann, E'],\n",
       "               'AU': ['Goretzki K', 'Habermann E'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Med Microbiol Immunol',\n",
       "               'JT': 'Medical microbiology and immunology',\n",
       "               'JID': '0314524',\n",
       "               'RN': ['0 (Antibodies, Monoclonal)',\n",
       "                '0 (Peptide Fragments)',\n",
       "                '0 (Tetanus Toxin)',\n",
       "                'EC 3.4.- (Peptide Hydrolases)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Antibodies, Monoclonal',\n",
       "                'Molecular Weight',\n",
       "                'Peptide Fragments/analysis/immunology',\n",
       "                'Peptide Hydrolases/metabolism',\n",
       "                'Tetanus Toxin/*analysis/immunology/metabolism'],\n",
       "               'EDAT': '1985/01/01 00:00',\n",
       "               'MHDA': '1985/01/01 00:01',\n",
       "               'CRDT': ['1985/01/01 00:00'],\n",
       "               'PHST': ['1985/01/01 00:00 [pubmed]',\n",
       "                '1985/01/01 00:01 [medline]',\n",
       "                '1985/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF02298124 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Med Microbiol Immunol. 1985;174(3):139-50. doi: 10.1007/BF02298124.'}],\n",
       "             '1984': [{'PMID': '6150553',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19850117',\n",
       "               'LR': '20151119',\n",
       "               'IS': '0039-6060 (Print) 0039-6060 (Linking)',\n",
       "               'VI': '96',\n",
       "               'IP': '6',\n",
       "               'DP': '1984 Dec',\n",
       "               'TI': 'Absence of high-affinity binding sites for beta-adrenergic blockers and lack of adenyl cyclase stimulation to beta-adrenergic stimulators in most normal and adenomatous human thyroid tissues.',\n",
       "               'PG': '1001-8',\n",
       "               'AB': 'To determine whether the beta-blocking drug propranolol had any physiologic effect on normal (n = 14) and adenomatous (n = 15) human thyroid tissues, experiments were performed to study the binding of the beta-blockers 125I-iodocyanopindolol (125I-ICYP) and 125I-iodohydroxybenzylpindolol (125I-IHYP) and the stimulation of adenyl cyclase (AC) by isoproterenol. 125I-ICYP and 125I-IHYP failed to show high-affinity binding in 27 of 29 specimens, whereas two (one normal and one adenomatous) thyroid tissues demonstrated high-affinity binding (Kd 5.5 +/- 1 X 10(-9) M) for 125I-ICYP. Thyroid-stimulating hormone (0.3 IU/ml), guanosine triphosphate (10(-4) M), and Gpp (NH)p(10(-4) M) stimulated AC in all thyroid tissues, although in two tissues (normal) Gpp (NH)p failed to cause a significant increase. Isoproterenol (10(-4) M), in contrast, had no effect on basal AC activity or on guanosine triphosphate, and Gpp (NH) p stimulated AC activity in 26 of the 29 thyroid tissues. In one of the two tissues that increased AC in response to isoproterenol, the beta-blocking drugs propranolol hydrochloride, bunitrolol hydrochloride, and tolilprolol hydrochloride decreased AC stimulation to isoproterenol at concentrations of 10(-6) M (p less than 0.05). Higher concentrations of propranolol (10(-4) - 10(-2) M) decreased AC stimulation to thyroid-stimulating hormone (p less than 0.01), not only in this responsive tissue but also in tissues that failed to demonstrate high-affinity binding for 125I-ICYP and AC stimulation to isoproterenol (p less than 0.01). Thus most normal and adenomatous human thyroid tissues lack beta-receptors and a functioning beta-receptor AC system. High concentrations of propranolol in vitro decreased AC response by thyroid-stimulating hormone, but this is probably a nonreceptor-mediated effect.',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Wahl, R A',\n",
       "                'Branscheid, D',\n",
       "                'Roeher, H D'],\n",
       "               'AU': ['Goretzki PE', 'Wahl RA', 'Branscheid D', 'Roeher HD'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'Surgery',\n",
       "               'JT': 'Surgery',\n",
       "               'JID': '0417347',\n",
       "               'RN': ['0 (Propanolamines)',\n",
       "                '0 (Receptors, Adrenergic, beta)',\n",
       "                '34273-04-6 (Guanylyl Imidodiphosphate)',\n",
       "                '58946-16-0 (iodohydroxybenzylpindolol)',\n",
       "                '83498-72-0 (Iodocyanopindolol)',\n",
       "                '86-01-1 (Guanosine Triphosphate)',\n",
       "                '9002-71-5 (Thyrotropin)',\n",
       "                '9Y8NXQ24VQ (Propranolol)',\n",
       "                'BJ4HF6IU1D (Pindolol)',\n",
       "                'EC 4.6.1.1 (Adenylyl Cyclases)',\n",
       "                'L628TT009W (Isoproterenol)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenoma/*enzymology/metabolism',\n",
       "                'Adenylyl Cyclases/*metabolism',\n",
       "                'Guanosine Triphosphate/pharmacology',\n",
       "                'Guanylyl Imidodiphosphate/pharmacology',\n",
       "                'Humans',\n",
       "                'In Vitro Techniques',\n",
       "                'Iodocyanopindolol',\n",
       "                'Isoproterenol/pharmacology',\n",
       "                'Pindolol/analogs & derivatives/metabolism',\n",
       "                'Propanolamines/pharmacology',\n",
       "                'Propranolol/*pharmacology',\n",
       "                'Receptors, Adrenergic, beta/*drug effects',\n",
       "                'Thyroid Gland/enzymology/*metabolism',\n",
       "                'Thyroid Neoplasms/enzymology/*metabolism',\n",
       "                'Thyrotropin/pharmacology'],\n",
       "               'EDAT': '1984/12/01 00:00',\n",
       "               'MHDA': '1984/12/01 00:01',\n",
       "               'CRDT': ['1984/12/01 00:00'],\n",
       "               'PHST': ['1984/12/01 00:00 [pubmed]',\n",
       "                '1984/12/01 00:01 [medline]',\n",
       "                '1984/12/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Surgery. 1984 Dec;96(6):1001-8.'}],\n",
       "             '1983': [{'PMID': '6887841',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19831021',\n",
       "               'LR': '20190817',\n",
       "               'IS': '0022-4804 (Print) 0022-4804 (Linking)',\n",
       "               'VI': '35',\n",
       "               'IP': '3',\n",
       "               'DP': '1983 Sep',\n",
       "               'TI': 'Serum and tissue T3 levels in endotoxin shock in the rat.',\n",
       "               'PG': '211-7',\n",
       "               'FAU': ['Goretzki, P E',\n",
       "                'Cavalieri, R R',\n",
       "                'Wahl, R A',\n",
       "                'Ellis, R J',\n",
       "                'McMahon, F A',\n",
       "                'Goldfien, S',\n",
       "                'Gerend, P',\n",
       "                'Clark, O H'],\n",
       "               'AU': ['Goretzki PE',\n",
       "                'Cavalieri RR',\n",
       "                'Wahl RA',\n",
       "                'Ellis RJ',\n",
       "                'McMahon FA',\n",
       "                'Goldfien S',\n",
       "                'Gerend P',\n",
       "                'Clark OH'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article',\n",
       "                \"Research Support, Non-U.S. Gov't\",\n",
       "                \"Research Support, U.S. Gov't, Non-P.H.S.\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Surg Res',\n",
       "               'JT': 'The Journal of surgical research',\n",
       "               'JID': '0376340',\n",
       "               'RN': ['0 (Endotoxins)',\n",
       "                '06LU7C9H1V (Triiodothyronine)',\n",
       "                '451W47IQ8X (Sodium Chloride)',\n",
       "                '9Y8NXQ24VQ (Propranolol)',\n",
       "                'X4W7ZR7023 (Methylprednisolone)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Animals',\n",
       "                'Endotoxins/administration & dosage',\n",
       "                'Female',\n",
       "                'Injections, Intraperitoneal/adverse effects',\n",
       "                'Kidney/analysis',\n",
       "                'Liver/analysis',\n",
       "                'Methylprednisolone/administration & dosage',\n",
       "                'Propranolol/administration & dosage',\n",
       "                'Rats',\n",
       "                'Rats, Inbred Strains',\n",
       "                'Shock, Septic/drug therapy/etiology/*metabolism',\n",
       "                'Sodium Chloride/administration & dosage',\n",
       "                'Triiodothyronine/analysis/*blood'],\n",
       "               'EDAT': '1983/09/01 00:00',\n",
       "               'MHDA': '1983/09/01 00:01',\n",
       "               'CRDT': ['1983/09/01 00:00'],\n",
       "               'PHST': ['1983/09/01 00:00 [pubmed]',\n",
       "                '1983/09/01 00:01 [medline]',\n",
       "                '1983/09/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1016/s0022-4804(83)80006-7 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Surg Res. 1983 Sep;35(3):211-7. doi: 10.1016/s0022-4804(83)80006-7.'},\n",
       "              {'PMID': '6304132',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19830729',\n",
       "               'LR': '20151119',\n",
       "               'IS': '0021-972X (Print) 0021-972X (Linking)',\n",
       "               'VI': '57',\n",
       "               'IP': '1',\n",
       "               'DP': '1983 Jul',\n",
       "               'TI': 'Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue.',\n",
       "               'PG': '140-7',\n",
       "               'AB': 'Experiments were performed to determine whether the TSH receptor-adenylate cyclase (AC) system in benign and malignant thyroid neoplasms differs from the TSH receptor-AC system in normal thyroid tissue removed from the same patients. TSH binding and AC assays were performed using the same in vitro conditions. TSH binding was rapid, reversible, saturable, and hormone specific in particulate fractions from both normal and neoplastic thyroid tissue. A positive correlation existed between the equilibrium constants for [125I]bovine ([125I]bTSH) TSH binding and the concentration of TSH required to activate AC, suggesting that binding sites were coupled to AC in neoplastic thyroid tissue. Mean values for dissociation constants (Kd1 and Kd2), capacity (site 2), as determined by Scatchard analysis, and nonspecific binding (NSB) for the TSH receptors were lower in neoplastic thyroid. Some normal thyroid tissue appeared to lack a high affinity site, and some tumors lacked a low affinity binding site. Hormone specificities (bTSH, human (h) TSH, hLH, hFSH, hGH, hACTH, and glucagon) in normal thyroid and neoplastic tissue were virtually identical. hFSH, hACTH, hGH, and glucagon failed to inhibit [125I]bTSH binding or stimulate AC in either normal or neoplastic thyroid tissue, whereas hLH inhibited [125I]bTSH binding and stimulated AC, but required 10- to 100-fold higher concentrations than hTSH or bTSH. The specific binding and NSB of [125I]bTSH in both normal and neoplastic thyroid tissue was highest at pH 7.0 and lowest at pH 8.3. In contrast to bTSH binding, TSH stimulation of AC was lowest at pH 7.0 in both normal and neoplastic tissues and highest at pH levels of 7.5-8.0. TSH binding and TSH stimulation of AC activity were highest in the absence of NaCl and decreased progressively as the salt concentration was increased in both normal and neoplastic thyroid tissues. Increasing the sucrose concentration and, thus, the osmolarity of the system had a minimal effect on the binding of [125I]bTSH. Preincubation with ammonium sulfate did not significantly influence binding. Basal AC activity and the AC response to TSH were greater in neoplastic thyroid than in normal tissues. These studies demonstrate that changes in salt concentration and pH affect the TSH receptor-cyclase system in a comparable fashion in normal and neoplastic thyroid tissues. The discriminatory properties of the TSH receptor are also maintained in thyroid neoplasms. Thyroid tumors, however, have a higher affinity for TSH and display a greater AC response to TSH than normal thyroid tissue.',\n",
       "               'FAU': ['Clark, O H',\n",
       "                'Gerend, P L',\n",
       "                'Goretzki, P',\n",
       "                'Nissenson, R A'],\n",
       "               'AU': ['Clark OH', 'Gerend PL', 'Goretzki P', 'Nissenson RA'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Comparative Study',\n",
       "                'Journal Article',\n",
       "                \"Research Support, U.S. Gov't, Non-P.H.S.\"],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'J Clin Endocrinol Metab',\n",
       "               'JT': 'The Journal of clinical endocrinology and metabolism',\n",
       "               'JID': '0375362',\n",
       "               'RN': ['0 (Receptors, Cell Surface)',\n",
       "                '0 (Receptors, Thyrotropin)',\n",
       "                '9002-71-5 (Thyrotropin)',\n",
       "                'EC 4.6.1.1 (Adenylyl Cyclases)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adenylyl Cyclases/*metabolism',\n",
       "                'Humans',\n",
       "                'Hydrogen-Ion Concentration',\n",
       "                'In Vitro Techniques',\n",
       "                'Osmolar Concentration',\n",
       "                'Receptors, Cell Surface/*metabolism',\n",
       "                'Receptors, Thyrotropin',\n",
       "                'Thyroid Gland/metabolism',\n",
       "                'Thyroid Neoplasms/*metabolism',\n",
       "                'Thyrotropin/metabolism'],\n",
       "               'EDAT': '1983/07/01 00:00',\n",
       "               'MHDA': '1983/07/01 00:01',\n",
       "               'CRDT': ['1983/07/01 00:00'],\n",
       "               'PHST': ['1983/07/01 00:00 [pubmed]',\n",
       "                '1983/07/01 00:01 [medline]',\n",
       "                '1983/07/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1210/jcem-57-1-140 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'J Clin Endocrinol Metab. 1983 Jul;57(1):140-7. doi: 10.1210/jcem-57-1-140.'},\n",
       "              {'PMID': '6194731',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19831123',\n",
       "               'LR': '20051117',\n",
       "               'IS': '0355-9521 (Print) 0355-9521 (Linking)',\n",
       "               'VI': '72',\n",
       "               'IP': '3',\n",
       "               'DP': '1983',\n",
       "               'TI': 'Surgery for hyperthyroidism: indications, pretreatment, operative strategy and results.',\n",
       "               'PG': '101-4',\n",
       "               'AB': \"In an endemic area nodular toxic goitre is the dominating type of hyperthyroidism, while Graves' or Basedow's disease with diffuse toxic goitre accounts for only 25 to 30% of the patients. Since antithyroid drug therapy has poor permanent effect and recurrence rates of about 50 to 60% and radioiodine in turn requires higher doses and often repeated application, surgery is to be recommended as the primary treatment of choice for the nodular hyperthyroid goitre. -For Graves' disease the method of therapy is not as clear cut. Operation is indicated mainly when the disease is severe with a larger goitre or in younger age groups (below 40 years) where radioiodine may not be advisable. For preoperative treatment the use of antithyroid drugs in preferred, although iodine perhaps in combination with beta blockers may be used safely as well at least for moderate cases. In the presence of alternative means of treatment surgery should not exceed an operative risk of 0.5-1.5% with virtually no mortality. Our own experiences are based on a retrospective analysis of 702 patients from three hospitals.\",\n",
       "               'FAU': ['Roeher, H D',\n",
       "                'Wahl, R',\n",
       "                'Goretzki, P',\n",
       "                'Branscheid, D'],\n",
       "               'AU': ['Roeher HD', 'Wahl R', 'Goretzki P', 'Branscheid D'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'Finland',\n",
       "               'TA': 'Ann Chir Gynaecol',\n",
       "               'JT': 'Annales chirurgiae et gynaecologiae',\n",
       "               'JID': '7609767',\n",
       "               'RN': ['0 (Adrenergic beta-Antagonists)',\n",
       "                '0 (Antithyroid Agents)',\n",
       "                '0 (Iodine Radioisotopes)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Adolescent',\n",
       "                'Adrenergic beta-Antagonists/therapeutic use',\n",
       "                'Adult',\n",
       "                'Age Factors',\n",
       "                'Antithyroid Agents/therapeutic use',\n",
       "                'Child',\n",
       "                'Drug Therapy, Combination',\n",
       "                'Female',\n",
       "                'Goiter, Endemic/drug therapy/*surgery',\n",
       "                'Graves Disease/drug therapy',\n",
       "                'Humans',\n",
       "                'Hyperthyroidism/drug therapy/*surgery',\n",
       "                'Iodine Radioisotopes/therapeutic use',\n",
       "                'Preoperative Care',\n",
       "                'Recurrence'],\n",
       "               'EDAT': '1983/01/01 00:00',\n",
       "               'MHDA': '1983/01/01 00:01',\n",
       "               'CRDT': ['1983/01/01 00:00'],\n",
       "               'PHST': ['1983/01/01 00:00 [pubmed]',\n",
       "                '1983/01/01 00:01 [medline]',\n",
       "                '1983/01/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Ann Chir Gynaecol. 1983;72(3):101-4.'},\n",
       "              {'PMID': '6193402',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19831021',\n",
       "               'LR': '20191023',\n",
       "               'IS': '0300-8584 (Print) 0300-8584 (Linking)',\n",
       "               'VI': '172',\n",
       "               'IP': '2',\n",
       "               'DP': '1983',\n",
       "               'TI': 'Monoclonal antibodies against tetanus toxin and toxoid.',\n",
       "               'PG': '123-35',\n",
       "               'AB': 'Monoclonal antibodies against tetanus toxin and its toxoid were produced by immunizing mice with toxoid or toxin. They were measured by an enzyme-linked immunosorbent assay (ELISA), by a toxin neutralization test in mice (in vivo prevention test), and by their ability to prevent binding of 125I-toxin to brain membranes or gangliosides (in vitro prevention test). Six monoclonal antibodies obtained by immunization with toxoid (anti-toxoid 1-6) were investigated in more detail. They belonged to IgG class 1. Three of them (anti-toxoid 1, 2 and 3) recognized both toxoid and toxin as well as fragment B and the light chain of toxin, but not fragment C. Two other antibodies (anti-toxoid 4 and 5) were directed against toxoid only. Neither of them prevented toxin action in vitro or in vivo. Anti-toxoid 6 recognized toxin, toxoid and fragment C, but not light chain, and prevented toxin action in vitro and in vivo. Immunization against toxin was initiated with a toxin-antitoxin complex and boosted with toxin. We studied six antibodies in more detail, all of IgG type 2. Their KD against 125I-tetanus toxin varied from 10(-9) to 10(-10) M. Anti-toxin 2 recognized toxin, toxoid, light chain and fragment B, but not fragment C. The others reacted with toxin, toxoid and fragment C, but not with light chain or fragment B. All of them prevented toxin action in vitro and in vivo. As calculated from the maximal extinction achieved in the ELISA, tetanus toxin combined with a maximum of two different antibody molecules from our set. Gel filtration data indicate that tetanus toxin reacts with monoclonal antibodies one by one. Compared with polyclonal antiserum, monoclonal antibodies yield flatter slopes in both in vitro and in vivo prevention tests. Thus, they cannot substitute for the polyclonal antibodies in clinical situations, and cannot be calibrated in international units.',\n",
       "               'FAU': ['Ahnert-Hilger, G',\n",
       "                'Bizzini, B',\n",
       "                'Goretzki, K',\n",
       "                'Muller, H',\n",
       "                'Volckers, C',\n",
       "                'Habermann, E'],\n",
       "               'AU': ['Ahnert-Hilger G',\n",
       "                'Bizzini B',\n",
       "                'Goretzki K',\n",
       "                'Muller H',\n",
       "                'Volckers C',\n",
       "                'Habermann E'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article', \"Research Support, Non-U.S. Gov't\"],\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Med Microbiol Immunol',\n",
       "               'JT': 'Medical microbiology and immunology',\n",
       "               'JID': '0314524',\n",
       "               'RN': ['0 (Antibodies, Monoclonal)',\n",
       "                '0 (Epitopes)',\n",
       "                '0 (Gangliosides)',\n",
       "                '0 (Immunoglobulin G)',\n",
       "                '0 (Tetanus Toxin)',\n",
       "                '0 (Tetanus Toxoid)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Animals',\n",
       "                'Antibodies, Monoclonal/analysis/*immunology',\n",
       "                'Dose-Response Relationship, Immunologic',\n",
       "                'Enzyme-Linked Immunosorbent Assay',\n",
       "                'Epitopes/immunology',\n",
       "                'Gangliosides/metabolism',\n",
       "                'Immunoglobulin G/analysis',\n",
       "                'Mice',\n",
       "                'Neutralization Tests',\n",
       "                'Tetanus Toxin/*immunology/metabolism',\n",
       "                'Tetanus Toxoid/*immunology'],\n",
       "               'EDAT': '1983/01/01 00:00',\n",
       "               'MHDA': '1983/01/01 00:01',\n",
       "               'CRDT': ['1983/01/01 00:00'],\n",
       "               'PHST': ['1983/01/01 00:00 [pubmed]',\n",
       "                '1983/01/01 00:01 [medline]',\n",
       "                '1983/01/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF02124513 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Med Microbiol Immunol. 1983;172(2):123-35. doi: 10.1007/BF02124513.'}],\n",
       "             '1982': [{'PMID': '7123975',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19821203',\n",
       "               'LR': '20220317',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '6',\n",
       "               'IP': '4',\n",
       "               'DP': '1982 Jul',\n",
       "               'TI': 'Coexistence of hyperthyroidism and thyroid cancer.',\n",
       "               'PG': '385-90',\n",
       "               'FAU': ['Wahl, R A',\n",
       "                'Goretzki, P',\n",
       "                'Meybier, H',\n",
       "                'Nitschke, J',\n",
       "                'Linder, M',\n",
       "                'Roher, H D'],\n",
       "               'AU': ['Wahl RA',\n",
       "                'Goretzki P',\n",
       "                'Meybier H',\n",
       "                'Nitschke J',\n",
       "                'Linder M',\n",
       "                'Roher HD'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Journal Article'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Female',\n",
       "                'Humans',\n",
       "                'Hyperthyroidism/*complications/surgery',\n",
       "                'Male',\n",
       "                'Retrospective Studies',\n",
       "                'Thyroid Neoplasms/*complications/pathology/surgery'],\n",
       "               'EDAT': '1982/07/01 00:00',\n",
       "               'MHDA': '1982/07/01 00:01',\n",
       "               'CRDT': ['1982/07/01 00:00'],\n",
       "               'PHST': ['1982/07/01 00:00 [pubmed]',\n",
       "                '1982/07/01 00:01 [medline]',\n",
       "                '1982/07/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF01657662 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 1982 Jul;6(4):385-90. doi: 10.1007/BF01657662.'}],\n",
       "             '1981': [{'PMID': '7342482',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19820722',\n",
       "               'LR': '20190825',\n",
       "               'IS': '0364-2313 (Print) 0364-2313 (Linking)',\n",
       "               'VI': '5',\n",
       "               'IP': '6',\n",
       "               'DP': '1981 Nov',\n",
       "               'TI': 'Prophylaxis of recurrent goiter by high-dose L-thyroxine.',\n",
       "               'PG': '855-7',\n",
       "               'FAU': ['Goretzki, P', 'Roeher, H D', 'Horeyseck, G'],\n",
       "               'AU': ['Goretzki P', 'Roeher HD', 'Horeyseck G'],\n",
       "               'LA': ['eng'],\n",
       "               'PT': ['Clinical Trial',\n",
       "                'Journal Article',\n",
       "                'Randomized Controlled Trial'],\n",
       "               'PL': 'United States',\n",
       "               'TA': 'World J Surg',\n",
       "               'JT': 'World journal of surgery',\n",
       "               'JID': '7704052',\n",
       "               'RN': ['Q51BO43MG4 (Thyroxine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Goiter/*prevention & control',\n",
       "                'Humans',\n",
       "                'Postoperative Care',\n",
       "                'Recurrence',\n",
       "                'Thyroxine/*administration & dosage'],\n",
       "               'EDAT': '1981/11/01 00:00',\n",
       "               'MHDA': '1981/11/01 00:01',\n",
       "               'CRDT': ['1981/11/01 00:00'],\n",
       "               'PHST': ['1981/11/01 00:00 [pubmed]',\n",
       "                '1981/11/01 00:01 [medline]',\n",
       "                '1981/11/01 00:00 [entrez]'],\n",
       "               'AID': ['10.1007/BF01657975 [doi]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'World J Surg. 1981 Nov;5(6):855-7. doi: 10.1007/BF01657975.'}],\n",
       "             '1979': [{'PMID': '456135',\n",
       "               'OWN': 'NLM',\n",
       "               'STAT': 'MEDLINE',\n",
       "               'DCOM': '19790925',\n",
       "               'LR': '20131121',\n",
       "               'IS': '0303-6227 (Print) 0303-6227 (Linking)',\n",
       "               'DP': '1979',\n",
       "               'TI': '[Mode of action and tolerance of a single weekly dose of 1 mg of L-thyroxine for the prevention of recurrence of goiter].',\n",
       "               'PG': '251-4',\n",
       "               'AB': 'After resection of euthyroid goiter, different doses of thyroxine administration for prophylaxis against recurrence were tested and compared. Group 1 (n = 30) received 1 mg L-thyroxine weekly; group 2 (n = 31), 0.1 mg L-thyroxine daily. The intermittent, high-dose thyroxine turned out to be equally effective as the conventional daily intake and showed no negative side effects.',\n",
       "               'FAU': ['Roher, H D', 'Goretzki, P', 'Horeyseck, G'],\n",
       "               'AU': ['Roher HD', 'Goretzki P', 'Horeyseck G'],\n",
       "               'LA': ['ger'],\n",
       "               'PT': ['Comparative Study',\n",
       "                'English Abstract',\n",
       "                'Journal Article'],\n",
       "               'TT': 'Wirkungsweise und Vertraglichkeit einer wochentlichen Einzeldosis von 1 mg L-Thyroxin zur Kropfrezidivprophylaxe.',\n",
       "               'PL': 'Germany',\n",
       "               'TA': 'Chir Forum Exp Klin Forsch',\n",
       "               'JT': 'Chirurgisches Forum fur experimentelle und klinische Forschung',\n",
       "               'JID': '0435763',\n",
       "               'RN': ['Q51BO43MG4 (Thyroxine)'],\n",
       "               'SB': 'IM',\n",
       "               'MH': ['Follow-Up Studies',\n",
       "                'Goiter/*prevention & control/surgery',\n",
       "                'Humans',\n",
       "                'Recurrence',\n",
       "                'Thyroxine/*administration & dosage'],\n",
       "               'EDAT': '1979/01/01 00:00',\n",
       "               'MHDA': '1979/01/01 00:01',\n",
       "               'CRDT': ['1979/01/01 00:00'],\n",
       "               'PHST': ['1979/01/01 00:00 [pubmed]',\n",
       "                '1979/01/01 00:01 [medline]',\n",
       "                '1979/01/01 00:00 [entrez]'],\n",
       "               'PST': 'ppublish',\n",
       "               'SO': 'Chir Forum Exp Klin Forsch. 1979:251-4.'}]})"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\"\"\"\n",
    "Improved PubMed Search Script with Better Author Detection for Jupyter Lab\n",
    "\n",
    "This script retrieves publications from PubMed based on a search query,\n",
    "lists all author names, groups results by year, highlights specific authors,\n",
    "provides links to the original papers, and includes a GitHub Pages header.\n",
    "\n",
    "Features:\n",
    "- Cleaner author search query structure\n",
    "- Improved handling of author names with consistent formatting\n",
    "- Better detection of collaborations\n",
    "- Easy-to-update author list\n",
    "\n",
    "Requirements:\n",
    "- pip install biopython\n",
    "- pip install IPython (should already be installed with Jupyter)\n",
    "\"\"\"\n",
    "\n",
    "import re\n",
    "import sys\n",
    "import ssl\n",
    "import certifi\n",
    "from collections import defaultdict\n",
    "from datetime import datetime\n",
    "from IPython.display import HTML, display, Markdown\n",
    "\n",
    "try:\n",
    "    from Bio import Entrez\n",
    "    from Bio import Medline\n",
    "    # Fix for SSL certificate verification issues\n",
    "    import socket\n",
    "    import urllib.request\n",
    "    # Create a custom SSL context using certifi's certificates\n",
    "    custom_context = ssl.create_default_context(cafile=certifi.where())\n",
    "    \n",
    "    # Monkey patch the default opener\n",
    "    urllib.request.install_opener(\n",
    "        urllib.request.build_opener(\n",
    "            urllib.request.HTTPSHandler(context=custom_context)\n",
    "        )\n",
    "    )\n",
    "except ImportError:\n",
    "    print(\"This script requires Biopython and certifi. Please install them using:\")\n",
    "    print(\"!pip install biopython certifi\")\n",
    "    sys.exit(1)\n",
    "\n",
    "\n",
    "def build_search_query(authors_list, affiliation, default_start_year, collaboration_groups=None):\n",
    "    \"\"\"\n",
    "    Build a structured PubMed search query from a list of authors with individual date filters.\n",
    "    \n",
    "    Parameters:\n",
    "    authors_list (list): List of author dictionaries with name, tag and optional start_year\n",
    "    affiliation (str): Affiliation to search for (can be None to remove affiliation filter)\n",
    "    default_start_year (str): Default start year for publication date filter\n",
    "    collaboration_groups (list): List of research collaboration groups to include in search\n",
    "    \n",
    "    Returns:\n",
    "    str: Formatted PubMed search query\n",
    "    \"\"\"\n",
    "    # Process each author based on their tag type and start year\n",
    "    author_queries = []\n",
    "    \n",
    "    for author in authors_list:\n",
    "        name = author[\"name\"]\n",
    "        tag_type = author[\"tag\"]\n",
    "        \n",
    "        # Get author-specific start year if available, otherwise use default\n",
    "        start_year = author.get(\"start_year\", default_start_year)\n",
    "        \n",
    "        # Create date filter for this author\n",
    "        if start_year:\n",
    "            date_filter = f\"(\\\"{start_year}\\\"[Date - Publication] : \\\"3000\\\"[Date - Publication])\"\n",
    "        else:\n",
    "            date_filter = \"\"  # No date filter for this author\n",
    "        \n",
    "        if tag_type == \"author\":\n",
    "            # Standard author tag format\n",
    "            author_query = f\"({name}[Author])\"\n",
    "        elif tag_type == \"custom\":\n",
    "            # Keep custom queries as-is\n",
    "            author_query = f\"({name})\"\n",
    "        else:\n",
    "            # Default to author tag if not specified\n",
    "            author_query = f\"({name}[Author])\"\n",
    "            \n",
    "        # Add date filter if specified\n",
    "        if date_filter:\n",
    "            author_query = f\"({author_query} AND {date_filter})\"\n",
    "            \n",
    "        author_queries.append(author_query)\n",
    "    \n",
    "    # Add collaboration group searches if provided\n",
    "    if collaboration_groups:\n",
    "        for group in collaboration_groups:\n",
    "            author_queries.append(f\"(\\\"{group}\\\"[Corporate Author])\")\n",
    "    \n",
    "    # Join all author queries with OR\n",
    "    authors_query = \" OR \".join(author_queries)\n",
    "    \n",
    "    # Combine with affiliation if provided\n",
    "    if affiliation:\n",
    "        final_query = f\"({affiliation}[Affiliation]) AND ({authors_query})\"\n",
    "    else:\n",
    "        final_query = f\"({authors_query})\"  # No affiliation filter\n",
    "    \n",
    "    print(f\"Generated query: {final_query}\")\n",
    "    \n",
    "    return final_query\n",
    "    \n",
    "    return final_query\n",
    "\n",
    "\n",
    "def search_pubmed(query, max_results=None, email=\"your.email@example.com\", additional_pmids=None):\n",
    "    \"\"\"\n",
    "    Search PubMed for the given query and return a list of PubMed IDs.\n",
    "    \n",
    "    Parameters:\n",
    "    query (str): PubMed search query\n",
    "    max_results (int, optional): Maximum number of results to retrieve (None for unlimited)\n",
    "    email (str): Your email address (required by NCBI)\n",
    "    additional_pmids (list): List of specific PMIDs to add to results\n",
    "    \n",
    "    Returns:\n",
    "    list: List of PubMed records\n",
    "    \"\"\"\n",
    "    Entrez.email = email\n",
    "    all_records = []\n",
    "    \n",
    "    # First, directly fetch the specific PMIDs if provided\n",
    "    if additional_pmids and len(additional_pmids) > 0:\n",
    "        print(f\"First retrieving {len(additional_pmids)} specific PMIDs...\")\n",
    "        # Start with these known publications\n",
    "        specific_records = []\n",
    "        for pmid in additional_pmids:\n",
    "            try:\n",
    "                handle = Entrez.efetch(db=\"pubmed\", id=pmid, rettype=\"medline\", retmode=\"text\")\n",
    "                specific_records.extend(list(Medline.parse(handle)))\n",
    "                handle.close()\n",
    "            except Exception as e:\n",
    "                print(f\"  Error retrieving PMID {pmid}: {str(e)}\")\n",
    "        print(f\"Retrieved {len(specific_records)} specific publications\")\n",
    "        all_records.extend(specific_records)\n",
    "    \n",
    "    # Then, search PubMed to get the list of article IDs\n",
    "    print(f\"Searching PubMed for: {query}\")\n",
    "    try:\n",
    "        # If max_results is None, use a very large number to get all results\n",
    "        # PubMed API has a limit around 100,000 but we'll never reach that\n",
    "        retmax = max_results if max_results is not None else 100000\n",
    "        handle = Entrez.esearch(db=\"pubmed\", term=query, retmax=retmax, sort=\"date\")\n",
    "        record = Entrez.read(handle)\n",
    "        handle.close()\n",
    "    except Exception as e:\n",
    "        print(f\"Error searching PubMed: {str(e)}\")\n",
    "        print(\"\\nIf you're on macOS and having SSL certificate issues, try running this in a terminal:\")\n",
    "        print(\"python -m pip install --upgrade certifi\")\n",
    "        return all_records  # Return any records we already fetched directly\n",
    "    \n",
    "    id_list = record[\"IdList\"]\n",
    "    print(f\"Found {len(id_list)} articles via query\")\n",
    "    \n",
    "    # Don't fetch PMIDs we already have\n",
    "    existing_pmids = [record.get(\"PMID\", \"\") for record in all_records]\n",
    "    id_list = [pmid for pmid in id_list if pmid not in existing_pmids]\n",
    "    \n",
    "    if not id_list:\n",
    "        return all_records  # Return any records we already fetched directly\n",
    "    \n",
    "    # Then, fetch the full records for these IDs\n",
    "    print(f\"Retrieving details for {len(id_list)} additional articles...\")\n",
    "    try:\n",
    "        # For large result sets, fetch in batches to avoid timeout issues\n",
    "        batch_size = 500\n",
    "        for i in range(0, len(id_list), batch_size):\n",
    "            batch = id_list[i:i+batch_size]\n",
    "            print(f\"  Fetching batch {i//batch_size + 1} of {(len(id_list)-1)//batch_size + 1} ({len(batch)} articles)...\")\n",
    "            handle = Entrez.efetch(db=\"pubmed\", id=batch, rettype=\"medline\", retmode=\"text\")\n",
    "            batch_records = list(Medline.parse(handle))\n",
    "            handle.close()\n",
    "            all_records.extend(batch_records)\n",
    "    except Exception as e:\n",
    "        print(f\"Error fetching article details: {str(e)}\")\n",
    "    \n",
    "    print(f\"Total publications found: {len(all_records)}\")\n",
    "    return all_records\n",
    "\n",
    "\n",
    "def group_by_year(records):\n",
    "    \"\"\"Group records by publication year.\"\"\"\n",
    "    grouped = defaultdict(list)\n",
    "    \n",
    "    for record in records:\n",
    "        # Extract year from the publication date\n",
    "        if \"DP\" in record:\n",
    "            # Publication date format can vary, so we extract just the year\n",
    "            year_match = re.search(r'\\b(19|20)\\d{2}\\b', record[\"DP\"])\n",
    "            if year_match:\n",
    "                year = year_match.group(0)\n",
    "                grouped[year].append(record)\n",
    "            else:\n",
    "                grouped[\"Unknown Year\"].append(record)\n",
    "        else:\n",
    "            grouped[\"Unknown Year\"].append(record)\n",
    "    \n",
    "    return grouped\n",
    "\n",
    "\n",
    "def normalize_author_name(name):\n",
    "    \"\"\"\n",
    "    Normalize author names to handle variations in capitalization and special characters.\n",
    "    This helps with more consistent matching across different formats.\n",
    "    \"\"\"\n",
    "    # Convert to lowercase for case-insensitive matching\n",
    "    normalized = name.lower()\n",
    "    # Replace hyphen with space to catch both hyphenated and non-hyphenated versions\n",
    "    normalized = normalized.replace('-', ' ')\n",
    "    return normalized\n",
    "\n",
    "\n",
    "def is_team_member(author, authors_to_highlight):\n",
    "    \"\"\"\n",
    "    Check if an author is a team member using normalized name matching.\n",
    "    This handles different ways names might appear in PubMed.\n",
    "    \"\"\"\n",
    "    # Normalize the author name for more consistent matching\n",
    "    normalized_author = normalize_author_name(author)\n",
    "    \n",
    "    for highlight_name in authors_to_highlight:\n",
    "        # Skip empty highlight names\n",
    "        if not highlight_name:\n",
    "            continue\n",
    "            \n",
    "        # Split the highlight name (which should be in LastName Initial format)\n",
    "        highlight_parts = highlight_name.split() if isinstance(highlight_name, str) else []\n",
    "        \n",
    "        # Check for last name match (first part of the highlight name)\n",
    "        if len(highlight_parts) > 0:\n",
    "            last_name = normalize_author_name(highlight_parts[0])\n",
    "            \n",
    "            # Check if normalized last name is in the normalized author string\n",
    "            if last_name in normalized_author:\n",
    "                # If we have a last name match, check for initial if available\n",
    "                if len(highlight_parts) > 1:\n",
    "                    initial = highlight_parts[1][0].lower() if len(highlight_parts[1]) > 0 else \"\"\n",
    "                    \n",
    "                    # For initials, we look for them after the last name\n",
    "                    if initial:\n",
    "                        # Look for the initial after the last name mention\n",
    "                        last_name_pos = normalized_author.find(last_name)\n",
    "                        if last_name_pos >= 0:\n",
    "                            remaining_text = normalized_author[last_name_pos + len(last_name):]\n",
    "                            if initial.lower() in remaining_text.lower():\n",
    "                                return True\n",
    "                    else:\n",
    "                        # If no initial provided, last name match is enough\n",
    "                        return True\n",
    "                else:\n",
    "                    # If we only have a last name to match, that's enough\n",
    "                    return True\n",
    "    \n",
    "    return False\n",
    "\n",
    "\n",
    "def highlight_author(author, authors_to_highlight, format_type):\n",
    "    \"\"\"Highlight an author name if it appears in the list of authors to highlight.\"\"\"\n",
    "    if is_team_member(author, authors_to_highlight):\n",
    "        if format_type == \"text\":\n",
    "            return f\"**{author}**\"\n",
    "        elif format_type == \"html\":\n",
    "            return f'<span style=\"color: red; font-weight: bold;\">{author}</span>'\n",
    "        elif format_type == \"markdown\":\n",
    "            return f\"**{author}**\"\n",
    "    \n",
    "    return author\n",
    "\n",
    "\n",
    "def get_pubmed_link(pmid, format_type):\n",
    "    \"\"\"Generate a link to the PubMed article.\"\"\"\n",
    "    url = f\"https://pubmed.ncbi.nlm.nih.gov/{pmid}/\"\n",
    "    \n",
    "    if format_type == \"text\":\n",
    "        return url\n",
    "    elif format_type == \"html\":\n",
    "        return f'<a href=\"{url}\" target=\"_blank\" style=\"text-decoration: none;\">{url}</a>'\n",
    "    elif format_type == \"markdown\":\n",
    "        # Using HTML inside markdown to remove the underline\n",
    "        return f'<a href=\"{url}\" style=\"text-decoration: none;\">PubMed</a>'\n",
    "    \n",
    "    return url\n",
    "\n",
    "\n",
    "def format_record(record, authors_to_highlight, format_type):\n",
    "    \"\"\"Format a single record with highlighted authors.\"\"\"\n",
    "    # Get basic citation information\n",
    "    title = record.get(\"TI\", \"No Title Available\")\n",
    "    journal = record.get(\"JT\", \"Unknown Journal\")\n",
    "    volume = record.get(\"VI\", \"\")\n",
    "    issue = record.get(\"IP\", \"\")\n",
    "    pages = record.get(\"PG\", \"\")\n",
    "    pmid = record.get(\"PMID\", \"\")\n",
    "    \n",
    "    # Format journal info\n",
    "    journal_info = journal\n",
    "    if volume:\n",
    "        journal_info += f\", {volume}\"\n",
    "    if issue:\n",
    "        journal_info += f\"({issue})\"\n",
    "    if pages:\n",
    "        journal_info += f\":{pages}\"\n",
    "    \n",
    "    # Format authors\n",
    "    if \"AU\" in record:\n",
    "        authors = record[\"AU\"]\n",
    "        formatted_authors = []\n",
    "        \n",
    "        for author in authors:\n",
    "            formatted_authors.append(highlight_author(author, authors_to_highlight, format_type))\n",
    "        \n",
    "        if format_type == \"text\" or format_type == \"markdown\":\n",
    "            authors_text = \", \".join(formatted_authors)\n",
    "        elif format_type == \"html\":\n",
    "            authors_text = \", \".join(formatted_authors)\n",
    "    else:\n",
    "        authors_text = \"No authors listed\"\n",
    "    \n",
    "    # Create link to PubMed\n",
    "    pubmed_link = get_pubmed_link(pmid, format_type)\n",
    "    \n",
    "    # Format the complete record\n",
    "    if format_type == \"text\":\n",
    "        return f\"* {title}\\n  {authors_text}. {journal_info}. {pubmed_link}\\n\"\n",
    "    \n",
    "    elif format_type == \"html\":\n",
    "        return f\"\"\"\n",
    "        <li>\n",
    "            <strong>{title}</strong><br>\n",
    "            {authors_text}. <em>{journal_info}</em>. {pubmed_link}\n",
    "        </li>\n",
    "        <br>\n",
    "        \"\"\"\n",
    "    \n",
    "    elif format_type == \"markdown\":\n",
    "        return f\"* **{title}**  \\n  {authors_text}. *{journal_info}*. {pubmed_link}\\n\"\n",
    "\n",
    "\n",
    "def generate_output(grouped_records, authors_to_highlight, format_type, github_pages_header=None):\n",
    "    \"\"\"Generate formatted output.\"\"\"\n",
    "    if format_type == \"html\":\n",
    "        output = \"<html>\\n<head>\\n<title>PubMed Search Results</title>\\n</head>\\n<body>\\n\"\n",
    "    elif format_type == \"markdown\" and github_pages_header:\n",
    "        output = github_pages_header + \"\\n\\n\"\n",
    "    else:\n",
    "        output = \"\"\n",
    "    \n",
    "    # Sort years in descending order (most recent first)\n",
    "    for year in sorted(grouped_records.keys(), reverse=True):\n",
    "        records = grouped_records[year]\n",
    "        \n",
    "        if format_type == \"html\":\n",
    "            output += f\"<h2>{year}</h2>\\n<ul>\\n\"\n",
    "        elif format_type == \"markdown\":\n",
    "            output += f\"## {year}\\n\\n\"\n",
    "        else:\n",
    "            output += f\"{year}\\n\" + \"-\" * 40 + \"\\n\"\n",
    "        \n",
    "        for record in records:\n",
    "            formatted_record = format_record(record, authors_to_highlight, format_type)\n",
    "            output += formatted_record + \"\\n\"\n",
    "        \n",
    "        if format_type == \"html\":\n",
    "            output += \"</ul>\\n\"\n",
    "        else:\n",
    "            output += \"\\n\"\n",
    "    \n",
    "    if format_type == \"html\":\n",
    "        output += \"</body>\\n</html>\"\n",
    "    \n",
    "    return output\n",
    "\n",
    "\n",
    "def pubmed_search(query=None, email=None, authors_list=None, affiliation=None, \n",
    "                 default_start_year=None, highlight=None, max_results=100, \n",
    "                 output_format=\"markdown\", output_file=None, github_pages_header=None,\n",
    "                 collaboration_groups=None, additional_pmids=None):\n",
    "    \"\"\"\n",
    "    Main function for Jupyter notebooks to search PubMed and display results.\n",
    "    \n",
    "    Parameters:\n",
    "    query (str, optional): PubMed search query (if provided, overrides authors_list and affiliation)\n",
    "    email (str): Your email address (required by NCBI)\n",
    "    authors_list (list): List of author dictionaries with name, tag, and optional start_year\n",
    "    affiliation (str): Affiliation to search for\n",
    "    default_start_year (str): Default start year for publication date filter\n",
    "    highlight (list): List of author names to highlight\n",
    "    max_results (int): Maximum number of results to retrieve\n",
    "    output_format (str): Output format ('text', 'html', or 'markdown')\n",
    "    output_file (str): Optional file path to save the results\n",
    "    github_pages_header (str): Optional GitHub Pages front matter header\n",
    "    collaboration_groups (list): List of research collaboration groups to include in search\n",
    "    additional_pmids (list): List of specific PMIDs to include regardless of search results\n",
    "    \"\"\"\n",
    "    if highlight is None:\n",
    "        highlight = []\n",
    "    \n",
    "    # Build query if not provided\n",
    "    if query is None and authors_list is not None:\n",
    "        query = build_search_query(authors_list, affiliation, default_start_year, collaboration_groups)\n",
    "    \n",
    "    # Search PubMed\n",
    "    records = search_pubmed(query, max_results, email, additional_pmids)\n",
    "    \n",
    "    if not records:\n",
    "        print(\"No results found for the query or an error occurred\")\n",
    "        return\n",
    "    \n",
    "    # Group records by year\n",
    "    grouped_records = group_by_year(records)\n",
    "    \n",
    "    # Generate output\n",
    "    output = generate_output(grouped_records, highlight or authors_list, output_format, github_pages_header)\n",
    "    \n",
    "    # Save to file if requested\n",
    "    if output_file:\n",
    "        with open(output_file, 'w', encoding='utf-8') as f:\n",
    "            f.write(output)\n",
    "        print(f\"Results saved to {output_file}\")\n",
    "    \n",
    "    # Display results based on format\n",
    "    if output_format == \"html\":\n",
    "        display(HTML(output))\n",
    "    elif output_format == \"markdown\":\n",
    "        display(Markdown(output))\n",
    "    else:\n",
    "        print(output)\n",
    "    \n",
    "    return grouped_records  # Return data for further processing if needed\n",
    "\n",
    "\n",
    "# CONFIGURATION SECTION\n",
    "# ===========================================\n",
    "# Set your parameters here in an easy-to-edit format\n",
    "\n",
    "# CONFIGURATION SETTINGS\n",
    "# ===========================================\n",
    "\n",
    "# Your email for NCBI\n",
    "YOUR_EMAIL = \"nora.bruns@uk-essen.de\"\n",
    "\n",
    "# Affiliation to search - set to None to search without affiliation filter\n",
    "# Change to None to find publications without the city in the affiliation\n",
    "AFFILIATION = None  # Was \"Essen\"\n",
    "\n",
    "# No default start year - each author can have their own\n",
    "DEFAULT_START_YEAR = None\n",
    "\n",
    "# Maximum results to retrieve (set to None for unlimited)\n",
    "MAX_RESULTS = None  # No limit, retrieve all matching publications\n",
    "\n",
    "# OUTPUT SETTINGS\n",
    "# ===========================================\n",
    "OUTPUT_FORMAT = \"markdown\"  # Options: \"text\", \"html\", \"markdown\"\n",
    "OUTPUT_FILE = \"index.md\"  # Set to None to disable file output\n",
    "\n",
    "# List of authors to search for - easy to add/edit\n",
    "# Each author is a dictionary with:\n",
    "#   - name: Author name in \"LastName FirstName\" format for precise searching\n",
    "#   - highlight: Name format for highlighting (typically \"LastName Initial\")\n",
    "#   - tag: \"author\" for standard [Author] tag, \"custom\" for custom query\n",
    "#   - start_year: (Optional) Start year to filter publications for this author\n",
    "AUTHORS_LIST = [\n",
    "    # Dohna-Schwake with different variations to catch hyphenation and capitalization issues\n",
    "    {\"name\": \"Dohna-Schwake Christian\", \"highlight\": \"Dohna-Schwake C\", \"tag\": \"author\", \"start_year\": \"2019\"},\n",
    "    {\"name\": \"Dohna Schwake Christian\", \"highlight\": \"Dohna-Schwake C\", \"tag\": \"author\", \"start_year\": \"2019\"},\n",
    "    {\"name\": \"dohna-schwake c\", \"highlight\": \"Dohna-Schwake C\", \"tag\": \"custom\", \"start_year\": \"2019\"},\n",
    "    \n",
    "    # Bruns variations\n",
    "    {\"name\": \"Bruns Nora\", \"highlight\": \"Bruns N\", \"tag\": \"author\"},\n",
    "    {\"name\": \"bruns n essen\", \"highlight\": \"Bruns N\", \"tag\": \"custom\"},  # Kept as requested\n",
    "    \n",
    "    # Other team members\n",
    "    {\"name\": \"Schwarz Simone\", \"highlight\": \"Schwarz S\", \"tag\": \"author\"},\n",
    "    \n",
    "    # Goretzki with variations to catch collaborative papers\n",
    "    {\"name\": \"Goretzki Sarah\", \"highlight\": \"Goretzki S\", \"tag\": \"author\"},\n",
    "    {\"name\": \"Goretzki Sarah Charlotte\", \"highlight\": \"Goretzki SC\", \"tag\": \"author\"},\n",
    "    {\"name\": \"Goretzki S\", \"highlight\": \"Goretzki S\", \"tag\": \"custom\"},  # Without [Author] tag for better matching\n",
    "    {\"name\": \"Goretzki\", \"highlight\": \"Goretzki\", \"tag\": \"custom\"},  # Added to catch partial matches\n",
    "    \n",
    "    # Remaining team members\n",
    "    {\"name\": \"Greve Sandra\", \"highlight\": \"Greve S\", \"tag\": \"author\"},\n",
    "    {\"name\": \"Brensing Pia\", \"highlight\": \"Brensing P\", \"tag\": \"author\"},\n",
    "    {\"name\": \"Paul Luisa\", \"highlight\": \"Paul L\", \"tag\": \"author\"},\n",
    "    {\"name\": \"Hojeij Rayan\", \"highlight\": \"Hojeij R\", \"tag\": \"author\"}\n",
    "]\n",
    "\n",
    "# Known collaborative groups that might include team members\n",
    "COLLABORATION_GROUPS = [\n",
    "    \"German Neonatal Network\",\n",
    "    \"GNN\"\n",
    "]\n",
    "\n",
    "# Specific PMIDs that should be included regardless of search results\n",
    "# Add any known papers that aren't being found automatically\n",
    "ADDITIONAL_PMIDS = [\n",
    "    \"36670127\",  # Goretzki S paper example\n",
    "    \"31444505\"   # Dohna-Schwake C paper example\n",
    "]\n",
    "\n",
    "# Extract highlight names for the output\n",
    "AUTHORS_TO_HIGHLIGHT = [author[\"highlight\"] for author in AUTHORS_LIST]\n",
    "\n",
    "# GitHub Pages YAML front matter header\n",
    "GITHUB_HEADER = \"\"\"---\n",
    "type: page\n",
    "title: Publications by our lab members\n",
    "---\"\"\"\n",
    "\n",
    "# OUTPUT SETTINGS\n",
    "# ===========================================\n",
    "OUTPUT_FORMAT = \"markdown\"  # Options: \"text\", \"html\", \"markdown\"\n",
    "OUTPUT_FILE = \"index.md\"  # Set to None to disable file output\n",
    "\n",
    "# RUN THE SEARCH\n",
    "# ===========================================\n",
    "# Build the search query and run the search\n",
    "pubmed_search(\n",
    "    email=YOUR_EMAIL,\n",
    "    authors_list=AUTHORS_LIST,\n",
    "    affiliation=AFFILIATION,\n",
    "    default_start_year=DEFAULT_START_YEAR,\n",
    "    highlight=AUTHORS_TO_HIGHLIGHT,\n",
    "    max_results=MAX_RESULTS,\n",
    "    output_format=OUTPUT_FORMAT,\n",
    "    output_file=OUTPUT_FILE,\n",
    "    github_pages_header=GITHUB_HEADER,\n",
    "    collaboration_groups=COLLABORATION_GROUPS,\n",
    "    additional_pmids=ADDITIONAL_PMIDS\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1eceae68-8296-464a-9bb0-5fc03aa7636e",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
